Experiment,Cellname,Library,Anchor,Tissue,Conc,CancerType,Gender,Ethnicity,AgeAtSampling,y_trueIC,y_trueEmax,y_predIC,y_predEmax
48538,SIDM00529,Afatinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,1.8286946,0.14780979,2.034211031077643,0.10638583742020687
37592,SIDM00301,Crizotinib,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.4028085,-0.17094244,-0.9398159707303039,-0.07489737206961816
73320,SIDM00097,Ribociclib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.7924232,-0.087340206,-2.408472430130814,-0.07708441584397945
70845,SIDM00628,Paclitaxel,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-4.2902713,-0.33544442,-3.8375648789448102,-0.2550345917157662
28866,SIDM00774,Lapatinib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.5187238,-0.059487242,-0.10309936004947648,-0.02967262322637403
88507,SIDM00893,ZM447439,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.413214,-0.032883067,-0.04219093038884348,0.04909373747606805
67456,SIDM00531,Dasatinib,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.3679242,0.06506744,0.629536635460838,0.05726480458503553
77893,SIDM00954,JQ1,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,2.828627,0.16777857,1.2888385446999886,0.09490017988230287
79860,SIDM00130,Gemcitabine,Linsitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.7626698,-0.22514558,-1.0034313502627719,-0.0242865684774807
107389,SIDM00866,Gemcitabine,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-2.5037813,-0.15893474,-1.1291235550425953,-0.04754495730899575
27410,SIDM00834,Dabrafenib,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,White,66.0,1.5712864,0.07127386,0.9736950650374653,0.02563264661344974
45308,SIDM00878,Alisertib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-1.7119399,-0.053421065,-0.4343739181055337,0.015298417742390746
92873,SIDM00875,JQ1,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.39358014,-0.042581365,-0.28945385125910245,-0.030420278446135898
101181,SIDM00673,AZD6482,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.3999227,0.07088779,-0.43252255575735027,-0.017442068643689402
74159,SIDM00954,Linsitinib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,0.8416014,0.060201697,-0.24098724983260764,0.07828972529820469
25457,SIDM00971,MK-1775,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.6140714,-0.07951592,-1.0618061461574213,-0.029752676263117915
102503,SIDM00954,SCH772984,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-1.7644188,-0.10814596,-0.4067836231256677,0.016211193197932187
16829,SIDM00866,GSK269962A,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,0.8101424,0.040369857,0.046031312353744955,0.020441060609749213
67363,SIDM00130,Erlotinib,Dasatinib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.8227494,0.14577702,1.6061016152335046,0.1217265103394434
47241,SIDM00971,Nutlin-3a (-),Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.6559062,0.06411246,-1.2759823525636893,-0.013038905489404588
97199,SIDM00332,Venetoclax,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0444142,-0.025852492,-0.41357646420915173,0.01100434172774893
60118,SIDM00774,Pictilisib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,1.0066516,0.01890594,-0.805757365500934,-0.07377901987897907
104815,SIDM00411,Erlotinib,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.4618715,0.07594096,-0.30047164326530124,0.01567052892171145
40903,SIDM00097,Ribociclib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3360072,-0.04457313,-0.7895057024096402,0.04045118878343839
31902,SIDM01233,MK-1775,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,2.464629,0.15931717,1.682556637004652,0.10119191381424615
103884,SIDM00893,Pictilisib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.0655396,0.092949316,-0.5999028744693999,-0.0928789999017559
27892,SIDM00875,5-Fluorouracil,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4076546,0.1599622,1.4022321556985076,0.1176159762122268
14804,SIDM00097,Docetaxel,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.608341,-0.14082964,-1.6265550457573754,-0.13376521138697378
88526,SIDM00411,Cisplatin,Trametinib,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,43.0,2.3717978,0.056405332,2.266992947797219,0.1023992109228445
30513,SIDM00529,Ribociclib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-1.3357235,-0.034972202,-0.7950437768245006,-0.018432540295075583
85997,SIDM00673,Lapatinib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,2.3450937,0.2308562,2.3917982041766326,0.15087798576066003
29974,SIDM00097,OSI-027,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9698708,-0.12348531,1.036615513857498,0.07866469669994487
1375,SIDM00332,Navitoclax,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.7303586,0.08846499,2.073219735358228,0.08211993655697256
49502,SIDM00774,Bortezomib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,0.22009146,0.017088328,-0.5319987840893186,-0.019936716205074076
50201,SIDM00971,5-Fluorouracil,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,5.244096,0.19829299,1.468527875766803,0.08427850232936912
104958,SIDM00875,Temozolomide,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9088613,0.02372374,0.4069914198740134,0.013606014836059034
86979,SIDM00866,ZM447439,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.4030412,0.114266,0.20294144896677557,-0.012332689207558326
31721,SIDM00774,BI-2536,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.5558294,0.07601106,2.5545034263429747,0.13258616536385115
53302,SIDM00628,Uprosertib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.4212986,0.12165172,1.0496654123779385,0.0995269295904812
69373,SIDM00875,Lapatinib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.4833357,0.04882436,0.448239419187636,0.021123459801177077
21469,SIDM01233,Vinorelbine,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,72.0,-2.7717538,-0.14994767,-1.2560560392892035,-0.04001853021300568
13568,SIDM00529,Olaparib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-2.3831089,-0.032370236,0.3070873524351797,0.03552221758389352
49613,SIDM00673,Taselisib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,0.835273,0.0631215,-0.7225657390800257,-0.046531203068171274
40652,SIDM00193,Crizotinib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,0.7965866,0.041774474,1.5783512771535153,0.11941554183804559
82720,SIDM00893,Vorinostat,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.3652786,-0.073110655,-0.9540449134099814,-0.019217100294942155
6554,SIDM00628,Dabrafenib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-1.3268323,-0.09917337,0.19193411308292635,0.023716861069519476
100269,SIDM00954,5-Fluorouracil,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,1.9516218,0.018800816,1.6254832298396469,0.08014413798080948
47139,SIDM00531,AZD7762,MK-2206,Pancreas,1.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.9127186,0.074524224,-0.27439843385642493,-0.004892040275790635
96323,SIDM00332,RO-3306,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6392132,0.042463783,0.448554794537048,0.05200827490283833
106974,SIDM00971,Navitoclax,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.7340949,0.096755736,1.49648735635116,0.12389493885921422
5409,SIDM00130,Erlotinib,Olaparib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.20260128,-0.01957347,1.1015644749149132,0.02510731490073662
27413,SIDM00954,Taselisib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,3.3549938,0.22275463,0.7320021926306411,0.11261142440280168
1569,SIDM00971,JQ1,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.6648307,0.2403022,0.6287768465700907,0.03235877208743677
11273,SIDM00332,PD173074,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,6.3016324,0.34647068,0.2720975596091084,0.02006991686876572
88260,SIDM00774,Cisplatin,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,2.6249804,0.066613555,2.28119750227788,0.07797856553636844
8842,SIDM00875,Uprosertib,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0306187,-0.097157344,-0.6477817231855652,-0.012148997115563076
73239,SIDM00971,Navitoclax,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.8878007,0.13576892,1.2151434006339676,0.04896454505024689
23624,SIDM00628,Alpelisib,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.74582744,-0.03679056,-0.5061862249970296,0.01567952191341958
39059,SIDM00875,Navitoclax,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.27218902,-0.030043608,0.4874415310504965,0.02678134158242311
19850,SIDM00779,Nutlin-3a (-),5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.4256846,-0.04812418,-0.012561121308581785,-0.01558763780924083
46594,SIDM00359,AZD4547,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,3.0340695,0.17269446,0.6268942145395558,0.034742748767127865
96006,SIDM00774,JQ1,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.769154,-0.12067299,-1.4009870471870365,-0.006610014827656026
26970,SIDM00660,Taselisib,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,32.0,0.70808166,0.057484783,0.38036987011465817,0.0025282267837047896
30700,SIDM00673,Pictilisib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.9116808,-0.10781229,-1.5827896506951549,-0.0753208262570568
37140,SIDM00097,Olaparib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5475465,-0.030275844,-0.4572083919617629,-0.003696760645390549
30845,SIDM00673,AZD7762,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,0.21121104,0.01603745,0.5629052682592844,0.02235968383748214
61643,SIDM00531,Crizotinib,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,4.099704,0.41864234,2.9798962657187293,0.17623537333557526
64700,SIDM00097,BI-2536,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.2748209,0.019946402,0.3257564867192148,-0.0073791982343512676
36068,SIDM00411,Dasatinib,Oxaliplatin,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.7572893,-0.04026428,-0.6304967215611315,-0.044913663961406954
30051,SIDM00673,Gemcitabine,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.45043248,0.037527397,-0.7631293759480473,0.011876098799093605
17051,SIDM00866,PF-4708671,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.031347,0.062296774,-0.9084003035149446,0.015841221982512053
47548,SIDM00875,Trametinib,Vorinostat,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5809971,0.06457906,0.6783997961494066,0.06388218926467398
35093,SIDM00628,NU7441,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-0.59429705,-0.024989499,0.1634932008487022,0.03941896834940478
49827,SIDM00893,MK-2206,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2653841,-0.12113635,-0.8463368740109037,-0.03152677193023539
3576,SIDM00301,5-Fluorouracil,Palbociclib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.136246,-0.2280805,-1.8740251536518335,-0.17962338826552143
75549,SIDM00774,Doramapimod,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,2.4404125,0.14748119,0.14407293626548884,0.05158237564546774
70075,SIDM00878,RO-3306,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-0.7434971,-0.04889829,-0.45472623045406824,-0.0019011842386645525
99059,SIDM00971,AZD8055,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.8639935,-0.05270386,-0.6422503469276849,-0.08137444072861268
9323,SIDM00359,Afatinib,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.3020507,0.089469105,1.1000674956430168,0.058472559290695905
32692,SIDM00875,Vorinostat,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1860431,0.104698434,1.403453637902339,0.12521472003936748
22864,SIDM00875,Bortezomib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.41497964,0.040663417,-0.008662657270927483,-0.0067722733599086616
91840,SIDM00971,Axitinib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.2128842,-0.07986632,-0.8170977795924674,-0.029171278921449613
99668,SIDM00411,Taselisib,LGK974,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.95143527,-0.05371599,-0.5032976598637422,-0.02641958464385109
47017,SIDM00893,GSK269962A,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.6631585,-0.12205496,-0.9767331339260247,-0.03227772832336512
31760,SIDM00628,Sorafenib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.6677974,0.11161499,1.0136621958121075,0.09871114209570826
19209,SIDM00774,NU7441,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,48.0,0.21923266,0.011652059,2.2767892106477183,0.11409032919638341
52380,SIDM00130,Irinotecan,Erlotinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.88539934,0.07278499,0.4142564818664749,0.006237338446052596
923,SIDM00893,RO-3306,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.645007,-0.12423979,-0.6766089052003622,-0.015693788297812462
80829,SIDM00411,Dasatinib,OSI-027,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.0788056,-0.054359164,0.45935836640835576,0.05371011026741936
29826,SIDM01233,Camptothecin,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,1.5609801,0.060564753,2.142065748423996,0.06425977978043612
13267,SIDM00673,Trametinib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.9974229,0.17148423,-2.3127170201912564,-0.13861787916620605
97664,SIDM00776,SB505124,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.5245338,-0.038559493,-0.21178266801254753,-0.022366186321587853
23733,SIDM00529,Alisertib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.468679,-0.10246134,-1.4903197975389972,-0.056711153964584315
35297,SIDM00971,Entinostat,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.9677126,0.18385085,0.8144103675708774,0.05933702717081416
82927,SIDM00878,5-Fluorouracil,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.73151505,-0.045740314,-0.3726268788225095,-0.01914198950674419
84631,SIDM00332,Pictilisib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.58332,0.22988084,-1.4115981557717334,-0.06437833679909409
43020,SIDM00673,GSK269962A,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.9237168,-0.12804697,0.37931486260939773,0.07489485330540092
36500,SIDM00834,AZD8055,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,2.3380964,0.16573991,1.0734322263848057,0.09874009579581453
1206,SIDM00660,Taselisib,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,1.3025801,0.10033507,-0.317742059816301,-0.048214370298908626
64968,SIDM00359,Navitoclax,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.24256699,0.01124508,1.7954694791328725,0.06575103117042258
83295,SIDM00866,Alisertib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,52.0,-2.9340153,-0.20228967,-0.4299702161291854,-0.00978507380661337
70254,SIDM00146,Alisertib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.84074587,-0.07761779,0.26794869091212764,0.01163605886666553
82489,SIDM00866,RO-3306,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-1.7161024,-0.088011466,-0.7533051848426702,-0.007352904832813226
86572,SIDM00954,PF-4708671,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-2.6160197,-0.10478761,0.44537881063597856,0.0286938579416503
79209,SIDM00875,Entinostat,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.29169807,0.030924354,-0.37786783610505925,-0.02492815365110887
41444,SIDM00782,AZD4547,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,Unknown,72.0,1.0563824,0.041904166,0.9481599115855406,0.06817180178612403
83419,SIDM00529,PF-4708671,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.17699283,-0.010036193,0.6868185575527017,0.08195113149451812
71694,SIDM00193,SCH772984,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,53.0,1.0567458,0.08900708,2.473589337207359,0.1230660258289788
28688,SIDM00954,Entinostat,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.032759,-0.07987764,0.37077261404839895,-0.025788389106292373
21952,SIDM00774,Sorafenib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.2713183,0.07983663,0.8724018010554234,0.008723910269005106
105150,SIDM00628,GSK269962A,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,Black,51.0,0.400789,0.038468983,-0.6206157566529228,-0.015278554834765536
56110,SIDM00954,Wee1 Inhibitor,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-1.3882729,-0.11298369,-1.1775679829341978,-0.044382611417616354
81468,SIDM00529,Gemcitabine,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,-0.9759551,-0.028066704,-0.6110896270586494,-0.05706089508154049
53355,SIDM00660,BMS-754807,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,3.902223,0.27546108,2.220518846435598,0.10319752050460443
59063,SIDM00359,Afatinib,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.9207066,0.044549767,0.7854722377100005,0.04980634403132869
84087,SIDM00875,Venetoclax,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.44201678,0.010892365,0.8144072520223529,0.032292716856015216
27184,SIDM00893,Wee1 Inhibitor,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.8989995,0.08102829,-1.1287720229735143,-0.07650409299827211
82018,SIDM00971,Alisertib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.74235314,0.017531348,-0.044930258509112954,-0.025513437344788344
43027,SIDM00875,Palbociclib,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.89986914,0.031049244,1.1554028957246771,0.09622763256860457
84447,SIDM01233,AZD7762,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,2.1384506,0.069493264,1.3519643188435135,0.04160453449323277
77929,SIDM00097,Luminespib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9571845,0.06213793,-0.36456132263523905,-0.05193866131307569
93419,SIDM00332,Lapatinib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5548161,0.14990294,0.5179022249093881,0.07579261939160643
38390,SIDM00193,AZD8055,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.010695,-0.075265236,-0.3728351526591541,0.013299095277773064
87442,SIDM00130,Gemcitabine,MK-2206,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.1773373,-0.07842035,0.13210046942899684,0.013343004501986012
40960,SIDM00866,Nutlin-3a (-),Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,1.1078324,0.039315242,1.3701531559474651,0.036119772117285974
59417,SIDM00146,Nilotinib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.93144,0.08216717,1.092642429217526,0.008990770175401603
58695,SIDM00660,Camptothecin,Dabrafenib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,1.3126252,0.08386902,-0.13492741911860168,0.024071985545198144
61900,SIDM00878,Alisertib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.20946558,-0.01959415,-0.28666400961961164,-0.03645718481337592
47552,SIDM00893,MK-2206,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.9069558,0.08409159,1.3236864264413164,0.05827714068425002
47726,SIDM00971,Axitinib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1210822,-0.044285733,-0.6279320889616818,0.030879463519764918
1260,SIDM00097,NU7441,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0238764,-0.08942363,-0.03471581350974113,-0.002734566462417294
18265,SIDM00834,Palbociclib,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-2.8494287,-0.17216766,-1.4899902764079311,-0.05708668091686312
16390,SIDM00097,Tozasertib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0343946,-0.03596878,1.0370923828381153,0.034560068781685174
72164,SIDM00878,Camptothecin,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,2.3993292,0.08004683,0.846228633817748,0.03586925538357516
105418,SIDM00971,JQ1,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.4059271,0.08013136,-1.558850905404742,-0.05162936449196473
23923,SIDM00774,Dabrafenib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,1.4242443,0.045250397,1.603289064622371,0.02691418941315019
66084,SIDM00529,Luminespib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-0.44496393,-0.044947043,-0.980616138731783,-0.06492594529343876
53874,SIDM00097,BI-2536,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.873517,0.18536519,1.654083640181919,0.16182617736540092
65799,SIDM00130,Linsitinib,OSI-027,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,3.4605772,0.287555,2.3415860996195903,0.14821956777934434
41509,SIDM00146,KU-55933,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.4804344,-0.048638977,-0.4271235773150057,0.059072859435151316
47517,SIDM00778,SCH772984,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,69.0,-0.94875014,-0.04058768,-0.38597037697107683,-0.06041763914872553
105952,SIDM00193,SB505124,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,East Asian,53.0,-2.7995822,-0.14029565,-0.13057898037345111,-0.009272714055631352
91142,SIDM00529,PD173074,OSI-027,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-3.0986989,-0.11743378,-0.4333372265753332,0.04312991591759296
2284,SIDM00782,MK-1775,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.48301837,-0.028022999,-1.0994843711566413,-0.04095882812656826
104394,SIDM00866,Docetaxel,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-4.3717775,-0.27876478,-1.8176490575496413,-0.11349223353274765
88556,SIDM00866,OSI-027,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-0.54107296,-0.017720796,0.17033883123751206,-0.010786599673037647
30344,SIDM00531,MK-2206,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.716579,0.3102923,1.7933064455906615,0.07881230396492697
8685,SIDM00776,Olaparib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.1999702,-0.07442654,0.6142986510067842,0.03578114196436539
12487,SIDM01233,Vinorelbine,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,1.4793253,0.10631059,-0.5832070559879176,0.03615003874376904
14765,SIDM00673,Wee1 Inhibitor,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.8823789,0.055875577,-0.4303777299087855,0.017143963587117898
93245,SIDM00779,AZD4547,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,-1.8802521,-0.006620507,-2.8886543157022797,-0.092847746848523
42285,SIDM00146,Cisplatin,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.7532065,0.029560886,2.2107395084874195,0.06567951854836983
53503,SIDM00301,Trametinib,Navitoclax,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.0378013,-0.122210346,0.8018094405665881,0.09205509944438832
58134,SIDM01233,SCH772984,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,0.47522086,0.041670755,-0.23958331884943238,0.011722817300366607
48944,SIDM00782,AZD4547,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,2.928844,0.12965402,1.1884809858447465,0.05964257646007371
36132,SIDM00097,Dabrafenib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.9351394,-0.089851856,-0.5104714328288905,-0.029458683930335388
24480,SIDM00332,Temozolomide,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4019339,0.026698,0.5351912252003259,0.023357595271138648
92384,SIDM00774,Gemcitabine,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.4573704,-0.026904171,-0.02380494412402898,0.024419898044594372
66400,SIDM00776,Crizotinib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.54350966,-0.047962375,-0.5607923365299466,-0.0524300433667883
61810,SIDM00332,Alisertib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.392866,-0.07127347,0.05880229997982556,0.023619673794491525
12378,SIDM00628,Olaparib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-3.058105,-0.0996832,-1.740381048362126,-0.0451294433329074
69746,SIDM00954,NU7441,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-1.6203027,-0.12285784,-0.560108468254365,-0.019488766109430143
49918,SIDM00774,KU-55933,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.7643601,-0.04072558,0.527764013346597,0.04107914324511961
19765,SIDM00774,5-Fluorouracil,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-0.6138584,-0.053891696,-0.6927854770361926,0.07879380626186624
74226,SIDM00411,Trametinib,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,43.0,1.7312115,0.061974663,-1.213392035612579,0.01334784280874852
76501,SIDM00130,LGK974,Navitoclax,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.6381828,-0.08620336,0.8296223119867815,0.10334960968017863
63033,SIDM00332,Luminespib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5125681,-0.06604275,-0.3468230420514645,-0.06932570640531878
26441,SIDM00411,LGK974,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,43.0,-1.8105958,-0.06399376,-0.7230035876172832,-0.042256172757166394
48986,SIDM00893,GSK269962A,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.5232728,-0.1140539,-1.5180617798562903,-0.08604649978947242
25006,SIDM00774,NU7441,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,1.8574696,0.11230782,1.1948531639661353,0.07782712980386924
60966,SIDM00529,Lapatinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,1.4305499,0.08558575,0.8720027372769413,0.11526710136816473
77824,SIDM00301,Irinotecan,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,50.0,-1.8410273,-0.15861063,-1.477680278119806,-0.10109605364800181
48995,SIDM00954,Doramapimod,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-2.4512427,-0.096508704,1.1914309379606332,0.143901974426709
53960,SIDM00146,MK-2206,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-1.1466078,-0.05838146,-0.07496094747836153,0.04381647920280531
90092,SIDM00776,AZD4547,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-0.92857385,-0.0187708,0.8062859940785403,0.045299439554745205
78014,SIDM00954,KU-55933,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,1.3755969,0.05330424,0.7492978140643359,0.10947827197514422
40025,SIDM00893,GSK269962A,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.667347,-0.051147927,-0.3954854434119815,0.03486123897018487
8615,SIDM00954,Venetoclax,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.0,-1.2850139,-0.09879995,-1.147319667355854,-0.05276833500626952
42628,SIDM00875,MK-2206,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.24861905,0.007592119,0.405020570122409,0.012800457909483226
57858,SIDM00097,Ribociclib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.151899,-0.08898846,-1.5129061213222523,-0.06759423524648507
105476,SIDM00673,NU7441,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,3.5733912,0.24635163,-0.9495358866049859,0.045447383115260774
71451,SIDM00971,Entinostat,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.847178,0.22177604,0.3795056581241878,0.07319282915154952
41333,SIDM00531,Olaparib,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.8229861,0.061710596,0.639313385076781,0.021666250752030148
98390,SIDM00628,Trametinib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-0.49659204,-0.046869416,-1.0499165847124872,-0.016811134032258552
43132,SIDM00776,Nutlin-3a (-),Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.69740564,0.02125906,0.03118774019366674,0.003352329936051957
31561,SIDM00774,Tozasertib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,48.0,0.5698934,0.018048404,1.9859747958205713,0.08286075969336251
95629,SIDM00875,Doramapimod,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4831059,0.051274654,1.5334187365583412,0.09207078118114531
23644,SIDM00529,Nilotinib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,3.20716,0.18715088,1.0512744995174574,0.12097724051143995
106018,SIDM00673,JQ1,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.2558013,-0.059867904,0.06850317811417976,0.07842387043059511
42425,SIDM00332,Ribociclib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3557407,0.09333928,-0.700023796010836,-0.03583646300928362
105457,SIDM00146,Uprosertib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.6719175,0.053227786,0.3430502441111399,0.10537692888874997
41776,SIDM00146,Paclitaxel,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.3581636,-0.12008801,-1.527139145225944,-0.13880724367806732
3955,SIDM00971,Olaparib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.969989,-0.06790857,-2.1334093985303824,-0.04080231673586805
96839,SIDM00332,Dabrafenib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.1939783,-0.10359891,0.4899793807466339,0.0491026544226392
89278,SIDM00193,Olaparib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,53.0,-2.1141956,-0.061269715,-0.5180713792989601,0.005372070030947142
90080,SIDM00529,KU-55933,MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.6184694,-0.010394211,1.384022893017899,0.078047204123436
38463,SIDM00097,OSI-027,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.4848672,0.03364821,-0.9107341973094318,-0.0470509476431245
57253,SIDM00774,Cisplatin,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,3.2745173,0.14883561,1.46536458885165,0.09032849268330995
15095,SIDM00673,Taselisib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.731375,-0.071936265,-1.365905621378031,-0.055006212833126546
102262,SIDM00673,AZD8055,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,2.774566,0.116824694,-1.3748492190804322,-0.09751646424291562
23573,SIDM00660,Nutlin-3a (-),Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,32.0,2.5536041,0.051576808,3.3737009113969423,0.09847877556651467
50091,SIDM00301,Taselisib,Crizotinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.7150617,0.20755841,-0.10027578397247297,0.019803493296605586
19975,SIDM00301,Dactolisib,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.8107089,-0.17840451,0.3399485191973948,0.02633333471399752
81378,SIDM00673,Temozolomide,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.3557294,-0.008064126,0.3870463722186894,-0.03837145559773051
47843,SIDM00359,Linsitinib,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.7840604,0.066177875,0.5769083168388028,0.04619826308849086
55,SIDM00971,AZD7762,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.73722655,-0.015564708,0.15846068199514482,-0.020110794621651766
52670,SIDM00866,BI-2536,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-2.9216816,-0.1737793,-0.7762259834919293,-0.05313548180002246
25432,SIDM00130,LGK974,Trametinib,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.482478,-0.057543114,-2.092354239483372,-0.027810352508089692
24226,SIDM00878,Uprosertib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-1.4255806,-0.09177439,-1.5121286687781608,-0.10197605365382782
4967,SIDM00332,Venetoclax,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0904073,-0.027495585,1.651950164161363,0.05325345511152491
52451,SIDM00411,MK-1775,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.8688366,-0.07413505,-0.872870450153997,-0.015128134715381667
1341,SIDM00875,5-Fluorouracil,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1871513,-0.114756614,-2.0113646634012246,-0.13039416690465214
85341,SIDM00130,AZD7762,Trametinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.504049,-0.03531484,-1.3337058032766969,-0.04313266066993499
31388,SIDM00893,Luminespib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.6237383,-0.089768484,-1.9170420719756234,0.0034505119806882327
32025,SIDM00774,PD173074,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,2.2749279,0.23291096,-0.20348951760686584,-0.003753766014432816
14676,SIDM00878,AZD6482,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.7734118,-0.09613556,0.5479092756737391,0.00994380015832846
38973,SIDM00782,Taselisib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,Unknown,72.0,0.45762965,0.039744228,0.2211845887025911,0.004104573768007124
77002,SIDM00971,MK-2206,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.6605119,-0.088134125,-0.9128501052604416,-0.035784780435587235
47189,SIDM00834,Taselisib,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,0.43489155,0.03398833,-0.7620724153546211,-0.046488891671915236
54250,SIDM00866,Trametinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-2.5537808,-0.06658229,-1.2212972656194896,-0.04720162687020918
67890,SIDM00893,Dabrafenib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.7192228,0.06580611,1.4986821003488038,0.052572409751604425
86833,SIDM00893,Olaparib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.861666,-0.05001492,-0.5415743480861355,-0.0018795242122962889
70875,SIDM00893,MK-2206,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.5736469,0.05793539,-0.9406928842731936,-0.05579970210636835
24844,SIDM00193,AZD4547,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,53.0,-1.4894078,-0.054798786,0.30492928588522533,0.04088574051416914
70557,SIDM00866,Venetoclax,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.3541201,0.008866836,0.3475728028421439,0.052878979849465144
44719,SIDM00954,Palbociclib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,2.503299,0.05825863,-0.43861002409505223,-0.03930268551995732
61567,SIDM00130,Irinotecan,Crizotinib,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-4.197161,-0.26965684,-2.3980069194281297,-0.14085669402212034
14439,SIDM00776,Navitoclax,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.8500077,0.027507652,2.172894765287701,0.042790783345667216
11518,SIDM00778,Vinorelbine,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,69.0,-2.6880484,-0.13321485,-2.6175809835553516,-0.1731422533165291
78818,SIDM00411,Dasatinib,SCH772984,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.9089794,0.1714446,1.8838471794294072,0.15443640027165867
78857,SIDM00673,PD173074,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.9763914,-0.0549588,-0.25747243965003924,0.004923846211704443
43568,SIDM00130,Taselisib,SCH772984,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.3843946,0.22445472,3.146594890941705,0.18237607085033242
100044,SIDM00146,JQ1,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.5934913,0.043509357,0.6036036883716768,-0.015027722856022017
100429,SIDM00971,Tozasertib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.5875337,0.06590901,0.5500976981284916,0.02541852876223305
20509,SIDM00411,Ruxolitinib,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,43.0,2.751366,0.05721048,2.300441654450562,0.0350324548279291
14387,SIDM00529,Linsitinib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.4566853,-0.047677528,0.5086706259489395,0.0423719569028641
86039,SIDM00893,Afatinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.9177155,-0.13807684,-0.8469141851753518,-0.07651586551001245
75422,SIDM00875,RO-3306,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.67317617,-0.06047936,-0.34199116827219245,-0.026618965547505726
97666,SIDM00097,MK-2206,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.982827,-0.22226734,-0.6148454030996555,-0.04120659350735683
67552,SIDM00332,Ribociclib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.867704,-0.14017214,-1.4916307202500858,-0.08167201024454078
78522,SIDM00628,AZD6482,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,1.796909,0.13558759,1.362247453112166,0.10293752629655917
80854,SIDM00097,Axitinib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.2514277,-0.17133175,-2.1206286975014508,-0.15434981438463852
90604,SIDM00971,Temozolomide,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.6556395,-0.039460886,-1.6200148653391189,-0.031503609979895715
48706,SIDM00529,Cisplatin,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Black,44.0,1.2245377,0.02674196,1.058569274857075,0.056336252827981305
42797,SIDM00893,RO-3306,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.8563207,-0.07039705,-1.0818812864755785,-0.0012209146842313545
28098,SIDM00359,LGK974,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.921548,-0.027841028,-0.7708436666760579,-0.007107429063811918
49745,SIDM00097,OSI-027,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.7453292,-0.04967571,-0.9645417924208965,-0.07779474663490198
65403,SIDM00332,Ribociclib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.6172569,-0.035366155,-1.5755290262017918,-0.09363187092373847
20596,SIDM00628,5-Fluorouracil,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-1.2329894,-0.050587814,-1.0397683588216244,-0.008499975252662271
12731,SIDM00971,Gemcitabine,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.4213355,-0.017009605,-0.0729958369305916,0.03696482375001536
38837,SIDM00866,Axitinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,0.71719015,0.052891,-0.4277198518153575,0.005833935330521138
46357,SIDM00954,Cisplatin,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.8394697,0.019103527,-0.22894225983597927,0.042075947247610324
31757,SIDM00834,SCH772984,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-0.35962886,-0.027696138,-0.35896673374315563,-0.005384202910777374
41328,SIDM00411,Olaparib,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.4012144,0.06634046,1.695510962102978,0.051825754700553284
75424,SIDM00097,Tozasertib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.435064,-0.0707924,-0.9982134778018767,-0.04446569241938706
40361,SIDM00954,Palbociclib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,1.3356904,0.055438284,1.4561095326910691,0.06522491991213855
89766,SIDM00893,Temozolomide,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.0204954,0.06668951,2.2476944214463024,0.050132962718178506
86571,SIDM00866,RO-3306,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.8096205,-0.09298486,-0.6285106869308148,-0.026605206647101524
60071,SIDM00146,BI-2536,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.8772712,0.025799757,-0.20735676090459884,-0.01699831967308986
20942,SIDM00782,Dabrafenib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,Unknown,72.0,-1.5015649,-0.037613034,0.9208915588505482,0.05061826635973118
88701,SIDM00628,MK-1775,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-0.95832014,-0.07781348,-0.2760528206928213,-0.020897457846607362
54025,SIDM00301,Lapatinib,Irinotecan,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.084727,0.06985407,1.8885535964854514,0.11521772741235695
108116,SIDM00529,5-Fluorouracil,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-3.0631208,-0.23525001,-2.0700692784634684,-0.11053434677007273
18969,SIDM00893,GSK269962A,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.6284625,0.0531764,-1.2040511865918846,-0.07222540947766388
74981,SIDM00146,Tozasertib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.6111364,0.13970575,0.08086551948650181,0.002031683546542002
92764,SIDM00130,Crizotinib,Paclitaxel,Pancreas,0.025,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.1081755,-0.12257843,-2.2319094669854347,-0.08329637613082028
103462,SIDM00628,Pictilisib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,1.2440828,0.12154244,-2.2491368333161574,-0.05233984821764594
34050,SIDM00673,Temozolomide,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.0530947,0.024207193,1.1832664205417651,0.03383200143579924
62717,SIDM00332,Linsitinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,2.3788686,0.11545174,1.9373427996554164,0.07043143298323958
5915,SIDM00954,Gemcitabine,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-0.7393261,-0.046093043,0.7102726580678517,0.05298250323624951
10564,SIDM00954,Uprosertib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-2.0967767,-0.16490215,0.3786669615976647,0.05471564055734465
7939,SIDM00193,AZD4547,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,East Asian,53.0,-1.8869578,-0.05796426,-0.1459936721568573,0.02230213592286024
71500,SIDM00411,Irinotecan,Erlotinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,3.1338193,0.18308322,0.8665579043951502,0.06766897184916927
38580,SIDM00660,Camptothecin,AZD7762,Large Intestine,0.0625,Cecum Adenocarcinoma,Male,White,32.0,5.4825897,0.5477723,3.54136796457665,0.2930419454963666
103598,SIDM00878,Lapatinib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-0.7474399,-0.075375624,-0.4708954503443342,-0.035336163794171045
381,SIDM00529,5-Fluorouracil,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Black,44.0,-1.0355176,-0.09472921,-1.3596516393537559,-0.07787640219207355
10777,SIDM00866,5-Fluorouracil,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-0.7532548,-0.027956374,-0.9713003102844613,-0.05448631066966814
17811,SIDM00529,Doramapimod,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,1.0322329,0.034142815,1.3510147820581186,0.050059843234374714
38943,SIDM00954,Cisplatin,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,0.2695148,0.008561598,-0.20592841106059456,0.06539855139350853
69437,SIDM00673,ZM447439,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.5823942,0.044035763,-0.9947015657626601,-0.06178486149193626
39721,SIDM00673,Luminespib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-3.238191,-0.21787445,-0.7645440466347004,-0.016673116295631826
2188,SIDM00954,AZD8055,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-1.843095,-0.12359245,0.5782642011851077,0.034217949114951934
103674,SIDM00301,Olaparib,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,3.3400118,0.3963575,0.771651329424072,0.053219640997432247
35260,SIDM00097,KU-55933,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2278173,-0.073919274,-1.9153844634993398,-0.06781199495431152
102295,SIDM00834,Trametinib,SCH772984,Large Intestine,0.05,Rectal Adenocarcinoma,Female,White,66.0,-1.2687668,-0.044881873,-3.206277218829816,-0.13608240500827845
72353,SIDM00673,Pictilisib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,0.24957922,0.022968225,-1.1937717326504977,-0.05417131739506028
108174,SIDM00778,SCH772984,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-3.5841243,-0.13240547,-1.9627400790275475,-0.09021380763226239
83931,SIDM00529,Venetoclax,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-1.3864073,-0.036192343,-1.178484386654088,-0.034812535625397455
62949,SIDM00301,Olaparib,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.5348555,0.13604134,0.8345570662574152,0.0638887114726281
13378,SIDM00628,Linsitinib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,Black,51.0,0.8780998,0.07019408,1.0868006379136874,0.09145816071614161
1044,SIDM00878,Wee1 Inhibitor,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,2.6006064,0.112576306,-0.6096091192340816,-0.045011034972876084
91455,SIDM00146,5-Fluorouracil,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-1.5067338,-0.07290245,-1.0497568625265017,-0.009027304574164969
36678,SIDM00776,Linsitinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.64115757,-0.03718914,0.37035083219100634,0.006302372007821615
65721,SIDM00660,Oxaliplatin,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,-2.9308252,-0.11850681,-2.314107428160045,-0.09807711771572476
104884,SIDM00529,Vorinostat,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.39459583,-0.0406971,-1.2838440858688387,-0.08461538545498026
21296,SIDM00097,Taselisib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2502725,-0.13359934,-0.4612213557414849,-0.04463715891553512
23868,SIDM00866,Navitoclax,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,1.5739362,0.072223015,1.713965098890369,0.09678950846992351
33473,SIDM00774,ZM447439,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-2.8235652,-0.11102115,-0.9965674463552641,-0.05130047199069164
13558,SIDM00779,AZD7762,Trametinib,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,33.0,-0.34499803,-0.027539846,-1.6232450673945096,-0.05497773207451508
57291,SIDM00359,LGK974,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.8812618,-0.02506485,-1.2279982051857905,-0.0142582973463258
4403,SIDM00782,Vinorelbine,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,1.6140363,0.15691803,0.7799618378577403,0.16011098452597303
9733,SIDM00866,Bortezomib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-0.6477505,-0.05259766,0.04599318381581823,-0.0072469037327925825
82509,SIDM00878,Entinostat,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.8101566,-0.07533996,-0.05106566777199787,0.02183698897506145
10689,SIDM00954,MK-2206,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-2.9200873,-0.19777276,-0.43320683779513586,-0.035591081399831505
25972,SIDM00097,KU-55933,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.1056223,-0.11699641,-3.016137323943649,-0.1096848416599704
25794,SIDM00774,Wee1 Inhibitor,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-2.29856,-0.09812613,-1.1035970461200004,-0.014347058631178968
46392,SIDM00193,Vinorelbine,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.732378,-0.1898009,-1.7130371409062486,-0.12579430011699053
52640,SIDM00866,JQ1,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,-0.5962551,-0.03887489,-0.3867090323514821,-0.0049433733774626445
4244,SIDM01233,BMS-754807,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-3.5187402,-0.19262826,-1.8324887210787242,-0.13400181127644037
60144,SIDM00531,Cisplatin,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.887,0.087125964,-0.5664354029126693,0.01980894606552688
608,SIDM00774,Navitoclax,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.7584009,0.013194896,1.8572794372299803,0.019180012437373984
64527,SIDM00193,Oxaliplatin,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.63704014,-0.021694258,0.6798479193734024,0.041554206649443017
61729,SIDM00660,5-Fluorouracil,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,-0.34794402,-0.03682663,-0.4691126253386726,-0.0471180872697294
65181,SIDM00834,Nutlin-3a (-),Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,White,66.0,0.6746455,0.018756693,0.9441744645308587,0.03430255931656731
75209,SIDM00776,Crizotinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.677227,-0.068807214,0.9640732181962928,0.04623353735463228
26948,SIDM00529,MK-2206,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-0.90184486,-0.02134134,0.8215696948131538,0.0919358596246136
50389,SIDM00971,Temozolomide,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.5003146,-0.030758424,-0.8950908140282627,0.02015950683676651
42482,SIDM00971,Lapatinib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.32272682,-0.017860834,-0.41894106013888305,-0.002834085777059515
67074,SIDM00778,Crizotinib,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,69.0,-0.4103628,-0.02354349,-0.23813050451869736,-0.012312795154382519
67789,SIDM00359,Nutlin-3a (-),Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0521771,0.028529154,1.0186449347296835,0.06565836948465092
61924,SIDM00146,OSI-027,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.8882819,-0.08131357,0.7306160686117074,0.060314543228524226
100935,SIDM00866,MK-1775,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.67114043,-0.03738011,1.4145053359016688,0.06596955439024728
65519,SIDM00779,Olaparib,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,2.0765438,0.033053838,3.5564947600642185,0.15101333397384287
73929,SIDM00529,Olaparib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-3.0979633,-0.10213263,-0.9305214784656946,-0.040917388201031114
48071,SIDM00097,PF-4708671,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.55587316,-0.021722555,-0.8703042707044962,-0.04481716547910831
86062,SIDM00673,Afatinib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,0.7796163,0.063769884,0.3187127910112275,0.04123697193805516
24910,SIDM00878,Wee1 Inhibitor,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.0270615,0.075743854,0.41178639102815723,0.008109724712442612
97822,SIDM01233,Linsitinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-0.41309276,-0.021495655,0.20489131963380514,0.04227313132248067
13436,SIDM00359,AZD4547,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.8135223,-0.05026384,-1.980137480548649,-0.05806811353613181
942,SIDM00146,OSI-027,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.054685,0.0718544,0.36557203407501976,0.05429535246248418
16956,SIDM00893,Alisertib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.3896357,-0.11344812,-1.305269224558006,-0.08725205381939088
56406,SIDM00531,Navitoclax,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.8232317,0.27216282,1.6375087726420925,0.118989259969015
24338,SIDM00301,LGK974,Sorafenib,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,50.0,1.3315122,0.1546684,-0.8810004019395518,-0.01573540624819906
71746,SIDM00130,Irinotecan,Oxaliplatin,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.2570486,-0.108045466,-1.752369843853771,-0.06495795181670717
63474,SIDM00628,JQ1,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-1.133411,-0.062532865,0.6933486374124097,0.023613644028554637
95252,SIDM00097,MK-1775,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.12666643,-0.008090409,-1.974351780147643,-0.15571712356811643
27007,SIDM00301,Lapatinib,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,3.3623238,0.31905898,3.5757730251309736,0.19172589659847955
51987,SIDM00411,Oxaliplatin,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.3427771,0.05579087,-1.034417089749589,-0.03350675543641054
43547,SIDM00778,Olaparib,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,-2.554738,-0.071569115,-0.1557165416415577,0.002599091209051606
58552,SIDM00628,NU7441,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.063835464,-0.0063007157,-0.7062226801358631,-0.0081591007257739
101662,SIDM00774,Alpelisib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.2976549,0.17177312,2.5202614004943134,0.08133770486872888
69201,SIDM00878,Palbociclib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.22444902,0.016825229,0.590369731827734,0.03438445188228326
70702,SIDM00529,Taselisib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-2.1143026,-0.105028115,1.9561235265068522,0.08337110035392442
58094,SIDM00097,GSK269962A,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.6792215,0.03240933,1.1503457221395508,0.04653462289111237
49211,SIDM00866,SCH772984,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,52.0,-1.408581,-0.104965106,-0.8271540506447822,-0.04188973472687472
35033,SIDM00531,5-Fluorouracil,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.13532309,-0.004577134,2.9503489306613018,0.12411330733826823
93898,SIDM00332,MK-1775,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6705663,-0.115782306,-0.2608717478788219,-0.09040061349938536
93135,SIDM00097,Camptothecin,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0098224,-0.037787322,1.4685811930301107,0.1121609817045351
61565,SIDM00834,AZD4547,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,1.8839736,0.047019597,3.3089502927842784,0.047879020735878186
26786,SIDM00301,OSI-027,MK-1775,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.7308557,-0.15160672,-1.0916183393554328,-0.02291905589747173
25445,SIDM00971,Pictilisib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.0631778,-0.070858076,-0.8394371884083223,0.01820729641269737
65791,SIDM00628,RO-3306,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-2.0976224,-0.11510794,-0.2773596321319196,-0.014653923066115092
59904,SIDM00893,Nutlin-3a (-),MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.5520665,-0.011192862,1.9593755305334417,0.03905189505876323
91020,SIDM00776,Taselisib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.5228426,-0.04169746,-0.09387618304240065,-0.0508727370507276
65408,SIDM00130,Erlotinib,5-Fluorouracil,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.6044814,-0.044096824,-0.24335699090124993,-0.013252979310261374
18655,SIDM00628,Gemcitabine,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,Black,51.0,3.3564496,0.052057598,3.1644460739260682,0.15600578960127054
8525,SIDM00628,Navitoclax,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.6340036,0.10406731,1.2758670346934489,0.08220557581654134
67155,SIDM00130,OSI-027,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.994999,-0.10482034,-1.2884836931772419,-0.060774530301321794
49289,SIDM00866,Dabrafenib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.31650853,0.0110490965,-0.19124391182570497,0.025446236015086953
25326,SIDM00628,BI-2536,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,-3.7831688,-0.18188678,-0.8800688583608353,-0.03215809838768646
36459,SIDM00097,Lapatinib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.826826,0.15824813,0.9214373207431918,0.07336475331720577
56307,SIDM00411,Lapatinib,SCH772984,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.6702116,0.10707048,2.2679015913713254,0.12435121201194443
79655,SIDM00097,Olaparib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.5543015,0.08325274,1.4472596584307111,0.058181647614237005
30827,SIDM00146,Taselisib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.73855686,0.068243265,-0.35187975500445734,-0.015958863503774776
45064,SIDM00529,Bortezomib,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.22975574,0.016178451,-0.6789115399453476,-0.01524837268629159
53818,SIDM00778,Crizotinib,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,69.0,-0.8857189,-0.045314107,-1.033914217291514,-0.057699426344615404
103472,SIDM00097,Lapatinib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.45066828,-0.029351098,0.434208071780414,0.0064433820926489685
106706,SIDM00097,Gemcitabine,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.47543,0.062833,-0.5062726472276674,0.018770851603182908
99458,SIDM00779,BMS-754807,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,-2.170124,-0.021245403,-1.417732009733189,-0.0063293302533577915
51040,SIDM00628,Dabrafenib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.4716825,0.18558176,0.1987399360178157,0.11877466056114139
95634,SIDM00146,Axitinib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,3.730261,0.30880862,2.7958086558160624,0.20229523096059512
98101,SIDM00774,Axitinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.9142231,-0.07522062,-0.6546504193410279,-0.05845403786477546
78199,SIDM00774,GSK269962A,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.9842343,0.10204104,1.0042144455728796,0.02652968009648897
95476,SIDM00628,5-Fluorouracil,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-1.5974407,-0.07004749,-0.31647593339404617,0.023485649116395408
17003,SIDM00628,Bortezomib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.42957366,-0.024724336,-0.5596939131588546,-0.031743761199880746
70662,SIDM00529,Sorafenib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,3.1957848,0.30838287,1.8439463794886335,0.08509802428338453
10017,SIDM00301,Olaparib,Sorafenib,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,50.0,-1.8432655,-0.12688787,-1.0475869936893054,-0.009169304928929622
100117,SIDM00782,Dabrafenib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,Unknown,72.0,-1.6687363,-0.045253713,1.1291622299578012,-0.009663144562443202
97353,SIDM00359,Nutlin-3a (-),AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.4321272,0.07646043,2.1110298558567817,0.0699300725062851
12276,SIDM00778,Olaparib,Trametinib,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,69.0,-1.9495882,-0.032419495,0.0011747753345761277,0.002388810702259493
79859,SIDM00130,Palbociclib,5-Fluorouracil,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.3487943,-0.09835834,-1.20928641188369,-0.06816125271041217
1441,SIDM00146,Linsitinib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,3.6015801,0.11352962,2.0667645925577434,0.1404245226114443
8057,SIDM00954,Palbociclib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,0.21313827,0.011205838,-0.14026684955984933,-0.01591978276261063
96029,SIDM00866,Entinostat,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,52.0,-1.0538344,-0.08164146,-1.0176164843011972,-0.05630102916412494
18818,SIDM00878,AZD8055,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.7564556,0.06270483,0.4060550461998567,-0.010760939301625496
30879,SIDM00146,Bortezomib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-0.8192527,-0.03200914,-0.45966521656957143,-0.02130576472671615
94994,SIDM00954,Nilotinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,0.26670516,0.019107515,1.2259254637893489,0.09444073635678636
56861,SIDM00971,GSK269962A,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.7655708,-0.049465973,0.15363332500584456,-0.030729452138923474
19407,SIDM00774,Bortezomib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.16130699,-0.012981061,0.09956066972984189,-0.0403683168911804
106370,SIDM00130,Gemcitabine,Dactolisib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.3528984,-0.15040231,0.15119245211897256,0.0002613920809629024
40310,SIDM00628,Vorinostat,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,3.0548997,0.20987031,0.4947945116990811,0.052861602450655534
43900,SIDM00971,Alisertib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.1054187,0.13490555,1.9122108725680556,0.087206906866399
63374,SIDM00673,5-Fluorouracil,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,1.6003963,0.08686279,2.091643441921,0.053306775688787014
56380,SIDM00954,Paclitaxel,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-7.4357886,-0.5061907,-4.201986215487502,-0.2941900345103969
35684,SIDM00893,Bortezomib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.46346888,-0.047987763,-0.870899248188321,-0.044478467436974554
21549,SIDM00866,Sorafenib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,52.0,0.7012898,0.037230898,0.6219942563225604,0.030592696856943265
81570,SIDM00097,PF-4708671,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5536809,-0.046869125,0.7417301153384377,0.06157372874037662
19584,SIDM00660,Afatinib,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,32.0,1.0972706,0.108887196,1.0367137831259732,0.012591795877287955
30675,SIDM00774,Paclitaxel,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.9857773,-0.072953194,-1.4249856153946752,0.03270079075323604
17965,SIDM00097,Sorafenib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.1817138,0.10637029,2.0685941264989993,0.11223768760875016
8231,SIDM00673,Camptothecin,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-0.7812431,-0.024443135,0.7468392602807424,0.027200167914262247
27962,SIDM00878,Uprosertib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.4861567,0.024070635,0.49544857417979415,-0.014405191776145437
80035,SIDM00193,MK-1775,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,0.39873043,0.033411603,-0.46152835720085417,-0.03488511279415394
36945,SIDM00097,BI-2536,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.49561545,-0.03406157,-0.8697150738169751,-0.09361755553080374
75292,SIDM00971,Paclitaxel,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.2650572,0.057277948,0.8314834353789556,0.0907064671137826
75227,SIDM00359,Dabrafenib,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.7207658,0.090998605,-1.0675498314026732,-0.00396077763886593
82231,SIDM00097,Cisplatin,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1430507,0.025578886,1.2918727776476076,0.04064809907006704
81084,SIDM00411,Oxaliplatin,LGK974,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.0905385,0.085221566,-1.7343634825490675,-0.0334802128312146
48454,SIDM00628,RO-3306,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.7868463,0.10663886,2.238616332393132,0.11841717069392423
37967,SIDM00660,AZD7762,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-0.8101645,-0.07487522,-0.3531335058916214,-0.08667861543494568
21240,SIDM00866,Ribociclib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-3.645416,-0.11939099,-1.2583903438670587,-0.05339712724922012
72240,SIDM00776,Nutlin-3a (-),Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.1386083,-0.03940317,0.34942883637552447,0.017160665919656374
63135,SIDM00529,Axitinib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Black,44.0,0.32868886,0.028925836,-0.4870928059131156,0.04085151039436308
90930,SIDM00782,Navitoclax,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.49199802,-0.048338056,-0.04689908373383402,0.013855791326579377
105159,SIDM00146,Wee1 Inhibitor,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-1.2232281,-0.08543983,-0.5750898341727771,-0.0212241903577135
70627,SIDM00529,Entinostat,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.0487769,-0.050969422,-0.13404500901371838,0.1025621918892819
31650,SIDM00774,Lapatinib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,6.2340646,0.09613493,0.8632801574134114,-0.04189764036656217
6384,SIDM00628,Navitoclax,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.6168848,0.056248516,0.315071394713846,0.049038889978220514
63408,SIDM00628,5-Fluorouracil,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-1.2078854,-0.047160096,-1.0576369511094732,-0.001494909125592281
1951,SIDM00097,Afatinib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.51225615,0.032221787,1.150957389312583,0.038896103039197646
91808,SIDM00193,SB505124,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.024028514,-0.002130014,0.1821345738082717,0.0017693070789480997
5310,SIDM00878,Luminespib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.3081402,0.14093757,-0.5826371321689283,-0.0007761497670151821
65164,SIDM00866,Ribociclib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-0.7231595,-0.033371653,-0.025654528699541494,-0.025156007973308848
55302,SIDM00529,Paclitaxel,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-2.3203592,-0.091763884,-0.7277778235466494,-0.05754925860409653
62596,SIDM00971,Alisertib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.2457218,0.061599188,1.722892304132479,0.08462522803046306
74436,SIDM00130,Palbociclib,Sorafenib,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.5376267,0.044383187,-0.2407952997178012,-0.0031856931358830195
104813,SIDM00628,Nutlin-3a (-),Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-1.0676259,-0.047031216,-0.3469385277160059,0.0357610884969038
99479,SIDM00359,Dabrafenib,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.3361814,0.07660765,-1.1914420777050352,-0.02837551105322165
36666,SIDM00878,ZM447439,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.0293367,0.015324787,3.23537113471562,0.16322199123315365
13917,SIDM00954,PD173074,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,3.4228716,0.09164795,0.6576131457690468,0.08789358623478429
101771,SIDM00774,Ribociclib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.3367138,-0.0313796,-0.8860189975364893,0.10558069695547088
100866,SIDM00097,Vorinostat,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.9754936,-0.06873789,-1.2937767606243258,-0.08936711515326451
18972,SIDM00893,Lapatinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.8481658,0.10836019,1.0100119994034658,0.0409439574586203
46678,SIDM00660,SB505124,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,1.4139665,0.110857084,-0.24589219895453146,-0.017806401931619725
48237,SIDM00097,Gemcitabine,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.6514406,-0.024839535,-1.6569980829367401,-0.05532167355493308
44803,SIDM01233,Nutlin-3a (-),LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,1.578638,0.063546956,0.6031172869099944,0.03179502992839583
82866,SIDM00954,Luminespib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,1.1675127,0.022012526,0.049816738642469216,0.040489702738978964
68797,SIDM00778,Oxaliplatin,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,-3.1418064,-0.09099958,-0.917369459714396,-0.03278195716396634
100259,SIDM00875,Pictilisib,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.3222532,-0.102151275,-1.5232361299072184,-0.09266287973975225
6171,SIDM00866,AZD7762,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-0.79758334,-0.045839615,-0.6870312293147197,-0.055434696340359996
29326,SIDM00776,SB505124,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-0.49516803,-0.03915778,-2.512651965586902,-0.09172733534092634
83493,SIDM00673,AZD7762,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-5.801981,-0.38468984,-2.4328008896958675,-0.08527518503050212
80096,SIDM00097,Entinostat,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.3878684,-0.13538544,-0.651032690743449,-0.06878248619652036
14634,SIDM00893,AZD7762,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.86075133,-0.033574965,-0.23117948372840297,-0.006928300781901288
28764,SIDM00893,Vorinostat,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.59959936,0.03463356,0.32039375893667504,0.04792981466108803
23778,SIDM00359,Navitoclax,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.34849375,-0.020684382,0.5031254605408163,0.05407738247971975
11465,SIDM00529,Camptothecin,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-0.86394924,-0.025953246,0.39697441764577374,0.02190777661919049
66456,SIDM00779,BMS-754807,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-0.84556204,-0.010337934,-1.6122100804874355,-0.10319205178033924
36767,SIDM00628,Alpelisib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,2.907696,0.10292092,0.46443119069504024,0.07344050035622995
100825,SIDM00893,Axitinib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2679212,-0.048529573,0.0601403476911772,0.05853040110110175
35292,SIDM00971,Doramapimod,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.2311008,-0.039674073,0.21141270889235841,0.05237418903705262
14332,SIDM00301,MK-1775,Irinotecan,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.9308838,0.10446988,-0.21886830990937706,-0.04321320780513774
96358,SIDM00774,SCH772984,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,48.0,1.9626509,0.05863416,0.9499825947770066,0.06540856657202772
72877,SIDM00660,Oxaliplatin,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,-0.5538544,-0.051074952,-1.1655954371758683,-0.0657293781503456
61071,SIDM00146,Uprosertib,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-1.6930257,-0.11371442,-0.22533021720361784,0.07881993133050949
20925,SIDM00332,Vorinostat,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5179268,0.052846093,0.18870852906471092,-0.02389842884876757
70000,SIDM00878,Nilotinib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,70.0,1.1539569,0.09803893,-0.011698816656861944,0.06954390666833155
22820,SIDM00097,PD173074,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.0172625,0.12774472,0.11031868892326728,0.003449797440503695
4783,SIDM00774,Bortezomib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-0.04497112,-0.0033335004,-1.1766616970051664,-0.03959088203936107
67004,SIDM00146,BI-2536,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-2.5784152,-0.12038913,-2.8652167048857615,-0.13745517892422074
52106,SIDM00529,JQ1,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,2.9481375,0.23907122,-1.1453284603528415,-0.03872884627721389
35126,SIDM00878,Vorinostat,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.7592009,-0.05133654,-0.8329693347125469,-0.04114372876922956
101157,SIDM00774,Venetoclax,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.4378355,0.04087561,1.2079239157172972,0.027910790356107506
32807,SIDM00529,Wee1 Inhibitor,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Black,44.0,1.441831,0.12371591,0.5924923239631604,0.03734217806229591
86337,SIDM00673,Bortezomib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.5639242,-0.031916592,-1.0050660131374591,-0.0478515331071213
106227,SIDM00875,Alisertib,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.351681,0.034322288,-1.9191792701891541,-0.14058326193499657
3918,SIDM00130,Trametinib,OSI-027,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.79897267,0.047337398,0.6523309234782212,0.10465199151387175
11869,SIDM00529,Vorinostat,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.3861811,-0.11371031,-0.0920894624624329,0.03639365869821343
84247,SIDM00146,Tozasertib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-1.8641975,-0.08593728,-1.4382697389047685,-0.007719022727345514
101564,SIDM00529,MK-2206,Luminespib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-1.9445792,-0.060238376,-0.37495201570175213,-0.015249247860329204
1767,SIDM00774,Doramapimod,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,48.0,-1.4760896,-0.062145215,0.41372795510640215,0.04586837818830633
19730,SIDM00774,Pictilisib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.34335893,-0.014103252,-0.36721385341962837,-0.1086069835074603
70762,SIDM00332,SCH772984,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9147162,0.054944746,2.9292788120374094,0.07369567992253508
43595,SIDM00130,Paclitaxel,Crizotinib,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.0528195,-0.15313807,-3.6531459326743776,-0.2092027893429318
56997,SIDM00971,Afatinib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.0136684,0.03532035,-0.949460259780628,-0.019122713162301352
105665,SIDM00893,Bortezomib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.28338253,0.0284701,-0.9290580138276033,-0.057399750326735874
80853,SIDM00774,5-Fluorouracil,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-1.1914746,-0.08415298,0.3561998951723738,0.05713217688041905
8603,SIDM00954,Taselisib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,0.19803376,0.016593745,-0.5541092255997262,0.04404358659723103
35037,SIDM00893,Gemcitabine,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.4185233,-0.16388476,-2.269240896654362,-0.06964109474622425
57752,SIDM00097,AZD8055,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5398276,-0.1087796,1.1927674398463628,0.06758529851952229
27968,SIDM00866,ZM447439,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.0183094,0.076330535,1.546908277998719,0.07568633421200117
18662,SIDM00628,PF-4708671,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-1.3207027,-0.12348337,-0.9090080094824455,-0.06731905505754045
28260,SIDM00097,Gemcitabine,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.2715647,0.0990968,-0.744348494132211,0.04349948954614738
60712,SIDM00875,Alpelisib,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1813868,0.12143064,-0.3671934930921316,0.06462519522103226
10615,SIDM00301,Linsitinib,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.1775901,0.13299228,1.7791467994922106,0.10353785577979537
64335,SIDM00411,Dasatinib,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-3.4568942,-0.18023242,-0.15515622432038156,-0.015948571886512025
101914,SIDM00954,PF-4708671,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,-2.5562909,-0.1217358,-0.9486464701515013,-0.09528032909983677
6621,SIDM00628,NU7441,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,-0.48764032,-0.046232104,-0.3373190767068472,-0.048823177745616
47303,SIDM00875,Linsitinib,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9163808,0.06861171,0.8307528374155644,0.04993264367058487
93340,SIDM00774,Afatinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.19591446,-0.0139796315,0.8445057758344249,0.010761564005435969
93467,SIDM00146,Uprosertib,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-1.4386492,-0.089750245,2.914141052585503,0.2561121440012324
16404,SIDM00097,AZD6482,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.44164646,0.0299375,0.16474337158367394,-0.04523605041744546
81590,SIDM00411,Paclitaxel,Trametinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.5009148,0.1266932,-0.1539634609960461,-0.00016531296405485383
13903,SIDM00529,Tozasertib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.35843065,-0.014124785,0.9739407690075985,0.09957101083948362
35251,SIDM00776,Camptothecin,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,-1.4598516,-0.09353677,-0.8313554924366441,-0.058714687119797195
78803,SIDM01233,Oxaliplatin,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-0.6961645,-0.057854205,-1.0903375439140428,-0.11117732637829544
22548,SIDM00130,Crizotinib,Irinotecan,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.4534144,-0.14400633,-1.4324497699951855,-0.08525847632216525
79630,SIDM00971,KU-55933,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.9922781,-0.027161852,0.10971205016244752,-0.0167754884576142
83864,SIDM00878,BI-2536,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.37298125,0.030720191,0.06493950609727986,-0.023323756794154757
41305,SIDM00193,Palbociclib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,53.0,-2.1676686,-0.055584002,0.20047417562687897,0.03642907973439443
63737,SIDM00130,Linsitinib,Navitoclax,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.95968777,0.05730655,1.8652439562290741,0.0768222785077019
106566,SIDM00411,Navitoclax,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,4.2241974,0.22491269,2.7490345891326573,0.14007022820662496
24532,SIDM00893,Cisplatin,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,4.2485185,0.22170925,2.0323969847924337,0.057401286538350985
77160,SIDM00146,Dabrafenib,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,1.6676831,0.10942771,-0.16381605392704868,0.0075973779694381485
107885,SIDM00097,Gemcitabine,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2772946,0.030007979,-0.034997395060477984,0.04374754349773468
65126,SIDM00778,Dabrafenib,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,3.69589,0.059225753,0.7715028964582211,0.09370217453197228
25832,SIDM00097,Docetaxel,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.222438,-0.18364201,-1.646548076050028,-0.16663971884097636
46890,SIDM00130,LGK974,Dasatinib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.0903546,0.07162664,-1.6335888959049254,0.006498149762905269
72111,SIDM00130,SCH772984,OSI-027,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.0618131,0.09929144,-0.2799520874678218,0.06108443856344111
52787,SIDM00529,Bortezomib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-0.107093856,-0.007395177,-0.754362288316233,-0.002950509933256979
91706,SIDM00778,MK-1775,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-3.8117197,-0.12996587,-0.42827881707559373,-0.024574470547835046
81483,SIDM00878,KU-55933,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,70.0,0.78306264,0.03197694,-0.935714445192183,0.007275397139948573
39068,SIDM00332,Wee1 Inhibitor,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9287428,0.061501224,-1.4429101609310366,-0.05506731412024735
83062,SIDM00130,5-Fluorouracil,Paclitaxel,Pancreas,0.025,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-3.4434583,-0.16389364,-1.9380316936146182,-0.0788833185886419
30424,SIDM00097,SCH772984,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1252646,-0.0984171,-0.5652616374996848,-0.031114512645855626
83963,SIDM00774,AZD8055,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.865226,-0.117365085,-1.7597918558028272,-0.09947973794233944
107995,SIDM00097,Nutlin-3a (-),Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1839151,-0.038202222,-1.0039119777981467,-0.03373066578690532
107664,SIDM00531,AZD7762,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.7048281,0.15368234,-0.1982095053542301,-0.019997120431318682
35273,SIDM00866,KU-55933,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.1142291,0.06095025,-0.34987739200306917,-0.006493516962977155
9355,SIDM00097,GSK269962A,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.3714062,-0.017852224,-0.25111528200724376,-0.0006307631791996514
13947,SIDM00097,Cisplatin,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.0918934,0.0748219,2.769402532511304,0.06305940511393043
67697,SIDM00332,Lapatinib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1361811,-0.103316545,-0.19770307764865735,0.005773961872602666
46334,SIDM00875,RO-3306,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5389371,0.15653934,0.0399163471401015,0.018583509021559797
18822,SIDM00146,Luminespib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.6805563,0.050332926,-0.2093481243030459,-0.009348818775188174
84623,SIDM00097,Palbociclib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1963289,0.041113142,1.4754774761951461,0.07594699377099443
17934,SIDM00971,Wee1 Inhibitor,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.737884,0.06300537,0.8208933724015757,0.05070142642933381
71691,SIDM00954,Dabrafenib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.0,1.6428174,0.06876773,0.6337189800029704,0.04690101408990547
16122,SIDM00529,Trametinib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,-2.2087128,-0.11822784,-0.8069092853980526,-0.08414790611171058
100254,SIDM00774,Taselisib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-0.6741364,-0.039822508,-1.1590684997002645,-0.08093706682273022
106877,SIDM00893,Doramapimod,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.57513183,0.02264917,0.7109995068029357,0.03054325187097277
88894,SIDM00130,Olaparib,Navitoclax,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.04219,0.07741286,1.4644546093751551,0.09091507612294139
9809,SIDM00193,Afatinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,2.137061,0.17497617,1.2270810978550748,0.13848334617197516
91793,SIDM00529,MK-2206,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Black,44.0,-1.0113587,-0.03538443,0.34023547195707293,0.05091596352465712
92234,SIDM00332,Temozolomide,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0634574,-0.020423982,0.8782552366031483,0.00448693073190315
32005,SIDM00628,5-Fluorouracil,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-1.0114571,-0.05045838,-0.9317508150037319,-0.003479114211231495
59745,SIDM00774,SCH772984,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,4.973221,0.17981745,2.2893920101508587,0.09282763491076158
47929,SIDM00893,ZM447439,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.8746701,-0.13883586,-1.3017283488868503,-0.048313992475048265
20273,SIDM00301,Dactolisib,MK-2206,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,50.0,1.0157812,0.1200398,0.8475516003868191,0.035710539863333585
78750,SIDM00782,AZD8055,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-1.5426311,-0.13052209,-1.110596324059599,-0.08152762978696666
77257,SIDM00673,Afatinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,2.14772,0.15394355,1.2231399229671116,0.09458069238460448
36466,SIDM00776,AZD7762,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,1.9272116,0.16122971,1.0151134710383678,0.09474613456216292
30038,SIDM00673,Gemcitabine,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,3.322006,0.17939559,0.330748314212803,-0.012998528237293833
39368,SIDM00774,Sorafenib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.1998556,-0.07269645,-0.2548127388119699,0.007134546114251168
12782,SIDM00332,MK-2206,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.8048,-0.05378577,-1.7239829817908061,-0.08069011099627664
105250,SIDM00971,Sorafenib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.5095463,0.030186994,0.4275215975463007,0.03122240229807805
49835,SIDM00954,Camptothecin,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.29508492,0.010103864,1.0343002009100946,0.13925429207940818
13485,SIDM00146,MK-2206,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,4.8238425,0.27088508,4.295500013094271,0.2733902454517545
1531,SIDM00628,OSI-027,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-1.0315248,-0.08461107,-0.6734123424848333,-0.05369712719990845
45414,SIDM00834,Trametinib,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,-1.2607503,-0.045044795,-1.4960861574545212,-0.08064439769052217
61958,SIDM00332,Cisplatin,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,3.3062654,0.12249982,1.520627004204809,0.05244643893814204
94344,SIDM00529,Navitoclax,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.3204125,0.02965559,0.9834289542995615,-0.005737958407277668
15931,SIDM00146,Temozolomide,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.2773979,0.0078597395,0.6042300881012457,0.018258481987332126
57814,SIDM00146,Vorinostat,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.51385874,0.043853737,0.46344417132864246,0.03742829496623445
56536,SIDM00782,LGK974,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.59966147,0.049868375,0.7262823828691858,-0.01040202811763974
12292,SIDM00301,Lapatinib,Cisplatin,Pancreas,0.8,Pancreatic Carcinoma,Male,East Asian,50.0,1.3809998,0.08726984,2.700827913256231,0.11583324459789493
65242,SIDM00954,Dabrafenib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,0.27742225,0.010153216,0.7609624566233156,0.037944028854042286
7230,SIDM00332,AZD6482,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.9831586,0.14745307,0.8205006614347453,0.0536935641399154
80809,SIDM00866,OSI-027,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,52.0,0.3695693,0.027597412,-1.5680742514823143,-0.04046099896651569
104012,SIDM00130,Oxaliplatin,Erlotinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.0616498,-0.033905588,-1.5699554590488456,-0.045448613432143584
3881,SIDM01233,MK-1775,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,72.0,-1.1459426,-0.07870927,-1.1438233672552123,-0.06566014661306495
19557,SIDM00301,Sorafenib,LGK974,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.76314265,0.08428958,-0.12220709008372282,0.016890445168719175
87134,SIDM00529,Linsitinib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.0559306,-0.027925272,0.0486214931721863,0.012074525630842955
53532,SIDM00875,GSK269962A,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.9550148,-0.089619614,0.13054286008924704,-0.014718339541581076
36262,SIDM00779,Nutlin-3a (-),Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,1.9203625,0.035293136,1.6177326963916259,0.06436402651953194
32385,SIDM00954,Camptothecin,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,0.67117316,0.026295519,0.4270928869235129,0.07685944370154847
85206,SIDM00529,5-Fluorouracil,Trametinib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-1.0612364,-0.092194885,-1.7893857538764257,-0.051302375456692674
62530,SIDM00628,Ribociclib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-0.5652319,-0.014149005,-0.653326043038704,0.00800091830664291
59022,SIDM00628,BI-2536,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-3.5637205,-0.09830839,-3.639081149282733,-0.05532957277889833
92798,SIDM00531,Lapatinib,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.42016,0.2612543,3.0297500131374617,0.22328375137529705
74876,SIDM00774,Entinostat,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.3709264,-0.07944659,-0.8759214664079666,-0.012833958577696928
63821,SIDM00531,MK-1775,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-3.4862266,-0.25445822,-2.477324834767341,-0.13268598653174582
60916,SIDM00193,AZD7762,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,53.0,0.995358,0.05303169,0.20616766507938308,0.06326283470230537
99534,SIDM00531,Taselisib,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.2627674,-0.0636365,-0.6547306508520669,-0.03334728859158353
2437,SIDM00971,5-Fluorouracil,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.9773732,0.07154429,0.46192421403476985,0.06152325589918206
88005,SIDM00193,Afatinib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.49778375,0.04142636,-0.186527677079985,-0.0009460884235997963
13164,SIDM00866,Afatinib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-2.2829142,-0.1887053,-1.670551716375724,-0.09133086022474858
29731,SIDM00531,Ruxolitinib,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.7906972,0.029646382,1.4439302009148465,0.034042838461275975
3668,SIDM00628,Cisplatin,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,2.741436,0.25657114,1.4529171504284248,0.1932765403453479
48808,SIDM00359,Dabrafenib,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.8380736,0.044611864,-1.7169574981023905,-0.03454601866118544
42670,SIDM00628,Axitinib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-0.38146067,-0.03130219,-0.8412332354370117,-0.02799899903761338
53943,SIDM00875,RO-3306,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.24949813,0.028430328,0.2952907398451132,0.01883535048329562
105334,SIDM00673,Axitinib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.3045135,-0.091954164,-1.0875769947699725,-0.06436008044458146
72787,SIDM00673,Linsitinib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,0.71496093,0.015734568,2.944802121402993,0.15542819347185066
70606,SIDM00628,Temozolomide,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.7459321,-0.022281665,-0.5093332931504743,-0.0003941711360778179
30445,SIDM00130,AZD7762,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.11888195,0.009536042,0.21170701265264688,0.05726152115122261
67217,SIDM00774,AZD6482,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,1.7727896,0.096998096,1.1527643352096966,0.08124880010620254
18897,SIDM00359,Navitoclax,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.32394895,-0.01717619,1.4684324552890093,0.06924215338498092
65485,SIDM01233,5-Fluorouracil,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,72.0,-2.4087641,-0.08966828,-1.7774497036188106,-0.07626799017970558
87910,SIDM00878,Olaparib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.50595134,0.011139423,0.8367526842234125,0.051561830164770145
19613,SIDM00782,Linsitinib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,0.8174006,0.0326664,0.5101608025463679,0.029580884151805775
71904,SIDM01233,Navitoclax,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,1.9152703,0.11028745,0.5240955350308486,0.0028523031324737417
22133,SIDM00097,Wee1 Inhibitor,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3356138,-0.075902596,-0.2937030049161162,-0.07032325430475672
4798,SIDM00146,Camptothecin,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.1766664,-0.06376809,-0.4382701731198502,-0.017295286874930878
86207,SIDM00332,Pictilisib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0406215,-0.09883375,-0.402265522848105,-0.08348875226811772
99890,SIDM00774,Luminespib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.14943455,0.007248381,-0.3402198724932476,-0.07609876039654498
53800,SIDM00782,Trametinib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.5417333,-0.047242872,-0.7576929347241536,-0.020938899563786553
106719,SIDM00778,SCH772984,MK-2206,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,1.496284,0.05955488,3.2330900440548844,0.08173065104046631
42856,SIDM00529,Bortezomib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.7363196,0.032686405,-1.0005330324605317,0.004859749900021025
83139,SIDM00893,Nilotinib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.9639156,-0.07581842,-0.8765996517830049,-0.07149300467063653
67434,SIDM00332,Paclitaxel,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4402822,-0.10200095,-1.0238509930388866,-0.11176339263759592
48743,SIDM00954,Venetoclax,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,1.9552125,0.09970192,0.41307548355428403,0.044639046832937776
106586,SIDM00673,Olaparib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.777077,-0.10464601,-0.5105146181440288,-0.042603571299116266
55794,SIDM00301,5-Fluorouracil,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,-2.2952383,-0.27936208,-1.6258952461246199,-0.15120617253570898
108151,SIDM00893,Camptothecin,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.28899223,0.025916364,-0.8789421947316522,-0.03989630538743093
39630,SIDM00097,ZM447439,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,4.8942375,0.3113224,2.845913408000137,0.2166619640353105
54370,SIDM00878,KU-55933,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,2.740334,0.1157653,0.9042377878778073,0.05644802306792039
104054,SIDM00660,BMS-754807,AZD7762,Large Intestine,0.0625,Cecum Adenocarcinoma,Male,White,32.0,1.3693812,0.13126773,-0.45409167416323404,-0.028518296558007444
65056,SIDM00673,AZD8055,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.2001812,0.0863963,-1.177068575753315,-0.04906771641857017
65628,SIDM00673,JQ1,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.7171209,0.047692645,-0.4361761626972325,-0.015699686670705846
11664,SIDM00782,Dabrafenib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,Unknown,72.0,-1.6847497,-0.04609482,0.43753773120855205,-0.011073231459350791
21136,SIDM00660,5-Fluorouracil,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,0.6884988,0.073010415,0.08297677232561752,-0.0001557065951337785
1589,SIDM00097,Taselisib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.358205,-0.29982173,-1.6882268337361273,-0.1495815407038262
33390,SIDM00878,Afatinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,70.0,1.9401588,0.15448815,0.6921606730768727,0.04462943443812429
95805,SIDM00411,Irinotecan,Palbociclib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,-4.2384014,-0.1375857,-2.5711507745708304,-0.06615096871554811
26386,SIDM00193,Dabrafenib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,53.0,-1.0196203,-0.023773473,0.4897876934736309,0.03658257310698502
26911,SIDM00954,Venetoclax,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-1.3110254,-0.102962494,-0.49232090352655505,0.005882506509184162
61877,SIDM00193,Crizotinib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,East Asian,53.0,-0.78356534,-0.034603238,-0.04789934084378755,0.02369814145514648
60796,SIDM00954,Lapatinib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-0.99320793,-0.0798016,-0.24409611113894067,-0.04892876870614662
61436,SIDM00332,Alpelisib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1702703,0.08699689,-0.04981578947556998,0.020688550172039993
28884,SIDM00893,BI-2536,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.23514074,-0.021242922,-0.7272138786300273,-0.028847420570541592
39424,SIDM00778,AZD8055,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,69.0,-1.4720042,-0.070945226,-1.41888631625686,-0.10453429485439938
102879,SIDM00673,Pictilisib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.249721,-0.16649424,-2.5788089739726083,-0.16185455193620207
93343,SIDM00628,AZD7762,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.8518082,0.08051144,1.129087506111663,0.108299742087191
28336,SIDM00778,Palbociclib,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,3.5015476,0.16679484,-1.9560384185220692,-0.07298169398090668
98404,SIDM00097,Axitinib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.7398872,-0.12826401,-0.5374833156866915,-0.0740925514287673
3852,SIDM00359,Navitoclax,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.32234988,0.019054307,1.173471075207941,0.043123897790367495
100289,SIDM00971,KU-55933,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.4479564,-0.022385664,1.6559638176442804,0.029227736315805372
31188,SIDM00529,GSK269962A,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-1.2906336,-0.100710966,-1.9721664012827962,-0.08953662473168283
92235,SIDM00146,PD173074,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-1.9096249,-0.120506495,-0.5229810091890302,-0.04749015715543077
46202,SIDM00875,Docetaxel,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3150946,-0.021625053,-0.06244213136408935,0.021561931926709882
76107,SIDM00660,Nutlin-3a (-),Dabrafenib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.8897842,0.017675212,3.2465065540760687,0.09382141869188802
52928,SIDM00531,Erlotinib,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.1909413,0.22626974,0.6569445618390817,0.08642272432696908
7973,SIDM00193,SCH772984,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.5581151,0.047640514,-0.4956732690519952,-0.026526816407584183
8391,SIDM00875,Nilotinib,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9401465,0.09858655,0.061718728622740554,0.00777130310609416
64280,SIDM00660,SB505124,Crizotinib,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,32.0,0.8936468,0.09822737,0.07861943677881214,-0.024997777985319877
92140,SIDM00529,Camptothecin,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.1454592,-0.04103682,1.214341251178894,0.16771521511043952
4730,SIDM01233,AZD4547,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,72.0,0.633531,0.016330566,0.07608205124031589,0.05242058291598149
49241,SIDM00529,JQ1,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.4810734,0.11741239,1.8211486919712374,0.08501788518615187
47245,SIDM00866,Palbociclib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.60623634,-0.015297041,1.2414095207240596,0.06852610061158397
82577,SIDM00774,Nilotinib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.6587543,-0.046723172,0.23387617611685738,0.0800472660922448
82789,SIDM00954,AZD7762,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-1.2846458,-0.09981771,-0.5479331507205468,-0.03625291245459721
22279,SIDM00875,AZD7762,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.24640621,-0.013694651,-1.429756744699857,-0.04417215967051319
32695,SIDM00673,Nilotinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-3.684592,-0.14869052,-1.3674087546208686,-0.04927001969558099
101681,SIDM00146,Linsitinib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,0.88980347,0.025524002,2.278373091658216,0.06855332777371395
50485,SIDM00774,MK-2206,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,1.3656373,0.04649543,-0.7025723808658086,0.02151093298247556
100306,SIDM00193,Afatinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,53.0,4.9027853,0.34315842,1.5277147803681395,0.13882323957745066
70158,SIDM00146,5-Fluorouracil,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.3547115,0.10590284,0.006889962873855628,0.01361002788395616
61789,SIDM00097,MK-2206,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.8678225,0.12185991,0.7305533766670872,0.01247339502244706
8682,SIDM00531,Navitoclax,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.3509937,0.043425974,-0.38583865856169974,-0.04147019819709104
22478,SIDM00878,Paclitaxel,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-0.816723,-0.07253535,0.19817555974869494,0.015339098340515432
56533,SIDM00866,Venetoclax,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.77813977,-0.015834993,1.0249782590738803,0.06560446888981637
57637,SIDM00776,Afatinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.34841108,-0.028308133,-0.8011033790331735,-0.08559493557089459
77993,SIDM00332,AZD8055,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1385883,-0.05827416,0.5980276308618703,-0.01747314672028058
71917,SIDM00878,Camptothecin,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,3.6327827,0.13635735,2.1436888592384222,0.10949955408211279
67049,SIDM00774,Paclitaxel,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,1.5279242,0.07946964,0.22651979885553833,0.05023745599044284
107390,SIDM00866,AZD8055,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.6637703,-0.052154656,0.19898899862024574,0.013858561313171307
22223,SIDM00673,Wee1 Inhibitor,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.2664235,-0.073373646,-1.0678599780085622,-0.08214509775841691
18973,SIDM00411,5-Fluorouracil,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.7846067,-0.048968375,-1.4258363644629906,-0.0063890307331920596
66802,SIDM00097,Nilotinib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1755093,-0.07428097,-0.8449650315745305,-0.0818249532247273
9055,SIDM00673,Trametinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.2722923,0.11877397,-0.3431740570058894,0.03039240930205004
84725,SIDM00971,Bortezomib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.405406,-0.04897635,0.23718541300486107,0.047342759888396486
49901,SIDM00971,Doramapimod,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.782122,0.13294178,0.581464828912091,0.03408183190945953
14315,SIDM00774,Nilotinib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-1.0184368,-0.04883436,1.0567817188534434,0.12705569746115103
73246,SIDM00878,AZD8055,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,70.0,0.9459232,0.08271525,-0.15064040784749883,-0.0216520159192527
39557,SIDM00146,GSK269962A,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.5889257,-0.09402285,0.2920436612295849,0.045686286036120634
71613,SIDM00893,Ribociclib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.7033682,-0.09017955,-1.5549444434015514,-0.06542216270668222
20953,SIDM00834,AZD7762,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,2.575139,0.20196538,0.9142428531042418,0.058085037930254116
12794,SIDM00893,Bortezomib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.2532313,0.026910042,-0.8593820071377914,-0.04593596445687746
92774,SIDM00782,Linsitinib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,Unknown,72.0,-0.31206182,-0.012857817,0.4561072081684673,0.046365232692426164
106367,SIDM00628,Axitinib,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,Black,51.0,0.28146282,0.022404471,0.20192851636131162,0.003942752343317389
47164,SIDM00673,Temozolomide,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.13360839,-0.0028533943,1.5580636114278306,0.03900101994095596
23687,SIDM00866,BI-2536,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-4.1558,-0.26511642,-1.1973427393493425,-0.01819445431779297
23328,SIDM00776,MK-2206,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,4.1924014,0.18386741,-0.13840373971345316,0.0013643885676378619
18839,SIDM00971,Crizotinib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.83217764,-0.021820981,-0.3487491381883717,0.026922908653702483
72528,SIDM00660,LGK974,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,1.5288508,0.09066288,0.40137292874525926,0.01707838802975153
32524,SIDM00332,Vorinostat,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-4.4071727,-0.4124844,-0.8896727980071671,-0.07033213185203495
95702,SIDM00893,PD173074,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.0013311,-0.022563366,3.080236772260683,0.18058900466823496
80589,SIDM00529,Alisertib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,0.61590695,0.060319096,0.4930543952846591,0.07543536211175879
51849,SIDM00628,Pictilisib,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,Black,51.0,-0.85109144,-0.079432316,-0.7050438510320152,-0.051304213661170786
16731,SIDM00954,Trametinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,3.9081109,0.19295865,2.5018423211090757,0.14017045985918178
72015,SIDM00866,Olaparib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.8429928,-0.0370797,0.9946154471197066,0.024137940780530887
46277,SIDM00359,Palbociclib,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.4002076,-0.06560741,-0.43364603175065186,0.011514385833365365
79733,SIDM00866,Bortezomib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.9070335,-0.06862618,-0.031740909105847606,0.023708404947092317
35016,SIDM00332,Venetoclax,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.72134346,-0.01841449,2.555920332916914,0.08975812916594518
41005,SIDM00954,GSK269962A,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,1.6876183,0.12366864,0.2573910306920318,0.08777234464883604
102424,SIDM00971,Alpelisib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.9132973,0.13501914,-0.40604418116889807,-0.021743645255135294
31198,SIDM00097,GSK269962A,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8124653,-0.069325,-0.2390536094001437,0.009314564061361106
47377,SIDM00971,NU7441,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.66091,0.103357285,1.795958440283271,0.096990393998615
53159,SIDM00866,Cisplatin,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.0236977,0.022987675,1.046196800233743,0.024745417955801027
11432,SIDM00146,AZD7762,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.5303521,-0.042331927,1.1508486363062047,0.08500070578515957
6648,SIDM00673,SCH772984,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.6261554,-0.17703235,1.7313705118980094,0.1087071554634395
107955,SIDM00782,Crizotinib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,Unknown,72.0,-2.6326573,-0.20680097,-0.5223928935463786,-0.011129566440187413
25282,SIDM00146,Olaparib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-1.7386684,-0.06383416,0.004630105159114319,0.06599649509553715
14612,SIDM00146,Wee1 Inhibitor,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-0.49756312,-0.034489077,0.4147695565550494,0.008707594852077293
83226,SIDM00774,Sorafenib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,-0.21255408,-0.015067808,0.29118245583827806,0.0407166013534962
22168,SIDM00878,JQ1,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-3.5684035,-0.11492276,0.26816067340959804,0.03715094600681507
93795,SIDM00660,SB505124,5-Fluorouracil,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-0.8320908,-0.072688624,-0.2538529599553118,-0.03688273942743035
11047,SIDM00878,Nilotinib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,2.004585,0.1733782,-0.6840842047802844,0.0016264715415784247
36765,SIDM00954,Gemcitabine,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,-3.1851342,-0.18880783,-0.09885749102059918,-0.04953088493185515
6234,SIDM00628,Taselisib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-2.2271872,-0.09530174,-0.021514544258057905,-0.0241380492443938
47184,SIDM00774,Alisertib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.39685404,-0.023968624,-1.802334819110264,-0.15855846641767585
33118,SIDM00529,Entinostat,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Black,44.0,-2.1949844,-0.1016849,-0.9139278081757382,-0.0578226927520546
82826,SIDM00954,Temozolomide,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,0.19656038,0.0025665883,0.6834682832042134,0.012821098684098857
35469,SIDM00130,Dactolisib,Ruxolitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.11430737,0.011933561,0.08736302920781312,-0.0328470831111306
13600,SIDM00193,Afatinib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,53.0,0.8251282,0.0719284,0.5723045518340172,0.05780095640927819
75069,SIDM00130,Olaparib,LGK974,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.0731666,-0.059988774,-1.2495773832269228,-0.09000776037955983
19024,SIDM00146,RO-3306,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.0191076,0.09139216,-0.5021411065846169,-0.03629624928068365
6491,SIDM00778,BMS-754807,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,69.0,0.99102265,0.039083865,0.12369606801914158,-0.019056084387475233
27777,SIDM00878,Dabrafenib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.5847067,0.063509956,1.945853946698129,0.0710957122246854
46276,SIDM00893,Luminespib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.93714076,-0.07827568,-1.470338747052929,-0.09877993779393632
57255,SIDM00097,Nutlin-3a (-),Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5406106,-0.052799363,1.3035147723424814,0.08374823547389133
18523,SIDM00779,Linsitinib,Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-0.8016598,-0.050491285,-0.6905698374074339,-0.06014571885218816
70406,SIDM00776,LGK974,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.9907175,-0.019451829,-1.1903433894943023,0.03432954731656964
75364,SIDM00628,Cisplatin,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,0.71330696,0.06075995,-0.23271302340462638,-0.017866491085123892
37176,SIDM00774,NU7441,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.4318116,0.09274146,0.7454091685403503,0.03435861587174501
88600,SIDM00893,Nutlin-3a (-),Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.5363529,-0.011117657,1.324083052961733,0.029806194209062085
23128,SIDM00774,GSK269962A,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,48.0,-0.72699034,-0.040447794,0.048933167445771523,-0.056360687256038565
101152,SIDM00146,OSI-027,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-0.4999484,-0.0494948,-0.04647678408987741,-0.014394095546437972
45420,SIDM00954,JQ1,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,0.52267563,0.030513406,0.7562769674439395,0.008614072208957118
29720,SIDM00332,Taselisib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1685846,-0.115015894,-0.5243069156466046,-0.04669788489934094
72840,SIDM00774,Alpelisib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,48.0,0.5091953,0.037104234,-0.35683056716878414,-0.017481251199148572
32603,SIDM00878,Alisertib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,0.4119112,0.03708035,-0.015484238180262157,-0.03979645967512752
262,SIDM00893,Axitinib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.1198932,-0.050086226,-0.8583051529774789,-0.016834420702891567
60689,SIDM00411,Navitoclax,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.929455,0.10195098,1.7739697321657566,0.1257692759218624
99377,SIDM00146,NU7441,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.33300024,-0.033072878,0.6282902627340113,0.04595621470578107
21602,SIDM00893,5-Fluorouracil,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.215328,0.23439348,0.03492782855772486,0.09017798828943341
93513,SIDM00673,PD173074,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.7850902,-0.10797659,-1.6236415114231393,-0.08851719709301575
3711,SIDM00893,AZD6482,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.7135396,-0.059871294,-1.3635806955732617,-0.06209708392501852
6810,SIDM00193,LGK974,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.8495336,-0.07963815,-0.10066234578446166,0.01032419983472968
93450,SIDM00778,MK-2206,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,0.33530864,0.019852554,-0.023455944787732323,-0.007147671190712292
50069,SIDM00776,SB505124,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.33150083,-0.02396765,-0.9018339746800599,-0.056407110255939606
2577,SIDM00146,Nutlin-3a (-),AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.5361401,-0.015298827,1.1714411069702966,0.06723893366419392
56508,SIDM00878,Doramapimod,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.62687075,-0.03252956,-0.1627240039286387,0.027380011841597007
97695,SIDM00779,Taselisib,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-2.9249763,-0.075744666,-2.446157217316166,-0.10741748794798929
65985,SIDM00529,Doramapimod,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.57064074,0.015977735,0.5538393487424154,0.03155139103771332
86950,SIDM00782,AZD4547,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.7829844,-0.022850238,0.3705326197550427,0.005967300959943632
13067,SIDM00878,MK-2206,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.3489356,-0.04115459,0.1731236156657856,0.017446002270731533
32653,SIDM00893,MK-1775,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.8770833,-0.11055123,-0.3309532420305619,-0.037533339421275784
73753,SIDM00628,Lapatinib,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,0.94026077,0.06885576,-0.22880281332809368,-0.0035120638287972645
21687,SIDM00954,Alisertib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.0,-0.52460325,-0.037710577,0.686573575140515,0.08116230789207411
83717,SIDM00954,OSI-027,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.3150723,-0.015302104,2.9432610247659126,0.17132005709808548
39960,SIDM00332,5-Fluorouracil,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3425128,0.047215503,0.8921324073530437,-0.03021563952905069
10860,SIDM00628,Crizotinib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-1.1981801,-0.1164902,-1.6762661045584921,-0.08683640771875943
12221,SIDM00878,Navitoclax,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,1.8903725,0.018468251,2.1285718564240086,0.044838890690209535
103879,SIDM00529,OSI-027,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.6921152,-0.10103952,-0.738793633432939,-0.030416479385607088
19534,SIDM00332,Nutlin-3a (-),Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,3.4684489,0.19997539,1.3155564173703165,0.033905646772729635
43186,SIDM00130,Sorafenib,Taselisib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.0389638,0.087710775,0.16555986359406452,0.008932809005681146
51726,SIDM00673,OSI-027,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,0.9504924,0.082052864,-1.4916903324840063,-0.10400200800852871
81895,SIDM00332,Navitoclax,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.9488106,0.0978663,1.5055726696068856,0.05431696144235819
66302,SIDM00779,Palbociclib,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-1.145846,-0.100301035,-1.9498832532102606,-0.0951415130154307
21146,SIDM00782,Olaparib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,Unknown,72.0,-0.52367413,-0.014062975,1.2179905031279081,0.057860877571462334
7484,SIDM00866,Alpelisib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.385672,-0.09071839,-0.7267360417325502,0.02055775931154906
12570,SIDM00529,Trametinib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-1.7102768,-0.09413916,-1.0564412138188084,-0.07066768517917318
48137,SIDM00866,PD173074,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,1.8293103,0.063853264,-0.17940423847462939,0.0055548002334976
83689,SIDM01233,MK-1775,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-0.5019236,-0.043820534,-1.5753945604750617,-0.07789573089974283
34253,SIDM00146,AZD8055,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.35202357,-0.027706997,-0.17876859143091894,0.007620525035357398
17686,SIDM00954,Luminespib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-1.3668003,-0.07042964,-0.3173227398195405,0.05383669895196744
95719,SIDM00097,Lapatinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.1200912,-0.15489474,-0.3819167560341635,-0.026133775245081814
40758,SIDM00778,AZD7762,5-Fluorouracil,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,0.26687688,0.00837602,1.7647885164808028,0.058117817350473805
7823,SIDM00779,Vinorelbine,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.6188279,-0.15105572,-1.1109534147066515,-0.09852335595957004
60855,SIDM00878,Crizotinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.24778467,-0.028211398,-0.14090131487925456,-0.08555090447903166
31243,SIDM00628,Dabrafenib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-1.3196977,-0.10115529,0.0655098246076628,0.024170161919072904
704,SIDM00628,MK-1775,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,Black,51.0,0.9697849,0.08991231,-1.1139103391685456,-0.05332250785271767
80010,SIDM00878,ZM447439,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,70.0,-0.56023455,-0.046332467,-0.2607584117857725,0.03776208203786986
36982,SIDM00971,Uprosertib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.0784476,0.13137467,-0.497470141312791,-0.032320995962615465
49127,SIDM00146,Wee1 Inhibitor,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,0.8030814,0.04878958,-1.2412688719067138,-0.06232828742568404
44571,SIDM00878,Bortezomib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.8307726,0.05059679,-0.5532655196027434,-0.035931045827112436
70119,SIDM00411,Irinotecan,Sorafenib,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.449507,-0.07096874,-1.7807173087280013,-0.042792267348760016
85293,SIDM00531,LGK974,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-2.5407386,-0.15609346,-2.590322215182205,-0.02489418281038616
16521,SIDM00097,Alpelisib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6559922,-0.09892917,0.6103108530366397,0.02210799875916045
52461,SIDM00146,Lapatinib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.3745628,0.033420403,2.0862297029067105,0.1753899125447594
93789,SIDM00774,BI-2536,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,0.57916564,0.043452404,-1.1865979231020232,-0.09025813883515192
70151,SIDM00531,Ruxolitinib,Erlotinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.1019714,0.109657,1.1155107353895843,0.03240432283848212
96726,SIDM00411,Navitoclax,MK-1775,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.3219557,0.09378724,1.8652584770105434,0.06343392268528462
80185,SIDM00531,Dactolisib,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.8166752,-0.0696642,-0.22264562823213416,0.02301995352820632
92237,SIDM00878,Dabrafenib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,1.711816,0.05640684,0.6322439028509851,-0.00622725953550912
36331,SIDM00893,MK-2206,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.9314823,0.23661801,-1.4828034875590044,-0.11203893871437004
36676,SIDM00954,Nilotinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-0.8497005,-0.06628752,0.25370177287389517,-0.020930182761980064
97263,SIDM00411,Irinotecan,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,43.0,-2.8063505,-0.10356688,-2.581930955734087,-0.06892616715649487
9403,SIDM00893,Axitinib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.6399852,-0.029771224,0.19532927849469792,0.022284505421884506
174,SIDM00146,Temozolomide,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.23209347,0.006399362,0.3104553274958041,0.037900555051796486
54569,SIDM00130,Olaparib,Sorafenib,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.7799164,-0.09546224,-0.6067283944082112,-0.06695388342897617
50234,SIDM00359,AZD7762,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.350028,-0.12175231,-1.6175264242184488,-0.11138151424989555
76654,SIDM00673,Dabrafenib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.0873659,0.058040254,2.4895091988908153,0.04670044052177132
20463,SIDM00893,Entinostat,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.8598764,0.12541215,1.7210643761782136,0.03787600456024831
53018,SIDM00529,Bortezomib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-0.21557267,-0.016429892,-1.4634487139937764,-0.01627368897994627
24068,SIDM00774,MK-1775,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.56446326,0.0651156,-0.04050069072410371,-0.014635894351313407
50734,SIDM00673,SCH772984,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,-4.7908826,-0.2941356,0.3130325554297159,-0.016994316814719784
100262,SIDM00971,Palbociclib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.8432676,-0.04845136,-1.2471474656510761,-0.03297882453450574
76796,SIDM00097,Entinostat,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8011068,-0.075892754,-0.4743260383030661,-0.029294748430369204
68596,SIDM00628,ZM447439,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,0.27071756,0.022360548,-1.6860947529692196,-0.12967076064355604
8869,SIDM00866,5-Fluorouracil,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-1.549309,-0.055904742,-1.4032364663622676,-0.03896682703942884
56662,SIDM00628,Camptothecin,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.0190318,0.15771231,-0.43929641596712193,-0.0022648436439025406
38445,SIDM00778,SCH772984,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,69.0,-0.55054283,-0.024636764,0.1027976626314049,-0.009945930215444352
68741,SIDM00130,SCH772984,Oxaliplatin,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.6149127,0.16128406,-1.6283975979591356,-0.1062163164711471
95881,SIDM00660,Palbociclib,AZD7762,Large Intestine,0.0625,Cecum Adenocarcinoma,Male,White,32.0,1.2392352,0.061574228,1.0307868351980218,0.034765631723022036
4123,SIDM00673,Lapatinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.617754,0.13424219,1.9047088279662545,0.14304731463193585
10673,SIDM00673,Linsitinib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.9731588,0.016941622,3.4923113545149422,0.11578197554687904
15065,SIDM00954,NU7441,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.0,1.1293557,0.09635166,-0.6684844261059057,-0.03258666728850032
31050,SIDM00146,Crizotinib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.76601005,-0.06495224,-1.2426800353174159,-0.06345463940680482
106298,SIDM00673,Wee1 Inhibitor,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,2.2054622,0.14276509,0.6452193254163555,0.04416177092530585
95301,SIDM00332,Lapatinib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4959832,-0.108188964,-0.015564340354458736,0.03205841858479374
54362,SIDM00628,MK-1775,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,1.1357504,0.057315703,-0.58549756040069,-0.03720490525386533
56390,SIDM00866,Dabrafenib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,2.2376533,0.08150416,0.34054126494950054,0.01965332912017725
23780,SIDM00146,Camptothecin,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.18999232,0.018735472,-0.26679987166647223,-0.032445716632585206
103015,SIDM00146,Alisertib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.693002,-0.064058974,1.5805147506664252,0.0864146536554492
99302,SIDM00866,Tozasertib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-2.107036,-0.09057368,-0.09814196141851583,0.05054724886852411
40838,SIDM00193,MK-1775,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,53.0,1.2400438,0.08932663,1.0968198614691353,0.052957697278700505
52801,SIDM00529,AZD8055,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.6129594,-0.031034978,-1.2378871842002468,-0.007030538453012403
91112,SIDM00332,Uprosertib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9555248,0.056932982,0.2792352116406151,0.047174173261461574
87592,SIDM01233,Vinorelbine,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-1.116495,-0.07419389,-0.7935032623292139,-0.012627241023700686
2212,SIDM00411,Crizotinib,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.3481534,-0.122286566,-1.078050652697074,-0.07404327563657852
102379,SIDM00628,Temozolomide,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.190202,0.023370096,1.3211304683524963,0.04671152283708724
71600,SIDM00332,BI-2536,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1576362,0.044195917,0.9105858801032117,0.0735989385882893
58651,SIDM00529,BI-2536,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,0.4671376,0.04000804,-0.011054328498064165,-0.04633999451571045
64611,SIDM00878,5-Fluorouracil,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-1.7820637,-0.0930002,-1.0913825857448407,-0.03974748782637469
61267,SIDM00893,JQ1,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.4268556,0.1592438,-1.1296917023225004,0.0018288495793120378
81726,SIDM00954,AZD7762,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.3139609,-0.08674129,0.10349731788722549,-0.03201369478170579
4818,SIDM00673,Luminespib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.3409625,0.10156975,0.47727778669888143,0.010867873436940989
107489,SIDM00628,5-Fluorouracil,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,-1.0577998,-0.037878882,-1.2559790081304327,-0.009990612393569813
5403,SIDM00954,BI-2536,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-3.720867,-0.101378955,-1.3243949475815875,-0.010941783534233659
482,SIDM01233,Afatinib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,-0.39392194,-0.030077994,0.6057639732768922,0.045129520197726904
42480,SIDM00529,AZD7762,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-0.25963137,-0.01853484,-0.29176204764426117,-0.014854822881275011
2762,SIDM00332,Axitinib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,2.5475166,0.20776008,-1.2238965953139804,-0.0825167997235404
85492,SIDM00332,Axitinib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.7463675,-0.2419935,-0.6228750648918966,-0.025518005979498232
34562,SIDM00359,Nutlin-3a (-),SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.9464302,0.07011455,2.7515957774991633,0.10710731760875877
11840,SIDM00628,ZM447439,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,Black,51.0,-0.41952217,-0.035567865,-0.3498853667297766,-0.02373372542168455
90779,SIDM00673,5-Fluorouracil,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.5464205,-0.024128737,0.31720514775343867,-0.003409171494946607
22076,SIDM00097,Nilotinib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.91658795,0.06338843,-0.6640171674463904,-0.07483466643712151
32361,SIDM00097,PD173074,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.6243298,0.16053349,0.037931136856117605,-0.011667066361084283
103001,SIDM00971,MK-2206,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.8483851,-0.09459748,0.4299832198481058,0.035183513299550974
84063,SIDM00660,SB505124,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,-1.4478221,-0.12327059,-0.08299256465979936,0.00622181415090986
107129,SIDM00193,Navitoclax,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.169718,-0.17843482,-1.0023691276067634,-0.07055701985306469
84194,SIDM00971,Navitoclax,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.9228956,0.02655867,0.07038360728893835,0.031068863827750964
37417,SIDM00971,AZD8055,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.2043455,-0.06968571,-0.6442880818510353,-0.07116292161187653
97838,SIDM01233,Olaparib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,1.1998218,0.03321595,0.32442057055408224,0.030644929594402175
44168,SIDM00529,PF-4708671,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Black,44.0,-0.8823782,-0.04637456,-0.6062387273817622,-0.004194401313319369
104808,SIDM00971,Alpelisib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.8927995,0.055929493,0.028981105881611586,0.011992488907811573
79486,SIDM00774,NU7441,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.5462039,0.03335643,0.9722223738221766,0.0584284672346804
44646,SIDM00130,Lapatinib,Ruxolitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.4248986,0.13787477,-0.22722848117524175,0.047006118653023114
87210,SIDM00779,AZD4547,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,33.0,-2.4123113,-0.011047361,-2.3097977739488,-0.06325730211170254
78630,SIDM00782,5-Fluorouracil,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,3.4636679,0.2173885,2.795256081870934,0.17320914715241092
10369,SIDM00529,Pictilisib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,0.9474522,0.08284745,-0.8667907869404416,-0.04721442679010242
17173,SIDM00332,Lapatinib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.8914583,0.08539209,-0.33817681075941963,-0.026345679013531756
31660,SIDM00146,MK-1775,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.779753,-0.06520392,0.05643415492031031,-0.0006370358288035833
80075,SIDM00660,Vinorelbine,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,0.47809425,0.040337123,-0.6351129275780598,-0.012925787826659546
24461,SIDM00776,AZD4547,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,65.0,1.4133878,0.05891522,1.993870552096256,0.09931902086272129
60233,SIDM00866,Alpelisib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.9923989,-0.110192716,-0.36673472361588666,-0.01340312123030107
72000,SIDM00774,Lapatinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,0.7663913,0.06701138,-0.1860830792284286,-0.024062780472240027
33283,SIDM00774,Pictilisib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.3794996,0.012965091,-1.0019424005028474,0.013079339601186863
62944,SIDM00893,NU7441,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.3977778,0.1156295,-0.567101647401884,0.004075820028868464
36161,SIDM01233,5-Fluorouracil,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-0.36903897,-0.022824474,-0.45089070685551547,0.00392905984532036
29470,SIDM00529,PF-4708671,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.9415577,-0.049996108,-0.9723947274156045,-0.012298099716110523
74129,SIDM00875,Navitoclax,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0260367,0.08185576,1.374615781871865,0.07305653641359822
11277,SIDM00954,Nutlin-3a (-),OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,2.770902,0.108067565,0.9047741080542203,0.06327997074283719
19959,SIDM01233,Oxaliplatin,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,-1.592952,-0.11517874,-1.7529177671891372,-0.12078191558720691
103509,SIDM00779,SB505124,5-Fluorouracil,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-0.36000666,-0.035358522,-0.650925608529948,-0.05166727766551116
101194,SIDM00193,AZD7762,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-1.3080076,-0.044086855,0.8573322912159839,0.0695582360320207
63440,SIDM00130,MK-1775,Gemcitabine,Pancreas,0.1,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.8339223,-0.115128055,-0.8169751976183199,-0.035626929494781245
42231,SIDM00954,Temozolomide,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.0,-0.2636946,-0.004675438,1.7205315695075531,0.0545146770505075
93973,SIDM00866,GSK269962A,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,0.80439633,0.037769005,1.3661564769147518,0.052198657312978396
48882,SIDM00893,AZD6482,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.4022902,-0.032587793,-0.4362229827459556,-0.005547177701764349
83035,SIDM00529,Luminespib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,0.57256806,0.048833236,-1.6121436600188488,-0.08021784913594134
12282,SIDM00778,Linsitinib,Navitoclax,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,-0.5492465,-0.033225603,1.7705630387991143,0.13734592248099406
22200,SIDM00359,SCH772984,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.9494733,0.14526168,0.7979810455049481,0.049748175114842516
45540,SIDM00774,Gemcitabine,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,48.0,-0.2483414,-0.015920628,0.2038879233515443,0.036468662814879683
75058,SIDM00097,Palbociclib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2740438,-0.044651013,0.3520041104005743,0.02650524955011683
45557,SIDM00628,Palbociclib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.3624744,0.013303683,0.893231157654938,0.06823345245527722
23690,SIDM00146,BI-2536,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.6979881,-0.027563572,-1.2176363564703778,-0.07349009610323917
101271,SIDM00875,Uprosertib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.0335228,0.168793,1.5544035235595046,0.13533295593393677
32006,SIDM00866,Doramapimod,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.1001095,0.029274514,1.666844349965817,0.08569924648756277
100082,SIDM00893,Alpelisib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.24022968,0.019456675,-0.6756790214314473,0.013223292187921459
21554,SIDM00660,LGK974,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,0.5772399,0.035332512,0.1473227958004351,0.02119428295025052
28781,SIDM00875,Docetaxel,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.41938028,-0.033586547,-0.006661355619379761,-0.004309188876904398
39031,SIDM00301,OSI-027,Sorafenib,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.863799,-0.14650889,0.2955525993784779,0.023841635264928208
62345,SIDM00660,Oxaliplatin,MK-2206,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.44956058,0.045285538,-0.7637684831001671,-0.03817614855568996
49025,SIDM00332,Venetoclax,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3281568,-0.036738932,-1.0822172627840136,-0.014759865672518203
75709,SIDM00954,Cisplatin,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,2.5985184,0.09907513,0.8363920449029341,0.06713751254078125
92989,SIDM00954,Docetaxel,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-2.3872457,-0.117096186,-0.8687479233061257,-0.07076352174832445
81631,SIDM00875,PF-4708671,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1559702,-0.03975669,1.2558287493354812,0.02937353831022358
71658,SIDM00660,Camptothecin,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,1.701871,0.14375156,0.4825989327500343,0.038564520623541064
7968,SIDM00834,LGK974,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,White,66.0,-3.3054392,-0.1511462,-2.668471726418037,-0.10247394433311895
5341,SIDM00332,Trametinib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,1.052224,0.10015784,0.6810604974213013,0.08072637188250828
11702,SIDM00673,JQ1,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.323332,0.08195137,-0.9572195500849868,-0.07376195765475592
44911,SIDM00875,Lapatinib,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.52103114,-0.058465496,0.9224234647594328,0.035486993501253186
87814,SIDM00954,RO-3306,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-1.0813714,-0.08179651,-0.6025908897256022,-0.07095340266285269
49783,SIDM00411,Palbociclib,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,43.0,-2.1146939,-0.06519936,-0.7514419256864587,-0.009758427036118886
79304,SIDM00875,AZD7762,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6786661,0.0384149,0.039299839059695675,0.10835935006078773
53353,SIDM00774,GSK269962A,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-2.5076807,-0.12203476,-0.9550576841598006,-0.10375014298226294
44836,SIDM00097,AZD6482,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.6191399,0.04444073,0.4715911288096518,0.021883420662280557
62154,SIDM00878,Ribociclib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-2.2744641,-0.07767734,-0.07563625187332249,0.038583709805545575
89173,SIDM01233,LGK974,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-2.309595,-0.13602778,-0.8289542376689045,-0.07328329724346473
38716,SIDM00971,MK-1775,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.0623223,-0.0391854,0.05481490938556669,0.05496551183874469
24694,SIDM00529,OSI-027,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-0.7819397,-0.068112396,1.0932317501345028,0.0929030185359895
14168,SIDM00411,Paclitaxel,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,-3.2922752,-0.11592389,-4.143249437880324,-0.103430458875752
19412,SIDM00875,Luminespib,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2338225,-0.13884708,-0.31442520526200163,-0.03093816703574394
36701,SIDM00875,SCH772984,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.3436164,0.03967889,0.5271324763109052,0.033337609348263665
107183,SIDM00971,Pictilisib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.5651155,0.1498206,0.6822447477051485,0.050586343584842694
89471,SIDM00097,PF-4708671,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.705824,-0.07478131,-0.474156227596787,-0.01336456840976905
7550,SIDM00875,MK-2206,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5584808,0.05216424,0.0033612871358101102,0.02050955006520818
18304,SIDM00875,Trametinib,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.9423089,-0.15142848,-2.0595864912425186,-0.13043908973710666
99721,SIDM00301,Sorafenib,Erlotinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-0.8829239,-0.10820309,-0.18840117003906953,-0.03651063175331629
106101,SIDM00776,Olaparib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,-2.2228057,-0.06865939,-0.1681734223627127,0.002164369398743995
74907,SIDM00146,Alpelisib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.0570418,-0.033553723,-0.422981499549816,0.08404833560732788
43041,SIDM00893,Tozasertib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2545613,-0.055592876,-2.4401221194169174,-0.038507806567600465
49537,SIDM00782,Oxaliplatin,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-1.7649035,-0.08444639,-1.5491708835459126,-0.03158810312495462
107738,SIDM00531,LGK974,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.60895,0.18449217,-2.358400685504455,-0.06400334883230335
75551,SIDM00875,AZD7762,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.10561458,-0.0069158874,-0.8522248768464894,-0.0486370527112265
73658,SIDM00130,AZD7762,Gemcitabine,Pancreas,0.1,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.93238306,-0.042275038,0.8455310911432111,0.10984034155497885
60440,SIDM00531,Dactolisib,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.64014804,0.056534514,-0.0014450269770697065,0.031316987895463416
25441,SIDM00660,MK-1775,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,-0.776912,-0.03333887,-1.2559089165846906,-0.06777258523492444
62729,SIDM00878,Navitoclax,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,1.1003896,0.019903447,-0.48496891318388224,0.010985790676864948
36488,SIDM00531,5-Fluorouracil,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.1808714,0.05612435,1.3174350581755785,0.057162069117500866
18693,SIDM00332,Trametinib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.7277238,-0.16080947,-1.1334119400709772,-0.10083532723003492
20533,SIDM00954,Gemcitabine,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,4.654345,0.37352195,3.8496195029454103,0.22700326855419037
15378,SIDM00097,Paclitaxel,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0213594,-0.12776506,-1.3017703634328834,-0.08025119143559982
18164,SIDM00332,Lapatinib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7339748,0.16917342,0.48898601227475486,0.028889815856608065
99588,SIDM00971,Dabrafenib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.5505106,0.012587035,1.1514769411865353,0.05337752521624307
101212,SIDM00097,Linsitinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2127676,-0.04801331,-0.38408113909253466,0.008325568869739909
97713,SIDM00954,GSK269962A,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,0.5042162,0.028448425,-0.2238410076266504,0.017255521585242795
106772,SIDM00875,Bortezomib,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0819918,0.023629066,-1.3955412556254447,-0.05681838899029251
45634,SIDM00954,NU7441,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.1756907,-0.08490493,0.3394999624368944,0.004759687994072394
2151,SIDM00146,SCH772984,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,-1.0210378,-0.09558861,0.012139666833705733,-0.04618955471096905
52602,SIDM00893,Wee1 Inhibitor,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.011193571,-0.0010078422,0.29178958477849304,0.0027019743664870384
60583,SIDM00673,ZM447439,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.11536952,-0.009153447,-0.2794948236066271,0.08590067410268416
82269,SIDM00301,MK-1775,Oxaliplatin,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.5253122,-0.14949942,-1.7597407727824574,-0.11825912600313851
7059,SIDM00146,Venetoclax,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.0132452,0.025822368,1.1723282793030823,0.059943738656754175
78313,SIDM00193,SCH772984,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,53.0,-2.7947135,-0.1513099,0.7099042963734713,0.060759772510976015
43907,SIDM00778,MK-2206,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,69.0,2.763629,0.11269135,0.017363249340079365,0.0412227058500541
11116,SIDM00529,AZD7762,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.21940337,-0.014417987,0.1198948053154618,0.00011457563088874315
11998,SIDM00866,Nilotinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.2748258,-0.01789713,-0.9631377858690632,-0.01960287716233993
1431,SIDM00628,Camptothecin,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.9177578,-0.09057703,-0.4596581416876073,-0.039787119009593475
8846,SIDM00774,AZD8055,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.68440944,-0.045945432,0.4388139864375653,0.019490949919843785
82772,SIDM00529,Vorinostat,Trametinib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-1.2930582,-0.11584881,-0.286030000865751,0.03998662378141079
89889,SIDM00893,Venetoclax,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.2824616,0.04263405,0.7870652371206057,0.05038118161593936
84152,SIDM00529,Wee1 Inhibitor,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.64674103,0.06021274,1.507091338915616,0.08812661603249493
5700,SIDM00893,MK-2206,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.4522429,0.21188015,1.5061834212938168,0.07227634997543676
89760,SIDM00878,PD173074,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.4276445,0.1254843,0.23264425705145378,0.020402104915316608
53315,SIDM00954,Trametinib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,5.205389,0.31973767,0.6334486979570935,0.033439225602464234
92401,SIDM00529,PF-4708671,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-2.1434398,-0.095094346,0.18205915555182958,0.04352726942725351
63716,SIDM00834,AZD7762,SCH772984,Large Intestine,0.05,Rectal Adenocarcinoma,Female,White,66.0,0.9604415,0.061638284,0.41066321835319386,0.030366949106933317
79046,SIDM00628,Dabrafenib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-2.5958035,-0.14271468,-0.3962964637562504,-0.0006392179152748183
100474,SIDM00875,Tozasertib,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.92852104,-0.035988957,0.916773266911384,-0.0017743891761646845
27471,SIDM00628,Uprosertib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.63113934,-0.041068584,-0.7653671729815943,0.03773658967677821
34717,SIDM01233,SB505124,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,0.12301152,0.005319245,-0.8258937117207007,-0.027565648129669284
4930,SIDM00529,MK-1775,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-0.15914273,-0.016020736,-0.8848095656777872,-0.03530092191838482
92661,SIDM00875,AZD8055,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.68016905,0.07612404,0.26473776528704196,0.005713267959305763
19787,SIDM00893,Gemcitabine,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.7315767,-0.1373697,-2.1784258983541753,-0.14661378167274325
36478,SIDM00531,Linsitinib,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.2565358,0.13919866,1.855050217190764,0.1009094153699889
25518,SIDM00878,GSK269962A,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.36181444,-0.032386847,1.0795636310960517,0.06727956606673685
94485,SIDM00776,Navitoclax,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.5450275,0.028014494,0.9048877874527759,0.028188105669080876
36240,SIDM00332,Nilotinib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.25455922,-0.018369857,-0.2877929527334222,-0.0044899516184997695
97667,SIDM00660,AZD4547,5-Fluorouracil,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-0.29963043,-0.017124064,0.03528395107305014,0.04095861176655608
15041,SIDM00878,Taselisib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-0.18732333,-0.015996534,-0.34101856734693814,0.05884127899096624
43472,SIDM00954,Camptothecin,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.0,0.9723177,0.041433003,1.531778440011243,0.07448751418671279
18985,SIDM00866,Sorafenib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,0.9227396,0.04687363,1.6084199489458246,0.05869228846960825
95940,SIDM00878,NU7441,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,70.0,0.93002784,0.08236012,0.0688024344857628,-0.024372016640932474
71762,SIDM00097,Olaparib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.0484765,0.054672424,0.7572317307703624,0.005678359514148475
87014,SIDM00779,Taselisib,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,-2.6026578,-0.13041976,-1.5772549903036703,-0.01710724775449563
63022,SIDM00878,AZD7762,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.86911744,-0.048757337,-1.0317626295133213,-0.03939096129358873
93853,SIDM00875,SCH772984,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.97849256,0.10316146,0.5511014757006308,0.04978644478239049
33131,SIDM00774,Tozasertib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.96241695,-0.026258238,0.7153077166395118,0.049187853941118284
107651,SIDM00878,5-Fluorouracil,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,1.9494128,0.078381635,0.20504149236886066,0.016184779787467393
11020,SIDM00628,Vorinostat,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,0.53366333,0.04656803,-0.5129371121662036,0.001121571234130854
7589,SIDM00971,Docetaxel,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.5453727,-0.09728381,-3.8909402793402674,-0.056469060008921
84085,SIDM00866,Camptothecin,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.836031,0.03460944,2.9739631350411457,0.033463148444576256
65573,SIDM00332,KU-55933,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.111406,-0.040399805,1.0202596061990874,0.03678599124478523
29463,SIDM00893,5-Fluorouracil,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.143417,0.25031248,0.9450890972915346,0.16641201057456162
34837,SIDM00628,Paclitaxel,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-1.1381356,-0.09157152,-0.735684124615458,-0.0792611342185104
24672,SIDM00954,AZD8055,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.2587463,-0.09871758,-0.06318877940970447,-0.06355987004472158
52178,SIDM00782,Nutlin-3a (-),Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,2.722766,0.0906944,0.7393430517076979,0.05262847092654381
76071,SIDM00875,Bortezomib,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.24843861,-0.024815543,-1.0981904527998685,-0.0732192150217561
97306,SIDM00332,Paclitaxel,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-4.408439,-0.14799996,-2.088693478461744,-0.11733954998682417
40633,SIDM00776,Linsitinib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.3606915,-0.11908205,-0.13909630721379368,0.027443671136245032
24466,SIDM00628,Doramapimod,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,1.1239619,0.03717566,1.4316327699212246,0.07172157564013346
47727,SIDM00332,Wee1 Inhibitor,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2341886,0.086559296,-0.6363600460411635,-0.01447513225775989
90168,SIDM00834,AZD4547,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,White,66.0,1.827622,0.025042538,2.788658721043491,0.0497072856920538
91746,SIDM00301,Paclitaxel,Lapatinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-0.538577,-0.033593968,-0.5066865955506851,-0.02791738576286134
90198,SIDM00673,Docetaxel,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-4.1806526,-0.19184414,-0.3419934308002195,-0.024743170131743597
19911,SIDM00866,Crizotinib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.6362952,-0.052521136,1.0574133572305942,0.03956236998169891
102945,SIDM00628,NU7441,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.3190525,0.09443384,1.1254682303276828,0.12845985117511563
99953,SIDM01233,Oxaliplatin,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,0.794668,0.063930556,0.47332798105047463,0.05198011087478455
45620,SIDM00097,Nutlin-3a (-),Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.9001153,-0.084223576,-1.015597279487468,-0.028837663167496756
86552,SIDM00774,Cisplatin,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,1.9033962,0.084800996,1.0807744829927466,0.07487770685324993
51189,SIDM00411,Sorafenib,Olaparib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-0.96974653,-0.05937572,0.25738289330060526,0.01619146686248468
85926,SIDM00866,Entinostat,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,52.0,-0.58601594,-0.041400686,-0.8512335425951909,0.005703690695269382
69234,SIDM00660,Palbociclib,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,32.0,2.1440897,0.11328743,1.6457248438751613,0.08546251276881102
89444,SIDM00778,MK-1775,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,69.0,0.8750529,0.04951965,-0.18947155448926495,-0.004248480728921075
58205,SIDM00673,Luminespib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.4608986,-0.11528545,-1.190352065928374,-0.06118011702114146
19232,SIDM00782,Camptothecin,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,Unknown,72.0,0.46448752,0.04006065,-0.4399582820851771,-0.041222544782724864
79008,SIDM00866,Crizotinib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-1.458292,-0.08526914,0.2448020883577301,0.021182678254231122
66393,SIDM00971,BI-2536,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.1703054,0.06484928,1.2961561601589766,0.07482742440833544
39904,SIDM00774,GSK269962A,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.3958309,0.16108239,3.0309522405506395,0.12305737556062615
51963,SIDM00301,Olaparib,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.409187,-0.053411968,-0.18418545986109575,0.002503334685862101
100019,SIDM00866,Trametinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-2.3885741,-0.16518334,-1.4027731243490662,-0.06390239747305834
47814,SIDM00531,Sorafenib,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.47727767,0.058668163,-1.3388075865356421,-0.07188099498277238
63212,SIDM00529,AZD7762,MK-1775,Breast,0.625,Breast Carcinoma,Female,Black,44.0,1.6196548,0.050743323,-0.09819592078715057,0.0044622893328489085
100343,SIDM00332,Uprosertib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.655761,-0.14117922,-2.0815245582334274,-0.06496926116363293
106168,SIDM00628,AZD6482,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.6043384,0.21486676,0.6097862554103826,0.12402130148184189
53169,SIDM00776,SCH772984,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.7151253,-0.114620455,-0.3867024771548086,0.01803239964034534
60786,SIDM00971,GSK269962A,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.6942885,-0.037438706,0.7343311928972674,0.011589947821738639
69398,SIDM00146,Navitoclax,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,2.9755206,0.14048456,2.520290057420386,0.13660208113953276
30923,SIDM00779,Palbociclib,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-3.6996152,-0.17217065,-3.0105500849483495,-0.13166508629701473
75185,SIDM00411,SCH772984,Palbociclib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.4557469,0.078797854,-0.11461362436697481,0.019623504614841122
11119,SIDM00954,Luminespib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,0.24433759,0.012787968,-1.0687200739041023,-0.02527754782846582
91761,SIDM00971,Trametinib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1908121,-0.018044574,-0.35021081427072664,0.0037388822799464478
21995,SIDM00146,Olaparib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.46042454,-0.01953209,-0.6107682477179683,-0.023252717905244528
72783,SIDM00660,Navitoclax,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,32.0,1.1592658,0.10656152,-0.9295334613151383,-0.05491278878087616
99248,SIDM00359,AZD8055,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.25579518,0.014193076,1.5017573151032724,0.06870241479072102
25003,SIDM00782,Vinorelbine,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,3.2153337,0.23639281,1.62552274352103,0.13051901304050562
22264,SIDM00411,Irinotecan,Taselisib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,-0.7851226,-0.027970871,-0.6413999572352188,0.03569312652099644
3781,SIDM00146,Axitinib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,-1.4435446,-0.10638463,-0.8736318984496031,-0.029393369614987494
9606,SIDM00954,Navitoclax,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,-0.7863194,-0.029878173,-0.25018977330518793,-0.030969906325515294
33149,SIDM00628,AZD6482,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,4.8587737,0.27189848,0.8907596898815825,0.10752306600286364
24623,SIDM00878,Ribociclib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-2.8394084,-0.116479464,-0.9937935217901446,-0.046026952092952114
22265,SIDM00146,Temozolomide,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.9398304,0.027934918,2.1479335462671023,0.08586029672761351
53167,SIDM00893,Linsitinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.8355702,-0.02134397,0.29251706371787534,0.04796080004241145
107202,SIDM00628,Nutlin-3a (-),Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-1.0215682,-0.049165957,0.8255389085703784,0.0907768480162454
85836,SIDM00866,Dabrafenib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,0.55392194,0.017936053,1.4024066902458385,0.04738212337875104
4327,SIDM00893,Uprosertib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.42840785,-0.033522394,-0.2966882739962187,-0.024717499944216362
45510,SIDM00866,RO-3306,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-4.227467,-0.19812754,-1.5494236512720962,-0.05972558520922947
62659,SIDM00776,LGK974,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,65.0,-1.6750513,-0.044244613,-0.3395143209553531,0.004337235439126304
83038,SIDM00778,Crizotinib,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-1.954346,-0.07623928,-1.1937945623722077,-0.038014535839872916
35528,SIDM00301,Cisplatin,MK-1775,Pancreas,0.2,Pancreatic Carcinoma,Male,East Asian,50.0,1.3650028,0.17200305,2.7696769517183966,0.12709429252801951
31379,SIDM00529,Pictilisib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-2.372749,-0.12449095,-1.4599053889254543,0.019568643388676643
107153,SIDM00130,SCH772984,Trametinib,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.4549611,-0.09360872,-2.0151301414136364,-0.08378987334976461
99994,SIDM00893,AZD6482,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.9720687,0.13640493,1.3255193419947955,0.12479965539453994
96976,SIDM00628,Gemcitabine,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-3.6111848,-0.14866523,-1.5204655118477357,-0.06503528069831989
77256,SIDM00097,SCH772984,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7199298,-0.07641348,0.2470101881782133,-0.019579489461274076
44701,SIDM00875,Cisplatin,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2260613,0.07110499,1.226028347751328,0.06701075331776365
15967,SIDM00971,Wee1 Inhibitor,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.6749636,-0.041640572,-0.15331671281828685,0.013762316656014729
43518,SIDM00146,MK-2206,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.1499966,0.0679294,2.075356329382678,0.1974586898638031
12208,SIDM00834,Crizotinib,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,White,66.0,0.7627123,0.061925713,1.094480414086088,0.04722909546169196
83721,SIDM00878,Palbociclib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.45241004,-0.032762736,0.2855697996493572,-0.015029170262712357
16223,SIDM00673,PF-4708671,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.9596967,-0.07221799,-0.07366845638564934,0.039595366597124954
65306,SIDM00782,Crizotinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.68262523,0.057738904,0.17951143742330022,0.021370232050867483
81516,SIDM00774,RO-3306,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.3708538,-0.021487162,-0.9223910000668819,-0.014683064667800817
13076,SIDM00332,ZM447439,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.2407436,0.10107047,1.9737984518792941,0.06426694360446138
75062,SIDM00834,Dabrafenib,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-1.6726978,-0.04134339,-0.6969606003791059,0.026196322260265734
63812,SIDM00411,OSI-027,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.787634,0.042714186,1.444251122317629,0.14261031345031946
9993,SIDM00954,Taselisib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.0,-2.2370918,-0.16859287,-0.44648595669605934,-0.04342431111115958
79266,SIDM00834,Crizotinib,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-1.2943622,-0.07843178,-0.9100984597554072,0.0012685407175329387
67190,SIDM00866,Cisplatin,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,1.9149628,0.04840193,1.6695878023503417,0.03842304264368584
64314,SIDM00529,Axitinib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.122634165,-0.010846615,-0.7594737982526346,-0.04779588651154051
86998,SIDM00531,Olaparib,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.8334215,-0.025826847,1.142238978045529,0.014942681766739446
44056,SIDM00660,Palbociclib,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,4.254193,0.3148729,2.8608721460235103,0.10030141013302005
7507,SIDM00628,Pictilisib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.2202084,0.09165451,1.148896638803823,0.10926311240882414
104910,SIDM00779,Navitoclax,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,33.0,0.72784305,0.01716876,0.705827911569444,0.0007513271621895538
70447,SIDM00774,Temozolomide,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,0.10716691,0.0027054276,0.3213792410204453,-0.005111114875481417
93991,SIDM00779,Olaparib,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,1.9587544,0.017867979,2.776636143506522,0.06607134060652342
71129,SIDM00954,Gemcitabine,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-2.9537616,-0.17249745,-1.5891601026883633,-0.10122639383540595
74743,SIDM00332,GSK269962A,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,4.0503845,0.17287391,1.5035194685724333,0.039590075895830065
102310,SIDM00628,AZD8055,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-0.93649006,-0.07953141,-1.229672085590072,-0.00875790060349674
43954,SIDM00878,Doramapimod,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,4.035068,0.19900548,0.8739796750249561,0.05450627440879709
10632,SIDM00774,Afatinib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,1.0318108,0.06628078,0.14353912790603018,0.016196416346074265
40026,SIDM00954,Wee1 Inhibitor,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.5329307,-0.08490945,-0.4981709710278658,0.03197403072547597
73538,SIDM00954,AZD6482,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-2.3847058,-0.09428609,-1.184512322058504,-0.04664909730296486
76558,SIDM00971,ZM447439,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.8070861,0.04257621,-1.2642822270965177,-0.03007003978203728
2197,SIDM00673,Lapatinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,2.2513685,0.18507603,1.3737375030878543,0.09877075370268294
39991,SIDM00875,Cisplatin,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7832469,0.11620159,0.7467022125260822,0.054549851930566155
9306,SIDM00778,SB505124,Camptothecin,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,69.0,-0.7861858,-0.053239644,-1.5330892905275655,-0.11784225994865433
97191,SIDM00097,Cisplatin,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.2986186,0.042356413,1.4196628160526856,0.054447713830648774
17492,SIDM00875,Camptothecin,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3820876,0.14080612,-0.09996295452359637,0.03187538538979632
107230,SIDM00875,Sorafenib,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.85161513,0.083188586,0.06157706272588824,0.0035226877740468245
15687,SIDM00971,Crizotinib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.6502001,-0.05423564,-0.9309204162450857,-0.024161162952646968
6684,SIDM00130,MK-2206,Ruxolitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.532819,0.051622108,-0.6018629868183198,-0.039991423508967665
33322,SIDM00130,Palbociclib,Taselisib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.8234369,-0.045446355,1.17241444980979,0.08236563964440692
38869,SIDM00097,MK-2206,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3603792,-0.08852929,0.9304669068898964,0.02304627650941533
41947,SIDM00097,AZD6482,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0232728,-0.071547456,0.12089613299781155,-0.01905554836164713
75667,SIDM00866,MK-2206,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.97542423,-0.06410886,-0.23708923976476454,-0.008648505277488755
78843,SIDM00411,SCH772984,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,43.0,-1.1035467,-0.054135714,-0.552252237964487,-0.027605361728098302
81613,SIDM00866,SCH772984,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-3.630551,-0.22837666,-1.3979779506548198,-0.04695998799683737
42635,SIDM00411,Cisplatin,Palbociclib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.8367934,0.08046463,1.9633426542665862,0.04758680757088542
4371,SIDM00529,5-Fluorouracil,Axitinib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-2.848867,-0.19143847,-2.1365334377611678,-0.09935580873091765
88317,SIDM00628,Pictilisib,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,1.5145146,0.14410116,-1.1166400005018249,-0.07482160255942572
56368,SIDM00971,Pictilisib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.5031698,-0.10301671,-1.3080676900157742,-0.05315493755719247
63870,SIDM00866,AZD7762,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.8873571,-0.124647535,-1.0375490488818202,-0.07114875436254624
1920,SIDM00359,Olaparib,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.5326312,0.09290043,0.21785031000065985,0.043156909954735805
78063,SIDM00673,Cisplatin,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,3.9252543,0.25272307,4.138819021033401,0.21496816764266002
9765,SIDM00130,Cisplatin,Palbociclib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.7525959,-0.086798675,-1.1870362090267077,-0.05839658851172469
51612,SIDM00146,AZD8055,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.67567396,-0.059993815,-1.263411745404285,-0.07969965627325735
15574,SIDM01233,5-Fluorouracil,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.3676465,0.09643966,-0.5435006453357141,-0.029998865892419724
23838,SIDM00866,Sorafenib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,0.90577924,0.05024149,0.7477449283783936,0.06150073761248552
21975,SIDM00893,BI-2536,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.8261548,0.16129673,-0.4667455989738045,0.021210955675538695
18573,SIDM00301,Trametinib,Linsitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,0.98918754,0.134491,1.1357352150356097,0.059047519535062876
85288,SIDM00776,MK-2206,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,65.0,1.6820499,0.14748524,-0.3481468521485307,0.006011731898803666
58620,SIDM00531,5-Fluorouracil,Lapatinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.2632952,0.009347828,2.285539591399654,0.03992338685078705
74195,SIDM00628,Alpelisib,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-1.7015566,-0.0726335,-0.30556501871980724,0.03605304299464671
72330,SIDM00954,Ribociclib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,1.2033944,0.035738196,0.23150896703864846,0.06241861921774065
4161,SIDM00971,Wee1 Inhibitor,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.4420379,0.051700413,1.2218232632701482,0.05420923647747717
66942,SIDM00673,RO-3306,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.0524962,-0.11533435,-0.7899561579109093,-0.0031155857402183434
62686,SIDM00778,AZD8055,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,69.0,-0.21386155,-0.012145518,-0.6132028135245764,-0.04292597034825759
96305,SIDM00673,Entinostat,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,1.2098212,0.093355,-1.453628068655853,-0.061106431701743145
62538,SIDM00971,Venetoclax,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,6.005836,0.17689012,1.9070450435560384,0.09243278791775862
2475,SIDM00332,Axitinib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.7061386,-0.17527542,-0.5790133558190707,-0.04963974821406248
23251,SIDM00660,Dabrafenib,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,32.0,-0.12253567,-0.007222611,-0.6436003181437608,-0.015413002496104139
31220,SIDM00875,MK-1775,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.26967257,-0.018079396,-0.611796383357833,-0.05964216804693087
97627,SIDM00779,Olaparib,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,1.079595,0.015978971,2.1367334565118052,0.020468000211594294
95753,SIDM00893,Trametinib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.16299278,-0.016863596,-1.9502769581987291,-0.061567754832626366
44837,SIDM00782,MK-2206,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,Unknown,72.0,0.26798737,0.020342913,0.4269560450913726,0.012163926527214453
92826,SIDM00411,Cisplatin,Ruxolitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.6966372,0.044225294,1.5338430083683656,0.05947394045012675
25777,SIDM00834,Crizotinib,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,0.83703256,0.06711241,-0.02500329994865093,0.06509219025164292
59079,SIDM00774,Dabrafenib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,0.3601143,0.012187579,0.2066161118854338,-0.003115600443175742
89612,SIDM00529,Doramapimod,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,2.6316936,0.033935636,2.1794745413986853,0.05613559911345775
98966,SIDM00529,Tozasertib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-1.4519875,-0.04883668,-0.896847030167662,0.011287745851660178
85522,SIDM00875,Uprosertib,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.74813133,-0.07187206,0.4295620381161617,0.025576034984145297
24659,SIDM00628,Bortezomib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,0.38926077,0.020341208,-0.14146251380519242,0.00010426205266657577
93440,SIDM00146,Olaparib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-1.9291811,-0.05233705,-0.7891128522928825,-0.0002542916588481953
55949,SIDM00301,Taselisib,MK-1775,Pancreas,0.2,Pancreatic Carcinoma,Male,East Asian,50.0,1.1174976,0.15128139,1.1896887883595553,0.10538218961948607
8885,SIDM01233,AZD8055,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-0.3463951,-0.028107336,-0.6254023352225577,-0.04918525978455704
91527,SIDM00971,Ribociclib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.8363229,-0.053350963,-2.212521292721897,-0.05061950061360641
96685,SIDM00146,PD173074,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.89012116,-0.05298498,1.299251371050033,0.09820769901032919
36211,SIDM00359,Navitoclax,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.561753,0.034934342,0.4413186396524307,0.036633330721849704
25716,SIDM00776,Linsitinib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.8413444,0.04842754,1.1143227704252645,0.07065096708512451
65337,SIDM00097,Crizotinib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.4276924,0.20013958,1.2615166891984722,0.11509862967984631
54226,SIDM00673,MK-2206,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.4021951,-0.05370575,-0.4760634054124764,-0.028801191390974566
52927,SIDM00774,JQ1,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,0.40293816,0.01945247,0.4421243357287791,0.05049819600613711
66637,SIDM00531,MK-2206,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.6324818,0.21992545,1.0080541863134063,0.05003553851558521
56582,SIDM00834,Crizotinib,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-1.0810252,-0.07300545,-0.965869009040107,0.006508556317513215
47359,SIDM00531,Olaparib,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.2608417,0.010880622,0.7103987204109786,0.01941035424948639
65739,SIDM00146,Gemcitabine,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.5839264,-0.04314555,-2.4671756478553637,-0.16886549212648988
20581,SIDM00776,Crizotinib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-1.1963059,-0.1060625,-0.32656212745673385,-0.0366038522207889
86728,SIDM00411,Erlotinib,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.8953696,0.044858605,2.5279434757757726,0.1419511825620861
9131,SIDM00774,SCH772984,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,2.0866027,0.06545782,0.896977243344704,0.03455751304725178
8558,SIDM00875,ZM447439,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7201305,0.081859134,-0.6172505313146929,-0.021379203646686596
21187,SIDM00411,Dasatinib,Ruxolitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.96764493,0.064582705,1.1259262290157708,0.10700434142733183
98119,SIDM00529,Afatinib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-2.44766,-0.119475916,-1.361163128341658,-0.07559996538314624
89197,SIDM00146,Nilotinib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.3891993,0.12662908,1.1556867265117439,0.053538658323677546
98505,SIDM00776,Linsitinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,2.9080975,0.14806351,0.9247051683396138,0.07613161839082344
10028,SIDM00628,Tozasertib,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-1.1599718,-0.11027453,-1.5086420182355924,-0.09240821779877248
27689,SIDM00529,Nutlin-3a (-),Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,-1.5178742,-0.04029211,0.08153769144309024,0.012898340371219699
33900,SIDM00531,Olaparib,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.75888896,0.0372444,0.41427890381616145,0.06240730415346331
66918,SIDM00866,JQ1,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,4.490907,0.33783552,0.5523713586928514,0.0251925921994108
7787,SIDM00673,Linsitinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.1652031,0.0154704545,2.7224707291203996,0.06833207260706314
61730,SIDM00531,Oxaliplatin,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.67693555,0.023722483,1.3732577012679619,0.06360217054127777
9129,SIDM00875,5-Fluorouracil,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.7409571,-0.05587171,-2.5464122328757024,-0.14831151384840313
58744,SIDM00097,Alpelisib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3514757,-0.0953945,-0.2814617624984991,-0.07583738708588557
79429,SIDM00097,ZM447439,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.6448761,0.08632648,1.1248721933556394,0.13641383802010212
5704,SIDM00130,OSI-027,Gemcitabine,Pancreas,0.1,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.866613,-0.074566856,-0.1309589047145763,-0.053608078172348854
72253,SIDM00893,Wee1 Inhibitor,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.1888895,0.107408,-0.957863446686891,-0.028325485836174006
38758,SIDM00893,SCH772984,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.5651554,-0.052118804,-0.603391403699634,0.017497407640372924
32768,SIDM00130,Navitoclax,Trametinib,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.746848,0.19430922,1.1532290907413147,0.10397340608312183
70424,SIDM00193,5-Fluorouracil,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.4427665,0.04099533,-0.5928829898040089,-0.032843955963149714
29595,SIDM00529,Taselisib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-2.5253706,-0.12537198,-2.0835987580797095,-0.04890030892884606
51009,SIDM01233,AZD4547,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,2.4926455,0.09269361,0.31476761166277545,-0.0011799791133830638
104921,SIDM00774,AZD7762,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-1.5251849,-0.14427355,0.0007483153894179076,0.01789921363480547
40249,SIDM00097,Doramapimod,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.973611,0.06509449,1.5672223333554485,0.07030359493918584
91343,SIDM00774,Temozolomide,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,0.08147408,0.0020966874,0.7910867012786778,0.017833426332823803
37246,SIDM00673,Tozasertib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.6566787,-0.030736836,-0.13829771181500292,0.013090852214567896
21981,SIDM00628,Temozolomide,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,0.95232755,0.018919589,-0.3556623043010489,-0.026178795163904155
99473,SIDM00893,Gemcitabine,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,5.614458,0.3879229,3.745874978016657,0.23061775436697785
4265,SIDM01233,Crizotinib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,-0.25037715,-0.017145218,0.12624017723287742,0.0264049962319119
9649,SIDM00359,Oxaliplatin,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.9634945,-0.095732115,-2.3096374399551984,-0.07574792105169208
75808,SIDM00673,Tozasertib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0253228,-0.0759399,-2.1731802801525153,-0.13105372682350522
47676,SIDM00866,Pictilisib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-3.2776432,-0.2378646,-1.7473067058508265,-0.07222076840530134
43384,SIDM00146,Alisertib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-3.6667492,-0.13951357,-2.8881470883448994,-0.1560946536723138
50146,SIDM00130,OSI-027,Dactolisib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.0263386,-0.0829219,-1.6030417860969868,-0.06720007687780187
79203,SIDM00130,Trametinib,Olaparib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.4590436,-0.12393827,-0.07035647348601792,-0.008154482181210653
67808,SIDM00834,LGK974,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-2.7499683,-0.1470409,-2.1714077860170793,-0.08884307159095917
18487,SIDM00660,AZD4547,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,32.0,-0.89180106,-0.035878357,-0.7268975401274786,0.0049522018069768445
85918,SIDM00673,KU-55933,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.0167253,-0.055810045,-0.7770757380395193,-0.05230009373217499
76186,SIDM00954,OSI-027,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,-1.2074134,-0.06854936,-0.26407883203300364,-0.0036056153187554
4593,SIDM00866,Lapatinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.6880041,-0.14689691,-0.5100266911081416,0.036719990876915375
87047,SIDM00529,Vorinostat,OSI-027,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-1.2867118,-0.11718573,0.45851532111596305,0.079517355256233
21534,SIDM00834,SCH772984,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,2.1241717,0.1610142,2.0875554461848798,0.16615787769771315
24064,SIDM00774,MK-2206,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.3913366,0.038570795,-1.2305601046395112,-0.0505910717835939
27937,SIDM00782,Camptothecin,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.48370764,0.04301355,0.5316672885488761,0.060286523955777084
41065,SIDM00971,Venetoclax,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.5257953,0.030364798,0.328465015864293,-0.00863572981546499
14502,SIDM00193,Oxaliplatin,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,53.0,4.384927,0.2965209,0.739739529483196,-0.0044109641994172855
72348,SIDM00954,Gemcitabine,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,1.2227126,0.09313516,-0.5613234928176714,-0.03792493958733801
76785,SIDM00146,AZD7762,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.6262305,-0.053567216,0.3058005074321396,0.038238042984142954
87819,SIDM00774,Paclitaxel,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.204284,-0.07444631,-1.1752340589438328,-0.014336074523908322
100826,SIDM00332,AZD7762,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.0388684,-0.14885567,-1.3212433671894697,-0.10411894300512295
54670,SIDM00628,KU-55933,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,1.9407562,0.14411052,-1.3190382796080948,-0.0698173866224615
101674,SIDM00628,Linsitinib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-1.5987365,-0.09791186,-0.7888191327972361,0.00837170646869792
38391,SIDM00774,Taselisib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,0.42446637,0.017812727,0.01303620662553622,-0.02335029661356841
64800,SIDM00411,Erlotinib,MK-1775,Pancreas,0.2,Pancreatic Carcinoma,Male,East Asian,43.0,2.789514,0.15760773,1.419959039016917,0.08025497843979294
24018,SIDM01233,SB505124,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-0.75217694,-0.038963094,-1.2543456884612738,-0.10645410150520837
5034,SIDM00332,5-Fluorouracil,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4264083,0.101647496,-0.5649396718376164,-0.06036628678169492
88429,SIDM00097,AZD8055,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0410498,-0.064110436,0.22716782394176596,0.03770228954038962
86689,SIDM00779,Trametinib,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,1.1419396,0.02781712,-2.442191998781992,-0.08187241912377409
22884,SIDM00774,Luminespib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.6471063,-0.073346905,-1.1800878952414928,-0.049305481632085695
43078,SIDM00893,Entinostat,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.5310884,0.035042416,1.1956659297488705,0.01592160493689312
47249,SIDM00774,Gemcitabine,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,1.2882785,0.11398849,0.9198112620978686,0.07587061770207505
11800,SIDM00146,Docetaxel,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,0.7260963,0.04302586,-1.4984815697254366,-0.042505141626005986
48058,SIDM00971,Olaparib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.090056,-0.041821517,-1.0224202159398454,0.007198731440519171
107899,SIDM00971,Alisertib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.6814343,0.040710792,2.812030463117516,0.10274007926869755
88991,SIDM00359,Linsitinib,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.9857153,0.14760706,2.3036041200042265,0.06430238916351382
92497,SIDM00332,Nutlin-3a (-),Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,1.6459866,0.07248529,1.1074574652393854,0.038643394025756304
70692,SIDM00529,Palbociclib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,-2.5173697,-0.084202036,-0.7803695872207537,-0.005242123087955959
39255,SIDM00146,PF-4708671,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,0.82070285,0.0253379,1.9580676728566015,0.08303409726801378
84176,SIDM00954,Vorinostat,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.36891332,-0.0072406386,0.7782923018515407,-0.010777105824861171
53239,SIDM00875,Wee1 Inhibitor,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.37874508,-0.02651471,-0.8346036895137556,-0.0551010110227992
28242,SIDM00954,Linsitinib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-4.283625,-0.21074057,-1.4457170477418886,-0.01579909049748989
103906,SIDM00531,Navitoclax,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.8087455,0.09634522,1.8482295302390348,0.10965501150002517
71831,SIDM00301,Sorafenib,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.9754433,-0.11803952,-1.4842177720143193,-0.09131652527353305
57503,SIDM00834,LGK974,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,White,66.0,-2.0797493,-0.13078563,-2.318018933136746,-0.0960306017885402
312,SIDM00660,Palbociclib,MK-2206,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,4.8573804,0.3948284,1.955063794724912,0.08071243245716245
61561,SIDM00782,SCH772984,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,-1.7293853,-0.13450983,0.43097427975909175,0.026956588709434102
38691,SIDM01233,BMS-754807,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-2.4083056,-0.15357257,0.40450720579730537,-0.018189290032996356
89392,SIDM00097,Olaparib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.618032,-0.033103492,-0.19311431880022667,-0.023768237245938423
92663,SIDM00954,Wee1 Inhibitor,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-1.7398376,-0.11312074,-1.2446457088255205,-0.02337381836933703
85853,SIDM00411,Linsitinib,Trametinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.5444424,0.08728387,1.0712248615875883,0.09661015333621782
45842,SIDM00531,Sorafenib,MK-2206,Pancreas,1.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.262641,-0.033292033,0.01815219647851464,-0.0014599658911050915
79921,SIDM00529,JQ1,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.8733066,-0.102279976,-2.1096434435094515,-0.09950133176678329
21042,SIDM00529,Bortezomib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-0.61948514,-0.045891732,-2.321257475824166,-0.0609271845549909
3447,SIDM00332,Sorafenib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6262287,0.045725986,-0.2518026869856674,0.0045532569604328
31226,SIDM00878,Axitinib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.16229025,0.015066447,-0.8955026936217555,0.01255751864022785
94078,SIDM00878,Paclitaxel,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.5929871,-0.045558877,0.7996317149349957,-0.01711809524502599
105013,SIDM00097,KU-55933,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.404793,-0.05583739,-0.40973431537619104,0.021861425430088614
7921,SIDM00893,Camptothecin,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,4.2344027,0.21341565,-0.043119687343195566,0.019932075740415084
79479,SIDM00529,OSI-027,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,-0.46226403,-0.041700333,0.27880982991601916,0.05406202367879137
16643,SIDM00971,Paclitaxel,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.9995874,-0.069939196,-1.5701281518785122,-0.029275398053212682
59155,SIDM00301,Sorafenib,Gemcitabine,Pancreas,0.1,Pancreatic Carcinoma,Male,East Asian,50.0,-2.0535383,-0.15468633,-1.862787365530014,-0.07662642851524638
107473,SIDM00673,ZM447439,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.6301831,0.050960373,0.7301498632096945,0.13393626722201657
29061,SIDM00774,Luminespib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.26132563,0.02469089,-0.10637645262786259,-0.07337607271695429
21497,SIDM00971,Temozolomide,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.4111664,-0.050928116,-1.2293948981216676,-0.01877848901928757
72755,SIDM00782,Linsitinib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,Unknown,72.0,1.9743646,0.11422989,0.9667463255562471,0.08166265187679911
17804,SIDM00866,Trametinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,0.6299382,0.039875057,1.2653699633375526,0.0606922612964723
61898,SIDM00146,AZD6482,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.0198634,0.076607905,0.33068208124753945,0.058851323916108644
76046,SIDM00878,Sorafenib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.7765012,0.13975374,1.551601184290367,0.11007146186425083
101576,SIDM00774,GSK269962A,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.8636768,0.040013485,0.8253359228722195,0.01150569838173306
54211,SIDM00971,Crizotinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.4789753,-0.07429096,-1.0117454360601,-0.003469552146075583
73593,SIDM00878,Cisplatin,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.6302988,0.021099068,0.8372322944427616,0.03742693197637291
23355,SIDM00193,Trametinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,53.0,1.9572496,0.12510978,0.6871691853340566,0.06236251314667578
52225,SIDM00529,Palbociclib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Black,44.0,-2.7749867,-0.10393102,-2.034773719658875,-0.051840900764879516
80256,SIDM00774,Lapatinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,0.9880614,0.08980567,-0.2703213665987282,-0.0580098190413396
23504,SIDM00411,Taselisib,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,43.0,-0.8912334,-0.057061195,-0.8614574076106103,-0.02254613326379907
14005,SIDM00529,Trametinib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Black,44.0,-0.528538,-0.030724583,0.2739650880214609,0.07497362581329363
98842,SIDM00673,Nutlin-3a (-),Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.2705005,0.03565251,1.8317170352297893,0.041962160561863006
18882,SIDM00146,NU7441,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.507674,-0.123155944,0.483431384647329,0.020217026935404864
35203,SIDM00893,Luminespib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.4552546,0.091754034,0.9435180041287863,0.07896350574559123
86877,SIDM00673,Tozasertib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-3.440649,-0.1907197,-0.7651836081788355,-0.07264823595494735
85135,SIDM00628,Vorinostat,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,1.187831,0.10594362,0.08166203942694786,0.0500579037211283
11447,SIDM00673,Linsitinib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,1.5955453,0.03634212,2.5449726868038924,0.06471781472935904
94884,SIDM00782,MK-1775,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,Unknown,72.0,-2.1386292,-0.1625915,-2.6340609666906927,-0.16841394386553776
39016,SIDM00774,Venetoclax,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.48005068,0.011229736,1.4970304398059167,0.048593580660376196
98177,SIDM00146,Doramapimod,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.0346757,0.063590065,1.2245086880821079,0.04230252750008312
30002,SIDM00146,Bortezomib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-0.41716117,-0.019746399,-0.07659248462361123,-0.03831478957656419
104291,SIDM01233,AZD4547,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,1.423517,0.05115042,0.9924303394889096,0.04440715391873055
104868,SIDM00411,LGK974,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.1464558,-0.06873899,-1.1798596587488206,-0.037846012079222106
74922,SIDM00776,Camptothecin,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.4296381,-0.15593669,-1.4825635663210246,-0.09432356855458583
74133,SIDM00628,Palbociclib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-0.4897416,-0.01551221,0.33255747912729583,0.03126523579680977
2959,SIDM00954,PF-4708671,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-0.093305126,-0.0057001775,-0.5406341520270314,-0.010082112155453347
30118,SIDM00866,Sorafenib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.2418544,0.058808416,0.8470251967789204,0.08338386725917493
3831,SIDM00097,Trametinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.50707245,-0.0077744476,1.3946913205078746,0.04394404738054805
46227,SIDM00971,Luminespib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.4289985,-0.11657595,0.3720505994346813,0.011635653462161272
89136,SIDM00866,Cisplatin,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,1.5389682,0.04198272,1.3546016738912432,0.049695853434737786
108271,SIDM00782,AZD7762,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.60698664,0.054937527,-0.22621064895366466,-0.022257110141547156
51336,SIDM00866,ZM447439,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.2603419,-0.080666,-1.323389965045222,-0.0679029102790711
67317,SIDM00893,Doramapimod,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.31868258,0.012668633,0.21661167594835404,0.01142670753146452
36693,SIDM00971,Alisertib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.5039191,0.03327524,1.9861945052180148,0.08652053078355004
11808,SIDM00359,LGK974,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.7364531,0.028422147,-0.9835985230547472,-0.004068301859472344
66760,SIDM00774,Palbociclib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,4.8082104,0.03608006,1.4991208187288332,0.016918804029594087
10176,SIDM00628,Alisertib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,0.6621014,0.01895113,-0.19243908889631237,-0.05174597069597232
47041,SIDM00878,Trametinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.27906346,-0.028382154,-0.4780073848647475,-0.05897091390742878
91237,SIDM00875,Linsitinib,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.9337244,0.1458206,-0.2621797534531733,0.03371879845055863
98767,SIDM00778,Linsitinib,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,0.8019512,0.047733936,0.7889168734397835,0.05434201813031609
87655,SIDM00130,Dactolisib,Linsitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.0686408,0.109602615,1.2389246607035884,0.07777883170657383
18183,SIDM00146,Taselisib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.0804055,0.07715071,1.168197674753739,0.1285187434853666
96226,SIDM00146,Paclitaxel,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-4.163961,-0.31205508,-3.045542697641726,-0.2580277556912243
48477,SIDM00875,Olaparib,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.55812144,-0.04363888,-1.5389670620150098,-0.05292006198363272
42478,SIDM00971,Paclitaxel,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.5969381,-0.10661165,-3.809804398733289,-0.09201488815404137
77775,SIDM00954,Entinostat,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-0.052385885,-0.0026736616,0.6176637027908769,0.03559833950986563
63479,SIDM00866,Gemcitabine,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,0.61433834,0.045847148,0.4153037739580973,0.03910693576999796
6385,SIDM00893,Entinostat,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,5.334996,0.2048267,3.1751881846346306,0.10691829998359847
4668,SIDM00878,Crizotinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.5707227,0.059730466,-0.6954448104559092,-0.07128187622772668
64570,SIDM00628,Tozasertib,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,Black,51.0,0.2870953,0.027123002,0.031748216052817614,-0.03498107521222351
52323,SIDM00628,Olaparib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-2.082945,-0.1349289,-0.5802449546367348,-0.0794270451955867
107648,SIDM00778,Olaparib,LGK974,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-1.6241318,-0.046794396,-1.9699483276623355,-0.05961357738893418
2793,SIDM00130,5-Fluorouracil,Navitoclax,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,3.407044,0.31082508,1.5457907379824893,0.13653235723256257
104637,SIDM00628,Axitinib,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.83732295,-0.05136208,-2.427339075556724,-0.11192526024658433
40554,SIDM00954,Wee1 Inhibitor,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,1.4591701,0.034689486,1.1561208792204114,0.08754320378606427
53648,SIDM00878,MK-1775,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.5353482,-0.054888938,-0.2582189533498222,-0.015970238531778907
5569,SIDM00529,Paclitaxel,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,0.6493341,0.06405178,0.4969172496864142,0.0853777888098645
72956,SIDM00130,MK-2206,Gemcitabine,Pancreas,0.01,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.4413594,-0.052583247,0.04728355424314352,-0.013204273362163496
6935,SIDM00893,AZD7762,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.54227036,-0.023604885,-1.159909787614098,-0.053680982717970324
70338,SIDM00954,ZM447439,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-1.8236355,-0.10222673,0.09869037620664647,0.029811499790862995
107550,SIDM00866,AZD6482,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,1.6211519,0.10822409,-0.7228539772442143,-0.0009450285847522626
75138,SIDM00146,Alisertib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.0570282,0.093604594,0.2180303955146438,-0.019135657972384094
17979,SIDM00359,Palbociclib,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.3662549,-0.06898531,-2.6383073244390216,-0.0973293052804031
56140,SIDM00146,Venetoclax,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,1.9326732,0.056618284,-0.07119573488887049,0.02692185351604754
61075,SIDM00673,PF-4708671,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-1.1120778,-0.06885873,-0.8995368943761937,-0.00905266505026777
81962,SIDM00146,Alpelisib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,1.7352821,0.10473711,1.5679820814115744,0.12166769785825983
66749,SIDM00531,SCH772984,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.4427435,0.21844964,-0.36199210646052127,0.03348448920820425
100693,SIDM00866,Afatinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-2.2938926,-0.085733086,0.014466094711598822,-0.01143705318032757
28312,SIDM00971,GSK269962A,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.30134,0.07171798,0.37829334254674646,0.0024460971826359597
5342,SIDM00332,Navitoclax,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,4.20528,0.15940736,2.305637508890847,0.11149494772879659
96106,SIDM00097,Uprosertib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0333744,-0.05645679,1.0976442571603306,0.09368881720509555
58983,SIDM00834,Navitoclax,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,White,66.0,-0.86516434,-0.057230014,-0.07798781441843093,0.028472603871979377
25614,SIDM00097,PF-4708671,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.7626823,0.077022135,-1.3183034144550343,-0.026856779121175466
89925,SIDM00673,Linsitinib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.5247231,0.0108015835,1.4579573029941495,0.06380029652590813
108189,SIDM00878,Camptothecin,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,3.2122586,0.1434937,1.8912366605974533,0.025948752422153325
44553,SIDM00193,Olaparib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.1555307,-0.07593644,-0.7234042645815271,-0.036840834939386016
95385,SIDM00834,MK-1775,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,White,66.0,-1.4596609,-0.12216383,-1.1728206996751045,-0.044464030913342875
50505,SIDM01233,MK-2206,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,72.0,-4.2542796,-0.2127623,-1.198690565618659,-0.053820572649277455
50797,SIDM00776,Linsitinib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.6421189,-0.040113725,-0.4881265243314153,0.000489166136642353
35592,SIDM00097,RO-3306,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2162914,-0.09686747,-0.5978296434109923,-0.05075575427487557
79542,SIDM00971,KU-55933,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.5373198,-0.023555493,0.03355999826918309,-0.007782777101538894
104232,SIDM00778,MK-2206,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,0.4919684,0.031087851,-0.5360362143569567,-0.014866779822510801
70779,SIDM00778,Camptothecin,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,69.0,-1.1611972,-0.042128947,-1.2040902918134013,-0.030440950665292007
72139,SIDM00954,5-Fluorouracil,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-2.0813718,-0.08440902,0.2012801311618017,0.05763785683043473
29739,SIDM00301,Irinotecan,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,1.9135193,0.2520984,1.8035034888984587,0.14817563722782365
56363,SIDM00866,JQ1,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.4521065,-0.095875405,-0.27645989649002817,0.05054276907191602
35778,SIDM00673,Luminespib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-3.4478538,-0.14515586,-0.8486961083249711,-0.011839028629076246
15566,SIDM00866,OSI-027,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,0.8101537,0.059726123,-0.36153683210509935,-0.017805382736399072
440,SIDM00301,AZD7762,Linsitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,1.6113324,0.15108414,1.2696261490145142,0.08144382825767954
90949,SIDM00774,GSK269962A,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,1.5045445,0.09623586,-0.14430560642355778,-0.025755449465952967
29117,SIDM00628,Sorafenib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-2.7800848,-0.133497,-1.9455404470997908,-0.057563044711920995
88677,SIDM00893,Trametinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.7119036,-0.07240125,-1.0049503398470458,-0.029258735255967075
55642,SIDM00875,Pictilisib,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.2780411,-0.02671712,-1.4755667145228817,-0.027031980142741083
8797,SIDM00875,Wee1 Inhibitor,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.22971518,0.014782498,0.025853096949716544,-0.012506633311131492
99498,SIDM00866,RO-3306,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,52.0,-2.9154954,-0.14754346,-0.7626525759609764,-0.016550005136181427
99072,SIDM00628,JQ1,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.73855615,-0.04702134,-1.3210544997720115,-0.10011379609515468
54312,SIDM00628,Wee1 Inhibitor,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.68541145,-0.06915381,0.1799385508604564,-0.022119588123151804
18052,SIDM00359,Linsitinib,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.4402761,0.10939355,0.34997455124152593,0.07607379380957359
60772,SIDM00673,Taselisib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.28151217,-0.029061267,-0.3484528737989976,-0.01237326267454298
82928,SIDM00660,Palbociclib,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,1.9253104,0.10348703,1.4450159114619552,0.07241424768374885
108341,SIDM00866,ZM447439,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-2.1861308,-0.13170737,-1.0103095396537025,-0.01774761868490228
63412,SIDM00774,MK-2206,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,0.50030726,0.020979652,0.8509587590593669,0.033819183106168584
36998,SIDM00954,Bortezomib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,0.40818575,0.018547056,-0.4045675885023824,-0.0014939694453202437
63181,SIDM00097,BI-2536,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1782475,-0.082188375,-0.9319068463655523,-0.03176461151000748
65675,SIDM00193,Crizotinib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.6892586,-0.062485017,-0.4946361194186509,0.024408790841332
45151,SIDM00954,AZD8055,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-1.6291332,-0.09984673,0.8123102389885404,0.02840282007275954
3509,SIDM00130,Trametinib,MK-2206,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.652345,0.2422008,2.199651302218169,0.1652926489846712
53709,SIDM00130,Taselisib,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.1447563,0.07857672,-0.7985703529111774,-0.005040654088387629
87871,SIDM00954,SCH772984,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.0,1.4123039,0.118344136,-0.2473397553636353,-0.033995059747684055
65119,SIDM00954,PD173074,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,0.83387274,0.042207804,0.7753045364971262,0.08618635753344885
71300,SIDM00130,Irinotecan,LGK974,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.0540644,-0.10120257,-1.6432768781959928,-0.09780313493718043
86073,SIDM00146,GSK269962A,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-1.4640235,-0.0816769,0.0761630338861724,0.036694741470072685
38821,SIDM00776,Dabrafenib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.5559152,-0.022483507,-0.6754588105370974,0.0007939725623390953
6865,SIDM00971,Ribociclib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.6316106,-0.07220119,-2.4809217463021986,-0.05905665403448187
34849,SIDM00529,Ribociclib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-0.9002313,-0.02452836,0.3712290686834532,0.05582877299556025
6023,SIDM00778,Linsitinib,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,2.768666,0.109013125,0.8499165927778612,0.06411775470733515
48227,SIDM00875,Taselisib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7758555,-0.08841906,-0.3283679016137561,0.01383678968662102
17574,SIDM00531,Linsitinib,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.7076921,0.043032657,0.07322251219546275,0.02011598347704962
62724,SIDM01233,Trametinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.3848766,0.09764232,1.960930284108759,0.15438354612296779
81417,SIDM00878,Dabrafenib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,0.09604134,0.0033375542,-0.33474203340321285,-0.0018833899488966334
806,SIDM00673,MK-2206,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.80824894,-0.054792967,1.3310318904289107,0.008346262635939879
103941,SIDM00531,Paclitaxel,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.88363963,0.11058176,-1.849026637563068,-0.08755530939691807
17345,SIDM00193,AZD4547,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.386024,-0.0726098,-0.3323330928405171,0.007834785964577214
81257,SIDM01233,Taselisib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,72.0,-0.81394225,-0.05153073,-2.3572254740765266,-0.16598988883860458
55369,SIDM00779,Afatinib,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,-0.7888642,-0.022057924,0.6677911971570712,0.0774999612605671
82896,SIDM00782,Navitoclax,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,2.633728,0.11264088,2.3647801108221804,0.09780284394584529
37899,SIDM01233,Nutlin-3a (-),Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-2.0757823,-0.056860726,-0.45564794982127793,0.06168474358479386
28416,SIDM00628,Cisplatin,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-1.4376105,-0.040668417,-0.6743503283442545,-0.0591334158083109
39818,SIDM00971,MK-1775,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.9084883,-0.08425854,-1.7700475263604283,-0.039093720410336694
76736,SIDM00332,Lapatinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0777873,0.09759022,1.0317120121626633,0.10931028895979344
4653,SIDM00778,Vinorelbine,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,-0.9611224,-0.03918656,-1.0110346521155156,-0.003969633071795397
15030,SIDM00529,ZM447439,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.15481265,0.012105644,1.2283332628624648,0.133075128720025
49175,SIDM00628,Entinostat,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,1.2256206,0.08849641,0.5022739213643107,0.03586194635271078
28933,SIDM00411,Paclitaxel,Dasatinib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,43.0,1.8586582,0.0844123,0.7455404090443516,0.027622082404793857
63609,SIDM00146,Doramapimod,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,2.9532125,0.20827416,2.6660799581493473,0.08477951480955248
28167,SIDM00878,Taselisib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.85665005,-0.052910455,0.2866501964463602,-0.016671331979496863
84992,SIDM00529,ZM447439,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.6383173,0.055561107,1.5087155239141004,0.08390091723964137
64564,SIDM00866,Venetoclax,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.9040615,-0.019842848,-0.32375329152806875,0.014050597976729914
56095,SIDM00971,Camptothecin,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.2625628,0.086823985,2.413958461871901,0.05815895221490264
26475,SIDM00628,AZD7762,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,Black,51.0,-0.6001417,-0.056274086,-1.7924752400829806,-0.0856399269379366
108192,SIDM00878,Bortezomib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,-0.08340678,-0.00520639,-0.6587085361808512,-0.038919160675745856
104370,SIDM00954,ZM447439,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-1.3327934,-0.10098955,-0.6783589046933937,0.0053668063629637944
3646,SIDM00146,Venetoclax,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.6810557,0.052312844,0.7211612202445657,0.07563209636179026
55594,SIDM00776,Dabrafenib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,65.0,-1.9745973,-0.0627539,-0.23276359216161624,0.008470696182625652
45011,SIDM00875,BI-2536,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.8260784,-0.09974998,-0.7905551090740729,-0.0044550694286315555
284,SIDM00193,Trametinib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.5389852,0.040804915,0.09017334270357226,0.0170772075617484
72282,SIDM00097,Navitoclax,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.8327606,0.10820155,2.603037932606257,0.17354544833693702
935,SIDM00332,OSI-027,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,2.2486694,0.19922051,1.4042522698263253,0.049362161724936814
17348,SIDM00673,Lapatinib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.43369532,-0.037769012,-0.2947554556265853,-0.017432996096412808
89783,SIDM00866,5-Fluorouracil,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.3540555,-0.049518615,-0.5463012377169402,-0.02612212196647864
102156,SIDM00778,Vinorelbine,Crizotinib,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,69.0,0.23335314,0.01601838,-1.3527086097396859,-0.06985124267315253
36315,SIDM00834,Linsitinib,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-0.123839065,-0.010495597,-0.07223038482965147,0.043636156918156005
23268,SIDM00301,MK-1775,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-0.98898995,-0.1131898,-0.5927654460228851,-0.08741177827919265
82642,SIDM00875,5-Fluorouracil,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.8903769,-0.09419355,-1.10745304607396,-0.06435982287107093
84117,SIDM00774,Gemcitabine,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.09945541,-0.0062824655,0.04481769715860061,0.028363529230342334
77878,SIDM00301,Navitoclax,AZD7762,Pancreas,0.0625,Pancreatic Carcinoma,Male,East Asian,50.0,-2.2733572,-0.118909046,-0.9310479764208475,-0.02931433605739165
76360,SIDM00529,ZM447439,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,2.3954585,0.22062774,0.8829807494722445,0.13708694534637286
20036,SIDM00971,ZM447439,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7617024,-0.073197216,-1.371248395388301,-0.009315553586050225
38934,SIDM00779,Oxaliplatin,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-3.7642815,-0.1498432,-0.9543387418280336,-0.03872853076730709
30350,SIDM00779,5-Fluorouracil,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-1.8926016,-0.053208955,-0.20713585826599906,0.048610162198398296
102848,SIDM00529,KU-55933,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Black,44.0,-0.843151,-0.013490144,-0.009229466492776475,0.022302496678864754
5859,SIDM00954,JQ1,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-0.66244125,-0.05698464,-1.0455291504375328,-0.09420268283151685
55020,SIDM00866,AZD7762,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,-1.9073873,-0.112943545,-0.9765364481947322,-0.04736919827409165
66435,SIDM00875,Alisertib,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2182708,-0.0913059,-2.1793693571733965,-0.07515144914998353
104927,SIDM00628,NU7441,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,0.8566284,0.08345836,-0.06403636761185165,0.015182107092294629
46417,SIDM00866,Alisertib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-1.8826437,-0.14420559,-1.0498668977068908,-0.05905917649204315
15518,SIDM00954,KU-55933,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-3.242828,-0.1110743,-0.41118448251642137,0.022864763266880445
26762,SIDM00954,JQ1,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,0.76396,0.058378644,-0.27342975382964424,-0.0826778219912206
12361,SIDM00971,Sorafenib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.6593217,0.041320603,0.5809044103370915,0.03939233696678371
89676,SIDM00774,Sorafenib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.2199868,-0.07561118,-1.090510397529686,-0.032898365090431564
70526,SIDM00954,SCH772984,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-2.4292076,-0.14868085,-0.31059560135514036,-0.01630070952533574
6597,SIDM00971,MK-1775,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.8906112,-0.0884585,-1.0273305175980048,-0.013409198971775093
36597,SIDM00779,Camptothecin,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.6037564,-0.0702638,-1.08709832583358,-0.041273219446868875
19993,SIDM00971,Taselisib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.8031092,-0.19813336,0.17919108021264102,0.009077837936511698
74823,SIDM00954,KU-55933,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-3.5820324,-0.11144232,-0.06396768654223395,0.048990480663542696
87647,SIDM00628,AZD8055,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.4020301,-0.03387105,-1.553879217390037,-0.11643694815965544
382,SIDM00628,Navitoclax,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.8527471,-0.082655564,0.5661846556334583,0.044681780370326725
24185,SIDM00332,Taselisib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,2.077222,0.09620857,-0.23741721091886578,-0.030880492416497214
93372,SIDM00146,Palbociclib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-2.3316908,-0.09218682,-2.2890831075177145,-0.04887888217251305
78924,SIDM00774,Entinostat,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,-2.7618747,-0.13443029,0.736335566604718,0.011010344736862786
36708,SIDM00332,Ribociclib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.5846243,-0.07691984,-0.32559884956802326,-0.017457626496873067
108234,SIDM00778,AZD4547,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-1.091437,-0.057758342,-1.4581347250534786,-0.08143965068603351
64313,SIDM00893,AZD8055,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.8923244,-0.15341298,-1.724258920185801,-0.14759707259160532
9093,SIDM00130,Crizotinib,Dactolisib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.1011838,0.07858098,0.6064352859023447,0.06573571384901326
6238,SIDM00146,Wee1 Inhibitor,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.43536732,-0.03133069,-0.4905986712332167,-0.07253668263798506
85529,SIDM00866,Wee1 Inhibitor,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-1.1485194,-0.07362737,-0.7946271727810467,-0.00021198268290205293
66547,SIDM00875,AZD8055,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.28975648,0.02532697,1.4604420607852198,0.0771035533153769
3380,SIDM00660,5-Fluorouracil,LGK974,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,0.6232374,0.06698573,-0.38234507443187,-0.011960829629177763
84439,SIDM00332,Uprosertib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.9010994,0.08647021,-0.053928213996388606,-0.014796997114410102
45544,SIDM00954,Afatinib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,2.081872,0.035329722,1.6820323260326107,0.057340362669556055
21941,SIDM00628,5-Fluorouracil,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,Black,51.0,-0.94506454,-0.047152396,0.12481007089129703,0.0615243412500153
38567,SIDM00893,Entinostat,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.7866915,0.041922126,1.0749295562549344,0.030564582724413893
91064,SIDM00332,Trametinib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1034865,-0.10989194,0.3385178773231324,-0.06760378820487886
73844,SIDM00146,Palbociclib,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,-1.200107,-0.07487001,-1.4424983808664527,-0.03261414332265289
10076,SIDM00866,OSI-027,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,0.98623,0.07058899,-0.22076860317940253,-0.009876524158497433
42663,SIDM00673,Wee1 Inhibitor,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.3723629,0.096117705,-0.45921052242797794,-0.009098221236292418
27458,SIDM00301,Irinotecan,Crizotinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.1566643,-0.13713184,-1.9107482081922202,-0.1585798232542775
3607,SIDM00146,Pictilisib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,1.1825588,0.094711535,1.7005057112574404,0.11034177149715671
11241,SIDM00875,Alpelisib,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.9967185,0.16783802,1.737176998158053,0.13507877422877293
94814,SIDM00782,LGK974,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,0.9005005,0.077861466,-0.8305915984196088,-0.06663442494659555
63519,SIDM00097,Docetaxel,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.5240488,-0.19198604,-3.7299157385625845,-0.31368064678128804
45183,SIDM00531,Crizotinib,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.3438096,0.18078037,0.20745112004529664,-0.006150338376096664
34511,SIDM00097,Venetoclax,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2175865,-0.054574713,0.22590531971083658,0.038843309655166594
87390,SIDM00878,OSI-027,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,70.0,0.3080587,0.036000192,-0.5463879600152705,-0.048266175975092106
32460,SIDM00193,AZD4547,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,-2.0140462,-0.0760102,0.3301831878506784,0.02546396429863891
79331,SIDM00146,KU-55933,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,2.1216118,0.08681292,0.7245401113470566,0.05476927445351594
104035,SIDM00893,SCH772984,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,5.258062,0.3446771,1.4527697516601885,0.18073498384561912
59003,SIDM00628,Crizotinib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.85955703,-0.07791802,-1.288626568111337,-0.10085603252785823
98081,SIDM00878,Nutlin-3a (-),Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.6492052,0.019451061,2.261907364282259,0.08935009824338865
106220,SIDM00875,PF-4708671,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0188986,-0.028279725,1.0151812000239546,-0.02646254092080497
85386,SIDM00529,Venetoclax,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,-1.2213356,-0.032964103,-0.05167713760837006,-0.030167836031100244
103513,SIDM00779,Afatinib,Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-0.8886577,-0.057794172,-0.3648761902313361,-0.008079385685895439
98942,SIDM00971,AZD6482,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.5411271,-0.04250838,0.12438289864217508,0.05207026899491888
85156,SIDM00875,Alpelisib,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2009408,0.113913774,0.12095674422841414,0.041528586386292074
31725,SIDM01233,Trametinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,0.64587003,0.048784457,-0.4040247469428504,0.021157942118548066
82597,SIDM00332,Sorafenib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.23687813,-0.018044828,-0.8159860660390448,-0.04550972096441031
70101,SIDM00893,Entinostat,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.7316549,0.04028444,1.9268590167903727,0.06176356191376219
76972,SIDM00774,Crizotinib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.6600428,-0.08354315,-0.3325362053608872,-0.06104274622376669
100127,SIDM00146,PF-4708671,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,3.3725379,0.17741758,2.589375307373178,0.08725747786601205
75602,SIDM00146,Paclitaxel,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.35242,-0.03215588,-1.6379287170754482,-0.1450383335458786
98210,SIDM00673,Tozasertib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.22935843,-0.016071586,-0.3353649226847286,-0.007711242715902952
32487,SIDM00673,MK-2206,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,0.75145245,0.048897132,0.11467006051558909,-0.02362481718992554
51951,SIDM00878,Afatinib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,1.6859432,0.13007595,0.536250125371297,0.029918858502119335
15321,SIDM00531,Taselisib,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.1470332,0.20196606,-1.4858198316542295,-0.0051358745111139996
53525,SIDM00332,Alisertib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.242484,-0.06455384,-0.7173387115851005,-0.03560437366160127
29851,SIDM00097,Olaparib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.7407077,-0.011329595,1.0926094599751048,0.023904340482638696
81485,SIDM00332,PF-4708671,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.0929363,0.07839219,2.615818609919699,0.12815346152230536
52443,SIDM00660,AZD4547,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,32.0,0.70939904,0.020248082,0.19192789431757645,0.033539082818328514
26243,SIDM00146,Gemcitabine,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,2.4493144,0.13863368,-0.5674366209565027,-0.020276752286078316
53602,SIDM00866,Crizotinib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,52.0,-0.57316816,-0.041858543,-0.7070624894926525,-0.016807352593702918
2440,SIDM00146,Lapatinib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,2.2192323,0.08979487,2.067640389747211,0.1379858482568585
61399,SIDM00776,Afatinib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,0.5665247,0.03084453,1.5488515882234606,0.03157514109950034
82570,SIDM00529,Trametinib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.7051797,-0.09316663,-1.2569615143931603,-0.03344610951432156
34593,SIDM00301,Dactolisib,Crizotinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.7305835,-0.20832902,-1.0337129850585818,-0.03558998876266426
56586,SIDM00782,SCH772984,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,1.7418941,0.14559671,1.166751310464776,0.07355957051963437
36133,SIDM00782,AZD8055,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.7957714,-0.05387916,1.5690064902220762,0.15373105416761426
29862,SIDM00332,Lapatinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0109423,0.093496904,1.417634497268281,0.1894440692053397
27553,SIDM00628,MK-2206,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-1.3769304,-0.099777885,-0.9165958128861789,0.00023450492125316353
65383,SIDM00774,GSK269962A,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,1.114022,0.066240706,0.1505235860574211,0.004275837635612916
73554,SIDM00529,Tozasertib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-1.0996236,-0.039083805,-1.1991106639953026,-0.002679091297002107
52005,SIDM00193,LGK974,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.23971516,-0.014068766,1.0814937509388483,0.046815965020678044
68205,SIDM00782,Navitoclax,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,2.166022,0.16933465,0.641869340282044,0.05768065906996567
58277,SIDM00193,Trametinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.013354,-0.11785197,-0.8682367700340995,0.02788958895664341
42500,SIDM00332,JQ1,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.9632763,0.092722155,2.1203512497828836,0.11598311250949364
11391,SIDM00971,PD173074,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.5321056,-0.033452135,-1.7393475958203806,-0.013256606331886786
4144,SIDM00782,Trametinib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,-0.89380115,-0.07865314,-0.46791523050217004,-0.010234713916045463
59136,SIDM00834,Taselisib,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,White,66.0,-1.7372065,-0.11877916,-0.9749761251635476,0.0007315347954358761
67186,SIDM00359,Afatinib,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.81232965,0.05666445,-0.08547117081606613,0.010498986906694997
64058,SIDM00529,Crizotinib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,2.2495077,0.19361928,0.8521192163886807,0.09848531046115584
31733,SIDM00875,NU7441,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7543594,0.07229317,0.48993730601960117,0.04478580628230621
75614,SIDM00779,Dabrafenib,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,-1.2617253,-0.046675652,-0.7823981618096855,-0.017655810113147995
58233,SIDM00878,Taselisib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,70.0,1.911414,0.13537505,-1.1796880012241509,-0.014286932752020799
27787,SIDM00531,Trametinib,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.0921524,0.35337284,2.3979011002275246,0.17812612867674107
36637,SIDM00779,SB505124,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-0.9789873,-0.0968642,-0.7472948109952716,-0.08146217894106939
10479,SIDM00778,Taselisib,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-0.087251455,-0.00535424,-1.3634502622778124,-0.06528469889443675
73287,SIDM00893,Alpelisib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.672255,0.12062751,0.17971542797408283,-0.04025997954892343
21649,SIDM00529,AZD8055,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,2.1028218,0.20063885,0.020120874986532554,0.07482574057140422
103037,SIDM00875,Navitoclax,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,4.041207,0.13362092,3.4213818465965944,0.10578068448959123
100670,SIDM00531,OSI-027,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.8798569,0.056946356,-0.19886597949797924,-0.01719267274156546
22839,SIDM00866,Wee1 Inhibitor,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.50128573,-0.03148148,1.6452824154073689,0.12554550281775287
94419,SIDM00834,SB505124,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,-0.494156,-0.04299514,-0.5296394817199513,-0.014379440170922802
76121,SIDM00628,Sorafenib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-1.6273439,-0.12926319,-1.2210272747452293,-0.027218483238300346
90028,SIDM00130,5-Fluorouracil,Olaparib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.041569557,-0.004217105,-1.6935338885054614,-0.0905122486214429
50921,SIDM00332,MK-1775,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-4.7534065,-0.22799164,-1.739760644394972,-0.10358918985028459
46456,SIDM00332,BI-2536,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,1.9089028,0.10739688,-0.5163424162186386,-0.033758162273501764
87256,SIDM00875,Axitinib,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.4545816,0.032042883,-0.07420150702376768,-0.040047314340059904
36228,SIDM00866,JQ1,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-3.1025736,-0.19277327,-1.934714352529441,-0.05114695582668838
13716,SIDM00779,Afatinib,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,0.952269,0.08672198,0.8411522198447166,0.10319156288970478
48343,SIDM01233,Olaparib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,72.0,-0.44853878,-0.009687073,0.501185885171696,0.0496234571640182
43401,SIDM00359,SCH772984,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.28848594,-0.022419348,-2.0175226657007848,-0.0804636234331023
18842,SIDM00332,Sorafenib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.48805183,-0.037464824,-0.7566426288772556,-0.026033786430457718
71043,SIDM00529,Nilotinib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Black,44.0,3.754826,0.15691902,0.7318332094015809,0.08070383302876158
69442,SIDM00332,KU-55933,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.9667441,0.0892176,-0.13438777419604464,0.034640129769521896
98785,SIDM00531,Trametinib,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.671694,0.31289238,0.6219282355696326,0.0601565103944778
10139,SIDM00774,Temozolomide,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.2953465,0.0074761724,0.3776970689716228,0.03388286999621261
106847,SIDM00875,Nilotinib,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4820182,-0.011365687,-1.497202672660588,-0.09426117628842297
88974,SIDM00875,Entinostat,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.6078718,0.110340774,0.5264297775466249,-0.05983946534726589
7375,SIDM01233,AZD7762,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,2.6573355,0.08954679,2.260983889528817,0.08495362688981495
52503,SIDM00673,Nutlin-3a (-),Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,2.1108818,0.06995308,2.0398441957401734,0.04787224636391003
87579,SIDM00875,SCH772984,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.37412325,-0.039637554,-0.25592996532808326,0.02118573692212842
23773,SIDM00359,MK-2206,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.822469,0.10074145,1.8524136570597254,0.08740342246214802
82287,SIDM00875,Axitinib,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.61976665,0.04595448,-0.4357759400157157,-0.016336545977864665
50307,SIDM00332,Alisertib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7752701,-0.1054758,-1.2028889716857605,-0.15396427529507642
63123,SIDM00193,Olaparib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.87470865,0.030257355,0.9566809250885614,0.09491090783662573
101046,SIDM00529,Cisplatin,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Black,44.0,1.2691851,0.024836315,0.9992042640595361,0.049330398849114394
17113,SIDM00628,Tozasertib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,Black,51.0,-0.58545935,-0.058537833,0.3207722349466744,-0.012790399116918238
77244,SIDM00893,Vorinostat,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.0047042,0.16098107,1.4252426347375962,0.08262961428121232
84773,SIDM00875,Bortezomib,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.885333,0.024934229,-1.5395679019334638,-0.017926418910710444
61701,SIDM00878,5-Fluorouracil,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-1.8054142,-0.099025354,0.375787581714624,0.0016948162186883001
94784,SIDM00529,Docetaxel,MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,0.20448385,0.018161153,-0.1009441149614114,0.024050376262448197
30735,SIDM00954,Ribociclib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,1.592201,0.07170599,-0.5771775719292536,0.04100644006994789
84004,SIDM00875,Doramapimod,Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5186568,0.055210672,2.4225562830011187,0.10116318662895524
48547,SIDM00875,Sorafenib,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.73670065,-0.0664301,-0.696944310858616,-0.043467601156386385
98376,SIDM00971,Axitinib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.7356677,-0.07686152,-0.8874375452537595,-0.01585669806125427
40916,SIDM00332,Entinostat,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,4.9112406,0.059656996,2.1682701460931186,0.06907093859273655
91193,SIDM00954,Alpelisib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-1.7180464,-0.12762372,-0.004975160866859062,-0.02754160440902528
107263,SIDM00628,Docetaxel,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,0.65396965,0.048199773,-0.2460953395707307,-0.005005302922304929
92049,SIDM00673,Crizotinib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0312208,-0.094716676,-0.958181027682192,-0.08371589465285642
59719,SIDM01233,SB505124,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,72.0,-0.5534607,-0.02621483,-1.0119685939924523,-0.09602781434171816
61271,SIDM00878,SCH772984,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,-0.9798451,-0.07332516,-0.3691697626161612,-0.024223068139750892
207,SIDM00097,Nilotinib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.2561919,0.018606048,-1.348774106539103,-0.06414309289968732
67646,SIDM00971,Axitinib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.976722,-0.084478,-0.6453882770646404,0.013861519986252164
55051,SIDM00628,Vorinostat,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.883819,0.06713527,1.2372185365562596,0.16216460768961746
17056,SIDM00954,5-Fluorouracil,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.2878667,-0.03711363,0.559747598866318,0.05246661887008765
107382,SIDM00954,Tozasertib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,0.9936752,0.06297035,-0.817343741617287,-0.02195645367819101
83189,SIDM00971,BI-2536,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.2782686,0.14670943,1.5728948382251045,0.1778746761076399
65527,SIDM00332,AZD6482,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.8942512,0.047261104,-0.29565598096153417,-0.02389813473142833
87441,SIDM00778,AZD8055,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-4.600675,-0.19277088,-1.0074094792346693,-0.057125504123430114
3588,SIDM00146,Alpelisib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-1.6651055,-0.06945643,0.9773456187488612,0.13102821596436
30039,SIDM00411,MK-2206,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-3.8183541,-0.11882845,0.9151149404914007,0.13135712930766197
91772,SIDM00193,Navitoclax,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,53.0,3.4306903,0.11459258,1.4740586807258287,0.03381903122687944
6352,SIDM00411,Olaparib,OSI-027,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.9849046,0.045640975,0.9074121110103315,0.03499764974268826
60922,SIDM00411,Ruxolitinib,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.2077428,0.017630335,1.617719306856526,0.01839106473605545
88689,SIDM00779,AZD4547,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-4.668743,-0.0325321,-3.088769067548493,-0.07930687169543595
80171,SIDM00359,AZD4547,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.1001256,-0.08881539,-1.68111178259162,-0.07400799829196929
87983,SIDM00193,5-Fluorouracil,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.8120956,-0.15668249,-0.8106340079597718,-0.0310943677645068
74175,SIDM00834,Palbociclib,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,-0.16446503,-0.009845134,-1.205822396133047,-0.07291661931576557
104028,SIDM00332,RO-3306,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5232068,0.025303131,-0.27747756832728,-0.008442331124497816
14445,SIDM00878,Venetoclax,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,4.421264,0.12194088,1.6522093125352795,0.06155898577085509
97342,SIDM01233,AZD8055,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-1.8382171,-0.10519639,0.5318703488425036,0.07588133782603372
16048,SIDM00878,Cisplatin,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,2.8114405,0.15795334,1.2975996645562184,0.07274757150249021
102741,SIDM00866,Trametinib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-2.9316337,-0.22860639,-1.9186433763686694,-0.09513286759613056
45378,SIDM00146,Luminespib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.8778984,-0.06755095,-1.1626733789729033,-0.0636033373139475
41233,SIDM00866,Pictilisib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.2957679,0.08783723,-0.7315020839424718,-0.0032302763899488382
20591,SIDM00411,MK-2206,SCH772984,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,4.230133,0.2575575,3.8210005594724725,0.21210388505673997
1923,SIDM00866,Temozolomide,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-1.1655728,-0.019491438,0.39656194187469257,0.0014612383535707219
88856,SIDM00332,Entinostat,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3250183,0.03564435,1.6070199953687025,0.060380245067207294
53274,SIDM00893,Linsitinib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.0563649,-0.046957944,-0.5187137437999977,-0.005761833142599015
51979,SIDM00778,Navitoclax,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-0.5125051,-0.03220031,0.7628969782945351,0.010358154595054483
76632,SIDM00673,JQ1,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.7039728,-0.14965674,-0.5811425787202297,0.018239856504775036
51202,SIDM00875,Sorafenib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6372909,-0.050614964,0.32270109911155753,-0.03402215622207529
28721,SIDM00774,Gemcitabine,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,3.5596812,0.24155697,2.7329369454813937,0.07907884946595972
57494,SIDM01233,Oxaliplatin,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,72.0,-0.8081432,-0.0638569,-1.4158235952870175,-0.11301539014705803
83724,SIDM00673,Taselisib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,1.817944,0.11870541,0.6226882270162971,0.03444457304681072
19713,SIDM00130,LGK974,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.4880744,0.09046654,-0.37907283973276723,-0.014865087037651693
84039,SIDM00893,Luminespib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.8351855,0.1741801,-0.27317229669905435,0.010465967229362978
84099,SIDM00878,Vorinostat,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-0.26964,-0.032875076,0.3180206597205078,0.037024167524410595
14140,SIDM00146,Ribociclib,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.9711797,-0.062227026,-0.9269178528077371,0.014190090885419927
60734,SIDM00774,Linsitinib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,1.6191989,0.16577408,0.2336990654304345,0.03518506872032872
106823,SIDM00893,AZD7762,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.4949352,-0.05382057,-0.7950147120379099,-0.014346861558855678
4222,SIDM00971,AZD6482,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1313262,-0.033149816,-0.15663549853206254,0.015194252425304517
22700,SIDM00193,MK-2206,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.1911739,-0.08132073,-0.48780963490182977,0.03981897921343691
25262,SIDM00893,Sorafenib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.84224236,-0.056027222,-0.83040896116716,-0.09604818194399534
107185,SIDM00893,5-Fluorouracil,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.5993792,-0.027051156,-0.9895067372127458,-0.00225521096023526
35255,SIDM00529,NU7441,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.1597977,0.10541037,-0.8106800416626063,0.0369412426356931
35440,SIDM00673,Nutlin-3a (-),MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.80453426,0.012205788,2.8680937871159586,0.015642006839512942
16036,SIDM00954,OSI-027,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.0,-0.49801627,-0.019444374,1.7697555208278564,0.1310363147672207
60279,SIDM01233,AZD4547,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,72.0,-0.91833586,-0.027318463,-1.0111686595171776,-0.023704021521829412
46199,SIDM00529,Tozasertib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-0.8897902,-0.033270102,-0.4204177450419246,0.022349928445800252
57003,SIDM00774,PF-4708671,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,-2.3121321,-0.09762584,-1.2163152952104146,-0.08778786177742144
10214,SIDM00779,Nutlin-3a (-),Dabrafenib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-0.4672761,-0.02020858,0.5821499326076881,0.06715297285100869
62830,SIDM00628,Nutlin-3a (-),Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,1.2645701,0.045803003,-0.09100928556652828,0.05324202465467681
105976,SIDM00866,GSK269962A,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,0.92325586,0.047050375,0.8563554191307222,0.03865871096595602
10867,SIDM00628,Bortezomib,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.28105468,-0.016331652,-1.1560899455335942,-0.039036325189170364
76496,SIDM00878,Taselisib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.6277745,0.010666741,3.686462733788761,0.08076430734803744
52292,SIDM00893,SCH772984,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.5463252,0.11489357,-1.0451129536472348,-0.05078965108610717
44845,SIDM00411,Lapatinib,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.3498863,0.03863414,0.20770066752330818,0.08961521180580194
49868,SIDM00146,Nilotinib,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.6154624,0.058866262,0.7460616029116524,-0.0010625856152033212
67083,SIDM00301,Dasatinib,Oxaliplatin,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,0.53478515,0.044676103,0.8549026214238685,0.0718800916384211
19767,SIDM00875,Temozolomide,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.59286654,0.01480925,0.9127677715708217,0.0386281157657829
62425,SIDM00097,Pictilisib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.68184483,-0.045444056,-0.2449539605898701,-0.029676533397624275
75661,SIDM00097,Cisplatin,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0756967,0.02054571,0.5387127242362203,0.0156012108485651
9258,SIDM00875,PD173074,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5524455,0.120513506,0.6845744071664204,0.057222852226945856
8952,SIDM00097,RO-3306,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3948388,-0.0641653,0.115372651206323,0.018485486226982314
107725,SIDM00782,Nutlin-3a (-),Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,1.1020631,0.028512664,1.8081580311815644,0.030864285435640074
52895,SIDM00531,Gemcitabine,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.0126373,-0.04304909,-1.4985774888256032,-0.131466607703777
6948,SIDM00774,Crizotinib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.8938044,0.09933141,0.8041943474300626,0.04126530086261982
7004,SIDM00411,Lapatinib,Taselisib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,1.0317024,0.030563414,1.6383009038655274,0.09960888758624234
40817,SIDM00774,Palbociclib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.3835034,0.15678659,0.8936581159632345,0.06202750388243039
19460,SIDM00673,Entinostat,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.9567601,-0.045028783,0.6729593991555914,0.07583813560692708
9531,SIDM00782,MK-1775,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.25706625,-0.015285908,-0.5246526577616557,-0.019720795888335512
105472,SIDM00660,Vinorelbine,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,32.0,2.3362856,0.22027366,0.22860819625992268,0.018992521151011153
17699,SIDM00971,AZD7762,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.73514014,-0.016669704,-0.6585072673567338,0.02703926871461086
47086,SIDM00774,Palbociclib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,2.9028957,0.07997835,3.1801923326447232,0.08566279038472067
11953,SIDM00529,Linsitinib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-0.9622847,-0.03505789,0.4077133372964499,0.054398115311179496
53992,SIDM00954,Afatinib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-0.9861447,-0.055670932,-0.5029575239865341,-0.005578166800559449
95926,SIDM00971,KU-55933,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.5885818,-0.02248581,0.43619896012995774,0.017012509989773706
15515,SIDM00776,SCH772984,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.0953801,-0.09818507,0.4829067003339843,0.041550284224597715
30646,SIDM01233,Palbociclib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,0.61532056,0.014082712,1.7281116083003927,0.057263935557578804
89719,SIDM00866,Uprosertib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.47222272,-0.022493495,0.6345636888484826,0.0884950471522741
57037,SIDM00782,Navitoclax,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,2.2128012,0.16554928,1.1847914396733106,0.007153300453892221
42667,SIDM00660,Camptothecin,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,2.3501723,0.17558393,0.018045007285216824,0.010715498691794825
20552,SIDM00954,Docetaxel,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-3.5265858,-0.27186286,-2.0954360530875284,-0.1911104367507046
26104,SIDM00628,RO-3306,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-0.49869096,-0.048886497,0.0533185589420414,-0.04223038287991167
76426,SIDM00779,Crizotinib,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.1986516,-0.08636709,-1.078833489240448,-0.11508826960476265
100705,SIDM00332,Luminespib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.1663604,-0.21861538,-0.864305728704095,-0.11064070767937784
29403,SIDM00529,Vorinostat,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.5390327,-0.051085953,0.0518001098133008,0.019420028895451847
98276,SIDM01233,Navitoclax,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,1.395932,0.092530355,1.2427602300970693,0.04884754726846397
58664,SIDM00130,Linsitinib,Gemcitabine,Pancreas,0.1,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.9463238,-0.048847087,-1.4976141993352394,-0.03335312261001765
102139,SIDM00673,Pictilisib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.7512506,-0.18349753,-0.4728520223386628,0.01314991823488008
107834,SIDM00332,Doramapimod,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.20691855,0.014439714,1.2394552267792316,0.05968336105572979
107750,SIDM00866,BI-2536,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-2.1362317,-0.12949426,-2.3045142557406204,-0.08468823322465867
13341,SIDM00628,KU-55933,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,0.4441641,0.02937806,-0.3850446983406071,-0.022971702143596257
62120,SIDM00332,Entinostat,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,3.2426934,0.09889557,3.3208922877637805,0.127531513235254
64540,SIDM00954,Entinostat,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.0,-0.44263256,-0.034772128,-0.32710003417375066,-0.04198701885185103
3501,SIDM00878,Temozolomide,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.15524232,0.0042177527,1.2737917550436153,0.042394581504418535
61302,SIDM00893,Olaparib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.0998552,-0.06720937,-1.3556628092893683,-0.04965393130236352
10809,SIDM00411,5-Fluorouracil,AZD7762,Pancreas,0.0625,Pancreatic Carcinoma,Male,East Asian,43.0,-2.1870844,-0.075006105,1.0026812936821985,0.04947949773616912
89606,SIDM00097,Axitinib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6997166,-0.069054745,0.9329104786148321,0.0778319301312974
22195,SIDM00776,AZD8055,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,-1.84002,-0.14068855,-1.8938582039343466,-0.12596612345378194
67478,SIDM00954,RO-3306,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,1.6467354,0.02986863,1.4552562360537618,0.13691679001003995
85882,SIDM00193,Navitoclax,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.5820738,-0.11146459,-0.9956566241722214,-0.027640682833374047
32242,SIDM00778,MK-2206,Camptothecin,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,69.0,-0.8806077,-0.054405484,-1.6637472685922592,-0.06038312341231859
56078,SIDM00531,MK-2206,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.381703,0.10184286,1.725114616258498,0.09005749908317355
53682,SIDM00834,Palbociclib,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,-0.8095755,-0.05803227,-2.0371656681015575,-0.11206697811652884
15300,SIDM00954,Navitoclax,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.0,0.7424644,0.013798409,0.9754729813716059,0.03579157632578571
63809,SIDM00893,Taselisib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.7314121,0.024295066,-0.4045281333664833,0.016849049520600255
21727,SIDM00971,Nilotinib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.1433412,0.07329418,0.6831450574157132,0.09106317427118416
4875,SIDM00893,AZD7762,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.5131238,-0.057024796,-1.227939696310133,-0.015296095034560864
13629,SIDM00834,Navitoclax,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,2.1795983,0.12286021,3.232508124949624,0.1686243589682077
76342,SIDM00776,AZD8055,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.1179142,-0.09115819,-0.9145047271655379,-0.06012968021505682
29258,SIDM00529,Pictilisib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Black,44.0,1.4783504,0.12291307,0.002106226127945652,0.07846756798290706
96838,SIDM00971,Navitoclax,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.0832683,0.026547099,2.8430674203595574,0.12046578117051232
99901,SIDM00878,RO-3306,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-0.45584014,-0.010152414,-1.4234425883651958,-0.04956388849565105
27898,SIDM00778,Oxaliplatin,Trametinib,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,69.0,-2.4236324,-0.050868586,-1.7897588585604485,-0.02434779215603904
11456,SIDM00776,Camptothecin,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.32690236,-0.025268886,0.17053453398885077,0.003991710332120622
17671,SIDM00628,Crizotinib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.6946611,-0.06757713,-0.7468338780294422,-0.05332709060401144
23112,SIDM00971,Nutlin-3a (-),Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.863877,0.072088726,-0.9488991511273457,-0.005805830890261326
48105,SIDM00866,Camptothecin,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,1.6571989,0.03276323,3.0970906965697744,0.09675531710156036
79629,SIDM00301,5-Fluorouracil,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,-3.4426613,-0.33229843,-1.8959603339841595,-0.12069062143713954
98252,SIDM00834,Trametinib,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,2.1224444,0.036603447,0.7732843110245585,0.018435673370499495
159,SIDM00878,AZD8055,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.80928737,-0.057837583,-0.0341259584906416,-0.00426511838138551
23929,SIDM00332,Afatinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.168602,-0.08775732,-0.3191567970243336,0.022798039978841035
86760,SIDM00866,Paclitaxel,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,1.3688616,0.104088046,2.346706045684629,0.1917832121484482
20870,SIDM00875,Alpelisib,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7311651,-0.061673034,0.811110093331386,0.10383378514539209
63933,SIDM00301,Irinotecan,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.5145164,0.19343947,0.7456542676048081,0.05279462075667554
70414,SIDM00866,RO-3306,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-1.7642015,-0.11034749,-0.7839585776666675,-0.0421231307067524
86045,SIDM00130,Palbociclib,Paclitaxel,Pancreas,0.025,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.8681021,-0.09256817,-1.6039565836337175,-0.06568794995299453
36082,SIDM00878,Nutlin-3a (-),Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,1.9183608,0.13041541,0.6191310072802021,0.048723686280117154
24081,SIDM00531,Oxaliplatin,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.9266676,0.08291847,0.496409850718135,0.07672096398636427
40323,SIDM00834,Crizotinib,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,2.7569406,0.2282984,1.0885096138712882,0.10049587591091619
52594,SIDM00529,Palbociclib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-2.5603118,-0.097419456,-0.7792010968991959,-0.012842682653036746
26582,SIDM00893,Temozolomide,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.4138749,0.041511383,0.10046498942588622,0.022285624685224437
16393,SIDM00660,Olaparib,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,2.896745,0.10309622,1.8403181285666472,0.056530145365692744
58179,SIDM00954,MK-2206,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,0.5533041,0.03832767,-0.7623937768474588,-0.027683169151703126
67463,SIDM00893,OSI-027,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.913085,0.1462165,0.14319629264229974,0.07158135458840596
89040,SIDM00971,AZD6482,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.9893916,0.071927354,2.7565474046135647,0.12054479337325003
21211,SIDM00776,Dabrafenib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.5159395,-0.05459368,-0.17600845643240282,0.0026702033844116127
20362,SIDM01233,AZD4547,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,0.9998295,0.029745715,1.0303069997941954,0.02168790517525619
37990,SIDM00660,Afatinib,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-0.7138613,-0.078621365,-0.4639168527557258,-0.007391711409427994
83584,SIDM00673,AZD8055,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,-0.58610964,-0.044446878,-1.2380526576136008,-0.033389743916057917
88876,SIDM00782,LGK974,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.1231505,0.09240303,1.0736478100213114,0.06216125269238561
4751,SIDM00878,Docetaxel,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.2808455,-0.024894554,1.9109255594531664,0.21286377614690016
98221,SIDM00628,GSK269962A,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.729288,0.069721416,0.27117985130782774,0.01868235791161846
96216,SIDM00878,Luminespib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-0.9439301,-0.09575912,-0.4848780420259097,-0.06441952735980262
326,SIDM00878,PD173074,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-2.8226914,-0.2724711,-1.9915045669783604,-0.1529295013206976
84185,SIDM00628,Ribociclib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.0564551,0.019670378,1.1015067069153732,0.04295550491428332
48342,SIDM00875,SCH772984,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.9097273,-0.2138894,-1.9372933332081692,-0.06874316592883493
35345,SIDM00097,AZD7762,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.2792592,-0.11006246,-1.3915738624498515,-0.07929516568345436
64109,SIDM00971,Venetoclax,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.550728,0.03097977,0.047993057251095816,0.005631587560839466
71196,SIDM00097,Sorafenib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.289446,0.1264433,1.2847118875324424,0.0761913302194746
18526,SIDM00146,Taselisib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.6714167,-0.053313125,0.8951229544132039,0.10638853743707787
78596,SIDM00359,Linsitinib,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.5944823,0.048984166,-1.1279418426138679,0.0025235117303708953
62256,SIDM00097,Entinostat,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.3014366,0.015322903,0.7351841598369163,0.05313251699868254
41366,SIDM00776,LGK974,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.13818,-0.086141355,-1.43851432382403,0.00746074431299485
6864,SIDM00529,Axitinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-0.9846578,-0.08364084,-1.1622860749224126,-0.07402917442487017
60498,SIDM00774,Palbociclib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,2.744752,0.17328541,1.1216341042890239,0.08118500806525515
25201,SIDM00971,Entinostat,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,8.465466,0.4237788,1.090676686962415,0.046178361554607826
85281,SIDM00673,MK-1775,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.22811118,0.023199966,-2.466117628645953,-0.13801762343048302
23779,SIDM00673,Nilotinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.51794994,-0.01485566,1.2011308177639335,0.08756815212599457
40054,SIDM00774,Alpelisib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.8671698,-0.05767358,0.5273493742791657,0.053636303193739195
23545,SIDM00146,MK-2206,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,5.65326,0.3312772,2.6560264544315677,0.18929425628251378
88665,SIDM00332,OSI-027,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2717189,-0.12253708,-1.3948114607023367,-0.14400265988793703
78068,SIDM01233,AZD7762,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,2.3889365,0.06924427,2.4489332724937722,0.08514277531769465
73116,SIDM00673,PF-4708671,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.240598,-0.112670295,-0.5978122746870007,-0.050032991004196066
24401,SIDM00529,Alpelisib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-1.7983829,-0.0846556,0.18679152326198065,0.07654061951557485
96111,SIDM00866,Paclitaxel,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-5.241957,-0.30392447,-2.3550271435270984,-0.14442935637646306
39473,SIDM00332,JQ1,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,7.7605195,0.29648185,2.6470529578841995,0.1630337162445888
30218,SIDM00673,GSK269962A,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.6703188,-0.16727912,0.12260560825775078,-0.013848364753592798
71529,SIDM00529,NU7441,Axitinib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.73781395,-0.056695465,-0.03430039917705617,0.04728119787274591
87688,SIDM00097,Wee1 Inhibitor,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0298978,-0.062474947,-0.3871385490448333,-0.018867156478491437
45229,SIDM00971,Ribociclib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.9552763,-0.07864295,-1.7720284112180482,-0.037138950481074344
76363,SIDM00193,AZD7762,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,1.3095784,0.070742644,0.08747496449832035,0.037502718187623685
62757,SIDM01233,Camptothecin,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,0.76156026,0.025157236,1.4247162235714672,0.050204301762054766
21036,SIDM00193,BMS-754807,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.7434886,-0.12172537,0.9229320879205575,0.0484057867317051
106335,SIDM00878,PD173074,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.8589545,-0.08985752,-0.23266766012283785,-0.011145631851672111
62495,SIDM00332,NU7441,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5858643,0.08229409,1.3648146489708615,0.1314270966395753
75442,SIDM01233,Oxaliplatin,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,72.0,-1.787259,-0.12794925,-2.039054118961507,-0.11603471886518313
40273,SIDM00628,Tozasertib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.91490066,-0.08889793,-0.22867928534293683,-0.02225543690807548
36293,SIDM01233,Dabrafenib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-1.3832753,-0.031100942,0.1872943496012277,-0.0007883968412048417
66065,SIDM00146,AZD7762,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.398034,-0.11629734,-0.3871948104165371,0.03818377711918544
81037,SIDM00878,GSK269962A,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-0.9883416,-0.08315226,-0.07123454711574558,-0.016006078310249416
95863,SIDM00332,5-Fluorouracil,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7372829,-0.08022301,-1.0445559376366322,-0.022123471883865323
11574,SIDM00146,Tozasertib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-2.4513948,-0.11257809,-1.2879590822413391,-0.0019371746168463757
92364,SIDM00893,Paclitaxel,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.23642386,0.018636884,-0.8055843766116424,-0.08221461461021845
101132,SIDM00332,Trametinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1509213,-0.11761684,-2.1238832350643047,-0.15315440796589985
51899,SIDM00411,Ruxolitinib,MK-1775,Pancreas,0.2,Pancreatic Carcinoma,Male,East Asian,43.0,1.7593327,0.04053654,1.8391158654839952,0.03323506015216173
101522,SIDM00529,Crizotinib,PD173074,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.5685427,0.13077918,0.5523724381486353,0.0715835876572817
65760,SIDM00954,Vorinostat,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,0.19487791,0.0115426155,-0.17449745836538202,0.01802461212472858
91934,SIDM00531,Trametinib,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.7204227,-0.12776944,-1.1377369907962163,-0.010526233718331437
78008,SIDM00782,Crizotinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.8274168,-0.13551807,-1.154769008348518,-0.055248917351079875
31959,SIDM00776,Palbociclib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-1.0348593,-0.033233654,0.6449046838879468,0.019662843104835653
55057,SIDM00878,Olaparib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,1.126914,0.043049224,0.13908341177436725,0.021350684246354532
24958,SIDM00971,MK-1775,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1920521,-0.03250777,0.5159706200172478,0.0207263863127579
100358,SIDM00660,Palbociclib,Trametinib,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,32.0,5.7695746,0.43466422,1.7616656405895152,0.0692841270384716
39531,SIDM00529,PD173074,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,-0.92434466,-0.04734923,-0.86819760254724,-0.031019515708367223
66961,SIDM00628,AZD6482,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,1.4717652,0.12712277,-0.08405890318407995,0.053879836182572194
65033,SIDM00954,Linsitinib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-1.6987698,-0.10188867,0.41220306154800496,0.02847070559039745
29539,SIDM00130,Linsitinib,Irinotecan,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,3.3316386,0.12583534,0.3121089796982046,0.06935893724551935
25924,SIDM00878,AZD7762,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-0.45459792,-0.025246162,-0.7341964396419948,-0.09460335839318888
88230,SIDM00878,Trametinib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,2.3624892,0.20780584,1.1840393996640728,0.10267804965072973
72887,SIDM00893,ZM447439,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-3.7821116,-0.21290803,-1.1225536700226824,-0.07078427297460814
14394,SIDM00097,AZD6482,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5711223,-0.108244024,-0.9807482649941363,-0.08385223286437729
90845,SIDM00529,Dabrafenib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,1.6728858,0.040554795,1.2710987037729125,0.09742287472728232
5418,SIDM00866,Nilotinib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,1.4312165,0.10764413,0.989465348819377,0.08481876212621639
975,SIDM00531,Erlotinib,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.243209,0.37473857,2.4308226511020665,0.1750264540677054
6614,SIDM00954,Sorafenib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,1.9837644,0.14104588,0.6156671506510204,0.1393631587285596
92887,SIDM00779,BMS-754807,Dabrafenib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-0.86811435,-0.016736992,-1.589098244555088,-0.08559643036271443
59612,SIDM00782,Trametinib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,0.5373105,0.03627376,0.8336301571210685,0.04775791438186714
35293,SIDM00774,Lapatinib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,0.98255455,0.08426007,0.13178797813310464,-0.019893752308373876
53513,SIDM00893,ZM447439,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.9047107,0.14030668,0.9361548235679833,0.08370489498701951
64221,SIDM00893,AZD8055,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.7985427,0.1293332,0.7529146693469284,0.045179999605454005
66359,SIDM00628,Palbociclib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,1.3600587,0.06329634,-0.134887520640124,0.008848900948630525
28963,SIDM00954,Bortezomib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.12887813,-0.0078696655,0.7324183417421443,0.0027899128832067433
96795,SIDM00097,Docetaxel,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6610651,-0.077281795,-0.7027995689381116,-0.039415924068950496
16350,SIDM00301,Crizotinib,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,0.7144644,0.08356866,0.020052499302984344,-0.024062423846480115
85339,SIDM00866,NU7441,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-2.4375136,-0.13593173,-0.5317182203901265,-0.018495807744479485
45810,SIDM00628,PF-4708671,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,0.7198864,0.061815135,0.5581507270881406,0.03201380491288159
30969,SIDM00130,Trametinib,Linsitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.465734,0.14605679,1.214719228816789,0.1096701343747676
40906,SIDM00146,Ribociclib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.23314245,-0.011588112,0.043999694265534975,0.0658958147160959
71753,SIDM00774,Vorinostat,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,48.0,0.16392174,0.010799209,0.19707141140736886,-0.01630870091431089
56051,SIDM00954,Venetoclax,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.1531041,-0.0920393,-0.3297362630151479,-0.011195021233697252
68214,SIDM00097,Entinostat,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.7519417,-0.09894197,0.552957225751885,0.019546311125873773
52584,SIDM00875,Wee1 Inhibitor,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9379256,0.04254891,-0.5254517205893451,-0.03913962386496654
95043,SIDM00628,AZD6482,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,1.0618165,0.09561507,-0.08429309152147241,-0.024812465372287814
39886,SIDM00954,Venetoclax,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,1.904542,0.07970887,0.39064211944457233,0.004537905017145294
59421,SIDM00628,AZD7762,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,3.804764,0.2627741,1.9508844732938073,0.22753931591079607
61080,SIDM00332,AZD8055,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.080208,-0.069894835,-0.5513281086468587,-0.06658411095924893
77605,SIDM00146,Nilotinib,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.2037609,0.10340756,0.8297901041214514,0.0095230348202052
56328,SIDM00097,Venetoclax,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1840086,-0.052839227,0.10880341295348289,-0.0023403425323289028
11881,SIDM00971,Tozasertib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.255171,0.089222245,1.2188248180000305,0.04854756863554271
50884,SIDM00834,MK-2206,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,White,66.0,4.805031,0.13328643,3.9446778837448946,0.13809910926332136
34179,SIDM00130,Lapatinib,Trametinib,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.4835644,0.19660869,1.9541716915834217,0.12305254753517943
82587,SIDM00411,Irinotecan,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,43.0,-1.5416865,-0.06793658,1.9472113588053803,0.1241231143128121
45913,SIDM00146,KU-55933,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.8565848,-0.035591293,0.8962471746117753,0.12358997874318141
57447,SIDM00778,Afatinib,SCH772984,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,69.0,1.021383,0.056433447,1.7021622631030453,0.0337077275536482
70026,SIDM00529,Paclitaxel,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,1.3850286,0.126626,-1.2954291397955984,-0.09738052357261112
48078,SIDM00359,Afatinib,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2002803,-0.08744511,-2.103848188391762,-0.05279443663190846
104073,SIDM00332,Luminespib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1211098,0.11264052,0.02239676121659017,-0.005556770538289295
98622,SIDM00866,Bortezomib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,52.0,-1.0175366,-0.083864,-0.46792796491607935,-0.008148913588535398
94381,SIDM00774,Vorinostat,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,0.18744984,0.012155044,-0.44749082542943336,-0.10548141474432758
85299,SIDM00971,Wee1 Inhibitor,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.6439145,-0.039681718,-1.1479994437100642,-0.06744836224434951
97650,SIDM00146,KU-55933,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,-0.46167922,-0.020742863,-1.2140509052856079,-0.02674590207305125
5288,SIDM00193,AZD4547,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-1.7449577,-0.06666324,-0.946870932942819,-0.01861293890585834
106810,SIDM00359,Vinorelbine,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,5.3574862,0.26993445,-0.44995608776246826,-0.015340259007357016
32153,SIDM00971,Venetoclax,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.0636737,0.04012638,0.5721702758327155,0.031888547312379126
23255,SIDM00954,Cisplatin,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,0.7498779,0.016653767,-0.09936813334485303,0.03366778036753738
38555,SIDM00776,Camptothecin,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.0632331,-0.07454984,-1.4981282854132005,-0.07971608626101752
84179,SIDM01233,Trametinib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,1.6990647,0.13656327,-0.29944287466841163,0.04691943404111515
86351,SIDM00531,Paclitaxel,Erlotinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.0868125,0.215148,-0.9355245320924759,-0.04841493386911759
81606,SIDM00834,Dabrafenib,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-0.7642489,-0.023229279,-0.07364335796587908,0.050425195905617025
46758,SIDM00893,Palbociclib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.6144922,-0.023661336,-0.5072350857383668,0.030615294191878247
48868,SIDM00954,Wee1 Inhibitor,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-0.7968413,-0.062027626,0.16069846689487927,-0.015721117284931228
45795,SIDM00130,Taselisib,LGK974,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.54305625,0.054669335,-0.9962605732625778,-0.056821932940482975
58573,SIDM00878,NU7441,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,70.0,0.695736,0.060582597,0.5246053803717798,0.09461709702779933
54959,SIDM00774,MK-2206,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.9583182,-0.0112965815,1.5252079065716633,-0.0174960828573969
105652,SIDM00954,Axitinib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-1.4659652,-0.111155145,-0.5841424652515552,-0.03961733208278296
51013,SIDM00301,OSI-027,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,50.0,-2.4780934,-0.20557758,-0.7985424424077706,-0.057686927780518246
78484,SIDM00866,Taselisib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,52.0,-0.49938354,-0.043519996,-0.11964737202602958,-0.02027821594362917
42699,SIDM00332,Paclitaxel,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,2.24163,0.13816643,-0.08741344387522747,-6.302653855853226e-05
12885,SIDM00673,Alisertib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.1417135,-0.06154838,-0.3741099171775457,-0.054480831653965806
44849,SIDM00875,Nilotinib,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.1724794,0.06477658,-0.2361846349223073,-0.03659718624342013
92762,SIDM00628,5-Fluorouracil,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,Black,51.0,-1.1302484,-0.053077776,-0.2639668285339453,0.0028962121019500517
10592,SIDM00673,Olaparib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,1.2438216,0.07790686,-0.4349646820855469,-0.01907251250265593
71970,SIDM00529,Sorafenib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,0.51763135,0.051417477,-0.522194912039531,0.016034879442308123
70619,SIDM00332,AZD8055,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,3.397488,0.16687936,2.9441398504463065,0.10259286161480392
15038,SIDM00146,Vorinostat,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.072377,0.094437025,-0.3180613510020282,0.021543071981778423
40814,SIDM00097,Nutlin-3a (-),MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.838053,0.03034431,0.06865492409291551,0.01532241225743256
47192,SIDM00893,Alpelisib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.38582236,0.03187875,0.24126890219134398,-0.007558469411674893
88037,SIDM00893,Entinostat,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.026251,0.05034997,1.2292881536564197,0.04546270961289409
21172,SIDM00628,Nilotinib,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-0.24700372,-0.020080626,-1.2387971651929426,-0.0975103087397843
30411,SIDM00875,Luminespib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7852403,0.07208337,0.31843742649557644,0.017169841365930683
10878,SIDM00782,Vinorelbine,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,0.6119878,0.04936802,0.18866445411890992,0.08041324015342849
30184,SIDM00529,Alisertib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-1.1495005,-0.0447738,-0.4351382175695293,-0.020613742419699554
42336,SIDM00954,ZM447439,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,-0.58473784,-0.04701839,-0.17619969221354378,-0.06881061042370008
71058,SIDM00875,Sorafenib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4255167,0.15583415,0.40772927911879586,0.02914429810314101
94159,SIDM00774,OSI-027,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,1.0446146,0.10374275,0.6805222549284884,0.025685526451068124
14755,SIDM00878,Nutlin-3a (-),Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,70.0,1.2614958,0.079730816,0.49982170807233617,0.03747682494123349
74250,SIDM00866,Dabrafenib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.37747616,-0.011843696,-0.03552733402036023,0.0682984974040821
29555,SIDM00834,AZD8055,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,2.3542912,0.1586787,0.17884707174014086,0.0032081572173321762
95171,SIDM00875,Gemcitabine,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-5.021987,-0.037378892,-1.347666089697023,-0.07560793315838556
37697,SIDM00866,Paclitaxel,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,0.85365665,0.06923975,-0.373562784625558,0.013190119175450531
51419,SIDM00776,AZD8055,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-0.7373683,-0.05663249,-1.1890043454619565,-0.07097751436884649
73511,SIDM00301,Ruxolitinib,Navitoclax,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.7777781,-0.017660907,1.571741131775128,0.06189089101196419
97543,SIDM00893,JQ1,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.6055124,0.10130308,-1.0466862340847065,0.02288442077938775
86342,SIDM00660,Olaparib,Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,1.3164501,0.038699675,1.333954241434329,0.033425054527817286
51120,SIDM00097,Gemcitabine,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.9718688,0.21903576,0.38572326828034054,0.06491401799886688
73974,SIDM00878,Linsitinib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,70.0,2.0116107,0.16255672,0.15030367812353246,0.028884928849015813
84259,SIDM01233,LGK974,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,0.5298762,0.039004896,-1.2153759057816775,-0.035589595434275874
61624,SIDM00660,Oxaliplatin,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,-0.9769106,-0.07201671,-1.3315182303213042,-0.06803475512661497
61440,SIDM00893,5-Fluorouracil,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.6525913,0.038823985,-0.8487408265589128,-0.00865700082736354
72072,SIDM00893,Afatinib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.1676044,0.09036749,-0.03335693749919992,-0.06937195770221863
9248,SIDM00878,Temozolomide,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.90031195,0.033155512,0.4247131005830851,0.017238722056286796
53318,SIDM00834,MK-2206,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,2.942263,0.10997921,1.2764681199571417,0.09057450158794603
2558,SIDM00673,Camptothecin,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.7057473,-0.01591661,1.4771268288830652,0.02801322460401361
82328,SIDM00193,Camptothecin,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.58434325,-0.018434243,1.2417826377992458,0.06453531200227199
97080,SIDM00875,Trametinib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2707279,0.12468964,1.8933937367510754,0.13132958806703446
63962,SIDM00782,AZD4547,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,Unknown,72.0,-0.38475114,-0.010025734,1.0909000456067,0.04818234818269695
94908,SIDM00660,AZD4547,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,1.319616,0.10623426,-0.3834456727422731,0.0008212013067133622
105157,SIDM00954,Cisplatin,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,1.796466,0.07341869,2.920706021101646,0.2352411635490605
73843,SIDM00193,AZD7762,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,53.0,1.1522878,0.060015187,0.0437506057824588,0.06106714128955138
37992,SIDM00529,Crizotinib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Black,44.0,-0.15555008,-0.009605223,0.2262721277531098,0.02088059755418214
84949,SIDM00301,MK-1775,Lapatinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-0.7389203,-0.09820016,-0.18159960631255645,0.0015775757885935508
14894,SIDM00411,AZD7762,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-1.6607642,-0.0609525,0.2229374048157281,-0.0026991717086591598
107563,SIDM00097,Afatinib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6643088,-0.10839256,-0.513594419490054,-0.027198762210366767
97824,SIDM00673,MK-1775,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.7738266,0.07852924,-0.5321431123457663,0.013774372414466884
14782,SIDM00097,Navitoclax,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.90887946,-0.061738946,0.4073440423106388,0.040160031871938735
51124,SIDM00893,Vorinostat,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.5460691,-0.0706037,-1.207837667056162,-0.02510210482221
7476,SIDM00332,Olaparib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3947998,-0.03230832,1.7807517833150108,0.08372958860994566
68220,SIDM00660,LGK974,Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,-0.5973897,-0.02378957,-0.25383924345116166,0.0002450543988230635
18986,SIDM00146,BI-2536,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.65693355,-0.023652758,-1.426008173369274,-0.06450532935570519
78211,SIDM00193,Nutlin-3a (-),AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-0.19648579,-0.003340988,2.432594836394633,0.10186505366576222
90097,SIDM00146,AZD6482,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.4021463,-0.08728384,-1.0288093754542225,-0.07868840953528544
34970,SIDM00301,Palbociclib,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,50.0,-2.0640185,-0.1980316,-2.4229644249026836,-0.1419633167342856
97714,SIDM00097,Olaparib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.0255148,0.06165474,0.44680532520433275,0.03761794590625053
3533,SIDM00146,Axitinib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-1.8914843,-0.13277534,-0.09410377787216087,0.03769027402576232
70680,SIDM00301,Lapatinib,LGK974,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.0736907,0.13129607,2.0363728967510846,0.10565869472562313
85317,SIDM00893,Camptothecin,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.8248022,-0.08742546,-0.968555231275129,-0.06562817322871786
269,SIDM00954,Docetaxel,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-1.0678614,-0.07769831,-0.4097066404807191,-0.05878729150986532
75511,SIDM00782,Navitoclax,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,0.76084054,0.07058137,0.8018528598856641,0.04489969129599982
19244,SIDM00411,LGK974,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.91177154,0.030161588,-1.0682881604936352,-0.012950611470923615
99100,SIDM00628,PF-4708671,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-0.14801672,-0.01287214,0.4846017445986698,0.09036091676633105
11318,SIDM00332,Ribociclib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.276807,0.087185204,0.12814671843241282,0.026806116786866643
87268,SIDM00146,NU7441,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.5062114,0.046998475,0.24048201145406922,-0.010648674619228127
98036,SIDM00529,PF-4708671,MK-2206,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-0.989766,-0.05221619,0.15520544466617256,0.083832897510085
23980,SIDM00971,PF-4708671,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.5699505,-0.028462104,0.4426272303605233,0.03176647994136929
29195,SIDM00660,Navitoclax,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,2.9697328,0.2112885,0.43774668299756475,0.06444479022003327
60661,SIDM00971,5-Fluorouracil,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.6673708,0.108681604,0.37799009648576953,0.07177778580974414
20847,SIDM00866,Camptothecin,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,2.455802,0.062192686,2.6910997552140765,0.13288838358599256
45015,SIDM00875,Tozasertib,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7623376,0.10528572,0.9007027057344716,0.044574959053180624
96996,SIDM00878,SCH772984,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.2449058,-0.102702804,-1.6549951467021629,-0.10160483812518935
14808,SIDM00673,Taselisib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.4559574,-0.04324145,-1.8221299611783002,-0.09918162902109028
33793,SIDM00531,OSI-027,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.031684,-0.044331282,-0.5935830683341269,0.00708679569003101
2100,SIDM00146,Bortezomib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.29060853,0.015366359,0.0022371985605874503,-0.03251991363907138
15076,SIDM00782,Taselisib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,Unknown,72.0,-0.9572435,-0.08760251,-0.8768940277418248,-0.049033630133356015
34533,SIDM00097,5-Fluorouracil,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2501897,-0.057739887,-0.5914577519562702,-0.019647478003699873
24966,SIDM00529,Afatinib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,1.7533978,0.13613121,0.6782893973285561,0.06568091499598439
4882,SIDM00774,Nilotinib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,48.0,-1.7242584,-0.10848704,-0.6285414125974051,-0.05251153766689006
71254,SIDM01233,MK-1775,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-0.8742603,-0.06794154,-0.6460654450658104,-0.03372690739668687
5327,SIDM00097,Linsitinib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.167546,-0.049338445,1.0390446409531289,0.02631565985260834
68063,SIDM00097,Wee1 Inhibitor,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.484909,-0.1058399,-2.42912577018565,-0.12981709540049366
76481,SIDM00529,GSK269962A,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Black,44.0,-2.3368037,-0.14846978,-0.5922773551472499,0.016503842581116264
53552,SIDM00531,Navitoclax,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.10725435,-0.013367223,0.8856052991619274,0.028483227382776727
49794,SIDM00878,Vorinostat,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-0.36585626,-0.03981576,1.5278514641221683,0.04221109973182495
92631,SIDM00893,Pictilisib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.1458789,-0.09854917,-0.6899331348036493,-0.08056498542921456
92670,SIDM00411,MK-2206,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-3.807136,-0.17542319,-0.8941953354300322,-0.03887600434146113
106002,SIDM00628,ZM447439,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-2.2735014,-0.09394092,-1.7816299325413636,-0.08494285559429174
45150,SIDM00778,Palbociclib,Camptothecin,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,69.0,2.816972,0.15184715,-2.059738847175002,-0.07202585598425694
44972,SIDM00673,Alisertib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.80017966,-0.044257056,0.014125174432964667,0.04601031573632459
28739,SIDM00130,Erlotinib,Taselisib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.0529255,0.085114256,1.142513287241594,0.08823931389794525
34736,SIDM00875,Gemcitabine,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9766041,0.0014208702,3.7759938111654074,0.10709610871602213
56521,SIDM00146,KU-55933,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-1.4162369,-0.04775694,-0.8578778692823765,0.025171385019297103
73880,SIDM00097,Venetoclax,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.0599272,0.08066593,1.0366796694643672,0.045163764482581914
87137,SIDM00782,Dabrafenib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.6783243,-0.048690535,0.2650012959426647,0.029926415472263254
25539,SIDM00529,5-Fluorouracil,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.7445026,-0.06551306,-0.6782488168706415,-0.0006413043181764568
38200,SIDM00875,Paclitaxel,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.1591624,0.010321133,-0.29884686774480806,0.04278754960714107
20245,SIDM00673,Taselisib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.63221276,-0.056509018,-0.6016272164044236,-0.052862634471507124
95721,SIDM00971,Docetaxel,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.4975202,-0.040190905,-0.3335505643956425,0.012088486055899536
17252,SIDM00878,ZM447439,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.806271,-0.07257484,-0.20897599155040045,-0.05677707773767474
76922,SIDM00529,NU7441,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-2.1576085,-0.13801932,-0.6585299918881843,-0.009864416471401778
33717,SIDM00834,Navitoclax,Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,White,66.0,-2.2566988,-0.13510904,1.7179076329922771,0.08266974202697523
92979,SIDM00301,MK-2206,Paclitaxel,Pancreas,0.0025,Pancreatic Carcinoma,Male,East Asian,50.0,-1.360791,-0.07560911,1.8506300364915405,0.04637852476827682
1865,SIDM00301,Oxaliplatin,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,-1.3764955,-0.1718175,-1.305716586404109,-0.07522494114604873
89954,SIDM00866,AZD8055,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,52.0,-1.2731194,-0.038683023,-0.27444460860935477,0.0122721630994892
78155,SIDM00673,Wee1 Inhibitor,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,1.8264699,0.13594411,1.674665355066293,0.08385797661893124
90452,SIDM01233,MK-2206,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,-2.1437478,-0.12252555,-0.35358202270507644,0.018201784192904788
60431,SIDM00776,Vinorelbine,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.9244625,0.068791695,0.2758694065848821,-0.0034868163973149654
26432,SIDM00130,Lapatinib,Oxaliplatin,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.0671022,0.194036,-1.1630828166724025,-0.01827194006131732
43417,SIDM00875,Pictilisib,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5811753,0.06292406,-0.7512786909176241,0.0022173255979817466
95973,SIDM00146,Alisertib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,0.9270874,0.08019219,1.2631637044317074,0.07847634033004919
105902,SIDM00878,Ribociclib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.8715519,-0.07956754,-1.6865870263859117,-0.06965466559650453
16985,SIDM00146,OSI-027,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-0.46691942,-0.0464408,-0.4869980214263155,-0.06817030668934643
60258,SIDM00782,AZD7762,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.1424996,0.10280437,0.41741716294425896,-0.0032200423765021777
92021,SIDM00834,Camptothecin,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Female,White,66.0,-0.17956708,-0.016003119,-2.567317705456915,-0.18863805071008205
26707,SIDM00834,Navitoclax,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-0.8850523,-0.057277896,-0.5270161427205825,-0.030245993370848937
75655,SIDM00776,Trametinib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.5374494,-0.041781332,0.7642221314957787,0.03614807900620115
103156,SIDM00834,LGK974,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-1.9586885,-0.11442124,-1.7393804858459119,-0.056896987250937246
34810,SIDM00097,Pictilisib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.2732629,-0.018427435,2.0964335600224904,0.11004207240408365
33876,SIDM00774,Taselisib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,0.29174843,0.013274738,-0.682177908390725,-0.05736218775441754
24245,SIDM00875,AZD8055,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6324658,-0.05661621,0.021749729701467508,-0.029513487791316535
42865,SIDM00130,MK-1775,Trametinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.7917891,-0.060489394,-0.9001566362098177,-0.03888543800402032
71403,SIDM00875,5-Fluorouracil,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.3139908,-0.099585295,-0.9920762434462305,-0.0866397686595114
101959,SIDM00779,SCH772984,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,0.34422415,0.02082523,-1.441785207313203,-0.0724518225360979
50197,SIDM00130,OSI-027,Trametinib,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.49314034,-0.038613655,0.9410975663038463,0.0014286933960081392
74536,SIDM00878,Wee1 Inhibitor,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,0.23699145,0.017933218,0.07641458731294488,-0.02137452189010461
47608,SIDM00660,5-Fluorouracil,SCH772984,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,32.0,0.25629905,0.027617656,-0.7737262647162267,-0.044880751061921464
90045,SIDM00893,Venetoclax,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2089304,-0.043617986,-1.9379246817913784,-0.005232721639019796
83232,SIDM00097,Gemcitabine,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.3669906,0.12411832,0.22565594541571907,0.0314887669506093
9340,SIDM00866,GSK269962A,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,1.7351917,0.08638434,2.064039914739196,0.09019600599200722
46651,SIDM00779,Trametinib,Taselisib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,1.3164539,0.02676944,0.6880945766599916,-0.033268581869545295
50779,SIDM00875,Alpelisib,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.1640761,-0.015121799,0.06432267782963463,0.0040058746047638115
6236,SIDM01233,SB505124,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,0.5330832,0.020071955,-0.8236121781053921,-0.04223604434841375
30044,SIDM00878,Palbociclib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-1.6445327,-0.102161035,-0.349536123587268,0.00983736616261959
21708,SIDM00875,RO-3306,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.3595484,0.04130088,-0.8978300697424599,-0.08826219197263946
6869,SIDM00673,Doramapimod,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,2.6213622,0.07382127,3.5145450727895176,0.09667194142270469
70828,SIDM00866,Afatinib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.436413,-0.123961076,0.4017751414328212,0.04132999697449349
1239,SIDM00779,SB505124,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,33.0,-0.6018259,-0.045812014,-0.7257675844986653,-0.05011415948652336
9707,SIDM00954,Dabrafenib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.40877315,0.016496662,0.6135942584557065,0.06627910373382703
64008,SIDM00866,Vorinostat,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.5294571,0.04344649,-0.3406295455008648,-0.024051664186728834
70497,SIDM01233,AZD4547,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-0.5317834,-0.017245496,-0.5090906586713254,-0.024759826407270487
106070,SIDM00531,Gemcitabine,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-2.0352445,-0.21079938,-1.774691387673215,-0.08142836914319289
39588,SIDM00628,JQ1,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-0.7248491,-0.049474288,0.19975615970679886,0.022313719942829515
23354,SIDM00097,Cisplatin,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.8393806,0.030380366,1.1598132404207995,0.023259367312068537
36735,SIDM00971,Pictilisib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.4020522,-0.09416459,-1.50980905604352,-0.024690592957028336
54951,SIDM00866,GSK269962A,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,1.0616305,0.05283143,0.5405790898624592,0.050759160673653644
35989,SIDM00332,GSK269962A,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.48628756,-0.024901064,0.7062937945508158,-0.049526401364373474
32232,SIDM00774,JQ1,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,0.8199032,0.04907413,0.14667166620765618,0.05811835308560791
60674,SIDM00673,Nutlin-3a (-),Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.18686067,0.0039309887,1.658052696760523,0.01540295214863454
54768,SIDM00529,Doramapimod,Trametinib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,2.4698591,0.12029681,1.5618991711144492,0.09517812951667917
87775,SIDM00774,JQ1,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,-1.2618779,-0.06792985,1.0773593445486855,0.059169990323171544
8527,SIDM00332,Sorafenib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.31327164,-0.021749686,-0.553551622127821,-0.04038648768217724
6452,SIDM00971,Bortezomib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.6731341,0.08544281,0.3343825351421962,0.05175255769976837
59344,SIDM00875,Camptothecin,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.63553077,-0.06737269,-0.6564027710685585,-0.021811859058938347
77701,SIDM00954,SCH772984,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,-1.2768431,-0.090317,-1.2494177655178935,-0.10420082736918605
31114,SIDM00146,RO-3306,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.3503071,0.103413485,-0.5654326521420873,0.007391041972798835
28409,SIDM00531,Trametinib,Navitoclax,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.7803904,0.20200047,2.637916230240425,0.08670198895976383
51596,SIDM00332,Navitoclax,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.714259,0.1416208,3.3638901818251643,0.1103450249616259
80953,SIDM00971,Taselisib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.52856517,-0.037289683,-1.2744362365270712,-0.08871294925497551
56606,SIDM00875,AZD8055,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.19092,0.24046339,2.059004487743453,0.10517440404506626
43497,SIDM00893,GSK269962A,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.50732476,0.040728558,-0.24899436876463205,0.04369888894935421
80040,SIDM00628,Palbociclib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.29508004,-0.008620882,-0.30727627669988744,0.04243603682631904
29393,SIDM00954,Luminespib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-0.8897341,-0.06589952,-0.12658062537204062,0.02517622903984161
92869,SIDM00878,Camptothecin,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.0135672,0.034752212,1.355924749881941,0.05101602620322257
25514,SIDM00834,Crizotinib,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,2.4186912,0.17782475,0.302863658349768,0.06614052290318959
31695,SIDM00628,Navitoclax,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,2.6992662,0.16337036,1.648754009252434,0.10199115859065339
58591,SIDM00954,Ribociclib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,2.3979733,0.104998976,-0.032761098637433386,0.039471015078439385
32450,SIDM00875,Navitoclax,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.97885364,0.090070605,1.1499911052307221,0.07272282736568393
79620,SIDM00875,Sorafenib,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0480559,-0.06418478,-0.9549512535155954,-0.0788186600184283
2884,SIDM00301,Lapatinib,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.83206177,-0.026965555,1.7344031805533022,0.061833221256760135
54289,SIDM00954,SCH772984,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-2.6284714,-0.16518508,-0.33673988323183024,-0.03396853087102385
5624,SIDM00359,Taselisib,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.791458,0.066164725,-0.9232390254922037,0.005757772244244448
73228,SIDM01233,Dabrafenib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.6130071,0.053193145,0.36596689929220133,0.002314892425710163
10708,SIDM00878,Ribociclib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-1.645939,-0.061551616,-0.3906860949010013,-0.013690884118612431
90146,SIDM00146,AZD7762,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.5830354,-0.040750023,-1.3091520612323304,-0.0946201454716113
24850,SIDM00531,Palbociclib,Ruxolitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.61646587,-0.02950189,-1.209259763085974,-0.008174853376809394
105174,SIDM00774,NU7441,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.6087279,0.089057304,0.4049064088430009,0.0589123756611469
18536,SIDM01233,AZD4547,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,72.0,1.704777,0.07381226,-0.27702326406481803,0.006508478536427521
96273,SIDM00146,Crizotinib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,1.2618804,0.07398943,1.4535820383099096,0.10382184413349334
1327,SIDM00660,AZD7762,5-Fluorouracil,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,2.6435578,0.19596936,1.6390909795280346,0.03940089404167711
57459,SIDM00866,Vorinostat,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-0.09133198,-0.008046622,-0.6259506332820657,-0.03726963867950296
3577,SIDM00301,Trametinib,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,-2.941497,-0.28468403,-0.7699530612929578,-0.07228701154098968
85748,SIDM00097,PD173074,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.9503183,-0.13291207,-0.9716790076450206,-0.041804754425397904
101865,SIDM00628,GSK269962A,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.475,0.17445186,0.69246653379989,0.10172393311857972
98198,SIDM01233,Dabrafenib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,72.0,1.0820905,0.044829514,-0.6616225600133144,-0.0032501045490943427
35171,SIDM00332,AZD6482,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.87443197,0.06487605,-0.1740334159202477,0.029000608420270368
106605,SIDM00097,Taselisib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.3830895,-0.19387737,-1.344628530009753,-0.0959865601522035
64691,SIDM00332,Ribociclib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.4810293,-0.110941716,-0.5170483432754424,0.02023828428709132
28765,SIDM00146,Afatinib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.8771948,0.082644746,0.2503712571995592,0.004134212993550955
16493,SIDM01233,BMS-754807,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-0.82786006,-0.053995676,0.1434095969415351,0.021939756929784
32502,SIDM00954,Taselisib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-4.425355,-0.20580296,-0.6856139229356009,-0.009026178105957308
38713,SIDM00875,Crizotinib,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1231617,-0.10270804,-0.6423605699119351,-0.053089888137357336
26583,SIDM00971,Gemcitabine,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.1399958,-0.0604896,1.388314426104741,0.09947980892342526
83968,SIDM00893,KU-55933,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.6064928,-0.07812589,-1.5613792261000272,-0.09717264806014929
10540,SIDM00866,Entinostat,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.2816169,0.09365901,0.020503255321701018,0.03196359093741629
87616,SIDM00878,BI-2536,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,-1.7631258,-0.14595577,-0.8860163108101943,-0.07608756501310465
33704,SIDM00359,AZD8055,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.16777,0.09509398,-0.6305066527241558,-0.052888775031180904
12541,SIDM00866,Venetoclax,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,1.0690365,0.011652675,2.138842086994362,0.06297563189621498
41412,SIDM00660,AZD4547,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,32.0,0.8825414,0.038155843,0.08199202221107658,0.022363576093654716
68102,SIDM00875,PD173074,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9981561,0.071475856,-0.9984907700036252,-0.02486049871288342
72826,SIDM00971,AZD7762,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.2352188,-0.005435739,-1.0177694696508421,-0.018608411637857494
97923,SIDM00875,MK-2206,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6303833,0.05885116,0.548881391927964,0.04407360036515356
95783,SIDM00097,Taselisib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.0195894,0.11068703,2.76687720282556,0.12788456246000598
102308,SIDM00097,SCH772984,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.85708,-0.119743034,-1.358014860538609,-0.09577155160997351
57904,SIDM00875,GSK269962A,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2080605,0.09443608,0.6242406044339034,0.0328402164519621
80249,SIDM00411,Navitoclax,Gemcitabine,Pancreas,0.1,Pancreatic Carcinoma,Male,East Asian,43.0,3.426581,0.15277928,1.5948999480271302,0.1106361949820813
102517,SIDM00332,Dabrafenib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.67966443,-0.017592939,1.0007276143399457,0.01637896089930085
101930,SIDM00628,Crizotinib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.6779592,-0.06440147,0.30657130334065763,-0.0032634624515463055
16384,SIDM00779,BMS-754807,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-2.7230854,-0.03872673,-1.6422978057681525,-0.0691668704438386
47998,SIDM00673,SCH772984,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-5.3902764,-0.33793676,-1.5315662117429518,-0.05735407463953779
9333,SIDM00529,RO-3306,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,0.43185964,0.017179044,0.7739176741673716,0.03488434120382734
14260,SIDM00866,Uprosertib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-2.0686195,-0.08528334,0.8083420488791503,0.07401110879045301
102776,SIDM00866,Venetoclax,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.7528941,-0.015709186,0.0945981873078725,0.06586848714802757
9681,SIDM00332,BI-2536,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5671499,0.051307023,-1.276803134352013,-0.04534069833758789
1732,SIDM00531,Erlotinib,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-2.243058,-0.12505123,-1.0777185345327993,-0.005481013403702735
1660,SIDM00130,Ruxolitinib,Dasatinib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.42282936,0.010864723,2.321777397791736,0.08111077013324851
95046,SIDM00660,SB505124,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,2.129609,0.15300676,0.39648258000024506,-0.018460105277067134
11650,SIDM00097,PD173074,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.9029396,-0.14135797,-1.6474400145336778,-0.07729739165620103
16207,SIDM00097,AZD8055,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.107934,-0.07393253,-0.4252267104712943,0.031498728230760796
6034,SIDM00779,Taselisib,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,33.0,-2.9025238,-0.18962234,-0.9003840088845868,-0.04129384032723604
72553,SIDM00146,Ribociclib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.5876116,-0.06101517,-1.0385801689303058,-0.00014353547304500052
42636,SIDM00866,Tozasertib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-3.2723937,-0.15954259,-1.641356139541893,-0.0723441387029252
97314,SIDM00130,Ruxolitinib,Paclitaxel,Pancreas,0.025,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.1120209,0.026044805,1.4563967195969432,0.034771830281384204
67015,SIDM00774,GSK269962A,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,0.5441108,0.033128843,-0.6727810533535383,0.011778458865544721
83745,SIDM00782,Taselisib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,4.0157046,0.160795,1.860354264425061,0.08807486161166236
66351,SIDM00878,AZD6482,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,1.4100742,0.08408937,0.7691669442465976,0.07987489069386891
65222,SIDM00301,Dasatinib,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.9406688,0.16962191,1.7709794874915163,0.07893348601861983
103181,SIDM00866,Nutlin-3a (-),Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,52.0,-1.1159561,-0.03258976,0.22003871092624377,0.011851961697357747
61343,SIDM00146,AZD6482,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.1367887,-0.0748759,-0.9560104077691426,-0.002392917110746055
76414,SIDM00146,Palbociclib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,2.1827922,0.19297796,-0.36810822485829653,0.0960353028885169
30432,SIDM00673,Temozolomide,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.31615153,-0.006984285,0.34094463657398993,0.014258694126868103
19352,SIDM00866,Doramapimod,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,52.0,1.3841928,0.036911085,1.8353812375948317,0.0492656478670313
24234,SIDM00954,RO-3306,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-2.9210184,-0.08092939,-1.4712119506487098,-0.05307536455535925
47007,SIDM00774,Linsitinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.8679395,0.22059357,-0.41784151512140316,0.019308774261491635
74638,SIDM00529,Cisplatin,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,1.1697447,0.0250301,1.0712191441103702,0.0239382797533838
5592,SIDM00146,Cisplatin,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,5.044276,0.23327035,3.9395667977469864,0.15133692872169158
32828,SIDM00866,Pictilisib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,-1.2946707,-0.09012338,-0.18339286929281806,0.024715898848754195
74055,SIDM00359,MK-1775,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.4700123,0.109962255,-0.4422273911555762,-0.04408142946213492
95195,SIDM00834,Palbociclib,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,White,66.0,-0.24298035,-0.016353268,-1.251335780427605,-0.06247389320473734
47839,SIDM00954,Entinostat,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-1.9390978,-0.1476677,-0.49105255050563434,-0.01819710704949368
82199,SIDM00774,BI-2536,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,1.789432,0.1301852,3.5107092696055804,0.12208450043855151
64706,SIDM00778,Afatinib,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-1.8722138,-0.07655473,-0.47129135006101724,-0.011426388250789656
68411,SIDM00531,OSI-027,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.5876434,0.20887156,2.389823243400964,0.10264423489900315
45228,SIDM00866,Docetaxel,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.5264275,-0.034880824,-0.43622815250740865,-0.022381597393957037
47291,SIDM00774,Uprosertib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,48.0,0.34415793,0.026263155,-0.2043322491066385,0.038382322606231575
8202,SIDM00146,GSK269962A,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-2.23533,-0.12512197,-0.14991331449663953,0.028591025981868936
91135,SIDM00097,Crizotinib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0162001,0.06978902,0.23705256415785642,0.03869653323992047
84708,SIDM00529,Olaparib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-3.1382518,-0.1068675,-2.424243546618314,-0.06102615716620976
52959,SIDM00866,Paclitaxel,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.0414802,-0.08766301,-1.4335541640507246,-0.1276121132615931
88772,SIDM00782,Olaparib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,-0.6846876,-0.017778829,0.8682609661297385,0.025289040746429566
100012,SIDM00332,Venetoclax,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.4502347,0.10257041,1.1652564427583991,0.0696756477134226
37893,SIDM00971,ZM447439,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.3066278,0.26108474,1.2724704111103364,0.07085210358736252
5987,SIDM00893,Lapatinib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.312579,-0.13034599,-0.23026195010506742,-0.028243965522050107
11174,SIDM00776,AZD7762,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.9923952,-0.07736922,-0.7936556389770294,-0.03753522926044025
70567,SIDM00778,MK-1775,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,2.330848,0.0665707,1.9319879378738978,0.08570049659273936
46820,SIDM00628,Venetoclax,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-1.3588667,-0.05801397,-0.33153327018544315,0.02421346406730468
32842,SIDM00776,MK-1775,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.3431556,-0.10432361,-1.5006302711258581,-0.07350426530925241
48940,SIDM00971,Uprosertib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.31323117,0.017607834,-0.5294768015557143,-0.025085265064322855
58991,SIDM00628,Vorinostat,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,1.285364,0.10740637,-0.7183146769663561,0.0014953640286953826
30315,SIDM00529,Linsitinib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-0.6973968,-0.014629173,0.4989643581706731,0.037819203881177606
81188,SIDM00834,Navitoclax,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,0.73075277,0.03833112,0.04936181587902657,0.1029541247903574
25239,SIDM00866,Bortezomib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-0.21994433,-0.015256564,-0.6990637596034671,-0.007671868262138477
60608,SIDM00954,Trametinib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,3.5618598,0.20072465,0.6185808814274585,0.09550567240771296
80616,SIDM00893,Venetoclax,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.89417833,0.03688061,1.3730165711924949,0.08228557818619149
46477,SIDM00779,SB505124,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,-3.0976598,-0.06872574,-0.6025850926812241,-0.0651218548904093
46911,SIDM00954,Alpelisib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-2.6572754,-0.1755753,-0.025843782732604948,-0.050513529402243
90893,SIDM00954,Sorafenib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,0.29813525,0.023881875,-0.07822529299239683,-0.02733428730324424
81801,SIDM00834,Nutlin-3a (-),SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,4.4000244,0.18950377,2.9610955369146374,0.07143957833234639
81140,SIDM00779,Palbociclib,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,-2.2620609,-0.05035058,-1.3029690919775083,-0.03734342605348474
91133,SIDM00779,Trametinib,Navitoclax,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,2.1858156,0.049430463,-0.12590752196535526,-0.05680177191630287
2725,SIDM00529,Alpelisib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.4386972,-0.07034689,0.9484159435241023,0.09851538895003284
47415,SIDM00529,JQ1,MK-2206,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-1.466099,-0.089363,0.18760563774146663,0.02826261734381463
48410,SIDM00301,Navitoclax,Dasatinib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,50.0,0.9600552,0.12754633,0.7943010701387019,0.06953613531059306
58457,SIDM00673,Taselisib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,3.4695897,0.2047778,-0.201799874832914,0.0063500405062406175
31249,SIDM00097,Linsitinib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.0360513,-0.108822174,0.5865074002753371,0.013250387644334444
1270,SIDM00893,Sorafenib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.2218044,0.110397756,-0.2845926880821474,0.0031468216740363412
77542,SIDM00893,PD173074,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.4466339,0.046617422,1.6579044501876974,0.07408379691428989
24015,SIDM00971,GSK269962A,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.3993057,0.09456005,0.27064370785230113,0.042783409400200395
45370,SIDM00893,Pictilisib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.7371544,-0.07478133,-1.4820718181729378,-0.11051816214324056
65844,SIDM00359,Nutlin-3a (-),SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.5564349,0.068965256,1.5002420634493328,0.020945009978768424
27460,SIDM00531,Olaparib,Palbociclib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.59483576,0.032886,0.9177630202385136,0.03720818981901717
77496,SIDM00097,Vorinostat,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.7423985,0.053328354,0.26589724895857747,0.04822716581760296
24829,SIDM00893,Bortezomib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.17415893,-0.017148495,-0.7094102244770745,-0.01869452104570014
100978,SIDM00779,Dabrafenib,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,0.4076156,0.008560005,-0.540612030839714,0.006431280602046351
17050,SIDM00776,Vinorelbine,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,65.0,-1.043292,-0.07182314,-1.2057138095842983,-0.04021821310785807
41241,SIDM00774,NU7441,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,48.0,0.1768264,0.010446348,-0.4545053545640144,-0.04207870182044157
104871,SIDM00954,Navitoclax,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,0.8306743,0.022395559,0.07070272094123393,0.06079684460051957
24599,SIDM00628,Wee1 Inhibitor,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,-0.4544606,-0.043282278,-0.5453574735721664,-0.031207965095021172
9337,SIDM00146,AZD6482,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-0.7811514,-0.052849326,0.5903086816389762,0.08485825374385936
85616,SIDM00332,Paclitaxel,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.253806,-0.15336512,-3.330410247131306,-0.2603420420991853
88564,SIDM00146,BI-2536,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-3.5660393,-0.19047886,-2.7535641204395933,-0.0659653907354766
72647,SIDM00954,Trametinib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-1.2646188,-0.05031534,-0.4087057835335205,-0.026192728491402747
16868,SIDM00130,Cisplatin,Crizotinib,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.5507555,-0.022652898,-1.4089151606587547,-0.03816904854809421
84775,SIDM00774,Trametinib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,48.0,1.8307846,0.08712677,0.7127853858487008,-0.006518972531515704
16709,SIDM00866,Taselisib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-4.2384133,-0.15232785,-1.168348863708547,-0.028206211565614286
34290,SIDM00954,Tozasertib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.0,0.22072431,0.016537677,-0.17213752094782847,-0.025029434264273877
80646,SIDM00778,SCH772984,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-0.48528802,-0.025206974,-2.05805512048103,-0.13114594976838348
35291,SIDM00673,Trametinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,8.10236,0.45357543,-0.41419143094511873,0.024215105539697385
59460,SIDM00097,Palbociclib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9134988,-0.07664655,0.13685802791295115,-0.04326922521760164
44688,SIDM00776,Trametinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,-1.86911,-0.15815645,-2.5753326627964688,-0.1164886243857171
11327,SIDM00359,Olaparib,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.34434408,0.006130982,-0.36909847436857707,-0.013360543819394227
33387,SIDM00628,Pictilisib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-1.093904,-0.09638153,-1.6424470515597682,-0.11233723081523464
88302,SIDM00778,AZD4547,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-0.48359793,-0.015470203,-0.33270713607809654,-0.0019369834744195475
106248,SIDM00971,PF-4708671,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.3646462,0.07764547,-0.6051131790171439,0.05995403229161477
15001,SIDM00878,Linsitinib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,2.7664692,0.25472414,1.460917021567378,0.11778101111272922
101299,SIDM00146,Vorinostat,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.0681348,0.09546143,-0.5664369566779888,-0.0550828890714279
85535,SIDM00866,Doramapimod,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,3.7773943,0.094423346,3.168967628906417,0.13472697775092435
78285,SIDM00193,Dabrafenib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.0329555,-0.0242537,0.22654643939705585,0.020718664830656833
89032,SIDM00097,Lapatinib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.5442803,0.11030228,-0.9091489008219469,-0.05238186605585922
59825,SIDM00782,Linsitinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,2.401189,0.14023907,0.9808763867312622,0.05894128283616384
42521,SIDM00875,Axitinib,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.3683518,0.022641953,0.40293551282001494,-0.015919914700799506
31194,SIDM00332,Camptothecin,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,0.99237853,0.024257569,1.85757983329176,0.06298477383251729
65552,SIDM00893,KU-55933,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2433683,-0.043218154,0.8867144108238113,0.025621569600334262
36867,SIDM00875,KU-55933,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.3059074,-0.050460864,-0.012138455789892973,-0.004877001086358722
6244,SIDM00332,Axitinib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2114648,0.084587105,-0.2662770379563504,-0.005859811403713287
71230,SIDM00673,RO-3306,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,1.8747542,0.1139774,-0.38342776530904504,0.007593923439529325
108208,SIDM00660,Olaparib,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,3.6849852,0.2085334,1.3870424002363357,0.0909407121330747
88350,SIDM00778,LGK974,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,3.1864595,0.07811854,0.8166382616647474,0.06708838149706343
25455,SIDM00971,Linsitinib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.4594597,-0.047834642,-0.6755195767094785,0.049864197877379036
57875,SIDM00778,MK-1775,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-1.0532867,-0.06000888,-0.8413946395871266,-0.03186681999575204
82521,SIDM00529,Nilotinib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,3.4638023,0.10207767,1.7707134685134558,0.10783857600770781
46747,SIDM00779,BMS-754807,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-0.4491547,-0.008349657,-0.6697012993844151,-0.029866641724092972
16303,SIDM00834,Vinorelbine,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-1.7962317,-0.13109668,-1.0409647480992696,-0.014533659489138859
73326,SIDM00628,Navitoclax,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,0.4864019,0.04361557,-0.5434968169361143,-0.021383544061305704
14374,SIDM00146,Bortezomib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.25157526,-0.01733175,-0.6130526206193935,-0.011602432193703095
48318,SIDM00097,Venetoclax,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.38363,-0.06114567,-1.1142355864651259,-0.053752898315355915
95522,SIDM01233,Afatinib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-1.219179,-0.08930093,0.970698170293861,0.04408595655262016
2636,SIDM00097,MK-1775,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.6111381,0.043649472,-0.6893631508610367,-0.07726134071333916
47927,SIDM00628,MK-1775,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,0.6621022,0.049342055,-0.9815213947427317,-0.06980238647840352
83535,SIDM00971,Alisertib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.0847063,0.027919853,1.1168581445469732,0.0999072181523253
64383,SIDM00628,Wee1 Inhibitor,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,1.0233979,0.09552244,-0.554054380042573,-0.048423426991761435
16442,SIDM00878,Uprosertib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-2.2180765,-0.045681916,-1.3081863065971064,0.02203529836027271
27837,SIDM00332,Doramapimod,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.40835458,-0.01627881,0.7066932336891691,0.04985186706384854
87654,SIDM00411,MK-2206,MK-1775,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.025022,-0.067612566,0.22720711415854147,0.041726665236360046
97137,SIDM00834,SB505124,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,1.0786259,0.082151905,-0.601699791591391,-0.004817422682691637
15083,SIDM00628,Entinostat,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,2.2062557,0.17583878,0.10898998000923256,0.0265862978569164
57268,SIDM00628,Ribociclib,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.6759456,0.015477095,0.21509818695581773,0.05076342683135952
92777,SIDM00673,Alpelisib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.8318055,0.13589881,-0.6999620694476598,-0.05292266482218736
66040,SIDM00146,Bortezomib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.5351047,0.03418592,-0.005258509531371899,-0.004309399766056657
4363,SIDM00776,MK-1775,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,0.44113806,0.029590152,-0.6311128071000511,-0.05500675120770231
15176,SIDM00628,Gemcitabine,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,-0.52818686,-0.015586335,-0.9848564098317155,0.008614439296347165
104977,SIDM00097,AZD8055,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.72439814,-0.050321016,-0.07155866154159625,-0.01449449456620284
33147,SIDM00866,Uprosertib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-0.86152554,-0.039715547,-1.2604004076487534,0.013386796873575682
21530,SIDM00893,Ribociclib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.3817616,-0.047414754,-0.32485997165220326,0.010897171339553242
101957,SIDM00779,Dabrafenib,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,33.0,-2.7989948,-0.1102708,-1.9510350547284123,-0.03988194469260662
73509,SIDM00531,Erlotinib,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.40948084,-0.028514639,-0.31745444847220794,-0.007246271946667309
26640,SIDM00878,AZD8055,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.0221615,-0.09599812,-0.4108017105267384,-0.05277803688649392
62134,SIDM00411,AZD7762,Palbociclib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.543033,-0.0856765,-0.6017485760389507,-0.04208082648807344
25546,SIDM00875,Entinostat,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.67154485,0.072299145,0.6841382345648914,0.0772854348197799
72312,SIDM00529,ZM447439,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.3763963,-0.07049172,-1.1000835414449868,-0.023206636509518933
22936,SIDM00301,Navitoclax,Irinotecan,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,5.0298257,0.29512504,3.461123267178979,0.22495496983372135
92480,SIDM00332,JQ1,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,5.486165,0.3532756,2.559696749934927,0.1761226023387351
68191,SIDM00866,PD173074,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,0.75560635,0.034837596,-0.39534494795073566,0.03709601859158001
23942,SIDM00097,5-Fluorouracil,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.87913144,-0.043690756,-1.0259047933126586,-0.007689958033274523
30352,SIDM00673,Afatinib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,2.5222797,0.19816986,-0.4749468676134712,-0.010919240436103709
26178,SIDM00866,Alpelisib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-4.771415,-0.26892808,-2.2806312167693155,-0.06805629850496066
85446,SIDM00954,Pictilisib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.4567232,-0.04380577,-0.09609545795625091,0.046815215740736056
78365,SIDM00097,BI-2536,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.6853595,0.13005884,0.9653460723862746,0.050924203688795563
78058,SIDM00878,AZD8055,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.8736136,0.0775496,0.4987482033088312,0.020891896945221422
40183,SIDM00866,Cisplatin,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.4252882,0.03719725,1.2343962043936314,0.04983565295167003
30256,SIDM00866,SCH772984,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-3.5708525,-0.21075179,-1.798579129153956,-0.06423697650245704
87755,SIDM00660,BMS-754807,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,1.1255544,0.10936192,-0.27147297969392453,-0.012558086486538977
47170,SIDM00628,Docetaxel,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.9683137,-0.089555755,-1.1969649368282056,-0.09481303647385257
30711,SIDM00673,Venetoclax,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-1.4348526,-0.03258721,-0.04037725693715812,0.02212535177254668
77840,SIDM00146,ZM447439,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,0.7493575,0.05254556,1.9689834951641763,0.1419700653872869
103770,SIDM00193,Oxaliplatin,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,0.1597664,0.005994449,0.610161717323911,0.028665554266317048
31133,SIDM00954,Camptothecin,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,6.387069,0.34662905,4.43079614542931,0.34516868497881215
85527,SIDM00776,Navitoclax,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-0.32070723,-0.019082118,2.395414166961032,0.027428327480845074
10617,SIDM00971,JQ1,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.8748684,0.30831367,1.1449150006117723,0.06452466531141163
104951,SIDM00193,Oxaliplatin,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,0.74903125,0.027960908,1.4386456228430329,0.044349397715105765
74842,SIDM00971,Temozolomide,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.482533,-0.05420575,-1.3991681096805682,-0.009918359055510927
91743,SIDM00097,Tozasertib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.107021,-0.0635361,-0.46028894657187874,-0.02150913925327258
88550,SIDM00866,SCH772984,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,52.0,-1.4943287,-0.104121186,-0.5093521769119611,0.01236348168521847
60101,SIDM00782,Crizotinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,2.8227508,0.24671887,1.8617866771235445,0.14954845502578776
93728,SIDM00782,AZD7762,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,Unknown,72.0,-0.3759306,-0.03482141,-0.9459275919468797,-0.03426107872572213
102008,SIDM00673,Pictilisib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.0420754,0.047141343,-0.15268941074504738,0.008730447950893389
29615,SIDM00146,MK-1775,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.65335596,-0.042722724,0.2859478499167245,-0.01991760215233982
103836,SIDM00529,Navitoclax,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,0.10383216,0.010005509,-1.0047266951330307,-0.10219333788064561
21769,SIDM00130,Erlotinib,Crizotinib,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.2710921,0.017813094,0.7106102802546006,0.06184490619631787
9898,SIDM00893,Nutlin-3a (-),Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.58682764,-0.011886965,1.5296162941172167,0.014948139128246378
7469,SIDM00971,Luminespib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.0381732,-0.13907698,-1.0078361682222219,-0.04057396375916279
15593,SIDM00097,Trametinib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8511868,-0.04974089,-1.1565983765648382,-0.05134409234492518
107300,SIDM00097,RO-3306,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.087022,-0.05650305,-0.34954717566784144,-0.02898105519646007
83595,SIDM00628,RO-3306,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-1.5522071,-0.12294124,-0.20940216390386057,-0.0345211496840864
25818,SIDM00866,Camptothecin,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,2.4329581,0.0635662,2.4800840988328123,0.07586251666732916
89426,SIDM00778,Oxaliplatin,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,69.0,-1.5207338,-0.035078943,-0.9249697352133184,0.005995347327522808
13823,SIDM00146,AZD7762,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-1.5130885,-0.12775569,-0.3453153953458451,-0.04933505237587266
25131,SIDM00778,Nutlin-3a (-),Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,1.7766849,0.02021042,2.4851402536466995,0.028061458926849792
25997,SIDM00971,Lapatinib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.62155795,0.026989538,-0.16090579605643868,-0.025629767780513932
19528,SIDM00660,SCH772984,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,0.3541075,0.02211081,-0.4474783682006433,-0.004724396737268753
10733,SIDM00332,MK-2206,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2907577,-0.124489546,-0.054305390508619905,-0.06583083972435298
60645,SIDM00782,BMS-754807,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.4367424,0.10938236,2.782841615934881,0.07893713366810808
16407,SIDM00774,Axitinib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.2422523,0.15043789,-0.88510930283555,-0.026801242050250786
43623,SIDM00146,MK-1775,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.26262257,0.020231057,0.6149703032399063,0.03373596737542579
75955,SIDM00359,AZD4547,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.0369575,-0.07176362,-0.6128999959784868,0.00853425957795312
7158,SIDM00130,Trametinib,Cisplatin,Pancreas,0.8,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.7934428,-0.1371519,-1.1535129181197514,-0.0692212207327024
101140,SIDM00673,Nutlin-3a (-),Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,1.0269343,0.02897579,2.0180760140721845,0.05731803884754598
104684,SIDM00673,Sorafenib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-2.099925,-0.10086125,-0.6628686390330295,-0.032143351190539585
75335,SIDM00332,Alisertib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-5.6077223,-0.20396912,-2.1024103012261515,-0.08515124014371604
83548,SIDM00878,NU7441,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.87893176,0.07477674,0.6593299790199897,0.06258483764371713
93517,SIDM00774,Docetaxel,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.03036668,-0.003078392,-1.1217198786536964,-0.12035288557016728
6517,SIDM00774,Navitoclax,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.67584515,-0.027526159,0.1220929766601574,-0.006191644866816323
57749,SIDM00834,Linsitinib,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,-0.22068295,-0.017612485,-0.6848165739572935,0.04029776864600367
4913,SIDM00531,Erlotinib,Ruxolitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.72585326,0.07195156,-0.18333858548155685,0.031259362578313445
96181,SIDM00531,Lapatinib,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.6042845,0.047823306,1.278901033577082,0.04446549940480632
57119,SIDM00778,AZD7762,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,2.1058407,0.113640815,-0.7999772341852103,-0.052456720762621784
79766,SIDM00301,AZD7762,Dasatinib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,50.0,2.0970874,0.21820344,0.9589095351143552,0.11544987550752452
23360,SIDM01233,Crizotinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,0.3957387,0.027569037,0.977954062289546,0.030215681739047054
88336,SIDM00673,Trametinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,8.327597,0.31828126,1.7138772756996623,0.10304292669976067
42060,SIDM00332,Venetoclax,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.43858534,0.0052293735,2.0571492615472478,0.039823475108152095
102625,SIDM00332,MK-2206,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,3.5823388,0.224852,0.6372229692024621,0.028539005202925932
35448,SIDM00628,SCH772984,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,0.1736865,0.013740861,0.5915112594249493,0.050492479182225554
53980,SIDM00301,LGK974,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,50.0,-2.539133,-0.10148201,-1.311462499790671,-0.03234478142988416
16398,SIDM00866,Trametinib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-0.5480725,-0.045048293,-0.723625933675449,-0.03724181639971044
81268,SIDM00193,Trametinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,8.716633,0.45398918,2.365467299427874,0.1521989368585527
57305,SIDM00628,NU7441,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.5534694,0.024518168,-0.36613173723814224,-0.020312344925536248
29153,SIDM00531,Ruxolitinib,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.5041178,-0.013892435,0.6704777623572118,0.006285470130451792
3483,SIDM00866,Sorafenib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.57939863,-0.019885322,1.1398652972056227,0.0780584834793383
107029,SIDM00866,RO-3306,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-1.6470913,-0.09796497,0.3214285574777814,0.015764808363126298
31763,SIDM00097,Linsitinib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.0027003,-0.10663142,0.23339539746830446,0.0009191423115307482
90683,SIDM00878,AZD6482,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-1.1269788,-0.063323244,0.06988861203221068,-0.023069244094296875
93360,SIDM00097,PF-4708671,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.9411144,-0.08926443,-1.2478476619011423,-0.04985618849548997
91366,SIDM00628,Ribociclib,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,4.6363473,0.27356094,0.7281855053159504,0.06882232223950809
47149,SIDM00954,Bortezomib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.0,0.3307009,0.011165722,0.9388454995765023,0.023329184656759618
51844,SIDM00866,Uprosertib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-2.2311783,-0.09314377,-0.7271201171606879,-0.03943538017534829
65072,SIDM00878,Pictilisib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.9199999,0.07544513,-0.7596913359682054,-0.1049236615897981
97004,SIDM00332,AZD8055,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.65763986,0.049447875,-0.11888924349303821,0.010625915738650515
82058,SIDM00673,KU-55933,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-2.2365823,-0.12414535,-1.889153362957273,-0.09929934940888893
72417,SIDM00875,Temozolomide,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8952856,0.024015035,1.2056695686572751,-0.008350311414718066
48287,SIDM00782,AZD8055,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.8331618,0.07997895,-0.044481107590156846,-0.007783343679359181
49350,SIDM00875,Axitinib,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7879617,0.05125809,-0.4124682374433104,0.010428827065731307
24657,SIDM00893,Dabrafenib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.8489742,-0.023550123,-0.13721782718822195,0.019915153732648207
83601,SIDM00971,AZD6482,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.9456004,-0.051338255,0.8901517916026163,0.07809866893601534
43470,SIDM00971,Pictilisib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.4814324,-0.058981504,-0.03895135309005304,-0.005626860589098995
88525,SIDM00529,Dabrafenib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Black,44.0,0.9057346,0.019727224,0.4211513900323275,0.027433026092776185
45789,SIDM00779,LGK974,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,5.5065417,0.11344617,1.309766179532703,0.035542319571381605
51739,SIDM00779,AZD7762,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,0.74375683,0.03291579,-0.8431738676924455,-0.06845129239292128
4515,SIDM00146,ZM447439,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.256206,0.10163372,1.3787426475679807,0.10545395963182333
12936,SIDM00301,Lapatinib,Oxaliplatin,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.7002859,0.024281077,1.885328081024357,0.06617970044360615
75462,SIDM00301,Dactolisib,Sorafenib,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,50.0,-1.390463,-0.16878772,-1.9722495041434789,-0.07561351250707939
94013,SIDM00778,MK-2206,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-0.78895897,-0.029781643,-0.734638556494649,0.03751691227275321
87236,SIDM00301,Paclitaxel,Ruxolitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.8113428,-0.05442611,-0.31345480111934904,-0.035099155658597954
19099,SIDM00673,PF-4708671,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.5340674,-0.100968674,0.04653513544478585,0.0001491288458998772
62625,SIDM00971,Vorinostat,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.8470647,0.10231972,1.3904356468475736,0.06644564033500663
49774,SIDM00893,SCH772984,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.743306,-0.10598203,-1.231678902837284,-0.04339258517786536
55245,SIDM00332,Nutlin-3a (-),OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.2942164,0.07734724,1.6790982864577229,0.030756449150438944
3828,SIDM00097,BI-2536,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.050658,0.14170137,-1.4677803228254913,-0.09250050351417985
26096,SIDM00776,SB505124,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.51742893,-0.03457914,-1.2190667670538917,-0.05166152332347939
5115,SIDM00332,RO-3306,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,1.8971922,0.11645325,0.14585439532017627,-0.018830677741094863
38701,SIDM00893,Nilotinib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.3201053,-0.10645539,-1.535848033180858,-0.09453830099004114
62496,SIDM00332,Dabrafenib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.295519,0.12936367,-0.2876746449109735,0.0024364063675741815
26555,SIDM00893,RO-3306,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.8476513,-0.06912641,-1.337093412961214,-0.04546520931214106
11991,SIDM00097,JQ1,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.440696,-0.1230016,0.3757777880340556,-0.016326269199984464
92253,SIDM00779,Oxaliplatin,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-3.1427596,-0.1920332,-1.5252123538871605,-0.10374125005112121
60813,SIDM00660,AZD7762,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,0.8217581,0.06763583,0.1745176862734948,0.014125794978379824
36910,SIDM00878,Lapatinib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.4104904,0.14753892,-0.7384620908598463,0.030615223172457396
24193,SIDM00778,SB505124,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,0.48984814,0.03128395,-0.6831653284023329,-0.006552845352616471
43261,SIDM00866,AZD7762,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-0.38124546,-0.025430465,-1.4746743410859173,-0.03616036985138256
4634,SIDM00146,Taselisib,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.8067443,-0.13374172,-1.1062851946673362,-0.0881167341805472
75232,SIDM00301,MK-1775,Sorafenib,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.7366166,-0.09689754,0.47523129110703377,0.010270674346098917
80165,SIDM00776,Taselisib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,0.84452647,0.07444152,0.7013650895116811,0.008898464445370135
86176,SIDM00411,MK-2206,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.677623,-0.11301773,-1.1098714662765023,0.01283908061261058
101065,SIDM00866,AZD6482,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.8624827,-0.034106113,1.457596472879515,0.10871607033401363
69948,SIDM00097,Navitoclax,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.10948315,-0.007465806,1.759969324895628,0.08933834649625777
27639,SIDM00529,GSK269962A,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-2.0166378,-0.13642783,-0.8371446323834855,0.02891490447099884
28928,SIDM00774,AZD8055,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.5363086,0.10790832,0.987761870627919,0.05738546561760231
94460,SIDM00531,MK-1775,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.80969894,0.09178352,-0.9846841631734093,-0.07314128034107278
62463,SIDM00971,Luminespib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.2785717,-0.058106065,-0.708522032818649,-0.057279226147020454
92524,SIDM00954,Tozasertib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,1.5621984,0.12568817,1.3290005706312402,0.08903435371247692
88524,SIDM00130,Oxaliplatin,Dasatinib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.91961604,0.047085334,-0.33700580816846093,0.02902562446224425
3281,SIDM00878,Ribociclib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-2.358018,-0.08072937,-0.4977757431464974,-0.03112786290448037
87329,SIDM00529,Entinostat,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-2.4631557,-0.06119112,0.30725051838296086,-0.007881332787732571
81314,SIDM00097,Luminespib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5760068,-0.1005148,-1.8163263307924915,-0.06940242897846063
10744,SIDM00954,5-Fluorouracil,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-1.0631537,-0.046156127,0.3447855658005086,0.0972575196914164
1371,SIDM00146,MK-1775,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.00355,-0.05376206,-1.33222444349404,-0.03253755157861811
27849,SIDM00774,PD173074,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,2.3228984,0.19978194,1.7968579200531725,0.07204331910484175
34181,SIDM00776,Camptothecin,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-2.3932536,-0.14549564,-1.439138562777565,-0.07193659477058409
5326,SIDM00130,5-Fluorouracil,Gemcitabine,Pancreas,0.01,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.5818787,-0.17613621,-1.90691944116449,-0.11545895418049214
35857,SIDM00531,Linsitinib,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,5.7186103,0.5744708,2.7200565157174026,0.17729481791085844
14994,SIDM00893,Alpelisib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.46759734,-0.03924411,-0.7268845656867369,-0.07420166499367323
4006,SIDM00146,OSI-027,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.6721841,0.14419673,0.9229362973682073,0.0618639917277593
77470,SIDM00866,Entinostat,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-1.4501606,-0.10818379,-0.13539262002635705,0.01637582747325143
51754,SIDM00097,BI-2536,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6240884,-0.112933695,-0.7779681514981625,-0.07658131224735995
106553,SIDM00332,JQ1,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,2.1414654,0.10099973,0.27087717708125203,0.06087053283976551
70833,SIDM00301,Linsitinib,Dasatinib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,50.0,2.6428025,0.19628772,1.785989192532987,0.1548995083763002
47201,SIDM00531,Oxaliplatin,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,5.3485603,0.45481756,1.3442524667440783,0.07074373555998457
91304,SIDM00673,Navitoclax,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,2.5347993,0.25006962,0.22816218940693916,-0.03830574373360233
28034,SIDM00332,Venetoclax,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.74619675,0.013687573,2.41310656121258,0.05937150368633987
53717,SIDM00954,KU-55933,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.5189611,-0.010807235,0.5600083604184166,0.02568088390943946
60745,SIDM00097,Uprosertib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.406756,-0.18171051,-0.8788659296701964,-0.052433802537610257
49197,SIDM00097,Vorinostat,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.62970644,0.042579867,1.2715321062075746,0.14692639335262628
16504,SIDM00531,Taselisib,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.1738908,-0.06436096,0.6352243058876444,0.08411950824991435
6867,SIDM00834,MK-2206,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,3.7408602,0.17107713,2.49316015223246,0.16121292828805633
5264,SIDM00774,Uprosertib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.6753123,-0.18602936,0.1975754129828358,-0.017652748891870497
84950,SIDM00954,Alisertib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-0.95047486,-0.0708645,-0.0474486041347601,-0.04672071811815026
105761,SIDM00774,Pictilisib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.7852259,0.019304834,-0.370412467509596,0.0017087167313701655
49751,SIDM00531,MK-1775,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.8160815,-0.14400512,-0.9552842268516473,-0.038654427751992425
45313,SIDM00779,MK-1775,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,1.5293262,0.052236315,1.0533392253117122,0.013338585348358679
70314,SIDM00359,SCH772984,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.3349444,0.081969395,0.1247098476804953,0.010559899787468807
102551,SIDM00359,MK-1775,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.84755814,0.06547723,-0.9354742312652785,-0.05050332375564525
90771,SIDM00411,Erlotinib,Sorafenib,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,43.0,-2.0073965,-0.07728977,0.46330276416415567,0.01812734104295602
33313,SIDM00878,Tozasertib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.0511432,-0.07231687,0.14502887606651985,0.05210117197065123
25975,SIDM00878,MK-1775,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-0.23706526,-0.027552053,-1.6137634144057937,-0.12498086428735353
101788,SIDM00878,Crizotinib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-0.46341357,-0.053393137,-0.974934099471803,-0.08963836056451671
20363,SIDM00875,Luminespib,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.30413842,0.032515846,-1.1712024189351,-0.0417356134435919
104316,SIDM00097,Cisplatin,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.86624545,0.017755238,1.9094511873977982,0.12645529991358653
33203,SIDM00866,Temozolomide,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.1727961,-0.02081683,1.0089492350177127,0.025740545419710922
102131,SIDM00893,SCH772984,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.0785584,-0.12421183,-1.850509158768021,-0.09581156542655972
25814,SIDM00878,PF-4708671,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,70.0,0.32680264,0.019121451,-0.8874296400039798,-0.04349004690716874
45004,SIDM00193,AZD7762,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,East Asian,53.0,6.003101,0.48216748,3.097996714408535,0.17675053137515198
45790,SIDM00628,Olaparib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-0.90078586,-0.057162244,0.3939246882922004,0.10402326501088255
98816,SIDM00893,Olaparib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.197768,-0.067659564,-0.7839612525306328,-0.024123734818072198
78039,SIDM00097,Alisertib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1064074,-0.061855398,-0.7652556825262916,-0.054584231796909854
28692,SIDM00971,Palbociclib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.50429904,-0.012408177,0.7842690671409105,0.06314871656710154
104337,SIDM00146,KU-55933,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.4973316,-0.05178398,0.36586012665583706,0.06200695178835028
48535,SIDM00834,SB505124,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,0.48555487,0.040871046,-0.6519689601996261,-0.005215106355719134
71929,SIDM00776,BMS-754807,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.2199888,-0.09013319,-1.7986588755064215,-0.08389048748420515
14973,SIDM00971,AZD8055,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.7986165,-0.04964473,-1.0406079147993286,-0.08139406960462628
98514,SIDM00529,Axitinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,-1.5631804,-0.10485418,-0.9655627735550077,0.004797628056650194
101570,SIDM00359,SCH772984,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.8940046,0.11663284,2.191164292394335,0.08812571894648417
67114,SIDM00878,Cisplatin,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,0.3745953,0.011251927,0.6278005745784258,0.024547103242242168
79682,SIDM00146,Gemcitabine,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,2.0098972,0.107038744,0.8193995855061612,0.10756402596336777
32497,SIDM00866,Tozasertib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-2.8178415,-0.122315,-1.8253040089889354,-0.0702535950061443
87116,SIDM00628,Alpelisib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,1.1384159,0.058390033,0.5601855416478015,0.08247541147065018
79336,SIDM00878,Navitoclax,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,0.16198356,0.0037094916,-1.0042532559105122,-0.028129060272660916
45525,SIDM00875,Navitoclax,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.45126337,0.03818225,3.089576678885985,0.1219223202439212
33202,SIDM00878,NU7441,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.38346535,-0.03690248,-0.09104988521517973,0.027678294289631547
16642,SIDM00774,PF-4708671,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.3950793,-0.04524328,1.0208021659425128,0.052823160631663785
16560,SIDM00628,BI-2536,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-2.3857143,-0.1105851,-0.25815930310004337,-0.03129594725897336
80744,SIDM00628,Vorinostat,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,0.1348654,0.013218041,-0.24875256944248963,0.027384897104930386
64624,SIDM00866,Uprosertib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-1.3525655,-0.060085602,-0.23072930860476487,0.007625614450637727
81702,SIDM00774,5-Fluorouracil,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,3.0365956,0.14674942,0.540483768051517,0.08482935744308408
39411,SIDM00893,Tozasertib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.7766762,0.099218756,0.19287271386734395,0.07206559777061629
66234,SIDM00529,Uprosertib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,2.556159,0.21217974,-1.8093708358870333,-0.006162278521815351
91195,SIDM00332,Dabrafenib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.725528,0.26396644,0.5597429044667616,0.0906007717821184
15870,SIDM00332,OSI-027,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.8819016,0.16452132,0.11146780948288479,0.017154100552736196
39201,SIDM00301,Linsitinib,Taselisib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.0913011,-0.02681186,0.8909763700151604,0.043626821261637826
74019,SIDM00628,Alpelisib,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,Black,51.0,2.0006862,0.14396594,-0.6916735874331159,0.0027250188371230237
49196,SIDM00130,Paclitaxel,Ruxolitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.725341,-0.07575154,-0.33595609369224155,-0.022937443869505695
46707,SIDM00146,Alisertib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.25811547,-0.022876756,0.24097732479986575,0.023435549249975825
58007,SIDM00193,Afatinib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,1.2721642,0.10524387,1.6281929739379444,0.1478451725965858
17606,SIDM00878,KU-55933,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-0.5904391,-0.019919872,-0.49497286714610766,-0.006323929365938634
52879,SIDM00778,LGK974,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,1.341983,0.02653599,-0.32790202138642704,0.01397694657617122
77831,SIDM00529,AZD7762,Trametinib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-0.36665675,-0.025353108,-1.2038732431572974,-0.0376949076192237
78745,SIDM00954,Dabrafenib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,2.2353694,0.09975513,-0.16364685686395014,0.00046366020974236715
8440,SIDM00097,ZM447439,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.6654231,0.033276692,0.6960728685018845,0.11810768966036161
2002,SIDM00866,Navitoclax,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.0498613,-0.09144713,-0.2954173044146191,-0.014410988154875081
69072,SIDM00332,OSI-027,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5227926,0.05264858,-0.0443219772253761,0.04079086502481567
33743,SIDM00834,Camptothecin,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,-0.86815685,-0.048650295,-0.4606036542665485,-0.006930662109923481
92717,SIDM00531,Gemcitabine,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-2.9086888,-0.31878564,-1.0689218121432815,-0.0839184015871435
34781,SIDM00893,AZD7762,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.92653495,0.045106243,0.4580161413048437,0.05578968736627328
15902,SIDM00866,Pictilisib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-1.7539989,-0.15654853,-0.901919617429398,-0.06711321254961707
4431,SIDM00660,Linsitinib,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,2.8290849,0.25052112,2.672960960253856,0.13508075833302224
4342,SIDM00779,Vinorelbine,AZD4547,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,0.7756322,0.019624574,-0.05442940521759984,0.0519214369907278
79661,SIDM00146,JQ1,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.3563439,0.02752792,0.8044527662908474,-0.00617563183045431
95718,SIDM01233,Oxaliplatin,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-2.6115303,-0.17230013,-1.905718741238325,-0.14657694193256837
53987,SIDM00954,Doramapimod,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-2.1145866,-0.09574469,-0.43734225918612557,0.05748925761953446
32546,SIDM00673,Ribociclib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.7120984,-0.07656349,-0.32718415142525753,0.06758496110771949
105949,SIDM00866,Axitinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.39749604,-0.009240355,-0.9815491433595321,-0.02082140384108462
40125,SIDM00193,AZD8055,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,53.0,-1.1276265,-0.08552263,-0.16377394893859631,0.024735538209166914
85675,SIDM00193,BMS-754807,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,53.0,-0.7451735,-0.042329237,-1.1696485830191095,-0.010646678390628115
106166,SIDM00531,Olaparib,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.4900087,0.09566909,-0.24432248875297646,-0.015637687938729074
43706,SIDM00834,MK-2206,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,1.722363,0.096686825,0.27196701614536917,0.08406148426837047
57944,SIDM00774,JQ1,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,-0.64550024,-0.03396285,0.9247561212885077,0.09035775626601336
28017,SIDM00866,Cisplatin,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.4734055,0.027788496,2.3925958563458334,0.08122091533044587
41292,SIDM00971,SCH772984,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.1513354,0.02698098,0.8190775612277832,0.04827174322613771
20961,SIDM00193,Vinorelbine,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,53.0,1.5231133,0.11549099,0.024496540225042062,0.0016312666501184451
35642,SIDM00779,BMS-754807,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-2.9428542,-0.02905088,-4.109527456613464,-0.1500817089484673
37227,SIDM00301,Sorafenib,Oxaliplatin,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.2450702,-0.22147079,-1.4573158171887513,-0.1067239790403872
44402,SIDM00146,Doramapimod,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.2732159,0.07558602,0.11163116611639529,5.70853690756678e-05
21920,SIDM01233,Afatinib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,3.2914455,0.2564492,0.15414731558817962,0.07571661603493228
24944,SIDM00954,AZD6482,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-1.1113359,-0.06779042,-0.44617193523309356,-0.05059352832478553
47112,SIDM00660,Oxaliplatin,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-1.6223593,-0.12614232,-1.5350322706736315,-0.09733238785164088
102652,SIDM00875,Wee1 Inhibitor,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6706161,-0.02961998,-4.4475896700877025,-0.15157179107794572
16568,SIDM00878,Palbociclib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.4896057,0.040348127,-0.13367159527403472,-0.0207642123915111
78238,SIDM00628,Navitoclax,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.6924453,-0.07033364,-0.586491546278697,-0.045813539248827084
54101,SIDM00779,AZD4547,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-2.40888,-0.014029131,-1.1368986254922446,-0.06244967557657548
47142,SIDM00529,Navitoclax,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.1991822,-0.01979591,0.14944546034544146,-0.04656761587311328
33779,SIDM00875,Wee1 Inhibitor,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.14328916,-0.00795272,0.523071803681945,0.02996309362157204
2972,SIDM00866,Sorafenib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.5108473,0.07843403,2.5637754403504043,0.08749366896444973
100384,SIDM00782,Trametinib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,1.0756396,0.06961068,0.7646712561866509,0.034059482831118135
86645,SIDM00954,Paclitaxel,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-0.69114935,-0.051856287,-2.40983747614785,-0.2049016013821141
92181,SIDM00660,AZD7762,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,1.1152611,0.07627209,-0.19974006486075577,-0.03926822447719697
9623,SIDM00529,Venetoclax,PD173074,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.8390494,-0.02373318,0.16794705687884356,0.019688109102268276
14908,SIDM00146,Camptothecin,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,2.8302693,0.2701057,1.5372653776832348,0.18316752213498574
50627,SIDM00971,Sorafenib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.188251,-0.11084668,0.45571004013415267,-0.010607020350044408
17161,SIDM00782,MK-2206,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,3.7592394,0.1973651,1.559722982770361,0.08985820712985311
107308,SIDM00628,Taselisib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-1.1027609,-0.0980586,-1.6090056482620922,-0.010948178582334553
78101,SIDM00782,Afatinib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,1.472054,0.11916644,1.45550209124894,0.09552984992525784
38469,SIDM00878,PF-4708671,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.618193,0.039081223,0.07460044406488997,0.009341098741746429
1227,SIDM00875,SCH772984,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4670365,-0.049376965,0.33294033348341817,0.0033037891491268633
15742,SIDM00628,Sorafenib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.07811429,-0.00774656,-0.7919437275695115,-0.049252384521166086
105272,SIDM00628,Alisertib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-3.5816576,-0.20725021,-0.4715361663114839,0.001279655524092187
106056,SIDM00301,Irinotecan,Olaparib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,2.1549368,0.28540903,0.5078095055621216,0.09090562977429063
34834,SIDM00971,Uprosertib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.64107215,-0.033580843,-0.21582458848970276,0.00773366574791451
74636,SIDM00893,JQ1,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.1916159,-0.055379875,-1.638613316826473,-0.004794003416608435
22258,SIDM00529,Luminespib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,0.6964514,0.071427554,-0.7129823065199349,-0.03059261926208864
65284,SIDM00660,Palbociclib,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,3.1799443,0.18972653,0.7849128108095346,0.04923555225937559
46067,SIDM00193,Nutlin-3a (-),Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,East Asian,53.0,2.341442,0.06314552,0.5546114170211618,0.03384209294831854
47542,SIDM00779,Nutlin-3a (-),LGK974,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-1.6278579,-0.053019177,-0.7322979285859038,-0.0011299412875899024
107559,SIDM00779,MK-2206,Vinorelbine,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,33.0,1.0056995,0.07485693,-0.16752479651859717,0.04282529026516061
40042,SIDM00971,Nilotinib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.3466325,-0.09050974,-2.0031261596393817,-0.1390943937366758
88352,SIDM00531,Palbociclib,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.2387217,0.08521339,-0.3470609541597434,0.0019306154629220244
65796,SIDM00954,RO-3306,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-0.5450577,-0.044646595,-0.8823609202249324,-0.02842648606701718
22078,SIDM00774,Cisplatin,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.0742139,0.036388915,0.6572110848270074,0.06855540973952925
103323,SIDM00774,GSK269962A,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.8724133,-0.046317816,-1.3965901309676378,0.006874036962351274
82266,SIDM00893,NU7441,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.1122386,-0.035891317,-1.3962916226891553,-0.01151243618349374
68038,SIDM00673,PD173074,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.8614295,-0.11623133,-1.250257191892084,-0.09367246492351353
81860,SIDM00146,Palbociclib,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.81688714,0.06335447,-0.16265088258004276,0.08508931641256459
7164,SIDM00628,Wee1 Inhibitor,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,1.8848606,0.15027586,1.221334689628952,0.1002812678991732
107231,SIDM00782,AZD7762,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,Unknown,72.0,4.492337,0.23876847,2.4789992372243663,0.13027449841347413
85570,SIDM00628,Bortezomib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.3277864,-0.016334705,-1.3755038666744555,-0.03212914492993087
27970,SIDM00673,Docetaxel,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-4.7195992,-0.2736,-3.569710573310404,-0.25775823422929356
65904,SIDM00097,Alpelisib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2809248,-0.089348994,-0.17867863719753438,0.07589142180150636
39245,SIDM00866,Ribociclib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.4406071,-0.06303406,-1.0144694855165832,-0.06382349935736002
27440,SIDM00893,JQ1,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2656275,-0.059935343,0.24563638262499557,0.05826694982121689
78077,SIDM00778,Navitoclax,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,2.0715883,0.11131136,2.2066953554193804,0.08844994239273198
87297,SIDM00146,SCH772984,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-2.0514746,-0.13682555,3.2208138097133068,0.13261093442588628
28949,SIDM00954,MK-1775,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,0.81643,0.061769728,-0.37840007718197616,-0.04274254220423718
91869,SIDM00834,SB505124,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,3.4880705,0.20917138,0.562861887756641,0.04436397464518229
59278,SIDM00875,Pictilisib,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.9543467,-0.0284005,-1.0266163498325813,0.0006566627353587219
85365,SIDM00529,5-Fluorouracil,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,0.8700667,0.081162505,-0.785362741926007,-0.01718456691137567
63371,SIDM00673,Cisplatin,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,1.4916584,0.07136714,0.725257698105575,0.05986218604949534
12174,SIDM01233,SB505124,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,0.5426253,0.015672646,-0.6070099015677158,-0.034096823775225965
90348,SIDM00774,OSI-027,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.4067344,-0.057133157,-0.03146003226517557,0.018108083438552348
3838,SIDM00097,KU-55933,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.0497193,-0.11293181,-2.5374297491202547,-0.08168802381571187
103045,SIDM00301,Dasatinib,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.5688721,0.19066311,3.348858186009542,0.16937130869460684
53379,SIDM00146,Alpelisib,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.5612874,0.10458665,0.582587927952357,0.04768120723469081
64296,SIDM00866,Palbociclib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-0.6813941,-0.017773738,0.8535683321649978,0.0633219461822822
103422,SIDM00130,AZD7762,Linsitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.9586496,0.09552194,-0.2415899121228752,-0.000530285679616492
78487,SIDM00097,Uprosertib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.49658948,0.032695297,0.9767899327624305,0.1308904757256617
45145,SIDM00878,OSI-027,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-0.65415937,-0.061293844,-1.325422911098512,-0.1015570810245161
73730,SIDM00971,Venetoclax,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.1202862,0.048639487,0.493306302623553,0.017175472134107025
27757,SIDM00866,PF-4708671,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.4938576,0.090625264,-0.1275379581389291,0.060481150110880386
55309,SIDM00628,Alisertib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-1.4620999,-0.062133905,-0.03557510977110925,-0.033821413355477704
56814,SIDM00146,MK-1775,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.43049768,0.026608396,-0.2715934169472276,0.005459674985319951
95011,SIDM00411,Sorafenib,Oxaliplatin,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-4.29063,-0.16946013,-1.199117254969355,-0.05120943673350496
26846,SIDM00332,Axitinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5200745,-0.11924404,-0.8984859402031364,-0.11281669415498224
103997,SIDM00866,JQ1,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,-0.8478218,-0.046375427,1.5415792773580135,0.14868703460814633
101607,SIDM00866,Docetaxel,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-4.1515136,-0.2852496,-3.006568267891154,-0.1871618977036093
82166,SIDM00673,Dabrafenib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,1.7856649,0.045663986,2.179521625106398,0.05118442228685102
42073,SIDM00866,Entinostat,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,1.5081402,0.12134995,-1.181219697646527,-0.05684063566181683
103793,SIDM00529,Alpelisib,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.29165086,0.01858299,0.9100363967883801,0.08427848492453371
29985,SIDM00878,Axitinib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,0.23629327,0.026202673,-0.4583937011162324,-0.017770467231178092
91273,SIDM00628,Doramapimod,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,2.4377525,0.06881507,1.546010348898144,0.07764703633500734
14433,SIDM00628,MK-1775,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.77115816,0.06513795,-0.43081025317904126,-0.025753931516021514
45190,SIDM00878,Bortezomib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.522528,-0.014806048,-1.3604714942260325,-0.08647872249900347
43545,SIDM00529,Navitoclax,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Black,44.0,0.09964144,0.009738439,0.628007287203049,0.08568844093007025
74140,SIDM00146,Venetoclax,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,0.7763143,0.019242406,1.426486512071417,0.07684677703252824
23688,SIDM00834,SCH772984,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-0.42027122,-0.034389906,-0.9307394094004623,-0.03303897580592525
48549,SIDM00628,Doramapimod,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.3390505,0.10142266,1.9985942588223993,0.0774097332481337
19701,SIDM00875,RO-3306,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1725949,-0.028769653,-1.1656316648672895,-0.12442314737391202
95096,SIDM00301,Ruxolitinib,AZD7762,Pancreas,0.0625,Pancreatic Carcinoma,Male,East Asian,50.0,1.8387828,0.10864746,1.168025718638133,0.016939401601185337
96129,SIDM00866,Entinostat,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,52.0,-0.13904357,-0.010652808,0.5343177243961493,0.053332879552285856
17849,SIDM00332,JQ1,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2745626,-0.044069473,-0.7443556959010221,-0.03803317634392814
79195,SIDM00332,OSI-027,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.87132907,-0.090257615,-0.5409983326549775,-0.06663869637023015
44608,SIDM00332,KU-55933,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.675869,-0.081203036,-1.0980655889753086,-0.03845256233579491
47946,SIDM00097,Afatinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.797868,-0.051569495,-1.1268444259492219,-0.08338205135413479
58264,SIDM00774,Alpelisib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,48.0,-1.7501317,-0.113843806,-0.23827324262526767,-0.015516525673644012
5865,SIDM00878,PF-4708671,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.7659075,0.10035915,0.32748576767864784,0.03747101544550971
26747,SIDM00146,Trametinib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.8604128,-0.07015649,0.8556493348814876,0.010152087631930455
25151,SIDM00779,AZD8055,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,33.0,-1.515142,-0.13722186,-0.5724816931956237,-0.06185371423066257
22945,SIDM00628,Venetoclax,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.7372795,0.11860969,0.14027763777471267,0.055072628142646844
100944,SIDM00971,Alisertib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.7383818,0.016669428,0.5428065879190731,0.07253296512300356
88285,SIDM00146,Trametinib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-1.6082926,-0.12509207,-1.060643370740654,-0.09437367541196803
39214,SIDM00660,Navitoclax,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,3.5692134,0.18305688,1.1116206409575657,0.036910775162484075
70981,SIDM00893,Wee1 Inhibitor,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-3.3041444,-0.2326484,-1.2845697964101717,-0.10389011009301839
82165,SIDM00531,Palbociclib,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.2916166,-0.048288334,0.2294100694283346,-0.00883561791256522
55496,SIDM00971,Wee1 Inhibitor,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.8657429,-0.024837727,-0.6871041238902409,-0.03443966659033771
87030,SIDM00779,Trametinib,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-0.76319534,-0.023509832,-2.057189147280213,-0.07862318653643274
44027,SIDM00332,JQ1,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,6.744491,0.24261868,2.8813943675476468,0.1290086639201061
4938,SIDM00673,Vorinostat,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0718995,-0.105007336,-1.0898224638069953,-0.011851392445092906
102918,SIDM00097,KU-55933,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3776355,-0.074584164,-1.2369684551361046,-0.03790654370785023
94896,SIDM00628,Pictilisib,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,-0.36494267,-0.032232855,0.2590257599704627,0.10032257189062375
42859,SIDM00971,RO-3306,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.41444,-0.094313234,-0.42817293627608455,-0.02966137422843977
52559,SIDM00866,AZD7762,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,-0.21112964,-0.01225779,-0.8165708791358673,-0.03237100728915918
1405,SIDM00146,Doramapimod,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,3.0626764,0.14386667,2.2733517821575098,0.08446640696250864
29603,SIDM00782,AZD8055,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,-1.6407102,-0.12976624,1.0898741744243523,0.03559587178805611
81757,SIDM00301,AZD7762,Oxaliplatin,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.8286994,0.14978106,0.23503192610555337,0.009329604351218403
70644,SIDM00411,SCH772984,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-1.4592648,-0.066508904,-1.4903305596389833,-0.08318221284010928
60767,SIDM01233,Taselisib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,72.0,-0.5042456,-0.040795796,-0.9991535128731578,-0.04267800291366204
29190,SIDM00332,PD173074,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-4.3632464,-0.08707879,-2.490241537121585,-0.07938099635610454
45983,SIDM00866,Luminespib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.41105914,-0.035015516,-0.8859743080824384,-0.01850574892280918
6520,SIDM00866,Olaparib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.9369317,-0.03530023,0.33730724213588,0.021305974763432114
53983,SIDM00628,Linsitinib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,0.83753735,0.06928689,-0.3926360552821574,0.006134702059404102
19442,SIDM00878,Cisplatin,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,3.586261,0.11767772,1.3947754117456357,0.11169412598495881
90770,SIDM00673,Camptothecin,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0824766,-0.031593252,-0.49523908236135317,-0.015074477333326031
24133,SIDM00332,Paclitaxel,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,2.8100836,0.19035625,-1.0586874990426831,0.02171073279982605
29513,SIDM01233,AZD7762,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,72.0,1.5856968,0.039449725,1.8024265643247481,0.07206299478132945
70597,SIDM00878,Olaparib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,70.0,-0.3711938,-0.009810218,0.16873844679736147,0.03103265059721281
37675,SIDM00146,Axitinib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,1.6833689,0.10006143,0.3173907219223626,0.09778457330135916
79981,SIDM00097,PD173074,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9790173,-0.09090127,-0.7215781203933469,-0.05005610502986954
10600,SIDM00893,Paclitaxel,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.47672468,0.037282795,-1.1919501846498883,-0.04786219801506914
106265,SIDM00529,SCH772984,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.9457377,-0.067133464,-0.28654987719449815,0.03454981129360027
2754,SIDM00097,Olaparib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.7923478,0.041511334,1.5909602482911953,0.03178053404972656
12264,SIDM00301,Linsitinib,5-Fluorouracil,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.9338267,-0.023033047,1.0983071815470233,-0.007676739902123513
38472,SIDM00954,Olaparib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-1.7435995,-0.03245034,0.4491148048368359,0.05317683035308059
41674,SIDM00146,GSK269962A,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-1.4097552,-0.0877841,0.852337910592165,0.09547267462383731
84922,SIDM00130,Gemcitabine,Navitoclax,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.1763337,0.10161068,4.13380269980086,0.16360518414730144
93296,SIDM00628,MK-1775,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,0.68685466,0.054623626,-0.35959179549137066,-0.033880765108244525
93430,SIDM00332,Crizotinib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.9933127,-0.17591205,-0.7267228446805196,-0.08928072201939909
92598,SIDM00782,AZD4547,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.46522874,-0.013345075,0.13819664535875867,-0.005252573680264276
74107,SIDM00193,Oxaliplatin,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,53.0,0.9738181,0.042763777,0.7722135962955641,0.02314000717486435
57079,SIDM00673,MK-2206,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.0747395,0.06573579,0.6456899969275889,-0.002583554938502878
60981,SIDM00628,Sorafenib,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,Black,51.0,0.1564533,0.014880044,0.020578151717106523,0.0038342383581437107
5952,SIDM00146,Lapatinib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.41866574,-0.039571196,0.4251101912494198,-0.03482442816511533
41773,SIDM00782,Linsitinib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,1.8960867,0.101678886,1.6890664290442612,0.14539167240933087
81748,SIDM00866,Navitoclax,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,0.29216793,0.019115875,-0.01668203763825098,0.039534815699163776
13225,SIDM00971,RO-3306,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.0932057,-0.056892283,0.5143791551840409,0.07282129109623726
13183,SIDM00628,Dabrafenib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-3.0707908,-0.14281926,-2.2980001212384686,-0.11150480658019762
7155,SIDM00531,AZD7762,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.2302687,0.22261061,1.8425765282981563,0.09550084288357717
26676,SIDM00875,Palbociclib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7807773,0.06165422,1.2755123928116427,0.05806689451606302
60538,SIDM00529,RO-3306,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Black,44.0,-0.43222573,-0.015221478,0.48167200535171967,0.027096197980786475
39104,SIDM00673,Venetoclax,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.1233256,0.07803594,0.6122060489214739,0.010178151497646393
30043,SIDM00834,Taselisib,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-0.39076415,-0.02720637,-1.5979626495647696,-0.05626816827616949
54840,SIDM00146,BI-2536,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,1.6969666,0.04791372,0.22923608700877493,0.008872535230813583
107400,SIDM00673,Uprosertib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.24422847,-0.017411973,-0.8900234494670255,-0.024992759873886643
61100,SIDM00971,Palbociclib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.92146325,-0.026766473,-0.9626906318967977,-0.010410170595817194
107924,SIDM00531,Irinotecan,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.6413702,0.054131422,-2.9603619315865584,-0.1635608059750914
90094,SIDM00531,Oxaliplatin,Palbociclib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.16180621,0.0054363315,1.1363405717105663,0.06024082084390457
72707,SIDM00130,Trametinib,Ruxolitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.8955162,-0.15338853,-1.0633959167708642,-0.06094495583784152
85170,SIDM00301,Erlotinib,Linsitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,1.8487066,0.1237286,2.9803127312010935,0.12335060775164616
4893,SIDM00954,Entinostat,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-0.98924476,-0.07018816,0.26775606759811504,-0.0029445726636689747
13534,SIDM00628,MK-2206,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,1.7086773,0.1173336,1.2575088329971562,0.16340713493347617
84355,SIDM00776,Camptothecin,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,2.168016,0.1966623,2.8405502032484793,0.22460990555856278
60185,SIDM00411,SCH772984,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,4.9236445,0.26435152,2.308756748881687,0.15968991502033245
103142,SIDM00529,NU7441,Taselisib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,0.57227665,0.047156204,0.5533841936578507,0.037344153643969244
51720,SIDM00971,Paclitaxel,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.372187,-0.07898662,-0.6931950333085023,-0.006843097812072393
28190,SIDM00301,Olaparib,Crizotinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.6345588,-0.101164326,-0.8515349638675878,-0.02160455411055959
93577,SIDM00673,5-Fluorouracil,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.48366475,0.024645975,0.3195275003071636,0.03303167815931945
12479,SIDM00097,Nilotinib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.55377024,0.036392182,0.7661969711072757,0.04543309228777423
17946,SIDM00878,Trametinib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,1.5590458,0.16698337,2.149846553222237,0.0942022043359364
57325,SIDM00778,LGK974,Taselisib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,3.3490012,0.08885857,0.5912820319177198,0.05936302459268355
51002,SIDM00332,Temozolomide,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.84184545,0.018256305,1.2385581340630818,0.005951747470567911
98545,SIDM00893,Alpelisib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.6052652,-0.054005608,-1.3828246515769669,-0.11483740383418549
62444,SIDM00954,Crizotinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,1.8811074,0.13394162,-0.332493785342822,-0.027537759583539455
57323,SIDM00893,Lapatinib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.1204147,0.21565554,2.189198693420401,0.189360740451447
3550,SIDM00875,BI-2536,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-3.3279834,-0.20519674,-3.359585923219362,-0.09355668547134095
71218,SIDM00878,Docetaxel,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-1.5776725,-0.1598467,-0.08508910702571996,-0.0027539061145186116
41738,SIDM00776,MK-1775,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.3136789,-0.09007399,-0.7910989922056354,-0.03963391351927738
106532,SIDM00097,Nilotinib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.3093707,0.022109177,-0.09909297099797187,-0.023052650042617504
1080,SIDM00878,Venetoclax,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,0.5771469,0.020787025,1.0541774106120918,0.05453054972658991
43838,SIDM00673,NU7441,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.7809456,0.061478555,0.18340485480756089,0.05577386253944603
89047,SIDM00878,Trametinib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.3011348,0.13640608,0.6675490368712548,-0.001874080011284947
88646,SIDM00834,Crizotinib,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,1.9604645,0.158145,-0.5498909726963829,-0.0016631498797329072
94376,SIDM00954,Entinostat,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-1.2066526,-0.09059822,-0.4807914482157448,-0.0012382726806012736
51109,SIDM00529,JQ1,OSI-027,Breast,1.0,Breast Carcinoma,Female,Black,44.0,1.0486003,0.08178894,-0.3356507255554842,-0.011546515915287336
87693,SIDM00529,RO-3306,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Black,44.0,2.433747,0.13865182,2.673048134938005,0.07695074971637351
27655,SIDM00146,5-Fluorouracil,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,-0.22997382,-0.016000362,-0.8142398332769528,-0.04902527393812512
51181,SIDM00332,Paclitaxel,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5972827,-0.04532555,-0.825198118193054,-0.06028553182597896
19457,SIDM00971,5-Fluorouracil,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.5719175,-0.016308907,-0.6101954015086963,-0.0032225736047379197
51482,SIDM00971,KU-55933,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.8385959,-0.025667237,0.40237886230487896,0.0040020978948872455
21542,SIDM00332,Camptothecin,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5370404,0.03078091,4.05117237166652,0.1360680687383576
49160,SIDM00954,Entinostat,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,0.9965324,0.076324485,-0.028412714165605656,-0.004042023639362785
52226,SIDM00628,5-Fluorouracil,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-1.2904149,-0.062059153,-1.0263812511131367,0.020828614898610442
14298,SIDM00776,MK-2206,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,1.4131615,0.124488145,1.2377855891906702,0.11057350858646829
85428,SIDM00774,AZD7762,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,3.91088,0.56520176,1.8378822883457546,0.19193707039628227
93749,SIDM00332,Cisplatin,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.8182071,0.03843575,2.0250083394918135,0.04420339676347951
37397,SIDM00866,Nilotinib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,1.3783983,0.09785286,-0.406840919251873,0.013673727555770277
87979,SIDM00529,MK-1775,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Black,44.0,-0.17032027,-0.01685235,-0.8223800556424142,-0.035249743950695266
88727,SIDM00411,Trametinib,Linsitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,3.6991534,0.14307275,2.0401737160020392,0.0908068473214161
85880,SIDM00878,Dabrafenib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.801331,0.065387286,0.9756135886805588,0.07064480052837031
16999,SIDM00866,AZD6482,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-0.8294042,-0.046240766,-1.0394892839311884,-0.04770346549225105
20793,SIDM00660,Nutlin-3a (-),Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,32.0,2.088591,0.06492533,5.434736838250209,0.22834764516252398
99163,SIDM00359,Oxaliplatin,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2417607,-0.06639913,-1.8444742764429392,-0.043300678939771804
87803,SIDM00779,Camptothecin,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,1.1357825,0.06161527,0.3756423968579543,0.010840297310088592
68749,SIDM00660,Oxaliplatin,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,1.4548038,0.1331184,-1.9474382871905902,-0.07131269223447
56435,SIDM00878,Venetoclax,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,1.9195702,0.02759974,1.5896730969173902,0.07713589771056124
88264,SIDM00893,Pictilisib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.20202585,0.013768408,-0.5239966261575779,-0.08922016388424155
31237,SIDM00146,AZD6482,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-1.7580407,-0.10935959,-0.6358809629617801,0.0398979840000794
75659,SIDM00866,Lapatinib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,52.0,-0.3027966,-0.02355447,-1.0924188558418648,0.0008715867468108269
24265,SIDM00660,AZD7762,Navitoclax,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,32.0,1.073004,0.09234081,0.6354907522982698,0.07915924422531806
100231,SIDM00875,JQ1,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4215295,-0.15760754,-0.16646119705659296,-0.07557795149945418
67827,SIDM00529,NU7441,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-0.9329749,-0.07161852,0.029783707519314275,0.004063172240453617
105456,SIDM00779,Navitoclax,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,33.0,2.9248931,0.049664594,0.8754163350457749,0.006452296078589473
2026,SIDM00774,PD173074,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,1.1594504,0.1032359,-1.1612151884832211,-0.0020132652945775427
2915,SIDM00878,Tozasertib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-1.7756891,-0.1418088,-1.2022132040649245,-0.07735839682450163
18753,SIDM00411,Dactolisib,Taselisib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,-0.18343523,-0.007631658,-0.1632597021033112,0.03502891110390731
14131,SIDM00660,BMS-754807,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,3.7519534,0.1856947,1.288580654559253,0.03982067841731227
30937,SIDM00301,Lapatinib,Sorafenib,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,4.6378884,0.20007543,4.268837675931355,0.15920476968108924
73112,SIDM00628,Dabrafenib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,1.4634491,0.12954684,-0.8575560131799767,0.025375777543209025
44832,SIDM00971,Docetaxel,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.7030206,-0.07493234,-2.4638484946484835,-0.042911331782643856
88765,SIDM00411,SCH772984,Olaparib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-1.2583258,-0.061569158,-0.1813930076288318,0.018608460184115827
48200,SIDM00097,OSI-027,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.85277617,-0.049939983,0.42124451464422913,0.0010223208972835497
9077,SIDM00660,Palbociclib,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,1.6833948,0.09196646,0.6992644344935927,0.056435941984482846
33902,SIDM01233,Vinorelbine,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,72.0,1.2782263,0.06525632,0.45216692111464546,0.09036747288400582
21058,SIDM00893,Alisertib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2550063,-0.09721971,-1.0819669523997573,-0.10637617858883924
98660,SIDM00782,SB505124,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,-1.1733805,-0.08627094,-0.31234553483841,-0.02420430383601034
6602,SIDM00971,Palbociclib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7899063,-0.047099464,-0.7021756652274174,-0.019417865241585716
39972,SIDM00130,Olaparib,Palbociclib,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.2689388,-0.05976069,-0.26259380859429193,-0.028987558328821376
49212,SIDM00774,Venetoclax,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.8330449,0.04706836,0.7568235589774756,0.009518120354730868
10859,SIDM00875,Olaparib,Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.79524267,0.076633066,1.616618578901579,0.1388722164038263
50279,SIDM00301,Paclitaxel,Erlotinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.1131079,-0.07580827,0.08912199419125652,-0.009234309487462277
26956,SIDM00332,Bortezomib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.18504152,-0.01069802,-0.1839749299537205,-0.0449907051590863
4407,SIDM00146,Docetaxel,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-2.0814779,-0.18869436,-1.8037053706525656,-0.21813392912153953
15815,SIDM00130,Trametinib,5-Fluorouracil,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.9558307,-0.085732244,-0.8276820481617928,-0.07385071643292568
1812,SIDM00776,AZD7762,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-0.54124963,-0.037104223,-0.5651534403496513,-0.07128158513749312
70237,SIDM00097,GSK269962A,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.9967126,0.11819364,0.3027763537050775,0.007666290142100767
42930,SIDM00097,MK-2206,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.385991,-0.022741515,1.0145522298307494,0.04083904746178486
35360,SIDM00779,Crizotinib,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,33.0,-1.8044822,-0.14634913,-1.6144318701788518,-0.12305881493586326
47264,SIDM00779,Linsitinib,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-2.21881,-0.043179367,-2.311167538774737,-0.06951777044394411
28600,SIDM00660,Nutlin-3a (-),Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.97775316,0.024798257,2.2503108510517755,0.079994451134117
46746,SIDM00866,BI-2536,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.5489995,-0.10078139,-0.9526046677070283,-0.01594620640854126
80012,SIDM00774,Venetoclax,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,48.0,1.8525732,0.04927401,2.7946240622756875,0.07656792596549748
25471,SIDM00411,5-Fluorouracil,Linsitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,1.2731496,0.049163315,0.9695624320655216,0.05526705440551614
80315,SIDM00673,Crizotinib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.9810885,-0.12015029,-0.5416287305475257,-0.024978899989087918
36539,SIDM00954,BI-2536,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-0.608461,-0.014191451,0.2598606652156387,-0.014016128805520014
47431,SIDM00660,MK-2206,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,32.0,4.597776,0.3446644,2.2448432594044943,0.1663693868489949
78366,SIDM00774,Ribociclib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.8150947,-0.062422287,-1.3783954214865262,-0.03216252403984432
92161,SIDM00673,MK-2206,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.481392,-0.14507805,-0.05267551394682586,-0.042935074307381166
70740,SIDM00778,MK-1775,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,69.0,-1.975177,-0.08404688,-1.439516010719931,-0.07592652746519156
82282,SIDM00893,Axitinib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.5587774,-0.027088586,-0.5020333372414815,-0.007467371947703365
7272,SIDM00875,RO-3306,Vorinostat,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0494556,0.11174249,-0.5424334697598948,-0.026804291145065315
58177,SIDM00673,Alisertib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.4759717,-0.11781147,-0.7369084452020354,-0.028141976645690927
2462,SIDM00359,Linsitinib,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.3823462,0.17529565,0.46985209772178177,0.07719766266400453
43651,SIDM00776,Olaparib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-1.5977304,-0.061682932,-1.038036979649067,-0.025642675393303577
10437,SIDM00776,Nutlin-3a (-),BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-2.175229,-0.062021006,1.6752095649896028,0.07503882388756533
3112,SIDM00954,Afatinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-0.8518727,-0.06605606,-0.9884946316257327,-0.06651750117567967
74296,SIDM00893,Lapatinib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.17661673,-0.018648049,-0.3085565481194261,-0.04509477566319893
62291,SIDM00776,5-Fluorouracil,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-0.4088572,-0.016639413,-0.34378244380563305,-0.018574186909108115
90324,SIDM00774,ZM447439,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.7787136,-0.04658403,1.9574966900155317,0.12929383718003667
83351,SIDM00875,Doramapimod,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.9560943,0.05330411,1.2360950720842923,0.049461060375016075
68854,SIDM00878,Afatinib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,3.8331203,0.08938852,2.8015478547951242,0.07819761264211918
17677,SIDM00954,MK-2206,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-2.597403,-0.20142083,-0.9598202926173656,-0.05327310179889828
79953,SIDM00673,PF-4708671,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.9869101,-0.060058758,-1.1827563933750844,-0.016551856255371134
46714,SIDM00834,Navitoclax,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,1.0415907,0.07761894,1.0439317440371982,0.07618478943330571
72898,SIDM00130,Gemcitabine,LGK974,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.2257624,-0.17196861,-1.1287112876893954,-0.09342553941236581
97200,SIDM00628,MK-1775,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.9914499,0.07381458,-0.40874988990042155,-0.0006764762627606738
98520,SIDM00332,MK-1775,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.0108156,-0.17848219,-2.2832488216261244,-0.21374841098095285
20841,SIDM00774,Palbociclib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.0351124,0.12697144,1.4581766874484474,0.050343129474268576
92738,SIDM00875,Paclitaxel,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.10590919,0.0074885734,-1.4164625758799052,-0.0349917630572959
96040,SIDM00146,Palbociclib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.9343098,0.14814612,-1.8115727463679883,-0.0021137118388723196
48556,SIDM00660,Camptothecin,MK-2206,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,2.0186589,0.18775558,1.0155438512049395,0.07224999029950951
82519,SIDM00878,Nilotinib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,1.1016101,0.09397057,1.1043326036011063,0.06429889024480485
83940,SIDM00193,Linsitinib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,53.0,1.264225,0.054808132,2.829810711557169,0.13773586090222462
29612,SIDM00146,Afatinib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,1.929041,0.13945425,2.549543575888598,0.12932212880367328
76691,SIDM00878,AZD8055,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-1.2306138,-0.10508603,-1.2049783913487468,-0.07939893726132018
35401,SIDM00971,PF-4708671,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.068208,-0.06395359,-0.7606727656718559,-0.013594163698765028
75269,SIDM00954,Doramapimod,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-2.4685893,-0.13569556,-0.1567733897247768,0.06898693970305309
43592,SIDM00673,AZD8055,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.87473166,-0.060274422,-2.0708240521171457,-0.11443531258065213
18993,SIDM00893,Pictilisib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.1899314,-0.121721,-1.7662811406905943,-0.13266244947956546
4673,SIDM00875,Entinostat,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6957104,0.18956396,-0.39670599246783844,0.01919243530450253
34957,SIDM00866,Nutlin-3a (-),Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,0.87783736,0.026763726,0.4029533548500529,0.027220726800748368
78110,SIDM00878,Tozasertib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-3.2859275,-0.16634518,-0.6561347474220004,-0.02462411349488985
35482,SIDM00359,SCH772984,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.4642401,-0.033817064,-1.2533823703005118,-0.06423828122122846
47567,SIDM00332,ZM447439,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3550991,0.09477236,-0.047963125990974353,-0.0003224039196147024
15659,SIDM00673,Navitoclax,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.5560465,0.15498407,2.364412780927338,0.07074339702159242
91913,SIDM00359,SCH772984,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.2138051,0.08926756,-0.6511770961310561,0.020272353129234838
94371,SIDM00893,Alisertib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.42328906,0.03772307,-0.2292699220651982,-0.027358295897411226
99732,SIDM00778,Oxaliplatin,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-1.7711068,-0.03282273,-0.652593400911365,-0.038901572222349926
19819,SIDM00971,ZM447439,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.0235207,0.11249271,2.135238474061926,0.15118805703078905
104932,SIDM00529,Docetaxel,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,-0.5976753,-0.05214733,-1.682029077022727,-0.047778232957801106
47870,SIDM00411,Erlotinib,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,4.7063513,0.2143618,2.841249759490774,0.1749366418706685
44296,SIDM00130,Dasatinib,MK-1775,Pancreas,0.2,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.89447,0.22893283,2.8870597563521807,0.17551813108123832
64057,SIDM00097,Linsitinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9678774,-0.082020424,-0.9279490375333979,-0.010503963361478526
81141,SIDM00531,MK-1775,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.3025074,0.15689294,-0.5829667233610241,-0.042689580888483285
69268,SIDM00866,Gemcitabine,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.4362208,-0.07486521,3.655875229959445,0.19521432348162662
30730,SIDM00971,Alisertib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.7542222,0.10498616,0.9504631804593533,0.05927561862740671
14406,SIDM00893,Taselisib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.39628017,-0.015073899,-1.7536053001090541,-0.09901644349348808
101443,SIDM00097,Vorinostat,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.51617396,0.023401834,1.2510027462634539,0.09702348838811284
59676,SIDM00971,Ribociclib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.6964765,0.0753381,-0.48164011924123457,0.005124001908148554
54694,SIDM00776,Nutlin-3a (-),AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,-2.3365242,-0.06953998,0.5144372834879752,0.030231036892767942
61163,SIDM00774,Paclitaxel,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-2.5027456,-0.09211493,-1.8807191438074156,-0.023157546052992948
46207,SIDM00866,Dabrafenib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.2347298,0.048306175,0.4166861706213438,0.02492415709161342
37041,SIDM00628,Linsitinib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-1.947768,-0.11303589,1.30772067266325,0.10184426346776984
8367,SIDM00878,KU-55933,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.25751245,-0.007698296,0.33081228125865714,0.04080049653517646
3563,SIDM00332,Paclitaxel,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.62643325,0.046837017,-1.187670663663717,-0.03919657366514465
73339,SIDM00529,Linsitinib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Black,44.0,1.0256505,0.05555721,0.2003465405476864,0.0489189959945685
30394,SIDM00878,MK-1775,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.34117916,0.033209786,-0.2332828189910878,0.0024569197443974084
94123,SIDM00628,PD173074,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,2.1851823,0.048156742,-0.07714991008555255,0.04755354414220971
90980,SIDM00971,Sorafenib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.66094685,-0.043711394,0.3974886237922229,-0.0012965640012493375
63760,SIDM00954,GSK269962A,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-0.20228635,-0.014791127,0.4986593765668683,0.007208004292453702
70039,SIDM00954,Linsitinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-1.2637948,-0.101128064,0.3093388164888115,0.06650191558242761
44697,SIDM00130,Cisplatin,Paclitaxel,Pancreas,0.0025,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.79057246,-0.046561234,-0.980203467106438,0.0028575488634995606
72287,SIDM00774,SCH772984,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,1.8052005,0.047238752,4.127815608280011,0.13150590262014294
26343,SIDM00774,Pictilisib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.3797185,0.013695818,-1.413597228384615,0.012367853517294287
83013,SIDM00332,Doramapimod,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.73438513,-0.049163762,-0.784379605503401,-0.049363149088960216
15183,SIDM00776,Linsitinib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,-1.2318158,-0.052917253,1.7614187703098785,0.11845064615519248
11624,SIDM00834,Trametinib,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,1.2384448,0.032269347,-0.7777105630094954,-0.020548249622161882
63744,SIDM00779,Camptothecin,Afatinib,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,-1.3274502,-0.061613433,0.2594913109886253,0.03622898331659571
99745,SIDM00628,Entinostat,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-1.541822,-0.08065755,-0.5889600588041609,0.002957864964811486
24486,SIDM00531,Cisplatin,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.0686965,0.226705,-0.6949436791791133,0.006608354606978696
51816,SIDM00146,Pictilisib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,1.0166861,0.084660575,0.11705115445483352,0.07177412912757686
47609,SIDM00146,GSK269962A,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.5166393,0.035975143,0.42518451048799555,0.044272829076340746
6856,SIDM00146,Axitinib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.6574753,-0.04951122,1.1340010939949932,0.1427852271789487
78102,SIDM00628,Cisplatin,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-1.4564264,-0.08910514,-1.9853574449844247,-0.09467238344876706
65109,SIDM00866,Alisertib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-0.9391114,-0.05743506,-0.23028794422335747,0.005495260097348126
50231,SIDM00878,Lapatinib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.7912275,0.099927895,-1.4639584224871889,-0.04665263161778133
19998,SIDM00097,Bortezomib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.54271555,-0.03777867,-0.27242486210864336,-0.05117968161269766
103233,SIDM00673,Bortezomib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-0.42605236,-0.021526935,-0.6222821112944718,-0.04580554871095584
41216,SIDM00893,Palbociclib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.7659427,-0.030672582,-1.1297227691244134,-0.007737085842049625
22341,SIDM00776,SCH772984,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.3890859,-0.11331834,0.4094061843976275,0.0385005668982295
43213,SIDM00531,Dasatinib,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.88965064,-0.08395344,0.42572996007132313,0.07207180271270035
49759,SIDM00971,Linsitinib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.0341809,-0.032597426,0.4418195655937888,0.03755149234414094
99336,SIDM00893,Axitinib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.81686646,-0.03938115,-1.1210507038408852,-0.04697739837745408
83715,SIDM00774,Cisplatin,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,48.0,2.4005218,0.11992262,0.9303695711859092,0.09020891309780592
71207,SIDM00411,Cisplatin,MK-1775,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.8525987,0.051354825,4.277516394904416,0.13043305461721014
68789,SIDM00660,Crizotinib,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,-0.24903153,-0.013592939,-0.21941154533799304,-0.031045951738990215
37281,SIDM00673,Temozolomide,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.1845936,0.0030422325,1.2617551485411793,0.02280871140358541
99343,SIDM00097,Tozasertib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0288758,-0.0560598,-0.4622293113561275,-0.00734525819402517
42315,SIDM00954,Docetaxel,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.0,-3.897206,-0.1753408,-1.3537102113993507,-0.08226344960807273
66089,SIDM00834,SCH772984,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,1.4733155,0.09864666,0.7274922058848969,0.09366410693477994
2013,SIDM00971,5-Fluorouracil,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.993382,0.06187656,1.1093532700055497,0.0640865363770578
76622,SIDM00954,Luminespib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.5539948,-0.042248674,-0.32622055112212833,-0.04140462035804095
80585,SIDM00097,OSI-027,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.516676,-0.14565891,0.22267328414051377,0.008669056634128152
75430,SIDM00359,5-Fluorouracil,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.58674866,0.030467274,1.7485884460057428,0.16052553638793804
63878,SIDM00875,Linsitinib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.9272444,0.2442158,1.1565075674717211,0.060557105169743664
77949,SIDM00782,SB505124,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-1.3455758,-0.0982605,-0.3023895532454144,-0.07558415746372484
65071,SIDM00628,Dabrafenib,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,-0.4240868,-0.032542348,-0.7409233014019767,-0.012191091641077767
74974,SIDM00628,Axitinib,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,0.18731351,0.014872205,-1.5969085991940999,-0.12449678909600548
71553,SIDM00628,Nutlin-3a (-),Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,Black,51.0,-2.0213008,-0.09426597,-0.8520523742806639,0.022263141027385785
4944,SIDM00971,Doramapimod,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7589943,-0.04555793,1.4975261004561706,0.07222475670523847
4083,SIDM00411,Cisplatin,Gemcitabine,Pancreas,0.1,Pancreatic Carcinoma,Male,East Asian,43.0,3.9710443,0.10061338,2.1061901527634337,0.09024115113676072
21284,SIDM00411,MK-1775,Sorafenib,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.3811733,-0.057310723,0.4282405277166258,0.016086833038519665
34951,SIDM00875,RO-3306,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.3235371,0.03759619,0.026745908152050666,-0.004382839329919099
29816,SIDM00146,GSK269962A,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.96112186,0.08396485,1.0572896159437297,0.07299930843116548
105384,SIDM00193,SCH772984,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,0.35601473,0.029239465,0.4709563570784988,0.07136378961729753
70753,SIDM00146,5-Fluorouracil,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.0998678,-0.061981596,-0.34926295587246986,0.00866213109985122
32492,SIDM00531,Navitoclax,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,4.11635,0.21412702,2.6564960248223866,0.1865709187969413
97008,SIDM00774,Cisplatin,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,4.1510386,0.33627,1.793495097600451,0.15367243451896864
80790,SIDM00875,Paclitaxel,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.3042855,-0.09747372,-2.0607992459487354,-0.0895700129098406
8036,SIDM00875,Vorinostat,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.68170345,0.07408888,-0.9794166831685077,0.015511544514519448
100877,SIDM01233,Oxaliplatin,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-1.2413236,-0.023506602,-1.9953841389088736,-0.08825674046388647
91283,SIDM00628,Nutlin-3a (-),Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-1.8716468,-0.08676019,-1.3001521372768963,-0.03231077341004704
81042,SIDM00971,Temozolomide,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.1770523,-0.050178237,-0.9418711381927352,-0.01199606091645469
12617,SIDM00878,ZM447439,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.4571793,0.016618673,-0.6468379105638272,-0.07391670144301099
50953,SIDM00531,Navitoclax,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.33970353,0.04465468,0.2307894172485575,0.018423875607464796
1702,SIDM00779,AZD7762,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-0.7110415,-0.06383009,0.2995624780658209,-0.04192145447730237
23333,SIDM00097,Trametinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.649328,0.10709207,0.026861795784912927,0.002194047490368804
93531,SIDM00411,Taselisib,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,43.0,-1.5145435,-0.077446416,0.8113531591328185,0.059659090218035095
8378,SIDM00097,Pictilisib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.4162316,-0.22598739,-0.359546242975933,-0.049845859945055714
103154,SIDM00628,Paclitaxel,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,1.0853331,0.065881945,-0.13791342843428028,-0.015805616350939026
78119,SIDM00529,BI-2536,Olaparib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-2.1857579,-0.21107997,-1.8384091827239781,-0.09900114634632465
43468,SIDM00866,AZD8055,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.1645595,0.04906509,1.3600068402678396,0.13163188444049775
69954,SIDM00875,KU-55933,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.8438352,-0.031010477,-0.030680418677660876,0.017107200423140376
94876,SIDM00146,AZD6482,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.9454125,0.07622496,0.9700725289658292,0.09389483465347803
19873,SIDM00332,Palbociclib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.0253987,-0.10160738,-1.1773831258285556,-0.05594253872570552
17609,SIDM00866,Navitoclax,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-0.479583,-0.041274745,0.0864864241016609,-0.02199174713421261
58260,SIDM00097,Pictilisib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1918721,-0.15502216,-1.206244366957252,-0.125431438072007
29558,SIDM00529,5-Fluorouracil,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.64412385,0.06136979,0.930579019869154,0.08873599719854591
39918,SIDM00097,Entinostat,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7140038,-0.08236583,-0.5237076630860121,-0.052364607698490294
81095,SIDM00893,Bortezomib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.55534637,-0.045662735,-0.02715264666548243,-0.018006574198499384
58405,SIDM00332,SCH772984,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.9911765,-0.046822652,0.9611486247895699,-0.013639096797756864
80230,SIDM00954,Palbociclib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.0,-1.8131685,-0.07567299,-1.3467780413552546,-0.06532480935074635
95556,SIDM00834,Camptothecin,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,White,66.0,0.7145188,0.057293773,-2.2788398884255736,-0.08036510293462663
20912,SIDM00866,Paclitaxel,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,52.0,-0.83689106,-0.07412428,-0.6936095538349248,-0.07706688845367374
32397,SIDM00097,Paclitaxel,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.6584888,-0.20497784,-3.251174347416508,-0.24449073409218858
24677,SIDM00628,PF-4708671,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-0.82169557,-0.06754028,0.2123664189803637,0.04870563703427366
43579,SIDM00529,Lapatinib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,1.0814033,0.0850097,1.0056814990814034,0.093111104649675
32792,SIDM00359,Camptothecin,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.85699,-0.16388252,-1.9571385266808063,-0.05354378024963151
60530,SIDM00878,Vorinostat,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,2.084156,0.050575476,2.9554321536181876,0.1398309403606108
16650,SIDM00878,Crizotinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.78543913,0.081725806,0.9351866884468789,0.04186516185056363
28966,SIDM00954,Nilotinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-1.6804066,-0.12762955,-1.3618750461109859,-0.08641546363311706
81678,SIDM00130,Linsitinib,Taselisib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.1100696,-0.049996722,-1.1110126214188663,0.012211112403812221
82769,SIDM00529,Nutlin-3a (-),Navitoclax,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.8150431,-0.05433235,0.9888100481430807,0.0826050453781583
98973,SIDM00779,Olaparib,5-Fluorouracil,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,1.1044683,0.027501527,1.2591296970992978,0.03549682576694864
17714,SIDM00130,Linsitinib,Ruxolitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.2398438,-0.09753149,-1.2947950110997037,-0.03736212333178908
36298,SIDM00628,GSK269962A,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.5522436,0.051670328,-0.10723653003421608,0.05607637384233956
57977,SIDM00875,AZD6482,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5207747,0.08294445,0.0526029596459594,0.025178114008491313
65833,SIDM00628,Axitinib,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,-0.7861459,-0.06577025,-0.4809421813961579,-0.042537765385493094
97654,SIDM00529,JQ1,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-2.0178132,-0.0728578,0.9604331236681468,0.07228592777563542
90353,SIDM00097,Alisertib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.706163,0.04373606,4.631945820382486,0.2910134386267716
38270,SIDM00146,Cisplatin,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.0321224,0.03922121,1.8511230723567862,0.06682643491817766
64788,SIDM00893,Uprosertib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.3342402,-0.02530546,-1.6258641507535536,-0.11970108693209816
102977,SIDM00146,Nilotinib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-1.6208586,-0.1285047,-1.2023192058189631,-0.058637976464140575
69128,SIDM00893,Palbociclib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.089268,0.059763882,1.4477637954816485,0.12013821022633271
16177,SIDM00782,Linsitinib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,4.329058,0.30073124,1.4025737106009992,0.08528974447228534
93391,SIDM00673,Afatinib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.374188,-0.027869774,-0.12432953589692149,0.03075298890211925
69545,SIDM00971,Pictilisib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.9323275,-0.041851807,-0.30361464027003754,0.0026946361725646876
62813,SIDM00778,Vinorelbine,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-0.6653136,-0.039360475,-0.7053750992159182,-0.016180521901062814
23205,SIDM00875,Paclitaxel,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-3.9382634,-0.11118332,-5.043530343783717,-0.26789643574739314
19477,SIDM00628,Tozasertib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,-2.9223258,-0.21155174,-0.8293227394781317,-0.07588331373232976
20616,SIDM00776,Vinorelbine,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.0310613,0.08701949,1.2290383737032498,0.10772431286560871
23703,SIDM00774,Pictilisib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,0.09814667,0.0037601953,-1.3254787951928078,-0.04931580511848629
90515,SIDM00673,ZM447439,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.14983507,-0.012260998,0.1181254649453071,-0.022692723863681277
23820,SIDM00529,Wee1 Inhibitor,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-0.8143896,-0.079653226,-0.5829523103041445,-0.07182000236411136
38526,SIDM00193,Dabrafenib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.68245894,-0.012884279,1.9273169276473994,0.0642441504962532
16408,SIDM00097,MK-1775,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.44183874,-0.029992979,-1.0732580109413172,-0.04769767012753168
73850,SIDM00411,Ruxolitinib,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.8012195,0.016648946,0.993647704305954,0.02808121587754831
21272,SIDM00774,Navitoclax,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.7112657,0.03229428,0.07601690285029708,-0.04100964096312424
37377,SIDM00332,Gemcitabine,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,3.2492414,0.20530845,2.9937748318582087,0.1657916783660009
57471,SIDM00774,Alpelisib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,2.4424152,0.12415246,0.5974418223192797,0.10442618469628619
92222,SIDM00866,Linsitinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,1.6226035,0.06609086,0.8944877155107597,0.06926371190524787
56365,SIDM00146,Trametinib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-1.9377604,-0.16226801,-0.21946270377884386,-0.0728405273260337
40312,SIDM00628,Luminespib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.20975813,-0.021230428,-0.46813189367316876,-0.003986545895124786
76732,SIDM00954,SCH772984,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,1.7188655,0.09915581,1.4876175951272754,0.12281997865044846
75394,SIDM00893,Uprosertib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.10332811,-0.007883882,-0.5215136300940799,-0.011961815182317813
14458,SIDM00776,Nutlin-3a (-),SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-1.5722814,-0.037796024,1.0865040864639492,0.05860289185272581
2166,SIDM00954,BI-2536,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-4.90246,-0.15240332,-3.8618645294065064,-0.06781033748220847
14122,SIDM00359,Navitoclax,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.31062886,-0.019494288,0.5885893003610758,0.03902749529412227
40871,SIDM00878,BI-2536,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.31045747,-0.023699086,1.1824239127572596,0.06201917562913776
41938,SIDM00660,SCH772984,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,1.4589653,0.06345385,0.13688356350939931,-0.002611081617685264
108163,SIDM00529,Gemcitabine,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Black,44.0,-0.52340645,-0.014622524,0.1416106199236841,0.010802859524217804
14060,SIDM00130,AZD7762,OSI-027,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.23660737,0.020925853,0.06339009779400273,-0.008211550595658014
31509,SIDM00774,Axitinib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,4.049148,0.30138874,2.4440000542211964,0.20697119948975462
62107,SIDM00878,ZM447439,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.710707,0.060073324,0.9749655425172521,0.0686252626734683
75588,SIDM00866,Tozasertib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.6747414,-0.035910204,3.615597056926765,0.17563334930746105
3883,SIDM00776,AZD8055,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.1426109,-0.10002904,-1.208998279781198,-0.0927603737923248
58423,SIDM00893,Venetoclax,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2304993,-0.041838303,0.9453012709015254,0.07554671548543254
61660,SIDM00359,AZD7762,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6153393,-0.1387716,-0.5784445809936785,0.013587555717895211
71396,SIDM00866,Navitoclax,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.6035819,-0.13319731,0.23434568971424438,0.0027912847750453124
80342,SIDM00971,ZM447439,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.5649233,0.029777894,-1.3763715349503005,-0.08401313380464097
23439,SIDM00332,5-Fluorouracil,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6410841,-0.077571265,0.39841562355021065,-0.038875639347052855
49150,SIDM00332,Nilotinib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,1.86189,0.13740616,0.9608032161695916,0.06414131667833436
96830,SIDM00778,Camptothecin,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,0.42917737,0.021702398,-1.6126216652199532,-0.10521067728129126
39563,SIDM00097,Bortezomib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0528167,0.061991636,1.0501126685651825,0.0950164857251396
5472,SIDM00774,Vorinostat,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-0.118502,-0.008266601,-0.9430135751700454,-0.08506916530680078
104292,SIDM00673,BI-2536,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.039293706,-0.0030239206,-1.8106145160776301,-0.046130393567305125
1337,SIDM00878,Bortezomib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,70.0,1.5873858,0.08069099,-0.4585824538141983,-0.025095617526025193
29225,SIDM00332,Sorafenib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.41967654,0.02956656,-0.9676416431762866,-0.07708649371537164
19331,SIDM00529,Lapatinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,2.7173076,0.22167477,1.8619874255181854,0.14837025065696816
40785,SIDM00774,KU-55933,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.4586191,-0.05134482,-1.851820639204833,-0.04452885516505558
91209,SIDM00130,Olaparib,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.254094,0.1047571,0.24761096792192236,-0.02491881160275026
12913,SIDM00971,JQ1,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7069958,-0.071746305,-0.613012657901894,0.0017216706389219663
41378,SIDM00866,Lapatinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.0367622,0.068913616,1.2308598966407827,0.10727227981747241
104228,SIDM00866,Nutlin-3a (-),AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,2.4322827,0.038783338,1.507416374612862,0.03624232908014294
101966,SIDM01233,Linsitinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-0.30754796,-0.020259216,2.3886161295917288,0.16083843664768346
87125,SIDM00146,KU-55933,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.8585982,-0.061943702,-0.2522411216034107,0.06318803468198013
84188,SIDM00774,Bortezomib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.13227502,0.005704067,-1.4266342659245062,-0.04207452730895686
74668,SIDM00954,AZD6482,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.0799305,-0.059658762,0.14518162246205152,0.030480265939321287
36590,SIDM00971,RO-3306,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.3004525,0.07359093,0.35243721384387067,0.05601229487947917
37382,SIDM00146,AZD7762,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,3.9360735,0.28138074,1.582520773260019,0.19831682475255114
28490,SIDM00954,Vorinostat,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,2.4568822,0.026858974,1.3680007439654707,0.11657119106149534
84245,SIDM00774,Taselisib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,3.7177322,0.072630756,-0.36598748482134763,-0.06501540059868027
87600,SIDM00146,PF-4708671,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,2.6447554,0.11274297,1.8759734546170967,0.061834972488333854
22463,SIDM00529,Cisplatin,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,5.7080946,0.092135526,3.285614072646161,0.10989981072993092
105733,SIDM00531,Cisplatin,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.65024996,0.054933146,-2.388945011297892,-0.045539818161090984
5872,SIDM00529,Tozasertib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,4.3006225,0.16883337,1.4577275406849368,0.08375593054755355
97162,SIDM00660,Oxaliplatin,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,-1.7145941,-0.105581924,-1.4247837337521483,-0.06046805757742946
14128,SIDM00529,Crizotinib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Black,44.0,0.9455179,0.07353031,-0.745344700833038,-0.007837618652873964
86966,SIDM00660,MK-2206,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,5.6061544,0.33961892,2.795252188758717,0.21509908009843132
99237,SIDM00673,Taselisib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.59297705,-0.04453303,-0.452039598160494,-0.007936051794263238
50858,SIDM00779,Dabrafenib,Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-3.0163229,-0.11572408,-0.8233312631099972,-0.03129452745271068
92218,SIDM00332,MK-1775,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.009291,0.08482295,-1.3571996974191338,-0.053515282158939304
99019,SIDM00971,PF-4708671,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.21042,-0.05250316,-0.5495482563368513,-0.0004319032804937764
21384,SIDM00954,AZD7762,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-2.2387578,-0.16897725,-0.12781895751234934,-0.012309829029307698
59437,SIDM00875,Palbociclib,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3301537,0.05185355,1.6934421930605055,0.08289783822056009
46145,SIDM00411,MK-1775,Dasatinib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,43.0,1.3749299,0.08412231,0.16466518004804892,0.031194644926728233
66772,SIDM00875,Palbociclib,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.79568,0.023994332,2.0832482074036527,0.050940400065698076
31316,SIDM00301,Crizotinib,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.71919554,-0.086497486,-1.440137337159834,-0.09064239472655342
61890,SIDM00146,Ribociclib,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,-2.2329059,-0.07413698,-0.7162510192901484,0.040176759576801134
83668,SIDM00673,Lapatinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.25314352,-0.022475518,-0.476325156719001,-0.050832908642467964
2342,SIDM00359,Afatinib,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.4649947,-0.11874547,-0.4724541297762753,-0.013195799140228238
48245,SIDM00130,Erlotinib,MK-2206,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.0511415,0.19528489,1.775525555064141,0.14545728735869604
47861,SIDM00782,Nutlin-3a (-),Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.53266126,-0.01116006,0.09211198430204907,0.012455163362101972
59244,SIDM00146,Paclitaxel,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.5736281,-0.051953383,0.1975546476547644,-0.004127697398657714
70289,SIDM00146,Venetoclax,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.8835008,0.025837775,1.4267560318259245,0.04886868070653548
75820,SIDM00660,SCH772984,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,1.1698838,0.06688559,0.3709965483667289,0.03361726838777177
65769,SIDM00774,Venetoclax,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.5475336,0.012887603,2.2099594589238567,0.026663125139040542
98872,SIDM00774,Ribociclib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-2.4828727,-0.06823031,-0.9476096012731025,-0.010686455283469131
50194,SIDM00774,AZD8055,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.1469498,0.08395012,-0.4208125101163356,-0.026183750452599595
500,SIDM00628,Afatinib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.53657496,0.03572225,0.08436976635052755,0.004804188496856689
55425,SIDM00130,SCH772984,Paclitaxel,Pancreas,0.0025,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.5941374,0.05399003,-0.6601937537358167,0.010097924980987176
56293,SIDM00774,JQ1,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,48.0,0.78019136,0.050252065,-0.7580721144764986,-0.035315892957474664
98569,SIDM00866,Vorinostat,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,1.0272806,0.08863561,-0.7894075609276274,-0.054383163476877334
51347,SIDM00971,AZD8055,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.48989454,0.029162506,0.14172045323235463,0.008326044126223396
9166,SIDM00875,Bortezomib,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5939694,0.06131886,-0.7400881207961965,-0.022123192799797894
63350,SIDM00411,Ruxolitinib,AZD7762,Pancreas,0.0625,Pancreatic Carcinoma,Male,East Asian,43.0,1.1777356,0.025465569,1.8014806895049602,0.04579158065580561
28283,SIDM00866,Crizotinib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.28510514,-0.016172588,2.260141122130276,0.1644428504153344
39065,SIDM00097,PD173074,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5790606,-0.04540398,1.0554030574127653,0.09417357391996399
77050,SIDM00875,Tozasertib,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.19938284,0.010181296,0.3539127892959159,0.002677979978967795
49447,SIDM00776,Oxaliplatin,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-2.5802126,-0.07939687,-1.8734932147601218,-0.04341290459505872
89435,SIDM00774,ZM447439,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-1.3297143,-0.0768082,-1.5955922629291828,-0.06976754596968865
61691,SIDM00130,Linsitinib,Sorafenib,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.4693358,0.14746399,1.1357682794498094,0.08944258399949602
37643,SIDM00301,AZD7762,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,4.678889,0.51938856,0.3704693142235331,0.05975903145417509
89923,SIDM00878,Camptothecin,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.8866142,0.024428021,1.5696493886038116,0.07396439463197059
2491,SIDM00954,Doramapimod,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-1.504775,-0.06913139,1.229417254572717,0.13231995804314522
83839,SIDM00529,Ribociclib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,3.3693123,0.08538743,1.3064165292838674,0.03557635900116701
7697,SIDM00097,Gemcitabine,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.42906505,0.013899363,0.0983574556983333,0.0338606454961655
99500,SIDM00193,AZD7762,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.99284935,0.050522577,0.8657650176128918,0.05234282939726066
93788,SIDM00878,Cisplatin,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.1329834,0.035954427,1.340363074295005,0.06887598060502527
98563,SIDM00146,KU-55933,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.8743915,0.05007133,0.05050158957992746,0.03699562869422054
77091,SIDM00971,Nilotinib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.3372555,-0.0864662,-0.20495895212753235,-0.06197274957198743
12675,SIDM00301,Irinotecan,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,1.219109,0.1202275,-0.20052098323927733,0.018454207256642804
32710,SIDM01233,MK-1775,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,1.0721396,0.07619728,-0.8121201488138668,-0.03276604878193073
102689,SIDM00359,5-Fluorouracil,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.1666722,-0.123693265,-0.9169535120973599,-0.0070858662202806216
71159,SIDM00097,NU7441,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.7438166,-0.035455614,1.348732929283156,0.0868084316532734
59795,SIDM00193,AZD8055,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.5966035,-0.11772413,-1.8972921973754207,-0.10145752101306484
16833,SIDM00531,Irinotecan,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.7062104,0.176622,3.6735624121385433,0.15803383975510946
14523,SIDM00193,Vinorelbine,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-3.2418294,-0.2845191,0.45210709440813757,0.032931360093177355
63203,SIDM00146,Doramapimod,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,1.7597711,0.11053178,0.8320057261700526,0.06867179099605908
92079,SIDM00971,BI-2536,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.455175,0.16248055,0.3378032037741611,0.04879695521567925
77171,SIDM00529,Sorafenib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,0.9342825,0.09477997,-0.38149094493832336,0.003794145966841925
35657,SIDM00875,OSI-027,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7662168,0.08442484,-0.4178828962793468,0.04417140050977556
38119,SIDM00954,KU-55933,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-2.4887514,-0.069952264,-0.8234000447629067,0.012715239529211953
98728,SIDM00411,Navitoclax,Oxaliplatin,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.8430376,-0.12266596,-0.3546618844006251,-0.015933751855411227
28907,SIDM00875,Navitoclax,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5803545,-0.06284974,0.9874801138382984,0.042232480953391716
76896,SIDM00673,PD173074,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,3.2852309,0.25109288,0.2148915450496853,-0.006522619544369586
104980,SIDM00146,Paclitaxel,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-1.5542116,-0.14118487,0.0027905010559784674,-0.03757110678299137
6884,SIDM00971,Luminespib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.2725301,0.08387752,-0.30009196316802367,-0.0073828181925342145
72765,SIDM00301,Taselisib,Dasatinib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,50.0,2.3817277,0.31605047,1.2769226759776082,0.1090827408002206
99116,SIDM00529,Lapatinib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.7710782,-0.10226402,-0.2479577741671277,0.08365756447389629
14093,SIDM00954,Luminespib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,0.17325881,0.00958327,-0.17480098395991533,0.036355970322284846
38169,SIDM00866,Alisertib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,52.0,0.7273311,0.05958521,0.6659103923109293,0.05898235034727141
13430,SIDM00866,Bortezomib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.40164495,0.024364013,0.5230865594355594,0.06678529180675322
72650,SIDM00628,Alpelisib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.4359806,0.14133592,1.1182411160023866,0.09934537182165581
31091,SIDM00673,Doramapimod,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.0125319,0.02254781,2.3106146026434007,0.008620393999876077
48531,SIDM00660,Dabrafenib,Camptothecin,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,32.0,-1.4348452,-0.14858614,-1.526261965657469,-0.06972475541796874
102081,SIDM00628,Crizotinib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.8938366,0.06280706,1.125286766353395,0.08570488876115497
72801,SIDM00673,AZD7762,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.9358774,-0.1560091,-0.8015855394099634,-0.06991746673429396
17890,SIDM00193,MK-1775,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-6.2449727,-0.44990295,-1.5291053883580983,-0.04641930380726138
19793,SIDM00660,MK-1775,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,32.0,-0.89799595,-0.030075397,-1.2245880014667745,-0.05840466094537682
105407,SIDM00332,Alisertib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.2835138,0.078666635,0.03442821240399466,-0.013745271061530959
89950,SIDM00411,AZD7762,Olaparib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-2.1928024,-0.08356795,-0.47021598104376666,-0.039543776407714205
28525,SIDM00954,JQ1,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,1.3190358,0.09044297,0.22092034377816197,0.03664574655573652
14776,SIDM00774,OSI-027,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,6.87049,0.20440277,1.3484004859502678,0.10887911661080807
4241,SIDM00301,Crizotinib,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.419217,-0.14543824,-0.37294130122420416,-0.05441332160549639
13433,SIDM00778,AZD7762,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,0.89581436,0.018736063,0.8439453565201962,0.05270880219973433
35742,SIDM00875,Docetaxel,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.4193152,0.030967018,-0.599572749812674,-0.018738580637167324
79697,SIDM00954,JQ1,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.0,-0.85832584,-0.0691745,-0.5554217850499195,-0.04761204527162495
99743,SIDM00774,PF-4708671,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-3.2866309,-0.1292326,-2.0812394205843745,-0.0925149572273059
41360,SIDM00866,Luminespib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.4491455,0.03866523,-0.12342972739653352,-0.0005502152158792405
51027,SIDM00878,PF-4708671,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,70.0,-1.2420528,-0.060712125,-1.6895917716717743,-0.041492733049389864
12126,SIDM00875,Trametinib,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.683049,0.16307342,2.5709060202887075,0.189851030985374
4304,SIDM00193,SCH772984,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,53.0,1.8784232,0.12198627,0.476404286938457,0.0456789966080358
45800,SIDM00531,Paclitaxel,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.40111887,-0.04224255,-1.1775860520680161,-0.04100676424769904
101817,SIDM00146,Olaparib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-1.1796745,-0.05553675,-0.6273909327268433,-0.006001931974439476
14290,SIDM00834,SB505124,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,White,66.0,1.060256,0.07914688,-1.3062253372829449,-0.024566703347552125
81998,SIDM00332,Afatinib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5060918,0.10791644,-0.26784788028661893,0.06371640629663411
46455,SIDM00097,Ribociclib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2540497,-0.0423834,-1.6302682848711094,-0.039433214431317046
44559,SIDM00673,Luminespib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-2.5825105,-0.15688622,-1.790130614413073,-0.07627969029351012
69044,SIDM00146,Taselisib,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-0.84447426,-0.06041741,1.7653410934421334,0.1698379162555269
16702,SIDM00673,KU-55933,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.8958414,-0.050125245,-1.1853324866783197,-0.08461936643479952
101336,SIDM00774,PD173074,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,3.45858,0.15843491,-0.019511557707311007,0.05545952343810256
99861,SIDM00529,Uprosertib,PD173074,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.3511707,-0.067863,0.7800353022058517,0.13613442030870335
34434,SIDM00193,Camptothecin,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,0.38078046,0.013445237,1.5246955403383216,0.04760822987865315
60601,SIDM00146,Camptothecin,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.36106727,-0.03448902,-0.4092094050488041,-0.06602814449978642
17122,SIDM00130,5-Fluorouracil,Dasatinib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.2691025,0.09712337,-0.4161104603846204,0.044995772892230175
104563,SIDM00146,Entinostat,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.39287907,-0.028731156,0.7802878299836027,0.05901723861997544
9308,SIDM00673,RO-3306,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.784386,-0.10919165,-1.741318078178212,-0.0885618889459955
44573,SIDM00529,Nutlin-3a (-),Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-1.836754,-0.05692665,0.26904587765723736,0.03554481113649252
67025,SIDM00954,Bortezomib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.31605914,-0.01972912,-0.3363164948752936,-0.00020973061223287582
20865,SIDM00782,MK-1775,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.89748865,-0.058454085,-0.5376312483487411,-0.03983027989441099
92114,SIDM00332,Temozolomide,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0618374,-0.024125585,1.4211438718667453,0.05154844732198053
77427,SIDM00971,BI-2536,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.2506151,0.08030155,0.6342967703359725,0.05870196390344085
58164,SIDM00673,Lapatinib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,1.1090544,0.06864245,-0.6094760983439717,0.01118112521437588
2321,SIDM00779,SB505124,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-0.9010846,-0.03774459,-0.20910684558377735,-0.04767487259074426
66596,SIDM00673,Navitoclax,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,2.8573928,0.28022584,1.2747408423220299,0.04431940544705997
12700,SIDM00359,Afatinib,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.4313757,0.11826901,-0.65093889151114,-0.023382525150319505
28330,SIDM00097,Cisplatin,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0091262,0.023143722,0.6269799344111826,0.030668128436346392
85681,SIDM00954,AZD6482,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-1.6923915,-0.07486088,-0.18012355472271466,0.06419263573624051
103288,SIDM00332,Linsitinib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3969791,-0.039021388,2.3559477943607625,0.10116626584490808
67010,SIDM00954,MK-1775,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-1.0145372,-0.080419384,-0.7262664295166685,0.05300238134673789
2346,SIDM00779,Vinorelbine,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,1.8577776,0.11543178,0.6923055230460874,0.11419539181407229
12987,SIDM00529,Olaparib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-2.8784354,-0.098463975,1.8050174413071107,0.07086793420294457
86057,SIDM00971,Camptothecin,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.7608457,0.12035355,3.0789562509189206,0.14826409127158702
34481,SIDM00971,Pictilisib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.9202159,-0.04148143,0.16561796161640874,0.0005054292309994505
44315,SIDM00146,Dabrafenib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-0.55551124,-0.021312337,-1.1379772287786358,-0.007321568935277582
46576,SIDM00628,Gemcitabine,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-2.745283,-0.07798257,-0.6281221602630591,-0.007357580708863999
999,SIDM00834,Crizotinib,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,White,66.0,-1.5438918,-0.10484801,-0.3778423447299938,-0.006295607233990675
9370,SIDM00130,LGK974,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.34520635,0.011023757,-1.2466773295951366,-0.01908088351461742
20969,SIDM00529,Entinostat,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.9479235,-0.098334014,0.4145941200332245,0.03445902495515436
23455,SIDM00782,SCH772984,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,2.7105322,0.23956393,2.04802435177286,0.10504981128239398
72427,SIDM00130,Erlotinib,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.7075845,-0.03515733,0.9531866580496291,0.04050167826003486
105329,SIDM00529,Navitoclax,MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,0.49756366,0.04357133,-0.5670727174487857,-0.019050858684803596
51014,SIDM00774,MK-1775,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,0.20212512,0.024215745,-1.0335560117709452,-0.0008592984574722342
83176,SIDM00954,AZD6482,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,3.2053473,0.10788819,0.24571985398609653,0.08570396214087105
51286,SIDM00875,BI-2536,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-5.3333373,-0.25299045,-1.3920305388308054,-0.04760813903624041
18411,SIDM00778,LGK974,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,0.48717967,0.008731529,-0.287028764724137,-0.00030752436467982333
47635,SIDM00130,Cisplatin,LGK974,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.1311564,-0.06216456,-2.141374940838908,-0.05962044610601549
56313,SIDM00866,OSI-027,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.8635894,-0.048370283,0.6069359021212967,0.08920407332910008
81601,SIDM00628,Camptothecin,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,1.0983502,0.09055775,-0.4159877601711408,-0.034313815863844375
56524,SIDM00782,SCH772984,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-2.047573,-0.14687036,-0.8355096662663248,-0.040968170131717614
24379,SIDM00529,Camptothecin,OSI-027,Breast,1.0,Breast Carcinoma,Female,Black,44.0,2.1082332,0.12048417,0.821392664336185,0.042120934905995534
92064,SIDM00411,Lapatinib,Paclitaxel,Pancreas,0.0025,Pancreatic Carcinoma,Male,East Asian,43.0,1.7273793,0.07100093,0.4846806481714573,0.08410777207733415
61254,SIDM00529,Venetoclax,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.3020937,-0.033775523,0.5009548917511484,-0.00266447146515058
35533,SIDM00359,Afatinib,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.98264766,0.063414976,0.2644742194177175,0.029109963874701873
92653,SIDM00529,Uprosertib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.7333593,-0.016308742,0.3964109774895573,0.10556381853362358
838,SIDM00866,Linsitinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.358994,0.09499589,1.1252150111270864,0.012285120350389195
8021,SIDM01233,SB505124,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-0.17588682,-0.008451619,-0.5633633961910305,-0.054914651563760054
94564,SIDM00332,Gemcitabine,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7209202,0.06259627,0.7629894431207792,0.05998344658430494
52051,SIDM00529,AZD6482,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Black,44.0,2.38223,0.11291585,2.3013477986353763,0.1349788819988272
58846,SIDM00130,Dactolisib,Crizotinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.42272264,0.043282762,-1.652286988649133,-0.06059965269242573
21587,SIDM00774,AZD8055,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,2.764883,0.18501516,2.10893573671754,0.12375082543088003
23678,SIDM00893,Temozolomide,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.7812296,0.02035385,1.0601511559260473,0.03456784030611784
67350,SIDM00146,Entinostat,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.379028,0.12064988,-0.030120436565297424,0.014028589213881405
56645,SIDM00971,5-Fluorouracil,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.4843729,-0.039877042,-0.46185351516470163,-0.018285004123569277
30083,SIDM00411,Ruxolitinib,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,3.1464105,0.06827613,1.4347569478267799,0.027092833676949157
13198,SIDM00875,Pictilisib,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7190823,0.07905726,-0.21713111154052236,0.005869831018168622
36752,SIDM00893,Uprosertib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.6155878,-0.10739345,-1.2072585112149115,-0.11616242253328342
28734,SIDM00878,GSK269962A,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.5093576,-0.13114655,-1.058274761074436,-0.10560213036305784
95250,SIDM00875,Entinostat,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7626668,0.077327736,-0.5545866624342622,-0.020490206831301275
38937,SIDM00660,5-Fluorouracil,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,32.0,-1.0492074,-0.07694955,-1.61715039178078,-0.1164232045164716
85040,SIDM00660,Palbociclib,Nutlin-3a (-),Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,0.84664947,0.038748514,0.630159633548418,0.0032990686300398055
46676,SIDM00778,AZD7762,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,1.1488961,0.052631553,-0.09760849570323758,-0.024263729877266667
40608,SIDM01233,Camptothecin,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-0.83268666,-0.026775267,1.3224363177466516,0.04494404684918411
22415,SIDM00774,Vorinostat,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.95218337,0.049912807,0.11181428612947389,-0.01770547753439431
103488,SIDM00097,AZD7762,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.292523,-0.049195357,-1.8546808362377194,-0.11726853837478549
74610,SIDM01233,BMS-754807,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,0.62469995,0.045810066,0.07170012572184961,-0.0734543931037149
2773,SIDM00878,AZD6482,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,70.0,-1.6335793,-0.08969348,-0.8286151802383281,-0.05607842619897774
103125,SIDM00628,Uprosertib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.84599423,-0.054979134,-1.2086470322418705,-0.02832669953944332
3754,SIDM00893,Luminespib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.48464,-0.10960576,-0.6835335754600804,-0.05882630197391502
4484,SIDM00531,5-Fluorouracil,Erlotinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.4977549,0.06578504,0.49271280079690055,0.01302978922646774
105898,SIDM00866,Crizotinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.2820117,0.10257549,0.35438640806783306,0.05907901762016385
81125,SIDM00866,Pictilisib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-2.6177907,-0.20151383,-1.277092550625745,-0.05905001815944935
59691,SIDM00301,Dactolisib,Trametinib,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,1.897386,0.2057846,0.6412998987752029,0.029607031984438724
78273,SIDM00332,JQ1,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,5.925977,0.34388274,2.7037257632291376,0.14973908880640144
14909,SIDM00660,Linsitinib,Trametinib,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,32.0,4.087475,0.37126037,2.466666490715033,0.14867670982983816
7956,SIDM00875,Tozasertib,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6474458,-0.062415957,0.17491154809329662,0.034669454274118675
77770,SIDM00779,MK-2206,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,33.0,-1.1626749,-0.104269534,-1.174875172681467,-0.03324168361252775
13994,SIDM00878,Luminespib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-1.9749274,-0.06890105,-1.303897107003784,-0.04823356366082674
13781,SIDM00193,Trametinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,East Asian,53.0,1.928269,0.15987605,-0.7736868620848367,0.006620712807875706
67720,SIDM00774,Luminespib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.11249478,0.009494086,-0.10939048012525834,-0.014735908864286284
16030,SIDM00529,Docetaxel,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.2808754,-0.10279108,-0.7164208751216986,-0.04855877414945679
92830,SIDM00971,Entinostat,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,6.0872693,0.31762892,0.7421701679338756,0.08204183426159146
23126,SIDM00660,LGK974,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,1.656854,0.08698219,0.8249962197711491,0.08979281743847821
92311,SIDM00954,KU-55933,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-3.6773043,-0.12082701,-1.5988915582974899,-0.023353323402726077
39640,SIDM00301,Irinotecan,Palbociclib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,-4.1234794,-0.3633258,-2.301954544849253,-0.20159573068473116
80878,SIDM00673,AZD6482,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.26313314,0.02040291,0.2850649104418262,0.0687821703990978
13659,SIDM00893,Camptothecin,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.6399767,0.21854483,-0.46453061656217254,0.03396790165209589
104444,SIDM01233,AZD8055,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.5194087,0.118110344,-0.6434041403669931,-0.06566743961572227
45753,SIDM00660,Navitoclax,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,0.9079203,0.092693664,0.6423680786327314,0.042643325666334546
67751,SIDM00774,Cisplatin,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.3783178,0.07013129,1.6433733961184165,0.0851059213230843
57281,SIDM00628,Docetaxel,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.8222585,0.06878613,-0.931461430113183,-0.07487121850680821
5578,SIDM00673,BI-2536,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-0.31683192,-0.025513554,-0.9253032662289462,-0.08021786027254191
100803,SIDM00673,Luminespib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.4101743,-0.04103691,0.6445906086811981,0.05389266200314151
55442,SIDM00332,Pictilisib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7192545,-0.074701004,-0.5420121741594267,0.003471369656257194
98744,SIDM00529,Entinostat,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-2.3726568,-0.11449422,-1.5449309013876475,-0.0447330960354986
24219,SIDM00779,Palbociclib,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,-2.6399848,-0.13059732,-2.182613783632064,-0.10995449608376223
6521,SIDM00673,PF-4708671,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.5824479,-0.09511585,-1.1710654375716318,0.0053631850970756265
62825,SIDM00893,AZD7762,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.1948504,0.063592575,-0.12320866774207964,0.0304934477585088
23647,SIDM00097,MK-2206,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.1761193,-0.21284354,-0.5649301286840755,-0.0625742411735446
92972,SIDM00893,Lapatinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.558788,0.08048153,0.5816145993542712,0.040107879740213764
21967,SIDM00097,AZD6482,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.5877903,-0.21759428,-1.3015745137257113,-0.1613212200897594
16324,SIDM00774,Linsitinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.41172817,-0.028492259,0.3434591317119963,0.04127732567415499
42780,SIDM00875,Ribociclib,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1183281,-0.032686975,-0.9120574291843854,-0.0014204996367640544
14823,SIDM00628,AZD8055,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-1.4923245,-0.058381986,-2.253704781729569,-0.08036820480743068
41996,SIDM00146,Dabrafenib,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,2.0081484,0.116271324,0.38834029374708073,0.04590070207497871
53696,SIDM00893,PD173074,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.5646256,-0.03927115,-0.41944122234354736,-0.0033175892870315324
1039,SIDM00529,Paclitaxel,Trametinib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-0.39215335,-0.0376608,-0.9373044416524409,-0.05211271255905767
103128,SIDM00097,Temozolomide,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2246268,0.026629074,0.7338425988667946,-0.004444836745222731
47974,SIDM00893,Temozolomide,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.8151189,0.020782085,-0.07196087987471565,7.295937012625642e-05
38623,SIDM00774,Alisertib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-4.021927,-0.22062035,0.9669511594966959,0.04321847768676586
90849,SIDM00673,Luminespib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,0.5462353,0.047018655,0.2879838381777972,0.031669774784598224
13310,SIDM00628,Luminespib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-2.085856,-0.07012933,-1.885535177310408,-0.06484396974043048
84783,SIDM00193,Afatinib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,2.2697833,0.19497497,1.0576044028371248,0.13513757727930084
80362,SIDM00866,Cisplatin,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.7739086,0.048677918,0.6617360393599423,0.07217615669759453
14671,SIDM00097,Ribociclib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5064012,-0.049970016,-1.0461882441363124,-0.040752824274397206
34790,SIDM00954,Navitoclax,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.086168,-0.043121446,-0.22107232559332224,-0.036205503825695894
14086,SIDM00359,SCH772984,Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.6891345,-0.05386289,-2.0425008228967316,-0.08641233872245929
87461,SIDM00130,Palbociclib,Navitoclax,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.2370347,-0.08839045,-1.130199378465155,-0.04550351993531466
86848,SIDM00359,Navitoclax,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.15016435,0.010573189,0.7604715594484374,0.03515051296789398
65231,SIDM00878,Paclitaxel,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.8878345,0.03988533,3.6125467960078943,0.2033714653173787
27574,SIDM00097,Uprosertib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.435737,0.0967041,0.5188483891826614,0.002763409952796759
88584,SIDM00193,AZD4547,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.0209181,-0.04784293,0.18958289775405532,0.027929553026372227
15705,SIDM00146,Trametinib,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-1.0132709,-0.071527116,0.3575468935772203,-0.021516146447527362
15770,SIDM00875,Nutlin-3a (-),MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8312624,0.023809567,2.37471321699513,0.0721056342985064
73815,SIDM00778,SB505124,Navitoclax,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,-0.24620628,-0.016547764,1.5105336972256915,0.06884324363940202
20379,SIDM00878,Camptothecin,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.42321467,0.011860312,1.1119613144173284,0.04964250860882606
55711,SIDM00774,MK-2206,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,0.42916155,0.018422935,-0.13627453567809472,-0.03689756790525725
69392,SIDM00774,Olaparib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,3.1681025,0.18373281,2.7032172202541416,0.13661336329039933
68468,SIDM00359,5-Fluorouracil,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.344333,-0.13206668,-1.385751414347814,-0.0690260666619277
14286,SIDM00529,Navitoclax,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Black,44.0,-0.3488515,-0.028662723,0.4233163800354801,-0.03887827658298402
85128,SIDM00866,Bortezomib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,52.0,-0.46165627,-0.03548267,-0.24402018970698724,0.02381166257777361
13862,SIDM00301,SCH772984,Palbociclib,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.6822145,0.17911236,0.030407779536411987,0.009781127825270642
89945,SIDM00778,SB505124,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,69.0,-1.0212425,-0.044433445,-1.1728241199641736,-0.017810180008583382
613,SIDM00954,BI-2536,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.8464446,-0.020562336,1.0960220650973564,0.007582279559706926
104654,SIDM01233,SCH772984,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,0.9276151,0.061879463,1.6645513901861013,0.12488154313410528
92909,SIDM00866,Alisertib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,0.48614582,0.040286884,1.0395334014502378,0.08734643755882046
90572,SIDM00878,Alisertib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.94441736,0.08522474,1.3360661677414105,0.09205578670971705
21066,SIDM00866,SCH772984,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,0.5046041,0.037457403,1.3242661945253897,0.1336183086546728
1976,SIDM00875,Dabrafenib,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2559716,0.03674299,-0.6362404803876442,-0.00962351679218256
30791,SIDM00097,Cisplatin,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0542669,0.021495536,0.0014123364576956387,0.035381828541224514
30910,SIDM00146,AZD6482,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.7043678,0.12950478,0.1023150510945198,0.08197220911951326
102751,SIDM00097,Trametinib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.9161301,0.067120224,-0.6372411770230431,-0.005848192562028506
14446,SIDM00146,Taselisib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-1.0132158,-0.08458069,0.8954245197830131,-0.02298409244183817
21409,SIDM00782,Camptothecin,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-3.0161939,-0.23384798,-1.1249337056117743,-0.08108323352322772
98434,SIDM00774,MK-1775,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.60515004,0.045927864,-0.5673370298573441,0.01881952852009576
76677,SIDM00146,Bortezomib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.4234398,0.02572434,0.3509012915123935,0.007401164900242176
49152,SIDM00834,Crizotinib,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-0.7247551,-0.05256515,-1.5610589433775865,-0.04524545617614369
88778,SIDM00301,Erlotinib,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,50.0,2.9662209,0.16970837,2.2658875639018383,0.11935344649099003
73156,SIDM01233,Trametinib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,72.0,-1.4134991,-0.10203328,-0.8156959188474062,-0.0485306604847499
618,SIDM00834,LGK974,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,White,66.0,-0.6965019,-0.05111369,-1.1101935626847645,-0.07118177640140907
34755,SIDM00673,GSK269962A,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.0858312,-0.09651153,0.17612058451694784,0.0153103603262886
8664,SIDM00146,Wee1 Inhibitor,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.3749294,-0.030337349,-1.0736177878250528,-0.11253653836029402
53461,SIDM00954,Alisertib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-0.8246618,-0.06046947,-0.786075164976822,-0.05448977638788451
78501,SIDM00673,KU-55933,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-2.7045798,-0.1163242,-1.953304663709647,-0.07303893585216023
86792,SIDM00878,RO-3306,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,70.0,-1.3833798,-0.072372705,0.024061640530211217,-0.019398398405157335
77583,SIDM00878,NU7441,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.56804866,0.054061446,-0.5832366893513783,-0.0241572921106258
80364,SIDM00301,Dasatinib,Erlotinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,0.5590923,0.057562884,1.7211684349824545,0.08015674555442995
8066,SIDM00332,Alpelisib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.2068925,-0.21064459,-0.9257556815452251,-0.09265169990729302
34393,SIDM00866,Alisertib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.8318919,-0.05565823,1.7308131175645525,0.08595437276456934
15855,SIDM00875,SCH772984,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0239598,-0.09280629,-1.0487209751304607,-0.028775802641050865
11008,SIDM00359,AZD7762,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.423534,-0.20545894,-1.6491695714173553,-0.03599932087664617
26534,SIDM00779,Trametinib,AZD4547,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-4.404809,-0.06580503,-2.112107598249357,-0.05670489981650845
90725,SIDM00146,AZD7762,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.044655308,0.0036569615,0.5225414884960723,0.039509738955663974
57021,SIDM00301,Erlotinib,Irinotecan,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,4.1485076,0.11865693,2.24400368977049,0.15329723297696202
64184,SIDM00628,Ribociclib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,Black,51.0,-0.54116875,-0.013136933,0.48436424908427084,0.08172833554916033
86601,SIDM00878,Camptothecin,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,2.1000755,0.077144936,2.646628359391082,0.1112686594076053
20640,SIDM00866,Sorafenib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,1.3761618,0.0738616,0.6486409671404638,0.060824616916019286
30523,SIDM00411,OSI-027,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,-0.51258767,-0.023777613,1.3239595287831167,0.05872833767762885
71649,SIDM00971,Entinostat,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.12036,0.16086918,1.9571815146240286,0.10889790458628729
63128,SIDM00779,Olaparib,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,2.371028,0.019908069,2.0293419711642877,0.07599114170875289
20017,SIDM00834,SCH772984,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,3.6694608,0.27172625,1.8088166894854614,0.10956992987577484
29594,SIDM00778,AZD7762,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,69.0,2.183493,0.099442735,3.3374641505080818,0.12955396782141543
4442,SIDM00875,PD173074,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3860126,0.10400735,-0.3814245951665266,0.04050108878273365
22018,SIDM00628,Wee1 Inhibitor,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-3.3732424,-0.12428173,-2.9817370173167905,-0.12653018938616423
22316,SIDM00878,MK-2206,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-0.30812296,-0.031010222,1.4638227805040491,0.10947289812577567
59552,SIDM00332,Linsitinib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,1.6295385,0.041423578,1.6615194850735238,0.10649063822097196
68921,SIDM00531,Palbociclib,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.9703107,-0.030017715,-0.9286022567153018,-0.04736842219048607
58867,SIDM00971,Camptothecin,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.4624686,0.114672996,3.3511861012591764,0.11811339303799237
72535,SIDM00359,Oxaliplatin,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6314303,-0.090821505,-1.7040718998749398,-0.0660485331505693
12909,SIDM00628,Linsitinib,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,-0.6201333,-0.042326856,0.7485487691914748,0.11351895906244212
15710,SIDM00097,Axitinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.0914083,-0.11911036,-1.390159821029918,-0.10839954158297815
26449,SIDM00628,Doramapimod,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,0.7965054,0.02347833,2.0709669994951887,0.12848067429446383
76139,SIDM00531,5-Fluorouracil,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.9329776,0.030831778,1.1408803567773569,0.025490186549178662
6377,SIDM00954,Dabrafenib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-0.31774375,-0.011705539,-0.06263144903321292,0.01924606301575356
89711,SIDM00529,Vorinostat,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,-0.81783766,-0.08251389,-0.41821426153782437,-0.058079670235250985
52698,SIDM00866,Alisertib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,1.2822673,0.071876764,-0.6880538933320889,0.009413835646075558
18932,SIDM00301,Sorafenib,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.68335027,0.0697002,-0.12783095008463388,-0.009877853403248737
30264,SIDM00097,5-Fluorouracil,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5992432,-0.09274403,-0.6908927294903326,-0.03574951130640186
64738,SIDM00866,Luminespib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,-0.75302964,-0.050244957,-0.0617166515326876,-0.0026514463617169667
63699,SIDM00628,Gemcitabine,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,0.99712414,0.014775401,0.4621407308040233,0.032622895253380274
65173,SIDM00954,GSK269962A,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,-0.6021408,-0.042337228,-0.19726678857705193,0.0022789460010021454
94719,SIDM00673,Entinostat,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.11734591,-0.009795312,-1.1008567632783843,-0.033907249050679975
72857,SIDM00660,Taselisib,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,-0.56843066,-0.025191426,-0.1594613041878045,0.005380296385755784
20949,SIDM00097,Temozolomide,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.2568037,-0.0038251162,1.3005291588558228,0.02515042842512132
58380,SIDM00971,NU7441,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.2414565,0.23031041,2.3009018000066197,0.09235331839496667
44702,SIDM00301,Irinotecan,5-Fluorouracil,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.1382208,-0.15420438,-1.9669542657978651,-0.1143539898311426
26102,SIDM00778,AZD8055,Taselisib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,0.32394153,0.016834617,1.1306777149159044,0.027956737860019877
64143,SIDM00193,Vinorelbine,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,53.0,-0.083702505,-0.007817332,-0.3467230514756397,-0.02293610876303601
89621,SIDM00130,Trametinib,Sorafenib,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.7194239,-0.099904776,-0.9735189523569251,-0.010834641147305719
96756,SIDM00628,SCH772984,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.76905686,-0.054129627,-1.7442552867249592,-0.08357896884069077
106801,SIDM00774,AZD7762,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.4002843,0.17042789,0.20106526960090218,0.06747316152773405
52931,SIDM00146,OSI-027,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.9790945,-0.1757756,-0.21655292159197057,-0.06616435844236095
105363,SIDM00954,Alpelisib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.2789218,-0.07053428,0.23455973789310078,0.057405457367044305
67449,SIDM00097,AZD6482,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0607467,-0.07109653,0.3863386759514559,0.023202608599224843
20514,SIDM00529,RO-3306,MK-2206,Breast,0.25,Breast Carcinoma,Female,Black,44.0,0.8485721,0.035661995,0.5866977021635293,0.09303215575602199
19539,SIDM00774,5-Fluorouracil,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.1500195,-0.101207376,-1.782943746086094,-0.07693481513192084
48726,SIDM00893,Docetaxel,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.7633757,-0.07085757,-0.6881770671800742,-0.01171256767117309
7273,SIDM00866,OSI-027,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,2.83843,0.20820424,-0.3074229453809512,-0.0436973997877567
90116,SIDM00779,Trametinib,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,33.0,-1.6308415,-0.054698616,-1.4128320540251063,-0.0852611164524147
92858,SIDM00531,Crizotinib,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.8194401,-0.07437656,-1.0727103161942029,-0.042186877025680976
45310,SIDM00866,KU-55933,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-2.3821256,-0.08875676,-1.5608113810978812,-0.07718525030540997
54234,SIDM00673,Paclitaxel,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.8282721,0.11853248,0.4829242617207604,0.03518069753322022
95909,SIDM00097,NU7441,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.968995,-0.07850583,0.49089988327089984,0.04386374932030607
31583,SIDM00628,Crizotinib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-0.60933673,-0.045975782,0.4813959861850156,0.020659051305259774
38044,SIDM00866,PF-4708671,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.9311593,-0.040233996,0.42872943581531,0.07044093072733902
84739,SIDM00673,GSK269962A,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-2.0421948,-0.12457708,0.09447179037553007,0.01937736339976749
3426,SIDM01233,BMS-754807,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,1.8511912,0.15508506,0.8795022986272508,0.0850672848707237
26235,SIDM00954,5-Fluorouracil,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-1.2702959,-0.03699494,-0.6640070574521335,0.010094128497541308
33083,SIDM00866,Alpelisib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,52.0,-1.2024037,-0.091182135,-0.5478116682380251,-0.010866746343231402
78861,SIDM00778,Afatinib,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,-0.4743549,-0.029557178,0.6575244547544451,-0.023526115748257973
36169,SIDM00193,SCH772984,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.6751331,0.05688664,-0.3683774522772426,0.018881145182045124
49605,SIDM00146,5-Fluorouracil,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.104193,0.062937334,1.3981351386272507,0.08933287955868899
107439,SIDM00954,Uprosertib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-2.0322046,-0.12763253,-1.328602520177936,-0.10393046631859389
80988,SIDM00875,Tozasertib,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.8056568,-0.068374835,-0.09087199609255184,0.01490343416293273
23706,SIDM00673,Nutlin-3a (-),Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,1.5515479,0.033756513,1.4281313279173653,1.6378300117569134e-05
18681,SIDM00878,BI-2536,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.1844633,0.10064647,1.4073618773574603,0.07456970526612366
63596,SIDM00097,Trametinib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8246939,-0.046922665,-1.3306342299829386,-0.048600875616655756
48172,SIDM00531,Dactolisib,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.9464318,0.091253,-0.450503710553047,0.0025663621758024884
87687,SIDM00774,Luminespib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,48.0,0.5446647,0.0412911,0.14244760181204333,-0.012692646925593737
17063,SIDM00778,Afatinib,Dabrafenib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-1.9250774,-0.13063727,-1.0180274459316523,-0.09753457511154111
48780,SIDM00097,Nilotinib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.5717626,0.104926325,-0.24304385909412077,-0.048544556445388375
53526,SIDM00301,Taselisib,OSI-027,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.2623692,0.24936269,1.3931465945838226,0.11626749283559994
31911,SIDM00146,Olaparib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,4.6551147,0.336827,2.256698545251744,0.1194085766379423
104772,SIDM00130,SCH772984,Sorafenib,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.73155,-0.06311377,-2.11291976993538,-0.03973008290065238
73247,SIDM00529,MK-1775,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.7693591,0.07117584,0.12328482064997824,0.03289632191517746
26006,SIDM00834,AZD8055,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,1.6855829,0.14165142,0.9104092653185004,0.1327941786542042
56172,SIDM00971,Axitinib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.6847724,-0.06145159,-0.7181666314982922,-0.0054751831358991615
12329,SIDM00774,Vorinostat,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.4203094,0.03159284,1.1517593664147194,-0.0017207180321926416
22295,SIDM00130,5-Fluorouracil,MK-1775,Pancreas,0.2,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,3.21578,0.29797676,-0.7810093293397082,-0.02709974786549079
14959,SIDM00193,5-Fluorouracil,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,53.0,-4.097683,-0.20555528,-2.5092197403362104,-0.08065216704633225
74209,SIDM00954,Alisertib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-3.7374449,-0.26689458,-1.7885575215321787,-0.11919158096395278
43594,SIDM00878,Luminespib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.8037874,0.0944293,-0.12123541048980307,-0.007281847986453232
29128,SIDM00875,Temozolomide,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.855026,0.022105264,0.852915027971366,0.010935509135631283
96030,SIDM00660,AZD7762,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,-0.29033482,-0.02823112,-0.31475174962266683,0.03775204785900831
49360,SIDM00866,Navitoclax,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.15768129,0.012284498,0.42430161475080463,0.0615609188434978
56726,SIDM00146,Wee1 Inhibitor,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.6114432,-0.048239317,-0.9578832478919969,-0.06737051095922282
35342,SIDM00673,Venetoclax,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.2060102,-0.02379295,0.6256229506495514,0.056749162147240455
102636,SIDM00893,PD173074,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.393689,-0.030618018,0.7127310827427078,0.05779981154100104
24026,SIDM00628,ZM447439,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.58196956,0.048204653,-0.43571486967871964,-0.06768316086161456
75533,SIDM00130,Gemcitabine,OSI-027,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.9749906,-0.15834929,-0.2650681810653861,0.002516244530908454
81548,SIDM00893,Nutlin-3a (-),AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.9789944,0.02767528,0.5832587481447781,-0.002885192213866965
79366,SIDM00971,JQ1,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.2402382,0.13338672,-0.16571786321327162,-0.032020615706387555
57498,SIDM00954,Afatinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,-1.6532288,-0.11815176,-0.114929913674223,0.005095914462317157
87567,SIDM00673,ZM447439,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.2852281,0.09955716,2.756267525118777,0.18330684549381734
8209,SIDM00529,Temozolomide,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-0.48754594,-0.009682182,0.24153123703283536,0.003724113656080714
61192,SIDM00332,SCH772984,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7167616,-0.09222381,-0.14771292132162475,-0.033640036855143614
51859,SIDM00628,Nutlin-3a (-),Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.7896599,0.13966128,0.46676574172778246,0.07512564336446521
59875,SIDM00359,AZD8055,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.1745507,0.07577732,-1.6071343226188315,-0.06517491781204737
103701,SIDM00971,Camptothecin,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.735407,0.081091195,1.7930215898824142,0.06840223120589917
48400,SIDM00875,AZD6482,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.94042677,-0.060958542,-0.25387416175173766,-0.027701127234013575
45478,SIDM00097,Nilotinib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.73611695,0.03806791,0.7240522685281258,0.051684566917341114
54015,SIDM00628,KU-55933,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,Black,51.0,-0.52240133,-0.03190749,-1.818541521087896,-0.05490374226306871
97402,SIDM01233,BMS-754807,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-1.8095415,-0.120118774,-0.3297655739120837,-0.019691183394885896
85826,SIDM00529,Ribociclib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,3.0771132,0.052957192,0.42524590785257743,-0.0017744597117022745
4235,SIDM00097,Uprosertib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.66469914,-0.042855907,0.8502626052867451,0.07021088070563315
82925,SIDM00875,Wee1 Inhibitor,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.15006545,0.009745789,1.0775247606499345,0.07471681596257589
84607,SIDM00866,MK-2206,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-3.745601,-0.1579415,-1.4531268041437506,-0.04708247805636809
90181,SIDM00628,Doramapimod,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,1.2624965,0.047528088,0.534595761385513,0.024183463396284445
71031,SIDM00531,MK-1775,Navitoclax,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.1915793,0.2584738,2.0044047706097015,0.13833449166776338
49582,SIDM00954,Axitinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-0.8039657,-0.064223275,-0.3591199709389463,-0.0469644729609436
13662,SIDM00531,Dactolisib,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.0122056,0.3052303,0.20657059867214012,0.01041426554311404
82790,SIDM00875,Crizotinib,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.32918748,-0.03517197,0.4700149303877513,0.023166115832774684
89569,SIDM00628,AZD6482,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,0.40937552,0.035437044,0.09228909670925843,0.006715631812285464
32932,SIDM00673,Uprosertib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.4549909,-0.13520786,-1.391805485520582,-0.12402892699101542
24031,SIDM00146,Axitinib,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-2.9418004,-0.16268629,-1.0897221973381193,-0.007996169861381323
97017,SIDM00673,Docetaxel,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,-5.156714,-0.35718188,-1.7420228725368414,-0.1111703224854137
61527,SIDM00834,Camptothecin,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,White,66.0,-2.7231817,-0.1497637,-3.180893203978979,-0.22403801004817528
51610,SIDM00875,Ribociclib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1999435,0.044763464,0.2914956366398616,0.06979491142548967
45449,SIDM00954,Nutlin-3a (-),Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,3.056024,0.019044273,3.081078833888755,0.08978459562773011
49996,SIDM00531,Irinotecan,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.0643008,0.16827565,0.6456659693809051,0.02472732405315354
26090,SIDM00628,Alisertib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-0.7288974,-0.0274765,0.2313104188658348,0.0061059671632504794
71437,SIDM00893,Uprosertib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.73163354,0.053676862,0.9520968826600222,0.06395429094225387
486,SIDM00097,Lapatinib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,4.3307734,0.2897625,0.48542177866727343,0.009720638288679717
62663,SIDM00774,Pictilisib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.402589,0.012348741,-1.6994403570753986,-0.05142933667227067
59396,SIDM00628,Paclitaxel,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-4.225754,-0.26467454,-4.587067142137757,-0.24817606717428617
102453,SIDM00332,Luminespib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.689364,-0.2713875,-1.3324364143067635,-0.03530637241651735
69439,SIDM00332,Pictilisib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1434964,-0.1163603,-1.2105403552426564,-0.06739160688611899
17142,SIDM00301,SCH772984,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.0608655,0.12763426,1.2778013186865886,0.13350729330761557
77245,SIDM00097,Docetaxel,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.675239,-0.16746303,-3.8116479028885153,-0.2771123619336409
75156,SIDM00529,Doramapimod,OSI-027,Breast,1.0,Breast Carcinoma,Female,Black,44.0,0.276578,0.008910515,0.32457218570939095,-0.0071606101568600184
62039,SIDM00893,Doramapimod,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.6157362,0.070731424,1.9770194491753095,0.0979238352450985
62841,SIDM00332,Uprosertib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.2748237,0.08477692,0.774677450166427,0.03116081779830046
60849,SIDM00146,Nutlin-3a (-),Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,2.062643,0.07126061,1.2961965789468253,0.07835190104392808
30914,SIDM00878,Alpelisib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,0.6659169,0.04838238,-0.08885567686975226,0.005374243737245372
104809,SIDM00146,Navitoclax,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,0.8004034,0.05564493,0.13614760195115744,0.01808088836687046
8912,SIDM00893,Alpelisib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.33202708,0.02737973,-1.0309570733257136,-0.08378926953672401
20626,SIDM00779,AZD7762,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,33.0,-0.5718578,-0.051753726,-0.7662091647305658,-0.05818832283324854
73565,SIDM00893,Alpelisib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.0827427,-0.006929034,-0.5327976910051928,-0.06942352618947026
85911,SIDM00971,Cisplatin,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.2722244,0.023358205,1.3917565304177235,0.02514196466965604
98479,SIDM00875,GSK269962A,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.71999323,0.014250766,-0.6644057996140403,-0.05555934115083894
28632,SIDM00774,KU-55933,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.59906113,0.027273556,0.23900749563749576,0.023491604020318458
72556,SIDM00866,Navitoclax,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,0.43534875,0.029001154,1.6430482150475367,0.10424480297055592
41823,SIDM00866,MK-2206,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,52.0,-1.6907002,-0.10502977,-0.3307008354732016,-0.010984020675972166
75753,SIDM00332,ZM447439,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.6012185,0.18991514,0.7054684312112302,0.10914189240359395
82441,SIDM00332,MK-1775,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7838288,-0.074034125,0.1031721242893847,-0.04659681073863919
47643,SIDM00332,Docetaxel,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.8032986,0.1585119,-1.0526419394514366,-0.05600423789016966
59410,SIDM00782,Navitoclax,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,2.3400471,0.13483267,1.5400473530317995,0.09169111563074478
98091,SIDM00954,Olaparib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-1.3663602,-0.025963861,-0.41199403807347595,0.02986146032509636
49754,SIDM00776,AZD4547,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,0.6014881,0.018276459,0.7953203747068217,0.04168917956202481
73136,SIDM00875,OSI-027,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5413798,-0.052367907,-1.0596390767066035,-0.01095195692829207
104010,SIDM00332,5-Fluorouracil,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2239095,0.09024959,-1.3714670263082926,-0.08155932522701949
53298,SIDM00878,Paclitaxel,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-2.4405086,-0.18071617,-0.408405372146902,-0.01808328869326985
3623,SIDM00782,Trametinib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-1.2445061,-0.10939908,-0.4489983228276941,-0.031109676022549895
91876,SIDM00531,Lapatinib,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-2.030428,-0.09709883,-0.213462953680146,0.05957767580542272
85433,SIDM00875,Sorafenib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.46677536,0.037868835,1.0653273999941795,0.0680325845399937
58492,SIDM00146,AZD8055,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.4526669,0.11877332,0.8594443911830797,0.09032147989453965
26894,SIDM00411,5-Fluorouracil,Ruxolitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.8375242,-0.061082557,-0.8990818150098503,-0.013377916004788645
58316,SIDM00878,Wee1 Inhibitor,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-0.7622774,-0.062425785,-0.5379524340389236,-0.0742849002299943
5707,SIDM00878,JQ1,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,0.65912586,0.06282929,-0.14302560560461203,-0.01148389532232711
99680,SIDM00782,Navitoclax,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.7207559,0.051447965,1.2106313045593236,0.030408632272062336
49722,SIDM00954,Lapatinib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.3813623,-0.0313574,-0.519406257563481,-0.05308351068998507
354,SIDM00146,BI-2536,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.9207381,-0.08348784,-2.118973066586416,-0.11323396594632437
25562,SIDM00628,Paclitaxel,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-0.23634289,-0.0139085,-0.7553034589368823,-0.049450882212483595
47209,SIDM00954,OSI-027,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,0.67661303,0.007867425,3.0712295520938935,0.13836086567337483
5991,SIDM00971,Vorinostat,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.6821744,-0.10587855,-0.3263717421283599,-0.01003110333245834
107642,SIDM01233,Taselisib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,0.69469565,0.05427142,-0.7286626857046877,-0.03925353540885066
92188,SIDM00878,SCH772984,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-0.95640844,-0.06673158,-1.210552792361511,-0.06405398761058112
78625,SIDM00954,5-Fluorouracil,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-1.7012995,-0.06743433,1.3833382360295428,0.0992168020278639
24141,SIDM00660,5-Fluorouracil,AZD4547,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,0.70035994,0.07447055,-0.49790786490499583,-0.07243021823633373
51783,SIDM00529,Pictilisib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.37735,-0.0705256,-1.5379883486332406,-0.05688511191871543
73249,SIDM00866,Ribociclib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-2.785262,-0.08172384,-0.6144868095983814,0.012749173760976977
38145,SIDM00301,Dactolisib,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,-3.2308207,-0.3383229,-2.2647450029487697,-0.15015501976507306
80018,SIDM00971,PD173074,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.21377923,-0.0045130425,-0.47652345954210973,0.052960280199962205
7863,SIDM00774,Camptothecin,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.0880805,0.0663922,-0.4278744693359651,0.01493405100529363
18070,SIDM00954,SCH772984,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,1.8231587,0.14208916,-1.066978561738891,-0.10330283885857564
90846,SIDM00774,Dabrafenib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-0.55300254,-0.014508156,0.47559963500183317,0.0035317327453024947
54995,SIDM00954,Olaparib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-2.1835318,-0.052664224,-0.8378602377974738,-1.7882256072096964e-05
47337,SIDM00778,Taselisib,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,-1.1576412,-0.035155956,-0.9823311378765897,-0.03314925867698378
6806,SIDM00332,Luminespib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3635015,-0.13849057,-1.191723750204125,-0.04748366390095417
71512,SIDM00971,Luminespib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.65111834,0.042329628,-0.4862271214693268,0.01361749826673207
27243,SIDM00776,Vinorelbine,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,-1.9221282,-0.12103088,-2.9366585515650057,-0.14842457611347126
48377,SIDM00971,NU7441,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.79682416,0.03731222,0.6970743740021584,0.08589664884129712
79508,SIDM00628,Axitinib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-2.651172,-0.24436879,-3.126965928253641,-0.17549483520794634
90958,SIDM00782,Dabrafenib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,2.8442736,0.15668169,0.8266968232360996,0.015948778322199087
67372,SIDM00878,Sorafenib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-0.4028974,-0.034538716,-0.4592111893664002,-0.0147273796301395
50490,SIDM00673,Olaparib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-2.078402,-0.074167445,-1.515427894916742,-0.03978685594120487
57874,SIDM00146,Cisplatin,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.1203871,0.04837451,1.7989032074017097,0.09071915194717507
97863,SIDM00529,Venetoclax,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-0.52944416,-0.01527506,0.9888406608400315,0.08572650527816054
74150,SIDM00774,Lapatinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,2.694705,0.09117994,1.1560010167555672,-0.012128236099922083
29174,SIDM00971,NU7441,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.5752772,0.07530475,1.4623881372564727,0.09313581184233835
27670,SIDM00782,MK-2206,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,1.5211748,0.11547832,0.7884229200549357,0.06523327200139582
30712,SIDM00774,Paclitaxel,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.9186833,0.039633486,2.661366177728561,0.1575739590471345
41494,SIDM00301,OSI-027,Linsitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,1.0236645,0.12733352,1.2523846469620428,0.058917399773259826
12713,SIDM00628,GSK269962A,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.4243428,0.10358316,2.164441134549423,0.22143256132181674
104743,SIDM00878,SCH772984,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.0841768,-0.059612885,0.5685169411163095,0.012170217497933936
59600,SIDM00782,5-Fluorouracil,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.6674253,0.029796729,1.2632254804292258,0.04173485558247959
1665,SIDM00866,Wee1 Inhibitor,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,-0.37019518,-0.02900153,-0.54621052962446,-0.015652962649478984
34023,SIDM00954,AZD7762,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-1.3445439,-0.09752989,-0.22349413211128638,-0.004479165430586429
45816,SIDM00332,KU-55933,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.2909484,0.17628236,0.7251299289105197,0.07587617283740333
59057,SIDM00660,SB505124,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,32.0,-1.4459858,-0.087828435,-0.13788822844312668,-0.034978915189424954
71310,SIDM00097,BI-2536,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2709374,-0.14880921,-0.9065283845754084,-0.020659419437215835
38392,SIDM00628,Cisplatin,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.3460002,0.098280974,-0.7116089296438709,0.03366221321131593
5938,SIDM00359,AZD4547,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.1669111,-0.07020203,-2.2251164947860125,-0.11642715518146776
61644,SIDM00628,KU-55933,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.0646114,0.074216165,-1.2880133088469814,-0.04652077806098949
77550,SIDM00146,Navitoclax,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.22321056,0.01729548,0.3393980930936336,0.020475371920857015
23220,SIDM00834,Crizotinib,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-1.3981146,-0.07367998,-1.398358679359964,-0.021663671601433575
65261,SIDM00878,Vorinostat,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.2949722,-0.037132613,-0.3501172089266615,-0.04157608860235103
89643,SIDM00875,Nutlin-3a (-),Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6693631,-0.019624148,0.12149980247665418,0.00519810802848258
77447,SIDM00875,NU7441,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.6513326,0.05342783,0.43535516571688054,0.03279014507802632
7364,SIDM01233,Taselisib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,72.0,3.491981,0.15216829,1.2179471830213684,0.09180782101338474
105094,SIDM00774,SCH772984,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,2.7321458,0.061308112,3.584547458178446,0.11017028751573202
7285,SIDM00776,Olaparib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,2.8577716,0.17153099,-0.3326894976641668,0.005605724109256961
88968,SIDM00834,MK-2206,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,White,66.0,2.8945704,0.11214623,0.5286850217316402,0.09650251411320303
62129,SIDM00531,Linsitinib,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.1792097,-0.04655803,0.17865147056821293,0.011218564183320547
47262,SIDM00332,Ribociclib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-4.1537223,-0.15450005,-2.8840328114306804,-0.10189196589020968
5684,SIDM00673,Trametinib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.7606614,0.07118745,-0.5332127854219286,0.0026146866090745696
17443,SIDM01233,AZD7762,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,2.8938572,0.09260219,2.113320681378588,0.06383112143449622
99933,SIDM00628,Docetaxel,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.78071386,-0.07178502,-1.983040187674444,-0.22379497229992895
92547,SIDM00971,Alisertib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,5.465471,0.2207641,1.2328875704636826,0.022733998425984607
20398,SIDM00628,PF-4708671,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-1.7339123,-0.10843493,-2.266900694191818,-0.09450050076093476
59914,SIDM00146,Crizotinib,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-0.77526474,-0.07057467,0.03164511270529806,0.01702238214200069
104318,SIDM00531,Cisplatin,Lapatinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.41739348,0.04608468,-1.0901890665127736,0.000511373713239587
3018,SIDM00673,Alisertib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.2153983,-0.10893765,-1.8688518453329999,-0.09884478161522316
91106,SIDM00673,Paclitaxel,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,0.704121,0.041950967,0.13883848967887652,0.031191725254099356
47913,SIDM00673,BI-2536,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,0.21281464,0.01687419,-0.49249811348849826,-0.03115305768010274
23197,SIDM00529,5-Fluorouracil,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,-2.1708362,-0.16904451,-0.5033793713694856,0.0011537862385614967
99400,SIDM00146,Wee1 Inhibitor,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-0.52744424,-0.042831425,-0.3591536308587768,-0.06639699958509904
6777,SIDM00531,Linsitinib,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,4.1200213,0.23824278,3.3366501843035055,0.20508696130156384
56867,SIDM00531,MK-1775,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.63510656,0.07316673,-0.18172509846824636,-0.006344385837947145
30359,SIDM00146,Sorafenib,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.5030461,-0.04593685,0.46838859289733314,0.07377024461124569
82252,SIDM00673,Uprosertib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-1.3966193,-0.096367866,-1.173274931762347,-0.07927631122390782
99434,SIDM00411,Cisplatin,LGK974,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.84134144,0.016732257,1.3851718763983336,0.041128664605229986
35516,SIDM00954,Crizotinib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.0,-0.71563065,-0.051547345,-0.035544932220331255,-0.036107580735304026
91041,SIDM01233,Nutlin-3a (-),Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,72.0,2.2039092,0.10663858,0.5577251446147383,0.011578124009541958
29222,SIDM00878,Alpelisib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-1.0563253,-0.03189516,-0.6556619602359337,-0.013503683497702939
103329,SIDM00332,Pictilisib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.419753,-0.13422371,-0.6538587849099017,-0.05554456655159732
3180,SIDM00411,SCH772984,MK-1775,Pancreas,0.2,Pancreatic Carcinoma,Male,East Asian,43.0,1.8510681,0.10791578,0.3311172766069198,0.011992670158451495
86493,SIDM00673,Alpelisib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,49.0,-1.1753243,-0.06605395,-1.2550688572114281,-0.060181554714504856
60882,SIDM00774,Nutlin-3a (-),Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.32075617,0.010092212,0.9058386787848758,0.04369934383696861
73982,SIDM00146,Trametinib,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,-0.20647037,-0.015771573,0.7957945806530814,-0.019195372699459732
71911,SIDM00782,Olaparib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,5.241418,0.20062515,1.5013425480219944,0.0295987848872245
103003,SIDM00531,Oxaliplatin,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.1073684,0.045646735,1.368272168570646,0.10077325775776243
46144,SIDM00146,AZD8055,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.7202045,0.06525639,-1.0856001036353962,-0.060229636747652415
98655,SIDM00097,SCH772984,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4731553,-0.07048757,0.5515186368036801,0.02658783102991837
47860,SIDM00954,MK-1775,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.6124955,-0.05011847,0.16008865685938814,0.015346866175270327
97085,SIDM00878,AZD7762,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,1.0736377,0.048179552,0.7441391108570762,0.07029657327682588
41088,SIDM00301,Olaparib,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.6763964,0.1520524,0.9155729631597926,0.027404946782336237
862,SIDM00660,Taselisib,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,1.8986182,0.13003428,0.3563471759554727,0.004613733844610405
33678,SIDM00301,OSI-027,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.6453172,-0.07689809,1.487465536929255,0.10303171022759074
106103,SIDM00866,RO-3306,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,52.0,-2.2492163,-0.10552646,-0.8997700865453211,0.025401519310174783
70933,SIDM00778,AZD7762,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,3.1438353,0.12795682,0.9646807480499445,0.03135793664575144
47499,SIDM00893,5-Fluorouracil,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.8158524,-0.03547875,0.07062632819632,0.06558417151621768
65409,SIDM00971,Sorafenib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.840851,0.05375528,0.9181624805304985,0.09613187047332841
48495,SIDM00954,PF-4708671,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.7489959,-0.0854172,-0.12851418118467398,-0.017894488771300007
102576,SIDM00660,SCH772984,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,2.901374,0.076106206,0.9123650012809652,0.06306346070168727
567,SIDM00628,Nilotinib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,-1.2262394,-0.10109479,0.4381215210700462,-0.06296634968490664
86562,SIDM00097,Trametinib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9102665,-0.051531356,-0.8043519881181188,-0.032704465568563414
91941,SIDM00097,Wee1 Inhibitor,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4359856,-0.07354617,-0.3257820066308116,-0.0187994503439718
93367,SIDM00193,Crizotinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.3018622,-0.049652223,0.7850623041645762,0.05482736277290806
51643,SIDM01233,Palbociclib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,1.1861198,0.026272742,1.5061499359362764,0.01934053677026792
18976,SIDM00673,Linsitinib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,1.1272172,0.015457175,1.9073859951431393,0.05465194378763649
85186,SIDM01233,Dabrafenib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,1.6208184,0.049969163,1.5839021675318476,0.05562639731549801
1604,SIDM00774,Olaparib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.61659974,-0.03008522,0.7491547339462347,0.08692258802791086
49877,SIDM00779,AZD7762,AZD4547,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,1.129225,0.020679828,-1.3372341846730091,-0.09137688255001991
22685,SIDM00875,Doramapimod,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.1872807,0.08961114,1.0134074016139287,0.05992558026373395
86388,SIDM00893,AZD7762,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.88192403,-0.03822499,-0.0968856060168244,-0.008296023088261573
3701,SIDM00776,Crizotinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.0770487,-0.093443654,-0.7010568619513269,-0.05331737539874379
15886,SIDM00875,Trametinib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0985667,-0.10871862,2.486795272122636,0.15744725325058034
73446,SIDM00660,Vinorelbine,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,32.0,-3.204856,-0.27350062,-3.936065781268595,-0.23626715554734237
45349,SIDM00893,GSK269962A,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.81542563,0.07049116,0.7517394563523789,0.10364863177750565
40389,SIDM00097,Venetoclax,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2151933,0.03744585,1.1271860222480186,0.03974069323106557
92621,SIDM00359,MK-2206,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.6880195,0.11032664,0.9278596685415149,0.10517572083974933
97926,SIDM00875,Camptothecin,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6160725,-0.014718255,-1.2830366003836897,-0.08369614856127676
8940,SIDM00097,PF-4708671,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.908262,0.1479458,0.86304450915588,0.05328868650583799
32070,SIDM00673,Ribociclib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.5377035,-0.076388486,-2.0186797146546,-0.05141338432919258
96753,SIDM00893,Afatinib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.7344463,-0.13396847,-1.3931480564191099,-0.11572051795090214
14254,SIDM00411,LGK974,OSI-027,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.30283,0.08660263,-2.229826528807925,-0.043788478217012976
3590,SIDM00954,Camptothecin,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.6172254,-0.021634968,0.21416747776913744,0.011506946788486083
12143,SIDM00097,MK-2206,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.45267442,0.03391675,0.8284844309486334,-0.006356713303513722
27617,SIDM00866,Trametinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.2167395,0.081315614,0.29004906367447114,0.03299841861362937
105955,SIDM00531,SCH772984,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.5235186,0.22718078,0.9387543391421767,0.06411383901867511
32041,SIDM00660,Afatinib,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,-1.9957268,-0.09317962,0.3331683373453879,0.022596832986604257
87885,SIDM00971,Linsitinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.207511,-0.04491727,-1.2114540609005013,0.007509744813397631
98925,SIDM00774,AZD6482,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.1029917,-0.062938906,-0.07254607041429205,-0.0018176639240417348
21674,SIDM00628,Taselisib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-1.2602743,-0.09497833,-0.24816159400181578,0.016010416253262924
79618,SIDM00411,Sorafenib,Linsitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,1.3769486,0.076571606,0.7795596326942881,0.06193834010358001
73935,SIDM00531,Navitoclax,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,4.5859885,0.32389152,1.5713659317062822,0.11262824021428246
70513,SIDM00529,NU7441,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.86251247,0.076406784,0.6145278620063718,0.05653368873125523
8529,SIDM00893,PD173074,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2704741,-0.026631286,1.9104137267767312,0.11851062307208123
75899,SIDM00782,MK-1775,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,Unknown,72.0,-0.48640743,-0.030230733,-0.7047673686804998,-0.040829219248021784
103494,SIDM00779,MK-1775,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.3473139,-0.090885855,-0.156441566664526,-0.047091811316855914
39483,SIDM00628,PD173074,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,2.5392814,0.11961317,1.0272103656747988,0.06820087174270245
57873,SIDM00782,Oxaliplatin,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,Unknown,72.0,-2.1076696,-0.10648105,-1.1375020618869593,-0.023162916105889775
6749,SIDM00954,KU-55933,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-3.0241714,-0.07720888,1.410293417875102,0.11326267022965537
71071,SIDM00875,Nilotinib,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1315626,0.10873745,-0.20293624642331332,0.013854937324251543
8213,SIDM00097,Axitinib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1114464,-0.11079579,-1.383874332276755,-0.09997665448138934
44079,SIDM00878,Dabrafenib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,4.0823145,0.04621234,1.6638514645631082,0.04564869622361364
20288,SIDM00875,Axitinib,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3128755,-0.020107953,-1.1470623977661336,-0.02892969400699151
77147,SIDM00411,MK-1775,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,-3.6027575,-0.20033348,-1.4286259931709802,-0.03576818730511978
68928,SIDM00097,Lapatinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9122934,0.05161755,0.773161317816091,0.05330122312177397
1597,SIDM00529,Trametinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,-1.5976458,-0.07585941,0.8283765713584932,0.06699239662635559
87294,SIDM00866,Olaparib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-1.5771149,-0.031052476,0.6212340369186644,0.04078372404825935
37485,SIDM00954,Palbociclib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.0279995,-0.03252196,-0.28221395641372227,0.03768653704234878
95094,SIDM00893,Olaparib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.6664325,-0.04195055,-0.3036288580857835,0.006965282006235581
18665,SIDM00097,Sorafenib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,5.110695,0.31355894,2.322529008813465,0.15621336237150713
32696,SIDM00774,Nilotinib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.6513672,-0.1682685,-2.1484111039226845,-0.09010938937480883
10672,SIDM00529,PD173074,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Black,44.0,-0.5735798,-0.030790623,0.32769519826582677,0.07336909446568042
31276,SIDM00779,Navitoclax,Crizotinib,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,33.0,1.1861688,0.030332658,1.3731033934447134,0.03614213548125643
61299,SIDM00878,RO-3306,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-1.0360711,-0.06644159,-2.1820043929675124,-0.07355536481288029
88997,SIDM00878,Afatinib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-1.5513018,-0.13700996,-0.9084062297095927,-0.06380706901974961
76085,SIDM00628,Doramapimod,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,0.95752245,0.027607324,1.943603236853886,0.06254024059864739
13775,SIDM01233,Olaparib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.1558611,0.027543928,1.4046711018256506,0.03960751459637911
42709,SIDM00097,Sorafenib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.4123752,0.13697146,0.5737822385846738,0.05512726918445778
55045,SIDM00779,Dabrafenib,Camptothecin,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,33.0,-2.6083138,-0.13588427,-1.041323738298272,-0.035497108217421684
83788,SIDM00878,Paclitaxel,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,-1.392758,-0.11127296,-0.7499070452971599,-0.029926820457006086
106835,SIDM00776,SCH772984,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,4.5088835,0.2518901,3.532576496401424,0.16537199572771533
5682,SIDM00411,OSI-027,SCH772984,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.2796044,0.1366897,1.9985042908942363,0.09668759496000577
61865,SIDM00971,RO-3306,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.2391515,-0.10738248,-0.040576873491726305,-0.005743448792494875
104440,SIDM00332,Sorafenib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.9174951,0.08291065,1.4184475109114696,0.06958539971517773
50373,SIDM00875,5-Fluorouracil,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.68747747,0.07868673,-0.6972488570417279,-0.04949032720722809
58267,SIDM00778,5-Fluorouracil,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,69.0,-3.5539417,-0.07642932,-2.0509004834219504,-0.05037912675699779
106270,SIDM00834,Olaparib,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,White,66.0,0.5363627,0.013881743,1.195155358401859,0.038449237568982865
58203,SIDM00971,Venetoclax,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.424364,0.026654983,0.3369491687984896,0.0208637231574634
45453,SIDM00411,Irinotecan,Cisplatin,Pancreas,0.8,Pancreatic Carcinoma,Male,East Asian,43.0,-0.73977154,-0.03525185,-1.683523906200999,-0.007877806415851998
96665,SIDM00332,Vorinostat,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.9161327,-0.30173412,-0.698652665209814,-0.05031835699065585
68311,SIDM00359,AZD8055,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,3.0292215,0.2013032,-0.34319054390603954,-0.03232673023126184
92993,SIDM00301,MK-2206,Oxaliplatin,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-2.111672,-0.12071054,-0.1224250945719837,-0.00359070067166504
85141,SIDM00866,Doramapimod,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.7428427,0.037070338,1.8019410133308493,0.06148395528868471
38316,SIDM00776,Trametinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,0.9864616,0.061405856,0.07470559598502019,0.01606191944751286
13961,SIDM00411,Olaparib,Palbociclib,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.6497759,0.046328213,1.4371557207290935,0.02928280641825939
37981,SIDM00529,KU-55933,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Black,44.0,-0.79844314,-0.012412698,1.0571339926516066,0.07336050047626258
82036,SIDM00893,Sorafenib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.3766055,0.032283258,0.2640298474548659,0.013487438594999632
60551,SIDM00878,Cisplatin,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,2.857697,0.13492547,1.728455371909735,0.07718072772376748
100375,SIDM00971,Entinostat,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,6.3161516,0.1671159,3.1169250923548377,0.18997922764057926
38499,SIDM00971,Dabrafenib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.7489284,0.01637827,1.3801334518795036,0.047606540143702636
10301,SIDM00866,GSK269962A,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,-1.1886321,-0.045122158,-0.059249147902477844,0.01936391099826006
45409,SIDM00531,Irinotecan,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.15014376,-0.01683087,0.18848792238303896,-0.04925903028999895
24622,SIDM00893,MK-1775,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.014216,-0.08883536,-0.9307482056369379,-0.04708754862277021
4078,SIDM00628,Sorafenib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-0.58743626,-0.054209653,-0.8283503574674259,-0.04587339999012795
51607,SIDM00778,Oxaliplatin,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-2.5289543,-0.04332745,-0.9448196206196712,0.0026001383574431533
81772,SIDM00531,Gemcitabine,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-4.0248933,-0.3885754,-1.6691278209972997,-0.1392092378475591
64157,SIDM00673,ZM447439,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.7618722,-0.13512784,-2.183122931667495,-0.14737830789254883
10980,SIDM00866,BI-2536,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.10893502,-0.004880941,-0.4978753363732211,-0.04929347739922058
9692,SIDM00776,MK-1775,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,-1.6146767,-0.11344331,-1.4991772911073833,-0.13609915092979252
9801,SIDM00193,Camptothecin,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,53.0,-0.8195936,-0.028193822,0.6725300822815558,0.05440606683543923
85939,SIDM00301,Palbociclib,Trametinib,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,-1.2556646,-0.11320213,-0.8044349733187967,-0.045871686599525834
101503,SIDM00628,PD173074,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,2.9253058,0.0766689,-0.3095684601693875,0.03730807502866267
96200,SIDM00529,Olaparib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.2848703,-0.052212745,-0.5741761062507044,0.008355842410077956
35688,SIDM00893,GSK269962A,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-3.159159,-0.14885463,-1.549470584655596,-0.07809005391419234
13583,SIDM00529,Afatinib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.8527727,-0.047638576,0.28889366741391187,0.03907305399212497
86962,SIDM00673,OSI-027,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.4757466,0.20800194,-0.23749295161658748,-0.009176832058246643
86227,SIDM00971,Nilotinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.238445,-0.0787556,-1.2783665616409923,-0.11051766934758607
33399,SIDM00866,Nilotinib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,0.8102008,0.048483737,0.3378587971404511,0.04086979484138038
81353,SIDM00778,Palbociclib,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,69.0,-3.185918,-0.0843717,-1.7554348343301878,-0.00044359229553577286
64445,SIDM00628,Cisplatin,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-0.8768281,-0.082526445,-2.1147135058462583,-0.13318364831597476
97547,SIDM00097,NU7441,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0151318,0.058205392,0.5487534691357178,0.036808870296622304
34439,SIDM00878,MK-1775,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,1.0663016,0.09949407,-0.6390191274987851,-0.02222879828273419
70240,SIDM00673,Vorinostat,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,0.93846136,0.097946174,0.6620701859182299,0.04821211798758476
56710,SIDM00673,AZD7762,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.49875507,-0.039579913,-0.891122072910348,-0.10026672478671919
44201,SIDM00332,Taselisib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.9045823,0.14377439,-0.16041511970438418,-0.002783843028636758
65925,SIDM00097,RO-3306,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1717833,0.060093507,1.2492844328307895,0.047716946003099545
49151,SIDM00097,MK-2206,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.5654334,0.11512396,-0.252107881367976,-0.02856526286850146
88050,SIDM00875,NU7441,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3054987,-0.024180189,-0.11222487381713918,0.046416072390743184
98475,SIDM00130,Linsitinib,Erlotinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.8181592,-0.07882012,1.3845605104313872,0.08313264663550422
91165,SIDM00866,Lapatinib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-1.035624,-0.08068745,-0.7122604463549744,-0.043595750765342306
90772,SIDM00834,5-Fluorouracil,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,White,66.0,0.40513432,0.023831276,-0.6122287338457965,-0.010055469049989085
24488,SIDM00971,Trametinib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.0396743,-0.014539056,-0.36794351857700636,0.016340824661224225
50596,SIDM00893,JQ1,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.29299,-0.054734416,0.7587916479500652,0.1312187084373829
11002,SIDM00782,5-Fluorouracil,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,1.2989935,0.06835454,1.3333869147421735,0.03191552536257596
42972,SIDM00097,PF-4708671,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.56946665,0.02441544,1.1447101791963739,0.0853246443467118
97432,SIDM00779,Taselisib,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,33.0,-1.615727,-0.13349223,-1.1882615200380238,-0.059136208187106416
5804,SIDM00971,Ribociclib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.8286505,-0.07692118,-2.4930596246877523,-0.054226482217565854
89024,SIDM00146,Dabrafenib,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.2338315,0.06093516,0.4665492999002827,0.04636568097559552
31161,SIDM00660,Navitoclax,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,3.2844336,0.21095246,1.6382509797547375,0.054371211335549265
35166,SIDM00411,Navitoclax,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,43.0,4.638955,0.24904399,4.229018979316772,0.18293589243007716
36568,SIDM00097,RO-3306,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.4017665,-0.095927864,0.014169946561741243,-0.04216631256220111
17167,SIDM00529,Luminespib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-0.7808866,-0.07297792,-0.7369252446929243,-0.013167738336594298
60210,SIDM00774,Vorinostat,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-0.12689677,-0.008878106,0.1108232347525089,-0.019358783107774113
50749,SIDM00628,Dabrafenib,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,-1.1064975,-0.07656166,-0.030934866218058913,0.061928264069419516
95508,SIDM00301,MK-2206,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.1986314,-0.11995608,-0.7728113019922025,-0.00852625599172384
15953,SIDM00875,RO-3306,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.10249757,-0.011106428,-0.06835794606346055,0.016969874738343747
39289,SIDM00866,AZD7762,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.89719087,-0.052269973,-0.16475579899059903,0.0050371987125967035
55254,SIDM00971,MK-2206,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.2060244,-0.15994424,0.8288590965491596,0.07971192839713902
4528,SIDM00301,LGK974,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.5437784,0.17593336,-1.2225437033886342,-0.03569533917381858
87324,SIDM00146,Camptothecin,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,0.97140074,0.09789743,-0.4525361097952596,-0.03840074103808358
54529,SIDM00954,PD173074,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.9473608,-0.038639884,-0.08012356803976205,0.060832626485288865
71402,SIDM00411,MK-1775,Trametinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.1851048,0.0729562,-0.9155382377302365,-0.020432352371558167
13193,SIDM00893,Trametinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.9373796,0.10691841,2.015248030241797,0.08966997844561866
47960,SIDM00146,Taselisib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.7579942,-0.062551826,0.3813762326118373,0.06368719372450739
24166,SIDM00673,Vorinostat,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,0.71461487,0.06855405,0.6215958644721321,0.09517736207657843
70848,SIDM00866,Sorafenib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.03267,-0.04027669,0.038944106514288236,0.009732448607880187
14359,SIDM00971,Navitoclax,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.4735732,0.12360974,0.0159083615079943,0.04133656263643494
30075,SIDM00628,GSK269962A,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-1.1085314,-0.09820753,-0.660563315298735,-0.01417953195102137
94053,SIDM00875,Linsitinib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.0113862,0.14664637,1.3657881509430005,0.07434380518231846
22974,SIDM00779,Olaparib,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,2.5518107,0.018770497,2.000658620834587,0.09662657881114314
57179,SIDM00301,Olaparib,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.0480233,-0.08158666,-0.7161632162499211,0.016609925565219955
48365,SIDM00529,Alisertib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,0.41260344,0.041748602,-0.07407749874311023,0.013388660138085725
75135,SIDM01233,Afatinib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-1.3279268,-0.076717146,1.5956346761728333,0.1327847950562899
31701,SIDM00782,Afatinib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-1.3718215,-0.11820688,-0.920140738279545,-0.039029010232157324
74313,SIDM00628,Uprosertib,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,3.1293468,0.24584262,2.0985493715768384,0.14724474705518623
93018,SIDM01233,Dabrafenib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-0.8612586,-0.018529728,1.7332852400310466,0.06281411301526744
71575,SIDM00529,Temozolomide,Taselisib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-0.4867342,-0.009659982,-0.8226390317527431,0.037566606720363264
58161,SIDM00146,Trametinib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.7073453,0.05420569,1.4331635402074765,0.057534230749745945
5207,SIDM00628,Temozolomide,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,3.3358755,0.19140217,0.46129266197541413,0.0219900750474308
10738,SIDM00893,PF-4708671,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.9099478,0.15569627,0.3047631848393719,0.04998423090159261
18599,SIDM00193,Taselisib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.18498516,-0.016380448,-0.7132508330316834,0.010107270971971288
96863,SIDM00878,OSI-027,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,2.5076127,0.2538258,0.6032322022552641,0.11572225873845743
92572,SIDM00332,Nutlin-3a (-),Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,4.5039716,0.14894933,1.8774329159249947,0.052795651724276374
85755,SIDM00779,AZD8055,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,33.0,-1.5855144,-0.11937407,-1.453513874607594,-0.14332456886970613
24904,SIDM00954,Vorinostat,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-0.8515552,-0.064742856,-0.4983723513824169,-0.07388050684774063
71362,SIDM00778,MK-1775,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-0.51942974,-0.02350715,-0.15494058125517057,-0.026833689718131888
55134,SIDM00878,Doramapimod,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-1.0968204,-0.056468513,-0.34332972468727607,0.031535476908559124
47934,SIDM00774,AZD7762,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.688474,0.092653714,-0.15382950990388802,0.029456211704090095
100516,SIDM00893,PD173074,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.3389063,-0.03401256,0.15132101168064455,0.03065224605900347
101642,SIDM00332,NU7441,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,5.141224,0.21320477,0.7043673347416906,0.0030227890861245035
48290,SIDM00193,Navitoclax,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,1.2116319,0.058270115,0.2762006686480111,0.04662655284837229
78089,SIDM00673,Docetaxel,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.4255123,-0.10111348,1.0257704751996872,-0.041938794978140834
23280,SIDM00673,Sorafenib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.86731017,-0.041503638,-0.4595265216795814,-0.01654886088636093
30536,SIDM00776,MK-1775,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.44646508,-0.020536842,-0.23996206067419676,-0.024619874572655298
21627,SIDM00529,Vorinostat,PD173074,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.81087685,-0.07403023,-0.028854034708058224,0.004574751713624126
35797,SIDM00529,PD173074,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-2.7168438,-0.11291884,-1.7729006692717184,-0.07258703445674962
62824,SIDM00411,Gemcitabine,Olaparib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-1.5380566,-0.09315727,-0.2998801723947336,0.002803641078200177
92514,SIDM00866,Temozolomide,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.1357127,-0.01885495,0.17103262997305838,-0.008696326723126544
86892,SIDM00866,Luminespib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,0.4769658,0.0422258,-0.28994787531126115,-0.029968036330161704
57114,SIDM00673,Cisplatin,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.044904,0.08852404,1.9658702228009588,0.0911233807384494
50832,SIDM00146,Afatinib,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.1338915,-0.10455135,-0.9982669476379074,-0.08133601324330543
88658,SIDM00130,Palbociclib,MK-2206,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.5261635,0.12948604,-0.334430481651306,0.04365179998560008
91729,SIDM00866,Alpelisib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.6825605,-0.051958,-0.5366123914946299,0.024834371856564223
95495,SIDM00971,MK-2206,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.4803294,-0.08033762,-1.8308277611644335,-0.07828800546228072
510,SIDM00146,GSK269962A,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.4943057,0.12166012,0.544212901218312,0.0588362472939792
84256,SIDM00531,Olaparib,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.092135,0.27075347,1.0670570232124008,0.05788287464742302
102126,SIDM00673,Temozolomide,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-0.3070118,-0.006741521,0.8858003721576333,0.027040384480810097
69387,SIDM00332,Navitoclax,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,1.8807236,0.06648529,-0.11748739708393684,0.03295051701442294
37800,SIDM00628,Olaparib,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,Black,51.0,-2.026401,-0.13863619,-2.289965210088508,-0.07846139467772743
36098,SIDM00332,Venetoclax,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.6019645,0.05978475,1.1880258645322874,0.07257542008117354
78187,SIDM00878,Olaparib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-0.47773662,-0.012605606,1.2498861289052219,0.057035379812884736
50610,SIDM00660,Trametinib,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,32.0,2.0827703,0.08512005,-0.6598968699895158,-0.026658590298904238
78409,SIDM00893,Nutlin-3a (-),Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.2887079,-0.0061887493,1.3445525241605596,0.039554035686510086
84885,SIDM00628,Navitoclax,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,2.292035,0.12631367,0.7573165489009862,0.09307178962894115
3357,SIDM00146,Trametinib,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,3.529155,0.16172796,2.0858648104351847,0.08746850408362232
3489,SIDM00971,AZD7762,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.37047496,-0.006810068,-0.5091739988422145,-0.0013861920803207143
52722,SIDM00097,NU7441,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.76946515,0.037303507,1.4873347626309985,0.09648892239740521
27727,SIDM00332,5-Fluorouracil,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1004906,0.020807976,0.645032564122573,0.08474905284500685
38630,SIDM00878,Dabrafenib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,2.5143642,0.113885,0.6783502365562515,0.06201390016891298
11651,SIDM00782,SCH772984,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,4.6542864,0.29919428,2.58874284290284,0.17877475672633103
19749,SIDM00878,SCH772984,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-3.150898,-0.21667887,-0.8322390992979551,-0.0695119112564371
8060,SIDM00332,Bortezomib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8681919,-0.04044718,-1.126127607775127,-0.02966967434197842
84122,SIDM00866,BI-2536,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,52.0,0.9579287,0.044351153,0.10174330430100662,-0.0022061518570693785
108060,SIDM00628,5-Fluorouracil,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,-1.0489546,-0.046563752,-0.32372903402144204,0.023176150415199884
56346,SIDM00866,PD173074,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-0.60760015,-0.019424617,-1.4798707096740908,-0.018395443799347832
75580,SIDM00893,5-Fluorouracil,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.78664434,-0.037960194,-0.8044674150761892,-0.011890337856201114
25249,SIDM00971,Afatinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.73085856,-0.031759698,-1.172433876511373,-0.04329080409192389
98078,SIDM00893,MK-2206,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.8760421,-0.120986745,-0.6363883994633471,0.04594924643499915
106350,SIDM00628,Navitoclax,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,0.77621996,0.064236715,0.7316891526892648,0.0166678656385748
62260,SIDM00097,Dabrafenib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.52592844,-0.023983328,-0.9597362351066883,-0.044486283205102936
31685,SIDM00097,Nutlin-3a (-),Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.457887,-0.05360081,-0.5106549616434333,-0.005346940017008411
39444,SIDM00146,SCH772984,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,2.628843,0.210331,3.3108639734329457,0.09537894723764134
44003,SIDM00893,Trametinib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.0311913,-0.10179476,-0.5580961320897193,-0.10452058788457796
46273,SIDM00875,Linsitinib,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.554572,0.036939416,-0.23862067091377975,-0.004967964033433308
65762,SIDM01233,AZD4547,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,1.3182845,0.036268234,0.8188417090072828,0.01390418019640863
94288,SIDM00531,5-Fluorouracil,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.20899142,0.0070471494,1.7587507000983764,0.05024228266630775
56312,SIDM00146,Nutlin-3a (-),Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,1.2229754,0.035379574,1.1154463870796707,0.10589658979628463
62755,SIDM00097,JQ1,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2349825,-0.08160813,1.268862307104127,0.058735356426629234
28238,SIDM00875,AZD6482,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.85505366,0.0665604,0.7328593622002569,0.023438119033332958
42291,SIDM00893,Lapatinib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.0281491,-0.10848046,-0.588142382156685,-0.062001304069153114
40798,SIDM00782,AZD7762,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,Unknown,72.0,-1.1024795,-0.10116442,-0.969290204793841,-0.06635132141795556
102000,SIDM00774,AZD6482,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.77196753,-0.033910908,1.004873852501553,0.006752701336918264
65860,SIDM00097,ZM447439,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.7416384,0.039335754,-1.8023781606475968,-0.04076719973412897
34013,SIDM00531,SCH772984,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,4.3850975,0.49143112,2.4997843732285374,0.19046655605111748
10045,SIDM00866,Uprosertib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.7230941,-0.02503118,1.7892346484233357,0.08964980309089574
87292,SIDM01233,SCH772984,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,1.2403469,0.09770895,-1.3603791418903506,-0.12545594475929076
38179,SIDM00866,Gemcitabine,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-2.009475,-0.13074884,-1.688748807109648,-0.04415431257052926
16475,SIDM00774,Uprosertib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.14722069,-0.008886284,0.7092849358880401,0.07670923961399265
100821,SIDM00866,Uprosertib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.777248,0.04461194,0.25061531754682076,0.07565721221090309
43409,SIDM00834,5-Fluorouracil,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,White,66.0,-0.8594324,-0.046519537,-1.485630831863243,-0.04454114484764337
6208,SIDM00776,5-Fluorouracil,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-1.8222089,-0.054115538,-0.49155933879724045,-0.03094891341253806
93646,SIDM00971,Axitinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.2702475,-0.044931382,-1.7082381804767084,-0.03339170675040739
66034,SIDM00529,Gemcitabine,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Black,44.0,-2.083966,-0.07613306,-1.3220689685678293,0.016929027672431176
66767,SIDM00193,Dabrafenib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,53.0,-1.037597,-0.023248404,0.5783811492482206,0.044896964303936804
75115,SIDM00774,Lapatinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,-0.07528577,-0.007650419,0.8946140735586219,-0.008163350542017438
33324,SIDM00893,Docetaxel,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.215909,-0.16467951,-2.418791863536744,-0.13194893304994068
16261,SIDM00301,LGK974,Erlotinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,0.8970638,0.098709926,-1.3803783829351406,-0.04687130029353286
16184,SIDM00097,Sorafenib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.4500647,0.14878887,1.536597708401989,0.07158467063829775
74955,SIDM00774,Bortezomib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-0.2889999,-0.026648412,-0.5297141071297247,-0.052699914611500275
86480,SIDM00301,Navitoclax,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.2628821,-0.123786055,0.5394654365661287,0.022172923377327805
2130,SIDM00954,Linsitinib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-3.0464845,-0.19122352,-0.0178855445215802,0.03241738434486781
55907,SIDM00146,Olaparib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.6947553,-0.033313196,-0.8517188550945879,-0.009465599880050397
59848,SIDM00411,Gemcitabine,Trametinib,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,43.0,1.9085547,0.11973699,0.5117312176775868,0.036604885724549514
97499,SIDM00673,RO-3306,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.3665321,-0.084177844,-0.3491047563326213,0.0606637255376208
71184,SIDM00193,Trametinib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,East Asian,53.0,-2.8961704,-0.14491129,-0.03189138809614553,-0.03181503703885628
78549,SIDM00673,Alisertib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.21126089,-0.013006555,-0.27534121853847476,0.007101044525248562
3362,SIDM00866,Camptothecin,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,7.162222,0.21078569,7.4023015888463775,0.2960465222707411
70003,SIDM00660,MK-1775,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,0.16190355,0.006064526,-0.5945230438309947,-0.029788450141032468
33653,SIDM00776,MK-2206,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,0.59154075,0.04478374,0.3384652009845425,0.05873666335438453
43784,SIDM00193,MK-2206,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,53.0,2.580237,0.21997233,1.6194779760057691,0.1379420159326404
95711,SIDM00332,Nilotinib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.33696792,0.025523216,0.49702766538552473,0.005368599515071902
65136,SIDM00893,Olaparib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.543079,0.080781244,-0.9288598903512769,0.002678606733805621
46547,SIDM00411,Dasatinib,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,-4.170945,-0.2049151,-0.9161638081967621,-0.0005196637405067583
71879,SIDM00332,Bortezomib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0804335,-0.036364507,-1.7880435836821325,-0.060850029389272496
40234,SIDM00779,Crizotinib,MK-2206,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-0.5033468,-0.02872486,-0.07041413932233108,-0.027860199015753533
2327,SIDM00130,MK-1775,Navitoclax,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.8836057,0.2264265,2.794168212915127,0.1233465956783557
32390,SIDM00834,5-Fluorouracil,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,White,66.0,-1.5767555,-0.079568475,-1.634317064181395,-0.09224721796373704
58941,SIDM00529,Lapatinib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,2.2042205,0.16055258,0.8936997045306289,0.12601426368704985
38052,SIDM00332,Wee1 Inhibitor,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.833598,-0.11036057,-2.140766232339411,-0.10919468251450842
57429,SIDM00146,Alisertib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-0.71296644,-0.06724057,-0.037729817962590784,-0.05704453920429798
99296,SIDM00628,Entinostat,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-1.1660807,-0.065090485,0.2577829318789448,0.08993510422958718
58455,SIDM00878,PF-4708671,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.936661,-0.048253894,-0.4229834329317722,-0.0022886781531679832
54767,SIDM00893,Dabrafenib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.3768258,0.08530244,0.8961583291863379,0.03731874474228332
70514,SIDM00660,Afatinib,SCH772984,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,32.0,1.0646933,0.11130801,1.273180633225623,0.023406075383727028
66362,SIDM00971,Docetaxel,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.5673082,0.061603043,-0.34532909408496554,0.040013768052275356
62764,SIDM00332,KU-55933,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.7800205,-0.07752196,-0.7820594466366256,0.006103437529215539
86352,SIDM00778,AZD8055,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,-1.9233979,-0.056562886,-0.21654018196163796,-0.009473940235888597
42266,SIDM00893,PD173074,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.4710246,-0.036290582,-0.007254467215481707,-0.0035000645369929703
102017,SIDM00778,AZD8055,Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-0.30704337,-0.017815314,0.13159657467254318,-0.043136704430355444
89243,SIDM00531,Irinotecan,Erlotinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.4552844,0.1258342,0.3076863035649133,-0.009117148238018003
25915,SIDM00875,AZD6482,Vorinostat,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1396705,0.097971894,1.538820871127996,0.09967044835083032
87113,SIDM00866,BI-2536,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.3655318,-0.07810956,-0.7525412469546695,-0.0493014993203859
61473,SIDM00301,Taselisib,MK-2206,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,50.0,-2.1407287,-0.18178704,-0.17434513710264157,0.01999482907119509
48704,SIDM00660,Camptothecin,Trametinib,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,32.0,3.213567,0.26077223,1.178976146670551,0.0645395875634436
52965,SIDM00893,Linsitinib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.319078,-0.05658232,-0.042154018263872196,0.026281263956444353
13289,SIDM00193,Dabrafenib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,53.0,-0.80864656,-0.018825674,1.54874741166332,0.04292604687974712
42740,SIDM00774,JQ1,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.1938137,-0.059571594,0.22724227281996748,0.03717005452295977
104252,SIDM00893,Docetaxel,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.030782852,-0.0028822473,-0.7705386329114368,0.04283606733176149
14026,SIDM00866,NU7441,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-1.3381318,-0.09524812,-2.1273677357729652,-0.08060722088525946
35828,SIDM00529,Nilotinib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Black,44.0,1.4358928,0.0619314,1.0500995894220349,0.15577002389325156
55943,SIDM00866,Afatinib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-0.94250965,-0.06598105,0.057120204065643006,0.054415893546200904
102388,SIDM00954,NU7441,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,1.5203212,0.114706405,0.5682308908951037,0.0745154817894695
80899,SIDM00660,Dabrafenib,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,32.0,-3.475541,-0.124451615,-0.2781798139659563,-0.004569132436508676
60344,SIDM00332,PD173074,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0886577,-0.11079003,-0.10753538803260118,-0.004041304435682684
34791,SIDM00878,Luminespib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,0.74074864,0.093317136,-1.4196120986620977,-0.09651328389015343
89832,SIDM00893,Tozasertib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,5.613294,0.38717464,4.895432313998522,0.22875460103563852
22947,SIDM00779,Navitoclax,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,0.94576055,0.028537557,0.7471632233976159,-0.0026504836165302035
57376,SIDM00954,Alpelisib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-0.83449066,-0.059390225,-0.1383311297973162,-0.04245688400578514
43374,SIDM00628,Palbociclib,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.0490417,0.10543312,0.40905267367234155,0.08198071757787162
39487,SIDM00628,Wee1 Inhibitor,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.34349102,0.030811846,-0.4151796332778046,0.0007936671590603827
106742,SIDM00954,Wee1 Inhibitor,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,0.87875617,0.06351194,1.2160283816251813,0.08680120493020801
83906,SIDM00866,NU7441,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.007943,0.08382523,-0.9635623897028048,-0.011716791723767231
61633,SIDM01233,Nutlin-3a (-),Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,0.5868284,0.020280726,0.08313229838282345,0.005956167184306938
74333,SIDM00875,Taselisib,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2735598,-0.02937695,-1.2437900978591228,-0.04003496486038957
67402,SIDM00673,JQ1,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.2420676,-0.13473462,-1.2866132809303352,-0.0812308695650414
43927,SIDM00866,Cisplatin,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,52.0,0.79888785,0.020166656,1.3517287722534823,0.04155294889215852
69625,SIDM00146,Docetaxel,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.8128354,-0.03723679,-2.687271471891567,-0.06837931600615353
44205,SIDM00097,Axitinib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.131648,-0.1245457,-1.0811653307391584,-0.07743720376676748
41119,SIDM00776,Trametinib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.02540161,-0.002266483,-0.7585603257275804,-0.06887286948738477
25873,SIDM00875,RO-3306,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6028789,-0.16341403,-2.3027351453568317,-0.16532013909653445
5171,SIDM00673,Nilotinib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.75866985,-0.03095132,0.9163174938741182,0.09118927443967327
20516,SIDM00531,Erlotinib,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.6326678,0.16158074,1.884777828720748,0.12200017475118767
102830,SIDM00875,Docetaxel,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-4.0586843,-0.19235343,-4.2566935911069,-0.28041653624551466
8736,SIDM00893,Cisplatin,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.49656397,0.014291593,0.38106974036796676,0.007126570949160528
3386,SIDM00893,5-Fluorouracil,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.2303171,0.079135,-1.065036135629895,-0.04302051291202031
30089,SIDM00778,Dabrafenib,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,2.4820883,0.044523314,1.5581523358669647,0.026146061421421066
94936,SIDM00893,AZD7762,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.53094774,0.028586416,-0.39788455256774763,-0.02407678997343889
64012,SIDM00893,Docetaxel,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.48856032,-0.046904758,-3.5489473454426004,-0.23735626017432263
81518,SIDM00146,SCH772984,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,0.25912398,0.0240552,-0.5143973565261255,-0.041947428395574644
87745,SIDM00875,JQ1,Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.54197943,-0.060272947,1.9853314647762141,0.11113403848022127
79651,SIDM00628,AZD6482,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,Black,51.0,-1.159484,-0.1135846,0.2462474457567636,0.04049021550083575
67793,SIDM00779,Navitoclax,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,0.32967535,0.00852454,0.2243413447282992,-0.04991368939297599
92230,SIDM00778,AZD8055,Dabrafenib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-0.92996323,-0.058371983,-1.1680075334968407,-0.08430204329094143
26161,SIDM00971,Axitinib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.487649,-0.086696625,-2.313594206398086,-0.06620531699633884
85615,SIDM00875,JQ1,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.661853,-0.14439152,-2.05889349901657,-0.07797429029038376
102565,SIDM00673,Dabrafenib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,1.1476356,0.025681594,1.31497990815122,0.03199345077766811
101015,SIDM00834,MK-1775,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-2.396835,-0.19223122,-3.759735940701999,-0.21923538003831736
93180,SIDM00834,Palbociclib,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,0.8393462,0.068473585,-1.9463980250681836,-0.06678327423191288
19094,SIDM00359,Olaparib,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.5574647,0.048445497,1.1487061348183627,0.01230102106546714
38370,SIDM00878,Navitoclax,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.34204617,-0.010253683,-0.1891992294241465,0.012733706165721162
100510,SIDM00628,Uprosertib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,2.4451303,0.22221088,0.6209083268697587,0.11757244332067468
30612,SIDM00097,Vorinostat,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9254429,0.062442966,-0.08268710530360956,-0.026832802358886975
18180,SIDM00130,MK-1775,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.1841122,-0.08951442,-0.21751906809242605,0.025234620271998097
19247,SIDM00834,Trametinib,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,White,66.0,-2.1557007,-0.064216666,-1.2554664876538162,-0.020106916305175474
105807,SIDM01233,SCH772984,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.0502062,0.07240156,-0.08993626832491876,0.04337278514320858
101235,SIDM00332,PD173074,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.8223106,-0.09136081,-0.7317753158860087,-0.05312117391769397
24714,SIDM00834,Linsitinib,Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,White,66.0,-1.8885251,-0.15829374,-1.4142046950878657,-0.05726218156021905
67047,SIDM00878,Tozasertib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.359411,-0.037277896,-0.9679800774040724,-0.034641821557184
33072,SIDM00531,Irinotecan,Dactolisib,Pancreas,0.0125,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.49337685,-0.05867474,-1.1704222441761938,-0.06467283568527171
44370,SIDM00776,Afatinib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.2855912,0.094217986,1.8825246716452324,0.06607436380299904
19606,SIDM00301,Olaparib,Palbociclib,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.316394,-0.07833143,-1.003043916917145,-0.0678182297913512
107195,SIDM00193,Navitoclax,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,1.0248418,0.055401094,2.013309328717523,0.08122660300352455
60705,SIDM00193,Camptothecin,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.7671066,-0.026876912,1.2609064446235931,0.05961727906162181
71348,SIDM00529,Afatinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,2.011608,0.1582134,1.646405261223946,0.13206970705877843
3131,SIDM00411,Erlotinib,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,43.0,1.4931017,0.06260702,1.6585902392169376,0.12000661745525053
92134,SIDM00332,AZD8055,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.9512012,-0.13663894,0.06786858622616555,0.012450522262040811
83727,SIDM00146,MK-2206,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,2.3654191,0.1851225,0.6580997769120871,0.07044313880909103
37742,SIDM00411,Palbociclib,Irinotecan,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,-3.3238542,-0.09327061,-2.3133526073923645,-0.021687026142660687
8495,SIDM00878,Doramapimod,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,3.0791533,0.19226167,1.7730149512363556,0.10454063208939958
84011,SIDM00866,Dabrafenib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-0.5873098,-0.017621554,0.12138799658408207,0.021535315690248413
84689,SIDM00130,SCH772984,Dasatinib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,4.300811,0.3769549,1.1460094510464878,0.11712218012042606
4061,SIDM01233,Olaparib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,1.8496977,0.042875674,1.1602259776678645,0.07401513239117158
85943,SIDM00774,Temozolomide,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.16750905,0.0041496446,1.5951090729298563,0.09905711516937722
87493,SIDM00146,MK-1775,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.67908597,0.044738285,-0.26829447909180865,0.0015038964096042709
21311,SIDM00778,Palbociclib,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,1.7290685,0.08234013,-1.29195835279328,-0.03952144008093069
49067,SIDM00778,AZD8055,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-0.44158506,-0.02664861,-0.27377829931077113,-0.045108466138629275
19308,SIDM00866,MK-1775,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-0.6733713,-0.044650447,-0.4266879633374902,-0.010687395125379565
33975,SIDM00893,Paclitaxel,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-4.842653,-0.38685676,-3.3021807489865016,-0.31092635740727365
66382,SIDM00893,BI-2536,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,5.036535,0.18700387,1.4417170518984799,0.06581877638662102
22573,SIDM00779,MK-1775,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-0.6764484,-0.04108819,-1.0113456951801911,-0.06921337187644185
80730,SIDM00332,Olaparib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.9034193,-0.04389591,0.0829752354750147,0.05622240102086529
8999,SIDM00673,Afatinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,3.327419,0.23033766,-0.2770784768006373,0.030389713110381685
83204,SIDM00332,Navitoclax,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.36422044,-0.03767501,0.8038067250552483,0.08575461426339992
50163,SIDM00146,Luminespib,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-0.7580522,-0.05487242,-0.11010012564324007,-0.01853806529228322
81270,SIDM00954,SCH772984,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,1.1716509,0.05882329,1.3297942766253246,0.1468817174192645
90621,SIDM00301,Gemcitabine,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,50.0,-1.0571979,-0.06218776,-0.25147181178209915,-0.036634533841435515
83043,SIDM00878,Ribociclib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.812752,0.090992056,-0.539389875434225,-0.04898982187599949
3371,SIDM00130,Gemcitabine,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-3.657473,-0.18364036,-0.7813415337261235,0.005555281450057984
44283,SIDM00954,Entinostat,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-1.2314823,-0.06374352,-0.27411851583209157,-0.02702223251292794
44412,SIDM00774,Linsitinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.8590019,0.14114825,1.706259064292728,0.13413926093016174
43323,SIDM00878,Gemcitabine,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.6684946,0.1806415,0.15684992839315468,0.03675864098140942
36996,SIDM00878,Olaparib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,70.0,2.4883316,0.12803988,0.011843302285412794,0.030533856984315984
107569,SIDM00782,BMS-754807,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.8237309,-0.074295074,-2.540125500518781,-0.11833306368287488
100484,SIDM00875,MK-1775,Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.1864642,0.0115158865,1.5420900869547165,0.05183822401445043
66292,SIDM00628,SCH772984,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,1.2310003,0.10703392,1.2241056104488222,0.12045727751635384
72843,SIDM00954,Gemcitabine,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-1.9102286,-0.08965257,-0.028249296226588238,-0.00012556031406914776
91118,SIDM00660,MK-1775,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,0.14529403,0.004930786,-1.1313731698488008,-0.046460220787086975
5902,SIDM00893,Luminespib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.1819832,-0.13278997,-1.2366984531773573,-0.07068288772525183
48152,SIDM00146,ZM447439,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-1.1291643,-0.08289913,1.2394412645121702,0.08490326654446502
7018,SIDM00774,RO-3306,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,2.7716851,0.19759054,-0.1595369520962796,-0.024923519239865792
9289,SIDM00834,Afatinib,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,White,66.0,2.7016118,0.13076913,-0.26470476927435765,-0.03426097121807889
45953,SIDM00673,MK-1775,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.2412711,-0.09875634,-0.3799046360080994,-0.032652673154209465
36941,SIDM00097,Camptothecin,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.2845281,-0.012387333,0.3914325878817764,0.05768595220235645
22995,SIDM00878,Temozolomide,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.33251584,-0.007457367,-0.12425568802308368,0.010477022818772037
79778,SIDM00776,Vinorelbine,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.68146473,0.053499807,-1.6919195190043115,-0.023443314155493004
40889,SIDM00529,Alpelisib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Black,44.0,-1.7033855,-0.07364518,-0.24154941377702793,0.047169759347774336
84660,SIDM00531,Cisplatin,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.370272,0.14788815,-0.8746867029824802,-0.03721608503138786
23231,SIDM00628,Luminespib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,0.83476985,0.07715317,0.3971387623289082,0.07342332575235107
13847,SIDM00866,Entinostat,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.33198687,-0.027593073,-1.405875952641827,-0.03495743582683123
87450,SIDM00779,Crizotinib,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.1229682,-0.030904882,-0.9857403727584355,-0.020593318859435057
12118,SIDM00774,Bortezomib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.4329267,-0.010222926,0.6101888401321033,0.02489761519123885
73064,SIDM00193,Linsitinib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,1.69558,0.06499994,2.445963561168443,0.13432666828653594
78612,SIDM00878,Wee1 Inhibitor,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.4633164,-0.038869742,-0.7089922875258433,-0.0004327320520998982
72836,SIDM00529,5-Fluorouracil,MK-2206,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-0.8256437,-0.06966612,-1.0847741344331772,0.003887329245576202
92581,SIDM00774,Taselisib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,0.8335848,0.02582449,0.3196549657354442,0.015336765867991793
79716,SIDM00529,Alpelisib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-2.1101587,-0.09277151,-0.16617555538451514,0.04528988781505948
20824,SIDM00774,BI-2536,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,48.0,1.3325617,0.1008697,-0.05164821741983978,0.030000238918918475
86993,SIDM00332,Trametinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,4.11659,0.26627666,1.107024691148718,0.03523640751025493
35017,SIDM00411,Gemcitabine,Cisplatin,Pancreas,0.8,Pancreatic Carcinoma,Male,East Asian,43.0,-1.379451,-0.086019054,-0.007965662753174488,0.04764467570746843
41187,SIDM00776,MK-2206,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,1.8575424,0.16749133,2.7412763389746844,0.11528344083272637
102810,SIDM00531,Irinotecan,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.68305266,-0.081721544,-0.9148990219347667,-0.09707986688056992
69800,SIDM01233,AZD8055,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,72.0,-2.4598606,-0.15948933,-2.280582534066719,-0.13312918259151826
49929,SIDM00301,Taselisib,Sorafenib,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,50.0,1.4457593,0.19235341,1.703933151910779,0.08081385918240727
101309,SIDM00529,AZD8055,MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,1.9551862,0.18009827,0.9030088626440196,0.11510763206892823
37903,SIDM00529,Cisplatin,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,1.0535455,0.02300649,0.42850698822983124,0.012476321543196958
49500,SIDM00866,Venetoclax,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,0.34963256,0.0073090913,1.133479489891182,0.05444933097154719
28010,SIDM00875,Ribociclib,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.27005106,-0.007838061,1.0437804209683759,0.055205236955283774
43536,SIDM00332,JQ1,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,4.0023146,0.18471082,4.207028657710268,0.16710353852703322
38236,SIDM00628,Afatinib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,-0.5816986,-0.046360385,-0.1352827981532263,-0.024238723185810183
106915,SIDM00866,Navitoclax,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-0.9404499,-0.07650411,0.0696633241246005,0.02792369951021021
78693,SIDM00774,Crizotinib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,1.4302593,0.18332843,1.284071346306582,0.05932734847269471
43437,SIDM00529,PF-4708671,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,0.37704074,0.02347746,-0.5208964464486551,0.0609967535898833
53781,SIDM01233,Vinorelbine,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,72.0,1.6514517,0.12470947,1.6516537860839402,0.06894412551983327
40222,SIDM00193,Trametinib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.5687447,-0.13543072,1.1157589455515278,0.09504391587679127
18924,SIDM00866,Temozolomide,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,-0.59652877,-0.009893975,0.17405995973776872,0.00856158543043179
96804,SIDM00332,RO-3306,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,5.4477477,0.34715006,1.0693090068776425,0.08975240182659468
21621,SIDM00411,Erlotinib,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,-2.8585124,-0.0994576,0.20178125315664913,0.10581373887154473
85246,SIDM00878,Taselisib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-3.2028952,-0.13036367,-1.8604677431479038,-0.09645249024749532
24899,SIDM00301,Oxaliplatin,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.8284119,-0.21788146,-1.2897755028575677,-0.07762141368444256
100949,SIDM00146,Sorafenib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.20510598,-0.016939325,0.23835039022440516,0.021453620720576647
67104,SIDM00628,Trametinib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,-0.3819505,-0.036275074,-1.0585104055358157,-0.035486291611613714
58386,SIDM00866,AZD6482,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.8161331,-0.0916773,-1.884870009803898,-0.07310459269267093
76937,SIDM00893,GSK269962A,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.65443504,0.052091006,-0.6441292712200041,0.015134379505740508
85415,SIDM00628,BI-2536,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-1.0393353,-0.043263227,-0.20191641057306317,0.00578949643420249
12952,SIDM00875,Lapatinib,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.9802886,-0.090439536,1.8464102027937719,0.06436566680886915
38403,SIDM00971,KU-55933,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.8690665,-0.02654719,0.8575442260294605,0.03419428520589199
33200,SIDM00130,5-Fluorouracil,Sorafenib,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.291891,-0.19848782,-1.27525080336518,-0.04459800828432228
3740,SIDM00774,MK-2206,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.32389998,-0.01679009,-0.3472563024811433,-0.048423831257737436
21102,SIDM00097,Crizotinib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.6262377,-0.03747719,0.5999034838089878,0.03267111373499395
83154,SIDM00193,5-Fluorouracil,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.5155512,-0.12160111,-0.7189392451986247,-0.08318506052553573
4935,SIDM00893,SCH772984,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.9607706,-0.11280824,-2.184119660588063,-0.09763393263903031
99136,SIDM00673,Docetaxel,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.9573226,-0.2824511,-0.966816987855104,-0.08661352480767653
25746,SIDM00673,BI-2536,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.49645486,-0.037663743,1.162393596731076,0.013934776693846174
102464,SIDM00673,Venetoclax,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.5701164,-0.038453467,-0.13032079771699495,0.011170541605792962
454,SIDM00130,LGK974,AZD7762,Pancreas,0.0625,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.2494973,0.100707166,-1.403086972181008,-0.02903094759341954
66959,SIDM00875,Temozolomide,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.84782666,0.02232897,0.38352393040574156,0.013933917119388937
108330,SIDM00146,Nutlin-3a (-),Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.0648878,0.03873582,1.3035674521892398,0.0363841883983157
84370,SIDM00146,Lapatinib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.92729163,0.09290538,1.3212879201756846,0.10345065679452832
35412,SIDM00097,Camptothecin,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3925178,-0.08512387,-1.299674831578471,-0.02068533260182544
65803,SIDM00529,BI-2536,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,1.9498723,0.13373378,0.8651063518068173,0.06616985005724532
93792,SIDM00878,MK-2206,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.8268161,-0.08055498,0.7314211931541784,0.05646115711066373
713,SIDM00779,Linsitinib,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,0.7632283,0.053506356,-1.081724405008738,-0.0187481676160704
86754,SIDM00971,Cisplatin,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.5513404,0.008433683,1.484636347170922,0.03707205795706696
38830,SIDM00332,Camptothecin,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.1172614,0.105102606,2.4845580983934576,0.08618227303629263
105563,SIDM00531,Erlotinib,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.7669904,0.07565872,0.9462001391622487,0.08615234445825729
76137,SIDM00332,JQ1,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,4.050537,0.24009153,1.2451320199590779,0.029579162652499862
72867,SIDM00893,Wee1 Inhibitor,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.1902378,0.01683839,-0.3391835104734136,0.02897673829033527
85660,SIDM00878,Lapatinib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,2.3473146,0.25680694,0.5610670612966375,0.10563949163606015
81759,SIDM00673,Nilotinib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,-0.7488001,-0.039315388,0.29490406525227647,0.08922293873487601
1749,SIDM01233,BMS-754807,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-1.1809452,-0.07997143,-0.8107675627090469,-0.07376544410612505
77446,SIDM00782,Afatinib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,Unknown,72.0,-0.76773226,-0.07394003,0.009427616794857714,-0.014426317980033871
25792,SIDM00411,LGK974,Gemcitabine,Pancreas,0.1,Pancreatic Carcinoma,Male,East Asian,43.0,-1.5815091,-0.053400934,-1.269658410524438,-0.07095916724106997
27853,SIDM00146,PD173074,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.1749271,-0.06972479,-0.3582550805258504,0.05662366579479699
40246,SIDM00834,5-Fluorouracil,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-1.524571,-0.06294023,-0.8810919890991037,0.02301230518484357
48107,SIDM00971,Alpelisib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.5143313,0.036145173,0.3345764825370709,0.027589419008182754
3530,SIDM00778,SB505124,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-3.9708962,-0.22316541,-1.1629521535295633,-0.062484051679480256
56469,SIDM00411,Lapatinib,LGK974,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.55223525,-0.01590183,-0.06846238130231934,0.08036842789471994
100043,SIDM00875,RO-3306,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.06124258,-0.0070100096,-0.6968262355159359,-0.029637346711141314
37203,SIDM00971,Alisertib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.1150858,0.07207518,2.453674342100865,0.13262116762791593
64861,SIDM00875,Entinostat,Vorinostat,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5208993,-0.050339002,-0.4645556808943177,-0.029597039213053216
13933,SIDM01233,Nutlin-3a (-),Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,2.445874,0.10116696,1.410702846205967,0.07661749618126605
71077,SIDM00954,Wee1 Inhibitor,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.3486663,-0.083109245,0.005058917681951662,0.016959644683133046
12728,SIDM00893,Tozasertib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.87641156,0.051064,-1.1311912586918063,0.009134681904121275
65890,SIDM00971,Bortezomib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.2900186,-0.07884592,-1.1646848828719494,-0.03547520509938246
45848,SIDM00971,Temozolomide,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.9492639,-0.043693952,-0.3931114187316239,0.030842296981336365
85704,SIDM00531,MK-2206,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.2789648,0.24226749,1.2884221449232764,0.04227568795112946
101534,SIDM00774,Doramapimod,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.4985499,-0.057336144,2.8698849142061795,0.1056712611798508
61385,SIDM00146,Nilotinib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.0164497,0.09262121,1.6178301978340874,0.08803871115260212
53957,SIDM00834,Linsitinib,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,0.67346805,0.05939017,-0.29772438126099704,0.03103582743426011
82974,SIDM00531,Ruxolitinib,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.56315905,-0.015862126,0.21405413014238933,0.009218102772037499
25647,SIDM00779,Vinorelbine,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,0.76272404,0.073223986,-0.8710478839246089,0.023871084052038388
56771,SIDM00332,ZM447439,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,7.1912837,0.36218414,2.8138305794433887,0.21449526643757477
84884,SIDM00130,Navitoclax,LGK974,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.3760847,-0.036809847,-0.16564757734370633,0.028599669355082676
11672,SIDM00776,Trametinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,3.8421912,0.18822996,2.091091832438003,0.12731114123446857
61664,SIDM00878,Venetoclax,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.2208408,-0.036068596,-0.8081700384559138,-0.01790774547402179
33040,SIDM00875,Nilotinib,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7127632,0.17667706,0.9783421097497428,0.07604438654895133
45906,SIDM00782,Trametinib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,1.216422,0.07855279,0.5986143646738961,-0.00434123030188218
7349,SIDM00130,Irinotecan,MK-2206,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.44827682,0.03868186,0.3093927405253209,0.06091658038958705
10769,SIDM00673,AZD7762,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.27129567,-0.022898491,-3.449039998976328,-0.232399930220211
8769,SIDM00193,Camptothecin,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.3106823,-0.009677221,1.506020094014544,0.02468431320841487
28284,SIDM00673,Doramapimod,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.8997359,0.048575547,3.0181949634235243,0.06701242514027847
36251,SIDM00193,Linsitinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,1.1667017,0.04927136,1.6750667069280587,0.10708854936968239
72816,SIDM00971,Nutlin-3a (-),Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.6166509,-0.018551026,-1.2518016209913703,-0.009589369108976505
20973,SIDM00878,MK-1775,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.4405246,-0.049676985,-0.5424995521068252,-0.007090228550318632
18609,SIDM00875,Lapatinib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3900976,-0.04525139,0.46748665707335924,0.01694732841636372
76314,SIDM00146,Uprosertib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.941899,0.0774561,1.8045395474027204,0.21717785282678698
50014,SIDM00954,Vorinostat,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-2.0373912,-0.14597595,-0.7702074385905059,-0.07692797887646975
44946,SIDM00954,5-Fluorouracil,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-1.3564469,-0.054541484,-0.38805157878963137,0.0005735080216396031
88452,SIDM00878,Docetaxel,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.36159506,-0.035629194,-0.363800271189456,0.03182710809148613
104806,SIDM00529,Doramapimod,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,1.2936596,0.02722358,2.626497161838926,0.08040938704364779
75682,SIDM00779,5-Fluorouracil,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,1.5493928,0.062342193,2.3484088048796963,0.17275481350721397
3312,SIDM00774,Afatinib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-0.3486515,-0.023841685,0.31553329765680105,0.021839953393964186
54889,SIDM00875,Afatinib,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2109505,-0.07579037,-1.049463384033767,-0.06498338138372113
6661,SIDM00193,SB505124,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,53.0,-0.68654674,-0.058973283,0.05080052628484734,-0.038893598413220806
50489,SIDM00628,Docetaxel,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-1.9204443,-0.15237425,-1.9954378587813244,-0.14496737416519961
52361,SIDM00673,BI-2536,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.3712064,-0.03170543,-0.5381091923760729,-0.09046739015701466
77412,SIDM00628,Axitinib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-2.090649,-0.16414429,-1.1013634738958251,-0.051063501178635104
53225,SIDM00866,Alisertib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.4137219,0.033036754,0.37821300575222966,0.03319117677320913
61779,SIDM00332,Docetaxel,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4852897,-0.12988082,-0.8105470751534408,-0.029114908118561513
37264,SIDM00834,Afatinib,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,0.8825911,0.04134134,-1.1554482331476588,-0.018192362614740134
15596,SIDM00097,Bortezomib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.7662464,-0.0500575,-0.6131287204388797,-0.03204398329665522
67013,SIDM01233,Camptothecin,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,1.5330338,0.06786841,0.20409182706374976,0.011498301381937874
99414,SIDM00971,Taselisib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.2187659,0.07908428,-0.5465937497530552,-0.02361088293650719
9750,SIDM00954,Tozasertib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.26483938,-0.010278557,-1.0524935030920062,-0.002499154956023699
47925,SIDM00193,LGK974,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.3564295,-0.06934457,-0.9096027004972195,-0.010348434784625776
18917,SIDM00531,SCH772984,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.5295455,0.16250584,-0.765264436963092,0.04023726477050334
28309,SIDM00301,Ruxolitinib,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.5133502,0.057684675,0.7002029126745577,-0.009928519920608333
29581,SIDM00097,Navitoclax,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9633767,0.0634415,1.9869441554118306,0.10721249442633699
27325,SIDM00774,Luminespib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.0024208173,-0.00022948823,0.1308378840832956,-0.04664138831931533
92681,SIDM00531,Olaparib,Crizotinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.0233252,0.15404841,0.08382596859971089,0.0032283604807087658
67242,SIDM00332,Cisplatin,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.8265747,0.051238045,1.9447234620027436,0.06621332797131046
42468,SIDM00782,Nutlin-3a (-),Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.42170206,0.008775339,3.0849530806905316,0.08027416454787245
91551,SIDM00359,5-Fluorouracil,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.0046687,-0.11079751,-2.284342101854114,-0.0698864530313111
96143,SIDM00359,LGK974,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.217565,-0.03481865,-1.3922139937151832,-0.006262956710545971
15288,SIDM00878,MK-1775,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-2.353629,-0.10654874,0.32959438861182844,0.07588871280762631
43794,SIDM00531,MK-1775,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.0469322,0.124628425,-0.07018208897967045,0.019047573765176486
82429,SIDM00673,BI-2536,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.2373854,-0.09572743,-0.1636770468982916,-0.0351799670472813
18445,SIDM00529,BI-2536,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,-1.3796983,-0.12071106,-0.1288040283628871,-0.015745488248105937
70244,SIDM00776,LGK974,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.0770643,-0.06472011,-1.0079634673332383,0.009983821163151562
16212,SIDM00834,5-Fluorouracil,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-1.0606068,-0.044148088,-0.44523900935631694,-0.016876082921800664
86482,SIDM00130,AZD7762,SCH772984,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.1453167,0.10055616,-0.8331325189352866,-0.006355778502887346
19919,SIDM00954,Cisplatin,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,4.0028815,0.056485996,3.453483867562152,0.18016614600922728
27257,SIDM00146,Dabrafenib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.1166683,0.06782111,0.19946240333142753,0.0291952817444975
87136,SIDM00359,SCH772984,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.0137427,0.11237323,2.377767728256114,0.12886739011161058
72346,SIDM00834,MK-2206,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,1.254233,0.071154125,0.9262195392373864,0.1487020197024811
79535,SIDM00146,Linsitinib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,2.50876,0.0923012,1.930068726892885,0.055149540763528536
67200,SIDM00146,PF-4708671,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,0.51567245,0.016868833,0.77926458419593,0.014239575779678696
27143,SIDM00971,KU-55933,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.2292224,-0.014684525,1.388874263436943,0.0698733764998243
51196,SIDM01233,Crizotinib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,72.0,-2.8566904,-0.14087112,-0.019779098042943807,-0.049348604086864374
72194,SIDM00146,Uprosertib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-3.4863448,-0.18275324,-0.15498770152410615,-0.0019236598530265258
81514,SIDM00893,Entinostat,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.1215065,0.05171161,1.7395788358654614,0.07048070056917241
77647,SIDM00097,5-Fluorouracil,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.6377788,-0.10670794,-0.28779641171856885,-0.01598896595511665
106186,SIDM00893,AZD6482,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.9072146,-0.07718543,-2.2275747439411857,-0.15616009320483296
80533,SIDM00673,JQ1,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.8532584,-0.13592036,-1.2001120620988306,-0.04526260957329244
80411,SIDM00834,Navitoclax,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,2.1276267,0.1427989,1.4184445991786419,0.1159773590111671
59394,SIDM00529,Olaparib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-2.299361,-0.019932294,-0.6200576265176627,0.008167573053266658
59028,SIDM00301,Ruxolitinib,Linsitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,1.3663145,0.071952224,1.719228122933852,0.024322259055089376
11485,SIDM00954,BI-2536,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-5.4866757,-0.17940713,-3.5998036816464647,-0.06242784523882198
43966,SIDM00097,Alisertib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.123603,-0.11116923,-0.2998595587717671,-0.06412696496724418
6915,SIDM00834,Crizotinib,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,White,66.0,0.43918478,0.030592084,-1.0900487368417922,-0.04476368298826496
68231,SIDM00146,Doramapimod,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,2.0469851,0.12488092,-0.23363643278373317,-0.028525299505460542
92654,SIDM00529,SCH772984,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-1.679262,-0.06278288,-0.7635032728959459,-0.014730643561976032
76232,SIDM00531,Ruxolitinib,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.67181116,0.027286286,1.455648442482082,0.01980686396587727
90218,SIDM00529,AZD8055,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Black,44.0,0.56162703,0.049473908,1.5152189061770138,0.11378870262670247
108299,SIDM00954,RO-3306,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-0.6954516,-0.049436368,-0.016419637161973234,-0.01594704685478204
62662,SIDM00628,Lapatinib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.46349266,-0.026027689,0.29554768953479815,0.030891319834885533
52058,SIDM00866,Camptothecin,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,2.2849932,0.052630845,3.6567899231825307,0.07093276331202235
47307,SIDM00779,Taselisib,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,1.945287,0.07599266,-1.101990197327498,-0.0033766234278235154
65387,SIDM00774,NU7441,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,2.769406,0.18154366,3.124697441047957,0.1635255083874249
107582,SIDM00130,LGK974,OSI-027,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.3738325,0.09462905,-2.091897102301059,-0.035348541977900286
57711,SIDM00834,Dabrafenib,AZD4547,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-1.857906,-0.049527813,-0.9412816029072923,-0.033610437123092377
50324,SIDM00866,Crizotinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.1667364,-0.094000585,-0.4013177874343223,0.023566855348529384
64136,SIDM00660,Linsitinib,SCH772984,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,32.0,2.808356,0.27315637,2.426377339875596,0.18861889774909818
107243,SIDM00529,AZD7762,Olaparib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.8227267,-0.14140679,-0.35441565453544305,-0.030300981137456166
28225,SIDM01233,Trametinib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.7287632,0.1411297,0.7595785764470873,0.08099813788890642
29823,SIDM00146,Uprosertib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.7174494,-0.11045007,0.03692339345950871,0.06185896579024723
77190,SIDM00628,Tozasertib,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,Black,51.0,-0.1962444,-0.018299997,-0.036599442481732226,-0.01577846847792338
17389,SIDM00875,AZD6482,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2553108,0.114838965,0.8520522254322294,0.07915047509716688
72059,SIDM00893,Bortezomib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.7503785,-0.07481096,-1.1613096422959137,-0.0854113890327214
46792,SIDM00359,Vinorelbine,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.6304082,0.10363105,1.87396168367965,0.13125730779932285
7521,SIDM00531,Oxaliplatin,Erlotinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.603678,0.06986291,0.2453984889962025,0.036712919648260484
81885,SIDM00875,Camptothecin,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.94493794,-0.015990043,-0.02330570784437545,0.00963639675259363
99826,SIDM00834,AZD8055,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,White,66.0,0.98918885,0.087387554,-0.1192432717483719,0.03801683187852717
42888,SIDM00774,Alpelisib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-1.281627,-0.079610385,-1.2212479119522042,-0.04525778400403091
79288,SIDM00531,Taselisib,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.6590963,-0.041774996,-1.0439992266800187,0.011263045929071592
77087,SIDM00893,GSK269962A,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.1037042,-0.07611205,-1.248262026686454,-0.11179014012389382
10971,SIDM00875,AZD8055,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.56042385,-0.04583568,0.7871512857269318,0.06606831978615287
100031,SIDM00529,Nilotinib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,-0.53634626,-0.017537102,0.3122291474430966,0.03186877255667589
13762,SIDM00673,PD173074,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.7726458,0.11024855,1.1511760226847152,0.07645494703233294
95085,SIDM00146,Linsitinib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,4.1321874,0.109152384,2.305472858582755,0.10296589733029245
92145,SIDM00146,5-Fluorouracil,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.2409658,-0.016382976,0.2512698434998494,-0.009119675191234513
18314,SIDM01233,SCH772984,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,2.3969266,0.13971865,1.7861212407110703,0.16221949022599563
101476,SIDM00097,Dabrafenib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.39676,-0.088923045,-0.42930963704655556,-0.02482531658481255
105236,SIDM00782,LGK974,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,Unknown,72.0,-3.455556,-0.1848473,-1.7275562989037792,-0.03711151641830249
34111,SIDM00628,Olaparib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,1.4154814,0.13374938,-0.6665823545172402,0.016839666153738185
102210,SIDM00779,Olaparib,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,1.2015011,0.030301113,1.058426393404417,0.02564994646417917
55605,SIDM00529,Wee1 Inhibitor,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-1.8529887,-0.09432749,-1.3227785682835167,-0.11726105019416054
72846,SIDM00332,BI-2536,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-4.4008446,-0.32710811,-1.7716951553046978,-0.10483027667922686
11342,SIDM00866,OSI-027,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.9191806,0.1087158,-0.09510897024746681,0.03442278330930211
3650,SIDM00097,Venetoclax,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4159559,-0.037786353,0.6638802779935271,-0.010190521949922935
2101,SIDM00529,Alpelisib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-0.34210026,-0.019621624,-0.14312436457258568,0.07768301235666697
51287,SIDM00971,Lapatinib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.4494889,-0.13647237,-0.6094318849231313,-0.02865797309208585
86548,SIDM00628,NU7441,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,1.4279188,0.12168626,0.008528870246361144,0.025828445299078847
38922,SIDM00893,Doramapimod,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.676509,0.026944421,0.7543812226108227,0.04599870272651328
87718,SIDM00531,Dasatinib,Crizotinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.0190301,0.12757367,2.495427185226221,0.16986719754798463
2443,SIDM00834,SCH772984,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,1.4154302,0.09706436,-0.5885385096311205,0.00985178990694488
83558,SIDM00130,SCH772984,5-Fluorouracil,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.3413916,0.10034895,-1.8898510725354598,-0.08821548606287793
27203,SIDM00774,PF-4708671,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.0141449,-0.047220767,0.5787081250613106,-0.02268255000674299
104146,SIDM00628,Wee1 Inhibitor,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-1.2437718,-0.11352017,-1.6035427983635413,-0.08116346139485352
81185,SIDM00529,Alpelisib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.9812791,-0.08973552,0.8383779164745441,0.09804183238658967
105657,SIDM00971,Alpelisib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.3272727,-0.14909829,-0.8335320340826364,-0.06491720545508797
73845,SIDM00301,Gemcitabine,Palbociclib,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,-4.7281127,-0.44196618,-3.371501688057469,-0.2899569514358103
17504,SIDM00954,Temozolomide,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,0.29886642,0.005601999,1.1188678501811167,0.04797518337269396
52337,SIDM00529,Pictilisib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.9579659,-0.111355,-0.7723356167265036,-0.03474311489602054
105248,SIDM00332,Crizotinib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.6203038,-0.06704813,-0.6212497467933111,0.02732034368595541
66713,SIDM00875,PD173074,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.7852758,-0.07674688,-0.6529801787580994,0.009542040530297986
47097,SIDM00774,Cisplatin,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.0713532,0.098634094,1.8321134008630333,0.07302840390851459
39180,SIDM00875,Camptothecin,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3676364,-0.040893227,0.2744262537854066,-0.015642528858088665
33444,SIDM00628,5-Fluorouracil,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,0.95673865,0.058542315,-0.10577769760379835,0.014869902343260034
101013,SIDM00097,Ribociclib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1838269,-0.041984078,-1.7094902489119965,-0.06904267229534847
30031,SIDM00146,OSI-027,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-1.6756251,-0.10383671,0.5914776059331659,0.08300237094717004
39514,SIDM00130,Oxaliplatin,Irinotecan,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.525918,0.014690244,-0.3104947631876136,0.00724922046860169
25663,SIDM00875,NU7441,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.20936672,0.018627202,-0.025962071551270952,0.016137084993561097
12976,SIDM00146,OSI-027,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,-1.5186774,-0.04732269,1.072139567044351,0.07239529917887305
28791,SIDM00776,MK-1775,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,3.0331652,0.14603348,1.3376554281276678,0.07534794622337819
67123,SIDM00628,AZD8055,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-1.4014434,-0.06281958,-0.8606052121619279,-0.04419177155626228
19178,SIDM00774,Pictilisib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,0.130684,0.0034144397,-0.5431780687348384,0.016377064708647145
39035,SIDM00146,Docetaxel,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,1.7960284,0.15401335,0.2689374369858748,0.0435821399355912
5802,SIDM00673,5-Fluorouracil,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.9980882,0.051170267,1.061462164947022,0.0645372624855836
32549,SIDM00146,Luminespib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.5489962,-0.049628686,-0.43437875888628963,-0.012909416654816954
97624,SIDM00359,Linsitinib,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.6440549,0.11382283,0.4398389200784699,0.030881126526540396
20407,SIDM00878,MK-1775,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,-0.31338912,-0.03460107,-0.468091154824834,-0.04750156197172884
25437,SIDM00954,MK-2206,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-2.4785721,-0.18151326,-0.4327208391356741,-0.08546853361369061
76176,SIDM00893,Tozasertib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.5240452,-0.018373083,-0.8368847907458478,0.04852329507932062
2003,SIDM00673,Paclitaxel,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-3.9384017,-0.20841253,-4.319095279375026,-0.2703459231043396
66200,SIDM00146,Nutlin-3a (-),Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.28849697,-0.007332822,0.9400953157715046,0.04801731148985475
22653,SIDM00971,Venetoclax,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,5.3269024,0.14604744,1.3359579164262179,0.03699340160540374
19509,SIDM00954,PD173074,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-2.1975586,-0.1205893,-0.8412835564160723,0.028405008050843335
39159,SIDM00359,Dabrafenib,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,3.0737748,0.17686836,-0.20244037978604204,0.030168605165610724
68635,SIDM00779,MK-1775,Taselisib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,-0.32107887,-0.013729338,-1.5096334035258538,-0.05255846849473343
17273,SIDM00529,JQ1,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-2.3822973,-0.12427357,-0.5330861300729866,-0.010927023685613107
101428,SIDM00774,Bortezomib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.5525405,0.02049125,-0.5401087610342372,-0.02565588254463061
28374,SIDM00866,Lapatinib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.0131887,0.07094908,0.5738935667063733,0.07384658879696396
8994,SIDM00146,Temozolomide,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,0.5917614,0.01492771,1.2940260382395978,0.04456432294419244
26256,SIDM00971,Doramapimod,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.6774998,-0.051446922,0.18097572325271985,0.04536605341158336
107855,SIDM00778,Nutlin-3a (-),Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,69.0,3.405072,0.09255025,1.7260922962895517,-0.010233071316714954
90996,SIDM00776,Nutlin-3a (-),Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,65.0,-1.9178855,-0.056024265,-1.312351948953267,-0.036565917441236585
2020,SIDM00893,AZD6482,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.82134324,-0.074303575,-1.0334160108639194,-0.08233357979159243
77218,SIDM00660,AZD4547,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,-0.8597695,-0.017277194,-0.838755935460612,-0.01825943474927347
10374,SIDM00834,AZD4547,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,0.18014576,0.004122394,1.3456269835640249,0.05459575159124283
28148,SIDM00529,Nilotinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,1.5611788,0.07277079,0.5985129345733825,0.05220501842615494
34864,SIDM00332,BI-2536,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-4.8606453,-0.30406427,-1.11025238133525,-0.028770268242282425
105766,SIDM00628,Temozolomide,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,Black,51.0,-0.720449,-0.022678575,-0.5979637668831355,0.0056783377904027505
17900,SIDM00774,BI-2536,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,-3.8502305,-0.20972377,1.7047302511346658,0.1135694896451632
60994,SIDM00779,Trametinib,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,33.0,-1.4512222,-0.04464965,-0.5965661169213606,-0.02000630101337146
91152,SIDM00834,5-Fluorouracil,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-0.6868308,-0.034978468,0.30703332685623336,0.04073901706217712
38364,SIDM00893,Palbociclib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.8944845,-0.034337457,-1.3629034954207364,-0.02118977623084182
68897,SIDM00097,KU-55933,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.9612045,-0.09290274,-1.3263139853241386,-0.03117883104535634
41174,SIDM00866,Uprosertib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.5144552,-0.0665334,0.3954327258177999,0.09115949619114518
23682,SIDM00130,AZD7762,Navitoclax,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.858301,0.18574193,1.3978969023330998,0.10073631919101722
101632,SIDM00332,Alisertib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.217999,-0.14870639,0.4029417924291916,0.001989941529260714
87773,SIDM00878,AZD7762,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-1.448171,-0.08823618,-1.1325148155553089,-0.05008161568213457
69806,SIDM00774,Afatinib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,48.0,-0.42704728,-0.03215644,0.17682484235548043,0.004066219617430611
59777,SIDM00971,Gemcitabine,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.7817269,-0.031028423,-0.0622558879951337,-0.003579996077182953
92029,SIDM00779,Olaparib,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,0.81507033,0.018792203,0.9877290354574181,0.0442172753958274
47484,SIDM00529,Olaparib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-3.1558683,-0.10896879,-2.3802504267463647,-0.008325869106940397
71459,SIDM01233,Palbociclib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,1.4565297,0.038104568,2.34526037910606,0.08326144308882483
21706,SIDM01233,5-Fluorouracil,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.4444265,0.10411474,-1.2176781328020847,-0.05545636672379308
5500,SIDM00531,LGK974,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.6783546,-0.05008008,-2.2305770712385335,-0.0183157564105601
48181,SIDM00130,Gemcitabine,Taselisib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.2824973,-0.08485401,0.3492334628461041,0.0030546413602829865
52647,SIDM00779,AZD8055,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-1.22507,-0.046095468,-0.2984739002847163,-0.04534491228239492
95903,SIDM00778,Linsitinib,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,0.4727628,0.0273976,-0.050818586484714025,-0.026600475272736793
38966,SIDM00893,Palbociclib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.61427194,-0.020652775,-0.6558006949805524,0.0074632961254747525
57273,SIDM00875,MK-1775,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.3711954,0.019937485,-0.07701321039667797,-0.0316528511450964
103929,SIDM00893,Vorinostat,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.5660455,-0.08559348,-0.10681203151963448,0.008050946092768876
70356,SIDM00332,Nutlin-3a (-),Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.6352339,0.06432542,2.4861164176150603,0.026074308843189453
37375,SIDM00971,Camptothecin,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.105392,0.12466,1.9941779134433282,0.09215752666434497
102785,SIDM01233,Olaparib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,72.0,0.007991508,0.000190793,2.115294708591205,0.057579512629764996
45276,SIDM00779,Vinorelbine,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,0.7388819,0.07219598,-0.4025150123934446,0.07342736249333795
58572,SIDM00130,Olaparib,MK-2206,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.7194651,0.043222655,0.3271874597007049,0.03062903884402521
13866,SIDM00097,MK-2206,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.56015396,-0.035952583,-0.31017056826872896,-0.07874671144835425
72418,SIDM00411,Trametinib,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,43.0,2.9049206,0.10805885,1.615071153175709,0.10502020124304358
106507,SIDM00359,Camptothecin,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.8657072,-0.18883365,-2.6164858057229066,-0.11057850065809265
45023,SIDM00834,5-Fluorouracil,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,1.3299843,0.089357056,-1.6948430354647595,-0.08319595850409355
48446,SIDM00531,Lapatinib,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.58626485,-0.039678045,-1.2093090945149363,-0.04286007760244617
75054,SIDM00628,SCH772984,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,1.5657271,0.1283642,1.4796571459524244,0.13779565939295318
29774,SIDM00866,5-Fluorouracil,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,2.81532,0.10620995,-0.05263778808166894,-0.013092776735172496
76357,SIDM00673,Tozasertib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,-3.1996696,-0.16771606,-0.443385035205063,0.0022068115682276693
78283,SIDM00774,OSI-027,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,-0.35899323,-0.053526197,-0.009034690039708276,0.025176776620669312
87170,SIDM00971,JQ1,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.140772,0.16508847,-0.12954162131781577,-0.0036844225488327693
1614,SIDM00878,Alpelisib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.4898824,-0.04317671,0.035060853444871636,0.024990158573424535
101961,SIDM00359,AZD8055,Navitoclax,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.4255518,0.035724644,2.705627990244717,0.1255136403311952
88038,SIDM00893,Afatinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,4.912858,0.19115417,0.9357807814995707,0.053036310184895435
74267,SIDM00411,Sorafenib,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.8466806,0.051988646,1.4679650941543143,0.10778019980046862
47982,SIDM00097,Alpelisib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.53257716,-0.037980355,0.5943369466627478,-0.020127892255867162
59996,SIDM00660,Vinorelbine,Oxaliplatin,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,-0.514033,-0.05221295,-1.189313760815133,-0.08585744643895853
107931,SIDM00774,KU-55933,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,-2.7723346,-0.08223956,-1.3456781861322797,-0.0102750488794478
10812,SIDM00878,Afatinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.8979788,-0.06410594,-0.10391752928767418,0.026035800283120993
14142,SIDM00878,RO-3306,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.3672038,-0.07591802,-0.35431533193463294,0.012237160275679549
36691,SIDM00301,OSI-027,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,50.0,-2.6789865,-0.07594526,-0.4113127532165664,-0.02391010134478781
56499,SIDM00776,Crizotinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,-1.5274274,-0.116513595,-1.8207209029760862,-0.11667850231858955
19805,SIDM00878,5-Fluorouracil,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.8381944,-0.10436395,-1.4714235988206954,-0.03095735527229998
33751,SIDM00971,Alpelisib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.47676623,-0.03320846,-0.4094362401387348,-0.015992703764296172
48753,SIDM00878,Afatinib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,2.4115834,0.19458936,0.38237621824967183,0.04377839836275201
51927,SIDM00359,Nutlin-3a (-),Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0906675,0.029607223,3.866950546504583,0.148522032299406
5680,SIDM00531,Olaparib,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.3195212,0.16170844,0.6685611748861385,0.1006300869688055
101424,SIDM00878,Ribociclib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.8451054,-0.05224851,0.13755215522997727,-0.011827480511520891
34175,SIDM00779,SCH772984,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,1.8220366,0.098764054,-0.9539001837629921,-0.027284291662230523
83777,SIDM00628,SCH772984,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.73455966,-0.05191246,-1.3538686833687672,-0.024495756666988024
18351,SIDM00954,Trametinib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,-1.8275268,-0.07453419,-1.0193802960521279,-0.03642396741603529
45507,SIDM00893,Entinostat,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.3458673,0.030004906,0.8767471872155731,0.025622116818425678
818,SIDM00834,AZD7762,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,4.4212065,0.35108563,-0.2742305375015203,-0.016128705239512504
23699,SIDM00774,Linsitinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,2.6810193,0.16363956,1.800278352531588,0.05696356745810614
104668,SIDM00529,RO-3306,Taselisib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,1.4316287,0.061060436,1.3353329338924929,0.08122481539890512
98678,SIDM00834,AZD8055,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,0.994327,0.073711574,-0.7896898989688278,-0.04868284282865923
46977,SIDM00971,MK-1775,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.132402,-0.051360168,0.6630605742997734,0.01775348170239733
18121,SIDM00954,5-Fluorouracil,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.9170533,-0.026839314,0.5504928727538064,0.05587139441082791
101438,SIDM00875,Olaparib,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7160077,-0.058117148,-0.39490624830724763,-0.05128307022275412
1835,SIDM00954,Nutlin-3a (-),MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,3.5044615,0.05494934,2.655778329661143,0.10799185906894686
92589,SIDM00628,Lapatinib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.45873386,-0.042456217,0.7434402250857921,0.07577299846303964
41250,SIDM00660,Afatinib,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,32.0,-1.0391583,-0.103360444,-0.433410029126565,-0.06216379910273083
18511,SIDM00782,Taselisib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,0.53088355,0.039268974,1.0921534327450715,0.038277037546317935
89038,SIDM00779,MK-1775,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,33.0,-0.63094723,-0.041106515,-0.5342104333797265,-0.029618319832034223
79506,SIDM00778,Olaparib,Afatinib,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,-1.7024274,-0.031587914,-0.820416616056028,-0.04987405079086905
687,SIDM00971,Entinostat,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.6249166,0.221583,0.04858152525899952,0.05221655524456814
42164,SIDM00301,Taselisib,Cisplatin,Pancreas,0.8,Pancreatic Carcinoma,Male,East Asian,50.0,-1.8920451,-0.18211083,-0.8687784933672738,-0.008946526963363545
83156,SIDM00531,LGK974,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.6757557,-0.066798285,-1.583946411529261,-0.0567652016096705
70880,SIDM00130,Oxaliplatin,Gemcitabine,Pancreas,0.01,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.34846503,-0.011272611,-1.3266975149025098,-0.0211795718380144
97818,SIDM00146,Temozolomide,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.47554567,0.012972258,1.5942874248140724,0.05912837301390075
42463,SIDM00529,Lapatinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-0.9632989,-0.06131301,-0.6253664385052624,0.051615909515694065
100071,SIDM00878,Trametinib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-0.41175327,-0.039384704,-0.45091485768723916,-0.06562051560314051
20817,SIDM00779,AZD7762,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-0.7916453,-0.07133983,-0.24487236710351173,0.01908852391487622
98266,SIDM00954,Trametinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,2.4185035,0.1382861,-0.5168088552684755,-0.02458780091755483
95915,SIDM00332,Docetaxel,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.517365,-0.18866529,-1.1585164850258864,-0.11809418030560066
87759,SIDM00954,ZM447439,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-4.738324,-0.3769091,-1.1665119855454285,-0.04825357774843405
76304,SIDM00971,Dabrafenib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.74797094,0.016194018,0.4991022328840643,0.07398122503816469
77119,SIDM00875,SCH772984,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.906091,0.06031472,-1.512827084332586,-0.10229524436667009
52033,SIDM00878,PD173074,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.6055546,0.15270743,0.617543342037944,0.12169502269798614
54549,SIDM00097,Alpelisib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0997424,-0.07757608,-0.331233698799446,0.02297475077501608
91679,SIDM00971,ZM447439,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.6852129,-0.030529136,-1.4845918379820628,-0.05655558615892453
55374,SIDM00971,NU7441,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.4482057,0.069763236,1.022075801511248,0.02237604120698604
18472,SIDM00971,Paclitaxel,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.4284916,-0.09445997,-1.758757456458275,-0.057992245799717713
108085,SIDM00529,Vorinostat,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-2.1481595,-0.19426659,-0.7111502964991662,0.0023930316869548362
45063,SIDM00866,MK-2206,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-2.3207061,-0.12706581,-0.9032414872539056,-0.036036619299312976
7768,SIDM00146,Camptothecin,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,1.7687491,0.12860739,-0.022074801735108198,0.007835091384735047
27412,SIDM00782,Linsitinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,3.7265015,0.13827577,3.5558708446424143,0.10430718165322769
85662,SIDM00332,Crizotinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.8006244,-0.14742261,-1.0549158829174496,-0.1118424033624823
64753,SIDM00782,Nutlin-3a (-),Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,0.43202785,0.010965341,1.9391789807663726,0.04994432757401492
92329,SIDM00779,5-Fluorouracil,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,1.4841516,0.020202477,0.4154979737894685,0.056243424741713836
73839,SIDM00778,Vinorelbine,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,0.70835316,0.03526896,1.2175234027616473,0.0627999837356441
29112,SIDM00778,AZD4547,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,-1.6675504,-0.026802024,-0.5349048606890853,0.03983732543850651
59008,SIDM00146,Camptothecin,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,-0.68122536,-0.06253387,-0.574903987450735,-0.05528245341867531
43809,SIDM00146,JQ1,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-0.89308864,-0.07687961,0.639628108489721,0.027327428516343608
9490,SIDM00411,Oxaliplatin,Navitoclax,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.4912939,-0.05248875,0.3124842558874313,0.04245390369903553
71942,SIDM00774,Palbociclib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,2.7575216,0.0713005,2.8834384229822403,0.10980377229366971
44435,SIDM00875,Wee1 Inhibitor,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.058820404,-0.004096947,-0.16723428864594259,0.008110460884488593
33227,SIDM00146,JQ1,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.8768592,-0.13862331,0.8995821143113865,0.09102420327564212
19421,SIDM00146,PD173074,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.35063228,-0.025290996,0.03026060206148346,0.11324315950724125
85180,SIDM00529,Vorinostat,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-1.1461517,-0.0921932,-0.9781362314461158,-0.05096225277783452
32089,SIDM00097,KU-55933,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1091702,-0.070921995,-1.3473237261376168,-0.026946372530790404
94481,SIDM00782,SB505124,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,Unknown,72.0,0.107632324,0.009575825,0.03459724404908738,0.03473356548139067
15842,SIDM00529,Olaparib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-1.4365362,-0.062736586,-1.5904066049489762,-0.026539783919651564
45126,SIDM00875,Paclitaxel,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5249838,-0.03539791,-1.5150445980931293,-0.12950522843700513
33135,SIDM00660,Linsitinib,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,32.0,1.5977969,0.12369025,0.1283006696937787,0.03202394541913085
63844,SIDM00411,Oxaliplatin,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,-2.6811583,-0.084476635,-0.22823287037472859,-0.0006294741474488938
91571,SIDM00529,Linsitinib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Black,44.0,-1.2039319,-0.038887303,0.6783461896572061,0.06252001582816004
35490,SIDM00878,Olaparib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.3661119,0.051256917,1.1792049175292458,0.04608556582205108
77188,SIDM00097,BI-2536,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4860127,-0.10550808,-0.4664930235550739,-0.058715890355487396
37756,SIDM00774,Sorafenib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,48.0,-1.7125497,-0.10795319,0.2424042395233992,0.04810719314155168
81877,SIDM00660,MK-1775,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,0.5490635,0.02601662,-0.5363473713861632,-0.019629838447018173
67930,SIDM00130,Navitoclax,SCH772984,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,4.08589,0.27120212,1.6699390557040434,0.10851147443515173
9957,SIDM00834,Crizotinib,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,1.6851807,0.1270421,0.673846193159022,0.0827212038215803
59549,SIDM00866,Venetoclax,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-0.83487135,-0.018234532,-0.16432427247656956,0.01913737929262583
3871,SIDM00875,Lapatinib,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.38711017,-0.03601856,-0.13372082863291823,-0.003012508190258457
2304,SIDM00660,Olaparib,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,1.2042885,0.026844446,2.011003005795156,0.05145566122202582
57609,SIDM00529,ZM447439,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Black,44.0,0.46900162,0.03879745,0.784501586900949,0.05626181136553696
80480,SIDM00332,Taselisib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.69164884,-0.06589777,0.5427586250811514,0.0036671033403100003
55715,SIDM00954,Trametinib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,4.9319677,0.069354795,2.6240239101783582,0.04133643945871687
79120,SIDM00893,Olaparib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.6898746,-0.058569547,-1.1803354329238802,-0.04089575223332583
43926,SIDM00875,NU7441,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3581314,0.099937916,0.9523022335150805,0.0921796848001931
6483,SIDM00893,Cisplatin,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.9405003,0.060106292,2.4508064768581694,0.07639107193629495
34614,SIDM00673,BI-2536,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.57038504,0.031190047,-0.6814452536337218,-0.040208155569269814
74123,SIDM00878,Docetaxel,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-2.4160402,-0.23763677,-1.1227566329394343,-0.11163875733543234
102601,SIDM00332,Taselisib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,0.79402775,0.072983764,-1.4650365013454105,-0.07693439239928844
56938,SIDM00866,KU-55933,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.8760269,-0.039942898,-0.34614909272987165,0.033715377590717244
52797,SIDM00776,MK-1775,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.0578111,-0.058870103,-0.3107797580993786,0.0008157119530297539
107501,SIDM00878,AZD6482,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,0.77332693,0.054123364,0.39583246610803274,0.0492371097278365
2053,SIDM00782,Camptothecin,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-3.2059922,-0.15607348,-0.841112397584844,-0.04143712356383183
107749,SIDM00529,AZD8055,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,1.3009434,0.11611138,-0.40300932168228976,0.01749499243784559
10059,SIDM00097,Paclitaxel,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9782146,0.047899287,0.00877424535047993,-0.015346209030844457
281,SIDM00660,SB505124,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-1.0038964,-0.09643434,-0.7835875100272778,-0.037645906575110834
24117,SIDM00146,GSK269962A,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,-2.1027203,-0.12907682,0.2101729394015616,0.01355183518129194
73197,SIDM00834,Taselisib,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,White,66.0,1.5031856,0.12431141,0.5554265282258131,0.042111010135210736
14442,SIDM00878,Venetoclax,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,70.0,-1.06494,-0.031586505,-0.20356923734304497,0.038139187147897276
26709,SIDM00779,MK-2206,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,3.2017207,0.12966682,-0.5956104980760872,-0.07975049747247127
45402,SIDM00971,Alpelisib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.292643,-0.08507758,-0.4913192361388798,0.030428855590809295
69670,SIDM00146,MK-1775,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-2.7677376,-0.21531457,-2.9732833288804352,-0.23668477052078116
101279,SIDM00628,RO-3306,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-2.4142113,-0.087022044,-2.0858563207031815,-0.07552997226684859
82176,SIDM00628,Bortezomib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-0.3407248,-0.020600673,-0.5267157993195134,-0.030033252559236664
70325,SIDM00774,Gemcitabine,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.7857269,0.17407948,0.17738124047970005,0.033388767837340474
29214,SIDM00866,Gemcitabine,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,7.683966,0.53259486,1.0919332965710455,0.09365047206579626
4015,SIDM00130,Oxaliplatin,Taselisib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.506759,0.1771301,-1.3194137458779502,-0.017774826362744193
33636,SIDM00660,Crizotinib,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,1.5549277,0.10728378,-0.46311479540426265,-0.04906377241051182
64714,SIDM00332,Paclitaxel,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,4.049777,0.18302974,2.4350622582934127,0.13493663714786225
103677,SIDM00878,Navitoclax,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.7588404,0.014829478,0.23130018437305172,0.0035749490826099775
8430,SIDM00146,Cisplatin,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.34912917,-0.012028432,1.8311578028758817,0.06290048778306245
100046,SIDM00359,Trametinib,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.3702037,-0.06848919,-3.5803847127310067,-0.11391706469820775
47162,SIDM00875,OSI-027,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8700865,0.09547099,0.25893020129641975,0.03477840050589932
80821,SIDM00774,Doramapimod,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-0.19993024,-0.009266757,1.7343224060591416,0.08014538742850395
94011,SIDM00878,Taselisib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.4434152,0.09531054,-0.9567622249084361,-0.10282133773860433
15854,SIDM00971,SCH772984,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.9226457,0.019008243,1.2939489022510449,0.04480481981064235
32873,SIDM00531,MK-2206,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.4855762,0.1167208,0.5056849708150193,0.011670974856996344
85119,SIDM00776,Taselisib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-0.77534384,-0.062117428,-0.040709662064398515,0.008731547940472482
32072,SIDM00097,Gemcitabine,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.54414296,0.019744925,-0.7587613585607119,-0.040863848484127364
94577,SIDM00193,Olaparib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-1.8082542,-0.074082375,-0.6728934478073272,0.027656943663471635
24841,SIDM00660,BMS-754807,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,2.1865704,0.19249055,-0.9202190727825031,-0.04686858286107359
51373,SIDM00954,Gemcitabine,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,0.92080665,0.07418625,-1.7645776847872983,-0.15865668161273358
39317,SIDM00097,JQ1,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.5793386,0.095246285,0.36125243283963854,0.022847829964319284
4946,SIDM00893,Palbociclib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.7104956,-0.024991404,-1.357062070873355,-0.0016652907025148935
61536,SIDM00411,LGK974,SCH772984,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.3811757,0.015615992,-1.1943817941549013,-0.012089107314600877
61243,SIDM00628,Nutlin-3a (-),Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,-2.3986466,-0.104970075,0.01885107147644908,0.020620694645429715
36304,SIDM00954,GSK269962A,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-1.0589411,-0.061596144,-0.277938383931915,-0.013429829891317165
96481,SIDM00834,Afatinib,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,2.2250805,0.08579624,0.109840228717995,0.009197786543635579
106722,SIDM00866,Doramapimod,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,1.6931045,0.04423141,2.3466903519393276,0.10016268225300255
3088,SIDM00332,MK-1775,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1920699,0.08694258,-0.5999637489329986,-0.053665419519457545
107302,SIDM00878,Nilotinib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,70.0,0.15970111,0.014439668,-0.5582435639884941,-0.06858697075893266
98579,SIDM00875,Doramapimod,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.5133553,0.09493319,2.20925060811482,0.0944349702410234
88782,SIDM00097,Nilotinib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8351915,0.050282322,1.2751870216583583,0.09282900924148363
28230,SIDM00411,LGK974,Ruxolitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,1.328917,0.063917466,-1.209797323185564,-0.037292204362070716
1391,SIDM00878,MK-1775,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.93331695,-0.1137813,-0.5682172315220718,-0.03779778731144049
54054,SIDM00954,Temozolomide,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-0.20749238,-0.003639986,2.136260842913093,0.07175321970941079
35993,SIDM00893,Nutlin-3a (-),PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.62941533,-0.01284471,0.3830616345138799,-0.0007764887796091816
53825,SIDM00359,MK-1775,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.8064954,0.17178209,1.262389199893481,0.06894886911046703
11605,SIDM00893,Taselisib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.6210632,0.10106057,-0.25033069995723284,-0.06580816790418528
94702,SIDM00628,Temozolomide,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.8187377,0.02284138,0.08676477531980085,0.024468921634471452
105424,SIDM00778,Olaparib,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,69.0,-0.9396716,-0.022195714,0.07468069798641945,-0.0008346837700469527
59764,SIDM00193,Trametinib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,53.0,-1.757238,-0.103696495,0.4505126554085307,0.058677300201616434
14609,SIDM00774,Tozasertib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,3.4017196,0.102640755,2.736470246919824,0.12920351537412111
46596,SIDM00301,MK-2206,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.0060202,-0.09340714,1.5472039229139845,0.08418136647582361
27363,SIDM00097,Alisertib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.4492067,0.09480684,-0.5193940256439467,0.0008568031315975668
66118,SIDM00776,AZD4547,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-1.1586747,-0.03222323,0.5777406191355182,0.011597336841046786
39192,SIDM00097,Camptothecin,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3369473,-0.044069014,0.04208320224317838,0.05036953368474715
24243,SIDM00954,Wee1 Inhibitor,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.1115009,-0.08921172,-0.5262986810803139,-0.02725180523929088
75361,SIDM00411,AZD7762,Trametinib,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,43.0,-1.3704466,-0.04854595,-0.3594036403592135,-0.03072862402765766
63077,SIDM00332,Uprosertib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5675546,0.038027577,-0.07709001194164017,-0.02235945764066733
79955,SIDM00774,Olaparib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.1518542,-0.037080325,1.4274054645815586,0.028937569359528497
72199,SIDM00097,Bortezomib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.49240994,-0.034509394,-1.3626048946266516,-0.08213463786911396
16777,SIDM00130,OSI-027,Linsitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.503587,0.25267693,1.903433751612366,0.12468722499065511
71679,SIDM00673,Entinostat,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.9313321,0.15199383,0.09783367630264499,0.0029061014996764898
34398,SIDM00782,Taselisib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,Unknown,72.0,-1.423215,-0.12674503,-1.1424091732064101,-0.08379463384999797
2711,SIDM00893,Nutlin-3a (-),Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.2363744,-0.004911898,0.5037846427305448,-0.0025069500660996552
69414,SIDM00893,GSK269962A,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.9414985,0.3112874,1.722280189097002,0.2117027257176519
42688,SIDM00130,MK-1775,Paclitaxel,Pancreas,0.025,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.68938756,-0.048444405,-0.7641539016183232,-0.0316774254975744
43476,SIDM00332,Alpelisib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.9554828,-0.12380825,0.10873058669814,0.10204035483528165
14635,SIDM00193,Camptothecin,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,53.0,2.87272,0.1403181,2.714465581597531,0.08600231322087132
30567,SIDM00146,Lapatinib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.0380728,0.09617259,0.06695730754822407,0.02373100264555952
10036,SIDM00301,Olaparib,Navitoclax,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.1719446,0.097631864,0.8743262702919478,0.10920057665084411
69565,SIDM00660,Linsitinib,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,2.1573448,0.19268829,2.0871367669918226,0.14186497512878385
22391,SIDM00146,Nilotinib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,1.6537849,0.11938211,-0.3784706574742359,-0.03442589429686674
100442,SIDM00893,NU7441,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.6778748,0.11232244,0.5852665213820235,0.04962087517695499
10697,SIDM00673,Venetoclax,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.5335741,-0.037128817,-0.5560479073209317,0.023593939376063015
15850,SIDM00146,Alpelisib,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.29867542,-0.014205314,0.9030812404840634,0.0953770401740859
88461,SIDM00301,Olaparib,Lapatinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-2.8202982,-0.1738683,-0.23292582812265772,-0.04436168100215505
84369,SIDM00878,Ribociclib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-2.2810674,-0.09295876,-0.3713322323939786,-0.007327497944348636
82474,SIDM00529,Paclitaxel,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-3.437018,-0.28159225,-3.0228635742759042,-0.23029334593295647
76032,SIDM00776,Oxaliplatin,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-2.4916463,-0.11681116,-1.7980245894288271,-0.07694475232775462
74988,SIDM00673,5-Fluorouracil,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.72223705,-0.030911203,0.38415109247756046,0.0031182104492482533
30294,SIDM00411,5-Fluorouracil,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,3.3261564,0.1416434,0.32205845799349286,0.04525849519623717
77403,SIDM01233,MK-2206,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-2.38775,-0.11480171,0.5051055734308988,0.08019110470539681
43819,SIDM00146,JQ1,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,2.1556568,0.12132305,0.8167933329727471,0.01067164671910112
26848,SIDM00628,Uprosertib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.4065541,0.09148118,1.8848872095925526,0.1649699983164283
10393,SIDM00097,RO-3306,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.254384,0.012689085,-0.26558927652590464,-0.0334285802572684
12647,SIDM00146,Camptothecin,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.4988427,-0.04253209,0.15497833632483662,0.00674101386093849
94659,SIDM00301,Taselisib,SCH772984,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,4.19589,0.43581328,2.262173454050911,0.13954021297469896
59838,SIDM00673,Olaparib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-2.1147194,-0.05757997,-1.5132466810303358,-0.04464641068431464
83045,SIDM00866,Nilotinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.6540153,-0.040206354,-0.554644807466677,0.037586026655429094
44591,SIDM00878,Alisertib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.9315283,0.13995296,0.883040609807088,0.06972751245614019
31839,SIDM00332,5-Fluorouracil,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4836735,-0.07306044,0.15363512924727413,-0.03402073278493149
33928,SIDM00779,MK-1775,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,33.0,-2.7843673,-0.17753093,-3.008370618040119,-0.21226075947936263
99655,SIDM00097,RO-3306,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0723865,-0.07901867,-0.768893295488754,-0.03550010154844428
6300,SIDM00097,Wee1 Inhibitor,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.9652177,-0.05425305,-0.19720888894896615,0.014887278855784098
993,SIDM00834,Oxaliplatin,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-1.0256159,-0.079872526,-2.285934186204389,-0.12574817365134355
65299,SIDM00878,Camptothecin,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,2.1402783,0.07719177,2.2179231139166427,0.04994040346834449
50326,SIDM00875,Venetoclax,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.42960006,0.012013214,0.34842506807159457,0.007275937782790643
36310,SIDM01233,Linsitinib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,72.0,1.4977709,0.11501075,-0.19384843495094348,-0.021099353431022094
30125,SIDM00866,JQ1,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,52.0,-1.2313511,-0.09019967,-1.5627995216856225,-0.024300754779098648
31024,SIDM00673,Olaparib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.1669838,-0.05490305,-1.3863360984345443,-0.07130180913531757
12549,SIDM00097,KU-55933,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.414856,-0.046542022,-0.6694959675003708,-0.03226376611377788
92362,SIDM00097,Dabrafenib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.315425,-0.1072779,-1.4857545971526807,-0.06788419424081857
74113,SIDM00529,Camptothecin,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,2.0823088,0.12695943,0.9380165369773512,0.032910900940700594
105356,SIDM00146,Palbociclib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.67946,0.12654006,0.624200713053505,0.11825520576811661
83927,SIDM00097,SCH772984,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7312468,-0.07832911,-0.8490288624893204,-0.06036016884268168
64703,SIDM00146,SCH772984,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.3690609,-0.115349025,-0.8818208174525358,-0.10815698295061116
59462,SIDM00866,Olaparib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-1.3111567,-0.029204855,0.4184676060841104,0.004493025859174123
30505,SIDM00628,Temozolomide,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,1.712906,0.033286706,0.4620163925195814,0.006435036179443981
41055,SIDM00332,Wee1 Inhibitor,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.78680676,-0.05527755,-1.4228897266390463,-0.05961008143115448
103621,SIDM00332,AZD6482,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.8244343,0.11415395,0.6848031320900987,-0.03709107272079727
60814,SIDM00774,SCH772984,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,3.089951,0.1107679,0.9803587663163656,0.03793007480840046
2869,SIDM00778,SB505124,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,-2.012986,-0.037937623,-1.6618508104895087,-0.07546598520793525
105876,SIDM00097,RO-3306,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.33263,0.082044594,0.05879419922878546,0.0029104971106662047
26219,SIDM00673,Gemcitabine,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.6927348,-0.031186657,0.007443254319597867,0.021030727601798867
29046,SIDM00097,Paclitaxel,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.0553837,-0.20830043,-2.3420055255588648,-0.17052277856946396
20818,SIDM00866,RO-3306,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.3560508,0.09464469,0.21956182238939823,0.057278888994475315
85432,SIDM00774,Nilotinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-2.068566,-0.130746,-0.8568382754043237,-0.03032880036326825
64493,SIDM00893,Uprosertib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.2628019,0.06952732,0.8844002418765435,0.07112344268322798
79410,SIDM00971,NU7441,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.3922508,0.12685981,1.1710319285174458,0.004183140207367252
29024,SIDM00628,Uprosertib,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,0.73441887,0.053316582,-0.7960076238393325,-0.0044605703893161345
80979,SIDM00359,Oxaliplatin,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6848735,-0.092504606,-1.2715591069878849,-0.042645885753862786
44486,SIDM00146,Camptothecin,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.308904,-0.028392946,-0.5890216437730069,0.02582643746326235
65891,SIDM00878,Nilotinib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,1.0067359,0.0903914,-0.3078565247829189,0.01829663603199815
73242,SIDM00782,Afatinib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.3126862,0.10423884,1.9177930637065093,0.07620282572459515
24776,SIDM00628,Entinostat,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-0.9761453,-0.057237662,0.9442876801570478,0.047886828154198424
63319,SIDM00782,LGK974,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-2.355921,-0.13988255,-2.3318452372921024,-0.11145601978275864
28495,SIDM00301,Gemcitabine,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.4652451,-0.03681472,0.3011085286828782,-0.006429185513435967
14636,SIDM00954,KU-55933,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,-3.5018408,-0.10310502,-1.366947423395541,-0.006503017303783963
2707,SIDM00779,Camptothecin,Crizotinib,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,33.0,0.63419014,0.03912519,-0.5355554484895924,-0.014901132457893219
33347,SIDM00529,Camptothecin,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Black,44.0,1.3361402,0.07443854,1.6976057100141897,0.10140846292796148
74550,SIDM00332,Gemcitabine,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4511391,0.11792022,-0.060761207930759606,0.05684529478372561
44720,SIDM00332,RO-3306,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.8630898,-0.07206465,-1.7935483787125859,-0.05203467363936464
40848,SIDM00628,GSK269962A,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,Black,51.0,0.465663,0.045823034,-0.4461979764279647,0.017015406405531466
107635,SIDM00628,Afatinib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-1.1330752,-0.07314651,-0.19321888324935052,-0.003009168836844809
50083,SIDM00529,Luminespib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-2.3008282,-0.101347014,-3.086380568655133,-0.07690763405102806
24485,SIDM00529,MK-1775,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,1.8166733,0.1354072,-0.9285734769357171,-0.05973301218822729
82993,SIDM00866,ZM447439,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.1435639,0.07833576,1.4295414227565642,0.12331699637290419
91864,SIDM00878,OSI-027,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,1.4504797,0.14914368,1.146853060578951,0.11452972687727016
7297,SIDM00529,Crizotinib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Black,44.0,0.9690455,0.07593598,0.5851973221431134,0.08871796057251652
39409,SIDM00866,Nutlin-3a (-),Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-0.7060242,-0.01939577,0.26645376883012317,-0.0008566631934963443
104547,SIDM00332,Linsitinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.5889952,0.13805541,2.5624158013253115,0.10560580676191841
12850,SIDM00776,Oxaliplatin,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,-2.220976,-0.10040597,-2.1371477433370036,-0.07181972834054351
64831,SIDM00301,Oxaliplatin,Trametinib,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,-2.340421,-0.22055423,-1.712801279809833,-0.0854518798837429
40488,SIDM00893,Alisertib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.5952654,-0.2003373,-1.7292081963886026,-0.16072338325271088
55222,SIDM00866,PD173074,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,0.21752971,0.009519261,-1.1495428661159774,-0.016231053376591156
77995,SIDM00779,AZD4547,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,33.0,-2.3844757,-0.013571724,-2.9327336711905816,-0.18406911344309826
46433,SIDM00774,NU7441,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.6332075,-0.032961976,0.8602152289597245,0.05554199294886632
95988,SIDM00971,Olaparib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.790057,-0.066363,-2.707322935393073,-0.05353165377085787
77464,SIDM00954,Navitoclax,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,1.1123298,0.008261134,-0.10542578222577768,0.02217351848921024
68058,SIDM00954,Nutlin-3a (-),Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,4.241781,0.20378038,1.0463807261594773,0.0642718419988413
23742,SIDM00878,Lapatinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,3.5195036,0.35915124,0.42788555318522364,0.035735654231544414
51565,SIDM00866,Cisplatin,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,3.632698,0.055818494,4.33188880293001,0.1763745070427455
49476,SIDM00193,MK-1775,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,East Asian,53.0,0.2097263,0.018506734,-1.1076743123644988,-0.01792351913840466
87238,SIDM00878,Taselisib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,70.0,0.42094254,0.038458604,-0.41447489308826213,-0.0010962113026314483
5118,SIDM00776,SCH772984,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-2.1592765,-0.18186837,-1.1621447701183327,-0.11378577956060017
11473,SIDM00776,5-Fluorouracil,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.348889,-0.03830354,1.2423802152424324,0.04491984412274955
23576,SIDM00774,Wee1 Inhibitor,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-3.6967027,-0.121917,0.36638506896263723,0.03770268842394061
51884,SIDM00628,GSK269962A,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,1.2575392,0.10293849,-0.42296080406984776,0.02692674263936228
18553,SIDM00130,Lapatinib,5-Fluorouracil,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.40878522,-0.023161849,-1.2477843656303245,-0.0272189748340462
69287,SIDM00146,AZD6482,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,1.5346726,0.12550019,0.20261152594188941,0.02872498797432128
91579,SIDM00954,Tozasertib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,0.7140388,0.046441957,0.4644221972441792,0.012814618818895833
69164,SIDM00531,Navitoclax,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.3609575,-0.041177113,-0.162188618713556,-0.03276735839736194
28014,SIDM00893,ZM447439,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.3958302,0.26910454,1.234422516556259,0.10607588200670855
52115,SIDM00954,Taselisib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.8976027,-0.06999874,0.1788896031281487,0.09024950285932577
2068,SIDM00954,Navitoclax,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-1.4261212,-0.057383083,-0.464520076177664,-0.007386332470013593
18185,SIDM00332,Pictilisib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.824433,0.1848748,-0.0014872420107611846,-0.06216682274103804
7894,SIDM00332,Temozolomide,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7303805,0.051591404,1.5057984761803316,-0.011183695238277024
18794,SIDM00529,KU-55933,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-0.82652354,-0.01359787,-0.18823409640043148,0.0045528980179136095
7020,SIDM00359,Afatinib,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.69264364,-0.045529258,-2.5307702234826897,-0.059136802819976325
58902,SIDM00146,Ribociclib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-2.2147112,-0.07428593,-1.8284646931926258,-0.014829539257786505
81164,SIDM00411,Gemcitabine,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-4.316624,-0.15334335,-1.092046858018219,-0.01378793911633377
64716,SIDM00893,Temozolomide,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.59881043,-0.012667098,0.6683454225723872,0.018642836953388853
32669,SIDM00332,Crizotinib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.1654177,-0.118073545,0.09076443308453135,0.01910455954597094
97794,SIDM00628,Trametinib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,1.5310615,0.13712093,-1.8734097322412504,-0.0873381220448174
3724,SIDM00834,Oxaliplatin,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,-1.853727,-0.13994865,-3.039542008480437,-0.08225103046414396
447,SIDM00332,SCH772984,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5262439,-0.07931175,-0.06337850813437859,-0.03144164971929079
5181,SIDM00875,Nilotinib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.583676,-0.05507005,-0.7788242069331894,-0.06514768256325167
1606,SIDM00531,Crizotinib,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.8040557,0.2872154,1.744942904790972,0.11516498209555211
29446,SIDM00779,BMS-754807,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.4173325,-0.03201846,-0.27218226645464766,0.0015942505827449425
25488,SIDM00834,AZD8055,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,White,66.0,0.29480046,0.021530302,-0.8868340768236054,-0.02990806935321302
81361,SIDM00529,MK-1775,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-0.35129404,-0.03449079,-1.6819803642597018,-0.07181017322456106
107609,SIDM00866,Axitinib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-1.3513877,-0.08912337,-1.2878192712064365,-0.035022894419408826
90545,SIDM00866,RO-3306,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-3.3969429,-0.10049112,2.106616376319039,0.13102372332111062
45600,SIDM00954,NU7441,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-0.6821962,-0.052727725,0.09024095612140462,0.011255348914903872
23684,SIDM00834,Vinorelbine,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,-1.4968491,-0.082429565,0.3051966675833711,0.10029578295026005
68955,SIDM00878,Lapatinib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,2.4630291,0.2576345,1.2546477864737504,0.12280334621805991
46637,SIDM00834,Linsitinib,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,0.69823503,0.055095218,-1.567340348826593,-0.013640538475439142
43388,SIDM00971,Trametinib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1503476,-0.017554246,0.8243857067987599,0.024223020935247964
79417,SIDM00332,MK-1775,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.222478,-0.13596357,-1.3077099673005,-0.0803949864180857
27207,SIDM00529,Sorafenib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-0.23936078,-0.022842832,0.730473104544872,0.07277917637578758
76494,SIDM00782,SCH772984,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,-2.4302745,-0.12492541,-1.6514222702427672,-0.03523648521714107
29694,SIDM00878,Uprosertib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.4541876,0.052804764,0.3471432673313656,0.015572823241190858
12665,SIDM00301,Oxaliplatin,Dactolisib,Pancreas,0.0125,Pancreatic Carcinoma,Male,East Asian,50.0,-0.82030463,-0.10320802,-1.0609187471853667,-0.033217555765692755
47961,SIDM00628,Paclitaxel,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,Black,51.0,0.48745072,0.033244815,0.31602355312206454,-0.0006410926678567895
11460,SIDM00332,PF-4708671,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,1.287731,0.0333114,1.2810146995232805,0.09993616595847239
10841,SIDM00673,Doramapimod,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,1.6984429,0.029208735,4.783238855634554,0.08863033052730498
54773,SIDM00411,Paclitaxel,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-1.1595179,-0.044197127,-0.360463176289886,0.011782633631546987
74818,SIDM00673,Ribociclib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.99417126,-0.035145722,-1.9997862188180153,-0.029349059430543882
69581,SIDM00531,5-Fluorouracil,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.8937047,0.10207778,1.5404424038417037,0.029982975070827315
57872,SIDM00193,MK-2206,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,53.0,0.6240938,0.050941292,1.9292322077435957,0.13202781189690957
69987,SIDM00779,AZD7762,Navitoclax,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,0.74000245,0.055462193,0.6043992666378801,-0.0012032326327635948
20771,SIDM00660,Trametinib,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,5.105948,0.16297555,0.6351959298649157,0.0018984253262225215
63661,SIDM00529,Entinostat,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-2.0238402,-0.101604946,-0.5812357853444365,-0.00691045958405599
34906,SIDM00866,Afatinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-4.614805,-0.29527837,-0.896774457759843,-0.059051576301503844
71883,SIDM00411,Ruxolitinib,Irinotecan,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.99579406,0.0155648,1.088730870684981,0.039454674526730724
68057,SIDM00893,Uprosertib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.3292702,-0.10539444,1.0623564717856053,0.05523091356387084
10566,SIDM00130,Taselisib,Sorafenib,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.8473074,0.09138034,0.7042059351242681,0.032671487924556306
86016,SIDM00529,Temozolomide,Trametinib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-0.23765998,-0.0048701526,-0.16581293252923013,0.0567562745435704
60771,SIDM00971,Trametinib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.2233851,-0.018458057,-0.7665602910818826,-0.037221146640745564
33491,SIDM00097,Vorinostat,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.74968004,-0.05448744,0.17231007725066405,-0.02792922929246122
50256,SIDM00774,Entinostat,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-3.5176713,-0.16942017,-0.391904187258349,-0.04926116598177118
2761,SIDM00301,Dactolisib,Ruxolitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.5026989,0.07036072,0.09968141944097646,-0.04357928708499781
104539,SIDM00866,AZD8055,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,52.0,-1.4144827,-0.045170873,-0.3081860133419749,-0.016378705703038923
80423,SIDM00878,RO-3306,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,70.0,-1.4030348,-0.078648336,-0.6432870445799198,0.0002652454748108232
4392,SIDM00193,Camptothecin,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,2.952523,0.17736107,1.2012701463467605,0.03875211033106426
78329,SIDM00097,Gemcitabine,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9221011,0.040390898,0.014701148516367639,0.0011392665528529124
46530,SIDM00778,Dabrafenib,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,1.5652303,0.015838427,2.3441289459403407,0.03583125695351733
31684,SIDM00529,PD173074,Trametinib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-2.4293919,-0.10143359,-0.9864115217799045,-0.01838260740301274
54308,SIDM00332,SCH772984,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6893603,-0.026907207,0.059860354254345084,-0.009761421077573058
37275,SIDM00628,AZD7762,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,1.1922294,0.10522201,1.0734623414283087,0.10291669227167166
100114,SIDM00954,Crizotinib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.0,-0.6449099,-0.047999587,0.42616644981015844,-0.0341557476756715
102274,SIDM00774,GSK269962A,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.4706702,-0.027203148,-0.5169015061726049,0.01804477828719109
50880,SIDM00146,Crizotinib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,1.8564572,0.07242821,0.8252838420959809,0.12439556389533085
68301,SIDM00411,Palbociclib,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-3.1296966,-0.095170245,-1.029040695218323,-0.023118648416753783
38038,SIDM00875,Linsitinib,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7675827,0.06461017,1.4436719425176274,0.015378852358147944
67393,SIDM00301,5-Fluorouracil,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,50.0,-1.8574784,-0.22611591,-2.533403106952794,-0.14231778450832702
104406,SIDM00097,Pictilisib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.628884,-0.21591672,-0.6636065144540425,-0.060245303494801734
26754,SIDM00971,Wee1 Inhibitor,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.45632017,0.015232173,-0.34931923702500395,-0.013603714677966729
47048,SIDM00673,Temozolomide,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.2945123,-0.00641351,0.6042120450124662,-0.010196877572973821
83342,SIDM00971,Trametinib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1996253,-0.017243238,-0.9999950764819192,-0.03382043906788398
36775,SIDM00529,AZD6482,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.06369704,0.002038711,-0.17842920721169356,-0.0016771332332011736
12588,SIDM00146,Venetoclax,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,2.4667246,0.0824826,2.338836970154008,0.07935249067423072
95564,SIDM00834,Olaparib,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-0.4044077,-0.007697354,1.1651210971321577,0.042705365155681636
79130,SIDM00875,Nilotinib,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.74952835,0.07507416,1.446604280051032,0.06779877379851272
82239,SIDM00875,OSI-027,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.83500165,-0.023216685,0.15965198621718873,-0.0964129847580288
72669,SIDM00301,MK-1775,Trametinib,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,-0.8601338,-0.09129951,-0.4642716684567101,-0.054125699756929185
19553,SIDM00673,Linsitinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.1743134,0.021538146,1.6429486889337945,0.026346853017722265
56154,SIDM00774,Afatinib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,0.49055895,0.035333093,1.3715629872677342,0.024375041956610603
59802,SIDM00779,LGK974,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,1.7823771,0.10117302,-0.8360964951913129,-0.005822767996757281
106359,SIDM00529,Nilotinib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Black,44.0,0.569236,0.021098346,0.8041913139945639,0.13258463284197408
84749,SIDM00774,RO-3306,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-2.9965365,-0.13943584,-2.1675869875437503,-0.10522695541120042
28999,SIDM00866,AZD8055,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,3.593751,0.18937668,0.48489292564189534,0.056451896041283096
896,SIDM00778,Crizotinib,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,69.0,-1.3951145,-0.065713085,-0.5176245093994786,-0.021750492733888408
93803,SIDM00954,Nutlin-3a (-),5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.29595032,0.00860417,1.073546162059,0.0037904376242693014
98715,SIDM00954,AZD8055,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.9749204,-0.08161367,-0.8611471685300144,-0.05255343293909249
13187,SIDM00359,Taselisib,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.8078899,-0.07052523,-2.1565536928843554,-0.11282506457505441
6283,SIDM00866,MK-1775,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,-1.0678915,-0.06577281,-0.6445365445051271,0.006013438393194734
57870,SIDM00301,Irinotecan,Dactolisib,Pancreas,0.0125,Pancreatic Carcinoma,Male,East Asian,50.0,0.50414354,0.06362655,-0.16312978664719788,-0.04622232715193034
51344,SIDM00971,Palbociclib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.4006245,-0.0389572,-1.266540347266617,-0.024558007278605465
30847,SIDM00097,PD173074,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.3418832,-0.13121545,0.17298214988954033,0.061359241720442693
105297,SIDM00954,Pictilisib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-1.8572751,-0.14038146,-0.3110170849235847,-0.04224577315876543
77590,SIDM00971,PF-4708671,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.26378146,-0.016273258,-0.3829717469929123,0.021485910373048027
14118,SIDM00971,Vorinostat,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.629213,0.02838831,1.1259633608805157,0.09970711577264783
82721,SIDM00971,Tozasertib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.7269565,0.0361751,1.9868061111404147,0.06326759719251218
108262,SIDM00097,Navitoclax,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.2473102,0.13489036,1.4511560679172593,0.079151077938868
67689,SIDM00878,Sorafenib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,1.0346497,0.07577499,0.5496819850418305,0.09788274798339826
26346,SIDM00673,Taselisib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.4839635,0.12479751,0.09507695043961259,0.023049763472563267
12494,SIDM00130,Gemcitabine,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.3365074,-0.084144644,0.3651624932648454,-0.0012663003128179165
63916,SIDM00834,SCH772984,Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,White,66.0,-2.0746148,-0.17597538,-1.7845285951245153,-0.08841023841432369
62768,SIDM00529,ZM447439,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,0.9961327,0.03532275,0.3979996672521314,0.04973800335291715
54181,SIDM00146,Sorafenib,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,2.1831298,0.1673399,-1.1398401008076038,-0.06287030155293213
77137,SIDM00834,Navitoclax,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,White,66.0,-1.8066769,-0.108592175,0.9988154901285737,0.07346341232479199
29898,SIDM00097,Palbociclib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0695462,0.05796714,-1.824740470111236,-0.11613414456844261
92091,SIDM00866,GSK269962A,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,-1.8610556,-0.055736143,0.17160116448325333,0.036149485309436395
44459,SIDM00673,Pictilisib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.90093017,0.07587929,-1.0923547227658277,-0.06561414242087321
20315,SIDM00673,Lapatinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.7054856,0.16964574,0.6531927130816876,0.10683492020688949
85744,SIDM00359,LGK974,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,4.150402,0.17678952,-0.4957258967141818,0.03088536152875501
28244,SIDM00779,SB505124,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,-0.5362263,-0.044902675,-1.6402257273713805,-0.05537757660521115
15777,SIDM00893,Vorinostat,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.1428291,-0.065105386,-0.7971996533166964,-0.023730034297015572
40099,SIDM00954,MK-2206,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-2.4763026,-0.13292351,-0.24895284714237806,0.010076150225820372
51499,SIDM00097,Afatinib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.32924065,-0.020289058,0.4167149077414842,0.035192386536609936
76565,SIDM00130,Gemcitabine,SCH772984,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.9452884,-0.19072786,-1.1021601865523263,-0.04602792425998369
89965,SIDM00971,Nilotinib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.41471863,0.026459355,1.0748574330970921,0.05688159770178334
69483,SIDM00774,BI-2536,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,-1.389227,-0.09121361,-0.47470219182364376,-0.08163950032586444
105551,SIDM00097,Vorinostat,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6527165,-0.09775605,-1.0953986318088653,-0.049570401858887905
28366,SIDM00673,Cisplatin,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.28880543,-0.010031226,0.7057963919766544,0.05425566696808382
89284,SIDM00875,RO-3306,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.475042,-0.10266456,-1.03756983995165,-0.08309815871973587
47208,SIDM01233,Olaparib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,3.3929734,0.121485755,1.1445050794630638,0.06723750037290871
43899,SIDM00893,Ribociclib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.4717894,-0.082798176,-1.5439085803816943,-0.041055687749024274
17350,SIDM00954,Crizotinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,0.73273134,0.052565247,-1.0661410253772214,-0.06103031622839538
15727,SIDM00878,Nilotinib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.54459596,-0.049503185,-1.317357585185874,-0.10513549717045448
2827,SIDM00673,RO-3306,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,2.1067953,0.10918985,0.4024591306942013,0.04643495300269701
26380,SIDM00332,Wee1 Inhibitor,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.02415465,-0.0017913254,-0.5778539855763007,-0.003928838574299963
746,SIDM00332,Alpelisib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,2.1173677,0.082477845,-0.6126169904653342,-0.03101332373350598
62639,SIDM00971,GSK269962A,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.0019697,0.06007506,2.7689485299630885,0.19799102247913944
35874,SIDM00193,AZD7762,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,1.7193066,0.10569678,-0.15805898835763948,0.017272199843222404
68954,SIDM00628,Entinostat,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,Black,51.0,-1.5441322,-0.074156314,-0.7311942158431385,-0.030469514536567373
74437,SIDM00779,SCH772984,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,1.9403541,0.085958466,-1.0300659187215195,-0.034330533902826456
105930,SIDM00628,Nilotinib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-1.0771649,-0.11148621,0.5155507320721653,0.0404351069543861
71580,SIDM00776,Dabrafenib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,65.0,-1.9864935,-0.06542975,-0.27203649198683433,0.0050819196522084225
81769,SIDM00875,Ribociclib,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.8378729,-0.0078234095,-0.2799964685263741,0.012333469446312703
34071,SIDM00878,Trametinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,3.3251207,0.39732122,-1.040241926123728,-0.05792562808940027
67736,SIDM00193,Afatinib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,2.1134243,0.18762644,-0.3750877133609567,0.014889438956013386
96895,SIDM00774,Axitinib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,48.0,-0.3772838,-0.034235004,-0.8727031544502594,0.008776203240557478
97284,SIDM00673,Sorafenib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.3090707,-0.07425266,-0.4763942343068242,0.042940089339332736
14289,SIDM00866,GSK269962A,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,52.0,2.1214268,0.123627655,0.7038952145206853,0.0572350170191623
28925,SIDM00332,Nilotinib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5833414,0.044124234,0.8914081805127761,0.1504624347096644
90793,SIDM00878,Bortezomib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-0.2491059,-0.0169401,-0.28489115517692676,-0.017984382534017226
52151,SIDM00660,MK-2206,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,2.7931023,0.21629834,0.9728639076305007,0.13056960190402483
69394,SIDM00971,Alpelisib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.5374148,-0.18204248,-1.2845849122108337,-0.04879693167912751
83990,SIDM00875,Paclitaxel,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-5.3765874,-0.54647064,-4.624153536987234,-0.30161023708924317
86564,SIDM00660,Afatinib,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,0.5607208,0.05644062,0.313328916937503,-0.01562734003838503
15487,SIDM00673,Afatinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.5264206,0.041826367,-1.2302051975548918,-0.10361707558440657
42878,SIDM00875,MK-2206,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.2153034,0.2276863,1.7657618833022135,0.12656602261314207
56168,SIDM00332,Cisplatin,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,3.2601554,0.070257835,2.1839501660027114,0.047409361135880936
2845,SIDM00782,Navitoclax,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.0312957,0.080896184,1.3553772890382494,0.05425479944635558
106585,SIDM00778,Taselisib,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,69.0,-1.1426504,-0.05529078,0.1332418820788483,0.025269185172205142
86539,SIDM00332,Gemcitabine,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3076646,0.09655442,0.32127364601224156,-0.0032899234681149376
13729,SIDM00834,SCH772984,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-0.5168422,-0.04684463,-1.086442436933828,-0.047421096098131
3517,SIDM00779,Navitoclax,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,1.3978024,0.021508327,-0.13362632604619165,-0.006961957871848591
34385,SIDM00531,Dactolisib,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.4563057,-0.037099358,-1.841475019555079,-0.023867601678689388
87479,SIDM00893,Paclitaxel,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.0098735,0.07369167,-2.077164835383728,-0.14291034322765597
23914,SIDM00673,BI-2536,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.6931284,-0.05306898,-0.3256726862081961,-0.039939864930515226
102835,SIDM00971,MK-2206,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.875017,-0.09622772,-1.5151990450573363,-0.06539952789913729
84336,SIDM00673,Dabrafenib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.8857334,0.04421766,1.7224522334568944,0.04422279522252912
17746,SIDM00660,Oxaliplatin,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,32.0,1.3914549,0.13821073,-1.8285032577357603,-0.10262590481904002
90539,SIDM00893,Trametinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.6285404,0.13982224,1.7715131942036222,0.11169950907250265
90991,SIDM00097,Dabrafenib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3462481,-0.07480663,0.02637404998670924,0.0002302125218062694
23737,SIDM00531,Linsitinib,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.6683121,0.09771869,0.402130193479838,0.041520577180775335
11080,SIDM00097,KU-55933,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.5694387,-0.08103221,-1.5220570392902228,-0.03201773383377977
10935,SIDM00866,Palbociclib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.6454651,0.05601959,1.7538896153907333,0.08352589465796144
21782,SIDM01233,Palbociclib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.3258927,0.03036434,2.6323825077431753,0.09144714225932725
87873,SIDM00834,BMS-754807,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,White,66.0,0.8145362,0.06875875,-0.5369450170597114,-0.03604234270697851
91312,SIDM00193,Afatinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.6836515,0.059146527,-0.3080333051775742,-0.012921805209308619
63978,SIDM00778,SB505124,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,0.83584523,0.03859897,0.08907002733021795,-0.0016975981401566873
61098,SIDM00097,Temozolomide,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.44796228,-0.0074998783,0.835378569449836,0.026049009374665692
12507,SIDM00332,Doramapimod,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.52621275,-0.03821353,1.0384503705913404,-0.0023040458764111596
31290,SIDM00971,Nilotinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.2569596,-0.08959361,-0.8569250966519372,-0.05121972562529006
16284,SIDM00097,PF-4708671,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9489943,0.04363353,-0.23126762993184571,-0.013601151751524635
84806,SIDM00097,Uprosertib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5513718,-0.097562194,-0.8527797118208161,-0.032361158192360864
77451,SIDM00411,Lapatinib,Ruxolitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,2.0884542,0.09050798,0.6992270054193791,0.04746661522845436
104416,SIDM00411,Palbociclib,Sorafenib,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,43.0,-0.68126315,-0.030582933,0.3511533683971458,0.04455084754321279
67245,SIDM00146,Sorafenib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-0.6703495,-0.051217616,-1.558916619834668,-0.07662578680912872
104486,SIDM00097,Tozasertib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7903627,-0.053375397,-1.1732607475338943,-0.015641132140924704
92418,SIDM00193,AZD7762,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,6.006445,0.45270917,4.313270894229882,0.2966113501340082
11791,SIDM00531,Sorafenib,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.3398816,-0.042342477,-0.6910421696016652,-0.046168012496879934
76803,SIDM00301,SCH772984,Trametinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.2454355,-0.17658454,-2.1023842406591227,-0.0697503080115661
1739,SIDM00193,Navitoclax,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,1.1472086,0.066771254,0.5600284662572654,0.04611328722607396
37132,SIDM00628,Bortezomib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,0.15300474,0.005084626,-1.3461925681428932,-0.028328057280053873
52290,SIDM00893,Nutlin-3a (-),Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.61396146,-0.012523489,0.8512899853344893,0.030513462241709293
40716,SIDM00866,Tozasertib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,1.1830035,0.08323336,0.4730957916577381,0.034281570759726473
93616,SIDM00193,Taselisib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,1.3785582,0.071134605,2.7290766309749204,0.16137928451838365
30734,SIDM00893,ZM447439,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.89212674,0.077102855,-0.2923499234372279,-0.01132160658827521
94821,SIDM00971,Navitoclax,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.42835394,-0.011023123,-0.09815577347240634,0.056369791708563585
20194,SIDM00774,MK-1775,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,48.0,-0.70080113,-0.097139865,-1.0911499564583051,-0.02901001290536201
75439,SIDM00411,Navitoclax,Ruxolitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-1.0081261,-0.061682113,-0.6550524038927628,-0.026893908659843226
105279,SIDM00893,Afatinib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.75837106,0.06061556,0.24709431754631592,0.02100572657462614
99899,SIDM00628,Ribociclib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,0.7851546,0.023644412,1.061525248350125,0.09562946337172387
67574,SIDM00529,Gemcitabine,OSI-027,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-3.533989,-0.15714826,-1.4375788239828107,-0.06028151001168121
34833,SIDM00866,Temozolomide,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.3359883,-0.022873344,1.4210877798033272,0.019744484467357794
77616,SIDM00778,Trametinib,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-1.3222512,-0.04799907,-1.5951180205745568,-0.0865950106139353
98502,SIDM00774,Bortezomib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-0.154765,-0.009915154,-0.6680705496857772,-0.007336696090079862
61330,SIDM00774,RO-3306,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,2.9864228,0.1853998,1.2967321106343346,0.0420864091344851
43179,SIDM00529,Nutlin-3a (-),Axitinib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.060518574,-0.0024983431,0.08731189255937394,0.014888611459375764
101979,SIDM00529,Tozasertib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.6117158,-0.055211484,-1.320158694252593,-0.01738523639486122
69091,SIDM00529,GSK269962A,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-2.8399045,-0.17301278,-0.6491280150680312,-0.03331998705052743
44420,SIDM00875,Tozasertib,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.612507,0.028996129,1.4035422820195087,0.024950889662082476
28444,SIDM00529,Entinostat,PD173074,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-2.3928006,-0.106712274,-0.09887163518939442,0.015393962938600217
57905,SIDM00529,Trametinib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-0.9232258,-0.056488056,0.1484331016535405,0.022890589315537547
87767,SIDM00971,MK-2206,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.562146,-0.08761906,-0.9211211924087696,-0.03657149138300117
42784,SIDM00411,AZD7762,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,4.19748,0.20898592,2.029115218256804,0.054246659504629334
39147,SIDM00673,Alpelisib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,1.7343284,0.12164044,0.3118957485258865,0.026800488178007065
32501,SIDM00146,Tozasertib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.27456066,0.020611884,1.0397294229232787,0.1184913739283853
21561,SIDM00529,Alisertib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Black,44.0,1.0140992,0.101717025,0.22645857548237552,0.040374370500371154
68758,SIDM00971,Afatinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.251198,0.1143836,1.8419824804769178,0.05366732386244959
25289,SIDM01233,Linsitinib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-1.1653818,-0.069604576,-0.030089864919591484,-0.0005377571691853877
78583,SIDM00866,AZD6482,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.259967,-0.014359186,-1.0905596736999505,-0.003154090813249058
75589,SIDM00866,ZM447439,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,0.6817924,0.048796378,-0.7453960366093033,-0.07351161651454063
2303,SIDM00097,Dabrafenib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.7025828,-0.100321926,-0.27151465576623307,-0.049358030476966984
54511,SIDM00782,AZD7762,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,Unknown,72.0,-0.7961272,-0.06855242,-1.1791238443086067,-0.0626794670531051
35427,SIDM00411,Crizotinib,Sorafenib,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,43.0,-2.364023,-0.13147268,0.3305876037553616,0.0012475228556304279
53659,SIDM00628,Trametinib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.28488123,-0.01930418,0.2841227769411878,0.09166193129204538
4233,SIDM00673,Doramapimod,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,1.48374,0.03679979,2.3386584371535473,0.057441953344754826
37104,SIDM00531,Ruxolitinib,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.0027764207,9.405896e-05,2.082654382402478,0.05093523935901222
104989,SIDM00866,Olaparib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-1.5441345,-0.012907596,1.5560553225393339,0.06595055550256529
4945,SIDM00971,RO-3306,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.85686576,-0.044037998,-1.348403181403277,-0.04051742042507663
5257,SIDM00778,SCH772984,Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-0.70675486,-0.03514068,-0.11338655549679837,-0.046002860439302955
49533,SIDM00834,Dabrafenib,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,White,66.0,0.49500966,0.019055087,0.5771168109908921,0.013882216263977643
76661,SIDM00782,Navitoclax,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.8665311,0.11960845,1.1048926800025514,0.07314620142295832
97750,SIDM00875,Dabrafenib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.2361546,0.14250918,0.6904679474392749,0.0477111616209824
72797,SIDM00782,SCH772984,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,Unknown,72.0,-3.0072207,-0.17373879,-1.066329807385198,-0.0650792765675608
77526,SIDM00774,Temozolomide,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,0.88719696,0.023870248,1.1207946745550936,0.032331616837154
100893,SIDM00332,Tozasertib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,0.330814,0.026311904,-0.9811719170543263,-0.09974829636017778
104855,SIDM00834,Olaparib,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,White,66.0,0.60128856,0.007220254,1.7086943329392317,0.04673916276602204
77042,SIDM01233,AZD4547,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,1.6294148,0.0643983,0.3895410981693932,0.027722969561217538
48523,SIDM00971,Dabrafenib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.6189536,0.013177222,0.41472865646827595,0.0017372552291702215
61067,SIDM00893,Paclitaxel,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.7633395,0.048292827,-1.4331037871576144,-0.09286694112605215
47628,SIDM00332,Vorinostat,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.52345294,0.041117456,1.0076348733728988,0.0814801291109184
70850,SIDM00782,Linsitinib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,Unknown,72.0,3.679683,0.20717071,2.2568240207786947,0.12718949337967014
91802,SIDM00878,NU7441,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.6080302,0.06072578,-0.735430510191979,-0.04095311386826972
25260,SIDM00628,Luminespib,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-1.0392421,-0.0977996,-0.826506067457451,-0.05867130153601096
88327,SIDM00673,Cisplatin,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.3562962,0.059182495,1.0863472482473844,0.04478655822989747
107436,SIDM00776,Oxaliplatin,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.6816527,0.11908721,-1.8784835473162753,-0.069100889655241
73741,SIDM00332,Camptothecin,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4452624,0.028954757,3.250840789757103,0.07579907661326854
88950,SIDM00866,Dabrafenib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.9453168,0.067335635,0.7207020227741918,0.03363101453565205
33941,SIDM00971,Docetaxel,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.3528078,-0.081005454,-2.201119463779605,-0.04102819272580239
71539,SIDM00875,Wee1 Inhibitor,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.25975898,-0.01816468,0.0832091919325989,-0.0005870158977569997
104154,SIDM00531,OSI-027,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.2719905,0.19074304,1.8402472910570573,0.12912650634066258
71687,SIDM00779,AZD4547,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.6912069,-0.008418911,-1.856877993653908,-0.052175734716972025
62872,SIDM00778,Olaparib,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,69.0,-2.218374,-0.042704515,-0.9364837342777902,-0.0015200781102539128
67406,SIDM00332,Camptothecin,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4530617,0.035314802,3.50381303202425,0.12093508128605367
103720,SIDM00971,MK-1775,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.1156597,0.06742526,0.4254994338601937,0.030833313848480932
64422,SIDM00332,Entinostat,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2018092,0.032391343,3.501673905312272,0.09135295403558887
1145,SIDM00673,Uprosertib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.82825375,-0.05580802,-0.7881464945441213,-0.045991687186959
6250,SIDM00332,SCH772984,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.854222,0.17453776,2.8995641686692393,0.11377188075185309
79823,SIDM00529,OSI-027,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Black,44.0,0.1809683,0.015908478,0.02621370881779294,0.11001170318711204
60176,SIDM00628,Dabrafenib,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-1.7796057,-0.12143903,-0.9978330385092498,-0.013926332696891468
84119,SIDM00332,PD173074,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.210205,-0.22483408,-0.5558345320856107,-0.053340240958502275
55951,SIDM00673,JQ1,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-1.5184894,-0.09374777,-1.4027785049040224,-0.06843652265954006
29193,SIDM00529,Sorafenib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-0.47014198,-0.04511927,-0.4818118050354599,-0.058488138939434386
86809,SIDM00097,PD173074,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2390944,-0.045469053,-0.1488154789305366,-0.0047365648178424235
75880,SIDM01233,Nutlin-3a (-),Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.8380306,0.081548266,1.894300168673268,0.05656375019692974
39063,SIDM00332,RO-3306,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5915883,-0.065742604,0.17419092141931772,-0.032593373712817224
26229,SIDM00301,Erlotinib,Trametinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.7365847,0.17758904,2.810461029645216,0.10868026401187089
55221,SIDM00893,Sorafenib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.2218688,-0.07844337,-1.4893133681865969,-0.0262316216184946
85679,SIDM00878,Palbociclib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,0.6050724,0.05180626,0.15499455333863357,0.010495389298809239
96365,SIDM00660,BMS-754807,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,32.0,0.5257712,0.05162973,-1.0974189736513646,-0.09325507991866543
37964,SIDM00531,Navitoclax,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.7330182,0.20002723,2.8102670302382124,0.1502221034388091
39452,SIDM01233,Crizotinib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,0.55662555,0.04089396,-0.24334312482689976,-0.01469318211086723
66493,SIDM00878,Camptothecin,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,0.20599775,0.0061024525,0.9906306973970286,0.037478770104205944
41468,SIDM00332,RO-3306,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3007728,-0.0556991,0.6357642591230526,0.011352734942091842
60243,SIDM00531,Trametinib,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.7329954,-0.12743782,-1.3731452270646076,-0.04104021691191985
102166,SIDM00411,Ruxolitinib,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,3.3607683,0.072384,2.882641827432286,0.07273135991154867
87237,SIDM00778,AZD4547,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,1.6017493,0.0648702,0.5633074579125059,0.01756035405596644
13772,SIDM00954,Pictilisib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-2.8875735,-0.21170323,-1.1960247425199733,-0.05694306086002909
67355,SIDM00097,Afatinib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.55681723,-0.041504323,-0.6779447217727734,-0.0639142451470568
105373,SIDM00628,Axitinib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.7188475,-0.0614727,-0.8417180698677237,-0.05111995331403969
76225,SIDM00875,JQ1,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-3.39324,-0.100833446,-0.97144463898984,-0.03654593513424832
65994,SIDM00628,MK-1775,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,1.7783735,0.14014968,-1.0621508841155511,-0.07150107534601058
87039,SIDM00971,Venetoclax,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.4378138,0.068774976,1.4767703865501884,0.04287196262611059
78687,SIDM00774,BI-2536,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.0398136,0.07836677,-0.2285792102109402,-0.06231840220306002
34079,SIDM00529,Tozasertib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Black,44.0,-1.1254663,-0.040108923,-0.6210490399224385,0.037629699787139904
95030,SIDM00660,AZD7762,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,-0.69648933,-0.05689922,-0.8989213807549183,-0.045613995689907864
4201,SIDM00097,Ribociclib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.574863,-0.081821136,-1.2516054028415033,-0.040126744097147046
6770,SIDM00779,AZD4547,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,-2.7251964,-0.010945797,-2.352591737455078,-0.046000905809884515
79145,SIDM00776,LGK974,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-2.184546,-0.084127896,-1.924866076247266,-0.05034388487755928
41420,SIDM01233,MK-1775,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,72.0,-1.4214975,-0.11661357,-1.6784443251020884,-0.04796841278763822
40255,SIDM00529,KU-55933,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-0.6168346,-0.008078787,1.3754879514653657,0.05910993502004167
40317,SIDM00866,Ribociclib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,52.0,-3.169788,-0.105775386,-0.8914183590065184,0.024449446112330107
72822,SIDM00878,AZD7762,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-2.2336714,-0.12160272,1.323521499724191,0.04569314106487755
65905,SIDM00301,SCH772984,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,4.284743,0.45296124,1.5617068121794893,0.0733752785460887
8668,SIDM00778,Palbociclib,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,1.4395671,0.071324214,-1.3074413246454777,-0.04247692600950398
99344,SIDM00146,Uprosertib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-1.6125238,-0.10835524,1.7663786861707662,0.20295220732137867
5644,SIDM00673,Taselisib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-0.7341296,-0.07367539,-0.03333213834702414,0.01075653726831096
47380,SIDM00531,Dactolisib,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.65420514,0.051783074,-0.3327051217945805,0.013641251455138816
50619,SIDM00660,AZD8055,AZD7762,Large Intestine,0.0625,Cecum Adenocarcinoma,Male,White,32.0,-0.83542687,-0.0770293,0.3319127520633901,-0.02151115708221993
98218,SIDM00097,Tozasertib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0567403,-0.06498195,-0.01678949919244577,-0.003251255278973505
13916,SIDM00531,MK-2206,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.6685383,0.121179014,1.4445902481519024,0.07543175849178078
81104,SIDM00529,Tozasertib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.0263878,-0.036497775,0.6521635493727169,0.0534935299783029
103399,SIDM00971,Nilotinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.0876257,0.050185576,0.37143923447509614,0.02452612130040812
4806,SIDM00893,BI-2536,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.8290058,0.06944378,-0.30370755856822146,0.040611977948519506
56530,SIDM00878,Alisertib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.6443938,-0.05614914,-1.076482635305442,-0.05340175210991968
28552,SIDM00411,Sorafenib,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.9465114,-0.042255547,-0.13843408740389365,0.01790551271425162
29547,SIDM01233,MK-2206,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-1.7074614,-0.088819504,-0.5753224143101492,-0.0481822352792743
95729,SIDM00673,Trametinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6800463,-0.06016698,-1.8990085465565574,-0.08353087532745593
5221,SIDM00893,Temozolomide,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.5921771,-0.013825048,0.4311821570186287,0.012724000789326406
77737,SIDM00774,Bortezomib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.22772159,-0.020394806,-0.8403168996860017,0.011823651110212103
226,SIDM00628,AZD6482,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,2.7538106,0.24032578,0.01719219149975779,0.023095293501948225
73013,SIDM00782,Palbociclib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.0679157,0.024103139,2.206121952756722,0.0406997097417433
25669,SIDM00660,5-Fluorouracil,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,32.0,-1.3391997,-0.085381396,-2.0276478994099065,-0.1180216819852117
59014,SIDM00332,Doramapimod,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.31556678,-0.022495853,-0.05233618549684201,-0.004731555490792633
31923,SIDM00411,OSI-027,Linsitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,2.622011,0.14974268,1.530832684588172,0.10248554382496868
20866,SIDM00332,Nutlin-3a (-),Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9747448,0.035873316,0.8158910879966748,0.012094238916653175
70599,SIDM00529,5-Fluorouracil,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Black,44.0,5.5618734,0.41644597,0.6705667011724527,0.052462513753567495
10000,SIDM00529,GSK269962A,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-2.0061717,-0.04593722,-1.2168506654781897,0.01791339848047183
69472,SIDM00778,Palbociclib,LGK974,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,2.6562746,0.14419638,0.23141842249729344,-0.001980098604611976
32489,SIDM00834,AZD4547,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,1.9716337,0.051039185,2.1738643243299007,0.08604323888800595
48234,SIDM00193,Vinorelbine,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.5494967,-0.21118069,-0.6992938947752023,-0.02951895313544522
62745,SIDM00866,Nutlin-3a (-),Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,1.3931485,0.05415426,0.44740638839271657,0.00033563519463463966
49653,SIDM00673,Ribociclib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.4182258,-0.07061234,-0.7600487797513062,0.024007395469696803
51520,SIDM00193,5-Fluorouracil,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.6726987,-0.18525167,-2.3253895870159482,-0.16671455917741748
55966,SIDM00971,RO-3306,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.9801012,0.059399396,-0.5907240663852185,-0.005298288420876229
54476,SIDM00146,Taselisib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-1.2518153,-0.1024711,0.013196714260463828,0.016246970989606504
11264,SIDM00097,Pictilisib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.9144967,-0.1645715,-0.048741515712332574,-0.04703319274656633
28812,SIDM00954,Sorafenib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,0.6073652,0.038503982,0.46510937961363796,0.08576765386247989
57701,SIDM00531,Olaparib,Lapatinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.9343628,0.053300582,0.3698244690731,0.014886167286875437
104470,SIDM00866,AZD6482,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,1.233191,0.08546494,-0.5485205539270657,0.02185803444634839
70121,SIDM00782,Oxaliplatin,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,-1.2661266,-0.058692712,-1.0816297015894565,-0.011380614209320794
34195,SIDM00782,SB505124,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.219452,-0.104497544,-0.4105048097301125,-0.037095692242021416
27371,SIDM00146,MK-2206,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.7256522,0.12054449,0.4675289848278703,0.07367156140381866
53291,SIDM00971,PF-4708671,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.8938422,-0.05445327,-0.8213678133326298,-0.03836283448839216
95827,SIDM00782,5-Fluorouracil,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.5729506,-0.05310632,0.13233868091099404,0.021843035544907262
2576,SIDM00146,GSK269962A,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.0319952,-0.07369097,-0.8834578052364817,-0.030599517386876673
69219,SIDM00529,ZM447439,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-2.1866992,-0.13224435,-1.0712937656067674,-0.04553829777833022
24812,SIDM00411,Paclitaxel,Taselisib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,1.8010867,0.07523008,1.5321944812173511,0.10422630511999893
87447,SIDM00878,Entinostat,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.8567337,0.052229982,0.4439446358477845,0.07700280983783261
65523,SIDM00146,BI-2536,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,2.9276826,0.06201093,-1.0698182974521768,-0.04321178181976181
42259,SIDM00875,5-Fluorouracil,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5450374,-0.04734673,-0.9986355780636258,-0.04388344329568736
41318,SIDM00332,Linsitinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8582939,-0.021293936,2.923455174188702,0.062346855073556535
76824,SIDM00529,Bortezomib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-0.19613025,-0.015637666,-1.781079890761053,-0.04757845455893238
99917,SIDM00954,BI-2536,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,1.5551083,0.025509723,-0.8840170504856844,-0.018963257314512726
65804,SIDM00628,RO-3306,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.6863259,-0.062340952,-0.48155763291133535,-0.06858291434593858
60753,SIDM00893,MK-1775,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.5133851,-0.053282183,-0.24022828458981244,0.004154308061947238
81804,SIDM00673,Nilotinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.1409678,-0.07858822,0.6127192487266336,0.08872075733208049
36297,SIDM00146,Temozolomide,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.31888402,-0.007914329,0.8173763547721921,0.04168089972568699
28652,SIDM00531,SCH772984,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.579029,0.184818,-1.3578124645883098,-0.012906088433519258
54122,SIDM00971,5-Fluorouracil,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.43938836,-0.010611085,-0.024354854425153064,0.01670669078225148
28029,SIDM00628,Dabrafenib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-1.8092896,-0.12654136,-0.8503276786883135,-0.0009237692092073153
99110,SIDM00954,Wee1 Inhibitor,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-2.054179,-0.110514626,-0.21460279494146656,0.0274981773228097
93160,SIDM00875,Wee1 Inhibitor,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.6056957,-0.05323251,1.4827993510667588,0.028356089945692046
87679,SIDM00628,Dabrafenib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-1.5131657,-0.08911395,0.36467337347947987,0.05652033718850273
81647,SIDM00673,AZD7762,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-0.17154782,-0.012966109,-0.7709660053049381,-0.06035068171669095
18642,SIDM00774,Docetaxel,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.9868572,-0.44199625,-1.3076736764747965,-0.1417109551854108
18561,SIDM00146,JQ1,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-2.2615738,-0.17322935,-1.254720057301433,-0.09912353970471444
107470,SIDM00529,5-Fluorouracil,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Black,44.0,-1.9591786,-0.15781829,-1.2856846692716883,-0.06639759566777557
85730,SIDM00971,Paclitaxel,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.3120342,0.062683776,1.8714347703353658,0.1743357559568704
248,SIDM00359,LGK974,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0698828,0.032363124,0.5281058298941816,0.028643017671050475
36372,SIDM00673,Camptothecin,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,1.1455024,0.037617277,2.715762240701273,0.06916908178999434
49118,SIDM00097,Luminespib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.39877456,0.027392594,-0.15532249234336531,-0.007950207442185239
69378,SIDM00130,MK-2206,Trametinib,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,3.401418,0.25204197,2.3184329045608774,0.16094765777518247
26007,SIDM00875,RO-3306,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1715342,-0.10678355,-0.8296436328827034,-0.07719850635751418
8457,SIDM00878,5-Fluorouracil,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.6058117,-0.10408234,-1.2718528385074477,-0.03685275536651485
60976,SIDM00359,Trametinib,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2924907,-0.047642164,-3.0620732758826,-0.04882602574669439
97810,SIDM00146,BI-2536,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,0.26703858,0.009517355,-1.8524349874509776,-0.042174063571309685
6567,SIDM00971,Crizotinib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.3709503,0.060417913,-0.46655029247606744,0.02759551693861734
85607,SIDM00875,JQ1,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.95433724,-0.088866405,0.11723701533001984,-0.04340568639103116
93490,SIDM00866,Entinostat,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.31362104,-0.023480672,0.18446943442464933,0.10004969614691775
949,SIDM00893,MK-1775,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-3.7338963,-0.3036635,-2.4411417085952776,-0.18882874379300324
25809,SIDM00834,Taselisib,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,-2.178783,-0.12362106,-2.001248437361361,-0.12658792323875706
65524,SIDM00529,Docetaxel,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-2.093886,-0.15128222,0.1633849771705646,-0.002327614387353261
76383,SIDM00660,SCH772984,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,2.3221986,0.09261324,0.5592830981103138,0.03712516099572565
86228,SIDM00954,Afatinib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-2.4123714,-0.20253997,-1.1088368272047942,-0.076485154619527
7486,SIDM00332,AZD7762,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,1.52006,0.14577894,0.29706153321801254,0.005570777743283778
60930,SIDM00359,AZD4547,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.29518187,0.017304558,-1.4361301242557012,-0.03281250210513305
54799,SIDM00954,Ribociclib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,2.6913562,0.095681794,0.37832492997708445,0.09801985112565376
65165,SIDM00954,Tozasertib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-2.1497455,-0.10100754,-0.2779355256874985,-0.008356692042769927
62218,SIDM00776,BMS-754807,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.3730202,-0.10524851,-1.117646890802124,-0.003728595800804479
55589,SIDM00866,Navitoclax,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,-0.8020719,-0.052130457,-0.10989939805051693,0.038650368817182194
107140,SIDM00193,AZD7762,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.84850085,0.038313467,0.3447424138582698,0.05432661031645905
65885,SIDM00332,RO-3306,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.53521,0.105383195,1.5192289362507576,0.03393412780376641
76879,SIDM00776,Navitoclax,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,0.6997916,0.025651475,1.4255517588955635,0.004690600948273431
47028,SIDM00774,OSI-027,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,-1.3684744,-0.15738116,-0.3838764410244857,-0.026844140625858433
53889,SIDM00130,Gemcitabine,5-Fluorouracil,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.5037292,-0.09652648,-1.9583210172052576,-0.09716974115939844
13621,SIDM00834,AZD8055,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,2.489881,0.19790235,-0.6238811159120907,-0.018903206259266142
58505,SIDM00878,RO-3306,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-0.12570569,-0.007769958,0.14508563128885293,0.002225268323162531
83370,SIDM00875,Crizotinib,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.49627677,-0.05551577,-0.3490627790695834,-0.019386686318184278
47656,SIDM00628,Docetaxel,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,Black,51.0,-0.9322999,-0.08732133,-0.3439951528388121,-0.04709010711329872
76338,SIDM00332,Camptothecin,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,1.686241,0.03917872,3.8015922101869073,0.0991611497484769
65081,SIDM00878,Lapatinib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,0.978418,0.11809218,-0.4600499308659744,-0.06346504953429989
81879,SIDM00628,Uprosertib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-1.7480744,-0.099036776,-0.5510083939603765,-0.014593403467941107
96700,SIDM00411,Palbociclib,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.1818929,0.07860974,0.13502372937089047,0.062461581007073406
80395,SIDM00774,ZM447439,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.871824,0.08699919,1.3287454505113416,0.22500649959715432
28197,SIDM00130,5-Fluorouracil,Erlotinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.9466254,0.08732374,-1.973154172448032,-0.0775329283253639
6419,SIDM00130,Crizotinib,Dasatinib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.1729198,0.015526165,1.0021482567298314,0.12651121272080007
13974,SIDM00628,Gemcitabine,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-4.044876,-0.16204469,-3.639521405327883,-0.10754577198970762
90765,SIDM00146,Linsitinib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,1.2673335,0.032478254,3.000508937270408,0.111162592382226
14152,SIDM00097,SCH772984,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.6000038,-0.031687953,-0.9255740455562003,-0.056868250136941315
43832,SIDM00146,Cisplatin,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.4681807,0.0690709,2.809945797667129,0.08078884988805796
11964,SIDM00130,5-Fluorouracil,AZD7762,Pancreas,0.0625,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,3.238644,0.3118154,2.129677472343411,0.1470531351692426
94691,SIDM00954,PD173074,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,1.7562019,0.11694705,0.10246394616951893,0.09867544019493464
72,SIDM00971,Wee1 Inhibitor,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.0763352,0.08371578,0.2342494790987125,0.016929597658211202
34881,SIDM00332,NU7441,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7640235,0.121501945,0.5908362421643959,0.08034131911791949
89748,SIDM00301,Olaparib,Dactolisib,Pancreas,0.0125,Pancreatic Carcinoma,Male,East Asian,50.0,1.1497937,0.08299843,1.169198121367622,0.030324529827150233
42946,SIDM00774,Vorinostat,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.35957986,0.022136299,-0.6066064659025405,-0.047812973152974864
88958,SIDM00875,Gemcitabine,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-7.94189,-0.022729361,2.0864966846700335,0.14064932265910282
106843,SIDM00878,MK-1775,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.54554135,0.041191027,-0.5109755890203165,-0.05572131165889461
84470,SIDM01233,Afatinib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-1.3433927,-0.093225114,-0.641291854295365,-0.019438449991140645
36254,SIDM00875,Nilotinib,Vorinostat,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6323508,0.06745115,-0.00635129989118975,0.01260525616345274
620,SIDM00834,Oxaliplatin,Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,White,66.0,-1.8593259,-0.15491529,-2.5289394011121877,-0.13754840520193795
23853,SIDM01233,SCH772984,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,-2.1406994,-0.16068204,-0.23949878584429515,0.05309114789039955
85888,SIDM00097,Paclitaxel,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3666887,-0.08527523,-0.5702816705266113,-0.09882168568944724
88043,SIDM00893,MK-1775,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.69135725,-0.056461744,-1.7049049594500183,-0.07058416766441691
40288,SIDM00971,BI-2536,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.4999267,0.08111371,2.157829861630779,0.16106130313893455
24373,SIDM00146,AZD8055,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,0.9140386,0.06695438,0.28051718659123626,-0.01931121612162086
27894,SIDM00130,Navitoclax,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.2762347,0.102702804,1.2167491676212676,0.10417483018777075
41865,SIDM00774,GSK269962A,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.8923138,-0.094926946,-0.9909747460850288,-0.08678205328074962
105907,SIDM00130,Paclitaxel,Navitoclax,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,4.1549244,0.28530887,3.766817198474078,0.2051294607476114
5980,SIDM00774,Olaparib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,48.0,1.2416116,0.099459715,-0.6238088289867242,0.0055704345792442255
3640,SIDM00529,Axitinib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-2.546437,-0.18414775,-2.343964443538671,-0.13186433040940082
89023,SIDM00893,MK-2206,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.92836183,-0.08918997,0.16435290249851056,0.03594438959082591
35596,SIDM00971,Afatinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.1627865,-0.07816413,-1.185422903410737,-0.023305042193100988
53836,SIDM00146,Afatinib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,0.6947261,0.04998279,0.6539301810408242,0.017670430059693213
69703,SIDM01233,Crizotinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,0.7155986,0.0514307,0.17891596769378487,0.03529745317511485
55453,SIDM00782,BMS-754807,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.6859242,-0.055063277,-0.4394490148807066,-0.07016969955348977
8026,SIDM00954,Uprosertib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.3058667,-0.057930227,-0.5316433409672162,0.07278001172012229
51177,SIDM00529,Nutlin-3a (-),Olaparib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-0.77313125,-0.02855874,-0.2254207748770763,0.033472975619890245
10553,SIDM00866,PD173074,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-1.0729556,-0.04014988,-0.7380333124827114,0.013963785418018973
84317,SIDM00411,OSI-027,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.8376225,-0.1009275,-1.624838141247538,-0.07704401404491296
22663,SIDM00301,5-Fluorouracil,SCH772984,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.3292234,-0.14709711,-0.7081030650396377,-0.0490117294010689
32455,SIDM00782,Oxaliplatin,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-2.411066,-0.06353838,-1.4849950017940075,-0.006989007709407595
66947,SIDM00866,Linsitinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.0073988,-0.045934185,-0.015863457026247623,0.014364006496669197
74558,SIDM00834,Palbociclib,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-1.4077889,-0.07586156,-0.24428714475332575,0.02345793790273029
65912,SIDM00778,MK-1775,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-3.5840373,-0.11780929,-1.5455747343313464,-0.11043916057354633
25775,SIDM00332,Vorinostat,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6232968,0.056371845,1.5112111729759654,0.08326756793995119
29373,SIDM00875,MK-1775,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.34361544,0.02061234,-0.3956010368452666,-0.025609047034376525
17458,SIDM00875,Lapatinib,Vorinostat,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.30018827,0.034146674,1.9758546284049374,0.11751032458577894
96556,SIDM00875,Vorinostat,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4186293,0.15447158,1.9746448748867076,0.126836643785502
87522,SIDM00097,Bortezomib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.19580972,-0.009697249,-0.17465055221443085,-0.004424573823376777
90492,SIDM00866,NU7441,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.4342529,-0.029443376,-0.7379148015910751,0.04421954451282792
48293,SIDM00778,Dabrafenib,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,1.379161,0.016269026,0.42110060128726434,0.016236519144194467
66504,SIDM00531,Cisplatin,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.2671504,0.15580928,-1.27790973695191,-0.04046901815164026
107567,SIDM00193,MK-1775,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.6491754,-0.060537536,-1.4986407936638333,-0.09925561015294836
63375,SIDM00673,GSK269962A,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,2.640347,0.21347493,0.6266073266705182,0.05694847092778845
91615,SIDM00531,Irinotecan,Crizotinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.5776792,-0.06703085,-1.9634212724623765,-0.16748373802343064
37336,SIDM00097,5-Fluorouracil,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.38272,-0.09299044,-1.5560366512029606,-0.11509812749818564
50757,SIDM00971,Lapatinib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.1469336,0.05786818,-0.05795121573198631,0.01947933009537357
43540,SIDM00332,GSK269962A,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1778964,-0.053524397,0.20813639873579837,0.03122578017666194
47459,SIDM00673,MK-1775,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.7329651,-0.069911055,-0.9108102920035114,-0.024016656923092062
18137,SIDM00878,Temozolomide,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.5400962,-0.013678189,0.8029981006963153,0.024094776358927383
74381,SIDM00301,Dasatinib,5-Fluorouracil,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.4033113,-0.07564679,0.39986860423091664,0.027840618428302783
25073,SIDM00193,Dabrafenib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.6027892,-0.012795924,0.704784818700811,0.05562165193498738
15361,SIDM00878,JQ1,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.93539006,0.036155958,-0.3595751865964394,0.009311854539977113
52511,SIDM00875,NU7441,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.34616,0.031357832,0.5533673759347099,0.05879845402747508
105445,SIDM00673,Lapatinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.539795,-0.13121599,-0.5342666466922552,-0.017940043789137907
48085,SIDM00529,Ribociclib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.1736751,-0.030318365,0.11744622251076335,-0.0024483248332876567
33689,SIDM00878,Linsitinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,70.0,0.28247216,0.019005938,0.4919290239771338,0.0030664039247890705
49407,SIDM00875,Uprosertib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.5899253,0.2548098,1.6044673886084901,0.12103292434763835
89584,SIDM00146,Paclitaxel,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-2.662345,-0.2163438,-2.9555997537737073,-0.227895057981822
5640,SIDM00660,Trametinib,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,1.5592272,0.08952871,-0.49854306759343897,-0.034419058613603976
90485,SIDM01233,SCH772984,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,1.5956415,0.02758712,-0.782904475384091,-0.06864069359446207
77433,SIDM00834,Afatinib,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,0.7388005,0.03714628,-0.8607306865756453,-0.05225213969011739
33404,SIDM00628,Linsitinib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.7240484,-0.044677664,-0.38081532471030693,0.01976946576261512
87513,SIDM00673,Doramapimod,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,3.2564254,0.10334451,2.2987156517832203,0.06963244297075262
4682,SIDM00332,Temozolomide,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2295197,-0.028051233,0.9837007091400743,0.047370153119707256
4592,SIDM00359,Vinorelbine,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,4.3279333,0.35622042,-0.8886858301620959,-0.0319153660822436
85049,SIDM00866,Ribociclib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-2.398811,-0.100774474,-1.482969429855298,-0.08666619036977531
46093,SIDM00359,BMS-754807,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.59324986,0.052924287,-1.8980159243644545,-0.10755987448539116
77294,SIDM00660,SCH772984,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,2.5841575,0.09595101,0.24220914781831757,-0.0004494188665807811
25895,SIDM00529,ZM447439,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-1.5564592,-0.10911229,-1.7427722528627785,-0.01301634515975962
32177,SIDM00193,LGK974,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.17636459,-0.006792936,0.7090779103765013,0.013436376235935677
24907,SIDM00529,Bortezomib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.35522962,-0.027158024,-0.2314178479074929,0.043063709992709184
95063,SIDM00411,Trametinib,SCH772984,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.4812882,0.09187488,-2.0193569438482477,-0.028336752046569606
22516,SIDM00774,PF-4708671,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.6353588,0.036874138,-0.23438304892038872,-0.04310845397955244
32598,SIDM00971,Lapatinib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.4209729,-0.023254393,0.08494590001665929,0.00835431313623663
91504,SIDM00893,Venetoclax,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.2432487,-0.059090175,-1.3086301661918105,0.015150936521436165
11916,SIDM01233,Taselisib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-0.5834575,-0.048581205,-0.6591842774426637,-0.04698002977381623
48350,SIDM00893,Sorafenib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.7072138,0.061225653,-0.3693072539395165,0.0038882773113774654
90444,SIDM00332,Alisertib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3262551,-0.08062669,-1.9525350519897828,-0.1370390033365215
84860,SIDM00971,Palbociclib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.8860738,-0.02698325,-1.4722476348504765,-0.020289164773242403
82803,SIDM00146,JQ1,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.8414859,-0.06782902,0.41850379386547576,0.006066327842429206
49139,SIDM00673,Uprosertib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.64466214,0.04218143,-0.12436320398489277,0.059135483215333795
25845,SIDM00411,Oxaliplatin,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,43.0,-1.4863521,-0.048926216,-1.7539420669854886,-0.04404554008763715
11015,SIDM01233,Vinorelbine,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,1.3030115,0.09614266,-1.2195576757263116,-0.044412441575139835
11708,SIDM00893,Axitinib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.0215442,-0.08143506,-2.0579100961358328,-0.04230486391475983
68034,SIDM00411,Taselisib,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.72481483,-0.04767828,-0.6157687117090394,-0.03174175379694965
31741,SIDM00130,Irinotecan,Dasatinib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.3768739,0.095661454,-0.2650679437036735,0.032789968179614555
32571,SIDM00782,BMS-754807,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.3770156,-0.07462751,-1.3018059019246266,-0.0539864673876851
22404,SIDM00146,Vorinostat,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.76025826,0.05752883,0.9576529435898923,0.038230834586744526
66533,SIDM00628,Nutlin-3a (-),AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,Black,51.0,-1.6541053,-0.08283305,-0.6214379757805545,-0.008466248628659098
105722,SIDM00866,PF-4708671,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-0.085274614,-0.0039898125,-1.598367608698835,-0.014672310256685448
51429,SIDM00531,Sorafenib,Erlotinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.6109331,0.072787926,-0.9765259311601234,-0.035416904315098426
69550,SIDM00628,Dabrafenib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.34665093,-0.027981482,-0.6046867675062564,-0.014257695776832724
108392,SIDM00628,AZD7762,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,0.71012735,0.06567878,-0.2790686610812335,-0.010488682894312604
6070,SIDM00332,NU7441,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.1650224,-0.11599355,-0.8367245612181853,-0.04610523344318923
65220,SIDM00866,PD173074,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.1935773,-0.037495557,-0.9041994757407888,0.02250260004322591
10814,SIDM00893,PF-4708671,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.0276706,0.08373995,0.08281722919250241,0.017040313667605236
93942,SIDM00628,BI-2536,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,Black,51.0,2.195137,0.050895967,0.048295346903159474,0.005026212902443329
42769,SIDM00875,Cisplatin,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.38971278,-0.018847628,-0.27932444121842304,0.047480342661401415
84484,SIDM00774,Alpelisib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.56524676,0.039359465,-0.26009172734939306,0.027315850624481625
18833,SIDM00776,MK-2206,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,2.3240025,0.14745246,1.9833474119610166,0.13552789444978144
42221,SIDM00776,AZD8055,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-3.1305857,-0.19703698,-0.2776763737874086,0.005284370284972911
34685,SIDM00782,Taselisib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.2847985,-0.118615046,-2.3105550712372653,-0.10036682965641808
82594,SIDM00782,Crizotinib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.8477637,-0.15619256,-0.5695858686479642,-0.04606017754930177
10166,SIDM00097,RO-3306,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.1309713,0.0072780293,0.0828301475482722,-0.03564984467833972
99016,SIDM00146,Entinostat,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.45782727,-0.0314643,0.25918884944816434,0.05327253131626335
48529,SIDM00193,Taselisib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,East Asian,53.0,-1.8444895,-0.12601717,-0.13772826677023975,0.027034326073628864
101998,SIDM00301,Taselisib,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-0.89150625,-0.09469243,-0.22160543831460666,-0.0013821543224203387
67107,SIDM00660,AZD8055,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,32.0,0.08218099,0.006113104,-1.448897630498219,-0.08209443211930623
50228,SIDM00954,Temozolomide,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,0.4363799,0.008470123,0.35345722625186443,0.03188459582955651
10295,SIDM00774,SCH772984,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,2.608665,0.08032115,0.9242389655721828,0.012275850773813603
57881,SIDM00779,Linsitinib,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,4.061041,0.15618163,-0.43998713508545867,-0.054686163994049304
51207,SIDM01233,Dabrafenib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,2.1431813,0.09579883,0.20978133072182123,0.007481294409170679
71830,SIDM00776,Palbociclib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-1.3362575,-0.0415597,1.4151940007155133,0.044711942332133936
48023,SIDM00971,Afatinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.987164,-0.0765219,-0.23927192822677942,-0.005582379257547373
87261,SIDM00866,Ribociclib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-2.8546183,-0.08741046,-0.6980585061294972,-0.015337278316386625
91605,SIDM00875,Sorafenib,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6712208,0.07160897,0.3355937504498217,-0.00307763078740085
54061,SIDM00779,BMS-754807,Navitoclax,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,2.6832159,0.025108246,0.6273945426720475,0.008525719887359963
80676,SIDM00673,Vorinostat,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.53021777,0.03807134,0.5733778066819202,0.06780328164171565
41327,SIDM00971,Uprosertib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.921944,0.054089226,0.11463001747178829,0.030758692882776478
78242,SIDM00097,Wee1 Inhibitor,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1801425,-0.07232507,-0.6153622982186029,-0.09610233002303487
105318,SIDM00774,Tozasertib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.81452966,-0.02286197,0.8728682174983445,0.03151092068242181
61899,SIDM00628,Linsitinib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,1.5283394,0.112542935,-0.577462074390788,-0.007792482381028632
32090,SIDM00971,Entinostat,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.87629545,0.030280037,-0.7210869405044076,-0.022185339077477554
95297,SIDM00954,Temozolomide,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,0.18360913,0.0023218293,1.5042822817169208,0.042597387960497404
91079,SIDM00332,Nutlin-3a (-),Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.7949946,0.114579596,0.9182921359820169,-0.017771717221178825
64751,SIDM00971,PF-4708671,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.4231355,-0.08292024,-1.0847835746697743,-0.029200350390358332
31104,SIDM00146,PD173074,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-2.3296144,-0.13724098,-0.9280024812837502,-0.012181851605031152
89300,SIDM00531,LGK974,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.9907963,-0.09062511,-1.615918435319819,-0.019697846051895732
34558,SIDM00893,Temozolomide,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.648105,0.0073070433,0.9033134849571065,0.0157668510852291
16023,SIDM00782,Taselisib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.44313,-0.041520912,-0.3507181725113237,-0.05524988932301935
99961,SIDM00146,Linsitinib,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,3.615866,0.15105322,3.465897595160399,0.17644385877014337
103773,SIDM00097,Venetoclax,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.4999268,-0.06753302,-1.2145222434674083,-0.05098447557767029
55504,SIDM00971,ZM447439,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.17266868,0.006888605,0.46721126742678837,-0.010400501083987233
52861,SIDM00411,OSI-027,Erlotinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,1.1300302,0.069284245,0.7285211120399512,0.049035907787635453
9868,SIDM00875,Lapatinib,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.79043275,-0.08435523,0.5151807813508098,0.016527134179376398
47163,SIDM00660,Afatinib,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,1.5384897,0.1445894,1.1064600173615033,0.0581156151579846
39007,SIDM00146,AZD7762,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.073891,0.10288093,-0.21101080549708534,0.06016181142619824
75321,SIDM00778,Linsitinib,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,69.0,-2.4588754,-0.09927583,-2.6887397182655097,-0.08505542833074324
79162,SIDM00834,Linsitinib,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,1.5879413,0.079830065,1.5693271330608176,0.09873930481468278
29921,SIDM00628,Linsitinib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,Black,51.0,-1.0819318,-0.07372952,0.2573347965960403,0.05125912606526574
2181,SIDM00878,PD173074,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,2.001962,0.14685112,1.089366551179479,0.084718408375386
83392,SIDM00531,SCH772984,Palbociclib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.1768818,0.2532678,-0.17477620548064138,0.025327332499997277
47046,SIDM00673,Docetaxel,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.8551651,-0.18745169,-1.3428902531031144,-0.028100243716007896
62241,SIDM01233,SB505124,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,0.5889061,0.02232367,-0.46095500525566335,-0.04561764420793438
29381,SIDM00529,Doramapimod,Taselisib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,0.20933945,0.006562531,0.3768527361471146,0.0032044379671468852
18393,SIDM00774,Pictilisib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.8266192,0.0084197065,-1.3268483111163725,0.012089919565244476
17258,SIDM00893,Doramapimod,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.0213629,0.04347017,-0.07426460119029808,0.026198452617976754
18959,SIDM00893,Camptothecin,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-5.048123,-0.33500358,-2.9078409490414883,-0.19482003642704207
380,SIDM00193,LGK974,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-1.4042861,-0.06932949,-0.5747226851926335,-0.01828484904428958
91738,SIDM00778,Camptothecin,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,69.0,-0.8567053,-0.043172818,-0.4466675480506786,-0.028391691021674194
46815,SIDM00878,Linsitinib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.9521133,0.06982425,0.17198277245938717,-0.01692596940210182
102855,SIDM00878,Crizotinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,0.75131196,0.07702511,0.6283507094932013,-0.023831046011747587
50909,SIDM00875,Taselisib,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6633505,0.07634036,0.4367291869775107,0.020630743623890505
44133,SIDM00193,Olaparib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.4768748,-0.06196112,-0.12088226279906912,0.02075223559404277
49487,SIDM00893,Uprosertib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.10286239,-0.0075795576,-1.251993798906691,-0.016157698631397755
30176,SIDM00971,Bortezomib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.6458015,-0.078906395,0.20140022486697665,0.05278511862239823
35415,SIDM00971,PD173074,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7359779,-0.03773707,-2.605204581066614,-0.04453841679463459
83504,SIDM00866,Nilotinib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.2243038,0.08606601,0.9045135027182364,0.1551454811983821
17567,SIDM00875,Palbociclib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8133864,0.027355207,0.5297439811236982,0.04074341990282935
84267,SIDM00529,Lapatinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,2.2410576,0.18544629,1.8494959385365974,0.1765025695904766
65392,SIDM00332,5-Fluorouracil,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5236807,0.09006287,0.8892866424657547,0.04588157796734028
73633,SIDM00359,Palbociclib,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6214918,-0.07846341,-1.1074820396405605,-0.03770696073373882
29733,SIDM00779,LGK974,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,4.318968,0.10539916,1.601057063106,0.11939042882587331
20268,SIDM00954,Camptothecin,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,1.3036737,0.03873227,1.4978554919362517,0.08096373461841617
22578,SIDM00529,Olaparib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-2.5785432,-0.048170704,-1.261793311235605,0.020819072543665846
53009,SIDM00774,BI-2536,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.79761946,-0.051469047,0.5446570986485445,0.11229144483189415
88815,SIDM00673,KU-55933,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,-3.5189254,-0.13517693,-0.6991802690935132,-0.010627517216739135
92109,SIDM00531,Gemcitabine,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.8075807,-0.199472,-2.5968098181323707,-0.14586021658473036
79788,SIDM00301,LGK974,Lapatinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-2.2735746,-0.16581658,-0.06982520885531929,0.012284951005893248
9674,SIDM00529,KU-55933,Taselisib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-0.7956825,-0.012584018,1.2413398685178414,0.031132365503551564
97758,SIDM00893,ZM447439,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.8987138,-0.19098349,-1.8571502464998977,-0.1104069700753912
81619,SIDM00954,Crizotinib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-0.6591983,-0.04407599,0.2365919380727971,0.02819515361169778
102728,SIDM00866,OSI-027,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-2.6367848,-0.15644506,-1.8540101689520123,-0.0757679561406275
97013,SIDM00893,Docetaxel,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-3.5354855,-0.24946707,-3.0163450521799593,-0.21730040010987609
4859,SIDM00778,Trametinib,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-1.4104534,-0.044838674,-0.116527952406082,0.024788527641168397
91545,SIDM00834,AZD7762,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,White,66.0,-0.6261387,-0.033745293,1.5026649828933227,0.08367514112768869
103,SIDM00774,Pictilisib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,0.18234436,0.0064823,-1.3500610503749286,-0.03352514257686066
100526,SIDM00130,Irinotecan,Linsitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.69726235,0.06329224,-0.39565984895666834,0.007496470166032559
16928,SIDM00146,Entinostat,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,2.6489859,0.19822389,-0.05032559409391481,0.07003626342338971
71260,SIDM00778,Camptothecin,Oxaliplatin,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,1.0599673,0.059511557,-1.2576574316791396,-0.06092235479506774
89547,SIDM00779,BMS-754807,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,33.0,-0.7102712,-0.011935396,-2.9581947721358532,-0.07402006670340679
8995,SIDM00866,Vorinostat,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,0.6123498,0.041524787,0.4038184213406846,0.006359249502974941
64857,SIDM00954,RO-3306,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.974122,-0.064577855,0.4964328530325358,0.032460305003927534
4316,SIDM00673,PF-4708671,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.164201,-0.113084204,-0.6943486044968207,0.005194886250827633
9608,SIDM00776,MK-1775,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-0.7775313,-0.03170355,-1.349504830763609,-0.053023742208554075
106848,SIDM00660,Palbociclib,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,2.5848298,0.14978173,1.6218774574592023,0.035898639182007315
106682,SIDM00878,PD173074,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-3.5666676,-0.23087695,-1.9988386172543902,-0.015654936853952493
102162,SIDM00146,Navitoclax,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,5.0657616,0.09866885,2.7746955403267015,0.04092234969708317
49442,SIDM00301,5-Fluorouracil,Ruxolitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.0582935,-0.14208788,-0.1606389692620704,-0.06488508377367103
24352,SIDM00628,AZD8055,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,1.5950452,0.089867584,0.4514193756476709,0.015293801415392338
86221,SIDM00097,PD173074,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.8968647,-0.10265612,0.4845713105058052,0.03742062220242614
69433,SIDM00097,Uprosertib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4757814,-0.096298896,-0.7910608201007134,-0.04677484195509682
107358,SIDM00954,5-Fluorouracil,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.71259826,-0.03010902,0.22137196468217557,0.032755393732473895
91775,SIDM00776,Linsitinib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,-1.90046,-0.08026938,1.8099162079411768,0.07008861154823906
67471,SIDM00146,Alisertib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.70355326,-0.05768085,0.5888495891716509,-0.011504757445197182
21194,SIDM00097,Entinostat,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0134858,0.059852567,0.16096195723653195,0.004554786532590322
11329,SIDM00130,Ruxolitinib,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.96370625,0.01756461,2.2759712158006233,0.026718862752090646
108303,SIDM00971,Alpelisib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7108328,-0.11424233,-0.11840849028363554,-0.014027365157592592
20262,SIDM00193,Dabrafenib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,53.0,-0.84001964,-0.01754518,0.9411575913296325,0.034167468733218485
77192,SIDM00776,Taselisib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.69480133,-0.062779054,-0.746834179349022,-0.0438977834257893
74534,SIDM00878,MK-1775,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.17864485,0.018039852,-1.0294050527506535,-0.07702935618116412
38122,SIDM00878,Afatinib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.9267892,0.16182901,0.7695296306949416,0.04908021647563709
45698,SIDM00332,Alisertib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.94386727,-0.049444877,-2.4831309276471685,-0.10642740763587141
19742,SIDM00301,Oxaliplatin,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,-0.727847,-0.09657906,-0.4570459668601009,-0.11592795709090908
46990,SIDM00893,BI-2536,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.382705,0.20396107,-0.08525156485119759,0.07233386458870188
47580,SIDM00359,Crizotinib,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.99568975,-0.06139238,-1.7140089215468186,-0.07644702538980457
96676,SIDM00130,Oxaliplatin,Sorafenib,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.0539764,0.0732708,-0.3042558719975016,-0.0029864703470241674
76886,SIDM00130,Oxaliplatin,Ruxolitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.53639936,-0.028950533,-1.9349867841640789,-0.06539952276967707
68852,SIDM00097,Sorafenib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8052317,-0.036364194,0.3736271128784312,0.028829868767683894
104825,SIDM00660,AZD7762,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,0.40154994,0.035925057,-0.5568536599492351,-0.042206526367743774
79740,SIDM00776,LGK974,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,3.6158676,0.19097759,0.6164646014267208,0.08811919103946095
36257,SIDM01233,MK-1775,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,0.94962025,0.054569464,-0.3332217525724002,0.016730424573386835
87190,SIDM00146,Luminespib,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.8622577,-0.07385922,-2.606146120716001,-0.12357116646284877
19266,SIDM00878,JQ1,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,70.0,1.3323289,0.1026798,1.3622879170361244,0.15268547232476384
56833,SIDM00146,Axitinib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.2261827,-0.077742286,-0.5139457634858553,-0.008621779334827757
80540,SIDM00146,AZD6482,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,1.4632368,0.10858577,0.10791606641765948,0.018743543259863004
78079,SIDM00301,Palbociclib,Linsitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,1.3644654,0.18906239,0.3206885644827941,0.006941535130725677
67156,SIDM00332,5-Fluorouracil,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5003135,-0.06394541,-0.11890478683077144,0.024907423696526192
106681,SIDM00332,Entinostat,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.6655633,0.083309576,1.9704195035306873,0.06899179309793396
40371,SIDM00875,Vorinostat,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0300069,0.0949766,1.4927248518750618,0.1149103048011402
20326,SIDM00531,Olaparib,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.9064348,0.12764904,0.9496838980120312,0.011475592688475892
3924,SIDM00893,Lapatinib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.78944975,-0.08341586,-0.2761213547436031,0.019044021314453482
46636,SIDM00529,Temozolomide,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,0.1487983,0.0029063765,0.0233545680152916,0.04646805506570071
19490,SIDM00776,AZD7762,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,65.0,2.2525182,0.1423998,-0.5139053833897027,-0.026247892487564678
79318,SIDM00531,Irinotecan,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.22598101,0.022713946,-0.523295001246382,-0.0064873730392296615
60799,SIDM00673,Doramapimod,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.0551031,0.024094347,1.7978726721361493,0.07614746361783262
10933,SIDM00774,MK-1775,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,0.7784153,0.07951325,-1.20227773783706,0.00799587584618888
4750,SIDM00774,Ribociclib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,-2.4021518,-0.04821232,0.1750561129314822,0.02567108966645891
62035,SIDM00628,Trametinib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,2.6622198,0.2444567,-1.3310473270792333,-0.05586661762171084
103947,SIDM00097,Docetaxel,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.8012028,-0.18855573,-2.715690052423083,-0.12085223121614794
40319,SIDM00782,MK-1775,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.21096048,-0.012318852,-0.4964287534264392,-0.02773431616068214
100152,SIDM00774,Temozolomide,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,48.0,0.30118778,0.007970081,0.04288657211541688,0.030836827301349637
79220,SIDM00359,Palbociclib,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.3924184,-0.08248301,-1.8369986104377092,-0.06442127770856945
79830,SIDM01233,AZD8055,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,72.0,-0.47407043,-0.038000613,-0.026627130922114387,-0.0012638402300565882
50243,SIDM00193,Taselisib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.652041,-0.11656436,-1.3300063061747407,-0.0659152170713356
60382,SIDM00778,Linsitinib,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,1.9523599,0.10314328,0.018367609512203606,0.013425747081068019
62810,SIDM01233,Palbociclib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,0.09222437,0.001949413,1.2723324946528336,0.06372469519492305
94324,SIDM00893,Sorafenib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.18546407,-0.017040526,-0.8474877977571972,-0.01933376811671131
100616,SIDM00782,Dabrafenib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.0199976,-0.019084578,0.5271173335408865,-0.0063113353323202915
52648,SIDM00954,Pictilisib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,1.9909941,0.14771606,0.3236872041061416,0.05942635307386515
51450,SIDM00097,Tozasertib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2485428,-0.04054491,1.5177735307195326,0.04683032165787289
38873,SIDM00776,AZD4547,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-0.68528664,-0.020518571,0.896278029962093,0.04413710060362311
22880,SIDM00332,Pictilisib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.85023713,-0.071670525,-0.3273840909572817,-0.02919123078544794
1114,SIDM00359,Trametinib,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.5339277,-0.10883123,-2.297324086021095,-0.04587974846404366
90919,SIDM01233,Nutlin-3a (-),BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,3.0651355,0.15976895,0.2537346939268507,0.08286455623270592
77141,SIDM00673,Bortezomib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.4921211,-0.028997354,-0.02511227490224318,-0.03718577196254701
102737,SIDM00774,AZD7762,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.7828295,-0.15774746,-1.0487356602841535,-0.06091177162762943
13784,SIDM00866,AZD8055,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,3.114626,0.13915075,2.136980420101683,0.10473381625801559
92432,SIDM00097,Tozasertib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.409734,-0.0703314,1.0304109466899485,0.024351619066545534
97279,SIDM00146,MK-2206,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.9761806,-0.084302545,-0.1387631964263453,0.007271995896956575
92934,SIDM00954,Olaparib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-1.7204335,-0.045378182,-0.19459605654696585,0.004950991004989382
56537,SIDM00954,Cisplatin,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,5.4831996,0.10953086,3.4345629448331336,0.14452905752862635
69977,SIDM00971,NU7441,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.27459452,-0.011402104,0.6277373914274216,0.002258698926980092
48734,SIDM00893,5-Fluorouracil,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.6037262,0.03376914,0.13390279376521014,0.04679819208410836
97358,SIDM00776,SCH772984,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.42317915,0.031004667,1.0759494489926773,0.08536652058686152
5778,SIDM00782,SCH772984,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-1.5632663,-0.12768033,-0.1591164951059208,-0.015483209458738613
87869,SIDM00875,Pictilisib,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.19092146,-0.02096941,-1.008363812503007,-0.052153378904775366
10038,SIDM00660,Vinorelbine,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,0.9405007,0.08178103,-0.41074404116959146,0.027480204071556665
83825,SIDM00875,Venetoclax,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.17446533,0.00394536,1.340892021941625,0.061652222584202346
35652,SIDM00971,MK-2206,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-4.0858855,-0.19625862,-0.8868399419244226,-0.0430490196891525
251,SIDM00301,SCH772984,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.58788395,0.07766265,-0.3965621541994127,-0.02256774185244761
52044,SIDM00673,Alisertib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.4219918,-0.04470783,-1.8426504464464935,-0.06589364150072823
95861,SIDM00301,Gemcitabine,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,50.0,-2.42593,-0.0787617,-3.1030952722411866,-0.10481843262070391
21816,SIDM00628,Olaparib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-3.5023093,-0.15660183,-1.1697907124063305,-0.05408630125535751
27932,SIDM00878,5-Fluorouracil,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.6991547,-0.112516545,-0.9770776240524507,-0.09193635671174523
57448,SIDM00866,KU-55933,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,52.0,-2.2534246,-0.08715432,-1.6529982716857499,-0.07854992378400752
99466,SIDM00097,Crizotinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5937814,-0.08348456,-0.8399242123588065,-0.07662003918008063
66955,SIDM00866,KU-55933,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,2.1841764,0.1036298,-0.3897860667123205,-0.033464718148734404
6324,SIDM00411,Navitoclax,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,43.0,-0.7981296,-0.040488515,0.0682285238691514,-0.0016270752082843491
62657,SIDM00774,Doramapimod,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.0458314,-0.072636195,0.17711947761882033,0.0876087072851756
68381,SIDM00673,Navitoclax,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-1.0754546,-0.07268162,1.5105918873674882,0.09230949137222709
102365,SIDM00301,OSI-027,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.0086397,-0.14053966,-0.5852281628828206,-0.030081509540565397
70040,SIDM00359,AZD4547,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.55119866,-0.03014044,-0.1409904773613333,-0.02844503990615052
68194,SIDM00782,Dabrafenib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,-1.2346061,-0.036356203,0.4475361658102995,0.007789271142115348
7246,SIDM00332,Palbociclib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.1649015,0.16184497,0.006187865194160236,-0.005472893876755596
87587,SIDM00332,JQ1,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.4804256,0.19526868,1.7459910423027112,0.057366077880420745
40363,SIDM00673,Ribociclib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.3032687,-0.07294856,-1.4436522441906527,-0.02675670137036378
74548,SIDM00875,5-Fluorouracil,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.10237387,0.011398602,-0.6841390273866399,-0.03875221399228358
19375,SIDM00954,BI-2536,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-2.8389332,-0.084735766,-1.173474538321979,-0.05697261010555012
59148,SIDM00971,Wee1 Inhibitor,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.8012998,0.10927993,0.775357110777906,0.042629361065293116
49271,SIDM00866,Nutlin-3a (-),Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.98728484,0.032164626,-0.8814676849840327,-0.015549770952482452
77288,SIDM00359,MK-1775,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-4.778653,-0.29925716,-3.551778616009633,-0.19188550336655183
108455,SIDM00146,SCH772984,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,-0.86444515,-0.07654365,0.6617574681890199,-0.008271772952444913
81325,SIDM00097,ZM447439,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9752133,-0.056927547,0.13300065747731235,0.0948714360062519
93905,SIDM00954,Nutlin-3a (-),Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,0.12881835,0.003084378,1.043503065736217,0.07390734205879092
6767,SIDM00411,Linsitinib,Dactolisib,Pancreas,0.0125,Pancreatic Carcinoma,Male,East Asian,43.0,1.9439782,0.118249856,1.7498878082615907,0.10904404911937154
100491,SIDM00893,Olaparib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.7046868,-0.052189175,-0.4364447741520679,0.001874889563771225
40346,SIDM00673,AZD6482,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.4933418,-0.08843275,-0.9064001758191653,-0.10963124851982321
9429,SIDM00866,Uprosertib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-1.5444167,-0.03880599,0.15157816528207246,-0.0042870059869938755
99406,SIDM00531,Palbociclib,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.1049007,-0.036854144,-0.9155417552876579,-0.023178071747844205
11252,SIDM00628,GSK269962A,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-1.2120882,-0.120301485,-1.4865677313600882,-0.03821118082432698
65198,SIDM00332,AZD8055,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3928771,-0.102272905,0.25406856827063645,0.010605927507263841
75797,SIDM00673,AZD8055,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.240547,-0.08952182,-1.1382240617890198,-0.05869143079804158
66867,SIDM00779,Afatinib,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,33.0,1.6476959,0.11775096,1.1770965838824312,0.08052781807557864
47419,SIDM00097,Palbociclib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.707212,-0.06679801,-0.8130364050795899,-0.0648453018428913
37302,SIDM00411,Palbociclib,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-3.1074967,-0.079297386,-0.1621126211641263,-0.008997511589713852
47144,SIDM00628,Gemcitabine,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,0.6154465,0.011333687,-0.8590176116082902,-0.07062388071004913
20251,SIDM00359,Olaparib,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.0255182,0.06258584,1.922171986101954,0.045779227174918516
70014,SIDM00531,Ruxolitinib,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.47074363,0.006356908,1.4541474971198662,0.02045704007858953
105339,SIDM00954,Palbociclib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-1.2197548,-0.05327787,0.30537801359374195,0.07245867310874642
75905,SIDM00954,Docetaxel,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,-1.168692,-0.09190594,-0.8351157362197377,-0.06295338414309705
77234,SIDM00628,Trametinib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,1.9611566,0.1928878,1.2457099346593457,0.12602231410277875
95271,SIDM00628,Crizotinib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-1.0246586,-0.09988121,-1.4889986029538065,-0.09989645470638124
78345,SIDM00130,Taselisib,Dactolisib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.11205345,-0.008463388,0.5070349256373595,0.06936943597684965
97963,SIDM00954,MK-1775,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,0.4779841,0.037156474,-2.017831173755047,-0.08641291229585572
73271,SIDM00097,PF-4708671,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.6871452,-0.08386819,-1.9621979733809674,-0.060801126648816387
81849,SIDM00878,Navitoclax,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,0.98857725,0.02128592,0.24685713470354362,0.02893251931504494
97477,SIDM00359,MK-1775,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.4696647,0.11063357,-0.22530388778348562,-0.0231741578608977
52908,SIDM00774,Trametinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.8602865,0.089782156,0.12725678213734196,-0.020086822603766468
73632,SIDM00673,Pictilisib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,0.6814511,0.05150109,-0.024525110290165957,0.05640933136965872
78868,SIDM00531,MK-2206,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,6.8260717,0.58680826,4.822650845129223,0.3050655948458703
82619,SIDM00359,Taselisib,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.8487836,-0.059187032,-0.18907962078216906,-0.00016158457769472346
42385,SIDM00332,Dabrafenib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.7046382,0.17102414,1.3106818152791737,0.04706023046803726
87891,SIDM00660,Olaparib,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,2.6148908,0.10694917,0.4768071230636717,0.0058691152041214865
28394,SIDM00782,Trametinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.5047937,0.04045099,0.585744049857932,0.0189453651164633
52799,SIDM00878,Alisertib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-2.1157722,-0.16439816,-0.4927550129385627,-0.08381938572134036
82613,SIDM00097,Bortezomib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9903312,0.046405233,1.2735745701763532,0.058167992384059126
31882,SIDM00875,Entinostat,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.41565192,-0.040256213,-1.1569657903836563,-0.08811412802416552
12751,SIDM00778,Oxaliplatin,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,-3.1500685,-0.06934825,-1.763212304787476,-0.041045392253759326
107071,SIDM00301,Lapatinib,Ruxolitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,1.8396419,0.13275291,2.0742447500140213,0.0794770624371293
92531,SIDM00529,5-Fluorouracil,PD173074,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.6147615,0.16075838,-1.1993870048328787,-0.05483849618522956
93852,SIDM00834,AZD7762,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,0.98933065,0.037988983,1.8740785689966777,0.06723319542078786
50721,SIDM00301,Dactolisib,Oxaliplatin,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-3.894134,-0.22244118,-1.074821675819732,-0.09802306217036695
43605,SIDM00529,Taselisib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,0.23827152,0.0059920168,-0.8685151116518013,-0.02476204578209646
2695,SIDM00875,BI-2536,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-3.90126,-0.07609839,-4.815610532314265,-0.13890602543763855
108451,SIDM00971,Gemcitabine,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.82898,-0.08660463,-0.36119982665384676,-0.003512826763283697
98057,SIDM00971,PD173074,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.7646651,-0.017981019,-1.1688720958182668,-0.0077741737605816
7064,SIDM00097,PF-4708671,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5863137,-0.08177141,-1.0176042197385204,-0.04616164209306515
52516,SIDM00673,SCH772984,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-4.3707547,-0.26860172,-2.455096207662507,-0.11179340463904985
92459,SIDM00893,Alpelisib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.26852852,-0.022778502,0.29444249613877305,0.026654252659724095
10912,SIDM00628,OSI-027,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,2.4576077,0.1985989,1.079713996006453,0.10152829693756325
84856,SIDM00146,MK-2206,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.1478039,0.07877314,4.2544028182143405,0.3145637206165086
37142,SIDM00332,Afatinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,3.5287771,0.23798181,1.531847519213978,0.1191936351256755
92266,SIDM00673,RO-3306,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.4089313,-0.12578593,-1.1597312321035818,-0.04554397388273821
73959,SIDM00834,BMS-754807,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,0.7789347,0.06549739,-0.016721256942160458,0.03748663030146476
25456,SIDM00774,Alpelisib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.8293085,0.12519866,0.23673695296005604,0.05575207595441047
30416,SIDM00529,ZM447439,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,1.506583,0.12485406,1.6213907283417428,0.15620200477669566
43704,SIDM00146,SCH772984,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,2.0108695,0.15908735,2.261659011613919,0.10375486955408081
76226,SIDM00531,Crizotinib,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.4669738,-0.12522462,-1.132380348811642,-0.06037866676346947
17095,SIDM00097,Paclitaxel,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9794589,-0.1060648,-0.06276503434868723,-0.0409559823633593
56692,SIDM00130,Crizotinib,Linsitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.3007643,0.12365548,0.06912326921349717,0.07444075180057406
21595,SIDM00878,AZD6482,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-2.6727886,-0.13853244,-0.8563228803858297,-0.07905088595174048
105630,SIDM00875,Olaparib,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.0040071527,-0.00036179757,0.3621359135858204,-0.014414068116495114
62063,SIDM00359,Dabrafenib,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.4494026,0.14126706,0.8438713607408853,0.022197958643937858
25916,SIDM00531,LGK974,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.93098825,-0.08668439,-1.414021229214093,-0.036998036225714015
4519,SIDM00893,Nilotinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.2783679,0.09531096,1.0194140700014982,0.05774433840440647
14725,SIDM00971,PF-4708671,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.33264944,0.02075354,-1.9476080436576535,-0.09747529195897986
21798,SIDM00866,Docetaxel,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-3.955577,-0.15954815,-2.8622633442640004,-0.10282914900708498
98046,SIDM00359,Trametinib,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.588317,0.034502417,1.3994240191260028,0.030504966846307678
215,SIDM00359,MK-2206,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0205238,0.059690267,0.3983701136678001,0.04082233889192599
42861,SIDM00779,Navitoclax,LGK974,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,0.5148321,0.01731976,-0.045671105361585126,-0.009256856958472606
101523,SIDM00893,Dabrafenib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.4682767,0.11052521,0.7345259781197243,0.04498058899312067
51914,SIDM00878,Nilotinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-1.4230423,-0.11023385,-0.6873970784175123,0.031272660678980144
88073,SIDM00146,5-Fluorouracil,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.7642406,-0.04598059,-1.431765383478592,-0.06057217646880002
90677,SIDM00971,Ribociclib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.8689866,-0.07127415,-1.7762064630334837,-0.02227706994676868
69969,SIDM00893,Palbociclib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.6594193,0.07821118,1.076843952397958,0.06963815343036203
37517,SIDM00878,Alpelisib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,-0.35628167,-0.028160814,-0.5598131404890895,0.0015684295343342076
75397,SIDM00529,Temozolomide,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.5690318,-0.012014186,-0.40703072283433,0.017484243057862465
15804,SIDM00529,Nilotinib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,1.539529,0.0695431,0.6398766279538698,0.12075477634678362
18668,SIDM00893,Temozolomide,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.1558821,0.028975764,0.8714729066932871,0.03709302371117639
101640,SIDM00673,Pictilisib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.16500875,-0.015944317,-0.6257971439735109,-0.03418119522015708
29793,SIDM00130,SCH772984,MK-1775,Pancreas,0.2,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.4795643,0.13762558,-0.04805824007478779,-0.017315182380521797
2533,SIDM00774,Temozolomide,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,2.297455,0.02340528,1.4664519130542863,0.03150452433968184
39271,SIDM00332,5-Fluorouracil,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,3.4630973,0.2596466,1.8674658086069693,0.11290217109661183
43597,SIDM00774,Paclitaxel,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.7010812,0.09295347,1.0412770663768125,0.07782083722625995
86529,SIDM00673,SCH772984,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.5726073,-0.18237042,0.3400447424128114,0.028027882106915904
41,SIDM00146,MK-2206,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.1632464,0.16897254,1.0332023571259819,0.15273390687196758
57474,SIDM00301,Navitoclax,Ruxolitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-2.9754796,-0.23218732,-0.2243249531018021,-0.03890435905474451
45878,SIDM00529,Afatinib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Black,44.0,1.2369926,0.09779709,-0.9255840908459916,-0.017698742270558
79039,SIDM00628,Venetoclax,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,0.75139517,0.044707667,-1.4006626703006255,-0.05158190416079861
37056,SIDM00660,Vinorelbine,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,5.1551204,0.41866812,2.4898922907304857,0.16772383514534034
66473,SIDM00954,Vorinostat,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,0.5772926,0.039263755,-0.4195331764920619,-0.027395832919571865
62566,SIDM00774,AZD6482,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-2.5333273,-0.12662087,-0.2475033070213909,-0.001131736200980701
44184,SIDM00954,AZD7762,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-1.4907507,-0.116566435,-0.5477719505744291,-0.05066061116781524
62330,SIDM00866,Axitinib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.43929347,-0.026883963,0.6907360709664502,0.05550187580033214
52682,SIDM00834,AZD7762,AZD4547,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-1.5871136,-0.0807603,-0.797989072079832,-0.05273873559988489
84,SIDM00954,Ribociclib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,4.521919,0.1314442,0.39560785789326364,0.06184705331661706
80938,SIDM00971,Doramapimod,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.805376,0.07505449,0.8513808853945608,0.04018940080816375
84216,SIDM00660,Oxaliplatin,AZD4547,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-1.0355635,-0.106098965,-0.6491236193358332,-0.07414967855466323
25827,SIDM00673,ZM447439,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.82177645,0.058213763,0.8661965985184242,0.053851620387942105
76983,SIDM00878,AZD6482,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.7619793,-0.050324008,-0.9912473595856859,-0.05001203325651993
35531,SIDM00971,Luminespib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.93799365,-0.048462804,0.5672591814280259,-0.00987573473754047
16477,SIDM00971,OSI-027,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.37357682,0.020475492,0.381869819999237,0.0207166618759166
39168,SIDM00834,5-Fluorouracil,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,1.5493827,0.106826305,-1.0137090281075087,-0.021283296452493224
32690,SIDM00776,5-Fluorouracil,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.7108489,-0.05895746,1.516681490812251,0.033480275479321295
14326,SIDM00146,Alpelisib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.71330804,0.04047785,-0.40464879540906756,0.054758957417325546
55514,SIDM00954,JQ1,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.0,-0.7976156,-0.059562385,0.2385179536687203,0.02905553668520821
57922,SIDM00301,SCH772984,5-Fluorouracil,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.5632982,-0.16251276,-2.1771602109747623,-0.09476693415687672
5564,SIDM00778,Palbociclib,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,-1.5721784,-0.029424094,0.1334460626197317,0.02663064745338663
48507,SIDM00628,KU-55933,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,0.84740156,0.053293847,-2.405527716214283,-0.0841580221029954
56183,SIDM00779,LGK974,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,33.0,1.114677,0.04337921,0.35461173363628595,0.06623473179758801
10852,SIDM00893,BI-2536,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.5790156,0.1409843,0.8081011780728229,0.13006065244120618
47178,SIDM00774,Uprosertib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.5604166,-0.11008946,-0.29213688282281913,-0.02901271248643392
20726,SIDM00875,AZD8055,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.439529,0.0473233,0.22096352636913244,0.0004077991582562109
83826,SIDM00660,Camptothecin,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,32.0,2.1364903,0.16519198,-0.2056439790161085,0.028295015006607926
93302,SIDM00774,Luminespib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-0.11658284,-0.008465878,-0.5308914856498679,-0.04534321403459223
7890,SIDM00875,AZD8055,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2749704,-0.028915863,-0.46180817769491783,-0.031765799535814716
35405,SIDM00878,Afatinib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.142809,0.013456985,-0.11526972810102083,-0.043178090587118044
104347,SIDM00878,Linsitinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,4.445942,0.36096764,1.0063870041795395,0.046083193311063045
87565,SIDM00971,AZD6482,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.6907842,-0.044585973,-0.33651818173041925,-0.014192641866737568
13709,SIDM00834,MK-1775,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-1.5624903,-0.12695318,-1.8674976666660101,-0.07249659742567462
76894,SIDM00130,Crizotinib,Olaparib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.4839889,0.043131456,-0.38148614300175343,-0.021524793937138947
36051,SIDM00193,Camptothecin,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,1.0406098,0.044285323,1.4305320321838497,0.050077984921777466
37841,SIDM00301,Gemcitabine,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.2444743,-0.08450643,-2.283775847235052,-0.10041785656533044
108082,SIDM00834,SB505124,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,White,66.0,1.457548,0.05285535,-1.3911445010156651,-0.03785155213063433
52145,SIDM00673,Sorafenib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-0.3829359,-0.024715127,-0.8841427731394701,-0.010235094460562973
16848,SIDM00875,Nilotinib,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5758995,0.17427263,0.9155724223137655,0.07994186405689063
79031,SIDM00875,Tozasertib,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.073261,0.07630294,1.233215733317173,0.015346188345720251
46551,SIDM00529,Nutlin-3a (-),Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-1.9949743,-0.06489878,-0.7858255004242688,-0.0034860700964485067
51805,SIDM00878,Paclitaxel,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,1.9882764,0.15006384,0.6104125742662355,0.046659190562711124
48122,SIDM00097,5-Fluorouracil,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.190419,-0.12755887,-1.6993709499393899,-0.08515382640355403
75120,SIDM00673,Luminespib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.3366293,-0.110337384,-0.887434928623533,-0.05244828677364094
48225,SIDM00673,AZD6482,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.3980299,-0.1078366,-0.5265053514921831,0.007754015890360357
105562,SIDM00301,LGK974,Oxaliplatin,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.6211495,-0.1006685,-2.03785051811697,-0.07280489788458457
25462,SIDM00097,Navitoclax,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.79295117,0.046436712,1.5705676874202135,0.11943154290197357
84088,SIDM00779,Camptothecin,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,1.5313282,0.058169365,1.4120527626947186,0.025194058380924353
67445,SIDM00301,Ruxolitinib,Sorafenib,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.0437217,0.013420435,0.8363722678721358,0.024336000902217512
32712,SIDM00673,Cisplatin,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,0.9920822,0.02817683,1.1928196748647049,0.057586652133027424
7428,SIDM00875,Axitinib,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3301063,0.03641955,-0.8230046691404781,-0.05305213795871792
54094,SIDM00875,Cisplatin,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3680911,-0.014408331,-0.9069186110515252,0.012752894782971626
59272,SIDM00866,5-Fluorouracil,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.5362684,-0.058541816,-1.331370545319173,-0.030841185723276886
38847,SIDM00411,Dasatinib,Gemcitabine,Pancreas,0.1,Pancreatic Carcinoma,Male,East Asian,43.0,-1.3161795,-0.054325912,0.9439647799363343,-0.005084794133491326
105087,SIDM00776,Navitoclax,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,0.6828686,0.03435347,1.5077464786188093,0.06662979272642766
4057,SIDM00774,5-Fluorouracil,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,2.9646268,0.036569737,-0.11151091735732702,0.061525831018578774
24602,SIDM00301,Trametinib,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.2665882,-0.13226876,-1.4583612875306653,-0.07200666596242059
89708,SIDM00774,5-Fluorouracil,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.5228266,0.059544228,-1.1523807500450998,-0.049426531989312815
104141,SIDM00971,MK-2206,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.2104077,-0.14634827,-0.49537132036179155,-0.027758501103222227
10282,SIDM00628,Lapatinib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,0.39469624,0.019479176,-0.2101192408676777,0.025440861640229816
28210,SIDM00971,SCH772984,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.9860736,0.02227405,0.30677081240334203,0.05499817900701277
39833,SIDM00893,OSI-027,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.6816674,0.16811116,-0.4216664293147945,-0.005492756152430623
10533,SIDM00954,Cisplatin,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-0.3722408,-0.011816547,-0.7930747849103891,0.018691968336849878
58439,SIDM00193,Palbociclib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-2.3142886,-0.060619287,0.785696655476242,0.0740885259201975
23872,SIDM00097,Ribociclib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.9374275,0.09559073,-0.9085518838150017,-0.015565879562734159
2089,SIDM00866,Sorafenib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,1.998135,0.1109239,1.692884498534315,0.05338570828032158
45521,SIDM00954,Nilotinib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-0.53337073,-0.04037017,1.465371211405058,0.1375116151681133
46116,SIDM00893,Linsitinib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.6482882,-0.07507225,-1.2421579962386164,-0.02139179478885164
13628,SIDM00778,AZD4547,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-2.5171652,-0.065628715,-1.8699032395841784,-0.06834351192415013
106898,SIDM00971,Dabrafenib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.1000878,0.025686195,0.2563282827435811,-0.0044513415780001045
17405,SIDM00776,LGK974,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-2.2708035,-0.08180908,-1.1776744772598353,-0.00941844209816441
97117,SIDM00193,LGK974,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,53.0,-0.85717005,-0.04923772,-0.7546157736733259,0.007583517337016248
37123,SIDM00866,NU7441,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-0.65150744,-0.04783768,-0.6667735846432353,0.018683309245446526
16450,SIDM00954,Axitinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.1900786,-0.05384532,0.05064471414066621,0.06504065507500734
52886,SIDM00878,AZD8055,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-1.4561197,-0.13383596,-1.150410287980562,-0.06025946316733653
101386,SIDM00628,AZD7762,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-0.4085621,-0.034092274,-1.0578047028540372,-0.021999990202366777
38587,SIDM00529,JQ1,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.4230702,0.031242032,0.20146464355967225,0.03141374456325288
75558,SIDM00782,AZD7762,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.71386117,-0.038515944,-0.5896018094727503,-0.013451486690130056
67359,SIDM00529,Trametinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-2.9863846,-0.14800182,-2.9929543006268196,-0.14088223608929096
55478,SIDM00893,Dabrafenib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.1077726,-0.027541377,0.17768651219661075,0.022416033211380373
95840,SIDM00660,LGK974,Vinorelbine,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,32.0,0.4606215,0.025628805,0.5429420221776637,0.05169211113977091
12475,SIDM00130,LGK974,Ruxolitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.9630535,0.07504114,-1.2132316812751758,-0.027514610516581366
92874,SIDM00893,Paclitaxel,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.7879544,0.056385458,-0.5470445275800037,-0.016613985687798774
83847,SIDM00778,BMS-754807,Navitoclax,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,1.3501637,0.08639299,2.977839493452368,0.1254732941988176
30515,SIDM00834,Afatinib,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,2.6046526,0.10182221,-0.4018061494726695,0.01808435230549657
15459,SIDM00097,Dabrafenib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4237791,-0.051364884,-0.3231253859047615,-0.035655549216124176
58133,SIDM00660,SCH772984,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,2.8566966,0.07255432,1.7697371460494022,0.0689806595760495
90070,SIDM00878,Uprosertib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-1.0556464,-0.045743346,-1.1255867125805104,-0.004967121348772597
17384,SIDM00954,GSK269962A,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,2.8500834,0.13545199,1.5867521208851267,0.13865914393789794
2575,SIDM00660,SB505124,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,0.60931003,0.06620263,0.8878384710875082,0.030072639032473352
29841,SIDM00971,Luminespib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.0261695,-0.06442152,-1.2747098667303964,0.008256406155436578
68862,SIDM00673,BI-2536,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.315087,-0.0241421,-0.18029635649874357,-0.006506862425751402
103410,SIDM00193,Linsitinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,0.9721453,0.035422664,2.085178655824999,0.07882483237514341
21358,SIDM00673,Linsitinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.819655,0.017411951,2.44044415458223,0.11489231969158013
1335,SIDM00893,Wee1 Inhibitor,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.46337122,-0.038720794,-1.065322841789437,-0.08980345725835674
44468,SIDM00878,5-Fluorouracil,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-2.1794832,-0.12937406,-2.0596594235420436,-0.0985913659389161
90926,SIDM00893,Dabrafenib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.4166234,0.047691192,1.405100176444318,0.09201383338165844
101477,SIDM00529,MK-2206,Axitinib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.737911,-0.05247174,0.6370851472012196,0.04603074899403155
36732,SIDM00529,Trametinib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.4644227,-0.030011727,-1.0848628669624814,-0.0018668968292935037
60636,SIDM00130,Oxaliplatin,AZD7762,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.0113505,-0.048558198,-1.5150673786287538,-0.04902312251267661
9967,SIDM00531,Erlotinib,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.7455897,0.0918909,0.8777335926182471,0.08728829598666571
6882,SIDM00097,Uprosertib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.37040287,0.025382368,0.06026443739498488,0.007874663228274778
61010,SIDM00875,MK-1775,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1101468,-0.078784704,-2.3259900752449534,-0.12815566501787284
15849,SIDM00332,AZD7762,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1615102,-0.114129804,-0.5626200921986841,-0.03493265892990076
36664,SIDM00529,Afatinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-1.1521574,-0.06718749,-0.7501670609321315,-0.055896332990486054
87241,SIDM00411,Lapatinib,Palbociclib,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.7765055,0.11652716,1.7147610538098987,0.14539119969522618
72040,SIDM00866,Paclitaxel,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.2894957,-0.020905409,-0.4326432641002686,0.005319291519546534
103531,SIDM00878,MK-1775,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-0.3017568,-0.032327842,-0.562579453108113,-0.02432654232310992
52152,SIDM00776,LGK974,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-3.0141878,-0.09886708,-1.364308384067292,0.016308900689597384
88273,SIDM00628,Venetoclax,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,0.6833265,0.03909836,-0.9386448952765633,0.002847309869151673
76097,SIDM00971,Uprosertib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.1885378,0.20134929,0.2887762896890441,0.06738903595260727
41829,SIDM00301,MK-1775,SCH772984,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.38779736,0.034927905,-0.13998951995195447,-0.04604816601618614
33269,SIDM00628,Pictilisib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,3.9781234,0.26543537,0.3159131248934676,0.09351026725215687
108477,SIDM00779,Olaparib,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,2.3816488,0.022420496,2.2513446109343205,0.041986882500545226
32305,SIDM00779,Camptothecin,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,1.0755773,0.07093554,1.1772419467520878,0.08830391619735001
94042,SIDM00774,PF-4708671,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,-0.8488428,-0.042111244,-2.062907060725729,-0.06874720268142465
46694,SIDM00878,Venetoclax,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.9859533,0.03904753,0.5157701733381121,0.04579421147516566
44765,SIDM00878,Linsitinib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,70.0,2.19026,0.19176577,0.23370952401358533,0.07119881633571368
11405,SIDM00866,PF-4708671,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.793995,-0.039806582,-0.6552195469241753,0.0056779594395011184
66873,SIDM00660,Navitoclax,5-Fluorouracil,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,0.79998237,0.083714046,1.1846727807282318,0.048711208406181525
12216,SIDM00878,SCH772984,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-1.5559179,-0.11725504,-1.5640383414563628,-0.10765116733666848
100665,SIDM00097,Navitoclax,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.5512269,0.10352699,1.4229657086323144,0.07544584761838076
16055,SIDM00146,Lapatinib,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,0.22050671,0.020363472,0.3683803945388983,0.035036345500713294
38794,SIDM00130,Cisplatin,5-Fluorouracil,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.91952085,-0.054226197,-1.3676082533870524,-0.024229797659758676
10352,SIDM00660,MK-2206,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,1.812786,0.12687035,1.2703425522718494,0.05596174607792007
88310,SIDM00628,Bortezomib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.02634904,-0.0016362742,-0.54965619303702,-0.017243772105139936
64528,SIDM00660,LGK974,Oxaliplatin,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,-1.307855,-0.0574874,0.1603344379033883,0.018202011207759824
52215,SIDM00875,KU-55933,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4847134,-0.05738851,-0.29073373189825785,-0.012698762119989458
61242,SIDM00097,MK-2206,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3922281,-0.114450835,1.0860476967157997,0.037919416228058056
73086,SIDM00893,Nutlin-3a (-),Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.8639973,0.019729126,2.0273261790923733,0.06784596901093991
47892,SIDM00774,Temozolomide,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,0.13486378,0.0033171386,-0.07690994176781014,0.012095725051188104
3196,SIDM00782,Nutlin-3a (-),BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,Unknown,72.0,-0.42040902,-0.008447961,3.250483361631589,0.13436010525920858
67127,SIDM00332,Luminespib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6103123,-0.07154327,-0.36056830802734735,-0.08450759332543424
54631,SIDM00866,NU7441,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.81464833,-0.05220306,1.2755927633520114,0.11480053304032366
56711,SIDM00776,Crizotinib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,1.0032694,0.076422065,0.531871734734122,0.06349951098624726
24125,SIDM00878,BI-2536,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.537854,-0.00964429,3.0463980998871207,0.11212509342033763
87757,SIDM00673,Cisplatin,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.14756809,0.00530526,0.017586326097035896,0.05251221383574165
96654,SIDM00411,Crizotinib,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.3531588,-0.07036342,1.069503072580257,0.07081764149451873
84753,SIDM00531,Dasatinib,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.1169653,0.22748388,3.3866061777937437,0.20119890002682725
93251,SIDM00193,Camptothecin,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,2.1995516,0.11957969,2.1599886173151344,0.09087808709214511
83984,SIDM00875,SCH772984,Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.28616607,0.033242226,2.4869825561471597,0.1678386394535557
63045,SIDM00776,Crizotinib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,65.0,-0.60198236,-0.03391814,-0.2515695724012186,0.015005408528284777
24457,SIDM00359,Vinorelbine,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.7792728,0.21570563,-0.6175899282255205,0.05170867538700931
8443,SIDM00774,ZM447439,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,-1.139058,-0.0645556,0.25028429020784065,0.017523879076765666
39127,SIDM00673,Camptothecin,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.396999,0.057113875,2.836153878513736,0.13735402828709686
41913,SIDM00193,MK-1775,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.46040687,0.040050466,-0.2755524132799993,-0.025664948023212147
18488,SIDM00332,JQ1,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7899666,-0.054983284,-0.264649973715815,-0.008027539021344616
67614,SIDM01233,Camptothecin,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-0.9089142,-0.028588748,0.7068900759299931,0.03311325492350497
8731,SIDM00878,Crizotinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.6890873,0.05055585,1.204121988378008,-0.008297569643075157
36651,SIDM00146,Vorinostat,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,0.42615947,0.03862654,-0.8133504901001085,-0.052158716549603835
10452,SIDM00875,Camptothecin,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.9063964,0.24373727,2.703935410580199,0.16115048052865627
892,SIDM00332,Gemcitabine,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.949584,0.15165997,2.9490942991804583,0.15940537444725347
98441,SIDM00332,Axitinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,5.049229,0.25662243,2.2220060787197773,0.10504456317458201
96377,SIDM00193,Linsitinib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,1.6982536,0.07014886,1.12311316449372,0.06013577427817412
76969,SIDM00954,Nilotinib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.31568986,0.02713124,0.2441681790856861,0.015610132614704682
37178,SIDM00146,Tozasertib,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.5870947,0.108264595,1.2245328935730788,0.11914540145163453
104194,SIDM00359,AZD7762,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.3003192,0.11528667,-0.07096442784799266,0.07989970260078438
106897,SIDM00673,Vorinostat,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.6513157,0.05419051,0.9746125127901117,0.05492074605502322
60739,SIDM00878,OSI-027,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.9745469,0.046135485,2.25846186644458,0.11107861477055231
36911,SIDM00531,5-Fluorouracil,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.38364205,-0.012160452,0.1596573151781278,0.016438424945425602
90127,SIDM00146,Docetaxel,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-2.787584,-0.24817927,-3.565716694735661,-0.2630476924647527
100691,SIDM00531,Dasatinib,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.8341652,0.20656672,-0.22741368513050847,-0.012695585397665077
69943,SIDM00130,5-Fluorouracil,Palbociclib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-3.2824106,-0.24518485,-2.2901998629307494,-0.1569264827023987
62200,SIDM01233,Trametinib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,72.0,-1.3907636,-0.10801704,0.5093715307867531,0.014564456864304373
20026,SIDM00411,Palbociclib,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,1.6214563,0.061282735,1.3748174008889704,0.0797434857659236
10155,SIDM00954,Taselisib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-4.736279,-0.21099462,-1.4514638096642012,-0.09565069288952723
1615,SIDM00878,Temozolomide,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,0.9494676,0.032403834,0.08003061287330837,0.014411509932127146
71816,SIDM00875,GSK269962A,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.6455305,0.3241586,0.1292473593420408,-0.00909972113074042
88879,SIDM00628,Lapatinib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.9611957,-0.08670814,-0.5598692245673447,-0.012521694252382642
36268,SIDM01233,AZD7762,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,2.634417,0.08792749,1.7260983799025185,0.05680538770512678
77723,SIDM00875,Paclitaxel,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.6199076,-0.17415419,-3.250733513419356,-0.1401182099943091
69353,SIDM00193,SB505124,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.3938164,-0.031866677,-0.7065769645492928,-0.08376911347918282
24933,SIDM00359,Palbociclib,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.5027726,-0.05733413,-0.3124269146398332,0.03677309934421578
17535,SIDM00878,AZD8055,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,70.0,-2.1260767,-0.19016881,-0.4116798664567513,-0.07942110781015646
100976,SIDM00866,Gemcitabine,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,52.0,3.1111913,0.23991567,3.3599340928037966,0.22494476183052542
69249,SIDM00673,AZD6482,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.7267158,-0.13653493,-0.9173389048884221,-0.05763493483239016
104695,SIDM00878,Wee1 Inhibitor,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.49841046,0.041806415,0.13558301406330084,-0.03465169953687582
56449,SIDM00954,OSI-027,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-2.6526437,-0.095813006,0.5057723273966099,0.05773861295502188
36218,SIDM00628,Taselisib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.19813332,-0.017912488,0.6664344124125522,0.09192900977033357
43792,SIDM00971,Trametinib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.2326286,-0.018193249,-0.7542266181282217,-0.034798898433904754
21256,SIDM00359,AZD7762,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.99597,-0.093018346,-1.5588426964027662,-0.05903815874206092
85095,SIDM00875,Palbociclib,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4133605,0.024302328,0.45723003503656867,0.014205175606609768
69866,SIDM00954,Luminespib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.0755159,-0.07937705,-0.49403989909289187,-0.028525369558773262
53204,SIDM00332,AZD7762,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,1.6162256,0.1651591,0.19067749834589703,0.019709337434400127
88168,SIDM00774,Luminespib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,1.4890817,0.060241003,-0.13953434340690316,0.009336370115746706
59183,SIDM00097,Wee1 Inhibitor,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1996818,-0.067504644,-1.0035399314382276,-0.06520209605111664
15555,SIDM00146,Olaparib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.7835836,-0.072877444,0.38538119417154726,0.04321991240502223
19505,SIDM00097,AZD7762,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.3032255,-0.11002038,-1.025526849338698,-0.057541614590203835
89572,SIDM00776,Vinorelbine,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.3132311,-0.07981433,0.34294389690142624,0.04872192258210804
25087,SIDM00673,Docetaxel,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.4521699,-0.14783928,-2.1161984307071844,-0.24336343755863488
71283,SIDM00628,Gemcitabine,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,0.96547186,0.020502893,-0.8040125539252815,0.0026365681562142713
67787,SIDM00954,Tozasertib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-3.1131306,-0.17621145,-1.3035516386742108,-0.0542986605857444
15074,SIDM00097,Lapatinib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.601228,-0.1514615,-0.43662158404245266,0.01358026130091019
32034,SIDM00529,Venetoclax,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,3.3985987,0.1696794,1.107637485333303,0.029442629777760288
51232,SIDM00332,Axitinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.75780064,-0.080406286,-1.2812032915476925,-0.12388958765618231
40991,SIDM00878,Ribociclib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-3.0609236,-0.12354171,-1.9733935246059016,-0.059541987696509556
24587,SIDM00875,Camptothecin,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.48277307,0.051066127,-0.4318935616363908,0.02355738725883408
9373,SIDM00359,Crizotinib,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0526242,0.062732115,-2.5648561141524455,-0.08497734968865249
35398,SIDM00531,Palbociclib,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.6522105,0.21283193,0.07121421893368257,0.010469615915761316
8125,SIDM00301,LGK974,MK-1775,Pancreas,0.2,Pancreatic Carcinoma,Male,East Asian,50.0,1.6487379,0.17351466,-0.23556346891920488,0.001078424772945696
9141,SIDM00971,Paclitaxel,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.3750794,-0.061709594,1.6312735108066134,0.12664408568176236
46840,SIDM00954,OSI-027,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,-1.855884,-0.12104385,-0.5054712699518039,-0.08439577252735161
91963,SIDM00411,Dasatinib,Navitoclax,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.3480996,-0.022385228,2.2596733987790474,0.10730657008037395
75936,SIDM00332,Taselisib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.524026,-0.15937392,-0.47575179251757244,-0.11624256331319513
16949,SIDM00834,AZD4547,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,1.8196757,0.055636343,1.9137678107739466,0.060004460942322306
39975,SIDM00878,Dabrafenib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,2.0447059,0.08113575,1.2739940078974403,0.05556056763039856
75441,SIDM00628,Crizotinib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-1.7728993,-0.1586901,-1.3597850533268945,-0.07907039780266813
27232,SIDM00971,MK-1775,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.3304062,-0.06405108,-0.23552324468349917,-0.0007417267013551358
11655,SIDM00971,BI-2536,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.3361266,-0.102344215,-1.4478075442863683,-0.008389744332104132
103180,SIDM00893,BI-2536,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.4475594,-0.20328945,-1.5358029364529158,-0.08031618611051698
60657,SIDM00893,PD173074,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.8228478,-0.019569708,1.040668687765954,0.08825592859621698
56827,SIDM00878,Vorinostat,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-0.23634656,-0.02546423,-0.3232046140076877,-0.03760489885617335
7086,SIDM00146,Pictilisib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.7362439,0.058897134,-0.752376478155923,-0.09808777913152177
32848,SIDM00878,Ribociclib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,70.0,-2.0040224,-0.090176664,-0.8474310396525792,-0.0428311007262729
11103,SIDM00774,RO-3306,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,1.6253616,0.10633965,0.5968624838101081,0.01259011321470121
54627,SIDM00531,Linsitinib,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.9140613,-0.03277622,2.0637874008265342,0.1263733138468972
81800,SIDM00673,Uprosertib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-3.772219,-0.18722533,-1.9065730258674658,-0.12057378488128465
106287,SIDM00529,Dabrafenib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,2.5723553,0.07352921,2.262825550982345,0.032368881483870064
91766,SIDM00332,GSK269962A,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.3018916,0.20237441,2.194311203696585,0.1373313673577793
66375,SIDM00971,SCH772984,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.46467575,0.009989925,0.5574315136987127,-0.0003727186903388042
82748,SIDM00878,AZD8055,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.5891241,0.11908949,-0.5860855626002476,-0.05262718360854085
83386,SIDM00782,MK-1775,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,-0.23193471,-0.0138871,1.191228097035882,0.03885131694717414
55853,SIDM00875,Afatinib,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4922982,-0.13194807,-0.6131006446453695,-0.07632257766244019
39232,SIDM00332,MK-2206,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9059003,-0.096539654,-1.2219539366406829,-0.09010247009779872
65896,SIDM00778,Linsitinib,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,2.438885,0.119369484,0.6244146994360142,0.09765911986478949
48336,SIDM00954,Alisertib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,5.9247613,0.11688592,4.741660363815858,0.3045134239442182
6248,SIDM00954,Uprosertib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.7365185,0.010222702,2.070946858929003,0.04554863337696071
86747,SIDM00776,SCH772984,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-1.12469,-0.053280845,0.294500183513658,0.021161065142147096
24074,SIDM00359,MK-1775,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.5582158,-0.042013053,-1.7843819928778617,-0.07698029042631013
60050,SIDM00866,Afatinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-2.070129,-0.14093956,0.46109594264689147,0.027260855185311513
89557,SIDM00193,Vinorelbine,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.4783434,0.029511284,0.744609546021147,0.029252142524343105
37818,SIDM00774,Temozolomide,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,0.27188,0.0059337527,0.41109677571733727,0.01758325213469005
65839,SIDM00782,Crizotinib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.31052935,-0.028234096,0.12084158948941394,-0.007659894961535774
3464,SIDM00875,SCH772984,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.9728316,-0.14522767,1.517328555795542,0.08855131942484304
69169,SIDM00878,Paclitaxel,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.2773614,-0.107383706,-2.754570192117831,-0.16067229853425877
94001,SIDM00866,Linsitinib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-2.5172572,-0.12895852,-1.1257186202307001,0.0037525134272710045
732,SIDM00954,5-Fluorouracil,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,2.371478,0.055843562,0.8122800816899621,0.09271217492408897
89365,SIDM00878,Pictilisib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.358459,-0.15134476,-1.1280587257772563,-0.10445735931391936
4565,SIDM00875,Tozasertib,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.19732888,-0.008586495,-0.575127318181046,-0.010145821178039876
50614,SIDM00875,Lapatinib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.26928085,0.02828161,0.5097285910967742,0.07513743307443439
55296,SIDM00834,Navitoclax,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,White,66.0,3.152018,0.08781364,4.098186004653906,0.15463119974498812
74048,SIDM00332,Alpelisib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,3.478295,0.18843655,-0.24089452273979836,0.012717658938352396
2530,SIDM00146,Cisplatin,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.3975328,0.052941035,1.5559967438404638,0.009454627031845029
67,SIDM00971,ZM447439,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.4536415,-0.06373505,-0.5091110321333223,-0.030306014064433274
74330,SIDM00954,Pictilisib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,-2.465847,-0.19784638,-0.6700216684176032,-0.07778120443882604
86302,SIDM00301,Gemcitabine,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.39341447,-0.030937757,-0.338429373716688,0.0088798187676974
67276,SIDM00146,5-Fluorouracil,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,0.68423057,0.053388845,-0.057886248360201786,0.05816794753263103
32210,SIDM00866,Dabrafenib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.5789948,-0.016619297,0.006628518563660222,0.031649015272590626
38721,SIDM00673,Alisertib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.8774997,-0.0857522,-0.45389647911139364,-0.05656023547546523
76714,SIDM00834,AZD4547,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,0.5507843,0.010596678,2.5455662573360525,0.06295167159287766
10465,SIDM00893,Afatinib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.1954867,0.107269675,0.28232299494261465,0.011177218083054882
72490,SIDM00146,Paclitaxel,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.2483648,-0.10272203,-2.546337490512689,-0.2197680908298722
44347,SIDM00529,Cisplatin,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.0934931,0.023219893,1.5590216496332727,0.060564540488533554
81288,SIDM00193,5-Fluorouracil,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-3.1175911,-0.22681792,-1.7090758426414123,-0.0854419061601605
6116,SIDM01233,Afatinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,2.9082136,0.22371615,1.673183312131398,0.13635757989225508
82046,SIDM00954,Palbociclib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,1.6941724,0.0672159,-1.0612704793568324,0.008259729764365453
92802,SIDM00529,Ribociclib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.48451743,-0.013674755,0.7647134651434017,0.02132695304368016
97801,SIDM00529,Alisertib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-0.90691775,-0.08694031,-0.2141372058406241,-0.018119099191400825
15099,SIDM00893,5-Fluorouracil,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.5700243,-0.024108743,-0.05524574495176875,0.01980806545340951
1021,SIDM00774,PD173074,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-1.2925528,-0.066842355,-1.4996824736129577,-0.08409205794706476
19224,SIDM00878,Palbociclib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-1.5947369,-0.08199104,0.9693582491980967,0.07817221919665451
40375,SIDM00673,Trametinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.6069009,0.15533076,-1.3803241026414932,-0.06767550371966327
46964,SIDM00301,Gemcitabine,Sorafenib,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,-4.8118095,-0.3594841,-2.3530543954165064,-0.12121985899334065
41560,SIDM00893,Nilotinib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.19885269,0.01703743,-0.03306890214388121,-0.045988584849605114
85022,SIDM00529,Docetaxel,OSI-027,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-1.9138912,-0.14230146,-0.5554748775443948,0.03384377357616481
17078,SIDM00628,Luminespib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,1.178647,0.09878309,-0.5988851287647857,0.0025007940051157613
27366,SIDM00778,Linsitinib,Trametinib,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,69.0,1.5031248,0.06670519,0.8008590368096636,0.04450272899607421
887,SIDM00875,Vorinostat,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7680916,0.072015524,-1.05519239698647,-0.05266743624149033
20605,SIDM00893,Crizotinib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.52037114,0.019245116,1.3674836810110067,0.05503912727489242
25149,SIDM00628,Doramapimod,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,2.0821543,0.052793972,3.047355099632455,0.054041127637012756
35413,SIDM00893,Tozasertib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.769601,-0.03580395,-1.921981986945327,-0.04403396857802313
52156,SIDM00332,GSK269962A,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5593591,0.09220388,-1.0307980343868965,-0.029131642054709802
2974,SIDM00834,BMS-754807,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,2.0455077,0.10397112,0.897238595286918,0.04012423138839723
28254,SIDM00628,5-Fluorouracil,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-1.602178,-0.07151359,-0.4611241732790433,0.012626533788206811
21014,SIDM00332,Linsitinib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7427015,0.05410677,3.0291627599731124,0.10010395802985747
32561,SIDM00301,Dactolisib,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,-0.86398226,-0.12018202,-0.5156373349514325,0.012766572607093322
22207,SIDM00971,Nilotinib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.44773212,-0.030741008,-0.729891986024324,-0.07524747265758139
59969,SIDM00146,Gemcitabine,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.9446096,-0.08993696,-0.941130712544716,-0.05185006617057398
38577,SIDM00954,Sorafenib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.0,2.3921642,0.15740621,0.6989348247878773,0.04123146389154484
79863,SIDM00628,5-Fluorouracil,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,0.9539032,0.05656591,1.9869074574317194,0.15298948294774586
82798,SIDM00774,Wee1 Inhibitor,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,-1.7996609,-0.10210786,-1.2583188362864628,-0.07527404623395652
54499,SIDM00774,Tozasertib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-0.70748323,-0.018807879,1.8763869889643763,0.046096853231020994
24996,SIDM00782,MK-2206,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,3.066392,0.24915032,0.535745608381527,0.07346102106518328
24232,SIDM00866,Temozolomide,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.033914,-0.015773764,0.7369886597015518,6.590383215013314e-05
71850,SIDM00776,AZD4547,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-1.1445365,-0.032222934,1.2569206313410208,0.06984033946616101
47191,SIDM00878,Nilotinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.3291777,0.110792175,0.90499551177063,0.07199172987988602
891,SIDM00954,Paclitaxel,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,2.4188979,0.05908199,2.840478695495666,0.1514972212660436
33739,SIDM00529,Docetaxel,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Black,44.0,-0.5024881,-0.03818751,-1.72328719951616,-0.04831835249863431
21905,SIDM00893,PD173074,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2846586,-0.03405376,1.0471362585133772,0.08160401925501234
40021,SIDM00875,MK-2206,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8965449,0.18011688,1.8858360511937677,0.0799429376470899
89769,SIDM00779,Olaparib,Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,1.9972049,0.04349267,1.4442353023815153,0.05941693060564979
89092,SIDM00878,Alpelisib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.89033854,-0.073591605,0.7882589424644039,0.091562507021832
88030,SIDM00774,Crizotinib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,1.4281828,0.18988906,2.29048522844653,0.053261761587113085
54910,SIDM00673,Venetoclax,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-1.4739172,-0.034229144,-0.9505399948830954,0.021856544270536214
62978,SIDM00971,JQ1,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.52491,0.0798391,-0.06963338212302235,0.012051485655684344
20631,SIDM00774,Bortezomib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-0.31974533,-0.02650769,-0.9841604895534173,-0.03216101366925217
18372,SIDM00130,Olaparib,OSI-027,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.5450806,-0.028974483,-0.4705665320617733,-0.024061556925424023
101121,SIDM00893,PF-4708671,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.2186582,0.018004457,-0.7505864320235485,-0.06323244017256269
82210,SIDM00529,Alisertib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.0107121,-0.09306404,-0.8777100075274201,-0.045359986326862715
82815,SIDM00628,Cisplatin,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.11692907,-0.0116008585,-0.6393122201883171,0.006577653490141149
88238,SIDM00875,Taselisib,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4284055,0.14100789,1.100483226162421,0.0258809141396565
43628,SIDM00878,Dabrafenib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,1.6854494,0.068913,1.4178824422428817,0.025745951785017228
86251,SIDM00878,Wee1 Inhibitor,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.2760565,0.08452225,-1.4141321689703918,-0.07798143129426896
5274,SIDM00332,AZD6482,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5927424,0.044591732,-0.09729966338586285,0.01817736850651619
63556,SIDM00878,JQ1,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.843351,0.13546534,0.6563583541369323,0.0631051685197773
122,SIDM00779,SB505124,Nutlin-3a (-),Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,0.5111735,0.049464136,-0.3728414075234606,-0.05407330896536011
65021,SIDM01233,Navitoclax,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,72.0,0.8559076,0.059594914,0.7491840691009014,-0.0030769630820515594
59408,SIDM00531,5-Fluorouracil,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.31477633,-0.008672665,1.519769997298253,0.05451840205796207
45366,SIDM00529,OSI-027,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.9321808,-0.032294136,-1.7087080116317515,-0.055753146294815106
74460,SIDM00875,Alpelisib,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.11097448,-0.0029081434,0.32748080171252225,0.012228088038212685
37376,SIDM00673,OSI-027,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.6617986,-0.0645145,-0.39937235481884953,-0.057391020653446034
12777,SIDM00779,AZD8055,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,33.0,2.4346073,0.15212014,-1.242537186682654,-0.14376060951365122
69259,SIDM00628,Doramapimod,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,3.496853,0.07596256,2.9374229235867326,0.11401360985978415
81402,SIDM00866,Gemcitabine,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.57916,-0.09886689,-0.7164302566280247,-0.03199888723469906
90079,SIDM00628,Venetoclax,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,-0.7404485,-0.03486964,0.6678234148398059,0.06732162329686601
7490,SIDM00878,Linsitinib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.0860434,-0.056627724,-0.5444438253164672,-0.04092508232113214
13686,SIDM00778,AZD7762,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,2.0457425,0.086416915,1.1509272048634267,0.06837196614709463
1680,SIDM00779,Trametinib,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,3.4073057,0.048771746,-4.119814825002011,-0.18674717576640262
31861,SIDM00782,Afatinib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.26723245,-0.025859527,0.5054038413324041,0.0316269046559028
72247,SIDM00097,Paclitaxel,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5059261,-0.15795116,-1.0093988140297094,-0.09965130262879021
41260,SIDM00332,Nutlin-3a (-),MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,4.1323943,0.063208245,3.152591741808651,0.050181619548375675
66391,SIDM00866,Bortezomib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.74849916,-0.05052422,-0.3740581635992751,-0.018986450579661595
35702,SIDM00628,Venetoclax,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.81294936,-0.026575027,-0.22313031226661162,0.03404740936391829
5425,SIDM00893,Dabrafenib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2597828,-0.03414952,0.45815918217484,0.03513113578810586
79703,SIDM00954,Lapatinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-0.44768658,-0.035682436,-0.43050207904485743,-0.009176771882424044
59149,SIDM00411,Dactolisib,Olaparib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-1.7020934,-0.0824753,-0.8315829456144531,-0.03662093226317513
49715,SIDM00971,Nilotinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.5847323,0.03130684,0.879099610580528,0.06188167022027357
64418,SIDM00146,Vorinostat,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,0.3201145,0.02587499,-1.2029726845852344,-0.04215336754312123
53024,SIDM00673,Venetoclax,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.72157085,-0.019500552,-0.23250887431025002,0.012896149909948435
100466,SIDM00146,Ribociclib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.9367747,-0.059154008,-0.9423868841482436,0.010535895507179842
95850,SIDM00776,Vinorelbine,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,1.0576322,0.050288238,0.04151807385390101,0.04916065866972025
31698,SIDM00878,Lapatinib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.47356117,0.05895366,-0.3131428141025116,-0.003532978770195987
11362,SIDM00954,Bortezomib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,1.8757433,0.09643576,0.07570650086158527,-0.01893545451272601
38227,SIDM00954,AZD6482,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.5275856,0.026921771,1.2730155684190927,0.16768009433656736
83054,SIDM00774,BI-2536,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,1.1364993,0.08089224,-0.2633497119803378,-0.06236433583805873
45970,SIDM00673,AZD8055,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.51283526,0.035812255,-0.6270602491275961,-0.007323331690718775
84889,SIDM00954,PF-4708671,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,1.971525,0.07594956,-0.6452393054304927,-0.005231639452277902
8674,SIDM00776,Nutlin-3a (-),5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.8220438,-0.058023088,-0.6230601976410749,-0.009719492357656978
36804,SIDM00332,Crizotinib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4350183,0.14673185,-1.0491450968099914,-0.02012880721276082
32564,SIDM00878,Gemcitabine,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,1.1636016,0.091386616,-0.19411832317799418,0.026681881360259025
56803,SIDM00834,Palbociclib,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,White,66.0,-1.1794177,-0.083602116,-1.845019608057803,-0.10137591697432863
101099,SIDM00866,MK-1775,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-0.04653855,-0.0030806393,-0.26681821415917967,-0.011849600906459205
99004,SIDM00971,Afatinib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.4089781,-0.01763682,-1.695954072339199,-0.03931918553634452
66181,SIDM00834,Vinorelbine,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,2.0694163,0.084433526,0.3321015990945476,0.03145037847940006
71019,SIDM00332,Lapatinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.3846738,0.15915702,2.472987380978539,0.139782114571158
74624,SIDM00097,Sorafenib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.24780537,-0.011559652,0.5808740997934799,0.03960016055718235
108087,SIDM00778,5-Fluorouracil,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-1.5858924,-0.030274821,0.23797501342851812,0.021282657788842217
30013,SIDM00529,Bortezomib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-0.41085106,-0.031104857,-0.8174679385580877,-0.001013556369189884
22984,SIDM00146,Nilotinib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.5823911,0.14646137,1.2857186145870998,0.09847538401143505
30639,SIDM00628,Venetoclax,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-2.3230712,-0.06844889,-0.4512087917837841,0.023067712687065683
34232,SIDM00782,Vinorelbine,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,2.03842,0.13408901,-0.2815572038486946,0.021467974771364435
62408,SIDM00893,Wee1 Inhibitor,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-3.805898,-0.11682785,-3.219677136330513,-0.12345364765436877
93643,SIDM00875,BI-2536,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6472153,0.02225677,-0.34707866034953994,-0.009750879673918994
86914,SIDM00146,Sorafenib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.7694069,-0.0666706,0.09656931621319206,-0.0011470893892189828
53290,SIDM00628,Cisplatin,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,Black,51.0,0.6261769,0.06273908,-0.4900869649862865,-0.015722297791857236
44912,SIDM00954,Axitinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,-1.003635,-0.0713503,-0.7684083551608482,-0.042293959504684876
71727,SIDM00866,SCH772984,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-0.03849773,-0.0029787305,1.247092887015269,0.1380374993560847
42369,SIDM00893,RO-3306,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.1322005,-0.16068055,-1.5870525747974025,-0.04065584205498213
66651,SIDM00954,Venetoclax,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,3.7478433,0.13644455,-0.3767305483427961,-0.028446549148479543
106451,SIDM00878,Palbociclib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,70.0,0.85920304,0.070094205,1.3611268266611913,0.101718278825293
93099,SIDM00146,BI-2536,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,2.0946014,0.038272236,-1.252565443015086,-0.05192536983191724
49947,SIDM00332,PD173074,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1715078,-0.11967261,0.10108342548155193,0.012002560223237948
23085,SIDM00866,Palbociclib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,0.8494454,0.027343772,0.930315396737928,0.07816156613043501
12981,SIDM00866,5-Fluorouracil,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-1.8835526,-0.07618574,-1.5733757805092297,-0.05903400970235702
90596,SIDM00878,BI-2536,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-2.687414,-0.09893907,0.17547836041050874,-0.004883608679334732
73299,SIDM00971,Uprosertib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.2321433,0.075380675,1.1883795465816607,0.06939814493540267
103575,SIDM00875,Camptothecin,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.23344718,0.02488145,-1.604437103242251,-0.0641399561015452
56217,SIDM00628,Vorinostat,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.5063242,-0.051840115,-0.5552962376907618,-0.02185017817360566
60719,SIDM00673,Gemcitabine,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,-1.4549409,-0.083886385,-0.5565817539871888,0.01389219657789321
107391,SIDM00097,MK-2206,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.9523766,-0.15614101,-0.026154504618984362,-0.013624829298142599
82833,SIDM00673,Palbociclib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6772928,-0.0299416,-1.6002532824677682,-0.055785908204734246
108084,SIDM00660,Trametinib,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,2.3195145,0.116698235,-0.07758403342461598,-0.05269251622036981
79824,SIDM00628,Crizotinib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-2.8506763,-0.103535645,-1.7607604826485816,-0.10463802881490253
49550,SIDM00146,AZD6482,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-1.9205099,-0.10013202,-0.464473099103056,-0.01686346034234287
44874,SIDM00866,Navitoclax,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,0.580657,0.038573362,0.9527607158186134,0.06967640788661694
24312,SIDM00673,Afatinib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,3.0705853,0.25167233,2.037476544612073,0.12679111045533778
45601,SIDM00531,Lapatinib,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Male,East Asian,60.0,5.226352,0.5315572,1.0286015275736704,0.033742092841683606
67238,SIDM00673,Afatinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.8998685,0.15400317,-0.27434701043846016,-0.001236167403371052
75931,SIDM00411,Dactolisib,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.71120715,-0.032257557,0.36457052093098413,0.07994064040945614
44862,SIDM00097,Navitoclax,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1209847,0.0708217,1.5487019894273246,0.11052379417123577
29274,SIDM00146,Palbociclib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.6561311,-0.044269376,0.429385198637231,0.0934670482523745
39074,SIDM00628,Cisplatin,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,1.3637395,0.13281249,-0.5784939335846204,-0.010068796295028716
91156,SIDM00893,Temozolomide,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.777657,-0.017167307,-0.09878425808168946,0.015069534628767367
20349,SIDM00878,Alpelisib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-1.8563464,-0.13071951,-1.1499029082232544,-0.08534523503952945
108258,SIDM00673,PF-4708671,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.5770149,-0.09000255,-1.1415769058861385,-0.06334689272244812
67562,SIDM00673,Axitinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.8877568,-0.08783646,-0.18488322531686452,0.023438789229987222
61226,SIDM00301,Erlotinib,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.2887535,0.15002877,1.7474821361573576,0.09060577149200202
105227,SIDM00332,NU7441,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.2266486,0.16325964,1.1218661647347947,0.08535217810785878
73016,SIDM00875,Olaparib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.45954755,0.03624294,-0.4807230843273812,-0.0584392544437486
23817,SIDM01233,Oxaliplatin,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-2.8079574,-0.13393232,-2.0790142241168375,-0.11185967350386801
32513,SIDM00878,MK-1775,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.8284215,-0.09608621,-2.6076331074630725,-0.2185341738211485
101150,SIDM00628,Sorafenib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,Black,51.0,-0.1899786,-0.018298555,-0.3938193075256494,-0.029829381481236285
56806,SIDM00779,MK-1775,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-0.79392123,-0.054022256,-0.8240419075500601,-0.0576635632408609
15163,SIDM00875,Ribociclib,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6581908,-0.04818411,-0.9885538786013894,0.004347368429519393
20801,SIDM00411,Olaparib,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.983371,0.08319501,1.9979098900023355,0.036810923492293875
8985,SIDM00778,Nutlin-3a (-),Afatinib,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,1.6246423,0.033793725,1.5024414864408262,0.017052672280795194
96061,SIDM00893,Alisertib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.32095903,0.028579175,1.0554956455852897,0.05866921206581272
79317,SIDM00779,Linsitinib,Nutlin-3a (-),Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-0.44121602,-0.03604531,0.4347695337501534,0.003614162990023989
37489,SIDM00878,Paclitaxel,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.2104354,-0.0992242,-0.4388052060687821,-0.009863888162166032
47228,SIDM00359,SB505124,Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.8452375,-0.074546084,-2.5325051653260315,-0.08754550992978849
92947,SIDM00774,PF-4708671,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,0.81029284,0.04604827,-1.0102603947225062,-0.09003023571482204
53215,SIDM00411,Gemcitabine,Ruxolitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.6125751,-0.04051738,-0.96566246940255,-0.07050694431432827
7078,SIDM00301,Sorafenib,OSI-027,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.7153268,0.1666884,-0.7430612452883529,-0.02577575887572324
108444,SIDM00866,Docetaxel,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-1.9714022,-0.1313189,-1.8718671490028873,-0.08961422069106366
27884,SIDM00954,ZM447439,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-3.6260788,-0.2816389,-1.1301796210615056,-0.10867936874808161
63129,SIDM00332,Venetoclax,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,1.605985,0.05158268,0.9426191606871991,0.047871141385993916
76812,SIDM00130,Dactolisib,5-Fluorouracil,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.3003892,-0.09372783,-1.2930069450175077,-0.06166386949569675
40715,SIDM00779,Taselisib,Trametinib,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,33.0,3.399079,0.09280951,0.17525815061278763,0.043800022617526066
50900,SIDM00146,5-Fluorouracil,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.64060396,0.05078251,-1.9360930169618802,-0.040745090654059186
99891,SIDM00628,PD173074,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.4431875,0.11707477,-0.062347175602949154,0.056114559059002825
60880,SIDM00782,Camptothecin,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.1751134,0.09213601,-1.4256710161751605,-0.11341824610895704
17103,SIDM00971,GSK269962A,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.7912596,-0.044521287,-0.1795161235769888,-0.00457216642898773
37344,SIDM00878,Pictilisib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,0.13617,0.013564707,0.4299665351426762,0.015081344842686917
7738,SIDM00529,Olaparib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.853016,-0.039284773,-0.6461450296278021,0.016445589261830974
50413,SIDM00193,BMS-754807,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.93511194,-0.0514904,-0.05226391179786735,0.029995017838990962
4182,SIDM00971,Docetaxel,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.199003,-0.08129273,-2.940346492537033,-0.06226235920138724
33123,SIDM00628,Paclitaxel,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,-0.6397641,-0.04862564,-0.40394101045038966,-0.05036839892644277
66924,SIDM00332,Paclitaxel,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.1740181,0.15642267,-2.1018801860173504,-0.10434954461519139
49105,SIDM00875,Vorinostat,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.479942,0.05520833,-0.5685060987652093,0.0013205779955630232
102610,SIDM00971,Cisplatin,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.36503983,0.005662152,2.2596533485295924,0.01404438854941041
61904,SIDM00779,Palbociclib,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,33.0,-2.137878,-0.18663508,-2.066432156773373,-0.1149240078846254
10645,SIDM00673,GSK269962A,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.792915,-0.1477198,0.15861344957584733,0.048415473267567795
54506,SIDM00529,RO-3306,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,2.7131479,0.15432268,1.7739170082801292,0.13862975920961196
92156,SIDM00673,Gemcitabine,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.67853653,-0.04664628,-1.280302761373867,-0.06006337770016322
7299,SIDM00193,AZD7762,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,1.4730328,0.06686227,1.3983211220293146,0.0694838495040617
24705,SIDM00774,Camptothecin,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.6654265,-0.11041367,-1.516861033944015,-0.06366712451890874
1555,SIDM00776,MK-2206,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,65.0,1.3050392,0.113651894,0.24645006563743962,0.020276904735068168
24570,SIDM00146,NU7441,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.79573965,-0.071799435,0.2060830268753146,-0.003549487647187059
35259,SIDM00878,AZD7762,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-1.3991565,-0.07251787,-2.041210952053396,-0.0767846186277563
1638,SIDM00878,Lapatinib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,0.21557729,0.022549694,0.6648397474906691,0.08252457410318893
33880,SIDM00971,Afatinib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.6342713,-0.07348119,-0.6945346633180698,-0.022435937006071095
23689,SIDM00778,5-Fluorouracil,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,-2.5296772,-0.03295318,-1.2721610331267876,-0.009859049508324218
48412,SIDM00954,AZD7762,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,1.0329424,0.08689175,0.9459946808229023,0.07503721293780098
48611,SIDM00878,GSK269962A,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,2.8659613,0.05525411,3.5974656778493825,0.15691533250113693
36578,SIDM00776,Vinorelbine,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,0.5036403,0.040516306,0.678897890807475,0.048651589706586604
88060,SIDM00529,Dabrafenib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,2.1390538,0.058833264,1.202932045586235,0.07704778834557256
60365,SIDM00866,MK-2206,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-3.5328283,-0.16544539,-0.08306371227717808,-0.0031575035113432753
737,SIDM00774,Afatinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-1.8157634,-0.142438,-0.6130151254429737,-0.08519001955808614
12858,SIDM00866,SCH772984,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,0.7717633,0.0662909,-0.5371431964365425,-0.00039388329123421896
95748,SIDM00971,Nilotinib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1639333,-0.08067447,-1.5605884558571745,-0.11087785403923156
25017,SIDM00332,Uprosertib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9044533,0.054091882,-0.22688211905663094,-0.00831730488205232
68806,SIDM00776,AZD7762,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,-1.3222212,-0.09982224,-1.4281787355862745,-0.08995642624759703
8186,SIDM00529,BI-2536,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,0.9484151,0.07741696,-0.8640033912850258,-0.08662756671483891
63543,SIDM00875,Gemcitabine,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.8428897,-0.004531931,-1.9402687261846285,-0.08619825233954866
64119,SIDM00866,Gemcitabine,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-1.8546485,-0.10508038,-0.4551523339759111,0.04046789576740941
80229,SIDM00971,Venetoclax,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.2935495,0.081458285,0.9785083452568066,0.053395370830357045
33128,SIDM00866,KU-55933,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,-0.4512903,-0.021232162,-0.17206693404297665,0.037662567625223874
41315,SIDM00673,GSK269962A,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-0.11236699,-0.008873571,-0.7695793313136137,-0.03163653531878727
12355,SIDM00779,Crizotinib,Vinorelbine,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,33.0,-0.17080933,-0.012141523,-1.436624864096761,-0.04002121167606385
14961,SIDM00774,Sorafenib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.69706535,0.032466818,1.0041927367993102,0.13251666476580107
11697,SIDM00146,Taselisib,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.9456912,0.074199855,0.02418329729504711,0.06105445088544836
93574,SIDM00954,Venetoclax,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.13210566,0.0019737447,0.5413501699129114,0.06782593929454166
89071,SIDM00673,AZD7762,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.2343104,-0.041585773,0.7173053185589364,0.07161017228451211
75065,SIDM00834,MK-1775,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-1.4851664,-0.12765358,-1.4635654027011187,-0.06716074322919761
17643,SIDM00301,Cisplatin,SCH772984,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-3.0709512,-0.20605075,-0.6759971718151575,-0.028454470283484957
1442,SIDM00411,Cisplatin,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.7109249,0.027325882,1.3754961022604661,0.04866105453216459
97799,SIDM00778,Crizotinib,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,0.90456784,0.05903949,1.0915716328836018,0.0769063724334562
2257,SIDM00097,MK-2206,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.21397,-0.23585825,-0.49932374328817886,-0.08858235422676447
53770,SIDM00971,JQ1,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1333549,-0.049662452,-0.4877555866720082,0.012173906458480451
32619,SIDM00673,Sorafenib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0001383,-0.050071254,-0.11901835818607591,-0.007834707718193834
36868,SIDM00359,MK-2206,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.2589278,0.16853921,-0.759110059194483,0.004557028134788572
88469,SIDM00875,NU7441,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.7460257,-0.09545668,-1.1962564945595808,-0.06878950751729414
87371,SIDM00359,Trametinib,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,3.3330262,0.06468086,0.7072964647404687,-0.019506704235351717
56215,SIDM00774,AZD7762,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.7696863,-0.16520037,0.16045224254358875,-0.00799025742541189
74966,SIDM00971,KU-55933,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.9149029,-0.026530089,1.2812856335205765,0.09156698828504911
101833,SIDM00097,Ribociclib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9221237,0.03971339,-0.8684988824336153,0.0037887996900930784
100771,SIDM00531,Linsitinib,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.7957532,0.35805538,3.0503940037197825,0.1811970045102634
64965,SIDM00628,Vorinostat,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.34553668,-0.03438788,-0.4009627524712818,0.0312342231375522
19124,SIDM00774,Taselisib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.2617196,-0.012865445,-0.11228455191055314,0.0001049764207040708
66766,SIDM00782,Oxaliplatin,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,Unknown,72.0,-1.7899672,-0.08952625,-1.1559800447650392,-0.0013502064854856218
14193,SIDM00146,Axitinib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,1.6823032,0.1406105,0.6307848584726197,0.1317449553004708
40689,SIDM00875,Tozasertib,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6413988,0.1099717,0.7378096299062085,0.05144040262900038
67940,SIDM00878,AZD7762,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-0.67512363,-0.03568656,-0.4427200800696371,-0.00025527598042552626
13212,SIDM00531,OSI-027,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.76238155,0.03645397,1.8887090847145156,0.05620296059641475
44408,SIDM00834,BMS-754807,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-0.707164,-0.045024432,-2.187036146007757,-0.0769775802685638
65895,SIDM00301,Dactolisib,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.0609963,-0.23266275,-0.04451793618287839,-0.0359792195529317
68182,SIDM00878,Docetaxel,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,0.51057786,0.046215292,0.1851971191369916,0.05587038898941129
38404,SIDM00774,Dabrafenib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,48.0,1.0315814,0.03724846,0.24394719302705029,0.002628600831231409
55517,SIDM00875,Temozolomide,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.547115,0.054668754,1.4496985459642464,0.025197735944412082
70872,SIDM00954,MK-2206,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-2.2773714,-0.109225415,-0.1461934672149401,0.04843814821442026
89397,SIDM00971,Entinostat,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.951528,0.0301466,0.7233951512682937,0.07771651354377092
103663,SIDM00875,Nutlin-3a (-),AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8948456,0.020069048,1.7838724736966756,0.020842361899158127
47433,SIDM00332,Cisplatin,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2157845,0.023010401,2.0864778677837488,0.08120572610587071
94697,SIDM00954,SCH772984,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,1.3159486,0.07303219,0.5337918793124709,0.04408540623685697
16476,SIDM00531,LGK974,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.6735263,0.07726601,-1.3335384960550447,-0.051149011837115975
54185,SIDM00332,Taselisib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.97815174,0.086261146,-0.029124713624279715,-0.028958943160105596
89475,SIDM00774,BI-2536,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,-2.0406873,-0.13147308,1.223376518499744,0.06554726503301743
31559,SIDM00893,AZD8055,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.6310112,-0.05659087,-0.6183982402966626,-0.11840898016106073
100685,SIDM00332,Camptothecin,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9635172,0.025660396,2.8435362215879185,0.08743656504726595
60116,SIDM00776,5-Fluorouracil,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.5342578,-0.053302854,-0.2588328843305909,-0.005988938615786618
58118,SIDM00628,MK-2206,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,0.96307737,0.08261576,-0.6372483390814139,0.056977368312252426
101245,SIDM00301,Cisplatin,Palbociclib,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.8287646,-0.14620855,-1.1543334381658674,-0.133919005577541
13587,SIDM00628,Entinostat,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,1.9751666,0.14821152,-0.6870048227362776,-0.0005059929763490916
51057,SIDM00146,5-Fluorouracil,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,1.1612343,0.09392758,-0.1490672737159629,0.016652199155834643
1088,SIDM00411,Dasatinib,Taselisib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,1.4039016,0.07465986,1.877253227863665,0.12653422478821671
52280,SIDM00531,Gemcitabine,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.7546905,-0.18295743,-1.9815729044017272,-0.13717177322046975
11111,SIDM00954,AZD8055,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-1.3943869,-0.10483483,1.9849758838923757,0.1067633385295139
105933,SIDM00834,SB505124,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,White,66.0,1.5026442,0.11165497,-1.1286958732369181,-0.05236076531429168
25552,SIDM00673,Doramapimod,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,3.177004,0.0836871,3.497308732465311,0.11123752632240892
37187,SIDM00779,BMS-754807,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,1.5098064,0.014009991,0.843499957539065,0.03863690377363755
85949,SIDM01233,Nutlin-3a (-),MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,-1.7546891,-0.053678118,0.857836222949381,0.06027862983993766
83753,SIDM00628,Sorafenib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-0.67349714,-0.0611851,-0.35476234454741123,-0.06241529172214099
3821,SIDM00332,Crizotinib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7745203,-0.1391585,-0.8178963081208853,-0.02280304988206638
13797,SIDM00673,Camptothecin,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.384269,-0.040622707,0.07878417842860906,0.06792683316245067
75573,SIDM00628,Camptothecin,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.79890615,-0.07252384,-0.15213922702935587,0.03383290384532775
67313,SIDM00971,PF-4708671,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1619693,-0.06575344,-1.3477370018354902,-0.07731517310662996
58226,SIDM00097,Alpelisib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4860874,-0.098902725,1.0208237172563843,0.06300587624140362
27888,SIDM00146,ZM447439,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-0.78946614,-0.04387023,-0.7200866955736728,-0.0023488709092647155
86867,SIDM01233,SCH772984,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,0.50061226,0.035935655,-1.1079988650062584,-0.06927594529833532
74903,SIDM00411,Linsitinib,OSI-027,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,3.5880165,0.18852755,2.3883975250276017,0.17268245454695136
57574,SIDM00146,Uprosertib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,2.4803193,0.14032324,3.55572588423155,0.23759048701189003
10896,SIDM00628,Afatinib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,0.9204726,0.06262087,0.22641245996566384,0.007415682374293883
103791,SIDM00332,Entinostat,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,6.2423162,0.17344847,3.253735573293625,0.10769609064494551
7006,SIDM00130,5-Fluorouracil,Ruxolitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.35592568,-0.035887092,-1.0586771511409605,-0.05526647788486407
21788,SIDM00529,Cisplatin,Trametinib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,1.3618193,0.028334921,1.5198952868424473,0.06313024859577354
90310,SIDM00778,Crizotinib,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-0.82118696,-0.049843058,-0.34254212637472575,-0.03790183354843944
39394,SIDM00146,Axitinib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.3217359,-0.04557333,-1.0832124677350015,0.02136025090857649
91636,SIDM00875,Nutlin-3a (-),Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.38322535,-0.012169726,0.6118715691068594,0.04814642060214761
61216,SIDM00866,Nutlin-3a (-),Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-0.48329246,-0.012884508,0.9623389872976226,0.0462301631098593
38150,SIDM00673,Cisplatin,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.84965664,0.025103271,1.6008986521349264,0.08379125881348487
41458,SIDM00782,Vinorelbine,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,0.7506023,0.05739199,-0.4459268900663003,0.06306069579371452
40161,SIDM00875,ZM447439,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0008569,0.086374715,1.156053912537068,0.099589292207323
17429,SIDM00893,Alisertib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.6421599,0.12269785,1.2540623129982664,0.07471267320809506
86338,SIDM00332,MK-1775,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5670619,-0.13185146,-0.409424171382753,-0.07156826220361391
46772,SIDM00774,5-Fluorouracil,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-0.8016587,-0.07603488,-1.5960076951894517,-0.060718829098424354
9699,SIDM00332,Luminespib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.6097324,-0.114615306,-1.3425026260656194,-0.09184667089378996
12491,SIDM00866,KU-55933,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-1.8131466,-0.07095964,-1.7914129011471926,-0.058017892285366995
29856,SIDM00878,MK-1775,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,2.751232,0.22916973,-0.8088792853270298,-0.04275460022435075
67120,SIDM00971,Crizotinib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.3078715,-0.04349926,1.071048197593237,0.10308227007119816
86380,SIDM00097,Alpelisib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.4681134,-0.034445055,-0.3233525504940817,-0.013715261130719672
82754,SIDM00628,Paclitaxel,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-1.2277335,-0.0943727,-0.24604714600549857,-0.008407001694722778
56545,SIDM00778,5-Fluorouracil,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-2.1638596,-0.042974096,-0.19991908699003416,-0.0015743407356304327
30479,SIDM00146,ZM447439,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,3.823002,0.2918439,3.613705962802755,0.2586693978791441
55010,SIDM00774,NU7441,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-0.63822865,-0.036818687,1.048985989088186,0.06709248437443374
67045,SIDM00660,MK-1775,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,-0.48044825,-0.011934415,-1.0174909898523474,-0.017112187422594554
17241,SIDM00971,GSK269962A,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.2317083,0.077988096,0.17579572183865202,0.027342429199737502
82708,SIDM00782,Linsitinib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,4.4444513,0.2897728,1.7748267091195338,0.11845515656579278
62701,SIDM00146,5-Fluorouracil,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.1956098,0.0885094,-1.0299417229998624,-0.04551707582741313
72303,SIDM00875,Wee1 Inhibitor,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.23419628,0.01593089,-0.5882088055175636,-0.03097398515473059
44523,SIDM00954,Ribociclib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.0,0.26046228,0.00966773,-1.146898393002775,0.09671427764339281
75347,SIDM00628,MK-1775,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.0485886,0.092684805,-0.3562348841048836,0.007384665128826635
93111,SIDM00411,Olaparib,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,43.0,-0.54205006,-0.010286551,0.9067476938184498,0.03324612666044387
56351,SIDM00875,Venetoclax,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.44266325,-0.010081105,0.6768941166034029,0.02914433939753019
34056,SIDM00893,Paclitaxel,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-4.9371367,-0.35435537,-4.721534322448616,-0.3672193567360311
36481,SIDM00359,5-Fluorouracil,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.268339,-0.08771572,-1.1960363645973748,0.004547613140650993
27117,SIDM00359,Afatinib,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.22394516,0.015738156,0.042244843382333495,0.002077006322593245
38984,SIDM00332,AZD8055,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.1106627,-0.13571377,-1.6557799776382627,-0.10289796925561863
66046,SIDM00332,Docetaxel,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.4721904,-0.21636483,-2.136663508163021,-0.09735386385537857
92741,SIDM00893,BI-2536,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.59333926,0.055028427,-0.6749367703996091,-0.032890276012760206
58729,SIDM00875,Trametinib,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.71376777,-0.01026218,-1.4408235067496746,-0.032514936910254526
11568,SIDM00878,Gemcitabine,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,70.0,1.866472,0.20746978,-0.4538263938357604,-0.0013541792243194413
40926,SIDM00301,OSI-027,Dasatinib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,50.0,0.96640366,0.11260688,0.9543879141124966,0.053567670717879955
820,SIDM00776,AZD8055,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.2450032,-0.059564296,-1.107642702218796,-0.01392768310719368
87160,SIDM00774,Entinostat,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.0602423,-0.056033667,1.8764958938447618,-0.01353945311642679
32511,SIDM00097,Taselisib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3844955,-0.079514764,-0.9632500383430382,-0.053812002883561694
24435,SIDM00875,BI-2536,Vorinostat,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.522058,-0.15060845,-1.1167823801360948,-0.021514471593922387
39242,SIDM00878,Nilotinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-2.55813,-0.055904392,-0.806387852593405,-0.03705697372764814
71699,SIDM01233,Crizotinib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,-0.26656422,-0.016861295,0.8598444564622071,0.09166977418350845
77852,SIDM00878,Pictilisib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.2190292,-0.02596907,0.6816922571990779,0.044890757617846694
64841,SIDM00774,Uprosertib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.3907223,-0.16062239,-1.1141240985026983,-0.07310821526683067
1816,SIDM00866,Sorafenib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,0.3034798,0.015441497,-0.8592728642783567,-0.034988694879498856
48784,SIDM00954,Navitoclax,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,1.1897231,0.023030581,0.8110250074667259,0.021998971748559058
9955,SIDM00332,Trametinib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1568923,-0.110018104,-0.7567677595792474,-0.05076100029163344
18499,SIDM00779,Linsitinib,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,33.0,0.53635854,0.027240701,0.22311896002440593,-0.015281913666054137
89108,SIDM00779,Linsitinib,Crizotinib,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,33.0,-0.68117553,-0.04892773,-1.6105708643552907,-0.0946234036005863
74961,SIDM00893,Axitinib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.9123365,-0.073201686,-0.603174134557496,-0.02571663022560949
37273,SIDM00332,Uprosertib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2319431,0.047654506,0.004868996109438961,0.039051540119654816
69335,SIDM00971,Taselisib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.091547,0.2451376,2.0640601426157907,0.14976794470820676
101378,SIDM00097,Uprosertib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.899735,-0.13899861,-0.8271615172288744,-0.06752513305242432
27438,SIDM00529,Axitinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-0.78151953,-0.065740205,-1.01692881593115,-0.05254215603401434
36329,SIDM00332,RO-3306,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5700924,-0.06986643,-0.598141567308436,0.012246131076143314
38015,SIDM00146,Nutlin-3a (-),Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.4532406,-0.013051906,2.9249014206266066,0.0878505138940877
57504,SIDM00778,AZD8055,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,69.0,-2.0343263,-0.10540512,-1.9977185262163724,-0.11307566335035779
22188,SIDM00774,Lapatinib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,1.3707927,0.105346486,0.7766592496127822,0.03196904585507866
67373,SIDM00779,MK-1775,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,33.0,-0.5411095,-0.03421152,-0.5565986783924144,-0.03445758927004132
59609,SIDM00971,Gemcitabine,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7101846,-0.046284866,0.3613176169521573,0.0011453502721210285
92259,SIDM00778,5-Fluorouracil,Afatinib,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,-2.8565679,-0.06839242,-1.1828765846987415,-0.02471994524899271
82698,SIDM00332,Docetaxel,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.5001383,-0.21952973,-1.772449868307047,-0.17906410841757553
17945,SIDM01233,5-Fluorouracil,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,72.0,1.1602386,0.077803716,-1.9164217593256696,-0.06426489461672434
5714,SIDM01233,Nutlin-3a (-),Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-1.6674905,-0.048564836,-0.8153563292526502,-0.029188003624996312
29544,SIDM00834,Camptothecin,Navitoclax,Large Intestine,0.1,Rectal Adenocarcinoma,Female,White,66.0,-0.35169482,-0.029738389,0.7983610548586266,0.08467048571646583
45463,SIDM00834,Nutlin-3a (-),Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-0.16443345,-0.00468359,-0.4248680274131026,0.05965654746136617
107522,SIDM00411,Gemcitabine,Palbociclib,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,-3.752288,-0.1943344,-3.174407736870773,-0.16473773290393123
28538,SIDM00971,Palbociclib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.6182617,-0.039404783,-0.1127167032123842,0.050804414202033875
68566,SIDM00971,Nutlin-3a (-),Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.3640518,-0.057785377,-1.886194402151754,-0.036926127910381426
36079,SIDM00778,Navitoclax,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,69.0,0.7672996,0.042178623,-0.4206572975310458,-0.041289842694342736
43992,SIDM00776,Camptothecin,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,2.1890519,0.13547556,3.2827901319428885,0.18209501635678588
8678,SIDM00529,Palbociclib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.3502979,-0.060980402,-0.22610533670060262,0.07179813586447578
89553,SIDM00776,Taselisib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,-0.8380213,-0.07131012,-2.2576334495037584,-0.11500889470316539
64344,SIDM00628,Linsitinib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-1.8107728,-0.103918314,0.3573305776552885,0.06754275488826474
63621,SIDM00866,Pictilisib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-1.7522942,-0.14505416,-0.8477548598911828,-0.07724897817530339
33541,SIDM00782,BMS-754807,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.44233516,-0.041186202,-0.3052547105567874,-0.043293413102695875
52188,SIDM00866,Afatinib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-1.9088106,-0.14142813,0.6863040536466648,0.04479447993592139
61635,SIDM00779,Vinorelbine,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,3.1901646,0.1831787,0.6696630066470838,0.05002383788968328
103627,SIDM00875,Gemcitabine,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.525607,-0.0009160231,-1.359072663779745,0.021627211398902595
57913,SIDM00301,Palbociclib,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.1138185,0.13577162,-0.2869081769509164,-0.002010570030244545
50273,SIDM00866,Wee1 Inhibitor,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-4.9197288,-0.35322428,-1.589958265687917,-0.11631228492105017
33005,SIDM00673,Alpelisib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.2702773,-0.07363783,-2.036434415725378,-0.10978959315930434
76003,SIDM00866,Wee1 Inhibitor,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-3.0565045,-0.23425092,-0.9066022680311151,-0.06091914830716277
104853,SIDM00130,Lapatinib,Erlotinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.32329047,0.02484019,-0.691719803454065,-0.001550478558453046
24909,SIDM00359,AZD4547,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.3270766,-0.05603198,-1.4086918522304608,-0.038044691668982465
6214,SIDM00779,MK-1775,SCH772984,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,33.0,-0.67123693,-0.0420547,-0.5866536742348516,-0.02744582339534978
1324,SIDM00628,SCH772984,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,Black,51.0,-1.9987996,-0.119730584,-0.4396762000226726,0.026720455891103105
72166,SIDM00776,Oxaliplatin,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.7987953,-0.049470127,-1.8685680915155283,-0.043512409756166666
1280,SIDM00954,Entinostat,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.4679147,-0.017022962,-1.0119129767999753,-0.027165773615968596
43162,SIDM00774,Bortezomib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-0.15837634,-0.01363383,0.14185666745390757,-0.008327231690352786
26647,SIDM00097,Taselisib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5066403,-0.09609508,-0.44321772905896556,-0.06235899335081819
16299,SIDM00529,Sorafenib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.7214644,0.07292032,-0.36225602920651845,0.034084328646836456
44095,SIDM00878,KU-55933,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,1.1120492,0.046524227,-0.36013503521016227,-0.006615605743088786
77139,SIDM00146,Navitoclax,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.42215577,-0.02906447,-1.0574395979328777,-0.09478816078732628
26157,SIDM00954,Sorafenib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,0.18266125,0.014494298,-1.16318414487112,-0.049146785890306605
72073,SIDM00774,AZD6482,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,2.6161864,0.16006155,0.9786787241040384,0.04722665863081499
27339,SIDM00529,OSI-027,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-0.8547778,-0.07427422,-0.6029797407770203,0.055085138705741436
49543,SIDM00529,KU-55933,MK-1775,Breast,0.625,Breast Carcinoma,Female,Black,44.0,0.2875802,0.0041618855,0.9403109285213354,0.03801133410366266
23245,SIDM00875,BI-2536,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.347891,-0.064142324,-1.1808196227519296,-0.03555921041183152
17421,SIDM00673,Dabrafenib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.5206378,0.032772332,1.47216390135065,0.036481789037680776
81408,SIDM00628,BI-2536,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,2.3196037,0.037573382,-1.6371835174290152,-0.022606354832541857
66038,SIDM00779,Crizotinib,AZD4547,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-2.785914,-0.053677265,-1.1497559737847438,-0.014240280933315396
15056,SIDM00954,AZD7762,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,-2.3034496,-0.17629965,-0.5830220861195179,-0.020534558068767722
102434,SIDM00359,SB505124,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.1099899,-0.08590138,-1.2400901258501529,-0.055563793301227356
14230,SIDM00097,GSK269962A,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.3296509,0.07057588,0.3937803240587215,0.023085978617345584
12525,SIDM00779,AZD4547,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,-3.772784,-0.017868944,-4.1682174191925325,-0.10553968967085904
78207,SIDM00628,Nilotinib,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,0.6898407,0.06693843,0.7443114011567117,0.03807965717055895
82690,SIDM00778,Taselisib,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,0.5093553,0.025523206,-0.8249129472731525,-0.08823021370007839
46701,SIDM00878,Pictilisib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-1.060092,-0.12456227,-0.5519909118760165,-0.06289823718440052
25324,SIDM00778,Nutlin-3a (-),Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,0.7209104,0.014725066,0.1795961776163747,-0.006750491952258441
100595,SIDM00834,Palbociclib,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,White,66.0,1.4005883,0.11105152,-1.311382089490274,-0.015442929080955663
86516,SIDM00531,Trametinib,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.7482114,0.18703534,-0.4059160754499022,0.03361202420673981
50825,SIDM00097,Alisertib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.9824631,-0.16275714,-2.623631877866179,-0.11824104120947908
8819,SIDM00954,Alpelisib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-2.0857072,-0.13487998,-0.26301731513443327,-0.003158709723866437
73575,SIDM00875,Gemcitabine,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-7.282704,-0.025070868,-3.263662525877839,0.055920684770975934
89996,SIDM00673,ZM447439,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.78734875,-0.034286357,-1.375409968464605,-0.0458104289853543
101051,SIDM00628,Crizotinib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,0.23674367,0.019473402,-0.23996887042591067,-0.004835863970790971
86191,SIDM00774,ZM447439,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,1.4538022,0.0807642,2.3261764126677376,0.17088989027233814
75562,SIDM00301,LGK974,Ruxolitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.92419153,-0.0849768,-1.3590547774242925,-0.060159879035040664
56407,SIDM00097,Linsitinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5686331,-0.06478372,-0.5306063365329929,-0.04520617763397813
56850,SIDM00878,GSK269962A,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,2.682448,0.23208801,0.9376455778862196,0.028848735520570438
56468,SIDM00954,Luminespib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-1.3050038,-0.071791254,-2.357228344707192,-0.05408890341325933
85222,SIDM00954,Vorinostat,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-0.25084147,-0.0126747675,1.118013064099023,0.05406140231106242
23418,SIDM00529,KU-55933,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.91785103,0.021320088,1.1973672692311865,0.08325025950306812
35177,SIDM00954,5-Fluorouracil,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-1.1688898,-0.050393328,-1.5794361296502006,-0.05052790836786799
58495,SIDM00971,Nutlin-3a (-),Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.724635,-0.021021064,-0.5510662983923726,-0.014289707758380706
107922,SIDM00660,Vinorelbine,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,0.57498044,0.05597377,0.09558206054112753,0.01594386436673635
3425,SIDM00776,Palbociclib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-1.2151262,-0.01901568,1.7835891357580629,0.05963173024566128
81971,SIDM00673,PD173074,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-2.5831587,-0.08787451,-0.9450719956507467,-0.006682013960320456
76261,SIDM00146,Alisertib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.83954865,-0.063265145,-0.5753760977307617,-0.061212450257520645
29646,SIDM00628,Uprosertib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-1.7242813,-0.10355386,0.18617527376131734,-0.0346766675808758
75626,SIDM00332,KU-55933,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5681258,0.06674748,0.6781552863789163,0.018027358800711612
48839,SIDM00097,Taselisib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.9205813,-0.24909532,-0.7288234652036115,-0.09627984136515874
102926,SIDM00332,Crizotinib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.977926,-0.22867125,-1.6482438074393553,-0.10731258726438979
97611,SIDM00971,BI-2536,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.1612831,0.05983704,1.4705945168913441,0.14014905815944728
5749,SIDM00146,GSK269962A,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.97049797,0.07891252,1.3900540795758067,0.06505238518458198
78137,SIDM00776,Afatinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-1.0325503,-0.049103707,-0.14504114837785548,-0.0444718150924774
84290,SIDM00097,JQ1,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.46501526,0.02715283,1.9797678399578813,0.09373146447456537
39356,SIDM00893,PF-4708671,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.8505603,-0.064334445,-1.8252182868534454,-0.11221905857014118
74244,SIDM00971,Alpelisib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.429507,-0.092263654,0.9530789730774147,0.08225506338050367
35183,SIDM00628,JQ1,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-1.5616031,-0.09290681,-0.6741066389953206,-0.04668288846643583
98336,SIDM00878,PF-4708671,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-1.3169714,-0.053447913,1.0466792595191925,0.0799832586271785
79109,SIDM00866,JQ1,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-2.797818,-0.09533663,-0.17134936846435667,0.05106290194148695
83029,SIDM00834,Nutlin-3a (-),Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,White,66.0,3.2692025,0.0644205,2.5508305925747443,0.053581971779503156
51982,SIDM00971,Alpelisib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.8067886,-0.053049833,0.7513750293612297,0.06802477483696746
40318,SIDM00193,MK-2206,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,53.0,0.557125,0.0454339,-0.24059026622456145,0.032286323832597885
18172,SIDM00193,Crizotinib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-0.76271755,-0.033483066,0.1480755136457117,0.04731018464492958
10499,SIDM00878,Wee1 Inhibitor,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.1415184,0.085764654,0.49144308190611535,0.030384830323042622
71920,SIDM00130,OSI-027,Irinotecan,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.6500571,0.06983622,0.3093453483258195,0.023003223155947067
28570,SIDM00782,AZD4547,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,-0.4839307,-0.014265835,0.8038438402087043,0.009986904984777787
39333,SIDM00866,Axitinib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,1.0736978,0.08163183,2.6527837591269843,0.20082633017403215
16143,SIDM00878,PD173074,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.0945182,-0.10408881,0.27746726666868504,-0.005394089025234067
91742,SIDM00411,Gemcitabine,SCH772984,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.0533555,0.06480495,-0.5281275301724282,-0.045254391286394365
56585,SIDM00411,MK-2206,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.0840988,0.09091114,1.5646084966544462,0.12537263844754618
63272,SIDM00332,Tozasertib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5104623,0.03716264,-0.40324383326210034,-0.04160234813376553
10579,SIDM00529,Taselisib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,0.35855803,0.0233209,1.3796734475640662,0.09804326190957789
10753,SIDM00529,ZM447439,Trametinib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,1.7103792,0.15440558,-0.027537241484416716,0.07528378750594315
11036,SIDM00146,Crizotinib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.9427649,-0.07046285,-0.6061748384895272,0.012966616080266169
104731,SIDM00146,Docetaxel,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.15656263,-0.013623875,-0.3877411573417381,-0.031352214942657664
99230,SIDM00146,Navitoclax,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.2664731,0.019308705,0.38038632547929235,-0.013022159525241266
24774,SIDM00954,Doramapimod,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.0,-2.2532215,-0.08305414,1.4049890533822436,0.154163782209173
103074,SIDM00875,Alisertib,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6312454,0.1629323,1.495843700950994,0.07961567781452533
2586,SIDM00866,Wee1 Inhibitor,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.345311,0.029515639,0.20188606239790358,0.0609382233762425
89252,SIDM00782,MK-2206,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-1.0224707,-0.060815547,0.4088574549286177,0.055861596343375244
108293,SIDM00834,Olaparib,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,0.4641339,0.010678147,2.130518411964036,0.06383077815390478
73759,SIDM00359,AZD7762,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.0885565,-0.10950385,-1.916897330208968,-0.07871715436482979
59110,SIDM00866,Olaparib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,52.0,-0.80204064,-0.017706223,1.2444505864452902,0.035112817986396525
97452,SIDM00097,Sorafenib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.9315451,-0.03892687,0.3260558899366644,0.012127035242442876
3015,SIDM00359,AZD7762,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.0868087,-0.17878076,-1.5296839264727782,-0.06456460576632138
29866,SIDM00878,Docetaxel,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-3.536639,-0.30959874,-2.98970704522312,-0.229837005197823
22266,SIDM00332,Nilotinib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.3596406,-0.07185071,-1.0028875421268817,-0.05054619711130925
7641,SIDM00893,Tozasertib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.3276417,-0.06051386,-0.01233656092084737,-0.00956532975195019
28902,SIDM00529,PD173074,MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-2.4357507,-0.099723935,-0.3401092372547222,0.021324852906863114
94045,SIDM00776,AZD8055,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.7498409,-0.14082241,-0.5560425692544954,-0.040699424503291226
79186,SIDM00193,Linsitinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,East Asian,53.0,1.7818997,0.08180925,1.2954237371476083,0.10443241816018466
68792,SIDM00971,Alisertib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.056196,0.09897548,0.15211191718175904,0.025116337349861
91801,SIDM00866,OSI-027,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.7941987,0.059141185,0.41343661502870754,0.013837154998444122
13096,SIDM00673,Doramapimod,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.1595225,0.024707489,2.7011542019227157,0.05702565606615448
106868,SIDM00875,ZM447439,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3078929,0.14185138,0.948584982081379,0.11348439806873171
35901,SIDM00673,Vorinostat,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,2.7710848,0.20250703,-0.005999187074826384,-0.025007866829414763
98812,SIDM00097,Venetoclax,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3222613,-0.061720178,-0.8660963229800328,-0.05248710102057154
93541,SIDM00875,AZD6482,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.3318584,0.057814535,1.2306212551145708,0.043713365106521185
48466,SIDM00301,OSI-027,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.3646855,0.10972875,-0.853802653726781,-0.022073537372562308
28316,SIDM00878,Bortezomib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.37419993,-0.017449891,-0.47732812464385893,-0.05382278603524098
73829,SIDM00866,Pictilisib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-1.0433906,-0.08024105,0.07983498413003655,0.03697760436793927
102412,SIDM00893,JQ1,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.5056567,-0.08719954,-0.42424360791999555,-0.02332855511028389
61937,SIDM00359,MK-1775,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.9674524,-0.1462044,-1.2375935195638939,-0.039746214177877014
8162,SIDM00893,Taselisib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.55319506,-0.034906298,-1.0882299557764428,-0.07971665647189512
81426,SIDM00875,Temozolomide,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.82865286,0.018866217,1.0156298156689383,0.002508226397525577
63063,SIDM00146,Nilotinib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-0.7770473,-0.07710119,0.23666793924515278,0.006885239574768274
13878,SIDM00301,Oxaliplatin,Crizotinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.1792226,-0.21991618,-1.7505792617246088,-0.11765102451957085
77818,SIDM00878,Pictilisib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.0431098,-0.12431773,-0.04799872967677243,-0.04166625848752387
65042,SIDM00529,Afatinib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-0.956073,-0.055183083,0.582973206781117,0.01432943987716712
8750,SIDM00301,Linsitinib,Olaparib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.7692256,-0.05975188,1.1861936573856664,0.06725813228526552
8361,SIDM00878,Docetaxel,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.09264082,0.010988355,-0.008230741147797108,0.049204189151408374
101258,SIDM00878,KU-55933,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.9146734,-0.020521188,0.05797521529507782,0.0575551513942699
2499,SIDM00673,Navitoclax,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,5.6316886,0.39272425,1.2245971119928574,0.07294668199872678
83410,SIDM00878,Venetoclax,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.8398557,0.033814237,1.2004935541958532,0.08177960250066361
98965,SIDM00146,Paclitaxel,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.6419587,-0.14028148,-0.18432610255559595,-0.04262251252356055
88659,SIDM00893,Cisplatin,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.2128997,0.03048737,1.333586949165737,0.03298507035482221
43292,SIDM00673,Tozasertib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-3.788338,-0.20463099,-2.2269876061061558,-0.11936594585265373
779,SIDM00130,Linsitinib,Olaparib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.4915115,-0.06866674,-0.29873759477503276,-0.01040348079736546
85984,SIDM00529,Taselisib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,-0.6553045,-0.0422424,-0.40197243357674955,0.011141016186905717
31030,SIDM00332,Alisertib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.45493442,0.022537224,1.2551841095741076,0.047258060711711077
84160,SIDM00774,OSI-027,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.26664865,-0.036577784,-0.3172976968768031,-0.03626305667987509
49045,SIDM00774,PF-4708671,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,1.0760444,0.052075073,1.4500690241797083,0.04085169945393046
87145,SIDM00097,OSI-027,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8479828,-0.121058375,-0.4215624506741231,-0.0875811963042312
29572,SIDM00774,Tozasertib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.1547459,-0.031151902,0.3001638924603108,-0.005267743988342693
9353,SIDM00893,Pictilisib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2504785,-0.121548064,-1.566064962286351,-0.06869515376124413
41721,SIDM00332,OSI-027,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.025867,-0.06508883,-1.1644247153308351,-0.0772221114790022
10561,SIDM00875,Trametinib,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.80400026,-0.089746565,0.8139422437897504,0.0803007252579127
55099,SIDM00779,Oxaliplatin,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.6294804,-0.056919742,-1.2490954917095256,-0.04515030816467382
73147,SIDM00628,GSK269962A,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.042097323,-0.0038365428,-0.20051013873912332,0.048264693051903944
87736,SIDM00130,Cisplatin,AZD7762,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.9383448,0.064169854,1.5791543581105096,0.1944530199296913
61960,SIDM00673,Alisertib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,0.95141476,0.05661591,1.3692597279864416,0.10398347502969783
83824,SIDM00774,SCH772984,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,48.0,2.8573606,0.09812371,2.3516989166401907,0.09759791850885646
6342,SIDM00778,Trametinib,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-1.0169042,-0.036682323,-1.8162787616527996,-0.04737393855273554
100300,SIDM00774,Uprosertib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-0.9777704,-0.06691091,-0.4554141701049365,-0.059818244784268795
21303,SIDM00875,Axitinib,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6198784,0.04590212,0.7191483234537169,0.010871718532959195
78938,SIDM00774,Bortezomib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,48.0,0.38411602,0.024925789,-0.6071747837010066,0.014465231715145199
86491,SIDM01233,Vinorelbine,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,1.6285726,0.06003701,0.9060697043555879,0.08304064671521696
99308,SIDM00130,MK-1775,Crizotinib,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-4.4859324,-0.26921803,-1.4440515286962174,-0.09707654237054585
85025,SIDM00673,Luminespib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.8130877,0.16770157,-0.3828072357907151,-0.023307189618548132
68593,SIDM00359,Palbociclib,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.9251801,-0.0973924,-2.898931361621029,-0.07015963531446003
35527,SIDM00866,Paclitaxel,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.344941,0.11168279,-0.3575514393087339,-0.06385738902885173
86001,SIDM00875,AZD8055,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.94290316,0.10431864,1.4265489705945527,0.07297912912751552
31160,SIDM00893,SCH772984,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.1066222,0.082918935,1.2774516313755304,0.0389809487333634
12028,SIDM00529,PF-4708671,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Black,44.0,-1.3241447,-0.064458646,-0.24679973396256738,0.018809114757708398
72934,SIDM00875,AZD6482,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0147841,-0.06718269,-0.0056366405143173925,-0.020961054648643406
107845,SIDM00782,Camptothecin,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,Unknown,72.0,-0.8180056,-0.07888767,-1.9166888146480843,-0.08627602991029223
19135,SIDM00893,Camptothecin,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.4840808,0.11687991,2.017349506777877,0.16536827039847618
66177,SIDM00411,Trametinib,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,43.0,2.7150044,0.10586758,0.6919724767346597,0.0764917259131005
90467,SIDM00332,Docetaxel,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.2734277,-0.06667039,-2.027811839607315,-0.11255480869510112
98908,SIDM00774,Doramapimod,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.47933474,-0.022537095,-0.29501736260418887,0.037354131695126164
77582,SIDM00875,KU-55933,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.8001194,-0.06955206,-0.776824165829258,-0.04309463862099399
40904,SIDM00954,5-Fluorouracil,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,0.65182227,0.034338746,-0.3901016379068939,-0.006548002130992631
68551,SIDM00529,Alpelisib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.2834378,-0.04742799,0.20825034720536073,0.06684419140601995
83884,SIDM00878,Luminespib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,0.40056497,0.0499246,-0.9802789059538312,-0.056299238005008384
107889,SIDM00774,AZD8055,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,1.7828007,0.1356317,-0.8594735221202612,-0.06630472198862866
83671,SIDM00301,Crizotinib,Olaparib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-0.51440144,-0.060321324,-0.19805844394183791,-0.02336898854508829
95045,SIDM00893,Venetoclax,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.4696608,-0.07496723,-1.2781281576690706,-0.017195600202609525
45351,SIDM00673,OSI-027,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.4218658,0.0741543,-1.3620225850289227,-0.11992039225369203
26678,SIDM01233,Crizotinib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,72.0,-0.7590257,-0.046245564,-0.8640379316066147,-0.012987420222658858
98974,SIDM00332,Taselisib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.4222767,-0.240527,-2.1390295573068805,-0.1400201633046657
103599,SIDM00332,PF-4708671,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,0.46450403,0.012848644,0.33871139781174614,0.05764792909385512
107640,SIDM00531,Crizotinib,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.525672,-0.126088,-0.12019942305970592,0.0003120544125081813
56562,SIDM00673,Dabrafenib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.6649681,0.042933263,1.6809321837354767,0.057332118459753355
89792,SIDM00779,Linsitinib,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,0.7456711,0.01815969,-0.40810449997311243,0.0023727316307051724
24442,SIDM00146,Dabrafenib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,2.540183,0.1612272,0.5865738679366627,0.0566126540016489
104434,SIDM00146,Uprosertib,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-2.7411687,-0.1701651,-0.5550846734526259,-0.028788337203842565
95352,SIDM00097,OSI-027,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.4191356,-0.029426225,0.18417409940457294,-0.02416758903628967
79110,SIDM00875,Trametinib,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.0998082,-0.17881948,-1.477618215242287,-0.059572880384831044
33164,SIDM00660,5-Fluorouracil,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-1.2028676,-0.09198264,-1.3320455602735137,-0.09174747177274531
69464,SIDM00834,Afatinib,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-0.22909406,-0.015046146,-0.331762947330564,0.006241737720761483
91465,SIDM00971,Crizotinib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.5157275,0.16212514,2.85287971228262,0.15355003123935293
83243,SIDM00628,PF-4708671,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,-1.6172522,-0.1133321,-1.6625603265915683,-0.03973336303161663
106312,SIDM00776,Crizotinib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.9766589,-0.08843711,0.3390007749870753,0.012290996128143676
34224,SIDM00359,Navitoclax,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.193406,-0.068700455,-0.7262981699477781,-0.04648110707618034
58676,SIDM00130,Oxaliplatin,Navitoclax,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.196669,0.07391222,1.0851689041197183,0.08169570768319293
59501,SIDM00146,OSI-027,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.3197583,-0.120336406,0.8196643753798947,0.04968896871749646
2077,SIDM00866,OSI-027,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.994117,0.14139572,-0.08987886448555994,0.023643661612635078
22608,SIDM00866,ZM447439,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.185434,0.07834931,0.5847493457793019,0.06313461593680104
54673,SIDM00146,Camptothecin,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-2.8554804,-0.2343453,-2.078056879818363,-0.10804966648915795
39261,SIDM00774,JQ1,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.7375267,0.047748193,-0.8448679630061079,0.08067647591907298
37709,SIDM00778,Crizotinib,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,1.8492529,0.07912371,1.8506396734239685,0.10288820314579637
43947,SIDM00971,Ribociclib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.951103,-0.07874801,-1.4938779344417947,-0.03180722538032059
94939,SIDM00146,GSK269962A,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-2.3700466,-0.12130628,-0.9095751950514596,-0.006190404579967021
43217,SIDM00301,SCH772984,AZD7762,Pancreas,0.0625,Pancreatic Carcinoma,Male,East Asian,50.0,0.7855354,0.10969992,-0.17196621024384492,-0.038989114793468706
36136,SIDM00628,NU7441,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,0.7057098,0.068010285,0.29477237924384303,0.07690408173884514
100611,SIDM00893,NU7441,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.51307136,0.043992013,-0.9909711759505555,-0.02500919899944329
19315,SIDM00673,Crizotinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-3.0495121,-0.15772843,0.6279185959423478,0.06222692807243514
100242,SIDM00878,Trametinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.76077014,-0.024007319,-0.22204644314945182,0.005402765470386563
55640,SIDM00660,Nutlin-3a (-),Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.8679585,0.021724384,2.635238723578158,0.05382685854053043
13116,SIDM00971,Alisertib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.9884626,0.025023399,-0.052238051720446786,-0.007907502502189122
34458,SIDM00628,JQ1,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.9833755,-0.05155232,0.5955302245783543,0.09657360728194618
91481,SIDM00893,Entinostat,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,5.5125484,0.23943004,1.9029785046018197,0.019052183833355225
94687,SIDM00193,Camptothecin,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,East Asian,53.0,6.5950613,0.5208538,4.037953113124625,0.28938761285441084
59647,SIDM00878,Sorafenib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-0.5029082,-0.0458848,-0.5346574917099219,-0.026626629041080315
88709,SIDM00971,Navitoclax,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.570724,0.1627262,0.5504134440240719,0.040306068536305334
86038,SIDM00332,Temozolomide,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,2.5244064,0.057358354,1.5553504582537023,0.043935020658476306
95579,SIDM00878,Tozasertib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.073838,-0.09086424,-1.7860472172811155,-0.09940143756942517
5787,SIDM00673,SCH772984,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-3.5033123,-0.18025152,2.142677275569557,0.07077560207188884
8814,SIDM00146,PD173074,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-1.5663811,-0.10050008,-0.5451648874032498,0.03536721030038274
67302,SIDM00893,Linsitinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.5141116,-0.05946965,1.7596274878420586,0.11053851357149086
90517,SIDM00359,Afatinib,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.6426915,0.04103272,-1.8268902175274009,-0.06435314565242882
54504,SIDM00332,5-Fluorouracil,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.2924104,0.080461755,1.7145039167855871,0.04870046715734594
18108,SIDM00866,Temozolomide,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-1.2450017,-0.019751929,0.1708125669089002,0.00976648048569996
48016,SIDM00774,Dabrafenib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,1.7256342,0.06704581,1.2834999308324837,0.057300874256984026
96573,SIDM00971,Palbociclib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.4351414,-0.0349131,-0.5958922689291996,0.01545132580163575
30787,SIDM00529,Wee1 Inhibitor,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.37219134,0.037311047,0.5229093638280553,0.06972736315758285
43211,SIDM00628,Docetaxel,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,-0.05635192,-0.0050636847,-1.041409165960639,-0.06258966968091939
58225,SIDM00954,Luminespib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,-0.89321876,-0.07083023,-0.9219582310704275,-0.0855644049863692
82943,SIDM00531,OSI-027,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.965854,0.024024136,2.458238934124173,0.09912146934740035
73091,SIDM00782,5-Fluorouracil,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,Unknown,72.0,2.5780299,0.1572237,1.099192391518945,0.03666633480634231
104734,SIDM00866,Trametinib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,2.685146,0.15701415,1.3480553907466997,0.09533339482321829
3755,SIDM00954,5-Fluorouracil,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-0.59643376,-0.026490016,-0.12089620810767361,0.001046133150344031
94525,SIDM00774,Dabrafenib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,3.2473645,0.13766058,2.1080879137037636,0.0407923224889638
52419,SIDM00097,JQ1,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.3011384,-0.16302489,-0.782734087264576,-0.10658232084791848
107705,SIDM00878,Wee1 Inhibitor,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.6837152,0.055489253,-0.3234040701630227,-0.029322488420550373
20658,SIDM00875,Cisplatin,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8572031,0.047288746,-0.1311013709962311,0.022519786615593118
6089,SIDM00301,Lapatinib,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.4136661,0.07404471,2.6318554594208883,0.13067480106213555
79289,SIDM00866,Sorafenib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,0.24629407,0.012109943,0.6821845279050721,0.036572806022096456
58853,SIDM00893,Docetaxel,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.6472584,0.06362952,0.12149128135187769,0.0393715109007174
705,SIDM00529,GSK269962A,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.7967062,-0.11763451,0.10049765606203273,0.05479633406536052
98414,SIDM00878,JQ1,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.6017959,0.12662269,0.9488198802623138,0.03552559052247781
24553,SIDM00893,Tozasertib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.548126,-0.026843766,0.4416524354925237,0.11369300356720002
16573,SIDM00411,Gemcitabine,5-Fluorouracil,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.0867524,-0.117159545,-2.2349013542139837,-0.07190243555172884
94516,SIDM00954,Linsitinib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-1.5679842,-0.12162216,-0.9436052479291825,-0.0178266933455958
14471,SIDM00866,Lapatinib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,52.0,-0.46960947,-0.03978845,0.014999215284388367,0.037854787347898794
100671,SIDM00332,Paclitaxel,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.50144285,0.037605472,-1.350768573335476,-0.14679447184232786
34984,SIDM00673,Alpelisib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-1.8343879,-0.09167476,-1.5597328959630987,-0.05321805143024571
57926,SIDM00878,Dabrafenib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,2.4619606,0.046304442,1.1560865688259185,0.010926214669994305
63724,SIDM00130,Linsitinib,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.247684,-0.041760612,-0.28072110826907143,-0.022680596626572094
7212,SIDM00332,5-Fluorouracil,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,3.1332943,0.24519017,1.1216030113582711,0.06429775856076089
67835,SIDM00878,Camptothecin,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,1.0780106,0.030380247,2.0104079872087484,0.07841620375411991
104926,SIDM00146,Trametinib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,2.280788,0.14165407,3.3572599966859795,0.14983768379197274
78344,SIDM00875,Crizotinib,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1792529,-0.12267898,-0.8892744468514447,-0.0709449908878702
19289,SIDM00193,Oxaliplatin,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-0.6923294,-0.02132123,0.21853019584309236,0.04091026505305393
80375,SIDM00301,Ruxolitinib,Trametinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.9877259,0.08646498,1.806862204201222,0.027556899818308132
80558,SIDM00774,SCH772984,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,3.928921,0.15066493,2.251976589450364,0.1327052619631403
16529,SIDM00875,Bortezomib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.71058136,0.054607317,0.5320354781527148,0.049904855399876484
25825,SIDM00878,Venetoclax,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,0.7378659,0.023061594,0.014931112451272419,0.019832159472894812
18422,SIDM00774,Axitinib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-1.4520826,-0.10274194,-0.8733199679406338,-0.020094592867919727
36864,SIDM00954,MK-2206,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-1.2250422,-0.094217226,0.042577191438579715,-0.00952772573396672
94952,SIDM00332,Camptothecin,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.81267333,0.020831319,3.1169841043795135,0.1008831782122402
13845,SIDM00834,AZD7762,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,White,66.0,3.5510025,0.2473904,4.230733391133722,0.25657488669692946
9195,SIDM00673,Tozasertib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-3.7535563,-0.19662207,-1.8371501193072175,-0.17619032434952445
27348,SIDM01233,BMS-754807,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,2.037928,0.074142866,1.422244261691471,0.03416612178878016
27333,SIDM00660,Taselisib,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,32.0,1.0323565,0.060510475,-0.0965442215113292,-0.021114087238229235
15283,SIDM00628,Linsitinib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.5910775,-0.02829863,0.6782106139742025,0.04837476444074674
5176,SIDM00893,Vorinostat,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.3641689,-0.075641684,0.18875049725104898,0.0410829814957196
10724,SIDM00359,Nutlin-3a (-),Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,3.8783672,0.1561483,2.4949929428558058,0.06068859024213715
80733,SIDM00954,NU7441,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.0,0.6595711,0.052973844,-0.37783207589834983,0.022679283829700192
28259,SIDM00301,OSI-027,Ruxolitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-0.33350518,-0.04627738,-0.32269152948850444,-0.07601685426679981
94832,SIDM00529,Temozolomide,Axitinib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.4762224,-0.009374313,0.011414248174564094,0.044977083797401084
82796,SIDM00130,MK-1775,MK-2206,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.44884917,-0.042112194,0.08084426685374965,0.004271462233129272
88130,SIDM00954,BI-2536,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.0,-2.475798,-0.062438782,-0.40034276799422963,-0.01045612285978162
39605,SIDM00673,AZD8055,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.3724741,-0.07994608,-0.619975547838866,-0.03318606917231693
1445,SIDM00531,Dasatinib,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.3102974,0.13254026,0.9138103418809822,0.09801293045039101
37712,SIDM00954,MK-2206,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-0.58946973,-0.04624168,1.3961553260358375,0.0670565554856072
30072,SIDM00774,Alisertib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,-0.5865298,-0.037616458,-0.636476385180591,-0.08460524681075911
24206,SIDM00097,Navitoclax,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.77015084,-0.049207263,-0.6077255301894229,-0.03192025206799195
46858,SIDM00954,AZD6482,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.56074667,0.03312956,0.29803364527702125,0.07996567051439425
28297,SIDM00332,Camptothecin,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,3.8965027,0.08281234,2.5167616591289463,0.028088169681347988
18484,SIDM00130,OSI-027,Cisplatin,Pancreas,0.8,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.2343519,-0.11495256,-0.5684277634805766,-0.06064300002940274
13000,SIDM00301,LGK974,Palbociclib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.0409143,-0.06752827,-1.8436648089806178,-0.08001680829107273
1199,SIDM00130,Dactolisib,Dasatinib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.27584118,0.020907432,-0.06726841730134407,0.026440261936832802
48724,SIDM00878,Taselisib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,0.7487454,0.049295217,1.3245022326970095,0.0742520566975088
68606,SIDM00411,Crizotinib,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,4.4097395,0.2664966,3.3102666459846053,0.19357903993001518
11359,SIDM00776,Vinorelbine,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-0.23601666,-0.01114524,1.02547266352608,0.05274785273333475
101499,SIDM00130,MK-1775,Lapatinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.8217364,0.073653184,0.3711315935325406,0.022625983176626514
5262,SIDM00332,Docetaxel,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.5039756,-0.2037485,-1.270938896010153,-0.08219297674200453
26125,SIDM00866,Sorafenib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,0.5334576,0.02731353,1.1446440244089076,0.08990975822861506
4960,SIDM00893,Crizotinib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.0310953,0.043132838,2.989340610988907,0.14036901557986786
63859,SIDM00097,RO-3306,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,5.0567784,0.31057003,2.874669813433527,0.20746822361059125
91669,SIDM00660,Dabrafenib,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,-1.583289,-0.074179254,-1.030549694009681,-0.016614179152328
40165,SIDM00301,Irinotecan,OSI-027,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.85410386,-0.07261384,-1.213130212109168,-0.07338152931531049
74191,SIDM00359,Vinorelbine,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.5776811,0.08333395,0.9999991230414563,0.08782506167008858
46123,SIDM00332,Nutlin-3a (-),Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,2.7710407,0.06930093,1.5365162003289903,0.018810394233283467
53083,SIDM00628,Trametinib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.4620805,0.099513024,1.3381224257611906,0.12554201387240568
9095,SIDM00130,Irinotecan,Taselisib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.82255274,0.06884797,-0.1731097163540869,-0.009238304344651237
67469,SIDM00878,MK-2206,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,70.0,0.47777203,0.056580767,0.10051809179311699,-0.03660350290265195
74461,SIDM00782,Afatinib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.5747213,-0.04982819,0.15776666605236941,-0.007915926740457059
17117,SIDM00954,RO-3306,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,0.59762675,0.04671883,0.07321054620491262,0.03070523963473999
106541,SIDM00628,Dabrafenib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-1.9212046,-0.12156219,-1.625040343234568,-0.051674857383710956
99937,SIDM00954,Axitinib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-4.003606,-0.25420475,-1.086470788828249,-0.141856031202483
67639,SIDM00673,Axitinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-3.4711764,-0.26703784,-1.7499688689363935,-0.11699905185950069
92006,SIDM00531,Erlotinib,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.5839375,0.05720721,0.6613295685207704,0.06998891577474821
14780,SIDM00866,GSK269962A,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-1.7653989,-0.065022975,-0.7507543779856802,0.001074341010535381
59836,SIDM00097,Palbociclib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.134548,-0.08048892,-0.4119616497463262,-0.004744567778725689
35815,SIDM00529,Sorafenib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Black,44.0,0.9133244,0.094853446,-1.744794920205331,-0.08153894544295905
69187,SIDM00866,MK-1775,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-4.557247,-0.3482755,-2.725563583481012,-0.18669271078005198
15011,SIDM00332,Temozolomide,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2233168,-0.027784016,0.14323192659781617,0.012378926793049947
17807,SIDM00782,AZD8055,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.3498005,-0.030555926,-0.8027351165368245,-0.02086810900439077
30742,SIDM00332,Navitoclax,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.38496026,0.038753014,0.5099398208853887,0.02555586235685294
24695,SIDM00971,Linsitinib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.0625288,0.045673583,0.657715356325666,0.07084977789508193
10593,SIDM00531,Crizotinib,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.4350653,0.25753257,0.7173610059712751,0.10919929052221178
53313,SIDM00971,Navitoclax,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.7757292,0.019485775,1.207627876339105,0.10638033295197506
4873,SIDM00628,Venetoclax,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-2.6336186,-0.09552286,-1.0459804243971176,0.006244724109832228
91776,SIDM00146,Dabrafenib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,1.9466523,0.1295194,0.9939866117964357,0.09966631222176853
28729,SIDM00954,BI-2536,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-1.0090994,-0.020732474,0.011120014364204518,-0.023672496204734193
37283,SIDM00834,Navitoclax,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,4.3405805,0.36840215,0.9652179363927963,0.04942652705503421
59774,SIDM00146,Uprosertib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.7265174,0.1364409,0.3888064410197248,0.08771077308334903
108235,SIDM00332,Afatinib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.8280065,-0.13237362,-0.7985325886963764,-0.02553020092430464
95497,SIDM00660,Vinorelbine,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,32.0,0.86166745,0.05561673,0.17467073448740905,0.041945716712302364
55310,SIDM00971,Taselisib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-4.4208407,-0.23948543,-0.5620869887485185,-0.05168775939930251
76995,SIDM00531,Paclitaxel,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.6924686,0.21923472,-0.22226055114367677,0.007752314701346788
51663,SIDM00893,Lapatinib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.4829036,0.14649852,1.8005841640896485,0.07355081563296643
75423,SIDM00893,ZM447439,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.3160338,0.09904747,-0.5438102565339701,-0.03749866508087802
27977,SIDM00774,Alpelisib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.81820846,0.054021,0.4033920094804773,0.06900236331541712
63139,SIDM00774,MK-1775,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,0.2875332,0.035547882,-0.49063409145680387,0.00936545033693178
53331,SIDM00660,Taselisib,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,2.5916355,0.23111151,1.38991265318243,0.07819138796783479
82687,SIDM00774,Olaparib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-1.3461491,-0.052681264,-0.7007700770208231,0.027336697109397966
95853,SIDM00878,GSK269962A,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.2881598,0.024108782,-0.534180130758888,-0.018771210763865953
4877,SIDM00866,AZD7762,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-2.0829654,-0.15469038,-0.5359847142285323,-0.026315692333588242
28160,SIDM00893,RO-3306,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.51172376,0.03900552,0.039063666849131984,0.04321419621363951
36035,SIDM00146,Linsitinib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.3749948,0.03935201,2.1886538203986214,0.07438122995638755
15616,SIDM00628,NU7441,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-1.0864849,-0.101148516,-0.3886163584499389,0.02041768513730487
104992,SIDM00332,MK-2206,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.95016867,-0.080929,-0.5821063466714967,-0.10009021802980078
108233,SIDM00146,NU7441,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.1052405,0.0918377,-0.18476581110623355,-0.0037997167405115716
5518,SIDM00774,Cisplatin,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,4.3023086,0.13626383,3.3232269810020534,0.1460427317367981
6637,SIDM00878,Uprosertib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.0061127,-0.05920301,-0.6086812138855944,-0.059245436550965314
25658,SIDM00130,Paclitaxel,Linsitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.77527165,0.0719889,-0.21969181745873304,0.0018309189752734962
19585,SIDM00301,Dasatinib,Taselisib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,2.0196035,0.22047587,1.6529318412863674,0.14767153165252248
83327,SIDM00097,Paclitaxel,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-5.593712,-0.31028825,-3.812709308849035,-0.2491717656123864
2161,SIDM00359,Camptothecin,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0623325,-0.066947,0.30427271413639295,0.04913502007358673
93889,SIDM00782,BMS-754807,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.0259104,-0.079808414,-1.4003184180694166,-0.08404530782148087
73012,SIDM00097,BI-2536,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9681839,0.059720077,1.480238637336325,0.1178511901101681
16612,SIDM00660,Dabrafenib,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,-0.23542832,-0.020376764,0.4527224082888573,0.06643515173218698
88515,SIDM00146,SCH772984,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,1.0241086,0.08436255,-0.3060538370835037,-0.02271402136685763
96541,SIDM00776,Palbociclib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.68981427,0.025131777,1.1476524947763929,0.03284067176772088
89180,SIDM00774,Alisertib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.2541595,-0.06792055,2.1685089703517306,0.08978051375038111
78608,SIDM00878,Nilotinib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,1.0666505,0.100901656,-0.25190719374277937,0.04063609147096006
77587,SIDM00673,MK-1775,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-1.299885,-0.1044004,-1.164060820008187,-0.07416676465323185
48633,SIDM00774,Pictilisib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,48.0,-0.2600135,-0.010011908,-1.0628102933506642,-0.017944448940069538
31142,SIDM00529,5-Fluorouracil,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-1.5749478,-0.13289785,-0.6945814494952147,-0.023607979313443387
12477,SIDM00971,AZD8055,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.2881637,-0.07462606,0.16275216219442207,0.06522006789326086
33570,SIDM00673,Taselisib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.1230923,-0.119784,-1.4729461290920425,-0.048817885842794416
64518,SIDM00954,Camptothecin,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,5.3005958,0.13734701,3.0619327041841387,0.1758017260676844
80326,SIDM00359,Oxaliplatin,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.1729336,-0.10404181,-2.1092582045944743,-0.06194607939755468
40121,SIDM00893,AZD8055,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.8599404,0.15552779,1.0771814266246245,0.1275271381090946
103943,SIDM00893,Doramapimod,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.32329127,0.01282908,-0.10053176000246243,0.00169205598378756
55631,SIDM00893,Crizotinib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.556,0.021757646,2.042901258647812,0.05061005475864229
48211,SIDM00834,AZD7762,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,-1.5903432,-0.07421823,0.3148687393783951,0.027152534630368885
32203,SIDM00097,Luminespib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1383636,-0.12934832,-0.9717795171493069,-0.10952091541337104
85031,SIDM00878,PF-4708671,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,70.0,1.7296238,0.119254425,0.856258476362581,0.09790118765504775
82538,SIDM00834,Camptothecin,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,White,66.0,-0.7364395,-0.059221234,-2.2148577269026246,-0.11135108271638532
49262,SIDM00673,Axitinib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.34729818,-0.035477575,-0.4573556338831492,-0.008312052458343626
21186,SIDM00782,Vinorelbine,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.3958142,0.08746388,0.7746488259552512,0.06920253621499653
69844,SIDM00893,Gemcitabine,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.4352823,-0.106998034,-0.20378246951530687,0.061417627614153335
31506,SIDM00779,SCH772984,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,33.0,1.0231171,0.0717675,-0.8837702763634512,-0.03856534190449101
86199,SIDM00834,Trametinib,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-1.8000674,-0.06427996,-1.2713736742533432,0.009579648095714391
37509,SIDM00628,Taselisib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,0.78918546,0.060967024,1.7818457011210573,0.12605313379970934
103216,SIDM00332,Taselisib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9654761,0.086648636,1.1161502409272372,0.012125478180514111
92651,SIDM00529,NU7441,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.5458628,0.047576506,0.567873354229419,0.08836981794188514
60216,SIDM00779,5-Fluorouracil,Afatinib,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,-2.1410384,-0.08564849,-0.2285225472203942,-0.01193103533632866
6902,SIDM00866,Crizotinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,52.0,-0.17954148,-0.01574832,-0.21716642090843558,-0.022649495841800968
95456,SIDM00778,Navitoclax,LGK974,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,0.17626509,0.011733219,-0.13094672878732003,0.014002781952007357
107561,SIDM00778,AZD4547,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,2.9804482,0.10758994,0.26478983720753957,-0.005554717639049492
12863,SIDM00673,Pictilisib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.22663304,0.02196138,-1.1967359768860912,-0.1014819122836384
33439,SIDM00628,JQ1,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,6.0799446,0.34672865,0.9396707257465367,0.09053365620192426
32948,SIDM00130,SCH772984,Dactolisib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.0258832,0.177381,1.0782648771586494,0.09639132724324273
82911,SIDM00954,Crizotinib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.3324305,-0.10460764,-0.5792031325346741,-0.040989894016418844
52061,SIDM00866,Axitinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,0.3046646,0.01761905,-0.6570290553562984,-0.015938293531584647
87992,SIDM00875,KU-55933,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1332386,-0.04938123,1.2475077750753552,0.07916645380579117
88970,SIDM00332,Ribociclib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.1665287,0.2311891,-0.368492625494163,-0.005216762590095261
35677,SIDM00146,Afatinib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,1.388669,0.08266109,1.1104538338699415,0.03176740286322801
88545,SIDM00628,ZM447439,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,0.50054115,0.03730723,0.09527509712517591,0.039925699976379674
33396,SIDM00359,Afatinib,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.5303295,0.18763635,1.5917317853681328,0.08187151412613894
27522,SIDM00782,Linsitinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,3.605289,0.2502497,1.5369812086579002,0.10771206549882874
104354,SIDM00531,Irinotecan,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.4507595,-0.17328589,-1.3794339398556945,-0.09937305731022249
88753,SIDM00782,LGK974,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-2.497147,-0.1284164,-2.2745841652950887,-0.11816155028018348
50264,SIDM00628,Ribociclib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-0.06138133,-0.001613368,0.9531576812292962,0.06688919703132218
66146,SIDM00778,SB505124,Oxaliplatin,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,0.4294861,0.028353829,-0.9716006862863809,-0.019770196694310797
97059,SIDM00301,AZD7762,OSI-027,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.8899794,0.20284571,0.8152776420322028,0.08199723152044665
34134,SIDM00774,Venetoclax,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,0.71962565,0.018349519,0.9064881778864257,0.013009685402749908
39399,SIDM00097,JQ1,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.6886342,-0.10189125,0.06978741509066778,0.044818082498635135
22935,SIDM00146,Cisplatin,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,0.3161133,0.009201484,1.71871188771964,0.0759566083341131
69996,SIDM00097,Uprosertib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6413922,-0.09242116,0.35650079126265555,0.04748907218967886
48778,SIDM00776,Taselisib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.7896051,-0.07053102,-0.967822046365239,-0.10911663339478551
35064,SIDM00411,Trametinib,LGK974,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.3619295,0.04494626,-1.0268572495595303,0.007603138581006613
63646,SIDM00778,5-Fluorouracil,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-2.410688,-0.077106886,-0.3784302487538549,-0.06459280845107306
67708,SIDM00954,AZD7762,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-1.8491155,-0.09068925,0.04079656494025839,0.0018216944672773973
67555,SIDM00866,BI-2536,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.5771705,-0.032667197,0.2580332105350662,0.0018577023456077
50970,SIDM00866,Vorinostat,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,1.3050438,0.101996236,-0.6787133349812638,-0.02967217899213712
80872,SIDM00660,Vinorelbine,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,1.6593767,0.17502417,1.8511095144402825,0.1086867371247835
43637,SIDM00359,SCH772984,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.40692195,0.026912453,1.336420645823778,0.05725853873886485
57152,SIDM00332,Tozasertib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.153985,-0.15829471,-0.8797384722271234,-0.130783294314011
19611,SIDM00774,Venetoclax,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.60215926,0.014797178,0.9081408915536541,0.024960852588868605
71568,SIDM00776,Olaparib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,0.9875958,0.047967408,-0.8730245192682771,-0.02706539012445351
25385,SIDM00332,GSK269962A,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6914234,0.024311338,1.6252089898105642,0.11187090222810102
8454,SIDM00332,Crizotinib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.9961642,-0.13545793,-1.4010112178834853,-0.06380029718468451
76355,SIDM00529,Crizotinib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,0.92607486,0.05943905,-0.7087742114855069,0.024322931834535967
94004,SIDM00893,Nilotinib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.7031336,0.15488784,0.8379528175301371,0.06128706494860983
73445,SIDM00875,NU7441,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4253612,0.039166667,-0.42061790419895717,-0.044160118779613004
13515,SIDM00411,Crizotinib,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,3.7200377,0.20252597,2.6744805925984347,0.19538253748097248
52634,SIDM01233,Oxaliplatin,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,-0.9951664,-0.08611355,-1.3323866355520133,-0.07959617366279476
77817,SIDM00628,PD173074,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,2.1094294,0.04732501,0.707545523579523,0.028618191721979935
51353,SIDM00411,5-Fluorouracil,Palbociclib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.9525366,-0.086776786,-1.5303784783271297,-0.0256895840913787
279,SIDM00779,Linsitinib,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-1.9856652,-0.103351995,-1.9702451375804086,-0.1605432529075907
99972,SIDM00774,Nilotinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,-2.595475,-0.16966304,0.13361717450944258,-0.012441800601830711
13283,SIDM00332,SCH772984,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.8835967,-0.10147871,-1.6256731885250824,-0.08104702899005067
38839,SIDM00531,Crizotinib,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.81273884,-0.07154564,0.2588009730050051,0.05855823785772826
17178,SIDM00971,Pictilisib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.3449581,0.05583568,1.538981240866304,0.07739546525577096
95244,SIDM00332,5-Fluorouracil,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2089787,0.07920963,0.7688126300486481,0.055652446949954956
27045,SIDM00954,JQ1,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-2.5093327,-0.20170753,-0.90081069361994,-0.08813899125386192
3830,SIDM00660,MK-1775,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,-0.42047778,-0.018614724,0.4479449568395862,-0.0013034655261810746
102127,SIDM00130,Taselisib,Cisplatin,Pancreas,0.8,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.6793834,-0.16443321,-1.7019238107778767,-0.04582911983308114
82212,SIDM00774,AZD8055,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.3210434,0.08251546,-0.6096450165879715,-0.009024276670047257
68729,SIDM00779,AZD4547,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-6.457262,-0.03381756,-4.884448065506905,-0.07998046989883803
57276,SIDM00529,Linsitinib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.4762193,-0.048797734,-0.032387327097618136,0.04291628278790626
29894,SIDM00411,Dactolisib,LGK974,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.8684356,-0.107529856,-1.5306530241814076,-0.10117968420872728
72976,SIDM00776,Trametinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,6.2294765,0.22278824,2.8152317860159783,0.08926699662843628
82910,SIDM00193,Vinorelbine,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-1.971882,-0.17223419,-2.065234434459825,-0.09280761959846695
57000,SIDM00146,Doramapimod,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,3.5411513,0.26178172,1.935492154925948,0.06526112306700174
8832,SIDM00878,Venetoclax,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.207252,-0.035863977,-0.07920665544370081,-0.00750107939131812
82089,SIDM00954,NU7441,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,2.278074,0.17258465,0.3277537751765943,0.06376081549998422
64253,SIDM00782,LGK974,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.6685783,-0.048779607,-1.178964502923871,-0.05005095852178672
70359,SIDM00774,Alpelisib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.54017013,-0.035366207,0.1838076757796263,0.004165546009098419
76633,SIDM01233,LGK974,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,1.6467623,0.11954312,-2.443415424414538,-0.05908036304084775
104650,SIDM00834,AZD7762,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,3.5967517,0.15221438,0.9511724952567513,0.1447849253796544
7276,SIDM00097,Wee1 Inhibitor,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1858264,-0.065462545,0.6530354096123175,0.022216109799476122
8158,SIDM00529,AZD6482,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,0.23822792,0.0074640955,2.3057279518737133,0.10083190096274149
90418,SIDM00411,Oxaliplatin,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,43.0,0.3283743,0.0106453225,-1.1073253514970132,-0.0222686098417828
19291,SIDM00660,Palbociclib,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,3.0804346,0.19054043,2.243647747078498,0.08415504980407117
102346,SIDM00097,NU7441,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0462608,-0.08399713,1.3730184258896212,0.10134536353512662
7197,SIDM00673,Palbociclib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,1.1840881,0.06862592,0.193365516685778,0.014351021678630838
37327,SIDM00776,LGK974,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.3295261,0.08005963,0.7915203582152999,0.07998000528017042
52210,SIDM00878,Docetaxel,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-1.341546,-0.15286836,-2.8867837260958753,-0.21179208967881152
40577,SIDM00660,BMS-754807,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-1.2930554,-0.122567855,-1.9153985384497796,-0.12062319490889048
94595,SIDM00097,Dabrafenib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1957479,-0.08274422,0.5320578969749766,0.03560420351972758
82884,SIDM00866,Entinostat,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.6359735,0.11592813,0.6259026347594827,0.032554944358680504
102632,SIDM00628,Entinostat,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.1784285,0.0872238,0.4515258081146734,0.0825069246591062
25059,SIDM00660,Afatinib,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,0.5812978,0.050162796,0.39851737578751883,-0.00540908760207122
62348,SIDM00893,MK-1775,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.37995943,-0.03823442,-0.8075506437852481,0.00299531559249109
8901,SIDM00130,MK-2206,Taselisib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.9340711,-0.057403997,-1.4223319825651788,-0.04417274033492018
102452,SIDM00529,RO-3306,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Black,44.0,1.3987604,0.063472465,0.870748646864592,0.046673012244644756
17175,SIDM00971,Entinostat,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.9691837,0.1178662,1.8134031643323105,0.11455161535033327
37915,SIDM00628,PF-4708671,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-1.7563062,-0.16280311,-0.679787660232102,-0.04092549634379765
43548,SIDM00866,5-Fluorouracil,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.9001962,-0.02872834,0.35003985636752327,-0.008061429847331106
77501,SIDM00971,Axitinib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.355455,0.067681395,-1.1488338434618803,0.003561756250264699
84993,SIDM00193,Oxaliplatin,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.27869767,-0.009313947,0.6394015895794058,0.04583056250733231
77263,SIDM00673,BI-2536,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,0.63383245,0.035010748,0.5881745103530728,0.057514250537521155
72481,SIDM00332,Venetoclax,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,3.3374305,0.13718277,0.27305101615102756,0.014338466219335412
105755,SIDM00332,Linsitinib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9710449,-0.028979668,1.24300402258548,0.007787954491076701
35108,SIDM00529,Camptothecin,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,1.7712195,0.09034933,0.4300002720994671,0.050960885637694436
55957,SIDM00834,Olaparib,Navitoclax,Large Intestine,0.1,Rectal Adenocarcinoma,Female,White,66.0,0.56455314,0.014609949,2.094868821576398,0.06467678074937892
105995,SIDM00332,AZD7762,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.933154,-0.16529481,-1.3796768099629386,-0.061830650916304984
23380,SIDM01233,Camptothecin,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,72.0,-0.8429118,-0.026124133,-0.32717018098728434,-0.002809226502954212
30005,SIDM00878,Wee1 Inhibitor,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-1.829388,-0.0692819,1.1979327117005902,0.0651488103139779
57617,SIDM00774,Venetoclax,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,1.7167854,0.04831672,2.0081947668431597,0.04230788822844533
67507,SIDM00332,Taselisib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.814666,-0.10820029,-2.643357696241595,-0.12677119144416313
22669,SIDM00971,PF-4708671,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.4427568,-0.023725597,0.2666329355246669,0.06631149599192726
28650,SIDM00097,Nilotinib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.6022723,0.041166224,-0.44457307962808756,-0.05948398271808432
32757,SIDM00359,Oxaliplatin,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.2195766,-0.07869773,-1.8110552532958197,-0.04275280084829553
14965,SIDM00673,BI-2536,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.40714896,0.026127495,-1.965566189331127,-0.13459613687861305
40718,SIDM00778,Vinorelbine,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,0.92628145,0.05794392,1.067200422023138,0.09561343110101918
100766,SIDM01233,BMS-754807,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,72.0,-0.48506153,-0.036157787,-1.6708516354107437,-0.09519948996583112
18449,SIDM00776,Palbociclib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.409187,-0.043513957,0.2376340497740119,0.04063754354330582
17133,SIDM00954,Camptothecin,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-0.38788012,-0.010638489,2.792468716669327,0.08458437546991601
19162,SIDM00411,Paclitaxel,Irinotecan,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.9653919,0.078270465,-2.8865188839338654,-0.047495216928859094
64417,SIDM00878,Uprosertib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.5300969,-0.027486594,0.3155912785560236,0.05346189207305946
99717,SIDM00531,Trametinib,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.4628332,-0.04184518,-0.08629948303705261,0.04161380200141423
18132,SIDM00660,Taselisib,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,1.3037149,0.10012183,0.6053396143452621,0.008138730581571
104422,SIDM00097,Bortezomib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8866146,-0.05129075,-1.1864600292296192,-0.04105847226811203
16567,SIDM00866,Ribociclib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-3.3729198,-0.11916766,-2.069415372068326,-0.06706377635831368
97047,SIDM00893,BI-2536,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.8762956,0.054045033,-0.901665429676705,0.05066951553131619
71345,SIDM00529,Axitinib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.2718354,-0.09733018,-0.5011888769088494,0.008291358903549382
33540,SIDM00097,Vorinostat,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0898988,-0.07957534,-0.6621263245862508,-0.07947637246962368
88662,SIDM00628,Vorinostat,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,1.1029557,0.08913171,0.4856436805366222,0.04320600543430581
31323,SIDM00954,RO-3306,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-2.0948145,-0.15731643,-0.6530419901749331,-0.01196393798598006
38022,SIDM00332,MK-2206,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0886794,-0.10832213,-0.6606563234403712,-0.06345590624299746
106438,SIDM00130,Irinotecan,Paclitaxel,Pancreas,0.025,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.041584,-0.13256332,-1.9419322997678137,-0.1164698884189221
21555,SIDM00673,Sorafenib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.416389,0.102884136,1.1803665155977865,0.03960322065596708
101673,SIDM00529,Bortezomib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.53846043,-0.044962455,-2.3393944228504027,-0.08857248051808911
46220,SIDM00778,Camptothecin,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,-0.52663445,-0.011069204,-0.40474311553848497,0.00020519923088338233
73385,SIDM00878,Palbociclib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.0998935,-0.072052814,-0.5455632696099139,-0.0309331894678116
74021,SIDM00628,AZD8055,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,Black,51.0,-0.45392358,-0.038645446,-0.9505328001566496,-0.03591148992246596
13431,SIDM00673,OSI-027,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.5575273,0.05686903,-0.03419473203093664,-0.0005170068939709606
85337,SIDM00875,JQ1,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.0541816,-0.117628515,-0.0012559058782775736,-0.004158721119856799
8592,SIDM00673,Uprosertib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.4086531,-0.06703382,-1.1941883787402674,-0.05616325367730529
78538,SIDM00878,Linsitinib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,3.5862741,0.27018973,0.49502891259386955,0.06315089262793852
69803,SIDM01233,Navitoclax,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,72.0,-0.5581105,-0.045628846,1.3086598305721122,0.060802759705036985
15500,SIDM00774,NU7441,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.2255654,-0.06373601,-1.5488198086653477,-0.03158788555996468
108449,SIDM00531,Irinotecan,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.48247707,0.05139918,0.7198505103968962,0.010028186396683922
22339,SIDM00411,Dasatinib,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.8463174,0.054062378,-0.6826157052531783,0.012167214563987672
89709,SIDM00893,Temozolomide,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.8275918,0.016360605,0.9566983813679775,0.019952278368469946
80351,SIDM00411,LGK974,Paclitaxel,Pancreas,0.0025,Pancreatic Carcinoma,Male,East Asian,43.0,-0.49382108,-0.019457612,-1.5996976746821752,-0.0370752030681781
4681,SIDM00971,AZD6482,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.370664,0.050930027,-0.22194268043488852,0.015656470157347634
32371,SIDM00628,Cisplatin,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,0.6538703,0.029526642,0.4184539117151531,0.022685201850475893
25290,SIDM00893,Camptothecin,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.3575766,0.117223345,-1.26652533477464,-0.09168345400513657
5008,SIDM00866,RO-3306,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,-2.9974585,-0.07153437,0.09227595496133358,0.027102789140171484
84112,SIDM01233,AZD4547,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,72.0,2.2904603,0.100980364,0.48310342469361633,0.016163035513039357
71595,SIDM00146,AZD6482,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-1.5633008,-0.09812309,0.0877734525022219,0.05731744519133947
20235,SIDM00628,AZD6482,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-0.48591042,-0.0378938,0.9094680460904143,0.04891246803502531
37918,SIDM00529,Alpelisib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Black,44.0,-1.9958546,-0.09029067,-1.0832035792753756,-0.025712165043464193
32671,SIDM00954,PD173074,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.7600485,-0.033281054,-1.1161446878409789,-0.018848128254736415
22131,SIDM00097,AZD8055,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3904965,-0.15572774,-0.2626105199091329,0.016640883957433447
102454,SIDM00673,Tozasertib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-4.2976413,-0.189457,-1.7301385033309489,-0.14688748534584098
10954,SIDM00628,Navitoclax,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,-0.5049394,-0.048804738,1.7942827431815391,0.09282933772569052
31999,SIDM00332,AZD7762,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.223463,-0.118831836,-0.6590605866146103,-0.057152389344309336
95971,SIDM00776,Navitoclax,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,1.4053289,0.048619166,2.1052120256941307,0.045146377459260555
13169,SIDM00673,OSI-027,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,2.0822887,0.180732,-1.4992063822104436,-0.12882985074095124
36671,SIDM00146,Ribociclib,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,3.0618849,0.20946935,0.07290495751036076,0.07162168254403793
26706,SIDM00834,Navitoclax,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,White,66.0,-1.2090484,-0.042071577,1.0508321603819837,0.0817272614507292
27625,SIDM00332,Cisplatin,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,3.385224,0.08605075,1.4021051650168288,0.05090490025697629
96246,SIDM00954,Nutlin-3a (-),Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,1.1883106,0.03182174,1.7368971615391011,0.09437715895212014
47667,SIDM00146,Nutlin-3a (-),Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,2.094274,0.08877879,2.015711545519163,0.09607714608242723
4502,SIDM00866,Pictilisib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-1.4279014,-0.11239823,-0.9834620654477795,-0.0649442648492416
56139,SIDM00875,PD173074,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.62577236,-0.030145105,-0.3375717424817347,-0.02086425690479089
100562,SIDM00776,Nutlin-3a (-),Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-1.4841957,-0.047743224,1.587653668385069,0.08227920162235082
65207,SIDM00954,Alisertib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.3602608,-0.026245445,0.32824848578840304,0.10750367986557281
73056,SIDM00834,AZD8055,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,0.2197203,0.01823379,-2.099488552034311,-0.043786559888413006
62561,SIDM00531,Irinotecan,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.6205695,0.060422294,-0.3865726047843158,-0.02351810345101521
71377,SIDM00866,JQ1,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.039998,0.08677614,-0.8529261931833724,0.0014772700038557646
97682,SIDM00411,Erlotinib,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,43.0,0.72869885,0.035610247,-0.12920854650155386,-0.0030850934288477556
92568,SIDM00954,NU7441,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,2.3856432,0.14885761,1.2302321111147103,0.11884798319768683
105923,SIDM00954,ZM447439,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.8942593,-0.062326174,0.5577080741169603,0.04172726336284903
6610,SIDM00878,Nilotinib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-0.86403567,-0.07037921,-0.3303932531795662,-0.024165115855106185
99228,SIDM00782,MK-1775,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.2834955,-0.07468607,0.44485122285786344,-0.023372551020662196
22224,SIDM00954,Nilotinib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.0,0.7617561,0.058671992,1.1101203017715937,0.052023970133016226
46992,SIDM00875,Venetoclax,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.27993375,0.007447147,1.6112454781513397,0.09081109636641885
102569,SIDM00146,Palbociclib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.48682982,-0.032300666,-0.22210532780295872,0.028136438613652403
2325,SIDM00774,Luminespib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.29484868,-0.030222803,-0.6200601395176519,-0.09069270145561403
53622,SIDM00878,Nutlin-3a (-),MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,2.3009233,0.06777449,1.0078725341062569,0.1082626036218208
76734,SIDM00529,KU-55933,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.48066217,-0.008468755,1.8318421921676962,0.09835002943181188
22530,SIDM00954,5-Fluorouracil,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.0,-1.1835872,-0.0427205,0.903730611863448,0.06544134870434826
88339,SIDM00866,RO-3306,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-3.2211547,-0.075948365,-1.333512968611529,-0.03913937455651082
92745,SIDM00875,Temozolomide,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7279745,0.019676767,1.0310187985714283,0.011310286219029167
25928,SIDM00529,AZD6482,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,2.1485336,0.07410762,2.1230386105381314,0.045935163690038604
86617,SIDM00779,LGK974,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,2.4300299,0.08902485,0.43736829368746055,0.048348432529111744
85236,SIDM00193,AZD4547,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-0.92615014,-0.04553683,-0.5508344145910393,0.013797069793245423
65546,SIDM00529,Ribociclib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.3276801,-0.03352854,-0.8035692099469822,0.04735313197986358
38686,SIDM00628,Gemcitabine,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-1.7659273,-0.06796588,-1.1206665285923596,-0.026041519289560493
8852,SIDM00673,Doramapimod,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.0551552,0.021583028,2.4363111563758983,0.05962112317815434
73672,SIDM00146,Tozasertib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.2388227,0.10238273,-1.6586632831305332,-0.04226295204545907
20741,SIDM00954,KU-55933,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-3.578142,-0.11657414,-1.8459568202120331,-0.04216285149603955
48222,SIDM01233,Trametinib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,-0.35317582,-0.024072709,-0.8621884430363609,-0.012814986898590735
49383,SIDM00875,Linsitinib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,4.479949,0.34914503,3.036526443000341,0.17148686695379942
14062,SIDM00146,Vorinostat,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,1.0712458,0.093490876,-0.6002512074308965,-0.06266975930210579
86577,SIDM00954,MK-2206,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.5588974,0.04299243,0.5360947173422772,0.019931067249555044
56696,SIDM00866,SCH772984,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.5925701,0.11230558,0.6347788791231039,0.07980855214652592
58613,SIDM00878,BI-2536,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-0.6577102,-0.060896184,-1.4184573727318925,-0.13348447522242607
17385,SIDM00893,Taselisib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.4842984,0.027220424,-0.8336023533300296,-0.11645982448496986
80054,SIDM00774,Nilotinib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,48.0,0.09705426,0.0070689004,-1.324716921620771,-0.06334220914150047
91077,SIDM00628,GSK269962A,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.5087445,-0.048955735,-0.2784535558269194,0.014762477570344067
97868,SIDM00971,Nilotinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.2388325,-0.15095793,0.0025699980824555376,0.028064203896630086
84883,SIDM00628,Pictilisib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,3.163378,0.13310938,-0.1971021972526365,0.024274804506685392
86671,SIDM00097,GSK269962A,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.995256,0.11395068,0.9420525048527458,0.030409087222955527
65959,SIDM00359,Oxaliplatin,Navitoclax,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.3794758,-0.024418723,1.1350838332405553,0.04259184771583663
17685,SIDM00778,Oxaliplatin,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,69.0,-2.9107656,-0.07617446,-1.7992356661157767,-0.019994708215109076
38501,SIDM00954,Afatinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-1.6294898,-0.1239577,-0.8175899762299795,-0.03048557589883976
107214,SIDM00774,ZM447439,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,1.400339,0.09469894,0.0741335680964586,0.05200774640907816
29227,SIDM00971,NU7441,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.8864398,0.0893362,2.089464142827858,0.11842401381695192
64948,SIDM00866,5-Fluorouracil,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-1.4315596,-0.049793307,-0.9519799732979375,-0.023034844562016082
5127,SIDM00628,RO-3306,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,1.0064067,0.054689758,-1.0026957713211386,-0.03397241099889093
58831,SIDM00531,Dactolisib,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.6797309,0.052291807,-0.9500948520215338,-0.018029432712607086
89934,SIDM00779,SB505124,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,-3.6898708,-0.08592678,-1.9974832115840595,-0.07243885438115481
39780,SIDM00332,Crizotinib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5264194,-0.1262836,0.2287199848130654,0.02643797319970806
50181,SIDM00954,Lapatinib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.22121078,-0.018058963,0.8058315067859096,0.022666757835863045
20061,SIDM00875,NU7441,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.5533333,0.07314004,0.3619343320653998,0.002685593034952304
46764,SIDM01233,SB505124,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,1.4070566,0.046181668,-0.7463564006180385,-0.030926426961992333
85601,SIDM00893,Lapatinib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2010752,-0.11772634,-1.7978720439173907,-0.0831822325266825
60742,SIDM00097,Palbociclib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5479037,-0.05326868,-0.6966151727474859,-0.01280180100524434
64023,SIDM00660,LGK974,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,1.9653859,0.13058013,0.2396726386066689,0.035213726555529984
73647,SIDM00529,NU7441,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-0.5230021,-0.039431814,0.8804663819649586,0.06549436847698172
63927,SIDM00774,MK-1775,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.6059989,0.077782676,0.051708647352435,0.03397133956942245
13156,SIDM01233,Afatinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,3.0603616,0.22689402,1.5463567074763935,0.13786256818343187
97968,SIDM00893,Navitoclax,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.6709108,0.06910295,-0.8388708992681605,-0.057190136132908756
70137,SIDM00146,Olaparib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-2.0426524,-0.07433089,-0.809112875159156,-0.023538078745889538
101660,SIDM00774,Nutlin-3a (-),5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.3021654,0.009614044,0.3148107649015235,0.03908051106995951
76220,SIDM00878,Paclitaxel,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.8962379,0.07298401,0.38336653493370587,0.03100826949623698
39353,SIDM01233,Olaparib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,72.0,4.338676,0.13155842,1.8987813694234463,0.07058874566088184
73404,SIDM00866,Venetoclax,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,0.86357576,0.023184674,0.053365310755187495,0.030490903639380413
96727,SIDM00774,Navitoclax,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,2.2687964,0.03651859,2.80996401779656,0.025554630817939444
40308,SIDM00130,Erlotinib,SCH772984,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.46121156,0.03613981,1.2447483986887793,0.07634332416558912
38293,SIDM00778,Trametinib,AZD4547,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-0.6900855,-0.023383215,-0.2382635927638668,-0.018354872731937234
107293,SIDM00673,Palbociclib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.63019925,0.022847366,-0.6196140571888092,0.00853227686146886
103091,SIDM00673,RO-3306,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.5643418,0.1101549,-0.029226126404719496,0.05376359894923531
90537,SIDM00774,AZD7762,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,5.992882,0.6864744,1.1663462115470216,0.19958335041347164
40708,SIDM00774,Wee1 Inhibitor,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-1.2173133,-0.06309163,-0.4504667029322733,-0.019242296918182297
82345,SIDM00332,Cisplatin,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,2.6358266,0.0886808,2.6434139142551656,0.07271321816786583
102474,SIDM00673,GSK269962A,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.4740953,-0.14430192,-1.5115454332454756,-0.12163305567720215
18239,SIDM00146,Luminespib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.443942,0.044904225,0.15695438303938133,0.0069264472364372965
56507,SIDM00954,MK-1775,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-0.34546986,-0.028984217,-0.033952130837295855,0.009022634985679175
49807,SIDM00971,GSK269962A,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.67166793,-0.042182755,-0.6137174986069862,-0.035521346508402586
25161,SIDM00193,5-Fluorouracil,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.3447912,-0.12277373,-2.4966771354120647,-0.16471558688349502
50452,SIDM00628,Uprosertib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,Black,51.0,1.1513293,0.09276508,0.9745301016513302,0.054845087398367486
20389,SIDM00971,Alpelisib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.6621248,0.11403206,-0.49325398780989527,0.0003871929052131889
61834,SIDM00332,Uprosertib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.22182459,0.014972879,0.13532532700024424,-0.0037073655348334126
106180,SIDM00779,AZD8055,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,1.0470617,0.05408377,0.2855144569129794,0.013052598736019083
50463,SIDM01233,Dabrafenib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,72.0,-1.1107181,-0.01887784,0.4547943701945125,0.022859554950326072
36937,SIDM00866,GSK269962A,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-1.0009062,-0.04252308,0.5647045721887872,0.003944243929417082
67886,SIDM00776,Afatinib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.6392639,0.04416049,1.772751455824898,0.09724791471212738
10244,SIDM00774,Alpelisib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.6460115,0.12520814,0.10147632635757978,0.05337080705185605
90345,SIDM00628,SCH772984,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,2.2147985,0.18043081,-0.992525707182494,-0.03407652448635199
83710,SIDM00097,RO-3306,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.62749964,-0.030943511,0.5767590056174391,-0.01580166888246651
47166,SIDM00778,Vinorelbine,Dabrafenib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-2.0835223,-0.13631871,-1.3406861200296387,-0.01743904764013197
10716,SIDM00146,Palbociclib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.3987155,0.11178021,0.48086855266789463,0.06090122513124749
70125,SIDM00971,NU7441,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.4881334,0.07372728,1.1859797368319316,0.06104753868874379
27714,SIDM00776,Dabrafenib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-1.1147594,-0.039973307,0.06689593881237449,0.025800602691421162
58083,SIDM00774,Afatinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.1117678,0.06409182,0.1757479560616922,0.04212636281813376
38411,SIDM00673,Uprosertib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.8438214,0.109754466,1.1177644988006639,0.06329695005763575
61444,SIDM00130,MK-1775,Sorafenib,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.64312494,-0.046064463,0.05084470183226912,-0.002981540260317149
35703,SIDM00834,Oxaliplatin,AZD4547,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,0.66544163,0.05805455,-2.2816997936647936,-0.10608325560448435
94679,SIDM00954,Nilotinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-0.6711422,-0.054136414,-0.40246071874250855,0.01748039522120492
12622,SIDM00660,AZD8055,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,32.0,-1.3365463,-0.09563873,-2.583034982357333,-0.1189743722148357
12960,SIDM00411,Trametinib,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,6.670769,0.3430905,1.9509358350649981,0.1832296654495448
91602,SIDM01233,Olaparib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,2.0679212,0.056716375,0.9162562210170573,0.04140528898484109
29588,SIDM00878,Uprosertib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.86974305,-0.051824596,-1.744800467635762,-0.07780014430456765
25104,SIDM00332,Wee1 Inhibitor,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.6535875,0.09827601,0.9901372715258987,0.04453001120710525
82607,SIDM00628,Taselisib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.3444182,-0.032881632,-1.3923412503581918,-0.07213423591116838
85364,SIDM00774,BI-2536,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.915401,-0.06093498,0.6385013166564318,0.08116351213587925
15446,SIDM00875,Luminespib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0116686,-0.09537785,-0.7362300642629952,-0.0787365067509954
75977,SIDM00954,Navitoclax,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,0.54758304,0.016455885,0.01039973263235458,0.016436460112555677
19903,SIDM00893,Axitinib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.1105995,0.15135284,1.7100163687749692,0.14315826909482915
29624,SIDM00411,Cisplatin,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.569893,0.06356386,2.588702083173593,0.07434597146696915
89878,SIDM00411,Lapatinib,Dactolisib,Pancreas,0.0125,Pancreatic Carcinoma,Male,East Asian,43.0,0.084789604,0.0028379876,1.454347772416831,0.07977124829418444
87224,SIDM00878,Linsitinib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.1971586,0.0785128,0.8423688370833583,0.12216395193707948
45058,SIDM00097,Gemcitabine,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.7973588,0.08049966,-1.811342955679351,-0.04212060654213817
6174,SIDM00866,Paclitaxel,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.7908316,0.13743791,-0.21481984743641522,-0.06361326109880515
81415,SIDM00628,JQ1,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-1.5195854,-0.043252558,1.3360069854787338,0.14803835867985285
71902,SIDM00529,Paclitaxel,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-0.73809326,-0.07272128,-1.3184515558509524,-0.06122915124522237
52512,SIDM00628,Paclitaxel,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-4.7653966,-0.4183169,-5.799035759708587,-0.2796374614600276
72931,SIDM00971,Lapatinib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.2287379,0.012075484,-0.19163004515930354,0.004364847846089125
55361,SIDM00097,RO-3306,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9365298,-0.083294,0.006596842609455342,0.0004775876383394198
78353,SIDM00878,Cisplatin,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.0453925,0.03067155,1.9354386873916614,0.07208821766143755
106437,SIDM00301,Navitoclax,Sorafenib,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,4.1981463,0.33938572,2.9241340078059084,0.1459023588242508
53387,SIDM00971,SCH772984,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.74371445,0.014595398,0.8511128348350485,0.07155070046700177
46090,SIDM00411,Gemcitabine,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,5.1708117,0.32257682,3.980788576520921,0.22678075821680763
63361,SIDM00778,MK-2206,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,2.4363403,0.12985992,-0.5190539394418591,-0.01716527236640877
26061,SIDM00782,MK-1775,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,Unknown,72.0,1.3975382,0.056420293,-0.7726121568100355,-0.032140060613136505
94019,SIDM00529,Axitinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-2.542647,-0.17691462,-1.3027921656174104,-0.06404611554371926
89826,SIDM00774,Entinostat,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.8101679,0.08189215,1.6796020260977125,0.12288079319945794
8238,SIDM00866,Luminespib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.3114212,-0.09904971,0.28093194354940637,0.026160253638881494
57311,SIDM00301,SCH772984,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.6976496,0.20957756,0.997318546690981,0.05813418534562225
25124,SIDM00893,OSI-027,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.68597317,0.06418549,-0.6827666300883991,-0.0371122523997046
41671,SIDM00531,Gemcitabine,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.3943213,0.03405094,0.37169690101722325,0.005177990823326307
102121,SIDM00893,Trametinib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.248696,-0.11988955,-1.585138030492137,-0.08462111796368689
9231,SIDM00954,Ribociclib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-0.2121192,-0.0076992786,-0.5002366343030579,0.036575919002687675
73836,SIDM00776,Afatinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.96476203,0.07565357,0.6341831238383258,0.007473880484253081
44657,SIDM00529,Olaparib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-2.791387,-0.06897144,-1.1031014242230461,-0.021635097838784277
52616,SIDM00411,Oxaliplatin,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.84470254,-0.021420047,-0.4532701636300309,-0.03153434739148251
96709,SIDM00130,Navitoclax,Paclitaxel,Pancreas,0.0025,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.7177026,0.22930062,3.7570411848799434,0.22520874586600134
4975,SIDM00332,OSI-027,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5037531,-0.15760563,-1.4339177926353341,-0.16620024934678326
29652,SIDM00893,Gemcitabine,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.1567838,0.10966341,-0.3668076510923725,-0.0030472183207823343
5534,SIDM00531,Gemcitabine,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.3591923,-0.016714359,-0.03745143821934379,-0.015400404499097993
70256,SIDM00779,AZD7762,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,1.0652505,0.08240213,1.2471707049701797,0.06172917703478086
25601,SIDM00878,PF-4708671,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,4.0705953,0.074729666,2.3302337018934756,0.1088606588274663
59205,SIDM00628,PD173074,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,Black,51.0,-0.377956,-0.011322396,0.2565062404302123,0.0635577439164918
37415,SIDM00774,KU-55933,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.63094544,-0.023035731,0.37370562058556667,0.04482533053240103
43087,SIDM00146,RO-3306,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-0.8763477,-0.052347153,-0.27309601065741196,0.026118055595464384
91336,SIDM01233,Afatinib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,72.0,2.379512,0.116887264,0.7338617850942625,0.03797521288937422
50868,SIDM00954,Docetaxel,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.0,-1.8202766,-0.1351836,-0.9191676306441099,-0.06913603592181918
93989,SIDM00146,Paclitaxel,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.0141665,0.07856054,-0.3139491406775703,-0.05632750276473928
37892,SIDM00193,MK-1775,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.6232817,-0.11143977,-0.7285763892828723,-0.031049194213366015
27119,SIDM00954,Entinostat,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,0.7817234,0.059999928,-0.07533229287383125,0.011292377349789289
42180,SIDM00866,Dabrafenib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,52.0,-0.5606806,-0.016883332,-0.11608318422139037,0.01947464330939274
68640,SIDM00779,AZD7762,LGK974,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-0.30802193,-0.025969114,-1.0539903587112451,-0.10259896486781907
66604,SIDM00778,AZD8055,AZD4547,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-0.95073,-0.061625775,-0.3725338167021598,-0.046415644886354135
65909,SIDM00531,MK-1775,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.7818684,0.09345333,-0.11933831540597224,0.006946578046936599
55990,SIDM00866,Palbociclib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,1.2237781,0.023843465,1.5918750921250133,0.052466718014768585
43928,SIDM00332,JQ1,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,1.8656656,0.08467094,-0.6217142065354186,-0.053817905908938424
61533,SIDM00673,Afatinib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.72932065,-0.05440642,-1.0449519430031873,-0.043872220234347066
37224,SIDM00332,Dabrafenib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.6538322,-0.16265698,-0.8325137827361365,-0.045320182997085394
14783,SIDM00834,Nutlin-3a (-),Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,White,66.0,1.1309417,0.042073645,0.6625610297694878,0.041158955374252286
96074,SIDM00531,Irinotecan,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-2.0078053,-0.24092706,-1.506732347739542,-0.10510356985967453
50247,SIDM00878,Wee1 Inhibitor,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,70.0,1.4932709,0.11612498,0.226967449787233,0.006408157076839796
99868,SIDM00628,Lapatinib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.990486,0.062243845,1.5539786727952412,0.15733723200245087
60536,SIDM00359,Trametinib,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.3827314,-0.13736588,-1.6363279237081818,-0.048115810509088176
83299,SIDM00774,JQ1,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-1.6498708,-0.07804061,2.944311479666522,0.11530363140040133
21568,SIDM00774,Linsitinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,1.1075362,0.10151051,-0.2791636423706883,0.03636605732142985
12927,SIDM00146,Crizotinib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.1317276,-0.07804325,-1.3599743852116792,-0.09818653493767532
37476,SIDM00893,Alpelisib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.6688191,-0.093580656,-2.1170276736190754,-0.1391507006071475
77140,SIDM00866,Docetaxel,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.297811,-0.10232639,-1.7369757299767152,-0.09483924411450005
9565,SIDM00878,Crizotinib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,-0.74078393,-0.08240497,-0.9766510418015311,-0.07902383814083519
62523,SIDM00778,Crizotinib,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-0.968737,-0.041482285,-1.6761639808798268,-0.05225451996879762
66735,SIDM00332,Bortezomib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.32326084,-0.019774048,0.9348993726872581,0.040336648376358614
23166,SIDM00866,Wee1 Inhibitor,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-1.3725591,-0.11452961,-1.3871816381233053,-0.021362690821536218
70518,SIDM00301,Erlotinib,OSI-027,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,4.3742485,0.26321346,2.8614246975440114,0.13215810746004783
71245,SIDM00866,Linsitinib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,0.90840334,0.06586025,-0.38110868426795375,0.030977912473896578
62632,SIDM00779,Navitoclax,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-1.2284143,-0.032246355,0.6580175857960674,0.0003689389317401973
86300,SIDM00097,JQ1,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3805175,-0.10794804,-0.8831235992532784,-0.05273611486140092
106514,SIDM00954,Camptothecin,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,1.5572579,0.06807757,2.653029926910684,0.10598669776609808
77860,SIDM00531,AZD7762,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.43145946,-0.02409179,0.45920469824820825,0.02985276917192251
52094,SIDM00529,MK-1775,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.1925442,-0.1163046,-1.1117286288966066,-0.037133024336711486
23982,SIDM00332,RO-3306,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,4.997097,0.27213496,2.5378880942308366,0.1385565350655243
95000,SIDM00301,Cisplatin,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.9855767,0.12990378,0.4910661959218021,0.02452627301478286
15015,SIDM00411,Trametinib,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,5.553849,0.21172196,3.1809299341477573,0.16107069467565707
33831,SIDM00893,Dabrafenib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.327215,-0.036761925,-0.5163703366170429,-0.01794005778094752
98923,SIDM00628,GSK269962A,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,1.3976182,0.115332976,-0.6343458658605182,0.039091666066353094
50689,SIDM00130,Irinotecan,Navitoclax,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.8806517,0.17257774,4.212870726741486,0.2247788648146665
20057,SIDM00866,Alisertib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,52.0,-0.5390489,-0.0412253,0.3556377261354504,0.05441280812075366
23727,SIDM00971,AZD7762,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.3900036,0.034793798,-0.057931860521198454,-0.001208918611893608
36800,SIDM00193,Nutlin-3a (-),Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.3307013,0.006226746,1.8402377099960199,0.07215978062292606
83447,SIDM00193,Nutlin-3a (-),Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,53.0,-0.21533315,-0.003691504,2.1099836423360574,0.06528654098220939
35841,SIDM00301,Lapatinib,Gemcitabine,Pancreas,0.1,Pancreatic Carcinoma,Male,East Asian,50.0,1.2063495,0.028432213,3.2144745601823397,0.057103655706677685
30751,SIDM01233,Linsitinib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,72.0,-1.7591364,-0.1018493,-1.1393231285825594,-5.4462171943940715e-05
68936,SIDM00301,LGK974,Dasatinib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,50.0,0.6689914,0.07426209,-1.242204826121038,-0.04810569757352397
34049,SIDM00411,Dasatinib,MK-1775,Pancreas,0.2,Pancreatic Carcinoma,Male,East Asian,43.0,1.7822515,0.11430614,0.9109250258617388,0.10377723880896635
18259,SIDM00834,Linsitinib,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,White,66.0,-1.0302044,-0.0470835,-2.2341895719535376,-0.051052273037602444
61936,SIDM00301,Sorafenib,Palbociclib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.5397801,-0.16009925,-1.1220360210287557,-0.06372761724292735
64468,SIDM00359,Afatinib,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.7941403,-0.06607681,-0.19801012404696694,0.007505604371915043
47605,SIDM00411,Palbociclib,Ruxolitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.6026306,-0.067768216,-1.1195906862075358,-0.027297682988426185
78398,SIDM00301,Oxaliplatin,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.1972264,-0.14400616,-0.8234441258097827,-0.03219489915546105
108099,SIDM00893,Uprosertib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.2426974,-0.018684797,-1.0704293903509463,-0.07445084369416755
74046,SIDM00779,Nutlin-3a (-),Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-1.7852609,-0.0641256,-0.46878782003344777,0.013166317087839071
62441,SIDM00660,5-Fluorouracil,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,0.547501,0.050100736,-0.4268192322254991,-0.0311226701212589
57624,SIDM00097,Nutlin-3a (-),Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.6267357,-0.06862316,-0.5330037484266844,0.015382906473600482
88169,SIDM00866,AZD8055,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,52.0,1.1886048,0.04940778,-0.28250990143958843,-0.00924912426564864
28043,SIDM00146,KU-55933,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-1.0928416,-0.04726395,-0.05267809585223081,0.06125821027212097
62603,SIDM00411,Crizotinib,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,-4.393065,-0.22179428,-1.1630064361161185,-0.0754338816930792
28308,SIDM01233,MK-2206,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,2.6772685,0.21875396,0.9001780053312234,0.059982838703034114
40572,SIDM00332,Ribociclib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.8892603,-0.11239682,-1.0644361265301827,-0.04415015145094545
3499,SIDM00774,Alisertib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,-2.171412,-0.093283914,2.069471131285498,0.06530846286095185
45205,SIDM00531,Oxaliplatin,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.9025526,0.037765883,2.025504710336643,0.07708299921056286
41712,SIDM00866,JQ1,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,1.1342881,0.08962422,-0.9950424643012721,-0.016132961457643334
58381,SIDM00893,Linsitinib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.43174112,-0.020836314,0.3073149559423916,0.019475655774425785
68208,SIDM00359,5-Fluorouracil,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0784885,-0.05839544,-2.084624575128358,-0.05149154921293011
38455,SIDM00673,RO-3306,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.0309151,-0.06576847,-0.6269559829160212,-0.045301439182909686
6755,SIDM00971,SCH772984,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.543884,0.07132949,1.0951537021587388,0.09645086065397288
97862,SIDM00834,LGK974,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Female,White,66.0,-3.3674881,-0.1880038,-3.0395402337053383,-0.09508857321814589
56992,SIDM00531,MK-2206,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.8105773,0.1404239,1.9281793833294603,0.10679247660786188
91102,SIDM00097,Sorafenib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.9253245,-0.037489146,1.2774346976039472,0.03630544952258016
103526,SIDM00778,Trametinib,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-0.49699616,-0.013156458,0.41067787137065603,0.0018635286179649096
50219,SIDM00332,Crizotinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.8739684,-0.25341296,-1.4024322802253832,-0.09773631160956679
22841,SIDM00529,Vorinostat,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-2.3182876,-0.081515916,-0.09912918045402715,-0.01103076051383072
20287,SIDM00332,5-Fluorouracil,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,2.1714804,0.08772611,-0.33743249145221743,-0.007787770975104231
24021,SIDM00529,Temozolomide,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Black,44.0,-0.48118904,-0.009715537,-0.6395075434186086,0.017789055122170046
43442,SIDM00628,Uprosertib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-1.442273,-0.039956376,1.0160622880730499,0.09596242698611439
4462,SIDM00628,JQ1,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.9968524,0.2773613,1.4882468570508236,0.11409895000255305
27855,SIDM01233,Linsitinib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,2.2620845,0.16493896,1.0402375181995913,0.09257379966572568
28413,SIDM00779,Nutlin-3a (-),Taselisib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,-0.5108763,-0.016908543,1.0749970857634352,0.04287373669859636
104147,SIDM00193,BMS-754807,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,53.0,-2.675045,-0.12011644,1.0964381741165043,0.10784091911420232
78565,SIDM00878,Taselisib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,0.8229911,0.059939582,-1.6436428730180128,-0.13729288158747024
88948,SIDM00776,Afatinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,-1.4933903,-0.12086825,-0.9266835794511687,-0.10701175687378674
40703,SIDM00531,Trametinib,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,4.9410915,0.5486433,0.2769855806808789,0.027908930845991647
36299,SIDM00893,Linsitinib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.5869617,-0.06424482,-1.2747501776134105,-0.02817519198710623
7333,SIDM00782,SB505124,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.68788,-0.054686036,-0.5316586896420736,-0.01790794240306654
44808,SIDM00776,BMS-754807,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.34361032,-0.03131284,-0.4864285711386805,-0.0925569392066659
28594,SIDM01233,Afatinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-1.9231217,-0.1240165,-0.37391517091700915,-0.014000407574107887
61951,SIDM00193,BMS-754807,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,53.0,-1.7034853,-0.088604435,1.0551017572591959,0.08350152088143084
59049,SIDM00834,Navitoclax,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,White,66.0,-1.5989821,-0.097294904,1.5891262950445053,0.1605462719120903
82711,SIDM00097,ZM447439,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8577232,-0.03939536,-0.4864575578544794,-0.004585007247859423
53145,SIDM01233,SB505124,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,72.0,-0.50804085,-0.015585372,-1.4013008897694776,-0.037565656221390124
89191,SIDM00301,Lapatinib,Dactolisib,Pancreas,0.0125,Pancreatic Carcinoma,Male,East Asian,50.0,0.7386809,0.03741707,2.186266096949124,0.08307344737645854
55466,SIDM00628,Lapatinib,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,0.51053643,0.03720678,0.14561334873279214,0.029859827655520824
64500,SIDM00779,AZD8055,Taselisib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,0.70386887,0.04577088,0.1348899724426929,-0.0030400653658586465
39296,SIDM00778,Vinorelbine,AZD4547,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,1.2320529,0.07992391,-0.7197301215080638,-0.03379489703224722
17510,SIDM00529,PF-4708671,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-1.4968566,-0.072330676,-2.419648326992548,-0.05000121420795056
104627,SIDM00878,Afatinib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,3.9100788,0.24925312,1.7448760784824706,0.06017270134930367
11294,SIDM00529,Uprosertib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.9188209,0.06190115,1.0440547865994598,0.17504029551143313
102592,SIDM00673,Palbociclib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,49.0,-0.51067895,-0.021359988,-0.5644376468182315,-0.023237602766163944
101442,SIDM00893,Lapatinib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.4086723,0.18596384,-0.15374459223134987,0.05067464780750831
70446,SIDM00529,SCH772984,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.0177187,-0.04112501,1.3170860089707948,0.09736375680882119
61580,SIDM00866,Olaparib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,52.0,-2.03669,-0.03991808,1.0639243901790025,0.02448877388983186
69475,SIDM00146,Axitinib,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,-0.65063965,-0.0514566,-0.02097565506924247,0.043535775283904184
47539,SIDM00774,OSI-027,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.668672,-0.09865833,0.18700941815017103,-0.008334538817774689
67925,SIDM00875,AZD6482,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1021127,0.07906647,1.9807783321271215,0.07515177382809232
18623,SIDM00660,BMS-754807,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.7512542,0.07369741,-2.3666691895479284,-0.06508033705290542
85996,SIDM00673,GSK269962A,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.9998722,-0.15939084,1.0047905527977803,0.07235546550500337
85510,SIDM00776,5-Fluorouracil,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.3507637,-0.04355175,0.5278147528703601,0.04042931694366729
66372,SIDM00774,Camptothecin,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.0618685,-0.055302832,0.15450060739701924,0.04059064683561296
94110,SIDM00971,5-Fluorouracil,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.19507068,-0.0053282008,-0.27938016289818696,0.01808345988670678
82921,SIDM00866,Vorinostat,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-0.07864246,-0.0068623023,1.1904349462887012,0.0459889099336102
68923,SIDM00130,Crizotinib,MK-2206,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.84017414,0.07403398,0.6203956160402814,0.07876324260149889
103118,SIDM00954,Olaparib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-2.2857158,-0.05266287,-0.7064962991779057,0.04215196240164813
30732,SIDM00875,5-Fluorouracil,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1824548,-0.1162633,-1.594999068503471,-0.07092378631800532
16724,SIDM00531,AZD7762,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.7707375,0.06309919,-0.6913600603498774,-0.04719921089660739
77623,SIDM00776,5-Fluorouracil,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-1.7742832,-0.048000712,0.8894998900348585,-0.00034861642090135814
85857,SIDM00146,Paclitaxel,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-2.9130962,-0.208226,-3.8028582392625814,-0.22348605027570334
56050,SIDM00628,Nilotinib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-0.5815354,-0.05088089,0.5362484903790662,0.03585149086922218
68762,SIDM00875,5-Fluorouracil,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.3348773,-0.16029696,-1.6901895697108853,-0.07659810429924127
58817,SIDM00411,Dasatinib,Linsitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,2.6207829,0.15406404,2.45626013544153,0.21390904256224003
71622,SIDM00779,LGK974,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,3.9260263,0.06774589,0.15334412468549588,0.052782079842019124
103457,SIDM00097,Palbociclib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.5091178,0.14816096,0.2024456965325391,-0.03369547872728211
105925,SIDM00782,AZD7762,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,Unknown,72.0,-0.6468938,-0.047885966,-0.8478029658280065,-0.024619038330987934
63433,SIDM00332,Vorinostat,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.88065,-0.15950306,-0.6012370184082355,-0.05409754513994502
84492,SIDM01233,Olaparib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,72.0,0.7672299,0.019104747,0.6079919093907955,0.027283720465988485
38707,SIDM00866,Taselisib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.4896381,-0.07433079,-0.3953599264509611,0.028713577119316446
75098,SIDM00776,Oxaliplatin,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-1.3541176,-0.07462091,-1.7124759316570668,-0.05799185070849301
73939,SIDM00332,Linsitinib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1399301,-0.03503963,1.747831776908383,0.04638105780568701
96131,SIDM00875,Uprosertib,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.229936,0.04084923,0.2772934233613309,-0.07463646386875857
24667,SIDM00774,JQ1,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.9042256,0.05524853,1.6172594850966604,0.08464063175691604
77539,SIDM00834,MK-1775,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-0.5100836,-0.029773554,-0.6142431441210496,-0.035976277321742266
96058,SIDM00878,Lapatinib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,2.9556632,0.27828118,0.7421644639960274,0.10035400378100592
47941,SIDM00097,Tozasertib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,4.6063666,0.24306315,4.954633512045579,0.24798074381133023
69589,SIDM00660,Vinorelbine,SCH772984,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,32.0,1.6440995,0.1708874,0.7693434362904369,0.046517293996816055
39112,SIDM00411,Paclitaxel,Dactolisib,Pancreas,0.0125,Pancreatic Carcinoma,Male,East Asian,43.0,1.6668326,0.08750963,0.2824931563163853,0.03771693557138197
10164,SIDM00660,AZD4547,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,0.50952,0.025807675,-1.3131122249524048,-0.025651369822762473
8114,SIDM00782,Oxaliplatin,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-1.7532316,-0.07717891,-1.0863346845074695,-0.0067959210517360025
41880,SIDM00529,RO-3306,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.4689026,0.018401278,0.8211015336418279,0.011313399939146752
29503,SIDM00774,OSI-027,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,0.26908776,0.0325055,-0.1395769894868861,-0.011165954816802215
11817,SIDM00411,Sorafenib,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-3.2610497,-0.11456096,-0.20734652089976577,0.025443795544422845
99863,SIDM00673,Bortezomib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.39349622,-0.020705098,-0.4871464665264411,-0.001592270425271468
17756,SIDM00778,AZD8055,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-0.27036032,-0.016838314,-1.0324454202273046,-0.06174055128713454
63500,SIDM00866,Wee1 Inhibitor,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-2.9954097,-0.25636372,-0.6459080128909173,-0.01683878682045684
5781,SIDM00774,Paclitaxel,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,-0.45825067,-0.019626167,-0.836956847209475,0.023834553442472102
73259,SIDM00971,Bortezomib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.6219323,-0.05470429,-0.821225446234249,-0.00790499245644872
88395,SIDM00779,Oxaliplatin,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-3.956078,-0.13533397,-1.655001481704346,-0.05718836084786715
58836,SIDM00971,Uprosertib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.8418429,0.050197165,-1.3437583692201178,-0.01870751254749602
41891,SIDM00673,Dabrafenib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,1.1770064,0.027228957,1.7639659947835618,0.04881585244538838
64815,SIDM00411,Palbociclib,Trametinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.8463036,0.034237478,-0.4883079516624421,0.02999920970763607
32852,SIDM00875,Camptothecin,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4235723,0.1469229,0.27229802981134443,0.01669805206250441
65032,SIDM00097,GSK269962A,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.60218966,-0.025233895,0.3062260358689987,0.006533514705209022
35583,SIDM00529,Nutlin-3a (-),Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,-1.0501323,-0.03849928,0.016384474097099894,0.017847254884764043
28529,SIDM00193,Linsitinib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,2.2661848,0.11225655,2.4155872842780006,0.12391074984795648
37430,SIDM00531,Erlotinib,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Male,East Asian,60.0,4.0159802,0.445546,0.09115449456171418,0.06487871745713733
194,SIDM00971,AZD7762,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.8296965,-0.018108953,-0.6784545357829943,-0.009661647004289143
74237,SIDM00893,NU7441,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.993125,0.21499519,1.047799266447063,0.13328239234842346
4860,SIDM01233,Palbociclib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,1.1135314,0.029815238,1.0659410970464536,0.04470933244236856
9570,SIDM00893,MK-1775,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.0837221,-0.10658122,-1.4312161969072017,-0.124675139560853
15989,SIDM00531,Dactolisib,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.0352311,-0.06619808,-1.038892828961222,-0.041957056485679475
103127,SIDM00774,MK-2206,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,0.3336665,0.014915107,-0.3649032098950297,-0.033178279189656
56201,SIDM00529,Crizotinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,1.9713346,0.15740861,1.0168833313989054,0.08552122601118074
53294,SIDM00332,OSI-027,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2072612,-0.11620193,-0.8126797552116664,-0.08794512923505846
13988,SIDM00529,Camptothecin,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Black,44.0,0.50491697,0.02291913,1.6249516885066881,0.050932640105481854
100608,SIDM00893,Nutlin-3a (-),Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.6112591,-0.012323799,0.6422649980063957,0.006830246701440838
97513,SIDM00332,Ribociclib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.8152418,-0.12322508,-1.2486556946654879,-0.04478388263937357
73991,SIDM00332,Ribociclib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1015711,0.05299046,0.07222033577234213,0.03061167207602585
93077,SIDM00875,NU7441,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.24255078,0.022156712,0.21363358463961116,0.04624877818237499
56834,SIDM00778,MK-2206,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-1.3348423,-0.04454519,-1.3292682100418027,-0.03616674571548134
32530,SIDM00531,Palbociclib,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.842686,0.2225878,0.23091133585163356,-0.007378341027209477
61055,SIDM00774,MK-2206,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,48.0,1.2071443,0.041771278,0.378083661977107,0.0077257338350377805
49016,SIDM00628,Afatinib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-1.8167303,-0.15510659,-0.7078609983288133,-0.011463003281563175
31389,SIDM00628,Nutlin-3a (-),Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,Black,51.0,-2.4217775,-0.11077923,-0.7740815984082201,0.024316972046585648
13881,SIDM00782,MK-2206,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.4775273,0.12780206,-0.16873872150334113,0.006357941992179157
79966,SIDM00866,Camptothecin,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,2.997977,0.07923212,4.485593498502558,0.16605100381776194
70547,SIDM00834,Vinorelbine,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-0.47525242,-0.04010458,-1.7903262220951792,-0.04895675536298379
21285,SIDM00301,Dasatinib,Crizotinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,5.7293797,0.55013245,2.5181505738888337,0.2238884513545186
86569,SIDM00774,Olaparib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,48.0,1.7861797,0.13581897,1.2175594994615286,0.05014512886563436
20331,SIDM00971,Axitinib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.4456297,0.07223759,-0.2779448564252735,-0.0015841590345002101
53293,SIDM00875,JQ1,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.19338743,-0.020463334,-0.3159255413034807,-0.03269504155388475
101077,SIDM00774,Crizotinib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,1.5052269,0.18730955,0.02437862384860441,-0.014507449787707965
92735,SIDM00193,Linsitinib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,53.0,1.2867403,0.05380288,3.181475446857726,0.14633159666106216
28994,SIDM00628,Uprosertib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,1.585765,0.12173868,1.8435838095987054,0.20273415075954274
71765,SIDM00097,Vorinostat,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.87982875,0.05682253,0.02822498715373292,0.009275519411991161
40837,SIDM00893,Camptothecin,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.7470996,-0.14937058,-2.8148809084699358,-0.20663462529358104
23473,SIDM00411,Linsitinib,5-Fluorouracil,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.1071848,-0.060864247,-0.41888231260824915,-0.001695239575548771
87640,SIDM00866,Camptothecin,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,4.3739233,0.11200554,3.9965055656204207,0.09616574977960493
107088,SIDM00954,Camptothecin,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-0.75807697,-0.023599861,0.6917776503476541,0.037663397497987916
55050,SIDM00097,Navitoclax,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.36939386,-0.02611413,1.0143182917832987,0.020049956836914816
100378,SIDM00893,Doramapimod,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.9543907,0.04136628,0.134753774543107,0.027165881502699853
27923,SIDM00673,5-Fluorouracil,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.57920355,-0.023576519,-0.21377875628597778,-0.019966225575749248
60736,SIDM00301,Taselisib,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.969245,-0.1429517,-0.7757661958062022,-0.07884521721148482
24159,SIDM00893,Nilotinib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.4654797,0.086850196,-0.5866288625610178,-0.0727569166395736
31434,SIDM00971,RO-3306,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.4131854,0.08430519,1.5053288734653012,0.17511426175101705
95405,SIDM00332,KU-55933,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.8925564,0.095640585,-0.3477957129769026,0.025165080987635896
106781,SIDM00097,Lapatinib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.745364,-0.13538526,-0.47659949576545635,-0.054265856472828666
19301,SIDM00866,Nilotinib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.22190644,-0.014654414,0.7985804766341301,0.09128562487851072
15658,SIDM00332,Crizotinib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.9970647,-0.11274934,-0.9336296790198766,-0.09913419090891525
87382,SIDM00866,KU-55933,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-3.1256273,-0.11318319,-2.3657013484277356,-0.09158850100722317
55618,SIDM00660,LGK974,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,2.6966412,0.16870655,0.14326766301830077,0.03622740501386231
13700,SIDM00529,ZM447439,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.3465201,0.117856026,3.246072808268841,0.1689171206081386
75879,SIDM00529,Pictilisib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-0.30983308,-0.0091003915,-0.8968164165363119,-0.011005600376840738
83219,SIDM00529,Olaparib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-1.5850815,-0.06426786,-0.7617906910026928,-0.029733370024942002
98360,SIDM00332,Camptothecin,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,4.8209634,0.101003975,2.2893639571138706,0.07184696727254093
79180,SIDM00097,Ribociclib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.011882,-0.079609126,-1.4841185131615744,-0.035661766295686195
96466,SIDM00628,Paclitaxel,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.5610743,0.038193602,-0.020250429624216523,-0.017428856357459156
51728,SIDM00893,Afatinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.9367123,0.12728149,0.2929964744553218,0.08831665103018807
30485,SIDM00893,Afatinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.6062025,0.14009045,-0.5497335769638323,-0.008888437764636483
18466,SIDM00778,Palbociclib,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,69.0,-1.5010141,-0.04955555,-1.733626097841012,-0.019382045502273893
35049,SIDM00332,Afatinib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.907782,-0.06516822,-0.10987890798615563,0.03189611918415603
70949,SIDM00628,Wee1 Inhibitor,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,0.39140514,0.034458876,-1.5415331409671469,-0.06057176263134192
41568,SIDM00893,OSI-027,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.236177,0.11409563,1.3490095829306845,0.06921052568262054
69907,SIDM00893,AZD8055,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.6815441,-0.057255823,-0.8415678571334185,-0.0692474855253044
76482,SIDM00971,ZM447439,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.5672122,0.087808535,-1.6694941603213715,-0.05061208503376044
60947,SIDM00954,Luminespib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.3520398,-0.026218897,-0.7273119798612317,-0.00983949384721759
52579,SIDM00954,Camptothecin,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,0.87982005,0.03305567,0.45311998420238486,0.04904958080986593
86416,SIDM00971,Bortezomib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1934319,-0.048017584,-1.6168624633135706,-0.042638595509422714
7062,SIDM00628,Taselisib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.9096589,-0.082015984,-0.9891372055262264,-0.013204024011424762
4419,SIDM00893,Luminespib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.94866407,0.09047116,-0.10613455552603107,0.0022505706263064897
7118,SIDM00878,MK-1775,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.6446728,-0.07988411,-0.10292883109761346,-0.013881386576910409
54954,SIDM00971,Sorafenib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.4407207,-0.029476626,-0.47505424993052536,-0.030234137388894827
40808,SIDM00893,AZD7762,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.3067787,0.14858916,-0.5742003776098172,-0.0115738852623186
11768,SIDM00146,Nutlin-3a (-),Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,1.8233355,0.04616272,2.7655044566470446,0.12196417233723567
12075,SIDM00332,Linsitinib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,1.8933777,0.05826578,2.9669984860175567,0.08863812071995279
24091,SIDM00893,JQ1,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.679914,-0.09637156,-1.9897490948090293,-0.04560316485518008
47153,SIDM01233,Oxaliplatin,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-1.9073944,-0.10709476,-1.9197616165720937,-0.11203277988320814
96845,SIDM00628,Docetaxel,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-2.6846204,-0.17861511,-3.6601519377799545,-0.2571944450245671
42772,SIDM00529,AZD7762,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-0.7670353,-0.055929784,-1.021462151149475,-0.04023486446470784
1922,SIDM00878,NU7441,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,0.42324528,0.039917257,-0.3590256204066455,-0.0034881484739206986
80215,SIDM00782,Trametinib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.7931325,0.05033626,1.607638826391604,0.035823485279878935
104170,SIDM00878,PD173074,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-0.31326678,-0.0342454,-0.1909279281182734,-0.015052380962112243
52439,SIDM00875,Entinostat,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3924037,0.02857699,-0.9768975699404203,-0.06224528991689303
1306,SIDM00971,Palbociclib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.3141932,-0.03650027,-1.3660585818422681,0.005362951859965729
55704,SIDM00628,OSI-027,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,1.883733,0.15900077,0.7139922925033322,0.07168993946827076
38497,SIDM00866,Alisertib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,-2.763086,-0.1825171,-1.2597236764597846,-0.07364635913640608
33082,SIDM00866,Luminespib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-0.32272866,-0.022561483,-0.10337991014532258,0.01813509374953336
89636,SIDM00146,5-Fluorouracil,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.854904,-0.046662007,-0.5305355938570295,0.0121538846782917
35238,SIDM00673,Entinostat,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.3554127,0.16598894,-0.1492733890770102,0.026322052941102757
84017,SIDM00332,Wee1 Inhibitor,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1763304,0.08690506,0.5485127991300665,0.01366819636402783
76837,SIDM00529,ZM447439,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-2.2479882,-0.13691254,-1.8638649785118426,-0.07301050718901167
56185,SIDM01233,SB505124,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,0.31248048,0.011103655,-1.6533738335582946,-0.05359640170817443
66334,SIDM00971,Cisplatin,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.036628366,0.0006388601,0.5900109723345515,0.013601714327144597
63365,SIDM00628,Nilotinib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,0.32198626,0.031044284,1.2213609883108705,0.030154465661457516
82242,SIDM00301,SCH772984,Oxaliplatin,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-2.5671248,-0.20119715,-1.1817146105180605,-0.0972350986246253
88559,SIDM00875,Gemcitabine,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-9.2744055,-0.082446665,-1.360622654237399,-0.02181589161837257
38053,SIDM00971,NU7441,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.962221,0.13266066,2.1665977655355144,0.10877562318058431
11295,SIDM00779,Camptothecin,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.2464918,-0.059275735,0.6847061406692699,0.06235268223998847
41995,SIDM00146,Nutlin-3a (-),Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-0.47620398,-0.013840902,0.9684714205757772,0.06566229553507505
8798,SIDM00332,Axitinib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.9202867,0.23643802,-1.5348715295963151,-0.09875806946203929
83790,SIDM00774,Nutlin-3a (-),Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,2.9962115,0.18812542,2.1931886807909637,0.030535075391753836
29004,SIDM00130,Taselisib,Linsitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.51109546,0.051784456,-2.143276002754579,-0.025708678219876577
88725,SIDM00193,BMS-754807,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.2582448,-0.06584564,0.14581666918324004,0.023642964053770837
38405,SIDM00878,AZD6482,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,3.2049615,0.27072975,1.1718105049837486,0.108097753146826
53279,SIDM00776,AZD7762,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,1.2279242,0.11162055,1.5828348631449058,0.10801177334268512
87215,SIDM00866,Olaparib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.9321722,-0.03350069,0.4950439706509031,0.014623359956953711
103151,SIDM00782,Olaparib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,1.4700713,0.050278958,1.4330826619353323,0.039625086615803086
37089,SIDM00529,Afatinib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-0.42539635,-0.015247276,-0.1549055170937988,0.01239295684731418
69750,SIDM00411,Oxaliplatin,Palbociclib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.6757016,-0.0533814,-1.5102569634170617,-0.03294576886142927
764,SIDM00673,Navitoclax,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.2944522,0.08991363,2.330719158208294,0.15068808888448842
7220,SIDM00875,Docetaxel,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.9104292,-0.29045182,-1.715762153225825,-0.19578706557118752
80078,SIDM00779,Linsitinib,SCH772984,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,33.0,-0.9742105,-0.08271742,1.3494367230681448,-0.003935906758177799
43556,SIDM00193,SCH772984,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,East Asian,53.0,-0.9127236,-0.07242058,-0.4604786514780681,-0.03035149143920933
58604,SIDM00097,JQ1,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1957479,-0.0643857,1.4951336739429941,0.09030918755118346
21660,SIDM00954,KU-55933,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.0,-2.102305,-0.056591157,0.502030019169499,0.08701493475247307
23548,SIDM00301,Paclitaxel,Trametinib,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,-0.7395235,-0.029903112,-0.3690999112727325,-0.05778017211269451
106596,SIDM00893,AZD7762,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.5111195,0.027494308,-1.2097531012160527,-0.05183056100096743
100371,SIDM00774,Gemcitabine,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.0282233,0.081488214,-0.45518432967933786,0.02225829600263451
13832,SIDM00529,BI-2536,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.0352789,0.0770086,0.4417413333698438,0.036651618126281066
88552,SIDM00954,Paclitaxel,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.5668699,-0.03462883,0.46608554397470214,0.04283743445837049
98734,SIDM00146,Sorafenib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-1.4711083,-0.13124272,-0.8041105365172356,-0.05278125349131923
82539,SIDM00954,Doramapimod,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.76676977,-0.018633032,0.7392167252032936,0.13892956831686448
76308,SIDM00146,Alpelisib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,0.6243662,0.025212461,1.4276697595945473,0.11982200183489344
73556,SIDM00866,PD173074,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.8294679,0.083590075,-0.6141812967852841,0.030260885238571674
61032,SIDM00130,Trametinib,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.2939051,-0.060788598,-0.4903821470025536,-0.02554433268376636
106273,SIDM00359,Trametinib,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.6612337,0.03671949,0.5772754698814083,0.046792247104356095
85723,SIDM00660,SCH772984,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,-1.9274291,-0.06612258,-1.2811121146134332,-0.05820560306102938
74763,SIDM00774,AZD7762,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,48.0,-2.1343944,-0.17687814,-0.8971399564444337,-0.05306205817479272
68613,SIDM00529,Taselisib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.6294622,0.044465963,0.2991388223900267,0.08549950945908039
30027,SIDM00834,MK-1775,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-2.0554729,-0.17801861,-2.3982298880681543,-0.11483304679643364
96408,SIDM00954,Doramapimod,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-1.4328799,-0.07559227,1.1960586486484883,0.10651196437914115
35963,SIDM00301,5-Fluorouracil,Olaparib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-2.045678,-0.24398814,-1.0923584167390157,-0.05782014967139909
75043,SIDM00779,Palbociclib,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,-3.7319567,-0.14048679,-1.4860436974893403,-0.05644075723239098
101598,SIDM00628,MK-1775,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.46398798,-0.037094332,-0.3459092984965717,-0.006085769552478606
59635,SIDM00529,Taselisib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-1.5673788,-0.083377324,-1.2615392474368907,-0.048175728737217614
70968,SIDM00097,AZD6482,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9166522,0.06154553,1.7999208665137245,0.0957112952282471
21277,SIDM00193,Navitoclax,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,0.4317435,0.025794685,1.2415916349657254,0.048255559757663526
81734,SIDM00411,SCH772984,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,3.0380337,0.14118959,1.7330991894178558,0.07938837351135047
107521,SIDM00878,KU-55933,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-1.4627078,-0.035657234,-0.9883364061615291,-0.01712578103983502
85042,SIDM00866,Bortezomib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-0.22609687,-0.017591024,-0.7663897168161666,-0.04428957477596982
63715,SIDM01233,Palbociclib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,72.0,1.1287515,0.02779419,1.7213114211359755,0.040876117874211935
58340,SIDM00774,Crizotinib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.7444478,-0.08573099,0.5861454622143127,0.026602842278407632
68190,SIDM00954,Venetoclax,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,1.6865612,0.092857204,-1.5692610460012664,0.02310968705479623
80819,SIDM00193,Crizotinib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.52070516,0.027980283,-0.5587592874648081,0.039706414125545895
61781,SIDM00673,Alisertib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.7440627,-0.1308107,-0.14817971294642363,-0.0013428412773000145
81234,SIDM00875,MK-2206,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5367438,-0.03736351,-0.789827368977366,-0.03921754128128633
52961,SIDM00332,Crizotinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5108048,0.12261393,-0.0760506214214451,0.0971853982695794
71624,SIDM00628,GSK269962A,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-1.2197777,-0.084937915,-2.9678442550327935,-0.07713077066243501
39610,SIDM00531,Trametinib,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.9704854,0.21347645,0.9880341455758372,0.06974811706623442
10162,SIDM00673,Gemcitabine,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.4898908,-0.09394255,-0.7692280765133156,-0.024543774874104824
48129,SIDM00778,BMS-754807,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,2.745748,0.13149916,-1.1121344675047478,-0.058278665925047796
37285,SIDM00332,PF-4708671,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2367322,0.045664564,1.1895289748876854,0.09902399893852018
13869,SIDM00893,Uprosertib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.2578523,-0.020974161,-0.922238208517629,-0.08843811914244684
71890,SIDM00893,PD173074,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.1596714,-0.02919531,0.9640067738455601,0.05010091141734078
75213,SIDM00529,Ribociclib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Black,44.0,-1.2087206,-0.031964395,0.07038071289475409,0.012310905389680554
66554,SIDM00875,Gemcitabine,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6675031,-0.0015493915,-0.42842480286074963,0.01694689068447734
87601,SIDM00146,Linsitinib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,1.5677185,0.033825908,2.0497240565211547,0.044051810204875405
1868,SIDM00673,KU-55933,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.318241,-0.099680275,-2.5722180816220415,-0.10108445999217254
99394,SIDM00146,Sorafenib,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.9716485,-0.08784235,-1.1239861940854505,-0.07786685554134612
7820,SIDM00673,Sorafenib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.8346353,-0.13646655,-0.8953200962100988,-0.03300419060181075
69434,SIDM00866,Alisertib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.088564,-0.03638997,-1.8741716610579169,-0.03309343648863233
8234,SIDM00779,Palbociclib,Vinorelbine,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,33.0,-1.9097633,-0.13896827,-2.182696096230893,-0.09886657847668096
13594,SIDM00878,Docetaxel,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.2217977,0.11748877,0.07230148039858018,0.04409062466876539
34177,SIDM00332,ZM447439,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7656455,0.11964244,-0.7129999328911278,-0.0523399944726648
46655,SIDM00779,MK-2206,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-2.099741,-0.116666645,-1.8381019725577403,-0.1563414488470409
88868,SIDM00774,SCH772984,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,48.0,1.3243818,0.03555467,2.007314878860252,0.07729524300941167
106397,SIDM00893,Crizotinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.7828772,0.030481188,0.6392921323711939,0.048247376877915665
79560,SIDM00529,Doramapimod,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Black,44.0,0.6053942,0.022075118,2.1002837305083126,0.03506373584991731
63280,SIDM00332,AZD6482,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.6977825,0.12492008,-1.2627772993136566,-0.10029530790936898
44158,SIDM00146,Olaparib,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,1.6797798,0.11344821,1.0690549232406201,0.10952153892421204
1496,SIDM00778,Linsitinib,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,69.0,1.6467291,0.07951164,1.2779673538402117,0.08563370243997682
58593,SIDM00673,KU-55933,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,0.8784142,0.058233466,-0.6760077436850387,0.0016147092888154824
56103,SIDM00782,SB505124,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,Unknown,72.0,-1.3022051,-0.098715246,-0.6515698449691064,-0.012941802613741131
3254,SIDM00097,5-Fluorouracil,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.3620415,-0.13864589,-1.4793952395096661,-0.08175980730519511
71523,SIDM00834,Crizotinib,Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,White,66.0,-0.5612575,-0.042251363,-1.80145364400905,-0.08641546100319744
96479,SIDM00774,Linsitinib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,48.0,3.221814,0.34761503,1.457332384041394,0.07524899941229363
96225,SIDM00301,Cisplatin,Oxaliplatin,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,1.8620366,0.22358431,-0.04070491777456647,0.022717922260887948
101290,SIDM00779,MK-1775,Vinorelbine,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,33.0,-1.0498016,-0.06373898,-1.6379511794312827,-0.02053580521554117
62940,SIDM00893,Olaparib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.0817709,-0.027168222,0.40834464991076397,0.05585635093401984
43134,SIDM00097,Cisplatin,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.3205355,0.02579956,1.2704772389771,0.041304714786741
60395,SIDM00774,5-Fluorouracil,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.290456,0.06410544,-0.13851075190683956,0.11879622400338875
41626,SIDM00673,NU7441,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.5677428,0.20669729,0.8881869109032917,0.09836921315709045
106730,SIDM00628,MK-2206,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-0.94250417,-0.0342945,0.18352649027282103,0.038047487498783
22050,SIDM00193,Trametinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,East Asian,53.0,1.5102949,0.12398226,-0.6664193291960364,-0.029526392076389265
104022,SIDM00776,Oxaliplatin,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,65.0,-2.5007954,-0.08330531,-1.5531627084677384,-0.04406466706130237
44355,SIDM00301,Trametinib,Oxaliplatin,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-3.010882,-0.20475042,-1.4026906035333249,-0.11446092278570871
45315,SIDM00531,AZD7762,Erlotinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.228288,0.09410015,-0.9556005666110234,-0.007796711256080159
64423,SIDM00628,Ribociclib,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,Black,51.0,-0.36807916,-0.009237622,0.2536458925977875,0.026216910389817303
37627,SIDM00954,PD173074,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-0.73441666,-0.039083637,-2.444748099241792,-0.10947195016911511
105491,SIDM00782,Camptothecin,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,2.6177979,0.21349701,0.19309128131695566,0.06510755664865248
38689,SIDM00866,Wee1 Inhibitor,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-0.53358954,-0.040659886,-0.26509824041004526,0.03999335607026011
56657,SIDM00774,Cisplatin,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,4.4831724,0.35885373,3.895339253951594,0.16794617613813378
34621,SIDM00866,Sorafenib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-0.34775725,-0.016916584,-0.11884622936620437,0.021670869516613126
68522,SIDM00411,MK-2206,Dasatinib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,43.0,-1.545417,-0.07606038,1.3599764594827282,0.07994534282109043
100797,SIDM00971,ZM447439,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.4822783,0.08170458,0.6547071227406642,0.09191094033097288
62076,SIDM00893,Vorinostat,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.1458228,0.08059939,-1.1542312714787395,-0.036539509130896666
51094,SIDM00954,Cisplatin,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.41361707,0.016528003,0.07604165949104813,0.05952512965654391
24431,SIDM00971,Ribociclib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.6060271,-0.05599958,-1.094907807281046,-0.0012131136862965695
49535,SIDM00779,Palbociclib,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.8197354,-0.15035035,-1.4235178667987654,-0.09248935122480348
47629,SIDM00774,Gemcitabine,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.4189603,0.13039282,1.0895712971946334,0.05341806167605353
95036,SIDM00673,MK-1775,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.621548,0.059801053,-1.2068197734533033,-0.040909325698136795
95471,SIDM00954,Paclitaxel,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-0.7436523,-0.05855883,-0.5644385404116189,-0.06632545479968466
71343,SIDM00146,Gemcitabine,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.0776203,-0.08392741,0.06198122642637712,-0.05317694999293501
41112,SIDM00954,Linsitinib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-3.801062,-0.18491721,-1.1587975781013193,-0.05952806253032391
71786,SIDM00774,Linsitinib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.8971014,-0.055944085,-0.1403597934525948,0.03941416972637657
9595,SIDM00660,SCH772984,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,-3.6424305,-0.24939209,-1.5342512172955156,-0.05476968464648455
86614,SIDM00193,Dabrafenib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.9363042,-0.019680697,1.2311972623509895,0.03554160300048735
76951,SIDM00097,Olaparib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2277775,-0.022348084,0.26426571803317506,0.007266599075417427
46069,SIDM00834,Olaparib,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,1.3316776,0.030844595,1.2058835831637875,0.054539883235576084
97152,SIDM00875,Entinostat,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.48198608,-0.044390455,0.4737295458717006,-0.007521224584676525
73618,SIDM00193,Taselisib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,53.0,0.24847627,0.023375101,-0.4099004383285397,-0.0032593932888948405
46308,SIDM00778,Dabrafenib,Vinorelbine,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,69.0,-0.21573189,-0.00349471,2.0650093814412473,0.030812899367593367
10627,SIDM00782,Dabrafenib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.6566625,-0.021097494,-0.46469645842282287,0.019691786162693573
23042,SIDM00673,OSI-027,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.5824753,-0.059935905,0.21745633237804196,-0.03702707877334137
30431,SIDM00774,Linsitinib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.40055463,-0.025988236,-0.15370359168896747,0.029626839231987577
71716,SIDM00878,Linsitinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,3.200222,0.30032057,0.6967694101743688,0.05974140366861763
22572,SIDM00779,Linsitinib,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,33.0,-2.2078536,-0.18778029,-0.750437327111716,-0.08129897483285552
39599,SIDM00866,Lapatinib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-0.5271675,-0.040106352,-0.4002715706618983,-0.00503530133607996
32311,SIDM00097,5-Fluorouracil,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9339131,-0.08960168,-1.7837011104594718,-0.06331940613648843
98628,SIDM00531,Dasatinib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.2946414,0.1629579,2.577386317472325,0.19194500839263068
29221,SIDM00660,Navitoclax,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,5.4960766,0.2474926,1.3864723506669778,0.06637795750987528
75898,SIDM00529,Wee1 Inhibitor,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.16972911,-0.017144738,-1.1855183468715005,-0.083819205851023
47357,SIDM00529,AZD8055,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-2.303964,-0.0984405,-1.274684320542923,-0.013561307352633346
12595,SIDM00866,Afatinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-1.8879296,-0.15604529,-0.7525341327592717,-0.015173807335955893
63764,SIDM01233,Nutlin-3a (-),AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,-0.8898428,-0.030535838,-1.1767087393303348,0.02148045169992438
81901,SIDM00779,Linsitinib,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,33.0,-2.6008024,-0.16193222,-2.74146566795423,-0.21436076288384284
54224,SIDM00954,JQ1,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-2.3199642,-0.1764133,-1.1759997075801183,-0.09094860780650611
92485,SIDM00130,Paclitaxel,SCH772984,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.48956499,-0.038328227,-0.7578698091062059,0.012619867277998532
12747,SIDM00782,MK-1775,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.2938353,0.015176211,-0.14039503935307912,-0.020982567930139452
12150,SIDM00628,Navitoclax,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,-0.4534689,-0.044787355,-0.14795175216324877,-0.014845198621372584
10328,SIDM00875,PD173074,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6264875,-0.07548727,-0.7173353146447414,-0.03910856103860854
23134,SIDM00875,BI-2536,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6862808,0.04807397,0.6193569051795966,0.0075265492505876205
25305,SIDM00097,OSI-027,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.1681793,-0.19471177,-1.2969829673426558,-0.12672205172269935
78628,SIDM00875,Paclitaxel,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7550272,-0.05746572,-0.6649738637931779,-0.007799111839694601
92117,SIDM00875,Temozolomide,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.58564305,0.013946297,1.1351856697282972,0.01672862745279922
67893,SIDM00332,Ribociclib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.9103483,-0.08386973,-1.3160305493043034,-0.06939926382901378
94325,SIDM00875,ZM447439,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.74311644,0.07785484,0.37346392159259534,0.03291856847595106
25417,SIDM00411,Crizotinib,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,43.0,-1.6201559,-0.09014279,-1.281833527328844,-0.05804671891736295
39032,SIDM00411,Erlotinib,Oxaliplatin,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-1.289206,-0.051695276,-0.237917856448612,0.034827659339998714
72807,SIDM00774,Tozasertib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.618453,-0.016198399,4.309870006904123,0.094620816775082
19716,SIDM00878,Alpelisib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-0.93896717,-0.073173285,-1.0423830550174455,-0.04573162499398936
77258,SIDM00529,Docetaxel,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-0.73103416,-0.061526187,-1.5745560903422506,-0.1328728953065474
47736,SIDM00146,Trametinib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,2.6915567,0.15974523,0.9505900768088977,0.011659846505092174
12593,SIDM00893,NU7441,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.7961676,0.16149113,-0.7171276107279287,-0.011153056640911698
105181,SIDM00332,Entinostat,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3715228,0.036656927,1.8206466869441724,0.07765270137561141
107,SIDM00878,Taselisib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-2.0737615,-0.108470485,-0.25649671604280344,-0.00412838915795636
93721,SIDM00332,Camptothecin,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,4.1868134,0.13509585,1.2408642647885613,0.05302943659301874
79617,SIDM00875,Dabrafenib,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.37998015,-0.014965035,-0.7608590128627264,-0.03728340475177855
21179,SIDM00893,Dabrafenib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.8891737,-0.020593863,1.4373229768112654,0.0950290985605663
18465,SIDM00193,SB505124,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,53.0,2.0757318,0.14237149,-0.2639406324476233,-0.008492281855410063
6388,SIDM00193,Oxaliplatin,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,53.0,1.251456,0.043018308,1.581224771251797,0.027839325087266407
75689,SIDM00332,Tozasertib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.86778146,-0.06820697,-0.39529915505486823,-0.04585895135566757
81161,SIDM00893,KU-55933,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.8084941,-0.057755854,-1.6622192750586726,-0.04659555234944202
60386,SIDM00866,Cisplatin,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,2.7430453,0.033853874,4.355397676993261,0.11135832530961165
95321,SIDM00875,Taselisib,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4777642,-0.13562395,-0.31920923375626964,-0.007838415270337212
98334,SIDM00097,Alisertib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.212684,-0.06346239,1.3241309757691158,0.04268115230212527
96309,SIDM00893,Doramapimod,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,5.915071,0.18032551,2.0975790447051557,0.09427413522215346
25308,SIDM00529,OSI-027,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-2.9398694,-0.1029011,-1.080600465065032,-0.053154468587823626
42730,SIDM00776,SB505124,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.14596885,-0.008615946,-0.6346589639159137,-0.0116336167670701
3526,SIDM00411,Dasatinib,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,43.0,-0.5150537,-0.033863112,1.3954473711686777,0.03748190964704644
66147,SIDM00628,Gemcitabine,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-6.903203,-0.17457029,-3.3874369690045865,-0.11822446154975073
89301,SIDM00628,BI-2536,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,5.1151967,0.065529525,2.1508354702517662,0.04016249290735491
71878,SIDM00971,Uprosertib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.8691187,-0.08352881,-1.6583034746885057,-0.03869828431019681
101384,SIDM00893,Gemcitabine,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.34463775,-0.02966904,-0.4578644675533008,0.0182684910454262
18434,SIDM00875,Lapatinib,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8446206,0.09298587,0.7613298261655929,0.06675715287547285
80721,SIDM00628,Docetaxel,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-1.8491341,-0.08102901,-0.9923656312388905,-0.08415527585067369
93006,SIDM00875,Camptothecin,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.095495,-0.18028337,-2.7632511306517884,-0.1269877934721452
65840,SIDM01233,Linsitinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,72.0,0.5793524,0.03079857,-0.6864384515911012,0.006588832709233817
108346,SIDM00146,RO-3306,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,1.2282848,0.10128913,0.1287839305644793,0.043452263219863216
69338,SIDM00193,AZD7762,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,53.0,1.7468086,0.107044935,1.272965113111136,0.06758989560686927
59218,SIDM00875,Nutlin-3a (-),Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.9710883,0.08425399,1.8398277329873922,0.06938143295327404
52913,SIDM00893,Entinostat,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,4.058978,0.075818144,2.340624441170857,0.05190131096297708
2023,SIDM00866,AZD6482,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,1.3541988,0.091889255,-0.08250216049144017,0.015268992830458386
101014,SIDM00866,Temozolomide,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-0.29865235,-0.005987689,0.4167037449588202,0.003234607792897552
950,SIDM00359,Nutlin-3a (-),Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,3.7423418,0.07580785,1.923673062267073,0.04766287991009911
33101,SIDM00774,Axitinib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,1.9116199,0.1799308,0.22055177674571777,0.08287771951933871
87288,SIDM00097,Docetaxel,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-6.527218,-0.2875082,-3.6825916114235024,-0.2608297049715964
100842,SIDM00875,MK-1775,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8120833,0.03732217,-0.4419667185814389,-0.04824520159831196
74582,SIDM00673,Axitinib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.9408572,-0.16895434,-1.3418842209627786,-0.07071349735440137
26835,SIDM00778,MK-2206,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,69.0,2.285978,0.12497331,-1.3337210813478662,-0.04638042185329106
101676,SIDM00097,Lapatinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.035814,-0.100413725,-0.22786093360918971,-0.0038231829884234733
75851,SIDM00146,Nilotinib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.7989931,-0.06889168,0.0681485254409446,-0.04347853915752022
47944,SIDM00776,Dabrafenib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-1.1716037,-0.03919223,-0.2722800467401772,0.011930341614858527
83977,SIDM00660,Dabrafenib,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,-1.1249058,-0.10024663,-1.843336900297536,-0.061493120100449605
52402,SIDM00529,Paclitaxel,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Black,44.0,1.1478088,0.11037567,0.49853425226787856,0.09388450268698331
7206,SIDM00971,PF-4708671,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.8210235,-0.048231374,0.36499014253752654,0.015640408907776106
47355,SIDM00893,Nilotinib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.6599863,-0.052553035,-0.1598150210133952,0.05475024507190604
23036,SIDM00097,Crizotinib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.1372067,-0.008666909,-0.7981829066837053,-0.0317789614397556
105728,SIDM00097,MK-1775,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.68626285,-0.048420496,-0.9352231230682198,-0.056201550767285044
62708,SIDM00193,Dabrafenib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,East Asian,53.0,-0.5765538,-0.009565139,1.787380508664503,0.05658739549514932
72525,SIDM00301,Trametinib,Ruxolitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.3217365,-0.14783636,-0.969335342238237,-0.08452968245674856
86239,SIDM00866,JQ1,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,1.1205583,0.087531336,0.6932233550976216,0.1118866264871818
101054,SIDM00411,MK-1775,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.115501,0.12241238,-0.22947630105820352,0.011623051697472625
101392,SIDM00531,MK-1775,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.5043829,-0.049900774,0.46268525710933006,0.05609772538244543
55664,SIDM00878,PD173074,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-1.6555514,-0.1430747,-0.05552272568373318,0.006414789774361478
58632,SIDM00411,Linsitinib,Navitoclax,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.5826323,-0.084232196,2.4167539332626204,0.145481993436944
14284,SIDM00531,Ruxolitinib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.131014,0.12629813,2.9514361650599317,0.05560022091013985
42698,SIDM00971,Navitoclax,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.9270816,0.14425038,1.6489615517467549,0.0814559466699065
65122,SIDM00332,Tozasertib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.416239,-0.10317994,-0.8693526187832042,-0.09645506596498965
68829,SIDM00866,Palbociclib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,0.7448912,0.019299185,1.0374248670162662,0.0338712399419793
69274,SIDM00878,Nutlin-3a (-),5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.4636335,-0.07075373,-0.7729790053810136,-0.05266639463177814
67997,SIDM00660,Afatinib,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,-2.2472644,-0.18283589,0.01808737120940713,-0.02079119090807059
93177,SIDM00878,Temozolomide,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,0.7131544,0.023637852,0.4362084358232768,0.026192648695422486
89452,SIDM00954,Camptothecin,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.090174146,-0.0022745186,0.9926374314472343,0.07617197105869525
18874,SIDM00776,Trametinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.5216748,-0.13639762,-1.4587941595727767,-0.037680476497441114
89901,SIDM00779,Crizotinib,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,0.30877683,0.011329782,-0.7739626623514615,-0.03791400664557215
46074,SIDM00673,Uprosertib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.7903777,-0.13163254,-0.148665343594965,-0.013729178435546397
51795,SIDM00097,Docetaxel,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0263278,-0.11966199,-1.5789823710720978,-0.08076564782982441
69790,SIDM00878,SCH772984,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.69809896,-0.05324283,0.2670288503849493,0.024691934469852544
38108,SIDM01233,Taselisib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-1.0399613,-0.06671109,-1.6344209284759785,-0.08852858884968157
93237,SIDM00130,Sorafenib,Palbociclib,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.89316946,-0.064259395,-1.2314589199759156,-0.07583763728775911
42051,SIDM00866,MK-2206,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,52.0,-2.6645246,-0.13306992,-1.2648346648569375,0.007969095102554932
61471,SIDM00673,Crizotinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.9389465,-0.15525866,-1.1901565108365098,-0.08676976815643059
84435,SIDM00130,Ruxolitinib,AZD7762,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.4121118,0.043759994,1.3296192172694523,0.057068023606276705
78324,SIDM00971,Linsitinib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.0546819,0.047331955,0.05440372070596513,0.01568057772356919
29885,SIDM00673,Navitoclax,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-0.73060495,-0.055911124,-0.005684566046510105,0.01879141804928455
59610,SIDM00774,ZM447439,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.3163383,0.07804843,0.9812981646816272,0.07313156974639645
56111,SIDM00875,MK-2206,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.19024496,-0.016249035,0.872976641591764,0.08659862341467829
11096,SIDM00954,OSI-027,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-2.9940288,-0.16527903,-0.28344676842347566,-0.0719891026544765
82663,SIDM00411,Taselisib,MK-2206,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,43.0,-1.9027971,-0.1052494,-0.5430581191863154,-0.01887850412375302
83758,SIDM00529,Camptothecin,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.4466939,-0.051204614,-0.2858772455789051,0.01738200864547716
49701,SIDM00971,OSI-027,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.4022574,-0.06607965,-0.5643881959699502,-0.029878096576662152
20402,SIDM00875,Trametinib,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5725889,-0.061735395,0.05383628943320439,0.04351908024327342
97501,SIDM00146,PF-4708671,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,2.0187128,0.08526362,0.908155030143227,0.0562649705714853
68716,SIDM00893,Temozolomide,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.8610099,-0.019465964,-0.1505056019913979,0.004103466907521628
30123,SIDM00301,Irinotecan,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.2282411,0.14718273,-0.08214396523808032,0.0036616021362406606
8670,SIDM00954,Axitinib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.0,-1.6822003,-0.13030206,-0.2596875041715275,-0.06107849400336366
46895,SIDM00529,SCH772984,MK-2206,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-0.5243107,-0.022872267,0.5389399947090525,0.08018981248071502
73457,SIDM00776,Afatinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,1.604759,0.057196938,0.6510663773224129,-0.0024496329828463453
28629,SIDM00628,Axitinib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,0.2608484,0.017982269,2.5032959266351082,0.17528364923445347
28821,SIDM00954,Ribociclib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,0.5800187,0.020653874,-0.621699092956413,0.0201854877565576
107890,SIDM00954,MK-1775,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,0.50179005,0.03309203,-0.44148267574908684,-0.0034539217955777803
21756,SIDM00866,Docetaxel,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,1.2115332,0.095837675,2.539308092466379,0.15934799924665016
21474,SIDM00778,MK-2206,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,3.2956347,0.12935561,1.0406310427625993,0.04822656519308696
67382,SIDM00875,Paclitaxel,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-4.1852055,-0.42306662,-4.1415853584433675,-0.1767970684500037
45283,SIDM00971,KU-55933,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.0232544,-0.028513588,-0.5028837280710043,-0.0207517174689062
98915,SIDM00411,MK-2206,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,-4.0473456,-0.13026574,0.1403738583544931,0.022555874333237285
30056,SIDM00146,Ribociclib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.571961,-0.046047732,-0.12454601183704005,0.018105148192689286
43596,SIDM00531,Lapatinib,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.5628812,-0.077888474,1.8136030710647533,0.1296121469230319
82830,SIDM00531,Lapatinib,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.49757862,0.03623487,0.8010315827985545,0.06786711355006024
9110,SIDM00628,RO-3306,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-3.449229,-0.13893645,-1.7341473370709655,-0.14586904952444288
46483,SIDM00971,Pictilisib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.6452174,-0.09983998,-0.5344806553129933,-0.0020408062860864497
55732,SIDM00878,OSI-027,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,1.8114403,0.20842084,-0.9543411035376196,-0.06570586354755055
102867,SIDM00866,PF-4708671,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,-1.4806365,-0.06796322,-1.587549586597405,-0.03798264047967046
68260,SIDM00628,Entinostat,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.89623255,0.053086113,-0.5929143327046769,0.021500039993849893
25704,SIDM00893,Navitoclax,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.2866297,0.18044655,1.1236443898496926,0.08337663010242383
58738,SIDM00866,Ribociclib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-3.2827654,-0.0899819,-1.3087127855880059,-0.030536041300725448
98089,SIDM00628,KU-55933,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,1.4067936,0.10138758,0.31359520070415625,0.07045778890895728
10117,SIDM00146,Vorinostat,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.5836751,0.052027773,-0.589345365017019,-0.07306334255449257
86224,SIDM00954,KU-55933,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-1.9682271,-0.07093609,-0.10740807748377548,0.08547715389348035
51745,SIDM00971,GSK269962A,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.33443972,0.022182751,-1.0161557147754514,-0.051087714888404565
26287,SIDM00529,Luminespib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-2.2489443,-0.06715483,-1.7387540180046703,-0.07880083020740761
44866,SIDM00673,KU-55933,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.9440114,-0.13484569,-1.2183717613491565,-0.037748685165089606
1984,SIDM00097,Bortezomib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.28526062,0.017963486,0.016700582380246902,-0.016669732028875974
23664,SIDM00893,Palbociclib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.6394674,-0.024005735,-0.24736739300820343,0.021157833575428373
76793,SIDM00529,Alpelisib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.2275217,-0.06155471,0.03210133318826747,0.056569343868290975
56755,SIDM00954,Palbociclib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,2.8301208,0.032850508,-0.2639586102027636,-0.02685515267392692
63004,SIDM00782,AZD7762,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.529922,0.039602354,-0.8984633900514033,-0.08716403239634389
74405,SIDM01233,Trametinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-1.9184663,-0.13528612,-1.3680770972861194,-0.06739625271810494
29017,SIDM00146,Docetaxel,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-1.0777081,-0.10233832,-0.9970420190115428,-0.03605732389847284
62555,SIDM00875,PF-4708671,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.74844056,0.03814794,1.4771468784548991,0.06407431817407852
57654,SIDM00866,Axitinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,-1.1956614,-0.045738067,-0.4694632184740893,-0.005989100792378977
67575,SIDM00332,Gemcitabine,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.342841,0.3280606,-0.02444490315628118,-0.0347128121613705
34569,SIDM00673,Navitoclax,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.1653447,0.1931312,0.7503705879724843,0.08784289633812162
10498,SIDM00673,Uprosertib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.52412564,-0.03863766,-1.317650740588371,-0.054061109100952874
44855,SIDM00673,Olaparib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6340224,-0.027180318,-1.2518436795812522,-0.03534899363893636
69399,SIDM00866,AZD6482,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-2.0634549,-0.10062549,-1.6642713570401446,-0.05751349683220244
21162,SIDM01233,MK-1775,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-1.9474764,-0.13487664,-1.4580220408300977,-0.08593621299826476
72999,SIDM00193,Vinorelbine,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,53.0,0.24547264,0.024725242,0.44634911051786863,0.022690731849604684
11430,SIDM00971,Navitoclax,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.3923951,0.010567321,0.05475496205509643,0.03137273710358963
81203,SIDM00673,5-Fluorouracil,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.59276325,-0.023924457,0.11696936509094884,0.02692547009508845
7002,SIDM00878,Cisplatin,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.9792805,0.0354801,1.5449481124152054,0.05483422359210988
36611,SIDM00875,5-Fluorouracil,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5361434,0.060171157,-0.2400729078391337,0.010993351397507315
27526,SIDM00130,Crizotinib,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.91741,0.20201214,1.881193755823425,0.173983788565244
44924,SIDM00893,Gemcitabine,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.3838284,-0.17259876,-3.090133793926391,-0.17445662857423178
8120,SIDM00628,OSI-027,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-0.1798798,-0.017412346,-0.23615679786921528,-0.034991506407553837
68553,SIDM00097,PF-4708671,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1895621,0.05475727,0.4998071336235764,0.025560350090417207
10519,SIDM00332,Docetaxel,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1687113,0.10128964,-0.9777016794973491,-0.10174658733170107
104545,SIDM00332,Entinostat,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,7.377855,0.16862848,2.4813730557114857,0.08799562022293031
69970,SIDM00332,AZD7762,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.9655762,-0.23817454,-2.0809100224307504,-0.23529864862379785
83402,SIDM00782,AZD7762,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.8484056,-0.16376035,-0.9339869379385396,-0.053372143377825025
74568,SIDM01233,BMS-754807,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-0.86439383,-0.06441936,-1.4170521298906527,-0.11071059068930802
81682,SIDM00875,Venetoclax,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.43876445,-0.009636934,0.1933634072634452,0.01925078038498771
60704,SIDM00146,Tozasertib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,2.7674196,0.1539332,0.8463453639967642,0.054479167162224666
81163,SIDM00875,AZD6482,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8455367,0.057757873,1.942662743663188,0.09506396747063052
47073,SIDM00411,Crizotinib,OSI-027,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.377353,-0.10373863,0.6958662966016798,0.029770731879635092
64180,SIDM00954,Temozolomide,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.18413064,-0.0033129111,0.36208966059661696,0.0019442906019022492
39116,SIDM00778,Dabrafenib,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,1.1577585,0.024578419,0.7645627713596647,0.0389963455432819
71208,SIDM00776,Vinorelbine,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.11609996,-0.00870792,-0.1565378174625884,0.009640172099872222
101636,SIDM00097,KU-55933,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.4388645,-0.09338981,-1.728575048315766,-0.05590635189985815
60211,SIDM00774,Camptothecin,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,48.0,-2.1959677,-0.094477646,-0.30893768631309737,-0.04488378753685176
79808,SIDM00875,PD173074,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2408162,0.078589134,0.8050062811859475,0.08408789743063397
19764,SIDM00130,Paclitaxel,Taselisib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.36592832,0.031803004,0.139641041965717,0.049321911592228485
34414,SIDM00332,Afatinib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.6589134,0.12134494,0.7552563017688613,0.07144920826318263
12876,SIDM00673,Afatinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.2120157,-0.08572774,-0.02305285628733918,-0.00449763561122615
7236,SIDM00875,Nilotinib,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2987714,0.14651576,0.6248591168211002,0.0941765423350556
73179,SIDM00778,Afatinib,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,69.0,-2.6236463,-0.13516836,-0.7877874944788386,-0.06814282575987972
2170,SIDM00193,Nutlin-3a (-),BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,1.1147393,0.024080282,1.9230267550327411,0.09721819932381436
21503,SIDM00628,Gemcitabine,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,-2.3542218,-0.07242863,-1.5495536928580487,-0.06725248380177655
2565,SIDM00097,Entinostat,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.117911,0.0859049,1.045638553013889,0.08536189554244282
17731,SIDM00875,Paclitaxel,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-3.5230079,-0.058872286,-3.192024287728843,-0.15133736078423704
43508,SIDM00875,Wee1 Inhibitor,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.21602099,0.013464871,-0.80706887901693,0.00638872891498743
48136,SIDM00411,MK-2206,Dactolisib,Pancreas,0.0125,Pancreatic Carcinoma,Male,East Asian,43.0,-1.6975473,-0.08388719,0.7500447697222314,0.06521317907548958
39558,SIDM00332,Doramapimod,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.58949995,-0.04367029,0.23833304053520776,0.0011217485485164969
88067,SIDM00878,Afatinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.0003842,0.064658694,0.4133667213282769,0.007851242104991997
41737,SIDM00878,GSK269962A,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.8737043,-0.062247504,0.3507924794300586,-0.011069153540888005
5612,SIDM00776,SB505124,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-0.29740682,-0.022918738,1.0204969200793113,0.061781753212177055
90965,SIDM00954,Alisertib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-2.4084074,-0.18286498,-2.3966377589136094,-0.12373806240865845
33915,SIDM00866,AZD8055,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.7059982,0.076691575,1.0897910956037788,0.09658687759715621
3964,SIDM00359,Camptothecin,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.1890064,0.015882632,-0.8103996666752744,-0.0003833817716688893
90423,SIDM00529,AZD8055,Trametinib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,0.46403447,0.04076252,-0.11049063017841002,0.025963696918559955
82248,SIDM00971,Sorafenib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.3333958,0.023303637,0.0047122925885136144,0.004138617268528242
63096,SIDM00875,MK-1775,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.4524946,0.021624194,-0.4954540035696398,-0.04289199499528201
95838,SIDM00954,Entinostat,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,1.6632373,0.10804442,0.7425145013621457,0.08222248765193764
105896,SIDM00628,5-Fluorouracil,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-1.0071899,-0.043787573,-0.4289627330447856,-0.0031735412616857293
62332,SIDM00875,Temozolomide,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.2056463,0.07863683,1.6595225760462227,0.039901179097561426
27749,SIDM00130,SCH772984,Crizotinib,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.91058284,0.06570069,-0.8601182382289091,0.006606042123401712
21495,SIDM00529,Nutlin-3a (-),Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-1.8845768,-0.059038665,-0.3273562737116925,0.03974922246426995
8428,SIDM00893,SCH772984,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.55363446,-0.03746781,-0.9983308657270212,-0.06784585172477839
42360,SIDM00332,ZM447439,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.5034513,0.18099228,0.21294031995664797,0.014584059000375226
1587,SIDM00834,AZD4547,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,3.286201,0.108188815,3.197691989794739,0.07692658219399516
17558,SIDM00332,Gemcitabine,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4996471,0.13612133,-1.5919422045633675,-0.10429211741244748
58170,SIDM00893,KU-55933,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.83353007,-0.031815134,0.3437167897028162,0.005906480338224583
102604,SIDM00878,PD173074,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,0.61562437,0.06787481,0.9762628001850793,0.08976851625114918
34827,SIDM00878,NU7441,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.8661774,0.16714746,0.7103971877175981,0.029774288430337224
24919,SIDM00878,Bortezomib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.23104885,0.010628661,-0.19695452081837855,-0.03837502542481189
49608,SIDM00866,Dabrafenib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.59857166,0.016906658,0.2825046420126473,0.03017164686473361
99865,SIDM01233,Nutlin-3a (-),AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,0.73442715,0.022029763,0.9365306137931501,0.043581987058520434
73589,SIDM01233,AZD8055,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,1.1921526,0.101222575,0.42322439375307336,0.011506524064330604
76912,SIDM00779,AZD4547,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-4.270743,-0.018583862,-2.8961108775866307,-0.06732007886846825
5489,SIDM00893,SCH772984,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.094094984,-0.00639387,2.2036653435697584,0.0968726788789512
80067,SIDM00332,MK-2206,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.0360162,0.17185725,0.42145731075367004,0.03850003188552042
23859,SIDM00878,PF-4708671,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.9295493,-0.087318785,-0.781547187408469,-0.019653913686338786
103848,SIDM00878,Gemcitabine,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,70.0,0.38589564,0.036576185,0.3021533446212494,0.010331487152097713
97511,SIDM00531,MK-1775,Lapatinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.88430697,-0.08843795,-0.3579891020524851,-0.001522293654615712
101064,SIDM00359,Oxaliplatin,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.1723583,-0.09641737,-1.1095795164014752,-0.07410892406749256
46249,SIDM00301,Ruxolitinib,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.1810966,0.049440388,1.5704247258712356,0.06234332469017498
95882,SIDM00531,Paclitaxel,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.1789128,0.14624505,-0.43546409631347216,0.0061540492370237496
78005,SIDM00778,AZD4547,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,69.0,1.6432537,0.09090577,-2.6404767914932683,-0.0808142870572326
20761,SIDM00332,Olaparib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.876233,0.0787954,-0.04157494046515078,0.031747535092914295
34956,SIDM00875,Camptothecin,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.5944734,-0.13135985,-1.676925232366613,-0.05161708020547644
69495,SIDM00529,Palbociclib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Black,44.0,-0.6485803,-0.030104978,-0.4416651377991418,0.06848492988942198
48409,SIDM00146,BI-2536,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.28609037,0.009169392,-0.05077508917252918,-0.046693703194521124
77884,SIDM00866,AZD8055,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,2.021474,0.0880363,2.381907133358379,0.11075364928049358
72638,SIDM00529,NU7441,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Black,44.0,-0.8280464,-0.064620316,-0.4048674642840695,-0.039683381085865777
106471,SIDM00332,MK-1775,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.56610686,-0.05374658,-0.737130458993759,-0.07051899956364896
78679,SIDM00866,Venetoclax,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,-0.7624118,-0.015633823,0.5558781957062403,0.053353591755117676
8014,SIDM00774,PD173074,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,0.11377641,0.0082308855,0.6562747003176723,0.09725541812181332
61955,SIDM00628,Docetaxel,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.5687796,0.04659832,0.027872783944806398,-0.03687232835664931
74652,SIDM00971,RO-3306,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.81763977,-0.043734837,-0.5633975364383708,-0.028570390555850093
16125,SIDM00776,Vinorelbine,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.7188969,-0.042984977,-1.0905255848259554,-0.07177501613469436
75218,SIDM00878,OSI-027,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,70.0,-0.6233866,-0.052245703,0.12019552684141774,0.010746994111649257
21873,SIDM00146,Bortezomib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.7481364,-0.059369765,-2.228529923570274,-0.11026612619056947
27845,SIDM00774,OSI-027,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.8739831,0.13045137,1.3454063515833548,0.08745376918680133
17927,SIDM00878,ZM447439,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,70.0,0.16476543,0.01492243,-0.09537532887711907,-0.032769484537441516
33045,SIDM00301,SCH772984,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.4798993,-0.1468451,-1.5611271611904534,-0.0841227085587931
20092,SIDM00774,Wee1 Inhibitor,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.13091648,0.008138135,0.15898291054862967,0.04424502588678477
7221,SIDM00893,Paclitaxel,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.94266886,-0.054968987,-0.8067414406332164,-0.08706108938246893
77815,SIDM00332,Camptothecin,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4777883,0.039759602,2.1876725720200416,0.0634797589443321
26452,SIDM00673,Nilotinib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-3.164718,-0.117270544,-1.6390979758245616,-0.07486289085082314
59461,SIDM00130,Irinotecan,Dactolisib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.7727064,-0.059494797,-0.3550519081158779,-0.052155483608525476
40331,SIDM00893,Pictilisib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.72367316,0.051893204,-0.3310883763080128,0.022182469501900746
57480,SIDM00779,AZD8055,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-3.3524919,-0.2637535,-0.6677839068166113,-0.07475186103477326
64681,SIDM00673,KU-55933,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-3.6976497,-0.16584784,-1.9220796811119922,-0.08391443917172473
73077,SIDM00097,PD173074,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.8154323,-0.14444426,-0.6227946489464383,-0.06332917290776298
67863,SIDM00332,Dabrafenib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3745599,-0.030053282,0.6977123675822319,0.006873222749722764
29518,SIDM00301,Olaparib,Ruxolitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.81695676,0.06419153,0.1285397153146156,0.004822401883493805
39937,SIDM00971,Lapatinib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7487005,-0.08839738,-0.3732309790777907,-0.006569870561215507
20142,SIDM00893,Taselisib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.1668558,0.087803945,-0.5673034508046824,-0.04879888809418687
11060,SIDM00878,Linsitinib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.2560532,0.09707365,0.10542778808620085,0.021287405553088102
4188,SIDM00332,Camptothecin,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3738272,0.030115943,2.49276002058457,0.09175154693208257
97338,SIDM00193,SCH772984,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.65467185,0.056889478,1.8598605344642793,0.16281611156220294
9186,SIDM00866,Entinostat,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,-2.0362613,-0.09922966,-0.9786078358651541,-0.06069826968808547
19847,SIDM00893,Navitoclax,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.2840714,0.03001581,0.5106561843602829,0.010658350556654329
7489,SIDM00893,Venetoclax,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.7015169,0.03128991,-0.30047221151910186,0.10217649908280949
15669,SIDM00673,NU7441,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,2.1409943,0.15590079,0.9604289116307446,0.12903347986313934
106446,SIDM00774,5-Fluorouracil,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-0.8921207,-0.08166105,-1.1289526677958672,0.007527780133302116
54024,SIDM00097,OSI-027,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7323976,-0.121032126,-1.5383770980337224,-0.09212343688254397
102027,SIDM00878,Crizotinib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,0.41755038,0.044856988,-0.8354259990527814,-0.11607268499336014
56653,SIDM00628,Olaparib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,-1.7323697,-0.079839915,-0.9572424644450622,-0.049395516430360734
37297,SIDM00097,Camptothecin,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9539496,-0.06608677,0.04111291085092515,0.02280929316876475
6345,SIDM00628,AZD8055,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,Black,51.0,-0.28557888,-0.023153992,-0.614294547609897,-0.035241549150207704
50715,SIDM00774,OSI-027,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.34507203,-0.05127005,0.3313745499703166,-0.005341988507993931
107910,SIDM00660,5-Fluorouracil,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,32.0,-0.70346355,-0.066024564,-1.8135744188726413,-0.1011663178158067
61028,SIDM00875,Afatinib,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.548382,0.11020074,0.7520005551732099,0.027351140732704695
41445,SIDM00411,OSI-027,MK-1775,Pancreas,0.2,Pancreatic Carcinoma,Male,East Asian,43.0,0.44027883,0.027432913,-1.6219195258199117,-0.0430567968299261
89812,SIDM00782,Taselisib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.2435625,-0.08610322,-0.9555622813157535,-0.0634877524526917
59789,SIDM00834,Crizotinib,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,0.31888095,0.023515644,-1.194792211145702,-0.01733784189342567
79755,SIDM00878,Trametinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-1.1077136,-0.035528407,0.31214686930704916,0.009856007682599605
25137,SIDM00782,Nutlin-3a (-),Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,2.3526287,0.08650558,1.216043522830779,0.023487313737139637
72688,SIDM01233,Navitoclax,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.7604433,0.096621454,1.6077302581750523,0.04481647144746248
83929,SIDM00774,Navitoclax,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,0.7971218,0.019761598,-0.6942474778028658,-0.03767238844463865
94605,SIDM00776,AZD7762,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.31708598,0.029566865,-0.8209687590291492,-0.02308415135136179
47594,SIDM00971,Linsitinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.6691505,-0.05632281,-1.2883527731267566,0.005093162102710917
69055,SIDM00878,5-Fluorouracil,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-1.4799956,-0.095570475,-0.6324992156319399,0.027192802435428726
18202,SIDM01233,Taselisib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,72.0,-1.0709312,-0.08224711,-0.09612167601137732,-0.01468545852087324
101288,SIDM00834,AZD7762,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,0.5880519,0.03694918,0.4741806198121201,0.048253941028712354
619,SIDM00971,PF-4708671,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.430863,-0.09931105,0.47056574959093395,0.08390770273997691
71519,SIDM00774,Crizotinib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,48.0,1.6072112,0.23016316,0.26140502344300137,0.014657238874789631
13194,SIDM00673,Venetoclax,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.271758,-0.030143099,-0.6227550452944447,0.02777538241230451
41347,SIDM00776,Olaparib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,1.6225737,0.086242184,0.1548375189210435,0.002735945075667522
105826,SIDM00301,OSI-027,Crizotinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.7333965,-0.081763074,0.5588662685487675,0.07669175603903748
35125,SIDM01233,MK-2206,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-1.7803751,-0.120779276,1.6702779010238498,0.09202557837183341
39346,SIDM00893,PD173074,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.453958,-0.036239956,-0.24318572418871132,0.04515418345922611
13085,SIDM00411,Paclitaxel,Palbociclib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.328335,-0.046107516,-2.1541545056118094,-0.022927265418636704
38228,SIDM00971,Taselisib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.6209162,0.101323545,0.425863296441362,0.01253116167533344
16015,SIDM00875,PD173074,Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1969438,-0.0599391,-0.3564001317063335,0.0638168933686889
91581,SIDM00332,Bortezomib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.350874,-0.05095237,-2.5173385762009888,-0.10956426096212671
64726,SIDM00332,Entinostat,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.8707728,0.051884547,3.8877904312697034,0.15150765001663394
20917,SIDM00866,JQ1,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,1.4459155,0.1259132,-0.9263497230171923,-0.021078265715550732
62439,SIDM00774,Ribociclib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.4531871,-0.052891415,-0.6287569594205421,-0.043771746526948395
90370,SIDM00097,Taselisib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2811899,-0.08744682,-0.16928543800742302,-0.02457637530957892
10823,SIDM00673,RO-3306,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.9349426,0.073617704,-0.43327793761113287,0.009025057887039369
56996,SIDM00866,Wee1 Inhibitor,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.40241322,-0.03467563,-0.8384292580057424,-0.0563209240926617
87234,SIDM00776,MK-1775,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.5872968,-0.06649566,-0.08863841357131778,-0.029820435105692877
81537,SIDM00097,Olaparib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2385842,0.031108212,0.3979512949827032,-0.00028476926164633826
9715,SIDM00301,Dactolisib,LGK974,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.3925698,-0.2758403,-1.8810169479174423,-0.09930706991512099
24756,SIDM00779,Navitoclax,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,-1.5525095,-0.01704898,0.6890716171330746,0.035181503623650884
72345,SIDM00301,Ruxolitinib,Oxaliplatin,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,3.069846,0.14269806,1.721251768358901,0.04209041959444693
76041,SIDM00531,Sorafenib,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.18908,0.33849022,1.5491618244833694,0.12544385065913005
5561,SIDM00529,Nilotinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,2.068054,0.09966102,1.658793628010119,0.13630889211988778
20464,SIDM00673,Uprosertib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.0919805,-0.15906711,-1.7424432506558505,-0.10767278695827677
67198,SIDM00875,Pictilisib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.200102,0.13433357,1.7108377631832556,0.17398594847528015
106910,SIDM00146,Afatinib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.32977653,-0.025112344,1.3905078213001398,0.06658475745824109
87005,SIDM00301,Dasatinib,Palbociclib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.1687024,0.21310888,0.7704098711055332,0.14778311216150028
78103,SIDM00774,SCH772984,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,4.6367893,0.13959995,4.102773980182665,0.13598911923283596
7237,SIDM00954,MK-2206,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.2053753,-0.0995876,0.31911356704510746,-0.04413413273546803
107061,SIDM00628,Afatinib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,1.0995636,0.032942995,-0.25453584338911517,0.04076680724945035
32376,SIDM00779,Nutlin-3a (-),Oxaliplatin,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-1.7749102,-0.061819516,0.44094078220276167,0.06176161807566982
87147,SIDM00893,Paclitaxel,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.3559457,0.025558501,-1.5540021821014174,-0.11769868696534697
32268,SIDM00628,AZD8055,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.7414513,0.04301703,1.2788316386936815,0.08531216953745072
30575,SIDM00193,Palbociclib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.24671,-0.060205612,0.7677324071233919,0.05559695548282245
9620,SIDM00332,Cisplatin,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3018035,0.030537773,1.6418206653320115,0.04709041784164057
31781,SIDM00411,LGK974,Sorafenib,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.7086558,-0.061086606,-1.3270470114706616,-0.055132231662394275
59127,SIDM00146,Uprosertib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,-2.9609208,-0.1747258,-0.5344089551336468,-0.02860150073719308
104474,SIDM00779,Navitoclax,Camptothecin,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,33.0,-0.86938167,-0.03452728,0.24883287646575553,-0.020504420157553518
73985,SIDM00628,Vorinostat,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.6790918,-0.06987303,-0.7455398327770716,0.022067210535639172
69140,SIDM00875,Afatinib,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.85850275,-0.060991935,0.28580134417691705,-0.049556924326547645
77248,SIDM00130,Paclitaxel,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.5354379,-0.038603324,0.47243480708384084,0.006131334619795697
23653,SIDM00529,Nilotinib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,2.19219,0.10303512,0.6631131187707833,0.04328337795199844
94540,SIDM00776,Nutlin-3a (-),Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-1.1455936,-0.035396617,0.9517153118183593,0.017250666338131715
4943,SIDM00660,Trametinib,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,4.3728504,0.13336523,1.814477662242268,0.05283486635364675
59123,SIDM00097,BI-2536,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.97586656,0.06834929,0.8977915777739218,0.04852282199832266
68940,SIDM00774,ZM447439,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,2.0247717,0.09801463,1.8514550459117751,0.10755087242515271
18564,SIDM00774,Linsitinib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,3.7818348,0.24590747,3.2782227328928224,0.11276033045191132
69964,SIDM00954,Docetaxel,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.0677195,-0.061442245,-0.6909748457623072,-0.06421110725086861
72305,SIDM00673,Navitoclax,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.6347507,0.14554621,0.019600528631254537,-0.0547844609446887
31654,SIDM00097,Ribociclib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.031033,-0.08424451,-1.274362407482227,-0.03921335473732718
93053,SIDM00875,Temozolomide,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7022085,0.049232177,0.9463627800053506,0.03700885168735443
33904,SIDM00875,Olaparib,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.8072886,-0.16613267,-1.3277455320995866,-0.08846708536502977
40231,SIDM00875,Uprosertib,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.9418437,-0.15205084,-1.0625133207045794,-0.0612394970263281
6752,SIDM00866,ZM447439,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,0.6449167,0.031846218,0.13875860967034037,0.025675899777852885
18785,SIDM00146,Bortezomib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.50898814,-0.033068907,-0.2712618864531021,-0.03176415848638783
14871,SIDM00332,Ribociclib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.4970343,-0.06686214,0.013502798567722678,-0.024375210072261212
40586,SIDM00193,MK-1775,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-6.834375,-0.48364127,-1.6250599020894054,-0.11574920623634256
36354,SIDM00146,Vorinostat,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,2.3028262,0.16198303,-1.1912992824472828,-0.051767229952616095
82373,SIDM00774,Uprosertib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.9994725,0.06838724,0.14965248732293931,0.07304099113374203
87053,SIDM00628,Sorafenib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-0.7416646,-0.052703824,0.1099216559866588,0.03907051426585533
61017,SIDM00866,AZD7762,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.7321237,-0.047868792,-0.6672338316853479,-0.05940063733437728
1087,SIDM00146,JQ1,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-1.9708649,-0.14190726,0.23331276346919777,-0.022121048700850795
27683,SIDM00193,Afatinib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-2.101487,-0.13365455,0.09792876461849871,0.011209441968421375
82778,SIDM00782,AZD8055,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.360525,-0.029203234,-1.919951825313505,-0.09177845539065925
56423,SIDM00878,BI-2536,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-0.7377219,-0.047796004,0.42155937762833695,0.003401844531215558
53143,SIDM00875,Trametinib,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.18200967,-0.017214302,0.18292670384803017,0.03386252712510597
101043,SIDM00954,Alpelisib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,3.0867054,0.06831617,2.5200527131041084,0.0356412802992005
81588,SIDM00130,Dactolisib,Taselisib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.1163885,-0.009085274,-0.06912662759706485,0.0008707398374542413
63771,SIDM00130,Dasatinib,Erlotinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,3.6353278,0.28676352,1.387141896152771,0.12339437216177475
12499,SIDM00774,AZD6482,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,2.7761183,0.19504799,0.018007256403960656,0.01735089715109708
55229,SIDM00971,KU-55933,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.028139,-0.028728098,0.7054858672909898,0.032397440835478256
76990,SIDM00878,PF-4708671,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,0.6278284,0.03956899,-0.16457300497290583,0.007623436892094975
34105,SIDM00529,Docetaxel,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.8427167,-0.0695854,-0.6830168161218314,0.027854265832003525
2085,SIDM00776,Linsitinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.8152486,-0.030040832,0.5629597095805889,0.05688965726359761
43411,SIDM00782,SCH772984,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.73286885,-0.05671102,-0.3905366517960643,0.020132625491260353
29900,SIDM00097,Doramapimod,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.9804666,0.09772674,2.5055358339620453,0.08281610427083726
69137,SIDM00774,Olaparib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,-0.8220879,-0.039025836,-0.6435412234005766,0.003975321405254999
34346,SIDM00531,Irinotecan,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-5.713313,-0.5995753,-2.7918913974457027,-0.24492733206333064
37237,SIDM00193,AZD7762,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,53.0,-0.5196826,-0.022589874,1.5771576200293957,0.10880710468118587
67879,SIDM00971,Bortezomib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.3576556,-0.051291287,0.1962766723300857,0.02255262444769481
83001,SIDM00875,AZD7762,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.44226333,0.022618532,-0.9141476902113204,-0.08906314965743818
76775,SIDM00875,Paclitaxel,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2431233,-0.09137788,-3.271477615155028,-0.266115774798291
53627,SIDM00782,Trametinib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.19262521,-0.014717433,-0.19810258749411433,-0.04624607193389113
39422,SIDM00411,Irinotecan,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-2.6828465,-0.09882374,-1.617456632720855,-0.06965142442539002
77811,SIDM00130,Trametinib,Dactolisib,Pancreas,0.0125,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.4366259,0.041437224,0.9737811910218885,0.09334814280618317
27707,SIDM00971,Dabrafenib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.6924226,0.014405879,1.1112161788399115,0.049186774554301434
75605,SIDM00097,Nutlin-3a (-),PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5447702,-0.07148938,-0.7894177272631968,-0.027805994418713967
66702,SIDM00332,PF-4708671,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.2704028,-0.00825491,-0.35804375530706173,-0.0050138985234853845
60413,SIDM00193,Taselisib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.4936823,-0.046327014,-1.2658331418441906,-0.009201052496196656
97241,SIDM00834,Olaparib,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-0.62564534,-0.013114156,2.058122840017551,0.06388252772047733
99955,SIDM00779,Vinorelbine,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,1.7052987,0.1556816,-0.9071063603110373,0.038241559489664276
74885,SIDM00774,Linsitinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.27801636,-0.019406265,-0.1717648365117806,0.07126156884838984
90226,SIDM00776,Camptothecin,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.0163661,0.08638437,0.7281838275173395,0.04422497936697405
44752,SIDM00097,Axitinib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.909962,-0.07793469,-0.06005136125537051,-0.05737682798292857
52126,SIDM00774,AZD7762,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,0.6548536,0.08287473,-0.1858821657202053,0.01389905980323498
7761,SIDM00146,Tozasertib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.3925248,-0.041438837,-0.9707257076652863,0.03869214091987708
106695,SIDM00954,Uprosertib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.0,-0.34761068,-0.029213686,-0.27449877629579816,-0.045226181610363604
77443,SIDM00411,Lapatinib,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,43.0,1.399533,0.052929915,0.6680393141149435,0.06817355268617042
99699,SIDM00875,Ribociclib,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1765206,-0.038698662,-0.3261520637441771,0.014879358992990628
94093,SIDM00878,Wee1 Inhibitor,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,0.56409806,0.047113594,-0.5068201187554139,-0.022572178717920596
92464,SIDM00411,Trametinib,Oxaliplatin,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-1.5467657,-0.04100738,-1.2597199166432211,-0.006391483779359392
34925,SIDM00971,Dabrafenib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.6468096,0.056495674,1.5715733916739867,0.0797996082000915
68539,SIDM00660,Nutlin-3a (-),Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.73819274,0.018173613,1.7895707573068855,0.04881973407936306
100576,SIDM00834,Vinorelbine,SCH772984,Large Intestine,0.05,Rectal Adenocarcinoma,Female,White,66.0,-0.5178755,-0.04079156,0.06134455398830676,0.07703987085759226
36969,SIDM00779,LGK974,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,2.242782,0.05544194,-0.9391727996973688,-0.03458202318438531
55091,SIDM00875,BI-2536,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.3070323,0.058186606,-0.01927202477445584,0.014085899814008571
95473,SIDM00628,Sorafenib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.60516834,0.049534343,-0.030554627372744884,-0.001924089717054088
75461,SIDM00779,Taselisib,MK-2206,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-4.497957,-0.2705355,-2.599945508231159,-0.13899258786887855
5290,SIDM00301,Irinotecan,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,50.0,-2.8892837,-0.07084034,-2.19034191300491,-0.10789594721117088
13666,SIDM00971,Axitinib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.6411316,-0.11578315,-2.6747536368366327,-0.0867019409115831
78646,SIDM00776,Nutlin-3a (-),AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-1.3980426,-0.021811482,1.2315221993398053,0.07554696061393518
21079,SIDM00097,Ribociclib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6580846,-0.056552615,-1.3080971577912726,-0.042040736020398296
81788,SIDM00866,Olaparib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-2.0467405,-0.04003264,1.112955129411285,0.04942211815282866
59859,SIDM00332,SCH772984,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.3626697,-0.07061663,1.168725399355119,-0.020865715477198187
24619,SIDM00779,5-Fluorouracil,Trametinib,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,33.0,-2.1277483,-0.06784218,0.02232404718439875,0.008786856466991112
22436,SIDM00866,AZD6482,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,1.6753755,0.09824478,0.4489301881230123,0.04505209344126109
7008,SIDM00878,Pictilisib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.5252211,-0.05487578,0.0365752601193544,-0.05544258966066334
17380,SIDM00531,Linsitinib,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.7708764,0.04188881,1.1542019045808811,0.04760983577249132
84601,SIDM00893,Entinostat,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,4.0945964,0.11085148,2.4874216973594665,0.10476479777170576
10146,SIDM00893,Dabrafenib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.86393857,-0.02564382,0.3538441305516976,0.024914364094331707
38479,SIDM00332,Camptothecin,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,1.6786715,0.046387322,1.3731215513710362,0.0319240263649767
3083,SIDM00774,PD173074,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,4.958315,0.29552975,1.4516347381324848,0.14715859170295414
59705,SIDM00866,Paclitaxel,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.0541759,0.08336703,0.29849624087406273,0.029614103530058573
74391,SIDM00411,Trametinib,Ruxolitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,2.7698865,0.11370837,-0.9413353279614819,-0.03131323982406742
85530,SIDM00146,Cisplatin,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.8718957,0.027534723,2.229901788983426,0.10118282749759046
7069,SIDM00782,Olaparib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,2.1406584,0.07227191,1.5276757470231985,0.04452646236282413
70496,SIDM00774,JQ1,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.8717554,0.08846618,1.079276193175661,0.12328814222406059
100910,SIDM00878,OSI-027,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-0.4797673,-0.046750277,-0.05424868080020161,0.028217230191594587
83681,SIDM00866,Sorafenib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-1.2632812,-0.05271581,-0.4753787138479684,-0.00668663842938889
104137,SIDM00776,Afatinib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.4484931,-0.037853643,-0.48950181324116226,-0.027628704785202046
39442,SIDM00529,Venetoclax,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.2957748,-0.033040937,0.30973667325260584,0.013905078782902501
11780,SIDM00146,ZM447439,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.1909762,-0.0143821845,-0.6266562636587272,-0.0021010206267394623
23697,SIDM00146,Dabrafenib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-0.8900913,-0.04194189,-0.32381623851465074,0.0014700806314841513
98719,SIDM00332,PF-4708671,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,0.89236563,0.027125267,0.30293893179955356,0.04205781283332932
54977,SIDM00097,JQ1,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0189569,0.06136521,2.637012228175043,0.18951769078415112
95841,SIDM01233,Navitoclax,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,1.1444796,0.06538689,0.9689966067278657,0.02874576874179363
79950,SIDM00893,Tozasertib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.3609183,0.138936,0.3139419423046447,0.037679774617199256
103164,SIDM00673,AZD6482,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-0.58966446,-0.04991342,-1.2674761365926344,-0.02383580581502014
8174,SIDM00130,LGK974,Linsitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.8047328,0.14038521,0.024454076006551986,0.014440434937502461
86210,SIDM00411,5-Fluorouracil,Oxaliplatin,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-3.0188696,-0.0809213,-2.6182656933539867,-0.07017597902164277
21245,SIDM00097,Doramapimod,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.7275116,0.05927799,1.31123017851343,0.03794218117311686
54391,SIDM00332,Palbociclib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,2.2190847,0.15791193,0.7853365854264496,1.0672293060264128e-05
10223,SIDM00866,AZD7762,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-2.861656,-0.17889221,-1.530140227990252,-0.06502190150456064
7161,SIDM00673,Dabrafenib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.2001662,0.056060832,1.8576872602651278,0.05646583172797117
18338,SIDM00971,AZD8055,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.823388,0.18347411,1.6835510388210033,0.13090414848123183
6296,SIDM00878,Sorafenib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,0.62297225,0.05544669,-0.51336114672961,-0.04264934225424288
54123,SIDM00332,Temozolomide,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3481193,-0.030424891,-0.14389298970902636,-0.02039999734493761
6472,SIDM00782,Linsitinib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.19768445,-0.008462583,0.4427038210371468,0.0061109675036102405
74676,SIDM00782,Taselisib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,Unknown,72.0,-1.9545752,-0.15459237,-2.0642815569673725,-0.11642399241442974
14542,SIDM00301,MK-1775,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.78828126,-0.08272484,-0.337559913547025,-0.02712835568041015
5088,SIDM00411,OSI-027,Sorafenib,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.2140706,-0.051206704,0.11842496092550793,0.03393366114355941
93999,SIDM00774,OSI-027,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,5.202714,0.05389986,2.1139398863132994,0.06905605015255413
99172,SIDM00971,Pictilisib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.0223417,-0.084925644,-1.162776706624283,-0.040545866095783596
89656,SIDM00954,Linsitinib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.8747676,0.062119782,0.5079847705871895,0.11884712600226345
79354,SIDM00411,Irinotecan,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,-1.3411071,-0.04769126,-0.25220865310416857,0.04709853864457579
10981,SIDM00660,Trametinib,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,3.7185948,0.11281007,0.6756534687357936,0.0017500590692048205
32534,SIDM00875,Navitoclax,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.47827503,-0.051626496,2.074338836761416,0.08270866112365927
19353,SIDM00878,Taselisib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,2.118574,0.106623635,0.23448088909790216,-0.027427344151836106
32909,SIDM00834,Vinorelbine,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-0.33511728,-0.020485245,0.005165965748457883,0.028891350617040314
41237,SIDM00893,RO-3306,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.6971723,0.05061629,-0.555960576874252,-0.010093229714140188
87683,SIDM00359,MK-1775,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.0495887,-0.090856,-2.6827107287329794,-0.05489730442266259
27370,SIDM00774,AZD6482,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,1.0452254,0.07114376,3.365184505650015,0.1593017018316312
14777,SIDM00875,JQ1,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.70144683,-0.07456997,0.7243755353414106,-0.02291087557292008
33945,SIDM00866,AZD6482,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.3446382,0.04573106,0.7840498347578038,0.0568840556344013
64368,SIDM00893,Ribociclib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.3246737,-0.07759124,-0.6176702965787754,-0.02119604807142935
78355,SIDM00971,Nilotinib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.1520128,0.07872926,0.7972325166925764,0.04694609168726749
47439,SIDM00628,Navitoclax,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.7006135,0.10704162,1.8421685342905127,0.09945545934729334
36392,SIDM00673,Vorinostat,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.0809572,-0.08804225,-0.28638746900510226,-0.039888812377211924
82595,SIDM00971,Lapatinib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.46229106,-0.025792018,0.04891786036898265,0.0015693600561768805
12829,SIDM00893,Bortezomib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.27929363,-0.028341394,-1.472202671912522,-0.0527625804260949
30832,SIDM00778,Camptothecin,Trametinib,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,69.0,0.90166354,0.03344455,-0.4196791537382905,-0.03033323844216235
59523,SIDM00834,AZD4547,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,2.9784057,0.08323122,2.6490649988390294,0.06069864559849234
62228,SIDM00673,Sorafenib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.32207716,-0.011425137,0.002780510531481469,-0.018383213762523
21567,SIDM00097,OSI-027,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4458033,-0.0816115,-1.5729277693089647,-0.015425133414868165
107898,SIDM00529,Sorafenib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.6092474,-0.055730384,-1.2715200876303798,-0.07146785586350696
6593,SIDM00097,Palbociclib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.309286,-0.08166269,-1.1585882011585562,-0.06879294341991166
60776,SIDM00628,Nilotinib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,0.67745733,0.06346134,0.6289477096961504,0.04862352691523907
78729,SIDM00774,AZD6482,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,3.1339223,0.19879618,0.4536205808979914,0.07691904103397962
95258,SIDM00954,Doramapimod,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.0,-0.91987514,-0.057236407,0.9392143076400156,0.07278089822249806
100772,SIDM00332,Alpelisib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.6553063,0.2066388,0.6755513053327994,0.05578298148074688
105392,SIDM00779,Trametinib,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-0.96691215,-0.039561495,-0.6039847745406883,-0.03863874677675556
9717,SIDM00778,SCH772984,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-0.7323727,-0.039374527,-0.3884166537879948,-0.0609439346649951
74824,SIDM00875,Crizotinib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4220933,-0.048550647,-0.2438618749421326,-0.03309497952815219
93078,SIDM00866,Axitinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-0.7550576,-0.053519107,-0.9657245858567141,-0.03924769114099384
85209,SIDM00779,BMS-754807,AZD4547,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-5.663086,-0.05514685,-5.133528062217506,-0.09393506358614893
7264,SIDM00628,Palbociclib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.13878837,0.0036099993,1.0635698217614913,0.05527528385944809
34611,SIDM00411,Paclitaxel,MK-1775,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.94305474,-0.02421357,-1.777551418096483,-0.020049823507880413
47483,SIDM00359,SCH772984,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.7424164,-0.053140845,-1.98923979368346,-0.055357612533804036
39216,SIDM00673,Palbociclib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.5612603,0.028984278,-0.25397520399973783,-0.020952508474601013
40135,SIDM00866,NU7441,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,52.0,-2.0959947,-0.1413332,-0.5085480046954008,0.02391147089509855
12432,SIDM00628,Alpelisib,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,0.44035995,0.023809003,0.4838853210284184,0.09183598597885163
50957,SIDM00954,MK-1775,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,1.6131796,0.12028049,-0.33910864309735367,-0.03514744658525125
24475,SIDM00875,AZD8055,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.86906594,-0.08745381,-1.0813110365305656,-0.01530034383114525
80861,SIDM00531,Lapatinib,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.5322626,0.3575835,2.5410075053641443,0.1474197683876851
24794,SIDM00954,Palbociclib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-1.9240284,-0.0783766,-1.6080427133019783,-0.056366592749073775
92512,SIDM00411,LGK974,Oxaliplatin,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-3.3942528,-0.08941135,-1.9479476250349161,-0.07035098927824675
53587,SIDM00097,Afatinib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8184983,0.061617367,1.4045445684159257,0.09253092193166444
3660,SIDM00878,Nilotinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.41232806,0.0369378,1.1731331691253644,0.08882849527596631
83255,SIDM00332,Dabrafenib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.4223845,-0.11175834,-1.2505460620639883,-0.05828469095085251
24683,SIDM00673,Bortezomib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.40369073,-0.01827736,-1.0518147977512515,-0.03488576142997671
105103,SIDM00971,AZD7762,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.2210515,0.0301827,-0.110609159262851,-0.006477026908655856
83539,SIDM00866,Olaparib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.8991907,-0.035244744,-0.07683058943818258,0.021921516613778107
52010,SIDM00776,Camptothecin,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-1.6587889,-0.09692418,0.4106439886213472,0.02995279828149731
45768,SIDM00776,Taselisib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.8638562,-0.06642399,-0.41633538926002733,-0.04877289579714943
18957,SIDM00301,Oxaliplatin,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.7157575,-0.19204609,-1.30050811517571,-0.07487164894406773
82649,SIDM00878,RO-3306,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.76850027,0.050981835,0.2029249934548578,0.009210642764283213
54138,SIDM00893,Sorafenib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.80523217,0.074698955,-0.8918775381061291,-0.03407815270530489
59448,SIDM00954,Entinostat,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.31121933,-0.025977854,0.471717393706003,0.03467861695338214
61438,SIDM00776,AZD4547,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,-1.3823406,-0.03572818,0.6851220852940909,0.014239302120821343
59210,SIDM01233,MK-2206,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-3.269083,-0.1852868,0.13562554804961846,-0.011879267867759254
73343,SIDM00776,SCH772984,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,65.0,-3.7418475,-0.2518998,-0.407305346643063,-0.03749635704108055
54903,SIDM00878,KU-55933,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.6473081,0.02632538,-0.478185666464285,0.024410411615861202
105338,SIDM00660,Oxaliplatin,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,2.038973,0.09792111,-0.33741362553346543,-0.010307182251426572
34975,SIDM00866,PD173074,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,0.6072206,0.009638518,0.7023798984220331,0.06831378527536726
13760,SIDM00782,MK-1775,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.92493194,-0.059229158,-1.691117503402292,-0.1079562576452326
40846,SIDM01233,Dabrafenib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,72.0,-1.0849425,-0.032837257,0.795377460264145,0.0037650474382223274
26068,SIDM00774,Wee1 Inhibitor,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-2.5816336,-0.13999385,-1.3300907380775218,-0.07172314617680178
15844,SIDM00774,Ribociclib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,-1.6453618,-0.05891256,-1.2899111651639164,0.02805482923477459
106257,SIDM00875,Alisertib,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9110867,0.08981877,0.24588572880832793,0.04017165624545359
38773,SIDM00097,AZD8055,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.34617874,-0.02360585,0.1536347589413642,0.041735906561505984
83739,SIDM00893,KU-55933,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.0919753,-0.04016071,0.003511340223442927,0.0006475153634466867
63633,SIDM00411,LGK974,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.3280027,-0.0643196,0.22047156951682811,0.025000090863865912
14735,SIDM00878,BI-2536,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.9041247,0.07272822,1.0436450033626687,0.06665315161704809
58586,SIDM00878,Paclitaxel,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.9995123,-0.16594213,-0.2504581719148884,-0.017559903880499265
52753,SIDM00866,Dabrafenib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.39798653,-0.01189649,-0.18162546922263068,0.04038659727067495
22165,SIDM00866,MK-1775,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-0.64470434,-0.053261265,-0.7437789891659288,-0.023513193218085347
4318,SIDM00893,Tozasertib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.97346747,-0.045246877,-1.9820544259280979,-0.05538609251740169
16636,SIDM00359,AZD8055,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.6507372,-0.04804464,-0.19545141350604275,-0.03365999464602727
11767,SIDM00866,Pictilisib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,52.0,-0.6919175,-0.060328286,-0.8532117588842199,-0.03218091914709089
76875,SIDM00776,MK-2206,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.7607262,0.14918542,-0.42573210355359453,-0.0012821544552274245
105924,SIDM00778,SCH772984,AZD7762,Large Intestine,0.0625,Cecum Adenocarcinoma,Male,White,69.0,-0.648479,-0.035558954,-1.2504518250017993,-0.08036785989180881
70751,SIDM00130,Taselisib,AZD7762,Pancreas,0.0625,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.23437653,-0.02534464,-1.0465188961075638,-0.05952821800931581
104281,SIDM00866,Afatinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,0.39083058,0.027789265,1.3820607972995314,0.09151842384783465
63528,SIDM00971,Dabrafenib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.2189424,0.060954496,1.4175023793735644,0.04796235109036293
29896,SIDM00774,Vorinostat,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.1204358,0.02017635,2.223574501064939,0.043338378767766146
52985,SIDM00146,KU-55933,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.4546638,0.09080982,0.19272341774118718,-0.0037539562401589454
48890,SIDM00893,Uprosertib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.8561442,-0.10678137,-1.7448019371894663,-0.10521692038423913
64369,SIDM00359,Nutlin-3a (-),Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.1396359,0.028349496,2.248112784005,0.06136578022459978
76595,SIDM00193,MK-2206,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.6570594,-0.14033575,-0.03286980190141297,0.060691240845848614
76670,SIDM00866,AZD6482,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,1.7172339,0.08441851,1.1320876622915756,0.0748557233232144
97616,SIDM00146,Taselisib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-1.9924216,-0.14681791,-0.48583107600324094,-0.021091386327894607
61114,SIDM00673,Alisertib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,3.0572944,0.20189479,0.3395336222689042,0.03945396001338731
58028,SIDM00875,Palbociclib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.9546757,0.14137685,2.2816475630787183,0.15320116467637246
78482,SIDM00971,Axitinib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.41597843,0.015365908,1.1150255760259107,0.0947089210849717
54829,SIDM00301,Ruxolitinib,MK-1775,Pancreas,0.2,Pancreatic Carcinoma,Male,East Asian,50.0,-0.7713445,-0.017432433,1.5639339952135674,0.04147557544897514
107240,SIDM00774,OSI-027,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,48.0,1.1730311,0.12975642,1.0433421653287076,0.12423626257163387
87721,SIDM00782,MK-1775,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.0639913,-0.06758535,-1.7306649827969056,-0.056610346526484515
68914,SIDM00673,JQ1,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,9.900486,0.32601428,1.1461002606795514,0.08864850540859062
108198,SIDM00193,MK-2206,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,53.0,1.8976603,0.17509563,0.02797386398215157,0.07140560400400603
18278,SIDM00628,Ribociclib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,1.0097597,0.019488646,0.21569150934497025,0.03949453349262946
12140,SIDM00878,Docetaxel,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,70.0,-2.242112,-0.2261192,-0.8204825565006288,-0.09143754515912156
27586,SIDM00834,Oxaliplatin,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-0.78078127,-0.06444201,-1.0834479318188937,0.004696748456147447
100080,SIDM00774,Entinostat,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,1.2416806,0.080578804,0.02749135928473939,0.015877117699926054
40824,SIDM00779,Camptothecin,Vinorelbine,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,33.0,-1.3740648,-0.06132527,-0.1580479816133483,0.022751070722458425
18454,SIDM00359,Vinorelbine,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.1495633,-0.04533305,1.4904892294002667,0.11602167265200156
40619,SIDM00834,SCH772984,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,1.769349,0.13178182,-1.4292936638167788,-0.09347414288797917
104092,SIDM00628,GSK269962A,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-1.136387,-0.09464515,-0.9132914267678893,0.013547656377029578
6328,SIDM00878,NU7441,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,1.4608952,0.12462917,-0.18449001194326653,0.013638477673968984
104587,SIDM00660,Dabrafenib,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,32.0,-1.3918103,-0.14064643,-0.2127097825452436,-0.018159232738515205
101037,SIDM01233,MK-2206,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,5.7198067,0.19320166,-0.25150893677095015,0.01292065885251838
5483,SIDM00774,Nutlin-3a (-),Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,3.041247,0.022817587,1.7574709561117008,0.04682443199653534
3938,SIDM00779,Dabrafenib,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-3.023014,-0.095377415,-1.415053430298412,-0.05057335794611927
27433,SIDM00776,AZD8055,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,65.0,-1.4916005,-0.1283409,-0.5789607257855154,-0.050335015687739376
93193,SIDM00146,Doramapimod,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,1.0292981,0.058675166,0.8210842359934014,0.013222485514836992
28303,SIDM00776,Nutlin-3a (-),Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-1.7628497,-0.051528927,2.0574344256888897,0.13554385347564019
40614,SIDM00776,AZD7762,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-0.25684568,-0.02055673,0.2260786145232505,-0.0028886441070742224
3752,SIDM00778,Olaparib,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,69.0,-3.1015444,-0.08028572,-1.7551508514465346,-0.07832725601881725
30822,SIDM00778,Nutlin-3a (-),SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,2.18664,0.029754287,2.292309907966621,0.06437288318137739
86356,SIDM00878,Tozasertib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.0951476,0.08072628,0.03154493383066479,0.010447669996376531
31974,SIDM00411,AZD7762,Oxaliplatin,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.7537177,-0.08720617,-1.3281215535200879,-0.03471502882944945
20,SIDM01233,AZD4547,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,72.0,-0.96859187,-0.0293043,0.6766105768499652,-0.01755639518288701
99718,SIDM00359,MK-2206,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.9380951,-0.053545985,-0.24796804689167068,0.016661018842316456
28503,SIDM00866,GSK269962A,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,52.0,0.72270596,0.037160907,-0.21367755611631167,-0.00024740608634278306
74795,SIDM00531,Oxaliplatin,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.2163422,0.026586218,0.5914614273350683,0.08036094390964163
16200,SIDM00673,Uprosertib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-0.19530532,-0.011847787,-0.510801335523529,-0.010807649354108701
57148,SIDM00866,Axitinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.3656511,-0.088685445,-0.48865832639231027,-0.015369097262189301
3916,SIDM00193,Dabrafenib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,53.0,0.8141701,0.024413785,0.8223629657537638,0.021261332169520815
12437,SIDM00301,AZD7762,Palbociclib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.8302089,-0.048313435,-0.5627779916334228,0.04588152093762913
49707,SIDM00359,AZD4547,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.4324226,-0.10563112,-2.0560578417826063,-0.056588174560757015
16706,SIDM00097,NU7441,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.69478035,-0.035672992,0.188635790395604,0.01191006773208656
47898,SIDM00673,Wee1 Inhibitor,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.2961514,0.09134179,-0.3284955578836794,-0.03546052114852056
1107,SIDM00954,Crizotinib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-1.8218747,-0.11237502,-1.0101529281776989,-0.0657789939086062
12732,SIDM00774,Venetoclax,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.62113285,-0.013088072,0.6543143752419226,0.03433500643484829
73253,SIDM00774,Luminespib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.60900325,-0.025472755,-1.8202270216436922,-0.0602862182134176
55266,SIDM00954,OSI-027,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,0.42436776,0.021428226,0.4275520864844843,0.09362961261320388
50522,SIDM00774,Wee1 Inhibitor,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.468871,-0.13693556,-1.871685025541258,-0.06460460131646971
24750,SIDM00774,JQ1,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,2.3221598,0.15613365,2.1495337723510604,0.1574782148912268
25404,SIDM00130,Gemcitabine,Olaparib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.0631816,-0.07622569,-0.5387417586525358,-0.035942512610480315
50150,SIDM00782,Oxaliplatin,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,-1.6501234,-0.06247858,-1.8349819514377146,-0.028557691224474633
101794,SIDM00660,SCH772984,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,0.7400028,0.03715829,-1.0683610820582221,-0.0031717921065784814
1151,SIDM00776,Crizotinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-1.810945,-0.12006939,-0.8866565202007431,-0.04321703076494425
102075,SIDM00971,JQ1,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.8814726,-0.040208515,-0.8208108983837986,0.011353556138793625
74183,SIDM00971,OSI-027,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.5198733,-0.027910525,-1.1148582533112297,-0.024250512212726814
50751,SIDM00673,MK-2206,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.2982441,-0.10898756,-0.5670534122910392,-0.02836327215119017
58242,SIDM00529,Doramapimod,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,0.70650285,0.025668738,1.5660064120614785,0.09143291294778166
85931,SIDM00332,Entinostat,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.9406242,0.063657425,2.2210094519290116,0.05559890141856744
15613,SIDM00673,Gemcitabine,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,5.2082067,0.47452438,0.9262030840175409,0.0844515917902426
49100,SIDM00954,GSK269962A,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-1.7088956,-0.10403419,-0.1215506001652565,-0.06593253990271243
66274,SIDM00971,SCH772984,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.68588215,0.015039571,1.1240911494124923,0.05312007940849332
43711,SIDM00097,Afatinib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0018971,-0.07261166,-1.4852218053160395,-0.048968376902716604
53245,SIDM00673,Venetoclax,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-0.9487226,-0.01551644,0.940444372539089,0.025639997582091036
31000,SIDM00774,Taselisib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.211946,0.03940898,-0.6874463083672129,-0.07010058188848996
87799,SIDM00301,AZD7762,Ruxolitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-2.1945555,-0.10215308,-0.13165766867742074,-0.010488642885837004
14238,SIDM00531,SCH772984,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.775365,0.42592818,2.2000283232060966,0.114804895230307
48268,SIDM00531,Paclitaxel,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.4395485,0.26157007,-0.48033640104423764,-0.03728410247968677
9288,SIDM00782,MK-2206,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.8741909,0.16611654,1.057378184520906,0.1412685932696246
2792,SIDM00971,Sorafenib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.0024107,-0.06781541,0.40643868299728725,0.037482106332189936
72192,SIDM00834,Oxaliplatin,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,0.7244449,0.060713187,-2.0874131462223158,-0.1131046484741294
11984,SIDM00628,Tozasertib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-1.953204,-0.1847306,-2.177809017381717,-0.13402831915510713
85503,SIDM00878,Luminespib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,-0.88387287,-0.09903406,-1.061410036069715,-0.05267599710072041
81933,SIDM00628,RO-3306,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.8013889,-0.074718714,-1.6274955935488704,-0.11968913063439442
22393,SIDM00097,Bortezomib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.47114554,-0.02894096,-0.401568112685322,-0.02137896674810433
94409,SIDM00660,Linsitinib,5-Fluorouracil,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,2.3272665,0.21870367,1.130933123451382,0.06120089561449002
93436,SIDM00893,PF-4708671,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.5855635,0.049399786,-1.376106257234235,0.002601731582440161
13554,SIDM00146,AZD7762,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.17790012,0.01596536,-0.4241621184115094,-0.005896039736315865
106011,SIDM00628,Olaparib,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-2.4464166,-0.13790964,-1.4204684882833594,-0.04027984172320437
64998,SIDM00834,LGK974,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,0.94770795,0.05989263,-1.1470395198792198,-0.050333385427665904
15440,SIDM00193,SCH772984,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,6.985957,0.3409741,2.869211596555979,0.15789488250374725
46704,SIDM00971,Uprosertib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.7118526,0.16466191,1.1994758419996399,0.1416496322137106
90505,SIDM00097,GSK269962A,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.53665406,-0.023387738,0.4233322778344289,0.0033092910613867453
71672,SIDM00779,Navitoclax,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,1.155351,0.020074924,0.4616132956601149,-0.029885477765291466
7205,SIDM00866,MK-1775,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-2.0795186,-0.16903383,-1.0385234133049004,-0.04401173580633018
71546,SIDM00097,ZM447439,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.486502,0.0834086,-0.008352739360865679,0.059342196870680514
59390,SIDM00130,Navitoclax,AZD7762,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.4389195,0.12483851,0.8654671683166416,0.043167751654110124
48417,SIDM00529,Wee1 Inhibitor,Trametinib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-1.1198024,-0.11174882,-0.7984029091302447,-0.04892212302976794
21436,SIDM00774,Lapatinib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.2668612,0.14654252,0.5959247256393664,0.016649258270358222
93976,SIDM00673,Afatinib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.8996276,-0.065132834,-0.8326078488944214,-0.052121954604091025
35937,SIDM00875,Nilotinib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0568237,0.081553,1.1125010519031908,0.11923260905125882
24967,SIDM00628,Tozasertib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-1.0772079,-0.10654423,-1.9659039640281133,-0.11463296986176626
10049,SIDM00971,Doramapimod,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.3597916,-0.041150443,1.2961747737135414,0.0565347439533579
1210,SIDM00628,Paclitaxel,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.066080846,-0.004409734,-0.28988375212704537,-0.004778996112607755
10931,SIDM00774,NU7441,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.7358831,0.077715546,2.0233845523616845,0.15754458643447117
107688,SIDM00529,JQ1,Axitinib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,1.6493224,0.14074105,0.6652062771357583,0.12206248033572036
32658,SIDM00301,MK-1775,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.0427065,-0.100648396,-1.8071676929050504,-0.10276867472864594
75694,SIDM00893,Gemcitabine,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.0685517,-0.08538096,-0.22382696490788084,-0.03221182160125815
36043,SIDM00774,PD173074,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-0.9806516,-0.057144605,-1.6330509626025294,-0.04850585283613195
66480,SIDM00776,LGK974,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-2.1433213,-0.065852605,-1.0581518983114226,-0.0009081110201987524
103373,SIDM00875,Tozasertib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4499526,-0.018058868,0.6684609180467791,-0.0003305582454426419
79761,SIDM00332,Temozolomide,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8304432,-0.017537134,0.8025911658869324,0.008631399183490674
71488,SIDM00301,Dasatinib,Dactolisib,Pancreas,0.0125,Pancreatic Carcinoma,Male,East Asian,50.0,1.0650835,0.11303003,2.1118956946152307,0.15252682852711436
69170,SIDM00359,Olaparib,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.1361724,0.032643747,0.7454855185259329,0.016386217122043908
61136,SIDM00097,Linsitinib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.80754,-0.10443422,-0.6300816579369855,-0.03137647587837714
60047,SIDM00954,NU7441,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,1.9185641,0.12511115,0.9765762436298092,0.08371935635393399
26158,SIDM00193,Linsitinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,1.4831285,0.03791725,3.7704565370872176,0.13057478022645988
80816,SIDM00332,Olaparib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.9615803,-0.04721955,-0.0954033761576088,-0.0021380218926723422
65060,SIDM00146,Alpelisib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.0455174,0.06079428,0.6542625671397619,0.16288487230539297
9885,SIDM01233,Crizotinib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,72.0,0.56736034,0.03258247,0.7335189899523724,0.032179306004058626
52829,SIDM00954,Afatinib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.0063519794,-0.00035825872,0.4802843919359413,0.06314657918918451
38528,SIDM00834,Crizotinib,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-1.2388123,-0.07603518,0.2818054776596913,0.0711777548011589
62549,SIDM00301,Dasatinib,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.932729,-0.1271823,-0.024368735646053696,-0.003058209645327515
67934,SIDM00673,BI-2536,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,3.0341415,0.16102222,-1.1054861056678444,-0.05445931995745975
44693,SIDM00529,Nilotinib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,2.0034103,0.097997926,1.4588983593358722,0.16833979257285867
90185,SIDM00875,Nilotinib,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.791198,0.19465396,0.009031322975859457,0.09090843636738133
99618,SIDM00954,AZD6482,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-2.2443614,-0.09549274,-0.9516287054460524,-0.04957171849752879
102834,SIDM00893,Vorinostat,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.9224112,0.2521952,-1.1375376595212516,-0.033035572784458275
22161,SIDM00782,AZD7762,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,0.5634597,0.04897908,0.5884832368212419,0.0734369296785762
50925,SIDM00893,Sorafenib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.06746669,-0.0059842877,-0.9499367434792858,-0.06850607980270784
106199,SIDM00332,Pictilisib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1957543,0.10195378,-0.23687072228440864,-0.017008684893928438
72617,SIDM00097,Paclitaxel,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.4169037,0.096760795,0.25701681996682596,0.004027722240036749
93155,SIDM00146,RO-3306,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,0.34787405,0.028586395,-0.8867552159543087,0.03039937058160453
41905,SIDM00097,GSK269962A,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.7618102,-0.034374684,-0.2850573387818901,-0.01731325566980358
102128,SIDM00529,ZM447439,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Black,44.0,0.28846434,0.024523266,-0.8585297536351512,-0.05487751718195365
58417,SIDM00774,Entinostat,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,-0.6793631,-0.040885195,2.099783775051152,0.06207461211791784
25950,SIDM00301,Gemcitabine,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.79930466,0.059665285,3.1344991405299463,0.06231567109776215
33665,SIDM00628,Docetaxel,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,0.3604345,0.03123621,-0.13628298247715628,-0.0004738669197392504
23641,SIDM00954,SCH772984,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.8031439,-0.121537,0.06588901879989398,0.013654832697260819
82715,SIDM00193,Trametinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.123142,-0.06525278,0.22769300610441645,0.03267381213390252
52116,SIDM00878,Vorinostat,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,0.9230628,0.07944187,1.2661597870284482,0.10926453187083869
49770,SIDM00097,Vorinostat,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5040748,-0.088434786,-0.4917943338778924,-0.04904150652868427
7793,SIDM00954,Dabrafenib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,0.6913094,0.02907387,-0.2620697683944433,0.022653142743836757
101205,SIDM00866,RO-3306,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-2.753933,-0.13595735,-1.63576917266878,-0.07291087227696937
9043,SIDM00782,Linsitinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,1.7480941,0.08039829,1.149198787659509,0.12319777183439266
6515,SIDM01233,Crizotinib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,72.0,3.340202,0.16321526,0.8387465580942329,-0.010743320673542722
59731,SIDM00628,MK-2206,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,1.6018445,0.118484735,1.108749915152323,0.11377988125372507
38948,SIDM00332,Vorinostat,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7513048,0.07404112,1.575163905147377,0.11982767298887828
99642,SIDM00097,ZM447439,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.4650973,0.08558945,-1.5142595030008543,-0.010301522532250444
39248,SIDM00628,KU-55933,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,1.2452186,0.09070101,-0.3707564050426177,-0.005461350223230088
19398,SIDM00866,Uprosertib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,52.0,-0.10677411,-0.0060684397,-0.25504790335038396,0.03325445663521233
2252,SIDM00531,Olaparib,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.0078022,0.14754264,0.7301678102080699,0.03349845128008084
103719,SIDM00878,Wee1 Inhibitor,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,-0.32562923,-0.027047902,-0.43329169136233137,-0.05368098803812884
89188,SIDM00875,Cisplatin,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,4.2768807,0.37635264,4.222960429698094,0.20431793972771836
69376,SIDM00097,Entinostat,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.6894057,-0.035203636,1.520184051739596,0.11965385943983647
63403,SIDM00893,MK-2206,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2111174,-0.11294286,0.606621401669022,0.014905383284279511
40250,SIDM00971,Uprosertib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.817745,0.049149763,-1.358678008121113,-0.0417384687317793
83921,SIDM00954,AZD7762,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,2.2817433,0.17031844,1.8042225378635168,0.17376118192326687
16436,SIDM00628,Gemcitabine,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-4.599011,-0.17783788,-3.1185959679011046,-0.0828439787140936
8219,SIDM00529,Taselisib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.8115584,0.055643283,-0.7242308648188706,-0.007506158811371128
100072,SIDM00954,Tozasertib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.5158604,-0.09779516,-0.4974754888807615,-0.020146139655464752
67622,SIDM00332,MK-1775,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9454459,-0.08703263,-0.6567115545910607,-0.08507000948903835
105899,SIDM00878,KU-55933,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.7890558,-0.025597082,-1.158584454422623,-0.008029177202645418
65863,SIDM00971,KU-55933,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.4945644,-0.018531106,1.3495720054672162,0.06545087217361448
74178,SIDM00301,Taselisib,Palbociclib,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.6891067,0.18902227,0.6002860546029106,0.07713875412331542
30316,SIDM00531,Navitoclax,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.0196407,0.103237994,2.219799777131551,0.20264403485670895
71316,SIDM00971,AZD6482,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.94745487,-0.027298836,-0.19780622203815665,0.05272395377910763
97791,SIDM00097,Cisplatin,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.91801894,0.020064283,0.2232777907872232,0.013364511635322849
96000,SIDM00834,LGK974,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,White,66.0,-1.6252795,-0.109228,-1.7532649685344643,-0.04927981032202351
63858,SIDM00971,ZM447439,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.0081227,-0.045927126,-1.4417233110830188,-0.06847513210266469
12068,SIDM00954,Afatinib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.0,-0.009392239,-0.0007022811,-0.6082324413280026,-0.020362368330602586
38456,SIDM00673,Alisertib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.83165634,-0.047759302,0.6024172452550948,0.09453825085274377
24459,SIDM01233,Nutlin-3a (-),MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-1.9020417,-0.050580174,1.0100171422981723,0.005669773282655431
44594,SIDM00866,Alpelisib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.9039468,-0.11777881,1.0791383867329845,0.02201467262492596
8441,SIDM00146,OSI-027,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,-0.7450555,-0.066705875,-0.5489394573671327,-0.021379058712520802
72568,SIDM00628,Tozasertib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.36572337,0.034191445,0.42381336158884136,0.004661789059999966
72494,SIDM00097,AZD8055,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5199776,-0.15556563,-1.250996831411729,-0.10730034276406296
47619,SIDM00776,Trametinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,-1.2757825,-0.1001895,-1.9154763343550811,-0.12844914531782303
102244,SIDM00774,Wee1 Inhibitor,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-3.2708762,-0.10478019,-0.23099582095396748,0.028901821144284193
74659,SIDM00776,Camptothecin,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,0.71709967,0.050519884,0.7179693268303533,0.03946421082195851
53869,SIDM00875,Dabrafenib,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1316897,0.06412183,0.20196362324153702,0.01797525500352304
54975,SIDM00954,Gemcitabine,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,7.3776727,0.18213703,4.24475811719624,0.22404107651538827
64284,SIDM01233,Afatinib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,72.0,-1.1028583,-0.07989591,-0.4755932760960012,-0.06548030781176309
79066,SIDM00774,Nilotinib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.85112095,-0.05943644,-0.409563507318257,0.009610063260480044
88313,SIDM01233,Oxaliplatin,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,-3.185261,-0.10844324,-2.411085596181044,-0.14696983722150037
52820,SIDM00834,Palbociclib,AZD4547,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-1.4094456,-0.09594644,-1.8134071979069069,-0.10206995882275116
94470,SIDM00774,Uprosertib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-0.40810937,-0.029728258,-1.0031569260956508,-0.04242261493679251
18341,SIDM00878,RO-3306,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-1.0003843,-0.054356102,-0.15408700465458777,0.04471882806017198
85148,SIDM00893,Afatinib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.5986244,0.044908848,-0.05229534606502387,0.0074294172888635795
67287,SIDM00332,Nilotinib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6380711,0.04937024,0.10636399122427949,0.028573789022099234
65076,SIDM00954,KU-55933,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-2.543747,-0.089850426,-0.15791627348941065,0.017526515689815822
13074,SIDM00878,PD173074,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.3621916,-0.035609946,-1.018916720307171,-0.026109407590207478
13769,SIDM00954,Pictilisib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-2.6235435,-0.13500872,-0.19211026932496963,0.003204822059317529
31824,SIDM00866,Luminespib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-1.3490555,-0.08477874,-0.7741457811122986,-0.06295203249497432
65459,SIDM00097,SCH772984,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.7234427,0.041903593,-1.435115968348955,-0.05094266146356319
41973,SIDM00774,Lapatinib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-0.24774398,-0.029674662,-0.33844656361233705,-0.06563833765912488
27016,SIDM00193,MK-2206,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,1.6129557,0.13962561,1.8745173542895701,0.18432462206643846
62399,SIDM00193,Palbociclib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.3695421,-0.05711982,1.0055138286840306,0.051541238032211896
88885,SIDM00954,Gemcitabine,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,0.89386964,0.07235214,-0.33373225063457257,-0.07401298798647021
6608,SIDM00146,Axitinib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.046024,-0.07154895,-0.08037258740094311,0.004852713939702544
80255,SIDM00866,Nilotinib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-2.991126,-0.12779677,-2.0640189679325416,-0.07429187134549314
85968,SIDM00097,AZD6482,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.6999049,0.11153979,0.14423229805363122,0.04847830306649218
29135,SIDM00660,Linsitinib,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,32.0,4.864081,0.38468766,2.214599931522978,0.1306701503172761
84543,SIDM00866,Vorinostat,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-1.690336,-0.13751782,-0.44167378216099307,-0.04745739216723551
74383,SIDM00332,MK-2206,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.734236,-0.080787234,-0.8316362697446613,-0.01658388434999664
65831,SIDM00193,Taselisib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-0.83171225,-0.07410279,-0.2986326839551704,0.007363786112279321
76784,SIDM00778,MK-2206,5-Fluorouracil,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,0.8706224,0.04277863,-1.0910525437174274,-0.02460443339482196
60031,SIDM00774,OSI-027,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,0.6187139,0.073338956,1.5131773052494903,0.07622245270384066
45612,SIDM00673,Sorafenib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.484482,-0.11742738,-1.1538084482393338,-0.05180220324030229
27434,SIDM00146,Cisplatin,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,1.9706215,0.095509276,1.55491139712596,0.0683215630367317
21441,SIDM00332,Bortezomib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.35296634,-0.021607138,-0.22216847847129836,0.0020746262656656063
64497,SIDM00782,AZD7762,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.2815514,-0.018195404,-0.05459933855260048,0.03858289991810495
65590,SIDM00866,Uprosertib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.5851638,-0.0780182,-0.5331193998816199,0.0285178818356373
100884,SIDM00130,AZD7762,Taselisib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.3443829,-0.0909656,0.2785744802755828,0.034220245431686974
2697,SIDM00779,SB505124,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-1.5072377,-0.07667045,-0.6224388505031319,-0.06852046823494876
107541,SIDM00628,Tozasertib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-2.7775967,-0.25369006,-2.7534023024689747,-0.14694517267310617
6615,SIDM00878,AZD8055,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.7251223,-0.1431199,0.9609288640846424,0.06390562727573124
83064,SIDM00332,Afatinib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.919047,0.07354245,-0.5839361021354642,0.003148964069325549
58686,SIDM00531,Crizotinib,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.89261806,0.09685345,1.8450480625808305,0.11918310671528504
15244,SIDM00332,Alisertib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,1.8190346,0.06736589,0.3121139673891396,-0.017712416423491514
73200,SIDM00774,Axitinib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.319951,0.31603837,-1.776221400762828,-0.06511815562317293
34715,SIDM00774,MK-1775,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,48.0,1.0900284,0.11779209,-0.7310618509820768,0.03735099280006488
49631,SIDM00866,Bortezomib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.5046844,-0.04093505,0.37057014172397096,0.00868440002816577
76942,SIDM00411,Cisplatin,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,43.0,3.4121296,0.12212735,2.8642305144380917,0.15435720463904887
92014,SIDM00954,AZD8055,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.14398745,-0.009643269,1.6970122286606426,0.12653442433013354
73439,SIDM00866,GSK269962A,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.6688161,0.088495605,1.5945883912008771,0.04730077565779422
100100,SIDM01233,Dabrafenib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,72.0,-1.2237862,-0.025924046,-0.06464676141772371,-0.013823357876110866
29438,SIDM00875,Doramapimod,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.9221423,0.070729874,0.713339356771386,0.054521398379912864
16042,SIDM00660,Afatinib,Trametinib,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,32.0,1.4491931,0.119821966,0.9255560329042267,0.04467163958074713
19775,SIDM00866,PF-4708671,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-2.917478,-0.120366596,-2.248940258853503,-0.04405264876835737
7825,SIDM00875,Wee1 Inhibitor,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.28952864,-0.021388542,-0.9591529727355042,-0.03282093401118517
77184,SIDM00878,RO-3306,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-1.097682,-0.06461106,-1.3493834931795186,-0.04901800496485909
770,SIDM00146,Taselisib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.47864482,-0.03860235,0.719283858283923,0.08074104193180139
84931,SIDM00628,Paclitaxel,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.8790246,0.08135458,2.092595680034826,0.10630771494843572
65246,SIDM00866,Pictilisib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.0509558,-0.094045065,-0.5283795947336277,-0.04113735873260657
89312,SIDM00875,Lapatinib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5183886,0.15620902,2.7786068273191833,0.17559713390207385
106622,SIDM00628,Temozolomide,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.86963516,-0.02748595,-0.5101344575454797,-0.013950013397525838
21050,SIDM00332,SCH772984,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.5718338,-0.16689527,-0.061207726272962865,-0.03490067276642023
59471,SIDM00529,AZD6482,OSI-027,Breast,1.0,Breast Carcinoma,Female,Black,44.0,2.830107,0.14253677,0.7173316471782952,0.025772931464742826
28381,SIDM00146,PD173074,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.6516557,0.12827675,0.033397178012111714,0.08259028842423481
93925,SIDM00673,Nilotinib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-1.4861836,-0.07527158,-0.8494113960326111,-0.022269127838707308
14369,SIDM00878,KU-55933,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.8682128,-0.025115717,-0.24971682034648413,0.011544029020488466
103818,SIDM00866,Dabrafenib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,0.80228245,0.02837499,0.2786058131988974,0.06256458206692103
91442,SIDM00971,OSI-027,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.2110733,-0.06303819,-1.5113299186369238,-0.03851318255432617
105700,SIDM00531,Sorafenib,Palbociclib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.6391511,-0.081582606,-0.3939099114753711,-0.07821692322167789
58512,SIDM00875,Ribociclib,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.3311223,-0.042839255,-0.3428046183772051,0.011935291353751555
602,SIDM00097,Taselisib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.592135,-0.22264433,-0.9940659413516089,-0.08178643648367415
105390,SIDM00954,KU-55933,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.0,-2.5345316,-0.089545384,-1.5444095953041201,-0.03396663659884655
94197,SIDM00531,LGK974,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-3.2796,-0.19116057,-2.36544604019845,-0.02381759991408739
67980,SIDM00673,Alpelisib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.1468253,0.09944266,1.1924508918543637,0.0425658588993132
90402,SIDM00193,LGK974,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.0029418,-0.07165006,-1.114785168822337,-0.02495414823471227
2177,SIDM00097,AZD7762,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.0071487,-0.09425952,-1.5210374619201688,-0.07447897845586741
70611,SIDM00893,5-Fluorouracil,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.7181441,-0.031388175,-1.6617531086140838,-0.05113402332752381
89918,SIDM00130,Sorafenib,Ruxolitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.43457925,-0.04076449,-0.8458215379606517,-0.041913126653372386
64307,SIDM00411,Oxaliplatin,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,43.0,-0.640667,-0.021412512,-0.5833044290534843,0.012138951418564761
68065,SIDM00673,Sorafenib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.5174744,0.034057986,-0.11004003859953027,-0.006854247966087962
42253,SIDM00954,Taselisib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-4.1408157,-0.20564218,-1.0409526375265976,-0.043313956977383924
85034,SIDM00097,PF-4708671,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5146767,-0.051277306,0.6870169944097525,0.038253532609492026
70731,SIDM00875,AZD6482,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7334812,0.15643711,0.47906696179100405,0.025796698310019763
10334,SIDM00193,Dabrafenib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.4244994,-0.010796169,0.2605623347685383,0.0345105335006383
74662,SIDM00866,RO-3306,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-3.0967553,-0.1560422,-0.7553387054239167,-0.028466671913068998
54013,SIDM00971,PD173074,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.4784831,0.046155293,-0.513633749775136,0.03138920354513716
41578,SIDM00875,Venetoclax,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.279275,0.009502768,1.7607725491849135,0.0699972324981583
20166,SIDM00097,PD173074,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3588796,-0.05205959,0.8467072887543347,0.05791104556653016
70387,SIDM00673,SCH772984,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,-4.180489,-0.25750327,-0.8190010606075901,-0.06384265805791223
75944,SIDM00971,SCH772984,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.1194625,0.09035587,2.498675099844084,0.11608103999652797
41110,SIDM00332,Palbociclib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.077025,-0.09795338,-1.8537777660451242,-0.0984138501016006
13626,SIDM00875,Nilotinib,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5373882,0.15899451,0.7458473871243789,0.03313728831438916
3059,SIDM00878,Pictilisib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-1.947349,-0.087770775,-0.24967026943670512,-0.014807242186692531
67582,SIDM00529,Camptothecin,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Black,44.0,-0.14575079,-0.006140592,1.8767016627147026,0.0797669918767405
98757,SIDM00893,Afatinib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.8587284,0.071215555,1.2119899849691778,0.09993107636434835
101237,SIDM00878,ZM447439,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.0101167,0.075391464,-2.2624047586784215,-0.12818236046531817
5726,SIDM00411,MK-1775,Ruxolitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.8084493,-0.111314796,-1.5331321289779114,-0.07856969638129252
69836,SIDM00866,PF-4708671,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,2.0259304,0.13334584,0.1502880094670523,0.07903969634317828
88599,SIDM00776,Palbociclib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.2460473,-0.039546583,-0.5192317869121836,-0.01625186672653557
85360,SIDM00834,AZD4547,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,White,66.0,0.099778734,0.00230145,1.6789982494860005,0.01323115586399714
75512,SIDM00529,Pictilisib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-2.9204707,-0.15586226,-1.6206743526165281,-0.041222839852740153
13280,SIDM00774,RO-3306,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,0.8447757,0.049522966,-0.5965186331514569,-0.0154711608450765
43799,SIDM00673,Tozasertib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-1.7151037,-0.1086655,-0.9956613826763837,-0.06621826826730862
79804,SIDM00301,Lapatinib,Dasatinib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,50.0,1.2952577,0.08024579,2.6208801796226227,0.08157451186176527
5568,SIDM00097,Vorinostat,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.4408886,0.06970816,1.5099019936575653,0.11747163839592845
105610,SIDM00146,Entinostat,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,0.6417562,0.04810743,-0.17837027735919775,0.04379186227290776
87812,SIDM00971,Docetaxel,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.6935873,-0.07470896,-4.0561354165331425,-0.06781402385154874
62146,SIDM00866,MK-2206,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-3.5741265,-0.12682544,0.4495648459523039,0.0560099206603021
81796,SIDM00193,Taselisib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,53.0,-0.15913181,-0.015912378,-0.9917384856919926,-0.034174727389372946
59161,SIDM00301,MK-2206,Ruxolitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.0666184,0.13661094,0.643649592417528,0.012681960061674347
38478,SIDM00130,Erlotinib,Navitoclax,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.508905,0.1357642,2.5958243121238374,0.15393097278933468
18840,SIDM00193,Palbociclib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,East Asian,53.0,-0.8464827,-0.028388131,-0.6560755753505,0.010516836682682702
87690,SIDM00971,ZM447439,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.897063,0.1413323,-0.7009181518624549,-0.028581985926388297
89088,SIDM00130,AZD7762,Crizotinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.7520887,0.07845347,-0.4075815466603057,0.017366697891255306
76777,SIDM00411,Paclitaxel,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,7.6311574,0.4147469,3.6814231957496477,0.22044398623627798
13529,SIDM00359,Dabrafenib,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7552981,-0.061161563,-3.1981193996678843,-0.05601282184284993
28337,SIDM00628,Paclitaxel,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-0.40119997,-0.0232958,-1.831600874281738,-0.08391121678159907
73711,SIDM00628,Taselisib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-0.8125492,-0.07889434,-1.1011562058093038,-0.0296393715080871
30999,SIDM00893,MK-2206,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.20108292,-0.020445332,-0.3088100639292351,-0.006709063983641316
35410,SIDM00531,Gemcitabine,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.5852175,0.1014782,-0.3436349088604269,0.00440412520542097
90927,SIDM00878,Olaparib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.39871654,-0.00878303,0.9782440381296164,0.048488596372047325
59896,SIDM00628,Olaparib,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-2.2275863,-0.11129732,-1.141966326595027,-0.0215365293742692
59997,SIDM00673,OSI-027,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.94671863,0.094998576,0.21695201495614158,0.008956371491155987
18453,SIDM00097,NU7441,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0164493,-0.047863502,0.2591822167948944,0.01314479959743209
88039,SIDM00301,Erlotinib,Sorafenib,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,3.8326116,0.14224707,1.7623548823898503,0.04058392433567991
102306,SIDM00660,Nutlin-3a (-),SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,3.440098,0.10096133,2.8268978617786,0.08634651084466997
92479,SIDM00954,Bortezomib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.68038625,-0.0074241073,-0.042714250467313544,0.040020678440826796
85287,SIDM00834,Nutlin-3a (-),LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,0.7883602,0.024632826,1.0697956513730218,0.06679287116380166
106008,SIDM00332,Dabrafenib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9778298,-0.025674883,0.1280035935536338,-0.0324896223566848
10691,SIDM00893,Docetaxel,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.7491848,-0.2096293,-2.414856910112316,-0.15692439562736973
6796,SIDM00673,Axitinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.7468178,-0.12415577,-0.382647214644693,0.00874013705179691
104979,SIDM00878,BI-2536,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.88397944,-0.080639996,0.0036229093151616647,-0.05665334145968301
45546,SIDM00628,Tozasertib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-4.081378,-0.17767063,-1.869623692815534,-0.11315542341812364
50570,SIDM00359,MK-1775,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.3682644,-0.11428504,-1.493442894846513,-0.06281879902389287
47712,SIDM00359,BMS-754807,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.09811304,-0.007521576,-2.488647149627428,-0.1352920347956169
101544,SIDM00875,Lapatinib,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.30698273,0.0347224,0.2794691582474253,0.0082390022659352
29455,SIDM00130,SCH772984,AZD7762,Pancreas,0.0625,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.1116251,0.11332971,-0.8299339745780003,-0.04384680927982312
25871,SIDM00529,SCH772984,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-2.1084635,-0.07367725,-1.1571046293253673,-0.02288038517260455
58816,SIDM00673,Nilotinib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.3661314,-0.06561534,1.047102303787629,0.06727342431129418
77425,SIDM00774,Venetoclax,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,5.4050837,0.2028156,4.116317690593232,0.07561974705014902
12662,SIDM00130,Paclitaxel,OSI-027,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.1860818,-0.09313679,-0.24929069456349018,-0.03309383332055713
30926,SIDM00097,AZD8055,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.9954941,0.13258721,-0.5741526058303624,-0.04616242291020768
73637,SIDM00893,BI-2536,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,6.2800756,0.39061424,2.202857052363885,0.2160070035238581
105586,SIDM00146,PF-4708671,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.561856,0.01691981,1.809578650521739,0.0766604637371698
103829,SIDM00866,ZM447439,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-1.3308539,-0.07907883,-0.7063468919562144,-0.0647852076075936
23808,SIDM00529,Bortezomib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.08887099,-0.006414961,-0.6147008163272267,0.01943666671236413
93269,SIDM00529,Ribociclib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-1.132631,-0.03050539,-0.5990092420175903,-0.013159147122116596
20682,SIDM00954,Docetaxel,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-4.830182,-0.092020325,-1.5430467684681544,-0.09385082102467053
8614,SIDM00411,MK-2206,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.90925235,0.049281616,1.9960482326034934,0.14275203501822664
60575,SIDM00954,Pictilisib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-1.2586409,-0.10426729,-0.6944072023187651,-0.057803705482602157
50123,SIDM00332,Uprosertib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9286208,0.056720056,-1.2230490771139892,-0.06788444714125975
68591,SIDM00954,JQ1,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-1.4605616,-0.12260088,0.19619059863795052,-9.100537014198108e-05
71027,SIDM00878,Olaparib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.6122556,-0.015985522,1.7995911020021575,0.09382037503470764
106873,SIDM00774,Pictilisib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.3934961,0.013629393,-1.5483235902483372,-0.018527184355848502
42666,SIDM00774,Crizotinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,0.7082984,0.106142685,-0.2987785519926029,-0.02799110564148122
38435,SIDM00776,Navitoclax,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.6243287,-0.04600907,-1.4456309715450533,-0.0986832403465213
42616,SIDM00893,SCH772984,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.1716512,-0.07645119,-1.0404753598469738,-0.07033618805380028
22890,SIDM00411,LGK974,MK-1775,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.16221859,-0.0047229147,-0.6669425850366769,-0.04955494449085249
102843,SIDM00628,Vorinostat,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.5494914,0.053202044,0.9977929527573172,0.08137823322139502
69980,SIDM00774,KU-55933,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-2.9630036,-0.08112263,0.044899375504468944,0.005516112080600766
63334,SIDM00834,SB505124,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,White,66.0,-0.63517326,-0.055784974,-0.6789708966214347,-0.01573207038559811
102724,SIDM00778,AZD7762,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,1.6149144,0.043827612,1.8018856345128411,0.09320287514766665
81081,SIDM00779,Nutlin-3a (-),Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,33.0,0.9368927,0.03558106,2.887264850941458,0.23784678001404536
65230,SIDM00146,Cisplatin,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,2.6490517,0.095042296,3.150891869049918,0.10480284561845857
68950,SIDM00834,MK-2206,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,4.5633245,0.32210922,1.3793166688310528,0.13521432330595498
39454,SIDM00779,Crizotinib,Oxaliplatin,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-0.4917396,-0.037067596,-1.474826879582846,-0.11403235465390257
25593,SIDM00660,AZD7762,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,32.0,-2.4999871,-0.26215246,-1.9418890597386493,-0.14562063003439513
91865,SIDM00893,Bortezomib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.2641663,0.024043802,-0.6121012947552255,-0.012627412721776657
106567,SIDM00866,Olaparib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-1.874083,-0.03069537,-0.0756334824032512,0.010331062380356259
104017,SIDM00673,Cisplatin,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.20757474,-0.00698984,1.1589770030405158,0.09144346863457158
82321,SIDM00193,Crizotinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,4.245195,0.21246293,2.6970195921715576,0.14194715846418468
62518,SIDM00893,Paclitaxel,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-3.725985,-0.14918043,-3.176259805372266,-0.15882612349934985
16221,SIDM00834,5-Fluorouracil,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-1.2655671,-0.06830713,-1.0931749419186412,-0.0413131428914982
104642,SIDM00097,Nilotinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.97331166,-0.054680973,-1.2250473037685305,-0.11233454927084251
42417,SIDM00779,SCH772984,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,3.3966596,0.17375624,-1.410126110881183,-0.10477525446085685
12408,SIDM00878,Nutlin-3a (-),Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,1.5101962,0.099517494,-0.43872319916966307,-0.01196405241474022
31015,SIDM00529,Docetaxel,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.27324107,-0.023465106,-0.9521474932451001,-0.04865488557651965
8919,SIDM00531,Dactolisib,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.31185657,0.027592637,-0.8999173207436376,-0.001100063266172293
89992,SIDM00779,Taselisib,Navitoclax,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,4.001173,0.15042487,1.0112475894574107,0.057861941219203517
57584,SIDM00971,AZD6482,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1035004,-0.026201097,1.0757493606394726,0.04846128937662864
76667,SIDM00097,AZD6482,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.485313,-0.13687846,0.6398240929407231,0.002316070465235702
75746,SIDM00193,Olaparib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,53.0,-2.8852682,-0.089997195,-0.14124784080667172,0.03143654148722291
35275,SIDM00866,PD173074,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.9229732,-0.061932664,0.049810238082739,0.06804610274263125
90291,SIDM00332,Cisplatin,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,4.0356126,0.15687415,2.6360301661690406,0.15395365291852112
61956,SIDM00866,Axitinib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,52.0,0.47261146,0.036462583,-0.22552402000929994,0.03563055315539727
76509,SIDM00673,Crizotinib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.39706156,-0.038378805,0.015285545635943901,0.03200811551038942
30857,SIDM00301,Ruxolitinib,Paclitaxel,Pancreas,0.0025,Pancreatic Carcinoma,Male,East Asian,50.0,2.5659373,0.09041725,2.2995843452808473,0.04139676568855861
48143,SIDM00097,ZM447439,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.86866957,0.04573912,-0.8826885646086531,-0.013318871199521376
84230,SIDM00774,Ribociclib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-2.6897318,-0.06405431,-2.2305938829138436,-0.055331579695798626
51972,SIDM00779,MK-1775,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.2619057,-0.07407623,-1.8693977257392675,-0.10722107831188164
88605,SIDM00660,Vinorelbine,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,1.7790989,0.13881233,0.027316494507934247,0.00929966796821759
29778,SIDM00971,Tozasertib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.020686,0.1051613,1.0754494134478092,0.014093803402266044
28173,SIDM00866,Nilotinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,1.4063038,0.09900625,-0.8247105414803702,-0.0023247137975467747
87912,SIDM00878,MK-1775,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.6893412,-0.0807093,-0.6208243882271759,-0.023755406873258545
14861,SIDM00130,Dasatinib,Navitoclax,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.047781,0.15767245,2.0370934121850124,0.1239121335627867
64618,SIDM00411,Dasatinib,Olaparib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-0.7173737,-0.048169173,0.630541132643068,0.0413471826243424
75214,SIDM00628,Linsitinib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-1.492251,-0.09023881,-0.811188139498661,0.009455810115143732
25314,SIDM00866,Tozasertib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-1.03059,-0.056328285,-0.12642593779762454,0.02232297453744502
10398,SIDM00782,Afatinib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.34235108,-0.03204497,-0.6179029922578613,-0.04462064840134929
91822,SIDM00660,Navitoclax,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,0.91114295,0.092441075,0.9468580084407389,0.05317957064077187
36007,SIDM00332,ZM447439,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7640637,-0.047132958,-0.02975714501151839,-0.052166307812608476
80311,SIDM00673,ZM447439,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.1071416,-0.09182816,-1.4589144485310503,-0.1262333505292408
8315,SIDM00097,Camptothecin,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1201699,-0.048104618,0.8300929052386423,0.06859869612854147
87188,SIDM00359,Afatinib,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2263451,-0.10637754,-1.3834872771520763,-0.028687716466015468
80590,SIDM00660,Dabrafenib,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,4.2506847,0.29190296,-0.9833904401005377,-0.03249019682611611
30042,SIDM00146,Dabrafenib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.20979653,-0.010319407,0.6163132880840039,0.05159032287908983
12309,SIDM00529,Tozasertib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Black,44.0,1.4390212,0.07598448,0.5707249494582342,0.02750570380568128
17306,SIDM00529,Nutlin-3a (-),5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.6047267,-0.042904004,-0.5925718120885837,0.03956935184951337
52028,SIDM00893,JQ1,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.9973077,-0.08134855,0.5948648297855109,0.07228110906888557
6981,SIDM00893,Cisplatin,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.4142993,0.010798646,1.4234280812505333,0.04875053546446091
19622,SIDM00628,MK-2206,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,2.155522,0.20580213,0.01022157454079265,0.06976723800319443
86403,SIDM00301,Palbociclib,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.2833201,0.17278744,0.688332796896624,0.01658601916378542
56304,SIDM00893,PF-4708671,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.8523747,0.14802726,-0.7488115229983661,-0.0608747178209362
57856,SIDM00332,JQ1,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,8.212924,0.28029326,2.934911665133764,0.13846495474460713
34311,SIDM00628,PD173074,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,1.1791967,0.044716097,0.7733012202048954,0.06678407513477765
22923,SIDM00332,PF-4708671,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,4.1931534,0.1557526,2.4571040866439207,0.11571099601917754
31984,SIDM00332,Paclitaxel,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.958333,-0.13951425,-0.8599208748818079,-0.14881023482945377
15196,SIDM00875,Vorinostat,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9851347,0.10437112,0.3162603394611581,0.00920442071535948
70262,SIDM00866,Venetoclax,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,52.0,-0.70397645,-0.014451258,1.3238740947214853,0.01430999478058532
9876,SIDM00146,KU-55933,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-2.119618,-0.069975816,-0.8235584520394649,-0.022778445338519512
99809,SIDM00878,Entinostat,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,1.163645,0.07476465,-0.06386868371790724,0.034240218447406844
93374,SIDM00971,SCH772984,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,6.621738,0.20649166,1.8802604777480223,0.07055924413587247
55546,SIDM00673,Tozasertib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.4861537,0.12098523,3.806187795494715,0.1441698068363508
90446,SIDM00971,Cisplatin,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.7904882,0.035404004,0.9016141280933504,0.014332674119669667
75494,SIDM00529,Palbociclib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-2.7387044,-0.09890203,-1.1655236927954333,0.02239694071453368
83655,SIDM00866,Palbociclib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.15654224,-0.0036037741,0.302823459458083,-0.0034604073431407575
105029,SIDM00875,Temozolomide,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8373927,0.048358288,1.2007307632649358,0.03479382251992232
55862,SIDM00660,Vinorelbine,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-0.47828317,-0.043005023,0.37627816456550345,0.010008712930151669
78256,SIDM00776,Taselisib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.9482881,-0.1350363,-1.3536232488754976,-0.07105086552119515
108352,SIDM00866,Doramapimod,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,2.5457413,0.06866105,3.033469854160284,0.12566600080422338
107383,SIDM00878,Nutlin-3a (-),Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.0167795,-0.0566593,-0.8697001847569399,0.020337111339438114
10739,SIDM00866,PD173074,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,52.0,2.09652,0.1120213,2.2267528319665084,0.10278707066788646
20059,SIDM00782,AZD7762,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,2.5824425,0.21522501,2.3030565257973485,0.17413390780388308
37166,SIDM00660,BMS-754807,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,-1.5848631,-0.15133254,-0.4507254557203076,-0.0071718336759657025
98363,SIDM00097,Docetaxel,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.514883,-0.13522825,-1.2081662886293096,-0.11375210602649685
42705,SIDM00866,Docetaxel,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.43491,0.03131392,0.13230670428579144,-0.017695022836024595
48947,SIDM00779,Vinorelbine,Dabrafenib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,0.49501824,0.047691915,-0.7001783926055009,0.0247017808926781
30794,SIDM00954,Nutlin-3a (-),Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,2.868433,0.110382564,1.0881373125577734,0.12109847187158859
1572,SIDM00971,Entinostat,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.8693056,0.11746826,1.4239064775083936,0.043722369514686076
107296,SIDM00878,RO-3306,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,0.8571988,0.065222315,0.18210848534986382,0.029043248855905687
66831,SIDM00673,Gemcitabine,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.3227781,-0.08732918,-1.3868959915126025,-0.06027540556188411
44374,SIDM00332,JQ1,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,6.4275126,0.31166983,4.740179462206312,0.2668610749074036
21452,SIDM00954,Gemcitabine,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.0,-0.25419933,-0.016519831,0.03160118282171074,-0.022620263456657328
105517,SIDM00875,Trametinib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5787214,-0.060946483,0.01228912049072041,0.002314930904893568
69915,SIDM00146,Alisertib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.31434616,0.029125439,-1.0886124336894885,-0.15008145826371586
14875,SIDM00971,Sorafenib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.5140183,-0.16863276,-0.949913447027557,-0.07246830493447334
67778,SIDM00778,AZD7762,Afatinib,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,1.9766892,0.08051407,1.6376148226948153,0.06146595266955187
105692,SIDM00893,Docetaxel,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.1933553,-0.10490908,-1.6163895300051256,-0.009771358502801156
23121,SIDM00774,Tozasertib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,0.3436947,0.010550002,2.071889787389146,0.09990757632665312
10973,SIDM00778,LGK974,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,0.9384902,0.02052983,-0.4487458307844246,0.00223258130936804
65276,SIDM00971,MK-2206,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-4.1775527,-0.19658218,-1.3730000117855592,-0.12280614081660977
49970,SIDM00878,Cisplatin,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,0.80566543,0.025951313,1.202521513289927,0.10281488259323135
78897,SIDM00673,Bortezomib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.14962544,-0.0076579917,-0.025014791928170382,-0.01876094408400965
65557,SIDM00332,Afatinib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9349116,-0.06712689,-0.9193832586008862,-0.05908107023553191
31900,SIDM00146,Afatinib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-1.0591125,-0.0956207,0.8004272593933552,-0.001419234690615007
68743,SIDM00332,Sorafenib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4175178,-0.1047974,0.5342127052584215,0.015975483021167445
75458,SIDM00193,AZD8055,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-0.67917377,-0.047920376,0.04928593484363582,0.015900436419965924
89316,SIDM00866,Crizotinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,-1.7199721,-0.07349159,-0.04692112018694198,0.06700701241916211
36615,SIDM00778,5-Fluorouracil,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-1.3955648,-0.043736514,-2.493500228483765,-0.0719816458471119
107333,SIDM00529,OSI-027,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,1.170487,0.104964696,0.5789045747643139,0.13794673931389656
70984,SIDM00954,Linsitinib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.70183986,-0.059026178,-0.6256153780309432,-0.009674904560213402
42510,SIDM00971,Crizotinib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.8605297,-0.02958058,0.057495082060659806,0.039130286848184016
104889,SIDM00146,Linsitinib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,2.0974474,0.07183943,2.830198164755243,0.19967318544438623
38484,SIDM00332,Palbociclib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,2.4289992,0.21473427,1.5218706654427097,0.06214948552525788
54881,SIDM00628,5-Fluorouracil,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.6624629,0.042087954,0.49866349530739557,0.02114089510195066
74952,SIDM00893,Venetoclax,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.1704917,-0.059645023,-0.9909850653160447,-0.009640952563463636
40773,SIDM00301,Crizotinib,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.9282908,0.20236996,1.7662395945661529,0.14743081637397706
17524,SIDM00875,Palbociclib,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.3038957,0.104819186,2.4507590722747916,0.10172690598451029
74182,SIDM00660,Olaparib,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,2.2328544,0.03164811,2.3351210201360324,0.04538181483033812
1209,SIDM00875,Vorinostat,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.2476025,-0.09703707,-0.7385525003540403,-0.018938682567771717
54669,SIDM00834,Nutlin-3a (-),5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,1.7128235,0.064246945,0.38112707100086973,0.04780828336763397
14149,SIDM00660,Linsitinib,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,2.8047473,0.22518022,2.431773358943782,0.1926116884743414
49089,SIDM00782,LGK974,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.8669779,-0.12665027,-2.0637459961265097,-0.11594974150553675
56526,SIDM00866,5-Fluorouracil,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,2.1885583,0.08284418,0.5779971638775743,0.055500237264205575
101940,SIDM00628,Tozasertib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.7249622,0.16131485,0.5027262981264602,0.06504664098102443
107356,SIDM00774,PF-4708671,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.7214642,-0.027044242,1.3298923280629604,0.03237899919924754
9205,SIDM00411,Ruxolitinib,Oxaliplatin,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.57993126,0.010284896,1.0966911011768807,0.016286041276320717
59661,SIDM00628,Uprosertib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.5746794,-0.03378246,0.5229018632483166,0.0327671072493101
91539,SIDM00332,KU-55933,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.4727914,-0.07176832,-0.5846776597644611,-0.0015183053118149605
105550,SIDM00332,MK-1775,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9458401,-0.084903784,-0.4248201502544063,-0.04121060740184944
61813,SIDM00893,Wee1 Inhibitor,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.011612,0.085373715,-1.1551523864091895,-0.0467696137296575
47564,SIDM00673,Dabrafenib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,4.676258,0.10018971,2.117509372966028,0.04625786858735945
20433,SIDM00834,Afatinib,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,-1.7305987,-0.07915777,-3.2042136688738356,-0.09392547410010481
23493,SIDM00130,Dasatinib,SCH772984,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,5.9391594,0.41183347,1.6972115978954243,0.1478393425575044
20227,SIDM00301,Gemcitabine,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.3760408,-0.1540596,-0.7021565187431879,-0.059686528570124665
96667,SIDM00146,Lapatinib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.0233103,-0.08022676,0.1341948833180061,0.022618877401218516
28730,SIDM00866,Afatinib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-2.929595,-0.17937161,2.0069559134831603,0.1290408163130754
35446,SIDM00774,PD173074,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.2802492,-0.06581576,-1.5592957450121592,-0.048321580190036344
89880,SIDM00193,Dabrafenib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-0.39998892,-0.010142755,0.40272735066468485,0.03546230679405751
15494,SIDM00660,SCH772984,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,0.9132939,0.04090943,-0.5437276652558977,-0.030788989428801247
31717,SIDM00146,Dabrafenib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,2.4731812,0.17958902,-0.45096637850176735,0.05835200307934691
100208,SIDM00878,Pictilisib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,2.2315345,0.18556453,0.15223368271540708,-0.006949233785409951
18950,SIDM00332,Docetaxel,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.710149,-0.14754206,-1.4257790672008126,-0.06805557888341789
33253,SIDM00628,AZD7762,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.95415443,-0.08252255,-0.508749061196279,0.015055280323846083
76008,SIDM00628,Alisertib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-4.1399918,-0.10950518,-2.830238492565558,-0.08585948610314759
52932,SIDM00954,Olaparib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-2.145548,-0.055306662,-0.339054386330957,0.004822230634836766
3751,SIDM00954,Nilotinib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,0.9189657,0.02471439,1.5583366679119444,0.09000811105619425
20939,SIDM00971,OSI-027,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.5591087,-0.06787883,0.15588098246040888,0.01852510896016042
364,SIDM00878,SCH772984,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,70.0,-1.4872346,-0.10601755,-0.2018656513290728,0.028248691235728724
49365,SIDM00866,RO-3306,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.8162806,-0.0962873,0.4617475574197544,0.04143520606737202
23582,SIDM00531,Crizotinib,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.5626564,-0.056077085,1.1857272156538827,0.09033858733241128
74681,SIDM00878,ZM447439,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-1.377311,-0.114274,-1.270376441303379,-0.16876656657089834
104452,SIDM00146,Axitinib,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-2.4056451,-0.15643527,-1.7119848215875642,-0.0976456552844042
50044,SIDM00146,PD173074,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-2.0969226,-0.1332919,1.2367128366961582,0.1506455260711893
58621,SIDM00332,Doramapimod,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,0.86064136,0.051536042,-0.02546148679695672,-0.0012343542543059533
17889,SIDM00893,NU7441,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.8563935,-0.07125443,-1.4793814344233915,-0.08033853535731679
49584,SIDM00531,Ruxolitinib,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.59122986,-0.017907424,1.7576113499608617,0.03333767770697946
44018,SIDM00774,Alpelisib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,0.74638796,0.049777627,-0.4184968394668683,0.04256099779605744
67927,SIDM00673,Paclitaxel,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-1.0158442,-0.061149176,-1.3573457516486822,-0.08606902690722282
37974,SIDM00332,OSI-027,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0668283,0.062845156,0.6083919026294741,-0.013396974571004723
62937,SIDM00411,Lapatinib,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.7973512,0.07329529,0.5323855536559151,0.095929977382224
69927,SIDM00776,SB505124,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.42656058,-0.028926939,-1.5809312602220185,-0.04891181135950172
77478,SIDM00146,Sorafenib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.1377053,-0.09250304,-1.2450510852254433,-0.07390775548519192
26865,SIDM00411,Crizotinib,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,43.0,-1.2489884,-0.06596704,-0.7155866642347835,-0.04956391214052552
70443,SIDM00971,Navitoclax,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.36754942,0.009116033,0.4293228749078117,0.03241739547769042
98426,SIDM00332,Tozasertib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,2.443859,0.16144097,-1.192392739718043,-0.04903250640701399
89208,SIDM00301,Linsitinib,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,50.0,-1.6833785,-0.054872885,0.24939762790127687,-0.018878273601350644
46921,SIDM00411,Palbociclib,OSI-027,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.9560337,0.073151566,-0.19303330985662823,0.04143915381786292
87029,SIDM00866,Cisplatin,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.405488,0.031135205,1.9449164628363704,0.04160708091108842
74221,SIDM00628,BI-2536,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-5.4453797,-0.22314984,-3.670474836134564,-0.06839580385139594
85294,SIDM00778,BMS-754807,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-3.0817523,-0.15221332,-1.4318193763937632,-0.10895712789640875
49490,SIDM00778,MK-2206,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,2.2806256,0.06580325,1.3481841718503433,0.09423980901603714
5032,SIDM00878,AZD6482,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.2980173,-0.08145575,0.11321727735331784,0.05655146420041686
15059,SIDM00628,PD173074,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,0.5930147,0.019901391,0.2608043940501,0.07464108005438921
30255,SIDM01233,MK-1775,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,72.0,-1.6540835,-0.102539435,-1.8684209611106992,-0.118756647895418
87042,SIDM00529,Olaparib,PD173074,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.9796005,-0.045780446,-0.9288198141238184,-0.05401336270276212
18269,SIDM00866,5-Fluorouracil,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-1.5974145,-0.0586577,0.2771970980376038,0.017715676183487027
15373,SIDM00954,Dabrafenib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-0.31263036,-0.010323791,0.26992188181047627,-0.0032038717754881226
7106,SIDM00774,Paclitaxel,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,0.9152725,0.043226104,-0.5199506468323737,0.041395686594738065
39811,SIDM00628,Axitinib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.19787873,0.0064737285,-1.2972143019201303,-0.026140781237380194
33375,SIDM00097,Docetaxel,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9789348,-0.10840375,-1.2712038959577303,-0.08748283201282257
10919,SIDM00628,JQ1,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,0.7755158,0.05870364,0.6181773783819318,0.06599967432054475
14077,SIDM00673,Tozasertib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.88390243,0.060563095,0.24661443972460645,0.024194456941235527
51883,SIDM01233,AZD8055,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,72.0,-0.21594754,-0.016301302,-0.6954511096382225,-0.009193071135797615
36669,SIDM00878,JQ1,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.0658163,-0.09233107,-0.47604559042601186,-0.06885021154012151
46896,SIDM00411,Irinotecan,Lapatinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,1.4338859,0.074452996,-0.277379452579416,0.03695944264787018
12555,SIDM00776,Vinorelbine,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.0295948,-0.06378477,-1.1266959336386861,0.05081141996165378
66199,SIDM00673,Entinostat,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,2.0498145,0.11117452,-0.9579734837561013,-0.042155371660540855
34762,SIDM00971,ZM447439,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.952319,0.13446848,-0.12951477426743516,0.009431096377480106
2341,SIDM00782,Palbociclib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.35553393,-0.007619709,1.6499097447646776,0.040807637004707395
61612,SIDM00097,Trametinib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.5750043,0.10779222,-0.41737068233762253,0.002750748916837578
77306,SIDM00411,Trametinib,Sorafenib,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,3.5122166,0.11905953,-0.24069832668746827,0.024264115066584078
37806,SIDM00782,Crizotinib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-1.0530472,-0.0877664,-0.09760214489591192,-0.02938823887274124
91522,SIDM00301,Sorafenib,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.1886464,-0.094816096,-0.8544835450808994,-0.02053980153615045
82850,SIDM00774,Nutlin-3a (-),Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,2.2552161,0.051576924,2.547676132546388,0.020357488401455737
37537,SIDM00875,Bortezomib,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.74088967,-0.026458146,-1.1543090534383897,-0.06891553088658868
36642,SIDM01233,LGK974,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-0.6708072,-0.04151611,-1.0071677819414027,-0.06346972312490622
102134,SIDM00097,5-Fluorouracil,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0537018,0.05944773,-1.5679643965291286,-0.08897164156857926
24194,SIDM00954,AZD7762,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-3.7908292,-0.13847005,-0.9757162149293216,-0.04240404785607706
21307,SIDM00779,Linsitinib,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,33.0,0.8724176,0.047669563,0.42747276185714134,-0.03262939504120864
99543,SIDM00411,Irinotecan,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.6164621,0.08082043,-0.32157974917215876,0.03347161296286197
64810,SIDM00893,Ribociclib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.2242773,-0.009904114,-0.38254677649462443,0.034517844516142294
32349,SIDM00660,AZD8055,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,-1.3824271,-0.099519834,-1.104341548398026,-0.07071878902014986
7447,SIDM00834,Vinorelbine,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-0.5722428,-0.046075206,1.4171592659490193,0.14800388631885758
39331,SIDM00660,Palbociclib,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,32.0,2.8126557,0.17802311,0.8939547451791987,0.010548437871161633
44627,SIDM00954,Entinostat,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-1.1097271,-0.08433991,-0.6630372576324071,-0.042338005178674
13642,SIDM00878,BI-2536,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-3.0854735,-0.1329507,-1.3725587904916197,-0.04105317888154222
94021,SIDM00673,Nutlin-3a (-),Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.5294625,0.04806186,1.6963007082339865,0.023814590132589332
73882,SIDM00954,BI-2536,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-0.8657057,-0.019076597,0.09828728393352684,0.01506442991403301
41676,SIDM00359,Vinorelbine,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.308675,-0.06599172,0.30417277953673943,0.06682337072059832
47379,SIDM00130,Taselisib,Oxaliplatin,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-3.484273,-0.2568041,-2.6541750366847014,-0.07640371359047057
65873,SIDM00866,ZM447439,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-1.3096223,-0.087650344,-0.48291828078397947,-0.033305086123082105
68210,SIDM00193,BMS-754807,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.2632833,-0.1096028,0.7169392762615219,0.10560151540336771
66360,SIDM00878,Navitoclax,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,0.20752831,0.004745056,0.5918263438076818,0.010234848690928663
22932,SIDM00866,Temozolomide,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.7728435,-0.009876832,2.957315337761323,0.030136563127484074
91149,SIDM00878,Taselisib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.7541405,0.065365694,-0.19792855335239307,-0.007484388321573555
18869,SIDM00193,AZD8055,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,0.94370383,0.077445,0.18470942044079125,0.07453575045973349
37296,SIDM00411,MK-2206,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,-6.0505576,-0.25709194,-1.0621617255678057,0.021852564408638024
9335,SIDM00776,AZD4547,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.6207612,0.06351669,0.16576316702533958,0.04824300061375627
18471,SIDM00673,5-Fluorouracil,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,1.6905696,0.097774096,1.6858257746600844,0.043013789459227736
7798,SIDM00411,Navitoclax,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.0926645,0.13786761,-0.5694834782624313,0.009324207849781356
42437,SIDM00875,Entinostat,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.4758297,0.04923854,-0.008884328588014063,0.014976878941370184
55749,SIDM00628,JQ1,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,Black,51.0,-0.9910346,-0.06161147,-0.11011914594103069,0.0031244519347196657
43448,SIDM00782,SCH772984,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,Unknown,72.0,-1.7679996,-0.12126918,0.9440037077175923,0.08794222370179876
81828,SIDM01233,Taselisib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,72.0,1.0197458,0.08047256,-0.5796311194308604,-0.04363142000657703
40925,SIDM00893,Doramapimod,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.3241066,0.05664426,0.8184815710390078,0.04808783971429957
56933,SIDM00359,Navitoclax,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.8915915,-0.0653073,-0.9406556338204696,-0.017922489059328923
78421,SIDM00971,PF-4708671,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.25037396,0.016605016,-0.39178783530545724,0.0077849024757755065
43445,SIDM00673,Lapatinib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.793736,0.16776848,0.4570448330883893,0.01768721115836888
58694,SIDM00954,Paclitaxel,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-3.9111,-0.13488501,-2.7358863247559717,-0.1306247287153469
1125,SIDM00875,Alisertib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3111082,0.12680247,4.561912067463675,0.28579433332361215
72856,SIDM00778,Palbociclib,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-2.1988451,-0.05223282,-2.185958107484702,-0.04093004628579437
80974,SIDM00301,AZD7762,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-0.6998089,-0.04139579,0.6505921334476532,-0.013786310306741332
87410,SIDM00954,Uprosertib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-1.2139205,-0.094170034,-0.2014092758512447,-0.028503165807764498
80926,SIDM00146,SCH772984,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-1.3275795,-0.12562114,0.16755335113202244,0.016897045463280712
10613,SIDM00878,Crizotinib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.8359119,0.036730796,2.4882568747194473,0.13064542460908485
18498,SIDM00531,MK-1775,Erlotinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-2.4598174,-0.18728162,-2.090794136591737,-0.07876165634591031
28087,SIDM00411,MK-1775,Taselisib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,2.6432822,0.13978289,0.08067501352306307,0.02825892103219079
92682,SIDM00673,Docetaxel,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.91172224,-0.09368511,-0.9275904847881615,-0.04476045316438796
105694,SIDM00673,PD173074,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.3535206,-0.10175326,-2.274984796006336,-0.11801490283870744
26085,SIDM00893,Venetoclax,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2129428,-0.042547375,-0.24781740799433422,0.06270551291545558
69449,SIDM00097,PD173074,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.967181,-0.15569577,-2.0262897569401908,-0.1478893579558827
60022,SIDM00531,Crizotinib,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.7141254,0.08041836,0.1475572526936754,0.023164430463418928
70094,SIDM00660,SCH772984,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,32.0,1.8562797,0.072928146,-0.10419928912121765,-0.016762457935778952
8453,SIDM00146,Lapatinib,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,1.3274801,0.12316979,1.5354900292108016,0.05376558686209837
43671,SIDM00971,AZD8055,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.1340933,-0.0855942,1.0506388395669675,0.06026411987368823
15045,SIDM00097,Luminespib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.478482,-0.13989283,0.17542544892425768,-0.013641607720214775
71206,SIDM01233,SCH772984,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-1.391319,-0.10934806,-0.4396847697876558,-0.03082324309793383
514,SIDM00673,Nilotinib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.2618136,0.14872769,0.13329046893255345,0.03777079902161261
19780,SIDM00673,MK-1775,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-0.5722669,-0.056392007,-0.372508094956102,-0.0179397087498733
89611,SIDM00875,JQ1,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.8065457,-0.17189617,0.5969827155052229,0.011433247086907006
46795,SIDM00774,Bortezomib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.4602555,-0.039836787,-0.10514707044002933,-0.020928849632935755
104748,SIDM00875,KU-55933,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.21139073,0.008956905,0.8992680093205974,0.06798313034509462
88239,SIDM00628,NU7441,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-0.23743281,-0.022645239,-0.40916519110152894,0.021704114262781585
78167,SIDM00782,BMS-754807,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.2269223,0.091776714,1.6370802169922205,0.05205730513357819
29410,SIDM00332,Vorinostat,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.0753605,-0.21288483,0.6463231450488875,-0.04056096020442719
21275,SIDM00301,Sorafenib,MK-2206,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,50.0,-0.48934847,-0.06083914,0.05760303632147203,0.02525738224697505
108002,SIDM00774,RO-3306,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,-0.7614943,-0.040755745,-0.6354056925164377,0.023466439076934274
90618,SIDM00971,Sorafenib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.35195673,-0.02155266,-0.8484442565463236,-0.05117463834945374
73017,SIDM00954,Uprosertib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-0.93294626,-0.0537528,0.32003990755107875,0.07730217877421848
17648,SIDM00130,LGK974,Gemcitabine,Pancreas,0.1,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.066919,-0.044379324,-2.0408845720998507,-0.05739318802778253
9215,SIDM00146,Entinostat,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.68345654,0.05367658,0.31104867980776696,0.0644372842593625
23459,SIDM00954,MK-2206,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.17174043,-0.014017671,-0.5663545182297514,-0.04744647953511186
4970,SIDM00834,Dabrafenib,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,3.731672,0.19751172,0.3633321772441334,0.006087651976442569
14699,SIDM00673,Alisertib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-1.0172741,-0.049988747,0.01083521411255919,-0.008741556540629558
34630,SIDM00774,Doramapimod,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.506633,-0.060784232,0.15012204655637174,0.01806813558353812
90524,SIDM00893,Ribociclib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.3328533,-0.061476253,-1.4904477867180543,-0.023093260371825367
61703,SIDM00673,Ribociclib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-2.7980788,-0.08137545,-1.3065288549637726,-0.018438103492011765
79425,SIDM00893,Cisplatin,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.4409082,0.0495431,2.02880787875096,0.05215670590633757
90649,SIDM00529,Entinostat,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Black,44.0,-2.0131292,-0.09270077,0.2647297844040849,0.06738551305058081
98410,SIDM00411,Oxaliplatin,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.2833025,-0.038797107,-0.7119085700975507,-0.019822466506340057
6743,SIDM00332,SCH772984,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.8802955,-0.113003045,-0.34789656268036623,-0.0494478820187177
35709,SIDM00411,Crizotinib,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,2.612276,0.14535752,2.4896501300264187,0.12678072504784918
36919,SIDM00359,AZD8055,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6127042,-0.081191964,0.45713706431692663,0.05432475362385146
51435,SIDM00628,Tozasertib,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,-2.0036578,-0.18228331,0.3399091064418719,-0.03369367583995264
12014,SIDM00628,Camptothecin,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.43678302,-0.036069382,-0.15639202030345123,-0.00457462831211564
68158,SIDM00954,BI-2536,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.9688994,-0.010567079,1.8069209440375382,0.03714658565118843
12058,SIDM00954,Trametinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.0,3.5858147,0.14532119,1.2485417437874706,0.11664300179396642
105768,SIDM00954,Temozolomide,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,3.6025994,0.11333563,1.3787563075550848,0.0623286017395791
6812,SIDM00779,Camptothecin,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,2.1523604,0.058042686,0.8315683257936235,0.05457095606929166
34587,SIDM00660,Trametinib,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,-3.1892908,-0.18396705,-3.985710452761865,-0.12301456716836746
30530,SIDM00866,Pictilisib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-2.2225146,-0.16113621,-1.2670951826743735,-0.07774516355847738
29564,SIDM00971,BI-2536,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.781838,0.16436657,0.9082033855386086,0.11968568936586749
35307,SIDM00878,Cisplatin,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,1.7054542,0.07003432,1.664754534296138,0.08783343662251832
71908,SIDM00673,Camptothecin,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.8673463,-0.022479149,1.4315801669236579,0.04738127108746395
48757,SIDM00301,Linsitinib,Palbociclib,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.8850507,0.10353506,1.641317978244587,0.07952263794155595
60056,SIDM00130,MK-1775,5-Fluorouracil,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.8471765,0.07682906,-0.30974590595564844,-0.02670256146739083
49384,SIDM00531,Linsitinib,MK-2206,Pancreas,1.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.1663326,0.08014275,0.6153134843923427,0.029879949586478924
69655,SIDM00779,MK-2206,Dabrafenib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-0.87641585,-0.073775224,-0.0844360988430869,-0.02690981899684119
6756,SIDM00660,Dabrafenib,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,-3.744202,-0.15710588,-0.7924477472638841,-0.029210817073868484
92288,SIDM00878,Palbociclib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.89571553,0.054991603,1.664235622431474,0.08010401913512503
74687,SIDM00411,Lapatinib,OSI-027,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.035082456,-0.0009925965,0.5610791654467325,0.09479158091697668
86452,SIDM00779,Afatinib,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-0.5358166,-0.049381193,-0.10870397271772272,-0.018978174802731076
95332,SIDM00875,Alisertib,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.57324314,-0.03608355,0.5781128203731283,0.043444826383777335
100263,SIDM00866,Crizotinib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.71996206,0.055842217,0.01310712772670889,0.040297199583294814
72549,SIDM00130,Taselisib,Olaparib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.5422524,-0.05412639,-0.4852154892380295,-0.010186335766386802
49281,SIDM00359,MK-1775,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.8088366,-0.055233955,0.36211370530228143,0.005435460564242354
77319,SIDM00774,Dabrafenib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.2205884,0.046568636,-0.21281163096412223,-0.021688410947478615
7763,SIDM00301,Ruxolitinib,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.0030041,-0.026998863,0.23537868846777563,6.519420637327085e-05
88159,SIDM00875,Alpelisib,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.22423291,-0.020821255,-0.7558839753427214,-0.006557646634283909
97462,SIDM00673,GSK269962A,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.2574428,-0.08510915,0.3370455335782969,0.009931408492107613
83212,SIDM00893,Doramapimod,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.66244376,-0.022024669,0.8614458393675105,0.08341244268607609
23031,SIDM00146,KU-55933,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.2390226,-0.053278327,0.537179869938983,0.062464666483301505
24636,SIDM00778,MK-2206,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,69.0,-1.1847873,-0.07377245,-0.9167382043748091,-0.01821564537562918
60105,SIDM00529,Gemcitabine,MK-2206,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-1.7500745,-0.05779152,-0.003053940117500651,0.013786767021832675
64198,SIDM00673,Bortezomib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.16833873,-0.008977969,-0.5399572054280223,-0.03853990451567643
62597,SIDM00878,Gemcitabine,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.4971561,-0.11351512,-1.6878838523723485,-0.08326256061829229
78092,SIDM00673,Camptothecin,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.1843327,-0.035357073,0.2268054157619136,0.018030399360957964
63980,SIDM00866,Lapatinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,1.9959134,0.09711772,0.33132480484334104,0.059807076696990494
12787,SIDM00193,Olaparib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.7001748,-0.07608825,0.009688036522414067,0.015422996814957911
52868,SIDM00893,Nutlin-3a (-),Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.44767267,-0.009246371,2.1028307417184386,0.042223401400245365
23949,SIDM00660,Oxaliplatin,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,-1.2204202,-0.08529287,-0.9850008119938918,-0.038745680791625284
99878,SIDM00673,GSK269962A,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.8198833,-0.17956221,-0.9892514388317033,-0.09089685293868723
70357,SIDM00971,Bortezomib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.6009278,0.13416962,0.2011463563795903,0.03628082079889291
97205,SIDM00893,Tozasertib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.6754916,0.12432136,0.8044324552026569,0.07996125653151105
58834,SIDM00529,PD173074,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Black,44.0,-2.1767983,-0.09353511,-2.2440012592850063,-0.054325335517859494
38994,SIDM00411,Irinotecan,MK-1775,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.8265445,-0.077046946,-0.5612137268780365,0.0028635824305078515
37090,SIDM00971,Cisplatin,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.5756625,0.010094856,0.6079357180498113,0.03727038693010282
8364,SIDM00954,PF-4708671,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-3.1998148,-0.14273809,-1.3877447627647785,-0.10852008228605532
97500,SIDM00875,MK-2206,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.3704028,-0.14012964,0.3033338655363492,0.029451117863120112
106372,SIDM00146,JQ1,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-1.8629436,-0.13556673,-1.4285632238852308,-0.10029431593830157
19685,SIDM00971,AZD8055,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.4475561,0.029336074,-0.3404311038080551,-0.00919816433342235
30245,SIDM00673,Wee1 Inhibitor,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.6963513,0.12696198,-0.5917817283512369,0.050373515401119985
80742,SIDM00301,SCH772984,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.457762,0.31371516,2.328914612958855,0.15399513246129576
76655,SIDM00971,PF-4708671,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1609548,-0.050103694,-0.6054579929155273,-0.027958619108293753
103875,SIDM00193,LGK974,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,53.0,-2.5031059,-0.11406062,-1.1788504253402685,-0.021591338844839346
36835,SIDM00628,Ribociclib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,1.1317797,0.0345618,0.7084754515711099,0.021747186946720974
49571,SIDM00673,Venetoclax,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.29229084,0.008503255,-1.2678002553259324,-0.01242893122870647
43160,SIDM00893,Alisertib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.4311619,0.114005804,-0.14436369995023066,-0.025659474172141847
9061,SIDM00774,RO-3306,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.3365519,0.086483926,-0.732143719885664,-0.04165758593576838
42017,SIDM00628,Entinostat,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-2.282244,-0.106094725,-0.16480461376835884,0.06063908477284599
95839,SIDM00529,PD173074,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.4151139,-0.06840686,0.5342979713440829,0.08018612888270012
47893,SIDM00875,Vorinostat,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.36032742,-0.034644693,0.019380871696529394,-0.027291335754136198
30081,SIDM00301,Dasatinib,MK-1775,Pancreas,0.2,Pancreatic Carcinoma,Male,East Asian,50.0,3.9659028,0.45398495,3.5287395093564142,0.217335036402852
13477,SIDM00893,Docetaxel,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.3471696,-0.11512173,-1.2661246397883026,-0.10479732378024781
64201,SIDM00529,KU-55933,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,1.787172,0.04596821,1.702152352445082,0.054254249756513134
87370,SIDM00971,Nutlin-3a (-),5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.8178399,-0.023551272,-1.5599257033443805,-0.028994003904875235
82234,SIDM00146,Afatinib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.9696407,-0.0800158,1.408161268728472,0.055820188099907304
68723,SIDM00782,Oxaliplatin,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.95575976,0.06027363,-0.1447103672250122,-0.04725574044352988
172,SIDM00893,Linsitinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.8785931,-0.076892935,-1.6884673696736723,-0.08795712766655724
47978,SIDM00529,Navitoclax,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Black,44.0,-0.16883348,-0.015919235,-0.5850371232069717,-0.023354203565702128
44258,SIDM00866,MK-2206,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-1.7860103,-0.08308417,-2.062921382887842,-0.04250383743269153
100471,SIDM01233,Trametinib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,72.0,-2.4032784,-0.16716635,0.4046948401805265,0.009915024371186968
59074,SIDM00782,MK-2206,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,Unknown,72.0,0.60896236,0.0480103,-0.061591749372116235,0.031087680899948796
82053,SIDM00878,AZD7762,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.8647188,-0.057242453,-0.08302262895453778,0.02650188104357198
13599,SIDM00146,Paclitaxel,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,0.93079776,0.07525975,-0.5494272403971511,-0.02469526440306442
26034,SIDM00628,ZM447439,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.78547287,-0.06504269,-0.9810577827002838,-0.08554284546094429
64545,SIDM00628,Paclitaxel,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.038361,0.05156406,0.009031004810804162,0.004387713350529179
56484,SIDM00878,Venetoclax,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,1.0780927,0.010985782,0.8015916839439148,0.05119837733233247
106907,SIDM00660,AZD8055,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,-1.824796,-0.07194312,-0.5477129682762035,-0.0297470287755783
42255,SIDM00130,LGK974,5-Fluorouracil,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.749219,-0.086353116,-2.535622286241759,-0.04250216124013839
42168,SIDM00097,Ribociclib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.5306055,-0.020275211,-1.1713745839039031,-0.011726219640037994
60357,SIDM00660,Taselisib,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,-0.45879513,-0.04567479,-0.1247680886230159,-0.037876717023398516
22333,SIDM00954,AZD6482,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-2.213748,-0.08603714,-1.0805791142089671,0.01086580935137926
32224,SIDM00779,BMS-754807,Oxaliplatin,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,0.24899359,0.003898899,-1.0569813201043936,-0.057124489002421557
49155,SIDM00893,Gemcitabine,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.6148275,-0.12562573,-2.3750231653324403,-0.04905680968645313
102572,SIDM00529,Dabrafenib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,1.8127756,0.045925364,1.2419864449044966,0.07437452568229605
93145,SIDM00130,Dasatinib,5-Fluorouracil,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.2886184,0.080778204,-0.21094406608346022,0.04323095242195189
51221,SIDM00531,Lapatinib,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.3119965,-0.0758081,1.6332194195178116,0.0948960247678018
86181,SIDM00660,Palbociclib,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,32.0,3.008751,0.16231848,1.6616418284031604,0.09474735655311474
72415,SIDM00866,Wee1 Inhibitor,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.3024411,-0.09926381,0.2036829788003233,0.03320983167816463
46681,SIDM00673,Luminespib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.3821232,-0.13546382,-1.915817335643729,-0.08219698865749293
56998,SIDM00628,Entinostat,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-1.1073459,-0.0606019,1.4099851217605894,0.11859519934457831
45988,SIDM00673,NU7441,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.573725,0.20881018,0.16854295342207135,0.05395028596846698
23666,SIDM00660,Olaparib,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,1.1819321,0.03459142,1.5154380598776067,0.06224812465923044
41901,SIDM00971,PD173074,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7858107,-0.03972614,-2.3636747475066064,-0.021296801003557977
71732,SIDM00893,Olaparib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.517278,-0.029588476,1.7256547085207699,0.04161840304956759
79672,SIDM00875,Luminespib,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.50990975,-0.04649479,-0.7522010307073269,3.3212829744464766e-05
71738,SIDM00971,Gemcitabine,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.0725669,-0.041412946,-0.16244613490695342,-0.01306722284584802
23987,SIDM00878,Alisertib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-0.5942909,-0.050730564,0.11305787751850559,0.05663207384948079
53634,SIDM00628,AZD8055,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.53001994,0.04151354,-0.7429046598828817,-0.03216906541501978
55304,SIDM00411,LGK974,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.33024642,0.010626455,0.7877353107487131,0.04639883907241171
95507,SIDM00834,MK-2206,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,White,66.0,2.8639655,0.18995069,0.7321045948952818,0.08980616233427492
33159,SIDM00954,Docetaxel,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.810163,-0.05926583,0.298035777095541,0.02843095984941557
95318,SIDM00834,Palbociclib,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,White,66.0,-3.3514469,-0.10808557,-1.9847206119358631,-0.09424257989690424
73857,SIDM00529,Nilotinib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,2.147654,0.103617474,0.9161443841787265,0.12165610188576738
78740,SIDM00779,LGK974,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,1.7268974,0.09752789,-0.7902138249429704,0.013470190589675208
36967,SIDM00971,JQ1,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.055565,0.11680033,0.886118854113626,0.029402652763545038
85121,SIDM00097,ZM447439,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1282916,-0.08234683,-1.1055402636736218,0.0008578717148780741
3118,SIDM00193,Nutlin-3a (-),SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,53.0,-0.2216441,-0.003813372,2.202501463113413,0.08737891093021131
48548,SIDM00097,NU7441,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.38978833,0.013548203,1.9244018810367425,0.10318748359205805
48063,SIDM00893,Doramapimod,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,4.001673,0.24723914,-1.1458142344530635,-0.0249600091769246
44376,SIDM00531,Crizotinib,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.57851034,0.068017066,0.3955723668983656,0.06169054321035082
93159,SIDM00673,Doramapimod,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,1.9099338,0.047955837,2.425774433701428,0.07551715214229354
102186,SIDM00875,Alpelisib,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.9841235,-0.08012194,-0.24450423800744545,0.008711008141017645
87036,SIDM01233,Linsitinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,3.083778,0.12650242,1.045902952115201,0.11788964236572287
86353,SIDM00776,Palbociclib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,65.0,-0.80857486,-0.028577102,0.2729880631455163,0.023500032642737815
50441,SIDM00834,5-Fluorouracil,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,White,66.0,-0.8951279,-0.050766595,0.5260656589348084,0.09592992456855393
7049,SIDM00834,AZD8055,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,2.813948,0.20543148,0.8684632883218879,0.09257957095475808
97062,SIDM00878,Navitoclax,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,0.22858673,0.0057726675,0.17962588427007203,-0.010856074731639537
55560,SIDM00146,Afatinib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,1.3376365,0.11664063,0.532344520084218,-0.0035303323923348874
28754,SIDM00193,Navitoclax,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.2472333,-0.07187611,0.5842356673366135,0.03878130413835798
90385,SIDM00193,Crizotinib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,53.0,1.0792121,0.06272834,1.4944068904026138,0.09874287191625765
63321,SIDM00531,Sorafenib,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.8666082,0.10501384,1.255760292771258,0.05598703030881232
6764,SIDM00893,Alpelisib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.5510935,-0.03646378,-0.22758183123798154,-0.01627607710698825
34219,SIDM00866,Tozasertib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,52.0,-1.4686174,-0.07830922,-0.8386195569947186,-0.006163678117643532
50479,SIDM01233,MK-2206,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-1.6800028,-0.108760834,-0.24008353908913688,-0.03688219204269025
47011,SIDM00779,Taselisib,LGK974,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-1.2981132,-0.10692643,-0.6854364024426832,-0.058856353070947325
77703,SIDM00332,BI-2536,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7461555,-0.055845786,-0.6058118549959643,-0.07135610030097402
6800,SIDM00782,Afatinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,Unknown,72.0,2.2160478,0.1840813,0.9443066783890102,0.0943688021575542
51289,SIDM00332,Palbociclib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1702899,-0.04087809,-1.0309784868222256,-0.0809037001768203
42009,SIDM00834,AZD4547,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,1.5145807,0.04038342,1.4671056847781043,0.03494835855012263
15397,SIDM00531,Linsitinib,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.9200723,0.25358108,2.5326040618360706,0.18503922036165216
105618,SIDM00531,Paclitaxel,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.0318983,-0.093841225,-0.058213691575941875,0.01164336246466564
10441,SIDM00893,5-Fluorouracil,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.44873968,-0.01888584,-0.8542533254137404,-0.007384140239714947
47460,SIDM00529,PD173074,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-1.2040092,-0.061143924,-1.2544539884830626,-0.01667298104896836
89375,SIDM00834,Taselisib,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,0.6886643,0.053196132,-0.8462687415289663,-0.04793902899989824
103766,SIDM00866,5-Fluorouracil,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.0056795,-0.040396113,-0.5329618223403263,-0.016352284435513356
63622,SIDM00359,AZD8055,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.30255866,0.023889296,-1.2115462598756506,-0.07430827767243675
23384,SIDM00875,Paclitaxel,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.054467,-0.18334907,-2.8807878666857403,-0.21600181302989838
75758,SIDM00660,Navitoclax,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,32.0,2.6579173,0.22718047,0.4318756063861026,-0.007597211655943602
60764,SIDM00359,Afatinib,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.6442633,0.131721,1.372038669706731,0.07705102211602093
35719,SIDM00660,SCH772984,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,0.88727695,0.039784737,-2.1749766932798282,-0.03869158320231832
81689,SIDM00893,Crizotinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.0620288,0.042963173,2.3115560863491527,0.08283851775218212
68909,SIDM00878,Camptothecin,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,3.4674535,0.047980215,4.592952079447688,0.14832135375106126
101696,SIDM00875,Temozolomide,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.52436876,0.012734911,0.5569798737021362,0.008041508385850753
48329,SIDM00301,5-Fluorouracil,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.179097,-0.15189111,-0.4535262538674506,-0.023993427988848334
44585,SIDM00529,Alpelisib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-2.619336,-0.1074231,-0.9127456120144364,0.03383825753628891
8744,SIDM00146,Temozolomide,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,5.0354614,0.17178099,1.4023014284589375,0.016143013367226244
56329,SIDM00660,Afatinib,Taselisib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,32.0,-0.5667685,-0.061982192,0.21469170162998413,0.02436404587313705
54389,SIDM00628,ZM447439,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,0.55955833,0.04689588,-0.11212977753610728,0.021308723509203684
75303,SIDM00332,Nilotinib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9575225,0.05856107,-0.9628338495399887,-0.02854714689109715
73588,SIDM00301,Linsitinib,MK-1775,Pancreas,0.2,Pancreatic Carcinoma,Male,East Asian,50.0,-1.5168018,-0.05202906,1.6704874840568011,0.05800514235567426
85105,SIDM00411,Olaparib,Ruxolitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.7291916,0.021382783,0.5808161115363429,0.020311454763290507
8487,SIDM00774,Afatinib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.22324273,-0.015971242,-0.446956917426138,0.015175311617509851
107825,SIDM00878,Linsitinib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,1.7696157,0.098429196,0.602729468397888,0.054095766500640644
98290,SIDM00834,Trametinib,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,1.6641532,0.036109705,0.36380192402892647,-0.007828229394760395
23849,SIDM00130,Gemcitabine,Oxaliplatin,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.0318989,-0.068376504,-1.8563650230662592,-0.08066092428003407
70242,SIDM00529,Doramapimod,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.55175567,0.01942316,0.7310539429257398,0.07591945464373773
50212,SIDM00774,Dabrafenib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-0.28511468,-0.0086757215,-0.25780619979174946,-0.008696866753030538
19357,SIDM00866,RO-3306,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-3.4887269,-0.1262054,-0.6110599610618569,-0.03035045326924122
72610,SIDM00776,Palbociclib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-1.7059175,-0.03871117,-0.0982832473003908,0.007823620124525551
38605,SIDM00146,Temozolomide,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,1.064133,0.034226365,0.7974715202708857,0.03981433705323741
32993,SIDM00301,Erlotinib,MK-1775,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,3.498113,0.11182929,3.521932956602298,0.11115718946858132
46349,SIDM00878,AZD8055,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.88325644,-0.083651684,0.017077296225732626,-0.033226587517688186
6115,SIDM00146,PF-4708671,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.8083409,0.055026088,2.056872665859199,0.08111201025131172
22696,SIDM00628,5-Fluorouracil,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,2.6934311,0.19446696,-0.10652124882011937,0.024671497468002856
32202,SIDM00776,AZD8055,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.4292362,-0.08885859,-0.8165578000647999,-0.0143451482115037
23836,SIDM00146,Alpelisib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.4473014,0.15970512,1.5018696460661443,0.16998357462224598
107447,SIDM01233,Dabrafenib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,0.40454766,0.013639327,-0.2536797945539902,-0.018319849698228027
50913,SIDM00776,MK-2206,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,1.9358509,0.15539525,0.391365410183414,0.036044665671900046
59576,SIDM00878,5-Fluorouracil,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.7127379,-0.08163231,0.13095151221595544,0.02417325827539992
51889,SIDM00776,MK-2206,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.9331571,0.16042674,1.88163636522123,0.1018718383242772
80111,SIDM00878,Alisertib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-1.4645101,-0.055059675,-1.9339566822421201,-0.10002910569993047
93518,SIDM00866,Pictilisib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.09799958,-0.008143454,-1.0310152510803507,-0.02247141728824891
76099,SIDM00778,SB505124,Afatinib,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,-0.6209026,-0.025331395,-0.7646964404489525,-0.06001729333378257
48163,SIDM00660,LGK974,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,32.0,-1.382614,-0.056489516,-0.29664570001134505,-0.012594358343914976
53413,SIDM00779,BMS-754807,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-0.9468777,-0.018481782,-1.2395322676837346,-0.0534169693358069
6098,SIDM00778,AZD7762,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,4.2555885,0.21802433,3.1913718375307027,0.15034618234564104
2783,SIDM00673,Dabrafenib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.626161,0.034779593,2.978589503284499,0.07805424523143983
9467,SIDM00866,Docetaxel,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-4.9403625,-0.2845469,-1.5277002229587362,-0.10985143124222767
96736,SIDM00878,Nutlin-3a (-),PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.59935814,0.041687075,-0.013972674473645943,0.014729653353624536
102140,SIDM00782,MK-2206,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,Unknown,72.0,1.2956167,0.10802507,0.7853494680554608,0.07984786410335948
13345,SIDM00193,MK-2206,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.3981569,-0.09183229,0.35896401066872713,0.06017663315296681
64851,SIDM00866,ZM447439,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,0.8850037,0.06792706,1.1561692241348813,0.04724696225547018
79884,SIDM00332,Olaparib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,2.6303968,0.14556417,1.585365950207196,0.0534946643456029
27171,SIDM00146,NU7441,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.5034154,-0.046289686,0.6900349300233128,0.044696654797582586
63525,SIDM00301,Palbociclib,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,-3.0876603,-0.19715156,-1.8987273994296587,-0.12434667148328708
108131,SIDM00332,Afatinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.2512672,-0.10528608,0.7710258437409161,0.1590869355789061
4027,SIDM00301,Irinotecan,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.3565718,0.17787167,2.491420702768997,0.17225265417896468
28070,SIDM01233,Taselisib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,72.0,0.56409836,0.02854744,-0.8169871259323361,-0.008332967788546348
21757,SIDM00954,Bortezomib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.0,-0.28052914,-0.016067557,-0.8654818538352789,-0.058092892047702516
52264,SIDM00971,5-Fluorouracil,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.10007006,0.0027535532,0.6501654341851006,0.04490411174078237
77938,SIDM00774,Dabrafenib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.8708906,0.07291729,-0.00833564862322685,0.039177680583863436
99139,SIDM00893,Nilotinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.7445035,0.027731514,0.6993415752449825,0.07739352213081264
86275,SIDM00875,GSK269962A,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9483364,0.06993734,0.19169918101200084,0.02453912786086332
99105,SIDM00529,PF-4708671,Trametinib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-1.742028,-0.08158158,-0.9882994200929348,-0.015857449279863413
82567,SIDM00673,Nilotinib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-2.6263835,-0.11041404,-1.0824698714147607,0.0019056330785558505
92430,SIDM00673,Trametinib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.3684348,-0.11132468,-0.4614392211379491,-0.03781395214949559
75379,SIDM00628,Palbociclib,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,4.226907,0.20771219,1.2767708253520125,0.08560731426024981
46065,SIDM00097,AZD8055,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.99650866,-0.06502268,2.340237406662106,0.20374642167807955
68837,SIDM00866,Alisertib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.4317205,-0.108806364,-0.9700849513259779,-0.08559805432531417
34058,SIDM00893,MK-2206,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.3378326,-0.11555333,-0.568075261312143,-0.0917395837877136
8853,SIDM00893,Taselisib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.5873266,-0.03360157,-0.3417832356563567,-0.06607031295600199
80738,SIDM00878,PF-4708671,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-1.1409974,-0.045675676,0.9445358873765203,0.0500815327469058
78301,SIDM00359,Navitoclax,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.3654024,0.0226458,0.8820455104437552,0.038768719349661376
68284,SIDM00875,Alpelisib,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6022907,-0.10731416,-1.5260803336592275,-0.04500036656469907
68185,SIDM00778,AZD8055,MK-2206,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,0.47401932,0.024918241,1.9935990158814614,0.0586554055118528
10511,SIDM00774,NU7441,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-0.8678031,-0.044755224,-0.6068141742810398,-0.011770624062356617
79704,SIDM00628,Temozolomide,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,0.69016004,0.025818618,0.008341237623827796,0.032742350619867404
34710,SIDM00531,Olaparib,Dactolisib,Pancreas,0.0125,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.3486866,0.018529968,0.1855927342264509,0.02601068356582496
75033,SIDM00878,RO-3306,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.0089039,-0.06457872,-0.990199331814162,-0.03823094673677621
80331,SIDM00971,Crizotinib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.190079,-0.061964348,1.8184683746698986,0.09758478392996946
107454,SIDM00097,AZD7762,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.4573555,-0.11603048,-1.7297219264084143,-0.10303990139102069
6970,SIDM00954,Paclitaxel,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-5.656334,-0.4035281,-3.2862012939683556,-0.24522479570650169
16360,SIDM00866,Taselisib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.6972986,-0.14924744,-1.6353469117030404,-0.06745741158603986
8898,SIDM00673,MK-1775,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.9574571,-0.09268269,-1.4349827085637317,-0.07953008660782686
91006,SIDM00097,PD173074,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9181726,-0.08470903,-0.22781118833192415,-0.049156977733955116
36961,SIDM00301,Cisplatin,Lapatinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-3.002909,-0.25252473,-0.5133100724256251,-0.038158439914205235
76476,SIDM00628,AZD7762,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,3.7357564,0.2899847,-0.06722216510391386,-0.010989758597772343
84108,SIDM00782,5-Fluorouracil,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,Unknown,72.0,-1.4257699,-0.04567938,0.7869984197064296,0.03754565879476169
89531,SIDM00097,5-Fluorouracil,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3703427,-0.060862724,-1.6561544664783676,-0.09902638371456925
81075,SIDM00146,Palbociclib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.9255235,0.069189236,-1.5607571094589745,-0.043811688808852896
107938,SIDM00673,Temozolomide,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.097502545,-0.0021586204,0.6195961069182353,0.025188100200814013
32470,SIDM00875,OSI-027,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3067745,0.1264941,-0.6635539399227008,-0.04878312813489299
51354,SIDM00529,PF-4708671,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,-2.0895357,-0.095935084,-0.9702987544566295,-0.04969121296382993
62934,SIDM00359,Crizotinib,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.6538143,-0.05663434,-1.5186605753809266,-0.029815710165942103
101639,SIDM00359,Olaparib,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.9809374,0.026781213,0.7386516294922122,-0.019361951666845394
83101,SIDM00529,Linsitinib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,0.3645902,0.016494684,0.3239891938786469,0.08170122948008605
22338,SIDM00628,OSI-027,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.3132977,0.09210961,0.3801560195136938,0.09296123634273694
19910,SIDM00332,Luminespib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6490502,-0.12999476,-0.40643290192230186,-0.040417415302425895
42689,SIDM00875,Sorafenib,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6604481,0.07113836,-0.6096489802621513,-0.023112119842043928
15335,SIDM00971,Venetoclax,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.31281194,0.0053536715,0.016156181325630632,0.005845409843936142
72714,SIDM00776,SCH772984,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,1.4124544,0.1013416,2.3491066923923203,0.14675516014458795
2984,SIDM00834,Palbociclib,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,0.95431966,0.07257997,-1.6729674402152255,-0.06800653280987069
13525,SIDM00778,Trametinib,MK-2206,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,0.7148575,0.01789407,1.5713616296620874,0.049192744907784025
103759,SIDM00776,Linsitinib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-0.633437,-0.03933031,2.4405333559489155,0.1440447920900915
2714,SIDM00878,Sorafenib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.7651529,0.060314193,0.4662880276346308,0.011686069526348906
30939,SIDM00332,Nilotinib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8387155,-0.058576547,-0.8661221266287598,-0.04786942365984415
45253,SIDM00866,Docetaxel,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-2.0323663,-0.14295335,-3.1087371816165685,-0.21975997470838238
102822,SIDM00875,Alisertib,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.25647783,0.023943756,0.20586330042137785,0.00973094781837478
19293,SIDM00146,RO-3306,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.91264796,-0.064330585,0.25060123898078057,0.01872327399452068
103718,SIDM00130,MK-1775,AZD7762,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.4644629,0.12248628,0.7665094951935285,0.06811471120596434
3903,SIDM00097,Alisertib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.4470956,0.0594838,1.4106975311714554,0.06987385870439346
73764,SIDM00866,Nutlin-3a (-),Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.8611172,-0.022792814,1.87787859009879,0.030425020915728455
77969,SIDM00411,LGK974,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.7450943,-0.02707691,0.2719963653206739,0.004363739069330721
99556,SIDM00778,Taselisib,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-1.2628286,-0.07626301,-0.9265831134089779,-0.048967686280204106
26387,SIDM00332,Linsitinib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.99301976,-0.03232017,1.6211021986197711,0.028860925790599103
37827,SIDM00529,AZD7762,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-0.8367147,-0.0630867,-2.2546916870361358,-0.15887991353979136
42496,SIDM00628,Alpelisib,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,3.3551657,0.20970452,-0.028235917229465283,0.10533791823969883
86150,SIDM00673,KU-55933,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.64327615,-0.037402593,-1.6984900386740702,-0.075231854137193
69489,SIDM00531,SCH772984,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,6.458632,0.6787315,3.466077644527467,0.20727094864387774
40248,SIDM00529,KU-55933,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-0.62706757,-0.010672888,1.3008392392333115,0.04903529508648777
23487,SIDM00878,Paclitaxel,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.1711277,0.10787762,0.9213953722171094,0.06233350095864927
87211,SIDM00954,BI-2536,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-1.9957161,-0.057967145,-2.041377482314272,-0.07672587817458494
11305,SIDM00332,AZD6482,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5453656,-0.039644442,0.3773125660492855,-0.010147866562442674
50639,SIDM00529,GSK269962A,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-3.2173743,-0.143266,-1.0157756496996877,-0.037180648305878194
29952,SIDM00866,Nilotinib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-2.6584673,-0.13776065,-2.038513950144794,-0.06244008831312607
84327,SIDM00782,Camptothecin,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,3.3572083,0.236439,2.3229590998084713,0.17244365723135407
2899,SIDM00779,SB505124,Vinorelbine,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,33.0,-0.15390797,-0.014461355,-1.1887858754397134,-0.06813171800496375
56547,SIDM00878,PD173074,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.4111216,0.13425204,0.05858804718605347,-0.018640689742845013
67649,SIDM00954,Paclitaxel,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-1.252501,-0.074548505,0.032554509908482646,-0.003651505631807598
68276,SIDM00875,Pictilisib,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0823002,0.100906104,0.9287735196903718,0.11971107151256553
86019,SIDM00875,Paclitaxel,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.052169025,-0.0030039998,0.37576326686096656,0.006679948808145303
45646,SIDM00097,Temozolomide,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.19992718,0.0035366847,1.3163308346238765,0.010856047658746027
7401,SIDM00628,NU7441,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,0.2154945,0.015442195,-1.0739265244173375,-0.07336366215247904
73903,SIDM00866,Doramapimod,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,1.7174199,0.04713647,1.315579432433375,0.05902380459831414
66507,SIDM00332,Ribociclib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.181375,-0.07823802,-1.2016620325742549,0.0024461068939163645
58864,SIDM00875,AZD6482,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.4705806,0.03821399,-0.09550775618347132,0.015611801873538535
45801,SIDM00660,Palbociclib,Navitoclax,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,32.0,1.4704877,0.0757214,0.1069039787173424,0.014014741374226909
27786,SIDM00778,Afatinib,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,1.8900666,0.061589137,0.729657772539087,0.03742221642362648
23472,SIDM00146,Tozasertib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-1.4654671,-0.09044866,-0.3255706527216666,0.025116885005741715
106092,SIDM00529,AZD8055,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Black,44.0,-1.2975036,-0.096367106,-0.8935505104272295,-0.10014301427957108
10445,SIDM00130,Navitoclax,Irinotecan,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,4.985209,0.13785206,3.1021887244599005,0.194852218510153
1077,SIDM00146,Uprosertib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.3613231,-0.08120334,-0.6040088057224158,0.05368684222473421
11149,SIDM01233,Olaparib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,2.8016524,0.09405904,0.8955866079600286,-0.002424345489360874
19517,SIDM00774,PD173074,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,1.3134555,0.13093306,-2.016211726502721,-0.07707506225374255
64600,SIDM01233,Linsitinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,5.049754,0.09366655,2.0373869350753466,0.05992030580002303
34632,SIDM00782,Taselisib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.4906431,-0.12228527,0.19756657590134227,-0.010302360347556635
32810,SIDM00130,Sorafenib,MK-1775,Pancreas,0.2,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.5224901,-0.042255037,-1.1242711637890206,-0.05515750933436517
4044,SIDM00875,Alisertib,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5965226,0.050911907,-0.9012110820880544,-0.02032038955885377
108108,SIDM00411,Oxaliplatin,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.7870083,0.02501322,-1.4268723796984677,-0.022228279117688904
81706,SIDM00866,BI-2536,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-3.0859616,-0.20135166,-1.978371026055972,-0.0937488782835896
61118,SIDM00332,Gemcitabine,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.89727086,-0.06612954,-0.04648509331323638,0.021963684470628773
72540,SIDM00193,LGK974,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-0.8640016,-0.04771154,-1.5044226100581992,-0.04715045549917211
25147,SIDM00866,Pictilisib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,1.6287906,0.077405974,-0.08536299822612665,0.033584143165809516
83201,SIDM00359,AZD8055,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.1182423,-0.098923355,-0.27167354060347026,-0.012018762290022368
52227,SIDM00193,SB505124,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,0.28935662,0.022661155,-0.8003530614680401,-0.05323768096295062
80909,SIDM00971,Vorinostat,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.9287376,-0.077254914,-0.803359267980024,-0.023771136354642446
23732,SIDM00332,Alpelisib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7931019,0.06015967,0.2919421119155796,-0.012751635305601996
27519,SIDM00779,AZD8055,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,0.71445054,0.06508374,-0.7634604517957491,-0.056207448239773465
71204,SIDM00097,Nutlin-3a (-),Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.322905,-0.056873202,0.8705634397222378,0.06802606976305618
47226,SIDM00529,AZD6482,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Black,44.0,0.12936893,0.0039402624,0.0755728641529259,-0.003962618585069852
15445,SIDM00097,Bortezomib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.63393575,-0.04252169,-0.6300206411266017,-0.08089927319846162
76673,SIDM00097,Camptothecin,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.576422,0.13175204,1.2113416029988964,0.09526684302081558
65662,SIDM00411,Erlotinib,Taselisib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,3.9006598,0.18525541,1.8028283172179875,0.13119925969500823
68548,SIDM00971,Doramapimod,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.7084711,0.027910043,-0.06693653963193238,0.003083161928262954
88938,SIDM00531,SCH772984,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.91427,0.16537659,-0.4719483203410907,0.02909432568588581
13693,SIDM00875,Gemcitabine,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-4.154348,-0.020264056,-2.5686669432285254,-0.06969111775726736
88660,SIDM00660,Navitoclax,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,32.0,2.4042482,0.17162482,1.7963444823531047,0.04138690595235481
25799,SIDM00834,SB505124,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-1.1691834,-0.08456423,-0.8492106456416917,-0.0625153111800802
44870,SIDM00875,Temozolomide,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.5756006,0.015822217,2.605101723969413,0.013947049364419584
44513,SIDM00954,NU7441,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.9975369,-0.0719405,0.9151051786223707,0.06383639172984261
79052,SIDM00971,PF-4708671,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.85230064,0.049200084,-0.5485063791511745,0.05658724349649475
48459,SIDM00778,Trametinib,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,69.0,-2.1173916,-0.07656297,-2.3661597431471466,-0.108704079207858
12002,SIDM00875,Wee1 Inhibitor,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5571985,-0.035099804,-2.6341126126137224,-0.1318213218894072
4150,SIDM00332,Alpelisib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.71856004,-0.04816918,-0.5960659471673789,-0.06702293115619004
97745,SIDM00529,Paclitaxel,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.64359474,0.06549081,0.8600958854817484,0.05959138442839676
108362,SIDM00878,AZD7762,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.7717477,-0.020794602,0.012433866459350209,-0.007871425540260052
66133,SIDM00660,Vinorelbine,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.88630944,0.08357331,1.223778764559694,0.09907553789304074
24809,SIDM00146,Crizotinib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.8961281,-0.078150675,1.166326756151679,0.1196922108036322
35721,SIDM00673,Pictilisib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0632567,-0.112771705,-0.7846592393909209,-0.04172029060955816
87503,SIDM00529,Ribociclib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.82839394,-0.021164225,0.7108858495735395,0.0703786638786315
82051,SIDM00660,Navitoclax,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,32.0,1.8938619,0.15944892,1.302027141922939,0.03532225567907768
106550,SIDM00893,Sorafenib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.3989196,-0.02189028,-0.9441275396136978,-0.04199662518218325
94995,SIDM00954,Axitinib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-0.28007558,-0.021021558,0.19007095670973964,0.058020087886665885
26551,SIDM00193,Nutlin-3a (-),Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.23726355,-0.00389963,0.2935394496472021,0.03035167495279341
48434,SIDM00673,SCH772984,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.770568,-0.1319916,0.742985299324667,0.09521692680474506
70543,SIDM00971,AZD6482,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.1242987,0.04076387,-0.48262698165078893,-0.00872093254815364
45686,SIDM00130,SCH772984,Erlotinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.4181025,0.11940025,1.3405012962468312,0.07005164506386809
80803,SIDM00875,KU-55933,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.0332062,-0.07485711,-0.6504661797865223,-0.030046253817890087
44450,SIDM00097,Docetaxel,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1217532,-0.042173073,-0.8005390346355441,-0.0642620591983154
25565,SIDM00776,Palbociclib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.3048706,-0.036581848,-0.22734406864760456,0.005678866614666501
47420,SIDM00097,Uprosertib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.6031816,-0.18886547,-0.6857581669890186,-0.04766325240642868
61212,SIDM00529,Lapatinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-1.3341194,-0.08027471,-0.7809573622083522,-0.042969797288853875
25642,SIDM00146,Pictilisib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.2321217,0.105593316,-0.707613411318084,-0.0214094234259376
17761,SIDM00628,Camptothecin,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,2.541572,0.20961681,2.1341211843805374,0.19424228464571452
4058,SIDM00893,MK-2206,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.3149779,-0.12945653,-0.8629008065802639,-0.10889398878081025
56194,SIDM00332,Luminespib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.640633,-0.12874894,0.8271617686458933,0.042972073868625206
21954,SIDM00529,AZD6482,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.7151654,0.056022562,0.21249294701439703,0.000632167971367025
68129,SIDM00774,Palbociclib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,0.9390078,0.038099717,0.6216238806970406,-0.006501389787992009
20155,SIDM00875,Crizotinib,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.2863262,-0.030484717,-0.7551383939864723,-0.09874267416242602
75581,SIDM00774,Dabrafenib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.2629399,0.043526422,0.639795313462316,0.03186327869876316
90574,SIDM00834,AZD8055,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-0.9303283,-0.062635906,-0.7787567709178045,-0.0065179111950711
15899,SIDM00878,GSK269962A,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.0130334,0.031189986,0.21527586342973,0.001738456945627801
70408,SIDM00779,Dabrafenib,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-2.2144096,-0.04925518,-0.6074867430853352,-0.009605444846383255
81635,SIDM00673,Alisertib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-1.5355798,-0.069347695,-1.1408519869804628,-0.08012103138118568
62482,SIDM00875,Camptothecin,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.42480072,-0.04742546,-1.5057330485586484,-0.05175277975754985
48732,SIDM00954,Alpelisib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,2.4635835,0.18792853,0.42320124542840304,0.04951981987837677
18896,SIDM00893,Paclitaxel,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.3863709,-0.029599367,-1.0555462881590347,-0.06111230630007955
37494,SIDM00893,Palbociclib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.5082971,0.083114915,-1.1661174249205641,0.005242552384540403
21070,SIDM00866,Nilotinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,3.071646,0.144305,0.4902098700860009,0.08436835306578654
36861,SIDM00673,MK-1775,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.49033257,0.025295552,-0.5677779921952872,-0.02191876901699804
265,SIDM00776,Taselisib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,1.9521201,0.06648949,-0.6646547268235065,-0.012973207592473054
59146,SIDM00774,Nutlin-3a (-),Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,0.35300723,0.010892717,0.7863395128296728,-0.010101813268392672
61177,SIDM00628,Linsitinib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,1.8261442,0.11983003,-0.19738461721832534,0.033686091054092995
95679,SIDM00779,Nutlin-3a (-),Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-1.6537924,-0.059156656,-0.2960303068068327,0.04379826849338743
81503,SIDM00971,BI-2536,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.65561974,-0.03383271,-0.8157409983505813,0.035216843015946915
21486,SIDM00628,OSI-027,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.8184052,-0.06968528,0.24095764057724814,0.02779302200569646
42260,SIDM00529,Alpelisib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-0.4800995,-0.027193312,-0.07181911908436753,0.03122971124223952
5110,SIDM00971,Trametinib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.2645037,-0.019131364,-0.46559610545148067,-0.013286047923204826
77577,SIDM00628,MK-1775,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,Black,51.0,0.51335436,0.04946765,-0.03845084591059286,0.010265960980398229
22114,SIDM00971,Paclitaxel,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.3952199,-0.040078864,1.3446849144821895,0.07248253055050657
71825,SIDM00332,Navitoclax,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5093372,-0.052369736,0.42259351075419627,0.06376274496106084
64739,SIDM00660,Crizotinib,Trametinib,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,32.0,1.3602146,0.08519645,-0.40992339742827527,0.018909451647071418
103802,SIDM00660,SB505124,Trametinib,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,32.0,1.184352,0.092224464,0.10974058518809292,0.006187391885999286
81429,SIDM00529,Wee1 Inhibitor,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.9604871,0.07002045,-0.04761211449479867,0.024081396779578636
78325,SIDM00774,Nilotinib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.417118,-0.028718833,0.8515133155960638,0.05959944105790418
3714,SIDM00097,Linsitinib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.764549,-0.10676333,-0.6958569772542521,-0.034070704587718346
90026,SIDM00097,Temozolomide,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.55360246,0.0070235687,1.1446982225901476,0.0031611641239600464
90306,SIDM00193,SCH772984,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.1200018,-0.14612618,-0.6113562052033549,0.05383613645212707
75706,SIDM00971,Paclitaxel,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.046876,-0.070243694,0.806564493981009,0.028931181420435034
67411,SIDM00954,Trametinib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,4.309968,0.16483608,0.5724618849496504,0.05172008246763594
36245,SIDM00875,Lapatinib,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8358133,0.17764416,0.6511417562324875,0.07502990825149898
25903,SIDM00529,AZD7762,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Black,44.0,-0.61879116,-0.04415388,-0.4123327105369842,0.002327002221795707
9121,SIDM00673,MK-2206,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.7385594,-0.14803754,-0.8027843887969327,-0.12308008898197352
93745,SIDM00332,GSK269962A,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.822321,0.12279293,1.555684439524362,0.052469984195351184
43032,SIDM00954,Cisplatin,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,1.1842682,0.0481804,0.5218419847055129,0.06583841880325143
1134,SIDM00193,Dabrafenib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.46508685,-0.006797702,1.734506157774381,0.051061754783012954
5044,SIDM00146,Olaparib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,2.4394584,0.14251804,-0.251477097750479,-0.006394158947021182
7107,SIDM00893,Trametinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,6.290778,0.22257063,1.73105568034571,0.14854625101695293
70979,SIDM00332,MK-2206,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3268491,-0.13259253,0.15300934204566938,0.022286672376088206
21103,SIDM00779,Olaparib,Taselisib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,1.4270289,0.024111668,1.7558697493428876,0.06729869079821241
91758,SIDM00097,Dabrafenib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3333527,-0.058718447,-1.0388188855873353,-0.07647574904690994
62432,SIDM00954,Pictilisib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.71401554,-0.05304513,-0.3468312442409762,-0.01545784776189646
27604,SIDM00359,Afatinib,AZD4547,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.17389801,-0.014869003,-0.04707803060318089,0.0008728391302760673
106904,SIDM00628,BI-2536,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-3.4056637,-0.09676478,-4.528992594734787,-0.07944331888842301
55974,SIDM00774,Temozolomide,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.7820337,0.011311201,1.1523939415182949,0.013496164551367588
3215,SIDM00878,Taselisib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.9271438,-0.093950875,-0.8659519302220552,-0.02390572449386685
103165,SIDM00130,Sorafenib,Trametinib,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.2504206,-0.01662014,-0.7882153567203204,0.004532841800265772
52332,SIDM00529,RO-3306,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,2.4667873,0.13235551,0.8803613740956571,0.03787973501068759
71238,SIDM00893,Axitinib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.864627,-0.07741446,-1.8958355667048346,-0.049738924096385514
19385,SIDM00875,AZD7762,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.537646,-0.029135283,-1.58706242132623,-0.07172865223270412
39507,SIDM00531,5-Fluorouracil,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.99127126,0.043518495,1.7213023092470046,0.07515656972251697
28696,SIDM00875,Afatinib,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4089783,-0.12703675,0.18889258035170325,-0.05202420082498676
17264,SIDM00660,Navitoclax,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,1.8697678,0.18005762,0.4896602528511243,0.041942404025319374
79415,SIDM00778,Palbociclib,5-Fluorouracil,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-2.8952672,-0.0706185,-1.1601975098608839,0.0039188788267011995
79050,SIDM00774,Nutlin-3a (-),AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,0.3789769,0.011630721,0.6404517651185603,0.05562972508526139
21265,SIDM00097,MK-1775,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.9181391,-0.061717376,-0.3930167322437644,-0.04643775654473156
81060,SIDM00776,Nutlin-3a (-),Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.0391283,-0.06062723,1.6285208285988417,0.08167893407635875
4855,SIDM00529,GSK269962A,MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-2.312763,-0.15071687,-0.3371348671469027,0.033222980954180865
18106,SIDM00774,Cisplatin,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,1.288038,0.04001461,1.4547249433709915,0.10773270797962237
62013,SIDM00097,Wee1 Inhibitor,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.6359577,-0.15951027,-0.8943932056196814,-0.09531135207932963
37897,SIDM00411,Paclitaxel,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.2362323,0.099692024,0.23862276021542914,0.039883123634553624
16388,SIDM00893,RO-3306,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.16810018,-0.011270573,-1.2738590741411115,-0.0744176969666497
3026,SIDM00660,Nutlin-3a (-),AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,2.1959324,0.0519372,2.359897312383114,0.07644833487234153
96311,SIDM00774,Nilotinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-2.0652304,-0.13996696,-0.45590846293976395,-0.027413484069870153
98610,SIDM00866,Linsitinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.9974658,-0.09810974,-0.4299263429492636,-0.008811855634543026
39042,SIDM00628,Crizotinib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.41436815,-0.03830469,0.08349114848337051,0.02645436610527656
80123,SIDM00673,Pictilisib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.0815202,0.090810046,0.8646210586681524,0.05758996125581696
107952,SIDM00660,Palbociclib,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,3.2536216,0.21226291,1.7758702369580974,0.06054780357341637
105840,SIDM00875,Dabrafenib,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.9449381,0.12452188,-0.14409571635605792,0.0110561395034301
88692,SIDM00146,NU7441,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.5109517,-0.04573021,0.6487350504714766,0.03855417487401282
51063,SIDM00971,Nutlin-3a (-),AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.056427,-0.05081733,-1.7877026601048163,-0.025362431597046837
9060,SIDM00531,LGK974,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.615763,-0.04916287,-2.8467030031751936,-0.09306210989248181
100091,SIDM00893,Luminespib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.803056,0.1683341,-1.3611880722459349,-0.058225301213430086
25391,SIDM00097,Camptothecin,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.45575723,-0.015991855,0.7205164064599646,0.06051176298041871
53217,SIDM00301,Paclitaxel,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-4.8718796,-0.17320304,-5.171840691289556,-0.2726639011809406
29008,SIDM00097,Doramapimod,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.92407715,0.02975118,1.0149649639444407,0.026853207622240916
74392,SIDM00878,MK-2206,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,2.118348,0.18762693,0.9607202527928878,0.04759686857933717
28809,SIDM00097,Olaparib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.67174506,0.017491953,0.7681120165779444,-0.00880444340306087
73231,SIDM00866,Nutlin-3a (-),Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,52.0,-1.0718063,-0.030700099,1.3964381819691967,0.019769953935864844
45392,SIDM01233,AZD7762,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,1.6685688,0.050703615,2.280957238265416,0.05910163292546073
78635,SIDM00971,Gemcitabine,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.46192002,-0.019688893,0.5230482245925037,0.03607569818723646
791,SIDM00893,Navitoclax,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.7105207,0.24412523,1.2286723286846648,0.023037997130385564
92416,SIDM00146,Alpelisib,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.8946941,0.1096704,1.2067485143844914,0.05422145575364711
82456,SIDM00411,OSI-027,Oxaliplatin,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.2448258,-0.11059891,-1.826458857852201,-0.06559657625362522
10810,SIDM00332,Taselisib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9904336,-0.09228466,-1.2458762481090073,-0.04633126497250463
58398,SIDM00776,MK-1775,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.035032637,0.002404949,-0.3751854408418529,-0.03027680557210615
78198,SIDM00097,Afatinib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.57112736,-0.041472238,0.05162327094378463,-0.020267624222340207
74806,SIDM00332,Alisertib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.69174284,-0.037426937,-0.04119765182141034,0.016769670208389223
8017,SIDM00971,Venetoclax,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.51027596,0.008413166,0.5461738885714694,0.026706096088109102
24953,SIDM00529,Sorafenib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.5283515,-0.113377504,-1.1034098206720835,-0.08266015783407976
827,SIDM00529,Pictilisib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-1.5126157,-0.091494195,-1.415895186910515,-0.024780438251863164
36805,SIDM00529,PD173074,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.7359316,-0.02348987,-0.6590380905102998,-0.010512694507356682
39005,SIDM00146,Axitinib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.8609928,-0.12513405,-0.21927105629001617,0.006925413573396869
77905,SIDM00778,MK-1775,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,3.2909524,0.15188146,0.9325327033054628,0.013899692888393045
35163,SIDM00893,Afatinib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.568297,-0.046909694,-0.2409398388804474,-0.0041412811461678
97232,SIDM00779,Vinorelbine,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,-1.0538988,-0.026773019,0.09727917454681242,0.038120710907375
59261,SIDM00875,Axitinib,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.81358653,0.060701806,-0.05649276417573256,-0.007302228477784894
2852,SIDM00778,Afatinib,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-0.88674575,-0.05662276,0.4052458304816159,-0.015997806323126355
50240,SIDM00411,Dasatinib,Palbociclib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.3435653,0.08654802,0.1558322396228948,0.00660927424800731
78405,SIDM00893,MK-2206,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.31237784,-0.03317875,0.2421380280176461,0.027130993716908754
104238,SIDM00954,KU-55933,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-2.3602028,-0.06903743,0.18735026249539546,0.065835239364265
100785,SIDM00411,LGK974,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,-2.4598074,-0.06072773,-0.6579247010770374,-0.03471984261132086
103452,SIDM00774,Olaparib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.0561467,0.079360805,-0.7688634822109238,0.067195036257208
30278,SIDM00971,Axitinib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.2162852,-0.09557548,-1.0272858444964987,-0.04954917195487265
80420,SIDM00778,BMS-754807,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-3.1087112,-0.1348527,-0.8405429142511,-0.06633208731378674
66189,SIDM00628,OSI-027,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,0.94626075,0.04552635,-1.2171889636221076,-0.06667594919855604
34740,SIDM00971,Camptothecin,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.9035934,0.048113722,2.172781012742306,0.060134870975895066
89215,SIDM00660,Linsitinib,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,5.5112963,0.5473226,0.8401292559227785,0.06007777807358968
39312,SIDM00971,RO-3306,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.8763964,0.10875324,0.08067197403898321,0.043114949050069316
92333,SIDM00660,Dabrafenib,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,-1.7764702,-0.108775735,-1.137842476471014,-0.04205760225863736
66750,SIDM00893,Navitoclax,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.5515718,-0.056901388,-0.6671022380461047,-0.08237010517257405
41049,SIDM00411,Erlotinib,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,3.3225431,0.13935995,0.6970002822624319,0.1288247343018101
10207,SIDM00359,LGK974,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.3160999,-0.043194216,-1.5606937833146504,-0.05677978920468135
97136,SIDM00971,MK-2206,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.62524,-0.07671407,-1.0177262779351797,-0.02685152228060662
55284,SIDM00878,KU-55933,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,3.7556849,0.195593,-0.14195119443017554,0.023167604897398955
34502,SIDM00782,Palbociclib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,Unknown,72.0,-0.49345928,-0.010175856,1.5250613775833328,0.009142751039178948
54380,SIDM00301,5-Fluorouracil,MK-1775,Pancreas,0.2,Pancreatic Carcinoma,Male,East Asian,50.0,-2.209234,-0.2400973,-0.3675163796231925,-0.027416530793107734
82686,SIDM00531,Dactolisib,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.5875111,0.10989833,-2.331577834673153,-0.07179525443819915
21768,SIDM00971,Alpelisib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1828238,-0.07710465,0.28130067668811776,0.03680508340484884
80750,SIDM00774,Nilotinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.0921209,0.08060102,0.862497745803833,0.07256802957561792
18837,SIDM00878,Nilotinib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-0.079324335,-0.006803825,-0.1833108002363867,0.024716333778686334
69592,SIDM00878,Alisertib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,-3.9121122,-0.22546966,-1.4150270663839912,-0.0721415818877953
21399,SIDM00878,5-Fluorouracil,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,-1.4295497,-0.08772739,-1.3524130254977704,-0.019081509456151387
16838,SIDM00097,Linsitinib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.2882539,0.014496259,0.49276663987848296,0.06505477534465431
28993,SIDM00411,Linsitinib,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.91657823,-0.03922499,-0.34092558616473917,0.027304505005995766
90548,SIDM00893,AZD7762,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.5291226,0.24978203,1.8373214475103647,0.15424943430009508
20525,SIDM00411,SCH772984,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,3.3274202,0.14148283,2.8012716960619994,0.1815328413436259
101948,SIDM00531,Dasatinib,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.1771078,0.2445143,-0.8116819792649641,-0.03148084373286271
8581,SIDM00878,Lapatinib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,3.9015973,0.33870953,0.5680804035101541,0.051455660953507364
82823,SIDM00954,Vorinostat,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.5931464,-0.049024727,-0.6712793391655922,-0.03988757111987112
67593,SIDM00673,Gemcitabine,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.111165136,-0.008352629,-0.5358333472429545,-0.018953163091462867
95997,SIDM00954,Camptothecin,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-0.29986042,-0.00797264,1.8492366041902701,0.08832432432699423
59339,SIDM00628,Afatinib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,2.3022568,0.13660817,1.0549902177439163,0.06738663315123548
21897,SIDM00097,Nilotinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8387448,-0.11879873,-1.993983350008414,-0.16433938680498505
22657,SIDM00774,Paclitaxel,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.57960695,-0.018576246,1.5095963118839917,0.12431156648285528
4166,SIDM00782,Afatinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-1.2368702,-0.09202986,0.03327424489059257,0.023195139839696313
106449,SIDM00878,Gemcitabine,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-0.5569702,-0.044677537,-0.9851956339432851,-0.044601831807821866
64697,SIDM00878,Ribociclib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.60135466,0.029913472,-0.1562143290696206,-0.004368343694589447
75790,SIDM00834,SCH772984,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,1.3407737,0.107802406,0.6211402920727946,0.05635196954547207
44737,SIDM00893,Doramapimod,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.30806673,-0.010586433,0.8454439317771772,0.03861068209922273
52011,SIDM00875,Afatinib,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.56496507,-0.04643994,0.560505991895548,-0.05306564867854051
81496,SIDM00097,AZD8055,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.233222,-0.13404272,0.6302528537384651,0.03898299398014555
31568,SIDM00673,Nilotinib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.138921,-0.094241396,0.16071144228082487,0.08592569295221403
6837,SIDM00332,Paclitaxel,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2786117,-0.055954866,-0.28814765935514564,-0.08135819295219035
85224,SIDM00834,MK-2206,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,White,66.0,3.231853,0.20703408,2.2522586188276597,0.16349510709740717
89096,SIDM00673,Palbociclib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,2.1020188,0.13948199,-0.9860144114068865,0.02287459086515972
26402,SIDM00130,MK-1775,Taselisib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.2204678,0.08819132,0.3589671158987953,0.02339835936517103
71599,SIDM00774,AZD6482,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-2.9693978,-0.15038739,1.0087128031525936,0.10190316028166395
59203,SIDM00778,5-Fluorouracil,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,69.0,-3.6029527,-0.07846488,-2.763182188176669,-0.07369223634652847
101425,SIDM00332,Alisertib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0441124,-0.051736396,-0.49831766818339746,0.0021461711671222545
31162,SIDM00893,Afatinib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.780741,0.226186,1.6312232126128565,0.06036798677387823
35487,SIDM00834,MK-1775,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,White,66.0,-0.9141385,-0.07168565,-1.3758175714129808,-0.05551228130871971
42090,SIDM00782,BMS-754807,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,Unknown,72.0,-0.8956591,-0.085243724,-0.5067459268081891,-0.06553540404594416
60260,SIDM00774,5-Fluorouracil,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,0.72134674,0.02440795,0.567806414650622,0.05941921162719885
70421,SIDM00774,Navitoclax,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.273464,0.03948295,0.6286061085909047,0.008752307644015954
8551,SIDM00779,Dabrafenib,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,1.9612147,0.045510426,-0.901292418980733,0.010679326352930913
23736,SIDM00774,Camptothecin,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-3.1704383,-0.13619289,-1.1592798466723404,-0.06320728055366336
19521,SIDM00779,LGK974,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,33.0,0.6824469,0.024683718,-1.0957244607226377,-0.010395859978909978
30889,SIDM00531,Dasatinib,Palbociclib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.11404281,-0.012639435,0.026539491453844065,0.05788862713185431
42460,SIDM01233,LGK974,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,0.42805696,0.021463456,0.02726538450434994,0.01345524391736825
61058,SIDM00130,MK-2206,AZD7762,Pancreas,0.0625,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.88515,0.088371485,-0.9572104413542523,-0.038538868376505366
77142,SIDM00878,Camptothecin,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,0.61980826,0.01772106,1.58434050753318,0.06952852238191724
77046,SIDM00673,Uprosertib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,0.68913615,0.045982987,0.6659169370658781,0.09871889193786657
8438,SIDM00866,Tozasertib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-2.0333564,-0.093958154,1.0192210830731605,0.07716693705904128
7605,SIDM00529,Camptothecin,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-0.6666472,-0.02617422,0.2726468936854728,-0.0015335240679508393
108446,SIDM00130,Ruxolitinib,SCH772984,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.5844883,0.04786875,1.2588328646346012,0.040013966977369954
46169,SIDM00673,BI-2536,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.34622124,-0.02367017,-0.6306916295927669,-0.04235480318735677
67328,SIDM00301,Cisplatin,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,-2.9000447,-0.22381786,-1.7373153215205523,-0.07482385804586231
6957,SIDM00529,MK-1775,Trametinib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-0.55424136,-0.052828897,-0.8681434360558998,-0.03426328820076596
82006,SIDM00971,Linsitinib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.40242833,0.0153990695,0.6922774567791553,0.016675798900220855
24842,SIDM00866,Tozasertib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.3940531,-0.07558159,0.2645175634160357,0.030239893200784424
87162,SIDM00301,5-Fluorouracil,Lapatinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.0473801,-0.10765739,0.46060400997557993,-0.012066445171290496
70811,SIDM00529,Afatinib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,-0.23213917,-0.015547345,-0.6654653453368112,-0.014606835462326336
53535,SIDM00531,5-Fluorouracil,Navitoclax,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.7911077,0.28451875,1.8911754834901817,0.06413232118340062
70672,SIDM00774,KU-55933,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,-2.962005,-0.0853362,-1.4974445601875177,-0.019845072372342284
94559,SIDM00875,Bortezomib,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.49748552,0.046005804,-0.6472858317602784,0.003874708870619617
1490,SIDM00301,SCH772984,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.4545336,-0.18183523,-1.142783978796581,-0.06636080840230964
4187,SIDM00301,Oxaliplatin,Gemcitabine,Pancreas,0.1,Pancreatic Carcinoma,Male,East Asian,50.0,1.3178135,0.16008592,-2.5226654604119405,-0.1408230210841432
20095,SIDM00778,Olaparib,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,69.0,1.293098,0.044484995,-1.0030936827067705,-0.02430535251686559
46105,SIDM00130,Paclitaxel,Palbociclib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-3.1880083,-0.2991827,-3.9492586270884753,-0.2530579341110446
19620,SIDM00893,PF-4708671,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.92935,-0.06931256,-0.9244365739884782,-0.01774709186884907
90613,SIDM00673,Docetaxel,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.9131222,-0.08754223,-1.9795371085788667,-0.1522863186433042
85791,SIDM00673,ZM447439,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.3430054,-0.020001972,-0.12101632317660152,-0.004718517566550974
8372,SIDM00893,NU7441,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.1919751,0.10329695,0.47559821550026443,0.016060150190208945
68428,SIDM00971,Wee1 Inhibitor,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.2213768,0.03186806,0.630704588741562,0.039050278787253936
54066,SIDM00673,Gemcitabine,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,3.4184225,0.3418297,4.451148686713685,0.25024735059437087
6209,SIDM00866,Gemcitabine,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-1.5289072,-0.1039509,-0.0843352180175621,-0.026470986913609156
4375,SIDM00097,Sorafenib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4881165,-0.060408123,1.2059441225951852,0.036765775228064075
104724,SIDM00878,Lapatinib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,70.0,1.3285182,0.14031222,0.16626103647764096,0.04745861337965836
5025,SIDM00893,Alpelisib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.5068234,-0.04274266,-1.0304988343624777,-0.050789126123846465
87677,SIDM00779,Nutlin-3a (-),MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,1.8077042,0.052415516,1.062030892263274,0.061859735903666925
69785,SIDM00834,5-Fluorouracil,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-1.1934406,-0.049551748,-0.8599056206799786,-0.018265278972651254
95265,SIDM00146,Docetaxel,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.37557468,-0.02749547,-1.5950802996988218,-0.1583624021777673
2688,SIDM00774,Afatinib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,3.0296376,0.1776209,2.033344154902125,0.06186208554045911
24266,SIDM00878,OSI-027,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.6989114,0.0672939,0.5434766824496888,0.06511032554351583
9636,SIDM00875,Venetoclax,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.27102333,0.0064400826,-0.14071535073408598,0.004082688131795336
62923,SIDM00971,Entinostat,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.52809924,-0.01469272,0.1905927090232965,0.06372715349541211
6753,SIDM00146,AZD6482,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.7452383,0.035902154,2.406991074086952,0.11964619350589686
55852,SIDM00954,Lapatinib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,3.8473775,0.07235503,2.003753220409327,0.11634862972803663
83091,SIDM00782,SB505124,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.5843519,0.052105367,-0.8433016649611739,-0.08356508794905368
74008,SIDM00866,Lapatinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,0.47629982,0.014884842,0.23975748040214473,0.02459167786708017
69452,SIDM00834,Trametinib,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,White,66.0,-1.7753099,-0.070455596,-0.9007343960253753,-0.036914127217193164
1997,SIDM00878,NU7441,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,1.6786991,0.13697642,0.4778488534076828,0.030613458224715947
49870,SIDM00893,Gemcitabine,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.166238,-0.08892164,-1.4912484522055347,-0.060132361404433614
4516,SIDM00529,Sorafenib,PD173074,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.8162734,-0.07392184,-0.7605016022659489,-0.01918982915179829
24755,SIDM00779,AZD4547,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-6.523723,-0.043488022,-3.877982706414366,-0.025704706236595116
87632,SIDM00301,Gemcitabine,OSI-027,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.1302843,-0.052503068,-0.07718206209224103,-0.017053935287555083
32791,SIDM00673,RO-3306,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,2.673172,0.18689999,-0.4148981352292676,-0.01698096590129396
28159,SIDM00779,Crizotinib,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-1.2786428,-0.0670075,-2.305238200980423,-0.09501620879003181
93487,SIDM00866,Ribociclib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,-0.82574475,-0.027039496,-0.10378094883410317,0.01898120745744698
41454,SIDM00660,Linsitinib,Vinorelbine,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,32.0,2.1439762,0.19525024,2.466218426813103,0.1453495023659261
68811,SIDM00097,Temozolomide,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.3218898,-0.0056150644,1.4552707131988665,0.04311282984626633
16180,SIDM00954,JQ1,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,-1.1177769,-0.08808196,0.881712863792437,0.05424482478909948
14668,SIDM00411,Paclitaxel,Gemcitabine,Pancreas,0.1,Pancreatic Carcinoma,Male,East Asian,43.0,-1.7668011,-0.04307289,-3.19031753756213,-0.03434403467982388
23443,SIDM00097,Paclitaxel,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.560717,-0.11071561,-1.6925960059579541,-0.1143315546008336
12393,SIDM00774,AZD6482,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,0.36562628,0.023010805,0.3782102041590177,0.021723356637363984
49479,SIDM00971,Olaparib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1550266,-0.031692773,-1.6667497620647835,-0.02406885046591813
36833,SIDM00332,Uprosertib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.596973,-0.038022216,-0.9048753891377456,-0.06570470798829832
75365,SIDM00878,AZD7762,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.5311732,-0.022608845,-0.6311921489368612,-0.07212705790682171
25666,SIDM00529,KU-55933,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-0.78749573,-0.012256509,1.3589246303653586,0.039917552902263495
69027,SIDM00332,Temozolomide,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9803251,-0.02073639,0.7543796199993896,0.04168748092851213
26365,SIDM00875,Afatinib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7065111,-0.060287055,-0.22844966407437067,-0.05033705036724745
44718,SIDM00359,MK-1775,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0231026,0.077009514,-0.6912689790830331,-0.04142099857700469
55172,SIDM00130,Sorafenib,Linsitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.1115396,0.11188484,0.4061236884677042,0.05371853326352735
66222,SIDM00146,Nutlin-3a (-),Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.66773206,-0.019571321,1.6172830236845792,0.06194306576009119
68513,SIDM00628,ZM447439,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.2965957,0.07747839,2.745234659738125,0.16758184691414527
51598,SIDM00866,KU-55933,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.2779616,-0.047999453,0.3084092612470244,0.03309126815073902
15657,SIDM00971,Vorinostat,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.49586728,-0.025305051,-0.3255747853988174,0.014839096263799999
8075,SIDM00774,Wee1 Inhibitor,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-2.5492234,-0.13170375,-1.118620182191729,-0.03763486522605885
83369,SIDM00774,Navitoclax,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,2.6508594,0.02000394,1.8916985623017961,-0.0018499918537748811
32123,SIDM00531,Dasatinib,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.7249529,0.20699944,2.9590115119543516,0.1882546133532568
7936,SIDM00893,Bortezomib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.49892032,-0.035429753,-1.765359447070054,-0.08108603848830506
33352,SIDM00971,NU7441,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.93251306,0.04307848,0.04132966106809897,0.014398942254236713
92069,SIDM00660,AZD8055,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,32.0,1.3724241,0.08683856,0.067648390519402,-0.0325534940720843
20371,SIDM00130,Gemcitabine,Crizotinib,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-4.6840467,-0.28101,-2.131358983027862,-0.11740124044767286
65087,SIDM00301,5-Fluorouracil,Erlotinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-2.7765398,-0.3066785,-0.6178880709962015,-0.0906761767813366
63442,SIDM00146,BI-2536,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-3.2249093,-0.09427979,-4.501720978272476,-0.08879846354048752
81296,SIDM00146,Temozolomide,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.30661714,-0.007598479,1.1012968457113885,0.05414715434121898
11472,SIDM00332,Uprosertib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4349465,0.08852231,0.27661684603581194,0.03732680155113111
8268,SIDM00332,Alisertib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.6730778,-0.14630327,-1.8694775135567263,-0.08423446815756003
43184,SIDM00531,Cisplatin,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.59173554,0.06378466,-0.6308565126893021,0.02763682563367538
48970,SIDM00878,MK-2206,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,-0.29749858,-0.030807279,0.375332366457248,0.02277377998465484
33514,SIDM00301,MK-1775,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.1917927,0.09507626,-0.15976266395142427,-0.012177014085043007
84999,SIDM00875,Luminespib,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5540838,-0.027809285,-3.1928866931849935,-0.10491870925531566
36437,SIDM00971,BI-2536,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.1001928,0.0624864,2.048051065714325,0.1786472589879948
39316,SIDM00875,Axitinib,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1399028,0.08701987,1.4311881309515933,0.07023438980394256
6779,SIDM00193,SCH772984,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,53.0,-2.4558575,-0.12515599,-1.3580043281232967,-0.03206963885380322
84712,SIDM00531,MK-1775,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.1716211,0.12931499,-0.45420166928384,-0.006358216669382293
59741,SIDM00971,Palbociclib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.8124675,-0.049100596,-0.9232115268598402,-0.03474193556729126
52482,SIDM00097,KU-55933,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.7290635,-0.104010396,-0.04017482944533294,0.028984412061290037
54911,SIDM00778,Nutlin-3a (-),Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,2.187358,0.052702386,0.24886342396859173,-0.010915110443672535
90929,SIDM01233,Taselisib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,0.6746347,0.050404876,-0.9394557886365714,-0.05233589123422848
63614,SIDM00779,Dabrafenib,Afatinib,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,-3.629637,-0.17065783,-0.8080295458486473,0.012400119898182118
83408,SIDM00097,Navitoclax,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0620645,0.041945625,2.3240200508737465,0.12738147957566803
3099,SIDM00193,Palbociclib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.1938708,-0.05574937,0.10352865183183874,0.03932942943205957
83529,SIDM00193,Camptothecin,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,2.0328107,0.108549304,1.2051969570666539,0.08185219705918724
99379,SIDM00146,ZM447439,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.6244562,0.12656498,1.5385448448730263,0.10071899882316729
104975,SIDM00097,Camptothecin,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0805764,0.06000539,2.0926139438286846,0.2086063622303463
30774,SIDM00332,Dabrafenib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.116917,0.1454467,-1.1956514573842054,-0.061385874932365816
34214,SIDM00332,MK-2206,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1639566,-0.11003391,-1.4687666845394527,-0.10112601422801733
51404,SIDM00628,Nilotinib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-1.9289415,-0.13036436,-2.878664562650554,-0.12015240436347116
51401,SIDM00193,Afatinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.8275452,-0.12527108,-0.6699785817101529,0.004140772324621214
35111,SIDM00146,MK-2206,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,3.8644981,0.23395716,1.331825475068484,0.14174627810040602
96666,SIDM00954,Linsitinib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,-1.185956,-0.10214132,-0.12257916585555126,0.014366425723913325
24698,SIDM00774,ZM447439,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,48.0,-2.2023232,-0.11444256,-0.029376682594893455,0.05597173497515823
104636,SIDM00359,AZD7762,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7410052,-0.13759705,-1.0172170209172697,-0.04133347593145403
9814,SIDM00531,Erlotinib,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.7072624,-0.104841426,-0.22514954047398203,0.009504230483962322
98890,SIDM00301,AZD7762,Sorafenib,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.251819,0.08737408,1.6054502858484583,0.06870697318420102
63567,SIDM00893,Tozasertib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.6152039,0.15836495,-1.1416332704835186,-0.038295189502951445
23309,SIDM00097,Camptothecin,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.081056,-0.07962503,-0.8508741611675531,-0.019804397698822224
104351,SIDM00628,Olaparib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-2.1615708,-0.1411134,-1.6140806413985116,-0.0856062582118239
103326,SIDM00673,Vorinostat,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.20504922,-0.02233454,-0.9958233266204336,-0.10850901424652022
27483,SIDM00954,Olaparib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-1.3231637,-0.02932951,0.062192859590808114,0.031504797607548374
54353,SIDM00893,Dabrafenib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.5538994,-0.015798947,0.2956705033642683,0.06649116691989337
28846,SIDM00531,Olaparib,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.4963802,0.10143989,0.3326393775727948,0.03652630391658892
56055,SIDM00875,Trametinib,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4860004,-0.15395205,-0.37416837453340224,0.0008514136173279217
99401,SIDM00866,Palbociclib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-0.40763426,-0.009587156,-0.09897550774198126,0.025584542618332477
77388,SIDM00332,Dabrafenib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5462061,-0.052904252,0.6869916915940326,-0.01838699221284952
32853,SIDM00893,Taselisib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.6732385,0.10872779,-1.4339467263998638,-0.17256349398248427
94177,SIDM00971,Afatinib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.5205473,0.05485193,0.43346025087366946,0.012356439109146905
4007,SIDM00875,Docetaxel,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5037496,-0.13423868,-1.9623891626739964,-0.12067036096155463
49680,SIDM00146,Venetoclax,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,3.189948,0.09712949,1.4255928072306463,0.06704237495173032
12280,SIDM00130,Taselisib,MK-2206,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.50299,-0.20185728,-1.573739083979984,-0.04483043721658204
76468,SIDM00954,AZD7762,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-1.8956542,-0.1445081,0.5251761701398593,-0.01640451298980184
61826,SIDM00529,Wee1 Inhibitor,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-2.6380594,-0.064548574,-3.2049016366715453,-0.13250353119344777
50111,SIDM00971,Nutlin-3a (-),MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.8557721,-0.04137435,-0.5959788064401758,0.020979071682176463
51646,SIDM00971,Olaparib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.8850497,-0.047110613,-1.1129497830459814,-0.005549459764747737
97204,SIDM00875,Navitoclax,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.51239663,-0.05703591,0.6932521222937291,0.005244320958534508
83186,SIDM00130,Navitoclax,Dasatinib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.3153359,0.13026397,0.35578359155051187,0.10166966201282947
79896,SIDM00971,Vorinostat,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.3409162,-0.11452998,-0.29767006644743327,0.011696594273765628
53718,SIDM00529,OSI-027,Trametinib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-1.1220504,-0.09024426,-0.3749359619828682,-0.001682413796066847
51201,SIDM00774,Luminespib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.73496354,-0.043857116,-0.5286816464433419,-0.05434271513142041
28077,SIDM00193,BMS-754807,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.5436011,-0.031572293,-1.1727999389692527,-0.026144989887817577
98720,SIDM00146,KU-55933,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.7696907,0.04340637,0.15293377739601172,0.004440609009767929
1584,SIDM00782,Camptothecin,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.069687,0.093080506,1.9683705004577965,0.10446642118866664
72849,SIDM00359,SB505124,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.5077123,0.035170503,0.9818878934834198,0.039818296880002116
46837,SIDM00875,Entinostat,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.29200956,0.030107263,0.19657351274899965,-0.006354347376119559
9840,SIDM00866,Crizotinib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,52.0,-1.1180689,-0.09347808,-1.351554022994935,-0.061425098387613467
48321,SIDM00529,Entinostat,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Black,44.0,-3.1945837,-0.13357772,-0.4302807666393327,0.034999934431363205
22893,SIDM00660,MK-1775,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,1.8848846,0.06841062,0.2817884023268061,0.013339673193151743
94164,SIDM01233,Oxaliplatin,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,72.0,-0.82094115,-0.065293394,-2.559459813032313,-0.15645186266066183
70503,SIDM00971,Trametinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.176227,0.086438045,1.5679402173090458,0.05455331053885146
91945,SIDM00411,AZD7762,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.7248763,-0.04967252,0.9610338047831275,0.015609506692190812
95615,SIDM00878,MK-2206,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,0.44692078,0.044353094,0.8155929610395123,0.06164806104002528
39085,SIDM00774,Pictilisib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.3876225,-0.0052532973,-3.5175569177377826,-0.11072392183260937
32701,SIDM00529,Temozolomide,PD173074,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.43458515,-0.008957797,-0.3512455045376286,0.012142489476615479
48850,SIDM00875,Luminespib,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0364299,0.09620991,-0.38919191266405284,-0.052272145356391686
74647,SIDM00893,Alpelisib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.5818412,-0.04144515,-0.5362943737356751,-0.044728269651204924
98287,SIDM00628,AZD7762,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.53753763,0.054945905,-1.6923787799098882,-0.13586123051180182
60852,SIDM00893,Lapatinib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.20112929,0.020160867,0.009654608305883277,0.02111012939844896
85375,SIDM00673,Wee1 Inhibitor,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.3414173,0.023263535,-0.054874078508997406,0.048506942067736925
90257,SIDM00878,Afatinib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.43415475,-0.038803462,0.6599932495121866,0.06793227510317874
13094,SIDM00774,GSK269962A,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,0.07287062,0.0030332685,0.7111525487228886,-0.023123456678877916
75382,SIDM00971,Taselisib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.5282662,-0.16362454,-0.21793290317329841,-0.04064983037401006
94425,SIDM00776,SCH772984,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,65.0,-2.2376094,-0.1861833,-0.5685378436329054,-0.011351795558950155
13435,SIDM00673,Palbociclib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,1.4713813,0.07570347,0.6388106249272505,0.0840009256252919
77250,SIDM01233,AZD4547,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,72.0,2.0241802,0.08791183,2.017128112087159,0.10277757319444308
7133,SIDM00529,Tozasertib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,-1.498529,-0.05230227,-0.20046936409591742,-0.022003018099261636
25925,SIDM00529,Dabrafenib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Black,44.0,1.2704369,0.030283436,0.8128646545216112,0.08461398791365243
62147,SIDM00866,Taselisib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,-0.22980972,-0.016867328,0.1241042315440213,0.01006678808474679
76323,SIDM00782,Palbociclib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.36744484,-0.006900751,1.6816278270402287,0.05648047254081299
48967,SIDM00776,BMS-754807,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-0.49892062,-0.029004551,1.612368396361436,0.05768205287272233
98771,SIDM00411,Oxaliplatin,MK-1775,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.003502,-0.046115547,-1.563301258999622,-0.02841589009080546
44456,SIDM00531,Lapatinib,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.210297,0.14247012,1.2288182987329133,0.08025390507448094
94532,SIDM00146,Paclitaxel,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.38782012,-0.03682123,0.09908332411372607,0.018667298863593043
12106,SIDM00332,Nilotinib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5419169,0.022746578,1.771545925797565,0.10071929916108972
34304,SIDM00660,5-Fluorouracil,Afatinib,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,-0.73661095,-0.07319429,-0.3835588723870885,-0.03422497444301175
11841,SIDM00531,MK-2206,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.1948714,0.15706202,1.7489494157896146,0.0930537857438644
63038,SIDM00971,Nilotinib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.0895113,-0.07400346,-0.4825594831277469,-0.03396021144396174
67119,SIDM00359,LGK974,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.41844144,-0.011618018,-0.38240426480763756,0.02070875333883539
58036,SIDM00097,Dabrafenib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.1591847,-0.11433296,-1.6152307009481834,-0.09487227377000036
20426,SIDM00531,Paclitaxel,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.2096232,-0.1287351,-2.9536820532182237,-0.13022204307951835
14611,SIDM00193,BMS-754807,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,2.2531948,0.16061595,1.3557868394954158,0.10225926865806166
101907,SIDM00893,Temozolomide,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.810258,-0.017608918,-0.1674219648119472,0.0063232852929354455
85523,SIDM00954,Cisplatin,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,0.39266318,0.009918275,0.44736613978825157,0.056202734328946666
83194,SIDM00359,5-Fluorouracil,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.2586584,-0.103062496,-1.5583423993967487,-0.017628926641638547
65435,SIDM00359,Palbociclib,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.4380759,0.029787924,-1.3009003956451786,-0.058686891304040416
50407,SIDM00774,AZD8055,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.5157884,0.08938176,1.2893201837869155,0.06523240357369207
52161,SIDM00673,Taselisib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-3.3313327,-0.15783551,-0.2840092486951055,-0.08567498863504126
48473,SIDM00146,Vorinostat,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,0.89773226,0.07756243,0.3660521789733582,-0.023955951398570267
6018,SIDM00411,Dactolisib,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,43.0,-1.238741,-0.05824348,-0.9983981838059518,-0.042293792673039954
24786,SIDM00878,AZD6482,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,3.8450763,0.07629922,2.4335046049966014,0.13479139369309417
30950,SIDM00193,Vinorelbine,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,53.0,3.607902,0.2786726,2.6101069884395534,0.14867149891885373
85541,SIDM00878,Linsitinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,2.025383,0.1672588,0.6773257261113235,0.06253670800892493
60751,SIDM00878,Uprosertib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.5226041,0.044404767,0.8678463197618591,0.040830078321971774
71789,SIDM00971,AZD7762,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.2004064,0.0049458453,-0.5743412078578062,-0.003618783872611073
77655,SIDM00628,Navitoclax,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-0.6822446,-0.0684563,0.7394028221251882,0.015415754590322055
9112,SIDM00673,Lapatinib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-0.5492794,-0.049410913,0.680861029443963,0.03426692554289252
18980,SIDM00673,Cisplatin,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.7350908,0.030472912,1.0023829128573194,0.05549266514346911
45034,SIDM00878,JQ1,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.28926292,-0.026406927,-1.5569593275756057,-0.09711184753381355
6636,SIDM00411,Navitoclax,Sorafenib,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,43.0,1.33632,0.090018466,2.0298580394273817,0.10501765598599716
103809,SIDM00878,Lapatinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,2.442132,0.123330526,0.7136112853317454,0.05900715644470566
103996,SIDM00529,AZD7762,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,-1.5586331,-0.10590371,-0.7840508401856615,-0.022666898442469344
90791,SIDM00779,AZD8055,Trametinib,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,33.0,0.5268681,0.042905174,-0.4352903640005867,-0.027912684040992786
106802,SIDM00673,ZM447439,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.0275466,-0.08721407,-1.678196590995866,-0.14030804075774364
23676,SIDM00529,MK-2206,Olaparib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.338036,-0.0454444,0.38097170302660033,0.03535869604734727
10012,SIDM01233,AZD4547,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,72.0,4.2776012,0.15571,0.8998486102458084,0.01594018185547245
67756,SIDM00779,MK-2206,Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-0.47047752,-0.030823054,-0.6063790218179607,-0.04727345026728502
30968,SIDM00866,Ribociclib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-3.5623991,-0.11273781,-1.5781417760450094,-0.06950029392069264
105290,SIDM00411,Sorafenib,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,0.989116,0.061504643,0.5629476392544422,0.009856421081170541
9790,SIDM00878,Alpelisib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,2.6647515,0.206769,-0.08951794970238933,0.014673134673248739
8825,SIDM00893,RO-3306,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.71584564,0.027256947,-0.59284436425103,0.023710649742013062
69586,SIDM00529,OSI-027,PD173074,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.51992565,0.048141677,0.29481771061620315,0.05098967334698104
20404,SIDM00673,Docetaxel,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,1.0328611,0.092425615,2.266811073362277,0.15117484751462543
70296,SIDM00628,Paclitaxel,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-1.8520293,-0.096361585,-0.39484912159266344,-0.04070937753044041
98009,SIDM00776,MK-2206,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.2820233,0.109305784,-0.03218650079242536,0.018632512390001767
43287,SIDM00660,Linsitinib,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,2.3087199,0.19104584,1.0016821623444656,0.06749532400764947
32439,SIDM00332,NU7441,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2723029,0.08654214,0.7285566948915837,0.04610932047967746
67043,SIDM00893,Linsitinib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.8862132,-0.079214945,-0.12888582975640733,0.058799236919437406
44185,SIDM00301,Cisplatin,Taselisib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.3081934,-0.11620854,-0.7042104339843526,-0.017586121815768446
66615,SIDM00875,PF-4708671,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.82856745,-0.032049038,-0.26925812659057025,-0.02450939078612798
16107,SIDM00893,AZD6482,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.06784788,-0.0057805907,-1.6587425607916122,-0.08643265950000556
43149,SIDM00628,Taselisib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.2219267,0.09476156,0.5944509061488467,0.06661238316617722
46343,SIDM00673,Camptothecin,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.4290443,-0.013071353,2.5190213253685396,0.03547945811045947
9592,SIDM00778,MK-1775,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-0.6153753,-0.03537341,-0.8353104812649498,-0.08137740858677328
62437,SIDM00673,SCH772984,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-3.24083,-0.23023929,1.3865199401649533,0.03976841138766018
31811,SIDM00673,Uprosertib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.3277775,-0.022355964,-0.05541698968597153,0.03936251171934587
67019,SIDM00130,MK-2206,Oxaliplatin,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.9217725,-0.064411804,-1.4356644937823813,-0.050674520163791724
32270,SIDM00097,Luminespib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.3091314,0.0902011,-0.7564594695192254,-0.05535978583469895
103072,SIDM00875,MK-1775,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5566474,-0.028919699,0.16364687584667476,-0.04378214080149761
67315,SIDM00954,Lapatinib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,0.5030138,0.02742366,0.46364092881378055,0.01864964428373249
33863,SIDM00776,AZD7762,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.5015207,0.042692102,-0.05220168190476026,-0.024505447902786706
35498,SIDM00893,Ribociclib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.820847,-0.0716241,-1.4083358834262536,-0.0665021393644417
89430,SIDM00866,AZD6482,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-0.7061699,-0.022560425,0.3501065601264771,0.04030395944601153
9964,SIDM00971,Trametinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1693857,-0.018202094,-1.1716638612110275,-0.014060940324014731
29818,SIDM00875,Afatinib,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6775532,0.04470075,1.5304778952875715,0.08827007816128489
86047,SIDM00673,Pictilisib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.632916,0.13353051,1.6456911964483432,0.08956448250888926
21611,SIDM00774,MK-1775,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.32227892,-0.038379464,-0.07255255360679726,0.0249214566443805
18062,SIDM00779,Afatinib,Navitoclax,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,2.3328643,0.18400858,1.160382269704616,0.06517131073660437
98442,SIDM00146,Nilotinib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-0.63376516,-0.05186736,-0.19886642231818694,-0.009881147884794545
89429,SIDM00971,5-Fluorouracil,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.064718,0.12441268,0.6531440406173179,0.07247589069543103
102718,SIDM00193,AZD4547,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.6597722,-0.09014114,-0.373176354223875,0.024812532182518734
23651,SIDM00971,PD173074,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.619916,-0.013398956,0.6318158081828017,0.05070967333443511
61673,SIDM00774,Crizotinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.9849913,0.2623842,2.104180964174146,0.1626748322119602
34030,SIDM00875,Entinostat,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.36077186,-0.03446403,-0.11429259456168901,0.015036223506500553
57167,SIDM00146,Camptothecin,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,0.4972513,0.046671633,-0.7773270528428121,-0.008854037221808117
79125,SIDM00776,BMS-754807,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,0.58006513,0.0472978,-0.034386758971875805,0.02057244076890654
47490,SIDM00411,Taselisib,Irinotecan,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.9235427,0.10739086,0.6654376437272653,0.07653857818106583
13111,SIDM00866,Bortezomib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.34547704,-0.031121213,-1.0062209074189115,-0.02821804290920714
69074,SIDM00301,Linsitinib,SCH772984,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,3.015962,0.2093055,2.5211230926286468,0.1373989751254078
34206,SIDM00834,Linsitinib,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,White,66.0,0.8839916,0.0728291,0.8974333623678531,0.06803257141411391
92317,SIDM00875,Venetoclax,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6564728,0.044703703,1.058800610950153,0.024252500031453888
47519,SIDM00529,Linsitinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,1.6315801,0.08924921,0.1187991307685917,0.020362969026317533
102103,SIDM00673,ZM447439,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.9473953,-0.070344605,-0.2080224740108846,-0.07528227341925686
8742,SIDM00774,Luminespib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,0.381688,0.030729774,0.35714368251644696,0.001086996955015813
49237,SIDM00628,Camptothecin,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,1.0239928,0.053508494,-0.2857647795667622,-0.07145994684564153
82654,SIDM00875,Pictilisib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6620283,0.1412869,0.459935939515041,0.09086139546055876
102043,SIDM00875,ZM447439,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3907357,0.124140985,1.659929544911544,0.08275480762766006
39325,SIDM00776,Navitoclax,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,0.2614303,0.016836911,1.3458857720522996,0.02343994217886249
11220,SIDM00866,Linsitinib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-2.214069,-0.1074735,-2.0752212596484014,-0.06667270284304594
51497,SIDM00774,Trametinib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.0600219,0.03901974,0.7461585173470919,0.0521079610513045
4543,SIDM00954,Nilotinib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-1.023552,-0.07446591,0.14078664358473392,0.01403459548458924
37797,SIDM00834,Taselisib,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-0.85397786,-0.05410298,-2.469277548570572,-0.07826482377308157
55607,SIDM00878,Nutlin-3a (-),OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-1.299266,-0.06282455,-0.030608776262850843,0.02334292921118051
22367,SIDM00776,Navitoclax,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-0.787646,-0.054064166,1.7215664656151761,0.047370900430468176
106474,SIDM00628,Uprosertib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,4.2318645,0.3870175,1.0294898800392784,0.13156742883633432
21259,SIDM00971,AZD7762,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.3538833,0.0726903,1.5004307842674112,0.13453316375253477
60861,SIDM00529,AZD8055,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,0.66334116,0.06206889,-1.0311102005580612,-0.07713546781040038
78651,SIDM00529,Afatinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,2.0282488,0.14627814,0.737335303881422,0.10294758814516776
50423,SIDM00146,Sorafenib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.2344767,-0.111760154,-0.9868188943156359,-0.0502827084001372
49231,SIDM00529,RO-3306,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.1969672,0.04928952,0.9971935562934674,0.04975532489840054
9268,SIDM00529,MK-2206,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.8309078,-0.052174397,-0.2678106327650534,-0.036477131550650056
107593,SIDM00878,Axitinib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,-1.0702978,-0.108192526,-0.7397302524845571,-0.06244591447207953
47313,SIDM00954,5-Fluorouracil,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.0,-1.9701425,-0.07771206,-0.938875934578424,-0.047924269362901784
50225,SIDM00893,Trametinib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.9376266,0.15661794,0.9836832853081314,0.1039002194440051
85101,SIDM00301,Trametinib,Cisplatin,Pancreas,0.8,Pancreatic Carcinoma,Male,East Asian,50.0,-1.8460319,-0.19195676,-1.7677784551052873,-0.08595166487977388
88009,SIDM00146,AZD7762,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.4052496,-0.03609394,0.6880822184227025,0.13520549742805107
90676,SIDM00097,Crizotinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5595405,-0.048156045,-0.12713989171582787,-0.021835558577670285
1829,SIDM00660,AZD8055,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,32.0,-0.59734434,-0.052117,-0.39150323272659837,-0.03623117549452916
23886,SIDM00529,Crizotinib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-0.62368137,-0.03613266,-0.22073300288561992,0.03189154333766
100617,SIDM00779,AZD8055,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,2.7907133,0.16674869,-0.2256868503403225,-0.038992372306206884
52817,SIDM00878,MK-1775,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-0.5712644,-0.06815396,-0.5038346536055932,-0.012693978756416919
94849,SIDM00971,Camptothecin,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.48636,0.07390579,2.9732981827513,0.08872623124930222
2334,SIDM00878,OSI-027,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,0.7896051,0.055092372,0.030002260244580223,0.0015301677651115122
99682,SIDM00875,OSI-027,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4322,0.1534029,1.194767810202127,0.1317080126347526
3604,SIDM00130,Dactolisib,Oxaliplatin,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.6621614,-0.07171741,-1.3762160621508237,-0.07834506232826335
13607,SIDM00878,NU7441,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,0.7740521,0.06406972,-0.8219633117776027,-0.03841181891969564
37843,SIDM00878,Alisertib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.76752865,0.06784525,0.7597450798456964,0.021830607191085788
9860,SIDM00130,Irinotecan,Trametinib,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.73981726,-0.04758166,-0.6575333823948472,-0.024301853324135626
50581,SIDM00776,BMS-754807,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,-1.052128,-0.08457237,-2.4107727651632387,-0.11527142451470172
98695,SIDM00834,Dabrafenib,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,2.6124136,0.1233002,1.4047959303780873,0.05693809215197821
98980,SIDM00411,Taselisib,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,43.0,1.4267395,0.09263841,1.5955183611883468,0.11534469382424048
11550,SIDM00529,MK-1775,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,1.0006026,0.079785936,-0.42497564201435173,0.009945991698729277
44742,SIDM00673,Alpelisib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,1.082722,0.07600131,-0.6774877692489393,-0.05428258306260738
91553,SIDM00193,BMS-754807,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.5751104,-0.11806123,0.33712893280898354,0.044249394140017086
97896,SIDM00531,Dasatinib,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.2998037,0.30849883,1.7273694965728044,0.09987477727822824
8538,SIDM00332,Axitinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.7504551,0.2742925,-0.8517740262330975,-0.062032109331836074
34517,SIDM00878,Cisplatin,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,2.8696625,0.04670182,3.5311701642491804,0.2202993630633886
96675,SIDM00628,Bortezomib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-0.24963215,-0.014976288,-0.7413912294362681,-0.0662990998226659
39124,SIDM00673,NU7441,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.9119721,0.07131914,-0.8591704325561018,-0.025935502304597853
22540,SIDM00866,Palbociclib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-0.44247237,-0.011225287,-0.08291843212610042,0.005777335817584322
8065,SIDM00971,PF-4708671,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.7953313,0.05346128,-0.7728238391963684,-0.022466210927468817
40118,SIDM00531,Trametinib,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.7691436,0.31361437,1.12924300695152,0.07535223116375066
7169,SIDM00301,Irinotecan,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.2956302,-0.15520886,-1.3349032586717782,-0.1103517379314027
41591,SIDM00359,SB505124,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.19098575,0.012449523,-0.6442152305413094,-0.0013568753610621867
59275,SIDM00146,AZD7762,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.19730513,-0.015808627,-0.10865084003999635,0.016423116323131627
66190,SIDM00782,Navitoclax,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.16205555,-0.01564842,-1.2786118680908785,-0.07320443989176673
48164,SIDM00146,Alpelisib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,2.658319,0.12063805,2.211171324169998,0.11375995628210979
44639,SIDM00673,Docetaxel,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-4.639435,-0.15931714,-1.5301903343079064,-0.08278064337021251
15797,SIDM00875,AZD7762,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.21847925,-0.014936991,-0.5630203120432172,-0.0572239389646321
104923,SIDM00971,Olaparib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.7194762,-0.06236188,-2.205954692656769,-0.06973314848579198
48033,SIDM00332,Luminespib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.9500146,-0.1461924,-0.7368470509932604,-0.032796891004630874
68188,SIDM00971,Nilotinib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.58232766,-0.039086163,-1.187140824848006,-0.04651613689428191
29790,SIDM00097,Paclitaxel,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.47567558,-0.029336665,-0.3662964434023923,-0.07035674006035567
37665,SIDM00301,5-Fluorouracil,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.2592056,-0.14452183,-1.6365938052607891,-0.10225862894494493
90424,SIDM00531,Oxaliplatin,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.9392715,0.27850416,0.5645069792228055,0.050045167650365444
34176,SIDM00628,Lapatinib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.71186364,-0.054178115,0.08585418528031027,0.04725388667540115
60533,SIDM00875,Axitinib,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.34176728,-0.02086672,-0.6010651453806495,-0.0495249797215385
26693,SIDM00774,Luminespib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,-0.3222355,-0.0266823,-1.1290473504345615,-0.02544274186626335
105645,SIDM00529,MK-2206,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,-1.222165,-0.044598848,0.5409190838888641,0.006287556295815696
3268,SIDM00774,PF-4708671,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-3.3936317,-0.1386619,-0.30397982178495603,-0.02179373315989037
91580,SIDM00866,Trametinib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,1.5580994,0.112601995,-0.5023247368190897,-0.018099346509734132
65309,SIDM00779,Linsitinib,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.7740327,-0.13875543,0.09894479707376722,-0.022937989895206727
166,SIDM00332,Palbociclib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.3739269,-0.1442761,-1.1851438614264553,-0.050922018855561434
26047,SIDM00130,Crizotinib,LGK974,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.3972176,-0.03612442,-0.8960166943780743,-0.03129355002924307
20405,SIDM00893,Nilotinib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.5259287,-0.044039533,-1.2934366353813431,-0.08768741923689956
44625,SIDM00893,Venetoclax,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.8642716,-0.05793454,-0.6807354511259804,0.00528825247629073
184,SIDM00893,Luminespib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.1581903,0.19050716,-0.459976324239096,-0.02521683338971544
7030,SIDM00774,Olaparib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.2371272,-0.052205507,-0.1464829300934597,0.023990264152882218
66628,SIDM00971,Ribociclib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.886554,-0.07706364,-1.528535318870869,-0.039550421840815544
17974,SIDM00130,Lapatinib,Irinotecan,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.9540044,0.0956218,0.8251789627872627,0.09088197633112265
40599,SIDM00866,PD173074,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-1.3418376,-0.049012113,-2.2770786121661635,-0.06251298781803578
68978,SIDM00097,Venetoclax,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.985889,-0.05570269,-1.2080049454120476,-0.020296297812189074
84045,SIDM00097,AZD7762,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.1825671,0.1260708,1.2578766356439828,0.13648260042196353
66414,SIDM00301,Crizotinib,Palbociclib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.6192579,-0.06359292,-0.7298262776233313,-0.051571293201931497
87901,SIDM00893,Pictilisib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.44746292,0.04256152,-1.6143708308019025,-0.05609478905780633
16062,SIDM00097,KU-55933,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.15554,-0.0715024,-1.2257581522150112,-0.06771738014841597
80844,SIDM00673,Palbociclib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.2403115,0.071431346,-1.4006238192830738,-0.012270527019075722
16582,SIDM00866,Navitoclax,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.52492625,0.042057715,-0.29073397367309406,-0.007189941493407233
85014,SIDM00878,Trametinib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,2.9121425,0.3386499,0.43744789953190094,0.006614215493420346
4169,SIDM00778,Taselisib,Nutlin-3a (-),Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,0.7215858,0.044321176,-0.11521519566597174,-0.007067486068625712
76650,SIDM00834,Afatinib,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,2.6910431,0.1266682,-0.7622643675528599,-0.028811926734873698
91097,SIDM00146,Ribociclib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.5881877,0.0957157,0.19600489564752244,0.03517305317781115
11569,SIDM00130,Oxaliplatin,SCH772984,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.2716144,0.08515388,-1.222929796979252,-0.0222325461320806
82094,SIDM00146,Nutlin-3a (-),Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.0525429,0.03173922,1.8905759210748907,0.07486246257483711
94020,SIDM00628,AZD6482,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,1.7551842,0.11364618,-0.30062416021144406,-0.006567923716864909
3465,SIDM00628,Venetoclax,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,-0.93640286,-0.040784348,-0.5229871251204387,0.033533054820082675
37571,SIDM00893,Bortezomib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.4774422,0.04800875,-1.138136202244998,-0.0912843161706054
18318,SIDM00866,Taselisib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,-1.0772517,-0.078036405,-2.412749409761487,-0.09510906695073
12506,SIDM00411,Taselisib,Cisplatin,Pancreas,0.8,Pancreatic Carcinoma,Male,East Asian,43.0,-2.4677832,-0.15350662,-1.3925817217778218,-0.04991651786379852
50735,SIDM00779,Nutlin-3a (-),Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,33.0,-0.5183118,-0.019705527,0.03782238068148206,0.005198384352470734
78114,SIDM00146,Ribociclib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,-1.1127582,-0.03017061,0.1469542470716191,0.0607568764138085
106794,SIDM00971,Alpelisib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.5333602,-0.08714417,1.2125644215636824,0.07016873964342121
106932,SIDM01233,SB505124,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,72.0,-0.1658247,-0.006713311,-1.3624238077552009,-0.051427294486538926
38436,SIDM00628,BI-2536,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-2.0066335,-0.079509936,-1.8346354571410872,-0.030932126803369667
57230,SIDM00893,Venetoclax,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.5614393,-0.055948757,-1.3666368702569913,0.031651312298849335
93426,SIDM00359,Linsitinib,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.6858704,0.14925008,-0.07204054826376906,0.05087118202035951
5338,SIDM00146,Ribociclib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.3064266,0.06983761,0.6173649567842157,0.055556107088652835
88688,SIDM00193,Trametinib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,East Asian,53.0,2.74053,0.19817393,0.6004243974000474,0.06488091652420079
106122,SIDM00866,GSK269962A,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-1.8032333,-0.06400906,-0.7998045605321964,-0.0035348335388133813
105909,SIDM00878,SCH772984,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.6139213,-0.12936692,-1.5979432738010237,-0.134872327519032
84202,SIDM00954,Venetoclax,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,3.886579,0.2057549,-1.5931333312378668,0.002619620949588541
21857,SIDM00130,Paclitaxel,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.8897402,-0.12999862,-3.446083786580677,-0.1876656674684927
85371,SIDM00778,5-Fluorouracil,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-2.4608827,-0.063606866,-0.20444632109539257,0.022201835768350307
24366,SIDM00332,BI-2536,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-4.8715897,-0.37627816,-0.6291119242311344,-0.040812809258599876
48631,SIDM00954,Alisertib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-2.2868648,-0.16797297,-0.6151471011041304,-0.024753105773856355
40001,SIDM00878,Taselisib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-0.41608843,-0.036653172,-0.8326802744670824,-0.08947103919116148
67764,SIDM00332,GSK269962A,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9289936,-0.044295687,0.9580650614751259,0.005827288991351666
24875,SIDM00529,Olaparib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-2.5986216,-0.07526238,-1.353460248722943,-0.03394646628122099
24374,SIDM00529,Vorinostat,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.9405734,-0.087691054,0.2208495652480325,0.08039024067264448
49376,SIDM00673,Navitoclax,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,-0.94970685,-0.06589693,0.022429499889795836,0.036245396049756275
5049,SIDM00529,OSI-027,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Black,44.0,-1.6557912,-0.13590237,-1.568458885313031,-0.08122388493284177
19750,SIDM00971,Bortezomib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.2008722,-0.075958475,0.4750945310496599,0.05146373769810939
50750,SIDM00875,Paclitaxel,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7013909,-0.05099551,-1.4388497010185082,-0.06581533417301191
58352,SIDM00097,MK-2206,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.8617558,-0.20284517,-0.03184093576177022,-0.08322353696282438
14990,SIDM00301,MK-2206,OSI-027,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.8084888,0.24388249,2.433794168721167,0.14936386163844198
82746,SIDM00130,Cisplatin,Linsitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.5029275,0.035814516,0.6781067166707421,0.07549840307560254
96209,SIDM00097,Navitoclax,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.945013,-0.17169535,1.287791510408416,0.05838923997046263
49178,SIDM00673,MK-2206,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6374627,-0.047104154,-0.427849345149131,-0.07700186587226401
63393,SIDM00529,Gemcitabine,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-0.65866554,-0.018217864,-2.2300388624214316,-0.054661677337565336
61030,SIDM00673,Vorinostat,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.2577794,0.080260925,0.6943459611981194,0.09393188898743321
81999,SIDM00529,ZM447439,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-0.58019507,-0.039061356,-0.6768516945338077,0.015661945648687316
22087,SIDM00628,MK-2206,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,Black,51.0,-1.1860088,-0.08136298,0.1519689077297481,0.10038325792388467
24110,SIDM00971,Cisplatin,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.02823956,0.0004645534,0.9998337038323953,0.02223879255981948
48213,SIDM00971,Venetoclax,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.95271814,0.017068135,0.687887510069866,0.03945352899320767
81563,SIDM00411,AZD7762,Irinotecan,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.553717,0.08954308,1.4835252670331478,0.12395755693903884
42722,SIDM00332,Wee1 Inhibitor,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1035953,-0.081306145,-1.5152919098614686,-0.12438225410357716
45838,SIDM00893,JQ1,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.1713908,-0.0089157615,-1.7199171700374625,-0.06872070565296827
46969,SIDM00875,AZD8055,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.623663,0.066525415,0.5021187118284486,0.009999798821448363
73478,SIDM01233,Trametinib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,72.0,1.0312982,0.053059902,-0.9263676781848843,-0.05180618544395085
72885,SIDM00660,LGK974,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,1.4448867,0.060649186,0.7827783798573814,0.03388201323852442
58250,SIDM00834,Nutlin-3a (-),AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,White,66.0,2.6798306,0.10849317,1.362090237519246,0.07010502021448099
85426,SIDM00332,PD173074,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.475028,-0.14770943,-0.2965737737977193,-0.033546016398724066
87529,SIDM00529,Linsitinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.0686014,0.053652618,1.2503199677413903,0.02356993571615023
25271,SIDM00866,AZD8055,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-1.6023841,-0.048910305,-0.5899234560381608,-0.006354215113733008
77483,SIDM00673,KU-55933,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.7009317,-0.08699553,-0.3821426865104677,-0.013512040609969399
37784,SIDM00834,Linsitinib,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,-3.4681664,-0.1870426,-2.442523008601474,-0.09633894209824127
71828,SIDM00878,Luminespib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,2.130082,0.1112826,0.43508470638617375,0.05640334861864426
93181,SIDM00866,MK-1775,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-0.6604285,-0.045413397,-0.9409982801309364,-0.07501599803971018
68634,SIDM00332,GSK269962A,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0374069,-0.042808786,-0.2347885826873793,-0.0423015929191017
77182,SIDM00954,Lapatinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-0.82393324,-0.064947985,-0.29072039638811364,-0.02752387682830908
47414,SIDM00097,Alpelisib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.26465046,-0.018504344,0.18369662501520292,0.011929968382521368
80226,SIDM00660,AZD8055,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,32.0,-0.50778633,-0.03734065,-0.7112812455459436,-0.054233714487712345
47632,SIDM00954,NU7441,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.2310321,-0.09254262,-0.227671372906144,-0.029649767866305063
50718,SIDM00660,Crizotinib,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-0.5320678,-0.05860349,-0.5394807461077902,-0.08574004090069519
108222,SIDM00529,Nilotinib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.4048276,0.060532667,0.8440615131736042,0.10700774132747773
99822,SIDM00097,Venetoclax,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1920378,0.046555124,0.30717723996889496,-0.002348167603463459
32166,SIDM00193,BMS-754807,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.5978966,-0.11143952,-0.3096931460274534,0.01191027228457937
13794,SIDM00146,Entinostat,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,0.41999605,0.030334197,-0.5300039396615935,-0.006398529688241085
33546,SIDM00411,Cisplatin,Erlotinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,5.08894,0.170466,3.1760288185642227,0.08578653820095881
68171,SIDM00954,Nilotinib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,-2.3527458,-0.17840494,-1.324959077406974,-0.12902700267668513
74035,SIDM00774,Alpelisib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.3528994,0.10040573,-0.27298255160723706,0.04398467318988018
84982,SIDM00782,Afatinib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,1.3205564,0.10551554,1.369144283573542,0.058883580047889614
22776,SIDM00332,AZD7762,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.4728026,-0.16561264,-1.000038678904015,-0.04752474960986398
32740,SIDM00332,Afatinib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.61181766,-0.049394462,-0.5057442985011535,-0.03457612772830546
91072,SIDM00778,Nutlin-3a (-),5-Fluorouracil,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,2.307804,0.04671145,0.8326968207815303,0.007920237440965145
86820,SIDM00097,MK-1775,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.02239,-0.055040363,-0.9170023410398327,-0.034564811969239294
104481,SIDM00954,OSI-027,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.7827873,-0.07212134,1.4304164503004881,0.10522101902513586
3649,SIDM00359,Palbociclib,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.3304179,0.10226933,-1.2804783617705884,-0.08675616368212855
96228,SIDM00660,Vinorelbine,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-1.1994497,-0.09700115,-1.0264265636091376,-0.07860366371316321
64319,SIDM00628,RO-3306,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-1.6482953,-0.1293879,-0.4162446471479817,-0.08483146177672649
73870,SIDM00097,ZM447439,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9493237,0.049323864,-0.19218770020873663,0.014823977053482387
9414,SIDM00971,Docetaxel,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.8059136,-0.04956945,-0.713085462115578,0.018106424505605366
87957,SIDM00628,Wee1 Inhibitor,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-1.9369302,-0.109162204,-1.7382902733753427,-0.1007151642465012
64255,SIDM00146,Trametinib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.8856694,0.060556892,0.7149394817954537,0.030157752448430785
72029,SIDM00875,Bortezomib,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.4835231,0.04747696,-0.32947194427571763,-0.046287545627108885
3943,SIDM00774,PF-4708671,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.0123146,0.06028168,0.4611055744850331,-0.005134111656182223
50342,SIDM00971,Bortezomib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.8890065,-0.038907185,-0.3603324724358002,0.03585292268466189
86721,SIDM00878,Docetaxel,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-0.08319753,-0.009455771,-0.6149380858134819,-0.008067379146211077
92271,SIDM00628,Doramapimod,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.0692961,0.029895196,2.5740583379254867,0.09564159421809805
73025,SIDM00673,RO-3306,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.41131,-0.10139751,-1.0467469819681618,-0.04782727155283132
95107,SIDM00774,Taselisib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,-0.3823431,-0.015164246,0.055750017192931954,0.0240822677665757
103187,SIDM00971,Alisertib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,5.000552,0.18292181,1.4785134861580378,0.16338777483542855
25530,SIDM00146,OSI-027,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.9102736,0.078698404,0.9132848225305426,0.06479942332615499
38486,SIDM00971,Alpelisib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.8463851,-0.11383005,-0.3405101852908743,0.042471343438361626
66987,SIDM00097,GSK269962A,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5810298,-0.06944061,-0.5397526611435367,-0.03235517205809219
77746,SIDM00774,Paclitaxel,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-0.854156,-0.03509269,-2.544148197585793,-0.0666039227209814
13037,SIDM00971,Alpelisib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.6285601,-0.108520836,0.5645011971229568,0.055041163522851995
86673,SIDM00866,SCH772984,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-2.89396,-0.09796031,-0.701447324622938,-0.019397157028924306
20600,SIDM00673,Olaparib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.8910099,-0.08678237,-1.0931106057793891,-0.052342208866898714
75978,SIDM00529,Alisertib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.7324861,-0.15727039,-2.2505298939594103,-0.08391546941761022
986,SIDM00875,Axitinib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8307524,0.0647076,0.08828078852028062,0.02634755548160523
1688,SIDM00359,SCH772984,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.0573575,-0.13040504,-4.517625249406767,-0.12159057928183291
32900,SIDM00779,Trametinib,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-0.49787778,-0.005972532,-1.4406188910725501,-0.07136339186884239
62473,SIDM00782,Nutlin-3a (-),SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,1.1755329,0.027715493,1.4394017962605803,0.026223433583582992
104656,SIDM00097,Taselisib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6364512,-0.10969879,-0.7439228941080419,-0.05640748536823991
61693,SIDM00673,Wee1 Inhibitor,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,2.9269028,0.1874246,-0.827170790559493,-0.07124900500446714
83237,SIDM00193,Oxaliplatin,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,53.0,1.2751789,0.0587283,1.217206792181087,0.03522270954575777
66971,SIDM00301,MK-2206,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.0662705,-0.108637005,0.8921926096709599,0.1057556577929131
83815,SIDM00531,AZD7762,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.77239454,-0.03803063,-0.5295008901666104,-0.01195436214753643
23614,SIDM00660,Camptothecin,5-Fluorouracil,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-1.3972844,-0.0828573,-1.1370730875926685,-0.039622112875475984
4417,SIDM00971,Doramapimod,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.5225985,-0.04765931,1.3580433146589572,0.10591750289688456
17566,SIDM00332,Docetaxel,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-4.151204,-0.30628416,-3.4203502110872703,-0.2812654404041235
4951,SIDM00628,Nilotinib,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.4732945,0.045932557,0.3424371722148677,0.05843097365162796
95280,SIDM00776,SCH772984,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.6617754,-0.14188236,-1.296512864343103,-0.07814171830593425
90616,SIDM00954,Alpelisib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-2.9172256,-0.20276475,0.2707769427475659,0.0706279993916882
76535,SIDM00954,Trametinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,4.69638,0.2656323,0.19486663213521202,0.04742236147310771
81988,SIDM01233,MK-1775,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-0.15780759,-0.012065582,-0.8805321278525907,-0.06525434121582063
1487,SIDM00146,Nilotinib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-3.1135795,-0.25167048,-1.5216270443787707,-0.09490329445055463
103775,SIDM01233,Camptothecin,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.5405391,0.05860389,2.8432731657993875,0.04944220262821676
36545,SIDM00782,LGK974,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,-3.2436364,-0.145534,-1.7542292652967673,-0.053872816557923135
22435,SIDM00628,AZD6482,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,Black,51.0,-1.0566539,-0.10251889,-0.5893704414848342,-0.02295885131090514
12239,SIDM00971,Lapatinib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.82296926,-0.0421996,0.025155183509505328,0.029664611351070843
80839,SIDM00774,Cisplatin,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,2.0198567,0.04811427,2.36381877482889,0.08401504563927512
105621,SIDM00834,MK-1775,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-1.2728466,-0.104850434,-0.827402777765832,0.012605312155473676
62600,SIDM00778,Camptothecin,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,69.0,-2.1188936,-0.073905885,-0.8306438597520744,-0.04985033605866464
39578,SIDM01233,Afatinib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,0.8972316,0.07319904,0.32890209569133305,0.04083620843551579
87434,SIDM00529,Pictilisib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.0734121,-0.06830969,-0.5010737783607602,0.02084041361400081
60311,SIDM00332,BI-2536,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-6.955772,-0.4497956,-1.7012404184202554,-0.10102748346826187
24625,SIDM00146,BI-2536,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-2.9222455,-0.13351786,-3.2453241248862876,-0.14273654099123703
83934,SIDM00146,AZD7762,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,1.0137372,0.09491423,0.41228904335630523,0.05956726589354314
37357,SIDM00893,GSK269962A,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.2969007,0.02364525,-0.4376182597192422,0.009828762764739435
62045,SIDM00866,Tozasertib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,52.0,-1.4493618,-0.07982734,0.06661768276165039,0.04576020271866871
96681,SIDM00531,Crizotinib,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-2.1056345,-0.12313913,-0.9152110227367042,0.011001274699888153
30404,SIDM00359,Trametinib,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.0667205,0.04490546,-0.03218654582802259,-0.015421845690029303
56947,SIDM00779,Nutlin-3a (-),BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,1.3734318,0.020929424,1.9972250595301078,0.09719967765607852
94299,SIDM00332,Venetoclax,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.07667,-0.02783223,1.0027534193274974,0.020584365093665655
90805,SIDM00628,OSI-027,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-1.1386579,-0.04747268,-0.018702256703972915,-0.022145082262728107
3698,SIDM00774,Ribociclib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,48.0,-1.2292314,-0.04500697,-1.2736268534805664,0.00018199829110104846
57024,SIDM00411,Gemcitabine,Dactolisib,Pancreas,0.0125,Pancreatic Carcinoma,Male,East Asian,43.0,0.4397804,0.027190438,-0.12805051472548262,0.053367817774477494
21514,SIDM00301,MK-1775,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.88627553,0.08725743,0.07097524441192547,0.009061965091570985
8273,SIDM00774,Afatinib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-2.4519582,-0.126598,-0.4413049492703658,-0.006058784418462738
24399,SIDM00301,Olaparib,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.4688022,-0.09680018,-0.30785809350638815,0.019982610950935353
62610,SIDM00866,Palbociclib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.1037009,0.037078116,0.2815561871866353,0.03319565317102478
52293,SIDM00779,Palbociclib,AZD4547,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-2.0332851,-0.040750496,-1.0789091196531566,0.012827859887449954
16349,SIDM00971,MK-2206,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.6963595,0.11442552,1.0214373133249584,0.08326481669916384
100398,SIDM00954,Sorafenib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,0.2006048,0.015010757,-0.8252058664251674,-0.029203461441510144
5511,SIDM00878,Navitoclax,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,0.19894952,0.0048614144,-1.4783723149577417,-0.1128745163498776
95066,SIDM00193,Linsitinib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.6303721,0.02326141,1.2918527377294984,0.06862121382249325
18209,SIDM00332,Tozasertib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.40008575,0.027006336,0.3187549657050464,-0.022085253009660976
46582,SIDM00971,Luminespib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.6767945,-0.10029771,0.22477895795646988,0.0357210462804057
95337,SIDM00893,Nilotinib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.4427369,-0.17752832,-1.3459916932702904,-0.1154108754162605
79701,SIDM00878,Dabrafenib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,0.2593252,0.0079170065,0.23748045997471187,-0.018574769740158984
28913,SIDM00779,Nutlin-3a (-),Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,0.85438067,0.013599988,1.9869982878399173,0.11921815371375091
58355,SIDM00778,5-Fluorouracil,Taselisib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,-1.290115,-0.03761839,-0.3554554543443723,-0.01719617860382004
106616,SIDM00893,Palbociclib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.0146655,-0.039660655,-0.5632343017786227,0.022461978254133964
61,SIDM00893,RO-3306,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.8952448,0.21556307,2.6983922467049286,0.18251231340432508
62181,SIDM00774,Gemcitabine,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,1.9788142,0.20779675,1.837604384457302,0.20858490311961808
103076,SIDM00954,Uprosertib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,-0.0047816173,-0.00041201577,-0.3698305605168842,-0.019760906607284506
1967,SIDM00130,Olaparib,5-Fluorouracil,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.9662931,-0.096289665,-0.7630622200455791,-0.0004496548388239398
90564,SIDM00878,KU-55933,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,3.2352602,0.16807498,-0.39919002464716863,0.021619566487839886
67264,SIDM00893,Bortezomib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.8886159,0.07886954,-1.0522095936756657,-0.02388598018353067
10133,SIDM00878,Uprosertib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-0.7638585,-0.038468,-1.0827946517807907,-0.045034156019074706
38977,SIDM00411,Olaparib,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.432919,0.07154725,1.3853281415774013,0.03340441147456324
54679,SIDM00866,Pictilisib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.9481113,-0.063566424,-0.5295858414232565,0.0016149495179595289
62715,SIDM00954,Sorafenib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,2.3502452,0.13977815,1.0450425289126841,0.11774953081301727
93865,SIDM00866,Dabrafenib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,52.0,1.5755063,0.06497898,0.3931326942616379,0.014986013288569985
55115,SIDM00878,Alpelisib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.21938655,0.020449338,-0.9892107801625556,-0.01184786758949828
42059,SIDM00146,MK-2206,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,3.1012754,0.24185249,2.1366089637002323,0.1759300081160374
100167,SIDM00628,PF-4708671,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-0.35201436,-0.03352007,-0.16676101562245949,0.001462005479855248
14095,SIDM00776,SCH772984,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-4.1038494,-0.23098363,-2.22938641965755,-0.10229643802280042
71024,SIDM00779,Dabrafenib,5-Fluorouracil,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,1.7878034,0.15372117,-0.7150621999146319,-0.01904611414097673
15719,SIDM00097,ZM447439,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.650028,-0.067998536,-1.0831227591642878,-0.0528487253589608
76770,SIDM00673,Paclitaxel,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.3401098,0.14504012,-0.7195613622229434,-0.03429063236932928
67846,SIDM00875,Alpelisib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3944407,0.12815662,0.9905144393922872,0.05751858792339177
77651,SIDM00529,AZD6482,Trametinib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,1.4102694,0.056248836,1.542898715171769,0.10303932153731768
13499,SIDM00628,ZM447439,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,-0.3800813,-0.03496069,-0.3124441962148873,-0.022989406823770778
39841,SIDM00097,Gemcitabine,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.4279444,0.044450328,-0.2762169224734653,0.02642687785532211
14955,SIDM00971,Afatinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.0065029,-0.089820534,-1.5477888323241993,-0.018356418564358563
16252,SIDM00893,Lapatinib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.6925963,0.12931487,0.03044974296869057,-0.018053230137667596
99651,SIDM00774,SCH772984,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,1.6974479,0.032593265,1.8967675503346968,0.09046203556579153
85674,SIDM00673,Lapatinib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-0.4198661,-0.03817691,-1.1093143880410332,-0.07715223482196365
53844,SIDM00673,MK-2206,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.5418376,-0.11956165,-0.9350571537205377,-0.10045965109670713
81940,SIDM00130,Oxaliplatin,OSI-027,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.003162,0.090994366,-0.5831589511503457,-0.03943905313133826
98293,SIDM00954,Ribociclib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,0.18311183,0.0059327628,-1.5122691373386006,-0.02141600015588299
98995,SIDM00673,MK-1775,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.93854773,0.09075327,-0.20025802892409714,0.00954175393058045
36143,SIDM00779,Palbociclib,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-2.5720499,-0.20772149,-1.3883001408098774,-0.10787829862442226
61375,SIDM00097,Olaparib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2695943,-0.020039639,0.7694716338183656,0.014388596277083674
21484,SIDM00893,Navitoclax,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.7972544,0.08450732,0.4289395879011697,-0.021625963729880942
59819,SIDM00954,Lapatinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,1.8817335,0.11010006,0.789530557739649,0.06783017369911722
104638,SIDM00875,ZM447439,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7107781,0.04710102,-1.9824467240287111,-0.12399343890027476
34261,SIDM00301,Erlotinib,Gemcitabine,Pancreas,0.1,Pancreatic Carcinoma,Male,East Asian,50.0,1.0738472,0.042419568,2.5082394146903066,0.03702296736334077
73162,SIDM00673,Doramapimod,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,2.3861375,0.06366326,3.7049062270050284,0.17696860918002888
17341,SIDM00531,Linsitinib,Palbociclib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.2731678,0.08902072,1.5100937178635636,0.117159291927655
79937,SIDM00628,PD173074,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,0.799993,0.00951494,1.557849744828166,0.08288165300226633
28158,SIDM00875,PD173074,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0173136,0.06855869,-0.19371304677351356,0.04152892819030629
31288,SIDM00774,Lapatinib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.1710032,0.09921801,0.1568273607546311,0.04180902597787641
5090,SIDM00778,Afatinib,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-0.6390423,-0.04135251,-0.5525611200520923,-0.042931767973004485
96594,SIDM00954,Taselisib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.0,1.4525113,0.06649342,1.6919091995247557,0.17451164701954355
25420,SIDM00301,Crizotinib,MK-1775,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.896349,-0.14978527,-0.7597907271339759,-0.04888821214920038
576,SIDM00130,Paclitaxel,Irinotecan,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.1294872,-0.11501335,-3.808171204740251,-0.2465258338008111
86891,SIDM00332,Cisplatin,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.409623,0.038113654,1.2531725608477162,0.04528290753655273
103644,SIDM00875,Trametinib,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5521308,-0.061323076,-0.362513967764155,-0.02536410528562977
69479,SIDM00146,Palbociclib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.3659106,-0.024143392,-1.692466946371727,-0.06006925636008759
70924,SIDM00529,JQ1,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Black,44.0,1.9146821,0.15897015,1.6377277068888358,0.16960747563361794
1113,SIDM00628,GSK269962A,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,Black,51.0,0.53154296,0.05224409,-0.17788180624573446,0.0029512766449923283
96256,SIDM01233,Dabrafenib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.5042387,0.059992444,1.3242921951261615,0.07316470054377354
94477,SIDM00332,PF-4708671,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7617048,0.025512427,0.27691778039565046,0.05893405455196482
60488,SIDM00971,Axitinib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.6806925,-0.024930969,-0.6282426211306109,-0.031032980855940764
30276,SIDM00411,Linsitinib,Oxaliplatin,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-4.373914,-0.16096427,-1.369040079969289,-0.013082375189135164
6337,SIDM00332,Vorinostat,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.5811434,-0.2568755,-0.3476871817570144,-0.0776637609167291
78840,SIDM00779,AZD7762,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,1.1724033,0.08931816,1.1115632005341591,0.06852208124405092
24867,SIDM00954,Alpelisib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-1.6441453,-0.11515048,0.2793345556833611,0.003806976373999518
70302,SIDM00359,Dabrafenib,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.99870986,0.056737673,-1.4485934720302043,-0.04319044789814583
72908,SIDM00834,Afatinib,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-1.6172204,-0.11325757,-1.5316768227560151,-0.04334896231513392
14781,SIDM00866,Venetoclax,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,0.78585935,0.019024523,0.5406264213435139,0.057841324582948356
60758,SIDM00660,BMS-754807,MK-2206,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,5.8890896,0.35181862,-0.07202959166131086,0.022866852025412197
41045,SIDM00146,Uprosertib,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,-1.5740068,-0.10483441,-0.3085849263768171,0.06371224798649151
21021,SIDM00875,PF-4708671,Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.3720931,-0.047651663,1.4105332999525548,0.0546982479559137
93143,SIDM00673,Docetaxel,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-5.857934,-0.44181535,-2.646141600248155,-0.22678611882573482
19835,SIDM00097,Nilotinib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0647606,0.078240745,-0.05197217867781232,-0.04722633648510689
25773,SIDM00893,Taselisib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.4288855,0.024000576,-0.8166673229591815,-0.0496306168050349
12689,SIDM00301,Paclitaxel,Oxaliplatin,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.7806451,-0.089043364,-2.96077914901348,-0.20078219488260143
84476,SIDM00673,Tozasertib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-3.952561,-0.14440453,-1.4357686509398189,-0.06452767160188545
76379,SIDM00866,5-Fluorouracil,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-0.64229226,-0.028193498,-0.0399373889526606,-0.024263636828604076
54535,SIDM00411,Palbociclib,Cisplatin,Pancreas,0.8,Pancreatic Carcinoma,Male,East Asian,43.0,-4.1572676,-0.14532821,-2.9077239352776827,-0.08282148555048344
106954,SIDM00971,Alpelisib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.5275427,-0.057899103,1.034260763817497,0.06404106588259859
25992,SIDM01233,Taselisib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,72.0,-1.1568184,-0.100730084,-1.8268742411748857,-0.10784329894405555
13757,SIDM00878,AZD8055,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.4587502,-0.13019007,0.1191837619689398,-0.03596511449341741
2789,SIDM00531,OSI-027,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.8088676,-0.029877117,0.5819346981197384,0.06555302844579916
40692,SIDM00971,Linsitinib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.7764164,-0.026704969,-0.055868031376427936,0.02619424249198333
85737,SIDM00146,Trametinib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.8481585,0.105914384,-0.25702298685987285,-0.04631851813109214
74007,SIDM00875,MK-1775,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.38627657,-0.022470167,0.02566222968601783,-0.0027884282809681874
75464,SIDM00146,ZM447439,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,0.7888449,0.05783752,1.038703499688034,0.04928654511666895
28467,SIDM00866,KU-55933,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,2.0051556,0.12208187,-0.5646561119499287,-0.017455153502488524
91630,SIDM00875,MK-2206,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2267729,0.10600148,-0.14058435360015872,-0.0015253960791063402
1859,SIDM00875,Crizotinib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.61878943,0.05695625,0.623294329882758,0.020063496957472178
30633,SIDM00878,GSK269962A,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.9796713,-0.08806334,0.3048502357922456,0.0007680124991127593
68974,SIDM00875,Alisertib,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.52807957,0.05111058,-0.1836082546472076,-0.01765164740677926
102539,SIDM00782,Afatinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.8572845,0.15914775,2.2216168595616983,0.12886029431315416
88680,SIDM00778,AZD8055,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,0.8809088,0.054139014,2.731654266798815,0.10425169448806806
107359,SIDM00130,Trametinib,Oxaliplatin,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.0393145,-0.14245947,-2.2854854058237164,-0.10604181425254497
96034,SIDM00866,Nilotinib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,1.2963535,0.06826437,-0.4774239655817289,-0.01793370474729897
30768,SIDM00774,AZD6482,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,1.585214,0.104644924,0.8349103535784166,0.0899576810014601
67813,SIDM00411,LGK974,Palbociclib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.8260791,-0.06155706,-0.8599551600529962,-0.03142929668726145
41500,SIDM00866,RO-3306,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,-3.1018362,-0.14761187,-0.16064336559188386,0.0125241670948084
57942,SIDM00660,BMS-754807,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,32.0,-0.6970453,-0.0742912,-1.9820676157387023,-0.12040704281856969
20982,SIDM00529,Linsitinib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Black,44.0,2.0384321,0.112585545,1.0611974188834323,0.09025375598284009
57131,SIDM00332,PD173074,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-6.4143014,-0.25101975,-2.7221167082676376,-0.10170355028398849
58520,SIDM00529,OSI-027,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.062183935,-0.0057042665,-1.1807025782015401,-0.06700747478791756
74782,SIDM00531,MK-2206,Ruxolitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.4218279,-0.064209916,0.20222778727337415,0.04038235159220365
19441,SIDM00130,OSI-027,Ruxolitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.9212753,-0.0859818,-0.7705823247472442,-0.07263526671261367
54656,SIDM00954,Temozolomide,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,0.324319,0.0056140353,1.7091413362611028,0.06283128016039306
31580,SIDM00529,MK-1775,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-0.1142586,-0.011224097,-1.1219633907348872,-0.041380227577610985
96692,SIDM00776,AZD8055,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-2.4530976,-0.17048283,-0.000825738808766115,0.009578227136331219
64878,SIDM01233,Vinorelbine,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,3.737138,0.30600414,3.9989427391124774,0.21355667350720675
9932,SIDM00866,Alisertib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-2.7514532,-0.15324852,-1.1211832059081097,-0.054570759775615804
56076,SIDM01233,SB505124,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,0.9787695,0.035726245,-0.6701701845166413,-0.0823059013606596
14589,SIDM00660,AZD7762,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.59189403,0.054178335,0.5476144592070288,0.035356581792598755
8524,SIDM00779,Dabrafenib,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,-3.0830927,-0.084492475,-1.2599473071946652,-0.02751855240590208
81285,SIDM00834,BMS-754807,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,White,66.0,1.291591,0.09647603,0.7903206355643855,0.029167087434073452
26234,SIDM00779,LGK974,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,1.5027686,0.05972562,0.16402253130817976,0.02286855367645705
101510,SIDM00411,Dactolisib,5-Fluorouracil,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.9664961,-0.05349425,-1.253719282444867,-0.07836956353892803
36242,SIDM00332,MK-2206,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1042948,0.110012375,-1.5437564186572705,-0.07871339539010185
73382,SIDM00332,Camptothecin,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.5730715,0.088049576,1.9903457872381654,0.05995122182079353
51309,SIDM00529,NU7441,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Black,44.0,0.6000268,0.050109025,-0.28010841530455693,0.04663044076754547
5876,SIDM00782,MK-2206,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.3718804,0.10606399,1.7376576174814673,0.09664736640985584
30836,SIDM00878,Entinostat,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.6426857,0.03464732,0.3628704990104933,0.029879476802597105
5885,SIDM00971,PD173074,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.7067548,-0.016965088,-2.0602408200500153,0.0022681371681120828
33999,SIDM00971,Trametinib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1196426,-0.016160129,-0.47842823252167804,-0.0017018627073418487
85835,SIDM00673,NU7441,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,0.38228244,0.029290663,-0.450008832873036,0.006516579909213947
101063,SIDM00673,Palbociclib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,2.0405045,0.09004447,0.7994571637366521,0.05499013102077788
18075,SIDM00954,ZM447439,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,0.91987973,0.056784865,-0.029152095530078366,-0.0060826300133412555
35550,SIDM00130,AZD7762,LGK974,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.62283206,0.06368432,0.08737510618257914,-0.008344533775041851
46288,SIDM00673,Pictilisib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.290348,-0.16944328,-0.46934602524825414,-0.05251540520375229
104950,SIDM00531,Lapatinib,Dactolisib,Pancreas,0.0125,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.2846588,-0.07586599,0.423103992212347,0.018357762346845247
16907,SIDM00673,PF-4708671,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.4312913,-0.07765865,-0.7365717898975198,-0.050168519122903626
36540,SIDM00673,KU-55933,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.74450195,-0.047291096,-1.2863526084493522,-0.06295634704458823
61376,SIDM00193,Olaparib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,53.0,-1.1411368,-0.035930783,-1.078747413589506,0.0025404390852058595
91337,SIDM00875,NU7441,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.1932168,0.21453698,0.8689007460183727,0.05610048340393398
106625,SIDM00359,LGK974,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,4.7557263,0.21789034,1.0708446816694597,0.07257857312892538
88739,SIDM00878,Temozolomide,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-0.60561866,-0.01567888,0.9697679339522548,0.03162090000142046
99396,SIDM00673,Linsitinib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,0.5846663,0.011640673,2.995849347489752,0.08904105121434241
83090,SIDM00866,RO-3306,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-3.3970091,-0.17661572,-1.7216399895471526,-0.09702740832025236
26635,SIDM00878,Palbociclib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.8023866,-0.04070376,-0.7922195842399783,-0.009573429096160284
6835,SIDM00529,Temozolomide,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-0.5229781,-0.010670996,-0.6455771954241439,-0.0010559549650610628
67000,SIDM00866,Linsitinib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,52.0,-2.0218954,-0.102568574,0.3220105927076649,0.01635985404774223
82232,SIDM00893,Palbociclib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.69765836,-0.029190788,-0.5121451957233211,0.04310305240551311
52029,SIDM00954,Gemcitabine,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-2.6386583,-0.11489501,-0.7971918525109385,-0.07680586678690535
51358,SIDM00146,Ribociclib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,0.25805655,0.011873405,0.30634052255970423,0.0714635581453025
50484,SIDM00531,Sorafenib,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-2.2833848,-0.09568627,-0.29926382627308085,-0.0432663338736489
37585,SIDM00779,Olaparib,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,1.5848868,0.016762335,1.05177002230906,0.02909597680745697
90088,SIDM00097,Doramapimod,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.35939002,0.010673498,1.0971680229669183,0.04158169040001843
36095,SIDM00332,JQ1,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0867429,0.04988954,2.4430772329551154,0.09442678259827994
494,SIDM00954,Pictilisib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-2.519919,-0.18655722,-0.36741187964303806,-0.06281999667915884
63029,SIDM00097,Gemcitabine,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2393761,0.053497426,-0.14516763771712207,0.023152621816795796
73947,SIDM00332,Dabrafenib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.8027831,0.12496634,0.11589544172400662,0.013094984601643798
100553,SIDM00673,Trametinib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,3.0465298,0.1904383,1.3384617724798609,0.04510230721024818
40007,SIDM00774,RO-3306,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,1.5334644,0.06962439,0.05181399530153539,0.01687710707271028
90129,SIDM00628,ZM447439,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,1.0178257,0.069034636,-1.2752589997614094,-0.0714010553424375
99589,SIDM00954,MK-1775,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,1.6990864,0.044950064,0.9633469324006398,0.07513347049818993
76773,SIDM00893,Alpelisib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.5218251,-0.042165298,-0.8792660808718119,-0.07356662953727856
70154,SIDM00628,Afatinib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,1.0433865,0.05766537,0.36046535166688615,0.024004343002420395
16427,SIDM00971,Sorafenib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.9722791,-0.048780795,0.10586255610988159,0.018865059117268764
39259,SIDM00628,ZM447439,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-1.541117,-0.12310839,-0.5166219818542546,-0.048708251435162914
52273,SIDM00531,LGK974,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.0004689,0.11052,-0.28834632920110126,0.020681297920220144
747,SIDM00878,Wee1 Inhibitor,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.65069,0.03936297,-0.41389136808850163,-0.02588383451466961
37106,SIDM00673,MK-1775,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.8177503,-0.07836518,0.5689327635762451,0.07464110916951082
99342,SIDM00866,BI-2536,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,-5.6125894,-0.3023839,-0.4439385101340494,-0.045250555159415735
15974,SIDM00359,Olaparib,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.5929496,0.038196635,1.8985259203817604,0.019949343243055993
106673,SIDM00673,Pictilisib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.77643687,0.065797456,-0.3682929222980965,-0.015942333192112242
104414,SIDM01233,Navitoclax,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,-0.2928092,-0.023005627,-0.20513776688635396,-0.07101442541028692
2277,SIDM00878,MK-2206,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.5822041,-0.19238792,-0.8410381660743159,-0.06766246735355362
55648,SIDM00834,AZD8055,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,1.3585572,0.111706115,-1.8981797662285658,-0.1392393201058889
61623,SIDM00411,Dactolisib,Palbociclib,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.0302421,-0.04490022,-0.20679619835519983,0.01881438279420442
10703,SIDM00628,Alpelisib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.42939073,-0.02250141,-0.09733465518496105,0.01979654806391365
13393,SIDM00971,PD173074,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.3583049,0.043361336,-1.6307994176281155,-0.0011907685570207067
76331,SIDM00971,AZD7762,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.4170259,-0.008624922,1.125349235988204,0.07788158388009622
20263,SIDM00097,Camptothecin,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.354557,-0.0965308,-1.305078181425492,-0.015240305416374599
32260,SIDM00866,GSK269962A,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.7050837,0.09022873,0.30673591042795484,0.040678780532947996
88250,SIDM00411,Olaparib,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,3.4850864,0.09881682,1.3764902082256263,0.03299111291093017
45146,SIDM00875,MK-1775,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.48403668,-0.01344216,-0.6584947657134458,-0.04140701320960002
16473,SIDM00971,Sorafenib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.6271424,0.04456207,-0.060550720045291904,-0.025727940545449742
93953,SIDM00774,Doramapimod,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.5704217,-0.08798998,-1.2008382006928255,-0.005488263664176443
102876,SIDM00954,Axitinib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.82366043,-0.038489416,-0.5196274085880044,-0.04345142137158863
28492,SIDM00130,Crizotinib,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.4449694,-0.105873905,-0.9574294561321447,-0.06462620904625414
35904,SIDM00130,Paclitaxel,Gemcitabine,Pancreas,0.1,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-4.3503437,-0.17442076,-3.8926267556001353,-0.2431647316048198
20256,SIDM00875,Luminespib,Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.38396943,0.04125416,1.0901578397718223,0.07545358133960801
40242,SIDM00097,NU7441,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5229734,-0.070218995,0.6527861000705394,0.03020895825390745
21235,SIDM00332,5-Fluorouracil,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4834926,-0.06746776,-0.5175625019541057,0.010476212635591035
31892,SIDM00097,Navitoclax,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.24038391,0.017618822,-0.008620755293284139,0.014227439057686564
58576,SIDM00834,SCH772984,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,White,66.0,0.90163,0.06832545,-0.4692737081453875,0.0014961296549461482
98575,SIDM00893,Ribociclib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.6850827,-0.07526575,-2.208062718841579,-0.07842807533772475
21777,SIDM00146,Dabrafenib,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,2.8192518,0.17786713,0.7602167667442847,0.09042040354080466
73368,SIDM00097,Trametinib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.86483866,-0.02670111,-0.7131413603793028,-0.01823329619972077
48131,SIDM00954,Nilotinib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,1.187447,0.10033424,0.5171177651996499,0.03907746730965018
33282,SIDM00146,GSK269962A,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.0776863,0.09120463,-0.6818245439800902,-0.028943196873350067
13648,SIDM00782,Oxaliplatin,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.3175164,-0.045054857,-0.8354537870049814,-0.017166953968580534
66748,SIDM00878,Camptothecin,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,1.7577603,0.056738626,2.185150464055597,0.06583970988195739
58054,SIDM00971,Sorafenib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.5704244,0.03712868,0.2741090528202195,-0.01081001299907346
94071,SIDM00130,MK-2206,LGK974,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.5429752,0.15779619,-1.4996228516419505,-0.06336920118322559
83828,SIDM00971,OSI-027,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.68522793,0.03846956,0.46194107811985485,0.07287542818585872
9045,SIDM00673,5-Fluorouracil,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,3.604302,0.23435366,0.2733383884803651,0.008682489631810909
6724,SIDM00529,Nutlin-3a (-),Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.2405689,0.063466564,0.7680454086462183,0.04634655353511678
49366,SIDM00531,SCH772984,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,4.8601584,0.53827524,1.888920278218471,0.1013872079531761
84090,SIDM00893,AZD6482,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.09231931,0.0036236811,-0.9308073231707068,0.02393211883395143
75732,SIDM00774,Trametinib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.1216862,0.04177128,1.8710103668497897,0.10630945041807772
65647,SIDM01233,Linsitinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-0.10006773,-0.005775902,0.645981598329392,0.007373942104623682
91110,SIDM00146,Luminespib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.5642399,-0.049781546,-0.890662983981397,-0.0340618536945269
49798,SIDM00971,ZM447439,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.5589789,0.08590307,-0.06837127986589307,0.010760612447004372
71525,SIDM00673,Venetoclax,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,3.548266,0.17639951,-1.291033034511892,-0.010975149895030607
60893,SIDM00673,MK-2206,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6980052,-0.037210062,-1.4209623397412061,-0.13158923525850869
38289,SIDM00332,KU-55933,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.6500015,-0.031370662,0.2813575003550121,0.02358582839187369
26518,SIDM00893,KU-55933,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.4487777,-0.073340744,-1.1331313011923156,-0.05800205741850271
72220,SIDM00673,GSK269962A,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.4263942,0.15288088,-0.5688548687191561,-0.0695737862098448
88589,SIDM00774,OSI-027,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.5421585,0.06610506,0.4856114068057086,-0.0007457079738271393
95833,SIDM00628,Camptothecin,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-0.58315605,-0.058929715,-0.7516400888988544,-0.056163822211610315
18534,SIDM00628,Cisplatin,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,3.2784817,0.22768024,1.3456074689266464,0.06630461460544905
56640,SIDM00875,Sorafenib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.1767774,0.24439603,1.3906129606298394,0.12431243044746458
93461,SIDM00529,Axitinib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-1.9913774,-0.095815636,-2.699830615558052,-0.11711403209274748
92878,SIDM00529,MK-2206,Trametinib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,1.5685161,0.08231974,1.2684882352586087,0.1398941086958942
93273,SIDM00776,Dabrafenib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,-2.04538,-0.064307146,0.033240729188148514,-0.010157276457945267
21539,SIDM00332,GSK269962A,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0436212,0.060498044,0.06938605416409888,-0.04250296393121528
45950,SIDM00332,Afatinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.0017378,0.14992118,0.8835805394652779,0.11248920383730389
95006,SIDM00673,SCH772984,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-4.949192,-0.30828577,-1.419435237398591,-0.07711524483250072
4412,SIDM00660,Trametinib,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,3.1425037,0.12851682,-0.5885235819741709,-0.03131350864139986
102104,SIDM00971,Olaparib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.3993944,-0.028420124,-0.42268350562364077,0.006652364985785181
37242,SIDM00332,Olaparib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5220289,-0.032629643,0.12274564729705656,0.0034407389664357626
74839,SIDM00971,Bortezomib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.7025756,0.08686224,-0.5699781484866938,-0.01074753079915043
91689,SIDM00954,BI-2536,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-1.175217,-0.024740305,0.6510573393879433,0.012145655849308705
11261,SIDM00146,Camptothecin,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.751311,-0.06379832,0.3315038631141341,0.04577107806177476
100740,SIDM00834,Oxaliplatin,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-1.9573985,-0.13498117,1.0910068743461405,0.06546625739096865
34168,SIDM00971,Vorinostat,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.4148039,-0.06404079,-1.0197816681389056,-0.05076830033667109
26774,SIDM00778,SCH772984,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,1.7846898,0.07002704,1.7349691574028934,0.0326356767329557
72259,SIDM00130,5-Fluorouracil,LGK974,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.3428278,-0.12493264,-1.2277544356161125,-0.07505689385437907
34478,SIDM00529,AZD7762,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Black,44.0,2.4901776,0.11430971,1.0687759284405587,0.057453301335978355
52318,SIDM00332,PF-4708671,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,3.5797682,0.16439764,3.524408980865599,0.1618516289565096
33903,SIDM00411,Paclitaxel,Oxaliplatin,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.8761864,-0.091176644,-2.8708326970240328,-0.1291325215429447
73101,SIDM00146,MK-2206,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.1096876,0.1620049,-0.1483920249427711,0.07821965470844014
41974,SIDM00878,AZD6482,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-1.7626269,-0.10128935,-0.3351567613221723,0.006089980704621747
35206,SIDM00866,Alpelisib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.5485021,0.111008026,-0.1087617200198061,0.03222967029927798
107625,SIDM00875,Doramapimod,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.5973787,0.096773036,3.0373421654713035,0.11074190390119291
63475,SIDM00782,AZD4547,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,Unknown,72.0,-0.6424285,-0.018016206,0.07681503957406188,0.01927870719992639
52894,SIDM00774,AZD6482,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,-2.0439985,-0.103829235,0.22612416679359884,0.06511479133299541
4323,SIDM00866,Camptothecin,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,5.6458893,0.10402742,6.404222461575526,0.15250436673924261
3225,SIDM00628,KU-55933,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,Black,51.0,0.86434585,0.06079934,-0.06201557188403334,0.0240468263290874
41552,SIDM00332,Pictilisib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4160076,-0.14557903,-1.7431809606934205,-0.1129815687827624
72861,SIDM00954,BI-2536,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-7.2684207,-0.4143354,-2.7943040608708087,-0.07493633864658217
52493,SIDM00411,MK-1775,Palbociclib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,-4.366691,-0.2045601,-2.920790125817419,-0.13266535997950887
87212,SIDM00332,Bortezomib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8524432,-0.05342225,-0.06707205336912403,-0.004745911870643812
5497,SIDM00774,Paclitaxel,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,0.75625396,0.024881858,1.4650403418471802,0.1316569592429211
9555,SIDM00774,Temozolomide,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,2.3283296,0.115041055,0.25917730733648897,0.013012273466404354
20907,SIDM00878,Venetoclax,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,2.9375389,0.11357085,1.8768094815362244,0.07328217030179406
87525,SIDM00878,Nutlin-3a (-),Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.55691624,-0.020097716,1.2414931118498378,0.023241345722255134
42775,SIDM00529,BI-2536,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.8898163,-0.07644321,-1.020058002974717,-0.08061031356302273
24888,SIDM00782,Crizotinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.1200733,-0.007270817,0.38917787019120326,0.03036725365176545
102910,SIDM00531,Dasatinib,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.2440984,0.2082007,1.6221604976630961,0.1336953171863839
11257,SIDM00954,Taselisib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-2.7278433,-0.15515764,0.08085144055324173,0.03833384832833097
48824,SIDM00971,SCH772984,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.5968035,0.0122960545,1.3965481947613994,0.05580351177789968
53774,SIDM00660,AZD8055,LGK974,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-0.16404763,-0.01474938,-0.5322765178583858,-0.014934995438146907
94858,SIDM00673,GSK269962A,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.222273,-0.084581055,2.725375826420286,0.16451853040724282
85143,SIDM00776,AZD8055,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,6.862506,0.12289594,-0.023549351411904788,-0.0074063613469183024
92126,SIDM00971,NU7441,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.5933267,0.07861042,0.4320849979194774,-0.0028702057800656503
96042,SIDM00875,Nilotinib,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.884992,0.09338801,-0.4545197289268813,-0.047348520040774535
31609,SIDM00834,Vinorelbine,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,1.1621342,0.062534995,1.280342963113138,0.08385535418794945
108212,SIDM00411,Ruxolitinib,Trametinib,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,43.0,1.4741056,0.030924758,1.7567748188098247,0.048384768389314395
12717,SIDM00097,OSI-027,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.917571,-0.10127285,1.776393278673376,0.049201286485979094
32618,SIDM00774,AZD6482,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,1.089024,0.071961105,0.8237810030035219,0.07432967254480487
26451,SIDM00529,Lapatinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-1.4223323,-0.08345223,-0.45538945415406806,-0.009268155912671055
41797,SIDM00628,MK-1775,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-1.3841958,-0.09464876,-2.2112814897744584,-0.1232105964490154
59602,SIDM00660,Olaparib,Nutlin-3a (-),Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,0.7083947,0.02407832,2.565471089352794,0.08638657283650532
52299,SIDM00834,5-Fluorouracil,SCH772984,Large Intestine,0.05,Rectal Adenocarcinoma,Female,White,66.0,0.86226565,0.059607536,-0.7008466965282085,-0.025524919472264516
62506,SIDM00097,Bortezomib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.423615,0.06254008,-0.02593891602629631,-0.0034174737962216544
68402,SIDM00529,Docetaxel,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-3.708634,-0.14921297,-2.9396637866116255,-0.12521703133661694
67103,SIDM00628,PD173074,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,2.2617047,0.09703471,1.8279001085788251,0.09460520711876076
100428,SIDM00146,Crizotinib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-0.2010447,-0.012655724,-0.6768673199003455,-0.0006894272533107549
43127,SIDM00193,Palbociclib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,53.0,-2.5008438,-0.06420843,2.063992624353817,0.0996118382911623
102857,SIDM00411,Dasatinib,Dactolisib,Pancreas,0.0125,Pancreatic Carcinoma,Male,East Asian,43.0,0.9781803,0.06582238,1.516463907977113,0.11117651521472353
5437,SIDM00097,Afatinib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3481333,-0.0965313,-1.0150163213137944,-0.11629866827777322
105386,SIDM00866,Paclitaxel,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,52.0,0.43491676,0.037807133,0.18757845273998244,0.029291241448353128
23410,SIDM00774,Wee1 Inhibitor,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.7708285,-0.049091652,-0.10149632073591981,0.01856789636484815
44592,SIDM00332,Nilotinib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.9639912,-0.2219634,-2.067855262293495,-0.10591341820553819
78638,SIDM00971,Dabrafenib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.5641596,0.07432832,1.1841660416076183,0.05403953613111264
88988,SIDM01233,Navitoclax,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,1.6937226,0.10999816,0.4682246527109234,0.048165519026003856
53362,SIDM00782,BMS-754807,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.93917257,-0.08222575,-1.121029538640912,-0.07616107284544933
7533,SIDM00878,PF-4708671,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,70.0,-1.5408312,-0.070790745,-0.20955825362874742,0.010810592973219022
73781,SIDM00529,Crizotinib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Black,44.0,-0.82512814,-0.04956176,0.06166063693784003,0.019860743426482603
5868,SIDM00531,5-Fluorouracil,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.45120445,0.013003648,1.8381756656542325,0.06426437085226312
36963,SIDM00193,AZD4547,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,53.0,-1.7899697,-0.07747702,-1.0862424637524295,-0.025856941095039825
52653,SIDM00878,AZD7762,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-1.2893394,-0.07195815,-0.5403541397725745,-0.025838054308124837
69932,SIDM00878,Alisertib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-1.9285086,-0.137245,-0.5008388063501726,0.0074510667775697466
62189,SIDM00954,MK-1775,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-0.9240175,-0.07381291,-0.27135613852032997,-0.05647550010258615
102566,SIDM00834,MK-2206,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,0.63456,0.02873601,1.429609049326209,0.14300734517564156
84215,SIDM00878,Navitoclax,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-1.1757252,-0.0104677845,-0.27043000121297817,-0.06717103261570861
30854,SIDM00146,MK-1775,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.47866863,-0.042196814,0.31038136673053196,-0.015329286005866596
84051,SIDM00097,Vorinostat,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.9509729,-0.059766352,-0.14176270778512462,0.011758085551169112
43736,SIDM00779,AZD4547,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-3.2937117,-0.014726729,-2.1517586633056602,-0.07423659835461136
14048,SIDM00332,ZM447439,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,1.6131923,0.10931475,0.8895774969740285,0.0721667596318328
85634,SIDM00146,AZD6482,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-2.3308377,-0.13402164,0.31526132597974393,0.04855226521929656
57742,SIDM00778,Olaparib,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-1.5807959,-0.03165317,0.025453366047961862,0.018094706101937117
91108,SIDM00301,SCH772984,Ruxolitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,0.76327115,0.10604129,0.00035631229007879065,-0.02659920152158128
103419,SIDM00878,AZD7762,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.7499818,0.027199173,-2.165073883691133,-0.11194544617552725
95939,SIDM00097,Lapatinib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.4102125,-0.1913691,-1.0878906950223988,-0.07985111649978265
49098,SIDM00971,Ribociclib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.6146061,-0.06813008,-2.1863864885838873,-0.037839202282458725
100504,SIDM00954,Alpelisib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-3.7210498,-0.18255879,-1.3976932563770637,-0.03291192089782365
8473,SIDM00866,Venetoclax,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.4651495,0.040155012,1.5445588524969767,0.04906338890030748
72304,SIDM00782,Nutlin-3a (-),Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,Unknown,72.0,1.1449364,0.028608115,1.048028349393894,0.03590809686342898
87826,SIDM00301,5-Fluorouracil,Paclitaxel,Pancreas,0.0025,Pancreatic Carcinoma,Male,East Asian,50.0,1.1504606,0.115307175,-0.7225856634709493,-0.018938484495759324
100088,SIDM00097,Palbociclib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.7159541,0.08818063,-0.6355362141617004,-0.02010405156623074
72952,SIDM00875,Doramapimod,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.1411994,0.07020909,1.9266324256025587,0.09719907164017064
18825,SIDM00779,5-Fluorouracil,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,-1.7150882,-0.0406753,-0.10634875885361839,0.030120149999162057
51950,SIDM00146,AZD7762,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.2919676,-0.10355234,0.08359171260600838,0.008594136722253145
102854,SIDM00332,Trametinib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,0.82469684,0.07158277,-0.2608852761519997,-0.05266775933974209
30291,SIDM00971,OSI-027,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.339707,-0.1402053,0.5889423656197939,0.017104987989332857
101110,SIDM00866,Crizotinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-2.0083537,-0.055004075,-1.2453819826715922,-0.05399464393282918
56777,SIDM00301,Paclitaxel,LGK974,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.7997775,-0.03619525,-0.8611717887097127,-0.08366543610995242
29911,SIDM00673,Axitinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-2.5310867,-0.10865812,-0.08493694022481445,-0.05478193633399187
105256,SIDM00971,AZD6482,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.6194024,0.10998822,1.4991656554163142,0.09726446451618372
2485,SIDM00673,Entinostat,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.2759358,0.0995374,-0.28967542541745606,0.013743353872646368
106588,SIDM00774,Nutlin-3a (-),Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,0.32804474,0.010276325,0.9826344419789953,0.03943093833863352
50458,SIDM00301,Paclitaxel,Gemcitabine,Pancreas,0.1,Pancreatic Carcinoma,Male,East Asian,50.0,-4.3045254,-0.2395447,-4.751406316164911,-0.23640458184357968
67724,SIDM00146,5-Fluorouracil,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,1.303563,0.107937865,-1.1505961957114248,-0.0062183692918955985
102334,SIDM00146,Temozolomide,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.07426751,0.0016961196,0.8134411127806617,0.025413353084986014
10314,SIDM00875,Bortezomib,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.33233938,0.027605586,-1.0308234918746333,-0.02238022675745111
14182,SIDM00866,Taselisib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,0.22834241,0.01950845,-0.2287333455865921,0.005289250823587654
31673,SIDM00954,Venetoclax,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,4.33191,0.10214664,-1.4805431999426784,-0.01767535958540355
19305,SIDM00954,JQ1,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.2507741,-0.104087725,0.4099437100757385,0.008870757449433095
2310,SIDM00660,Trametinib,Nutlin-3a (-),Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-0.46035135,-0.035140052,0.2576539652497373,-0.0020292715560893963
72923,SIDM00628,Bortezomib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-0.31277415,-0.019024568,-0.8099604054839215,-0.033540962111040205
7374,SIDM00954,KU-55933,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-2.0492308,-0.054670352,-0.98705144655568,0.008161715672143636
94671,SIDM00834,Palbociclib,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,0.7010335,0.055770293,-0.9964688455089968,-0.06863053752000789
79589,SIDM00774,Crizotinib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,0.8055562,0.10816188,0.948960374293098,0.008993328462875486
100458,SIDM00660,LGK974,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,2.0936937,0.09487561,1.8090438567850062,0.05817406730307073
95086,SIDM00628,PF-4708671,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.8157682,0.07502268,0.25222220255247724,0.0492624266487122
93893,SIDM00893,KU-55933,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.0138838,-0.063708834,-0.6553631686172708,-0.012353143906411814
77963,SIDM00893,Crizotinib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.7979841,0.09672726,2.245305626161721,0.041604644305316
13758,SIDM00529,AZD7762,Axitinib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.102490805,-0.007103424,-0.8991251156374438,-0.06193765067850118
85618,SIDM00893,PD173074,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.4191337,-0.03671912,-0.013398271416518942,-0.012720491416396605
56046,SIDM00097,Venetoclax,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.6852407,-0.019987933,0.5458648851906902,0.018476700495117893
5353,SIDM00875,JQ1,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.0872822,-0.16604307,0.1762270674161044,-0.011867756691139602
90136,SIDM00146,Linsitinib,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.5559165,0.0141166095,1.864825107243594,0.10081819957893623
92475,SIDM00359,Navitoclax,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.2373617,0.07199402,0.9403440992298059,0.04912174502124589
81818,SIDM00878,BI-2536,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,70.0,0.9576516,0.07110373,0.9410521163919354,0.050872153462715654
96877,SIDM00782,Palbociclib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,1.9134897,0.055463366,3.6236239143823195,0.10245307832456517
39725,SIDM00954,Afatinib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-1.5965118,-0.11406262,-0.6418535941547446,-0.05567661008655892
50362,SIDM00954,GSK269962A,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,0.74457765,0.063295856,-0.7569640325190435,-0.0660205271607474
28937,SIDM01233,Navitoclax,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.1767128,0.07555287,-0.3324264384175192,-0.03552245285257272
106319,SIDM00779,Nutlin-3a (-),AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,33.0,-1.2047296,-0.032844093,0.7417933929196125,0.038421331868270736
80465,SIDM00866,Taselisib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-0.73825926,-0.059177056,-1.309956001737453,-0.06736751162273297
97414,SIDM00834,Oxaliplatin,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,White,66.0,-2.3134172,-0.17740583,-1.2399505990464386,-0.08691097770065202
27305,SIDM00774,BI-2536,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,-0.60944253,-0.039269667,1.1079571601164298,0.10123725294140269
92121,SIDM00359,Trametinib,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7480619,-0.06728803,-1.5927371225390485,-0.04921051298614305
96637,SIDM00332,ZM447439,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,2.5777438,0.09839457,0.6722423852486541,0.0021220753936298828
39252,SIDM00529,Lapatinib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,1.0174477,0.080305375,0.5341367972108604,0.08748249969814281
93573,SIDM00673,RO-3306,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.60094786,-0.03633811,0.06287310463167159,-0.015479432684653365
100204,SIDM00893,BI-2536,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.8938303,0.24932943,1.6854029858816428,0.1359635594214965
68519,SIDM00971,OSI-027,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.6810884,-0.085309714,-0.813081009466488,-0.0572553712171345
22287,SIDM00778,Palbociclib,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,2.3753982,0.12023955,-2.3850790930499826,-0.04509321610440017
74649,SIDM00779,Palbociclib,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-2.6912239,-0.06474913,-1.0436045200133925,-0.013238008401642954
29298,SIDM00875,Alpelisib,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5591114,0.12428397,1.3169131695514433,0.1068241825431296
104503,SIDM00193,AZD4547,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,53.0,-2.7384162,-0.10501484,-2.2762416449991565,-0.06103333971644661
74386,SIDM00776,Vinorelbine,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,1.4026507,0.097367816,0.6225779566521232,0.06158115449522045
103353,SIDM00146,Uprosertib,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.762569,0.059262436,1.6415100621742686,0.1629716090784103
25102,SIDM00097,Temozolomide,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.11893662,-0.0020457979,0.7584111006777962,0.03877788806270872
47546,SIDM00971,Afatinib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.7331791,-0.031898003,-0.6393988688059423,-0.043542545482907404
71289,SIDM00531,Dactolisib,Navitoclax,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.110517,0.10297454,0.9294302910566176,0.07746696071021976
78320,SIDM00971,Afatinib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.562998,-0.10067246,0.49369129715641624,-0.02558469644676591
17975,SIDM00954,NU7441,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,1.276525,0.09275819,0.3840229504367828,0.13825053546704383
87580,SIDM00097,Alpelisib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.81511,-0.17286114,-1.2404312055587567,-0.061994518477695014
80749,SIDM00628,Sorafenib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.6607078,-0.066073276,-1.0063072523333871,-0.06264924404267683
2248,SIDM00834,Vinorelbine,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,White,66.0,-2.648415,-0.13972946,-2.3597115152460884,-0.10346362677094507
38858,SIDM00954,Venetoclax,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,0.87076145,0.05274586,0.05505485017492382,-0.03391199672945608
86040,SIDM00529,RO-3306,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Black,44.0,1.853556,0.09633503,0.9414424230679834,0.04889634642385519
105429,SIDM00146,5-Fluorouracil,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.7169794,-0.045802504,-2.0291313721774524,-0.04625101280121376
64789,SIDM00954,Vorinostat,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-0.5146293,-0.023185235,0.28758729120552,0.0161303616077181
4520,SIDM00866,Luminespib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,0.5742142,0.042479806,-1.3819164538937916,-0.059670797709865
86225,SIDM00529,ZM447439,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,-0.57558215,-0.04515304,-0.11274267265182844,-0.026100124143063178
104489,SIDM00097,BI-2536,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.86072725,-0.05737364,0.43967480649359564,0.07763684762015403
12071,SIDM00660,Crizotinib,Vinorelbine,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,32.0,-0.7230976,-0.06897032,-0.6628883918105508,-0.052612568406627425
71648,SIDM01233,MK-2206,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,-3.1398015,-0.18014461,-1.0105506447095784,-0.03077983588445518
69733,SIDM00660,Palbociclib,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,5.6016855,0.4661141,2.1009326686121006,0.05311127192000221
65402,SIDM00332,Nilotinib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8115548,-0.05941826,-0.47406144803074235,-0.030312811164134104
77731,SIDM00411,Trametinib,OSI-027,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,4.4431043,0.15438335,0.5818331300570799,0.10332940219993779
49266,SIDM00673,Olaparib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.6429206,0.03962878,-0.7333396729363211,-0.0419405430393656
34523,SIDM00332,KU-55933,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3755947,-0.043787666,0.10864957897988065,-0.006656343560294344
61206,SIDM00779,AZD4547,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,-10.81717,-0.09902797,-6.220140032496063,-0.09621470252711779
49291,SIDM00531,SCH772984,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.8089796,0.18043476,-0.6108284983386423,-0.011532671206904727
3366,SIDM00782,Vinorelbine,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.8052965,-0.07503673,-0.8317457810702069,-0.016469765377321432
81334,SIDM00301,Cisplatin,Navitoclax,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.152616,0.1445246,1.6523984966714131,0.16984651084918137
15904,SIDM00774,MK-2206,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-0.42105907,-0.022169996,-1.4362865300163838,-0.09290269108037195
50435,SIDM00875,PF-4708671,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.297524,-0.0428532,0.3009461150592441,-0.032283356368758155
5553,SIDM00130,Paclitaxel,Oxaliplatin,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.834263,-0.19656688,-3.8004528984450014,-0.22791618232064903
67818,SIDM00332,Temozolomide,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1908075,-0.027644439,0.46283430014197335,0.03379233169815525
60641,SIDM00359,BMS-754807,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.4256917,0.120857574,-1.5685297855454468,-0.11635753271712983
103870,SIDM00774,Navitoclax,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,1.0978204,0.025851559,0.8025038742345965,0.004558643785964717
45985,SIDM00875,Pictilisib,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.79794526,-0.08966814,-1.119576628275792,-0.06721166020789432
88933,SIDM00628,Nilotinib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,1.0873224,0.07927825,-0.9050911430574555,-0.06038615070145151
10554,SIDM00866,Bortezomib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.5729206,0.04900289,0.4289014017396713,0.02405147637087765
24192,SIDM00628,Paclitaxel,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.24794972,0.018609287,-2.2051124823973134,-0.1624676462569498
106738,SIDM00660,Olaparib,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,32.0,2.9886131,0.1304026,1.699300370648569,0.04233596073275479
12167,SIDM00332,Camptothecin,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,3.9534254,0.07248657,2.533014530278214,0.0817470895908838
39529,SIDM00774,Luminespib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.28902858,-0.030234668,-0.15776563423402287,-0.01859482585374036
71427,SIDM00332,Gemcitabine,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1770172,-0.06660187,-2.4279525527401113,-0.1565529697462095
60214,SIDM00529,Paclitaxel,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.7895852,-0.12517422,-1.1232792277619785,-0.06250682607746924
99892,SIDM00878,Paclitaxel,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-2.6611586,-0.08139121,-0.2867298994261438,0.01677381952597498
99450,SIDM00673,MK-1775,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-1.4456327,-0.12359436,-0.44061777882381514,-0.05289192064122625
75843,SIDM00954,Bortezomib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-0.410567,-0.02020603,-0.8975209696090957,-0.04964838710638284
105158,SIDM01233,LGK974,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-0.082274795,-0.004964181,-1.366436916922031,-0.07430795605954739
30190,SIDM00146,Vorinostat,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.2050066,0.08335366,0.20203438588450032,-0.024741741205692086
9432,SIDM00628,Temozolomide,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,0.6084001,0.012878993,0.41913347961986963,0.022116426415869896
105023,SIDM00531,OSI-027,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.85141337,-0.037104636,-0.24378527326845298,-0.010138811897917831
100518,SIDM00954,Taselisib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-0.95894796,-0.07170612,-0.3683582646183132,0.050361733343227036
12841,SIDM00779,5-Fluorouracil,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-1.0837815,-0.016522823,-0.4147951316317304,0.025386720961297
80260,SIDM00954,Wee1 Inhibitor,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-1.493887,-0.12657194,-0.4133395062749403,-0.011419970871419329
64770,SIDM00878,Luminespib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-1.1842223,-0.0725019,-1.6132058982303037,-0.08384011336679857
62454,SIDM00774,Gemcitabine,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,11.526245,0.7776152,3.612789070219413,0.3813835233785176
27362,SIDM00628,BI-2536,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,-5.4523168,-0.24629031,-1.1763196629214376,-0.024296964402877742
59016,SIDM00097,Afatinib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.35296094,-0.02516763,0.15100281432769086,0.02703421819645119
63191,SIDM01233,Palbociclib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,72.0,-0.25879678,-0.005513252,0.542045409674429,0.027784420020692067
17136,SIDM00130,Oxaliplatin,MK-2206,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.41452232,-0.020492662,-1.1137831974397265,-0.03659065594346743
36647,SIDM00878,Taselisib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.437688,-0.13937466,0.5466467582723579,0.05310681766728269
95263,SIDM00778,BMS-754807,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-2.0511873,-0.08191061,-1.8551684576487923,-0.0791549788847514
3388,SIDM00411,Palbociclib,MK-2206,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,43.0,1.726526,0.07496186,0.8887644489290364,0.09788465423981078
12300,SIDM00971,Paclitaxel,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.77762914,-0.017063346,1.468654869514527,0.1324748514940461
93244,SIDM00893,Dabrafenib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.4496894,-0.008556562,2.119357455004708,0.052873037046367484
35186,SIDM00673,Tozasertib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,0.458423,0.033835668,-0.445041181781751,-0.022846003777307586
14421,SIDM00878,AZD7762,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.2694738,-0.08607382,-0.28619805402305265,-0.014053727957048082
81181,SIDM00834,SB505124,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,1.1995203,0.09269195,1.1338715140063567,0.0640698014449912
47284,SIDM00529,Nilotinib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,3.659239,0.22356856,2.195017298267433,0.13906315207001396
12213,SIDM00866,Lapatinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,0.5001669,0.039871227,0.0035244761345501565,0.07012051509274342
74915,SIDM00673,Palbociclib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,0.53927076,0.027658401,-1.283963720017162,-0.02170129933399379
89542,SIDM00866,5-Fluorouracil,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,-1.327454,-0.044423226,0.9193449853098191,0.03601206221614684
23259,SIDM00628,Palbociclib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.0031248804,0.00010554164,1.8508631928777077,0.07903919355485782
25150,SIDM00954,ZM447439,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-2.3063412,-0.17929494,0.8145720615030676,0.0641048990782032
67394,SIDM00660,MK-2206,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,4.841646,0.364912,2.756686070857879,0.20549982443267137
95447,SIDM00866,Alisertib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.3433306,-0.10248008,-0.6854212705517482,-0.02098524034723212
27602,SIDM00893,Uprosertib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.908888,-0.07399686,-1.4912028447481136,-0.08974197699575188
91653,SIDM00332,PD173074,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,6.0222464,0.3678351,-0.035386251372429886,0.07623723581352278
29145,SIDM00779,Linsitinib,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-1.2088956,-0.100025035,0.05550789612600416,-0.036038248593568016
50227,SIDM00130,Irinotecan,Palbociclib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-5.5111356,-0.43722457,-2.6758182540005144,-0.18507782762758004
41013,SIDM00834,AZD8055,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,White,66.0,1.5479778,0.13427031,-1.350936701162531,-0.09265135228356763
69406,SIDM00834,Taselisib,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,2.1926177,0.14439906,0.23739126490364523,0.042390625621921765
23558,SIDM00332,Taselisib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.731025,0.07044449,-1.192210767834543,-0.08314921160615643
96562,SIDM00878,Luminespib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.611283,-0.06378864,-0.14971022991526947,0.026107109282583776
42944,SIDM00673,Cisplatin,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.9402909,0.095495686,1.2354932118265112,0.07636862974845925
76078,SIDM00878,Entinostat,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,0.06259667,0.003177897,1.8800889878526457,0.11053831396721699
106342,SIDM00097,Docetaxel,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9085512,-0.12666214,-1.3599301590112223,-0.06922721424469741
84776,SIDM00893,OSI-027,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.1337646,0.11248822,-0.22917922103321117,-0.04112017981137689
63570,SIDM00878,Temozolomide,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.34304813,-0.007162494,1.1187440709297507,0.0287724368341743
8786,SIDM00146,Alisertib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,0.26541275,0.023433207,0.30400290389237183,-0.05010002447284551
104876,SIDM00332,Cisplatin,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,3.414279,0.047140405,3.874054631197498,0.08944559917073976
63789,SIDM00875,Nutlin-3a (-),Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.71161264,-0.021197813,0.7110096622589007,-0.0027103725599975964
24618,SIDM00146,ZM447439,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.4306153,-0.02916495,1.2793045005043613,0.060928434074559557
45895,SIDM00146,Crizotinib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,4.410032,0.18504559,2.467562897814129,0.1943457336949498
92997,SIDM00531,Olaparib,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.58872515,0.021907635,-0.1311000790290202,-0.00502204629339113
92120,SIDM00097,Alpelisib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.785402,-0.049625307,0.40551194829636067,0.048375529728318385
103909,SIDM00778,Afatinib,5-Fluorouracil,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-4.0782948,-0.19233398,-1.238070596947049,-0.08436149423320775
86466,SIDM00130,Ruxolitinib,Sorafenib,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.99010277,0.031416833,1.484376721107579,0.040196054379835804
50235,SIDM00776,SB505124,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-0.71060985,-0.0533137,-0.9852448560761362,-0.020150810351464418
4341,SIDM00866,MK-1775,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,-0.8436253,-0.038285464,-0.9005026573289664,-0.04019933303369443
1894,SIDM00954,Olaparib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.9274417,-0.033570476,0.3341031096086304,0.06040574287696099
87326,SIDM00774,Wee1 Inhibitor,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-3.4102771,-0.15057424,-1.5842057245241277,-0.062356914466796566
57580,SIDM01233,Dabrafenib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,72.0,-1.925975,-0.05496019,-0.6733619756427467,-0.012840699448052677
1336,SIDM00971,Tozasertib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,5.289992,0.17870721,4.205998343585825,0.23944979939753247
79895,SIDM00834,Dabrafenib,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,0.9634775,0.038588647,-0.7039369288498635,0.03570404217964595
81279,SIDM00954,Crizotinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,1.3950256,0.017344242,2.392205488615545,0.12336851245681583
47779,SIDM00875,Taselisib,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.24860461,-0.029375007,-1.8117092370311776,-0.0939731232901725
103576,SIDM00097,NU7441,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9504089,-0.08123443,0.8031557768507799,0.050633877468415474
81316,SIDM00411,Olaparib,Sorafenib,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,43.0,0.5678388,0.01567806,0.6303781338484049,-0.013025992888892755
17204,SIDM00332,Alisertib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.28103974,-0.014174322,-1.180351713480287,-0.01354335193780572
9342,SIDM00411,AZD7762,MK-2206,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,43.0,-2.0281198,-0.063942075,0.6628190747042374,0.0342153757212616
97068,SIDM00774,MK-2206,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.9914031,0.05460835,-0.49158314591025437,-0.0123667268785981
59114,SIDM00971,Camptothecin,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.0061376,0.051857285,1.3958741315663679,0.07433749568489123
2409,SIDM00875,Taselisib,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8931198,0.1028674,-0.1566059682939188,0.0019783411876110554
27204,SIDM00875,Palbociclib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.9068894,0.077801265,1.2550717539041252,0.11245656786057522
95090,SIDM00529,Trametinib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.8411115,-0.009013228,-1.0716030257532945,-0.026697375559631063
61989,SIDM00893,Navitoclax,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.2753347,0.12846608,0.8754096893218419,0.08087787199896215
38938,SIDM00531,Ruxolitinib,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.5865107,0.022326145,1.4258755255143039,0.03200065882557008
45197,SIDM00893,RO-3306,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.22307435,-0.018477095,-0.4500848063787253,0.06634728184612874
68198,SIDM00628,Sorafenib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,-0.9273933,-0.057498768,-0.6659402420112752,0.016980410089212784
5659,SIDM01233,AZD7762,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,4.6919303,0.0840043,2.4669750071700274,0.054816483187357344
6101,SIDM00097,Alpelisib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.9090772,-0.063179635,0.202647870548464,0.028532443443786158
80624,SIDM00774,Doramapimod,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,2.1371024,0.11603209,0.49583619827529507,0.0629186851707358
8235,SIDM00866,Taselisib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,0.55910695,0.039960947,1.021217387773125,0.12360515940630301
85800,SIDM00893,Vorinostat,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.8405097,0.05604696,1.4745001707665168,0.04481388455611503
16539,SIDM00954,Alisertib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-1.1376885,-0.08856653,0.1154513516506315,0.06171542405384066
67596,SIDM00971,GSK269962A,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.6057703,0.105826765,-0.011612347827647189,0.02439313337415599
89163,SIDM01233,LGK974,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,72.0,0.7224421,0.0438094,-1.6095542621350583,-0.045484565839006036
31329,SIDM00531,Dasatinib,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.5612658,0.19899058,-0.5115735169892633,-0.0426286666514387
88127,SIDM00130,5-Fluorouracil,Trametinib,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.0855693,-0.076932736,-1.059095475930656,-0.05454451964092311
12496,SIDM00875,GSK269962A,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5521446,0.032545477,2.2265517239764225,0.07133880671599302
34212,SIDM00628,Alisertib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-6.1303725,-0.4269979,-3.8472607146936397,-0.13977281356884338
6803,SIDM00776,Palbociclib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.3458978,-0.020360108,-0.021686208192213757,-0.022818145148509356
44165,SIDM00779,Camptothecin,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,0.9273979,0.047149826,0.3204490647419732,0.029891097746427963
72311,SIDM00097,Axitinib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.1457632,-0.115349695,-0.19906604808518746,-0.04776957484290782
90925,SIDM00774,Axitinib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,48.0,1.2918564,0.14251393,-0.11246223692380447,-0.04592116154379284
28116,SIDM00954,Camptothecin,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,0.8657099,0.031941928,2.0943069702716905,0.09783755612964208
66263,SIDM00971,RO-3306,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.165834,-0.1465039,-2.047604746653571,-0.10079779697978872
57294,SIDM00774,Navitoclax,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,2.1879685,0.0230449,0.6475583077892659,0.02044406326540536
42935,SIDM00834,AZD7762,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,2.7728076,0.21550928,0.5991941746004232,0.07606563499560873
68401,SIDM00332,SCH772984,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,3.3385892,0.23914795,-1.2413518943270003,-0.03702979669499634
100969,SIDM00301,Crizotinib,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,50.0,-3.0893772,-0.11337383,-3.4423385300377287,-0.11004636414880532
95159,SIDM00529,AZD6482,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,3.0249329,0.056365725,2.028202359987579,0.06068948605582313
47341,SIDM00893,AZD6482,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.6624324,-0.069641896,-0.5386475134254132,-0.09980984654443997
84862,SIDM00146,PD173074,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-3.6854208,-0.19055712,-0.9318251379262674,-0.041001545801008295
37568,SIDM00875,Dabrafenib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6187844,0.08986641,0.22968396707995375,0.011944950839870981
33382,SIDM01233,Navitoclax,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,2.060549,0.10222425,2.545388523689493,0.08879037478313258
67645,SIDM00529,NU7441,Luminespib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-0.29680786,-0.023468977,0.649827847677615,0.03182458042504929
76469,SIDM00866,Cisplatin,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,2.1018765,0.058501244,1.7225064671870258,0.07349201437237315
12226,SIDM00776,BMS-754807,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.3328247,-0.115138926,-0.09503445566838435,0.0048846723844935755
104799,SIDM00359,Afatinib,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.9803023,-0.1491367,-1.003216394439501,-0.0009108653878410896
4777,SIDM00954,Trametinib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,3.1026735,0.1395414,1.9949601122957932,0.09685279290222538
80309,SIDM00529,Venetoclax,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.2475612,-0.029815137,0.23211554237048376,0.07916983177186024
80314,SIDM00097,SCH772984,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.20197299,0.009983409,0.6577016004523759,-0.003029080206884837
13142,SIDM00359,MK-2206,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.9710144,0.059466653,-0.6282514659632811,0.026330595241804523
544,SIDM00628,Palbociclib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,0.67563707,0.012499957,-0.10146919391976929,0.007194069017301201
51451,SIDM01233,Palbociclib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,0.17395806,0.003625508,0.6625430323451493,-0.013519519223830477
106867,SIDM00878,AZD6482,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,3.7900865,0.14875972,0.49177283203563904,0.06026679901797903
6359,SIDM00866,Trametinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.55873525,0.04825248,-0.8286861976477919,0.009728839923553842
3784,SIDM00359,AZD7762,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7616327,-0.15138054,-1.1739910650911614,-0.08383508147488668
5375,SIDM00146,Bortezomib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.4516914,-0.031390823,-0.34751945450486715,-0.050758080550873004
44999,SIDM00332,AZD6482,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.74580795,-0.053711604,-1.5703882186914133,-0.13028787831845526
50314,SIDM00146,Cisplatin,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,1.1284069,0.049146283,2.1418872961573454,0.06120100612157171
34559,SIDM00875,Wee1 Inhibitor,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3497909,-0.02497643,-0.4555663500729257,-0.060123574335420614
69951,SIDM00834,Trametinib,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-0.7058524,-0.013740288,-0.14599260644012138,-0.023108649744149966
44481,SIDM00954,5-Fluorouracil,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-2.098927,-0.08185573,-0.7528604510531884,-0.04020634024074834
9192,SIDM00130,Taselisib,Navitoclax,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.9640452,0.17332347,2.1255623334366436,0.13797387698756536
82502,SIDM00628,Wee1 Inhibitor,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-0.5397827,-0.05227128,-0.18485087544007164,-0.041671223003737594
35359,SIDM00878,PD173074,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,70.0,-0.9997989,-0.11261499,-1.144036362060015,-0.05035615449165643
84162,SIDM00146,Bortezomib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,1.2530838,0.032395355,0.5917947130029655,0.04825871683326535
41127,SIDM00332,Paclitaxel,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.42611036,-0.033346538,-0.3856095333863691,-0.021873016022359207
17156,SIDM00193,Nutlin-3a (-),MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,4.2847557,0.1599924,3.038307309232127,0.0958672681349593
33782,SIDM00332,Palbociclib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.3806643,0.0816554,1.907384124933997,0.05906400163101195
63597,SIDM00673,Alisertib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,2.9794464,0.17247002,2.4463086440793247,0.11978874924015222
19930,SIDM00774,Ribociclib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,-2.6772351,-0.07980532,-0.9515202625734616,0.0044733185792364535
65103,SIDM00146,Tozasertib,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.4729989,-0.09165416,-2.209049367745227,-0.07117157991181221
99411,SIDM00301,Gemcitabine,Trametinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.7092149,-0.045615874,0.29685311008312054,-0.028054836778363398
73387,SIDM00866,Dabrafenib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,52.0,0.7172205,0.027123349,-0.2781836234580839,0.006120811399032195
56982,SIDM00146,Navitoclax,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-0.3134867,-0.0140476795,2.2370696518619155,0.06005927171522815
66008,SIDM00834,Palbociclib,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,0.63066787,0.045084443,-1.8024002978003861,-0.1021782220181278
23551,SIDM00893,Nilotinib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.86604255,-0.07264103,0.08881252080035963,0.0346832068382836
29769,SIDM00332,Ribociclib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.576603,-0.051544752,-1.7075224676723353,-0.05627130683107093
76056,SIDM00411,Gemcitabine,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,-4.8765507,-0.16140385,-2.5036930340202717,-0.12000277303262832
6897,SIDM00673,Alpelisib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.7801643,0.052338686,-0.06581151962653992,0.022295543107050845
20208,SIDM00782,5-Fluorouracil,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,Unknown,72.0,-0.42474186,-0.016384576,0.48299394397116113,0.02861274265540744
97163,SIDM00875,Linsitinib,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5456592,-0.03295899,0.415264422961604,0.01038891835580693
1970,SIDM01233,Palbociclib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,72.0,0.35818726,0.00803476,1.159436628701041,0.04464232907164232
57790,SIDM00411,Linsitinib,MK-2206,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,43.0,-0.46433657,-0.022670226,0.991438315831302,0.05794609253487786
24943,SIDM00971,Navitoclax,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.8048006,0.023910487,-0.5042287141821535,0.037524064411351477
62252,SIDM00778,Nutlin-3a (-),Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,3.9865634,0.11753092,1.4131929261631622,0.03537157821068796
53968,SIDM00301,Taselisib,Dactolisib,Pancreas,0.0125,Pancreatic Carcinoma,Male,East Asian,50.0,1.6531717,0.2180782,0.6016112403102065,0.08872494934102976
4785,SIDM00146,Uprosertib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-3.7602446,-0.19693282,-0.268393604376024,0.011354639106725493
87459,SIDM00673,Nilotinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,5.0746083,0.31395766,-0.4982420299699882,-0.005469130264248577
26164,SIDM00866,Doramapimod,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.3621703,0.034731258,1.5429231008866797,0.06609199944169851
70669,SIDM00673,Navitoclax,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.9473956,-0.12721156,-0.34578849295380437,-0.02253983375499684
22464,SIDM00301,AZD7762,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.0324833,0.17864868,1.3575853408301934,0.08124356910472351
75636,SIDM00878,Doramapimod,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-0.4024634,-0.021405645,-0.693433856043411,-0.0052292289343282535
58116,SIDM00411,Dactolisib,OSI-027,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,-4.231195,-0.1327957,-3.5883453920941015,-0.11805732950486328
104955,SIDM00097,Gemcitabine,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.361335,0.06679882,-0.4726814213637565,0.07419698929436329
87838,SIDM00866,Crizotinib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-3.2141185,-0.18117751,-1.1107925521573812,-0.0849630256850019
50743,SIDM00531,Linsitinib,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.424427,-0.053315517,-1.4206291326672613,-0.022810898245858472
79987,SIDM00332,Vorinostat,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4657549,0.11920748,1.7936107666627823,0.06193879562590891
84754,SIDM00774,Navitoclax,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,4.2193847,0.025550839,1.6264425874328994,0.07735998299983234
21663,SIDM00628,Cisplatin,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.35363632,-0.03243144,-0.6603814464529895,-0.01718609086180067
33272,SIDM00359,Olaparib,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.8019986,0.058275618,-0.2594004508391173,0.006164268436280699
106071,SIDM00875,Tozasertib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.32706976,-0.015414251,0.10241821337886198,-0.009708066419799452
49850,SIDM00778,LGK974,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,1.4075828,0.028290613,0.9607642664865782,0.008030188475386993
29138,SIDM00359,LGK974,SCH772984,Large Intestine,0.05,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.9612262,-0.031569373,-1.2211738137056698,0.004316883701042623
73104,SIDM00875,ZM447439,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.017197568,-0.0014299318,1.4962990666089873,0.04640489534632815
47993,SIDM00971,Dabrafenib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,5.7479424,0.1967855,1.419682274237415,0.039965543214587985
85765,SIDM00834,AZD4547,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,White,66.0,1.4749438,0.044524346,2.2834028325678655,0.021153468573891054
59320,SIDM00875,Ribociclib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5072091,-0.04235242,-0.012546221661860008,0.03439643678817154
72299,SIDM00301,Trametinib,Palbociclib,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.2049807,0.13857235,0.2576211729761106,0.004962781683533425
67280,SIDM00776,MK-2206,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,0.5431582,0.023546137,0.9273046005076253,0.11098595399513132
60127,SIDM00878,Alpelisib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-0.5493381,-0.018041153,-0.13834667295393904,0.030646416612192445
60609,SIDM00878,Ribociclib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,70.0,-2.1685224,-0.08383817,-0.9962603208749533,0.0152417385222902
54536,SIDM00878,Ribociclib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.0999881,-0.015970191,-1.0178313048475247,-0.024128829648277565
84246,SIDM00782,Oxaliplatin,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-1.0467395,-0.059155226,-1.0377345561090117,-0.03325428306186713
72527,SIDM00660,Nutlin-3a (-),Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,1.2127684,0.026072592,2.404251495089486,0.08797022280262803
27488,SIDM00146,OSI-027,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.1934303,0.10760622,1.5319836017918573,0.10090687109558268
60943,SIDM00146,5-Fluorouracil,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.52603555,-0.03240506,-1.1385548584158895,-0.06311299487428967
30826,SIDM00782,Crizotinib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-1.2350338,-0.10815912,0.5600675992369989,0.055126769547389085
16720,SIDM00954,PF-4708671,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-2.3200717,-0.07853616,-0.16963581011065693,-0.012141452113531272
33635,SIDM00146,Nilotinib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.2093663,0.118672825,0.863818305113794,0.07744594667439633
48896,SIDM00774,Gemcitabine,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.4269081,-0.025561662,0.14726144404669889,0.0467915545645868
28980,SIDM00673,Palbociclib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.1241084,0.026884006,-0.684159436759693,-0.015765770401637912
44539,SIDM00673,AZD7762,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.3162093,-0.117699884,-2.0561083959791238,-0.12184238580301877
100176,SIDM00778,Afatinib,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-0.8353757,-0.050787583,-1.1258914698238565,-0.04913564389421235
107384,SIDM00531,Oxaliplatin,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.8484371,0.091917396,1.4940978938033371,0.03171829395273051
11654,SIDM00878,Tozasertib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-0.645028,-0.052539576,-1.0570821155861545,-0.006932770923814091
70130,SIDM00529,Trametinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,1.3982869,0.10997137,0.9442746308944275,0.0659047905334571
37660,SIDM00866,Doramapimod,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,2.8059165,0.06967979,3.0092442006058246,0.1001283242706956
17269,SIDM00332,Trametinib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.6505444,-0.13596149,-0.3483871189648773,-0.05227243760060198
71163,SIDM01233,SCH772984,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-2.5359516,-0.14444776,-1.6826037901898017,-0.09207447324611912
9819,SIDM00359,Navitoclax,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.16602327,0.011296149,0.6188686716056109,0.06490683163939251
80443,SIDM00529,Trametinib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.133108,-0.066090055,-0.6219134495492633,-0.02626221354401523
20274,SIDM00628,Vorinostat,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,1.8953091,0.08328591,-0.16936710524565254,0.003210186634984738
79105,SIDM00193,Linsitinib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,53.0,1.0733702,0.046150457,1.7295999087638163,0.0713783539651249
38423,SIDM00097,Navitoclax,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8193391,-0.05746566,-0.029245641369966408,0.03478823027945245
6490,SIDM00332,JQ1,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3831131,0.0642399,2.497555345394481,0.09586585038536352
75529,SIDM00146,Camptothecin,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.3301056,0.031371325,0.7032737947342372,0.0321330243962267
45328,SIDM00878,Nilotinib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.3501331,0.12698407,0.43397051953638116,0.017225434176268498
104924,SIDM00875,GSK269962A,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.92447,-0.087826334,0.2742085374437532,-0.00773349114369779
51749,SIDM00301,Erlotinib,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.4904997,0.058336973,2.5651840884185204,0.0781276892117298
4928,SIDM00146,Axitinib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-2.3882618,-0.12852973,-1.1691715365348094,0.011307976718237422
26122,SIDM00332,Paclitaxel,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.30456,-0.08469513,-1.2555669691045994,-0.09526471122284132
13505,SIDM00782,Linsitinib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,2.7586594,0.15500565,1.7122943256282719,0.06438843393784957
103385,SIDM00130,MK-2206,Sorafenib,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.9873495,0.18824649,-1.0953088853969046,-0.013716868961934133
100933,SIDM00301,MK-1775,Ruxolitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-0.98222655,-0.12351453,-0.3373766285243734,-0.08198023769543122
53412,SIDM00146,AZD7762,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,0.73490167,0.0682001,-0.7133982204122936,0.009801678414115556
64526,SIDM00146,Vorinostat,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.61710465,0.055002727,-0.20184105783116615,0.006561631459526282
5063,SIDM00782,Palbociclib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,Unknown,72.0,1.9402797,0.05266437,3.0115121913116982,0.079026113966688
71370,SIDM00628,Docetaxel,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-2.0905106,-0.17635226,-2.4878818963424503,-0.1694720794479976
12480,SIDM00146,Uprosertib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.4365994,0.096022226,2.224860073329098,0.16960162917769564
27196,SIDM00146,ZM447439,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.5154895,0.13256751,2.1620705221657786,0.15224408042450843
83114,SIDM00673,Venetoclax,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,1.4685785,0.040514532,0.8407033258061303,0.003969686368049047
7304,SIDM00332,KU-55933,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.573868,0.09477068,0.0118853462775909,-0.011783071511974347
54441,SIDM00878,Dabrafenib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,3.1879163,0.15738623,0.7160222855222627,0.04932741846538972
73230,SIDM00866,Navitoclax,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-0.38992068,-0.033378858,0.6127199101340915,0.06895249233953847
39376,SIDM00332,Sorafenib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9498946,-0.03677619,-0.961799183795391,-0.009302606021221514
32257,SIDM00332,Pictilisib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2608076,0.116318874,-1.0504215652920181,-0.07748843061917296
50938,SIDM00866,Alisertib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.0700941,-0.06508065,4.747423824307503,0.2343141233353365
49315,SIDM00301,Oxaliplatin,Sorafenib,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,50.0,-1.9702253,-0.2520453,-0.577497519760922,-0.003147490329430461
71176,SIDM00866,Nilotinib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,2.6112335,0.1897173,0.44609537516673153,0.05923116301522636
22556,SIDM00954,RO-3306,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.0,-0.7535006,-0.0422623,-0.3242479181141155,-0.03098036212096807
65567,SIDM00774,Tozasertib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.6573485,0.061400782,0.8835747789361804,0.10048768128187348
29276,SIDM00774,RO-3306,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,0.4692107,0.02951384,-1.2346203911584628,0.01694886114849356
50460,SIDM00673,BI-2536,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.176554,-0.095248826,-1.444211583849612,-0.07123810851401563
26968,SIDM00866,AZD7762,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,-0.30885935,-0.018558918,-1.4368910755997129,-0.024212820843066127
43187,SIDM00779,AZD4547,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,33.0,-3.8679457,-0.024070945,-3.985914488710835,-0.06220311616362272
75783,SIDM00301,Taselisib,Linsitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.230682,-0.13198957,0.18062442809323578,0.020694247152000397
94511,SIDM00130,Cisplatin,MK-1775,Pancreas,0.2,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.714249,0.13898599,1.5043667017942832,0.0805551795501409
6320,SIDM00301,Crizotinib,OSI-027,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.3836265,-0.13298735,0.12080464629663716,-0.008820471038666162
72622,SIDM00301,Linsitinib,MK-2206,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,50.0,-1.6352402,-0.053553887,2.1412185126010734,0.04678778432118101
18522,SIDM00834,SB505124,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-0.30022916,-0.025041535,-1.0913996584755226,-0.03117406247834115
64574,SIDM00411,AZD7762,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,43.0,4.14742,0.23307762,2.2865937023086853,0.1407624607456067
63890,SIDM00097,KU-55933,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.4423535,-0.068686,-0.27301797735464844,0.02157433533305112
12945,SIDM00782,SCH772984,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,4.125139,0.21483038,1.6926369013017464,0.14530844467325918
20618,SIDM00411,Navitoclax,OSI-027,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.872164,0.09196089,0.24490229040132916,0.0436259474827581
2230,SIDM00782,AZD7762,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.62516546,-0.060691804,-1.3236008188267931,-0.052043255978841144
76343,SIDM00878,Bortezomib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,0.0024257067,0.00015279932,-0.7859202830939384,-0.05628550294896564
94734,SIDM00782,AZD7762,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,-0.17608318,-0.016561132,1.0494387476091604,0.08244797324323289
10101,SIDM00531,MK-2206,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.1917864,0.08802617,0.220648282660318,0.012184794782990596
95766,SIDM00878,Navitoclax,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.1443847,0.01772415,0.7560770735857228,-0.01388876401115781
15551,SIDM00359,Camptothecin,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.65502375,0.057987142,-0.19735697830269153,0.014003884988921795
86063,SIDM00954,AZD7762,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-2.5140202,-0.19378473,-0.6715242809484231,-0.06195614831744071
53328,SIDM00971,Ribociclib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.0878327,-0.07972791,-2.781772583093358,-0.08634691949324139
47175,SIDM00673,Paclitaxel,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,1.2907091,0.08907147,-1.0348147427939933,-0.06466692013142353
93667,SIDM00097,Dabrafenib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.768768,-0.09830352,-0.7972112386920766,-0.06625370332803344
106066,SIDM00146,PD173074,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-0.24915527,-0.0144666275,-0.042962318682565184,0.06090099146707773
60461,SIDM00130,MK-2206,Paclitaxel,Pancreas,0.025,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.6669227,0.122743644,-0.11547041344066727,-0.011323039579677677
57182,SIDM00673,Dabrafenib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,1.4995338,0.030005079,2.2565595118171715,0.07012204416262294
99905,SIDM00529,KU-55933,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.8483652,-0.0138678225,0.9824683529500434,0.017206772726661924
77500,SIDM00776,Linsitinib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-1.7977486,-0.08835145,3.200901998812508,0.11411408852487948
13767,SIDM00146,Gemcitabine,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.123353,0.07525781,-1.166690256621393,-0.07767046418034969
66745,SIDM00866,Bortezomib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.1486528,-0.095762596,-0.8348869007379902,-0.019797967120835574
92529,SIDM00529,Pictilisib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.684997,0.05399953,0.8329939825906358,0.06862612967514913
23903,SIDM00359,Crizotinib,Navitoclax,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.6541464,0.058355983,1.5409499965285585,0.02751968866974417
52056,SIDM00875,Alisertib,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0622466,-0.07421822,-0.18951332279571112,-0.04593954453573501
20145,SIDM00971,AZD8055,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1508728,-0.060076717,0.7161026130416766,0.0826731655893196
38498,SIDM00893,Camptothecin,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.6654277,-0.047006156,-1.0856041194606272,-0.09646298140329887
102209,SIDM00529,Venetoclax,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-1.3127728,-0.033478223,-0.29445910792405255,0.014161420354706909
14184,SIDM00782,Palbociclib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.24588652,-0.004259482,2.9980942595980693,0.08121163839689606
47181,SIDM00866,SCH772984,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.31038803,-0.023655172,-0.19757848012416296,0.029355588750827825
33742,SIDM00332,Bortezomib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3530313,0.062145676,-1.4134288648459166,-0.05389191047019759
38709,SIDM00146,Gemcitabine,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.32542312,-0.022917064,-0.7876904051649387,-0.062361084090669955
36370,SIDM00878,OSI-027,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.8258793,0.15825939,0.508297951334669,0.024477581306479496
15182,SIDM00779,Afatinib,LGK974,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-0.07779597,-0.007179393,-0.5328826259045869,-0.016181979503185926
100326,SIDM00628,Pictilisib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.80540925,-0.060261592,-0.9819597242319777,-0.05273191366776089
106309,SIDM00878,Entinostat,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.2470659,0.05842982,0.7054145377338681,0.057815129432256945
14261,SIDM00359,Vinorelbine,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.2129773,0.031893477,1.1684179064825684,0.05800691635190405
103538,SIDM00778,Camptothecin,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,0.2835809,0.008531135,-1.3812052421967116,-0.057442837789428686
13166,SIDM00893,Entinostat,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.3343976,0.056314107,2.683932008891714,0.05694183468367006
100895,SIDM00097,Crizotinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.739021,-0.07800599,-0.74749730618739,-0.06187104045334562
90551,SIDM00866,Palbociclib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.51112074,-0.012449757,1.058313645775893,0.0652309212034049
51761,SIDM01233,MK-2206,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,72.0,-2.2902312,-0.14693268,1.258500931514052,0.10378059939018226
48064,SIDM00893,Entinostat,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.8121178,0.1039853,3.4650156382101294,0.13861404346786543
92252,SIDM00774,MK-1775,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.5330448,-0.078780755,-2.3460771628428247,-0.16812986779321662
102206,SIDM00673,SCH772984,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.7248592,-0.08608106,-0.4616353648501184,-0.03563891610234024
30600,SIDM01233,Trametinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-2.939317,-0.19633283,-1.5228858582696467,-0.059599100131821334
34848,SIDM00673,Sorafenib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,0.6703338,0.040207785,0.11578159526941854,0.0359995870880213
45268,SIDM00774,PD173074,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.6263249,0.054302424,-1.3919789197458743,-0.07556342385215893
75624,SIDM00529,PD173074,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Black,44.0,-1.3554566,-0.058916043,-0.7108038436305403,0.0073552908744739685
9484,SIDM00130,OSI-027,Erlotinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.6110364,-0.049721804,-0.07679794772574029,0.011009583331596571
26735,SIDM01233,AZD7762,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,0.35758483,0.008711862,1.398611201609535,0.03833761333736937
76467,SIDM00875,Afatinib,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.31495738,0.006225344,-0.5022549205475362,-0.08449085081390481
34826,SIDM00875,Venetoclax,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.48845276,-0.011047487,0.7826575727426215,0.03524966414644294
75868,SIDM00359,MK-2206,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.7437253,0.09572764,0.8696626755590304,0.09369809923201257
105288,SIDM00774,Alisertib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.6541806,-0.07117232,1.3133753515733062,0.1788270125786147
86401,SIDM00529,5-Fluorouracil,OSI-027,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-1.9445915,-0.15512691,-0.95061266253761,-0.05190002073020343
98844,SIDM00097,PD173074,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.3352995,-0.11892644,-1.6736732434063837,-0.12015579092667733
107546,SIDM00782,Palbociclib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,1.3941448,0.039201275,2.753917447665929,0.10261182001669757
8230,SIDM00866,RO-3306,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-2.5796657,-0.1137513,-0.3149696495528671,0.04641079265575885
28975,SIDM00359,Olaparib,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.8287973,0.050755292,1.0089995626251396,0.024744266721966692
45322,SIDM00673,Pictilisib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.3609307,-0.03666823,-0.7609191469695927,-0.07049027742847386
30851,SIDM00531,SCH772984,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.5783827,0.2674409,-1.7758800004838458,-0.07313697335452232
77269,SIDM00097,Bortezomib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.15619342,-0.010408887,0.06101960690966343,-0.026108981886079286
80157,SIDM00301,Oxaliplatin,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.468162,-0.17416319,0.36282223950154985,0.04591650588898652
78040,SIDM00779,Palbociclib,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-4.7298627,-0.2675299,-1.9258451188223016,-0.11494261766806572
20028,SIDM00529,AZD8055,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.5435725,-0.1098593,0.014904176504464964,-0.011203153865775401
10226,SIDM00774,Camptothecin,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.6157187,-0.07554025,1.7015591086934285,0.13209246711975325
16357,SIDM00971,Wee1 Inhibitor,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.87090486,0.030116625,0.6435778703408878,0.03939680078125879
46634,SIDM00097,Venetoclax,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.914123,-0.051113136,-1.1347442316220304,-0.038518460294363524
54493,SIDM00332,AZD6482,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,4.0915737,0.14248869,1.2635358058616262,0.032092946698376215
62746,SIDM00971,Paclitaxel,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.8543346,-0.09322245,-1.7472792487125104,-0.04576731025117803
102711,SIDM00779,Palbociclib,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,0.719328,0.040982317,0.5912215453066105,0.029564838802983235
89491,SIDM00673,Uprosertib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.5641723,-0.10889513,-1.1689018406797225,-0.09505602371824058
72019,SIDM00954,Navitoclax,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.4784122,0.012318777,0.5186812517803517,0.060461047522047034
84808,SIDM00097,SCH772984,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0881948,-0.09313626,-0.6597727827719372,-0.046361280180207146
57105,SIDM00301,MK-2206,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.7357806,0.15835492,0.8903474965511116,0.10139630071016936
102160,SIDM00774,Venetoclax,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,1.292346,0.031069063,2.9174984364523184,0.04327968216171135
65945,SIDM00628,BI-2536,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-1.4326305,-0.062939696,-1.9351484342095802,-0.06735917932140324
18571,SIDM00834,SCH772984,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,1.6770093,0.12603483,-0.029700472855692554,0.01903554429140426
29748,SIDM00628,BI-2536,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,Black,51.0,-1.8540001,-0.082890674,-0.3399564053784076,0.009623627322305841
100338,SIDM00301,Cisplatin,Dasatinib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,50.0,-1.8860002,-0.16470666,-1.1393566189958686,-0.0254128823704752
58976,SIDM00776,SB505124,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,0.8671177,0.031037614,-1.5398794268145024,-0.06099093439020665
106387,SIDM00673,Sorafenib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.42166469,-0.025825232,0.10572325638620951,-0.01766917255765235
86133,SIDM00628,GSK269962A,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,0.34026787,0.029896708,0.34699637948978246,0.05631837542736167
52083,SIDM00878,AZD6482,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.28529876,-0.019322932,1.2066249389974106,0.059792945598145124
36337,SIDM00878,Venetoclax,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,2.1837506,0.09971812,2.0755625847116717,0.08931906437360194
65352,SIDM00411,SCH772984,Paclitaxel,Pancreas,0.0025,Pancreatic Carcinoma,Male,East Asian,43.0,-0.1936338,-0.0096299015,-0.153408370648933,0.00260264608147376
3696,SIDM00628,MK-1775,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-0.60016245,-0.057828534,-0.219501474067804,-0.04314949242139414
7187,SIDM00411,Paclitaxel,OSI-027,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.7164867,0.11196537,0.31374277729905203,0.04719139249213268
55306,SIDM00875,Palbociclib,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0665866,0.029924234,1.4962704304943548,0.07187276480977454
82536,SIDM00834,AZD8055,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,2.1995258,0.17012277,-0.5985803562922689,0.03661343037931978
34116,SIDM00866,Navitoclax,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-1.556725,-0.12934895,-1.6443265197692367,-0.08578479444425671
52088,SIDM00774,Uprosertib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.6400713,-0.04219554,0.7781621815772923,0.08133589091496092
3110,SIDM00954,Nutlin-3a (-),Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.0,1.1348683,0.020080106,1.7553198497792837,0.08146760521183949
33020,SIDM00529,PD173074,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-3.1930141,-0.12856953,-2.833980658035198,-0.1069339357911116
47388,SIDM00332,MK-1775,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.65422535,-0.06556461,-0.7470669458206001,-0.05046422146904563
53562,SIDM00893,Alisertib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.6527202,-0.13268588,-1.500624702185695,-0.11428000033085607
6267,SIDM00875,Lapatinib,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4544908,0.14154781,0.8617349986257252,0.02123519296312259
36328,SIDM00628,5-Fluorouracil,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-1.1901047,-0.044796642,-0.09398760573363975,0.018095555627709
69702,SIDM00146,AZD6482,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.85528076,0.048476752,-0.6028812138573859,0.06694209629431051
64149,SIDM00130,Palbociclib,OSI-027,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.6987332,0.14977056,0.005308358896429017,0.006556792000302694
95818,SIDM00893,Doramapimod,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.2920997,0.051394712,1.0827120668890848,0.06265198379762972
11732,SIDM00660,Trametinib,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,32.0,2.7901947,0.13045666,-1.6954656172915954,-0.09027739200359648
36914,SIDM00866,Doramapimod,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.1882974,0.03158998,2.2957125470827235,0.1099842392497379
8937,SIDM00146,Linsitinib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,0.7883859,0.021853045,2.092501292776358,0.09487789792569652
45057,SIDM00893,BI-2536,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.26500458,-0.024111526,-0.3155649525917435,0.0195300096325472
52818,SIDM00954,Taselisib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-2.1763368,-0.16262798,0.20937924504236027,0.02034517850149063
47051,SIDM00531,Cisplatin,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.833183,0.09887594,-0.424479876497617,0.014080303351118277
55626,SIDM00774,Paclitaxel,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,-0.7954134,-0.034944583,0.5689964321981544,0.09248696901624161
75020,SIDM00971,Pictilisib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.81683385,-0.035596576,-0.6126791357342174,-0.03139162351488055
50717,SIDM00774,5-Fluorouracil,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,48.0,-1.4032217,-0.110241055,1.1196682828776239,0.10815888269251367
40544,SIDM00529,5-Fluorouracil,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Black,44.0,-2.9529347,-0.20455611,-1.635281739116279,-0.09159247498487544
100036,SIDM00774,Vorinostat,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,1.8359936,0.028401313,2.1971818692298846,0.07447731539002615
103060,SIDM00782,Linsitinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,Unknown,72.0,1.6043973,0.08874685,2.3240085326848994,0.1453677251271799
66095,SIDM00301,Paclitaxel,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,1.2412745,0.053515352,-0.009743411614486958,0.005144271587657095
58343,SIDM00971,Lapatinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.81671965,0.04137908,-1.1419733116101067,-0.014680706534322822
30704,SIDM00971,Tozasertib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.5854328,0.051538818,2.166623058249305,0.06633301090593847
35,SIDM00954,Alpelisib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.0549761,-0.07556971,0.5523836311747792,0.04394817484738
43039,SIDM00097,Entinostat,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0462396,-0.085830286,0.19501297671442447,0.00861611310950253
29009,SIDM00971,OSI-027,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.06505137,-0.003818115,-0.23278227731980816,0.012234835449883389
50060,SIDM00834,Vinorelbine,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Female,White,66.0,-0.9469131,-0.07712162,-0.6686085912619012,0.008328883603436027
97237,SIDM00954,BI-2536,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-3.408497,-0.11934378,-0.9237463018419939,-0.04689671067777606
59337,SIDM00332,Entinostat,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,3.291835,0.1067045,0.9074235940667859,0.029062979275124533
50679,SIDM00301,Lapatinib,Erlotinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,1.0615586,0.059165377,1.1653408369535485,0.06460261855794663
16947,SIDM00834,Dabrafenib,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,0.49505258,0.01520522,0.3068008363440456,0.0480568146631789
81952,SIDM00878,GSK269962A,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,1.2742572,0.117277436,-0.4086781555909173,0.00822934874636679
24279,SIDM00875,AZD8055,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.66510034,0.054456893,1.2959175412367647,0.09594068613894534
96942,SIDM00893,Crizotinib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.5171075,0.068876676,1.7761232105194735,0.0633943266824946
27252,SIDM00359,Oxaliplatin,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.40146,-0.13428253,-1.506837554611967,-0.043328294702274756
20647,SIDM00779,LGK974,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,1.9001496,0.10395153,-1.077466653088306,-0.012235039264186426
37221,SIDM00971,Uprosertib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.6145188,0.0988809,-1.5319188156645993,-0.033059804343227236
98566,SIDM00097,Taselisib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.6986263,0.15068486,0.10914203120430271,-0.019688625580175107
34284,SIDM00875,Taselisib,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.34881434,-0.039941963,-0.4528646010636141,-0.019500298688351254
31749,SIDM00782,Dabrafenib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,-0.9470806,-0.023393756,1.2353756059603753,0.019385096942810494
31159,SIDM00774,Alisertib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.5114247,-0.09186868,-1.0146297358245422,-0.045484864242580636
32704,SIDM00332,KU-55933,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.0312707,-0.0816426,-1.8080482986324078,-0.028828874879479438
16988,SIDM00193,AZD8055,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.6100436,-0.09541934,0.6709576158522707,0.06806694053087169
75600,SIDM00660,MK-2206,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,0.88491565,0.054557905,0.7525529767281858,0.07377266041713547
55719,SIDM00359,AZD7762,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.3895369,-0.028213155,0.07517346402006098,-0.012835065578538135
64392,SIDM00776,Navitoclax,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,0.8355575,0.043393575,2.4223356453995475,0.09541945815769486
81887,SIDM00774,Luminespib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-0.8119842,-0.09385291,-1.2208720699166224,-0.09320026682782685
3625,SIDM00875,Doramapimod,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,6.0199075,0.093320124,3.432589539187071,0.04207227158160325
22297,SIDM00893,Trametinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.9243543,-0.1049938,-1.0142861023656038,-0.014238377907321463
28459,SIDM00875,Crizotinib,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.7594224,-0.15015048,-0.5252223483485575,-0.06334256384826678
10990,SIDM00878,PD173074,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-2.478587,-0.07420425,-0.38486798194434857,0.012569901119994552
19333,SIDM00531,Ruxolitinib,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.5728763,-0.017124252,1.3228114889312672,0.04695717076396864
64002,SIDM00954,Wee1 Inhibitor,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-0.3556788,-0.027164139,-0.16453159430764694,-0.043784269171339124
23286,SIDM00875,PF-4708671,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7201608,-0.023648102,1.5100519945822535,0.025253337127254357
8226,SIDM00660,Linsitinib,Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,3.3896,0.32493755,0.7270730040704932,0.08363622083320542
8788,SIDM00893,Taselisib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.3028599,-0.06128613,-2.4414116100970165,-0.11366492027377903
64236,SIDM00193,Trametinib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,0.6584103,0.049641848,-0.4014964828405469,0.0007746734218933298
90196,SIDM00332,AZD7762,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,4.094623,0.38137966,1.8732222220222705,0.10183369689700099
55958,SIDM00954,Afatinib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.0830625,-0.08206616,0.25052553207830275,-0.01126950821633844
11239,SIDM00875,Trametinib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4587502,-0.116178066,0.8875053396800396,0.1140098683394522
23478,SIDM00301,Erlotinib,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.3186493,0.06984435,2.324991116934236,0.08351041501251112
68297,SIDM00531,Taselisib,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.1736376,0.31829488,0.5906081367078414,0.09284187208069283
79687,SIDM00097,BI-2536,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.2192329,0.013909793,0.16551970643123037,0.038778689259192915
22531,SIDM00673,Entinostat,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,3.7113132,0.15205866,-0.5334970823575929,0.0018228478995611767
29353,SIDM00130,Gemcitabine,Dasatinib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.3055817,-0.08120263,0.19335576621173095,0.026865651939970397
10510,SIDM00146,MK-1775,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-0.32449704,-0.025436396,-0.7093174043735959,-0.010345485324611775
74240,SIDM00301,Paclitaxel,Irinotecan,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,-3.2911499,-0.25253618,-3.6095577657252425,-0.25710935066573587
107800,SIDM00776,Crizotinib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-1.5366278,-0.14166236,0.08700671602853559,0.02137723424883966
53414,SIDM00866,OSI-027,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,0.9520038,0.056193117,0.7381282474691964,0.06307899248988014
25817,SIDM00097,Camptothecin,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.36769393,-0.017225126,0.11194123679250355,0.04103938796980775
48182,SIDM00875,Sorafenib,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8950676,0.054699462,-0.46532977065535064,-0.06922830299618324
26095,SIDM00146,Linsitinib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.3368098,0.033301663,1.707966534259582,0.058080942041328666
16815,SIDM00628,AZD8055,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,0.73502165,0.056599468,-0.900838623598144,-0.034764069695322926
36979,SIDM00878,Linsitinib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,1.6030567,0.12743714,-0.49593662188444426,0.005807404317894649
24097,SIDM00834,Dabrafenib,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Female,White,66.0,-1.9454116,-0.05479425,-0.0679758532418227,-0.0005444394334769803
3177,SIDM00778,LGK974,5-Fluorouracil,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,1.9576955,0.059370466,-0.5452458533645776,-0.004143140321750967
64628,SIDM00628,PF-4708671,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,-1.4581265,-0.12521994,-0.8826527997712939,-0.02852753027521985
83869,SIDM00531,MK-1775,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-2.324794,-0.19872737,-2.4567234518166923,-0.15160553013925868
31866,SIDM00146,PD173074,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.5802086,-0.044690862,-0.10072560539729399,-0.04833266867276752
90821,SIDM00529,Entinostat,OSI-027,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-2.8442128,-0.12712374,-0.49333377405117673,-0.010347192506063795
26795,SIDM00193,5-Fluorouracil,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,-4.3362074,-0.1981468,-2.179648471440681,-0.09135670340588221
92667,SIDM00878,Crizotinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.5915153,0.060304105,1.8915878750647235,0.10651339810081903
64988,SIDM00411,Palbociclib,Oxaliplatin,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-3.882932,-0.12542668,-2.254142359402625,-0.05698326235585329
98270,SIDM00776,Linsitinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,1.6106029,0.06944558,1.8471534195144845,0.129044264896326
41449,SIDM00531,Cisplatin,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.0564587,0.09718278,-0.4552096106336655,0.018808451883990968
957,SIDM00866,Afatinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-2.4048448,-0.17107223,-0.3342595102804921,0.005892098730576556
25069,SIDM00673,Palbociclib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.7404764,0.18716456,-0.07666177443666976,0.009132496831469999
81493,SIDM00893,SCH772984,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.69188917,0.0514113,1.5530286824858406,0.09227354474503013
50040,SIDM00628,JQ1,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-1.0464138,-0.052270163,-1.0812021912315155,0.01729145454913951
24649,SIDM00778,Linsitinib,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-1.7594388,-0.060540427,-0.32717206089467915,0.029099459909973643
69298,SIDM00776,AZD7762,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.765656,-0.14900601,-0.9885857728176382,-0.09976104375559364
18500,SIDM00146,Vorinostat,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.7154166,0.0625677,-0.04324243104148091,-0.007000956517652459
99807,SIDM00875,PF-4708671,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.3076051,-0.04344391,0.5566670280633185,-0.031721707748354054
83093,SIDM00878,Paclitaxel,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.65283585,0.0502198,-0.25242787509113856,0.02010709493447455
24326,SIDM00875,Tozasertib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0552337,-0.03841301,1.4853571956382268,0.025272145652527413
98821,SIDM00529,Luminespib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,1.0691029,0.11061427,-2.2238465738570268,-0.07536243016381185
76016,SIDM00628,Crizotinib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-0.35754773,-0.0337172,-0.7396393411075276,-0.08460437600258523
39728,SIDM00660,Taselisib,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,2.4971442,0.15705866,-0.9380413338873891,-0.050041612282645885
53765,SIDM00411,Linsitinib,AZD7762,Pancreas,0.0625,Pancreatic Carcinoma,Male,East Asian,43.0,-1.2374152,-0.06514857,-0.7609520439950359,0.04269153502037882
11304,SIDM00529,ZM447439,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-1.2363572,-0.08758054,0.0032489113101267205,-0.04479406657124333
103406,SIDM00130,Dactolisib,Navitoclax,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.33963662,-0.02884879,1.5282627053796953,0.08403201114947438
38742,SIDM00779,Trametinib,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,33.0,2.337425,0.04232789,-1.365621834917931,-0.05754911029185731
33341,SIDM00954,Crizotinib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,0.29224482,0.023394598,0.46839970573394796,0.035088404284605426
91413,SIDM00778,Nutlin-3a (-),MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,1.9559591,0.03482426,1.9131379051126718,0.048275882024692976
59692,SIDM00776,Afatinib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,2.0351565,0.11673104,1.3468509824319512,0.04352180332072727
37330,SIDM00097,Doramapimod,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.6328229,0.032921553,2.031060719595823,0.05220748222220306
23686,SIDM00878,Luminespib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,70.0,0.38114902,0.04279431,-0.9939606747865307,-0.07051386957896072
52315,SIDM00778,Camptothecin,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,1.8177881,0.10619158,1.1228602809872683,0.038133350146065795
105304,SIDM00332,NU7441,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.4211886,-0.12009358,-0.09564761311141731,-0.014645901330699223
105308,SIDM00146,Wee1 Inhibitor,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.3358322,0.024439543,-0.3797341096211596,0.020308751325036532
100267,SIDM00531,Erlotinib,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.7348627,-0.09755185,-0.7286608515949292,-0.0038086713265417407
99678,SIDM00660,LGK974,Navitoclax,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,32.0,1.5309864,0.10777669,0.11990889190902279,0.07315061327941684
91774,SIDM00875,KU-55933,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2715702,-0.052889753,0.10711922627838084,0.05767913716950565
79427,SIDM00875,Alisertib,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8780547,0.08499888,-0.504449497948338,-0.029974044330859477
33242,SIDM00097,OSI-027,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3257117,-0.08092684,-0.11140040552273496,-0.06722021483754126
9054,SIDM00628,PD173074,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.67077047,-0.019396171,-0.03157140842707586,0.035377110550407646
58875,SIDM00529,Linsitinib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-0.103028655,-0.004399793,-0.7925485597993879,-0.0010695082467633511
56810,SIDM00893,Palbociclib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.95689607,-0.03887763,-1.9844210333251036,-0.015482235422767918
36505,SIDM00866,SCH772984,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.6218553,0.12194574,0.046354602998685726,0.048922840234788156
72225,SIDM00411,Erlotinib,Palbociclib,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.6556469,0.08266786,1.1039980146725472,0.10304012606030456
57688,SIDM00778,Navitoclax,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,1.361054,0.042735755,2.5524556867810024,0.11091683155243733
80955,SIDM00628,Axitinib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.91522235,-0.06615661,-0.8314641239003937,-0.05766588056106272
71387,SIDM00954,Doramapimod,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-0.633673,-0.038257863,-0.0645105842652615,0.03882144047654331
73298,SIDM00779,Taselisib,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,33.0,-4.624185,-0.2760514,-2.989612979230188,-0.18577341033551692
8796,SIDM00778,Vinorelbine,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-0.3296456,-0.011887097,0.5415156112391547,0.051709615102905934
5949,SIDM00193,BMS-754807,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,East Asian,53.0,-1.397799,-0.07170763,0.44524020621423777,0.027406940051007096
39480,SIDM00673,KU-55933,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-4.4047503,-0.15334408,-2.8713872180110247,-0.1531305682744066
94315,SIDM00893,Olaparib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2552117,-0.046342,-0.7776522786810585,0.01016948513677079
81501,SIDM00628,Crizotinib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.8429455,-0.040192056,-1.1985604509595356,-0.046456555432087446
103568,SIDM00971,Palbociclib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.9023023,-0.053808488,-0.8830719754676634,-0.00877542591822204
27624,SIDM00834,AZD7762,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,White,66.0,-0.8707361,-0.034788333,-0.89067927564925,-0.008258203876715463
25556,SIDM00893,OSI-027,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.8627248,0.23777166,-1.615507213908588,-0.10830458312433167
89829,SIDM00971,Docetaxel,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.7348974,-0.09503848,-2.1289317563262626,-0.035425938109214176
8152,SIDM00628,Dabrafenib,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.6938443,0.1257213,-1.7777855275166832,-0.017572373809661125
63395,SIDM00774,Alisertib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.5381495,-0.035413396,5.753696039962962,0.24102009064534638
49347,SIDM00411,Gemcitabine,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.7409502,-0.08214382,-0.7472171923582233,-0.009534249028819618
33086,SIDM00893,Vorinostat,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.044463,0.16977882,-0.27609439301665367,-0.03741515041855743
31659,SIDM00779,Taselisib,Nutlin-3a (-),Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-1.6663487,-0.13231583,0.15073175335905611,-0.018429540857009336
70871,SIDM00774,KU-55933,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,3.3396642,0.17055382,0.6625191070985804,0.008626764432453124
93716,SIDM00146,JQ1,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.35382047,-0.02952137,-0.01969002000810301,-0.02481317486774862
1299,SIDM00878,Crizotinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-0.43524265,-0.051454715,0.036946704123160416,-0.005862123044440363
45278,SIDM00776,AZD8055,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,1.2016615,0.08463585,-0.3475033011279167,-0.014902292093067631
69088,SIDM00834,SCH772984,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,0.1964975,0.016680073,-0.2683422668453462,-0.013864769367540154
32510,SIDM00660,MK-2206,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,4.05883,0.3092045,1.3275199172865508,0.10239299264085266
8426,SIDM00866,Entinostat,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-0.28085035,-0.020347212,-0.024726258457941,0.03537759363218709
61089,SIDM00097,SCH772984,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8707395,-0.076529525,0.014044326549530698,0.006858275264683938
76251,SIDM00875,AZD7762,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6690804,-0.033375293,-1.1134285857941961,-0.029293302571953186
86923,SIDM00778,Navitoclax,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,69.0,-0.2108922,-0.013268468,0.8914484697439912,0.0242539084551493
34542,SIDM00411,Irinotecan,Gemcitabine,Pancreas,0.1,Pancreatic Carcinoma,Male,East Asian,43.0,1.3333906,0.07089784,-2.9378735182600484,-0.05588849219891356
100383,SIDM00774,Dabrafenib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.7681342,-0.021454787,1.1666395647494163,0.030330849110103777
61773,SIDM00301,Lapatinib,MK-1775,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.5687435,0.08673603,4.015614264034397,0.1340208360201212
5095,SIDM00332,Alpelisib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,5.7899423,0.22013864,1.240674179472647,0.06918441948421528
52658,SIDM00878,SCH772984,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.6591433,0.11237075,0.011851970251699269,-0.021010555561056327
85368,SIDM00774,KU-55933,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,48.0,-3.02155,-0.08646542,-1.1904834710622145,-0.03416174284233239
91904,SIDM00332,MK-2206,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0239158,0.09863815,-0.7260348834612234,-0.03729194083060046
45110,SIDM00782,BMS-754807,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.2422739,-0.11887109,-1.1651597915051424,-0.10308805698465608
85316,SIDM00875,SCH772984,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.26398134,-0.026054537,1.2950055442129025,0.10319009385279453
57064,SIDM01233,Afatinib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,72.0,-2.938908,-0.13928649,1.2263332690206623,0.09830725987681188
48696,SIDM00774,Olaparib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,1.1128842,0.06412242,0.49644021022060725,0.044409365397449614
55861,SIDM00878,Axitinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-0.5307956,-0.067441426,-2.5824729190090756,-0.11828064611221979
64312,SIDM00529,Navitoclax,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.44052848,0.041455515,-0.07395966652370789,-0.03170524404285696
3720,SIDM00776,Trametinib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,65.0,2.67309,0.14626819,0.21652976568068194,-0.021838511059746567
41689,SIDM00359,Olaparib,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.7141318,0.045764912,0.59429318144907,0.027212041260954948
88513,SIDM00673,Linsitinib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.2958115,0.0274964,3.0492282109733275,0.06079405698343948
79369,SIDM00332,Lapatinib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.84678,-0.2721012,-1.196558326192257,-0.0904028531883805
86180,SIDM00359,Crizotinib,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.8057157,0.05938199,0.010954517973044746,0.020263577418000816
53435,SIDM00878,Alisertib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-3.434308,-0.21188287,-2.24348085802711,-0.11749197519877419
6095,SIDM00359,LGK974,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.739707,-0.023999695,-0.8665785112914166,-0.04200131776126621
30117,SIDM00531,Taselisib,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.7064066,-0.037895266,-0.402437618366872,0.037885908300284196
13838,SIDM00971,Afatinib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.266739,-0.1698253,-2.3693667253863073,-0.0744098230272323
95072,SIDM00097,5-Fluorouracil,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.98026514,-0.045540094,-0.5168335887495228,-0.020405496699724548
101732,SIDM00130,Erlotinib,Paclitaxel,Pancreas,0.0025,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.9505206,0.09108816,0.8362070878137784,0.05045687129098531
54678,SIDM00954,Tozasertib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,3.180605,0.2545971,0.8589954739319977,0.07247645300191959
93199,SIDM00878,Doramapimod,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.8065823,0.0928172,0.8760909502557584,0.0381378296337453
51820,SIDM00834,Navitoclax,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-0.9722852,-0.06181908,-0.4630319434701954,-0.009429714820208372
4138,SIDM00954,PD173074,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,0.8274,0.052968495,0.013832640062935705,0.03657014475124181
74457,SIDM00411,AZD7762,Sorafenib,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.7374291,0.09577945,1.3707885224622773,0.038903919291919484
85305,SIDM00779,Taselisib,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-4.2601233,-0.13870543,-2.342617416616282,-0.08448651951367213
46150,SIDM00954,SCH772984,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,0.9134919,0.06935675,-0.9773511446065425,-0.04088321843415113
6398,SIDM00776,Olaparib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.5569743,-0.055086,-0.7136366615062419,-0.015159515627860356
90294,SIDM00531,SCH772984,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.8342824,0.2013593,-0.5963317113080727,0.03091227355483611
7757,SIDM00359,Camptothecin,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.711636,-0.12504438,-1.5305068930157506,-0.04179050265462385
70398,SIDM00411,SCH772984,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.8407915,-0.08256564,-1.1790249030145608,-0.06725523817568388
45639,SIDM00782,Vinorelbine,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.39480612,-0.034899693,-1.5731986158323656,-0.015683488635149304
32813,SIDM00774,Doramapimod,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-0.6240883,-0.026677089,1.2544478924584244,0.07200715254120876
19415,SIDM00971,Taselisib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.93478674,-0.058938913,0.7127627616072812,0.00044483206490254264
104471,SIDM00097,Axitinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.6893077,-0.13477477,-1.1267212758539102,-0.10458913471550661
95251,SIDM00673,PF-4708671,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.874215,-0.15663074,-2.0524796816663136,-0.08785978054466824
81349,SIDM00893,AZD6482,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.7162063,-0.06283235,-1.0592611205386875,-0.060323712512551794
94860,SIDM00146,Nilotinib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,0.83892906,0.08427575,0.06669549384593342,-0.014510250028230812
8729,SIDM00529,Vorinostat,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-0.6991994,-0.067461245,-0.02134371707136633,-0.049384882837934206
50846,SIDM01233,MK-1775,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,0.5628565,0.04549059,-0.3642793805035818,-0.03005347221173408
63059,SIDM00301,Linsitinib,Dactolisib,Pancreas,0.0125,Pancreatic Carcinoma,Male,East Asian,50.0,2.7866714,0.20217447,2.184721917694054,0.16939698942713935
63539,SIDM00529,Tozasertib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,2.3203502,0.14341617,3.6237351865806873,0.20673163974372977
47994,SIDM00776,LGK974,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.4172192,-0.075343564,0.249854450485335,0.05382944677329168
33445,SIDM00782,Camptothecin,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-2.1156464,-0.18259028,-0.3200444756706976,-0.015407841817702357
59413,SIDM00673,Crizotinib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,1.2509153,0.10629687,0.3654008091129987,0.04991652988839547
69211,SIDM00954,Nilotinib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.28819,-0.087577805,-0.1317042206065392,-0.03904417364002674
34190,SIDM00660,Taselisib,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,2.4240887,0.18167832,-1.2168869248985736,-0.026495380994136383
13043,SIDM00332,ZM447439,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2626568,0.088490866,0.8443974175772999,0.015443407278371277
86604,SIDM00130,SCH772984,LGK974,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.5987919,-0.048337918,-2.777219856986947,-0.1119605869861582
19665,SIDM00660,BMS-754807,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,3.8278615,0.29261112,-0.2811961148308656,-0.027913818665706237
19628,SIDM00097,Ribociclib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6325072,-0.050940394,-0.6970106550273086,0.022546330404623203
60691,SIDM00875,ZM447439,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.4279156,0.060809225,-0.7082513765591387,-0.05403631611592888
89710,SIDM00834,Crizotinib,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,2.0920043,0.13870382,-0.3713691165619821,-0.04892511798153198
67748,SIDM00875,Cisplatin,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.48323092,-0.023970945,0.019022896686430937,0.04549919875567206
7411,SIDM00673,Paclitaxel,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,1.0725931,0.08702901,-0.16628816149330117,0.004924750062967282
74959,SIDM00878,ZM447439,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-0.55575824,-0.04860286,-0.883922518848954,-0.04933235557846331
5627,SIDM00359,AZD7762,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.32179895,-0.026292263,0.3567436462558437,0.01802354363181757
31366,SIDM00529,Camptothecin,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Black,44.0,0.5242522,0.023749089,0.5684436844884235,0.03605117603087547
37407,SIDM00893,Crizotinib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.5212102,0.059381504,1.7763264659970768,0.046224940068143164
85458,SIDM00971,Wee1 Inhibitor,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.2344644,0.07902011,1.0315386577464731,0.015786787074429612
25625,SIDM00531,AZD7762,Lapatinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.45932728,-0.028617622,0.770108780084826,0.02272316678878876
105935,SIDM00875,Olaparib,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2127988,-0.09522116,-1.2283328060416714,-0.09176152572818295
101902,SIDM00834,AZD4547,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,0.5902573,0.014740901,2.5673916428236505,0.08104127819172628
18438,SIDM00411,OSI-027,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,43.0,0.81202805,0.0471699,0.2809913150679993,0.02898690677940458
106171,SIDM00628,Afatinib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,0.9745996,0.06907364,0.8127147872273328,0.03997617196302714
82169,SIDM00130,LGK974,Erlotinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.6897024,0.12582627,-1.3023324059256212,-0.03894747566823021
75018,SIDM00875,Bortezomib,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.22564451,-0.01859067,0.8379887597206436,0.005074474535404976
86855,SIDM00971,Tozasertib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.656519,0.036028035,1.6593775253312284,0.025663554290539455
4496,SIDM00097,AZD8055,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3143789,-0.07962296,0.6010857236997257,0.052541617920029884
5702,SIDM00893,Entinostat,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.15961,0.054403737,2.208568267969584,0.0995212727901092
23556,SIDM00097,JQ1,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.9657376,-0.1516604,-0.8181618528643592,-0.07476205097543437
71127,SIDM00866,Linsitinib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,-0.96027905,-0.050927293,0.7803372255319936,-0.006295673382479258
22073,SIDM00673,MK-1775,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.97452277,0.0952932,1.4066192886519449,0.06984144838407753
92487,SIDM00893,Tozasertib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.0894163,0.20082901,1.3058428739464338,0.10287016964998424
42264,SIDM00628,Gemcitabine,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-2.331242,-0.10657932,-2.683295051472037,-0.10539699526885848
2757,SIDM00673,Paclitaxel,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.2954998,-0.10422241,-2.9987886263960633,-0.22661616371543158
14174,SIDM00776,SCH772984,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-1.0749568,-0.08430175,-0.4090371526778463,-0.029901524936491234
21419,SIDM00660,Taselisib,Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.6196377,0.04767828,-0.6068507256686511,-0.026786582797305388
43363,SIDM00893,ZM447439,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.5650854,0.04860709,0.6522975347879644,0.10409957393199974
90040,SIDM00878,Trametinib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.668238,0.19307968,0.06457923224559958,0.011770601261132156
79721,SIDM00971,Dabrafenib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.5103562,0.011461409,-0.22472533071178286,-0.0007796835574512595
37099,SIDM00411,OSI-027,Lapatinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,2.0649827,0.13376023,1.1216557143827197,0.06220360882331034
38314,SIDM00332,PD173074,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-5.9412007,-0.2525096,-0.9018671013314176,-0.009180419079688463
34272,SIDM00954,Uprosertib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-1.109316,-0.09311944,0.15769509328234216,0.02544750197665163
29599,SIDM00673,Vorinostat,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-0.8099733,-0.08573462,-0.6941767512920484,-0.03657455580349344
16700,SIDM00875,MK-1775,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.25857785,-0.0159078,-0.5741446704296315,-0.03112485762894833
92203,SIDM00628,Afatinib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.46518695,0.03457937,-0.343205162687177,-0.032395127656748235
42118,SIDM00660,AZD4547,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,-1.3124858,-0.034310717,-0.2645349373905914,0.005338705062015913
80429,SIDM00660,AZD7762,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-1.2439637,-0.1253962,0.4411384802926396,0.04619602701949994
77261,SIDM00776,Afatinib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-0.60177094,-0.051368244,1.3240309987431385,0.03968096377918945
74090,SIDM00673,Alpelisib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.70793164,0.04463676,-1.1956287122077156,-0.03280932309116579
31324,SIDM00875,Tozasertib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.0935369,0.1449124,5.361814369104866,0.2215349037267601
39292,SIDM00893,Doramapimod,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.6338876,-0.020872585,-1.0518444832148532,-0.029664750285353227
49226,SIDM00893,OSI-027,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.3090266,-0.10259527,-1.7281367982966762,-0.10086305388247865
68982,SIDM00878,Camptothecin,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,70.0,7.1625013,0.496851,5.772233735021733,0.3014643453629227
36530,SIDM00130,Taselisib,Ruxolitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.5544354,-0.15896823,-0.9901015345485479,-0.051997919020967426
72381,SIDM00866,Alisertib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.6423643,-0.038044494,0.6244934293106301,0.042342666248159334
84301,SIDM00954,Olaparib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.77934664,-0.011458837,0.1252848355627427,0.032408696698565095
20833,SIDM00097,Axitinib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.7048402,-0.095009215,-0.18487067327531573,-0.061985231855896945
16599,SIDM00332,Cisplatin,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4714338,0.039564222,1.4381404521012773,0.0505054673740268
41413,SIDM00954,ZM447439,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-1.6718565,-0.13111262,-0.1658031389509231,-0.004541302058793368
72295,SIDM00878,Doramapimod,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,70.0,0.60713524,0.038414743,0.08162630891499459,0.015290169960117303
82060,SIDM00971,MK-2206,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7241083,-0.09324651,0.29048861538728143,0.02794713780397001
90639,SIDM00878,Docetaxel,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.62189907,-0.07370981,-1.0333920499593936,-0.035452223708858054
52663,SIDM00878,5-Fluorouracil,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-1.4157187,-0.08843242,-0.42052177427389453,-0.035871643083620695
96087,SIDM00971,RO-3306,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.5873926,-0.059109114,0.27237596982634726,-0.006900824992237949
204,SIDM00866,Nilotinib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,52.0,-2.7531374,-0.13985156,-1.0538052126432271,-0.0298863153757697
34649,SIDM00332,Trametinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,4.781191,0.33910212,1.4006073765563292,0.06890290486237485
15836,SIDM00673,Axitinib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0601597,-0.10386511,-1.678100852651585,-0.12694585070644707
15080,SIDM00359,Afatinib,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.3971584,-0.14338228,0.22439701853731028,0.025375085817028492
89951,SIDM00954,Palbociclib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-1.5641956,-0.06863008,0.2900402961378214,0.016304952980621866
86629,SIDM00193,AZD4547,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-2.209505,-0.08703035,-0.09179196677224769,0.030640297911122223
31903,SIDM00778,5-Fluorouracil,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,69.0,-4.2307277,-0.12121277,-2.3765596521769567,-0.08959356046863405
9615,SIDM00971,Alisertib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.295429,0.034119546,2.246978644154029,0.0823386636793602
53241,SIDM00774,Ribociclib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.2273092,-0.06775615,-0.10819117967149862,0.0184935427800555
31618,SIDM00875,Wee1 Inhibitor,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.05191746,-0.0035893787,0.4316944870740424,0.011710934184173743
25146,SIDM00130,Linsitinib,MK-1775,Pancreas,0.2,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.1788024,-0.05940817,0.0704755510320292,0.04750187263690159
55118,SIDM00146,MK-2206,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.2524204,0.14595574,2.7114489539710434,0.20230081201586303
8143,SIDM00628,Wee1 Inhibitor,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-1.019251,-0.099453725,-0.9295544451706838,-0.0979189226444326
96154,SIDM00971,Wee1 Inhibitor,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.8787518,-0.050071575,-0.41242375929644226,0.04088817122329139
83089,SIDM00130,5-Fluorouracil,Oxaliplatin,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.5446961,0.058252357,-2.3780746568847535,-0.14574283749913458
66132,SIDM00779,Oxaliplatin,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,33.0,-2.6812704,-0.13587245,-0.9526733708024123,-0.05208036904223076
9083,SIDM00875,Nutlin-3a (-),Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6361295,-0.019353166,1.3833035234602347,0.07175816206965206
5357,SIDM00332,RO-3306,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,1.9458866,0.072396845,0.22915850766634824,0.0024552926790348635
9367,SIDM00097,RO-3306,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1581559,-0.054071847,1.4699105772396837,0.07662277404833337
82942,SIDM00301,Lapatinib,Trametinib,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,1.8969258,0.11375968,3.1270092064249324,0.0834794616959167
11324,SIDM01233,SB505124,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,0.689542,0.027667742,-0.3621964045442569,-0.05288249062831394
32946,SIDM00875,NU7441,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7373641,0.06574988,-0.4664873023297966,-0.004507970910115306
104952,SIDM00774,Afatinib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.5467775,-0.03780696,-0.8716305254764771,-0.04227023212504782
105084,SIDM00411,Ruxolitinib,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.29656568,0.0057055955,1.209377865530308,0.0688730923274791
25810,SIDM00628,KU-55933,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-1.3025688,-0.054300506,-0.7835505607026649,-0.014293855356592758
96602,SIDM00673,Dabrafenib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,3.1616976,0.100381866,1.4972280742455146,0.06614342629717027
22861,SIDM00332,Alpelisib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,5.717973,0.25828847,1.4622459007897937,0.05564494779831291
11815,SIDM00146,Entinostat,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,1.3418417,0.11577135,0.9183716679501164,0.10634000672430237
28141,SIDM00332,Entinostat,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7979083,0.019064108,1.4148949104188564,0.05646747881177915
80937,SIDM00954,Wee1 Inhibitor,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.0,-0.8973586,-0.07437611,-0.840640780354562,-0.07588570363385681
88231,SIDM00673,Gemcitabine,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.1614406,-0.13264672,-2.202906977024493,-0.08582839227189847
34016,SIDM00301,Palbociclib,Sorafenib,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,50.0,1.2812536,0.1702358,0.0734326631933564,0.027601110426306124
5582,SIDM00673,MK-2206,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,0.5838552,0.03850195,0.6617879771787292,-0.0019148266129610993
96279,SIDM00774,Crizotinib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.6320376,-0.07544596,-0.3060860734497966,-0.08008403497810909
51141,SIDM00332,Wee1 Inhibitor,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.2851887,-0.15939847,-1.8367027664884414,-0.12686404751991257
87709,SIDM00774,Bortezomib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.8070513,0.028968796,-0.16641366355034454,0.004747593009553477
77865,SIDM00529,Uprosertib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.6243585,-0.07581728,-2.0068838862342426,-0.07163954665055663
3451,SIDM00878,MK-2206,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.68529665,-0.07666084,0.4817486881224015,-0.044636491534355074
90888,SIDM00971,Crizotinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.2202628,-0.06536026,-1.3758624266043606,-0.0027111839199478365
100061,SIDM00301,Olaparib,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,2.035416,0.24751368,-1.3363180964275125,0.0272118669059237
8961,SIDM00774,Trametinib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,3.5960057,0.13731344,1.9221997915045397,0.0882890386168452
108240,SIDM00954,Navitoclax,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.98756737,-0.041485906,-1.6379641330308272,-0.11479963257811202
102708,SIDM00529,PD173074,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.990164,-0.090099245,-0.7766130385894132,-0.00449092328430637
67816,SIDM00971,Taselisib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.0355031,-0.12394295,-0.23338427038879858,0.009292936515172665
69312,SIDM00130,Palbociclib,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.1134787,-0.0719672,-2.626965953666242,-0.09597826502810378
108199,SIDM00875,AZD7762,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.25736678,-0.017045777,-1.274925654604649,-0.007546446988390341
54203,SIDM00782,MK-2206,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,2.2101011,0.18499406,1.736476352443106,0.0940713186981303
23757,SIDM00628,Paclitaxel,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.7025741,0.048456203,-2.4135570618394104,-0.19207250581495605
83857,SIDM00660,AZD8055,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.42773032,0.031179944,0.060982205921923244,0.018356385086501656
3364,SIDM00878,Lapatinib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,70.0,0.75211096,0.094334535,-0.3909886003438073,-0.0011059956719619655
77022,SIDM00529,Sorafenib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,0.25095633,0.025099548,-0.44207332709722674,-0.01989560420131254
53016,SIDM00097,SCH772984,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.1912012,-0.11480838,-0.7851253539182979,-0.07210823613740928
45965,SIDM00774,Docetaxel,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.25121072,-0.011699116,-0.47086971595591265,-0.008329289694710416
47725,SIDM00673,Lapatinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,2.3160162,0.23188794,0.2650040302173107,0.050646591923091705
3032,SIDM00971,PD173074,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7536042,-0.03965546,-1.6792364867869027,0.003971718223603536
18374,SIDM00097,ZM447439,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0172677,-0.07401155,-1.5658947494098676,-0.02837858425205467
43121,SIDM00529,RO-3306,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,2.8613868,0.1627028,3.000638406932111,0.12655035804385698
21214,SIDM00875,Cisplatin,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.94608325,0.05835446,0.3768281083508405,0.0486522122844939
78401,SIDM00866,Alpelisib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,-1.6176237,-0.090666406,-0.10975254136721964,-0.0024677797117731584
2613,SIDM00774,Tozasertib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,2.520474,0.09967863,1.4364825747082937,0.08033136961747346
55242,SIDM00130,Gemcitabine,Ruxolitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.9836063,-0.07395133,-0.9081405281666235,-0.08046322705355069
58286,SIDM00531,Oxaliplatin,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.7050915,0.1483566,0.5770184389459183,0.0655015169426716
95074,SIDM00130,Trametinib,Navitoclax,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,4.526181,0.3418603,3.0820599617606477,0.1543289031270598
32430,SIDM00359,Palbociclib,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7442942,-0.09280599,-2.1761558696749552,-0.05221663784232863
4192,SIDM00146,5-Fluorouracil,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.674446,-0.07239003,-1.9212517667441653,-0.03343609906349966
28389,SIDM00359,5-Fluorouracil,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.9205773,-0.13393523,-3.087278987569178,-0.10515726204485558
43660,SIDM00628,Trametinib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,0.8197689,0.08141294,-1.3486528995583,-0.052074105107702544
77082,SIDM00866,Dabrafenib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,0.19511746,0.0047616675,0.7192288375689829,0.03379717882741059
98295,SIDM00673,Venetoclax,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.7171795,-0.0094612995,1.112114663770437,0.040861013586015724
25369,SIDM00130,Trametinib,Lapatinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.0789895,0.20526831,1.615028723287091,0.14113646734505572
19254,SIDM00660,AZD4547,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.95217943,0.06303831,0.44560892748514874,0.0360700372337766
87946,SIDM00971,PF-4708671,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.2799289,-0.07846905,-0.8993721956347149,-0.031254538760512124
108007,SIDM00971,Olaparib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.4250002,-0.060158994,-1.489654498818523,-0.04071597410063193
3764,SIDM00782,Crizotinib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,1.1929872,0.10271015,-0.27665662274991076,-0.021213567891584965
83264,SIDM00130,Taselisib,Lapatinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.50927806,-0.049591623,0.9407255473996594,0.054477881011228226
32780,SIDM00971,Olaparib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.0584443,-0.05577229,-1.7008014004541856,-0.012697067400170204
51913,SIDM00971,Uprosertib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.7185764,-0.09604066,-1.1985478331224737,-0.04320890459905897
11117,SIDM00866,Trametinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-0.9845366,-0.08087349,-0.08343952759040409,0.026763383586346962
56597,SIDM00531,5-Fluorouracil,Dactolisib,Pancreas,0.0125,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.47845766,-0.014471332,1.2069392818071158,0.04785044745478298
106082,SIDM00971,AZD6482,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.1807077,-0.054777596,-0.6973074427973593,-0.06333249289400233
50230,SIDM00971,Nutlin-3a (-),Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.6590129,-0.045449656,-2.2532817223800823,-0.03678103234048528
40801,SIDM00866,Temozolomide,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-1.2780197,-0.020684745,1.274805560932457,0.030653300570023075
60781,SIDM00359,Camptothecin,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.54055184,-0.04395296,-1.8480091411907507,-0.09460603254886303
25517,SIDM00332,AZD6482,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.75234616,-0.045168445,-0.2998459659790032,-0.09421862329819101
107435,SIDM00778,Navitoclax,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,1.3618324,0.0891869,-0.436192000556378,-0.018966360812729014
68496,SIDM00130,Navitoclax,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,5.337558,0.21858351,2.396263156866108,0.16698824750128186
88318,SIDM00834,Trametinib,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,2.1679363,0.04979178,-0.22497243130313369,0.0034353682906560316
42812,SIDM00332,Dabrafenib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7136147,-0.08912743,-1.2154902649785564,-0.055246037911384174
62517,SIDM00893,Navitoclax,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.9648264,-0.09641814,-0.42237870640742886,-0.005114471437779922
56405,SIDM00673,BI-2536,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.2787816,-0.022476181,1.0286109036324824,0.06760198679789
55417,SIDM00673,Tozasertib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,-4.3161697,-0.18295205,0.06323153469886136,-0.025901365341665178
101759,SIDM00774,Ribociclib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-1.0895526,-0.0373417,-1.4046495831292647,-0.03666846974062846
11084,SIDM00954,MK-2206,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.0,-0.9220498,-0.07108235,0.016973108429821082,-0.005347511443222913
57292,SIDM00529,Vorinostat,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,0.44140542,0.043653823,0.2696605358870542,0.061894345460087735
108242,SIDM00971,Tozasertib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.1903858,0.04656626,0.967657339910451,0.04165806098806276
81956,SIDM00673,Ribociclib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.4735537,-0.025265021,-1.704080805301142,-0.024194079947380612
21264,SIDM00097,Olaparib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2297782,-0.022927102,0.14808593358164288,0.004326047298007819
69916,SIDM00628,Venetoclax,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-1.3007582,-0.054270726,-1.2694386043578396,0.005339051980752053
84573,SIDM00875,Alpelisib,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5099346,0.047502622,0.5819851964271179,0.07073777488374525
50524,SIDM00834,Crizotinib,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,White,66.0,0.8938242,0.065315455,-1.0423033990946087,0.019792557669995468
89214,SIDM00954,Docetaxel,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-0.6887296,-0.05137014,-0.340760143015247,-0.022083829355036763
75775,SIDM00529,KU-55933,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,2.2889829,0.03373543,2.0491572424858306,0.041754537557834044
80712,SIDM00774,Linsitinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,0.76752734,0.070218645,0.7204345763095938,0.04183051102257525
68313,SIDM00660,Crizotinib,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,1.6207107,0.08078465,-0.0017089143202248188,0.015064362829439763
2517,SIDM00878,Cisplatin,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,4.4393735,0.05690335,4.185179870286182,0.15853518346536655
44526,SIDM00529,Dabrafenib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,1.5104332,0.02411782,1.2831834856907256,0.01761630416374613
65100,SIDM00628,RO-3306,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,-1.0937349,-0.075757064,-0.4336681419968933,-0.05197244690313572
75727,SIDM00628,Temozolomide,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,1.0335649,0.042516097,-0.3752896326005889,-0.0016047677672132745
59989,SIDM00778,SCH772984,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,0.6806584,0.034560647,3.4961039521970814,0.07766155729641147
23040,SIDM00878,Vorinostat,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,2.7194376,0.22172573,0.7826935183533772,-0.006096556675025707
62151,SIDM00774,Linsitinib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.894808,-0.056077156,-0.28486034994401094,0.04752802275039273
96493,SIDM00954,Doramapimod,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-1.2850766,-0.07800671,-0.10462592657261062,0.06578367103848637
94985,SIDM00359,SCH772984,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.1851141,-0.1369853,-1.4429191989577208,-0.053499011813499454
2354,SIDM00774,Doramapimod,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,-2.6625624,-0.09522602,0.8302830935918367,0.07605861409260767
3946,SIDM00893,Nutlin-3a (-),Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.3374611,-0.0069916947,1.7128195097897756,0.03940949343486433
11802,SIDM00878,Axitinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.35312682,-0.042241246,-0.02590515083705893,-0.06387493163382389
67236,SIDM00878,JQ1,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,1.2070928,0.0998343,-0.005498514656969202,0.06010975378842713
20757,SIDM00146,Pictilisib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.8696358,0.07937405,-0.749890561079716,-0.03704343221856061
33507,SIDM00332,PF-4708671,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.328481,0.083226,2.912099815884525,0.14110010468303785
1251,SIDM00774,Bortezomib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,48.0,-0.17896748,-0.014384718,-0.28173491132772327,0.010450274307084291
82475,SIDM00529,Luminespib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.8075666,-0.026873944,-2.492153548299386,-0.07193731970639854
35491,SIDM00866,Afatinib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,52.0,-0.7653593,-0.06537889,0.4420121974277768,0.05820791076260268
99438,SIDM00531,MK-1775,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.8856847,-0.16666988,-0.6899127696960649,-0.047346238449742575
84584,SIDM00866,Palbociclib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.5914475,-0.014825523,1.2338440026312636,0.08730366340915068
3908,SIDM00130,Lapatinib,Paclitaxel,Pancreas,0.0025,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.4643054,0.24055162,0.17765198385215525,0.07771365873740503
35979,SIDM00875,Olaparib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.56504864,-0.038459726,-0.0012522866520877512,-0.05197227730467934
51563,SIDM00834,MK-1775,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-0.7989432,-0.06044498,-0.8259484479516597,-0.054034453742847655
21032,SIDM00971,Nilotinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.61527336,0.041940127,0.863428683106165,0.07871081898018283
106043,SIDM00146,Wee1 Inhibitor,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-0.77495193,-0.06296475,-0.1435006164907288,-0.003571980255428691
62853,SIDM00875,PF-4708671,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.80057734,0.01267936,2.9132341031154554,0.017778609653427407
16936,SIDM00866,PF-4708671,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-1.8604455,-0.0746892,-2.5988040909947943,-0.06487066137500325
56604,SIDM00878,Cisplatin,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.6298273,0.016279347,1.2195319984416029,0.0499037051038764
30916,SIDM00193,AZD8055,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,0.30724564,0.02682691,-1.2907401571745434,-0.035584469022159865
79609,SIDM00779,BMS-754807,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-0.82661027,-0.016086867,-0.40478476703438243,-0.03999942228342024
96112,SIDM00359,AZD8055,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.42498198,0.031540345,-1.5496007908814662,-0.037122355446104885
60048,SIDM00866,Camptothecin,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,2.5105665,0.058754396,3.11171661619502,0.14336368711109604
15098,SIDM00193,Taselisib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.52358466,-0.04279882,-0.4224398156867715,0.009536265309743325
29223,SIDM00097,Gemcitabine,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.5593857,0.02201621,0.12017449249833048,0.044772969415460405
38311,SIDM00529,ZM447439,MK-1775,Breast,0.625,Breast Carcinoma,Female,Black,44.0,1.3951808,0.073227696,-0.5683244520298876,0.025823833968622936
62578,SIDM00878,Docetaxel,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-1.9353572,-0.08002456,-1.3449427630190667,-0.03660246474283063
69032,SIDM00866,Uprosertib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,1.3731383,0.09531185,1.6381799610092325,0.13706809503528503
95235,SIDM00875,SCH772984,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.0620584,0.1987536,2.3272690201353177,0.13551218920617858
65650,SIDM00332,Venetoclax,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.539869,0.10984634,0.6154892146029037,0.038831115529711906
3445,SIDM00893,AZD7762,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,6.584442,0.49577323,2.392894000585212,0.19580651355744522
68499,SIDM00193,5-Fluorouracil,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,53.0,-1.1459267,-0.10449879,-2.3723335241025456,-0.1189349510904504
68656,SIDM00660,Trametinib,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,4.6613116,0.16761594,1.8673845487296157,0.04151856675912212
39824,SIDM00971,Taselisib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7040162,-0.11070639,-1.2835103176378402,-0.09499809658503423
56784,SIDM00531,5-Fluorouracil,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.7418138,0.086948566,0.5409795572450365,0.024039722252503993
31818,SIDM00875,Palbociclib,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8358675,0.027961528,0.853053880187917,0.03387345286393839
14540,SIDM00529,Alpelisib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-1.7137538,-0.058513336,0.3535556877261923,0.012091578116255487
45936,SIDM00628,Lapatinib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-1.1477816,-0.108225994,-1.5351008897018643,-0.07907393688093181
74031,SIDM00776,Linsitinib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-1.886656,-0.08986398,1.3614355920483594,0.08230295238675919
60051,SIDM00954,Navitoclax,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-0.702274,-0.018805414,0.13795673127928126,-0.02493851674149095
2569,SIDM00875,JQ1,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.45942175,0.045508366,-0.08612206727946367,0.0030993294069872417
30985,SIDM00782,Palbociclib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.35824698,-0.007044158,1.838177852276678,0.06159975076925393
27694,SIDM00097,Luminespib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7767301,-0.09166373,0.04469085917189857,-0.001744413916735281
56302,SIDM00971,Doramapimod,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.9418492,-0.054052807,0.38339233423195895,0.026043529509682813
26648,SIDM00146,PD173074,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-3.5147104,-0.14644012,-1.336824664019437,0.007950531394388168
68068,SIDM00097,JQ1,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0959128,-0.053985927,1.4796125234651685,0.1583601388510909
28931,SIDM00673,Afatinib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,1.6674639,0.09969592,0.28458502667334784,0.04259003532587454
38971,SIDM00529,KU-55933,PD173074,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.7964836,-0.012189712,1.5702860959577252,0.06603969895913345
88221,SIDM00954,PF-4708671,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-2.089883,-0.10597365,0.3171448368530238,-0.010408153434324973
96948,SIDM00332,SCH772984,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.5230048,-0.16064297,-0.7793457623582253,-0.07981901020740498
41716,SIDM00301,MK-2206,5-Fluorouracil,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.3271827,-0.13692172,-0.5000695790218973,-0.036921534308326585
79511,SIDM00866,Uprosertib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-2.362202,-0.09987205,-1.504398939770673,-0.01948056811894893
70123,SIDM00411,SCH772984,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,6.8716116,0.3303247,2.94087158731408,0.1725541006204835
70512,SIDM00529,Sorafenib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-0.93434155,-0.081489675,-0.4027884738011991,0.008976902372132887
94541,SIDM00411,Olaparib,Dactolisib,Pancreas,0.0125,Pancreatic Carcinoma,Male,East Asian,43.0,0.9284771,0.025226995,1.3869054743646256,0.02050749820987485
8102,SIDM00531,Oxaliplatin,Dactolisib,Pancreas,0.0125,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.746706,0.08530242,1.0928636996621908,0.08022011276451123
27173,SIDM00778,AZD7762,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,1.5792402,0.07634242,-0.4597211952911093,-0.04366985758029045
27282,SIDM00332,Camptothecin,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3898468,0.04117365,1.8098551812774615,0.056196763984604915
35860,SIDM00193,LGK974,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,53.0,-2.4493482,-0.11059853,-1.8118282295919699,-0.06728141714403428
24642,SIDM00875,Cisplatin,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.23625328,0.012544591,0.3119678915386946,0.0411213770477194
53777,SIDM00332,Crizotinib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2268187,-0.099123575,-0.7838569489525703,-0.011654792902085837
85477,SIDM00660,Linsitinib,MK-2206,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,4.939304,0.4975261,0.9849410056033833,0.08673668988586652
16734,SIDM00531,Lapatinib,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.0667198,0.19596337,1.3929471942808884,0.11819173513808721
66778,SIDM00411,Lapatinib,AZD7762,Pancreas,0.0625,Pancreatic Carcinoma,Male,East Asian,43.0,1.9023452,0.08232334,1.5729155222079216,0.09914121788556715
15763,SIDM00097,Doramapimod,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.5245829,0.09443874,1.9987424123908122,0.06725336505804243
59833,SIDM00301,Irinotecan,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.311295,0.16952397,0.6600835882335698,0.0500018251983401
66871,SIDM00954,Gemcitabine,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,0.32918897,0.025523648,0.1673204557818647,-0.027430824064797382
77254,SIDM00130,Olaparib,Crizotinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.5267165,-0.08259535,-0.5907867168393334,-0.03680107861154933
84062,SIDM00146,Temozolomide,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,2.4940484,0.06778558,1.5956171588199284,0.05538741860135927
28404,SIDM00893,Navitoclax,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,4.1443596,0.34313503,1.7396060678078802,0.11256230144557561
74316,SIDM00673,Camptothecin,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,2.4450073,0.09251011,2.3184703458973273,0.10419980613377261
28293,SIDM00893,Gemcitabine,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.2289786,0.20929186,-0.6515026105268851,-0.01887572896763209
86524,SIDM00875,Cisplatin,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6540907,0.01837702,-0.44852664843855927,0.007660957680736254
25908,SIDM00866,AZD7762,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.2793981,-0.07974282,1.1479508036042343,0.11139520987357937
41512,SIDM00778,BMS-754807,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,0.17716324,0.006685601,0.6651493982437042,0.012155192750567152
44593,SIDM00130,Ruxolitinib,5-Fluorouracil,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.69810075,0.0148711,2.0656062431624966,0.03763632663893018
70630,SIDM00628,AZD8055,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,0.6472633,0.020585032,-1.5999393815978942,-0.09854353462005852
39843,SIDM00875,PF-4708671,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1007098,-0.032218505,0.07672038491732268,0.0008796668754046359
46589,SIDM00628,AZD8055,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-1.0339704,-0.090655595,-0.7593962980599447,-0.02076063673914419
48173,SIDM00130,Linsitinib,Palbociclib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.6019757,0.039834026,0.8006739968962278,0.03222300535516128
39006,SIDM00878,SCH772984,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-1.2945492,-0.10837919,-0.43313764488106365,-0.051197238317772606
35792,SIDM00411,Palbociclib,Gemcitabine,Pancreas,0.1,Pancreatic Carcinoma,Male,East Asian,43.0,-2.926468,-0.07184046,-2.135914806442904,-0.05362648577048603
25479,SIDM00776,Trametinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.5796032,0.051742747,-0.14288630338326158,-0.007266630677170641
98002,SIDM00146,NU7441,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-0.8526321,-0.06807021,0.3751824635226382,-0.009355605698792787
16574,SIDM00776,Olaparib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.6797975,-0.03020016,-0.79023428296435,-0.012296245761634163
72967,SIDM00673,Lapatinib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.8702933,-0.07406794,-0.674353093456135,-0.014910299321014812
23062,SIDM00866,Wee1 Inhibitor,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.925741,-0.07732062,0.42888670125739403,0.037225739523896746
20318,SIDM00146,Wee1 Inhibitor,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.8312396,0.059130993,1.4202863973981439,0.07956311854719572
106308,SIDM00673,GSK269962A,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.5356872,-0.04163263,0.6523034224002401,0.02868668273373291
63277,SIDM00954,MK-1775,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,0.27406722,0.0155568095,-0.4872273710999661,-0.008440896543719462
69947,SIDM00146,Axitinib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.2705793,-0.08596443,-0.600171188382582,0.048552972818988745
102177,SIDM00660,Camptothecin,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,1.3021954,0.09153601,0.5952329358578409,0.014101109604020072
102165,SIDM00628,Vorinostat,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,Black,51.0,0.16466378,0.01656822,-0.05730577779676014,0.04915539408543494
27165,SIDM00660,Camptothecin,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,32.0,-1.741955,-0.08871031,0.07316513519393052,-0.011561086762305084
57031,SIDM00866,Lapatinib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-0.2566566,-0.019207155,-0.31177449750315495,0.035493945941230745
86115,SIDM00866,Trametinib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,0.9354152,0.08064014,1.1980994033088659,0.13118694993870847
26222,SIDM00359,LGK974,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.368033,-0.041417338,-0.8719915477261321,0.010489079309102055
12835,SIDM00146,Pictilisib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.1329117,-0.08886294,-0.10043257426627034,0.014429948667644828
73901,SIDM00673,Wee1 Inhibitor,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-3.0407875,-0.08524741,-2.0980641433758866,-0.08393038778084867
69264,SIDM00971,GSK269962A,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.0489658,0.0615991,0.7793362078048599,0.05278332840028765
80415,SIDM00628,Alpelisib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.9015079,0.120938845,0.8961174044958091,0.09729837556961132
92561,SIDM00130,Palbociclib,AZD7762,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.4467798,-0.095260546,-1.7038185991444779,-0.10446600073857894
66120,SIDM00954,Nutlin-3a (-),PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,1.149675,0.035137624,0.3830995184838767,0.04917914333054518
68567,SIDM00779,SB505124,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,33.0,-1.584995,-0.10934025,-0.7522892776222632,-0.06680614270795887
37109,SIDM00411,Dasatinib,Erlotinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,1.1678755,0.070032574,1.2756246027733134,0.1058893599926047
59083,SIDM00146,Uprosertib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-1.7414916,-0.1151141,1.2637351498224114,0.10898900608458674
62232,SIDM00628,SCH772984,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-1.0743707,-0.033935428,0.45542384367247996,0.04601630970147213
41757,SIDM00774,Doramapimod,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-2.8435094,-0.10857881,-0.7051169070229025,0.005705757798669104
53335,SIDM00628,Trametinib,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,1.1381149,0.100004785,1.3829696301677843,0.07701394059610968
78930,SIDM00971,5-Fluorouracil,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.5750511,-0.014337127,0.13101201758941192,0.024392530970120705
28335,SIDM00954,5-Fluorouracil,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.6049204,-0.056395546,-0.2585405649956179,-0.0001541911748602266
77227,SIDM00834,Olaparib,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,2.006488,0.048158314,3.0463314298197997,0.049094895279920586
46379,SIDM00834,MK-1775,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-0.44084454,-0.027683444,-0.49248954344266843,-0.024502221273707797
23735,SIDM00332,NU7441,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4287295,0.09127819,0.8580881578649678,0.03880587353474073
61541,SIDM00529,BI-2536,OSI-027,Breast,1.0,Breast Carcinoma,Female,Black,44.0,2.1602092,0.13778742,-0.23746116026938033,-0.042306017615238334
102659,SIDM00628,Doramapimod,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,2.3412178,0.11204614,1.473362354419105,0.08925155231750703
64080,SIDM00673,Afatinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.5175381,-0.109586544,0.4905327958183665,0.10116766758867667
8705,SIDM00332,Navitoclax,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1794305,0.088083886,0.055971767317532506,0.0033739782048326497
66612,SIDM00782,Dabrafenib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,Unknown,72.0,1.8593631,0.08940482,0.7999275570844644,0.015582762489595964
92028,SIDM00866,Gemcitabine,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,-2.335806,-0.13735911,-0.3344675076328308,-0.05104442475143555
46052,SIDM00954,MK-1775,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.7635845,-0.045335457,-0.5465326153823549,0.017272410452312238
56723,SIDM00875,Temozolomide,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.4381166,0.017981302,1.3711473302695862,-0.0037118864065240516
23912,SIDM00529,GSK269962A,Taselisib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-0.8691498,-0.06642315,-0.29625310677692834,0.030608586899864915
5078,SIDM00332,Tozasertib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.48690245,-0.039576836,1.0127872499422146,0.05166293010235492
95672,SIDM00411,Linsitinib,MK-1775,Pancreas,0.2,Pancreatic Carcinoma,Male,East Asian,43.0,1.2299196,0.07331762,-0.6743448912085683,0.029940245941435375
60160,SIDM00628,Axitinib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.3667962,-0.024191858,-0.1754824629646601,0.02508610534779426
35544,SIDM00866,PD173074,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,4.100189,0.24855691,-0.7356684003678297,0.022133589171285387
72575,SIDM00878,Camptothecin,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.1286966,0.038302828,2.3458407250505786,0.11418215526871733
21150,SIDM00359,SB505124,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.5066992,-0.07082672,-1.4303547133772803,-0.01214320872250159
35046,SIDM00411,Sorafenib,Paclitaxel,Pancreas,0.0025,Pancreatic Carcinoma,Male,East Asian,43.0,1.1920856,0.07715112,-0.014838709569031902,-0.0010484740481519238
86843,SIDM00774,KU-55933,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.1999061,-0.030077748,1.3390020131579305,0.0385325383268766
104295,SIDM00774,Alpelisib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,48.0,-1.5040511,-0.099712506,-0.5056575966438072,-0.05235613902246792
92087,SIDM00660,Taselisib,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,0.68949085,0.060373373,-0.23744359372192858,-0.02121993732114991
82510,SIDM00301,Lapatinib,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.3305724,0.18847342,2.799419170688179,0.16827572545317088
7138,SIDM00628,AZD7762,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.49889147,-0.047473423,-1.3863724792468668,-0.037407755414636375
41331,SIDM00971,SCH772984,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.1539491,0.026163155,1.1635467306451401,0.05170630209987432
63223,SIDM00971,Sorafenib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.5344751,-0.03837821,-0.6138930280618857,-0.028791205026407547
47702,SIDM00130,Lapatinib,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.9270736,0.13573039,0.300495488228154,0.04970282066266638
18595,SIDM00779,Trametinib,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-2.309477,-0.067645766,-2.9177493604685973,-0.050096236739422484
55610,SIDM00971,Axitinib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.71092594,-0.027525095,-1.32400632449678,-0.005361684126375301
18428,SIDM00778,MK-2206,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,69.0,1.1205592,0.057778478,1.0546620593469298,0.10377267560286242
70155,SIDM00971,AZD7762,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.5003122,-0.009882554,0.24130808257502848,-0.006154458603342171
22924,SIDM00660,Palbociclib,5-Fluorouracil,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,0.9430021,0.045333687,1.046965687789722,0.0863765362707117
75016,SIDM00875,Dabrafenib,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.857695,0.20340064,0.4258362140525341,0.026319150099133017
78906,SIDM00954,Lapatinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.0,0.39228958,0.017947245,1.26759796264773,0.03523611248182513
84536,SIDM00779,Afatinib,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,33.0,-0.63968456,-0.0480422,0.4905015911482199,-0.0333782660712935
9519,SIDM00954,JQ1,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.0,0.6612035,0.037099198,3.451335862434695,0.13835447610017007
79143,SIDM00146,Alpelisib,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,-0.8648323,-0.04211364,0.6809255568816415,0.08649402187000708
69817,SIDM00332,Palbociclib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.8200645,-0.085078344,-0.7235546755217434,-0.06711585211811423
44250,SIDM00834,AZD4547,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,White,66.0,1.1962485,0.030096702,1.603460362630608,0.01857069017788854
99186,SIDM00774,MK-1775,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.26922706,0.036150448,-0.18950448036482218,-0.005059116368336565
86267,SIDM00628,PD173074,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,2.4217792,0.11587253,1.1966300907782237,0.114178738077816
105025,SIDM00146,Wee1 Inhibitor,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.690216,0.050382156,1.3417545410593368,0.06949945740928161
43400,SIDM00875,Nilotinib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.1805702,0.018630262,0.7632074786890833,0.06575217447816332
67421,SIDM00529,Nutlin-3a (-),Pictilisib,Breast,0.5,Breast Carcinoma,Female,Black,44.0,-1.7915521,-0.051450185,-0.668461981612805,0.009880813177050744
94717,SIDM00673,MK-2206,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.131248,-0.08369636,-0.4685059024806013,-0.14024639295860128
34912,SIDM00673,Alisertib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0810045,-0.058244213,-0.9507529690727303,0.010444787275375025
60915,SIDM00097,Nutlin-3a (-),Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3079445,-0.075169526,-0.6182275431567019,-0.023153627892832155
2439,SIDM00875,Bortezomib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.32775944,0.03090287,-0.20444634521299715,0.04139116973388514
34627,SIDM00130,Olaparib,AZD7762,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.40899,0.109241724,1.0938183950354479,0.05979683353091048
93509,SIDM00673,Bortezomib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.0265133,-0.030877657,-1.4289525751742442,-0.07282631344703758
5925,SIDM00875,Crizotinib,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.48715466,-0.05586517,-0.7391314397481347,-0.07789111863255839
67839,SIDM00779,5-Fluorouracil,Taselisib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,-1.0375153,-0.032828454,1.1248379162733246,0.09264204543620308
30236,SIDM00673,Bortezomib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.24009638,-0.007443281,-0.5918511131583615,-0.019779288631348955
62101,SIDM00782,Trametinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-3.0488567,-0.23870096,-0.5450562440610017,-0.03243181485220055
51821,SIDM00971,PD173074,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.6221497,0.017707933,-1.1673692180720951,0.048229732521242887
63676,SIDM00778,LGK974,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,69.0,0.8713362,0.017301962,1.3108595084730106,0.04560403938871364
106945,SIDM00834,MK-2206,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,White,66.0,4.8060536,0.33697045,1.1437122550086167,0.1622761174346558
55272,SIDM01233,AZD7762,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,72.0,1.8860426,0.057052784,4.914407411869307,0.207531367315187
57721,SIDM00878,Venetoclax,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,2.2065167,0.08561586,0.516958202971346,0.06784482671015293
14044,SIDM00332,ZM447439,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.8583087,0.09481648,2.1179530386773684,0.1500180873120969
18775,SIDM00359,Camptothecin,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.18674198,0.012700029,0.2492718686746942,-0.015819055692324027
55256,SIDM00332,Axitinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-5.4811163,-0.37813488,-0.8037854183008097,-0.11085553272492428
15702,SIDM00332,Camptothecin,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7710152,0.049846552,2.953655852129092,0.1157963803622867
45619,SIDM00774,Camptothecin,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-1.6810874,-0.07759169,0.059169641279011705,0.033573377981657146
105394,SIDM00359,Oxaliplatin,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.804489,-0.04380588,-1.881807077904776,-0.029942196839759523
24612,SIDM00097,Uprosertib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.231199,-0.1680209,-0.2419093839428291,0.032626614118837334
50641,SIDM00628,GSK269962A,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,-0.9992327,-0.08464664,0.15801857947239525,0.03370765001632715
24600,SIDM00531,Cisplatin,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-2.1086497,-0.15374441,-2.087879779567147,-0.0816464376789072
55901,SIDM00097,SCH772984,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.8401587,-0.10075837,-0.7571827622934109,-0.015307337846909994
21043,SIDM00673,Olaparib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.893351,-0.062377572,-0.9371338868938723,-0.04948646094736751
48212,SIDM00774,Uprosertib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,0.8230357,0.059348643,1.4426613911914108,0.09839362705463202
61704,SIDM00332,NU7441,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.8321285,-0.055715106,0.17324035235622803,0.008750817851302726
64412,SIDM00146,AZD8055,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.95708984,-0.08968004,-0.9848749611517745,-0.04602210014536474
67762,SIDM00971,Temozolomide,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.5364107,-0.039103806,-0.838374883711354,0.008421789570644878
88669,SIDM00954,Entinostat,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,0.8148631,0.063238196,-0.48318695928231037,-0.053736010577731044
19830,SIDM00332,GSK269962A,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6322385,0.031823393,0.9928668778987545,-0.03166311530391608
43748,SIDM00332,Alpelisib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.358251,-0.090484455,-0.28771616553192364,-0.009129957293261978
4352,SIDM00954,Afatinib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-1.3155631,-0.10448747,0.04831927860226709,-0.02032314056061392
75039,SIDM00875,Crizotinib,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2468606,-0.035536952,-1.8226410160464912,-0.07699840917021732
49767,SIDM00628,SCH772984,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.0659378,0.18430617,0.9298752539487248,0.17881768519107927
13288,SIDM00673,Bortezomib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,1.1458184,0.04028372,0.8083397781007039,0.012197874946703595
63196,SIDM00660,MK-2206,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,3.2135723,0.26028895,2.304472917630033,0.14621487714724343
95035,SIDM00529,Wee1 Inhibitor,Luminespib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-0.082218125,-0.007937299,-0.1454547259512685,-0.018246003226304465
60841,SIDM00628,Lapatinib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,0.6686009,0.018819632,-0.3707256861447936,-0.02946948837526403
36311,SIDM00774,Camptothecin,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.5376389,-0.0683854,-0.9469056192441706,-0.04367965096155149
59908,SIDM00529,MK-2206,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.4009498,-0.044724032,1.158021194815068,0.03285842909841113
46265,SIDM00359,Taselisib,Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7220354,-0.13265978,-1.8313762125940938,-0.07942935057376731
94877,SIDM00359,MK-2206,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,3.0862913,0.22388585,0.24891280593824394,0.07570612796247005
47093,SIDM00776,Crizotinib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.8968185,-0.16345921,0.9160804513547712,0.048768819738683224
93555,SIDM00866,MK-2206,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-3.085713,-0.15575282,-0.13362135193918503,-0.0005682105491688675
35326,SIDM00301,MK-2206,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,50.0,2.8012834,0.2463749,1.2738360968109832,0.09556972148418282
25862,SIDM00130,Lapatinib,LGK974,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.36434162,-0.025264129,-0.24872084790065563,-0.0007520873822514255
83827,SIDM00301,MK-2206,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,-1.2130758,-0.13276084,-0.13649330844045718,0.007226512396205187
58224,SIDM00359,AZD7762,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.8225625,-0.063798524,0.1814421800488469,-0.01767489619850324
10346,SIDM00776,Olaparib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.3811464,-0.07747795,-0.353965781073312,-0.009989625090163002
100919,SIDM00779,5-Fluorouracil,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-1.6099095,-0.037987106,0.8642722966282768,0.08249243484737546
99141,SIDM00531,AZD7762,Dactolisib,Pancreas,0.0125,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.5007378,0.13772215,0.02832510469413408,0.04681799664883192
34680,SIDM00778,Crizotinib,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,1.1291889,0.058939878,0.6947002359355207,0.07742754259426722
1878,SIDM00673,OSI-027,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.34894815,-0.035484225,-0.9611858066514781,-0.044559354421558166
56852,SIDM00782,Taselisib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,2.7294884,0.1767494,1.7496223615865976,0.08587292811912947
107413,SIDM00954,Navitoclax,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.0979209,-0.044208713,0.17902135449714118,-0.04368741653328991
3661,SIDM00411,Cisplatin,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,43.0,1.1002215,0.022119455,1.7456978790299373,0.0410271730597677
95127,SIDM00301,Trametinib,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,50.0,-2.7748685,-0.23849292,-1.1051182370212709,-0.06551906046796739
73044,SIDM00774,Afatinib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.6123097,0.042501695,0.7861264331421475,0.05813668172298993
41386,SIDM00332,AZD8055,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1562976,-0.089550145,-1.7478020009178705,-0.1064525894682283
39815,SIDM00778,Olaparib,Crizotinib,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,69.0,3.8582106,0.19319265,-1.5355330427335456,-0.06266036670709751
6687,SIDM00673,MK-1775,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.84824884,-0.07780329,-0.42550494383288684,-0.034433416915812406
37840,SIDM00660,Linsitinib,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,32.0,1.1401318,0.092080235,-0.28921017938238514,0.03542049764414738
103702,SIDM00301,SCH772984,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,50.0,-1.3095728,-0.13708924,-0.8049386465613899,-0.0658114026390002
75151,SIDM00778,Nutlin-3a (-),BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,5.5311747,0.17297527,2.2288863020446703,0.08771547399742013
40252,SIDM00529,Doramapimod,MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,0.17551847,0.005671188,-0.26508423516655794,0.05420782278134943
23758,SIDM00628,Cisplatin,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,1.9094759,0.17303006,2.3790948791006397,0.1510935015707813
54620,SIDM00097,Luminespib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.9931139,-0.066995464,-0.44226128223508515,-0.06755206138221936
108263,SIDM00146,Entinostat,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,2.3084445,0.20029247,0.5499854884688469,0.11225659377313851
54460,SIDM00866,Luminespib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,52.0,0.46430802,0.041906055,-1.1432037800631278,-0.07793546305113531
74689,SIDM01233,LGK974,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.8396653,0.14535499,0.9139772261814092,0.07069643058604913
59075,SIDM00779,Camptothecin,Oxaliplatin,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,2.0703669,0.15724991,-0.08716862941541278,0.036122448653098695
76503,SIDM00529,Camptothecin,MK-1775,Breast,0.625,Breast Carcinoma,Female,Black,44.0,6.4452963,0.35732096,2.6831880065842704,0.11536156045276114
20300,SIDM00130,LGK974,Irinotecan,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-3.2809658,-0.14279255,-2.7866412281787336,-0.021262271246903705
738,SIDM00097,5-Fluorouracil,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0445454,-0.09501025,1.1216764795176597,0.07996080501509395
96757,SIDM00954,Cisplatin,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,1.8924242,0.0745399,0.5407506287611173,0.12135650874735217
92669,SIDM00628,AZD6482,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,0.7896736,0.0691081,0.26425463113267367,0.00032780722688379544
69130,SIDM00954,BI-2536,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-6.0835376,-0.12760697,-4.104833593990033,-0.054318693149054374
91732,SIDM00097,Wee1 Inhibitor,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.16133428,0.009695744,0.29980996582779756,0.004528869103815908
51339,SIDM00332,Wee1 Inhibitor,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4549743,-0.11452888,-1.2455149741539462,-0.09342157205020546
36357,SIDM00529,Gemcitabine,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.2908608,-0.039900813,-2.518490198139053,-0.052618108886837406
62287,SIDM00776,Palbociclib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.65674675,-0.021071555,-0.013308450007391285,0.019928950611417254
30632,SIDM00193,5-Fluorouracil,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,-0.43490005,-0.034614455,-1.303747686341882,-0.08669177431321201
71713,SIDM00673,Bortezomib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,0.16972326,0.0055065504,-0.8031806469309355,-0.04416153877258587
59678,SIDM00971,Bortezomib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.093808,-0.048788752,-0.13952179855819932,0.0774279077810012
54375,SIDM00893,Axitinib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.1252148,0.13873369,1.0355990930977195,0.08041509316753984
69362,SIDM00866,KU-55933,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.7333877,-0.058171805,-0.5850309529648103,0.004027498175042802
104333,SIDM00954,Luminespib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.1852691,-0.060784176,-1.0084697587784281,0.012922194869618412
60300,SIDM00875,SCH772984,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5684693,-0.12587263,-1.768502651186915,-0.09043721535682493
71328,SIDM00411,Dactolisib,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,-3.4797702,-0.10964734,-1.512689440242486,-0.05303578080082425
9731,SIDM00673,JQ1,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,4.328369,0.335772,0.059709603022083085,0.04398469713923679
96362,SIDM01233,SCH772984,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,72.0,-0.84089166,-0.06267919,-0.3940790371846925,-0.016726289821068063
59052,SIDM00673,Venetoclax,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.39575,0.09657847,0.3123757468710074,0.020267946141763696
55210,SIDM00097,SCH772984,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5569701,-0.10940887,-1.9120193897626936,-0.09834879599259722
45739,SIDM00875,BI-2536,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5732131,-0.064642146,-0.8456170435462911,-0.01664016813829183
13246,SIDM00875,AZD8055,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6421467,-0.050188012,1.7195640868245345,0.0829465211244219
13232,SIDM00332,Luminespib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.8437333,-0.12761433,-1.1021484649750708,-0.09032194674795758
99207,SIDM00774,AZD8055,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,0.6124765,0.041533407,0.18906000506983772,0.007345098171091874
84818,SIDM00673,Linsitinib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.59225756,0.011727164,1.979038155567815,0.008378563827119134
74079,SIDM00130,Dasatinib,MK-2206,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,3.2073874,0.2951304,1.5437498924513973,0.14710645982704265
33727,SIDM00875,Doramapimod,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.2692018,0.1492509,1.1363150523263104,0.04738831648132127
52084,SIDM00673,Wee1 Inhibitor,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,0.8383188,0.05587961,-0.8015051712384403,-0.039827508063113186
100094,SIDM00673,Palbociclib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,0.5058208,0.022407083,-0.5634618252796888,-0.013941176046244801
5851,SIDM00628,Trametinib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-1.3467803,-0.102763854,-0.8411707182904551,-0.04678862316198358
44783,SIDM00971,Olaparib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.04814,-0.041248683,-0.9651979479071614,0.007276388359731667
18432,SIDM00875,Palbociclib,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3070358,0.03271465,1.8242338067188788,0.08711318397344628
25037,SIDM00893,OSI-027,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.2163045,0.30790097,0.7868890015848453,0.11485327423618247
24946,SIDM00673,MK-2206,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.2321248,0.11372728,1.021720975603494,0.04383198767767115
67564,SIDM00971,Crizotinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7374356,-0.051049415,-0.9091140206288264,-0.010902395502499863
57493,SIDM00193,Olaparib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,53.0,-2.8116102,-0.09828143,-0.8674475072686562,-0.0009382383480331479
16181,SIDM00146,Doramapimod,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.1052765,0.064657226,0.7793359856442754,0.07614745360231119
98256,SIDM00878,JQ1,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-0.6383252,-0.057416778,-0.6543691569106475,-0.0016502602957761835
5921,SIDM00875,MK-1775,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.35898855,0.021477085,0.10318071310347217,-0.013489626505301472
47352,SIDM00774,NU7441,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,2.9262652,0.15661103,2.4538975167445045,0.09748468375765801
78130,SIDM00130,Lapatinib,Crizotinib,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.7467391,0.19221744,1.805724541968635,0.14785371829270255
60117,SIDM00673,Venetoclax,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.4982266,-0.035272174,-0.4864483379601571,0.0317985142815434
35739,SIDM00866,Wee1 Inhibitor,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,0.18095927,0.014584526,-0.2965922862968244,-0.008914330811136241
12760,SIDM00332,Uprosertib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.85499203,-0.05640963,-2.1140039912077135,-0.09595148343600754
2431,SIDM00332,AZD6482,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.35318705,-0.025737504,-0.2767363151573697,-0.054515636964801155
92349,SIDM00332,Venetoclax,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2934438,0.040907275,2.492797523987134,0.09427612103815358
24725,SIDM00673,Tozasertib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.4128836,-0.089784995,-1.7321822835562,-0.13259913052852604
76044,SIDM00097,Gemcitabine,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,5.0753794,0.2287215,0.2503307486597505,0.056080433149046906
71121,SIDM00776,BMS-754807,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.2448511,0.10702238,-0.4238684346477994,-0.03770802369582421
38241,SIDM00660,Olaparib,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,1.2960109,0.037308827,1.618613835937044,0.023749843983222697
54366,SIDM00628,PD173074,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.5450693,-0.015990986,-0.47012911709424243,0.031446078846686966
33401,SIDM00097,Nilotinib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.7576479,0.047972355,0.743642462888002,0.05210900032192303
18503,SIDM00875,Bortezomib,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.52166235,0.048635177,0.042736475274342045,0.019814941485066025
95526,SIDM00893,Nilotinib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.6976079,-0.0562783,-0.0635320854397819,-0.06351950000578356
101379,SIDM00531,Dasatinib,Navitoclax,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.5954732,0.19275434,2.744568956680099,0.16424487021256573
88411,SIDM00779,Palbociclib,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-3.7407603,-0.11677605,-0.717562379844364,-0.04498225906274324
15377,SIDM00332,Lapatinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1169593,-0.098409474,-1.3575723688172492,-0.07951102941465824
30169,SIDM00779,AZD8055,AZD4547,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-0.7553911,-0.015600835,-0.8874073770048846,-0.04095108450200117
1546,SIDM00778,Oxaliplatin,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-2.4932797,-0.04974157,-1.259115586108055,-0.06384743445601009
98845,SIDM00834,MK-2206,Navitoclax,Large Intestine,0.1,Rectal Adenocarcinoma,Female,White,66.0,-0.3411479,-0.01596089,0.854687213344316,0.06667462726572816
58876,SIDM00146,NU7441,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.9853637,-0.086104095,0.8829136586759259,0.034929451779404354
52195,SIDM00866,Entinostat,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-2.158403,-0.06326566,-1.8641602545812324,-0.023223022331231347
53366,SIDM00332,Sorafenib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,0.95497566,0.066934526,-0.38219127433638544,-0.022633179297071395
2195,SIDM00529,Gemcitabine,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-0.68114674,-0.019941088,0.2950751200351178,0.06930720305897654
98690,SIDM00673,OSI-027,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,0.51687366,0.05287778,-0.6088589766451423,-0.06376679456344736
43708,SIDM00878,Ribociclib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,70.0,-1.712649,-0.07941107,-0.5192835645508461,0.01663892060550608
34555,SIDM00774,GSK269962A,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.93616366,0.05637561,1.3703575521437603,0.1040577701345535
42089,SIDM00529,Docetaxel,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.9753225,-0.047383655,-1.6998214229317736,-0.037353398369729646
39892,SIDM00779,Olaparib,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,1.1267761,0.01620895,2.087119521643406,0.07997191076752364
17938,SIDM00778,Nutlin-3a (-),Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,1.3560722,0.024767105,2.7454237095365,0.07951075092654072
84830,SIDM00875,RO-3306,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.6869075,0.29425046,2.4427713188462277,0.18463409501447986
46320,SIDM00779,BMS-754807,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,1.7952251,0.014681684,-2.0587982520904657,-0.09074131277595379
84251,SIDM00628,AZD7762,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,-0.7706629,-0.048645012,-1.3432850431039571,-0.04662204716308943
17880,SIDM00193,Afatinib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,2.6293507,0.19998492,2.3142491886823198,0.14689329831430895
3143,SIDM00834,LGK974,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,White,66.0,-2.9124281,-0.16793397,-2.173155524815722,-0.05582800092442083
77702,SIDM00673,Cisplatin,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.0799626,0.04810357,0.6153994551658512,0.09678152123236905
53056,SIDM00332,Sorafenib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5961099,-0.03845111,-1.4050300026787053,-0.04865461645753158
46691,SIDM01233,Trametinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,0.82110906,0.050207186,0.28104806084070677,0.03402158909439813
2572,SIDM00971,MK-1775,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.3811562,-0.069106296,-1.2901460089575303,-0.017961736723267768
35058,SIDM00146,AZD7762,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-1.7452374,-0.10208646,-0.9021360099801755,-0.022318460853507586
8660,SIDM00529,MK-1775,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,-0.717111,-0.05697964,-0.719212472002497,-0.045987506006594216
64695,SIDM00332,AZD8055,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.5704765,0.22593428,1.677172384826982,0.11288828027062514
18364,SIDM00866,Entinostat,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.9685127,-0.13590828,-1.290422346546304,-0.04005548989721154
75802,SIDM00776,AZD7762,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-2.1421492,-0.108209886,-0.8821069516804431,-0.05719339276617941
5279,SIDM00954,Paclitaxel,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-0.052448515,-0.0031194089,0.8339558112859766,0.03899816922061172
72145,SIDM00146,RO-3306,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.7260695,-0.0502337,-1.0425166182069738,-0.043407886202997736
91055,SIDM00628,BI-2536,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.1068368,0.0018449582,0.10393599385070003,0.015521003662670523
54747,SIDM00971,Taselisib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.9208536,-0.19583768,-0.5351916861887522,-0.07114831387337872
81197,SIDM00774,PF-4708671,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-3.366191,-0.12924477,-0.48739555339837864,0.011375404915069217
85211,SIDM00130,OSI-027,Navitoclax,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.78783023,-0.07391395,1.1790893592179275,0.06795644336985923
73019,SIDM00301,OSI-027,MK-2206,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,50.0,1.5402994,0.16965596,1.9371741552892046,0.1167417130551695
80268,SIDM00774,Nilotinib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-4.3580685,-0.17982122,-1.9858545811335682,-0.07167243278240888
47919,SIDM00971,Temozolomide,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.0236883,-0.045114923,-1.0617370116589493,-0.0057088193880664075
41244,SIDM00130,OSI-027,AZD7762,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.86851794,-0.077906825,-0.9418259951444979,-0.05203071922646296
70808,SIDM00628,Temozolomide,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,0.8409292,0.022402495,-0.24203096420702613,0.01088632611338616
92630,SIDM00531,Taselisib,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.9232641,-0.09361255,-0.2192983078330717,0.0056052647937700545
18734,SIDM00146,Olaparib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.6858526,-0.03807151,-0.21965704009431689,0.05395355523694584
93678,SIDM00954,PF-4708671,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-1.1335388,-0.05838145,0.4737830518160583,0.11129758983780969
315,SIDM00411,Oxaliplatin,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.4170735,-0.034361113,-1.4466554344719396,-0.03186271901687958
49832,SIDM00779,Afatinib,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-0.21761498,-0.007482176,1.4204630338198367,0.13370622398488521
36759,SIDM01233,LGK974,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,72.0,-1.4943746,-0.06871674,-1.9209292275388934,-0.07544741276566508
41802,SIDM00954,MK-2206,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,0.75243497,0.05803709,0.30004718415771736,0.028407627503372192
33982,SIDM00332,GSK269962A,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.8134072,0.1031521,0.21444634585254901,0.02703294492069892
5242,SIDM00878,Olaparib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,1.2083682,0.044715393,2.3661016754630393,0.061523623834199605
96893,SIDM00878,AZD7762,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.9480836,-0.04268203,1.2854576969404132,0.024296755113307422
70691,SIDM00097,PD173074,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.4083414,-0.1503355,-1.371486709252693,-0.018540060339193254
19300,SIDM00878,Ribociclib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.0389222,-0.04110917,-0.7901695679478831,0.002853697049379134
19274,SIDM00097,JQ1,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5381982,-0.061841585,1.471487251979356,0.0673652058775834
10877,SIDM00411,MK-1775,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-1.156906,-0.067540765,-1.2996741200651485,-0.05334991418676326
46194,SIDM00529,Ribociclib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Black,44.0,-1.2825264,-0.032839518,-0.08687678006816867,0.024086302025912415
42929,SIDM00531,MK-1775,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.7079801,-0.069617376,-0.7800187741109852,-0.044231353819494855
59624,SIDM00301,Ruxolitinib,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.204858,0.042103235,1.4232994676473194,0.012032893484093778
30858,SIDM00146,MK-2206,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.1718223,0.08204124,0.6475411671416528,0.059343314971825045
106884,SIDM00834,MK-2206,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,0.9370936,0.052157074,0.4974661290461553,0.05857167074744661
11495,SIDM00097,Bortezomib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.62221634,-0.03970699,-0.7435846189680072,-0.05278065584050867
86471,SIDM00628,Bortezomib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.023960887,-0.0014170255,-0.4829895520219989,-0.00892634356660192
43309,SIDM00660,Camptothecin,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,0.24405032,0.01773092,-0.9024752851590276,-0.005969253153882774
43524,SIDM00971,AZD7762,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.41729018,-0.009532265,-1.0340568516353006,-0.05480514571810796
67675,SIDM00954,PD173074,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,0.54136765,0.02443923,0.42088958573591395,0.03968259434362388
32764,SIDM01233,Dabrafenib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,-1.5823628,-0.04022416,-0.3163698499449674,0.04620147960986183
59687,SIDM00774,OSI-027,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.45296252,0.05712389,0.5517491946001454,0.040521015966330905
59100,SIDM00878,Temozolomide,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.53518856,-0.013128977,1.5544276169585174,0.06169467021401437
44858,SIDM00097,Vorinostat,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.62537354,-0.044586692,0.24864961373555744,-0.005953183806126538
84097,SIDM00332,NU7441,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5045821,-0.027741702,0.7166826191661416,0.04388733382380402
54728,SIDM00146,Bortezomib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.27958247,0.016576458,-0.1172196034165117,6.49565824977527e-05
22931,SIDM00332,Lapatinib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.540042,-0.13126671,-0.42849737862872533,-0.01394746972995085
83763,SIDM00146,Doramapimod,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.83399457,0.04688524,2.2626719013992873,0.08590747183329804
13727,SIDM00878,Temozolomide,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-0.44635075,-0.010679138,0.5844716765358692,0.03080979267819658
73110,SIDM00529,JQ1,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,-0.48717242,-0.032969464,-0.12259393490490988,0.02858948294963782
76722,SIDM00776,Afatinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,2.938514,0.14719784,3.059087596566114,0.13500909350663765
31186,SIDM00878,SCH772984,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.7652665,-0.11820432,0.8509172167975453,0.08217760613181171
46468,SIDM00359,Navitoclax,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.6263499,0.035774358,0.19928539716929963,0.022900703537358243
87518,SIDM00954,AZD7762,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-2.9235258,-0.12053755,-0.03678842212676857,0.014967213141941433
8221,SIDM00779,MK-1775,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-1.0960556,-0.0288722,0.25081038795570976,0.011787967637452986
93416,SIDM00529,Sorafenib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.31968528,-0.031492133,-0.31561260501956656,0.005211756470305643
96907,SIDM00531,Dasatinib,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.67925924,-0.06312857,0.08363872973252562,0.04648827378206074
84555,SIDM00301,AZD7762,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.6947817,0.14158496,1.1772229860052839,0.034272543826964444
22408,SIDM00146,AZD8055,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.039639708,-0.0030953924,1.9692640517921536,0.10036826855376589
76754,SIDM00954,RO-3306,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-1.7628801,-0.13297929,-0.7154835064591731,-0.04379477473642544
66677,SIDM00776,AZD4547,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,-1.128054,-0.028350133,0.4617139051238608,0.04434853711469664
96813,SIDM00130,Olaparib,Irinotecan,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.66895956,0.051614758,0.20696434160939392,-0.02509970037227214
45441,SIDM00878,Alpelisib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-1.9618863,-0.16441147,0.31346110786691017,0.05212223593942553
57436,SIDM00097,Uprosertib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5199046,-0.08791692,-0.8570575911836894,-0.07436079897924544
8947,SIDM00301,Navitoclax,Palbociclib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.2427683,-0.15279648,-0.43539905138201274,-0.01068371950916977
12489,SIDM00878,KU-55933,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.5392753,-0.044766355,-1.7516650644620826,-0.043725155453855066
14125,SIDM00866,Tozasertib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.863543,-0.09901491,-1.2725178583787469,-0.018794084329102106
40990,SIDM00097,Pictilisib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-5.7250934,-0.1936329,-2.644757444992849,-0.16403221708172272
60901,SIDM00097,Trametinib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8176107,-0.023247372,-1.159458442749422,-0.04848330774682854
7967,SIDM00673,Lapatinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.2194336,-0.019461948,0.5696383864597482,-0.025506089870826733
23803,SIDM00097,Doramapimod,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.2889723,-0.0072878134,0.48477004528982154,0.024570751311502787
49849,SIDM00954,SCH772984,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,4.133104,0.06933149,2.8182764568554752,0.17099526106487148
108141,SIDM00778,AZD4547,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,0.9353334,0.054573257,-1.0840729307571846,-0.03622521833760474
87985,SIDM00971,Cisplatin,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.54097486,0.009847575,1.051767544191203,0.0498771235100145
83791,SIDM00878,AZD7762,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.64134836,-0.025149545,-0.8469416500515827,-0.08009696841938028
98136,SIDM00529,MK-2206,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.59811825,-0.0060841693,0.9910470357448792,0.10089570546704374
58141,SIDM00954,RO-3306,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-2.2334204,-0.16768017,-1.278013056119854,-0.03151792747317085
75485,SIDM00332,Temozolomide,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7384229,0.052493244,1.433316109868218,0.03765875976353839
13461,SIDM00193,LGK974,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,-2.1161249,-0.06622048,-0.8275733941743392,-0.008311826173213252
92791,SIDM00531,Taselisib,Lapatinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.6712408,0.28629953,1.8813459233516057,0.10029146749153384
56620,SIDM00146,Cisplatin,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,1.5157748,0.0706822,1.9631429219122665,0.07947513605911814
38576,SIDM00954,MK-1775,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-0.7583324,-0.063147806,-2.4125303523960797,-0.1758754744843295
73194,SIDM00779,MK-2206,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-0.98300457,-0.021941854,-0.4518377110280402,0.00820432932768057
40341,SIDM00628,AZD7762,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.6119051,0.05887667,-0.8368546392436138,0.015799292242764183
98751,SIDM00411,AZD7762,Cisplatin,Pancreas,0.8,Pancreatic Carcinoma,Male,East Asian,43.0,-3.8796349,-0.13011158,-0.523475290703952,0.027337224848443847
62941,SIDM00531,Trametinib,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.0059018,-0.08089617,-1.1712666518596078,0.003308289206942605
69124,SIDM00774,Pictilisib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.9605842,0.028394353,-0.7265167722090486,-0.05020210326920073
89233,SIDM00954,AZD8055,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-1.2511644,-0.09888338,0.08727579699773094,-0.016640491208686374
96340,SIDM00332,Wee1 Inhibitor,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.90564555,-0.03891701,-0.1302455355238798,0.03288442095439721
33567,SIDM00332,Dabrafenib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4703736,-0.043946672,0.24843959009814157,-0.033985639527804354
51388,SIDM00529,Palbociclib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,-1.7660823,-0.07929994,-1.2184201458742094,-0.026537221419097402
11092,SIDM00359,AZD8055,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.176802,0.13040768,-0.2879329923771056,-0.018092836806523783
63964,SIDM00531,Oxaliplatin,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.4369984,0.13283536,-0.18720834428935712,0.030410863571208972
42451,SIDM00146,Linsitinib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,5.678421,0.19344965,3.4347301636600207,0.08854853564106784
46282,SIDM00660,Camptothecin,Afatinib,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,1.0757216,0.085459314,1.4407057612445582,0.06806422482855715
13959,SIDM00954,Sorafenib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.0,2.16118,0.17474557,-0.15546747034952174,0.0007882432186921555
96248,SIDM00893,Gemcitabine,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.6224357,0.1423704,0.2574445654064631,0.04613372546720072
16778,SIDM00774,BI-2536,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.1356816,0.14355515,1.0705093986851444,0.09518730560290675
53197,SIDM00193,Camptothecin,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.56074727,0.016674278,2.3010235055170005,0.07451957913638026
44901,SIDM00834,Nutlin-3a (-),Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,1.2298169,0.04541365,1.7300862230785548,0.05100197058041868
60793,SIDM00893,PF-4708671,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-3.9237282,-0.18198854,-2.771869003190364,-0.1316034943926861
26362,SIDM00628,Dabrafenib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-2.4890494,-0.15577032,-0.4350888096966906,0.016187884006894436
78943,SIDM01233,Oxaliplatin,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,72.0,-0.6336386,-0.052029654,-2.231640311851713,-0.14375195518426595
98181,SIDM00411,MK-2206,Cisplatin,Pancreas,0.8,Pancreatic Carcinoma,Male,East Asian,43.0,-2.118147,-0.12370722,-1.1089650811944944,-0.004411907632236294
19159,SIDM00782,SCH772984,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,Unknown,72.0,-1.0388087,-0.09166126,0.6330536674994112,0.026724170106347814
54145,SIDM00660,SB505124,Oxaliplatin,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.49840623,0.046090063,-0.005838324417087049,-0.013396943644702824
63067,SIDM00146,Camptothecin,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.27048013,-0.026371261,-1.2205967211423503,-0.06653594064902987
95528,SIDM00774,Ribociclib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.49762708,-0.017681215,0.03909954754178536,6.70869657581922e-07
18738,SIDM00673,Axitinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.1997669,-0.1941828,-2.2529817725716033,-0.12800304624426226
101172,SIDM00193,Vinorelbine,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.6708472,-0.20639084,-0.5850084817348555,-0.04811297519310308
53221,SIDM00531,5-Fluorouracil,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.36213568,-0.01166104,0.02875401746797474,-0.016325681899808847
34226,SIDM00359,Linsitinib,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7505548,-0.09238873,-1.7201925155336406,-0.06322709426473042
34716,SIDM00893,Sorafenib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.56523615,-0.04739633,-1.1568634306507388,-0.08962731793352183
104509,SIDM00193,5-Fluorouracil,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,East Asian,53.0,-1.1106364,-0.10312026,-2.5079073975841504,-0.12348421800906463
64795,SIDM00866,Palbociclib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,0.79556316,0.008079938,0.45822703883310895,0.023384130147008787
23165,SIDM00301,LGK974,5-Fluorouracil,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.9845893,0.11805508,-2.180297630059103,-0.09489515546594667
27565,SIDM00628,Ribociclib,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-0.40077633,-0.009558625,-0.5951613979201003,0.009926119892441715
45450,SIDM00146,Lapatinib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.0056813504,-0.0004744688,0.8154579531354242,0.06705965716297321
12088,SIDM00878,SCH772984,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.8687942,0.14194822,1.0347430467774343,0.04539054806307264
623,SIDM00130,Oxaliplatin,Trametinib,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.8030341,-0.026716534,-1.429042896093096,-0.03590051604752947
11972,SIDM00193,AZD4547,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.6530274,-0.03429249,-1.5091713699224942,-0.05363486660409326
47553,SIDM00893,Temozolomide,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.8465588,-0.01853872,-0.17336683194370406,-0.0036013707732946002
62428,SIDM00866,Linsitinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-1.6747035,-0.09115038,1.201786036715385,0.03913267844160747
31643,SIDM00146,Vorinostat,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.9546938,0.05270633,-1.3780214018862385,-0.04328758392797096
62863,SIDM00097,NU7441,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.834278,0.094944164,1.433968949435659,0.10242221899908882
661,SIDM00673,Olaparib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.6255823,0.022910064,0.41579417088469134,-0.015757871069745515
106496,SIDM00130,Dactolisib,OSI-027,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-3.002766,-0.15491161,-2.1910926997550026,-0.10327798448676757
32363,SIDM01233,AZD7762,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,72.0,0.99202263,0.0265818,1.361046805478611,0.07120902436141961
87872,SIDM00878,NU7441,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.49550208,0.035438605,0.5797369446715059,0.06332626111191962
11395,SIDM00332,Sorafenib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4745733,0.06414162,0.2270795020340539,0.04804264628881062
3449,SIDM00893,Lapatinib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.68511766,0.06695615,0.21625473732724668,0.05425024225337059
72433,SIDM00359,Camptothecin,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0169266,0.08798767,-0.4780734574218048,0.023231351494046353
74737,SIDM00359,Palbociclib,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.150638,-0.10105641,0.27685734055374717,0.055667791115202245
95657,SIDM00332,Axitinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,4.2511644,0.28020242,-0.9041277057650922,-0.057922899598529726
51662,SIDM00146,Trametinib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.1054118,0.12648544,2.4529683696721762,0.11413282717379954
17617,SIDM00893,AZD6482,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.8971155,0.073007904,0.8840463503606547,0.0751541957595772
107767,SIDM00531,MK-1775,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.0708156,-0.11298143,0.7149625701383019,0.05162150732710522
47003,SIDM01233,AZD8055,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-1.5973226,-0.1168981,-1.6176562333708304,-0.059048105763369337
71374,SIDM00097,Pictilisib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.90111476,-0.061350927,0.08454032744462221,-0.015755904756264386
72449,SIDM00628,MK-1775,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-1.9581915,-0.08880533,-1.8978596728646535,-0.06840924322386768
91361,SIDM00954,Sorafenib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,2.184215,0.17933889,0.45838890219083467,0.055282364394340006
20279,SIDM00628,BI-2536,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-1.4568478,-0.05871455,-1.3020098030140559,-0.04890282775294483
19970,SIDM00893,Lapatinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.2646294,0.12082405,0.7860381442783846,0.0929551243706201
73508,SIDM00779,Crizotinib,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-0.37515384,-0.028812604,-0.8418693935337553,-0.07701977723090438
92375,SIDM00130,Erlotinib,Trametinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.1742663,0.09005495,1.7152109961808895,0.08423191285760837
80510,SIDM00332,AZD6482,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4427093,0.11016037,-0.08345365472613517,-0.027806710406053533
26217,SIDM00130,Dasatinib,Sorafenib,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.7381561,0.16151595,-0.8463413670178999,-0.028326159953575434
50062,SIDM00628,AZD6482,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-1.1365533,-0.10917769,-0.5149017559907099,-0.030439987357020144
59242,SIDM00774,Venetoclax,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,1.1058761,0.022226524,0.016182093755582105,-0.04185644890318084
69306,SIDM00193,5-Fluorouracil,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.2428017,-0.15569775,-0.7281644161446725,-0.017124851894780233
26378,SIDM00529,RO-3306,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Black,44.0,1.1675957,0.051879812,1.3853638244824258,0.0827924778143349
96068,SIDM00411,MK-2206,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,43.0,0.53716826,0.03188291,-0.7410513200194986,0.0025518382229421147
49525,SIDM00332,Wee1 Inhibitor,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.15195663,-0.010748741,-0.3521632636456938,-0.038958184808226624
108399,SIDM00628,Doramapimod,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,3.1469321,0.06882401,2.605913268791575,0.07766540474941237
14100,SIDM00774,AZD6482,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.9345962,-0.09697449,-1.2274028391054732,-0.03394519256111241
108176,SIDM00146,Olaparib,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.8122735,-0.03448832,0.4452826700026185,0.04573893628500839
99068,SIDM00954,Vorinostat,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-0.76066875,-0.0585537,0.7276696293292833,0.05549318031858811
64532,SIDM00301,Palbociclib,Dasatinib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,50.0,0.82431054,0.10448637,0.4670250706567963,0.011032067311959676
90145,SIDM00866,Olaparib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-1.9651229,-0.03534377,0.38508094498569906,0.03334239856030193
24365,SIDM00971,OSI-027,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.7226908,-0.11645942,-1.059745600310467,-0.07358142529661496
10594,SIDM00193,BMS-754807,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,53.0,0.7583506,0.05277621,-1.0413794677441315,-0.02343260811736585
76992,SIDM00866,Gemcitabine,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,52.0,0.7324983,0.057410955,0.11266620640366097,0.01958590022247595
50284,SIDM01233,SCH772984,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,72.0,-0.009111118,-0.000786198,-1.1338530568162772,-0.04621562761274493
57697,SIDM00875,JQ1,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-3.6012824,-0.0897929,0.20468188296979606,-0.05009161245361011
36135,SIDM00971,Axitinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.4838216,-0.08851991,-1.5759498609492348,-0.028041984135701754
93331,SIDM00778,AZD4547,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,0.57407707,0.031331424,-2.096445588573375,-0.056166921973051565
106017,SIDM00875,Vorinostat,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.42262655,-0.04567095,-0.09389448902818645,-0.011646835341313002
87981,SIDM00531,5-Fluorouracil,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.22149159,-0.0070485016,1.1732339412869952,0.010576210892632217
82731,SIDM00834,SB505124,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,2.184612,0.18667293,0.1421576269077173,-0.0008402425281854161
37863,SIDM00878,NU7441,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.8812109,0.080094956,0.37164064800787655,0.017844830460552994
95470,SIDM00130,LGK974,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.6189102,-0.062020626,-2.4376266889644302,-0.07779229451310016
13160,SIDM00774,Lapatinib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.11118823,-0.012981229,-0.5098533674585395,-0.03209110693940669
24684,SIDM00529,Cisplatin,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,1.3519008,0.02662609,2.1228276047901016,0.06635632802231757
16367,SIDM00866,PD173074,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-1.1115059,-0.037565824,-2.052763325963032,-0.06091630839459532
86125,SIDM00673,OSI-027,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-0.55930525,-0.055028223,-0.42402580289351344,-0.07186465803210296
93959,SIDM00673,Linsitinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,0.5570297,0.011909428,1.8707494230802888,0.05664505900871119
16543,SIDM00301,Erlotinib,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.5566735,0.15284409,2.284510670434292,0.10899118982198058
104657,SIDM00971,Uprosertib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.2705431,-0.012236943,0.9643266577222435,0.055819006543059484
25939,SIDM00776,BMS-754807,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,1.1443632,0.10395154,-0.06653074350115842,0.025250083772698207
22498,SIDM00866,Lapatinib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-1.2879884,-0.105956554,-0.999382956222711,0.005871016681289458
1259,SIDM00893,Sorafenib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.2353777,0.11000377,-0.42763150038374753,-0.025887409603198224
15069,SIDM00097,Uprosertib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.31515366,-0.020687116,0.6949396935872382,0.018581453871568662
67209,SIDM00774,Cisplatin,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.1416063,0.037531935,1.0099699548882761,0.07181679737975806
45603,SIDM00529,Entinostat,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-2.7292955,-0.12482641,-0.8396680027644191,-0.06208528865779746
22412,SIDM00359,Dabrafenib,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.37498525,-0.01808398,-1.432019581224398,-0.06105444148755041
51695,SIDM00673,AZD7762,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.3264759,-0.063501716,-0.7136088811053548,-0.0769538059196617
464,SIDM00878,Gemcitabine,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.1178054,-0.073043644,-1.1395192088710417,-0.06868836099855882
853,SIDM00774,Palbociclib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.7030959,0.051057678,2.663696154160188,0.08606619519285946
66283,SIDM00971,PD173074,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.6637971,-0.037804782,-2.093425468179156,0.012331897197348252
6792,SIDM00774,Taselisib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.8536952,0.024413718,2.9022925492572718,0.012641707684479033
97460,SIDM00776,Afatinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,0.44805577,0.02788861,0.40487836648070663,0.019753551326637444
64266,SIDM00866,Palbociclib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.3126163,-0.007972811,1.388970214333035,0.07346616577248856
691,SIDM00332,Wee1 Inhibitor,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5775863,-0.04584048,-0.8721811487839555,-0.050358963806073576
40338,SIDM00529,Uprosertib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,0.70469785,0.04692079,-1.0780551012250223,-0.03979838564275397
61277,SIDM00097,AZD6482,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.4190239,-0.029614365,-0.0270333639397281,-0.010844470507651197
57927,SIDM00628,JQ1,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,1.421301,0.10859494,0.1280350197674123,0.05761175319448907
15245,SIDM00529,MK-2206,OSI-027,Breast,1.0,Breast Carcinoma,Female,Black,44.0,2.2366395,0.1266239,1.27426227382443,0.09936262782544948
108378,SIDM00779,Camptothecin,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,1.2269417,0.026237506,0.25652387126119186,0.032097905904977526
66328,SIDM00146,Entinostat,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,1.2985805,0.10665463,0.31906315490621373,0.04692684170678648
89098,SIDM00673,MK-1775,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.1394253,0.11221853,-0.5437208679543599,-0.05418674008758988
51627,SIDM00673,SCH772984,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-4.87999,-0.3080371,-0.9987979351736043,-0.07994279027284132
8681,SIDM00954,Afatinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-1.6545131,-0.13424179,0.21055011790373943,0.022663990076007088
82084,SIDM00971,Ribociclib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.401076,-0.05814969,-1.4986896663944134,-0.023734831566469793
3383,SIDM00531,Palbociclib,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.4380097,0.08330901,-0.29936716561272164,0.006150425903760211
64557,SIDM00779,Palbociclib,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-2.1808715,-0.08794226,-0.020632582963689187,-0.0028057438078955476
58843,SIDM00146,AZD8055,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,2.076071,0.1513785,-1.165547868430159,-0.04285235145437502
33591,SIDM00411,Paclitaxel,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.4748341,-0.051882017,-2.1942368128440255,-0.03787905921898367
15129,SIDM00778,Olaparib,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,3.992278,0.089501075,-1.226359845470709,-0.030347295884262902
11189,SIDM00875,KU-55933,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.59481555,-0.025825283,0.1081934042488184,0.018495144012190927
57410,SIDM00359,Vinorelbine,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.2737836,0.08491893,-1.440728493199733,-0.03280189118337174
82313,SIDM00878,Linsitinib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,4.9457455,0.11839452,3.2615498040090487,0.1359229920607629
1866,SIDM00782,5-Fluorouracil,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,Unknown,72.0,-1.4256976,-0.0492657,0.20542321905082156,0.01807629553118481
14153,SIDM00954,GSK269962A,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-1.5946062,-0.12699236,-1.362005084407541,-0.0865330406073379
20526,SIDM00130,Sorafenib,OSI-027,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.85165644,0.049256884,-0.7118684777701383,-0.04561710845419291
24569,SIDM00878,Alisertib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,0.46262237,0.03768703,1.1995328220637576,0.06477336265580816
22673,SIDM00954,Doramapimod,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-1.1418539,-0.04468204,0.4454070344665761,0.07445479047209883
26173,SIDM00359,5-Fluorouracil,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.7589633,-0.0728802,-1.232478758613209,-0.01455639009648842
20819,SIDM00130,LGK974,Sorafenib,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.7923731,-0.082666874,-1.7717131547293428,-0.032946555143636785
76978,SIDM00193,Crizotinib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.65510905,0.03415529,0.23586110009018835,0.07231359334562563
95190,SIDM00411,Dactolisib,Dasatinib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,43.0,-1.8480523,-0.08223293,-0.6367218376380379,0.01897892299984658
11816,SIDM00359,Taselisib,AZD4547,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0283872,-0.09101571,-0.9923474800477854,-0.06278238278755208
18443,SIDM00673,Vorinostat,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.20754671,-0.020911034,-0.613339775799751,-0.0149594211695842
59279,SIDM01233,Olaparib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,1.1180156,0.028374366,0.650997709147914,0.02115896086799623
69117,SIDM00954,Paclitaxel,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.4609904,-0.08270954,-0.5253766738966675,0.0037210393077438337
33655,SIDM00893,Bortezomib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.0041701,0.09117442,0.1263683832167905,0.010634394298963937
16041,SIDM00411,Dactolisib,SCH772984,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.6608918,0.090665,0.8463385094438244,0.023226231981345356
14333,SIDM00411,5-Fluorouracil,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-3.131223,-0.0937305,-1.24583881323824,-0.010956252096725343
83516,SIDM00673,NU7441,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.4842592,-0.032863673,-0.12458606488697897,0.01965065917124422
87330,SIDM00628,RO-3306,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-1.9501444,-0.16730404,-0.7086911829795414,-0.07555973543433216
5422,SIDM00529,AZD8055,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,1.0153388,0.08617197,0.5990485411675844,0.07428238637154826
67164,SIDM00776,Crizotinib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-2.2589426,-0.15449163,0.83346615755253,0.026199259642139438
52948,SIDM01233,SCH772984,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,72.0,-0.38380954,-0.024022073,-1.1926251909194665,-0.06017793347194469
14213,SIDM00531,Linsitinib,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.2605674,-0.044400677,-0.24585804195211386,0.0149172955013805
24385,SIDM00774,OSI-027,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.5024991,-0.075735964,-0.6215875794850652,-0.051362219907019495
72243,SIDM00359,MK-2206,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.4693378,0.09967766,-0.2507158018473918,-0.0033966536067379888
61689,SIDM00971,Alpelisib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.9941285,-0.13034515,-1.5067870602110935,-0.09002580802796753
80189,SIDM00954,AZD7762,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,2.2535634,0.15778325,0.7146778066027065,0.06514568261166329
104206,SIDM00875,Sorafenib,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.67302984,-0.063019514,-0.9048274199114645,-0.04865761288204043
96707,SIDM00301,Paclitaxel,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.5355393,-0.024813216,-1.658877347116221,-0.09845484732410363
35646,SIDM00774,Alpelisib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-3.1048515,-0.19228901,-0.606665939162904,0.008453356596935566
80385,SIDM00529,Linsitinib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.5296948,-0.05194142,-0.5947695855884827,-0.013348751164432168
56960,SIDM00660,Camptothecin,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-1.5165689,-0.07696571,-0.39712624036876276,-0.014534886994562709
53883,SIDM00866,ZM447439,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,52.0,0.55518466,0.040203646,0.11549454758174035,0.03565559176279261
97861,SIDM00778,Oxaliplatin,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,-1.5744611,-0.019970382,-1.15858230834687,-0.038835461503625456
15120,SIDM00774,Trametinib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,3.956834,0.16830356,0.953482923681821,0.003054617967208693
51791,SIDM00893,PD173074,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.9550592,0.08803654,2.2767436781888124,0.12136763564122577
53654,SIDM00893,Uprosertib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.8014125,0.103654064,1.2347063430803344,0.045251968829492686
26597,SIDM00628,PF-4708671,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.47731948,-0.04873816,-0.09397797588856772,0.007616862460256297
94757,SIDM00782,Olaparib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,2.277727,0.0971762,0.7895476422968527,-0.00814680019375795
5247,SIDM00097,Lapatinib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0682093,0.073533624,1.2983084209734963,0.06163421195756298
92455,SIDM00779,Palbociclib,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-4.019353,-0.2526983,-2.202646622563069,-0.0893482191303914
46350,SIDM00628,Vorinostat,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.8299114,-0.055575717,0.09481290439872707,0.05979896179151863
5664,SIDM00097,Wee1 Inhibitor,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.3293236,0.022105888,1.0240128689990315,0.05123310764060557
11837,SIDM00660,MK-2206,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,5.8169966,0.54968965,1.3020380065018395,0.08904564948198138
47787,SIDM00954,Afatinib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.90092,-0.15594602,-0.030339441606351287,-0.055269399206131414
26204,SIDM00779,Afatinib,Dabrafenib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-0.5405002,-0.049146406,0.030328352973407503,0.0013091970704602405
104398,SIDM00774,Docetaxel,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.6280088,-0.2138673,-2.7902884172569564,-0.2443724387587984
56249,SIDM00954,Pictilisib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.0,-1.1438934,-0.09324523,-0.34729946697157227,0.018406115858023823
27456,SIDM00971,Tozasertib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.0209718,0.06934722,2.1227143046260077,0.06738382668647931
82517,SIDM00097,Temozolomide,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8608082,0.013457294,0.7547435951956055,0.030496110959126795
101789,SIDM00893,Lapatinib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.41441357,0.03822734,0.5350760432496827,0.08946182875074772
70803,SIDM00359,LGK974,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.2495015,0.036051862,-0.45472355278694204,-0.0014496556292489069
20011,SIDM00146,Cisplatin,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.54966444,0.020892564,1.8230339292687274,0.08250709781290376
62160,SIDM00332,PF-4708671,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.3504865,0.06681902,2.6406667852568484,0.13117466683317214
98216,SIDM00332,Uprosertib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3308066,-0.08637039,0.0679098509770007,-0.04007270400090314
39083,SIDM00130,Cisplatin,Navitoclax,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,3.9400597,0.3113508,3.1732390181396664,0.19696750524220633
45220,SIDM00628,5-Fluorouracil,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-1.4058636,-0.056905847,0.895025289942301,0.059781360403059855
23011,SIDM00529,Pictilisib,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,2.0457127,0.18255776,0.2046517575588387,0.02655442827023289
20657,SIDM00778,SB505124,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,0.48067328,0.028322281,-1.1754383757147187,-0.043336436811737794
32038,SIDM00954,SCH772984,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.7460588,-0.108827956,0.11256441221150476,0.03359256236430336
10951,SIDM00954,Docetaxel,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-5.0156317,-0.353052,-0.8255799842207668,-0.10650515055573863
73557,SIDM00971,KU-55933,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.0044034,-0.028530357,1.2527607295800889,0.08771891923782023
72113,SIDM00411,Oxaliplatin,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,-3.1939743,-0.09178712,-2.6629090888767206,-0.06713529058322376
14815,SIDM00878,Palbociclib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,70.0,-1.7406688,-0.09380517,-1.123501630896228,-0.014365249343987979
42766,SIDM00332,BI-2536,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.46061283,-0.031551912,-0.4632489591558756,-0.038963328721165244
32811,SIDM00660,Camptothecin,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,1.0873861,0.09366307,0.8600302609812698,0.11489657962226908
8449,SIDM00332,Doramapimod,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.26594114,0.021234743,-0.222830667741094,-0.09029451859727047
18880,SIDM00628,Cisplatin,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,1.6263299,0.16160262,-0.30092439718828845,-0.004042849542237835
37354,SIDM00878,GSK269962A,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.7811708,-0.14796942,-0.34443681269551407,-0.0734161498407038
53472,SIDM00866,Navitoclax,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.7769532,-0.060239233,2.183264283559624,0.06804112374256809
97504,SIDM00332,GSK269962A,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.6389391,-0.030918928,-0.3841198076909599,-0.011377100337506758
78241,SIDM00628,Paclitaxel,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,-2.2625992,-0.14564568,-1.2366672327890742,-0.0430488239983113
40008,SIDM00673,AZD6482,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.6038323,-0.051757853,-0.08036402145323808,0.03740139555161811
80606,SIDM00332,PF-4708671,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,4.347304,0.11494172,2.7745762016581232,0.06716177923380133
23332,SIDM00301,Cisplatin,Sorafenib,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,50.0,-2.8289454,-0.2015816,-1.0253839453506326,-0.026552653065045426
73749,SIDM01233,Afatinib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-2.732586,-0.13883007,-0.08362429523454758,-0.007466807624118457
100703,SIDM00097,Tozasertib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3033118,-0.06964053,-0.8858163843616674,-0.03228030788016757
97746,SIDM00866,Entinostat,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,2.0053148,0.15164666,1.0188635896112663,0.07680590052653827
26922,SIDM00878,5-Fluorouracil,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.99593097,0.017497152,1.4437199347166043,0.08444114078366641
22459,SIDM00146,Trametinib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.3767542,-0.12182772,-1.6664421016338649,-0.13903985190294527
51866,SIDM00774,AZD7762,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.071428984,-0.0031197905,1.430018159686409,0.161252099604464
66050,SIDM00529,Navitoclax,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.0794401,0.08673636,0.29254683050107244,0.03326452688650561
55637,SIDM00332,PD173074,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.831415,-0.26355183,-0.6715689744510481,-0.030411909191882316
46360,SIDM01233,AZD8055,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-2.241545,-0.1604846,-0.029410395479799723,-0.046632309947032796
73493,SIDM00130,Linsitinib,5-Fluorouracil,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.8913414,-0.0745393,-0.14174662968036675,-0.033863992367756425
97061,SIDM00301,Ruxolitinib,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,50.0,3.1549275,0.14971171,1.6775480634004722,0.03892694423555711
104476,SIDM00778,BMS-754807,Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-0.83473986,-0.04726593,-1.2436173776225259,-0.11921241857052955
41985,SIDM00673,RO-3306,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.0116307,0.07480351,-1.8332701618961664,-0.06936211638602888
5153,SIDM00774,OSI-027,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,1.342439,0.11087265,2.119163776476832,0.1067857084871298
63286,SIDM00954,Doramapimod,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-2.1645765,-0.10436839,1.4279772619620645,0.12660345225835123
4295,SIDM00673,AZD7762,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.26920477,-0.022354359,-1.3225567785266203,-0.04817238044450629
22159,SIDM00971,Lapatinib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.9259589,-0.12826431,-0.8684561526089857,-0.05225297288084529
78053,SIDM00893,SCH772984,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.3385818,0.10631854,2.42313943180537,0.0977089474578283
48288,SIDM00332,Vorinostat,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1997389,-0.036542624,-0.23812932635549142,-0.025634444260157423
10512,SIDM00146,Wee1 Inhibitor,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.409981,-0.03490778,-0.12899150035577367,-0.038523294140568924
22837,SIDM00774,Uprosertib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.4031828,-0.031000713,-0.2321516400616755,0.021870697368869055
102706,SIDM00193,MK-2206,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.2929229,-0.08561935,0.9529340486375034,0.15074056696707283
105449,SIDM00971,Gemcitabine,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.4349697,-0.014409956,-0.7040585142008909,-0.027715439719002494
85534,SIDM00411,AZD7762,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.349669,0.098368734,1.7411911141712577,0.06379547991686843
12010,SIDM00893,NU7441,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.0503515,0.078315884,0.017573512846368787,-0.013794489374794987
83355,SIDM00628,AZD7762,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,3.976865,0.3557366,2.375000036190718,0.15328326610520696
39534,SIDM00776,Trametinib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.8439686,0.06410568,-0.8267221685282347,0.005464502752533384
38325,SIDM00774,Venetoclax,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.35204917,-0.007945408,-0.2629638131980469,-0.032942324328470926
15559,SIDM00193,MK-2206,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,-2.1514714,-0.116524294,1.0965361297153715,0.1326444093886882
105350,SIDM00411,Dasatinib,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.3853894,0.0765917,1.286485581933835,0.06355033312371883
21624,SIDM00774,Pictilisib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.4821808,-0.016386317,0.13360554957047877,-0.007277436715771572
75733,SIDM00866,AZD7762,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-6.308066,-0.46470293,-2.688130659999547,-0.20708989938632627
85016,SIDM00332,SCH772984,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1530839,-0.059281215,0.85371063421429,0.03645078471539779
32823,SIDM00893,OSI-027,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.2686417,0.22795871,0.744722009626023,0.07080285354704074
42159,SIDM00875,Nilotinib,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6858386,-0.13723959,-0.5107457004434467,-0.0094082997094433
74255,SIDM00971,Tozasertib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.7933977,0.0721902,1.060567539834694,0.02159649020632762
103552,SIDM00673,Axitinib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.6705081,-0.1577251,-1.1244001659064744,-0.029134771635499837
25025,SIDM00866,Uprosertib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,-1.6046914,-0.061773583,-1.5192457503791827,-0.01467354103316854
47402,SIDM00779,Linsitinib,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.3575279,-0.112048015,-0.06725273443968381,-0.051704523028566166
39890,SIDM00332,Doramapimod,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7659274,0.09126365,0.636087247359213,0.02842282312736646
99285,SIDM00673,Entinostat,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.20207511,-0.016234335,0.48503526333729013,0.05175529208935858
99847,SIDM00332,Trametinib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.8769507,-0.08471487,-1.1508336529510605,-0.06918594882222844
30112,SIDM00332,RO-3306,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.9782834,0.0950656,-0.09614459830175194,0.024206739070802476
40516,SIDM00875,GSK269962A,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.62809,0.10316857,2.0559907166758644,0.07317403989779643
3109,SIDM00954,Alisertib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,0.6879833,0.059531547,-0.6008004981483225,-0.06999295011135367
102112,SIDM00673,Trametinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.708957,-0.13181819,-1.0137214602490745,-0.09099707051932078
85907,SIDM00531,Sorafenib,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.8299375,0.108381994,-1.4390277199984982,-0.06409156866440426
14902,SIDM00301,Olaparib,Erlotinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,0.6045079,0.06662164,-0.2907897114395899,-0.004354411254007694
105198,SIDM00878,GSK269962A,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,70.0,0.68385947,0.063797526,-0.1754262762899769,-0.026263803919302775
52501,SIDM00332,Nutlin-3a (-),Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,2.225678,0.115881085,0.9470204578088204,0.035541112434727164
11883,SIDM00971,Paclitaxel,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.830085,-0.090345785,-2.8331617397830056,-0.06237515958303358
44923,SIDM00359,BMS-754807,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.5163522,-0.031807505,0.2988794794784848,0.03382389004741702
89566,SIDM00866,NU7441,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,52.0,1.028765,0.08380961,-0.8466339286366964,-0.011720674077229395
74427,SIDM00130,SCH772984,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.3819492,0.18198155,-0.29155643400366893,-0.03919717031319319
25847,SIDM00774,KU-55933,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.695628,-0.04940796,0.7548824198953308,0.026932474310004683
63467,SIDM00774,MK-2206,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.6430204,0.052366517,-0.42653252357606813,-0.041482269816422855
108190,SIDM00660,SB505124,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,1.7006077,0.17745289,0.5527535789272306,0.0666362041002625
81960,SIDM00954,OSI-027,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.75466293,-0.0480115,1.1518714021708525,0.009469577519251517
95977,SIDM00332,Wee1 Inhibitor,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.43558705,0.032263484,0.4256168802656708,0.004275396168207098
85063,SIDM00097,Nilotinib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.356154,0.17218885,1.0267386988558933,0.06257609359504729
63351,SIDM00878,Pictilisib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-3.6217487,-0.10330493,-1.290516076494786,-0.08773568582407563
85605,SIDM00774,MK-1775,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.1268065,0.06974657,0.30070900611164353,0.10167732099156898
14226,SIDM00628,Linsitinib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.8794031,0.10324153,1.4392029805240403,0.13614349218123892
90844,SIDM00971,5-Fluorouracil,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1629691,-0.029833514,0.1127567006249935,-0.001117086751522583
62037,SIDM00097,MK-2206,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0960388,0.07999323,1.4842235792528735,0.15012358920563787
97871,SIDM00301,Irinotecan,Oxaliplatin,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,0.90015644,0.10804369,-0.9192156529365428,-0.0761981623455932
39565,SIDM00866,Alpelisib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.6354267,-0.043194205,0.655451554945696,0.0849144381735634
78922,SIDM00097,Dabrafenib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.7816093,0.039495643,-0.3717460687976978,-0.05014610149541897
34578,SIDM00673,Nutlin-3a (-),Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.35240576,0.008949375,0.8030520464395189,-0.006052494981547544
97648,SIDM00359,SB505124,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.8031082,-0.2163424,-0.97070248214381,-0.060852316206469
101664,SIDM00866,Venetoclax,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,52.0,1.7129427,0.058350313,-0.49348081574169533,-0.012587746590477783
28935,SIDM00878,KU-55933,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-0.59347963,-0.01594416,-1.1540999383105486,-0.0227818281594977
49906,SIDM00146,Trametinib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,2.1825416,0.055682786,1.0715385453513382,0.06970493217189057
69807,SIDM00130,OSI-027,5-Fluorouracil,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.6839083,-0.059022527,0.0837963621780988,-0.008932138362938507
95534,SIDM00660,Crizotinib,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,-1.5518181,-0.06439669,-2.3058905495960156,-0.07369522232836102
39714,SIDM00332,Alpelisib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.6448097,0.10325951,2.1201423132146053,0.08118002122132895
74268,SIDM01233,5-Fluorouracil,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-0.9518328,-0.050238673,-1.4964699532870454,-0.05748375667033034
10175,SIDM00529,Axitinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,2.4401498,0.22662674,0.4987085270988086,0.08652941544239105
68104,SIDM00628,BI-2536,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,0.6169058,0.017171578,-0.4949139884237243,0.0024867020679966213
69403,SIDM00359,Palbociclib,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.012572,-0.04759466,0.013358631262234917,0.05274683043399126
74063,SIDM00971,Vorinostat,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.8071055,-0.1142848,-0.689088537802856,-0.025289035223440084
51799,SIDM00097,Temozolomide,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.32411617,-0.0057958257,1.0878372880469658,0.028821935726154307
42462,SIDM00146,Tozasertib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.5423597,0.13126498,0.7561465113017385,0.04879439768512487
49445,SIDM00866,MK-1775,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.18960306,-0.012780724,-0.18099005509236382,0.001586463813091825
22185,SIDM00531,MK-1775,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.2439118,-0.027786402,-1.6441880660720007,-0.08848633911435062
101963,SIDM00529,PF-4708671,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.4891079,-0.028777419,-3.0432360676657377,-0.09195437427752759
10371,SIDM00673,Ribociclib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.1618383,-0.049868625,-0.6950908857348779,0.06970975496941721
8112,SIDM00878,Ribociclib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-0.66513854,-0.00874013,-0.03487444639094437,0.016335589260512904
13807,SIDM00866,Tozasertib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-2.2285357,-0.115913376,-2.3137151192406527,-0.05123687109774473
67710,SIDM00301,Trametinib,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.6055036,-0.21510153,-2.773365104914512,-0.06943101028178748
23224,SIDM00774,Wee1 Inhibitor,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.47288764,-0.027421456,-0.7662050286647616,0.012087237758167897
21525,SIDM00628,Navitoclax,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-0.2090363,-0.021119826,-0.5215852327940406,-0.03961205106853135
18891,SIDM00660,Navitoclax,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,1.4658886,0.13634215,0.9421109004754697,0.02753001429730549
93800,SIDM00529,SCH772984,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Black,44.0,-1.2868854,-0.045136042,-0.6302955681737993,0.030857068714824572
98187,SIDM00359,Crizotinib,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.276773,0.10386685,-1.4596478857428208,-0.06188063233929533
92649,SIDM00301,AZD7762,MK-1775,Pancreas,0.2,Pancreatic Carcinoma,Male,East Asian,50.0,3.6195843,0.40375856,3.6449894184480254,0.2051437175166297
74138,SIDM00529,MK-2206,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.8419048,-0.06120299,0.4593815247046765,0.044143651434775805
91856,SIDM00774,Crizotinib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,2.2513473,0.2235079,2.8848075819888517,0.20043475636020197
76657,SIDM00893,PF-4708671,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.94146323,-0.073329516,-2.1516053261769854,-0.15762400028357157
87791,SIDM00531,OSI-027,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.169948,0.16838545,2.182772506118572,0.08947952089059162
87802,SIDM00673,Navitoclax,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,-1.5970932,-0.0951555,1.177111639785445,0.030431987557748483
52267,SIDM00774,Uprosertib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-2.5783737,-0.17327468,0.3911374018067731,0.05077442384624402
74238,SIDM00875,MK-2206,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.5578015,0.22494705,1.7570783937727874,0.11918340572819797
34412,SIDM00301,Gemcitabine,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.2479281,-0.08374082,0.7792852345885305,0.005721755076606043
2857,SIDM00776,AZD8055,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.44652435,-0.036396757,0.7270017483071717,0.03700921702708778
93867,SIDM00893,JQ1,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.5315382,-0.075774945,0.8503324825591764,0.15119981683906522
35437,SIDM00628,Nilotinib,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.8745,0.11928296,-0.6269093999808695,-0.03740029701785198
40015,SIDM00779,SCH772984,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,2.4626288,0.11822646,0.23284184076279105,0.01919037522527045
82083,SIDM00878,Afatinib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,0.34740868,0.02951194,0.10067738403167185,0.01573738274345165
63457,SIDM00971,Cisplatin,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.13450418,0.0022528886,0.13550330119083884,-0.0007314886670351445
21565,SIDM00301,MK-1775,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,50.0,3.0922947,0.22262599,-0.46656524642822117,-0.03686209173025335
59712,SIDM00660,5-Fluorouracil,MK-2206,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.7289326,0.07278522,-0.37715423822908317,0.006484561009111291
14674,SIDM01233,MK-1775,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,1.8081225,0.031820714,-0.45099117102829284,-0.02213987627628991
25389,SIDM00878,Pictilisib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.44675747,-0.04603055,-0.5359581583452118,-0.06217537555715215
34375,SIDM00971,Bortezomib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.2449136,-0.052421283,-0.14851461848606826,0.025344493834948707
103173,SIDM00529,Entinostat,Taselisib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-1.9847612,-0.09672692,0.19317190622167968,0.03211991136524713
12947,SIDM00529,Ribociclib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,0.84071565,0.03206545,0.1518329029384294,0.03809958175057415
108065,SIDM00971,Nutlin-3a (-),Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.01145,0.08270487,-0.7168653070007509,0.007283781342290983
97463,SIDM00146,Entinostat,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.41167563,-0.02783951,1.1774122840188597,0.11661644282482078
26051,SIDM00954,Olaparib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-2.3474615,-0.057225123,-1.1631552814290635,0.012781229718594671
15236,SIDM00301,LGK974,Trametinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.8681746,-0.13287477,-2.086315770872697,-0.05986043383436217
103640,SIDM00954,Luminespib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.0,-0.5926211,-0.04501697,-1.4620675564335506,-0.02602055801013674
26468,SIDM00779,MK-1775,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-1.1432016,-0.036650974,-3.5150544505256365,-0.12099584324441293
101016,SIDM00097,Pictilisib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.6703162,-0.18281108,-0.4997565021955294,-0.057812385224573215
6647,SIDM00359,Dabrafenib,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.5905305,-0.07126585,-0.6426212937903277,-0.027359602314145297
43842,SIDM00866,Trametinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,4.9658575,0.18765168,0.02151321330887954,-0.006184194318031045
38153,SIDM00971,AZD8055,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.6889143,-0.12924704,-1.3520013978291947,-0.08259655534868818
45042,SIDM00866,Bortezomib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-0.28746232,-0.020904932,-0.3869818357745775,-0.012355164603969293
79595,SIDM00359,Dabrafenib,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.74187225,0.04228923,-2.752808961045328,-0.06904156186325082
55801,SIDM00097,OSI-027,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8357553,-0.054846145,-0.20685538813679435,-0.026990636220014335
18638,SIDM00875,Navitoclax,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.33902913,-0.037666414,1.4384019983392828,0.055800900552531896
67729,SIDM00878,Palbociclib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-1.0045274,-0.061007522,0.8991059884536945,0.06671979995655226
61569,SIDM00359,5-Fluorouracil,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.556505,0.042712763,-1.5459392027911094,-0.06511598593157299
74514,SIDM00776,Linsitinib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,0.8196427,0.047597118,0.019670580030203975,0.05831706876435917
43108,SIDM00332,Olaparib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3475862,-0.03235123,0.11267320553310693,0.018316168054551454
81195,SIDM00301,Lapatinib,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,4.144602,0.3905635,3.993745454078059,0.17804417094112815
41652,SIDM00130,Navitoclax,Sorafenib,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.4547874,-0.04538266,1.581877810229907,0.1255952568227679
25995,SIDM00782,5-Fluorouracil,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.5082248,-0.020020876,0.23459668550266918,0.006216060846104135
19702,SIDM00954,Sorafenib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,1.0952986,0.062190503,0.3029128505739387,0.06982761108691295
30146,SIDM00359,LGK974,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.1703793,-0.036226794,-1.9945164281845236,-0.039630468143205234
38673,SIDM00875,Sorafenib,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7277292,-0.062671855,0.31521916305089126,-0.028709636493380753
20323,SIDM00834,MK-1775,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-1.3781729,-0.091705896,-2.7792731710047267,-0.11952983864239645
107100,SIDM00774,Tozasertib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.5103304,0.05461438,0.3822063651695685,0.04738637621423921
13971,SIDM00776,Trametinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-3.6077383,-0.15361848,-1.22562277396395,-0.03024289069513678
22025,SIDM00971,AZD8055,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.7428382,-0.04454568,-0.8582037442186408,-0.07014119489545599
46500,SIDM00866,PD173074,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,3.520893,0.22109103,-0.5855616163870652,0.04613004319887513
19523,SIDM00359,BMS-754807,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.9473636,-0.17688188,-1.3207063626114561,-0.0675348527589653
37557,SIDM00875,5-Fluorouracil,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5011159,-0.049187846,-1.7171388426985512,-0.10452350096219354
100308,SIDM00359,Vinorelbine,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2906139,-0.053166606,-1.898647203247263,-0.027542264727860838
107581,SIDM00971,BI-2536,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.3384862,-0.019478492,-1.1962332124931427,-0.09253845755361387
72399,SIDM00878,PF-4708671,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.77891,0.11239398,-0.5399040501054977,0.04060755707883214
77207,SIDM00893,PF-4708671,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.35060376,-0.027303942,-0.1661468242262307,0.020629329102614516
35967,SIDM00628,Alisertib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,Black,51.0,0.57002586,0.01678219,0.6419240827952998,0.04126194367444733
52880,SIDM00673,Alisertib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.0885681,-0.031678744,0.6784755834800882,0.019872861410027292
101348,SIDM00866,Olaparib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-1.5276387,-0.030015033,0.40582046743617745,0.03176141804154293
101620,SIDM00878,Alisertib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-2.0729983,-0.11980147,-1.2066449424797663,-0.10114805739354521
97847,SIDM00971,Crizotinib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.3204143,0.049027905,0.018427311587320413,0.033076527619965546
44981,SIDM00673,Taselisib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.31538123,0.015112956,-0.09466703734639217,-0.00622702427896293
84107,SIDM00673,Gemcitabine,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.017586,-0.114354745,-1.6562415556008419,-0.08950649141112282
107638,SIDM00782,Taselisib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,2.814394,0.17359321,1.990094184781691,0.08748137287308633
14449,SIDM00971,SCH772984,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.2404597,0.028480986,0.445473485106113,0.008914112721958852
106120,SIDM00971,PF-4708671,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.226167,-0.07338167,1.2808846513293106,0.11299224091289344
57355,SIDM00146,ZM447439,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,2.2726815,0.19330093,0.717922637453616,0.09124817787320318
87905,SIDM00866,Doramapimod,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,2.6995585,0.07957721,2.419043731165401,0.09499727974072286
34331,SIDM00628,Entinostat,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-1.5178882,-0.0815971,-0.8967377506016765,0.0372659613834523
16878,SIDM00359,AZD4547,SCH772984,Large Intestine,0.05,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8155065,-0.104802996,-0.9650467092827929,0.011453443750089606
85847,SIDM00776,MK-1775,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-1.3551854,-0.103461884,-1.0449100450556952,-0.06360800232658423
3382,SIDM00834,MK-1775,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,0.38173562,0.027373187,-0.08713615068960805,0.011387984549894222
36618,SIDM00878,Pictilisib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-2.3472145,-0.20213272,-1.0260657256683383,-0.07783016291895703
72189,SIDM00628,Entinostat,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,3.4053822,0.2706986,-0.5793406673375924,-0.002333955690190972
78030,SIDM00778,Navitoclax,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,2.9757915,0.081445344,2.5191391656813242,0.1036097829457361
17123,SIDM00411,Trametinib,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.99313146,-0.027106687,-0.3719018629478543,0.0044249446535253
82412,SIDM00878,Venetoclax,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.9033526,0.054851975,2.412633669129552,0.06983916397224596
53388,SIDM00776,SCH772984,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-3.107384,-0.13159151,-0.16589878574612682,0.019022672169191287
66753,SIDM00875,Alpelisib,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1870834,-0.042929493,-0.2743002089114332,-0.035958406801889956
94361,SIDM00628,AZD6482,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,1.7407943,0.124638036,0.5470842085397839,0.0031968950052717773
101945,SIDM00097,Docetaxel,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7733979,-0.11556133,-2.1081125180127573,-0.16977542001324433
15987,SIDM00779,AZD4547,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-1.4259379,-0.007053877,-1.2779234910053006,-0.08898902958020782
46443,SIDM00875,Afatinib,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.577418,0.13389355,2.0376096909176873,0.02999899079030563
51219,SIDM00146,Doramapimod,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.737561,0.10810231,1.6488238856495328,0.05843246268944408
64399,SIDM00779,AZD8055,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,33.0,-0.9681292,-0.08915189,-0.24281948918320484,-0.04523946045239872
80294,SIDM00875,ZM447439,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8807951,0.195769,3.073236701302369,0.20751503199678167
26985,SIDM00146,Pictilisib,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,3.0155227,0.21834919,1.3745183535069732,0.1168619556261274
12979,SIDM00866,Wee1 Inhibitor,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,52.0,-0.3183015,-0.025574178,-0.6882028921122562,-0.0483419789075347
38668,SIDM00774,Crizotinib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,0.65377825,0.098461494,-0.6528740980229695,-0.0573934257327638
87233,SIDM00146,Afatinib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.0423235,-0.08858645,-0.6458246657983345,-0.04773273007864083
60080,SIDM00779,Afatinib,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,-1.1355025,-0.055897962,-0.44253252500838797,0.02178507204718531
33113,SIDM00878,Olaparib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.45800093,0.012454638,0.9058214866603587,0.03237541117202765
11981,SIDM00774,Docetaxel,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.9881503,-0.04558187,-1.2612651690264143,-0.04223424593391349
77630,SIDM00146,Trametinib,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.9333533,0.059719153,-0.842860072990708,-0.0390762498084789
49444,SIDM00834,Nutlin-3a (-),Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,White,66.0,-0.6257211,-0.01843653,1.224578102516505,0.03867444724490593
90304,SIDM00332,Olaparib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.4717457,0.09960297,0.41563088227203526,0.01662453653116407
18178,SIDM00878,NU7441,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.9508158,0.030200567,2.6830160548809188,0.11012855888925176
64262,SIDM00332,NU7441,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0088433,0.06848526,0.5071097561255834,0.012200203743906905
46663,SIDM00866,Cisplatin,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,4.5494757,0.17749295,2.040330307762323,0.07132193770388745
27822,SIDM00971,Cisplatin,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.1592449,0.02151898,1.0250794926939175,0.050319378428611145
71081,SIDM00673,Sorafenib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.83757854,-0.05115809,-0.9065472234195096,-0.060198970744871814
85157,SIDM00529,MK-2206,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,1.3998858,0.07613152,0.5511674237607684,0.09396472612135891
52118,SIDM00774,Nutlin-3a (-),Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,48.0,1.0353796,0.040801954,0.6890889850852954,0.02333450805775998
42608,SIDM00146,AZD8055,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.0676603,0.09412406,0.7202872673386816,0.01824841353165483
64923,SIDM00529,Nilotinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,1.2263584,0.051249698,1.7730629184286077,0.13057817978581132
87235,SIDM00673,Vorinostat,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,1.6332014,0.13029091,-1.0025397413216788,-0.03736165660969666
54837,SIDM00628,OSI-027,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,0.6113671,0.052965455,-0.27997492810015745,-0.006366147902007402
38224,SIDM00778,Dabrafenib,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-0.56274414,-0.010551537,0.8655753400719522,0.029699005710688425
72069,SIDM00359,5-Fluorouracil,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.6472037,-0.09559438,-1.4793828056206657,-0.017058414884786224
17559,SIDM00875,Temozolomide,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5718667,0.013565437,0.4808051207266398,0.0046282439872634504
106518,SIDM00529,Doramapimod,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,1.4433849,0.029380977,2.470468132861278,0.078550154502217
15268,SIDM00673,Dabrafenib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.1946752,0.036207218,2.9047192036061755,0.09128987172617652
72910,SIDM00971,Docetaxel,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.06588578,0.0025902234,-1.3840023006991893,-0.001978051310109703
37406,SIDM00866,MK-1775,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.68495166,-0.056962114,-1.582589884353894,-0.10456071111940239
34763,SIDM00628,RO-3306,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-0.34310442,-0.026241986,-0.9706867305569555,-0.019763857432849103
15394,SIDM00146,NU7441,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.3268907,0.11808192,-0.19819788246590342,-0.00017295759585335267
37107,SIDM00660,LGK974,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,32.0,1.8818079,0.12959465,0.38741631611912186,0.013809176549417851
52310,SIDM00146,Luminespib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-0.70348954,-0.060429115,-1.9696903444255776,-0.08160051624379105
83704,SIDM00774,OSI-027,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-0.7685843,-0.11868806,0.727557801478661,0.10135166378672618
107067,SIDM00954,Gemcitabine,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-2.7385638,-0.1424897,-1.0253911724817275,-0.08615209453654313
48831,SIDM00130,Erlotinib,Dactolisib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.620688,0.045806486,1.1997002914997394,0.09446260759991068
39125,SIDM00529,AZD6482,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,0.34744856,0.011947392,1.4585439465781613,0.06849732171216437
82667,SIDM00301,Lapatinib,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,4.2037463,0.1699918,4.038012632284094,0.1431372353380598
41135,SIDM00893,Trametinib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.5714803,-0.14584884,-0.5608395213875121,-0.028238125238238775
66052,SIDM00097,Crizotinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.52074593,0.022521991,0.6956874374670111,0.05387989448461679
16611,SIDM01233,Navitoclax,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,72.0,2.3156562,0.10860411,0.9383958895373657,0.04153644376635896
16893,SIDM00097,Sorafenib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2369555,0.06491774,0.6937133000344072,0.011160859920018825
41480,SIDM00628,KU-55933,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,0.5916909,0.029493108,-2.122430714653963,-0.06965548881709009
25458,SIDM00878,Sorafenib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.0720855,0.102036394,0.640128546390623,0.04537005102183099
101823,SIDM00660,LGK974,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,32.0,0.6188343,0.014307466,0.6381978309127815,0.035658696208254764
68480,SIDM00893,AZD7762,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.5245362,-0.022884492,-0.7122661371539358,0.014030199004809433
55241,SIDM00531,OSI-027,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Male,East Asian,60.0,4.7272754,0.45249316,1.0326787674221767,0.020986217013662368
46200,SIDM00301,Oxaliplatin,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.0103538,-0.26765883,-0.4391524548595155,-0.07966543017908796
69588,SIDM00411,Ruxolitinib,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.8188184,0.029927632,2.812784554251775,0.05166130040478525
97956,SIDM00971,Palbociclib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.8648124,-0.051997583,-0.9630408843212532,0.0008558646482162726
9305,SIDM00193,Taselisib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,53.0,2.0468035,0.14527746,1.1720229478727564,0.10294120852408706
9313,SIDM00834,MK-2206,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Female,White,66.0,2.6105716,0.17362632,1.3251142945630066,0.1411376946984125
71511,SIDM00411,Dactolisib,Ruxolitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,1.7175136,0.110339805,-0.4482906990400146,-0.03234506380384332
61402,SIDM00332,Ribociclib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0922654,-0.047629073,0.02906559889635438,0.02073851976185896
47630,SIDM00774,ZM447439,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.3424553,-0.071770415,0.034097973061409666,0.012741190179490236
88752,SIDM00146,Cisplatin,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,3.9077075,0.15211114,2.914777313831109,0.11815408835707769
37232,SIDM00866,Entinostat,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.48912933,-0.03795724,-0.48202651634395677,-0.011494994736542752
96931,SIDM00878,OSI-027,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,2.6159766,0.31231627,-0.5335811838122237,-0.02947159383318277
64238,SIDM00332,Axitinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.978183,-0.20227258,-0.783673808070425,-0.07695884217509752
7528,SIDM00782,Linsitinib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,3.1904027,0.22065425,1.4676932241423424,0.08948469766485093
99275,SIDM00779,SB505124,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-3.379941,-0.09701459,-0.5730928780578387,-0.047207424120892155
48516,SIDM00954,RO-3306,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.497739,-0.10727618,-0.3621647679333518,-0.021785980663645798
62668,SIDM00531,Irinotecan,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.8425596,-0.21707746,-2.230110335483867,-0.1678204096703184
11641,SIDM00531,OSI-027,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,5.8834724,0.5951312,2.3462450640541594,0.08968548481179223
2727,SIDM00893,Wee1 Inhibitor,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.95966303,-0.080633335,-1.9023765719719719,-0.10914277887603323
80098,SIDM00146,PF-4708671,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.6875626,0.05905695,1.1579344943752468,0.06087195051232071
103685,SIDM00971,Navitoclax,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.0076635,0.05922913,0.5671549770711798,0.0509512743635312
11032,SIDM00893,Cisplatin,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.053513,0.07635251,1.7159209968619327,0.08680287341890772
43675,SIDM00893,Docetaxel,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.8080909,-0.1445421,-1.5747526608225542,-0.033522597581974053
76018,SIDM00673,PD173074,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.71470374,-0.040104654,-0.46004694630091736,-0.010342509945765677
15542,SIDM00332,Gemcitabine,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.963392,0.093188554,-0.752645484505974,-0.042129343549330456
108274,SIDM00893,Paclitaxel,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.5708125,-0.12715356,-3.5457145342361622,-0.3091559772787287
91851,SIDM00834,MK-2206,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,6.205454,0.35988364,4.1078216150156175,0.24178284802215994
16968,SIDM00878,5-Fluorouracil,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-1.1104819,-0.08064545,-0.3288785946030993,0.008301973279627714
18385,SIDM00193,Crizotinib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.056628823,-0.002610959,1.3167405109769967,0.10222452075854646
9171,SIDM00673,Dabrafenib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,1.3104808,0.027740918,2.140844660357842,0.04548821425240721
105270,SIDM00332,JQ1,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4722732,-0.051067453,0.4264350057445073,0.053180282215105866
48489,SIDM00097,Paclitaxel,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.82816815,0.046965864,-0.0946418860905851,-0.011053177019140359
29621,SIDM00774,MK-2206,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.8783306,0.02982482,0.8761757039162344,0.04731532103732441
22810,SIDM00332,BI-2536,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.0346348,0.11923599,1.0527609866955532,0.041671835491397656
42293,SIDM00531,Dactolisib,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.5605757,0.31653258,0.6765290922560594,0.041920609589862615
50826,SIDM00529,Dabrafenib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,1.8550727,0.02428071,1.788901556864692,0.03028184469494525
87530,SIDM00834,AZD4547,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,0.52462584,0.011824314,2.1669910449527787,0.05272828713463141
99301,SIDM00971,AZD7762,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.50003666,0.012899034,0.9458434115582561,0.10525481513848337
24577,SIDM00097,AZD6482,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.8672223,-0.14402269,-0.06379775280206763,-0.022722000637140447
20270,SIDM00779,Taselisib,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,33.0,-1.2103709,-0.07916437,-2.4783821294670143,-0.1556566465571516
31514,SIDM00875,Taselisib,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4549825,-0.041790783,-1.4294839973319171,-0.07489445735987231
54387,SIDM00954,Paclitaxel,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,-1.7898331,-0.13869223,-0.7407933558159319,-0.05980917166285582
51055,SIDM00146,Tozasertib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-2.1952329,-0.11168073,-0.35681730699550446,0.008021115563756634
69652,SIDM00878,OSI-027,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.48573875,0.05770279,-0.34327820515671975,0.03888117190466394
88171,SIDM00097,Nutlin-3a (-),Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.216368,-0.07134183,-0.6831646305580014,-0.03598641048151787
36230,SIDM00866,Tozasertib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.466515,0.10150207,-0.795251124655372,0.014716737409906647
38058,SIDM00673,Olaparib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,0.5426738,0.03236422,1.1330604813107124,0.04195288981242627
72405,SIDM00301,Taselisib,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.0655186,0.2757579,0.5506110661558412,0.008859764574389627
81886,SIDM00411,Linsitinib,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,43.0,-0.41663194,-0.023011487,-2.031611851934463,-0.012663932081408239
4916,SIDM00359,5-Fluorouracil,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.4485867,-0.121060334,-2.5628713650544976,-0.06330968699109091
66527,SIDM00628,AZD8055,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,-0.57243776,-0.046709873,0.9947323450235919,0.057267011998328475
2034,SIDM00778,MK-1775,Afatinib,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,-3.3845785,-0.15046965,-0.34293121415170125,-0.050267188034951976
12793,SIDM00628,Camptothecin,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-0.5230394,-0.0352709,-1.5395251057022104,-0.07035115464058152
21269,SIDM00332,Gemcitabine,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.57463616,0.050087716,-0.44939747644330125,-0.0630292629031734
66423,SIDM00301,Lapatinib,5-Fluorouracil,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.9032991,-0.031890273,0.9714732834277402,0.030147320957595432
71149,SIDM00834,Camptothecin,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-0.5831313,-0.040498897,-0.9249694111739594,-0.03288848722985592
54635,SIDM00411,Cisplatin,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,4.421223,0.14451244,3.4367160705096085,0.13996825351206427
55959,SIDM00673,Cisplatin,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,3.4180477,0.20373379,2.645878991785571,0.1259517925629852
44052,SIDM00893,Taselisib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.1878189,0.050702132,-2.538317473577054,-0.1948184587768324
60835,SIDM00529,Uprosertib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Black,44.0,1.2469205,0.084068514,1.1584673053052477,0.19974702023979976
66664,SIDM00834,Dabrafenib,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,White,66.0,-1.6317362,-0.046354864,0.10775530686064522,0.02328296296473734
7590,SIDM01233,Taselisib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,72.0,3.2629778,0.085845195,-0.41189522375321846,-0.024756737081669877
40803,SIDM00359,Nutlin-3a (-),AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.0934186,0.0505416,2.4424909533748584,0.06666313827195625
60390,SIDM01233,MK-1775,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,72.0,-0.3706373,-0.030322598,0.08644875585307019,-0.0003194235962009201
16189,SIDM00866,Vorinostat,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-0.4396532,-0.030181982,-0.5601166866137003,0.024383933115678696
81712,SIDM00875,Camptothecin,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0791417,-0.12393487,-2.9958117503819293,-0.14533796657154083
61265,SIDM00529,AZD7762,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-0.2616301,-0.016836736,-0.4984385254898526,-0.00919521946428732
96515,SIDM00130,Dactolisib,Gemcitabine,Pancreas,0.01,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.2150607,-0.10266058,-1.8514163381227549,-0.022827098595734324
40595,SIDM00971,AZD6482,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.068739,0.13426955,0.8728688458541948,0.08755795239468334
90718,SIDM00529,PF-4708671,Taselisib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-1.1268408,-0.057268083,0.010685368356112002,0.056183308715850706
55533,SIDM00359,BMS-754807,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.1272578,-0.18709984,-1.7568453728279874,-0.08293863197128427
33486,SIDM00875,Doramapimod,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3264998,0.043796416,0.7088973377579256,0.04729429224397621
13649,SIDM00866,SCH772984,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-0.76606363,-0.057533056,-1.1861119955513735,-0.0004811845296343539
102593,SIDM00146,Taselisib,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-2.8084068,-0.15640128,-0.8805808710890871,-0.08368018383122176
64563,SIDM00529,Alpelisib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,1.1372813,0.044657372,0.5491093978108513,0.00861239111897812
106740,SIDM00893,KU-55933,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.6106191,0.07436786,1.8480295098562436,0.055747289926793585
48104,SIDM00097,Doramapimod,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.5776403,0.08862192,2.412714673469035,0.07492065542988789
36308,SIDM00954,Palbociclib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-2.121543,-0.08894046,-1.0865643863032552,-0.05375413514352761
74942,SIDM00529,BI-2536,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,1.1145048,0.088550046,1.0934085536392677,0.026731376257809646
80116,SIDM00774,Dabrafenib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,48.0,0.25512776,0.008354529,-0.22068649102672572,-0.005523272573808408
57285,SIDM00893,Linsitinib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.3449241,0.08719831,0.3350443855122991,0.0007090488237703544
82142,SIDM00782,Crizotinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.1727185,0.0860572,1.2310931721813292,0.07100573706574106
106353,SIDM00146,Luminespib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.19180031,-0.016051304,-1.0290693927641161,-0.04985214287354477
92304,SIDM00954,OSI-027,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.6140997,-0.0822222,1.1171539998782218,0.08882076003292329
79657,SIDM00954,5-Fluorouracil,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-2.0351114,-0.078647174,-0.26736433856959174,-0.0062968852498820746
57824,SIDM00628,Palbociclib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,Black,51.0,1.4808431,0.06760634,1.1326935024058542,0.10016924177318602
5975,SIDM00971,AZD6482,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.78249955,-0.022798948,0.18854165134544437,0.056764957588711897
89763,SIDM00411,OSI-027,Ruxolitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.3900154,-0.08246968,-1.0590015462251483,-0.06589682240518968
31221,SIDM00411,Dactolisib,Cisplatin,Pancreas,0.8,Pancreatic Carcinoma,Male,East Asian,43.0,-2.0674908,-0.10575671,-1.3363198951523736,-0.04582118319833389
230,SIDM00776,MK-2206,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,1.8720767,0.14887407,-1.2499292715322836,-0.003061060399191785
58145,SIDM00332,Dabrafenib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.90182,0.06274819,1.380510282363552,0.012971432541205925
40096,SIDM00893,Entinostat,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.256581,0.04916734,3.1401814656131406,0.16172121317566837
75564,SIDM00660,SCH772984,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,-0.4402252,-0.021001091,-1.4752469067616907,-0.047819451639635316
74570,SIDM00359,Trametinib,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.5224865,-0.016609918,0.0421676484063982,-0.0039536217841127964
16793,SIDM00146,RO-3306,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.44078,-0.03242555,-1.162393542024771,-0.0722412324369683
19264,SIDM00359,BMS-754807,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.7138844,0.12097917,1.199239084971738,0.0294811810419413
4669,SIDM00866,Doramapimod,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,3.1593773,0.053858742,3.3236338586406786,0.09168706427697962
965,SIDM00875,Nutlin-3a (-),OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7322916,-0.022070182,0.20217013357188157,0.0020861954117207347
64005,SIDM00878,AZD8055,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-3.9055815,-0.11728635,-0.35419779629898884,-0.011907027903760645
28153,SIDM00878,Docetaxel,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-0.09212317,-0.009409895,-0.5212000835216112,-0.030555766785535704
59192,SIDM00774,Temozolomide,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,1.9732056,0.08884036,0.5062561652115058,0.008083989183221906
99971,SIDM00628,Tozasertib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,3.6869397,0.24431878,4.043223247542332,0.14630607587746344
10024,SIDM00776,SCH772984,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-0.9127896,-0.07736543,0.45457925105121527,0.05877648711137488
32830,SIDM00628,Palbociclib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,1.2421807,0.051668413,1.517233026436883,0.06804508213774506
13334,SIDM00878,OSI-027,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,3.449302,0.38049757,-0.33593728612773305,-0.024905358672911833
7829,SIDM00893,Nilotinib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.022409,0.15515298,-0.7297639127344445,-0.04942005481772266
6763,SIDM00875,PD173074,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5644819,0.09698067,1.634439247826593,0.1196232867012769
106480,SIDM00875,Linsitinib,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.644554,0.3053283,0.5276525848596579,0.044785646223144
44917,SIDM00301,Navitoclax,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.6974938,-0.14626776,1.2790739470647399,0.08101177860582442
100971,SIDM00097,Bortezomib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.525496,0.031371098,-0.6048483079756377,-0.054669454933771046
32163,SIDM00673,Luminespib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.684734,-0.06901847,-1.300691578391144,-0.09582981455376635
20643,SIDM00875,Navitoclax,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0354906,0.089940086,2.478938894614592,0.10330849852644025
10546,SIDM00893,Vorinostat,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,4.153207,0.38308972,0.07775682054529333,0.010544970646344623
96266,SIDM00411,Cisplatin,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,3.6942492,0.08833914,3.249341851941483,0.10310261410890616
27085,SIDM00971,Gemcitabine,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.0959297,0.052119937,2.8040306390087593,0.15752665139735697
27303,SIDM00359,Olaparib,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.6282191,0.07946379,0.8500611315652561,0.02188967435179443
43700,SIDM00529,Pictilisib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-1.5825012,-0.05636616,-1.9711326549007067,-0.02041798002115299
75356,SIDM00332,Venetoclax,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,0.23967591,0.003310362,0.49397365864397397,-0.026939236531883536
18677,SIDM00971,Olaparib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.612516,-0.042183008,-1.303343637093554,-0.004441534890811823
67707,SIDM01233,Crizotinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,1.0559915,0.078095235,-0.6949797878279443,-0.061466040209428204
7046,SIDM00332,Axitinib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1588459,0.1134129,-2.0364387238241934,-0.15639308052768333
84203,SIDM00097,Pictilisib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2023609,-0.13474709,-0.55245974316854,-0.049307443169810575
53165,SIDM00130,Ruxolitinib,Trametinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.0069085,0.024373032,1.5427412269284297,0.04289716971641619
37323,SIDM00529,5-Fluorouracil,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Black,44.0,-1.5077916,-0.13323875,-1.3736494399691435,-0.10521682100666593
70281,SIDM00866,JQ1,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-0.4637564,-0.0343182,-0.7183964722482669,0.07547040000976653
94954,SIDM00778,LGK974,SCH772984,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,69.0,3.7742853,0.13249663,0.6555349515360153,0.06664920340701026
8274,SIDM00673,Temozolomide,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,0.107489586,0.0022616081,1.5112832595075407,0.027479281314843028
5998,SIDM00411,Taselisib,Trametinib,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,43.0,2.8501284,0.17545845,2.4278629600273898,0.1398526185374582
33946,SIDM00971,Cisplatin,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.509664,0.009312515,1.0045853946741736,0.0033319242805195447
14788,SIDM01233,Taselisib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,1.7706056,0.10802685,-0.08345457641804115,-0.02362412051922765
16362,SIDM00878,PF-4708671,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.6058538,0.036331255,0.21271568075605446,-0.005489313984966837
76707,SIDM00411,SCH772984,Ruxolitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-0.33794627,-0.017643854,0.06439185166159844,0.005311369794996891
84654,SIDM00332,PD173074,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,5.471686,0.3306289,-0.6310003144560618,-0.04130975735326996
16095,SIDM01233,Afatinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,72.0,-0.7172108,-0.05148078,-0.2129557825514972,-0.03084615213890807
36063,SIDM00628,Vorinostat,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.998088,0.09758081,0.6052757600206489,0.1278827516801468
68510,SIDM00971,MK-1775,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.8752364,0.0759344,0.11210145260587172,0.05210203632316249
97964,SIDM00774,Temozolomide,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.14658386,0.0038576918,0.21505692374035604,0.03194832152632314
911,SIDM00130,Palbociclib,Erlotinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.596031,-0.08364203,-1.605058509350353,-0.041143556215996524
62605,SIDM00660,Olaparib,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,2.6648247,0.06374852,2.1823173210531492,0.05505625367027179
107985,SIDM00130,Irinotecan,AZD7762,Pancreas,0.0625,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.2858455,-0.029390704,1.425798527776277,0.14194426987817763
67026,SIDM00875,Wee1 Inhibitor,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6546661,0.03925996,-0.34181110019562755,-0.029421012265938108
38323,SIDM00971,Vorinostat,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.71400195,-0.0358067,-0.4359827024105816,-0.006309449261818684
72464,SIDM00878,Entinostat,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.2969932,0.016892366,0.4505937909920783,0.01906311306031847
30458,SIDM00778,MK-1775,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-1.1966859,-0.06852198,-1.3684943016324629,-0.0497760134286111
26239,SIDM00878,Ribociclib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-2.4891608,-0.09381854,-2.15735754206803,-0.07723084829493403
1873,SIDM00954,PD173074,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-2.2473576,-0.12001363,-0.25367462235423366,0.006345416953380471
44768,SIDM00628,Palbociclib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-0.37508857,-0.011351575,0.1649555083381206,0.018782375835418887
39094,SIDM00866,Doramapimod,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.2594194,0.03133367,1.4669869070926065,0.039992508012127566
18275,SIDM00531,Palbociclib,Erlotinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.7231498,0.12267215,-0.7334635658043841,0.007893733128295949
5323,SIDM00628,OSI-027,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-0.33139208,-0.014145166,-1.3956772670842175,-0.017705383251239295
61559,SIDM00660,Nutlin-3a (-),MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,3.6260693,0.08180906,4.315434442484518,0.10922351764699198
35455,SIDM00971,NU7441,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.2646623,0.061841644,0.6249391154863132,0.04566669391003479
80115,SIDM00776,MK-2206,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.52209735,0.045636892,-0.5583474961060999,-0.0065634714128293276
105031,SIDM00776,Olaparib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-0.848412,-0.023400495,-0.053319139895800186,-0.012253450252226253
26570,SIDM00531,Cisplatin,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-2.25703,-0.17666863,-1.375272240600153,-0.049668535765619914
30136,SIDM00866,Luminespib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,0.99087185,0.07724854,-2.210304781071982,-0.12281286343679206
37238,SIDM00332,Lapatinib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3618044,0.13239437,0.5797637502230041,0.0857922679234701
11985,SIDM00529,5-Fluorouracil,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.15660119,0.014338549,-0.9990860199607478,-0.006720404747679858
48413,SIDM00866,Luminespib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.6070588,-0.04686274,-1.1655415672567286,-0.06763362346089223
22927,SIDM00146,Lapatinib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.4181379,-0.036263604,1.5898632800138772,0.14553523592831347
70402,SIDM01233,Oxaliplatin,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-1.3385271,-0.08497339,-2.395758376396799,-0.150819059510704
107695,SIDM00130,Oxaliplatin,5-Fluorouracil,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.2947563,-0.01648203,-1.8935707265371842,-0.05914991176513185
36284,SIDM00875,Nutlin-3a (-),Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6172737,0.020984016,1.9432791088367958,0.0623469651713757
69985,SIDM00866,Tozasertib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-2.1454368,-0.09628606,-1.3590194808032554,-0.045801104399474844
74088,SIDM00954,PF-4708671,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,1.3170091,0.07359418,0.08916326870930333,0.014577786669506673
78052,SIDM00332,Venetoclax,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.98473644,-0.024109075,0.7222401005782982,0.011687355025792325
98278,SIDM00673,AZD8055,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.7062271,-0.057513718,-1.6874305018410174,-0.13775446974149427
22823,SIDM00332,Bortezomib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0624572,0.05369699,-1.1747426924891222,-0.03196631780224087
45669,SIDM00529,Navitoclax,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,1.4626424,0.07647687,2.689364996282694,0.06100680611680494
37670,SIDM00954,Alpelisib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.9477471,-0.14625323,0.6795427393667596,0.015636502942119376
33103,SIDM00774,Alisertib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.46665177,-0.03227214,-0.607479882735536,-0.053318506535758745
51204,SIDM00878,MK-1775,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,0.37685558,0.033904675,0.019365833178723604,0.017140021621535065
57975,SIDM00529,MK-1775,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Black,44.0,0.32522705,0.030774396,1.1372392051354834,0.08260224782526204
70521,SIDM00954,Nilotinib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-1.1052542,-0.06600056,1.1969388226886948,0.04092396315885569
90737,SIDM00866,JQ1,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,52.0,-0.7801824,-0.061662555,0.38692365062156736,0.09285485636043338
19662,SIDM00878,Venetoclax,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,2.8052468,0.14557908,0.6164027786932509,0.05226666302173032
103520,SIDM00531,Oxaliplatin,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.7218041,0.24653395,1.4679573289040537,0.0781994457422017
43867,SIDM00776,AZD7762,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.9762795,-0.23533556,-1.7469809132862293,-0.1414374032703235
32351,SIDM00673,Wee1 Inhibitor,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,1.0070095,0.06725925,0.4159903726235142,0.05687257833585339
78542,SIDM00097,MK-1775,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5249941,-0.09024666,-0.40737883712637013,-0.08512173544689589
55149,SIDM00359,AZD4547,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.26016945,-0.017143134,-1.1362148663423117,-0.06983629192922579
47391,SIDM00782,MK-1775,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,-0.4647968,-0.021125058,-1.6656012675752214,-0.05457799451864858
75457,SIDM00529,Bortezomib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-0.21742356,-0.015550007,-0.9227926103889725,-0.03412149836382684
74410,SIDM00301,MK-1775,OSI-027,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.1942741,-0.057665672,0.380836324743769,-0.038763514321507916
89698,SIDM00778,5-Fluorouracil,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-2.9511163,-0.061588746,-1.125167674275694,-0.01663441166240781
49110,SIDM00971,Camptothecin,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,6.5499115,0.12994885,3.5473356257108355,0.08996117103789071
104628,SIDM00893,SCH772984,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.8355725,-0.112585045,-2.108265207086629,-0.1259501268901998
56921,SIDM00954,Nilotinib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-1.9658519,-0.1382408,-0.5494785140860098,0.01828444173416037
100782,SIDM00531,Ruxolitinib,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.3098586,0.13738419,1.9175180992731313,0.05639814466852665
718,SIDM00628,NU7441,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-1.2976191,-0.11281342,-1.2669822842329783,-0.07934564969791391
73654,SIDM00097,Dabrafenib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.0927992,-0.10886573,-0.970330834894049,-0.062459728958655814
69272,SIDM00954,Docetaxel,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.2608062,-0.09374892,-1.1850206835542922,-0.13917916007376493
64470,SIDM00531,MK-2206,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,6.481083,0.55198044,4.300766078125972,0.20407050324642992
64137,SIDM00193,SCH772984,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,0.46213308,0.038511124,0.6922148229942472,0.04616193682992711
98613,SIDM00878,RO-3306,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.3216599,0.024643166,-0.7917394867376553,0.01724346257626019
15923,SIDM00971,Nilotinib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.3166939,0.02156365,-0.06710920714783554,0.02093759092179195
52140,SIDM00146,Entinostat,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,2.331803,0.15267844,0.3679437378331246,0.03470453404782076
64265,SIDM00301,AZD7762,Irinotecan,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,6.389748,0.4494844,2.178320839411834,0.19532258478668416
9262,SIDM00529,ZM447439,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Black,44.0,-0.88899845,-0.06504867,-0.01446636492835315,0.06381309281863216
103964,SIDM01233,BMS-754807,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-1.0851303,-0.0671839,3.112246914991958,0.16367531808153157
101781,SIDM00411,Crizotinib,Ruxolitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-0.8345371,-0.048720308,1.326697494525832,0.07092057346371321
38636,SIDM00359,LGK974,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.5814003,0.017770028,-1.0138489397812573,-0.00733279081294868
48325,SIDM00893,ZM447439,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.3453219,-0.0442969,-1.1550262992915812,0.018460072478387886
15194,SIDM00893,Alisertib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.47634476,0.0428511,0.8838231617235712,0.06522612158969245
44819,SIDM00529,Wee1 Inhibitor,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.377633,0.12201241,0.23955690736950316,0.05582542502404831
89533,SIDM00774,Sorafenib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,-0.6831561,-0.04488026,0.009579754365884086,-0.013055601024529772
44338,SIDM00097,OSI-027,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5841541,-0.15366745,-1.2239965500933452,-0.07860742848771854
14486,SIDM00332,Tozasertib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.9013662,-0.14859055,-1.2720177674354023,-0.12854364532100845
106423,SIDM00866,Crizotinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,0.35130987,0.022600425,-0.31627852018498065,-0.024012730714991826
30173,SIDM00097,AZD7762,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.514605,-0.09871581,-1.5864593415118473,-0.08352027270472961
75391,SIDM00878,Gemcitabine,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,4.666118,0.10571526,3.8856532360058966,0.23734375547356956
19786,SIDM00893,RO-3306,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.8609677,-0.07093669,-0.9607376688598046,-0.017954036629017615
84189,SIDM00866,Doramapimod,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,2.8847008,0.09245482,1.558372438970868,0.040933116907658176
29335,SIDM00628,Luminespib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,-2.2153065,-0.14445467,-1.2501799317682663,-0.04378559896112508
74497,SIDM00875,PF-4708671,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8803762,0.10663374,1.9049533549670323,0.018252593227898798
94,SIDM00971,Doramapimod,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.5211868,-0.04646633,0.6211180689858494,0.03372565463974539
36376,SIDM00776,Oxaliplatin,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-2.85694,-0.10971342,-1.3028022074127852,-0.03710826336846161
40437,SIDM00778,Dabrafenib,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-0.65120256,-0.012175403,1.0133701451344428,0.024375085534878133
93972,SIDM00146,Ribociclib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.396416,0.08819745,-0.9994304136398133,0.038840011839152616
67497,SIDM00660,Afatinib,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,32.0,0.5786431,0.05107694,-1.0358135250582197,-0.03808790970265648
1662,SIDM00673,Sorafenib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-1.409993,-0.07624974,-0.9415946451012324,-0.03616315440967007
53586,SIDM00411,Ruxolitinib,Paclitaxel,Pancreas,0.0025,Pancreatic Carcinoma,Male,East Asian,43.0,1.3272017,0.028357375,1.4708074862484117,0.020952337181700132
103370,SIDM00774,OSI-027,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,0.3043706,0.04085022,-0.4261059277401504,-0.05481059617874508
34237,SIDM00529,RO-3306,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,0.74332756,0.014553027,1.5376297412773403,0.04281460474271054
82014,SIDM00878,Sorafenib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.4453253,-0.12797184,-1.019869673646223,-0.07238366408336544
91224,SIDM00529,Luminespib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.9267823,0.08999538,-0.694931597340597,-0.009385108726183491
53115,SIDM00332,Alpelisib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.48017842,0.036580432,-0.09093265300019507,0.0007792768586531766
412,SIDM00893,OSI-027,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.0353358,-0.08445792,-1.535416651148886,-0.06738423259693098
33729,SIDM00411,Trametinib,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,6.623786,0.29009414,1.1011657928674545,0.11115577234578458
27114,SIDM00774,RO-3306,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,2.3448453,0.15084422,0.9411982552901492,0.03217947807603773
18439,SIDM01233,AZD4547,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.3521905,0.042112526,1.4588779445041489,0.04275329112775867
11210,SIDM00097,Alpelisib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7071964,-0.12256668,-0.17047028816817655,-0.04367188745847432
82482,SIDM00774,PD173074,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,48.0,0.6851106,0.055966508,-0.3839586331151531,-0.008402307819456776
67223,SIDM00130,Irinotecan,Sorafenib,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.5116662,-0.038722586,-1.7596450191903754,-0.09576384712073682
44748,SIDM00774,Nutlin-3a (-),Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.6317675,0.07721595,1.62246294345855,0.09017995933800194
79463,SIDM00866,GSK269962A,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,2.1127043,0.10581216,1.052104017792353,0.12579742362149018
24955,SIDM01233,Trametinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,72.0,-1.0121851,-0.07592605,-1.6104701934954622,-0.06751047638634287
22844,SIDM00893,Luminespib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.1633538,0.11479101,-0.5812516897377558,-0.024298478838996884
24950,SIDM00097,Olaparib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.55221313,-0.013221257,-1.025479302100684,-0.04189396096755851
60875,SIDM00628,PF-4708671,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.5011686,0.037072957,-0.5519915401327816,-0.01748885528855458
96850,SIDM00529,Nilotinib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Black,44.0,2.0590484,0.09734385,1.0459153732824389,0.06112011975353567
49911,SIDM00782,Taselisib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.98511034,0.080989525,-0.10895353091615848,-0.04421848008415669
72340,SIDM01233,AZD7762,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,72.0,1.7968614,0.057578713,1.37916950398033,0.022216026360227167
95322,SIDM00866,Alpelisib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-0.93390113,-0.06391694,0.13415888020962238,0.032086633789750185
13720,SIDM00774,Paclitaxel,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.0049098,-0.03825919,1.8255062746319435,0.07455241696460833
86759,SIDM00146,AZD7762,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.6550831,0.15213244,0.9263975570713224,0.12868185438628485
37837,SIDM00332,Docetaxel,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.202155,-0.22448474,-1.9233485707465159,-0.15257385769240744
36796,SIDM00660,SCH772984,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,32.0,0.50935316,0.020384481,-1.2468908771808263,-0.03864168292915058
7650,SIDM00628,Paclitaxel,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,-1.1110142,-0.07282692,-1.4205851807120085,-0.12523536512730732
54699,SIDM00359,LGK974,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0400683,-0.027669258,-1.0720203447493775,-0.0260181190062161
52180,SIDM00782,Dabrafenib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,Unknown,72.0,-1.4052325,-0.033246424,0.8210770968701384,0.01855037009114098
37245,SIDM00660,AZD7762,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,32.0,2.4402122,0.18127435,2.7615578536929233,0.12524792314281138
31097,SIDM00782,Navitoclax,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,1.7009311,0.11853187,1.3923851266688982,0.09910477269458616
86087,SIDM00628,RO-3306,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-2.5122337,-0.23206735,-2.0751840278772784,-0.15324605593810212
70704,SIDM00782,Olaparib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.511006,0.059703995,1.0820435936022272,0.02260785302311166
67611,SIDM00531,MK-2206,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.4686017,0.11916611,2.0428759429625267,0.08362632292075964
59909,SIDM00130,5-Fluorouracil,Dactolisib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.5277371,-0.12659709,-1.0089452265238559,-0.04922741113050292
21989,SIDM00097,Palbociclib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0788683,0.055305813,0.17510535497714938,-0.01357452946101708
37008,SIDM00893,Entinostat,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.9032992,0.04257397,1.0151649791120272,0.030360453522798796
75306,SIDM00531,Irinotecan,Lapatinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.0444206,0.09729689,-0.8296300591008418,-0.02030848702950126
105646,SIDM00660,Dabrafenib,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,2.9806962,0.2919187,-0.09049108602558825,0.06764904142478512
82226,SIDM00130,SCH772984,Navitoclax,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,4.963225,0.41317198,3.3297538814851784,0.18435126901505497
90295,SIDM00628,Linsitinib,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,Black,51.0,-1.1174777,-0.07193741,0.2691624688175417,0.03376630211525334
67187,SIDM00359,SCH772984,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.4969733,0.1319933,1.6739336910269016,0.07768956962524969
79328,SIDM00954,RO-3306,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-2.7077637,-0.2131371,-0.7811433561815659,-0.08658267165887304
7199,SIDM01233,Vinorelbine,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,2.4601967,0.17627594,0.480083555359967,0.10039218457927183
28686,SIDM00779,AZD7762,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,33.0,1.218964,0.07195537,-1.2674628749140624,-0.07626000565349794
66197,SIDM00778,Nutlin-3a (-),AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,4.5788345,0.103709705,1.9643554135117307,0.03236776511374981
96591,SIDM00531,LGK974,Ruxolitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.4241593,0.04849157,-1.715431916425388,-0.09206622354057946
75601,SIDM00146,Doramapimod,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,0.93030405,0.038527306,0.1532893877320717,-0.015620800053101944
30189,SIDM00971,Wee1 Inhibitor,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.43652308,-0.013242286,-0.5661997369639503,-0.046896149143600206
63210,SIDM00778,Dabrafenib,LGK974,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,1.1310598,0.026842825,0.26470693227058817,-0.0012767166774256085
82674,SIDM00628,AZD6482,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-1.2489417,-0.11757503,-0.8102751629576875,-0.04069643140130515
10631,SIDM00146,Vorinostat,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,3.2167087,0.22189762,2.1376234819821627,0.10660427173032866
28193,SIDM00146,Docetaxel,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.66462076,0.06203403,-1.316860301885906,-0.09012435113937342
42177,SIDM00875,Tozasertib,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.3903852,0.021699702,-0.9178122892905273,-0.0074255449252292535
82253,SIDM00779,Dabrafenib,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-0.61585236,-0.023441209,0.6245872236780788,0.04368158045444362
61419,SIDM00782,AZD8055,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.7924957,-0.045869697,1.39359160219098,0.07844296974014706
12730,SIDM00097,SCH772984,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.3629749,-0.015682546,2.4828206577327716,0.0793247253777638
36252,SIDM00782,Camptothecin,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-3.7996104,-0.3204452,-1.3756546932140064,-0.07851197174570274
535,SIDM00893,Tozasertib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.2138971,0.07534178,0.556462980588312,0.06552871738635785
55987,SIDM00529,Lapatinib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.40810943,-0.026418254,0.2715917564091699,0.030091649722155098
8795,SIDM00411,Paclitaxel,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.9922775,-0.06252732,-1.3026785587922145,-0.04581123328563436
78428,SIDM00529,Venetoclax,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.6598258,0.056582984,0.9604061536853721,0.1077770775662868
98919,SIDM00778,Taselisib,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,69.0,1.1111276,0.059557863,-0.1452682857987634,-0.008242707752707914
82071,SIDM00778,MK-2206,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,1.9906507,0.11911305,-1.3301627490824859,-0.0544847666741956
92142,SIDM00971,Docetaxel,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7182767,-0.054981686,-0.8602440435254461,0.009647681208059691
83134,SIDM00954,Lapatinib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-0.92403394,-0.050394416,-0.07144892370347802,-0.04156559067975727
19112,SIDM00359,Crizotinib,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.83417994,-0.05285247,-1.9972908055461494,-0.0560095105307482
68116,SIDM00878,Dabrafenib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.51804894,0.017334618,0.8194416279510814,0.021333334340684327
50025,SIDM00971,OSI-027,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.075522,0.10616669,0.10283273153513009,0.03818398871034661
62047,SIDM00332,5-Fluorouracil,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4364278,0.090071626,0.30568313137150577,-0.020684626157055772
101567,SIDM00954,AZD8055,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-1.3130072,-0.087941885,-0.5293422804900597,-0.025324073084604787
95335,SIDM00660,5-Fluorouracil,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,-1.9911337,-0.12975685,-0.888473114876395,-0.025588318115702464
34532,SIDM00893,Camptothecin,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.38343772,-0.03446209,-1.1758802908149333,-0.07142208140862448
72567,SIDM00774,Axitinib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,48.0,1.6173667,0.20944,0.25647915375915903,0.09199076241377017
76361,SIDM00875,SCH772984,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.084237,0.1188191,2.0697155381024377,0.1384641925494739
50987,SIDM00529,Venetoclax,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,1.5876842,0.03053544,1.1577115319173057,0.07668317736603271
59732,SIDM00875,MK-2206,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.3941014,0.24752003,2.147377684719685,0.0673793542416367
12682,SIDM00628,ZM447439,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-0.036401365,-0.002933183,-0.6561184149051764,-0.02147212942045605
50344,SIDM00875,Docetaxel,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.887548,-0.070283554,-1.031364024768107,-0.0806467192670506
69826,SIDM00193,Dabrafenib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.53271174,0.015764283,1.4951396539874349,0.06413248891483805
89140,SIDM00971,Olaparib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.6627858,-0.05067395,-2.05119563901185,-0.04282097094026299
39984,SIDM00774,Pictilisib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.08654757,-0.0034718064,-0.4161727972833147,0.004047196496379749
33237,SIDM00628,Wee1 Inhibitor,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,-1.2141894,-0.09544129,-1.0081515099827314,-0.047559316120229234
5359,SIDM00146,MK-1775,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.7490158,-0.062523276,0.2302619788041914,0.02231279150006209
33785,SIDM00193,Oxaliplatin,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.72640175,-0.021980379,0.48369836719225595,0.010744295763346122
33238,SIDM00332,OSI-027,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0333714,0.08166127,-0.37315500246794375,-0.04924084829863114
69172,SIDM00411,MK-1775,Linsitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,2.3134634,0.13532102,0.34370122609737097,0.04933408847174994
11209,SIDM00776,AZD8055,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,2.0676043,0.097718336,2.8425677428429084,0.08902166655736894
16070,SIDM00529,NU7441,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.35623273,0.029292215,1.439690539197284,0.09889186974721663
73090,SIDM00893,PD173074,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.1741264,0.09967931,0.3690462723028145,0.0009754139431732351
34504,SIDM00146,SCH772984,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.4242872,-0.1327805,-0.978000702435608,-0.09504022823320157
22926,SIDM00628,Palbociclib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.3451493,0.02547385,0.8992072231074494,0.026475626222519023
13385,SIDM00130,MK-1775,SCH772984,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.4239061,-0.03433065,-0.5200814995152147,-0.033494973909001975
103682,SIDM00529,OSI-027,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-1.980218,-0.057873078,-0.32734747935713715,-0.058539210657031215
31859,SIDM00146,Taselisib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-0.7569227,-0.050616123,-1.081665246071721,-0.05517007004909358
41481,SIDM00301,Paclitaxel,Palbociclib,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,-4.4750147,-0.3827909,-3.446641151411099,-0.2748627000396756
14626,SIDM00866,Ribociclib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-2.1956255,-0.07917098,0.20056883970134534,0.020378394473187216
62963,SIDM00097,Alpelisib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.139991,-0.00996318,0.3768048698372503,0.013023295907572561
31964,SIDM00954,Alisertib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-3.8892632,-0.17247558,-1.3178949329241887,-0.06491272239696239
6331,SIDM00673,Camptothecin,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,4.053294,0.14604306,5.909358981835113,0.34195208544719835
5164,SIDM00866,Alisertib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-3.6786077,-0.24591938,-2.3309347116370454,-0.1559187027710709
84827,SIDM00774,Uprosertib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-3.1155167,-0.22563608,-1.2355547497652684,-0.0999202917004447
52398,SIDM00971,Sorafenib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.3480036,-0.02330391,0.7393302185900833,0.06497366351929464
70112,SIDM00779,SCH772984,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-0.006457277,-0.000594294,-0.022388931019322787,-0.029529438729481605
55575,SIDM00628,Entinostat,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-2.143651,-0.10235764,-0.6122567240399708,0.0025336660757684644
22010,SIDM00774,Venetoclax,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-0.18630451,-0.0039114184,-0.3541579406021313,-0.06733904580251841
69455,SIDM00673,AZD8055,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-0.19488595,-0.015907928,-0.6893666085668374,-0.07464130489315403
22980,SIDM00778,AZD4547,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,0.9748751,0.0440795,-2.4326634939466145,-0.12477931888128935
89389,SIDM00776,Olaparib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.1794709,0.067127995,-1.0373948724332702,0.00845203008200559
38056,SIDM00193,AZD8055,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.41392276,0.036848344,-0.4131575139120405,-0.008487858259876566
41611,SIDM00628,Bortezomib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.1369858,0.04489946,0.04123535178461418,0.00047231079295839836
39342,SIDM00529,Cisplatin,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,1.0862256,0.02314166,1.5018870972032516,0.06958114175280292
66341,SIDM00130,MK-2206,5-Fluorouracil,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.95957285,0.09515528,-1.165204099350258,-0.05984143009468801
105036,SIDM00893,JQ1,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.8686204,-0.095822,-1.082850580117736,-0.0291742937722127
3247,SIDM00097,Bortezomib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.662435,-0.043711238,-0.09680505413540488,-0.05829538332183553
59520,SIDM00866,Nilotinib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,0.65064913,0.04174344,1.168615415691234,0.08362341040256366
91570,SIDM00529,AZD8055,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-0.610674,-0.03921398,-0.966086941168256,-0.0045937553962596975
23,SIDM00097,Venetoclax,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.74735457,-0.024050396,0.23154130056558211,0.01819963442788715
55688,SIDM00097,AZD7762,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3042672,-0.073046446,-0.5796849161161555,-0.05674529840970356
37282,SIDM00130,Erlotinib,Ruxolitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.23772907,-0.022831077,-0.021813103719763086,0.005678417417071386
90969,SIDM00146,Afatinib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-1.0480397,-0.092826925,-0.32625453185859943,-0.018158158225562458
84067,SIDM00875,Crizotinib,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2252192,-0.10026357,-0.5321699868908492,-0.10338418832913812
34070,SIDM00778,Dabrafenib,Afatinib,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,0.15456748,0.002132696,1.3967789488823807,0.012306127888284496
77580,SIDM00673,Bortezomib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.6151659,-0.033551384,-0.5372731350366277,-0.03721211746760573
95320,SIDM00778,MK-1775,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-1.1457942,-0.036539007,-0.7265520917589445,-0.031206899927153014
65695,SIDM00866,PF-4708671,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,52.0,-2.70055,-0.10566971,-1.4709850317856281,-0.07373742948901768
67654,SIDM00193,MK-1775,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.8661503,-0.07619371,0.14577777206290068,-0.0067553404314753445
27612,SIDM00971,Alpelisib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.3684592,-0.18520766,-0.39954120328499176,-0.031012995819250957
6712,SIDM00774,Afatinib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-0.926231,-0.055095527,-0.9380756636536473,-0.06073968044712336
101338,SIDM00866,Trametinib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,-1.9583614,-0.13130182,-1.5472654656488276,-0.03833206110302522
16378,SIDM00529,Camptothecin,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,2.1775713,0.13167307,3.3271729002027013,0.15658432814014578
97634,SIDM00097,Nilotinib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.5079127,0.034102008,0.7532648802357184,0.062240947230137234
7151,SIDM00359,Trametinib,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.3201786,0.034299947,-0.6930224438561586,-0.01153095540950775
66169,SIDM00660,BMS-754807,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,32.0,3.518911,0.22718921,0.29792669470489275,0.042804097428629666
94795,SIDM00878,Venetoclax,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.5330489,0.063124046,-0.07682539064709049,0.00920305480444135
8170,SIDM00878,RO-3306,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,4.0670567,0.27682063,-0.2871473250273891,-0.0028507929954670655
49295,SIDM00130,Irinotecan,Olaparib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.83467555,0.08134424,0.17818529655807516,0.037313329293909965
49393,SIDM00893,Entinostat,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.6318322,0.038300835,1.2375692412486927,0.008801692370803407
25030,SIDM00971,Nutlin-3a (-),Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.3280966,-0.035906557,-1.0113925896484195,-0.0018367881562315472
70710,SIDM00628,Pictilisib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,1.2387398,0.109889165,-0.42330147714910143,-0.01938780504452007
59466,SIDM00529,Sorafenib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,0.6459528,0.06085393,0.16898105069608396,0.009193596773122687
93946,SIDM00954,Crizotinib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-1.3086504,-0.09512973,-0.6857570978361224,-0.047413090552117385
98330,SIDM00893,Olaparib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.8840277,-0.050896805,-0.7375473892654946,-0.004058178980794372
43911,SIDM00628,Bortezomib,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-1.0389714,-0.05673221,-1.0962317386093545,-0.04497125003270453
8318,SIDM00971,Nutlin-3a (-),Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.7260668,-0.020349795,0.008791836626047326,0.005597352813389159
92249,SIDM00782,Nutlin-3a (-),LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.4815983,0.037095435,2.2817225965722567,0.05597904834483325
92749,SIDM00531,Taselisib,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.479658,0.21620145,0.6509692201157415,0.04398746873468798
99076,SIDM00531,Linsitinib,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.9004208,0.07032646,0.3399390871085765,0.019077125606956295
100362,SIDM00673,PD173074,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,1.3889079,0.10193758,0.17519321556961986,0.016052085202990157
84500,SIDM00673,Venetoclax,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.4552649,-0.037166238,-0.5492013818500389,0.008308491168717813
24060,SIDM00782,Palbociclib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.57225263,0.014915794,1.6344187256811948,0.03276045218331036
24096,SIDM00673,JQ1,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.2380884,0.1798932,0.8973072898945207,0.07997447357584013
94126,SIDM00301,SCH772984,Dactolisib,Pancreas,0.0125,Pancreatic Carcinoma,Male,East Asian,50.0,1.1530195,0.13985,1.2796362830476886,0.07356096577525319
85813,SIDM01233,AZD4547,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,72.0,-0.9462365,-0.028412,-1.0698272041562147,-0.00692023781825347
103147,SIDM00332,Afatinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.0275698,0.12904027,0.75406108336873,0.13346465598612242
63526,SIDM00878,RO-3306,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.9315173,0.073847696,0.37951018630549566,0.04790808331962569
85630,SIDM00359,AZD7762,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.80464536,-0.05348929,0.15160646627992516,0.026803176983770143
87475,SIDM00628,Wee1 Inhibitor,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-3.5613651,-0.13741335,-0.5732350763050306,-0.03310422095933901
18426,SIDM00628,JQ1,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,1.8476048,0.16085792,0.7917142541275923,0.07293456730505586
79137,SIDM00097,Axitinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.5690866,-0.16516675,-1.2579717155686272,-0.08704728090290868
93014,SIDM00529,Entinostat,MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.1860353,-0.06479926,0.4530344708922473,0.1134302727724782
92853,SIDM00875,PD173074,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.43238723,-0.02453442,-0.6357275893124352,0.05809594025159049
76867,SIDM00954,Vorinostat,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,0.74267656,0.055701792,-1.0043628339047337,-0.11636818233063248
101519,SIDM00332,Ribociclib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5087014,-0.03008024,-0.22573026513522448,-0.008925166572458242
40584,SIDM00971,BI-2536,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.8269122,0.11184674,-0.2658947157818324,0.050568193862670564
82033,SIDM00954,Docetaxel,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-1.2588648,-0.09670836,-1.6831532140498302,-0.19205858163090242
4623,SIDM00529,Paclitaxel,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,0.6289262,0.061846044,-0.3614879278995957,-0.013562409932919062
10407,SIDM00146,Venetoclax,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,2.3401408,0.08572429,0.8827966198489042,0.0276378316295252
93429,SIDM00146,Taselisib,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-1.3218915,-0.10806418,-0.242264166965751,-0.033385230056991046
21412,SIDM00893,Alisertib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.0750555,0.09255805,0.8830257837768163,0.053507988092013105
59288,SIDM00097,Temozolomide,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.33229628,-0.005202799,0.954675864722847,0.010424680360248045
77779,SIDM00529,JQ1,Luminespib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-2.058023,-0.10542162,-1.3130520371944865,-0.06628692493455059
107453,SIDM00628,GSK269962A,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,1.0476807,0.092665404,0.44538243312244963,0.024353712706534712
67240,SIDM00878,PD173074,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-2.520191,-0.22588348,-2.0239302085762167,-0.10607067663429273
4118,SIDM00332,Linsitinib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2074777,-0.032080445,1.6280567676124245,0.035267037895112055
90411,SIDM00774,Trametinib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,48.0,2.2995563,0.12517112,-0.21436091496112125,-0.02978419095385358
29776,SIDM00954,Venetoclax,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,3.5720065,0.12748103,-1.0808532445729313,0.013152688499858407
45730,SIDM00834,Trametinib,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,White,66.0,-0.66713023,-0.022393575,0.1108751125898538,-0.005195848760630205
5093,SIDM00866,Trametinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.3093512,-0.087296315,-0.187445473236232,0.02632976548931521
77720,SIDM00774,Camptothecin,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.2123643,-0.04957691,0.9672747763482749,0.0505680743898277
62989,SIDM00146,Nutlin-3a (-),Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,0.5340504,0.01627899,1.0942622442807846,0.03732642014493939
50253,SIDM00673,JQ1,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.4715966,0.110800065,-2.3027466580618863,-0.09171881119295253
98207,SIDM00954,Uprosertib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-2.2512846,-0.14027987,-1.0003938560864216,-0.07366597446967708
74814,SIDM00971,SCH772984,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.8810137,0.016830849,2.326383957484424,0.10128621973799459
31947,SIDM00146,Alpelisib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.7223927,0.10973058,-0.3201691868642779,0.015081271474354618
8470,SIDM00673,Cisplatin,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,2.0887284,0.090287626,1.557951469781748,0.10115966703780563
5667,SIDM00130,Linsitinib,Dasatinib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.7534934,0.050265927,2.2592212294042526,0.18873983568805922
27877,SIDM00782,SCH772984,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.6217912,0.060923167,-0.022621697305937542,-0.019840475369401943
50696,SIDM00628,Entinostat,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.13321209,-0.008531267,0.47374531171912726,0.07093592042235851
72037,SIDM00779,Dabrafenib,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,2.2966065,0.1538471,-1.0016955442929047,-0.0011630643631632645
11385,SIDM00628,Nutlin-3a (-),Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-2.0175796,-0.09510931,-0.47529308643443785,0.008112975285855391
11595,SIDM00628,Navitoclax,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.6337511,-0.063846976,-0.09973778438514898,-0.029682262790420508
15919,SIDM00301,OSI-027,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.6426988,0.06246974,1.2176729680770628,0.059156723846445186
70074,SIDM00411,MK-2206,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,4.7731323,0.25913325,3.6422002169875305,0.2979664864098227
64064,SIDM00332,Afatinib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.5637789,-0.20567168,-0.6358377763825652,-0.05597115318809588
81385,SIDM00193,MK-1775,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.34222588,-0.031255756,-0.23067453005030017,-0.015775983796635074
9148,SIDM00878,Taselisib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,0.4588573,0.040190283,0.07859181960451653,0.04035939455748706
58268,SIDM00866,MK-1775,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-2.6220388,-0.1647938,-1.2897788092951976,-0.06736440982280399
58553,SIDM00971,MK-2206,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-4.812797,-0.17865783,-0.9934480958164889,-0.045849641557886144
100563,SIDM00411,Dactolisib,MK-1775,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.4001044,-0.050410375,-0.5707464660398974,-0.05066498595496021
62580,SIDM00893,GSK269962A,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.3320141,-0.095175415,-1.1656660566217365,-0.03461682255734016
26372,SIDM00529,Gemcitabine,MK-1775,Breast,0.625,Breast Carcinoma,Female,Black,44.0,3.1038404,0.024529623,-2.060850406287539,-0.005925596235481609
7243,SIDM00875,GSK269962A,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.884157,-0.083454534,-0.4945060617584466,0.008510828657521683
36071,SIDM00893,Tozasertib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.9112123,-0.07663735,-0.7897247935256277,-0.008753188255013783
92936,SIDM00673,Nutlin-3a (-),5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.7145685,0.017198479,1.1242778557583195,0.017022745897017584
98877,SIDM00866,MK-2206,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-2.4728434,-0.13044035,-0.34737946459192953,0.007072537608814296
38259,SIDM00834,Linsitinib,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,2.8950312,0.20686434,1.0847326026653565,0.03408976113478278
56813,SIDM00673,AZD7762,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.34233588,-0.023030918,-2.0202964165714357,-0.08733804665635385
45434,SIDM00660,MK-1775,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,0.37851492,0.018742451,-0.09953283999737209,-0.015109805521965962
60388,SIDM00411,Sorafenib,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,43.0,-2.3627608,-0.097819135,-0.8638450035907845,-0.015375558937563798
92160,SIDM00193,AZD7762,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,3.1972466,0.2143165,1.3515881308328241,0.11234036005430771
40095,SIDM00193,AZD8055,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-3.000336,-0.16009264,-1.0693240295765112,-0.047695773505915376
37965,SIDM00779,Olaparib,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,1.848597,0.014396707,1.6777922810972767,0.03504638025636522
107330,SIDM00130,Linsitinib,LGK974,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.0578723,-0.050519653,-1.1228928260398126,-0.04420228094647118
46128,SIDM00875,Afatinib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1519547,0.07116033,2.7694084557178944,0.09833670036070817
100351,SIDM00628,Afatinib,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,0.84438866,0.05888592,0.21723204398568585,-0.00449088071597954
84177,SIDM00866,Ribociclib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,52.0,-0.7373482,-0.03642526,-0.7690531216924775,-0.016255135412443937
102842,SIDM00332,SCH772984,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.819021,-0.1405333,-1.2442858994286152,-0.0676475872036513
70793,SIDM00954,Navitoclax,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.0,-0.74825007,-0.023783706,-0.3919064092486564,-0.03624191650785367
62758,SIDM00332,ZM447439,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7207327,0.06889952,0.14729973476189678,0.034543274365332506
91780,SIDM00774,Gemcitabine,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.7703424,0.20810856,1.5112007324412655,0.07481401171119079
75645,SIDM00971,ZM447439,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.5734448,0.11056279,0.5706287836744168,0.03974211365906657
80274,SIDM00774,Taselisib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,4.51099,0.033981584,-0.7779561143037536,-0.114676574380014
40477,SIDM00660,Trametinib,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,2.7470627,0.12220961,0.3859462948612053,-0.022165704892749553
33364,SIDM00782,Olaparib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,Unknown,72.0,-0.95278364,-0.02333306,1.990165973248538,0.08436900693037615
21278,SIDM00628,Olaparib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-3.550637,-0.17937319,-1.7736899088459133,-0.07228464041685036
19615,SIDM00954,Linsitinib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-2.9922745,-0.10308216,0.04177361990326205,0.07909910414160694
91359,SIDM01233,MK-2206,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.7384881,0.1218685,1.502048310168734,0.1335568021748364
73066,SIDM00954,NU7441,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,1.0690212,0.06414608,0.4799717599282622,0.037284402476096025
53824,SIDM00866,Paclitaxel,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-5.8079476,-0.40779927,-3.1856942435309783,-0.2755169950697968
12375,SIDM00628,Venetoclax,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,-1.9300998,-0.06764547,-1.9882026580713716,-0.03682585272081854
77229,SIDM00673,Luminespib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.498245,-0.1588162,-1.02517107713328,-0.09121071052539512
25772,SIDM00301,MK-2206,Palbociclib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.9520959,0.21446918,1.1178789508984373,0.1158946074765187
41322,SIDM00782,Nutlin-3a (-),Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.7895806,0.021032255,2.4982369374905122,0.06723890514555173
73448,SIDM00660,AZD4547,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.9651364,0.06358333,0.1361417283356606,0.04934732326292979
33223,SIDM00866,Gemcitabine,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.0035497,-0.075054534,-0.22025680450984164,0.011486662548396089
91875,SIDM00097,Nutlin-3a (-),Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4030383,-0.048109055,0.060466062499007746,-0.017777287997629364
15753,SIDM00954,Temozolomide,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-0.16718574,-0.002893669,1.650748244016307,0.04207747730279322
98957,SIDM00954,GSK269962A,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-3.0229046,-0.14220062,-0.06881343247438917,0.03055910119752127
105442,SIDM00866,BI-2536,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-2.3131678,-0.118203215,2.1934720860961803,0.05685500893619221
80672,SIDM00875,Gemcitabine,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-4.4352293,-0.020099668,-3.688651265773249,-0.099087238250436
358,SIDM00146,Pictilisib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.15658997,0.009612912,-0.5593568630103601,-0.0024327599259930553
83177,SIDM00774,Doramapimod,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,0.936951,0.04946198,0.838081620214741,0.046854932997115364
35304,SIDM00097,Doramapimod,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.7794755,0.04594937,2.823582798575872,0.10577385696034856
104558,SIDM00531,Taselisib,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.8995159,0.27922958,-0.6371070504099232,0.00801772340292753
73340,SIDM00866,AZD7762,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-1.8760259,-0.1309505,0.39274030107059393,0.07298688306404816
81683,SIDM00332,PF-4708671,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,4.121753,0.18674156,2.387695665172688,0.15310959715562938
60785,SIDM00893,AZD8055,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.8768618,0.072541185,0.42298151590719146,0.02354382357497041
99130,SIDM00130,Linsitinib,Dactolisib,Pancreas,0.0125,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.5797367,0.18828231,2.553061356279974,0.13090533105394317
83783,SIDM00875,PD173074,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.26324365,-0.01481597,-1.5090710649202395,-0.03874483053564968
78291,SIDM00893,Afatinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.24381348,-0.020715328,1.2681597084495753,0.1000522795187655
29251,SIDM00193,Crizotinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-1.2750607,-0.04606192,-0.0743882405662823,0.03411829441409988
50412,SIDM00878,Trametinib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.0391177,0.120616004,0.2147930549907959,-0.02081141234686847
52268,SIDM00782,Trametinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,4.9867063,0.13727097,2.027434626932272,0.08430549487444358
79608,SIDM00971,AZD8055,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.801073,0.12444596,1.2071486875605602,0.08896914370484395
105983,SIDM00878,Cisplatin,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,0.85526145,0.022659363,1.3863451779508469,0.061780014560771375
99298,SIDM00893,Nutlin-3a (-),Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.586039,0.09307545,1.9556349402103532,0.0756192091153085
20296,SIDM00332,Paclitaxel,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-6.825199,-0.43064514,-3.688087128378177,-0.31660130875111514
41447,SIDM00146,Alisertib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-2.183085,-0.1510585,-1.491769628074973,-0.12422332827343702
70523,SIDM00878,Trametinib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.2583745,-0.102865994,0.32864779222259555,0.0758756438479562
72853,SIDM00628,Temozolomide,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,-0.49423134,-0.013888231,-0.7038847444264282,0.005917741813709642
85452,SIDM00878,Tozasertib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.3795292,0.117162086,0.6947181717415952,0.09952662906258136
50976,SIDM00834,LGK974,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,1.9425391,0.14095053,1.1885354993623847,0.05493058026522942
27826,SIDM00301,Oxaliplatin,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.9675873,-0.10668915,-0.6607272112563972,-0.08433218493562045
53196,SIDM00193,AZD8055,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.5934695,0.033231568,2.3826843153931847,0.12542608612384365
33093,SIDM00660,Trametinib,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,5.8752356,0.16196933,0.4420783584088222,-0.01051977133170844
53592,SIDM00774,Docetaxel,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,48.0,-0.7292856,-0.08162484,-1.1253945793767108,-0.09359024870817757
33197,SIDM00971,Docetaxel,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.752039,-0.09572648,-3.6664945768366595,-0.06817126408108513
90214,SIDM00529,Temozolomide,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.50570166,-0.010338626,-0.3758951183221645,0.042021060416048195
68094,SIDM00782,AZD4547,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,Unknown,72.0,-0.84416443,-0.024390996,1.2633961314452462,0.03243362589357806
32328,SIDM00411,Olaparib,AZD7762,Pancreas,0.0625,Pancreatic Carcinoma,Male,East Asian,43.0,2.0035486,0.061085496,1.4380878983732701,0.030963933997428836
1334,SIDM00875,Luminespib,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.975084,-0.1030559,-1.1622623060519799,-0.04602738596887819
66023,SIDM00332,Wee1 Inhibitor,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.21726833,-0.01625211,-0.3375347793996805,-0.006754742759901508
20136,SIDM00332,Linsitinib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.4822161,0.14243683,1.4508781241006736,0.025277399150516452
68883,SIDM01233,MK-2206,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,72.0,-1.9307164,-0.12615414,1.1377974074816313,0.06074691760411931
18881,SIDM00875,Doramapimod,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4090431,0.043374173,1.5677715433050796,0.03952427848389535
74764,SIDM00866,AZD8055,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,3.2181592,0.07963881,2.4653964826538877,0.15834811349100172
99389,SIDM00782,BMS-754807,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,Unknown,72.0,-2.6492267,-0.21217641,-2.3057353215506624,-0.12997253184812177
50301,SIDM00529,PD173074,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,-1.6103481,-0.0803266,-1.4830373150957974,-0.06195147953700362
23547,SIDM00673,Crizotinib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-0.34387478,-0.033198684,-0.842959177789603,-0.06336545915154118
80657,SIDM00411,Linsitinib,Palbociclib,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.6221313,0.16081107,0.4404092660164761,0.052899520570045024
5142,SIDM00529,Paclitaxel,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-3.8909109,-0.29057688,-3.6601340572658843,-0.30230630187321345
90811,SIDM00954,Bortezomib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.0,0.83193135,0.042877946,-0.31252588607366844,-0.0018129536485374583
6750,SIDM00529,Entinostat,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.6042873,-0.07946115,0.6713676986795805,0.06915733945766651
17911,SIDM00774,SCH772984,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,1.1021006,0.027177833,2.4042990640389963,0.08374341099501621
17107,SIDM00529,Nilotinib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-0.8184892,-0.025911245,1.1282197630855197,0.039123610961820765
84490,SIDM00875,Linsitinib,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8776946,0.13238472,0.9151871319733418,0.014250541651545387
43481,SIDM00673,AZD8055,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.9373065,-0.14901696,-1.3762763749739506,-0.1195233223354175
38242,SIDM00411,Sorafenib,OSI-027,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.2568797,0.063065134,-0.667880239069014,-0.04071611209268247
66105,SIDM00411,5-Fluorouracil,Trametinib,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,43.0,-1.8516574,-0.055621084,-0.7735979787984444,0.003280912620492588
76893,SIDM00673,Luminespib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-3.3496456,-0.17875756,-1.8582922824347106,-0.07517373437949161
7458,SIDM00875,Luminespib,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.37623549,-0.04023203,0.277198784934295,-0.032448561712567825
86813,SIDM00628,SCH772984,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.657935,-0.038726762,-0.13519585115506394,0.049005251124930906
101790,SIDM00954,5-Fluorouracil,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-1.0575683,-0.03449588,0.8824247011723126,0.0524174240918516
41839,SIDM00774,Wee1 Inhibitor,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,-1.4074019,-0.084001854,-0.08854063006519626,-0.022689654288386034
48038,SIDM00529,Tozasertib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.2378685,-0.04176292,-0.4473207955540647,0.014082707866363722
8530,SIDM00146,Luminespib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-0.73106724,-0.06364467,-0.42539137538171673,-0.05688928532142427
81375,SIDM00628,Vorinostat,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,1.369897,0.07012856,-0.7283981668927757,-0.022838987834748147
4024,SIDM00778,Palbociclib,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,69.0,1.6452385,0.084845334,-0.7454835786322938,-0.03975222917309646
25226,SIDM00971,Alpelisib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.864158,-0.16918333,-0.47027947913045004,-0.0017716168709667383
100230,SIDM00146,Linsitinib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,0.8057738,0.021659961,2.4067398478987543,0.0796851333463225
29429,SIDM01233,MK-1775,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.0842203,0.070213385,-0.38491487569833754,0.012918501334554846
94494,SIDM00954,Trametinib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,2.1738646,0.12446937,0.3779612091985196,0.007539402852328437
37943,SIDM00529,Bortezomib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Black,44.0,-0.33314276,-0.02661504,-0.9461054799503056,-0.06213324211404617
70622,SIDM00146,Tozasertib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.2481465,-0.07702591,-0.7002000148710575,0.03997885146167439
7583,SIDM00628,KU-55933,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.1035774,0.1481202,-0.5154002120031262,0.009020806347103285
55814,SIDM00628,Alpelisib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,-1.5260149,-0.06637573,-0.3744023426345919,0.00724769319156885
75233,SIDM00332,Nutlin-3a (-),Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.8879912,0.12281189,2.6516055483883565,0.021544895011383874
100841,SIDM00774,Alisertib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,48.0,-2.0442357,-0.1214396,-0.1528022865645764,-0.04266680325167774
2255,SIDM00097,Cisplatin,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2641828,0.02820921,1.2263947793778032,0.024720999719900653
5709,SIDM00531,Dactolisib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.0625527,0.2211036,1.5622100346437253,0.07088313155515304
28982,SIDM00301,Palbociclib,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-3.124321,-0.22500595,-1.565266843880714,-0.10676937576133319
6400,SIDM00878,Nutlin-3a (-),MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.77629733,-0.03308653,0.9343721616336902,0.039393235638565165
646,SIDM00893,ZM447439,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.49628708,-0.040003493,-0.7721832920674031,-0.029078228142346223
69485,SIDM00628,Alpelisib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.94934887,0.048643596,1.6638520563873316,0.14666856118874688
88490,SIDM00866,NU7441,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,1.4279792,0.100731805,-0.7978234309900296,-0.02292976220373444
53026,SIDM00332,Paclitaxel,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3800569,0.093465246,0.01944748959096592,0.03393297645806963
49538,SIDM01233,5-Fluorouracil,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-0.67420506,-0.028360272,-0.4680529886953362,0.011580759603359034
15184,SIDM00893,GSK269962A,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2559549,-0.09219662,-0.7271528288825974,-0.041536265609910264
53372,SIDM00097,Crizotinib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8103612,0.0416899,0.5076738900670036,0.014779277221836662
104496,SIDM00878,Ribociclib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-2.646036,-0.10798993,-2.144927885391255,-0.0745688562859863
20197,SIDM00660,LGK974,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,-0.27529556,-0.006603717,0.5786599237396336,0.01817125186267771
88527,SIDM00628,JQ1,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,-1.586341,-0.08492233,3.0310203463514567,0.1986414052670188
102894,SIDM00359,LGK974,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0720947,0.03289336,-0.2740921816219836,0.020337737682481264
99312,SIDM00971,Dabrafenib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.6729836,0.117099985,0.6731547178940821,0.02190338582025894
53918,SIDM00971,Palbociclib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.4332873,-0.041273743,-0.5510530815363002,0.017037056043840055
99459,SIDM00875,Sorafenib,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.17858815,0.014375415,0.13457533815934614,0.018117869035736114
49189,SIDM00130,Oxaliplatin,Dactolisib,Pancreas,0.0125,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.2007377,0.08045522,-0.7912765198296661,0.001248226212546159
26980,SIDM00628,Ribociclib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.44433877,-0.01153467,-0.5092926631109309,0.014806965229621154
52505,SIDM00774,AZD7762,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,1.4177457,0.17758064,-0.23428944269171614,-0.03820112896580801
12440,SIDM01233,Camptothecin,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,72.0,1.7338805,0.07663656,3.73015438926071,0.12282568699819198
87932,SIDM00779,Oxaliplatin,AZD4547,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-2.08367,-0.035452854,-1.730430924093657,-0.06021348599402277
63879,SIDM00866,Docetaxel,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.0301671,0.09176469,-1.1520804093309744,-0.02532211185443819
63001,SIDM00971,Cisplatin,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.1890657,0.079470225,1.1400252092908014,0.013739677496770025
105372,SIDM00673,ZM447439,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.0328507,-0.17225558,-0.34175290407340025,-0.0396310811130846
57092,SIDM00097,Lapatinib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.0224133,0.19004956,0.6341603079558388,0.01359159408814967
107721,SIDM00193,MK-2206,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.6314602,-0.13614732,0.17738941216949963,0.04406760282858979
11864,SIDM01233,Linsitinib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,72.0,2.3995228,0.13422932,0.9267844172520157,0.08029814161208854
85867,SIDM00531,MK-2206,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.4844465,0.30057648,1.8695909164461335,0.04957523546821107
91724,SIDM00628,ZM447439,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-0.86165535,-0.07726723,-1.0033498592586783,-0.10671941362392248
89785,SIDM00774,AZD6482,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.2566564,0.077855185,1.2291455240148825,0.09416953879484871
25402,SIDM00673,Vorinostat,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.65950763,-0.06865727,-1.2391757182873202,-0.04429144759506487
106776,SIDM00193,Trametinib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,2.6085668,0.21219079,-0.9557156091876378,0.001152259310066807
91666,SIDM00878,Paclitaxel,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-4.557839,-0.29750645,-3.5302326421920913,-0.24100463947469788
94827,SIDM00774,RO-3306,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,1.1175994,0.072757944,2.7628643976302434,0.17073296493843185
46562,SIDM00778,SCH772984,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,-1.690126,-0.046978675,-1.140881023028984,-0.020656337921001234
103966,SIDM00878,Docetaxel,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.0946352,-0.009140091,-0.06467672949963245,-0.062092323779168554
90298,SIDM00893,MK-1775,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.9344407,-0.19051023,-1.6238086120275756,-0.10208581066118796
53888,SIDM00954,Alpelisib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-1.3986238,-0.104942545,-1.1779252147445114,-0.082031020546357
26,SIDM00782,Afatinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.747203,-0.049196415,-0.6288544678595364,-0.0064086435855667525
26995,SIDM00878,Palbociclib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,70.0,-1.5455459,-0.0905252,-0.9770584768761206,-0.02198873012381019
50850,SIDM00778,BMS-754807,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,69.0,0.21990234,0.014443549,0.01805238276562487,-0.020100832803260332
18232,SIDM00866,Luminespib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.0191151,-0.08282537,-0.9386754209838525,-0.04969914591602807
80684,SIDM00628,Afatinib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,1.4449929,0.095308036,0.0911270423624551,0.033995449899949806
39632,SIDM00954,Taselisib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.16590862,-0.014182961,-0.4599234588305646,-0.01958850926312347
98652,SIDM00878,Axitinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,70.0,0.056662314,0.006988217,0.22950891047272862,-0.009063082538408698
105316,SIDM00097,Nutlin-3a (-),OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.7680068,-0.07601555,-0.6379138720519532,-0.013220349099342296
47425,SIDM00146,Sorafenib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.48359525,-0.041913364,-1.1130697465786443,-0.04758741996914842
70616,SIDM00782,BMS-754807,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.74724895,-0.0578205,-2.598331693748195,-0.14345341498409142
32845,SIDM00971,SCH772984,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.5252184,0.011074979,1.4373822403140668,0.044894981245844734
89434,SIDM00866,Temozolomide,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,52.0,-1.3309928,-0.022676103,0.3433447515044767,-0.015665254521641456
51651,SIDM00776,BMS-754807,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,0.4248871,0.01973696,0.9152667206270059,0.022765612244772533
43693,SIDM00660,Oxaliplatin,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,-1.1305751,-0.05537279,-0.9148295747658228,-0.027647009850888096
11115,SIDM00673,Temozolomide,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.6658689,0.016458884,1.4994235307811643,0.019695263172116655
64631,SIDM00146,Sorafenib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.8223165,-0.07687061,0.04815795445368102,0.014647601296824603
52557,SIDM00893,AZD8055,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2197471,-0.10127559,-1.0357057104680951,-0.09430197161162804
34245,SIDM00866,Linsitinib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,0.121491134,0.0066840467,-0.11842995188496376,0.014394688057751385
93263,SIDM00130,5-Fluorouracil,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.5795732,-0.09109005,0.03119277628840296,0.011984458645488376
6212,SIDM00866,Paclitaxel,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,-0.75901085,-0.06491469,-1.3023988944121152,-0.06559930010443206
15572,SIDM00130,MK-2206,OSI-027,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,4.0855546,0.36608297,0.8177766584940993,0.12854681203078433
82180,SIDM00097,5-Fluorouracil,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0054862,0.0417443,-0.17004853846363382,-0.026216582367513133
49263,SIDM00146,Lapatinib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.29138184,-0.024110591,0.23892654868594104,0.031267727628488146
79871,SIDM00332,Linsitinib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3592116,-0.03929981,1.866709553048166,0.03633540684649051
20696,SIDM00866,JQ1,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.5345348,-0.10992745,-0.24150223003120788,0.01933494467802953
42280,SIDM00628,RO-3306,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.09038692,-0.008342049,0.11900965200817326,0.004198088170791364
102740,SIDM00097,Crizotinib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.6427422,0.10818002,0.42392780601228974,0.04768897098354714
30528,SIDM00779,Oxaliplatin,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,-3.6995745,-0.12201767,-1.2327184815407481,-0.06944862541768812
33856,SIDM00531,MK-1775,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.72789544,-0.079301745,-0.1870996591280717,0.0015636854540363634
51158,SIDM00673,BI-2536,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.33702654,-0.02735603,-1.5096869310685554,-0.06628451457042618
98884,SIDM00776,AZD4547,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,1.374812,0.03806474,1.0907912399054716,0.061060505625796895
58263,SIDM00893,Taselisib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.9921162,-0.046478156,-1.6246566506768485,-0.14020385386225656
68481,SIDM00673,Axitinib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.15258773,-0.016084092,0.8425040264837231,0.06387991622106323
21316,SIDM00529,Docetaxel,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.5146879,-0.11835275,-0.5980780280242363,0.008348744238460252
100614,SIDM00673,Venetoclax,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.51314473,0.010490516,2.4166236105887484,0.050075274282043565
12215,SIDM00878,Afatinib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.199078,-0.113684215,-0.8509576370863459,-0.07596993156778797
16953,SIDM00875,Navitoclax,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8796842,0.083307914,2.254090514439725,0.10692137689957672
82817,SIDM00954,Axitinib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-0.57387966,-0.029600691,-0.6377509093567549,-0.04449486996699003
75114,SIDM00529,Wee1 Inhibitor,MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.2595721,-0.02451789,0.23873556180900488,0.046086281965722266
100735,SIDM00531,Gemcitabine,Dactolisib,Pancreas,0.0125,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.481709,-0.046934787,-0.6035387033981251,-0.0075528457330200725
81069,SIDM00875,AZD6482,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4457742,-0.032620065,-0.4434644285438756,-0.0047583518898130315
58539,SIDM00774,Alpelisib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,2.373494,0.13624547,1.9063622522969863,0.10743808795315923
11455,SIDM00878,5-Fluorouracil,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-2.2990963,-0.14342299,-1.6882075529165663,-0.1321965619288431
55968,SIDM00529,Paclitaxel,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-5.028449,-0.34888753,-3.588285531265461,-0.18743542983689052
21064,SIDM00411,Erlotinib,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.9722918,0.10278695,0.44678640735774305,0.09795605390209357
50071,SIDM00097,Alpelisib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2454934,-0.078865096,-0.14483777976596693,-0.017652365139311017
18025,SIDM00529,Navitoclax,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,1.2501475,0.10504805,0.5150978395460372,0.030079714339781984
98305,SIDM00193,AZD7762,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,53.0,-0.9897214,-0.039274804,0.2926919470235064,0.07030821061129097
91032,SIDM00954,Dabrafenib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,0.5967484,0.015268194,1.5390541831117417,0.07237520133532124
30171,SIDM00673,MK-2206,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.13492471,-0.009025448,0.06078354754802218,-0.07858118846727202
82486,SIDM00097,AZD7762,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.4302847,-0.07625984,0.895732865110135,0.10070143309839232
20924,SIDM00193,LGK974,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-0.7075458,-0.038990345,0.17112566102822904,0.011700061822526557
76530,SIDM00875,AZD6482,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0278233,-0.07009262,-0.16192602902240189,-0.019971039252069177
40550,SIDM00774,Palbociclib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.9114056,0.06931389,2.1401437541330703,0.03494502958710842
98220,SIDM00411,Trametinib,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,4.4292464,0.1444906,0.2807545740944658,0.06064941114903458
32298,SIDM00834,BMS-754807,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,1.1418203,0.09281806,-0.1823766218456015,-0.028075048300924357
73690,SIDM00878,MK-2206,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.7752366,-0.08107738,0.8959611314397773,0.0397985079060126
49210,SIDM00146,MK-1775,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.5723838,0.04177776,-1.4278786271572712,-0.09383840529772022
94354,SIDM00893,BI-2536,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.618584,0.14079854,0.9399349697093952,0.12148005005727527
49940,SIDM00531,OSI-027,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.3864145,0.20670873,0.9325321378801146,0.08013137326404632
32829,SIDM00954,KU-55933,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-2.3829315,-0.08297354,0.4585702547863527,0.04339764305520282
31192,SIDM00097,Sorafenib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.8231437,0.09219817,2.338194927113658,0.07930917598376304
96772,SIDM00628,Linsitinib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.6530918,0.058574896,0.6529511874072924,0.07649930621851941
41144,SIDM00954,BI-2536,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-4.851711,-0.2080249,-3.027371247060092,-0.07163212462859507
15299,SIDM00332,Uprosertib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.25091377,0.016566832,0.1804137298958501,-0.00603345943766374
83562,SIDM00529,Dabrafenib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Black,44.0,1.740926,0.042641226,1.4532414556383138,0.05024515078733134
89565,SIDM00782,Trametinib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.3552471,-0.11401163,-1.467991293487987,-0.05120044413823896
41678,SIDM00529,Palbociclib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-1.8385649,-0.07568438,0.44895928113084027,0.06019000711104732
11591,SIDM00660,SB505124,Camptothecin,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,32.0,1.2811042,0.14217705,-1.2665253299487054,-0.07705809610625676
12094,SIDM00866,PD173074,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,3.6354532,0.17229192,0.607207374214892,0.030312344181240267
66025,SIDM00531,Trametinib,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.3926485,0.26727235,-3.547090157628803,-0.10419591660188501
16264,SIDM00529,Nilotinib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,3.8049324,0.24657267,2.574807825639284,0.13837767148998006
14279,SIDM00878,Taselisib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.7847245,-0.1487848,-2.3101869859064577,-0.15010557054445475
86141,SIDM00893,RO-3306,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.11197089,-0.0086434465,-0.7725598359051454,0.01890726467908403
33023,SIDM00673,Camptothecin,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.0763737,-0.029058984,0.04366890551883238,-0.01083222995743506
36188,SIDM00875,Olaparib,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-3.1016846,-0.17747895,-1.6245887051816243,-0.12266860861353565
73453,SIDM00893,PD173074,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.8156932,-0.022883637,0.8079025773588054,0.05916770544441651
32859,SIDM00673,Uprosertib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,2.9328501,0.094898246,-0.6495752646542594,-0.031469431019506396
37633,SIDM00878,OSI-027,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.6800691,0.02865167,-0.6209491267084765,-0.027977012426133246
94740,SIDM00673,Paclitaxel,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.26262012,-0.020280072,-1.0406795271132718,-0.019788738049881273
94198,SIDM00529,BI-2536,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Black,44.0,1.5417538,0.10738374,0.36971972940598785,0.01469187125130542
70694,SIDM00954,Nutlin-3a (-),Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,2.4575248,0.067712724,0.6829835200605986,0.03594147281072372
106094,SIDM00971,Taselisib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-4.9848876,-0.22523409,-1.6032312531457877,-0.08413746331284774
92963,SIDM00866,JQ1,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-2.8808475,-0.078879565,-0.7788232153516218,0.05339855252097537
99748,SIDM00529,Trametinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-2.693089,-0.13055979,-1.1544724727767501,-0.05728087715779469
20954,SIDM00878,Venetoclax,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,70.0,-1.0868268,-0.0314451,-0.13577248745353065,0.026021066696182916
53670,SIDM00097,Camptothecin,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0526936,-0.028586993,0.6301318546582683,0.0480900118661308
107241,SIDM00146,NU7441,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,-1.2197073,-0.11449363,-0.1926362202648032,-0.03283802752743656
41544,SIDM00097,PD173074,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.2713304,-0.13716364,-0.42322343646017413,-0.03884097547212072
88366,SIDM00878,OSI-027,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.5756261,0.16918404,0.032920104097741404,0.04997881915540736
105820,SIDM00866,Taselisib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,1.7790028,0.12835425,0.277514989587698,0.026765654351302202
83081,SIDM00301,Trametinib,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,3.9313283,0.45013133,2.141698025015238,0.1450552789619417
92664,SIDM00776,MK-1775,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,65.0,-2.8049557,-0.22072423,-3.6920755714572935,-0.20420434451238328
61821,SIDM00778,Olaparib,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,69.0,2.1206431,0.057941493,-1.3192006787066892,-0.05560508244400761
40738,SIDM00130,Sorafenib,AZD7762,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.795462,-0.12258069,-0.5147316909232201,-0.028143839389149192
102557,SIDM00971,NU7441,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.525479,0.13566753,0.7859721478562232,0.0067881288981318155
23374,SIDM00878,OSI-027,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.7838266,0.09057765,0.12935466249869512,0.06231157791975623
3260,SIDM00193,BMS-754807,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,53.0,-1.3891382,-0.07212786,1.207143126997748,0.09695212340962907
94226,SIDM00866,Axitinib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-0.23690194,-0.017680429,-0.762989945072094,0.005756234328863221
19216,SIDM00531,Ruxolitinib,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.7805405,0.15223563,2.275226566990044,0.09280773148480069
42178,SIDM00529,Pictilisib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-1.7266897,-0.104161076,-0.08904195711210446,-0.0059664405731438995
108435,SIDM00146,Crizotinib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.051081374,-0.0036285603,1.2059249746779501,0.10771547900719679
39020,SIDM00875,Wee1 Inhibitor,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7473185,-0.054362655,-1.9585224834284634,-0.08049278079814737
39978,SIDM00332,Temozolomide,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.76383257,-0.010058405,1.4623593606440042,0.0004909494989745304
37304,SIDM00834,5-Fluorouracil,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-1.4210536,-0.072967775,-1.4117482124474707,-0.04827878797055983
4103,SIDM00529,ZM447439,OSI-027,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-1.2787981,-0.08839944,-0.8914736039761322,0.03263791281711739
100684,SIDM00673,Crizotinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.832193,0.042515025,0.842644528208974,0.03782166409682678
16245,SIDM00971,MK-1775,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1486299,-0.041256852,-1.2306550839345702,-0.02039218195359383
64228,SIDM00130,Ruxolitinib,Lapatinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.3643682,0.04451485,1.9748610713369863,0.048783329914434057
11040,SIDM00130,Ruxolitinib,Crizotinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.28025788,-0.006739164,1.0749649544549382,0.03780019029517545
107735,SIDM00531,Gemcitabine,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.20551889,-0.017279433,-1.0547304587133202,-0.020640977091490684
33835,SIDM00359,MK-1775,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.1080779,-0.09718497,-2.2001399836953754,-0.13636161023080906
95462,SIDM00778,AZD8055,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,0.803251,0.039358933,1.455387030391233,0.0368483769728299
92974,SIDM00875,Tozasertib,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.55070835,-0.007973417,-1.241620755845085,-0.06448249853205189
34586,SIDM00866,Bortezomib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,-1.1432693,-0.0866246,-1.1823196016295896,-0.04314011442329681
80243,SIDM00531,Olaparib,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.2700044,0.056655876,0.382975140267924,0.019498370458027024
38217,SIDM00779,MK-2206,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-1.6393931,-0.0874,-0.7598129034918483,-0.04396631328873273
102919,SIDM00782,Camptothecin,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.35858825,-0.0348285,-1.7496785630606642,-0.1597162034239522
59613,SIDM00193,5-Fluorouracil,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.9082545,-0.13198772,-1.3743747601816105,-0.043886441230635356
18071,SIDM00628,Temozolomide,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.670199,-0.019323848,-0.5774385514530193,0.008680434833170369
54547,SIDM00146,GSK269962A,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.44327223,-0.029152354,0.2284497969982257,0.012438458112273053
48471,SIDM00878,RO-3306,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,70.0,0.23586132,0.017444912,-0.6065361155778193,0.008444581001778558
32109,SIDM00628,Ribociclib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.35376886,-0.009086181,0.20620489878752726,0.05702268562902524
27765,SIDM00193,BMS-754807,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,East Asian,53.0,1.1564535,0.076761514,1.36500005628736,0.11196443824602663
7248,SIDM00529,Bortezomib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-0.5822324,-0.042543482,-0.8384517570583144,-0.030691985757195728
43767,SIDM00628,Afatinib,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,2.935316,0.16695613,0.8337323229868222,-0.003494947194217705
53766,SIDM00875,Wee1 Inhibitor,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.66949207,-0.046902124,-1.6568602358318203,-0.07188474307523005
34939,SIDM00332,Palbociclib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.183686,0.11498639,-0.8406485942467056,-0.11130165387997346
7359,SIDM00971,Palbociclib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.6564096,-0.04646816,0.30617218048403905,0.06790649748932728
92202,SIDM00893,Bortezomib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.57258767,0.056090403,-0.7328978123998373,0.020093036584073853
102188,SIDM00130,Olaparib,Taselisib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.5619665,-0.058907717,0.4379675714024148,0.01379902063827078
80688,SIDM00529,Linsitinib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.4873883,-0.050253026,-0.3856718721609212,0.06109205988909846
34982,SIDM00776,MK-1775,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.26456892,-0.018684734,0.3855714521110053,-0.00988621414417864
77661,SIDM00782,Vinorelbine,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,-0.2617015,-0.021168182,0.049661538658787654,0.02654300161236262
99047,SIDM00893,Alisertib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.5899337,0.05253139,0.41413185146927617,-0.02772242412400472
80696,SIDM00778,Afatinib,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,2.6030548,0.0793767,2.1347124770786277,0.07632185524039321
25864,SIDM00531,Dasatinib,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.7600168,0.1588011,-0.149876109823511,0.04357865555891729
87540,SIDM00866,NU7441,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-1.5317798,-0.104814336,-1.1927105537280729,-0.0897127218495384
23189,SIDM00875,Cisplatin,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.52076197,-0.026096763,0.6379530175640661,0.04647904270827495
91858,SIDM00301,Paclitaxel,MK-2206,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,50.0,2.3726954,0.04706009,-0.020607942947671033,-0.03663573730072311
69317,SIDM00411,Paclitaxel,Sorafenib,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,43.0,2.5426502,0.13038339,0.8746143614719274,0.045634103316168115
78554,SIDM00878,Tozasertib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-2.6287239,-0.1906009,-2.436375060400123,-0.08681376295282088
71363,SIDM00097,Axitinib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.9959626,-0.120618664,-0.9556226974011091,-0.0650025149692776
61494,SIDM00130,AZD7762,Olaparib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.31891397,-0.03438634,-0.4606670819629704,-0.013557835404920565
64402,SIDM00193,Trametinib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,1.2919115,0.10514059,0.7908046129156188,0.0638373959883499
55397,SIDM00146,KU-55933,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-1.992372,-0.075353615,0.26802287035279604,0.03160107365414013
58132,SIDM00866,MK-1775,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,52.0,0.49660012,0.03899008,-0.8738864218992393,-0.05741405308145084
52977,SIDM00866,Camptothecin,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.4436954,0.029039782,1.5688817741880694,0.06292049208532995
33930,SIDM00529,Pictilisib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.5063321,0.038740378,0.4211302746745814,0.019897735237574436
41199,SIDM00097,Gemcitabine,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,4.6388335,0.26184326,2.7438225026190253,0.23812673086106684
75744,SIDM00146,Wee1 Inhibitor,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-0.5136277,-0.027149359,-0.9268368372820963,-0.031071811955677937
99988,SIDM00878,Doramapimod,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,2.3116724,0.15485266,1.0587755456065122,0.07759301710980156
27426,SIDM00332,Vorinostat,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8795188,-0.09044446,0.06555216339111129,-0.016413249060716225
23776,SIDM00971,Alisertib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.3396938,0.08959131,1.6899203300338996,0.0887641529544779
67661,SIDM00332,Entinostat,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,6.1033363,0.24490221,3.232919174238767,0.12194549044256275
24658,SIDM00097,Doramapimod,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.2272708,0.07813863,1.8882495210314127,0.071144895601214
90839,SIDM00878,NU7441,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,2.267742,0.19837381,0.674531634008616,0.018759743871658865
12189,SIDM00866,Docetaxel,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.46630442,0.036933273,-1.3054740227669905,-0.05013863414492764
48154,SIDM00971,Trametinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.9115638,0.013038299,1.3997744724647612,0.04498238019673236
101774,SIDM00097,MK-1775,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2605708,-0.13272497,-0.10922609156518304,-0.06407804168497708
72966,SIDM00774,PD173074,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,48.0,5.42005,0.58402526,1.6600228382888444,0.09530499115542522
14196,SIDM00529,Doramapimod,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.59653026,0.022164326,0.7836147747703639,0.0901113903045239
87706,SIDM00411,AZD7762,OSI-027,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.8650632,0.10404479,1.0420537038573325,0.03731529007798037
61091,SIDM00628,Doramapimod,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,0.35150552,0.011025817,1.3013947048940961,0.06310007753686134
10653,SIDM00097,Docetaxel,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.049108,0.13378114,1.7483730134743682,0.1890120920481687
54681,SIDM00332,SCH772984,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7467411,0.021633124,0.6881933165605846,-0.0072186161806873485
99996,SIDM00893,KU-55933,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.018688,0.17703101,0.12130106441203446,0.01700096277914363
42830,SIDM00529,Navitoclax,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,0.054324098,0.0042027943,1.6003441214707315,0.07128100687430622
35885,SIDM00359,Palbociclib,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.91381174,-0.044383142,-1.6440261334231594,-0.05262608533047188
44414,SIDM00529,Crizotinib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.7451696,0.13981915,1.3112196734523969,0.17966404167480576
81305,SIDM00954,RO-3306,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.3694257,-0.10496573,-0.44282817119561774,-0.04302816457056002
18376,SIDM00774,Navitoclax,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,2.4086263,0.014822158,0.666167315451051,0.006487415388326818
74253,SIDM00776,AZD7762,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.2953551,-0.110496745,-1.1181741956148274,-0.0552677449795357
18762,SIDM00893,Afatinib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.9888644,0.21792924,0.8973851483208872,0.055726753367075894
48430,SIDM01233,LGK974,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,1.0552967,0.06880898,-0.9924016046920662,-0.04527450452222333
108028,SIDM00628,Palbociclib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,1.9053174,0.029932825,0.6284204109907546,0.06886549934464062
57771,SIDM00359,AZD7762,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.1113477,0.1444588,1.842840490960174,0.07873518289090171
26142,SIDM00529,Pictilisib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-2.061382,-0.106782176,-1.16006815374255,0.007928159044512497
37396,SIDM00130,Linsitinib,Paclitaxel,Pancreas,0.0025,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.430136,0.1794808,0.7989514414301844,0.08450584539961933
54376,SIDM00782,AZD4547,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,0.46200705,0.014809134,1.599157680806264,0.06879544611826251
67171,SIDM00875,Cisplatin,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.28257412,-0.01197311,0.35192136588660006,0.04659927880143047
68710,SIDM00531,Gemcitabine,Crizotinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.5457982,-0.052447543,-2.498202750231097,-0.17023737870080846
36487,SIDM00875,MK-2206,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.8018348,-0.06036833,0.8262518882782333,0.08928142212021595
58687,SIDM00332,Paclitaxel,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.579166,-0.08702184,-2.738576017389294,-0.14550887172178284
72188,SIDM00193,5-Fluorouracil,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,53.0,0.57222927,0.052521218,1.0777458856660034,0.10613780529172957
48907,SIDM00332,Vorinostat,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.5480793,-0.24366638,0.4071697030289047,-0.007344212239357544
93612,SIDM00893,OSI-027,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.2830008,0.11346297,-0.16578146950824205,-0.08928649411489506
75615,SIDM00778,Vinorelbine,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,0.8359899,0.024085596,1.8531457393581476,0.09881389060966868
93790,SIDM00971,MK-2206,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.943828,-0.18379493,-0.8060584313548945,-0.016098392037268077
62410,SIDM00776,Dabrafenib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-2.0148137,-0.06310926,0.5851098191248169,0.007017084068401282
71930,SIDM00146,Camptothecin,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,2.0341613,0.15546207,-0.14384502245958847,0.036123878907967234
46682,SIDM00301,Crizotinib,Dasatinib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,50.0,2.7391052,0.22956595,1.0113226815806766,0.06097977799503898
39427,SIDM00673,GSK269962A,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-1.9305195,-0.13435595,-0.9841646020058806,-0.07773506732742452
20595,SIDM00097,Pictilisib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.510021,-0.11161533,-0.6518270003841089,0.009279122163089753
59176,SIDM00954,Sorafenib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-0.35180518,-0.025785979,-0.3398006544865439,-0.007109611589375342
82285,SIDM00097,Nutlin-3a (-),Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8801204,-0.04731117,0.15307470542446022,0.005988724395920024
2528,SIDM00411,OSI-027,Palbociclib,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.2337513,0.0138584,-0.5992163493598844,0.012244045529659143
4379,SIDM00193,Afatinib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,53.0,0.72145253,0.062531404,1.0381353671868119,0.14391649819279362
3979,SIDM00779,5-Fluorouracil,LGK974,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-0.58372664,-0.02758851,-0.8255247362852918,0.008259059338970866
67725,SIDM00774,GSK269962A,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,0.5504847,0.033579513,0.44995762335987777,0.05402389291133202
48271,SIDM00130,Navitoclax,Linsitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.9694118,0.094657935,0.8600551770998569,0.12266805728273834
34015,SIDM00971,Olaparib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.5466738,-0.02428216,-0.46319442999454086,-0.016395524425649517
100594,SIDM00866,Camptothecin,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,1.8616229,0.039087422,2.6606663305591156,0.05483490699310572
84684,SIDM00529,Sorafenib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Black,44.0,-0.7494133,-0.07254218,-0.971533925013571,-0.019465429916851778
4663,SIDM00146,5-Fluorouracil,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-1.1358774,-0.06666608,0.09845944162398182,0.07866869656845496
36728,SIDM00971,Axitinib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.8743246,-0.087668985,-1.2946606346120717,-0.049161998766970326
64934,SIDM00301,SCH772984,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.9969542,-0.22962731,-1.6434819687920326,-0.07132944964307911
54554,SIDM00778,Crizotinib,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,1.6756223,0.07405751,1.287880784554409,0.03805613932831756
28671,SIDM00866,Crizotinib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-0.8264277,-0.05938036,-0.6806540652310432,-0.041193257324030896
98149,SIDM00411,OSI-027,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,43.0,-1.5068026,-0.07790766,-1.4352432888327178,-0.003100847371387528
37707,SIDM00673,Camptothecin,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.685518,0.02518097,0.7538851017063375,0.061374442066858166
72509,SIDM00531,Oxaliplatin,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.20119372,0.006653712,0.5973160445029267,0.06457924513967976
59530,SIDM00875,SCH772984,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.28385273,0.03195683,0.0021940596520301885,-0.0021339249912658495
9023,SIDM00359,Dabrafenib,Navitoclax,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.37695616,-0.019233195,-0.4001519642093806,0.019214630401192527
91411,SIDM00628,MK-2206,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,1.5669732,0.13317382,1.7776533478216445,0.14479992837872105
96798,SIDM00146,SCH772984,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.3544036,-0.09858366,-0.308584746265532,-0.029206236601630332
57150,SIDM00146,Uprosertib,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-2.1174486,-0.11763782,0.5418817018486444,0.012120951950988335
96673,SIDM00411,OSI-027,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,-2.178088,-0.12112935,-0.4509282970724571,-0.018939974365756545
24006,SIDM00875,Linsitinib,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6656393,0.11176114,0.3736574152675466,-0.008448806457176139
50673,SIDM00774,Trametinib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,2.192851,0.11236539,1.3978421531019205,0.060073424151970284
102327,SIDM00097,Alisertib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.407241,-0.1601065,0.2790895700535168,-0.022989643640690394
58973,SIDM00130,OSI-027,Paclitaxel,Pancreas,0.025,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.72188896,0.060333863,0.05740260830711971,0.029059965592083608
15126,SIDM00146,Luminespib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.7676846,-0.06826237,-0.6318705107740156,-0.013199103578825765
85080,SIDM00875,Tozasertib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.513358,0.029687187,0.15687377884218223,0.007048954190334264
31196,SIDM00359,Oxaliplatin,Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.4555275,-0.08548112,-2.368826127268656,-0.07878887635901889
98768,SIDM00774,OSI-027,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-0.5483115,-0.08527593,-0.5300320519394159,-0.10545754407510301
14113,SIDM00774,Axitinib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.4552721,0.18956977,-1.4743800429845164,-0.03764709511408825
66268,SIDM00893,GSK269962A,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.6526733,-0.04334313,0.15209149909885744,0.07493530672628651
49612,SIDM00774,Sorafenib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.25452787,-0.013636553,0.2704409611517754,0.08227483458555007
24770,SIDM00878,Paclitaxel,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-4.3482914,-0.2740232,-0.7936109958806147,-0.10273491599427163
80088,SIDM00529,PF-4708671,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.77775604,0.048586804,0.8812222588447038,0.10310482277861353
77588,SIDM00359,Crizotinib,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.88330764,-0.061660238,-0.8252305639920013,-0.0036478606135771515
16625,SIDM00332,Nutlin-3a (-),PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.331922,0.047196485,2.6381971359372187,0.007524267940901172
70580,SIDM00776,Nutlin-3a (-),Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,-2.0969908,-0.05734093,-1.0505534446442815,0.014558024503979791
71001,SIDM00875,GSK269962A,Vorinostat,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8302868,0.058579814,1.6788582537784247,0.07939414244596518
85743,SIDM00893,BI-2536,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.4558439,-0.11877843,-0.08227846178905907,0.09196314341632204
32661,SIDM00866,AZD6482,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.5405642,0.09096707,0.047402270765252705,0.026985127329186998
43366,SIDM00875,GSK269962A,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8782402,0.053077567,2.0911773531978475,0.0706382993223377
93270,SIDM00776,Trametinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,4.4170423,0.16117838,-0.8703318561115218,-0.041241416326150034
46208,SIDM00774,Lapatinib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,4.664752,0.09979389,2.4565103323805357,0.07737665143104303
72090,SIDM00529,NU7441,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,0.72180116,0.06415054,0.05002594719566644,0.060426091554424584
37420,SIDM00875,Temozolomide,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9634257,0.024001334,0.015229078644583633,-0.0068411671114929195
29384,SIDM00778,LGK974,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,2.1915848,0.07061709,-0.823911113434832,-0.01553206531484379
25854,SIDM00875,Alpelisib,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.94057465,-0.06730191,0.5472470474883976,0.02285579262974407
90466,SIDM00146,Nilotinib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,0.8831617,0.08889322,-0.31740480877358324,-0.06454002812722902
70901,SIDM00878,PD173074,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-2.1217208,-0.04127349,-0.5233724554818522,0.03598788207125937
76900,SIDM00782,5-Fluorouracil,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.5843792,0.021524021,0.35578809174192777,0.017043763783897724
16060,SIDM00893,AZD7762,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.0399525,0.118619435,-0.19672806232367843,0.04549425445315146
50357,SIDM00878,Lapatinib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,70.0,0.6811128,0.07965245,-0.4643809840341029,0.007710716587998223
34889,SIDM00866,Linsitinib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,52.0,-0.6032101,-0.037767757,0.2975805233117609,0.006988609723047144
72616,SIDM00130,MK-2206,Palbociclib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.1950223,0.21541606,0.0962153943765149,0.05945172762664565
104836,SIDM00875,Wee1 Inhibitor,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.3195127,0.018506376,0.45194624656374527,-0.0017466638424754053
63036,SIDM00332,Entinostat,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.1139343,0.06020632,1.3536496267689169,0.08555461035024783
6110,SIDM00778,Camptothecin,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,69.0,-2.4340603,-0.08245925,-2.43410136913193,-0.1019546518118145
35794,SIDM00301,Sorafenib,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,-0.7705283,-0.110048436,-0.38640421833086486,-0.027452132673358394
55159,SIDM00866,Tozasertib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-2.8594482,-0.12958354,-1.132595934537407,-0.05029338128952845
19342,SIDM00332,Pictilisib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7104622,-0.07344238,0.18572704443434093,0.07374393413794952
83293,SIDM00531,Olaparib,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.1393615,-0.041553505,-0.1334463738487046,0.004439386295952597
24049,SIDM00834,Nutlin-3a (-),Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,0.9004562,0.032308713,-0.0019560047882710868,0.05169916707755981
91500,SIDM00673,PD173074,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,0.975862,0.04791894,1.9833616750649492,0.09622627601750516
71313,SIDM00971,BI-2536,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.5623296,0.030323457,0.8476276007658123,0.0799657530503328
79642,SIDM00954,OSI-027,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.5287273,-0.059700407,1.699422492292512,0.15483041446815257
100546,SIDM00776,AZD8055,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-0.49782652,-0.041586425,-1.1790429921959624,-0.03235082672472599
67695,SIDM00866,Nutlin-3a (-),Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,0.40151763,0.01089753,0.21964993973492808,0.002015380618379729
78772,SIDM00971,Wee1 Inhibitor,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.0228345,-0.022803538,1.2463810281321392,0.040230163835987306
790,SIDM00146,Olaparib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.8261272,-0.07269241,-0.2089997336742185,0.03151112003132155
54324,SIDM00878,Crizotinib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-0.24622485,-0.027673783,0.6098064120440655,0.03459810241916069
19242,SIDM00660,SCH772984,Camptothecin,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,32.0,0.27831128,0.017767983,-2.3447077531015705,-0.0885404144154806
104922,SIDM00130,Lapatinib,Dactolisib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.2292242,-0.06490356,0.7346324544152926,0.06865861206322968
74261,SIDM00193,Crizotinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,East Asian,53.0,-1.761356,-0.06512248,-0.8092912492343022,0.015694910515004618
74404,SIDM00875,AZD8055,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.66545236,-0.018099274,-0.35316927915539376,0.009754163283117807
22523,SIDM00146,Docetaxel,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,0.5568751,0.03811502,-0.14389164741915778,-0.0031199561156910736
57402,SIDM00878,Uprosertib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-0.81486666,-0.04733976,0.04347847386580648,0.023977554430477804
52717,SIDM00971,AZD8055,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.9102787,-0.08163854,0.9596174797416233,0.06573826305313682
32968,SIDM00660,5-Fluorouracil,Taselisib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,32.0,-0.37393856,-0.036658198,-0.7605719212205291,-0.017862368526818228
22511,SIDM00301,Paclitaxel,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.2459582,0.0484555,0.1279584953221001,-0.019593773076338403
102976,SIDM00954,ZM447439,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,-2.8657584,-0.20869757,-1.0075575579430334,-0.0657951927491726
38284,SIDM00878,SCH772984,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,70.0,0.2308241,0.020035317,-0.028013928289064183,-0.00916178115900236
21715,SIDM00774,KU-55933,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,48.0,-1.8806556,-0.05741431,-0.12675577281626338,0.014375126995143988
58894,SIDM00130,Dasatinib,Trametinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,7.259109,0.47800386,2.838050848323578,0.16149242131401068
79405,SIDM00130,Dasatinib,Linsitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.5916564,0.21076041,2.0918480807301867,0.1748635315594771
49880,SIDM00097,Alisertib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.637237,-0.13009894,-0.5158036862554356,-0.0667615791557955
67694,SIDM00834,Trametinib,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,White,66.0,-2.7931929,-0.11356437,-2.2441817581159453,-0.1033990936760614
96911,SIDM00531,Trametinib,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-2.1661482,-0.13533084,-2.859881752672951,-0.040405067781378874
83097,SIDM00778,SB505124,AZD4547,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,1.5376825,0.08815497,-0.35099265866693424,-0.0037970289360403898
74861,SIDM00359,Crizotinib,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.6998919,-0.06296216,-1.1890697670006583,-0.06458612211368812
84362,SIDM00954,Luminespib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-1.5002177,-0.084741674,-1.3198960463576859,-0.034515699623192314
1006,SIDM00971,Temozolomide,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.9270597,-0.032825112,-1.3221087376433376,-0.0015911946576452171
106063,SIDM00875,Vorinostat,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.31463024,0.034520045,-0.8518008654101145,-0.06389177642992949
83218,SIDM00332,AZD8055,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.8305928,0.0598076,-1.1315711337469145,-0.06212623759189592
96699,SIDM00893,Nilotinib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.6358649,-0.106202796,1.1231997609468691,0.07984612807740356
52346,SIDM00778,Trametinib,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,-6.7970476,-0.16419415,-3.9842771357188465,-0.17904617919396945
43196,SIDM00359,Trametinib,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.8202476,-0.030752407,-0.596287497294218,-0.00023259622050592635
73797,SIDM00875,KU-55933,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.834025,-0.05729284,-1.3683311208508657,-0.04008587269198536
56197,SIDM01233,Nutlin-3a (-),Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,72.0,2.6035802,0.11425824,0.6428164195611583,0.05372315800521671
102435,SIDM00097,Pictilisib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.5397147,-0.038381554,-0.4553550872294908,-0.026482669391535964
23520,SIDM00097,Temozolomide,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.48012528,-0.008186663,0.6553207064886707,0.024260308460618673
63377,SIDM00130,Linsitinib,AZD7762,Pancreas,0.0625,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.95658886,-0.051470645,-0.604185817630212,-0.00955397171675992
98532,SIDM00146,5-Fluorouracil,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,1.1969489,0.09638069,-1.1739690136994259,-0.0432655771824857
42348,SIDM00531,Olaparib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.3508403,0.08716522,0.3340693729386118,0.005772379481159468
83618,SIDM00097,Linsitinib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.65150964,0.0330912,0.6173514740105347,0.060491941723412185
96120,SIDM00893,Bortezomib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.7493722,0.06725101,-0.5356076181234203,-0.006747637606107915
83251,SIDM00774,Crizotinib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,48.0,0.5886194,0.090312794,-0.5576703242123698,-0.08201981993904026
4494,SIDM00097,Tozasertib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.87884164,-0.021911476,0.18082768378748587,0.05452517494228663
71327,SIDM00301,Gemcitabine,Crizotinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.9176011,-0.0766112,-2.0357752144404553,-0.11831414442453214
102698,SIDM00193,Nutlin-3a (-),Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-0.25494948,-0.004267365,2.0605100634244726,0.057134751231502794
29942,SIDM00779,SCH772984,LGK974,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-0.15569256,-0.0145188,-1.8883401688252601,-0.1311924991359747
32079,SIDM00529,MK-2206,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Black,44.0,2.024499,0.11531892,0.8658932259608001,0.1428701980349422
96393,SIDM00193,Trametinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,1.1991209,0.08818821,0.33690717855552127,0.048862489648054445
4714,SIDM00673,Alisertib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.8354429,-0.04713343,-0.3865108192135429,0.04557192017193504
83770,SIDM00529,Camptothecin,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,1.646,0.089695826,1.3021821310447155,0.07655100363200197
19522,SIDM00834,Olaparib,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,White,66.0,3.7682147,0.12221456,1.846324994398032,0.09376373390562161
99773,SIDM00146,Venetoclax,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,1.3008146,0.032751545,1.8214149247332196,0.10890621350621499
12327,SIDM00866,Cisplatin,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,3.6374888,0.07381225,2.467208358205487,0.06783267499676351
48543,SIDM00332,Navitoclax,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4165146,0.10940781,0.19965309604157608,0.032394975026395045
21828,SIDM00834,Linsitinib,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,White,66.0,2.2869036,0.17733476,-0.11113077265659937,0.07670200905387067
7927,SIDM00893,Uprosertib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.5879928,0.043894734,0.08539904209676959,-0.0034068148995741207
2144,SIDM00146,Nutlin-3a (-),PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.59480065,-0.01696501,1.3422760889565362,0.08902891341499655
31299,SIDM00332,NU7441,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.5172586,-0.13249402,-1.3638841874911731,-0.09005208271119554
70321,SIDM00531,Gemcitabine,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.378679,0.120081894,3.9678138015390263,0.1537489324201711
20523,SIDM00878,Doramapimod,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.41595,0.09434185,0.34987394042980846,0.09061656903836618
26098,SIDM00411,LGK974,5-Fluorouracil,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.5227077,-0.084502764,-2.257186751766493,-0.051953073548419534
60780,SIDM00628,Alpelisib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,1.1231942,0.07360752,0.15295358576853968,0.009683395266591859
32667,SIDM00954,Nutlin-3a (-),Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,1.9920994,0.062145185,1.205160842679527,0.0894669913407347
1603,SIDM00193,MK-1775,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,-2.4294968,-0.15087448,-0.8028995923587492,-0.06726016959673548
80253,SIDM00834,Linsitinib,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,2.4321084,0.17663908,1.3107993569963305,0.10148173366707934
84477,SIDM00673,Pictilisib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.25538418,-0.01961964,-0.1782046816114234,-0.09044990525107335
79957,SIDM00359,Palbociclib,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.66906714,-0.032210484,-2.02332468862481,-0.03713238049853145
47723,SIDM00774,Venetoclax,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,1.7239484,0.041834556,1.1885084457756825,0.038415865749041385
21267,SIDM00778,Oxaliplatin,Navitoclax,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,-2.039533,-0.06950855,-0.17307366144266073,0.02134551381668229
22566,SIDM00893,JQ1,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-3.0869665,-0.11125496,-2.7477858273468714,-0.08641913547401654
33548,SIDM00146,Luminespib,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.9413744,-0.06598952,-1.0970665613550712,-0.06159044693217564
46848,SIDM00130,MK-2206,MK-1775,Pancreas,0.2,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.7278421,0.16938986,0.8344060964222814,0.03986181149480775
102421,SIDM00875,Tozasertib,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.38632,-0.042507585,1.275192670041933,0.046653667957689084
95964,SIDM00893,AZD7762,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.6409578,0.29124787,0.8761304248786902,0.10013487040161936
31354,SIDM00971,Alpelisib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.4537513,0.22275475,0.9176898468522278,0.050553471926194186
96230,SIDM00776,AZD7762,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.185744,-0.016347213,-0.7026268991790388,-0.02863763763550392
20292,SIDM00866,Navitoclax,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.8137491,-0.12613592,1.490530590216889,0.08347281846984546
17715,SIDM00529,Alisertib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-2.2995868,-0.19929224,-2.084527850778259,-0.12710286726626033
63555,SIDM00893,BI-2536,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.926599,-0.14482638,-1.2639785367477492,-0.06074791559237835
102120,SIDM00628,Palbociclib,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,-0.35389328,-0.011435395,0.3291406231556631,0.010580077643673823
77274,SIDM00411,SCH772984,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.8443509,-0.058558114,-0.6474702699521522,0.04519960887324887
41855,SIDM00301,Olaparib,OSI-027,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.4860791,-0.05575895,0.09262453110882025,0.0014816427432645853
97446,SIDM00332,Wee1 Inhibitor,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-4.7359676,-0.14376634,-2.9671535489905914,-0.12200974011776074
27479,SIDM00774,AZD8055,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-3.1526911,-0.18760003,-0.9522189391032116,-0.03485527008120787
27422,SIDM00971,MK-2206,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.5176382,-0.12540253,-0.26669936729600496,-0.02139158009155975
12972,SIDM00332,OSI-027,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0454786,0.08289763,-0.052370484861806156,-0.02454448249206051
15070,SIDM00529,Lapatinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.6522822,0.13538031,2.2835693204479606,0.14232595488630753
52686,SIDM00332,Doramapimod,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.453059,-0.035076775,-0.6024073197752241,-0.05797067948515581
10090,SIDM00097,MK-1775,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.6843155,-0.030742757,-0.5552006894643001,-0.03335271610759471
55603,SIDM00301,Irinotecan,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.72687787,-0.08255656,-0.5034651547675058,-0.02685580152519641
84397,SIDM00097,Alpelisib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2476057,-0.08287427,-0.28866377899349144,-0.018508226847439097
71633,SIDM00776,MK-2206,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,-0.22893493,-0.017803214,-1.174757718813902,-0.044968012499183814
57206,SIDM00878,Olaparib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,4.843507,0.29161957,1.4989358483522188,0.06259689388361254
27850,SIDM00660,Oxaliplatin,5-Fluorouracil,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-1.7414827,-0.14876811,-1.7486238438988884,-0.06149656879384938
31927,SIDM01233,Trametinib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-2.5235226,-0.17338791,-0.3434673477422653,-0.007364483745084482
42975,SIDM00660,MK-1775,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,32.0,-3.3755238,-0.18170184,-2.9181985362056557,-0.16777071116364284
43473,SIDM00971,Palbociclib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7662611,-0.045141328,-0.8143804524451238,-0.006517340369321879
4839,SIDM00146,Entinostat,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.14292507,0.011116246,0.4753713503561933,0.06403936594361131
57334,SIDM00893,MK-2206,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.24157763,0.025327517,-0.7356955436266028,-0.07023777508467488
98480,SIDM00878,AZD8055,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.1799362,-0.08258311,0.5432971089000155,0.027814020931564532
101041,SIDM00628,Uprosertib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,4.0800204,0.3135983,1.7873808088542373,0.13229323727122708
92532,SIDM00774,Trametinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,4.0943513,0.14791258,1.7414736492945322,0.044610765157606466
106073,SIDM00954,Olaparib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,2.8836336,0.14157146,-0.20294859456321465,-0.00932432363770132
106046,SIDM00130,Trametinib,Irinotecan,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.6424747,-0.13853958,-0.41860355353674283,-0.03126910047155253
25964,SIDM00774,Wee1 Inhibitor,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-3.0723417,-0.14227886,-0.4358276026464807,0.02013655880444899
19376,SIDM00146,Vorinostat,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.1972425,0.092291094,0.4244510693832499,0.026045598272912897
16807,SIDM00893,Sorafenib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.21154872,0.017246075,-1.2947027506367055,-0.024566501496169197
93919,SIDM00628,SCH772984,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.8832847,0.056579426,-2.0205708892933223,-0.0403833985037865
10078,SIDM00332,Vorinostat,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.45352185,-0.04466979,0.9075177546188411,0.03546321847532754
20614,SIDM00628,SCH772984,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-0.93993235,-0.05798496,-1.5728516653195155,-0.02168179867944554
4196,SIDM00529,Dabrafenib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,2.1105025,0.022920465,1.7314531917481035,0.060843736159570894
164,SIDM00971,AZD8055,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.18896993,-0.011344332,-1.4310698824481853,-0.08036668043226824
30840,SIDM00893,GSK269962A,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.38752374,-0.030082786,-0.08541889701816821,-0.011457416451195135
3251,SIDM00332,Pictilisib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.5733883,-0.15368707,-3.1782153514728857,-0.16702399503360416
92758,SIDM00411,Sorafenib,Palbociclib,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.4247668,-0.07204423,-0.6950360017282446,-0.0504348718448687
103492,SIDM00774,Linsitinib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,1.384158,0.11905079,0.4051579448317538,0.05941215408092345
82611,SIDM00146,MK-1775,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.5345063,0.028409576,-0.30600315764567215,-0.02049300321034265
95025,SIDM00954,Lapatinib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-0.89280903,-0.06837338,-0.019567011602407345,-0.036923723174375755
46365,SIDM00875,ZM447439,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5237079,0.0610869,0.9477342091608618,0.049063349158688103
59020,SIDM00875,NU7441,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.855798,0.082032695,-1.1231487679257102,0.012317887405746058
102070,SIDM00774,Uprosertib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.37713122,-0.029634262,-0.7019730989530317,-0.05546085992342238
42962,SIDM00878,Entinostat,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.68032587,-0.030511025,0.5026088078834564,0.07728393121073303
73489,SIDM00529,Vorinostat,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.04758214,-0.0047774045,0.040056335572949804,-0.011523685946489894
49771,SIDM00782,Nutlin-3a (-),AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,2.9681938,0.11837236,1.7750998638722768,0.0513727565321107
5446,SIDM01233,AZD4547,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,3.8871272,0.17366743,0.8931132471050666,0.049605124644494444
47593,SIDM00673,MK-2206,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-2.4214811,-0.102441266,-0.9105158970653136,-0.09099116214475522
11325,SIDM00875,Temozolomide,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.994056,0.12292549,2.379503901394542,0.0757430324807215
39468,SIDM00130,Trametinib,Crizotinib,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.67942864,-0.03968396,0.5242947796417846,0.017780941985376844
70520,SIDM00531,Lapatinib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,4.0390286,0.4709546,3.6558690221097714,0.22863802738240308
460,SIDM00332,PD173074,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6294672,-0.15752247,-0.6098404987974664,-0.01771435987801719
7639,SIDM00878,JQ1,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,1.4182487,0.038439423,2.4301377012532517,0.11586626003687585
10400,SIDM00628,PF-4708671,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,0.51120365,0.049735617,-0.27719465651986275,0.05478028523265472
52872,SIDM01233,AZD8055,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,72.0,-1.1800071,-0.088971354,-1.1192282411623213,-0.04679705455961831
3237,SIDM00893,Alisertib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.650152,0.21129158,0.6572379929396267,0.04452646717824378
6247,SIDM00778,Navitoclax,Dabrafenib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-0.63180697,-0.0438498,-1.4462726339372318,-0.03917053164988191
11531,SIDM00097,Navitoclax,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8129094,-0.052251317,1.1731950780173503,0.09360680376271269
7083,SIDM00774,JQ1,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,1.1292562,0.072015814,0.9952955485844032,0.06892957144700534
88188,SIDM00628,Linsitinib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,1.8316115,0.15705861,0.4352603436275591,0.10510595106054928
19382,SIDM00332,Tozasertib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1514996,0.09024644,-0.8666482185798279,-0.07029610150786963
94776,SIDM00971,Trametinib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.1268064,0.019191965,1.7171840930548063,0.04863100624502754
107585,SIDM01233,Trametinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,3.3822942,0.24390028,1.3720356560885956,0.07689016742958439
107259,SIDM00954,Entinostat,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.0,-1.4324636,-0.07677046,-0.1970435240816606,-0.03942060913024311
21943,SIDM00097,Entinostat,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0577843,-0.07839594,-0.7394268655620684,-0.027466636748518018
90917,SIDM00866,Olaparib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-2.008952,-0.037838988,-0.2841642612155674,0.00878313630001267
52174,SIDM00875,NU7441,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.31790838,0.029049976,0.19565708738788193,0.07275195752747922
89780,SIDM00776,Trametinib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-1.6415023,-0.1383148,1.1075778987774576,0.04957850069108554
73175,SIDM00779,Olaparib,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,1.0559295,0.015907519,2.48923829327843,0.036575660267345045
22801,SIDM00866,OSI-027,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,52.0,0.37514102,0.025838947,0.6578561247826766,0.09222522086557082
68177,SIDM00529,Temozolomide,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,0.7646963,0.01003509,1.1102272967006228,0.041458193170726854
37891,SIDM00628,Lapatinib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.72818273,-0.069141,-0.7853393095518664,-0.04687199816050383
3968,SIDM00776,BMS-754807,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.46124798,-0.04251161,-1.2757019343979288,-0.0449255070430524
94935,SIDM00193,BMS-754807,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,53.0,-1.803963,-0.08425606,-0.89054864438391,0.035003697676402865
93769,SIDM00954,Alisertib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-0.6818111,-0.04364962,1.194073924507505,0.13009387871296157
99265,SIDM00301,Erlotinib,Oxaliplatin,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,2.162492,0.09411145,2.955329187590951,0.0660374966332417
18829,SIDM00782,Vinorelbine,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.8999817,-0.07890492,-1.049660157986269,-0.038074915442318835
75363,SIDM00971,Venetoclax,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.708318,0.012967687,0.2696897763072072,0.031086744055307564
26313,SIDM00359,Taselisib,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.5668814,0.15702926,0.9773837685178904,0.1034318568336798
88966,SIDM00774,Pictilisib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.050364964,0.0016384682,-1.0945779080413192,-0.05546431613085273
96945,SIDM00531,MK-1775,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.40675598,0.04802353,0.31799116162880636,0.01945455207570519
42143,SIDM01233,Camptothecin,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,72.0,3.113415,0.16131595,0.9524715047697485,0.0528244715567397
22946,SIDM00954,Docetaxel,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-3.0526626,-0.13618422,-3.211291899243861,-0.195875671811531
102811,SIDM00878,Entinostat,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.9262029,0.045184836,0.36355789460350013,0.0676608443563942
1091,SIDM00878,Wee1 Inhibitor,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.73214155,0.06294695,-1.3334238146307995,-0.12752461068259865
63830,SIDM00628,Sorafenib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.5121931,-0.051338535,0.1720936059503814,0.02849935279576113
104049,SIDM00531,AZD7762,Palbociclib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.60504335,-0.03814992,-1.5066495324366433,-0.022308833286567402
17164,SIDM00628,Docetaxel,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,0.4147579,0.03012621,-0.4193661172489483,-0.03725142751586658
55070,SIDM00146,Vorinostat,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,2.503966,0.08681277,-0.29779307251569664,-0.01102304690858287
17054,SIDM00971,Olaparib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.5193493,-0.052209545,-1.2465580858730956,-0.04351219100518973
70494,SIDM00673,NU7441,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.8506424,-0.12399015,-1.3620136216414012,-0.12310278514711727
69175,SIDM00971,KU-55933,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.4325783,0.029533925,2.4713445980780997,0.07513159288407323
62908,SIDM00954,OSI-027,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-0.80447924,-0.050865725,-0.10499798987553322,-0.0014093412540466383
57970,SIDM00628,Luminespib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-1.3639785,-0.07048419,-1.682255079302635,-0.07638842188456153
3349,SIDM00411,Sorafenib,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,-1.5451019,-0.08746517,-0.8159891845031885,-0.03162571968129609
51267,SIDM00778,Linsitinib,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,69.0,2.9771159,0.12007825,0.5867489993206421,0.07912725014449229
68927,SIDM00878,BI-2536,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.41227788,0.03566171,-1.3040056400111504,-0.1292373417473744
63643,SIDM00878,RO-3306,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.5984382,0.042854536,0.10483936284737846,0.008090777433171433
38546,SIDM00660,Linsitinib,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,3.2965913,0.30558136,1.3169291325109367,0.09990094812873627
77457,SIDM00332,Uprosertib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.1505895,-0.19385235,-0.8943905142104311,-0.0759873045073118
49170,SIDM00875,Alisertib,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7635821,-0.023329785,-0.7772687263233912,-0.10407542690742673
59646,SIDM00878,Vorinostat,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-0.81262416,-0.038083017,0.5419499201665211,0.025961355913313378
101362,SIDM00782,MK-1775,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.33875075,-0.01598171,-0.8393394905089975,-0.06632693176705029
31636,SIDM00332,RO-3306,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6242329,-0.068987966,-0.0932142320129628,0.05230844177005882
46938,SIDM00097,Taselisib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.207238,-0.14221974,-0.2687260017868969,-0.021806099235096216
11018,SIDM00875,Venetoclax,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.14203198,0.0028192885,1.5945801333406828,0.08035943970923996
36705,SIDM00359,SB505124,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7494498,-0.11063382,-1.005820508198685,-0.028324845232638837
20935,SIDM00628,PD173074,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.823603,0.10303045,2.176085795029548,0.1529371616155969
8385,SIDM00359,AZD4547,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.6211338,-0.14545935,-3.0173482336039537,-0.07042195563697534
70996,SIDM00954,SCH772984,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.0,0.8059104,0.044641547,1.4155290179199114,0.14882216233602255
82506,SIDM00875,KU-55933,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.61419165,-0.030376181,0.23781674138255768,0.021301316490659496
73886,SIDM00301,Irinotecan,MK-1775,Pancreas,0.2,Pancreatic Carcinoma,Male,East Asian,50.0,0.9403836,0.12599829,0.016243619953261505,0.030533052214234715
25545,SIDM00782,Oxaliplatin,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,Unknown,72.0,-1.0777009,-0.058651492,-0.8189072745347493,0.005292830834945624
72516,SIDM00332,Alisertib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.9678828,0.07373723,0.14418391477758855,-0.01009535714855274
74144,SIDM00673,Doramapimod,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,2.839842,0.08782355,2.924757642070759,0.08753879839233931
27984,SIDM00097,Dabrafenib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0629694,-0.07073477,-0.9027873573536175,-0.059691436727398274
10913,SIDM00774,OSI-027,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,0.7932396,0.098542035,-0.06727339988004721,-0.02419239103066912
63273,SIDM00782,MK-2206,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,3.3677316,0.28851315,2.4909291826968603,0.2272035136646651
21976,SIDM00673,AZD8055,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.41026667,-0.033792526,-1.3017877649591638,-0.04962709922531176
28214,SIDM00673,AZD6482,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.794746,-0.15036327,-1.7049980651845318,-0.11361171245833179
20604,SIDM00130,Taselisib,Gemcitabine,Pancreas,0.01,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-3.4307506,-0.17940764,-2.2867251258791277,-0.060388771851128765
81786,SIDM00673,Temozolomide,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.29517913,0.003890606,2.772917582729042,0.029494167842249737
55426,SIDM00146,Venetoclax,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,0.64480704,0.017424062,1.5282520360869576,0.03632480052457526
26106,SIDM00954,Venetoclax,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,2.6209059,0.13756566,-0.9992522096463695,-0.03293490988738864
41475,SIDM00332,Afatinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,2.1106925,0.15726781,0.11902919804641954,0.014146789162777491
3974,SIDM00301,Erlotinib,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.8311484,0.18731397,3.377016435317664,0.15250286126431215
90210,SIDM00866,SCH772984,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-2.4991539,-0.069951735,-0.2589417965805433,-0.022990791003519924
8830,SIDM00529,Linsitinib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Black,44.0,-1.5605495,-0.053807408,-0.06663532090416208,0.021085363803940525
71953,SIDM00954,Bortezomib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.180216,-0.011261995,-0.12612716318398073,-0.03892897383618652
85887,SIDM00782,Olaparib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,Unknown,72.0,-1.0495638,-0.025605325,0.9895264733499871,0.031420366213363804
89538,SIDM00971,Sorafenib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.26378816,-0.017391594,1.5212023045631269,0.10812005924819475
58634,SIDM00359,Trametinib,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-4.712647,-0.15045042,-3.1187599525521836,-0.05357291608661318
36375,SIDM00878,Doramapimod,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.3127958,-0.0651772,-0.7005069127922648,-0.0061060935022035565
44868,SIDM00954,PD173074,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-2.2554684,-0.13173254,0.5850945111574941,0.048416545684371246
105642,SIDM00866,5-Fluorouracil,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.39917785,-0.017863274,0.2012638713443131,-0.03158352075552172
25880,SIDM00866,Palbociclib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,52.0,-0.3605643,-0.008757112,1.6942354555646122,0.11078103454637148
54459,SIDM00834,5-Fluorouracil,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-2.6522787,-0.103663325,-2.76310316582297,-0.07513404353912906
62307,SIDM00531,Ruxolitinib,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.7418926,0.08583292,1.2817502933611753,0.03356673274002871
7335,SIDM00097,PF-4708671,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,4.8840127,0.28390953,1.2581735338786162,0.061231758153180924
50401,SIDM00301,5-Fluorouracil,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.2092323,-0.14625546,0.432574587136723,0.059383433815192566
80763,SIDM00779,Nutlin-3a (-),MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-0.8256881,-0.02186768,2.3134915863522436,0.12238021736438749
74334,SIDM00875,Camptothecin,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.60321724,-0.07000463,-1.1917204783175195,-0.055311430649857676
3835,SIDM00411,Dactolisib,Oxaliplatin,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-3.4886947,-0.1341738,-2.1400439132100892,-0.10914024952392404
94187,SIDM00875,Luminespib,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.3537608,-0.11368706,-0.6718472088861648,-0.0730189081710148
8897,SIDM00193,Navitoclax,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,East Asian,53.0,0.23583618,0.015523668,-0.8022906510110349,-0.0022135886268398928
29535,SIDM00529,Camptothecin,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-0.20988414,-0.008905139,0.9233845675839533,0.06398052127242976
49128,SIDM00774,GSK269962A,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.19750182,-0.011122591,-0.646743859188547,-0.0350322206025457
97615,SIDM00893,Alisertib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.1296213,-0.16306815,-0.5699560661171976,-0.07785152647465421
37817,SIDM00146,Entinostat,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.0410241,0.07904486,-0.033810240476752046,0.050439166072408004
81494,SIDM00359,Navitoclax,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0475113,0.041748703,0.8132076572512648,0.04576997378937216
83173,SIDM00097,GSK269962A,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8379199,-0.03366142,-0.3873350201541887,-0.018726686814442357
57919,SIDM00529,Palbociclib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-2.258298,-0.05804727,-0.8269509026618493,-0.0048611481697268906
7544,SIDM00954,Linsitinib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-2.1816618,-0.14391905,0.20863689660722393,0.062257995760492665
30034,SIDM00875,Alisertib,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1109618,0.103493705,-1.2850408542145744,-0.05185909483767221
91601,SIDM00660,5-Fluorouracil,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,-0.7160515,-0.06241478,-0.22931184347782652,0.021918490682070038
57791,SIDM00146,Doramapimod,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,2.788042,0.20552671,0.047186903035223694,0.022606076006535723
24149,SIDM00893,ZM447439,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.8907003,0.119670175,1.2400103578687123,0.10280053550494667
90507,SIDM00097,Paclitaxel,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6173803,-0.09639818,-0.3383223894924766,-0.03694893480571063
76636,SIDM00529,JQ1,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,-1.1893526,-0.07490668,-0.41709342594308235,-0.053258844018925215
3290,SIDM00875,Trametinib,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.37334275,0.042526145,-0.4542098866151225,-0.03837078774987331
40948,SIDM00332,Temozolomide,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2719805,-0.02982265,0.11099485780091378,0.017059558666929934
37081,SIDM00097,Trametinib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,5.116362,0.2503442,1.221832173646638,0.039744060267506875
100857,SIDM00866,ZM447439,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.3432385,0.044791922,0.2392131647223143,0.0346480943131426
79738,SIDM00774,AZD8055,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,2.962975,0.1547398,0.7399853013867724,0.05991412809804649
8132,SIDM00332,OSI-027,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9722286,-0.10326547,0.5464314845858514,0.0871889886004302
18115,SIDM00834,Vinorelbine,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,1.6159735,0.13061701,0.06251101879253045,0.03877789591029749
42057,SIDM00529,PF-4708671,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Black,44.0,-0.968385,-0.049961347,0.15072754473141645,0.05858293762785134
18365,SIDM00834,Afatinib,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,White,66.0,-4.3739758,-0.14999272,-1.961928277367331,-0.05847540472087718
10945,SIDM00673,Ribociclib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.5513012,-0.07596142,-1.5915860454299644,-0.004469557118189181
66321,SIDM00673,Luminespib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.97206765,-0.050736453,-0.6435795904674144,-0.0056991770985116725
23622,SIDM00834,Nutlin-3a (-),BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,2.0434716,0.07434483,2.599439515754482,0.09565172404319594
72991,SIDM00875,BI-2536,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-4.5704412,-0.09273319,-0.30865923854435673,-0.035385997162948074
13135,SIDM00954,MK-2206,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-2.400734,-0.1346821,-1.5942466107532562,-0.08910284514882405
30942,SIDM00146,Paclitaxel,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-0.9288866,-0.08936767,-0.19652111055875218,-0.05451343357964368
88915,SIDM00529,Bortezomib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.0340427,-0.04576022,-2.5946308270050755,-0.07960660996499111
13595,SIDM00774,Entinostat,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.8828751,0.043208227,2.843427240168236,0.03362057397527515
15792,SIDM00778,5-Fluorouracil,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-1.7511415,-0.040925026,1.1081885021179316,0.003451047319884153
22304,SIDM00875,Nilotinib,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.43677512,-0.040893346,-0.7058674921299334,-0.03955608421314346
66570,SIDM00531,Taselisib,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.4044194,-0.079957955,-1.9501039329449663,0.006465957517862628
88971,SIDM00954,MK-1775,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,0.6227297,0.043945957,-0.0729547521686807,-0.013889079895857625
51519,SIDM00628,PF-4708671,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-3.06385,-0.22579338,-3.0109482074269063,-0.06401633957116634
76560,SIDM00954,Temozolomide,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,0.85966754,0.018025061,0.6592812542370305,0.014312033893921213
66620,SIDM00774,KU-55933,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.1959354,0.05310372,0.10479057352879599,0.037968780473727114
69692,SIDM01233,BMS-754807,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,72.0,-4.4497514,-0.24100551,-2.6559061557315085,-0.11989304737460423
81561,SIDM00774,Docetaxel,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,48.0,1.2178727,0.08288605,-0.3231762421398756,0.048805175076009746
22708,SIDM00971,Cisplatin,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.40499914,0.0064817714,0.6768889336265691,-0.004158343209938259
92155,SIDM00097,Sorafenib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.4874917,0.05741572,1.6693256316152654,0.037141076206401266
105859,SIDM00866,ZM447439,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-0.89916813,-0.059390124,0.03576859330204725,-0.025196229854169753
34583,SIDM00954,MK-1775,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-1.0400692,-0.064910814,-0.7807610407117721,-0.03163486232288954
101844,SIDM00875,MK-1775,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.50504684,-0.035525385,-0.5204548984077618,-0.033513783960872644
71046,SIDM00954,ZM447439,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-1.2425886,-0.10145936,-0.35974715910599264,-0.05257210535410845
40049,SIDM00146,SCH772984,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.0061833,-0.099789865,0.48419856731520894,0.008503329898018825
59650,SIDM00531,Palbociclib,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.3398616,-0.0508257,0.0032173665117991336,0.013852446564004707
96236,SIDM00971,Afatinib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.9164894,-0.07683848,0.7868189471358482,0.003663002988993048
19939,SIDM00954,Paclitaxel,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.12094649,-0.008249944,0.00107218106455412,0.0515705288682807
54321,SIDM00875,5-Fluorouracil,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2680153,-0.10564062,-0.3388893240259319,0.015993560419383473
98608,SIDM00097,MK-1775,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8854869,0.050812148,0.08458932647992311,0.01281566702720643
21640,SIDM00774,Doramapimod,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-1.5470891,-0.05447116,-0.47343161449796123,-0.016689623121300585
102170,SIDM00866,Alisertib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-0.604955,-0.04149241,0.6848131857492319,0.02502732741230285
89221,SIDM00954,Gemcitabine,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.8531479,-0.07620253,-1.4128928284629132,-0.06414839298099433
99639,SIDM00628,Paclitaxel,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-0.38389587,-0.028553195,-0.8203916355587776,-0.05131046739930604
68752,SIDM00878,Nilotinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.77824104,0.044515952,1.278230870106882,0.046600099716829706
25618,SIDM00146,GSK269962A,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-1.0104307,-0.07308996,1.721409187016315,0.106956692448096
102527,SIDM00660,Dabrafenib,MK-2206,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,2.9322526,0.26471844,0.42989096498888896,0.04668618078031932
63061,SIDM00130,Cisplatin,Trametinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.2411972,-0.043309923,0.2797660749368109,0.03199365991838955
89602,SIDM00146,ZM447439,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-2.1580403,-0.13878709,0.24762473810606303,0.010610610393654896
52231,SIDM00531,Paclitaxel,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-3.4186208,-0.23605965,-3.717408367972233,-0.2005804542355041
94703,SIDM00782,Dabrafenib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,2.7089636,0.1308726,1.678166427295767,0.08496405211904205
94848,SIDM00893,Linsitinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.0331326,-0.03659515,0.7790077654212815,0.046664972045686245
78439,SIDM00660,Nutlin-3a (-),Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,32.0,0.47421986,0.011178402,1.7786343390467994,0.058292658175740635
62719,SIDM00954,RO-3306,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-2.3203819,-0.119941056,-0.7145422621812465,-0.05600597311916636
18192,SIDM00097,Alisertib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.0866401,-0.1384942,-1.7860227065017225,-0.08248172441962383
63746,SIDM00193,AZD7762,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,-0.46701008,-0.015523805,0.989690729157417,0.09587540375516496
6408,SIDM00878,JQ1,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.7904077,0.11208479,1.2263316430556221,0.042443726487851004
35570,SIDM00146,MK-1775,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,0.44112688,0.029843044,-0.45866435757453783,-0.05847156766926613
93761,SIDM00660,Crizotinib,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,-0.49874517,-0.031257182,-0.6315053388498417,-0.08660690982523041
3442,SIDM00774,Alisertib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.7396896,-0.044957362,1.549826606374015,0.062048105652874996
25687,SIDM00673,Dabrafenib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.6551408,0.037958987,2.07384930868722,0.07679590898427095
64609,SIDM00875,AZD6482,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.9588612,-0.06526421,0.36292528466140195,0.035453966423406896
83111,SIDM00628,Alpelisib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,Black,51.0,-1.3724723,-0.060866367,-0.5012008211527633,0.03229271654207131
97130,SIDM00954,Alisertib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,-4.0654798,-0.24161023,-0.848261846119746,-0.05051144767428666
103096,SIDM00774,Alisertib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,1.8457826,0.14023608,-1.709250112453904,-0.12966272304808904
88647,SIDM00332,5-Fluorouracil,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3607882,0.08167406,0.666929536595603,-0.020927809646085295
26927,SIDM00878,Taselisib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,1.177022,0.09573155,-0.91970954429542,-0.07765248085639583
93622,SIDM00193,BMS-754807,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,2.9591303,0.18005864,2.755872721780252,0.18127721161322674
5037,SIDM00971,AZD6482,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.06709685,0.0015047032,0.10935109537757343,0.03462292801042485
68630,SIDM00878,Olaparib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,4.6107407,0.15419832,2.7642862438552536,0.06420856917166141
59890,SIDM00875,Navitoclax,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.1779735,0.06787278,2.4057776801174855,0.07332345933312798
95290,SIDM00954,Uprosertib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-2.9218242,-0.22512627,-0.8945253339908221,-0.04859443189478472
80094,SIDM00332,MK-1775,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7495829,0.14106438,0.8953258441186084,0.03696246736166158
14943,SIDM00954,Dabrafenib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,2.9322283,0.1591956,0.27756858285292385,0.0377404694229757
2877,SIDM00146,BI-2536,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,-1.4648944,-0.06273641,-0.7725329461749902,-0.0491630890014788
92411,SIDM00332,GSK269962A,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,0.62372005,0.031846568,0.76673742057227,0.0312022571783663
63432,SIDM00146,AZD8055,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,1.0973713,0.09295188,0.24971569207118574,0.06806007513663656
59558,SIDM00954,AZD7762,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-2.504524,-0.18189664,-1.9373681057724033,-0.16383475824607943
53370,SIDM00097,Wee1 Inhibitor,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.3053285,0.017076053,0.38989502931460224,0.01756959221783681
9253,SIDM00359,5-Fluorouracil,Navitoclax,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.8996756,-0.15764609,0.9350484865363925,0.04185161998485248
52995,SIDM00531,Lapatinib,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.7412772,0.16717263,0.1052127300217481,0.05204184856104395
88506,SIDM00778,Trametinib,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,69.0,-2.1939352,-0.07160627,-2.2977307117267096,-0.06510995641457913
32896,SIDM00834,Afatinib,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,0.8079632,0.03320215,0.23798519287774703,0.026871594743964954
17418,SIDM00778,Navitoclax,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,0.5408737,0.033971854,-0.28889897204866066,-0.0073385354155240555
103186,SIDM00529,5-Fluorouracil,MK-1775,Breast,0.625,Breast Carcinoma,Female,Black,44.0,7.013609,0.3143945,-1.1529532213127043,-0.033884875006350366
79381,SIDM00411,Navitoclax,Olaparib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-1.0313656,-0.063885964,-0.1185352574960541,-0.0005986281828541958
61790,SIDM00866,MK-2206,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-3.5372126,-0.18095708,-0.6846312175653395,-0.024249151120960835
26610,SIDM00779,Trametinib,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,-1.147905,-0.013733881,0.1675661475510938,-0.06387660069668274
13371,SIDM00866,MK-1775,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-2.2481503,-0.19272284,-0.997273227838195,-0.036473503148464356
22652,SIDM00971,Paclitaxel,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.346202,-0.0818609,-2.4291658559912284,-0.010337648686022155
66345,SIDM00875,Trametinib,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.3566941,-0.1462049,-1.5078602662322302,-0.04104547006232792
7828,SIDM00878,AZD8055,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.0191566,-0.090899944,0.1961366392936794,-0.031987185684760694
71173,SIDM00628,Pictilisib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,0.74349797,0.07478101,-1.6616309873980681,-0.1189740043009077
89109,SIDM00875,Afatinib,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.47178686,-0.03471827,0.2361196491113626,0.0465658074638691
27423,SIDM00971,Cisplatin,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.42867538,0.0078114443,1.2264137227485672,0.019766419781807976
74036,SIDM00782,MK-2206,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,3.4790902,0.26435307,1.8809548728274224,0.13099010475296288
101906,SIDM00531,Dactolisib,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.1443456,0.0834778,0.2164278765682022,-0.010469278953842424
24608,SIDM00875,Docetaxel,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.25365952,-0.020976366,-0.8805393319342935,-0.06427071274555805
65270,SIDM00146,NU7441,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,1.7520894,0.10825065,0.3102051076759943,0.004501735014235459
10952,SIDM00097,MK-1775,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6104877,-0.107378095,-1.163919170121901,-0.1355988439171242
103751,SIDM00529,MK-2206,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.7115754,-0.050299093,-0.25304580545361616,0.049445287326335186
69833,SIDM00146,NU7441,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.2228476,0.07735052,2.0281557797656804,0.11211650594955844
68227,SIDM00359,MK-2206,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.55941534,-0.03248,1.2811286936796107,0.11490749015095661
83423,SIDM00130,Erlotinib,Oxaliplatin,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.304102,-0.10652124,-0.7551692894498586,-0.027190481908462797
96718,SIDM00866,Temozolomide,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-1.2750525,-0.021773025,0.3849695522382422,0.021214609054135036
22598,SIDM00673,Palbociclib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,2.281556,0.16100411,-0.22300865011671048,0.02160106101671278
18134,SIDM00146,Camptothecin,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-2.3365982,-0.18224628,-2.543661194622203,-0.15655071596737752
39181,SIDM00146,Lapatinib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,-1.3433826,-0.115204655,0.3794378472624361,0.020069569356372736
8405,SIDM00130,Olaparib,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.2143724,0.14791651,0.4113646012107276,-0.021360442831125183
85177,SIDM00301,Ruxolitinib,Erlotinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-0.82509106,-0.019387243,1.1449852899127138,-0.0021544479333741287
53198,SIDM00776,SCH772984,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.8767934,-0.14968319,-0.6240750038214957,0.004360194520434745
87384,SIDM00776,AZD7762,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,3.9910004,0.304981,1.0965002973744,0.17690162532038042
76666,SIDM00774,Nutlin-3a (-),MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,5.6745,0.21620856,2.8336639568695046,0.11645530040094908
70980,SIDM00332,Ribociclib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.2279696,0.16113487,-0.9648058939906862,-0.03415876578776163
90134,SIDM00359,Camptothecin,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.434826,-0.10002307,-2.199818784352291,-0.08199773657315153
10991,SIDM00774,Temozolomide,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,0.1423349,0.0035203923,0.8174975278881889,0.06014027537077708
14068,SIDM00193,Oxaliplatin,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,0.58422416,0.015795384,0.9696065526935832,0.029650772981804793
26866,SIDM00332,GSK269962A,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.52511984,-0.022818958,1.3050035834611424,0.07813195735150723
62667,SIDM00866,BI-2536,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,-1.0481606,-0.061080102,-1.5690334299041109,-0.03465225075681021
49705,SIDM00878,Pictilisib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,-1.3033174,-0.13717234,-0.1411893766533803,-0.0017505564934150357
80397,SIDM00954,Bortezomib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-0.49492985,-0.031021276,-0.9866233088967046,-0.02757221838240679
34615,SIDM00531,Olaparib,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.66408026,0.032036617,0.9230694081907082,0.0013395189580647862
89364,SIDM00529,Ribociclib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-1.2460163,-0.031568613,-0.14198828151600473,0.014226832453638361
52561,SIDM00146,Trametinib,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-0.8329695,-0.0678913,-0.36693877981321876,-0.05036806636442083
52558,SIDM00529,AZD8055,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,0.74468875,0.0682999,-0.5053655943452402,0.04133904722000953
60221,SIDM00359,Dabrafenib,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.7252089,0.06400539,-1.3772880258822846,-0.01763310237732457
30805,SIDM00774,ZM447439,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.34622088,0.01938385,2.101846738779485,0.1366644820743856
94948,SIDM00866,RO-3306,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-3.0377898,-0.13586268,-0.06421553625483593,0.020763434712763516
70655,SIDM00628,Crizotinib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,-2.289912,-0.1682849,-1.2179038216448617,-0.0661741845466495
106187,SIDM00893,Venetoclax,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.419559,-0.07052703,-1.492310707031711,-0.04119698040361363
15744,SIDM00875,Axitinib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.8886464,0.27788717,3.8519961637942597,0.2066442249995498
38725,SIDM00628,Bortezomib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.2241449,-0.011635759,-0.5947585228569653,-0.019846901433944034
89648,SIDM00866,Docetaxel,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,0.88916975,0.0723048,-0.2535266768413849,0.02150297400526742
13192,SIDM00954,Alpelisib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-0.29529116,-0.020769723,-0.041406186610397445,0.056512143016934045
46165,SIDM00834,Camptothecin,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-1.1797117,-0.0983787,-1.835952781526359,-0.1110103109721481
47470,SIDM00628,Bortezomib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-0.3004415,-0.015007179,-0.7731304874838724,-0.039384898806321234
62515,SIDM00893,PD173074,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.5044646,-0.036634352,-0.16828157007309114,0.008724784063499478
32389,SIDM00782,Vinorelbine,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,Unknown,72.0,-1.7228229,-0.14115529,0.06485737378953282,0.05071776290418463
86496,SIDM00834,SCH772984,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,White,66.0,1.4779481,0.12654664,0.3388195388286289,-0.010265255343933063
45260,SIDM00193,SCH772984,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-0.1662682,-0.013284948,-0.794797229346895,0.015250412660170706
65644,SIDM00954,Nutlin-3a (-),Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,-0.24129407,-0.006380954,-0.5658394660538707,0.01656926106721452
19883,SIDM00774,Ribociclib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,-0.9023846,-0.033018973,-2.1398984189714336,0.0005570190337837369
71107,SIDM00774,Doramapimod,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-2.1066022,-0.062545784,0.01727396788998615,0.03181818600587036
77992,SIDM00660,Dabrafenib,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,32.0,4.286158,0.33303532,-0.5973080714798537,0.0022470389166554037
1933,SIDM00359,Palbociclib,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.8259068,-0.049863745,-2.2399294928370064,-0.056608847265713816
39151,SIDM00332,Trametinib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.433222,-0.11553795,-0.7393430731114142,-0.047082435382689934
14719,SIDM00332,Lapatinib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1357825,-0.09146912,-0.4022348107347772,0.005080049859362487
41745,SIDM00529,Venetoclax,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-0.121204235,-0.003916137,0.8380249952602113,0.08504620333478191
87882,SIDM00893,Wee1 Inhibitor,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.58088154,0.05115517,-0.5773264035868375,-0.015011706220555265
14654,SIDM00097,ZM447439,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6754891,-0.07182944,-1.9295635786800525,-0.033876071258990136
73269,SIDM00359,AZD8055,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.5542629,-0.12735349,-1.5387315616145447,-0.08034639861580585
91451,SIDM00673,Trametinib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,1.7451395,0.17134179,-1.0972300970446953,-0.10286955765164316
32542,SIDM00954,Trametinib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,2.1414838,0.08848088,0.4842037384123721,0.02371177401407897
95606,SIDM00130,MK-1775,Palbociclib,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-3.2531073,-0.2753825,-2.9455145258688513,-0.20631014894070737
78800,SIDM00971,BI-2536,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.7196619,-0.040164154,-1.2841761668417182,-0.0441585792376387
18482,SIDM00130,MK-1775,Erlotinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.8740466,-0.18675426,-1.555347842490479,-0.04325966499481769
65715,SIDM00954,MK-1775,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,0.8274622,0.05948794,-0.2711501195981977,0.004415509632392582
50281,SIDM00130,Dasatinib,AZD7762,Pancreas,0.0625,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.0671906,0.08954387,0.9232575774830319,0.11662262686854172
84135,SIDM00878,SCH772984,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.518278,0.025220698,2.598281349258305,0.13674589891302696
68987,SIDM01233,BMS-754807,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,72.0,-0.9928761,-0.068677686,0.2696594972647295,0.019215100805353755
3013,SIDM00954,Gemcitabine,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.0,-2.1417592,-0.08085945,0.1672672975149154,-0.010539892425825592
42687,SIDM00954,Camptothecin,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-0.54212236,-0.018518815,0.8968782793753162,0.07470431049384048
59352,SIDM00866,Camptothecin,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,52.0,1.3511531,0.028432418,2.1258992132577417,0.06990874866310177
85359,SIDM00893,PF-4708671,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.3111425,0.026161363,-1.0422371656940856,-0.0493229920027525
11468,SIDM00834,Oxaliplatin,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-4.4769263,-0.28154176,-2.8325349813026133,-0.14791071450885
23233,SIDM00529,Axitinib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-0.37281197,-0.031858508,-0.4370147391505027,0.04370596515535584
44012,SIDM00097,SCH772984,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.2034113,-0.009967712,2.0809959166166907,0.07915641269269749
14069,SIDM00866,Gemcitabine,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-3.2615044,-0.1912026,-0.503373516793818,-0.0016177447387046248
75837,SIDM00893,PF-4708671,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.6362658,-0.047156144,-1.3155543022723175,-0.10247132413933638
99769,SIDM00531,Lapatinib,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.1764274,-0.069806084,-0.768996007928643,-0.0058585420446239525
37045,SIDM00529,MK-1775,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Black,44.0,0.7354737,0.065723516,-0.12755882778767988,0.03537083192940073
68644,SIDM00971,Camptothecin,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.4132855,0.08025296,2.5817779634337312,0.07493154887366425
36556,SIDM00834,AZD8055,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-1.2056073,-0.094298184,-1.0930831023785221,0.0009926949821293966
101608,SIDM00332,Docetaxel,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-4.101292,-0.14992806,-3.319148560006243,-0.2923192135740256
13333,SIDM00529,Nilotinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-0.81912804,-0.02592863,-0.7905270480770085,-0.003358282304681275
442,SIDM00130,Dactolisib,Trametinib,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.66320825,-0.051392928,0.6154837820372153,-0.005129542131278826
70852,SIDM00878,Ribociclib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-2.939765,-0.12038831,-2.4147511091313705,-0.11888617988382684
59369,SIDM00875,Venetoclax,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6265794,0.05536607,1.4785391475113048,0.0542769519648478
49592,SIDM00529,Tozasertib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Black,44.0,0.21954918,0.009665789,-0.2505247216002431,0.02964583124655015
17669,SIDM00779,Linsitinib,Navitoclax,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,3.1930635,0.1476018,1.5296916409949115,0.02032572531105167
10567,SIDM00332,MK-1775,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.8674613,0.07778986,-0.4172199471723955,-0.0219628967261998
105452,SIDM00332,BI-2536,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.141232,-0.15814489,0.9572398858282497,0.06807396716682965
40081,SIDM00673,RO-3306,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,-2.0363941,-0.11743309,-0.9709859412833309,-0.04426000940413992
107678,SIDM00332,Cisplatin,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.6490853,0.04151093,1.3205373529959252,0.01513975287821747
21800,SIDM00875,MK-1775,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.626179,-0.033213496,-0.8407136495896766,-0.04882427396572535
26012,SIDM00893,Wee1 Inhibitor,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.6792609,0.06023956,-0.5260326212407385,-0.021397959871219247
7827,SIDM00878,Cisplatin,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,70.0,1.1860048,0.047093317,1.0813039721028548,0.05883396488286209
98619,SIDM01233,Nutlin-3a (-),Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,72.0,-2.1080253,-0.05862758,-0.9030743496600141,-0.009561825366640408
28995,SIDM00954,Temozolomide,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,0.13422489,0.0018234164,0.6244533609078511,0.040932838780835874
84466,SIDM00954,Linsitinib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-4.720605,-0.2974922,-0.6627137042239432,-0.034763115911615954
54221,SIDM00776,5-Fluorouracil,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,6.622,0.48824686,2.8851629803784604,0.17192845507992716
24791,SIDM00971,Lapatinib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.6810294,-0.08607572,-0.40428401144877724,-0.06139573204233865
103445,SIDM00878,Dabrafenib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,1.5122619,0.058548447,0.9560743979368505,0.021676976046046972
76710,SIDM00971,Taselisib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.8132552,-0.12253326,-1.4734159494280465,-0.14750945478140157
32760,SIDM00673,Alisertib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,2.0638046,0.078672834,-0.3643587355688375,-0.0242669897012588
64806,SIDM00875,Olaparib,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.0598109,-0.039039563,-1.1343119364902443,-0.07707090716720266
104892,SIDM00097,Entinostat,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.092937,-0.03732571,1.332720177842269,0.08602837260106004
29231,SIDM00411,Navitoclax,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.54172325,-0.030985419,0.0509297840562242,0.0008481599543754658
82196,SIDM00954,PF-4708671,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-2.2074518,-0.10071345,-1.45453499879842,-0.06464385373892098
24027,SIDM00628,AZD8055,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-0.60058016,-0.046160765,-0.5031552597820698,-0.03668146754098043
63386,SIDM00774,Afatinib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-2.472527,-0.1710231,-0.9086912593569211,-0.09926828237653111
23960,SIDM00875,Paclitaxel,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.05760766,-0.0039889114,-0.6721913635726229,0.013477799195257134
19597,SIDM00193,Olaparib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-2.9595246,-0.09156996,-1.0491934161793741,-0.03806494902038122
92746,SIDM00866,Trametinib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,0.6892861,0.045130093,0.5251706907279438,0.036353335197366915
60528,SIDM00193,Taselisib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.035044886,-0.002960889,0.12972272879880206,0.06584060094521316
62405,SIDM00774,Trametinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.820935,0.115013316,1.658508115726428,0.06005512895575966
37787,SIDM00359,Nutlin-3a (-),Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.8458066,0.020641914,1.1868535327395833,0.023595177838008685
56544,SIDM01233,Crizotinib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,0.6764504,0.038503062,1.3051338860461652,0.11254505557154292
60722,SIDM00097,ZM447439,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.7906973,0.17610799,-1.2960207086445557,-0.0031134982925369635
8115,SIDM00971,JQ1,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.6833171,-0.051006567,1.7472224129242881,0.08327180754084834
58924,SIDM00834,MK-1775,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,0.65652657,0.043491073,-0.763725187645563,-0.031865645052599034
41758,SIDM00531,Dasatinib,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.1487023,-0.10344905,0.0399516814287409,0.01710066984375885
21838,SIDM00866,Gemcitabine,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.8341101,-0.080076344,1.8397827310203927,0.1314723387130947
31536,SIDM00834,Afatinib,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,1.8591135,0.08038814,-0.11212856116627964,-0.03891048861227018
74562,SIDM00359,MK-2206,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.9051639,0.047114454,0.5629278428636452,0.07221551297194108
99161,SIDM00893,Navitoclax,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.7568699,0.17637633,-0.13573529620643812,-0.045576196676695484
87643,SIDM00531,Irinotecan,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.7066072,-0.17120266,-1.4329543401137501,-0.11438813465319815
27396,SIDM00332,OSI-027,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.5190797,0.24231909,0.8438137100667537,0.06540395312161358
76475,SIDM00332,Alisertib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,5.86098,0.117789246,4.354351592202034,0.17045478267254482
16839,SIDM00782,AZD8055,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.0325098,-0.0896278,0.059775816981081815,-0.02366433273466391
44525,SIDM00954,Vorinostat,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,1.055082,0.068689585,0.98777739552558,0.07499144242459922
101941,SIDM00893,PD173074,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.9232525,0.08412358,2.506628195895929,0.11884946093267328
29524,SIDM00411,Cisplatin,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,3.3436368,0.086845934,3.010053735400553,0.09675139077795848
6899,SIDM00878,Dabrafenib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.9845922,0.06894818,0.7618556584648647,0.06053617541313078
15988,SIDM00332,ZM447439,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7666394,0.054212246,2.2042127028452723,0.13718707934328334
89142,SIDM00411,MK-2206,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,43.0,-1.7146449,-0.084700614,0.18737084056469436,0.02526627574101739
8148,SIDM00774,Bortezomib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.3836204,-0.028871723,-0.033524023910172625,0.024878160617640508
53329,SIDM00628,NU7441,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.1026648,0.09577857,0.7457901451769483,0.06400912070125653
92954,SIDM00866,Nutlin-3a (-),Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,-0.9275427,-0.026019342,1.4076187430599856,0.030110561188006306
103067,SIDM00301,Taselisib,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,50.0,3.4408529,0.1840273,1.293677163620442,0.07677062125252397
71931,SIDM00097,Pictilisib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.80184656,-0.055504855,-0.9522746847048119,-0.08769961531214421
85274,SIDM00893,5-Fluorouracil,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.94836926,0.04916739,-1.0009514481016757,0.019545803865591033
73572,SIDM00866,AZD6482,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,1.6422269,0.095046885,0.26625922097619026,0.08705203465688928
6064,SIDM00332,NU7441,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.116969,0.06748422,0.5042993717468821,0.036109522003040684
16753,SIDM00097,Palbociclib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0847943,0.05604368,-0.20806756203269228,-0.04897850266326768
33995,SIDM00774,Navitoclax,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-1.1492193,-0.052991893,-0.2673012646699567,-0.03720170969961849
37169,SIDM00628,AZD7762,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-0.5434007,-0.046082743,-0.09085053469315285,0.06285294117979129
75716,SIDM00097,Dabrafenib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8537179,0.04630732,-0.7136553342166267,-0.05042147813623995
83647,SIDM00673,Trametinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,3.285775,0.23238619,1.6907717880860211,0.08001279525861708
21487,SIDM00359,Linsitinib,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.3083825,-0.12257829,-2.0782984396471975,-0.06580750249449384
24115,SIDM00893,Vorinostat,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.31011522,-0.019583521,0.43435000542000535,0.04657734433623148
24822,SIDM00146,Trametinib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.71647495,-0.059588924,0.19574366030901166,-0.013541508318227518
52515,SIDM00834,Linsitinib,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,-1.0625837,-0.08152151,0.17788045355906248,0.03780194756788574
36962,SIDM00893,Afatinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.614658,0.19631849,-0.9590517858691151,-0.06223630110905752
29902,SIDM00954,ZM447439,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-5.0883975,-0.25997752,-1.392537216510509,-0.06668805453547189
59469,SIDM00774,ZM447439,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.57611114,0.034636855,-0.6591069033054072,-0.005700245039936942
84400,SIDM00411,OSI-027,AZD7762,Pancreas,0.0625,Pancreatic Carcinoma,Male,East Asian,43.0,0.6450024,0.04044678,-1.5931414580376693,-0.03266117974617989
106013,SIDM00146,Alpelisib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.6703617,0.039462313,1.5005731051506865,0.20302374022774042
97952,SIDM00332,Nutlin-3a (-),Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,4.026934,0.15722047,2.53484933116657,0.07321125303646739
60397,SIDM00875,Dabrafenib,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8997135,0.10539666,1.0543216265154844,0.048535606548463686
33585,SIDM00893,Luminespib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.0997634,-0.08558677,-1.3838522861655336,-0.044004745556875
68339,SIDM00097,AZD8055,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5014906,-0.10577466,-0.7371996408917586,-0.043210074959661234
30447,SIDM00146,Pictilisib,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.1343665,-0.0845145,0.3508903147944364,0.0491609444545207
40699,SIDM00332,Vorinostat,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.573559,-0.055329565,-0.19098261223201682,-0.018395977068713782
11638,SIDM00529,PF-4708671,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-2.265452,-0.10132794,-1.4003552229391136,-0.009689868662376087
5530,SIDM00193,MK-1775,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,53.0,3.461431,0.22402687,1.4641885297826474,0.05211074918305056
81616,SIDM00893,BI-2536,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.41584325,-0.03658769,-0.5316808973613437,0.025982301414366943
22469,SIDM00673,Ribociclib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,-2.666578,-0.07696996,-0.0847603149274752,0.024913758594643006
22014,SIDM00782,Navitoclax,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,Unknown,72.0,0.92981535,0.08423572,1.0879826323038673,0.129258623422266
49336,SIDM00954,BI-2536,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,0.31766734,0.006201936,-0.5361917412069349,-0.01640200664947532
100126,SIDM00531,Palbociclib,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.0166641,-0.0322855,-1.184597744248263,-0.040233232850535046
89101,SIDM00146,Navitoclax,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.9402999,0.09883077,1.1458585908799788,-0.02403331707701111
44243,SIDM00779,SB505124,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,33.0,-1.0203924,-0.09269574,-1.442776517508117,-0.11540685323833319
71749,SIDM00628,Alisertib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-1.9377997,-0.07358403,-0.14977182146239432,0.0010488421973845305
78933,SIDM00774,Nilotinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.6981512,-0.070504,1.9164542451185602,0.10205345455058443
52982,SIDM00866,Wee1 Inhibitor,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,52.0,1.6037288,0.12164728,1.072979471769529,0.06452173508332175
54166,SIDM00130,Trametinib,Erlotinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.7229702,-0.05657808,0.41854892420752265,0.06121735870657892
63171,SIDM00774,Olaparib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,-0.834258,-0.032584857,0.6439027349363077,0.008286265402796875
33935,SIDM00301,Taselisib,Oxaliplatin,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-3.46223,-0.21705323,-1.7386845623643985,-0.09343019972398153
9557,SIDM00301,Oxaliplatin,MK-2206,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,50.0,-1.5731785,-0.18281235,-0.49799798130083905,-0.02584675038038138
44500,SIDM00359,MK-1775,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.4700787,-0.041310385,-0.00503471441759602,-0.0062822573051731
67869,SIDM00097,Trametinib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.9443074,0.051965035,0.6322357167032807,0.07033566053407583
31148,SIDM00193,Crizotinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.0901504,-0.031163882,1.7970372049326275,0.11634891560516938
93069,SIDM00628,Taselisib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.4974364,0.092669964,0.37413616533949046,0.08175900594270093
93641,SIDM00301,Crizotinib,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.2056097,0.14260723,0.5513359375689498,0.04730448281981554
102620,SIDM00529,Lapatinib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Black,44.0,-0.1553925,-0.010328182,-0.8156801255821478,-0.014146445393717977
55939,SIDM00954,Dabrafenib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,0.2672126,0.0077203764,0.6868557760084227,0.04399701822468245
52746,SIDM00782,Palbociclib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,Unknown,72.0,-0.36787492,-0.007610401,2.2670272371349602,0.05162370622778362
108322,SIDM00628,Taselisib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,2.183785,0.18740422,0.25103644217389937,0.056981404150852615
23035,SIDM00529,Crizotinib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Black,44.0,-0.68687886,-0.042912565,-0.004623540419792575,0.00040563302460867314
45648,SIDM00774,Nutlin-3a (-),Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,48.0,1.6305801,0.078193106,1.1640091630262053,0.10811539022839572
84292,SIDM00878,BI-2536,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.62286127,-0.05689289,0.1536848732661278,0.00294027178571834
66756,SIDM00529,AZD8055,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.6534106,0.15486833,-1.669402228660501,0.005864977444996406
32160,SIDM00628,Wee1 Inhibitor,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.7081677,0.05255824,-0.24875946164897866,-0.009807059431444436
64006,SIDM00971,BI-2536,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.1558857,0.23641732,1.0104767870107576,0.11734642305240724
51684,SIDM00332,GSK269962A,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5628426,0.07704624,1.2755505116020185,0.03922022655648472
81837,SIDM00954,Afatinib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-1.196475,-0.07044159,0.04067016378915762,0.03111366719876745
28276,SIDM00332,KU-55933,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0739907,-0.041567568,0.2833369178948185,0.05496591915926695
63091,SIDM00893,Uprosertib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2799248,-0.09954736,-0.10636518237733388,-0.026180961237804275
87003,SIDM00782,Oxaliplatin,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,Unknown,72.0,-0.04621345,-0.002998473,0.1337455014062322,-0.02212703120791156
35340,SIDM00878,5-Fluorouracil,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.89761734,-0.04294979,-1.2971073011196534,-0.05958189670194222
50498,SIDM00097,PD173074,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8500613,0.03023291,1.1643308226057862,0.06248137593827849
12430,SIDM00097,Taselisib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.4331567,-0.1757326,-0.9561451449321217,-0.10514541061990344
25357,SIDM00531,Trametinib,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Male,East Asian,60.0,5.9990253,0.5559289,-0.6722772676883926,0.022760718069789014
8969,SIDM00778,BMS-754807,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-3.5529306,-0.1251484,0.18888223458598769,-0.0191112812899563
90569,SIDM00660,Trametinib,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,-4.2356634,-0.3378538,-1.0943174803705031,-0.06679893964072285
27211,SIDM00774,Trametinib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.764079,0.08026709,-0.12031162896704657,0.005406984079781575
66586,SIDM00878,JQ1,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,2.1864815,0.17427336,0.4693258804321344,0.022692462633773464
59727,SIDM00954,Alpelisib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,1.2680887,0.09468452,0.35890461677255187,0.02828509008688718
85825,SIDM00628,Olaparib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-1.7993389,-0.1245642,-1.8833497652566007,-0.07452671140699425
107261,SIDM00531,Lapatinib,Erlotinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.9466431,-0.05484669,-0.22098506091933656,0.003944454947958839
23352,SIDM00878,Luminespib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,70.0,4.4623885,0.39120606,-0.12702786215690767,0.016365935849681667
23500,SIDM00332,Ribociclib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.568178,-0.06727914,-0.9532953038396365,8.44974451782602e-05
84348,SIDM00782,SB505124,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.57630634,0.042048752,0.7938592219123676,0.02776872249075623
93201,SIDM00954,PF-4708671,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.0,-1.5093874,-0.058947127,0.07552836418225076,0.03127918264752789
3419,SIDM00301,Dasatinib,AZD7762,Pancreas,0.0625,Pancreatic Carcinoma,Male,East Asian,50.0,1.60335,0.15948537,2.7118069896949213,0.13990796242043646
99193,SIDM00875,Pictilisib,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.307694,0.029771632,-0.5126067844770115,-0.043265030118386755
7485,SIDM00779,Olaparib,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,33.0,0.63780165,0.014351913,1.3937711516011426,0.041990959838044295
34830,SIDM00193,MK-1775,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,-0.11615359,-0.008991237,-0.003991672096193854,-0.04722547669642697
5031,SIDM01233,Nutlin-3a (-),Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,1.0104631,0.044057816,-0.5876118884165247,0.035396337262389346
53309,SIDM00782,Vinorelbine,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.6511088,-0.06160243,-2.219899124737764,-0.06851181855943576
101879,SIDM00971,Uprosertib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.20493108,0.010436295,-0.33502793519973684,0.011409999771781346
46804,SIDM00193,Nutlin-3a (-),5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,0.43586698,0.008072442,2.217702040633381,0.06573418350339363
9475,SIDM00893,Alpelisib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.9760963,0.12635447,0.7879489574910649,0.038596779054259484
43531,SIDM00673,Afatinib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,0.32772672,0.024282774,0.6485181891161649,0.06652031210247744
59815,SIDM00866,Temozolomide,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.67837214,-0.010598988,0.5216007604519627,0.0048095124447464
27464,SIDM00146,AZD6482,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.3078017,-0.08260608,1.0484894558791584,0.025304987646200774
78762,SIDM00332,Wee1 Inhibitor,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5983115,-0.116864175,-0.6124777965099896,-0.06583354957905621
26476,SIDM00878,Alisertib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,70.0,-2.6318073,-0.17521894,-0.5059461798074866,0.012718924280014591
50491,SIDM00529,RO-3306,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Black,44.0,1.1372932,0.05284542,0.5495705073647605,0.07700190747205231
30996,SIDM00971,JQ1,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.1778476,0.09456964,2.478491282229204,0.15198009261796572
79684,SIDM00411,Lapatinib,Olaparib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,1.5615914,0.065870635,0.8012495360702225,0.08798158024808059
79641,SIDM00097,Paclitaxel,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2984881,-0.08957428,-1.9620584173145803,-0.13945614655485913
81373,SIDM00673,Palbociclib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.0209095,0.09570634,1.0605063757032025,0.08433382058157704
73425,SIDM00673,Axitinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.34855676,0.03411658,0.24864677774613075,0.018786094601827067
85120,SIDM00146,Alisertib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.75801945,-0.061825648,1.4191260497699159,0.05877503519843093
45585,SIDM00529,5-Fluorouracil,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Black,44.0,1.177835,0.105359145,-0.7763852131193324,0.017979196366343254
56234,SIDM00893,Nutlin-3a (-),Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.64814574,-0.013418287,0.14196619892758366,-0.004680133661839803
73429,SIDM00971,Ribociclib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.4293993,-0.05679718,-1.5553574769381044,-0.032279559647408244
44030,SIDM00411,SCH772984,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,3.992123,0.19125532,1.9442919769036227,0.09679926470446797
72759,SIDM00971,BI-2536,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.1041288,0.13344432,0.1512832924474249,0.09995463737595166
51284,SIDM00301,OSI-027,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.1387656,-0.13718069,-0.8406926137432887,0.00387403522800376
56008,SIDM00529,AZD7762,Luminespib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-0.41057163,-0.028835831,-0.48866121874556967,-0.04491845531531065
66170,SIDM00782,SB505124,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,1.0029827,0.08530433,-0.19157348519922582,-0.0061549239807220085
97404,SIDM00778,SCH772984,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,69.0,-0.93871427,-0.043543115,-2.0167663005730687,-0.05556924845064766
73063,SIDM00778,MK-1775,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,-4.085974,-0.08643337,-2.498003897889331,-0.08027646489531085
2710,SIDM00332,Palbociclib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.1818178,-0.13081495,-1.025272739764429,-0.10617128424664583
69231,SIDM00893,PD173074,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.7920601,0.06420354,3.1002495316217873,0.10609463411598465
91040,SIDM00146,Wee1 Inhibitor,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.38884485,-0.03217916,-0.48213557360028386,-0.03828234787379843
72639,SIDM00146,Gemcitabine,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.26285338,-0.018808054,0.15550389795609806,-0.08215005919290526
39635,SIDM00875,Taselisib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2384288,0.13808541,1.924601381300015,0.1359914447558087
58420,SIDM00971,Alisertib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.5454062,0.040621694,0.9017882890704919,0.09732137383971738
33934,SIDM00660,Olaparib,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.5613535,0.015793247,1.8242659976923916,0.07178358301636602
9550,SIDM00878,AZD6482,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,1.0484936,0.076256715,1.1706112329755183,0.10570318014936722
83813,SIDM00878,Lapatinib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,3.244459,0.079132795,3.4340017137503422,0.17437902648126763
97984,SIDM00673,Nutlin-3a (-),Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,0.480055,0.012124878,2.008352432271059,0.02321112877351693
50574,SIDM00971,Nutlin-3a (-),OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.2282393,-0.049785618,-1.0733207138385417,-0.011855471024446491
59285,SIDM00776,Taselisib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,2.4778438,0.1610375,1.7982239388094805,0.08187025458988517
81351,SIDM00778,Nutlin-3a (-),Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,69.0,2.4171517,0.055202737,4.796182991668731,0.16832099057554875
86020,SIDM00875,Docetaxel,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.12944245,0.01038312,-1.6090702003302437,-0.09019419391792949
31983,SIDM00893,SCH772984,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.325347,-0.08123607,1.179223453719032,0.16734439201904985
31718,SIDM00332,KU-55933,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.8859615,-0.09243099,-0.9303240781867916,-0.06300526548232514
106409,SIDM00531,Linsitinib,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.9852136,-0.029427333,1.046009381382977,0.036009385281825367
61718,SIDM00130,Trametinib,Palbociclib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.48128763,0.048816975,-0.18612349395233746,0.02828873905673191
10260,SIDM00097,Gemcitabine,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,6.0733757,0.3557189,3.113612434157507,0.2120054152910418
10018,SIDM00954,Pictilisib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-0.5093407,-0.04075615,-0.9214197882320062,-0.051349177326051425
73316,SIDM00875,NU7441,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.98767,0.07419752,0.5730497466875516,0.07563698723686428
12591,SIDM00875,ZM447439,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5807104,0.061421815,0.8219372946957545,0.04944607604579816
75642,SIDM00866,AZD6482,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,2.1795793,0.14539406,0.545076127703047,0.10821218990634728
38066,SIDM00779,Vinorelbine,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,33.0,-2.890535,-0.24018484,-4.109215023026983,-0.29464836878655865
33281,SIDM00531,Palbociclib,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.1081926,-0.046861596,-0.809998699222574,-0.019636761238305413
50259,SIDM00146,AZD6482,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.409054,0.10705293,1.4406237903843655,0.10113817312383087
20522,SIDM00834,BMS-754807,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,0.61044973,0.052033875,-0.07371445088597717,-0.001671719904216516
30537,SIDM00875,JQ1,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.2534408,-0.022590656,0.49226732272167173,0.001108300644768457
47138,SIDM00628,Axitinib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.8402732,-0.06808501,-1.305458443530902,-0.09478629510622949
34691,SIDM00878,Taselisib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.5901638,0.04792016,-0.48913702500065603,-0.0491690387665401
88064,SIDM00778,AZD4547,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,69.0,-1.7343329,-0.06195246,-2.3294851380904382,-0.08709598589211548
27525,SIDM00660,Vinorelbine,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,32.0,2.5760558,0.11255104,0.7341019964833365,0.02973162785435737
86376,SIDM00866,Taselisib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,1.1345525,0.08643107,0.9453969168422032,0.0786135869355093
96118,SIDM00779,Camptothecin,MK-2206,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,1.0744872,0.048324503,0.8313384453762659,0.03325281390279954
87186,SIDM00893,Docetaxel,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-3.1392472,-0.23107381,-3.8171929477979805,-0.21511226150295606
48054,SIDM00332,Gemcitabine,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0599036,-0.060582153,-0.15063227968316123,-0.06062530061594104
90319,SIDM00529,Palbociclib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-2.4070706,-0.093719766,-0.031152020104584004,0.04236295378400806
37563,SIDM00866,Camptothecin,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,1.4471416,0.029071275,2.259806593459976,0.07144098452544548
44665,SIDM00628,AZD8055,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,2.5801067,0.15183653,0.5215587282168542,0.04550273717907728
75307,SIDM00782,AZD8055,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,-0.88284665,-0.06643982,0.2380370996791851,-0.021248640556780416
13382,SIDM00332,Docetaxel,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.9198632,-0.23201056,-0.4720030364164573,-0.08463472878064893
6965,SIDM00954,PF-4708671,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.8683005,-0.045606766,-0.028859111665476105,-0.0007785376126051392
73877,SIDM00097,Luminespib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.8618608,-0.12013427,-0.9230685152398679,-0.05256746617154586
102858,SIDM00971,Dabrafenib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.4721302,0.025143133,1.1304990095950136,0.0732678448395804
94203,SIDM00628,Linsitinib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-1.3325163,-0.08694454,-1.0845308603565986,1.0770528408455748e-05
40909,SIDM00776,Crizotinib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,-0.70497173,-0.06333191,-0.5872512506519086,-0.019597819611131113
44266,SIDM00893,Wee1 Inhibitor,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.6340542,0.20400321,1.486439316481954,0.11712923850906456
96424,SIDM00954,Navitoclax,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,2.6167092,0.03503666,0.6122231334559259,0.022699162880080004
84220,SIDM00411,Erlotinib,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.2199743,0.107439056,-0.1879191592114152,0.0482720922483813
65482,SIDM00971,OSI-027,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.7072982,0.097565405,0.43411774725733204,0.052834141426035895
84961,SIDM00301,Palbociclib,Taselisib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,1.9713304,0.249347,1.1086078159478183,0.05199757125828261
75470,SIDM00778,Oxaliplatin,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-2.0424922,-0.066163175,-1.7078998690033202,-0.0586974258836226
56823,SIDM00776,Taselisib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,1.5088078,0.11133502,-0.025629991657643854,-0.0025339993876771047
70214,SIDM00332,Bortezomib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9750323,-0.049002655,-0.4899800225716958,-0.0749381503394384
10145,SIDM00673,JQ1,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.2127283,-0.1322391,-2.0661478627766177,-0.0917971359802309
83082,SIDM00673,Taselisib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.37713835,0.03067554,-1.0311244936096873,-0.08284754567332744
52009,SIDM00130,Sorafenib,MK-2206,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.5826783,-0.045917373,-0.09459730334526406,0.003945074531146849
31392,SIDM00866,JQ1,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.1646369,-0.08312697,-0.6392416889180454,0.013249904109774068
7913,SIDM00193,5-Fluorouracil,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-3.2771947,-0.23132735,-2.008939694517776,-0.14771086470082606
11725,SIDM00774,BI-2536,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-3.5407827,-0.20431904,-1.0125457622234009,-0.05630097658289461
91191,SIDM00954,NU7441,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,1.9951091,0.12322336,1.4352403548254444,0.1562339277314235
24228,SIDM00673,Axitinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.4692956,-0.14051865,-1.2785267982113662,-0.043622093017155736
35921,SIDM00875,Uprosertib,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.3513546,0.2368362,1.1950584902248418,0.1234305651430877
83051,SIDM00301,Lapatinib,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.1673638,0.067107715,2.067717247299538,0.07369545595031468
107685,SIDM00332,AZD6482,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.4067733,0.14449121,1.5992741042797964,0.10069360729300117
24354,SIDM00628,NU7441,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.27849254,-0.026071236,-0.0997060320893721,-0.04887042250301627
64054,SIDM00411,Crizotinib,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.85529727,-0.054576214,-0.8931043767059991,-0.06302951673789106
89868,SIDM00779,AZD4547,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,-10.268507,-0.107605904,-4.343413452567188,-0.07155564430327412
46521,SIDM00875,Alisertib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5516558,0.03966097,1.8053606256740422,0.10070259753743145
8747,SIDM00130,5-Fluorouracil,Taselisib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.8012003,0.13980608,-0.49058563683304307,-0.001217236671864765
48312,SIDM00954,SCH772984,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,0.99161166,0.07531692,-0.07227516991298756,0.02983905934244719
84222,SIDM00531,Cisplatin,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.3876419,0.153802,-0.8855258257716266,0.02636788452209505
69852,SIDM00529,Dabrafenib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,0.9872592,0.020698229,0.8675035895054525,0.0521554173758956
6417,SIDM00673,Entinostat,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.9106447,-0.1423202,-1.2593875466712943,-0.08351830474816971
85696,SIDM00146,Bortezomib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.23896612,-0.015387609,-0.21369773335138814,-0.013235438543878918
81871,SIDM00146,Nilotinib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.95658123,0.0961733,0.8036414271799103,-0.013249916605152326
71042,SIDM00878,Venetoclax,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.7737412,0.058081888,0.9080016232756809,0.05048005775585948
100776,SIDM00332,Bortezomib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5502471,-0.061587762,-1.0696588824553326,-0.054811122521311484
45160,SIDM00893,Navitoclax,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.7288781,0.13115546,0.30883439984425415,-0.04237326162776301
95732,SIDM00866,Doramapimod,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.2740161,0.032848574,2.046449072004059,0.09698179452471264
107085,SIDM00146,AZD6482,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.9180343,-0.10828941,0.21998093686520043,0.03755293896707031
49777,SIDM00097,RO-3306,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.5240107,0.093852915,0.4559605165335943,-0.022732906783840053
28555,SIDM00097,Afatinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.1775742,-0.19532092,0.22026640595228453,-0.012107040322523537
90915,SIDM00673,Nutlin-3a (-),Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,2.5707672,0.09659465,1.872100603883908,0.0576301250793642
10568,SIDM00778,LGK974,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,2.3176455,0.073480375,-0.10725267911416383,-0.012804871598700028
92180,SIDM00673,SCH772984,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.2110322,-0.15812507,-0.20026749704919455,-0.03401617343378707
73784,SIDM00146,RO-3306,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,0.3293496,0.018582253,0.014711438552751548,0.02789944711008333
38385,SIDM00193,AZD7762,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,East Asian,53.0,1.5486372,0.089947425,0.5153781900555667,0.026971842361023863
76726,SIDM00673,BI-2536,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,2.6348424,0.15925068,0.03296366376453437,0.02811559792772594
12775,SIDM00359,Dabrafenib,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.3831053,-0.06177525,-2.6548158106109727,-0.059317328249264445
26888,SIDM00097,Crizotinib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.50638217,0.03324019,-0.04258283086829553,-0.02841646050110943
86911,SIDM00529,Uprosertib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.9289051,-0.08488404,-1.0455787988970677,0.012221107929829618
95065,SIDM00146,Tozasertib,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-2.200888,-0.116196506,-0.5825558451730138,0.014073182698182916
31848,SIDM00774,MK-2206,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,3.044922,0.03494306,0.4812875876976944,-0.021595720908390466
89327,SIDM00097,Temozolomide,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.90831697,0.015977884,2.2627122907474373,0.03749113003436729
6444,SIDM00146,Gemcitabine,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,0.3777048,0.026971593,0.17337751542159807,-0.04492905833664005
42018,SIDM00531,Crizotinib,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.27026883,-0.028422995,-0.4049154915251099,-0.007223112208908715
82454,SIDM00628,Crizotinib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.7698616,-0.06420016,-0.5806493947418192,-0.04054644875352614
4650,SIDM00866,KU-55933,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-1.8046833,-0.068761684,-1.1780361079816564,-0.010150285885802844
20446,SIDM00130,Sorafenib,Irinotecan,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.737467,0.07337754,-0.9125906593509183,-0.07465350778192587
91130,SIDM00971,Doramapimod,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.4458313,0.053396784,1.306917161634972,0.0975826850714965
29142,SIDM00529,Pictilisib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,0.7028594,0.055082966,0.6715272675517698,0.05012489772237616
93089,SIDM00332,Linsitinib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5318589,0.077899516,1.5805956718816885,0.04462062616236085
63717,SIDM00878,NU7441,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-0.29568478,-0.026579613,-0.20001076176972782,0.009915353721887978
64580,SIDM00774,Alpelisib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,0.52042925,0.034529056,0.8566793489114091,0.007455041861941028
4248,SIDM00875,JQ1,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5232368,-0.056339618,-0.9895578390982983,-0.10929716435750848
18380,SIDM00411,Sorafenib,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.0952805,0.0636675,0.2495387075848125,0.027172078124269885
68000,SIDM00193,SB505124,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.0549598,-0.08013111,-0.6143237747566958,-0.01169338481312889
70566,SIDM00097,MK-1775,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7710887,-0.07804422,-0.08245750467605263,-0.014866630811308493
62407,SIDM00529,SCH772984,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Black,44.0,-1.2515734,-0.045690265,-0.1506841285969916,-0.017245842585683638
62910,SIDM00332,Pictilisib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.4102889,-0.041111887,-0.6658933927429105,-0.0732459027188244
100213,SIDM00332,Olaparib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.9025837,-0.04370887,-0.3631637798311737,0.011686816321273014
93116,SIDM00778,SCH772984,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,1.5315545,0.047982723,-0.07790029538457721,-0.028833777262628087
68106,SIDM00146,Sorafenib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,1.6242638,0.13350804,1.7918140253528254,0.05884090810168255
74198,SIDM00097,OSI-027,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.7431498,0.15962856,0.21000371661039247,-0.005827166993702572
90285,SIDM00332,Camptothecin,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7405528,0.04144896,1.549292278139087,0.017435687499787265
41836,SIDM00878,AZD6482,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-0.2876514,-0.01962395,-0.7475284780101762,-0.015800212574938993
70009,SIDM00878,Lapatinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.4942775,0.12927553,0.7712099800778556,0.056773025860939
103078,SIDM00893,Olaparib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.9230133,-0.06353922,-1.1388107526252254,-0.06851564529168847
85932,SIDM00875,RO-3306,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.52276444,0.057331868,0.29424082915296484,0.015561236944249017
83651,SIDM00531,Paclitaxel,Lapatinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.7537267,0.31218928,-0.16795134192865135,-0.020905504561026057
54437,SIDM00097,Navitoclax,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5431663,-0.085877985,1.108551725421337,0.07559840404523527
92794,SIDM00954,JQ1,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.6077653,-0.13498497,0.3316399002938505,0.01027034031292967
42948,SIDM00673,Ribociclib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-2.8725417,-0.085088976,0.20924602435097742,0.04459249182824443
105947,SIDM00628,RO-3306,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.95067406,-0.09011823,-1.110895408487399,-0.07092059422806822
12007,SIDM00774,Pictilisib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,0.84998673,0.023004593,-0.4004909529161731,-0.019729794169267064
57612,SIDM00097,Lapatinib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.1894677,0.15567425,0.05289214124675546,0.012613779041606323
80363,SIDM00866,Ribociclib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-3.569686,-0.117575444,-1.025583992415804,-0.06056449015496053
35176,SIDM00774,Dabrafenib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-1.0538248,-0.030444955,-0.6529447612002549,0.002478247722013319
93243,SIDM00866,Paclitaxel,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-2.194218,-0.183561,-2.6468698256448175,-0.22910863916442922
74891,SIDM00193,Navitoclax,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.2570477,-0.083244175,-0.09585111316682582,0.01513449652988154
52416,SIDM00411,Sorafenib,MK-1775,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,-3.365235,-0.11307894,-0.7550940791519464,-0.050087946643845735
14603,SIDM00146,JQ1,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,0.9491524,0.07148164,0.12824390981435796,-0.04114839760318502
69794,SIDM00332,Alpelisib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.5588837,0.18165107,-0.7829295680316308,-0.01689891160275396
44886,SIDM00673,5-Fluorouracil,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,3.7959552,0.28103194,0.891398905171709,0.03250809241913397
22986,SIDM01233,Vinorelbine,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,0.6087663,0.04528253,0.13005881187628393,0.00907203833432732
52921,SIDM00628,Palbociclib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,Black,51.0,-0.22059937,-0.007732483,-0.5261728772570591,0.006022998022594556
40954,SIDM00893,Crizotinib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.3070086,0.059086304,1.8983783999445407,0.10720318581983786
9539,SIDM00866,OSI-027,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-1.8859241,-0.10808991,-1.6117066553810087,-0.08831513425699378
102837,SIDM00875,AZD8055,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2307827,-0.12085042,-0.8172597354526433,-0.03004344092039263
60888,SIDM00146,Gemcitabine,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.43784958,0.028479027,0.6139520368271456,0.002566749244301719
41267,SIDM00875,Entinostat,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1219573,0.116318226,1.1426334495867343,0.09589975840040632
29660,SIDM00878,Vorinostat,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.839294,-0.09841405,-0.8538024043365423,-0.07691510962729281
101637,SIDM00778,Afatinib,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,-2.1200838,-0.06280367,-1.2517665094466006,-0.0663470955673675
2314,SIDM00628,AZD7762,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.7091409,0.12163195,-0.8575281864268536,0.013918656475061235
85959,SIDM00097,Venetoclax,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.576567,-0.040566836,-0.09070524051663079,-0.009271385396722603
22039,SIDM00529,GSK269962A,OSI-027,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-3.284955,-0.17543243,-1.2650073262539676,-0.037674427770511124
33294,SIDM00776,Afatinib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,0.95359945,0.061718907,0.47630330707501595,0.025789090319281942
44156,SIDM00130,MK-2206,SCH772984,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,4.326367,0.28268462,2.365412559942319,0.18011640128926848
4762,SIDM00774,Temozolomide,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.6861312,0.00904675,1.1332517639048842,0.0076324626434137845
87143,SIDM00834,Olaparib,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,White,66.0,0.37724465,0.009354256,0.8037165602873518,0.018974884122791826
89480,SIDM00193,AZD8055,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.4179393,0.03412585,0.23607443505174913,0.05619727953313304
93822,SIDM00529,Dabrafenib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,1.0327482,0.021384241,1.022022297676885,0.05740132307688151
92754,SIDM00146,Alpelisib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.6662596,0.1042938,0.13317530246556397,0.04977532030371175
43320,SIDM00878,Cisplatin,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.97877765,0.02555677,0.855214035673328,0.034108408551033136
89118,SIDM00774,Sorafenib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,0.7770888,0.055918958,0.04105785041035336,0.018660135759586614
21648,SIDM00866,PF-4708671,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,-0.015814072,-0.0008543798,-1.173664595233009,0.0048001099874148655
30387,SIDM00954,PD173074,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-2.5437694,-0.13068064,-1.859482741026141,-0.1296117885827954
81932,SIDM00893,RO-3306,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.7332948,-0.13594262,-1.5622248401812524,-0.07512236599669529
37589,SIDM00779,Oxaliplatin,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,-3.4361672,-0.11382055,-2.2267706951341086,-0.06247160167491
5777,SIDM00531,Sorafenib,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.56699574,-0.06848228,-1.3496754543197027,-0.10167027969166724
15925,SIDM00778,5-Fluorouracil,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,0.23865673,0.010785408,-1.3661320122312575,-0.0752540136350214
51890,SIDM00359,Vinorelbine,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6614875,-0.07534172,-1.4490681240966938,-0.018952913177520684
43111,SIDM00097,RO-3306,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0968937,0.065113045,0.002964313333285996,0.0370574273410455
99324,SIDM00778,Nutlin-3a (-),AZD7762,Large Intestine,0.0625,Cecum Adenocarcinoma,Male,White,69.0,1.0456204,0.026509514,0.7632724652352392,-0.0032450751724600237
32106,SIDM00673,5-Fluorouracil,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.31169376,-0.013316861,-0.28845040675927786,0.005370701351903044
33893,SIDM00411,Irinotecan,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,5.1233807,0.29886487,3.681398443609954,0.21279898718595072
21604,SIDM00971,PD173074,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.5666485,0.08749211,-0.38973777739294163,0.05111563880234122
68666,SIDM00146,Taselisib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-2.5881886,-0.11815106,2.6967810190121706,0.15305200744115863
68397,SIDM00628,Gemcitabine,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,1.8768251,0.035865393,3.693437879978593,0.055802287821602126
46736,SIDM00673,Tozasertib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.2121096,-0.15288909,-1.2631269067941369,-0.04714567366345364
22291,SIDM00529,OSI-027,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.95930284,0.091055356,-0.06870516648903054,0.06924018008250298
40511,SIDM00774,Temozolomide,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.35354152,0.009013076,1.2412906638311842,0.035650507730551666
81699,SIDM00359,AZD4547,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.30916435,-0.01691014,-1.869016139699023,-0.05895965800117916
86836,SIDM00146,5-Fluorouracil,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-1.5989809,-0.09046765,-0.886977626646785,-0.022777678906719896
97020,SIDM00774,SCH772984,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.996532,0.10058742,2.9303593744242042,0.14426011216660706
95080,SIDM00097,Trametinib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.86279213,-0.01877293,0.7462363397263894,-0.0062638015698417105
55064,SIDM00866,Axitinib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,1.3977622,0.105617434,-0.17824897566349035,0.047779147396300944
81499,SIDM00893,MK-2206,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.0593011,0.13516144,-2.1037190754404653,-0.14691602171905785
39344,SIDM00875,Vorinostat,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5045376,0.058963496,-1.077319732554402,-0.019423367718501536
8690,SIDM00893,MK-1775,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.073286615,-0.0078121205,-0.8195972821883261,-0.0652800146775411
29916,SIDM00097,Camptothecin,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.0569808,-0.0024244871,0.3161922337930592,0.04346463608265355
11740,SIDM00875,5-Fluorouracil,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.8380716,-0.086353675,-2.040520423948656,-0.0973013277074355
93337,SIDM00359,AZD8055,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7842147,-0.07713717,0.06923262453385416,0.03426881010187488
49905,SIDM00332,KU-55933,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.6488154,-0.054864552,-1.4512456482996876,-0.017072134739934748
21518,SIDM00146,PF-4708671,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.1543413,0.039637547,3.1619993139064864,0.15612392984661455
26498,SIDM00875,Lapatinib,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1629753,0.123387106,1.5942753842159663,0.07194109122738808
51393,SIDM00628,Camptothecin,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,2.324918,0.1833163,0.9072139563374197,0.060115667264913554
38347,SIDM00954,JQ1,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-1.0306959,-0.081953675,0.30773111588639185,0.0664086864868245
95868,SIDM00660,Navitoclax,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,1.9963542,0.18165474,1.1233144670430262,0.0852535650498262
52038,SIDM00774,Afatinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.6395905,-0.048363995,-0.4697809535035627,-0.027441640598305263
60163,SIDM00971,Luminespib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.3620954,-0.10730486,-1.7045490092708977,-0.07670386609434927
53730,SIDM00097,Docetaxel,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-6.298429,-0.33491483,-3.3653013560951988,-0.2337945920383835
89363,SIDM00332,Taselisib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.0384967,-0.17565958,-3.2755462722429485,-0.17081575072166702
21867,SIDM00411,Taselisib,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.70377356,-0.034214415,0.29979495342706713,-0.005841279508616895
99871,SIDM00660,AZD8055,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,-2.278797,-0.11346782,-0.6298056710920235,-0.0443481215350771
95733,SIDM00193,MK-2206,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,53.0,-0.82933253,-0.061135698,0.4062500811785378,0.08896614772086907
12932,SIDM00878,Entinostat,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,2.3603609,0.14763644,1.4994927855942588,0.12458591003679793
87898,SIDM00893,RO-3306,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.39756837,-0.031540643,-1.273583651703359,-0.049211038145759625
81963,SIDM00971,AZD7762,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.5213728,-0.010889647,-0.5325845578991827,0.04453465895701901
82082,SIDM00097,Nilotinib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0001391,-0.058436472,-0.1215899748261474,-0.02080896945841367
55170,SIDM00193,Dabrafenib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,East Asian,53.0,-0.8190548,-0.019028248,-0.22894257358897482,0.005401226273008365
49658,SIDM00097,MK-2206,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1616375,-0.07639558,0.7379189598646818,-0.02314471016833135
6984,SIDM00628,Alpelisib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,3.0699215,0.23359738,0.7621557342135661,0.14639427682133205
25621,SIDM00301,MK-2206,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,50.0,2.8429945,0.29986933,0.24983840496179568,0.03075770702150585
23300,SIDM00097,Luminespib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.19611824,0.013846043,-1.044572723829699,-0.041038013236094996
73587,SIDM00531,Ruxolitinib,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.059035,0.118161194,1.720842320059269,0.046744502832729795
76703,SIDM00782,Navitoclax,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.38237867,0.035485197,0.16387925103143308,0.0183142826161082
70947,SIDM00776,Crizotinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.3548281,-0.11294498,-1.7988239966172443,-0.04932851702167712
80983,SIDM00531,Ruxolitinib,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.5292277,0.15004218,1.5483025108649773,0.03035511179515439
87222,SIDM00529,Tozasertib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Black,44.0,3.9326031,0.20988397,-0.014798362785427793,0.04601964730111765
25823,SIDM00146,NU7441,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-0.8480905,-0.082366094,-0.23085141774175716,-0.013500167929625299
94016,SIDM00301,Linsitinib,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.0987699,-0.027146844,1.274436339730896,0.010842131012678002
48715,SIDM00878,Dabrafenib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,2.4325306,0.04904779,1.0758862261406354,0.014822724169810094
102847,SIDM00193,MK-1775,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.5902062,-0.043247905,-0.3162832752697445,-0.011105279945193966
80665,SIDM00097,Tozasertib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9888655,-0.061981265,0.37435933889121653,0.024575511077420252
73890,SIDM00097,Alpelisib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8867398,0.06527975,0.8180147006724127,0.07498025614534312
4558,SIDM00130,Navitoclax,OSI-027,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.48542193,-0.041910727,0.47929705345434864,0.07211651378972658
103459,SIDM00893,Venetoclax,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.0952979,-0.027482899,0.38266315221425634,0.0030607649251357875
22451,SIDM00778,BMS-754807,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,0.1959792,0.012090148,-0.09122668064253954,-0.043076828858181836
62584,SIDM00531,Palbociclib,Dactolisib,Pancreas,0.0125,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.6870309,0.1256761,0.5937775640045531,0.02490589778719206
45142,SIDM00097,ZM447439,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.92637646,-0.033429317,-0.8019642527844487,0.007879163440550672
101678,SIDM00097,MK-1775,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.6510136,-0.041681077,-1.2265717827034432,-0.07520232042999188
3149,SIDM00628,Bortezomib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,0.7643209,0.042575445,-0.15661826043241708,-0.011638632272047188
64433,SIDM00673,Axitinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.21462782,-0.021538781,-0.6570112125312182,-0.03263490096701557
36183,SIDM00332,Luminespib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.9126532,-0.19270684,-1.54357983020025,-0.11826403075376317
32414,SIDM00146,Lapatinib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.85640085,-0.06497596,-1.2642277443339587,-0.07166957022917961
9091,SIDM00875,ZM447439,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.43794852,0.051721074,0.3359296094502234,-0.01025751125903739
64356,SIDM00097,Olaparib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4386305,-0.029539501,-0.837679411903735,-0.023753133913058916
34110,SIDM00332,Bortezomib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.34694424,-0.022048885,-0.6764808313425703,-0.02369613934518617
101682,SIDM00097,5-Fluorouracil,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.2452786,-0.14104247,-0.7378211835950546,-0.07223912773345677
5887,SIDM00332,Nilotinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.3771267,-0.029189799,-0.8727648405290951,-0.042009335517561405
60562,SIDM00893,Temozolomide,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.8819774,-0.019969115,-0.18561854800713376,0.0069717160494285535
47141,SIDM00866,Sorafenib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-0.9675058,-0.038354784,0.2914026148427773,-0.0008292294307697242
85631,SIDM00673,ZM447439,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-0.93388647,-0.066147156,-0.7461392138326267,-0.053362152470776684
48588,SIDM00875,Tozasertib,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.1417696,0.14371854,1.1350858900930838,0.00234872150986987
107336,SIDM00834,Trametinib,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-3.816473,-0.19464521,-1.6414015506081399,-0.10286387631946071
96550,SIDM00866,Doramapimod,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.4223121,0.034149744,1.8098789365130483,0.07055899294219999
68625,SIDM00673,Nutlin-3a (-),Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,3.7367618,0.17700726,1.9675345538970248,0.024399277410512316
108447,SIDM00531,Linsitinib,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.83679956,0.047409993,2.0889560029831102,0.12025465677136465
103530,SIDM00529,Crizotinib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Black,44.0,2.3148296,0.14549641,-0.7584469691864086,0.019353442607353225
5161,SIDM00971,Taselisib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.30554584,-0.021147704,-0.08224276481164376,0.02297835565079581
108135,SIDM00097,Linsitinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7820913,-0.052458882,0.45929345616822165,0.023028738377483267
101527,SIDM00130,Irinotecan,Gemcitabine,Pancreas,0.1,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-3.9932675,-0.20950776,-2.253870879244072,-0.14226912316562468
39948,SIDM00778,Palbociclib,Crizotinib,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,69.0,-2.0913644,-0.079395466,-0.00918480376922439,0.03078611532974766
83108,SIDM00878,ZM447439,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.8396462,-0.07362044,0.10480702176678287,-0.07326286331306968
36730,SIDM00097,Palbociclib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8870276,-0.03768181,-1.305055375929253,-0.007888076108146866
88077,SIDM00332,Olaparib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2696096,-0.028019253,1.4394520697241495,0.057380498273252735
91268,SIDM00954,OSI-027,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-2.7869549,-0.10780382,1.1538280858221386,0.12162793319035828
13661,SIDM00778,Palbociclib,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,2.508871,0.107546344,0.507101948875549,0.002066530877034951
32650,SIDM00875,GSK269962A,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4526187,-0.062163714,-0.5774401612129836,-0.011414434109215233
77492,SIDM00660,5-Fluorouracil,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,32.0,0.34866768,0.031779427,-1.0772438943526557,-0.07896923106211755
12192,SIDM00531,LGK974,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.598202,0.06707806,-3.106295939581923,-0.10719868092985374
54351,SIDM00774,Docetaxel,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.53555197,-0.05687582,-0.5894191128924445,-0.06842772455075796
80319,SIDM00529,BI-2536,Axitinib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,0.8807701,0.06842829,-2.1316403141969715,-0.09917833526140409
95062,SIDM00834,Linsitinib,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,White,66.0,1.2407794,0.095387936,1.0819017485927478,0.035654303373801655
13084,SIDM00954,AZD7762,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.0,-2.7439616,-0.18474014,-0.8762809087191353,-0.06303409905864585
57349,SIDM00875,Vorinostat,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.54101646,-0.058224972,-0.12214968623516607,0.026446947487155415
53913,SIDM00774,Uprosertib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.8323142,-0.060829345,0.5614265569878933,0.06082196595998767
2326,SIDM00778,Taselisib,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,0.55715406,0.026182989,-0.279879021178876,0.0036091659493737525
60136,SIDM00146,OSI-027,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.1712894,-0.11186605,-0.083127137950316,-0.00022815908341750733
62467,SIDM00893,Palbociclib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.72749025,0.038457897,0.2556299975918317,0.0938097393625782
81644,SIDM00146,Crizotinib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.7280642,0.059243076,-0.391434956165093,0.04300230037648802
62043,SIDM00359,AZD4547,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.60824746,0.041879565,-0.18144894815783694,-0.005593093311013375
41162,SIDM00529,Taselisib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,-0.5866213,-0.036297873,0.5947975348794445,0.10560842836420561
73576,SIDM00778,Taselisib,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-0.5541125,-0.03458719,-0.5621120026110374,-0.050541413653857316
8082,SIDM00878,Afatinib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,70.0,0.51053107,0.04391758,0.3883363396592785,0.03416987739662485
61614,SIDM00779,Olaparib,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,1.4749871,0.016681949,1.8412557422413325,0.05916311467551166
91499,SIDM00834,Palbociclib,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Female,White,66.0,-0.7197839,-0.055172578,-2.166842076258952,-0.08615910211499711
59084,SIDM00529,Venetoclax,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-0.34226152,-0.009824712,1.1969859445371007,0.07028440116320032
61505,SIDM00866,Alisertib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-2.5986016,-0.16946675,-0.3789113743240652,0.005193126874852544
706,SIDM00628,MK-2206,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.3401533,-0.02435476,0.46496251383509435,0.04296775443575656
51775,SIDM00834,BMS-754807,Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,White,66.0,-0.4071508,-0.033734042,-2.1190971375283576,-0.1146344687073146
27129,SIDM00673,Olaparib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-2.0740347,-0.08880971,-1.128467787524162,-0.026343782575295526
75134,SIDM00893,GSK269962A,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.3371617,0.08106502,-0.7112756528699882,0.016459514887498063
104111,SIDM00529,Bortezomib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-0.096227996,-0.007160772,-1.212047889649327,-0.061094053875989845
31144,SIDM00866,BI-2536,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-0.59468657,-0.03030131,0.5577136442822686,0.040694483201132184
58713,SIDM00097,Palbociclib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1348283,0.039331015,1.4835090624447924,0.06409770443369554
55521,SIDM00673,Navitoclax,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,2.2410426,0.22104253,0.44574785781924303,-0.02336175670343479
71273,SIDM00130,MK-2206,Irinotecan,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.4363439,0.13486893,-0.14890753383099042,-0.019207587765198108
54721,SIDM00774,MK-1775,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.3329586,-0.04696858,-1.399790125744789,-0.06845462224004076
65522,SIDM00673,Taselisib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,0.50227565,0.043455254,1.1522646512083654,0.12348265989804855
56513,SIDM00774,AZD8055,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,-1.1237309,-0.072289065,-1.2296087069080874,-0.08012562977740437
44375,SIDM00866,NU7441,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-0.69929546,-0.024723696,-0.5466767060943167,0.006650899999947427
19997,SIDM00954,Camptothecin,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.8291409,-0.027554706,-0.07682579776861931,0.014508703567786484
94677,SIDM00411,Irinotecan,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,43.0,-0.7922588,-0.030723264,-0.22051287591313756,0.025694681998534138
91691,SIDM00146,Alpelisib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.548902,0.10152943,1.0115075035720318,0.13802123436637104
92057,SIDM00097,BI-2536,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3691976,-0.17225213,-2.2209887121188117,-0.13229072721941706
5243,SIDM00954,Wee1 Inhibitor,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.0,-0.76330394,-0.06051325,-0.9179905475920334,-0.0774999746280019
90474,SIDM00774,Docetaxel,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.43148616,-0.04496685,0.20980249397799028,0.0123185551427132
101582,SIDM00332,Palbociclib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.4826329,-0.14516906,-2.1760679286139295,-0.14976893019834414
31825,SIDM00893,BI-2536,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.65802205,0.05875574,-1.2226656960017641,-0.03588525067881881
99202,SIDM00097,Camptothecin,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.37619004,-0.018866751,0.2882230536264511,0.01661735906917503
25084,SIDM00834,Oxaliplatin,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-0.47065026,-0.0345172,-1.9542501660236817,-0.10013386283648976
14498,SIDM00776,Dabrafenib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.8722856,0.03838303,-0.5269160895597035,0.013567919265105572
65612,SIDM00673,Axitinib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,1.0927615,0.09253429,-0.392335806459191,0.028874864608091078
15103,SIDM00529,Bortezomib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,0.46589795,0.026143016,0.3710656440313604,0.033842416993884725
49431,SIDM00146,Afatinib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.331318,-0.115907066,0.5275592532121847,0.04583699727439553
79986,SIDM00146,Nutlin-3a (-),Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.41504622,-0.010991798,1.6663128352626293,0.061683279909542296
52957,SIDM00359,Linsitinib,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.1153572,0.08284921,-0.4735822390342927,0.07217717319078155
48101,SIDM00146,MK-1775,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-0.5371977,-0.045847077,-0.7535083353051264,-0.05562113747771832
93081,SIDM01233,Afatinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-1.8920057,-0.11096164,0.719948496542002,0.08004885747371102
74602,SIDM01233,SCH772984,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,1.9276925,0.085506566,-0.18239530207473925,0.04805350858073613
6289,SIDM00893,JQ1,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-3.05994,-0.10875399,-2.803271188148921,-0.12310299027530827
70275,SIDM00301,LGK974,Gemcitabine,Pancreas,0.1,Pancreatic Carcinoma,Male,East Asian,50.0,-2.6607928,-0.16807978,-2.474701486365053,-0.11358694962789337
45406,SIDM00628,Nutlin-3a (-),Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.3596473,0.07030828,0.2987629103005145,0.09099073624400723
1460,SIDM00332,PD173074,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,6.093047,0.24445209,0.4300154084578511,0.03219156515708715
73486,SIDM00529,Dabrafenib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,1.0178217,0.021031106,0.7231777745194942,0.04858048242169675
36550,SIDM00893,Ribociclib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.7173169,-0.08780312,-1.2279240108322516,-0.005625058295946164
7919,SIDM00834,Taselisib,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,4.449274,0.34077308,2.6638220510791544,0.14547384440228392
65340,SIDM00893,GSK269962A,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.2456942,0.094743386,-0.12775806572887785,0.04137489896397218
23607,SIDM00531,Palbociclib,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.4025568,-0.05491535,-1.3948826503002862,-0.02512572689489426
35435,SIDM00971,KU-55933,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7531849,-0.025194237,0.1259064591475328,-0.008714718402578028
26115,SIDM00782,Vinorelbine,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.4412695,0.12934038,2.8826477671537227,0.19887852752422444
49078,SIDM00776,Olaparib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.46278974,0.022061603,-0.4419959769226061,-0.026848582777818365
93556,SIDM00893,Taselisib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.1901659,0.03727689,-0.5894959360086733,-0.0122287335975783
79303,SIDM00782,AZD4547,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,2.634909,0.08812156,1.8662021994700126,0.04596815124981638
87368,SIDM00673,AZD7762,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6150811,-0.05034629,0.669095209753751,0.003201546390905613
86817,SIDM00411,Navitoclax,AZD7762,Pancreas,0.0625,Pancreatic Carcinoma,Male,East Asian,43.0,-1.4694604,-0.08309552,-0.3170068807088684,-0.004473272635494359
79424,SIDM00778,Dabrafenib,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,69.0,0.65903276,0.015277473,-0.3183767095508482,-0.0020084166062614935
73533,SIDM00866,Venetoclax,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-1.0180715,-0.02383126,-0.27762240090758433,-0.005627316031383016
22716,SIDM00529,KU-55933,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Black,44.0,-0.8307448,-0.013042457,0.603908746401394,0.02420981405374697
100420,SIDM00529,AZD7762,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-0.9744164,-0.074933454,-1.1570375194734481,-0.0553508955325976
2496,SIDM00130,AZD7762,Paclitaxel,Pancreas,0.0025,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.5874214,0.057793003,-0.027984952503555396,-0.004880755640740643
9538,SIDM00660,Nutlin-3a (-),BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,4.097105,0.16707315,4.165515457816423,0.13337630841891998
66013,SIDM00782,Trametinib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.15136753,-0.011277728,-1.1052543142475109,-0.07196925458088231
76914,SIDM00774,Axitinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.3089253,-0.09811689,-0.7476701387649011,-0.004787482190002717
24839,SIDM00875,Ribociclib,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.47567326,-0.0028138126,0.14157467218019637,-0.0033207578644290003
69904,SIDM00673,Entinostat,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-1.6814139,-0.106766865,-0.6896043018292466,-0.06279087212775379
74916,SIDM00146,GSK269962A,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,6.7379637,0.3839492,3.3276946484738286,0.19376381437325163
85439,SIDM00673,Olaparib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.2687973,-0.051725484,-2.277170211148567,-0.07350602038774294
26377,SIDM00628,Luminespib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-2.919764,-0.20718691,-1.3015137008690374,-0.06552823906896917
22970,SIDM00779,AZD7762,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,33.0,0.60542953,0.03102722,-1.131992983135983,-0.07492700382843927
9724,SIDM00866,SCH772984,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-1.3256936,-0.093699284,-1.5843219855000998,-0.08294629383722842
38628,SIDM00878,Temozolomide,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.37366256,-0.009950646,0.8922080519875147,0.02689681416037333
85638,SIDM00673,Lapatinib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.8967959,-0.07683599,1.0357172545012248,0.08318658788545805
83271,SIDM00146,Camptothecin,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-2.1631598,-0.15335067,-1.780126320536674,-0.15341468285519563
93974,SIDM00529,Temozolomide,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.58246017,-0.012418236,-0.612683517178913,0.02323315448728671
83600,SIDM00878,Gemcitabine,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.9305151,0.087445684,-0.7629264931294524,-0.008952948418137369
44067,SIDM00971,Afatinib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.8152173,-0.14805724,-1.6982685312421728,-0.0663281520583818
16538,SIDM00660,Taselisib,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,32.0,-2.0385642,-0.14214738,-2.428851134645106,-0.11432926566996764
94788,SIDM00782,Oxaliplatin,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,Unknown,72.0,-3.0376358,-0.11302524,-1.710587925339589,-0.02059890392292472
86487,SIDM00301,Navitoclax,Olaparib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-2.2992384,-0.11901812,0.1291612508320897,0.06003444933613358
53838,SIDM00660,MK-2206,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,4.2253566,0.32970044,2.7911091198265052,0.20266519817522713
80677,SIDM00628,Docetaxel,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-4.9721727,-0.45047367,-4.10227155699435,-0.225620342883659
41353,SIDM00097,5-Fluorouracil,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0032947,-0.083064884,-0.5873141576652563,-0.06444778337904963
91270,SIDM00097,Doramapimod,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1839195,0.03228505,0.8806616923166998,0.021233919604523102
42813,SIDM00301,5-Fluorouracil,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,-1.3818011,-0.18440887,0.8576539472006257,0.021990301136997268
10722,SIDM00866,Alpelisib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-2.51757,-0.13413711,-1.326063746644552,-0.08934908746318745
35310,SIDM00301,Sorafenib,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,50.0,-0.8728201,-0.06991576,-0.6700480287295745,-0.019404300750846502
91536,SIDM00866,Olaparib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.0727687,-0.022537544,0.1374142624487874,0.035556658455253506
91676,SIDM00954,PF-4708671,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-2.7246258,-0.11231439,0.03717154062584504,-0.042737579699844847
62193,SIDM00628,Venetoclax,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-2.2572083,-0.08362776,-1.2819740390694658,0.005267624069328842
76031,SIDM00774,Docetaxel,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-0.54164153,-0.0395229,-0.07036933038492012,-0.04443153659156213
4550,SIDM00146,NU7441,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-2.2266576,-0.2105052,-0.6248983321714869,-0.06268055470880365
61524,SIDM00531,Paclitaxel,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,4.79834,0.44837075,3.449758882386773,0.23400475754846528
93203,SIDM00866,AZD6482,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-0.22286567,-0.013229042,-1.0400652736004767,-0.011296111669373669
49541,SIDM00866,Nutlin-3a (-),Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,1.4431607,0.060006812,-0.3236594238626646,0.017002187607414017
81991,SIDM00875,Entinostat,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2720276,0.12850961,1.1132832098968148,0.05837536975213569
47354,SIDM00130,MK-1775,Irinotecan,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.68931025,0.0663182,-0.8988367394592428,-0.009680170036295281
65307,SIDM00531,Oxaliplatin,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.9240222,0.17596398,0.5507928461251602,0.0439580769429898
96458,SIDM00893,Wee1 Inhibitor,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.5742455,0.048294794,-1.106432014525309,-0.06911096464281022
53334,SIDM00782,Linsitinib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.5655462,-0.021174012,1.2312831505379618,0.07684762642355204
46939,SIDM00971,PD173074,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.014703,0.10695957,1.911425075378485,0.09711995911425339
82621,SIDM00146,RO-3306,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.9742483,0.1654338,0.38604545998257705,0.024080356300258857
23683,SIDM01233,Vinorelbine,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.2822112,0.083097756,2.1735785193277377,0.15708406185304397
60964,SIDM00878,GSK269962A,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.998119,-0.08432752,0.21508220914666049,-0.005527756137606705
98284,SIDM00673,Axitinib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.399334,-0.13142383,-0.8438887654210682,-0.0747777244908377
76586,SIDM00529,AZD8055,OSI-027,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-1.4016916,-0.09600849,-1.2812615470406852,-0.07456732596187146
67275,SIDM00878,OSI-027,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,70.0,2.8879943,0.30052784,0.6354099144953383,0.1112786883652519
48964,SIDM00097,Camptothecin,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,4.9745874,0.33162284,2.896171076135156,0.16923780489286144
70086,SIDM00954,Tozasertib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,1.8321136,0.13379052,-0.8937774053234573,-0.022025380147989555
8433,SIDM00875,Navitoclax,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.28973442,-0.03370103,0.14530975666855844,0.008717108082431476
82934,SIDM00875,Navitoclax,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0713766,0.09245049,0.579437967804528,0.01611822201453483
49792,SIDM00875,Navitoclax,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.431002,0.046846747,0.3621701760732443,0.004564888888405324
62226,SIDM00971,SCH772984,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,10.742307,0.27615076,2.478656071692284,0.10802698424960203
67021,SIDM00529,Crizotinib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.1327451,-0.0644222,-1.0511287625265746,0.00619900109812304
69181,SIDM00628,Gemcitabine,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,1.2990651,0.03240599,-1.2087805538530487,-0.04754831230006278
73370,SIDM00146,Uprosertib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-3.0337489,-0.17726776,0.1335524936588386,0.01856219708980276
97065,SIDM00628,SCH772984,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,1.5233915,0.12262971,-0.3846910014897344,0.019898060922326332
95917,SIDM00411,Trametinib,Taselisib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,8.0305195,0.32629913,2.9385759932242914,0.1747593185664472
85688,SIDM00359,Crizotinib,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.77019155,-0.047336303,-1.6701943106468655,-0.08929218805818676
47101,SIDM00774,Trametinib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.2197535,0.11520584,0.31983931016125877,0.00604787536261823
72994,SIDM00866,Venetoclax,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,1.8406551,0.062015582,0.5808835285461275,0.03507010033553013
98697,SIDM00529,Pictilisib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-1.7523774,-0.112342864,-1.7464000005730784,-0.02310581906377966
20217,SIDM00893,Tozasertib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.735569,0.040791392,-1.30966983658657,-0.028448843945883668
44380,SIDM00529,Entinostat,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-2.19321,-0.04101951,-1.4555006982304681,-0.0273075289216688
26552,SIDM00834,MK-2206,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,1.297106,0.075931855,-0.5540571226307928,0.024412547029458137
55462,SIDM00130,Taselisib,Trametinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.334184,0.18582858,2.228418358704534,0.13968166894053197
51530,SIDM00628,Nutlin-3a (-),Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-1.3799661,-0.033599548,-0.1795057720390682,0.047455560390776405
201,SIDM00893,RO-3306,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.1609676,0.17808066,-0.5266505130756362,0.027614812543074678
48306,SIDM00971,Nutlin-3a (-),Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.9911132,-0.05123793,-1.9521109119867217,-0.051698515066400115
100729,SIDM00673,Crizotinib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,-0.60672563,-0.05068122,-0.14301863129743145,-0.0485446629294628
91378,SIDM00193,AZD7762,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,2.2238789,0.089185625,1.600356155422281,0.07366207450109145
14163,SIDM00971,Uprosertib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.1199424,0.09957658,-1.1019510520222364,-0.018817870156629207
95688,SIDM00866,AZD8055,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,3.113809,0.10512381,1.2662557079951484,0.05261866926714528
29324,SIDM00673,AZD8055,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.7040308,-0.05920928,-0.9475929985016759,-0.07074929930284965
91693,SIDM00893,Entinostat,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.6351194,0.037351273,0.817930775034619,-0.010270023362302132
40431,SIDM01233,5-Fluorouracil,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.6430129,0.10372115,-0.5825581781842841,0.011639105405030742
51771,SIDM00971,Paclitaxel,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.4501076,-0.10537632,-1.5997087100175469,0.018040563205350097
4164,SIDM00097,Axitinib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.2977357,-0.13581128,-1.454677185907037,-0.14791438169489887
72136,SIDM00774,MK-2206,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.59155273,-0.032548405,0.16283878725139303,-0.05604425287389317
2645,SIDM00834,Dabrafenib,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,White,66.0,-0.9865729,-0.028469482,0.1761406362774056,-0.004154574607437817
80114,SIDM00782,Vinorelbine,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,Unknown,72.0,-2.09463,-0.16936746,-3.578476547823184,-0.1854776675636189
70127,SIDM00531,Navitoclax,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,4.7193956,0.16253935,4.1334110123997965,0.2379203388751239
12178,SIDM00193,BMS-754807,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.9723351,-0.08581299,-0.12985146617381674,0.03880061732393232
103059,SIDM00529,Temozolomide,OSI-027,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-0.4826895,-0.009549662,-0.7315104517755441,0.02253825195455839
28202,SIDM00359,Dabrafenib,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,3.4161234,0.20844626,-1.731614301878845,-0.029237033543120704
22679,SIDM00774,Doramapimod,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.2846739,-0.055583384,0.22785064057096263,0.039321347725094616
14413,SIDM00954,Uprosertib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.6187961,-0.03780511,0.14042437684669506,0.04653020663710473
75371,SIDM00193,MK-2206,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.4997138,-0.09240317,0.1582853211304995,0.07062202426725452
101175,SIDM00332,Alpelisib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3146279,0.10509727,0.564741036982175,0.047449655367604926
53484,SIDM00866,Uprosertib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-2.7720714,-0.11460724,-0.5664378318107948,0.03390488100752917
91604,SIDM00778,BMS-754807,AZD4547,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-1.5884728,-0.10048006,-1.2362434470172816,-0.089198086581921
107613,SIDM00628,5-Fluorouracil,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.7727237,0.15417846,-0.996705271292178,0.035489730163062644
20727,SIDM00954,Alisertib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-3.7782638,-0.25144464,-1.3652749397907946,-0.04070876307683571
36292,SIDM00529,Linsitinib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-0.6325805,-0.012678789,0.44476095541642946,0.0063007807076999765
2220,SIDM00660,LGK974,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,32.0,1.3514582,0.074850924,0.20479452700313674,-0.008224904432568483
16285,SIDM00130,Lapatinib,Linsitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,3.3317518,0.31984475,1.8950330682022838,0.2263946094885215
80066,SIDM00332,Nutlin-3a (-),Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3406421,0.06069924,0.49134659520678664,0.018628386670958706
59222,SIDM00411,Paclitaxel,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.1054178,-0.032281134,-1.6597645740222702,-0.0034429000520825688
65610,SIDM00411,Taselisib,Lapatinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-1.0556695,-0.065439366,0.5879915502088621,0.0918375105157926
63835,SIDM00332,Luminespib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6191773,0.063133284,-0.6630632955291262,-0.04783984187240868
17988,SIDM00146,Palbociclib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,3.0909448,0.23082541,-0.335689747314018,0.07040672785859795
44356,SIDM00673,Nutlin-3a (-),MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,3.2585318,0.07628159,3.364416771055293,0.10124425784238816
54515,SIDM00866,NU7441,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.59905463,-0.038857076,0.4661799717437218,0.04562991223665682
28375,SIDM00359,Crizotinib,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.78009784,-0.054132584,-0.17562369046761167,-0.006717787476817212
32195,SIDM00673,Olaparib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-2.2697046,-0.048280638,0.4473252236601293,0.06349722516494354
8327,SIDM00774,ZM447439,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.0770446,0.07014956,-1.1460536249450506,0.0004537179589273566
14072,SIDM00971,Camptothecin,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.8066795,0.0752624,2.1292559848572807,0.07695012293354532
16603,SIDM01233,Crizotinib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.1796867,0.08146103,0.6617914541536531,0.06910536773564781
103570,SIDM00878,ZM447439,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,0.40449736,0.03463767,-0.7199376716869894,-0.03607536461828264
75611,SIDM00954,Uprosertib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.0,-0.27873686,-0.015504601,0.8401333400724765,0.11346410912411627
53452,SIDM00097,Alpelisib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.24167718,-0.015366999,0.7745646657940437,0.061646208095865726
61127,SIDM00146,RO-3306,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.7812356,-0.058019266,0.6186212260979873,0.07577769754658256
29241,SIDM00774,GSK269962A,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.53020155,0.032973725,-0.2575919727289011,-0.014651323712975957
21536,SIDM00660,Afatinib,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,32.0,-0.94422853,-0.103280134,-0.23650834358504122,-0.040410021903001254
94349,SIDM00893,Gemcitabine,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.4662969,-0.10816697,-2.2200861800446035,-0.06919974441775353
7137,SIDM00130,5-Fluorouracil,Linsitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.8364817,0.19558783,-0.2666218665380831,0.017951154334272062
69132,SIDM00954,Camptothecin,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-0.30973515,-0.008441487,1.592432342318121,0.06053995826058416
57603,SIDM00954,Palbociclib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.0,-1.9867904,-0.07984692,-1.7987625435714827,-0.03254088938244413
80400,SIDM00332,MK-2206,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,2.1416118,0.14271425,0.12015844203353225,-0.003086743211776047
26473,SIDM00359,Crizotinib,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.7790958,0.05783704,-1.019801179096407,-0.05400735127273948
18051,SIDM00673,Afatinib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.46736708,-0.035574343,-0.7313435744451553,-0.07393770334983137
60318,SIDM00660,Linsitinib,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,3.9927213,0.35106072,0.7460694520819112,0.058945996230676215
48671,SIDM00893,Luminespib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.2459345,0.09289502,-0.7526104368486958,-0.02427458128124084
40230,SIDM00097,JQ1,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8445585,-0.07332803,0.33114471561971115,0.026966613434685684
19277,SIDM00130,MK-1775,Ruxolitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.406273,-0.14313425,-0.7893399492905133,-0.07021240592444887
18502,SIDM00878,Vorinostat,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,0.25425974,0.030032886,-0.641903968597492,-0.053942715701763004
20168,SIDM00971,Sorafenib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.153067,0.07103527,0.15228320105811965,-0.03457060461739924
26369,SIDM00531,LGK974,MK-2206,Pancreas,1.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.21742958,-0.022320433,-0.6115926628587257,-0.002448250058222225
62289,SIDM00774,KU-55933,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-3.1181633,-0.09283618,-1.2821123046506622,-0.03165583947158998
93621,SIDM00529,Tozasertib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.7562051,0.03790748,0.6494366994190693,0.08518035664224673
58776,SIDM00875,AZD7762,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.056826305,-0.0038487234,-0.9347160801423977,-0.0406117136368363
28367,SIDM00130,Ruxolitinib,Linsitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.3175135,0.04274795,1.3779930100145492,0.0709337162592425
11952,SIDM00529,Lapatinib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.8770029,-0.055451907,0.7838596992434875,0.11231583201362771
72899,SIDM00146,Gemcitabine,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.48787677,-0.03752076,-1.3103596425882515,-0.11568546179134692
42890,SIDM00782,MK-1775,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.65590173,-0.042839676,-1.9739233460460914,-0.09969757518651898
104430,SIDM00893,Lapatinib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.6783368,0.06246084,0.19578991894655526,0.02440825335795077
39073,SIDM00954,Bortezomib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-0.49539703,-0.031151054,-0.6464221530608966,-0.005405742645695566
17062,SIDM00673,Docetaxel,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.3598963,-0.13273095,-2.5810919965096173,-0.21634825435055194
100207,SIDM00193,AZD4547,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.9129844,-0.08087731,-0.3068762849792625,0.02739232553369331
53446,SIDM00954,Docetaxel,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,0.88098496,0.054799985,0.3275813477711913,0.00796734210677716
93413,SIDM00878,Gemcitabine,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-1.4031578,-0.10003244,-1.28125450525439,-0.049547064137453155
36024,SIDM00971,Trametinib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.7481642,-0.012037459,0.18231817911145073,0.037434471955666675
33616,SIDM00146,Navitoclax,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.4643554,0.032767102,1.2256841816594577,0.03947982709274352
19773,SIDM00193,AZD4547,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.8483878,-0.06253271,0.27010150229005786,0.03430254588640565
44398,SIDM00971,Tozasertib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.8444579,0.07464868,1.1294299563293935,0.01436634057205442
88721,SIDM00971,RO-3306,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.7218735,-0.12432889,0.5967845773092969,0.022205728043657197
13622,SIDM00332,JQ1,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3350552,-0.042919397,2.4158041950773814,0.05586261516660778
91799,SIDM00954,Nutlin-3a (-),Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,3.0161316,0.06926397,0.986054888132267,0.02946546073378307
21629,SIDM00097,Alisertib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.8139796,-0.1640662,-0.13336972225919183,-0.0011426437197943954
78161,SIDM00776,5-Fluorouracil,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,1.5801493,0.066738494,1.516870472530738,0.07772030311944937
63339,SIDM00893,Crizotinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.6520016,0.02160886,0.953339566662964,0.060204365910892725
3504,SIDM00834,SCH772984,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-2.24447,-0.16253027,-0.4084875713309395,-0.01667573398824845
64977,SIDM00097,Venetoclax,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.149322,-0.049338765,-0.0278815835651857,0.0251458815313617
71446,SIDM00529,Ribociclib,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.61001796,0.021467844,0.8009724599605981,0.025332478661139374
14510,SIDM00529,Temozolomide,MK-2206,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-0.50130016,-0.01028427,-0.7551794495210125,0.03286219089750498
65767,SIDM00954,Gemcitabine,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,1.1969413,0.08694115,1.1348983204698935,0.08756039455930802
90256,SIDM00359,MK-1775,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.86663854,-0.07213514,0.18666344794587653,-0.013815774529440475
34962,SIDM00875,PD173074,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4190524,-0.066752575,-1.699576273689283,-0.022291458795360097
17053,SIDM00097,Pictilisib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.3184318,-0.021232098,-0.34651088852102935,0.018843158482284777
50518,SIDM00097,Luminespib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2180233,-0.086182766,-0.13826915786354804,-0.01896920409683858
29794,SIDM00875,ZM447439,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.88089293,-0.06967709,-2.0009624304201328,-0.13021564630444488
98317,SIDM00628,Linsitinib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,1.4658331,0.099051796,0.4754697557483205,0.08844656595159413
71916,SIDM00332,Olaparib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7206789,-0.03383974,1.1615088637113204,0.039971787312817454
48505,SIDM00954,PF-4708671,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-2.193534,-0.072456785,0.9553940216760002,0.0949236482621788
74953,SIDM00893,Cisplatin,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,6.1208835,0.35106108,4.554605604070537,0.14720749938410002
103985,SIDM00971,MK-2206,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.2455579,-0.06877157,-0.9683559635746073,-0.054929373387121574
7856,SIDM00332,Nilotinib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.17515606,-0.013570404,0.10172523107620984,0.0034216212168998806
24533,SIDM00097,RO-3306,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2896264,-0.1034244,-1.1923098631875442,-0.06068254081432854
76688,SIDM00954,Venetoclax,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-1.8455273,-0.13300171,-0.6036913996755194,-0.037567866097503566
64632,SIDM00301,MK-1775,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.98651224,0.09894201,-0.37647780242619944,-0.025029107987368893
65354,SIDM00628,Camptothecin,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-2.4460557,-0.16124979,-0.9474046420540881,-0.022481468649716466
42977,SIDM00301,Dactolisib,Dasatinib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,50.0,-0.75366277,-0.09989682,0.024124333577265608,0.034177160067250884
18045,SIDM00411,Lapatinib,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,4.6132765,0.17702973,4.646926186503413,0.1954557539458804
107996,SIDM00878,PF-4708671,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.9681574,-0.050839096,-0.042769428358293414,0.01882986176355014
81001,SIDM00628,Docetaxel,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,Black,51.0,0.29755533,0.025806136,0.5586912739429852,0.011396970581523896
102114,SIDM00875,Pictilisib,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.25192022,-0.01319358,-0.7930992084381122,0.03380709758875515
78985,SIDM00097,AZD8055,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3192482,-0.15617082,-0.2715440031545637,-0.03445516276808018
46759,SIDM00146,MK-1775,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.056648124,-0.0047447355,0.17759794095831688,-0.0034747912868851325
106626,SIDM00628,Uprosertib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,-0.89561427,-0.057896517,-0.10056868829007956,0.03940621345525066
50879,SIDM00776,SB505124,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.67119825,-0.049993213,-1.4288710118979626,-0.08519178011623842
32063,SIDM00774,Alpelisib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.3213662,0.09454503,1.5018384390371866,0.12323727557358267
26150,SIDM00097,MK-2206,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5350446,-0.09331154,0.7635035208318237,0.0051354853025541635
15633,SIDM00834,AZD7762,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,White,66.0,0.06215777,0.001803338,0.11950060037508954,0.030004264869470127
18401,SIDM00673,Bortezomib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.6821662,-0.029716346,-0.6197172268550454,-0.019823529736102716
70057,SIDM00359,Camptothecin,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.803478,0.15355283,2.3773770382243935,0.209278426301065
2728,SIDM00779,LGK974,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,33.0,0.1861567,0.007819516,-1.7868895507848428,-0.02172552585545582
48626,SIDM00878,Axitinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.79456013,0.079477176,-0.0559898928443365,-0.02989590414375425
94797,SIDM00097,5-Fluorouracil,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1543647,0.06246868,0.38664010817436933,0.016679960764545133
53393,SIDM00628,Uprosertib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,0.45214686,0.030806417,0.2675640772455664,0.03838156867279354
80162,SIDM00193,Navitoclax,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.616251,0.03861671,0.3651097122084865,0.05379055850610217
65313,SIDM00673,Cisplatin,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,2.336068,0.13170433,0.8074109599664243,0.08562597752564687
66526,SIDM00332,Lapatinib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1947961,-0.09444969,-0.4425084799414009,-0.012415567276494932
94397,SIDM00776,Taselisib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,1.2161771,0.09938739,-0.07113127080416765,0.010801579854718404
65026,SIDM01233,Taselisib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-1.6561666,-0.12079486,-1.3322590023297227,-0.058293375318036425
58910,SIDM00660,Oxaliplatin,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,32.0,-0.7535646,-0.030405395,-1.2676542823192571,-0.013687216094677601
785,SIDM00878,Doramapimod,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,0.19602315,0.0048912573,1.6796488191292156,0.09361699990863744
107624,SIDM00954,Dabrafenib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,1.2940502,0.059450533,-0.33301321860332866,0.05511478340635915
41134,SIDM00866,Nilotinib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.94201505,0.062803775,1.0888645167406108,0.09411741417092309
57019,SIDM00778,BMS-754807,Camptothecin,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,69.0,0.55446315,0.03542079,-1.5145486209396202,-0.1276880267633655
74265,SIDM00954,Cisplatin,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,0.3097318,0.01148891,0.8740720607546503,0.08932822183400871
72297,SIDM00411,OSI-027,Navitoclax,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.0235394,-0.05958142,0.38508326305060164,0.07302163297563413
77698,SIDM00673,Sorafenib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,-0.8318306,-0.04796834,-0.519564642916558,-0.035276090648493186
59486,SIDM00529,Axitinib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.0684154,-0.08409463,-0.3821251660610326,-0.0353202291085904
12890,SIDM00673,PD173074,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.17785,-0.09920729,-1.5049603729236638,-0.08079934807250881
21175,SIDM00529,Gemcitabine,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.1522787,0.02310799,1.3938999371963479,0.04343838999134917
10381,SIDM00878,Ribociclib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-2.9763577,-0.115214184,-1.737614644310259,-0.01966073361863688
94826,SIDM00332,OSI-027,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7624077,-0.08109448,-1.1479256446994657,-0.0626288445026909
54141,SIDM00774,Camptothecin,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-0.6779564,-0.024658196,0.21387079427781172,0.054056743840602106
76872,SIDM00673,Doramapimod,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.0107124,0.022841161,2.355316547116695,0.06380897849282835
41755,SIDM00774,Docetaxel,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.1468151,-0.1395354,-1.4073798175942696,-0.1347474202985234
66408,SIDM00875,Wee1 Inhibitor,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.92363083,0.047382392,-0.11217918791754683,-0.030700382949719298
56983,SIDM00332,Vorinostat,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.5247467,-0.22160314,-0.7691132790834425,-0.10239366313341722
48979,SIDM00531,Linsitinib,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.3006537,-0.041703247,0.26205553632297324,0.00856283671658452
73717,SIDM00779,Palbociclib,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,33.0,-3.1227365,-0.18179935,-1.8408616267608626,-0.10576611674709298
27997,SIDM00301,AZD7762,SCH772984,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.3287246,0.20111857,1.2432035757903481,0.04831189678851396
22047,SIDM00529,Axitinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-1.5061376,-0.11767177,-1.0272440937805978,-0.046974203251533286
77966,SIDM00878,Afatinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-3.6206288,-0.22408728,-0.23284348446452474,-0.008392630435389894
53958,SIDM00332,SCH772984,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2176914,0.08250387,-0.6751682435788546,-0.03189261142693748
8680,SIDM00529,AZD6482,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,0.042852923,0.0013976606,0.7363167667933992,0.044822465555537476
29408,SIDM00893,Uprosertib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.6732209,-0.04768027,0.1991689232922785,0.031290539893311896
14864,SIDM00878,Vorinostat,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-0.27336755,-0.031464487,1.232166407704243,0.09730853776295684
14503,SIDM00893,Luminespib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.075544,0.30983612,0.29121207965810775,0.01584733265958296
90375,SIDM00193,Trametinib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,53.0,0.56338894,0.042173922,-1.6329094099650783,-0.03494746958943671
30785,SIDM00893,Vorinostat,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,4.9390154,0.46400273,1.7881074216010806,0.1545069633094414
28668,SIDM00774,Entinostat,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.53869474,0.029972104,0.041154294746191165,-0.0023133604117019585
102473,SIDM00875,OSI-027,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6402634,0.16971028,1.6639528884300303,0.11414308103720099
1598,SIDM00782,Olaparib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.5359656,0.044983875,1.7831831719008735,0.05131995000945204
6281,SIDM00866,BI-2536,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-4.549141,-0.3586647,-2.716249845981124,-0.11615782326429466
37419,SIDM00875,GSK269962A,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1791874,-0.036097433,0.30632293053042575,0.026197794199399098
38819,SIDM00097,Nilotinib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.9734349,0.12121504,1.0066301819275054,0.0120284555809794
106594,SIDM00628,OSI-027,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.9440956,-0.09159986,-0.3752318523017626,-0.03765585446047754
45623,SIDM01233,SCH772984,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,72.0,-2.8638847,-0.21008563,2.208876018469574,0.12678021770500936
8116,SIDM00971,AZD8055,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1925881,-0.068737134,0.5732140366470951,0.042528973992395074
48858,SIDM00529,AZD7762,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Black,44.0,-0.34927806,-0.022757603,-0.7349984090477434,-0.026804601066198187
13930,SIDM00875,ZM447439,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.9813162,-0.09936052,0.02323830539108286,-0.04417376946930718
65604,SIDM00193,5-Fluorouracil,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-0.75948346,-0.0692174,-0.5989581755833281,-0.06945380397760924
1384,SIDM00146,Alpelisib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.77062446,0.04598619,0.3607178932350323,0.09319174252477672
73126,SIDM00971,Camptothecin,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.50956,0.06613223,2.4026846783509392,0.08118268954614026
72154,SIDM00529,Cisplatin,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.1497246,0.026262771,1.084850408260852,0.0491104217101187
99242,SIDM00146,AZD8055,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.6904163,0.058304947,0.8555684065632382,0.021169081307850293
7453,SIDM00782,Vinorelbine,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.0814433,0.0855654,0.21423476624745086,0.009428813420858948
86907,SIDM00097,OSI-027,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3609262,-0.14237742,-0.48962294897024145,-0.016639406963630518
35633,SIDM00779,MK-2206,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,33.0,0.6022158,0.035224006,-0.6835066749688523,-0.03539758318043851
82751,SIDM00776,SB505124,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.45040688,-0.032088716,-1.160260218830432,-0.07750481387194039
8973,SIDM00359,Trametinib,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.7218273,-0.12038619,1.3040780338331361,-0.009208466493051987
21129,SIDM00774,SCH772984,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.8093847,0.046033993,3.2594368798901727,0.13128007341295642
106349,SIDM00193,Linsitinib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,53.0,0.30203938,0.011351439,0.6079005022675948,0.06115911712685554
23717,SIDM00778,Afatinib,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,69.0,-0.46847442,-0.023353603,0.279586091335219,0.008153577972592713
29932,SIDM00146,KU-55933,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.3447716,-0.048422437,-1.9253885487518054,-0.02602663528462504
96776,SIDM00971,Nilotinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1846763,-0.08451386,-2.2482599400983414,-0.16456275648907226
49107,SIDM00146,RO-3306,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.19278666,-0.015606568,0.27252941480617726,0.04806174510689102
97090,SIDM00332,Navitoclax,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.819923,-0.081255,-0.012880084653961269,-0.003173951618228832
90936,SIDM00411,Olaparib,Lapatinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,1.3758165,0.038231164,1.449988383766521,-0.000964017062223625
3522,SIDM00130,Dactolisib,Irinotecan,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.1279845,-0.091579236,-2.4419684828638784,-0.18246889295014862
22271,SIDM00411,MK-1775,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,43.0,-0.94357586,-0.043579154,-0.31250458799276204,0.007064282260179967
35211,SIDM00954,Olaparib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,-1.8895661,-0.043013304,-1.33162165334251,0.01646982723623081
15269,SIDM00097,NU7441,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6257458,-0.076522574,1.0204799175419503,0.07008638219104098
61113,SIDM00893,5-Fluorouracil,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.37616727,-0.01874857,-0.547155219431444,-0.0034742890131047757
87122,SIDM00097,Afatinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.162512,0.15084356,2.855416800799654,0.1782935756567877
39874,SIDM00866,BI-2536,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-2.1480072,-0.1307679,-1.1155207012829884,-0.040719290306848066
18560,SIDM00097,Luminespib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.12421146,-0.008404121,0.971696171972852,0.09143778708109739
73323,SIDM00878,BI-2536,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.6265541,-0.058154542,-1.134826197984639,-0.07141037024662267
45506,SIDM00097,Axitinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.4951692,-0.114031866,-1.369792183764608,-0.10915601020756922
20913,SIDM00146,Pictilisib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,1.1895759,0.08487917,0.3012368031728893,0.039361435523468075
97108,SIDM00146,JQ1,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.194846,-0.10414369,-0.7202146874371966,-0.02424224890705638
10573,SIDM00779,5-Fluorouracil,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-2.2024076,-0.081253305,0.1825968707132289,0.030174821654833435
62628,SIDM00146,Tozasertib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,1.0356513,0.078250304,0.7813778314635237,0.04822347076258047
87320,SIDM00954,Lapatinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-0.28869197,-0.02341992,-0.9495512941175727,-0.06608790099754727
14109,SIDM00628,Lapatinib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.2895796,0.06556251,0.5360124563939714,0.03160148590955535
4259,SIDM00531,MK-2206,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.9935193,0.17050824,0.09779576983835177,0.038771055163224065
43268,SIDM00776,AZD4547,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.2742815,0.004219816,1.8307592227793632,0.0841217793922077
80700,SIDM00774,Nutlin-3a (-),PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.4940112,0.06563287,0.07025315808158243,-0.01272168962543468
86925,SIDM00954,Wee1 Inhibitor,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-0.87677664,-0.061404277,-0.0663152132013291,0.016577152422614903
9348,SIDM00893,AZD8055,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.7841341,-0.06935414,-0.12111343481360615,-0.02913737839335366
24009,SIDM00531,OSI-027,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.85135967,-0.03787191,-0.468054656387975,0.002860663570946241
31054,SIDM00893,Vorinostat,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.2804577,0.1386779,2.278736268654649,0.13832781125020657
52378,SIDM00866,ZM447439,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.3690558,-0.018999487,0.1363453780367054,0.012413062693913223
2809,SIDM00332,Navitoclax,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6233087,0.05966318,1.2509438789100567,0.07468260795078423
52548,SIDM00779,Afatinib,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,33.0,-0.5175793,-0.03147993,1.082519560667173,0.06156376572906174
23630,SIDM00411,Crizotinib,Palbociclib,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.3369045,-0.018304605,0.10062878134591238,0.004985964716426236
11230,SIDM00878,Olaparib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,0.1620731,0.0017769361,2.000418023814843,0.11392655712714796
79170,SIDM00893,NU7441,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.22038943,-0.01885407,-1.2303868429702138,-0.07146646705644329
51171,SIDM00359,SCH772984,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0765057,0.08341662,-0.39926651669656354,0.018042113117696105
94310,SIDM00866,SCH772984,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-2.2506146,-0.13052294,-2.076295227646817,-0.07936868801978555
73776,SIDM00673,Ribociclib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,-2.6735935,-0.08147737,-0.1980881260307416,0.011544864275228049
86304,SIDM00776,Palbociclib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,-1.9259175,-0.05933934,0.17009723013554948,-0.017459079595332917
92456,SIDM00866,Afatinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.7470863,-0.14902015,-0.8557207378549324,-0.03503400859563177
47049,SIDM00778,MK-2206,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,2.6271873,0.14603558,-0.4378078904085039,-0.017122647036434686
26571,SIDM00774,Entinostat,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.6468952,-0.08958178,0.2958769572416898,0.017776055339618402
44596,SIDM00971,AZD8055,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.0151285,-0.05485912,-1.1210155942194968,-0.04292538750208862
8890,SIDM00411,MK-1775,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.8827895,-0.08794983,-1.9642265753848545,-0.06585334013406796
63380,SIDM00332,AZD6482,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0007255,0.069903,-0.7419936233578281,-0.03034074111000693
48013,SIDM00628,GSK269962A,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.67588013,-0.06903207,0.34803631534444174,-0.01717093903302324
70375,SIDM00878,Docetaxel,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.4757128,-0.15022977,-2.4059305213221847,-0.14696890712257513
47231,SIDM00875,Axitinib,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7612826,0.05724838,0.4761893726396956,0.05063536636401168
54279,SIDM00411,OSI-027,Trametinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.172032,0.068954386,0.14141553673084364,0.04167821758306015
100335,SIDM00146,Pictilisib,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,2.4862974,0.20984979,-0.25514169290719524,0.026300727246472838
29301,SIDM00097,KU-55933,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.0183144,-0.11675276,-1.351963971306475,-0.0679163596951934
22433,SIDM00971,Crizotinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.44272158,0.017685443,0.12161537124505666,0.07128899542584999
61674,SIDM00878,Uprosertib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.5472233,-0.027936134,0.44260365168025,0.08395663802750425
69089,SIDM00130,Erlotinib,AZD7762,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.141592,0.10921174,0.4125944338179543,0.04804706894959006
101580,SIDM00359,Dabrafenib,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.3161943,-0.05907947,-1.3973805244325836,-0.05187866692754133
63020,SIDM00529,Alisertib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,-0.24536934,-0.024381362,0.6874240004706059,0.0830996955698172
77084,SIDM00673,OSI-027,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-1.0519083,-0.10486737,-1.5660718569658636,-0.12879934769812537
20926,SIDM00332,Entinostat,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,3.1022892,0.09523698,3.2176683785343054,0.10602427247086575
106405,SIDM00146,ZM447439,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.5949835,0.050293725,0.47996539108396985,0.014493969325695641
100502,SIDM00673,PD173074,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,2.7101092,0.20823942,1.6580844453476773,0.08893728677733415
100304,SIDM00878,Navitoclax,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.91772497,0.017966118,1.0540875956771705,0.07258051986026325
73685,SIDM00097,Taselisib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8768114,-0.11865524,0.17216475803837417,-0.0030054779655642053
53942,SIDM00954,PD173074,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.0,-1.5108529,-0.08572593,-1.173129257469022,-0.09532939908004272
93785,SIDM00971,Taselisib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7823896,-0.09337852,-0.015243704491762041,-0.0027996520269150337
76864,SIDM00332,Gemcitabine,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7076237,0.15132926,-0.2991551092918495,0.013396168014013332
15741,SIDM00878,AZD7762,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.97371805,0.04390932,0.5624031559093234,0.09012719123420558
11124,SIDM00628,PD173074,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.8495948,0.030885454,1.6375671141566053,0.09133202297736587
21923,SIDM00531,Dactolisib,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-2.1184146,-0.092706434,-2.987629053013969,-0.08795136953891772
35393,SIDM00954,Crizotinib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-2.5170457,-0.07191968,-0.923296063442801,-0.051944721442165574
101518,SIDM00778,Navitoclax,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,2.1504807,0.08276249,2.190167343811272,0.08683116994220322
49879,SIDM00878,Gemcitabine,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,0.61837,0.05702734,-0.37832379229882346,-0.0012344670981326476
81714,SIDM00673,OSI-027,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.2216625,0.022713171,-0.519340019498253,0.0179064362151868
45219,SIDM00778,SB505124,Taselisib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,0.6228265,0.02712419,-0.5353153233219183,-0.030524497484917385
44612,SIDM00529,Ribociclib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-1.2987589,-0.032128632,0.05121399545401143,0.005869195726965865
37735,SIDM00893,PF-4708671,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.4485618,-0.10313335,-1.7989963779609754,-0.09540066624099854
5874,SIDM00359,Oxaliplatin,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.9490036,-0.10750366,-0.5188253760309588,-0.01904920248298742
104925,SIDM00971,JQ1,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,7.7876077,0.24871357,2.4489868847149974,0.15226650135952252
35036,SIDM00673,Paclitaxel,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.8245766,0.22537503,2.4896299850449046,0.14077235993677586
11522,SIDM00776,Vinorelbine,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.5867555,-0.091282256,2.2623742384225904,0.1365175460809836
2786,SIDM00774,AZD7762,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,48.0,1.6425899,0.21553558,0.726185094248019,0.10936715200649184
45035,SIDM00776,AZD8055,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.5810107,-0.09274199,0.4141470784920063,0.04529541504955656
41732,SIDM00893,Tozasertib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.7468185,0.17136125,0.5558282579506894,0.09597015972423757
82411,SIDM00097,Doramapimod,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.31558943,0.009246074,1.5676787324125256,0.05023890581194384
29815,SIDM00531,SCH772984,Dactolisib,Pancreas,0.0125,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.2510917,0.252593,0.9076271791154858,0.0881781003238582
97035,SIDM00628,Tozasertib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-2.6555548,-0.22065015,-1.2883427472766216,-0.12731792913422607
53216,SIDM00332,Linsitinib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2359729,-0.037456524,1.0940042455199497,0.045527842436979306
44489,SIDM00774,Navitoclax,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,4.565474,0.017566213,2.2595658277288355,0.041338953685180195
45447,SIDM00529,Lapatinib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-0.73492056,-0.023312235,0.884014298507012,0.02967453852418878
28609,SIDM00866,Alisertib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.653057,0.13316534,0.02845438484271283,0.013121170867648567
22376,SIDM00146,AZD8055,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.9017864,0.07991042,0.582632759268075,-0.01244546867555958
86079,SIDM00878,Navitoclax,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,0.7822926,0.0131129315,0.8616811521625382,-0.002381954792031133
31747,SIDM00971,Vorinostat,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.5694345,-0.072806545,0.41730182145931055,0.040180189208951556
49883,SIDM00782,Trametinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,3.1834316,0.18197143,2.16265030675812,0.04947989924882806
92386,SIDM00359,Vinorelbine,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.7576236,0.10658112,0.16694733077071397,0.0370785247999369
14034,SIDM00778,Navitoclax,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,69.0,-4.8728414,-0.22793546,-1.2624506205843253,-0.12350360141455678
86951,SIDM00774,Dabrafenib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,2.0693054,0.079924144,0.36263111315220975,0.010854561669916092
24242,SIDM00774,SCH772984,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,2.6434164,0.081959404,1.4227632349568347,0.09387810161369636
94696,SIDM00774,MK-1775,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,-0.4711373,-0.056712847,-0.8775646841940559,-0.033029197887854696
34945,SIDM00130,Paclitaxel,5-Fluorouracil,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-4.1106296,-0.3032759,-2.3546282080349505,-0.13986200420639341
81165,SIDM00779,AZD7762,Oxaliplatin,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,0.55080515,0.0446239,-1.0658030486492467,-0.09280247647863006
13446,SIDM00130,Cisplatin,Dactolisib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.7730602,0.09476219,1.0287513083606807,0.08009951891721777
107666,SIDM00774,AZD8055,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,48.0,1.130791,0.079934575,0.8650421532821678,0.08676398675477134
101517,SIDM00628,Vorinostat,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,-1.0216177,-0.07764559,-0.3152279335813082,-0.010057070464560855
362,SIDM00130,Lapatinib,Gemcitabine,Pancreas,0.01,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.9044523,-0.07779169,0.5598181635149722,0.0716554181893183
83374,SIDM00875,PD173074,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3133902,-0.0038563209,-1.1174791462703066,-0.0022403286474365633
96744,SIDM00866,MK-2206,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-1.4082099,-0.077969946,-0.34416792927759693,0.028814890822726685
73430,SIDM00673,Olaparib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.9728868,-0.048067726,0.2048522957933264,0.004642905574623636
67316,SIDM00866,GSK269962A,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,1.0616488,0.052390926,1.2456216410514693,0.08360886798949851
960,SIDM00301,Palbociclib,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.3042436,-0.21541467,-1.107115609615769,-0.035344478909858396
80851,SIDM00971,Paclitaxel,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.0389864,-0.08007735,-0.2752198941830648,-0.004660803574586995
42634,SIDM00875,Nutlin-3a (-),PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.74090815,-0.022438342,0.13649736865829243,0.017958357080556438
106999,SIDM00531,Erlotinib,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.0368004,0.20820549,1.864276077625855,0.09987994488440108
21027,SIDM00779,Navitoclax,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,0.970548,0.021278627,0.7487050678578986,0.023962117084866615
7728,SIDM00628,PF-4708671,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,Black,51.0,-0.39476874,-0.036521535,-0.5899391726676804,-0.031603620399109945
80213,SIDM00130,Ruxolitinib,Palbociclib,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.98070365,0.026986841,2.749284147136214,0.06280590344833197
10706,SIDM00774,Dabrafenib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.0910969,0.039240867,0.1848335056538948,0.025945109507572117
72664,SIDM00875,Lapatinib,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.2464762,0.21738957,2.135131723133651,0.12172514187781956
85866,SIDM00954,AZD6482,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.0,0.94642985,0.049878303,1.7188386110373959,0.14891409331450087
100838,SIDM00954,ZM447439,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-3.5212617,-0.13799518,-0.45566800810282265,-0.0727466567170378
25665,SIDM00301,Oxaliplatin,Ruxolitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.5006893,-0.20784262,-1.3012306536923277,-0.1129115897236515
78785,SIDM00893,Cisplatin,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.33822128,0.009013496,0.8522005457500349,0.0001628210890516403
2978,SIDM00774,PD173074,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,2.4544635,0.25948083,-1.3195876529382644,0.015067960638046838
96558,SIDM00778,SCH772984,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-0.9274841,-0.04237843,-2.0050683891182755,-0.13868837677710097
22001,SIDM00774,PF-4708671,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.85087,-0.08958461,-0.5528558091269827,-0.04997088670174496
12363,SIDM00893,Ribociclib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.9476372,-0.040598854,-0.5647690655639364,-0.00945493113699981
82004,SIDM00146,BI-2536,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,6.1853623,0.086294666,2.678574608562287,0.05968441856526025
94097,SIDM00782,Vinorelbine,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,0.69490653,0.06238343,0.22500823527698227,0.07446318579505697
58840,SIDM00875,Taselisib,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.17812139,-0.020808423,0.37395736745612645,0.013478482441947954
17816,SIDM00193,Camptothecin,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,53.0,-0.39930648,-0.011337539,1.9520842632249056,0.0552025634050163
95296,SIDM00779,Olaparib,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,33.0,0.86209714,0.015210003,1.5242578236296656,0.04351256359359494
22194,SIDM00097,ZM447439,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.3044499,0.014451628,0.6865808924716248,0.08500454037612093
68072,SIDM00834,Crizotinib,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,1.9623506,0.13653432,0.7572386940051038,0.057346494645927344
41492,SIDM01233,AZD7762,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,72.0,3.1836922,0.09567193,2.387725525207193,0.10713494481035314
17913,SIDM00531,MK-2206,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.4660599,0.05025592,0.9172422509640876,0.0023968631666097255
56658,SIDM00866,MK-2206,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.4632611,-0.08678819,0.5807787597143775,0.08689006636792329
18416,SIDM00628,PF-4708671,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-1.5226377,-0.112611294,-1.0279425468708614,-0.07976138896529227
87118,SIDM00893,Dabrafenib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.8635909,0.02918801,0.5975369643129614,0.08762815482968939
35564,SIDM00774,MK-1775,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.32957003,0.031928387,0.4419706095371418,0.007366055422283065
82183,SIDM00971,Bortezomib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.6933122,0.15669122,-0.2482784682941348,0.0313709650418034
30856,SIDM00130,Crizotinib,OSI-027,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.34728935,-0.03204777,-0.13372425200604074,0.02954305631654611
103411,SIDM00673,NU7441,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,0.25960943,0.02058213,-0.27587439553394366,-0.02846998761755847
10745,SIDM00954,RO-3306,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-3.540058,-0.15655145,-1.7305030580156702,-0.13404599005376275
19492,SIDM00332,Sorafenib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.4031798,-0.028536672,-0.3346517731841969,0.02037401015590307
30527,SIDM00628,Bortezomib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.33640435,-0.021262394,-0.8038591815423373,-0.04319174551659856
74775,SIDM00628,Nilotinib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-0.9461233,-0.08932576,-0.5785198421249399,-0.08249619745340679
5560,SIDM00893,Wee1 Inhibitor,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2704747,-0.046567064,-1.5974658147761913,-0.04951186054218345
95792,SIDM00774,Axitinib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,1.6046157,0.19605969,0.8085358263725252,0.023223826379588773
76610,SIDM00834,Camptothecin,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,1.5740901,0.12150253,2.327119869300299,0.15457549811771495
67786,SIDM00097,Camptothecin,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8249222,-0.03839968,-1.1316002316016556,0.005409275733985946
68856,SIDM00411,Dactolisib,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,-4.2309504,-0.18877353,-3.0066970653177254,-0.10487503513966102
90627,SIDM00778,AZD8055,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-0.8593157,-0.052187245,-0.49527915086845903,-0.03230081558518378
31897,SIDM00954,JQ1,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,2.0966687,0.05167399,2.7102878880663774,0.07564489159020985
80039,SIDM00097,Bortezomib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.4348125,-0.028890863,0.2722751269848107,0.0009563658957781581
43611,SIDM00097,JQ1,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.8191905,-0.14782554,-0.6767512382574136,-0.05630161760260765
91131,SIDM01233,Dabrafenib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-1.6492244,-0.040955216,-0.167893771922187,0.02322581240320439
7570,SIDM00411,Gemcitabine,MK-1775,Pancreas,0.2,Pancreatic Carcinoma,Male,East Asian,43.0,1.873251,0.116904736,1.0745354902034845,0.050839845382605255
55604,SIDM01233,Navitoclax,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,0.5460537,0.037331916,0.5546169181951234,0.04865415800270281
53885,SIDM00529,Luminespib,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-3.3654559,-0.24976695,-0.06479655266179313,0.057714738669185514
11260,SIDM00097,Taselisib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1103032,-0.1515781,-0.6494341351841382,-0.022630888379456603
105064,SIDM00628,Crizotinib,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.6809849,0.05792641,-0.20628296774424962,-0.00872473986321979
59587,SIDM00529,Entinostat,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.8143714,-0.050089385,-0.058645110514869946,0.02146578191375916
57317,SIDM00893,Venetoclax,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.0241406,-0.06529844,-1.6429443978397258,-0.004595329559571298
26656,SIDM00774,Vorinostat,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.1635484,0.022035085,1.819933778367519,0.0024818257490549
20593,SIDM00782,Dabrafenib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.5514414,0.021875734,1.290409673464582,0.04761540873914777
61769,SIDM00660,Olaparib,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,32.0,4.070407,0.232089,1.8327902664803468,0.06131368422985458
12472,SIDM00097,Docetaxel,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.6853065,-0.1519074,-0.6051416387883065,-0.08958192788552928
18175,SIDM00332,OSI-027,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2013724,-0.11969637,0.25274819919207553,0.045517233364570114
102026,SIDM00774,JQ1,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.4246566,-0.07418059,3.0410625822023234,0.15427795775643827
103455,SIDM00782,Crizotinib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,Unknown,72.0,-0.6880826,-0.056910884,-0.17124998849402595,0.013353179606506562
78609,SIDM00893,Camptothecin,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.0046198,-0.08831617,-2.668858261749528,-0.16916886254710556
9666,SIDM00866,Paclitaxel,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-5.5324135,-0.3695531,-4.203153498023222,-0.3004747190695276
75574,SIDM00893,Sorafenib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.9092118,-0.08054433,-0.3936355014711009,-0.034477651819941835
22830,SIDM00776,Oxaliplatin,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-3.4196706,-0.116311386,-1.6937375577946823,-0.06970520532666857
33573,SIDM00301,Palbociclib,Ruxolitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.95954514,0.13601385,-0.473579005767106,-0.0744861559155104
28465,SIDM00834,Linsitinib,AZD4547,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-0.5285669,-0.04290179,-0.1560491420875093,-0.005042784048265387
25134,SIDM00673,Docetaxel,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.3895077,-0.092457734,1.07604924296472,0.008782719841544315
33707,SIDM00954,Gemcitabine,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,6.660521,0.3562427,3.2498130661440165,0.10966077935537695
64942,SIDM00146,AZD8055,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.54586273,-0.046499126,-0.12338396954669456,0.01253454952033905
11678,SIDM00359,SCH772984,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.5731493,0.09205347,0.013750016961485905,0.0035456882794357965
5267,SIDM00875,Alisertib,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0467476,0.022504557,0.5305216729215525,0.030770155498660277
54485,SIDM00628,Alpelisib,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-1.6585252,-0.068151034,-0.3684549271928344,0.09549533917158397
86797,SIDM00146,Nilotinib,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.5944487,0.046475865,-1.1541495730361964,-0.04725306532423292
81865,SIDM00146,PF-4708671,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,1.7030466,0.05567301,0.8711627485974739,0.04230537128127027
96370,SIDM00359,SB505124,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.79151684,-0.04821017,0.028593040864117503,0.007048887129020914
65195,SIDM00971,Temozolomide,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.033215,-0.040716644,-0.797828189281449,-0.009863144792144025
12051,SIDM00834,SCH772984,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,White,66.0,-0.7790625,-0.06948939,-0.5316301304132082,-0.0341564996236693
69875,SIDM00893,NU7441,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.9214135,0.08392961,-0.5272699495007573,0.023900583999599323
49352,SIDM00628,AZD7762,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-1.2943505,-0.11647773,-0.2835223187513973,-0.018960782911213732
22458,SIDM00954,Dabrafenib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,-0.3850264,-0.013246181,-0.41817894169398273,0.03425515265432718
81111,SIDM00776,Dabrafenib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.7067157,-0.027002087,1.285731163152998,0.04358984379111326
103046,SIDM00097,Venetoclax,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6177586,-0.032978248,1.0484128278583336,0.004401882603167723
94080,SIDM00673,Temozolomide,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,0.6166965,0.008293256,1.705129750277997,0.0437423428578339
105079,SIDM00878,AZD8055,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.36168095,0.027924873,0.8176145960255986,0.05274838581202374
72805,SIDM00834,Vinorelbine,Navitoclax,Large Intestine,0.1,Rectal Adenocarcinoma,Female,White,66.0,1.162251,0.09740352,2.231389749093254,0.20089071628562705
59919,SIDM01233,Taselisib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,2.753663,0.19367364,2.2688507087195138,0.13748887405699053
68540,SIDM00875,Palbociclib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.34060088,0.010631023,0.9855274698385389,0.06070735894738791
71448,SIDM00782,Navitoclax,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.7426043,-0.07335205,-0.55703878278509,0.006145405390946145
90169,SIDM00097,Vorinostat,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5600185,-0.10372372,0.11548992404231687,0.018039100372644615
26363,SIDM00954,Doramapimod,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,-2.1853898,-0.10352955,0.24998225344148908,0.08445731201754572
86461,SIDM00130,SCH772984,MK-2206,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,4.730345,0.41806898,2.489476993030083,0.17411842782979284
14831,SIDM00954,Doramapimod,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-2.4365563,-0.12913257,1.0840200010647205,0.08442197281981159
89078,SIDM00146,Docetaxel,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.6797146,0.06364014,-0.46234445472165914,-0.02526734454286907
10520,SIDM00779,MK-2206,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.4943317,-0.12842838,-0.9480625843968398,-0.09560595840063535
99087,SIDM00673,Trametinib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.75752443,-0.064302996,-1.0704672608831,-0.05619464631952541
43533,SIDM00529,BI-2536,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.2539772,-0.11677196,-0.2617085023942865,-0.044454745883502
27706,SIDM00779,LGK974,5-Fluorouracil,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,1.8673179,0.1035143,-1.6431380370673192,-0.011664735254733024
24894,SIDM00301,Linsitinib,Ruxolitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.1394582,-0.02906227,0.7026522895874109,0.018537285967268814
60660,SIDM00097,Nutlin-3a (-),Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5600063,-0.046224315,0.005287815349424367,0.028479024740568026
40330,SIDM00774,Pictilisib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-0.40224198,-0.018228732,-0.8153220961941593,-0.05471774909198802
92217,SIDM00301,Trametinib,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.2777002,0.2878781,2.297153696312252,0.1644901773074768
1123,SIDM00628,Luminespib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,-0.5129179,-0.051341068,-1.1223507337039669,-0.05695945799040909
61430,SIDM00778,Nutlin-3a (-),Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,69.0,0.2993367,0.005999107,0.5445166520122114,-0.014807353814503191
67568,SIDM00660,Oxaliplatin,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-0.8782228,-0.09219999,-0.6402447131227517,-0.042015295054137286
38646,SIDM00866,Luminespib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-1.6664497,-0.05139917,-0.8135037045200769,-0.07201492908410718
108247,SIDM00971,Crizotinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.5985208,-0.07574528,-0.3978903536281018,-0.005819986675668679
10628,SIDM00332,Pictilisib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4684874,-0.14738017,-0.7232074636838643,-0.05497367394874305
15831,SIDM00332,Lapatinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.906291,-0.12571521,0.39473055575402394,0.054891035533907374
76406,SIDM00971,Linsitinib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.4901696,0.0627853,0.26386541662156227,0.052669931242596744
10453,SIDM00774,AZD7762,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,4.5723476,0.56888205,3.5064659577490036,0.2499302680995104
49837,SIDM00774,Taselisib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,0.83120006,0.028546361,-0.3225320732935678,-0.0556813119437976
69811,SIDM00332,Trametinib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7297194,-0.073600665,0.4440998133945569,0.04295484069100659
36461,SIDM00971,Nilotinib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.5808442,-0.11150353,-0.8503685353362862,-0.09234576633966106
101233,SIDM00301,Trametinib,Paclitaxel,Pancreas,0.0025,Pancreatic Carcinoma,Male,East Asian,50.0,-1.3724673,-0.11404682,-0.3468097855700401,0.03852977612350144
15526,SIDM00893,Palbociclib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.1992551,-0.008819545,-1.1953033053633735,0.0016765202264044682
70384,SIDM00301,Dasatinib,OSI-027,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.9039573,0.06651822,1.028055661449668,0.090809614677373
52176,SIDM00971,Temozolomide,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.2707235,-0.024677943,-0.5032949522721875,0.00945748959119986
60523,SIDM00878,Crizotinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.0311544,0.08001623,0.09198526119716233,-0.034226575898928135
77105,SIDM00146,ZM447439,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.22096078,-0.017955119,-0.030341283381017818,0.0220439984543738
30500,SIDM00893,GSK269962A,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.3063602,-0.094522744,-2.369981190237756,-0.14295805562420752
42055,SIDM00866,Pictilisib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-2.921233,-0.17374599,-2.4080488205480473,-0.10157557855201725
12706,SIDM00774,Paclitaxel,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.6507078,-0.057131752,0.1229145586262948,0.061087974115319604
30792,SIDM00878,Trametinib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,3.0170112,0.15644127,1.9642808478461735,0.0982642986241453
22870,SIDM00875,MK-1775,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.13998172,-0.00861438,-0.5532821937324525,-0.03520975403323172
72122,SIDM00097,Temozolomide,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.1809628,0.0035617615,1.2009530846299168,0.027941981541025947
104349,SIDM00529,MK-1775,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Black,44.0,1.5777386,0.13062727,-0.29630408726035906,0.060265303658470194
5461,SIDM00875,Alpelisib,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6161945,0.16403145,0.44809917795987014,0.057700074982971764
59856,SIDM00628,RO-3306,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.68335366,-0.068600826,-0.5451259463704446,-0.08688410341504259
55209,SIDM01233,Crizotinib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-1.0716763,-0.062336236,1.515076424142398,0.12971603191092163
82406,SIDM00531,Cisplatin,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.8400059,0.33410096,2.7867983506162255,0.16889928941259222
7357,SIDM00782,Crizotinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,-1.0939138,-0.06869401,-0.07948239792176512,0.03334292484347589
36301,SIDM00875,Cisplatin,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.0043550176,0.00017453167,0.8364251109573673,0.07644255692104837
2008,SIDM00778,Linsitinib,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,1.5384175,0.05442798,0.05188148149616204,0.048972493848293
99925,SIDM00411,Ruxolitinib,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.4469997,0.027798459,3.4215346730661507,0.08378205168922166
64341,SIDM00097,Bortezomib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.6736236,-0.034916606,-0.368855277943403,-0.05019190005895225
105204,SIDM00875,Alisertib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.20023988,-0.013852954,0.29497873931906504,0.032184306066496485
63402,SIDM00875,Crizotinib,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.76278037,-0.06930807,0.7665536860608732,0.02892233134008521
28280,SIDM00531,Navitoclax,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.019845,0.1643309,1.8618522939271966,0.12009415969718988
71517,SIDM00875,Alpelisib,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0122871,0.10343497,0.11316511463312316,0.06786792078974148
30998,SIDM00301,Dactolisib,Taselisib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,-0.9669797,-0.12259827,-0.30833515221888375,-0.017335809836988222
91289,SIDM00878,NU7441,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.98011184,0.07925007,0.7040203191866621,0.014738402617854642
85924,SIDM00774,Taselisib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.3151789,0.036521718,-0.400274079364018,-0.047808867772136734
1985,SIDM00866,KU-55933,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,52.0,-2.211734,-0.08033575,0.11685345648027592,0.03452030785137455
55787,SIDM00529,Vorinostat,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Black,44.0,-1.8780208,-0.1566221,-0.2144014302123573,-0.00288469395986713
15111,SIDM01233,5-Fluorouracil,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,1.8678972,0.1321567,-2.401797550822674,-0.05389379299117937
103324,SIDM00778,Afatinib,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,69.0,-1.905253,-0.09760314,-0.30682027634396203,-0.06770378975516697
781,SIDM00774,Ribociclib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.8481542,-0.06326515,-1.814957183636559,-0.03669966770176812
22607,SIDM00628,Pictilisib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,0.96465516,0.045612853,-0.9851653550902302,-0.026477375619467745
42026,SIDM00774,SCH772984,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,2.6719854,0.08014331,1.4867029659233804,0.054431285635119446
4140,SIDM00628,Olaparib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-2.3862412,-0.064655945,-1.7472977978625293,-0.072222863035296
1165,SIDM00954,AZD6482,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-0.8473252,-0.0470703,-0.06778199423929508,-0.014583750716014785
34985,SIDM00834,LGK974,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,White,66.0,-1.4329939,-0.04326795,-1.2508247029847273,-0.03369858324205838
91552,SIDM00878,Afatinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-2.5576117,-0.080346644,0.02573741228518657,0.01027401112543317
92377,SIDM00893,Palbociclib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.85077065,-0.03410561,-1.9139043113661258,-0.04016642829429832
31593,SIDM00628,Gemcitabine,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-1.2862601,-0.048293117,-5.117783250740422,-0.24687865003224496
90453,SIDM00971,Uprosertib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.1077385,0.20211875,1.7798041758415977,0.09012636194563221
29644,SIDM00878,Palbociclib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.2153893,0.01541844,0.43736716451315927,0.0024029310859158843
7915,SIDM00878,JQ1,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.24680614,-0.021430857,0.2647761002797042,0.045828204758334504
54479,SIDM00673,AZD7762,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.9443417,-0.11660914,-1.5375693072507397,-0.05120781204115109
81254,SIDM00359,Palbociclib,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.46223333,-0.029599901,-2.439438404950603,-0.061672219202763674
12111,SIDM00193,Camptothecin,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,1.5658045,0.05249473,3.4947345630783864,0.17957520865212767
33671,SIDM00878,Dabrafenib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,0.5715817,0.019246807,1.0659796491752422,0.042763942982289714
104415,SIDM00954,Uprosertib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-1.7625239,-0.14505132,-0.806990798549666,-0.05400804024366792
49499,SIDM00782,Nutlin-3a (-),MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,7.005477,0.26701653,2.753482219451596,0.08233259344690505
7245,SIDM00954,Axitinib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.0,-1.5428514,-0.11120782,0.560301646964728,0.02901247087195501
32572,SIDM00193,BMS-754807,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-0.8560454,-0.04835403,0.3368172822644138,0.07646447156758056
93448,SIDM00332,Temozolomide,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,3.4494815,0.16762272,0.3481123294748567,0.02238593924042226
86620,SIDM00146,Camptothecin,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-0.50322527,-0.04074223,-1.1352649376645891,-0.06069929210338736
4281,SIDM00529,SCH772984,Taselisib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-0.11465353,-0.005106405,0.7000656526538456,0.08114805523472449
45266,SIDM00875,Doramapimod,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5360556,0.055232868,1.239178038145701,0.07633820672880218
86183,SIDM00774,Cisplatin,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,2.434079,0.05589369,2.4152533918588435,0.06168179889775611
64283,SIDM00529,Taselisib,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,1.9504548,0.15881453,0.8436893163302114,0.028230044412301387
79861,SIDM00875,Wee1 Inhibitor,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3429035,-0.019015357,-1.1425485530903552,-0.010198169194210962
40090,SIDM00776,Crizotinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-2.2445755,-0.18521734,-1.5915294252327739,-0.08369460354856095
51125,SIDM00529,AZD7762,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,0.5356136,0.03614145,0.20154193132596573,0.05722835584013091
18726,SIDM00193,Vinorelbine,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.0792675,-0.19298875,-1.8099435258328407,-0.11117903148636879
105823,SIDM00866,JQ1,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-2.4161623,-0.16340946,-2.5736797060294996,-0.07796367951273125
108312,SIDM00834,Palbociclib,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-0.33953416,-0.021868514,-0.5721493326112624,0.00872966927347437
22963,SIDM00146,Dabrafenib,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.5116719,0.08778696,0.019113445553501397,0.0618180477612027
94816,SIDM00878,SCH772984,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,2.4551516,0.17830676,1.3760357695997059,0.06343046983730515
26790,SIDM00146,Pictilisib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.72477293,-0.058710154,1.1219557671821083,0.1679990643427476
23739,SIDM00875,5-Fluorouracil,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.80913436,0.01583973,-0.5632837359653807,-0.03133067873667572
17374,SIDM00332,PD173074,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5168524,-0.14878318,-0.8832863944516863,-0.05650542909419043
69305,SIDM00778,Trametinib,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-1.9602754,-0.06618473,-2.501797685938784,-0.12126068122837153
13616,SIDM00411,Gemcitabine,AZD7762,Pancreas,0.0625,Pancreatic Carcinoma,Male,East Asian,43.0,2.4719431,0.16817938,3.249373975556034,0.18345709663748747
51488,SIDM00097,Lapatinib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5013484,-0.053897973,0.2893301321195406,0.021828980202492295
10874,SIDM00878,Nutlin-3a (-),Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-1.4592619,-0.0676677,-0.3238531366743527,0.0198639354134194
60482,SIDM00779,Afatinib,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-1.4397258,-0.06110739,0.242084984993908,-0.003939475514350058
15582,SIDM00130,MK-2206,Erlotinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,3.3032382,0.2468808,0.8544565165739817,0.07734373825656551
16369,SIDM00971,KU-55933,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.0214913,-0.029784074,-0.511980327420116,-0.01141085183884312
81328,SIDM00875,MK-2206,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.69437325,0.052126784,-0.5422867352886103,-0.014259133367140674
27537,SIDM00146,Linsitinib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.3740754,0.042902347,1.4699507136205383,0.09677904305362782
96483,SIDM00954,Crizotinib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-0.5879015,-0.047279306,-1.3955037352243862,-0.10914851916520936
105744,SIDM00301,LGK974,Navitoclax,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.9435714,0.11151769,-0.04953408818884443,0.0631755736106948
55198,SIDM01233,Olaparib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,4.4298673,0.17119876,0.7278086203247336,0.05681080544558097
74703,SIDM00893,JQ1,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.150559,-0.05457034,0.015600509777794308,0.0635230465686106
7055,SIDM00774,Ribociclib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.7939963,-0.07872977,-2.285412512398426,-0.06966236979067987
42752,SIDM00301,Navitoclax,MK-1775,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.8582547,0.19372848,2.354748016380471,0.10092483942741379
22125,SIDM00866,Vorinostat,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,52.0,0.60135937,0.048901506,-0.0969190022744898,-0.013490308429743638
10960,SIDM01233,SCH772984,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-1.2490457,-0.09363423,-1.806008121828597,-0.04836316204686863
50323,SIDM00359,Camptothecin,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.316504,-0.100480646,-2.3403307361322527,-0.07552598146466587
20271,SIDM00971,Nutlin-3a (-),Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.8846956,0.030004311,0.4962118335489028,0.034216605584360876
59601,SIDM00411,Erlotinib,Paclitaxel,Pancreas,0.0025,Pancreatic Carcinoma,Male,East Asian,43.0,1.4786359,0.07659124,0.7000545836110845,0.07273424145278472
86709,SIDM00971,Tozasertib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.5353805,0.032811597,1.1218004267972166,0.01541127750791116
73517,SIDM00146,Vorinostat,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,1.0517018,0.091831595,0.4033766268482652,0.08763275145977004
61297,SIDM00411,MK-1775,OSI-027,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.5974779,0.08522299,-0.3555136898220572,0.04097819368608828
80267,SIDM00301,LGK974,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.4629306,-0.0936552,-1.5183598153532698,-0.052823051888228105
73161,SIDM00893,Sorafenib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.3686963,0.12195039,-0.9583483856491163,-0.051158457167748854
70620,SIDM00779,SB505124,AZD4547,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-3.9854944,-0.07494695,-0.8511688924415659,-0.05657509418736143
24278,SIDM00193,MK-1775,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,53.0,0.51149696,0.042204358,-0.669958046895368,-0.019356865000802935
87098,SIDM00097,NU7441,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.5337799,0.08367888,0.741491381062782,-0.004387954132334229
23948,SIDM00893,Cisplatin,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.6541118,0.01689327,1.5826456805895077,0.07538148385537413
34018,SIDM00776,AZD8055,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.3260998,-0.11165793,-0.7238413643327073,-0.030786854828946823
15215,SIDM00893,AZD7762,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.2485611,0.06665832,0.630914597157427,0.063402930981287
60980,SIDM00628,Luminespib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-2.8764246,-0.09207501,-2.1034103947576828,-0.10414959101443863
12256,SIDM00834,5-Fluorouracil,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,White,66.0,0.43366143,0.026389698,-1.96451040346581,-0.06776323523082638
24067,SIDM00954,Pictilisib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,0.22378242,0.01784466,0.0705311675723722,0.052090158703186555
6160,SIDM00878,MK-2206,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-1.3729094,-0.12077507,-0.08859428700946173,0.02340041661666568
36918,SIDM00146,NU7441,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.52417225,-0.042718485,-0.5500009251513409,-0.04905965265563764
56121,SIDM00971,Pictilisib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1410059,-0.05041243,-1.0886377865474235,-0.011345915527928662
2356,SIDM00893,ZM447439,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.70355904,0.060620915,0.6460588398433308,0.08484401358863394
36151,SIDM00774,Axitinib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,1.1542579,0.13987802,-0.8021986998665999,0.00694481858083566
88237,SIDM01233,Afatinib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,72.0,-1.2863238,-0.09212432,1.3029913130293806,0.06303957634638216
4545,SIDM00301,Oxaliplatin,Palbociclib,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.8157506,-0.23904201,-1.604356232252581,-0.12552651840545484
83476,SIDM00782,Camptothecin,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.23209909,-0.022266706,-0.20164772627629332,-0.026820282550793748
62055,SIDM00332,PD173074,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.015919,-0.106530204,-1.037252783007431,-0.049415961762135904
94236,SIDM00954,Bortezomib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,0.16456528,0.008482654,-0.5459648659407856,-0.026479797350676328
87287,SIDM00359,Dabrafenib,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.1887876,-0.050998777,-1.6567974906268526,-0.05035042938183064
30932,SIDM01233,Palbociclib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,72.0,1.613625,0.043155055,1.3387648451852003,0.06514372872841612
27839,SIDM00411,Cisplatin,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,4.232905,0.1472469,0.9450652894271646,0.0548383969590762
9643,SIDM00529,Doramapimod,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Black,44.0,0.19374208,0.00611179,-0.2355220742412068,0.03156149948369361
5216,SIDM00778,MK-1775,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,69.0,0.66631395,0.037813004,-0.46753231013490637,-0.037872443679224044
86846,SIDM00411,Palbociclib,SCH772984,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,3.0661092,0.1542292,0.589016760368017,0.09114812543928798
60307,SIDM00628,Taselisib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,-0.65426946,-0.06329975,-0.03905166593313119,0.04971629998563863
26916,SIDM00529,Ribociclib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.1839181,-0.029753376,0.7329410383542198,0.04540915010830573
100006,SIDM00954,Pictilisib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-4.890355,-0.20536155,-0.038048603352101515,0.0351490429725525
49739,SIDM00779,SB505124,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-3.7248247,-0.08554511,-0.015925553067797672,-0.0016019264677397686
78492,SIDM00866,Nilotinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.3308266,0.08045466,0.09943843915661446,0.06972896691434499
8533,SIDM00954,BI-2536,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.0,0.596225,0.011648335,1.0780424803681157,-0.001974309372693911
55247,SIDM00359,Crizotinib,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0089678,0.07116152,0.1586743097278283,-0.009570478231855263
42955,SIDM00146,Camptothecin,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.5846575,-0.09999247,-1.4426646962159304,-0.08251188555544899
73220,SIDM00146,MK-1775,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,0.6263172,0.046753936,0.19149880502834282,0.07171851757241311
78571,SIDM00878,Nutlin-3a (-),Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.048032,-0.042182107,-0.0904305828507517,0.04102208740120782
85771,SIDM00782,Camptothecin,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.3652525,-0.120162494,-0.5734210894606574,-0.054190462155789015
77185,SIDM00774,Vorinostat,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.3234492,0.020804567,-0.13908755220027227,-0.04067700775271741
6149,SIDM00954,Camptothecin,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.0,-0.8385766,-0.026815033,0.4939318296809402,0.054237705902259056
24019,SIDM00834,Camptothecin,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-1.5310074,-0.10931351,-2.903043307569929,-0.16405891431729686
100416,SIDM00097,Linsitinib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.7749374,-0.1059934,-0.5303588185607324,-0.00881551657077809
7736,SIDM00628,NU7441,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-0.8696659,-0.082530685,-0.0860453675526022,-0.022437461031308416
77233,SIDM00332,Paclitaxel,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.33702174,-0.025593853,-0.5363374359528273,-0.03625260112528986
78331,SIDM00875,Navitoclax,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.15049554,-0.016901646,-0.9837298664226917,-0.03279073794440777
79978,SIDM00971,Ribociclib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1140321,-0.031007305,-0.8731827682078593,-0.0080837387230402
70800,SIDM00893,Trametinib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.376979,-0.22434388,-1.0837916521468274,-0.08745531917505579
92595,SIDM00146,SCH772984,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.589418,-0.05189243,0.03643087988257865,-0.03628138910472452
81099,SIDM00097,Trametinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.59089893,-0.014767762,-0.9323527562802753,-0.031150361603511013
60452,SIDM00529,GSK269962A,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-2.6093113,-0.13317946,-2.2134415211444503,-0.08735146758806243
17604,SIDM00146,Navitoclax,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,1.2360297,0.07566678,0.11796039763693689,0.007056854057944951
96938,SIDM00332,Palbociclib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3021766,-0.06182972,0.019448892974381918,-0.0006731487957436569
97827,SIDM00529,Luminespib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Black,44.0,0.3727799,0.03848019,-0.11729312699334839,0.017723186467477683
28648,SIDM00628,Olaparib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-2.4606926,-0.1520106,-0.819161849240805,-0.030368749449902938
101720,SIDM00673,Wee1 Inhibitor,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.7430116,-0.044250064,-0.5054715276379039,-0.057571529656115894
19828,SIDM00301,SCH772984,Sorafenib,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,50.0,-0.5428545,-0.065914586,-0.37699728285751083,0.013542620058357763
77934,SIDM00411,MK-1775,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.54895675,-0.034727342,-1.2369010621663366,-0.07948132164711486
4553,SIDM00529,SCH772984,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.7505078,-0.06076071,-0.6275579797550744,-0.008129471037392196
63635,SIDM00893,Taselisib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.963728,0.09853934,0.08143734297978189,-0.03983778425369875
42422,SIDM00834,Linsitinib,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-0.53190476,-0.03228962,-0.9460894513161429,0.030890128004819457
105156,SIDM00971,Temozolomide,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.2552886,-0.050500385,-1.6329481409824276,0.002239364273863895
44340,SIDM00774,BI-2536,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-0.5848723,-0.038835157,-0.012104004964367981,-0.003901288044305503
33410,SIDM00529,Entinostat,Axitinib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-2.9832742,-0.12810081,-1.0092393694589674,-0.04012548229988994
13157,SIDM00146,Navitoclax,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,2.005984,0.124243565,1.6841777487020946,0.011260489785380969
41598,SIDM00411,Sorafenib,Dasatinib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,43.0,0.97899,0.05738175,-0.08449785132673504,-0.011239546277353414
42725,SIDM00130,MK-1775,Olaparib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.65340084,-0.06507886,-0.9785890103268315,-0.03563866937737314
32979,SIDM00893,AZD6482,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.020176252,0.0012072623,-1.2860023437598176,-0.10285025994130731
2148,SIDM00332,AZD7762,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4666213,-0.11751119,-0.11597993959618853,-0.02530381350761461
66807,SIDM00834,Afatinib,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-1.4356352,-0.06827374,-1.4579276877012854,-0.060173768993797415
77400,SIDM00866,Doramapimod,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,1.6254871,0.037548304,1.4973577674258824,0.066433132816221
85678,SIDM00954,Linsitinib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-1.8860129,-0.101096384,-1.0394766258164896,-0.05457776645808558
103161,SIDM00660,AZD7762,Oxaliplatin,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.12740333,0.012160821,-0.8256456519860351,-0.08582489332591355
93322,SIDM00954,GSK269962A,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.61139727,-0.014094404,-0.7659662200169195,0.025520743824870948
101838,SIDM00893,Pictilisib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.1298113,-0.107563265,0.25254111358887754,0.015853877194114487
76470,SIDM00875,MK-1775,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.19184683,-0.012186086,-0.9972295837722219,-0.08694787797712018
3528,SIDM00301,Olaparib,MK-1775,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,3.9329543,0.2319334,1.371517968692527,0.04714865002389045
14537,SIDM00971,Doramapimod,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.4627976,-0.06860327,-0.7923906666024496,-0.025055867964082688
41259,SIDM00878,ZM447439,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-0.42783186,-0.03935979,-1.2269019689868086,-0.07704348277387704
51486,SIDM00529,Cisplatin,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,1.2095647,0.02633613,0.8250753173274664,0.033188170201365705
89131,SIDM00673,Venetoclax,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,3.2921472,0.12007908,1.1224182597708263,0.037115168100457174
46536,SIDM00971,OSI-027,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.9529873,0.05576321,0.39543011635237757,0.06232318140431309
79958,SIDM00531,Navitoclax,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.0059712,0.115034804,0.8400024615147201,-0.030790841025764237
70914,SIDM00954,Taselisib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,-1.8116232,-0.12690613,-0.3181094560084946,-0.005476349054328358
44216,SIDM00529,Luminespib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,-0.86528873,-0.061976608,-1.2491396516988822,-0.04428692692743925
63561,SIDM00774,Camptothecin,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.6741117,-0.07107909,1.8556263971040259,0.09718627433882894
67489,SIDM00893,KU-55933,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.2849345,0.104170226,-0.9138853117126369,-0.056008318331752245
3976,SIDM00971,Ribociclib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.5800612,-0.07223484,-2.0868781589496304,-0.04835975548160052
80600,SIDM00866,KU-55933,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-1.3582959,-0.055620406,-1.275258624974294,-0.042990469278822274
4130,SIDM00776,Palbociclib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.3907532,0.016136982,1.2754264125802381,0.034757957828416335
60982,SIDM00673,Doramapimod,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.4656837,0.06894081,3.842091068955913,0.10977443215288951
92650,SIDM00954,Uprosertib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.2465037,-0.10495717,0.052018567065306956,0.011688277546674335
71760,SIDM00146,Bortezomib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.4123601,-0.028149704,-1.1117955091031109,-0.056443885266952064
39597,SIDM00130,Dasatinib,Taselisib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.1783693,0.088132806,1.2320326493948455,0.09531489135404465
13184,SIDM00893,MK-2206,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.1151326,-0.10688259,0.3511421392468515,0.01706441801238294
56886,SIDM00628,PD173074,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,0.3457669,0.012323008,0.19975268367711288,0.027869721737015678
22051,SIDM00529,AZD6482,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.6715695,0.023969773,2.57218040758374,0.1730722460223249
100513,SIDM00866,OSI-027,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,-0.020154543,-0.001239512,-1.0686500319383991,-0.046236490547902936
100833,SIDM00332,Pictilisib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5238436,-0.14856392,0.27042240113375543,-0.013242811668492503
33922,SIDM00193,Afatinib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,1.2705302,0.11201647,0.09947342552208148,0.05974849672634888
451,SIDM00954,Lapatinib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.0,0.20557891,0.01686445,0.9723552567556182,0.021737970313561176
94803,SIDM01233,Dabrafenib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,72.0,6.0943875,0.1595913,0.569641920623306,0.022079568239564328
43019,SIDM00529,Dabrafenib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,1.823804,0.046495583,1.7150167994603387,0.07812006595616691
85188,SIDM00146,Linsitinib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.359959,0.03604871,1.790079838196175,0.11296000544164775
3948,SIDM00097,GSK269962A,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.5655201,-0.025102938,1.7743598206850577,0.06699770987268897
8692,SIDM00411,Sorafenib,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.786638,-0.15193261,-1.423622869859176,-0.05755289145825415
21038,SIDM00834,AZD7762,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,White,66.0,3.731579,0.08498053,0.8223356072743758,0.039159117644728327
41704,SIDM00875,Olaparib,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.2646563,-0.055817835,-0.9473018003238525,-0.10352563873458691
78142,SIDM00774,Venetoclax,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.9132925,0.023364417,1.0749880912330412,0.0663138199067659
31638,SIDM00146,Doramapimod,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-1.0708765,-0.047942866,0.06204608792605604,0.011624936467161883
59567,SIDM00875,PD173074,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4883313,-0.004192623,-0.9087276238261491,-0.03402615216248055
92955,SIDM00866,Alpelisib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,0.38584644,0.029667918,0.38603148621771477,0.034364026064412884
35225,SIDM00332,Tozasertib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0430887,0.07260349,-0.6531628906828509,-0.02480394426598428
54815,SIDM00531,MK-2206,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.5789157,-0.027437862,-0.34319165330216506,-0.043659772692522816
47720,SIDM00193,Afatinib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,2.088934,0.19807267,0.6696566651291462,0.10774506506362502
54403,SIDM00531,Taselisib,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.8054256,0.09204992,0.8565421601863978,0.09227598209594477
47569,SIDM00411,Olaparib,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.6258816,0.05035677,-0.8696321031684637,0.010467819303689464
34972,SIDM00866,Bortezomib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.456788,-0.039312717,-0.24372638788593748,-0.00883536614061526
84882,SIDM00893,Docetaxel,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.1371117,-0.09685561,-1.1259015512384214,-0.09950100982692874
16259,SIDM00875,OSI-027,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.3001196,-0.1498053,-0.5261801828511445,-0.045113861842012236
60172,SIDM00774,Ribociclib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.5793864,-0.037152417,-0.0235406788508123,0.019855700021101427
50095,SIDM00954,Trametinib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,3.563417,0.21795858,-0.6537464583560898,-0.029547599950919073
88897,SIDM00097,Temozolomide,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.6227503,0.037422188,0.4582372139850466,-0.003853871338016774
15058,SIDM00332,Entinostat,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.55270225,0.012977946,1.1931598515862247,0.03567049615557121
83003,SIDM00878,MK-2206,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-2.854677,-0.07663883,-1.1800676493948856,-0.06797261841534259
10033,SIDM00776,Olaparib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-1.7318485,-0.046619385,0.25563888536403,-0.0020589709509372454
94929,SIDM00954,Trametinib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,4.4907312,0.25780028,1.3277860582883398,0.03976823082542802
89127,SIDM00146,Entinostat,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,3.7918997,0.31239623,2.2492360581287856,0.1382232458674134
101965,SIDM00866,5-Fluorouracil,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.1670321,-0.037628766,0.4941534948351539,-9.821056580817913e-05
99297,SIDM00097,Linsitinib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.290378,-0.0872338,-1.0151699162067862,0.003992109344884028
15938,SIDM00332,PF-4708671,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5547439,0.050919063,2.8399498795210367,0.1402594238727467
75088,SIDM00834,Oxaliplatin,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-0.74746025,-0.046584878,-1.4995853642129162,-0.06892452570326318
44337,SIDM00529,Entinostat,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.34122404,-0.02133746,1.1860374427293319,0.059213806180794824
80713,SIDM00866,Pictilisib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.0240903,-0.0674371,-1.0132281141021489,0.0034233439033679123
68938,SIDM00774,Alisertib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-4.9067564,-0.2450602,-1.7381636438722785,-0.12313396436023338
85767,SIDM00778,Navitoclax,Vinorelbine,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,69.0,1.4486425,0.08914365,1.7555777986090493,0.14653444983973352
48837,SIDM00301,Oxaliplatin,MK-1775,Pancreas,0.2,Pancreatic Carcinoma,Male,East Asian,50.0,-1.2354054,-0.14889896,-1.4695394243941056,-0.04751832765419634
10618,SIDM00359,AZD7762,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.79863626,0.056800105,1.0328530891717305,0.028952940734717516
18700,SIDM00531,Navitoclax,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.6792208,0.09114678,0.2933573071934423,-0.006612768236413853
105965,SIDM00971,PD173074,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.6184084,-0.036535136,-2.2889183422839374,-0.016690964006043585
35656,SIDM00878,Temozolomide,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,70.0,2.3697858,0.11922045,0.4668968760159492,0.03974530346786845
51718,SIDM00866,Sorafenib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,52.0,0.7783558,0.042861376,-0.06370680057288015,-0.003374826084009658
59855,SIDM00866,RO-3306,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-3.6738527,-0.12561898,-0.9860388484618754,-0.003783203634588809
79299,SIDM00954,Cisplatin,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.6148895,-0.020956006,0.05085803482723188,0.06038970488138164
14457,SIDM00628,Tozasertib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-1.6673536,-0.15132272,-0.15238223423853486,-0.04836351011939042
101769,SIDM00834,SCH772984,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,0.5861655,0.049352873,-0.6556861623590658,-0.026353727143467787
37478,SIDM00301,Sorafenib,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.0017167,0.1207536,0.9287406112127288,0.04724911506981534
54192,SIDM00774,Venetoclax,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.55437833,-0.011736511,-0.0009795167758012606,-0.03982337783033395
31493,SIDM00875,Cisplatin,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5463778,-0.027576076,-0.4616981527093751,-0.0016039865454668977
663,SIDM00529,Tozasertib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-1.1275321,-0.041573215,-0.5022923840766889,-0.01672995590050817
99709,SIDM00971,Nilotinib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.4884014,0.07660371,1.0791159347240054,0.08694844927472406
78992,SIDM00097,Tozasertib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2912204,-0.04363236,0.5931873473658503,0.03786177938579335
49077,SIDM00628,PF-4708671,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,Black,51.0,-0.6441097,-0.060732044,-0.932359342040869,-0.047582776180550054
28710,SIDM00893,Docetaxel,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.5800533,-0.053948674,-2.182148084039622,-0.11314065922801207
25617,SIDM00954,Crizotinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.6175506,-0.083311126,-0.32597287914237233,0.00547347458986324
44395,SIDM00954,Pictilisib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-4.850902,-0.20982063,-1.5861038586299514,-0.09969002510401093
63385,SIDM00673,KU-55933,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.7251897,-0.09839463,-1.4628379191165366,-0.04588309747396392
32161,SIDM00673,MK-1775,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.66081244,-0.03707191,-0.4369999484967552,-0.010842765314925736
56174,SIDM00193,LGK974,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.2307473,-0.056541722,-0.04397723591176437,0.026285524906109428
26215,SIDM00628,Temozolomide,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-0.7726787,-0.023367204,-0.5787603965727446,-0.0006384898503885533
79095,SIDM00332,Nutlin-3a (-),MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.035539,0.085998155,2.4343227978307436,0.03973976134344892
67400,SIDM00878,MK-2206,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,70.0,0.14687331,0.015572885,-1.0892318140821535,-0.06197089771590801
26024,SIDM00866,5-Fluorouracil,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,52.0,-1.7111844,-0.065274924,-0.7346165854336821,-0.038911908330095744
82591,SIDM00301,Ruxolitinib,OSI-027,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.2929044,0.04727176,1.611592199942738,0.046116972262516084
78370,SIDM00130,Sorafenib,Olaparib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.6627484,-0.06090878,-0.3566029337556709,-0.05727352811332422
96658,SIDM00531,Cisplatin,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.7617272,-0.14673276,1.1301589538605132,0.15958691314086831
2696,SIDM00332,AZD6482,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9289469,-0.06844117,-0.9747792943340733,-0.10054506711532145
68810,SIDM00332,Nilotinib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.5718129,-0.07023616,0.5935478130721298,0.022669242758772058
75076,SIDM00628,5-Fluorouracil,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-0.84834033,-0.035833932,0.44072702372171574,0.06416236228489075
2730,SIDM00193,Linsitinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,2.3849618,0.10277431,3.0778699898976214,0.08520147365102834
95273,SIDM00628,Afatinib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-0.17737895,-0.012879863,-0.47907505636479214,0.010074859460891013
6382,SIDM00866,Crizotinib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.0714598,-0.08484298,-1.4747904079190468,-0.09273457242815972
63314,SIDM00782,Afatinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.55596244,-0.04571624,0.14250752277403939,-0.0126412983935302
87486,SIDM00878,Luminespib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-1.177767,-0.13623573,-0.4449201659730815,0.0014290535612795827
47062,SIDM00673,MK-1775,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.40762258,-0.028660635,-0.10976781277883005,-0.01887975598289271
38277,SIDM00332,Palbociclib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5278202,-0.06985823,-1.304882300398258,-0.06537150026911841
47203,SIDM00332,Olaparib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7504338,0.044521004,1.6268646339951738,0.020240108619141915
18271,SIDM00866,NU7441,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,1.6088754,0.12845983,-0.8843824523765859,-0.035323825418833325
32605,SIDM00834,Afatinib,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,White,66.0,0.8777663,0.051101685,-0.5235962934387322,-0.017992702720576265
16608,SIDM00359,5-Fluorouracil,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.2057168,-0.16649927,-2.87692884539194,-0.07808500337635786
18272,SIDM00529,Pictilisib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Black,44.0,-0.5910591,-0.038249467,-0.7870644506284796,-0.0007283279876617188
40436,SIDM00954,Pictilisib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-2.1530898,-0.16214974,-0.6336293278645401,-0.10699603048333543
20238,SIDM00332,Palbociclib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4707565,0.11137963,0.8473513636135427,0.07798711189182905
34193,SIDM01233,Nutlin-3a (-),Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,72.0,-0.5932723,-0.020084538,1.9057917678661114,0.15556856780375
15049,SIDM00529,Lapatinib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Black,44.0,0.43938208,0.033745628,0.3393607220476644,0.06492358178745977
63506,SIDM00097,OSI-027,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4258187,-0.09123858,-0.5070316703611907,-0.06970833763937292
93005,SIDM00971,Wee1 Inhibitor,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.9340787,-0.027564827,-0.12831721235313268,0.001878498585812641
67430,SIDM00774,AZD7762,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,-0.5759716,-0.06456301,0.6922401030692903,0.05482176796123272
72392,SIDM00193,MK-1775,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,East Asian,53.0,-6.453945,-0.45005968,-2.648284230301219,-0.19282831837129927
81922,SIDM00332,5-Fluorouracil,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.0056357,0.07507019,0.12199526355664482,-0.013765969959071108
86731,SIDM00529,PF-4708671,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-1.27994,-0.052370828,-1.9122573492468184,0.022159073570997907
105750,SIDM00954,Pictilisib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-0.42783147,-0.028879544,-0.27653565118283435,-0.02479317284636007
19281,SIDM00954,KU-55933,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-3.027439,-0.084252976,0.11645987636264789,0.04234491491005071
84942,SIDM00893,Trametinib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.024547,-0.09923027,-0.765606473189682,-0.01685157302216494
100912,SIDM00782,Palbociclib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,Unknown,72.0,0.45154148,0.011133272,2.210259902589047,0.06420575120478014
57113,SIDM00531,Gemcitabine,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.0073783,-0.09019241,-0.6640175628277494,-0.05282147656464346
44971,SIDM00776,Afatinib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.2916129,-0.024526631,-0.7277905245382892,-0.046220898148971006
67353,SIDM00628,Wee1 Inhibitor,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,1.0809665,0.05965968,-1.197254090542995,-0.08724168703683767
36395,SIDM00954,Taselisib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.3264569,-0.009508137,2.3416856991404624,0.1351965505432838
95231,SIDM00954,MK-1775,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.0,-0.40620318,-0.033610858,-0.8403753532969539,-0.06299987039807259
29016,SIDM00673,Alpelisib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,0.31560525,0.020013198,-0.28239898370183864,-0.03066255802143417
2703,SIDM00529,Uprosertib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Black,44.0,-2.4800236,-0.10204949,-1.2717001379172719,-0.03893499033945547
19153,SIDM00628,NU7441,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.8175877,-0.06485695,0.0022860030300042057,0.011541436059533375
36182,SIDM00301,Olaparib,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.6735469,-0.12009311,-0.9853326377345933,-0.07407574124000854
88670,SIDM00332,AZD6482,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,1.6624371,0.11735632,0.3243766085800445,-0.01612518296608256
84036,SIDM00529,NU7441,OSI-027,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-1.2384973,-0.087767184,-0.20689854636471575,0.004231030447417775
15178,SIDM00834,Dabrafenib,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,1.7889365,0.07670622,0.5711750720683577,0.03024941420446714
5635,SIDM00878,Alisertib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-4.290302,-0.28850204,-1.9554258245459049,-0.15918777130981537
51116,SIDM00878,Bortezomib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.29653582,0.01627075,0.16503163615159835,0.016385971663679832
104286,SIDM00146,GSK269962A,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-1.0219499,-0.07039756,-0.17046719040257824,-0.007571232848989885
27820,SIDM00097,Alisertib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3741018,-0.068983994,0.09515824405408689,0.062088906068013136
77303,SIDM00332,OSI-027,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.6741433,0.2225512,1.153501139638109,0.11063712279648324
10375,SIDM00097,Paclitaxel,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5976566,-0.10823889,-1.5447214261171154,-0.13680827276038388
28373,SIDM00779,AZD4547,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.507546,-0.007201478,-1.299679390379493,-0.0013711589067396538
74435,SIDM00332,Axitinib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4588255,-0.14378083,-1.3025551546130785,-0.14975600772054348
69507,SIDM00301,5-Fluorouracil,OSI-027,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.4766376,-0.16802306,-0.2898476746800364,-0.03209098013599455
53312,SIDM00875,Afatinib,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.62738425,-0.0138523625,0.7555239737153556,0.022944819063602274
28048,SIDM00332,Navitoclax,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5501141,-0.054524638,0.3761795379079041,-0.01886117793657114
91930,SIDM00893,AZD8055,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.6121056,-0.17242922,-1.842789158268717,-0.12943874631706867
11794,SIDM00531,Cisplatin,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.4820814,-0.047659133,-1.941118060786619,-0.06100531463980435
6530,SIDM00097,ZM447439,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.44301727,0.02065832,-0.20600631863392516,0.07892135565520593
103421,SIDM01233,MK-2206,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.3012743,0.0890185,0.5624894911265025,0.01415555130721428
53320,SIDM00332,Doramapimod,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.9728403,0.15395306,1.0016815605389497,0.03292619149920681
90350,SIDM01233,Olaparib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,4.193079,0.1329988,1.6205906133681838,0.053393760308271664
58815,SIDM00893,Olaparib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2986718,-0.046519194,-0.45484428896113255,0.014645827654001213
59077,SIDM00673,AZD8055,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.74678373,-0.060411066,-1.1180383041546436,-0.07473020210535823
7227,SIDM00097,Uprosertib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.1394606,-0.13287602,-0.9299321216602177,-0.06577247846447581
70866,SIDM00097,Trametinib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0830294,0.04071271,-1.1437129074134977,-0.048187754310727686
88844,SIDM00776,Navitoclax,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,1.2857462,0.055508085,2.0901962494112056,0.05439511329888151
92760,SIDM00834,AZD7762,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-1.1039864,-0.061405364,0.04613411634193098,-0.001170256514341099
26270,SIDM00628,Alisertib,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,-0.9178834,-0.035284586,-0.7523674374767781,-0.03779488544439328
104685,SIDM00954,Uprosertib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,-1.2813504,-0.09779433,-0.5983933595228631,0.03591013140681369
15791,SIDM00193,Olaparib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,-2.1910672,-0.072228886,-0.1509205949223731,0.01985968885285218
60146,SIDM00146,PD173074,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-1.0204976,-0.07140353,0.5173961237803973,0.10151511949943635
96520,SIDM00878,Uprosertib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.7686379,-0.045165703,-0.3850378431490121,-0.00011989834466205336
53775,SIDM00834,Oxaliplatin,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,White,66.0,0.51222694,0.035735384,-2.716618120086841,-0.13119378693648923
94157,SIDM00878,Dabrafenib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,1.3650494,0.048990794,0.4139590871161467,0.040822333808732146
85759,SIDM00878,5-Fluorouracil,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-2.0880542,-0.1356877,-1.0940738894875754,-0.025264968883971017
42325,SIDM00971,Tozasertib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,6.3832984,0.116792925,3.3883173105681688,0.09043175206353768
100860,SIDM00776,Taselisib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,1.6872927,0.14070329,-0.83880743451109,-0.04567956243190442
41890,SIDM00778,Afatinib,Taselisib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,2.9869375,0.12843783,1.2466540380854951,0.01057954491993427
72332,SIDM00529,NU7441,MK-1775,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-2.1842685,-0.08078535,-0.18563654713878622,0.024752006874131708
100197,SIDM00866,Alpelisib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-3.2013943,-0.10132862,-0.12506614375807867,-0.02243102207561668
105922,SIDM00875,Nutlin-3a (-),Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.43466273,-0.013013855,0.3304240475732042,0.039485778888331935
86108,SIDM00776,Dabrafenib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.800449,-0.046783626,-0.31831529822426063,0.003920222846361377
78277,SIDM00531,LGK974,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-2.4324346,-0.13991196,-2.781022765530913,-0.11898609095212997
91986,SIDM00529,Entinostat,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,-2.9860926,-0.13451993,-0.8678356990169218,-0.04877510741701549
23324,SIDM00411,Dasatinib,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.8825456,0.08711909,2.693173550280255,0.12661343272008968
96689,SIDM00866,Alpelisib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.8294875,-0.062356867,-0.7075739633598992,0.013918940617742489
16502,SIDM00878,GSK269962A,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.4517328,-0.07270607,0.9936590389357101,-0.0020485219895334614
93861,SIDM00774,5-Fluorouracil,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,0.7062732,0.06012285,-0.981128635187708,-0.028945225306663713
112,SIDM00529,Luminespib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-0.304604,-0.029398337,-0.2669790207149595,0.010939254353148803
106967,SIDM00673,Olaparib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.9537169,-0.08593292,-1.3694702823956164,-0.06405184204766504
17591,SIDM00529,KU-55933,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,-0.81342447,-0.012526372,1.2203031677483829,0.07232058809189369
29679,SIDM00332,RO-3306,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2961365,0.07246659,0.6150046911819412,-0.019176476538860933
26436,SIDM00774,Taselisib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,2.7671363,0.011580753,2.1399282796532493,0.028383993073256817
68902,SIDM00875,Taselisib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3573498,0.1310031,1.2446186555360212,0.08579637560449303
71285,SIDM00529,Alisertib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Black,44.0,1.153962,0.11901547,4.683123571732166,0.25742593972287314
2057,SIDM00673,Paclitaxel,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.78602636,-0.06251132,-0.5293091780528897,-0.05313256479225763
24964,SIDM00301,Palbociclib,Crizotinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.5157577,0.17460282,-0.49734304701711407,-0.020034050112569625
94800,SIDM00359,Linsitinib,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.054692134,-0.004354673,-0.2338639673294738,0.05502051012091083
68237,SIDM00776,Trametinib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,-1.0799907,-0.09028169,-1.2579900608800496,-0.06943253057126682
49539,SIDM00628,Uprosertib,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.548572,0.22489789,0.9613411244867102,0.19344458004758341
38474,SIDM00531,Oxaliplatin,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.27807456,0.009309255,1.0060613329358825,0.02117029107300901
47614,SIDM00954,Ribociclib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,0.32282162,0.011664186,-0.047013630882141944,0.030211992162347767
74476,SIDM00531,Paclitaxel,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.52213216,-0.05410663,-1.098099678042697,-0.05811725786516675
65278,SIDM00893,SCH772984,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.23391022,0.016571203,-0.7404520177650925,0.006443788471764858
31545,SIDM00878,Navitoclax,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.014178268,0.00031339267,-0.2877812627922629,0.036071969625974545
7274,SIDM00146,Afatinib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.6614649,-0.065002285,0.4656932678613582,-0.004464782656346061
7876,SIDM00193,AZD4547,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-1.2997079,-0.061068,-0.9110678178451258,0.01582065629315885
44389,SIDM00971,PD173074,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.6279237,0.046497658,-0.8871956733989427,0.03741882707233642
37030,SIDM00628,Sorafenib,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,-0.24604048,-0.022658316,0.1623729750386532,0.012273715550835099
77066,SIDM00097,Vorinostat,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.99357605,-0.05462703,0.27891203009230137,0.027736486911427032
47468,SIDM00628,BI-2536,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,1.5611856,0.031234533,-1.1233127223575052,-0.0349294933550256
60723,SIDM00301,Gemcitabine,MK-1775,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.486693,0.034414623,1.0416845053475314,0.041840682114244195
46975,SIDM00971,OSI-027,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.9406645,0.09697674,1.8022402226063865,0.13016567468055476
8831,SIDM01233,Linsitinib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-1.6456923,-0.08521298,0.836880666856621,0.07746306582634314
49727,SIDM00529,Luminespib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.39742395,-0.039091814,-1.1005438422800633,-0.040802369319289884
82131,SIDM00359,BMS-754807,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.1954919,0.09453857,-1.6031322606914982,-0.13134614874583872
81423,SIDM00332,Cisplatin,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.6509944,0.049707565,1.3089225020213238,0.05327034309614005
30764,SIDM00411,Linsitinib,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.4144375,-0.11574581,-0.503163969753229,0.060297384961636426
104308,SIDM00673,Ribociclib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.5177894,-0.06059905,-0.568435726303916,0.04004799716657831
42465,SIDM00875,OSI-027,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.22739974,-0.022152478,1.6243183035963529,0.08526780438590427
75913,SIDM00531,Erlotinib,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.2582,0.10831295,0.2613147177775258,0.026705713146250917
78426,SIDM00301,AZD7762,Crizotinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.966507,0.27173194,1.4747534509539681,0.09331054512927867
35279,SIDM00628,ZM447439,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,-0.07891777,-0.0062425863,-0.2702149215864343,-0.02879032933023875
71442,SIDM00893,ZM447439,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.5777833,0.18452299,0.6412825747574178,0.08178657006071828
3760,SIDM00782,Crizotinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.5416628,0.049939454,1.051269059094246,0.043763801962074377
1833,SIDM00878,Axitinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.34645537,0.011612662,-0.9079320874266928,-0.03302154531237265
66566,SIDM00782,Taselisib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-2.421507,-0.16452734,-0.34826801791082435,-0.01784177561845815
98621,SIDM00875,KU-55933,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4359485,0.08748912,0.6082690816023295,0.06224524207616372
82968,SIDM00954,PD173074,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,3.003279,0.08252728,-0.7354437848744694,0.06683550949440252
84870,SIDM00301,Trametinib,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,-1.4754848,-0.17602041,-0.8350947921861881,-0.012424944431100116
46730,SIDM00778,Palbociclib,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,1.9366908,0.06270335,0.9018186252023076,0.055131880606823086
76897,SIDM00193,5-Fluorouracil,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.7632218,-0.065497786,-0.9480611190631,-0.07157536572512478
68582,SIDM00866,Uprosertib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-2.449759,-0.09796902,-1.6114190132818842,-0.003204480424243394
83501,SIDM00130,Ruxolitinib,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.982149,0.089369014,2.3358987985159665,0.06135553377211472
101999,SIDM00411,Linsitinib,Ruxolitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,0.593328,0.035843488,-0.8027668705137025,-0.00017601908914759333
94289,SIDM00778,AZD7762,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,1.2342137,0.026657188,0.21363944154800427,-0.009238409261306771
76945,SIDM00529,Trametinib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,1.6524075,0.09325049,-0.949283589386192,-0.032752821671469395
56294,SIDM00774,Venetoclax,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,1.0149721,0.027021453,0.8931756397139133,0.005177629066631045
66913,SIDM00971,SCH772984,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.7534528,0.10423549,3.1017306246293845,0.10603919215204372
13405,SIDM00332,Olaparib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.29072982,0.008708297,1.2335581773830617,0.03996463230949772
26622,SIDM00332,Nutlin-3a (-),Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.0153477,0.09497468,2.778514404604217,0.0879788704045377
14450,SIDM00971,RO-3306,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.842152,-0.09345443,0.04626382718454495,-0.03898664013766485
6733,SIDM00866,BI-2536,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.24075195,0.011441183,0.45260524488922144,0.008823403376363942
94710,SIDM00097,Sorafenib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.5319139,0.07863602,1.7560584020538876,0.10857762359138708
94219,SIDM00954,Dabrafenib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,1.1350923,0.03504629,1.0983219959896096,0.050527319874972935
28101,SIDM00411,Navitoclax,LGK974,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.63659763,-0.034684043,0.5079115639736399,-0.006235561231656911
42926,SIDM01233,Olaparib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,72.0,1.026443,0.025851503,0.5172693996554429,-0.012977170679016319
27893,SIDM00954,Entinostat,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,0.88854843,0.052489124,1.5031390642837186,0.1436162798213189
15821,SIDM00332,Entinostat,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.77653146,0.017998673,2.489344766343185,0.08306470456549207
100799,SIDM00866,SCH772984,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-3.2926762,-0.18028949,-2.1256236339390795,-0.07610418082253036
64371,SIDM00097,Gemcitabine,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0562046,-0.03672619,-1.1176966234606527,-0.016227345612515983
59207,SIDM00834,SCH772984,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,6.5827665,0.32914296,1.949609692331438,0.1481625651493552
96638,SIDM00866,Bortezomib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-0.14282708,-0.012182226,-0.12157754006840504,0.006626971882487089
31491,SIDM00878,KU-55933,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,4.130286,0.18510321,0.44785210858203267,0.042360135788682474
24214,SIDM00893,Camptothecin,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2973608,-0.10520417,-1.6164555126211781,-0.1006819265268757
93393,SIDM00893,Camptothecin,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.6535099,-0.05801403,-1.1564750176444036,-0.04349260434527068
50028,SIDM00660,Nutlin-3a (-),SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,0.644985,0.014101989,1.793432483260294,0.07585369125974221
8347,SIDM00130,Palbociclib,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.2792203,0.07798739,0.723540479197745,0.05030475385878694
51452,SIDM00146,Luminespib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-1.7237024,-0.10611802,-0.6033477049319601,-0.05231872773509454
32251,SIDM00971,NU7441,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.0784099,0.04752426,1.489269237270482,0.0486625707636116
92711,SIDM00782,AZD8055,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-1.1200075,-0.09191694,0.16481475880443594,-0.029029270146511004
21387,SIDM00878,Pictilisib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,0.5258889,0.050223995,-0.9985280953752581,-0.09979857818209516
65172,SIDM00097,Doramapimod,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.6155357,0.0956238,2.5925854474380947,0.10576885833493667
70316,SIDM01233,MK-2206,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-1.89021,-0.11696103,0.4418839157518964,0.06371157086484791
89532,SIDM00130,Dactolisib,AZD7762,Pancreas,0.0625,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.27181682,0.027580358,-0.8101585648680628,-0.010824272883040852
74319,SIDM00971,Olaparib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.5371267,-0.03532595,-1.3384808035314233,-0.018056458669533575
39726,SIDM00878,ZM447439,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-0.5235838,-0.039655995,0.6396400300153386,0.04203431554233933
88505,SIDM00673,Olaparib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0953434,-0.037205152,0.0346004021300108,-0.025292015231094384
100967,SIDM00531,Gemcitabine,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.81832397,-0.07577323,-0.9983345278558116,-0.03757016670051569
19368,SIDM00774,BI-2536,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,0.55085593,0.04161337,-0.43240210477314217,-0.039641831662074904
91253,SIDM00878,Bortezomib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.4086504,0.022203665,-0.5277195407812191,-0.040549463992434726
94901,SIDM00893,Entinostat,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,4.144265,0.11816094,2.419731875367581,0.10129495216636983
102936,SIDM00332,Dabrafenib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7042329,0.08528089,-0.27420804731088544,-0.014850364665209328
86420,SIDM00875,Doramapimod,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8183202,0.05152119,0.9609760212927859,0.052417241436409794
102266,SIDM00628,Olaparib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,2.150621,0.19002466,0.05648012289576207,0.08088894465301996
15661,SIDM00628,GSK269962A,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.62293154,0.055088345,0.55865482926923,0.10259985931539219
32992,SIDM00301,Ruxolitinib,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.821871,0.17079404,2.9188912584844733,0.0533712699292931
88905,SIDM00878,Doramapimod,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,3.852213,0.048124976,3.0317218607549155,0.12276603442171065
2694,SIDM00097,BI-2536,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.58654416,-0.0395063,1.0627447385796513,0.053670503175767124
103230,SIDM00893,AZD7762,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.95533866,0.043693107,-0.47903617884932875,-0.0024466253583487287
60694,SIDM00660,Dabrafenib,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,1.2951894,0.11220182,-0.8828625032345876,-0.049735675117510036
24396,SIDM00875,Sorafenib,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.41833985,0.043909468,0.05421079924469036,-0.020677792703770796
30267,SIDM00359,Olaparib,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.27371725,-0.006230327,0.5630217227777546,0.026054117590380028
104502,SIDM00954,OSI-027,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-2.9223375,-0.11385467,-0.8848821564078342,-0.07465516479298152
63136,SIDM00130,Trametinib,Taselisib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,3.117799,0.23871405,2.863638700602512,0.16282261995830763
15755,SIDM01233,AZD8055,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-0.8492645,-0.05151397,-0.714322534374878,-0.08680452724950423
42939,SIDM00875,Ribociclib,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6202993,-0.017816542,-0.09186083977260782,0.013375530737364716
33736,SIDM00146,Alisertib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,7.158573,0.21053936,5.43852670591877,0.19650468529080986
15234,SIDM00774,Wee1 Inhibitor,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.1177638,-0.08339453,-0.572580480763294,-0.04014059962862347
94882,SIDM00776,AZD8055,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-2.6182046,-0.21618125,-0.20558927342094732,-0.042821937202741744
95938,SIDM00146,Cisplatin,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,4.4521227,0.14251018,4.044528269024926,0.1352693136023803
105402,SIDM00866,MK-2206,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.8650041,0.14007956,1.3632203438790524,0.10764387587754332
77330,SIDM00130,Crizotinib,AZD7762,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.2893289,-0.10654314,0.02126095840465849,-0.006626686495593974
98300,SIDM00878,Paclitaxel,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-3.329825,-0.11040747,-2.1027700213693206,-0.06486750157271644
73267,SIDM00531,Sorafenib,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.90229017,-0.091670625,-0.0020159123842499477,0.01831400713529093
57825,SIDM00130,Dactolisib,Paclitaxel,Pancreas,0.025,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.2484971,-0.08048814,-0.8827629375493755,-0.05994405496904436
70153,SIDM00146,Axitinib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.3363011,0.028242934,1.0078392764241093,0.13602951606962663
93823,SIDM00779,Trametinib,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,33.0,-1.2674125,-0.050191794,-1.9562666618918725,-0.09824749249205475
46785,SIDM00359,MK-1775,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.4632185,-0.16060571,-0.9238683627441919,-0.03688988008636637
58509,SIDM00301,Dasatinib,Trametinib,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,4.6891465,0.45260197,3.0737925862669226,0.16309319044172277
97444,SIDM00971,PD173074,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1807052,-0.0235671,-0.9671655210001627,-0.00024636666220622424
59637,SIDM00146,Crizotinib,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-0.976646,-0.07407052,0.19400330055137782,0.0325598898841798
96251,SIDM00878,MK-1775,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.48292083,-0.058899306,-0.5232219282467175,-0.027096622890059114
56871,SIDM00774,Linsitinib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,0.64196813,0.05396571,0.602718864552321,0.05287078839844999
74400,SIDM00878,Docetaxel,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-2.4850357,-0.25156417,-2.503004894202259,-0.2013358769403557
2480,SIDM00779,AZD7762,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,33.0,-1.6018262,-0.116173945,-2.8448056261682635,-0.19493799905875023
72715,SIDM00893,AZD6482,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.8944685,0.13190752,0.6385673990379557,0.03769551446980516
62389,SIDM00628,Camptothecin,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-2.0147197,-0.16623822,-2.278568125841139,-0.12724800695941152
31554,SIDM00146,Wee1 Inhibitor,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.11575738,0.008325249,-0.1180279914705447,0.021496731540599417
77560,SIDM00130,Palbociclib,Gemcitabine,Pancreas,0.1,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.9642869,-0.06280726,-2.2629405666584304,-0.1113427236803459
53606,SIDM00529,Vorinostat,Olaparib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-0.9693756,-0.08858335,-0.6291486065914134,-0.06103761179169116
14308,SIDM00660,AZD7762,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,-1.1060596,-0.06869561,-0.765844138882273,-0.06251104054833014
82755,SIDM00971,AZD6482,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.4152955,-0.030171257,0.5687496542598396,0.03670807542016491
75519,SIDM00673,AZD8055,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.091587,0.06112649,-0.2678922823838927,0.021141550248264848
24643,SIDM00878,Vorinostat,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.28337386,-0.029827563,0.003637673626130526,-0.05825175336952123
61483,SIDM00332,Gemcitabine,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,3.078053,0.1630532,0.3291337223375892,0.006959014201191112
28512,SIDM00878,MK-2206,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.6498581,0.07067701,1.2205131295939715,0.023223407681146883
90787,SIDM00301,Paclitaxel,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.5737373,0.03869925,2.1542640563109705,0.0779350303325893
80902,SIDM00673,AZD7762,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.48364717,-0.04137951,-1.7006324289067891,-0.039159561497847606
106401,SIDM00359,Vinorelbine,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.98650885,-0.040202726,0.9818640452490658,0.054542693867059844
54124,SIDM00954,Cisplatin,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.5126713,-0.016944075,0.4272338478104932,0.057402343871724805
11025,SIDM00875,Taselisib,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2992412,0.13923863,-0.3677200433939897,-0.008086325611175428
10502,SIDM00834,Afatinib,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,White,66.0,-1.3607894,-0.06756044,-1.4239510611083634,-0.06592048585893583
7678,SIDM00893,Uprosertib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.1938307,-0.1800726,-1.2590258168291875,-0.07816548295019562
58623,SIDM00193,Vinorelbine,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,1.6266352,0.14825553,0.3030704644564884,0.058501433033008594
7041,SIDM00774,PD173074,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.2970923,-0.066656604,-1.3056165439733993,-0.07643151905361412
17302,SIDM00878,Wee1 Inhibitor,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-4.4911704,-0.16079032,-2.302786886099931,-0.13100806676726517
68475,SIDM00628,AZD8055,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,Black,51.0,-0.44005796,-0.038603805,-1.7771297775107133,-0.08923102968372701
64181,SIDM00866,AZD7762,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.0011383,-0.04959652,0.23719112494396952,0.04539563480817
105080,SIDM00878,Afatinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-1.4398862,-0.13872808,-0.28937035989341214,-0.05917524188656706
14198,SIDM00531,LGK974,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.1883974,0.22363271,0.8749871462269135,0.16000002404739652
97872,SIDM00834,Oxaliplatin,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,0.147739,0.012426748,-1.6535061798171833,-0.0799819773079789
73664,SIDM00971,AZD6482,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.85610634,-0.020786107,0.181860425760728,0.0055164285736004
62268,SIDM00774,Camptothecin,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.72988015,0.044436168,1.569281571537759,0.1092618424745238
65233,SIDM00875,BI-2536,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.089191,-0.115699895,-2.5672712437502545,-0.06463807942106047
44113,SIDM00878,Alpelisib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.09051223,-0.008581286,0.8911585618036738,0.09429513400807751
39152,SIDM00097,Alisertib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.99581337,-0.058103994,0.10039150601695412,0.014463257909630139
28065,SIDM00411,MK-2206,Trametinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,4.962806,0.2851659,2.5107557852826274,0.19830382269167016
96782,SIDM00778,Oxaliplatin,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-2.2674797,-0.04716208,-1.5283173377781918,-0.04482850088168619
22906,SIDM00411,Ruxolitinib,Olaparib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,0.7354619,0.015770633,1.0087704920371845,0.04883704618052782
86640,SIDM00301,Palbociclib,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-3.1709626,-0.24677734,-1.5511213399104449,-0.08292582379611727
47748,SIDM00971,JQ1,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.246792,0.1333117,-0.02878469611797423,0.05835193135071089
10264,SIDM00866,Navitoclax,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-1.6104014,-0.12878536,1.3460281457759848,0.08459166361092968
47091,SIDM00097,Nilotinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.96904266,-0.06540091,-0.6517444986755742,-0.045547465543035626
26924,SIDM00097,Sorafenib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.6937525,0.0963968,-0.3546803309087246,0.0029936398927282257
4149,SIDM00628,AZD6482,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,-0.5318759,-0.051444463,0.18095663343190233,0.012374620396910486
50590,SIDM00673,Vorinostat,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.89798427,-0.086657085,-1.623640553831347,-0.09964623493519141
17213,SIDM00875,Linsitinib,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.661572,0.025539685,0.501434072762872,0.02984111970247796
27555,SIDM00776,Camptothecin,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.94466454,0.07038861,0.2611439179276009,0.04668372057110241
65162,SIDM00954,AZD6482,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-0.68764603,-0.042222727,-0.45474247705586107,-0.03391638028359071
100084,SIDM00146,MK-2206,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.45742908,0.029598178,0.860539061536932,0.06898417120063599
10884,SIDM00673,Gemcitabine,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-1.5888146,-0.09438677,-0.8990578930292717,0.00988575640628477
31260,SIDM00332,ZM447439,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2888206,-0.08028876,-0.3850343775882368,0.010862637839857948
17491,SIDM00673,MK-2206,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.49797058,-0.032826167,-0.24865457155630474,-0.04340834810598197
57972,SIDM00097,PD173074,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.5445662,-0.13496536,-1.0114907207080022,-0.0741960937172838
96980,SIDM00893,AZD8055,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.277812,0.1704299,1.8670741372519386,0.1574411251446713
45267,SIDM00875,Luminespib,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.41216278,-0.03436488,-0.29421329884690256,-0.06922889921009218
11506,SIDM00971,Sorafenib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.0648712,0.07204739,-0.8287878646599618,-0.03366598580625493
13906,SIDM00673,PD173074,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.1600906,-0.060226142,0.6843686429039584,0.07848658468923711
67357,SIDM00193,Nutlin-3a (-),Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,53.0,-0.25732988,-0.00429447,1.9683744476767462,0.060236414759635586
30688,SIDM00878,Tozasertib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-3.51021,-0.2352788,-1.5562900258297967,-0.10147517569737742
102329,SIDM00776,Nutlin-3a (-),Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-2.0729187,-0.058713555,-0.267870532780452,0.008137020713007228
75161,SIDM00776,Olaparib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.3784056,-0.07333843,-0.7760606030591041,-0.030756084573031136
101337,SIDM00893,Navitoclax,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.1034998,-0.113038294,-0.6906074318797975,-0.0204521698081125
22574,SIDM00146,Dabrafenib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.5486318,-0.021682179,0.7591960459574599,0.0671441494850106
48640,SIDM00893,Ribociclib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.9590335,-0.09779733,-2.3751657264241954,-0.06802467570917325
40736,SIDM00971,Vorinostat,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.3296536,-0.057735685,-0.7810330806600039,-0.009848701183093186
101719,SIDM00301,5-Fluorouracil,Oxaliplatin,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-2.7165892,-0.2988928,-2.5797117829314398,-0.17220172768727143
41885,SIDM00779,Camptothecin,LGK974,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-0.5492475,-0.02906626,-1.0218852343063816,-0.02559117411554614
59156,SIDM00193,MK-1775,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,53.0,-0.56026363,-0.039839555,-0.3729554512409334,-0.05178299268343024
83908,SIDM00097,GSK269962A,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.26133698,-0.011370924,1.2177708963987817,0.06014591920564882
32924,SIDM00875,Sorafenib,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.079806834,-0.008126803,-0.3108061216332229,-0.04735523800295349
20920,SIDM00954,Linsitinib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-3.7520702,-0.19548641,-0.7077693330772812,0.019579107330131046
84696,SIDM00301,Erlotinib,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.5993154,0.09215044,1.4035324307263846,0.025710358978614997
28237,SIDM00954,Camptothecin,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-0.30835292,-0.009395268,0.4626420569460245,0.04967363400383918
34010,SIDM00954,Cisplatin,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,2.239863,0.10679192,1.5180955892724475,0.10827822139138107
9015,SIDM00146,Trametinib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-2.724315,-0.14117882,-1.0221092847332187,-0.045268471809124265
14640,SIDM00866,Doramapimod,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,2.7410014,0.08856497,2.0006267649385268,0.11137730757986265
4632,SIDM00301,Dactolisib,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.7633593,-0.21497592,-1.7564742733006338,-0.08247040335356323
52555,SIDM00673,NU7441,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,1.216093,0.08518105,0.23703606463142513,0.047574027992527836
1354,SIDM00875,Uprosertib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0738271,0.11317135,1.93116979952532,0.13994621929526505
83020,SIDM00301,Sorafenib,Ruxolitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-0.35285282,-0.047285005,-0.38626370512922253,-0.03313173051972872
18417,SIDM00628,Olaparib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-2.3571968,-0.15105182,-1.6499569429485434,-0.09142249033363134
42805,SIDM00878,Navitoclax,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,1.1653537,0.009188203,1.5046675993564929,0.017597509569811667
107620,SIDM01233,MK-2206,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,72.0,-2.0887218,-0.11755163,-0.1441131664212535,-0.04084920570289517
86752,SIDM00529,Olaparib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.56824493,-0.02751203,-0.8381142654754231,0.019554475568148537
104870,SIDM00776,Vinorelbine,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.5625464,0.09896561,1.5098411820973476,0.1258207588048555
68638,SIDM00971,Wee1 Inhibitor,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.2191157,-0.0318495,0.6655631120405849,0.06074085724232985
43492,SIDM00411,Dasatinib,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,43.0,-1.5316188,-0.07839863,-0.07670780705770114,0.04979050806346259
78880,SIDM00673,Navitoclax,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,3.753476,0.28922877,-0.0527045722446151,0.039826611863593264
11999,SIDM00971,MK-1775,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.9957458,-0.057720706,0.446457345001022,-0.011214286861432688
99440,SIDM00529,Entinostat,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-1.4226403,-0.075287625,-0.5043263210724567,0.041054067889649125
58731,SIDM00332,PF-4708671,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,0.8260169,0.02259827,1.9083613082146342,0.06931541445040255
101615,SIDM00359,LGK974,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.058099,0.034769792,1.2194100990017114,0.019746404640874602
26680,SIDM00301,SCH772984,Paclitaxel,Pancreas,0.0025,Pancreatic Carcinoma,Male,East Asian,50.0,-1.0213063,-0.10097923,-0.2647688764144333,0.000338401253197425
3002,SIDM01233,MK-2206,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,72.0,2.054894,0.13877936,1.3294898361393284,0.1279544971038167
46009,SIDM00782,AZD7762,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,Unknown,72.0,-2.6086557,-0.24318431,-2.0607950852331123,-0.12348756268865325
51699,SIDM00782,Navitoclax,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,2.522655,0.1820485,1.8256894998978772,0.06528914784640559
74281,SIDM00774,PD173074,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.9655821,0.36878562,-0.17595629728900433,0.07467202755316561
93060,SIDM00529,Crizotinib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,2.3257978,0.20061536,-0.01475158440610469,0.05060261802514248
41415,SIDM00097,Docetaxel,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6631376,-0.09758884,-3.09382624882002,-0.29195260777625
59295,SIDM00359,Nutlin-3a (-),MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.3203135,0.04852095,2.1559950477117047,0.050164161474514385
46550,SIDM00628,Crizotinib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.1897128,-0.0154109765,0.23410454192097216,0.023820465125611957
57854,SIDM00529,Axitinib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-2.2103817,-0.13945533,-2.0978815270504763,-0.1055316041011306
24550,SIDM00878,Wee1 Inhibitor,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-0.2099006,-0.016078738,0.17507382497612475,0.0385112302310052
90773,SIDM00359,Palbociclib,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.3547896,-0.023025611,-1.6760186212798014,-0.07491557461982304
88861,SIDM00146,Venetoclax,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.605472,0.014039367,1.6698380698577056,0.06309176697140867
22438,SIDM00954,RO-3306,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.0,-0.057702787,-0.004970151,-0.12248815913901939,-0.06366837090249801
6691,SIDM00954,Bortezomib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-0.42914584,-0.026102081,0.017771602132317713,-0.03063942341798934
66373,SIDM00866,GSK269962A,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.9161108,-0.059785157,0.023301372621964703,-0.015207511174295274
37844,SIDM00834,Olaparib,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,0.22975373,0.005390439,0.4959749981622573,0.01081452004234582
20782,SIDM00878,Gemcitabine,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,70.0,2.7228322,0.26292256,3.2159084930015203,0.31447204869392764
69773,SIDM00776,BMS-754807,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,0.62940216,0.058170483,1.754219352290375,0.07659410612298585
95390,SIDM00097,Palbociclib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2025172,-0.03697358,0.1578645052504473,0.05305808343916718
72641,SIDM00673,Uprosertib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.6738344,-0.0713355,-0.45980424376120343,0.03209499661222481
60788,SIDM00875,Linsitinib,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.85146016,0.019014198,-0.1498257103730414,-0.03752475321965527
95137,SIDM00971,Docetaxel,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.639941,-0.07813716,-2.075943922240529,-0.048420022268772706
73720,SIDM00893,JQ1,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.9065949,0.11564742,2.6109998710123627,0.1694156087009546
6976,SIDM00954,Nilotinib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-1.2966242,-0.090298526,-0.1605662956178719,-0.030492853015523545
71607,SIDM00875,AZD7762,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.24285933,0.01462865,-1.7176768903328932,-0.017875474133888177
95891,SIDM00971,Navitoclax,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.5318677,-0.012944216,1.080137367755058,0.06988021313052997
59173,SIDM00332,Olaparib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1604445,-0.024941627,1.6459381938787188,0.05994190723326769
86188,SIDM00411,Olaparib,MK-1775,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,3.1363275,0.06579166,1.7799276616006898,0.08317386454501605
39326,SIDM00301,OSI-027,Oxaliplatin,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.4979242,-0.17140499,-1.4489644882400667,-0.10805907092634516
4823,SIDM00628,PF-4708671,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-0.2742706,-0.020749472,-1.6394271779106873,-0.05184741199083835
29416,SIDM00097,Nilotinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.23698929,-0.0154358875,1.079566412891888,0.06819915669699939
16696,SIDM00673,Trametinib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.817917,0.24847615,0.29433438583160915,0.025667555854148934
18601,SIDM00834,Crizotinib,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,1.3687491,0.112634756,-0.4834275330626425,-0.014681296195698199
43201,SIDM00193,Crizotinib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,53.0,-1.2350817,-0.041253068,1.4685312515901385,0.09936398956684861
86419,SIDM00097,Entinostat,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.1495295,-0.12267182,-0.6438339598265158,-0.03589556883117914
97496,SIDM00774,Camptothecin,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-1.9962375,-0.089986905,-0.049688184174368155,-0.0025261373564512625
59389,SIDM00531,Lapatinib,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.2613087,0.10918714,1.6704572157275661,0.11461244640662534
64106,SIDM00778,Oxaliplatin,Dabrafenib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-3.3278542,-0.1052952,-3.0529445383860656,-0.10082951450735228
79025,SIDM00776,Palbociclib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.2971612,-0.042851266,-0.04187787935527291,0.012647303309639507
22594,SIDM00774,ZM447439,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.5307758,0.095455706,1.4066417029346827,0.11040825404401709
90271,SIDM00774,Nilotinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,2.3091614,0.14317037,1.887514124369396,0.030539426369210147
904,SIDM00954,NU7441,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-0.84109515,-0.060013857,-0.09750642312367769,-0.0073936601586562555
65290,SIDM00660,BMS-754807,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,32.0,1.6801895,0.14873357,-1.1668837301138,-0.0775314380030802
84899,SIDM00193,MK-2206,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-1.8818954,-0.12381506,0.521080090755211,0.046855009199654414
21601,SIDM00971,Lapatinib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.3742406,-0.0782558,-1.3431924886795206,-0.04920920925658826
92914,SIDM00778,Taselisib,Navitoclax,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,0.7835328,0.04801797,3.0599505229094417,0.11382228672276268
67597,SIDM00660,Oxaliplatin,Afatinib,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,-0.14741363,-0.015516403,-0.01404382594306155,-0.043359336303063045
46522,SIDM00529,Uprosertib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-1.0132701,-0.052343275,-0.34133931795276395,-0.003354359425105809
29633,SIDM00628,MK-1775,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,Black,51.0,0.43111628,0.04321713,-0.7377441646191009,-0.020257858115671136
33846,SIDM00866,Palbociclib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,52.0,-0.6787953,-0.017685836,0.5035406030548731,0.020022210422299413
36204,SIDM00097,Crizotinib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.93527174,-0.05767338,-0.5133198044549059,-0.04581491588484266
7540,SIDM00878,NU7441,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.7912564,0.117865175,0.8320804854443234,0.038699967751477445
65599,SIDM00146,Olaparib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,2.1501672,0.0592484,0.148892276184615,0.04586516604537088
28268,SIDM00878,AZD6482,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.1005526,0.053682644,0.12629004414289566,-0.015430577716119364
46448,SIDM00774,NU7441,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.4866071,0.095765956,1.4901897994050424,0.05995979590647921
104885,SIDM00660,Taselisib,MK-2206,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,3.83009,0.26572677,-1.3008603366011033,-0.04030470924849687
31519,SIDM01233,5-Fluorouracil,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,2.4671319,0.18593855,-0.19224400442863185,0.036819596478720705
12076,SIDM00878,Luminespib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.1518974,-0.08413373,-1.0186674919798937,-0.04901488173360087
88734,SIDM00954,Trametinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-0.97485226,-0.040995397,1.0843864858247334,0.08716379755612888
81989,SIDM00954,PF-4708671,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-2.0855088,-0.10243931,-0.09552885092900876,-0.008338803815605478
64466,SIDM00332,Linsitinib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,2.7826297,0.11969438,1.0160483249581658,0.04650757457358276
94604,SIDM00782,Oxaliplatin,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-2.351914,-0.10220515,-1.1315407390525947,-0.036916457129138186
42130,SIDM00875,Axitinib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.69836,0.20498383,2.303525930841814,0.09295921342083942
47232,SIDM00834,Afatinib,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,1.4779484,0.07767593,0.8920083705543567,0.06384078466604783
37137,SIDM00971,Pictilisib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.8174233,0.2902642,1.1961419086624383,0.11375207199074044
35077,SIDM00878,AZD7762,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.3154377,-0.049842466,-1.466112877683784,-0.0847326365079444
53616,SIDM00954,Nutlin-3a (-),Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,2.66532,0.06942434,2.818567224931133,0.13867479552306972
72961,SIDM00954,MK-1775,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-0.9068864,-0.07339469,-0.1449522485523248,-0.0034479349628909616
95038,SIDM00954,Linsitinib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.2777752,-0.021271512,-0.1511432952134198,0.03672607874578642
35895,SIDM00878,Nilotinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-2.160892,-0.053703174,0.4358766873722176,0.06825494164897902
13556,SIDM00774,5-Fluorouracil,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.0856216,0.110103756,1.380539830473114,0.130808230603443
80386,SIDM00834,Navitoclax,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,1.8251709,0.1390555,-0.005947677982043599,0.06138458027730833
22324,SIDM00866,Lapatinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,52.0,-0.34134284,-0.029879166,-0.2386056220379979,-0.00417196344436688
104618,SIDM00097,SCH772984,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0410683,-0.043783575,1.5276626322095213,0.07659134710991884
16274,SIDM00531,Sorafenib,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.31063277,0.034315407,0.16709986822637865,-0.013573156019549063
74572,SIDM01233,5-Fluorouracil,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-1.6567166,-0.06672034,-0.16252898646890396,-0.029382264639197058
61453,SIDM00774,Palbociclib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,1.4054657,0.057942342,0.6172660273652542,0.01331774639662349
91317,SIDM00332,Doramapimod,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9490068,-0.062765,1.3794162676870754,0.0637998175353936
65462,SIDM00628,Luminespib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-0.9506107,-0.07228156,-1.0874799741329313,-0.057730743746067195
57684,SIDM00097,AZD7762,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2407877,-0.068474576,-1.1429319209846258,-0.05075641488509286
68786,SIDM00954,Ribociclib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.8092478,0.022076754,-0.0014392663859744419,0.03238879974927804
8241,SIDM00866,Entinostat,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,2.9073553,0.20461011,-0.2502435090785207,-0.0023926913993159403
18240,SIDM00673,Temozolomide,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.22477354,-0.004710164,0.466782050230577,0.002892868790582864
34493,SIDM00866,Vorinostat,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.39865705,-0.031820267,-0.7876054488076909,0.008973274946376184
37634,SIDM00332,ZM447439,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8988187,-0.048832346,-0.14307205253365737,-0.04461231856333092
73085,SIDM00332,BI-2536,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-4.119553,-0.27060854,-0.6567218995680238,-0.07125822540943752
79164,SIDM00332,Uprosertib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,2.0624146,0.068038605,-1.1324377750771057,-0.034011929414005354
45025,SIDM00878,GSK269962A,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,2.1321313,0.19196369,1.4253595907291645,0.08706237288174613
32432,SIDM00866,AZD6482,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,52.0,1.1024343,0.07498468,-1.3893861308448068,-0.011139384007387506
9474,SIDM00660,Camptothecin,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,0.7614965,0.05933716,-0.11142030620176371,-0.00862378442940289
21547,SIDM00774,Afatinib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,0.56532335,0.03960097,0.6371891432316515,0.059455193205729666
33264,SIDM00529,Wee1 Inhibitor,Taselisib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-0.46492562,-0.04256138,-0.1712230420668567,0.002615115821911985
4644,SIDM00866,Lapatinib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-0.26190302,-0.021484932,-0.11482400019925805,0.014531514830340514
17373,SIDM00146,Alisertib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.608521,-0.05577429,1.1361309979101262,0.06020093657377795
98303,SIDM00878,GSK269962A,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,3.354484,0.22326851,0.6160738614320943,0.024914454561935983
17513,SIDM00146,MK-2206,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,1.9091467,0.10866338,1.5753023077082047,0.1654427283978371
60878,SIDM00774,Tozasertib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,48.0,1.1665981,0.038924605,1.3473183754037672,0.03246466164732414
11882,SIDM00332,5-Fluorouracil,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2550544,-0.061095435,0.5270931066139133,0.003409376447171227
23751,SIDM00097,OSI-027,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.304568,-0.07649535,0.4437692599545574,-0.01947603680567199
96217,SIDM00673,5-Fluorouracil,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.2852122,0.0685381,0.5076462262054917,0.04185619798280051
98484,SIDM00193,Linsitinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.5151601,0.015456763,1.7592535984383006,0.07721685572713861
77488,SIDM00778,Dabrafenib,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,3.934076,0.0980687,1.3757952051761735,0.059973435119774196
79108,SIDM00531,LGK974,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.4577737,-0.113936655,-1.4928082313562085,-0.00684083429260869
68046,SIDM00660,Navitoclax,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,32.0,3.954599,0.16419296,1.0307362151769963,0.05256628847184951
22557,SIDM00866,AZD7762,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-1.3806114,-0.0953314,-0.5838462960499412,-0.06072459928910706
79302,SIDM00971,Doramapimod,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.0350814,-0.061455067,0.6034638340251018,0.03217351805375365
78359,SIDM00628,Nilotinib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,0.5693351,0.05140797,-0.8066008861476425,-0.062143751647298656
68310,SIDM00893,PF-4708671,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.8107624,-0.06497672,0.31213639313746455,-0.008542969309023842
29710,SIDM00954,Paclitaxel,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.4885367,-0.039702825,0.054955284013506876,0.01959966580069249
68597,SIDM00301,5-Fluorouracil,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,50.0,-1.6801071,-0.14982633,-1.4310452936212743,-0.08568193504038789
28608,SIDM00146,Dabrafenib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.43264633,-0.021148408,-1.3399702004423992,-0.03438586525976666
54516,SIDM00673,Entinostat,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,0.6638892,0.050555676,0.7364611042277318,0.09773339781364551
28875,SIDM00146,Alisertib,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-0.4423388,-0.033904966,-0.0950478037622766,-0.05631553870880936
58930,SIDM00097,Nutlin-3a (-),Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.8382237,-0.08258048,-0.026844016497802086,0.022083594868484872
17783,SIDM00097,Vorinostat,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.9187151,-0.060097154,-0.353227000356257,-0.01046322265152472
42877,SIDM00893,AZD8055,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.1581287,-0.014104207,-1.471120748027621,-0.05252636653948745
24143,SIDM00774,PF-4708671,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,-1.1331129,-0.054220658,0.34341654716711995,-0.018415064231013318
97107,SIDM00779,AZD4547,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.7498473,-0.006755915,-3.6458896849452547,-0.12844963620297645
25141,SIDM00332,Tozasertib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2846344,-0.08932404,-1.4094770538700652,-0.10979003575266592
53944,SIDM00893,Gemcitabine,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.62361467,-0.052428167,-0.5635436739643132,-0.00550951086494187
82584,SIDM00954,AZD8055,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,1.0942847,0.07843175,0.4880199985969201,0.03733145023438652
97073,SIDM00097,SCH772984,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.62640643,-0.0334826,-1.0758657402994132,-0.07906221833281889
61986,SIDM00834,Trametinib,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,White,66.0,1.0586137,0.027763369,-0.9524369239793403,-0.03597287242663311
63268,SIDM00774,JQ1,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,0.9433712,0.05764964,4.578931844684269,0.23008460460580224
71601,SIDM00193,Trametinib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,1.4292701,0.114568405,-0.5022624689229419,-0.01269711602079757
65023,SIDM00332,Crizotinib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5948148,-0.15911092,0.6505270669322357,0.06108467686099576
23029,SIDM00893,Pictilisib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.0121577,-0.09084559,-0.7541232207998004,0.05479793284324197
67610,SIDM00878,BI-2536,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.51688796,-0.04868074,-1.1208936216587315,-0.07299205556490779
82249,SIDM00971,RO-3306,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.5421432,-0.030651817,-0.34456222697505695,0.013906930033702193
62699,SIDM00660,Taselisib,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,0.916662,0.09622347,0.762666533458328,0.04441871240484456
53107,SIDM01233,Linsitinib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,1.9272289,0.1371992,0.06722244440214542,-0.0008447640775803802
19631,SIDM00529,ZM447439,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-1.4943339,-0.050974756,-1.1306652668853694,-0.0325822889486596
106544,SIDM00893,RO-3306,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-3.8846862,-0.23212017,-2.5903986269035264,-0.16256339716254128
60333,SIDM00866,Venetoclax,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-0.7326526,-0.016306484,-0.6727323448525583,0.003504124443375799
21605,SIDM00193,MK-2206,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,53.0,-0.010884281,-0.000868574,-0.10353851457144062,0.019601752174795244
31074,SIDM01233,Afatinib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,72.0,0.72659516,0.0601141,0.46851049625069735,0.028447568244094293
50788,SIDM00954,ZM447439,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.3410758,-0.10817428,-0.6311286608048468,-0.06412263428049857
94582,SIDM00778,LGK974,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,3.4436965,0.07204922,0.6406105504827563,0.029971154847254013
37208,SIDM00878,RO-3306,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.94300306,0.06937409,0.7213549194069427,0.03687180572152213
48162,SIDM00097,BI-2536,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.41064852,-0.030014427,-0.3325720681526625,-0.047508022049943255
13611,SIDM00332,Alisertib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4642587,0.06310128,-0.5015347505825786,-0.05016002853813778
1916,SIDM00411,Irinotecan,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.0401466,0.105168946,0.5985356157539968,0.09515702406612017
5112,SIDM00531,Cisplatin,Ruxolitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.9527844,-0.09312154,-1.3445108971497113,-0.00038864136783399786
38982,SIDM00130,Crizotinib,Trametinib,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.6398631,-0.046100765,1.1130227752149138,0.03537729015403133
77291,SIDM00146,Tozasertib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.1727855,0.16912428,-0.7434857554901222,0.009265463528312626
90648,SIDM00130,Sorafenib,Erlotinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.8087626,-0.06373662,-0.7631092660168586,-0.033062922346018916
4427,SIDM00834,Navitoclax,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,5.0408664,0.3530123,1.9963681150082198,0.10936965544833308
45522,SIDM00628,JQ1,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,Black,51.0,-1.9877152,-0.10761308,-0.4121822189344845,0.014553018182152407
9581,SIDM00673,Wee1 Inhibitor,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.5139404,-0.029886749,-0.9844302109522113,-0.04941966594557449
18773,SIDM00782,AZD8055,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.2534978,0.11916274,1.5129640256229206,0.09540408501228828
6551,SIDM00875,ZM447439,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0455025,0.11947701,-0.1920827005697818,-0.08187253068226856
100695,SIDM00529,OSI-027,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,0.6440146,0.06457712,-0.8299903201826819,-0.06667797424613164
15492,SIDM00628,MK-2206,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-0.6006944,-0.049732473,-0.0635973799966581,0.04694285402180472
95186,SIDM00531,AZD7762,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.4313611,0.03179729,-0.4787183116491385,0.028834939906446796
71070,SIDM00529,Gemcitabine,Luminespib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-1.3558767,-0.04198965,-2.4469023727868935,-0.11209499635845929
36278,SIDM00332,Navitoclax,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.65150124,-0.059131768,-0.018168312386419416,-0.005355611881552808
20872,SIDM00529,GSK269962A,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,1.246844,0.112221815,0.5195579736847398,0.1336304204526825
55399,SIDM00971,JQ1,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.3891028,-0.057718232,-1.6784048175160942,-0.09984288326247062
26042,SIDM00778,Taselisib,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-0.64348274,-0.022064636,-1.2941510712427435,-0.08308128318150637
68159,SIDM00411,Sorafenib,Ruxolitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.6712462,-0.09329063,-0.3991308339062135,-0.023338339432313684
62303,SIDM00971,Uprosertib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.0359846,-0.05121138,-0.010840347501976003,0.06008708913041903
21231,SIDM00628,BI-2536,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-2.55924,-0.120988786,-1.2303731155643842,-0.03933036407573788
76719,SIDM01233,Taselisib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,72.0,0.22925025,0.017026871,-2.69576758210128,-0.10916038644890368
33317,SIDM00332,Nilotinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.0635345,-0.21896607,-2.061836401722749,-0.1141758612752038
52253,SIDM00954,ZM447439,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-0.87748104,-0.06874672,-1.314131230255887,-0.0948387288167093
39891,SIDM00954,Doramapimod,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-2.2997177,-0.11688132,-0.4924950127702658,-0.02640068578461787
20393,SIDM00774,Trametinib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,2.076027,0.09660855,1.3179977527898616,0.03460639871443696
12998,SIDM00531,Navitoclax,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.9525514,0.11822603,0.17604928407702083,-0.017982429442643864
1411,SIDM00411,Linsitinib,Sorafenib,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,43.0,1.1047795,0.064319804,1.884123400636455,0.1337512439534285
72608,SIDM00146,Alisertib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.0808325,-0.09631333,0.2977326353785619,-0.04330868449577974
52143,SIDM00301,Crizotinib,Sorafenib,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.3546185,-0.07955325,-0.7173033693313758,-0.031085981653854584
37363,SIDM00893,JQ1,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.499665,-0.100270174,-0.45755419965937466,0.012226810488268073
33034,SIDM00531,Paclitaxel,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-2.495368,-0.21524605,-2.910079889102734,-0.18984147073685084
78185,SIDM00332,Olaparib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2948549,-0.030446716,0.46255441226071964,0.03238392917080947
75567,SIDM00875,OSI-027,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.84687996,0.08121543,-0.06782630904034087,0.04101140107455086
67842,SIDM00776,LGK974,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.4788291,-0.03622491,-1.5030000918854924,0.016605334534265378
7027,SIDM00531,Trametinib,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.6229813,0.422828,1.8779545985138915,0.09663299107905016
11619,SIDM00779,Oxaliplatin,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,-2.614651,-0.10678145,-0.6879338012563543,-0.020071207064894216
10478,SIDM00971,Temozolomide,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.4178483,-0.050932147,-1.8406056050161153,-0.03541999378199936
20375,SIDM00411,Taselisib,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.48775,-0.08749925,-1.2450360174825545,-0.05153756496384884
28840,SIDM00893,Doramapimod,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.5424992,-0.017533554,-0.5819468125208168,0.024192307239115404
102117,SIDM00529,Axitinib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Black,44.0,-1.0340714,-0.08395892,-0.09095647982608222,-0.014978418702714906
26201,SIDM00529,Axitinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,2.0517313,0.1886078,2.0122622863670494,0.1437810806788127
21775,SIDM00866,Luminespib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.7334172,0.14110434,-1.0878828596177594,-0.061357828018530666
8474,SIDM00332,Entinostat,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,6.8762136,0.21686684,4.457436874420025,0.13600660992660296
14365,SIDM00673,Camptothecin,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.61848253,-0.014753598,1.0906068155769406,0.08131358362153482
105819,SIDM00893,Docetaxel,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.2328944,-0.17722055,-1.4571177106400284,-0.07917646291443291
74510,SIDM00660,SB505124,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,0.056331493,0.002662844,-0.2980181564537871,-0.012191339513078268
63198,SIDM00359,Vinorelbine,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.3657944,-0.059424214,1.8782300882198275,0.13730777278645498
19942,SIDM00130,Cisplatin,Dasatinib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.9687882,0.07530341,-0.5399461855199397,0.0412539210020734
22095,SIDM01233,Vinorelbine,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,2.1102386,0.13121967,0.6768072318458437,0.056925451490631586
25348,SIDM00954,AZD6482,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.0,1.6788659,0.12679684,-0.45865104346996693,0.04684099790354362
15385,SIDM00834,Oxaliplatin,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-1.9484674,-0.1566591,-2.7488064733993105,-0.11669482536590454
21145,SIDM00866,OSI-027,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,4.0677004,0.18940905,0.31946847881054236,0.06439740666323807
89872,SIDM00411,MK-2206,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,43.0,-1.1497648,-0.067750596,-1.0007224741966807,-0.016936650538468455
105370,SIDM00359,Nutlin-3a (-),LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.9829005,0.058616765,1.7392022756997618,0.04809890187809806
50211,SIDM00146,JQ1,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.3233244,0.097499005,-1.0507183310049966,-0.06585758718124488
51246,SIDM00878,Nutlin-3a (-),Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.63712776,-0.035828393,0.2309240851742546,-0.014022058507588727
81572,SIDM00954,PF-4708671,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-2.521496,-0.09900953,-0.4975508054558879,-0.008213318877848857
73663,SIDM00660,5-Fluorouracil,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.43802214,0.04599681,0.9960368700212131,0.0756210425295698
17794,SIDM00971,Afatinib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.30008093,0.011681599,-0.13056115504258528,0.008955731387597848
69755,SIDM00332,Crizotinib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5659341,-0.15164912,0.25537365737682266,0.00914196735469364
104575,SIDM00893,Tozasertib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.6616708,-0.06846902,-1.7658748205906636,-0.008636236566527651
19150,SIDM00778,Afatinib,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,1.3184634,0.07507791,2.5623898532284985,0.10255954978394528
34302,SIDM00866,Camptothecin,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.5070841,0.029593714,2.48754758490101,0.059024377614115386
52360,SIDM00866,Tozasertib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,52.0,-2.1620774,-0.10717959,-0.6228060051680688,0.01694557948455402
34358,SIDM00628,Sorafenib,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.3607212,0.031565405,0.525834538143323,0.057068645508921025
36731,SIDM00097,Paclitaxel,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.82644004,-0.0584152,-0.7707318939761291,-0.04298304892130105
105734,SIDM00866,MK-2206,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,-2.5899441,-0.082523614,0.49033311799117724,0.06341232595966204
14653,SIDM00875,Lapatinib,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.2837955,-0.02728005,0.22360490250046625,0.004770077179220706
96485,SIDM00954,Alpelisib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,-0.37969133,-0.031820875,-0.2679403884603818,-0.05665309261971755
10983,SIDM00878,Entinostat,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,70.0,1.5490534,0.09141002,0.582584026611311,0.06913721597019974
43697,SIDM00628,AZD8055,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.2730957,0.05285247,-0.028773933285873528,0.027982186995015427
87085,SIDM00954,Alisertib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,0.7018008,0.050327126,-0.1409371655609408,0.04031441734371842
90659,SIDM00411,Crizotinib,Oxaliplatin,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.2428215,-0.10784742,-0.9590018319869205,-0.09010787953825428
54086,SIDM00529,SCH772984,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.7537432,-0.062239006,-0.1492602537746042,0.03253003216226103
19669,SIDM00628,Alpelisib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,1.7134902,0.11222352,0.041951452099684726,0.054460753442084106
43042,SIDM00673,AZD8055,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.96418804,0.06617799,0.24171713148294813,0.00819585369381921
88930,SIDM00878,JQ1,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,4.6523423,0.25724912,1.7325163169389002,0.07868240264238206
104196,SIDM00954,RO-3306,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,-0.46184886,-0.034898225,-0.5723187198221561,-0.017644926075254894
67284,SIDM00782,AZD8055,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,Unknown,72.0,-3.674747,-0.25075898,0.7255021723049939,0.009518468666748818
78968,SIDM00866,Ribociclib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,52.0,-2.827245,-0.10659719,-0.18118521428520998,0.010102547489571262
73052,SIDM00834,MK-1775,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,White,66.0,-0.45557752,-0.03630204,-0.222995737711969,-0.019193226274128842
86610,SIDM00411,SCH772984,OSI-027,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.6587728,0.024575569,0.0717246586515129,0.022186843332974472
96435,SIDM00097,AZD6482,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.7019035,0.043924175,0.6756870182321144,0.027058735427674816
83119,SIDM00673,AZD7762,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,0.5848875,0.04519314,-0.6697118274680475,-0.04690136798217325
39985,SIDM00778,SB505124,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-1.6805259,-0.099004306,-1.0862708960153942,-0.08161868461519436
106791,SIDM00971,PD173074,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.16579041,0.003939262,-1.745559757674262,0.016435739604869812
107667,SIDM01233,Oxaliplatin,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-1.6039876,-0.1172007,-1.2919154896490972,-0.15541440207936472
105006,SIDM00097,AZD8055,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9334412,0.0696641,-0.10747437605973098,-0.00024785334600081575
74598,SIDM00779,MK-2206,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,33.0,-2.5372434,-0.21339065,-1.3258634530509374,-0.09390335453574275
83835,SIDM00359,Crizotinib,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.9520613,0.14151406,-1.050490132131235,-0.016522571222223007
91716,SIDM00146,Venetoclax,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,4.707487,0.14748952,2.5405967181999114,0.09531199031599065
30502,SIDM00954,Bortezomib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-0.46064088,-0.027331429,-0.08382783972049591,-0.007021122413307632
90535,SIDM00332,Tozasertib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,6.797007,0.2930517,4.040771044285168,0.19479988988481417
100883,SIDM00146,OSI-027,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.91449964,-0.090426214,-0.25701165000171156,0.012700090606178426
25699,SIDM00673,Wee1 Inhibitor,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,0.8149744,0.05528391,0.06263253633386871,0.024998552755901172
89390,SIDM00779,LGK974,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,1.2702674,0.040862374,-0.33476080550802967,0.017815979428112683
47060,SIDM00971,Paclitaxel,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.9035723,-0.08184884,0.7668557010685518,0.0567291144002727
14241,SIDM00673,Paclitaxel,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.1817569,-0.09253086,-0.34745306462694625,0.04206092745724636
77728,SIDM00332,ZM447439,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.45024174,-0.0124013545,0.5030831986705532,0.025270400485606973
79777,SIDM00893,Linsitinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.3959498,0.030210659,0.7760036438479053,-0.02199176087846771
6671,SIDM00893,Nutlin-3a (-),OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.39384726,-0.0073169973,1.3215430994423079,0.042971637566830305
3972,SIDM00531,Gemcitabine,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.054608,0.075834945,0.041348234948254854,-0.006487191714669189
84583,SIDM00776,Camptothecin,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.2650802,-0.09131741,-1.2745555149009307,-0.045844285051843015
42529,SIDM00146,Sorafenib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.6716823,-0.06098088,-0.06368099031841234,-0.019729961728845433
60597,SIDM00097,Trametinib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2045519,0.04582225,-0.14099701026612096,-0.029217733212270627
19278,SIDM00628,Entinostat,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,-0.9168148,-0.053250205,-0.7650997051841055,-0.015240865046395212
88319,SIDM00130,Dactolisib,Erlotinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.2833303,-0.078681685,0.5562343999805147,-0.005189143922747261
74888,SIDM00097,Alpelisib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0917845,-0.111129664,0.1873401106507135,0.010678434634010891
15198,SIDM00411,Paclitaxel,Linsitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,1.905401,0.08471308,0.5950998147003133,0.06432597977332205
56116,SIDM00893,Dabrafenib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.3435857,-0.037511643,-0.4469912946824633,-0.007376232487977593
49869,SIDM00776,AZD8055,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.2338823,-0.10618871,-0.9016220392810358,-0.04675578863301341
39772,SIDM00878,SCH772984,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.5952621,-0.047101304,-0.3443991077927125,-0.05462715754869705
67099,SIDM00411,Crizotinib,MK-2206,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,43.0,-1.5793881,-0.08089692,1.1949207528408974,0.08777562974068674
93838,SIDM00359,AZD4547,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.5376583,-0.09423676,-1.6345217999446098,-0.05172903138228492
38627,SIDM00971,Wee1 Inhibitor,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.2542279,-0.034295555,0.31364564856142546,0.034090158723056416
3685,SIDM00146,Dabrafenib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.57968116,0.01735155,-0.8625738740054422,0.0052716697842543495
35859,SIDM00971,Palbociclib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.5787406,-0.017365385,0.15688328448857095,0.07374054579333732
34107,SIDM01233,Nutlin-3a (-),Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-1.0664891,-0.034359373,1.2377708874854356,0.05139967743369675
10470,SIDM00774,Alpelisib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,0.85259277,0.06219369,-0.16992105185089107,0.023479406638070112
6437,SIDM00878,OSI-027,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.4296899,-0.044940863,-1.0913672498246056,-0.09070499639381291
27662,SIDM00146,Palbociclib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.7805021,-0.06847616,-0.44870215240765365,-0.025724463144575382
104236,SIDM00332,Olaparib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7707496,-0.03837247,-0.1039591457928172,-0.00464921055124259
57049,SIDM00834,MK-2206,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,2.06041,0.11023338,0.379665136414673,0.1329664119189359
103392,SIDM00954,NU7441,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.8870692,-0.037939172,-0.4033043256843754,0.016772115757421727
56859,SIDM00146,Uprosertib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.14905728,-0.011292368,1.7988339064394336,0.18017027786619666
64129,SIDM00130,Cisplatin,Ruxolitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.7424052,-0.04778149,-0.5828670773268795,-2.6071609127686935e-05
66797,SIDM00130,Navitoclax,Oxaliplatin,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.33161247,0.03400311,0.0715012113988146,0.005432261407969305
16081,SIDM00782,Palbociclib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,-0.5244481,-0.01090118,1.040727554348276,0.0021393972366976657
61162,SIDM00875,AZD7762,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.5805898,-0.035378862,-0.751645602341467,0.07784967398408604
76681,SIDM00893,Bortezomib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.9526309,0.08277662,-0.9924004536442261,-0.09216547061711673
82797,SIDM00893,Nilotinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.8090771,0.057215624,0.7685981511660248,0.0320384019905926
92706,SIDM00971,Vorinostat,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.3012936,-0.013369089,1.0564896657435918,0.06635609260047826
6375,SIDM00301,Oxaliplatin,5-Fluorouracil,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.4540008,-0.17692776,-1.8376397062499628,-0.1248097418698502
37333,SIDM00531,Irinotecan,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.5710917,-0.06193914,-0.185026403844757,-0.07402721938511965
65412,SIDM00782,Taselisib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.6685983,-0.059713494,-0.26958898997195485,-0.01749437237727586
85746,SIDM00146,PF-4708671,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,1.6230707,0.059220158,0.7051187765501951,0.021310820383151356
69956,SIDM00301,Trametinib,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-2.0514631,-0.18583544,-0.965434022348948,-0.05356054363985709
21722,SIDM00332,Venetoclax,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0887768,-0.028360693,1.720320834512319,0.07575385512474311
68445,SIDM00878,Gemcitabine,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,0.8395197,0.08337134,0.7892966988228266,0.02486996600539256
70175,SIDM00673,PF-4708671,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.4163269,0.029297505,-0.2140975858370757,0.015109617006581512
103368,SIDM00774,MK-2206,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.2854886,0.013613753,-0.7477603567902762,0.014611944343669315
54443,SIDM00359,AZD7762,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.86994714,-0.061079454,-0.7842082445468495,-0.037841507887795216
25489,SIDM00193,Crizotinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.55964494,-0.021721205,-0.3618446867217607,0.026667407745097287
8900,SIDM00628,MK-1775,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.96437734,0.09120957,-0.47776943025597507,-0.02207258588305782
4321,SIDM00778,Trametinib,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,0.6707867,0.016217973,0.5828276602936077,0.004346774971888426
83322,SIDM00875,Tozasertib,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5067977,-0.047740486,-0.747936245223212,-0.03395678202536483
44085,SIDM00097,AZD7762,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2428117,-0.06032971,-0.3935859252808009,-0.0270388271137221
103361,SIDM00146,Olaparib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.2449489,-0.047232818,-0.43233735186029343,0.016478284091596046
35917,SIDM00774,NU7441,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,0.7824703,0.049265604,-0.5156939767083363,-0.012821701150051231
82064,SIDM00146,Doramapimod,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,1.1945349,0.068284206,1.5200600820582126,0.062234458051647915
55908,SIDM00130,Lapatinib,SCH772984,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.856371,0.27190477,1.3969272922390312,0.1302928567265799
21020,SIDM00875,Alpelisib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4534293,-0.036333308,0.4191831275961371,0.054057000023422265
74838,SIDM00097,ZM447439,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5602584,-0.10403775,-1.5303769259393727,-0.010601310991378043
26749,SIDM00411,Gemcitabine,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.5199282,0.093689404,0.5465380944865106,0.06671608892018059
81891,SIDM00954,Paclitaxel,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-0.2652445,-0.020931453,-0.571183664506163,0.006105156794876734
101020,SIDM00866,Axitinib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-1.5481104,-0.092186846,-1.482298732322308,-0.03420522934051409
83700,SIDM00359,Navitoclax,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.41735166,0.020987183,0.49495455052577825,0.02049300563851735
29398,SIDM00673,Trametinib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,1.2797059,0.111643955,-0.7278579872850033,-0.024916509972349624
2422,SIDM00097,Nilotinib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.5238793,0.15506536,0.8375840924304628,0.06812340659139658
68396,SIDM00779,SCH772984,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,33.0,-1.6821901,-0.13244663,-0.9212628410509245,-0.11180424574864305
51351,SIDM00531,SCH772984,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.6662299,0.06646047,-0.463927406273449,0.03283786516699078
16132,SIDM00673,SCH772984,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-3.6299036,-0.25382873,-0.14417951684561836,0.0021712539300680995
62297,SIDM00529,Docetaxel,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-3.2613199,-0.17521283,-3.4124559066404054,-0.21773028866997504
74555,SIDM00193,SB505124,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.4122438,-0.088840716,0.0887464720765301,0.0038267269195279593
102752,SIDM00878,NU7441,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.5441303,-0.05127218,-0.9625523480631042,-0.0847603104165623
24071,SIDM00893,Cisplatin,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.8606029,0.026110467,1.5510423606576935,0.09991205397534435
81343,SIDM00301,AZD7762,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.8966426,-0.08949514,0.10273929502610654,0.03428560604857052
81708,SIDM00146,Alpelisib,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,0.63078916,0.032753915,0.6927272951876653,0.11972409189651896
54343,SIDM00774,PF-4708671,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.525578,-0.10292653,0.4283808254045426,-0.014541714206117938
38541,SIDM00866,Alpelisib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-2.4341555,-0.15301545,-0.25714269968149117,-0.0012344060924588376
48390,SIDM00866,Crizotinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-0.56625986,-0.04149101,-0.01169788723225798,0.04802487060419277
50118,SIDM00866,AZD7762,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,52.0,-0.52002406,-0.036752153,-0.20291737005878832,-0.008623163408233261
44598,SIDM00875,Gemcitabine,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.661667,-0.0014263188,-0.49617127574504455,-0.007625982673143256
80942,SIDM00628,MK-2206,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,0.6475164,0.04543574,0.3928589542010101,0.1095383371273756
26935,SIDM00673,Palbociclib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.1111245,0.117372215,0.40144300642541636,0.022402774184220813
15402,SIDM00954,Axitinib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-2.01408,-0.13929111,-0.3070256761609969,-0.04200419560454794
30540,SIDM00628,Taselisib,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-1.0042018,-0.08707335,-0.869660420992702,-0.016358234510811323
81595,SIDM00779,LGK974,Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,1.6650115,0.06904758,0.08697752611268281,0.02235158197755993
80108,SIDM00531,Gemcitabine,Palbociclib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-6.385375,-0.67829293,-3.357238267621635,-0.25904710916141027
32907,SIDM00332,KU-55933,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.0318801,-0.08992575,-0.03084429083460379,-0.025192041518973394
29035,SIDM00875,Uprosertib,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5709438,0.060105998,0.9556295791822892,0.10245422984675571
67630,SIDM00097,AZD8055,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.362813,-0.1463724,-1.0582765854083662,-0.11036796621262455
86715,SIDM00301,Dasatinib,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,4.449431,0.41778824,3.2919579222921356,0.17276162334604694
81530,SIDM00778,Vinorelbine,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-3.5983114,-0.18909045,-2.371085367138428,-0.09857811033025993
86651,SIDM00146,Alisertib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-2.9529417,-0.19935864,-2.2289618250778758,-0.17810266456310028
56702,SIDM00866,Axitinib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.4661599,0.110920355,-0.02417164525297463,0.07067885278744568
48277,SIDM00628,AZD6482,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,Black,51.0,-0.70804656,-0.0678063,0.27773895075364363,0.009265173156800808
90216,SIDM00628,MK-2206,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,3.5861247,0.32607573,1.0574352490116963,0.11425244840538037
97883,SIDM00776,Camptothecin,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-1.8653357,-0.12212635,-0.9300499298918096,-0.045184537782312344
61627,SIDM00893,Taselisib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.68762654,0.023932872,-1.397152679736861,-0.09391445392716312
10343,SIDM00097,Olaparib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3946669,-0.030195402,-0.4964123565956539,-0.008764818862052383
2549,SIDM00097,MK-1775,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.61200947,-0.042367518,-0.8907740679134772,-0.12947016753838922
34846,SIDM00893,5-Fluorouracil,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.72530854,0.016804945,0.5033109560868966,0.049243129903186474
70541,SIDM00866,NU7441,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-0.04021213,-0.0026928375,-0.19677072951496488,0.05761301653844971
25344,SIDM00660,Crizotinib,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,1.0077605,0.06233554,0.0337189608262789,0.005334973099569832
26509,SIDM00359,Vinorelbine,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.8949432,0.074990265,0.20060967443728997,0.09181056506609873
32462,SIDM00193,Palbociclib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,53.0,-1.989509,-0.04925067,1.1229352804495814,0.054974989440385785
96075,SIDM00529,MK-1775,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-1.1524745,-0.11700976,-1.3128618343919365,-0.07367244999994885
53497,SIDM00875,Pictilisib,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.34511063,0.03118834,0.4492888233248691,0.05196128165629945
84534,SIDM00531,Erlotinib,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.5381596,0.04703339,1.3525791919178969,0.088431005060087
25121,SIDM00875,KU-55933,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0399083,-0.046567407,-1.705109287819327,-0.014778886849927123
38001,SIDM00529,Ribociclib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,2.2197177,0.10257706,0.7945549331525468,0.002825785040442257
99585,SIDM00628,Olaparib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,Black,51.0,-1.5602655,-0.112463765,-1.9711232105212961,-0.09410432410351231
99376,SIDM00628,Wee1 Inhibitor,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,0.8817429,0.07790453,0.2916524334408569,0.017443258930416962
36665,SIDM00628,MK-2206,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-1.740305,-0.11361342,1.4642919487587545,0.12893110802535496
93338,SIDM00332,AZD8055,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8889215,-0.027696008,-0.9429087444573914,-0.044166763417420235
18446,SIDM00097,KU-55933,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.4534159,-0.09833771,-1.9857464881427722,-0.06654420167909458
22609,SIDM00193,MK-1775,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.8961234,-0.07001365,-0.46355056075465506,-0.03494900394437111
46852,SIDM00411,Erlotinib,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-2.0453386,-0.07312261,-0.8698453719310668,-0.003773339784760962
9977,SIDM00529,Cisplatin,OSI-027,Breast,1.0,Breast Carcinoma,Female,Black,44.0,1.1322111,0.02370595,1.8229469088514336,0.03316109567629895
81043,SIDM00332,RO-3306,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,1.798246,0.10037406,1.4171586326690393,0.08290822119900314
69649,SIDM00673,Sorafenib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.764106,-0.06939847,-0.16426980250119286,-9.035134838787518e-05
107122,SIDM00778,Vinorelbine,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,-0.7914907,-0.03332815,-0.21233594216932908,0.0014642899528319743
91062,SIDM00660,Oxaliplatin,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,1.3319879,0.14091806,0.47641679276764193,0.07092024353090418
28377,SIDM00878,Tozasertib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-1.0218621,-0.08632637,-2.3801799916103636,-0.09877396628767886
27059,SIDM01233,Crizotinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,72.0,-1.4212213,-0.08072338,-0.3512247761592877,-0.018877760336169985
78918,SIDM00359,Olaparib,Navitoclax,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.4869192,0.013263862,1.1789067146484236,0.05475230405729582
67206,SIDM00878,Trametinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-1.0150906,-0.086257435,-0.14028838399678925,0.02656559181756289
15640,SIDM00529,JQ1,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-1.5274409,-0.09233602,-0.9464070028921383,-0.02322252916679521
13746,SIDM00146,Navitoclax,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.2507203,-0.017896898,0.26689069940947235,0.014215402131240847
72321,SIDM00776,Navitoclax,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,-0.4317364,-0.026989682,0.1747956584427838,-0.03729956424130143
49009,SIDM00628,Trametinib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,1.6159316,0.10038525,0.23001760507715982,0.02483699293936739
57428,SIDM00628,Axitinib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-1.7315387,-0.0792042,-0.06596451908552482,0.026453647927669535
24854,SIDM00628,Gemcitabine,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-1.6739503,-0.06837065,-2.4596414862465688,-0.11687555942446386
13241,SIDM00146,Pictilisib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.1924337,-0.08311632,-0.45484209796481667,0.021514257124825076
85998,SIDM00529,Palbociclib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-2.8467104,-0.10386277,-0.629701427830446,0.03229757867887945
71851,SIDM00332,AZD6482,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,4.502939,0.2520186,1.2593281066296933,0.1330466286093025
42572,SIDM00774,5-Fluorouracil,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.4809505,-0.12013963,-0.5193247508765476,-0.07045429820715854
58301,SIDM00878,Nutlin-3a (-),Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.276591,0.0909235,-0.2844113576515609,-0.002402883533699385
13121,SIDM00875,RO-3306,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4851086,-0.13202877,-0.9497659100784039,-0.09541717117141417
59441,SIDM00774,Cisplatin,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,1.3071827,0.041859787,1.300065841757254,0.07140654137790374
103436,SIDM00531,Dasatinib,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.9374857,0.20612606,2.3159489366464014,0.1746765405121495
48460,SIDM00878,Venetoclax,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,2.419013,0.10840299,-0.10576852789860627,0.006392249243096845
89255,SIDM00411,MK-2206,Sorafenib,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.5276682,-0.09916579,-0.5253525016448283,-0.005430534578680216
104149,SIDM00971,Ribociclib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.0591466,-0.063026726,-1.1367768038562118,-0.02315762736485185
87729,SIDM00878,Tozasertib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,2.961086,0.088614956,4.043535385398844,0.22029222498770992
98161,SIDM00971,MK-1775,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.4185128,-0.07046577,0.5266371020005005,0.05330073057064542
32466,SIDM00529,Vorinostat,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-0.22887465,-0.021119928,-0.2485075493594883,-0.013154177070410313
31566,SIDM00774,Taselisib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.7286645,0.018732347,0.3435104484838271,-0.0031667288650141616
22013,SIDM00954,Axitinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-0.8459944,-0.05697014,-0.8339662475635,-0.051603580115132004
92522,SIDM00866,Cisplatin,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,52.0,1.3298568,0.034717172,1.343250387108862,0.03773994595880243
43226,SIDM00954,AZD7762,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.0,-2.881034,-0.11876563,-0.37617766460328944,-0.02016390698211606
78535,SIDM00834,Palbociclib,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,2.232419,0.16594292,-1.4947796343759,-0.07966374092900118
19489,SIDM00878,ZM447439,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,0.5487651,0.04653215,-0.004964970996784416,-0.001759679195615606
22912,SIDM00660,Crizotinib,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,32.0,-0.28322816,-0.016737176,-0.6937694996230607,-0.017537083628840888
50548,SIDM00146,Lapatinib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.7724596,-0.15583663,1.4194765532817315,0.13632599596846232
90469,SIDM00878,Alisertib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-1.4487324,-0.12481472,-1.5685715870719419,-0.09695423328587977
12937,SIDM00776,Olaparib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,-2.230534,-0.07471159,0.828984646654213,0.07473156231607163
87456,SIDM00660,Crizotinib,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.97291744,0.07954422,0.13686307100336179,-0.0142008792014192
101179,SIDM00628,Axitinib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.049273428,-0.0037123112,-0.6630878114572992,-0.01456221819649429
44519,SIDM00628,Gemcitabine,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-6.4232984,-0.37675428,-2.136098109829917,-0.08336680409826515
11643,SIDM00875,Sorafenib,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.3118336,0.0322028,0.28656971641254997,-0.011948381509176861
28756,SIDM00778,Olaparib,Dabrafenib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-3.1388104,-0.082414284,-2.498206474766243,-0.07107218619642548
36066,SIDM00776,SCH772984,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,1.2126272,0.074169844,1.8625328753071015,0.09778303674005634
37364,SIDM00146,Sorafenib,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-0.15404163,-0.014615217,-0.6724411064008312,-0.04505598722872018
9276,SIDM00660,MK-2206,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,2.6687305,0.14287938,1.8092293953733358,0.1426281713972464
8144,SIDM00954,Temozolomide,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.22970617,-0.003996362,1.0486763982222878,0.0243446705761459
56843,SIDM00778,Oxaliplatin,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,69.0,-2.6111054,-0.05536043,-1.1994647301231287,-0.04487179440977231
31671,SIDM00411,AZD7762,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.1012862,0.08302971,0.7744767663957671,0.03688440840745715
46719,SIDM00332,Taselisib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.5313613,-0.2599649,-0.8635136986972158,-0.06411744597076237
29111,SIDM00954,Taselisib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-3.2611256,-0.14081644,-0.7034372902678536,-0.06858068795075145
31405,SIDM00628,5-Fluorouracil,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,-0.329932,-0.018276347,-0.7107026523777,-0.014762657228290954
103542,SIDM00774,BI-2536,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-2.0972252,-0.12348689,1.7265639515209577,0.08122891838734296
79439,SIDM00301,Palbociclib,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.6345682,-0.15323816,-0.0906859552738991,-0.01235823182282708
49443,SIDM00875,Dabrafenib,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7730478,0.03718005,-0.36063399552224495,-0.0232553903903436
36368,SIDM00866,Docetaxel,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,52.0,-0.69790554,-0.061230905,-1.0502080622704482,-0.04052937945383295
76548,SIDM00529,KU-55933,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-0.8816724,-0.014809849,1.077824870777561,0.008215481853354478
83629,SIDM00878,Doramapimod,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,2.550797,0.17865932,1.00948519846215,0.05084341884129189
62461,SIDM00875,Alpelisib,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.29303044,0.027019704,-0.4867595913725357,-0.03650486665575812
46806,SIDM00628,Venetoclax,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-1.0748407,-0.04361173,-0.49915543124297884,0.03872121380653839
93874,SIDM01233,Taselisib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-0.34997737,-0.028675584,-0.4942254674768971,-0.02452316334020239
63781,SIDM00875,Entinostat,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4304094,-0.091901705,0.7153350081445448,0.098015537496741
91674,SIDM00193,Navitoclax,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,53.0,0.62984425,0.03780917,-0.2616979471247569,-0.006355039390478118
53383,SIDM00954,NU7441,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,1.0401666,0.06869996,0.1856675442960307,0.05460801067646366
98121,SIDM00660,Trametinib,Oxaliplatin,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,1.6462785,0.09171102,-1.4478684385438185,-0.07586415527299707
57507,SIDM00774,ZM447439,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,48.0,-2.925101,-0.13620692,-0.5381777604469364,-0.017705595084764884
27560,SIDM00776,Taselisib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.78849626,-0.073825814,-0.7552471606913256,-0.00915323284724192
88025,SIDM01233,AZD7762,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,1.3050236,0.036543883,4.251236449731116,0.18299234095915026
14508,SIDM00954,Olaparib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.0,-1.7851596,-0.027398573,0.3844356136836401,0.06518867022744208
81344,SIDM00673,MK-2206,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,0.83906084,0.04435327,0.8355799688740126,0.03104875304378949
22299,SIDM00628,Taselisib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.4633758,0.1594494,0.7687865996894429,0.11424023340375929
53902,SIDM00866,Linsitinib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-1.2373525,-0.06592402,-0.8987450391005487,-0.03064404261505157
26752,SIDM00875,Docetaxel,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-4.475946,-0.42685556,-2.5335331991281884,-0.2134739042795591
93723,SIDM00774,Nutlin-3a (-),Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.32322997,0.010154911,0.14122946038369635,-0.028730436753499417
58373,SIDM00301,OSI-027,Palbociclib,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.2689704,-0.13717146,-0.16417622501710857,0.01949077030784407
39165,SIDM00875,Alisertib,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1297666,0.095827624,1.4903624752889344,0.04154997254826593
52514,SIDM00866,Venetoclax,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,1.3858457,0.030775715,1.8455229345440283,0.0488291509739654
92677,SIDM00673,Taselisib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.3636198,-0.14013414,-1.2709324886968723,-0.09663459898065531
44385,SIDM00834,Vinorelbine,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-0.52922213,-0.03324722,-0.009860628497156906,0.07627949621903585
39158,SIDM00301,Taselisib,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,50.0,-1.3087659,-0.12210519,-0.8371631629590344,-0.03388232514286048
74519,SIDM00834,Dabrafenib,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-1.2310013,-0.030583233,0.036330217480757834,0.012500684244942297
82031,SIDM00673,SCH772984,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-5.3595605,-0.3048996,-1.319633694458137,-0.1135698918577896
85667,SIDM00875,NU7441,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.23582843,0.018813938,-0.29813207256316554,0.06929122851127502
14855,SIDM00971,AZD6482,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.9723591,-0.053365067,-0.6437789455492265,-0.00898795413030667
88741,SIDM00332,JQ1,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.149314,0.14047852,3.926585258155457,0.15985612847894407
39359,SIDM00673,JQ1,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.0206995,-0.06662416,-0.5801421844480533,-0.05473681836077717
21427,SIDM00954,ZM447439,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-0.940201,-0.066112705,0.795664508127591,0.0874024282022291
79096,SIDM00866,PD173074,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.3115846,0.051060885,0.9707552907684969,0.07138766760257235
30571,SIDM01233,5-Fluorouracil,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,2.0924423,0.14918002,1.5378455106601039,0.12330466779731286
90522,SIDM00782,5-Fluorouracil,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,Unknown,72.0,-1.5394223,-0.04432554,0.33470284473919837,0.025052924196043387
83787,SIDM00130,Paclitaxel,MK-2206,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.95754576,-0.08621238,-0.43653699944240937,0.06047081925350308
56607,SIDM00301,Trametinib,Dactolisib,Pancreas,0.0125,Pancreatic Carcinoma,Male,East Asian,50.0,2.1097898,0.26102743,1.5591628996144349,0.10309755719335774
15982,SIDM00878,AZD8055,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-3.813698,-0.088625915,-0.8994951650923447,-0.007880254700545267
75336,SIDM00875,Cisplatin,Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.0210896,0.15259981,2.001563258881655,0.18922462164087592
51735,SIDM00866,Navitoclax,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.2573056,-0.021457328,0.89635855118663,0.08872860143201138
56680,SIDM00893,5-Fluorouracil,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.7869877,-0.030467264,-1.6919033111937642,-0.0408794980573339
24571,SIDM00893,Nilotinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.74822825,-0.024340667,-1.865201564975236,-0.07435738228400474
55816,SIDM00834,AZD4547,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,3.572383,0.13329224,1.9445337390217108,0.06481208551836744
35563,SIDM00866,Entinostat,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.2120937,-0.06901249,-0.814894207153619,0.00984803088612559
92584,SIDM00411,Erlotinib,SCH772984,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.6667569,0.13056393,1.661551589801106,0.10582413038725132
17751,SIDM00782,Camptothecin,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,-1.1683155,-0.0945807,0.18890566437191983,0.005250708756972261
56799,SIDM00146,Luminespib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,1.9872762,0.06009504,-0.9772897934791563,-0.07871053386680765
96800,SIDM00893,Paclitaxel,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.25058657,0.01964782,-2.5717963054365622,-0.0943592505736409
67306,SIDM00834,Camptothecin,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-0.6877759,-0.060363647,-1.7126601011344669,-0.10733646301467364
46618,SIDM00834,SCH772984,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,White,66.0,-1.8761672,-0.14847489,-0.45709549998036514,-0.02849083462328727
100664,SIDM00875,MK-2206,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2475487,-0.09179126,-0.18616818239148408,-0.03965361901214913
98077,SIDM00774,Docetaxel,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-3.535316,-0.51786035,-1.2745749531082353,-0.14145191290091708
57161,SIDM00660,BMS-754807,AZD4547,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-1.4697157,-0.15476188,-1.762670590575608,-0.07359824450669017
88993,SIDM00971,GSK269962A,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.9272506,0.13452208,0.8181178981751066,0.014867348649041576
30721,SIDM00529,RO-3306,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-0.39812756,-0.013428505,0.1966559289920683,0.002640433929193011
46008,SIDM00529,Olaparib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,-2.3037252,-0.07497922,-0.7906787111636225,-0.014763301243582955
97386,SIDM00866,Camptothecin,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,1.616151,0.030649621,3.049560459666298,0.07962251823631648
2861,SIDM00193,BMS-754807,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,-0.73591596,-0.042448137,2.083783884421215,0.12751361473791892
28287,SIDM00878,RO-3306,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,2.5506043,0.037700925,2.9894085682539533,0.15516569246188872
77608,SIDM00628,Temozolomide,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.68329704,-0.021982238,-1.0751205474342833,-0.00667051127831337
8617,SIDM00146,Sorafenib,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,-0.4044781,-0.03576455,-0.3330601003578824,0.0007380362839299915
4884,SIDM01233,SCH772984,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,72.0,-1.4274591,-0.11019883,-1.8516201833847437,-0.10564316270015249
13997,SIDM00971,Crizotinib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7503036,-0.053021893,1.0276281587577007,0.02959945706978435
850,SIDM00954,ZM447439,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-6.3688264,-0.48725134,-1.7758168165069232,-0.16341737208393453
1993,SIDM00834,Navitoclax,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,White,66.0,0.34472054,0.02425908,2.2300336699238588,0.12755008759194617
95583,SIDM00097,Nutlin-3a (-),Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.0485215,-0.09405025,-2.1705988907457545,-0.0765668921515531
84277,SIDM00529,Linsitinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.3282666,-0.045873314,-0.768972634385574,0.03266753287522925
107562,SIDM00893,PF-4708671,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2964143,-0.097360775,-1.1872300472597406,-0.037032542053991716
23991,SIDM00774,PF-4708671,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,-2.2352557,-0.09902124,0.803913314766681,-0.01935750960538214
75685,SIDM00531,Lapatinib,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.3143828,0.12798119,0.9244501372529194,0.053492902560562584
16130,SIDM00673,MK-2206,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.44359732,0.025911946,0.08351075266237526,-0.009286472498586754
64573,SIDM00878,RO-3306,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.92340124,-0.061019655,-0.7758873182829188,-0.042353510803160285
31463,SIDM00774,Navitoclax,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,-0.6501585,-0.024481425,-0.5924249446014361,-0.04993036101527296
40168,SIDM00875,Alisertib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7120548,0.16251403,1.1839130696962008,0.0999298545507279
49054,SIDM00875,Olaparib,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.9001685,-0.12740889,-0.8992713797273353,-0.08345953156184445
86832,SIDM00774,Cisplatin,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,48.0,1.5627686,0.06288567,0.7315120223148192,0.0595377135684489
41945,SIDM00954,Axitinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,1.6723417,0.13352372,-0.48356325336678185,-0.0030023471627492974
96400,SIDM00866,Paclitaxel,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.5986581,-0.12500785,-3.662347391130598,-0.23951032994068822
36862,SIDM00529,Sorafenib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.5944839,-0.13662405,-0.986675343667859,-0.056354670264640326
67231,SIDM01233,SB505124,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,72.0,-0.59921587,-0.031423137,-1.2380846069738158,-0.06183181572230674
2624,SIDM00529,Bortezomib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,-0.31588963,-0.025527498,-0.8564187114895305,-0.04719170203711907
54624,SIDM00878,GSK269962A,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.366898,-0.119218685,-0.9099357466165034,-0.0725125238501921
93361,SIDM00531,Sorafenib,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.0094662,0.12848876,-0.3867498130217866,0.00973443925414488
60448,SIDM00660,AZD8055,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,1.8056451,0.118207455,0.4199924358189235,0.06002188355059885
105266,SIDM00097,Dabrafenib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.237407,0.010923544,0.45084309743486567,-0.025179978079152822
4232,SIDM00130,Palbociclib,Oxaliplatin,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.85501206,-0.053399164,-3.0108642227332907,-0.12808290490162036
51155,SIDM00875,BI-2536,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8467482,0.022329908,0.0708562029000447,-0.023198577150584532
59885,SIDM01233,LGK974,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,2.7274113,0.20311359,-0.37848188440485997,0.0042781567209179226
101080,SIDM00875,Entinostat,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8685934,0.09154504,0.15624092734337977,0.01515564757913561
32340,SIDM00660,AZD7762,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,32.0,0.2032001,0.015099362,-0.47802395727555086,-0.05369655563787162
64159,SIDM00673,Linsitinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,1.1442899,0.015551177,2.9085651474762737,0.05157600514341256
42837,SIDM00130,OSI-027,LGK974,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.1162913,0.10714619,-0.6429495190604257,-0.05079838781664308
34711,SIDM00097,BI-2536,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6985935,-0.12085027,-0.7273962278507808,-0.07173230195823177
16446,SIDM00146,SCH772984,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-0.5529737,-0.05018173,2.0692945622779515,0.13280309100108723
91831,SIDM00628,Alisertib,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-1.1192007,-0.04196772,-1.409235587537856,-0.060814854281528656
67848,SIDM00146,Dabrafenib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.34186766,-0.015918985,1.1530655888411112,0.08620796718736852
2932,SIDM00130,Olaparib,Oxaliplatin,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.5559725,-0.07748522,-0.5636180008502899,-0.07408238859229531
42893,SIDM00332,Venetoclax,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,2.5767355,0.069421336,0.7543532617244377,0.0543248574921379
53235,SIDM00130,Ruxolitinib,MK-2206,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.5999851,0.09877054,2.6133455566193518,0.08321832764854477
28227,SIDM00529,RO-3306,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,2.1598265,0.108321786,0.747505137422385,0.035741051611253044
47948,SIDM00146,OSI-027,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,0.69221467,0.047954716,0.23160755453529566,0.003965593494624549
49061,SIDM00332,Pictilisib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4154867,-0.14438403,-1.1379304120284663,-0.1358550835260431
53523,SIDM00893,Gemcitabine,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.3157154,0.05339775,-0.015057741161925308,0.01632466301493822
91962,SIDM00628,OSI-027,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-0.91504407,-0.085631415,-0.0495661913090827,0.03372503680705216
104365,SIDM00782,AZD8055,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.3190744,0.027758481,1.9093255692070488,0.13216730742816402
70535,SIDM00359,Palbociclib,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8625971,-0.097571164,-3.7954906686987835,-0.12992923022401276
21953,SIDM00529,Vorinostat,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-0.53054106,-0.050446074,1.2817290210989178,0.06562663959305601
57876,SIDM00875,RO-3306,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.3298929,-0.16126853,-0.851925783612735,-0.07240496133732023
11424,SIDM00878,Temozolomide,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,0.516238,0.013304997,0.179471662355947,0.011578822496294633
86123,SIDM00971,JQ1,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.101189,-0.051707022,-1.4369151319220501,-0.03200496301148797
51802,SIDM00954,Navitoclax,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-1.1401128,-0.044450976,-1.1904549134086377,-0.08479228388163938
9499,SIDM00878,Axitinib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,0.6046386,0.049521506,-1.1041338183228515,-0.023239329768871105
90133,SIDM01233,Dabrafenib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,1.999959,0.087705724,0.13119943219913008,-0.004159749370862127
2665,SIDM00097,NU7441,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8651637,-0.0867064,0.713885588591288,0.04312055920539343
20195,SIDM00893,Linsitinib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.5591452,-0.056803167,0.23715740606667166,0.06904728755648774
101243,SIDM00359,Navitoclax,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.7555298,0.0403916,0.14812069728548508,0.039963878241757615
66381,SIDM00097,KU-55933,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.6454036,-0.10175909,-1.2478844023527924,-0.03800822073532767
89200,SIDM00301,MK-1775,AZD7762,Pancreas,0.0625,Pancreatic Carcinoma,Male,East Asian,50.0,-0.6738294,-0.080895305,1.4893143787457486,0.0690201177311957
32570,SIDM00531,OSI-027,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.9995345,0.028075235,1.0560662644742225,0.012663804704493574
69281,SIDM00130,Taselisib,OSI-027,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,3.1275203,0.29167932,0.989550172900164,0.09353516365581797
105754,SIDM00866,Afatinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-1.7109308,-0.1483338,-0.6666433580892722,-0.026555331484069897
14547,SIDM00893,Camptothecin,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.5630082,0.05177088,0.13049054851056016,0.013781847620970983
34927,SIDM00332,Nutlin-3a (-),5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.6082954,0.07604541,0.3643580843232256,-0.000749159712552273
60531,SIDM00097,Alpelisib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.36342043,-0.025475381,-0.19656054189948383,-0.021247952158061422
37497,SIDM00893,Nutlin-3a (-),5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.6489937,-0.013444514,0.6599688683841618,0.008302554423226843
25211,SIDM00954,Alpelisib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-1.9980245,-0.12509027,0.6710356146339622,0.07326544275958712
107622,SIDM00834,AZD8055,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-0.7828334,-0.06195376,-1.2596537933711867,-0.02923713720382897
76202,SIDM00866,Tozasertib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-2.852765,-0.1372889,-2.3009538815535993,-0.09237372752351938
54771,SIDM00878,5-Fluorouracil,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.5508405,-0.09119163,-0.1712155378169659,-0.023604089177973606
31530,SIDM00774,Ribociclib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-2.580986,-0.07237617,-0.11159726435009247,0.013434334352049512
30790,SIDM00893,Pictilisib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.5025989,-0.1490648,-1.247229046753238,-0.059881298321195695
5318,SIDM00628,Nilotinib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,0.44251433,0.039817233,0.691709191299013,0.05463846061915446
100904,SIDM00673,Docetaxel,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,0.24918868,0.020254426,-0.32753744205967733,-0.058028493331375795
1133,SIDM00954,Ribociclib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.8569386,0.03254018,-0.32012445437588344,0.07041827905608886
106102,SIDM00146,MK-1775,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.54688156,0.030848635,2.024671640992073,0.10627820927252879
37504,SIDM00878,Wee1 Inhibitor,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.59556514,0.04696048,-0.007604284139530675,-0.01509098034963899
30843,SIDM00878,Luminespib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.6155544,0.06673635,-0.7045918795804892,-0.08372461271829933
47151,SIDM00332,PF-4708671,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.4047377,0.09568555,1.7579082291877097,0.1135778618860705
5283,SIDM00778,Vinorelbine,Afatinib,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,-0.6192343,-0.024972038,-0.02795479006160116,0.022544322651658802
43813,SIDM00130,Erlotinib,Irinotecan,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.8849018,-0.08316558,0.09306774967242398,0.03337653653879401
49055,SIDM00529,RO-3306,Trametinib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,3.3926249,0.20999803,1.1303729872723658,0.08719473685735386
56039,SIDM00971,MK-2206,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.91045797,-0.050424363,0.1674902268070921,-0.007238906012290627
45655,SIDM00778,SB505124,Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-0.37675688,-0.022686714,-0.7352758662411261,-0.05323350448401923
25129,SIDM00193,Oxaliplatin,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-0.67640346,-0.020061368,0.8871787702064026,0.01627751467604164
104044,SIDM00660,AZD4547,SCH772984,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,32.0,1.5853224,0.1293122,0.34968406767408006,0.06497321930042374
102814,SIDM00529,AZD6482,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,3.1262908,0.07561825,1.487781353510336,0.03960624442485224
104833,SIDM00332,SCH772984,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.713331,0.11980146,2.727527247601645,0.07821311447561038
13417,SIDM00529,AZD6482,MK-2206,Breast,0.25,Breast Carcinoma,Female,Black,44.0,0.32879728,0.010874007,0.34064123141698466,0.02743047438840569
86937,SIDM00875,Nutlin-3a (-),Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6509566,-0.018728908,0.1960577972186492,0.008054054993242342
98468,SIDM00529,Alpelisib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,-0.84508914,-0.037813075,0.3792825006950251,0.09112698598011794
63455,SIDM00878,PD173074,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.93119234,-0.09817466,-0.8712255217417186,-0.06578875059717894
3887,SIDM00875,SCH772984,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.9214348,-0.15749446,-0.17262860965854665,-0.02998427332963935
9547,SIDM00097,Olaparib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2950795,0.029317776,0.4877038718541073,0.004608811521486425
81866,SIDM00875,Tozasertib,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5308702,-0.04898372,0.06207043763717036,-0.015687565587546946
60168,SIDM00146,Crizotinib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.4154029,-0.037005562,-0.3695018172194379,-0.012901976635209714
74702,SIDM00776,BMS-754807,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,-0.99538845,-0.08492218,-2.060474159160763,-0.1414799164639184
18205,SIDM00332,Nilotinib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5512745,0.11632219,1.0602048377260076,0.08664822622558778
49925,SIDM00193,Olaparib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,53.0,1.7466102,0.11027858,-0.04509981463677599,0.04218189932555274
89603,SIDM00628,Wee1 Inhibitor,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.052661758,-0.005296007,0.16959047869719798,0.035226087861323675
57116,SIDM00782,AZD4547,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,0.12085813,0.003448554,1.8084748187007258,0.0729604344498531
44077,SIDM01233,Palbociclib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-0.105640285,-0.002133387,2.3032395369336895,0.11418014881406298
93634,SIDM00782,Taselisib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,Unknown,72.0,-2.1220026,-0.15853944,-0.7355606182371233,-0.06583818386928374
99782,SIDM00529,MK-2206,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Black,44.0,-0.35908908,-0.014954836,0.535501663319431,0.07920252268486894
16624,SIDM00332,SCH772984,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,5.3741426,0.24832729,2.2435790751094666,0.09007853812288977
36606,SIDM00778,Crizotinib,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,69.0,1.2846162,0.053751037,-0.43550033924877546,0.020523842795818766
12612,SIDM00359,Oxaliplatin,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.445443,-0.077494256,-1.5576680156320002,-0.050810233763699676
106488,SIDM00628,Dabrafenib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,-0.4668439,-0.037469205,-0.42874753020625317,0.006721872716024951
95517,SIDM00332,AZD7762,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.286723,-0.13223994,0.7229112841163089,0.07011496230372449
32446,SIDM00776,SB505124,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.6028171,-0.046908848,-0.7090976902527967,-0.04729584684214587
74500,SIDM00301,Dactolisib,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.2172072,0.10007092,-0.23863733956602082,-0.015582231987960351
6709,SIDM00301,Palbociclib,Erlotinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.5265405,-0.18054038,-0.6720851163960013,-0.05030787307170345
66829,SIDM00660,SCH772984,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,0.9136575,0.025028195,-0.46804900911572317,-0.019042131907033102
11847,SIDM00776,Afatinib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,0.41511965,0.030174686,1.1412711231970118,0.035044661767169014
99672,SIDM00774,AZD7762,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.31255558,-0.037246697,1.2262470808807244,0.20662261680158478
81894,SIDM00673,Paclitaxel,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-4.520822,-0.285591,-3.909509030892049,-0.2935904190211527
91978,SIDM00878,Dabrafenib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,2.0707815,0.07670177,1.2169581955019222,0.057170907635976397
73716,SIDM00778,AZD8055,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,-0.6091449,-0.03826189,-0.6963004363368756,-0.051610489107158666
5423,SIDM00097,MK-1775,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.38658428,-0.021892468,-0.257536917204385,-0.01889701066959212
83981,SIDM00954,Nilotinib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-1.784962,-0.09501102,0.7913328683428923,0.07883839349712764
25032,SIDM00866,AZD8055,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-0.9498908,-0.021342268,1.2209572697435997,0.005864290768593712
20489,SIDM00954,Camptothecin,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-0.7587851,-0.026172783,0.9412382010832663,0.061597420299844184
70047,SIDM00834,Trametinib,Navitoclax,Large Intestine,0.1,Rectal Adenocarcinoma,Female,White,66.0,-1.3014938,-0.05119872,1.61855724236602,0.036651756696672734
83873,SIDM00146,PF-4708671,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,1.8849424,0.06851821,3.1486383689323576,0.12994071901896967
68761,SIDM00878,Palbociclib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.642433,-0.08646152,-0.5992155369455107,-0.07258525435479088
80227,SIDM00878,PF-4708671,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-2.194192,-0.09537062,-1.5678373386219604,-0.031100313123894347
77825,SIDM00875,Trametinib,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8928352,0.027338557,-1.7789959865016984,-0.10588110171147957
99864,SIDM00673,Alpelisib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.48161453,0.028502218,0.38972763535009414,0.0627772156782211
54358,SIDM00146,Sorafenib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-1.3545594,-0.12193375,-0.434897207458357,-0.05317927309112246
53567,SIDM00097,Dabrafenib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.7888134,-0.033880766,-0.7772661253297901,-0.0391940952356154
2071,SIDM00866,Temozolomide,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-1.3611432,-0.023877032,0.9975143348457771,0.029990832366437216
58758,SIDM00834,Taselisib,Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,White,66.0,0.56074584,0.044954687,-0.7398592747947498,0.006226433961147287
1420,SIDM00774,Temozolomide,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.3868757,0.010793699,-0.04662373277025304,0.023428005031710282
96688,SIDM00097,Cisplatin,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0403571,0.020990117,0.814123431738182,0.05438376094631602
53843,SIDM01233,SB505124,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,72.0,-0.272565,-0.012184057,-2.0650815629612245,-0.15222913755701958
42342,SIDM00834,BMS-754807,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-1.8994422,-0.107061185,-1.5559271601563103,-0.0645420549957971
5529,SIDM00332,AZD8055,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2176261,-0.08818012,-1.6322969793924365,-0.10992711807162533
52784,SIDM00875,Navitoclax,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1504271,0.11447428,2.371312858732728,0.10513443790720099
94263,SIDM00866,Tozasertib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-3.3889353,-0.14094147,-2.20161897974292,-0.07490716707651787
98840,SIDM00893,Docetaxel,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2345982,-0.06082383,-2.6690070300831894,-0.03372231631802405
50375,SIDM00782,BMS-754807,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,Unknown,72.0,-1.5407624,-0.14208403,0.8452957411054077,-0.0008920380224933166
47089,SIDM00954,Entinostat,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,2.103806,0.17472768,-0.19712117745923097,0.032587324748116965
8022,SIDM00954,AZD8055,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-1.6848823,-0.12003971,0.0155361735842903,-0.02438220166251752
16900,SIDM00628,Ribociclib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.5959729,-0.014924923,0.5096907224119296,0.03962795283719444
99025,SIDM00673,Camptothecin,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.6018987,0.057444472,0.3190135610088646,0.01729695919172601
20382,SIDM00954,OSI-027,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,1.6996845,0.1332421,0.3145226372771787,0.07622120449781887
78164,SIDM00866,Docetaxel,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.1048912,-0.07818164,-1.173630592339223,-0.06691825309076882
39859,SIDM00954,Trametinib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.7203205,-0.06635362,-0.32793717433229325,0.0207078561021754
33774,SIDM00332,Crizotinib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7925799,0.16976391,-0.353691244846683,-0.006521171425866766
45287,SIDM00893,Uprosertib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.19168802,-0.014134995,-0.5980851398530086,0.013019676577370558
67897,SIDM00893,Gemcitabine,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.7045481,-0.06530232,2.341182645286947,0.1802136888822043
48276,SIDM00529,PD173074,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-2.4880755,-0.08608225,-0.44357834254947176,0.03944884431414384
42237,SIDM00893,Alisertib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.8682663,-0.09253573,-2.6053157470494637,-0.12915822921817366
34667,SIDM00774,Temozolomide,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,2.3351798,0.08922473,0.5520886835860173,0.04837704803571383
33075,SIDM00774,Gemcitabine,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,3.4153316,0.22421783,4.760758753148533,0.25677634395052346
88125,SIDM00097,GSK269962A,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.274318,0.16764945,2.0460651445366613,0.10308198515607252
58990,SIDM00782,Afatinib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.5493722,0.1294886,1.9730159604510422,0.12375268966742403
99404,SIDM00097,Luminespib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.4157436,-0.025061298,-1.0795280416692357,-0.07385556102477053
80668,SIDM00875,Palbociclib,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.750528,0.06309893,1.8881486359608948,0.11810296657265695
25985,SIDM00673,Trametinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.0836499,0.10406581,-1.3309268932266571,-0.0030366680331870245
12244,SIDM00673,AZD6482,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.7147254,-0.06137631,-0.33773192981424366,0.0014158880232544352
10098,SIDM00782,LGK974,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.5334623,-0.07027362,-0.10329777564797221,-0.027313563086566312
83942,SIDM00866,PD173074,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,0.9803988,0.04776933,0.37474354911877605,0.06822007344981922
62418,SIDM00878,Entinostat,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,5.2685437,0.31999537,0.0599554414407135,0.03931232392834448
47182,SIDM00146,KU-55933,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,1.4487162,0.08089096,0.3823746761830174,0.062238277140714664
84611,SIDM00673,Temozolomide,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.14901958,-0.0032970875,0.5959064842400471,0.0215163655330394
102518,SIDM00893,KU-55933,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.2690537,0.12514731,1.0461436411995586,-0.0016553315855455735
32890,SIDM00673,Uprosertib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,3.1080127,0.1484965,0.4824342641838537,0.05015263221849861
62546,SIDM00097,Pictilisib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.89384496,0.056359798,0.4887020510176622,0.04286945881516569
102643,SIDM00774,Navitoclax,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.7438687,0.017643029,1.1157544137567752,0.024335027052070277
11930,SIDM00146,Dabrafenib,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,2.7137935,0.17167181,-0.0177286124352163,0.061317022885155184
58328,SIDM00875,Pictilisib,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.37642732,-0.041884154,-0.3076300876143319,0.032168638978093314
41120,SIDM00531,OSI-027,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,4.3736243,0.4214537,1.4334986072759686,0.0558137509221186
23151,SIDM00673,Nutlin-3a (-),Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,2.0564306,0.0746328,1.7566847914742296,0.05952436077612426
89915,SIDM00774,PF-4708671,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.0619383,-0.04970495,0.12408709073922629,0.009392541931440696
63427,SIDM00411,SCH772984,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,5.3699756,0.32203108,2.851076880025715,0.17238214202232846
49319,SIDM00893,Lapatinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.326366,-0.029827751,-0.8121860374871136,-0.06897917002274444
69045,SIDM00628,GSK269962A,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-0.59413725,-0.059822526,-1.3987557680940943,-0.04397336912459175
94373,SIDM00411,Palbociclib,Navitoclax,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,-3.2298326,-0.11631008,-1.0520255411618182,0.0033873152569611526
44353,SIDM00628,Docetaxel,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.640117,-0.05606711,-1.96875301408447,-0.14522014151694318
39171,SIDM00097,GSK269962A,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,4.7534437,0.29723406,3.907598102226319,0.16657828014142276
107349,SIDM00332,Sorafenib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.79544896,0.052764837,-0.36026407399453514,-0.059476651111847835
24013,SIDM01233,Dabrafenib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,1.4506354,0.061763477,0.3424188608746396,0.011578993969370562
28634,SIDM00531,MK-1775,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.5909863,-0.1432849,-0.5454104807115056,-0.015415229050325125
67700,SIDM00893,Pictilisib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.8108833,-0.11174151,-3.6109916089463696,-0.19044116205006004
103811,SIDM00893,Pictilisib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.4319828,-0.04329278,-0.6626967074323911,-0.051839391576422554
64958,SIDM00774,Alpelisib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-0.24477266,-0.016604062,-0.3701441430843007,-0.012149418540697081
67087,SIDM00332,PD173074,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.388825,-0.21405673,-0.5661803360722847,-0.04118426211341711
54364,SIDM00146,Gemcitabine,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-2.149561,-0.15336145,-2.0432353195091255,-0.15616133807209728
101536,SIDM00971,SCH772984,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.299116,0.052817665,3.2867599830335474,0.15322578605743967
4780,SIDM00893,Crizotinib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.93818265,0.039361652,1.2401507485284002,0.043679983252693594
93813,SIDM00878,Afatinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.6057859,0.039831895,0.565882968100669,0.027995467803503826
75627,SIDM00776,5-Fluorouracil,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.6376933,-0.041220147,-0.04998622603621881,0.04842028577643329
40034,SIDM00893,MK-1775,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.5878273,0.15557708,0.10014827773612059,-0.004306487420570557
81519,SIDM00954,BI-2536,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.0,-1.7981927,-0.05046272,0.13665316223224785,-0.05305439928156656
92944,SIDM00971,Luminespib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.2907858,-0.1532963,-1.1029650020541677,-0.044163485903311414
48555,SIDM00878,MK-1775,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-0.32198992,-0.015954737,0.13081733144742277,0.06162606482091901
39453,SIDM00411,Cisplatin,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.84298766,0.01727465,1.4372012448496545,0.03582867015917657
63246,SIDM00875,Doramapimod,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8298322,0.05058368,2.1248958749003473,0.09550956192269366
72219,SIDM00782,AZD8055,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,Unknown,72.0,-1.9287405,-0.12053722,0.27132582570548314,0.009681704623450879
64919,SIDM00146,RO-3306,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.940004,0.07645188,-1.1971833186629137,-0.041800283922046155
26358,SIDM00774,Tozasertib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,1.6054215,0.056388102,0.617733299510263,0.07298186648391196
102966,SIDM00893,JQ1,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.89442414,-0.016652869,2.634092870056097,0.09293307923892977
65205,SIDM00529,Linsitinib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Black,44.0,-1.2501239,-0.038180005,-0.2125162247295562,0.025807972508065845
107332,SIDM00146,Temozolomide,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,3.0368993,0.13181013,0.949479208041406,0.03375728335481998
78950,SIDM00146,Axitinib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.3674147,-0.097740665,-0.13976546984438554,-0.007191998166021676
81961,SIDM00893,Sorafenib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.87904847,0.07800248,-0.11968735819329888,-0.03020948332176136
14813,SIDM00411,MK-2206,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.1024637,-0.10868822,-0.9555909912148333,-0.04259200946718298
54626,SIDM00875,Gemcitabine,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.48331103,-0.0010608595,0.0017615060213641226,0.034120889630532475
343,SIDM00776,Crizotinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,3.3026574,0.11063929,-0.39798857996130954,-0.06834032631918002
21091,SIDM00628,Dabrafenib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.0283754,0.0510973,-1.683598530215245,-0.0165974226051746
67468,SIDM00866,Dabrafenib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.71322876,0.02335821,0.7014499096248272,0.0579621442182153
77994,SIDM00673,Wee1 Inhibitor,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.548983,-0.033887427,-0.6788195744236633,0.006204668534813899
7996,SIDM00411,OSI-027,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,43.0,1.6471202,0.09991618,-1.4792075671820997,-0.06270544987739714
103339,SIDM00332,AZD6482,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,2.4143085,0.19409059,-0.08242439432178905,0.010538791154641382
38482,SIDM00411,Lapatinib,Irinotecan,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.6204696,0.0970124,1.145248688504008,0.10647495530469962
21631,SIDM00875,SCH772984,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-3.5700607,-0.30234092,-1.192797799407207,-0.06220614332292764
28719,SIDM00893,MK-1775,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.73986334,-0.072375454,-1.097762451228859,-0.0701030195527446
49813,SIDM00673,Crizotinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.6496816,-0.057155058,-0.5531994804186866,-0.041052617436868014
74119,SIDM00893,Bortezomib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.2662253,0.08510905,0.6153573646728732,0.06348014608029487
96724,SIDM00971,Tozasertib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.8535962,0.06268856,1.6424434084371005,0.02932725388037748
88379,SIDM00097,Doramapimod,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.0786414,0.12029583,2.460341823805408,0.10708335774761747
14477,SIDM00878,AZD8055,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.0866034,-0.060585115,0.17459992742859415,0.011872703956550455
41545,SIDM00529,ZM447439,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Black,44.0,0.9696788,0.08415315,-0.24527904570334333,0.0651479874194641
16414,SIDM00954,OSI-027,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.6386242,-0.094288066,0.2843008817968853,-0.017751442048423795
20981,SIDM00782,Camptothecin,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-2.5502028,-0.21838836,-1.8574507769717699,-0.14438104657664577
77096,SIDM00193,MK-2206,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,2.0372937,0.18277197,1.1274627136427793,0.08968872200785741
107151,SIDM00776,LGK974,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,1.4989792,0.0914449,-2.036543969269249,-0.05829211685839251
2875,SIDM00779,Oxaliplatin,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-3.254448,-0.066348374,-1.419624149017815,-0.03749965139031079
76122,SIDM00529,JQ1,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-2.3168821,-0.061430562,1.1148101706734574,0.052363176453519476
147,SIDM00866,Pictilisib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.22196808,-0.018608049,-1.0193782402601939,-0.03106988846937732
36434,SIDM00878,Axitinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.2442213,-0.11302325,-0.9141978147054974,-0.03173884639332346
16527,SIDM00878,ZM447439,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.49685258,-0.029424218,0.0428945617603901,-0.032500323826912404
74132,SIDM00774,AZD6482,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.2220948,-0.11819961,-0.7421753177479163,0.02835184423629149
41414,SIDM00893,Axitinib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.4121773,-0.062063716,-0.4736710619368225,0.02731789157186035
78224,SIDM00332,Cisplatin,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,2.24055,0.065968916,1.594388970356172,0.056873142355416885
67059,SIDM00332,ZM447439,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1843786,0.07495283,0.9945666847663736,0.049241962286287216
20501,SIDM00301,Linsitinib,Oxaliplatin,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.5865372,-0.0472499,0.8645488752083034,0.013233624780621208
84237,SIDM00628,BI-2536,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,1.7176844,0.038415078,0.22266834006109892,0.04141038204897502
38393,SIDM00531,Trametinib,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.152479,0.121027656,-1.50218225775651,-0.07385821134619745
108227,SIDM00628,SCH772984,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,Black,51.0,-1.3558933,-0.08461164,-0.7623087218553319,-0.015802088890484314
10083,SIDM00673,Nilotinib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,1.3099737,0.0778307,0.7206017319360084,0.13552246473470045
94435,SIDM00673,BI-2536,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.3935174,0.031133575,1.7942191585811282,0.12148916512298466
18117,SIDM00130,Gemcitabine,Trametinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.60660475,-0.03034527,0.5044466293535101,-0.027680994954183285
70607,SIDM00954,PF-4708671,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.0,2.0514243,0.13481787,0.3768728362614679,0.05127997734816343
81004,SIDM00878,Trametinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,0.6233024,0.05781323,-0.2908792128477871,-0.05137643732258576
51408,SIDM00332,SCH772984,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1691471,-0.06466475,1.339337201798712,0.039805063072987805
13373,SIDM00779,AZD7762,Taselisib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,0.9213317,0.053353112,-0.8808014159155613,-0.05547872703256199
71944,SIDM00954,Dabrafenib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,0.36592877,0.014123703,0.7434010588077726,0.04147617883676407
34443,SIDM00878,MK-1775,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-0.66002995,-0.068279356,-0.9421923729668681,-0.03665324529423168
69345,SIDM00097,Alisertib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.8320477,-0.124157414,-1.6260900960569844,-0.12590570525276548
13481,SIDM00954,Olaparib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-2.1760602,-0.04734306,-0.38847867129213876,0.07836607820976388
90331,SIDM00673,Paclitaxel,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-1.6984065,-0.1185846,-0.9939081540698658,-0.08333926839109515
71411,SIDM00782,Oxaliplatin,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.48308018,-0.02855932,-0.2508882988746822,-0.015206909731989224
20950,SIDM00529,MK-1775,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.22313614,0.021792592,-0.15901983799812916,0.04611582992679419
26003,SIDM00359,MK-1775,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.817741,-0.16296546,-2.228314664624655,-0.08583425478974398
5502,SIDM00097,Taselisib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.1324854,-0.19371456,0.4814077551280669,0.0048768989398964855
39432,SIDM00332,Sorafenib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.38340503,-0.024242995,-0.2226430432304778,-0.006947957790602408
91346,SIDM00774,Crizotinib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.5931696,0.08346368,0.5414875172842164,0.025562245572555032
74917,SIDM00531,Linsitinib,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.526997,0.30859807,1.035598643535584,0.07701306447369825
43984,SIDM00875,Nutlin-3a (-),Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6717522,-0.019560369,0.8290147934723047,0.021847948708299664
86931,SIDM00776,LGK974,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-3.0925214,-0.10569905,-1.9243786754182741,-0.0013922878592282605
96019,SIDM00332,Sorafenib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7566244,-0.05835092,-1.217131308995131,-0.036332944471046805
79695,SIDM00954,Ribociclib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,0.6652454,0.02484857,-0.2640525896268247,-0.00934416604036373
37309,SIDM00878,NU7441,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,2.148034,0.17897227,0.3473824329973743,0.012048808686607628
83354,SIDM00893,Wee1 Inhibitor,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.43708277,0.038747903,-0.8667695953295883,-0.03664036559846953
10666,SIDM00531,Erlotinib,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.7909319,-0.10147405,0.6113756366544679,0.07061962042317509
29905,SIDM00301,MK-1775,Navitoclax,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.74326956,0.081931196,0.5446718631502324,0.07782074443772392
50366,SIDM00411,MK-2206,OSI-027,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.656673,-0.09877495,1.061835713619631,0.10108605729406306
5308,SIDM00673,Gemcitabine,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,3.0418751,0.21368735,0.18847278568863934,0.043576904849466455
76280,SIDM00146,Afatinib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.1674534,-0.07591368,-0.6789340775915194,-0.039280145444215944
50136,SIDM00673,OSI-027,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.8404768,-0.08240066,-0.671975776621483,-0.09407061228315408
73170,SIDM00130,Sorafenib,Cisplatin,Pancreas,0.8,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.5974901,-0.0573953,-0.895582335067795,-0.06832439575110669
37858,SIDM00834,AZD8055,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-1.5736877,-0.11414495,-2.242823624471182,-0.04662287552952681
55750,SIDM00971,Sorafenib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.6752275,-0.10731426,-0.41310100249823767,-0.021440602201334504
90176,SIDM00866,Taselisib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,52.0,0.45900217,0.03932464,-1.4220700865768268,-0.041174998987892654
84274,SIDM00529,5-Fluorouracil,Olaparib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-2.2760003,-0.1810507,-1.7640570864014011,-0.07477674374061943
33878,SIDM00529,Tozasertib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.1090494,-0.03228892,-1.2171100698403643,-0.03170043466182683
43206,SIDM00146,Gemcitabine,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.6831374,0.040619712,-0.25740424445013227,-0.024295408928840908
79185,SIDM00628,Tozasertib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,Black,51.0,1.0974653,0.102180235,-0.7264478458989874,-0.060371704759481296
23105,SIDM00875,Venetoclax,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.47550476,-0.010624375,0.08532547163326606,0.005026454367054073
70438,SIDM00875,Tozasertib,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.7483717,-0.06400687,-1.1028050321622447,-0.06797441935250458
34350,SIDM00971,Luminespib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.4534209,-0.11287441,-0.5906607270827964,-0.024809046198564055
3311,SIDM00834,Taselisib,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,1.0819325,0.07049607,0.31569959895959315,-0.035199553228455326
72963,SIDM00971,Axitinib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.629921,0.06939324,-0.3820660998484988,0.047937191231919765
50335,SIDM00628,Nilotinib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.2602233,0.08770832,0.4754133259017347,0.03769513707446378
93184,SIDM00774,Bortezomib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.2992445,0.016349861,-0.5909454962237307,-0.021791940865243817
83387,SIDM00531,Palbociclib,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.560495,-0.02373635,-0.8994237420578274,-0.02384814573866415
16987,SIDM00971,Venetoclax,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.127658,0.04698062,-0.4429618038790511,0.005429840944847654
95331,SIDM00332,OSI-027,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,2.1557937,0.188029,1.4087781306380045,0.105022675550445
11714,SIDM00628,Linsitinib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-1.0344024,-0.0696155,-0.5912376976941607,-0.0028716831663002473
40013,SIDM00529,BI-2536,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,3.385473,0.20196363,2.0100943455653972,0.09046042313289913
86354,SIDM00878,MK-2206,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.9883339,-0.109671764,0.22255237339816347,-0.0246221333964022
97860,SIDM00673,Navitoclax,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,1.994482,0.18746896,1.642859860948075,0.08491691315441832
90691,SIDM00893,RO-3306,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.5611144,-0.044919822,-1.7494772355195818,-0.06271241377555767
31449,SIDM00097,Paclitaxel,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1195805,-0.07596018,-0.7138687107833345,-0.13128621479083113
39863,SIDM00130,MK-1775,Dactolisib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.0521263,-0.07879371,0.059811734850944154,0.00838792818611445
37775,SIDM00954,Nilotinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,0.5606181,0.035283107,1.5441605140347314,0.0934287705708857
107486,SIDM00776,Oxaliplatin,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-2.3563666,-0.11722491,-1.9877748332697516,-0.0915784894949217
24935,SIDM00779,MK-1775,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-0.48003435,-0.03058539,-0.5064483128875946,-0.054904546475812804
70971,SIDM00782,Olaparib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.4572836,0.051200055,0.5355605268023053,0.011839948836107774
36013,SIDM00628,JQ1,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.9334704,-0.05921403,-1.7101474186270997,-0.08123710100595187
76986,SIDM00866,MK-2206,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-3.0340216,-0.051222753,0.15068831049021073,0.01045446555899759
1269,SIDM00875,AZD8055,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4473511,0.14418142,0.03569768201354204,0.04364765289928589
52980,SIDM00673,Crizotinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.9053454,-0.13645919,0.6410351757758229,0.04528524394792114
82713,SIDM00866,PF-4708671,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-0.614197,-0.032691803,-0.516074117004588,0.004140222989223052
47966,SIDM00778,Taselisib,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,-0.34012467,-0.021465497,-0.5949934299079122,-0.032270304818141006
21126,SIDM00411,Dasatinib,5-Fluorouracil,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.2931334,-0.0776796,-0.6359457357730304,-0.02216630067549531
45213,SIDM00875,OSI-027,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4139979,0.1373469,0.9899946154859058,0.08407833312139852
35939,SIDM00774,KU-55933,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-1.7729822,-0.05621914,-0.7569564007284608,-0.029097041199134466
5456,SIDM00531,Olaparib,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.30568367,0.016259314,0.3358684923950917,0.002285214186072858
63984,SIDM00971,Camptothecin,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.951604,0.0836237,1.625819104007548,0.07004507610410761
63080,SIDM00776,Vinorelbine,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,-0.9743357,-0.057618394,0.5484813321274815,0.09207237650903095
21583,SIDM00778,Trametinib,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-2.84867,-0.07655125,-3.078260669869959,-0.07536291690925775
91874,SIDM00359,SB505124,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.8206357,-0.07167011,-0.13241846116504183,0.00417476847850601
24551,SIDM00782,Trametinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-2.2159336,-0.14831339,-0.4615633844046075,-0.01622852371884617
8640,SIDM00878,Sorafenib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,70.0,-0.38842008,-0.030783065,-0.30804040649345527,-0.001627062795051242
58736,SIDM00673,Venetoclax,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.66830176,-0.0130193755,1.1365146182083439,0.0444977700477295
73296,SIDM00893,AZD6482,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.0280023,0.08370127,-1.1002513925999682,-0.1193993326609276
71907,SIDM00878,Navitoclax,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,1.3392814,0.020165246,-0.6377141958087188,-0.03524777204732806
93488,SIDM00878,Palbociclib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.0465013,-0.061263055,-0.8613818071329593,0.0005620352447457129
96091,SIDM00097,GSK269962A,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8108597,-0.07477695,-1.1085200562026958,-0.08170535863442463
21035,SIDM00774,KU-55933,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,0.70439285,0.027185353,-0.7242661110212643,0.006251035685305054
106917,SIDM00779,Palbociclib,Navitoclax,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,-1.4089907,-0.09679103,-1.7328194960307115,-0.06197699190943782
106193,SIDM00776,MK-1775,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.9715607,-0.07019668,-0.9960480076644754,-0.06841551076902512
43543,SIDM00866,Lapatinib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.15298119,0.012870498,0.9219566092299207,0.07503004496956764
19475,SIDM00130,LGK974,SCH772984,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.2884045,-0.062153794,-2.1086340164306616,-0.03963574238234127
19373,SIDM00971,JQ1,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7359916,-0.06072795,1.5190229629847813,0.04390631762517625
26826,SIDM00130,Navitoclax,Erlotinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.5876807,0.038548842,-0.03529774531722187,0.033112328766370214
51372,SIDM00332,Afatinib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.22961836,-0.018169865,-0.5616426317079128,-0.046187584124719905
753,SIDM00893,NU7441,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.95691526,-0.08026249,-2.009752601756317,-0.11955170906729508
105283,SIDM00673,Palbociclib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,0.5403739,0.030404123,-0.842672760465117,-0.03769035535470696
19052,SIDM00971,Trametinib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.0647179,-0.015113656,-0.36928979555356073,-0.012271498532147405
73186,SIDM00866,JQ1,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-2.8630157,-0.18315847,-2.151946159222374,-0.09528756696852968
4141,SIDM00529,MK-1775,MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,0.22648185,0.022902878,-0.11241798096346538,0.02153251955620673
70822,SIDM00411,Irinotecan,Oxaliplatin,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,1.3338435,0.071492,-1.1844730726558106,-0.03223565131283138
2149,SIDM00774,Gemcitabine,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.34430045,-0.021109374,0.3395093264007117,0.07862487394456397
33345,SIDM00779,SCH772984,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,0.39425698,0.035206463,-0.40051811090089473,-0.0168224482877595
94993,SIDM00529,GSK269962A,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-0.31749105,-0.024438273,-0.7158965694115612,-0.005208077270218644
96354,SIDM00776,Vinorelbine,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.0532213,0.08558981,-1.3755374846412094,-0.0679592847197231
11017,SIDM00774,GSK269962A,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,-1.6419643,-0.08606102,0.24597361138112364,-0.03556689238832774
87154,SIDM00866,PF-4708671,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,0.21752864,0.0077148406,-1.1970512869380732,-0.019481814594783525
92481,SIDM00893,RO-3306,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.7826045,-0.060054358,-1.5009119392323917,-0.029892818643116433
17237,SIDM00673,PD173074,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.4270365,-0.06143211,-0.025679880603897694,0.037696018716583506
70243,SIDM01233,BMS-754807,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,-1.5674374,-0.10606272,-0.675909972328998,-0.0367558636183415
63572,SIDM00130,Linsitinib,MK-2206,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.3833783,0.090946734,0.492637123050909,0.03342524708428563
38412,SIDM00779,Trametinib,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,0.22130711,0.007485676,-1.06095585395266,-0.10173983831286317
103418,SIDM00097,Lapatinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.8579211,0.2633964,2.3496772411235014,0.20597981792194872
30676,SIDM00359,BMS-754807,AZD4547,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.5617512,-0.05053239,-1.8482674228447544,-0.0917447036161151
33225,SIDM00834,Palbociclib,SCH772984,Large Intestine,0.05,Rectal Adenocarcinoma,Female,White,66.0,-1.488885,-0.09896643,-0.4811807633547904,0.020211596407667815
71642,SIDM00529,AZD7762,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Black,44.0,-0.9461869,-0.068460174,-1.5613776184860038,-0.10002907070308324
70748,SIDM00193,Trametinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.0198869,-0.062509626,-0.9641391659981139,-0.005950670363012699
55731,SIDM00660,Afatinib,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-0.7897078,-0.07343128,1.0632106925992062,0.0009655896198039554
14984,SIDM00673,Paclitaxel,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.1818764,-0.16427296,-1.7655201914183862,-0.1549111644028179
49686,SIDM00146,Crizotinib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.9931452,-0.08075308,0.06116552334284875,-0.0019404536837263342
107104,SIDM00834,Nutlin-3a (-),Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,1.8975135,0.052341316,1.9446015628779951,0.0722116168026145
46942,SIDM00529,Olaparib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-2.0181215,-0.08262885,-1.1568247668415905,-0.0447181339751225
29146,SIDM00332,Docetaxel,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-5.3525543,-0.38477227,-3.382753249029858,-0.31101251956102755
74384,SIDM00628,Venetoclax,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.7464333,0.116646826,-0.6047722130261906,0.03703544487615886
35627,SIDM00774,ZM447439,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-1.2876202,-0.07416338,0.517289418389718,0.042860877012861974
28922,SIDM01233,AZD7762,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,72.0,1.1672522,0.034349736,2.9900841532480236,0.10238899707081957
541,SIDM00628,Alisertib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.7781961,-0.028624695,0.4632221332754337,0.039662679907760665
105929,SIDM00529,Trametinib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.2473875,-0.076655164,-1.7190372087341432,-0.007681888079879115
81031,SIDM00332,BI-2536,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,4.5640187,0.19826911,0.18959617882082255,0.06204121775386325
77165,SIDM00875,Afatinib,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.59154665,0.03913356,1.2176037113619556,0.043591557618354974
12572,SIDM00628,Axitinib,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-0.47275913,-0.03457666,0.30054716974494855,0.03194197144302595
83965,SIDM00774,Trametinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,1.3884608,0.057662018,-0.6413531960464263,4.864413964190294e-05
217,SIDM00971,Gemcitabine,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.9398805,-0.0301877,0.44607031421297333,0.03848755172433156
81303,SIDM00878,Sorafenib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,0.29618454,0.028197909,-0.8932517079320561,-0.0031255657301173592
37068,SIDM00875,Camptothecin,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.4088125,0.2221183,2.169175211798438,0.18551147829711265
82700,SIDM00673,ZM447439,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,1.0934547,0.066351674,0.2534575779000961,0.03728955207149024
98687,SIDM00673,Temozolomide,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.12645563,-0.0028818948,0.7599374818858198,0.00019472414061541624
74900,SIDM00774,Afatinib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,48.0,-0.24221611,-0.017564287,0.1788116913056932,-0.005128493949326058
82638,SIDM00673,5-Fluorouracil,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,49.0,-0.35285047,-0.015105485,1.0397037572371273,0.010187993551741175
46528,SIDM00893,Navitoclax,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.4574108,0.121341474,2.8216030702497066,0.11745410792688935
61852,SIDM00878,Entinostat,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,2.3217018,0.15116172,0.605425699770021,0.05448174497368741
85175,SIDM00146,Ribociclib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.91650516,0.0503926,-0.827474242530888,0.06706285865427229
23656,SIDM01233,SB505124,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,72.0,-0.40674952,-0.018931137,-1.0283802180407273,-0.06389354763739354
95363,SIDM00971,Trametinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.2008102,-0.017276974,1.076207648679194,0.02615916041749035
89402,SIDM00971,OSI-027,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.5539813,-0.11341861,-0.8596754060865582,-0.0648330172122229
58739,SIDM00097,Wee1 Inhibitor,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5151837,-0.13909172,-0.8405853959026788,-0.12852059017579903
50726,SIDM00778,Camptothecin,Taselisib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,1.0319514,0.045735717,-0.1935206634043019,-0.03547735925542131
101708,SIDM00971,JQ1,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.4001619,-0.056035895,-0.3928573259604384,0.03019960960461527
73530,SIDM00332,Trametinib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2379353,-0.12433434,-1.2706417627294455,-0.12984142896636758
79914,SIDM00875,NU7441,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4111447,-0.034884673,-0.5997131274695336,-0.00495288270906684
96032,SIDM00673,Dabrafenib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,3.0526586,0.078088984,2.4008059066726672,0.09175195354357364
49400,SIDM00782,MK-2206,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,Unknown,72.0,1.207361,0.09317598,0.6564073454629074,0.09541583479415097
105980,SIDM00971,Camptothecin,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.9976398,0.0488331,2.32528760293022,0.09835735165521041
72307,SIDM00774,NU7441,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.4590056,0.09297944,1.7904661187602366,0.06460732078721643
40465,SIDM00673,Doramapimod,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,1.9076793,0.048354167,2.741870575862832,0.07721580573770774
88017,SIDM00301,Dactolisib,OSI-027,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-3.174854,-0.2593186,-2.8561872195059483,-0.13958552691061868
50090,SIDM00893,Luminespib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.967075,0.09008134,-0.49553349291272475,-0.0389684504310597
76335,SIDM00628,Sorafenib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,0.5448584,0.04974128,-0.05454604239273027,0.006266045758454028
21053,SIDM00130,Lapatinib,Palbociclib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.0016673,0.20237212,0.6067803545659866,0.05535581859970949
7790,SIDM00529,Sorafenib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,0.30996352,0.032550614,-0.3898722365425973,0.010445190109905257
55946,SIDM00866,Afatinib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-2.6498601,-0.21656613,-1.5793550877463844,-0.06943077215231079
29203,SIDM00954,Doramapimod,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-2.7892852,-0.13929598,-0.42220311571033076,0.08152140783454638
786,SIDM00097,Crizotinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.8428435,0.19210331,2.283442019618083,0.18827609171176315
45511,SIDM00875,RO-3306,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2206435,-0.1244906,-1.4191885364151144,-0.09441218948572022
35747,SIDM00954,BI-2536,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-2.5642815,-0.07826408,-0.6074633178865079,-0.04012175902949629
84289,SIDM00411,MK-1775,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.2495127,0.074508265,-0.9839691470541513,0.011426626406827645
67798,SIDM00411,SCH772984,Trametinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.3330327,-0.059383612,-1.3310276689429308,0.020309898404013118
46766,SIDM00673,Alisertib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.41128242,-0.02295518,-0.7397985955697416,-0.026233520311209395
79118,SIDM00531,MK-2206,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.85882276,-0.034817148,1.321834255975132,0.022570384206664528
40370,SIDM00954,Paclitaxel,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,0.98687166,0.07061843,-0.46524582014284827,-0.03009359175868403
33419,SIDM00774,BI-2536,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.44203672,-0.030547306,3.6569627091385755,0.23012169709804184
748,SIDM00529,Paclitaxel,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-0.7767167,-0.07577449,-1.8455854394976778,-0.16640987507313829
34246,SIDM00529,RO-3306,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,2.6825185,0.14043172,0.7398683947169186,0.04420795823799731
1018,SIDM00359,BMS-754807,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8467404,-0.11139683,-0.2827174235143866,-0.04185332241988125
19330,SIDM00875,Taselisib,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.2398416,0.027893825,1.0701531689252421,0.024419398535599664
15830,SIDM00673,Nilotinib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.3083024,-0.06456866,-0.32095356336682335,0.029571022729445492
47128,SIDM00529,Wee1 Inhibitor,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-0.19437096,-0.018997282,-1.52532798369917,-0.11266321124464772
28143,SIDM00878,Entinostat,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.6610956,-0.07622451,-0.729588673383642,0.017067615741760158
45834,SIDM00893,Docetaxel,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.17749554,0.013273014,-1.713612316741044,-0.07674301638927437
106167,SIDM00332,ZM447439,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7624424,0.10875539,1.9294354942262355,0.11389300375238559
39963,SIDM00660,Olaparib,AZD7762,Large Intestine,0.0625,Cecum Adenocarcinoma,Male,White,32.0,4.680507,0.29928383,3.026119370652511,0.13709671596161535
28655,SIDM00866,Cisplatin,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,1.2447873,0.025224725,1.497416644986974,0.03851676500751405
77635,SIDM00146,Tozasertib,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-2.0531583,-0.106920116,0.29008825544653255,0.012376111400037889
7695,SIDM00778,MK-2206,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,3.7323508,0.1121534,0.5687644278158999,0.11546168024035756
47098,SIDM01233,LGK974,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-1.0017059,-0.06388232,-1.024421838811955,-0.07159435885166847
87628,SIDM00359,Oxaliplatin,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.3494327,-0.091180734,-1.3721355374363124,-0.03242160603857157
60202,SIDM00529,Palbociclib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-2.7376816,-0.09571369,-1.0979551760992243,-0.013995440515736694
13738,SIDM00531,SCH772984,Navitoclax,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.4520822,0.25611818,2.5829027872932864,0.19547216216670765
43929,SIDM00971,Gemcitabine,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.6315088,-0.08925048,-1.2436495944402137,-0.04219849998028947
18868,SIDM01233,5-Fluorouracil,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-1.5393739,-0.052746497,-0.007538945193820777,0.032577153302018734
79908,SIDM00529,AZD7762,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.5510103,-0.037950277,-0.40778803367242245,-0.029691552565971564
26422,SIDM00971,Taselisib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.32993573,0.023540594,0.18024784721795967,0.008020771321130663
82599,SIDM00411,MK-1775,MK-2206,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,43.0,-0.8680422,-0.045359988,0.13075589515954175,0.024418951996900445
93638,SIDM00971,Luminespib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.7833762,-0.10036859,0.11517366813493893,0.017990489701775945
4568,SIDM00875,Doramapimod,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.462027,0.051925912,1.0031281958359046,0.02442513043955273
104597,SIDM00774,Dabrafenib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,-0.7376466,-0.02002996,-0.49074748463536855,-0.006312187705624992
87498,SIDM00529,Wee1 Inhibitor,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.7433613,-0.07285176,-0.5777759122873215,-0.010998522952961828
40779,SIDM00779,Trametinib,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,2.6269186,0.040894303,-2.0640003547768226,-0.11544565245563031
83793,SIDM00776,Oxaliplatin,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.7458172,-0.045372263,-2.1313784380072613,-0.08046339843857137
33700,SIDM00875,5-Fluorouracil,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.70498836,-0.0683892,-0.13643719261333423,-0.02524166990966783
58117,SIDM00971,Cisplatin,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.8880885,0.039444663,1.5920793962146749,0.026054974009412857
15993,SIDM00779,MK-2206,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,3.4192915,0.14606562,0.6489365742224127,-0.015140913207753197
92372,SIDM00146,Olaparib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-1.9745133,-0.059873458,-0.4987318236511371,0.04216643992259522
15948,SIDM00971,Alpelisib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.758465,-0.13277894,-0.36387730872380725,0.040311002980358474
82012,SIDM00866,Camptothecin,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,1.837384,0.03937746,3.5096819311373366,0.061983882886694146
73777,SIDM00878,5-Fluorouracil,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,70.0,2.19054,0.17892478,2.1143712916950164,0.1477832513805521
54208,SIDM00097,Dabrafenib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5270271,-0.060179528,-0.0823532060372992,0.014666482683828223
65091,SIDM00097,Crizotinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.242719,-0.07559818,-1.1519646776676442,-0.08446894932802859
79772,SIDM00097,Lapatinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.785429,0.033016156,1.4452878004734226,0.07602733917399072
65068,SIDM00628,Lapatinib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.45042267,-0.030670242,-0.24605269829635515,0.006373563971714446
27377,SIDM00097,Sorafenib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.93274933,-0.03793455,-0.014304471150438279,-0.0054285773078661176
24212,SIDM00097,Sorafenib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.03445,0.05318088,0.551158679922563,0.042323437317219034
61607,SIDM00774,ZM447439,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.69573456,-0.036972385,0.3862859377320408,0.11090121120930053
7703,SIDM00774,Axitinib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,2.3926525,0.28189033,0.05864847781530114,0.03197272661302446
42382,SIDM00146,Paclitaxel,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-2.9037983,-0.21786399,0.13280827900047715,-0.0331477285785624
107119,SIDM00875,Vorinostat,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5176704,0.14986035,1.4915702195980178,0.1364534879611201
60164,SIDM00866,Sorafenib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-0.7989179,-0.032193474,-0.1594033917859513,-0.02109247355045742
759,SIDM00776,5-Fluorouracil,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,65.0,-2.013839,-0.065355904,0.0977468469226962,0.02189373675601896
57487,SIDM00529,Palbociclib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-2.4428463,-0.09054998,0.08643547171786393,0.07328778203462176
50400,SIDM00866,Vorinostat,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.9978048,0.1132593,1.0553366408527487,0.06585412726429879
96518,SIDM00971,Uprosertib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.8880415,-0.080662124,-0.05818049309732251,0.015500632278209282
51133,SIDM00779,AZD8055,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,0.7688683,0.06650826,-0.30085398305220107,-0.04270809473682638
108328,SIDM00971,Entinostat,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.513,-0.015068425,0.40203251708691556,0.04523989983153881
63439,SIDM00971,Temozolomide,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.2900357,-0.046911664,-0.7526931485075513,-0.0008524032367142691
89111,SIDM00866,KU-55933,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-2.0612628,-0.046151236,-0.13330551417756534,0.015890477697158074
48092,SIDM00193,Nutlin-3a (-),MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.8717131,0.014197742,2.27260363515377,0.07749935138785628
97149,SIDM00531,MK-2206,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.3287277,0.07655743,-0.25921037507282424,0.007529559445722464
88560,SIDM00660,5-Fluorouracil,Vinorelbine,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,32.0,0.7966225,0.0809778,-1.3758367700486502,-0.07789092606956043
405,SIDM00529,Gemcitabine,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-3.3690388,-0.15539081,-4.031272973168998,-0.1291707416047027
58173,SIDM00130,Gemcitabine,Palbociclib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-3.5235682,-0.3337284,-4.540932290924747,-0.29313857712274954
26383,SIDM00954,Vorinostat,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-1.2845972,-0.05649027,-0.6342519176576623,-0.04488839386689703
103133,SIDM00878,Alisertib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,2.2779043,0.036375236,5.8747917974326525,0.23575983988273944
87821,SIDM00878,Trametinib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,-0.01596505,-0.0015407179,-0.25915686457919823,-0.019427791994327977
4573,SIDM00778,Vinorelbine,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-0.4681279,-0.029572697,-1.1173390043620635,-0.10828608683207956
9180,SIDM00893,JQ1,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2015318,-0.056770884,-0.3009136387070516,0.04674189508414823
78466,SIDM00875,ZM447439,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3912765,0.13125782,-0.9813789701675029,-0.06115836070676248
24414,SIDM00866,ZM447439,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,1.1288347,0.08433135,3.2222634482019044,0.23166450846556666
65457,SIDM00782,Linsitinib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,2.4135988,0.10300983,2.7117425636280177,0.09098587591024435
53091,SIDM00893,KU-55933,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.8770375,-0.05616148,0.2004970096245633,-0.02313280681934986
77386,SIDM00301,Taselisib,Irinotecan,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.3990686,0.18614033,0.49823607982489865,0.0745523101970679
62575,SIDM00673,Olaparib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.1739812,-0.05710841,-1.540374552625553,-0.05912304204492455
80722,SIDM00097,Olaparib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.6442444,0.07448067,-0.21588517522222508,0.011262508221075216
32449,SIDM00359,Nutlin-3a (-),Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0163059,0.024979573,2.2907230345456924,0.03885862712322746
45261,SIDM00834,Camptothecin,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-1.9188076,-0.10494813,-2.97465154038876,-0.13618465997006635
53148,SIDM00866,Cisplatin,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.4006053,0.027097045,0.9120424702187128,0.05172206936846945
42978,SIDM00531,MK-1775,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.0830101,0.119978316,-1.09467747018662,-0.03852716746977049
20966,SIDM00954,Luminespib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-0.115052454,-0.007828466,-0.6700278893618272,0.046983834037562074
1312,SIDM00866,Wee1 Inhibitor,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,-1.1076553,-0.078536175,0.09819460254234579,0.031167092105418744
39004,SIDM00531,Linsitinib,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.1525437,-0.040886454,0.20801869672277046,-0.01324847539976444
3717,SIDM00097,MK-2206,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.009597,-0.19583763,-0.1702523594084218,-0.06954814767011336
74722,SIDM00628,Uprosertib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-1.467817,-0.09105832,-0.48213497604781796,0.06828649873343301
100040,SIDM00954,Axitinib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.9576999,-0.049553733,-0.2650753877858691,-0.029418189370409437
14573,SIDM00332,Gemcitabine,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.6332955,0.12781404,-0.2695803980575879,0.05138082724908145
67018,SIDM00529,AZD6482,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.1907651,0.047461182,1.2390393564449216,0.08760791960490782
15955,SIDM00628,Temozolomide,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,1.4517646,0.05671327,-0.2078833144309483,0.03487564920573957
88423,SIDM00673,Dabrafenib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.4580531,0.029696196,1.0872040836658878,0.013774267242717011
74503,SIDM00411,Taselisib,Palbociclib,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.61357653,0.038362157,0.20880911548754513,0.01638729101328446
34459,SIDM00332,Temozolomide,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.0869029,0.050595656,1.8342101271556703,0.01972933705300415
31728,SIDM00954,OSI-027,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-1.0605053,-0.04550666,0.964848947188399,0.12784315883707748
7409,SIDM00411,Ruxolitinib,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.169849,0.048645552,1.3774080126465054,0.04150243770548145
41047,SIDM00146,MK-1775,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.40900734,-0.030841695,0.1000922841256455,0.02677171311407883
2159,SIDM00193,Taselisib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.8497042,-0.082944736,-2.2653405165096734,-0.08723548401110098
29365,SIDM00332,Afatinib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-4.1182117,-0.22712623,-1.0225189021652918,-0.11251001659245612
32518,SIDM00866,Alpelisib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-0.7930131,-0.05816112,0.5411987820378924,0.030762549437166487
72972,SIDM00411,Gemcitabine,Sorafenib,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,-4.880637,-0.16486429,-2.3092856434247913,-0.12210679667581578
93132,SIDM00531,Cisplatin,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.98987436,0.10518599,-0.8709859412965864,-0.008764630738649698
31413,SIDM00332,Entinostat,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,0.81543326,0.017723525,1.8020932116461603,0.08013196816754048
17366,SIDM00866,Luminespib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-0.50212514,-0.042897217,-1.4219421075127896,-0.08832439336142335
105718,SIDM00893,MK-1775,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.9119212,-0.0720526,-0.5070403140415783,-0.03603382295607251
41680,SIDM00193,Nutlin-3a (-),Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,53.0,0.24429798,0.00445533,1.184501560759855,0.07423475788363862
53990,SIDM00878,Axitinib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.41338277,-0.04562617,-0.8854995569713416,-0.0797580619658092
92611,SIDM00774,GSK269962A,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-1.3684359,-0.054088276,-1.0651758964181255,-0.04232132071216967
88283,SIDM00097,Axitinib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5673165,-0.080782756,-0.24905910344662768,0.002259035562128677
74258,SIDM00774,Sorafenib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,48.0,1.4806435,0.10683662,0.19770435489388688,0.02922308106378702
95274,SIDM01233,SCH772984,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,1.6473273,0.14536253,-0.15128074650759657,0.025305191261664084
45590,SIDM00146,RO-3306,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,0.9099033,0.06740001,-0.911002922078241,0.012507293671065508
26408,SIDM00529,Trametinib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.94977105,-0.056484528,-0.9745950325039776,-0.028443453100964737
91509,SIDM00834,Dabrafenib,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,-0.33143735,-0.008147024,0.4269765626666812,0.03463583148909225
3151,SIDM00411,Dasatinib,Trametinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,3.655965,0.21982208,2.5225548463637173,0.20357531079131128
11204,SIDM00971,NU7441,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.61259973,0.026368134,1.1380911402059675,0.05883125651429104
81019,SIDM00332,Bortezomib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.77314526,-0.046348494,-0.13222485749270785,-0.06257780544141338
90899,SIDM00411,Lapatinib,Sorafenib,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.553168,0.046536636,1.7663346336899834,0.1092819132077927
14534,SIDM00776,LGK974,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,-2.9133534,-0.1027436,-0.7505462501843133,0.002965555428925903
95439,SIDM00875,AZD8055,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.8350222,-0.08274029,-0.4541723739158154,-0.03830508999490116
57973,SIDM00893,AZD8055,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-3.1683545,-0.10661797,-1.1247572926596785,0.012081424397998154
80641,SIDM00332,Entinostat,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.9155598,0.054058217,1.6554089680349309,0.07775307524186004
36017,SIDM00531,Sorafenib,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.3463515,0.14874879,0.5141324104063213,0.05953781606797168
95959,SIDM00778,AZD4547,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,0.39263996,0.02301247,-2.023888691986279,-0.051489191587069175
83937,SIDM00875,Axitinib,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8435247,0.052214563,0.5158141226991065,0.03166494670961071
12390,SIDM00878,PF-4708671,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.5148685,0.08554101,1.2578562677931293,0.08875025073062912
39788,SIDM00774,Afatinib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,48.0,0.7702866,0.047700524,0.7987427717901594,0.03699263235134647
52146,SIDM00628,Alisertib,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-0.38835886,-0.013201269,-1.255081154158689,-0.0462939241048442
37480,SIDM00971,Alpelisib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.3738403,-0.15220125,-0.17681612574750585,-0.015470401680711952
39767,SIDM00359,AZD8055,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.2511084,0.08720075,-1.6294873927000633,-0.07397622697987555
20037,SIDM00954,Vorinostat,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.76353526,0.056220304,-0.06571483223934375,-0.013266356534905587
104155,SIDM00628,Venetoclax,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.53655636,-0.026846616,0.7333625224834209,0.09010713545751847
43570,SIDM00971,RO-3306,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.2582678,0.07354659,1.4751561063158665,0.131902312420081
38784,SIDM00146,Olaparib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.71725273,-0.029750738,-0.3547745190930595,0.040961057870897724
58401,SIDM00875,OSI-027,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0290643,0.019041982,-0.6718046068970319,-0.07184118725873855
8211,SIDM00774,ZM447439,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,1.1086526,0.07066328,-0.06087593719484711,0.05301967206877249
13886,SIDM00628,MK-1775,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,1.0794874,0.093064055,-0.4650614982694684,-0.014856219218996679
48615,SIDM00359,Nutlin-3a (-),BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,3.3303986,0.104456045,2.222888943386764,0.08756304433765633
23564,SIDM01233,BMS-754807,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-2.592027,-0.15494335,-0.40118201168028966,-0.034162254912798326
15765,SIDM00878,Temozolomide,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.62257564,-0.016322715,-0.03385822604698754,0.007333503973030231
67560,SIDM00130,Trametinib,SCH772984,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.3444154,-0.13139562,-2.4495982579338675,-0.0586666152295253
87151,SIDM00301,OSI-027,Lapatinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-2.3371649,-0.32980675,1.1306243190376064,0.026812862861994913
51039,SIDM00774,NU7441,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,1.3761842,0.071074076,2.744385247462757,0.15767156138892996
34963,SIDM00146,Entinostat,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,1.7816031,0.13613603,-0.9804697974096501,0.005442736846309466
76721,SIDM00971,AZD8055,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.483874,0.07181481,1.536231915300814,0.06245698481241539
5190,SIDM00628,PD173074,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,2.2829776,0.06747427,0.38671805964970657,0.04672828173769659
26799,SIDM00673,SCH772984,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-3.1928563,-0.23666073,-1.3273773530062642,-0.10090443128618888
66276,SIDM00875,PF-4708671,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3546461,-0.014092919,1.3715135052376977,0.016056445657695453
22930,SIDM00660,SB505124,MK-2206,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,1.9187499,0.19042578,0.5501697859857564,0.022327609991557033
14425,SIDM00866,Entinostat,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.26308712,-0.02105325,-0.20747135245884699,0.027960681791609005
77391,SIDM00971,Nilotinib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7700427,-0.118624136,-1.0436599716301171,-0.027761411944827355
77085,SIDM00866,Doramapimod,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.4517596,0.040770918,2.303762627436691,0.08830551544767347
88093,SIDM00878,Linsitinib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,1.3261737,0.10745334,-1.0921295741510446,-0.030901250512292675
52489,SIDM00628,Alpelisib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,1.4467088,0.09389708,1.087824742462969,0.10321477611733477
68607,SIDM00878,Linsitinib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.8508831,0.06331174,0.002086152162034904,0.005573601989298383
84137,SIDM00301,Olaparib,Trametinib,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,1.7728493,0.137683,-0.045010086141607356,0.001152406228855391
61128,SIDM00193,5-Fluorouracil,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,53.0,3.8229914,0.33447862,1.0055459797729194,0.03288613634554067
38967,SIDM00774,Sorafenib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,2.0816844,0.15148355,1.2536123103962316,0.08967553628020108
28793,SIDM00193,Afatinib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,East Asian,53.0,1.2656496,0.09500116,-0.2489338136175396,0.06039721186914643
4097,SIDM00893,Olaparib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.7480328,0.09905888,-1.0644561390442921,-0.026172636275660424
99166,SIDM00774,Linsitinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,2.0667515,0.124718815,1.3517536951743463,0.020954717143426217
68585,SIDM00628,Olaparib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.6825534,0.12553273,-0.6206506884342061,-0.03352748335372751
9194,SIDM00529,Docetaxel,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-4.183002,-0.25845504,-2.8309409371728256,-0.16569069944897244
53911,SIDM00893,Crizotinib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.637312,0.12818834,2.4059508449826907,0.14834131588622157
62614,SIDM00193,Camptothecin,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,0.5888078,0.024917286,1.4581612397513866,0.06048520520451325
32541,SIDM00779,AZD7762,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-0.704727,-0.06244223,-0.7153215189597812,-0.04389394885290763
53029,SIDM00782,AZD8055,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,1.6522789,0.13649598,0.232333462078574,0.037862074220714574
75358,SIDM00332,NU7441,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.8936634,0.17417124,1.8269652838199528,0.10066958292993743
48597,SIDM00332,KU-55933,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.7640524,-0.077937804,0.0029280997205600556,0.017677568426505114
56730,SIDM00332,Taselisib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7169914,-0.06887407,1.5606806280575742,0.053378156078533384
16186,SIDM01233,MK-2206,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,72.0,-3.2651913,-0.18128,0.017183159334484402,-0.02469742190955661
96564,SIDM00146,Lapatinib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,1.4566605,0.09078012,1.5403030180682011,0.1074309434163478
93137,SIDM00774,Gemcitabine,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,48.0,0.57477057,0.04047211,0.9639485872689074,0.10684900064526054
90729,SIDM00359,BMS-754807,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.5003646,0.041377507,3.1716106878261208,0.12184525598299803
35855,SIDM00875,Sorafenib,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8950115,0.095839225,-0.2563188212719896,0.017244191082884962
87083,SIDM00628,Doramapimod,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.32040322,0.010187543,1.2422911078355872,0.03953431611536776
15481,SIDM00628,OSI-027,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,-1.1099616,-0.11001878,-0.08752132666766362,-0.03740270368099581
29078,SIDM00774,Wee1 Inhibitor,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.72446865,0.049230333,-0.989476313715207,-0.024248601922456762
53456,SIDM00301,5-Fluorouracil,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.4273041,-0.14896944,0.5503060951183495,-0.016784441541038128
86327,SIDM00628,Nutlin-3a (-),Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-2.3526082,-0.07750594,-0.3940706458243167,-0.004142645579299811
44397,SIDM00332,Taselisib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.4881697,-0.11903188,-1.9288299256043453,-0.01217710442448739
10999,SIDM00146,Axitinib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-2.978569,-0.13676654,-0.7053430734502233,-0.00018903407775888243
89616,SIDM00971,Lapatinib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.3841578,-0.0684138,-1.902840911631089,-0.07862905986138594
108057,SIDM00332,Doramapimod,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.1964457,0.17152542,0.5992074805725505,0.052309450152806546
44360,SIDM00971,Entinostat,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.149638,-0.0281764,-0.5293854031592714,0.0727456380976936
66251,SIDM00878,Alpelisib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,2.6590228,0.23150487,0.6562036139859067,0.04797930118664551
72390,SIDM00301,Irinotecan,Trametinib,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,-1.8336465,-0.14194977,0.4332705151610328,-0.019509141661043394
50672,SIDM00779,Dabrafenib,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,1.2884195,0.10646478,-1.3014688947303399,-0.03187404775236076
102574,SIDM00628,OSI-027,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.8918254,-0.084640115,-0.4858683601577471,-0.05701112985351575
49746,SIDM00529,Axitinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-1.7029662,-0.14071196,-1.9638509784615326,-0.06118725015154172
79244,SIDM00660,Crizotinib,Afatinib,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,0.7804564,0.07269252,0.34797489244501006,0.01622862725741524
25853,SIDM00893,Ribociclib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.4370084,-0.05763996,-1.4989568631480747,-0.016056337137212138
7090,SIDM00774,Nutlin-3a (-),Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,1.6424601,0.027441226,1.660990366666332,0.00883828067133907
62999,SIDM00866,Ribociclib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.6615762,-0.06259547,-0.7771946751371985,-0.04532880245344912
8740,SIDM00875,Alisertib,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6965352,-0.057917777,1.7466404877100237,0.08375349886466375
3648,SIDM00875,Nutlin-3a (-),Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6831895,0.026477536,1.7388733485843269,0.0397686119414876
87921,SIDM00673,Gemcitabine,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,0.54684156,0.04544011,-0.8484615935729111,0.016176778210124913
43688,SIDM00146,Navitoclax,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,7.240593,0.15571462,2.908031468917477,0.07457499775536433
53077,SIDM00774,Vorinostat,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,48.0,-0.33490494,-0.023418939,-0.43112077053429265,-0.03524900610404589
3674,SIDM00866,RO-3306,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-4.194279,-0.18197934,-0.4282099534018623,0.010153062126101758
8733,SIDM00954,Paclitaxel,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-3.7914605,-0.29752868,-1.9461747739053135,-0.13930348867020126
49091,SIDM00130,OSI-027,Lapatinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.50884986,0.051338423,0.8280918764528068,0.07476768882338224
49305,SIDM00529,Wee1 Inhibitor,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-0.19003499,-0.018023437,-1.2048153262869699,-0.06546967249171504
65170,SIDM00878,AZD7762,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.98829234,-0.050510295,-0.9076274031241826,-0.02247443020140553
89207,SIDM00866,Linsitinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.8692437,0.12363737,1.5560384090633452,0.11461430841724203
78352,SIDM00301,Gemcitabine,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.5122712,-0.26111802,-1.2256848010216632,-0.05992789163778114
96871,SIDM00146,Lapatinib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.9535063,0.08096219,1.5250026320398937,0.14456731109382373
83495,SIDM00954,AZD8055,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.0,-2.194663,-0.17263485,-0.473866782035427,-0.06184580938368633
15620,SIDM00332,Sorafenib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.59878176,0.04079347,-0.11712273048811044,-0.007577294396976983
83420,SIDM00529,Olaparib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,-2.2555733,-0.092799105,-0.13151315762088917,0.02840914358196528
37759,SIDM00529,Uprosertib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Black,44.0,-0.68138003,-0.03696947,0.012115660147546788,0.07349634687577963
44372,SIDM00782,AZD4547,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,1.576705,0.060587443,0.8595807842423968,0.05724087503703325
5699,SIDM00097,NU7441,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0606356,-0.097550474,-0.6328273565267564,-0.052334387451590976
3519,SIDM00359,SCH772984,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.4993013,0.10389967,-1.750875489564808,-0.0817900410545385
48618,SIDM00529,MK-1775,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,0.49048454,0.04811179,-0.44771724543970004,-0.005821083441156388
90744,SIDM00779,Olaparib,Afatinib,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,0.36472154,0.007786857,0.22246890933429606,-0.006931046821593641
88022,SIDM00834,Palbociclib,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,0.20942388,0.011034814,-1.3357189711568112,-0.06936921662095413
14352,SIDM00359,Oxaliplatin,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.21702914,-0.013858061,-2.346488543325046,-0.08781073470617828
80470,SIDM00673,Taselisib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.4179488,-0.041169055,-1.5690621921950085,-0.08419692112500418
11844,SIDM00673,Nutlin-3a (-),Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,0.73537636,0.019732816,1.3580352991755857,0.02535340169115346
52148,SIDM00628,BI-2536,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,-1.9577283,-0.08880204,-0.550844782101527,-0.03250324714757264
100468,SIDM00531,Trametinib,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.3529593,-0.10531699,-1.486850720499519,-0.05577308302427641
36333,SIDM00529,OSI-027,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-1.3512701,-0.11303878,-1.0925625153557275,-0.09132793849571572
84669,SIDM00097,Cisplatin,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.7186399,0.035105452,1.2592560152565644,0.046112637154715044
69704,SIDM00778,AZD8055,Nutlin-3a (-),Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-0.50475293,-0.032924898,-0.43886780972984274,-0.01817820908601771
45915,SIDM00779,5-Fluorouracil,Navitoclax,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,2.573655,0.16232567,1.0788558666308938,0.10330346515639892
23979,SIDM00628,AZD6482,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.41486034,-0.041851077,-1.212624910401388,-0.054253775957659386
86682,SIDM00866,Axitinib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-1.8817059,-0.11153425,-0.8709412055535141,-0.0365081537993516
7638,SIDM00893,Luminespib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.66080934,-0.054098442,-0.6349884402722463,-0.008512003981210325
102702,SIDM00529,Olaparib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Black,44.0,-2.404419,-0.08043919,-0.5592169919000237,-0.00861060435524793
103152,SIDM00531,Gemcitabine,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.3195981,-0.1388011,-1.0981794729525574,-0.08914370428889705
55581,SIDM00834,MK-1775,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,White,66.0,-0.6218312,-0.03596298,-3.012147357071504,-0.06654102449190535
39603,SIDM00875,Vorinostat,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.39669386,0.03483493,0.20874682047982865,0.07481169280165534
55086,SIDM00893,AZD8055,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.1081071,-0.09527555,-0.18765352197180585,0.052048623781694545
62065,SIDM00893,RO-3306,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.21483,-0.067863576,-1.9947939213040282,-0.04438041633442201
92163,SIDM00628,AZD6482,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.2229166,0.08753549,1.5199317854645102,0.13079134918809776
108377,SIDM00893,KU-55933,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.6784323,-0.05313213,0.023244126106474593,-0.02662608801812516
7735,SIDM00146,OSI-027,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,1.3388108,0.12570775,0.613139426710768,0.07988063303738505
58093,SIDM00779,SCH772984,Navitoclax,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,3.211822,0.18933469,0.7224386263683431,0.041028298714372
96875,SIDM00878,Temozolomide,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.8623917,0.0075073293,1.3021929478061647,0.0336218360561601
78274,SIDM00954,Navitoclax,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,0.69242656,0.019296804,0.49530315683611836,-0.005515386343251855
99770,SIDM00954,Pictilisib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-2.3460155,-0.13358693,-0.5125502777062517,-0.007181257335205537
90055,SIDM00774,GSK269962A,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.3963278,-0.022788193,-0.4964921003108666,-0.00731135874456074
78464,SIDM00954,AZD8055,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.3480207,-0.07072054,1.0162412175670046,0.11849694931189866
13987,SIDM00359,Afatinib,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.54915404,-0.044610485,-1.1308353233306079,-0.027526697539983495
73774,SIDM00529,Nutlin-3a (-),Palbociclib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.8585953,-0.0573276,-0.4182792640638591,-0.010692196658460577
19874,SIDM00782,LGK974,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.42633572,0.035426132,0.08608171654655009,-0.016163174862641357
23663,SIDM00893,Navitoclax,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.34783033,-0.03581498,-1.0069190051685026,-0.05914419167242605
98055,SIDM00893,Alpelisib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.16307057,-0.0131624155,-0.08586890524855409,0.027491430480564464
10870,SIDM00971,Afatinib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.0564141,-0.04727488,-0.8952876721743601,-0.040027279109816585
94621,SIDM00146,Axitinib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-2.8071382,-0.15246849,-0.7703502028065218,-0.032060055558753554
64790,SIDM00893,Paclitaxel,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.27795094,-0.019184396,-1.5360793849112784,-0.1224654983387329
45030,SIDM00778,Navitoclax,Nutlin-3a (-),Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-3.3367143,-0.20001431,-0.10130111675158088,0.03944196450830191
57978,SIDM00971,BI-2536,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.0915685,0.061676506,1.5026966305178842,0.15192071221311593
42365,SIDM00097,PF-4708671,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.4691963,-0.078759894,-0.38269950300578087,-0.013337076365541637
3216,SIDM00866,Taselisib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-1.7385435,-0.15333061,-0.8031411328846414,-0.0870117327077831
68957,SIDM00301,Paclitaxel,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.7974169,-0.1310241,-2.155972722577298,-0.1392390954471873
103971,SIDM00411,Navitoclax,Irinotecan,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,4.251549,0.18929401,2.603513898886318,0.17209987309413077
14205,SIDM00673,Gemcitabine,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.84956753,-0.032438897,1.676186967449308,0.08476930195382955
41145,SIDM00097,MK-1775,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8200071,-0.11030848,-0.8563849848008706,-0.08319208541580453
83117,SIDM00660,Dabrafenib,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,32.0,3.213505,0.26733705,-0.4084780577549237,-0.0032412854724523333
43793,SIDM00954,Doramapimod,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-2.4550393,-0.125069,0.1736783918592896,0.10301672463032356
91105,SIDM00878,Bortezomib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,0.44399443,0.025114182,-0.056961927122556655,0.00111822521994042
55413,SIDM00954,MK-1775,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,0.38652658,0.031100987,0.17345559993801082,0.007940612658326424
82869,SIDM00779,Navitoclax,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,33.0,-0.556716,-0.022652002,0.09236580484995735,-0.02445455480901552
39021,SIDM00097,5-Fluorouracil,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2519474,-0.09876682,-1.357357777162712,-0.10281741323238758
80792,SIDM00866,PF-4708671,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-2.0976524,-0.06419612,-1.7530661202437372,-0.013224756597739912
32753,SIDM00875,Ribociclib,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6562096,-0.048333205,-0.30294117091797734,0.0036281964605853955
56829,SIDM00332,Linsitinib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2335987,-0.032280058,2.5311271462327696,0.07477397762568554
65630,SIDM00411,Ruxolitinib,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,43.0,0.86274827,0.017926576,1.1726934091119006,0.018262615130862525
104047,SIDM00893,Afatinib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.8399616,-0.13636029,-1.0227240945870213,-0.13617460410579382
30709,SIDM00878,PF-4708671,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.95278984,-0.039072648,0.9382894252787255,0.0923563504767897
40862,SIDM00531,SCH772984,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.5486128,0.1698897,-0.5305435950282661,0.044862580746170166
93063,SIDM00878,Tozasertib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.72834283,-0.048428,0.6423499141099375,0.021980006318120915
31307,SIDM00878,Cisplatin,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.49770582,0.014232591,1.683319901366226,0.06253012729132333
7961,SIDM00332,Sorafenib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5837511,-0.056431368,0.278859188551676,0.04867553509000112
78337,SIDM00660,Vinorelbine,Taselisib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,32.0,1.2897317,0.13633457,0.9322726496409859,0.05062062919052361
44565,SIDM00774,Olaparib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.63237435,0.04036591,0.6515224259120427,0.03933477192846932
24634,SIDM00774,BI-2536,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.301831,-0.08744568,-1.9186883858247237,-0.12953115528051637
45459,SIDM00130,Lapatinib,Sorafenib,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.9271694,0.1479467,1.2534835792892032,0.08892274051652839
77597,SIDM00529,Dabrafenib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.534686,0.03690886,1.5056046113347188,0.08619752577661115
57932,SIDM00332,Axitinib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7533188,-0.078774646,-0.02727151761764148,-0.01965222028314296
37111,SIDM00774,Luminespib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.8339821,-0.07649655,-0.8635082169556174,-0.09124892769066
36490,SIDM00971,Trametinib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1051862,-0.014795352,0.582528225911935,0.017065841077588982
5145,SIDM00774,Nutlin-3a (-),Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,1.9065814,0.08849577,1.3928911593119129,0.07482287477760875
54696,SIDM00673,Nilotinib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.0173662,-0.090026766,-0.12991151759919142,0.04562116288764136
75171,SIDM00834,Oxaliplatin,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,White,66.0,-2.787918,-0.0883287,-2.3197856210666834,-0.06946079906952539
37442,SIDM00878,Pictilisib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-2.7164657,-0.25460333,0.12019160570595966,-0.05739172407893494
48879,SIDM00529,AZD7762,OSI-027,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.8198227,-0.05696028,-1.0121070290440923,-0.056580325610316735
20344,SIDM00893,Alisertib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.77487826,0.064478666,-0.36803746881274246,-0.047029855432922915
82459,SIDM00628,KU-55933,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.402346,0.13884154,-0.3322024539761416,0.014474361561025561
29270,SIDM00776,MK-1775,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-0.95097756,-0.0446911,-1.192560125440315,-0.049806208140006435
51990,SIDM00893,Sorafenib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.6888942,0.059344,0.4476091163065901,0.07872062277311759
85913,SIDM00774,Doramapimod,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.3320177,0.063843384,0.4498592954803259,0.04722425734884113
29686,SIDM00971,Doramapimod,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.582335,0.06737376,-0.2012664413017287,0.011579633179829529
87712,SIDM00673,PF-4708671,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.6082933,-0.10780513,-0.5787460764363378,-0.0024982772317503708
46656,SIDM00971,OSI-027,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.4360435,-0.08688733,1.570030415527809,0.14077003277772654
11943,SIDM00875,Nilotinib,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7138005,0.1635282,1.3389877633887808,0.11555283378441382
38189,SIDM00673,Navitoclax,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.0906678,-0.07612837,0.17287625147840735,0.04264243131985214
54428,SIDM00971,Linsitinib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.5261344,0.020497106,-0.6633509275839139,0.024074896524060134
64378,SIDM00359,Trametinib,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.62227494,-0.023248777,-0.6294038306895929,-0.023018802175989263
91983,SIDM00971,Ribociclib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.8456063,-0.048569378,-1.058727448747686,-0.021444342694421404
6616,SIDM00893,Crizotinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.7471194,0.041239206,3.1467441437215546,0.05842180094991251
7348,SIDM00893,Alisertib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.1838906,0.10882901,-0.348620751299919,-0.041488194953760105
93720,SIDM00893,Wee1 Inhibitor,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.6650325,-0.050484046,-0.12910380187921294,0.005604173909183676
58470,SIDM00778,Navitoclax,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,3.0637228,0.078682154,2.643253063795339,0.09960979437068054
1325,SIDM00878,Linsitinib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,3.5108867,0.20321682,0.9823774814644833,0.08448467750758046
87548,SIDM00866,BI-2536,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-2.6621926,-0.17794469,-1.4630197044319346,-0.07859504291340275
86981,SIDM00628,KU-55933,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-0.9493629,-0.05163902,-0.7562293555991033,0.018425661304515492
16483,SIDM00146,PD173074,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.52447563,-0.04023781,0.134640987862108,-0.0005224017975542602
12357,SIDM00529,AZD6482,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,1.9095588,0.08329109,2.080871576316884,0.04397453114876555
43529,SIDM00531,Paclitaxel,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.5350689,-0.11182272,-3.530296133447433,-0.17601329973811408
74697,SIDM00779,LGK974,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,4.868822,0.13352002,0.9339597911618435,0.03290603515342484
8216,SIDM01233,Linsitinib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,1.9232725,0.14948513,-0.43260176737076683,0.004945404219766916
48428,SIDM00673,ZM447439,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.66466993,-0.055090014,-0.9304610468880229,-0.06357178418404795
22815,SIDM00146,Crizotinib,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,-1.4840894,-0.116375506,-0.5292958574401662,-0.02145237788653908
55002,SIDM00782,SCH772984,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.3940489,-0.035203326,-0.8082215412154876,-0.046965211595175596
86185,SIDM00531,Olaparib,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.9591707,0.059304208,0.8323307066487705,0.04740524875225897
10967,SIDM00776,Afatinib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,-0.65932125,-0.060679372,0.7039741117356819,0.02709444241108707
79667,SIDM00673,Ribociclib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,2.2597744,0.12894098,-0.4831368841161693,0.0044118534615618845
7097,SIDM00146,Nutlin-3a (-),Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,0.9254786,0.035657566,1.1313574171589762,0.030272058411633124
102607,SIDM00359,SB505124,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.70445365,-0.045798656,-0.7666300949411649,-0.008724697971566414
23365,SIDM00332,Axitinib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0421578,-0.10335674,-1.406039687330474,-0.1138562765860786
57880,SIDM00782,BMS-754807,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,1.3493632,0.1028677,1.0733656273514915,0.05036143517357027
522,SIDM00332,Trametinib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.7725358,-0.15891306,0.1240961457964033,-0.047443651842710974
74605,SIDM00866,Afatinib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-1.4058064,-0.11734762,-1.535888146930831,-0.07398039268477692
66439,SIDM00893,Axitinib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.9991739,-0.07970298,-1.1330606027437182,0.011919637637063123
79853,SIDM00866,MK-2206,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-1.6663454,-0.1039265,-1.2883123253073854,-0.07026695384062501
36244,SIDM00779,AZD7762,MK-2206,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,0.99060565,0.055396575,-0.8087850697729332,-0.03089543549144854
3374,SIDM00774,Docetaxel,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-4.5633993,-0.630878,-3.242632641374373,-0.2827442869695617
43438,SIDM00628,Trametinib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,0.57993543,0.023774218,-1.6778588931171736,-0.039288666960035405
108471,SIDM00834,Navitoclax,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,White,66.0,2.5821042,0.21168533,0.7511383499654175,0.13224086162628723
104027,SIDM00097,Nilotinib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.186288,-0.19652368,-2.4429238507096813,-0.15454345001783867
103986,SIDM00878,Nutlin-3a (-),Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,1.0135384,0.070195965,-0.3021583384913614,0.007845371911723563
60563,SIDM00866,Olaparib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.6809171,-0.023437306,1.416027317941075,0.054135529648516395
103327,SIDM00193,Trametinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,2.0546944,0.13992842,1.5047727619347249,0.13470798979529142
48789,SIDM00332,Lapatinib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.92753935,-0.022685053,0.5773048609441863,0.05238278533032601
36000,SIDM00660,Oxaliplatin,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,1.2119113,0.111719064,-0.6900905537441916,-0.06555465942276334
26327,SIDM00673,PF-4708671,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-3.269589,-0.13058524,-1.6908805993103535,-0.10614064143567192
74009,SIDM00193,AZD8055,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-1.2279979,-0.088503286,-1.0738802753509253,-0.012207851473233803
52726,SIDM00893,OSI-027,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.92382044,-0.0758739,-1.3843447651681808,-0.06140086966373159
94423,SIDM00878,Vorinostat,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,0.7399254,0.06369209,-0.9977027080141088,-0.09307579637871982
43192,SIDM00301,Paclitaxel,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.53510284,-0.025792114,0.26140327125578644,-0.02555137762278287
73099,SIDM00146,Nutlin-3a (-),Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,5.9772787,0.25419182,2.8925358218880057,0.08654308819460037
41186,SIDM00893,PD173074,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.6038585,-0.040271226,0.5525615979066496,-0.018623116007158456
75210,SIDM00878,Taselisib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.121036455,-0.01007802,0.45946825412969644,0.010841894421540365
83359,SIDM00875,Lapatinib,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2576339,0.14071381,1.3018291916823277,0.08597176173517315
102523,SIDM00332,GSK269962A,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.632469,0.087812304,1.4513694875042924,0.017189938920662635
41258,SIDM00875,AZD6482,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.1782942,0.30365983,1.2988052904120555,0.13362255583838795
93422,SIDM00954,Alpelisib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.7744483,-0.0529815,0.19868487198355003,0.07880788888712303
37318,SIDM00774,AZD8055,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,0.8991942,0.06549674,-0.09617969747532065,-0.0019529673556331957
53341,SIDM00628,Afatinib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-1.3076934,-0.11262218,0.951713033237809,0.01823145241804459
97533,SIDM00875,AZD7762,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.12326387,0.006948473,-0.26541053929229536,-0.03930937672363347
68500,SIDM00971,Linsitinib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.6089579,0.027180847,-1.2247761904116068,-0.03212457755220317
45870,SIDM00779,Linsitinib,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-0.6426982,-0.052881155,-0.007143378804518121,-0.05355552488403081
20971,SIDM00673,Luminespib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.6441991,0.118423134,-0.49477993550340643,-0.020881421396706602
69822,SIDM00893,Temozolomide,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.47713342,-0.0112220915,1.258910345509231,0.05549961201181655
67929,SIDM00954,Entinostat,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,0.61771363,0.049899105,-0.4586998674899861,0.007066766194972591
92070,SIDM00097,PD173074,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.0353396,-0.111305885,0.05120355284801361,0.026133454829352688
28645,SIDM00893,Linsitinib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.5494925,-0.062124506,0.29550843662589593,0.03132152000868173
30775,SIDM00893,MK-1775,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.71162117,-0.06488921,-0.8798215280227953,-0.048886785475730866
24574,SIDM00146,ZM447439,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,1.2574062,0.09786513,0.030206697726341665,0.05764402165580729
46234,SIDM00866,Nutlin-3a (-),MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,2.8402092,0.05656011,2.5192687262125624,0.0650079813100278
105834,SIDM00146,Temozolomide,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,1.1802084,0.025686622,0.9824588313776033,0.024397595332583552
21337,SIDM00954,Ribociclib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.0,0.8907663,0.036667533,-0.02974583326774752,-0.008710174241727495
107010,SIDM00782,Linsitinib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,3.3773515,0.20208076,2.0016519865534477,0.1438363238967231
42279,SIDM00954,OSI-027,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-2.5274193,-0.084012315,0.4104460643831416,0.01599082196418463
50769,SIDM00531,Palbociclib,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.1147717,-0.046998017,-1.362854435565452,-0.04035741932922793
46445,SIDM00875,AZD8055,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6528223,-0.08892708,-0.981646282266445,-0.03090754155622564
57288,SIDM00332,Alisertib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-4.4231944,-0.13160518,-3.5216831093038916,-0.12233935018609747
57686,SIDM00971,Navitoclax,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.2068561,0.037286695,0.5778261005458122,0.028493504527124992
78234,SIDM00130,5-Fluorouracil,OSI-027,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.186832,-0.15049417,-0.32595755174765323,-0.05040654341356676
83069,SIDM00774,Bortezomib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.097817175,0.008124943,-0.2131367335107542,-0.0062647403207451305
84533,SIDM00673,Linsitinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,0.9053078,0.015200201,3.8769303387158183,0.06945848179090765
65286,SIDM00866,Palbociclib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-0.3515641,-0.007882655,0.4748748887327069,0.034587773266387525
76642,SIDM00529,Nutlin-3a (-),Trametinib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-1.0897461,-0.03625853,0.2650988700981658,0.027475121406625065
37581,SIDM00332,Bortezomib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3511708,-0.03827834,0.16496390903575398,-0.038222650730492795
86455,SIDM00130,OSI-027,Crizotinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.4381322,0.045504842,1.1567408338970497,0.1040873298453784
37335,SIDM00146,Ribociclib,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.64608896,0.031544037,-1.2023644717494404,-0.010374015057107071
75945,SIDM00097,Crizotinib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1078168,-0.0664457,-0.6019287351008605,-0.06993874200721738
83122,SIDM00529,Alisertib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Black,44.0,-1.018186,-0.09788296,-0.40034874732127346,-0.04364896898228819
66,SIDM00776,Vinorelbine,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,1.4020283,0.11421101,0.5403136217753486,0.03860761319533262
48083,SIDM00332,Vorinostat,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,2.8420074,0.122954965,0.035768242867356186,-0.013734934928780399
23908,SIDM00866,NU7441,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.2317039,-0.014333748,-0.1317597510415207,0.021237922156735187
92251,SIDM00301,Linsitinib,Cisplatin,Pancreas,0.8,Pancreatic Carcinoma,Male,East Asian,50.0,-1.7974932,-0.061854187,1.060861616306465,0.022832068546708374
100682,SIDM00878,MK-2206,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-0.490334,-0.058184505,-0.9571280608248512,-0.11212186957576337
47368,SIDM00146,PD173074,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.1781219,-0.079498634,0.6100580823593083,0.09406863831558447
81152,SIDM00146,Afatinib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.3253452,-0.028624492,1.2052095765089397,0.0372259467279087
50617,SIDM00893,ZM447439,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,4.056234,0.3029956,2.9449613983077074,0.22280819335598195
64583,SIDM00774,Vorinostat,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.6704566,0.03353221,0.670174580614178,0.013508799311769081
77167,SIDM00628,Doramapimod,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,0.4121768,0.013514673,0.7376180490247938,-0.007429228900816071
8053,SIDM00301,Palbociclib,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.1802666,0.133841,0.4975534539889571,0.045543325458928
93030,SIDM00778,Olaparib,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,-2.3757017,-0.04538468,-0.4109826251391625,-0.004406735122335083
44469,SIDM00529,Alisertib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-2.6161828,-0.23035733,-1.4865916837471198,-0.08615263659948984
66017,SIDM00875,Taselisib,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.13163798,-0.012203997,-1.1776575790629724,-0.04712706345095179
96261,SIDM00146,PD173074,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.5923072,-0.043686386,0.5266431519343866,0.12156186744817497
67188,SIDM00875,Paclitaxel,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.25258613,0.016654247,-0.5117284232925632,0.04854795327262278
87550,SIDM00954,Sorafenib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,0.48220775,0.03623827,-0.1115752191223902,-0.0033873318915534963
107113,SIDM00954,Sorafenib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,5.192626,0.07432438,2.155296011237408,0.12422151070932715
71091,SIDM00097,Axitinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.6469927,0.09955304,2.3668123162795807,0.18206736516873662
105520,SIDM00193,Olaparib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.9936415,-0.047098193,-0.46055477841115955,0.04287474109740741
51078,SIDM00834,AZD4547,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,White,66.0,0.11800221,0.002796639,1.4285801141778627,0.00740818035996169
60276,SIDM00146,Crizotinib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.7018718,-0.06802509,-1.1976612397794668,-0.020458139052779326
34899,SIDM00332,Olaparib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,4.7434034,0.23948847,1.1854112198401894,0.08882040239028673
105654,SIDM00866,KU-55933,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,52.0,-2.413678,-0.095084764,-1.287793132184096,-0.060387291425459545
103916,SIDM00531,Palbociclib,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.6390752,-0.030097423,0.6748746965516821,0.05716516804925837
20794,SIDM00332,Nilotinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.8446884,0.13469493,0.52748760174537,0.08583428921730495
48513,SIDM00332,OSI-027,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2830772,-0.12993012,-1.3162864365002194,-0.1555791208146831
43003,SIDM00531,Irinotecan,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.7877612,0.07419221,-0.8653004924564772,-0.0821000550768022
84464,SIDM00779,Navitoclax,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,1.0939204,0.0312951,0.10963541644884435,-0.027020100098339342
88522,SIDM00954,Tozasertib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-1.5352082,-0.08976111,-0.4810983729404742,-0.022697145350199587
97443,SIDM00332,Navitoclax,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5856101,-0.057822492,0.9799027581434185,0.02397156403891181
26821,SIDM00097,Vorinostat,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.73000866,0.04729166,-1.1630799350552206,-0.05618823325202448
60847,SIDM00774,Cisplatin,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,4.178134,0.032870345,2.1473480287934765,0.06412982774108261
84746,SIDM00971,Tozasertib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.906676,0.043790262,0.9333716741537734,0.03609932733648922
6269,SIDM00359,Linsitinib,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.8076822,0.15152751,0.18809876310454626,0.0675546622641511
93816,SIDM00529,Tozasertib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-1.644515,-0.057276767,-1.0553468756447155,-0.02783623250364816
75613,SIDM00529,Alisertib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-0.5939149,-0.05913228,-0.8010848404156283,0.03812219984122547
26184,SIDM00779,AZD4547,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,33.0,-1.9524114,-0.008151547,-3.2331589337842157,-0.08389348952654828
107532,SIDM00971,Bortezomib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.9801006,0.15604211,0.5729405786459122,0.07912434310702139
14539,SIDM00673,Nutlin-3a (-),Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.23530512,0.0054930993,1.0413285769518195,-0.018803084634300297
45207,SIDM00359,Afatinib,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.5720333,-0.11583615,-1.4289632579120088,-0.047624608041597224
45430,SIDM00628,Olaparib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,Black,51.0,0.83749455,0.07831656,-0.10700973677663385,0.038483453351866356
34915,SIDM00971,Lapatinib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.1148589,0.049876392,-0.48259724638932183,-0.032001985225147495
58207,SIDM00529,Wee1 Inhibitor,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,-1.3221531,-0.11362172,-0.44153586367566516,-0.017725742448681307
64233,SIDM00529,AZD6482,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,0.71372426,0.024762284,0.6622729501174173,0.04179670233168633
17838,SIDM00146,Bortezomib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.19190702,-0.010287421,-0.1044131307024977,0.005383912487731778
94875,SIDM00411,Trametinib,Palbociclib,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.823239,0.10892808,0.6735657667653253,0.062434167873011814
58556,SIDM00954,Venetoclax,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.0,-0.18742147,-0.013826724,-1.421741775967757,-0.06589449249267146
38935,SIDM01233,5-Fluorouracil,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,72.0,2.225253,0.17575942,1.0946766319573067,0.08538294993499199
96580,SIDM00866,AZD7762,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.8073986,-0.05003293,-0.8767323811460727,-0.07689595165623565
25339,SIDM00774,MK-1775,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,0.12536645,0.017051002,-0.258605475202386,-0.011828791192207557
76683,SIDM00875,MK-1775,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.16988313,-0.011319651,-0.33212604680406294,-0.045239156811549656
71946,SIDM00529,Cisplatin,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,1.0864291,0.02329745,0.8742419328013392,0.029593448655328702
56022,SIDM00878,AZD7762,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.6603713,-0.030221019,-0.7164291035590692,-0.060154073206551535
94081,SIDM00875,SCH772984,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.9158118,-0.19512938,-0.5424359999913693,-0.0013086717605005935
7117,SIDM00774,ZM447439,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,-1.5991399,-0.08254334,-0.8750447315613129,-0.058389315522616385
43133,SIDM00301,Erlotinib,LGK974,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.1972177,0.10616787,0.9889463781286285,-0.0007042963659047175
74438,SIDM00779,BMS-754807,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,1.3422899,0.018082986,-3.9022114819300975,-0.0592415971966429
84560,SIDM00782,Navitoclax,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,Unknown,72.0,2.1532655,0.1457223,0.7122030983542809,0.05352723745030154
99716,SIDM00954,Olaparib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,-1.1058447,-0.031965103,-0.4789779457158198,0.022393739935099483
8242,SIDM01233,BMS-754807,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,72.0,1.8509594,0.125634,0.7447678492253066,0.06089405205884243
102985,SIDM00529,Dabrafenib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,1.6580247,0.041483667,1.3570532944507152,0.07040505552405495
49637,SIDM00954,Tozasertib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.0,1.0465477,0.08250005,-0.9620529725416618,-0.049242080885251394
64062,SIDM00146,Palbociclib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.25239864,-0.01733116,-0.7534890734976469,0.03582174777533365
94599,SIDM00875,Bortezomib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.17854622,0.018976036,-0.2518826568815946,-0.03536170783804124
79928,SIDM00954,Alpelisib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-2.5945518,-0.18907976,-0.29309601991328477,-0.0401439545325411
31528,SIDM00893,Linsitinib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.81663936,-0.03507205,1.8635733651440283,0.12440530316394277
16453,SIDM00893,Luminespib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.733359,-0.16253872,-1.5671783034498832,-0.09725922728191123
17043,SIDM00875,Vorinostat,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0433491,0.116583355,-0.8324825723937715,0.018154184804686373
94233,SIDM00529,Temozolomide,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.12867245,0.0020749702,-0.3540228068789456,0.02265888105631703
101302,SIDM00893,Uprosertib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-3.5774639,-0.28993765,-2.271469982154124,-0.11869295364788707
44108,SIDM00834,Taselisib,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-0.9501117,-0.06584625,0.09049323792620985,-0.0007832508021948818
79544,SIDM00866,Venetoclax,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.293192,0.031780303,0.9463309711650502,0.04069042128406298
35734,SIDM00411,Sorafenib,Trametinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.2573016,-0.06332869,0.09244295021610581,0.02736811129252162
34599,SIDM00954,Taselisib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-2.1900892,-0.1212051,-0.26866143714797486,-0.041172761821010435
93353,SIDM00673,AZD8055,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,1.1454514,0.06413399,0.2640341825003376,0.05361697151250704
10816,SIDM00893,Entinostat,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,4.40137,0.15602386,2.7798799133581498,0.05150527191567687
42401,SIDM00301,Paclitaxel,MK-1775,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.2592568,-0.059304778,-3.137041068007641,-0.1094620374234164
60353,SIDM00866,Luminespib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.84993035,0.06292206,-0.42034815614874776,-0.05910378540739174
92539,SIDM00878,SCH772984,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-2.1376657,-0.06929096,-0.3804691472053223,-0.012999581731923785
104894,SIDM00411,Trametinib,Olaparib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-0.97720295,-0.02922057,-0.8841063964705237,-0.016606421728762324
51970,SIDM00146,AZD7762,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,2.4896185,0.20154482,0.28554220345073855,0.06071541733647512
33247,SIDM00866,Vorinostat,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-1.3612462,-0.093469106,-0.9729885391303253,-0.054961474877867865
55740,SIDM00097,Wee1 Inhibitor,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.56422573,-0.033937834,-1.0085336499592088,-0.0608784878017627
68421,SIDM00628,AZD6482,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,2.79714,0.18084726,0.6131778900255364,0.03961811352898521
41526,SIDM00130,Palbociclib,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.7494576,-0.12166603,-2.4517901446642103,-0.1060882780634386
84816,SIDM00878,JQ1,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.37954095,-0.036929104,-0.38694725594480517,-0.04319186540668948
32124,SIDM00878,5-Fluorouracil,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.4898406,-0.07303513,-0.6523221742457611,-0.07281826477650023
20224,SIDM00359,Trametinib,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.1401885,-0.035866216,-0.32322258251957053,-0.008023366662414195
74790,SIDM00673,Gemcitabine,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,1.5711986,0.11076051,-0.2507630480012507,0.05467424026864967
98027,SIDM00954,Axitinib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,3.337891,0.0904773,2.399566498337419,0.13437501293637563
101572,SIDM00954,Lapatinib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.0,-0.55886453,-0.045489326,-0.42254144537314525,-0.0522916558855615
18780,SIDM00782,5-Fluorouracil,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.868627,-0.018059017,2.7510563965171544,0.07126454796139822
76618,SIDM00146,Navitoclax,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.9312491,0.109680474,2.3000958601010724,0.07529533959874297
76092,SIDM00531,SCH772984,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.6110597,-0.10937094,-1.401165607026968,-0.02964535271134029
49927,SIDM00529,Gemcitabine,Trametinib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,0.66808456,0.014585978,-0.5667784921639534,-0.017955031849611433
39163,SIDM00971,Entinostat,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.5839553,0.16288428,0.44421751338252025,0.03934225201219267
27750,SIDM00782,5-Fluorouracil,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.3870887,-0.040554408,0.3620747085867214,0.048962438970510135
73951,SIDM00834,Camptothecin,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,White,66.0,-1.838993,-0.1362509,-1.7258641809137198,-0.08457674298020815
38763,SIDM01233,5-Fluorouracil,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,3.27192,0.05831455,-0.01006271605163683,0.013041169771687506
59839,SIDM00878,Axitinib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,1.0585958,0.10836064,0.2686205888645473,0.04019892845982335
87230,SIDM00660,Vinorelbine,5-Fluorouracil,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,1.6967393,0.16696995,-1.6013601414044556,-0.06187924932198378
6358,SIDM00875,JQ1,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.57652557,0.05694468,0.9835595340490303,0.08318857736714284
33824,SIDM00782,Palbociclib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,-0.5401718,-0.011274683,2.659000111299151,0.013555231107211059
105853,SIDM00866,Alpelisib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-0.9330544,-0.061647996,-0.8373382319461534,-0.04073861484372582
103493,SIDM00130,Linsitinib,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,3.4419596,0.20476893,2.6208407438560295,0.14893532431032278
30508,SIDM00529,Tozasertib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-1.4046801,-0.04873328,-0.8163378136832524,0.065733210350467
44988,SIDM00529,Paclitaxel,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,0.17213824,0.017238004,-2.6983410893689856,-0.19527825004304783
32092,SIDM00332,Luminespib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1602491,-0.10743006,-0.6517383109044115,-0.045942208312790736
7174,SIDM00954,PD173074,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.869924,-0.097328275,-0.1368295123044557,0.002026393008705065
64892,SIDM00834,SB505124,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,White,66.0,0.729035,0.042438947,-0.6581371298133905,-0.04442670667093244
4293,SIDM00332,Alisertib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-4.326415,-0.15210931,-1.053616021962876,-0.05729492316632969
12790,SIDM00776,MK-2206,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,3.324123,0.18797638,2.7692005874863503,0.11610273548541085
79758,SIDM00332,RO-3306,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1117951,0.06834618,-0.5503023762611967,0.006026695362826047
27531,SIDM00875,OSI-027,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.81931317,0.08456008,-0.3124422491396826,-0.0006888323547563947
107247,SIDM00660,Vinorelbine,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,32.0,-2.1638656,-0.15100466,-2.216499191998009,-0.1703925210076217
3334,SIDM00146,Pictilisib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.9757976,0.08529732,0.18221133979732626,0.07263978605214465
74358,SIDM00673,Entinostat,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.5854208,-0.046764437,-0.6446555258348927,-0.04682371010700137
2677,SIDM00954,Tozasertib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.0,1.3859266,0.103484534,-0.11008198647608697,-0.06696870175217638
55458,SIDM00866,BI-2536,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-2.3788226,-0.09166277,-1.032089528381772,-0.02763896748066153
59938,SIDM00332,NU7441,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.1862466,0.16425271,2.052612473518067,0.12363235993439527
13508,SIDM00531,Cisplatin,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.7519995,-0.06785825,-1.4761639142143723,-0.07433097381053173
55122,SIDM00097,Tozasertib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2995245,-0.059669882,1.122670372565349,0.06130540718151368
30808,SIDM00673,RO-3306,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,0.8931696,0.053902775,0.3725241357338013,0.020209857028246247
56874,SIDM00954,Navitoclax,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,0.5846805,0.014745574,-0.12605514535854834,-0.007933373956359423
53969,SIDM00359,AZD8055,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.1454103,0.08245787,1.4937992940038916,0.0813947579673446
101189,SIDM00954,5-Fluorouracil,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,-1.8409051,-0.066482045,-0.6117575733598408,-0.014748116113120555
57051,SIDM00971,Temozolomide,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.988198,-0.031720687,-0.447712082583997,0.023664021013152587
60697,SIDM00971,Venetoclax,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.37039325,0.0061772517,0.2958891270424261,0.010665939705123374
434,SIDM00774,5-Fluorouracil,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,-1.0353687,-0.07987563,0.5620089480972222,0.030644197112041662
51863,SIDM00146,Pictilisib,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,0.2746422,0.023255954,-0.627506945947221,-0.007577125977609563
63581,SIDM00954,SCH772984,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.0,-0.30604136,-0.020174325,-0.19244419380853545,0.04486143332464058
87893,SIDM00628,Ribociclib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,-0.46259364,-0.010789121,0.6277956465737939,0.040006105377937785
25259,SIDM00529,Crizotinib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Black,44.0,1.9870353,0.16183595,2.6025251708649435,0.1425367761743806
74315,SIDM00097,PF-4708671,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2951472,-0.06877966,-0.6465683503107872,-0.037148372988192874
99491,SIDM00301,Gemcitabine,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.3875732,-0.15062672,-0.6286378089349024,-0.05933629031874582
102269,SIDM00146,PD173074,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.74609524,-0.04462618,-0.2943172168875733,0.04616661347765119
37590,SIDM00774,Lapatinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,3.6973567,0.041243322,1.9391431098730618,0.004748440815312822
10456,SIDM00332,GSK269962A,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,2.5113945,0.16097553,1.2862151944596363,0.06340099886475754
5945,SIDM01233,Palbociclib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,2.106441,0.026863756,0.8245337930605141,0.06329648963966593
57959,SIDM00146,PF-4708671,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,1.6477365,0.06538702,1.8590853177037727,0.0940896550679295
19176,SIDM00866,Pictilisib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,52.0,-1.7965895,-0.15575545,-0.7749073703820057,-0.05879445140832065
7300,SIDM00779,Oxaliplatin,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-2.704993,-0.10466782,-1.4117289079458961,-0.08652530745153424
26782,SIDM00778,Afatinib,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,-1.4483776,-0.032895494,0.8387105816976311,0.007947226722952151
82118,SIDM00628,Nutlin-3a (-),Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,1.5529397,0.11040161,-1.0569291812793953,-0.02361233807515295
51917,SIDM00146,Afatinib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.60053605,-0.05924319,-0.34310308314242516,-0.0688817239376054
89956,SIDM00130,Gemcitabine,Paclitaxel,Pancreas,0.025,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.129703,-0.1187225,-1.6326933552878495,-0.1113537477928237
34320,SIDM00529,OSI-027,Axitinib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.79418063,-0.06620244,-0.7208069501853003,0.015126235515135247
57284,SIDM00529,Venetoclax,MK-2206,Breast,0.25,Breast Carcinoma,Female,Black,44.0,1.2051545,0.04834876,0.2543254365151504,0.1047784591718479
21968,SIDM00875,Pictilisib,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.81767005,0.09044845,-0.8166712466709759,-0.05236611659085406
84178,SIDM00332,Entinostat,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,4.0221376,0.12648503,4.145370107992973,0.14988144206776105
85210,SIDM00097,Luminespib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.098655,-0.124825835,-0.7556636367235824,-0.06755486299874738
37244,SIDM00529,Alpelisib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-1.9605639,-0.0888927,0.732881328173313,0.06762933098619921
100151,SIDM00875,Cisplatin,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6348189,-0.030828234,-0.2962524070062132,0.02973826178365256
55647,SIDM00673,PF-4708671,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.4869955,-0.055853743,0.07725150450190207,0.030986198345119596
66716,SIDM00660,AZD4547,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,0.4579687,0.033736646,-0.0847240498011512,0.015524132975944087
552,SIDM00097,Pictilisib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.54568,-0.09975459,0.5708910631607813,0.005324635711780064
53396,SIDM00673,PD173074,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.6386142,0.1252359,0.08567329688264641,0.06414115345713665
101226,SIDM00834,Afatinib,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-0.75034225,-0.045566402,-0.5006755636626709,-0.001598395968152353
104272,SIDM00628,Palbociclib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.5639777,-0.018689826,-0.11225681185792638,0.032911791911608985
8119,SIDM00529,Venetoclax,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Black,44.0,-1.111614,-0.02947946,-0.09388454419921864,0.050088027667445634
6999,SIDM00782,Olaparib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.005987,-0.02392912,1.0515495270764632,0.0467840441355056
30409,SIDM00834,LGK974,AZD4547,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-1.5405968,-0.102382556,-1.043758223380859,-0.10242765827110197
53399,SIDM00097,Vorinostat,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.4550328,0.079849,1.7234714380568823,0.08806536512055946
44054,SIDM00097,Tozasertib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5149556,-0.047399607,-0.4831889678990024,-0.0025131032118622066
33620,SIDM00971,AZD6482,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.0553776,-0.030737473,0.27523468488065156,0.06128055807802663
90339,SIDM00130,MK-2206,Dactolisib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.871019,0.11401852,0.4825078834077108,0.10113442457035828
33552,SIDM00628,Temozolomide,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.444513,0.015135882,-0.5079385055607719,0.04065625615979032
95799,SIDM00778,AZD4547,Camptothecin,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,69.0,-1.7798386,-0.089814626,-2.618937209618804,-0.12744306074772113
24467,SIDM00332,Axitinib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2206867,0.094888486,-0.7947729204235309,-0.09936609367294587
34310,SIDM00097,Vorinostat,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8113935,-0.12382604,-0.7183926374326496,-0.04300393664202901
56093,SIDM00875,Trametinib,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2270846,-0.10407909,-1.454109987936352,-0.04077469727669244
34793,SIDM00971,JQ1,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.2000213,-0.117869236,-0.4912442220992033,-0.015512904502018058
23162,SIDM00776,AZD4547,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,65.0,1.666166,0.07100257,0.4402463957541989,0.03595646305141339
1231,SIDM00774,AZD8055,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,0.886203,0.062623,0.6348683759171964,0.025355991469863046
74978,SIDM00301,MK-2206,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.0761229,-0.10864926,-0.592118296775076,-0.002650371418431998
75302,SIDM01233,Camptothecin,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,72.0,1.5078436,0.06425053,2.128277933474752,0.07592850678831599
17994,SIDM00875,Navitoclax,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.253022,-0.029065939,1.121908074015292,0.06597775645140355
43353,SIDM00531,Lapatinib,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.076222986,0.0055008875,0.16249373023734148,0.05454426230813345
14872,SIDM00193,Dabrafenib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,0.31639248,0.008777634,1.401606710897013,0.05188159101996277
51299,SIDM00971,MK-1775,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.5818045,0.06820619,0.48203225841495523,0.04611164860826279
30018,SIDM00893,Doramapimod,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.4139402,0.18354568,1.1111578020588144,0.04401106408390254
74789,SIDM00332,Venetoclax,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0817202,-0.027995117,1.5539904252860197,0.03870123193454067
88595,SIDM00628,SCH772984,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.4507483,-0.029248416,-0.5293620627576402,-0.009150317968889526
72658,SIDM00875,JQ1,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.17592977,-0.01920822,0.7526228915447984,-0.0032781648872731543
35458,SIDM00673,PF-4708671,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,2.3575032,0.15863991,-2.7864661506108184,-0.1294756830325102
64111,SIDM00193,Nutlin-3a (-),Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.27774528,-0.004725586,1.9815009154119294,0.09212324948893592
54298,SIDM00673,SCH772984,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-4.204853,-0.2446074,-1.2618467841587115,-0.11966358662538902
11224,SIDM00971,Lapatinib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7075568,-0.095425256,-1.2058580186883088,-0.0754646884870994
27253,SIDM00301,Irinotecan,Ruxolitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.9578445,-0.12877588,-0.8727651849219149,-0.05647520407793211
75068,SIDM00774,Pictilisib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.65696955,0.019954799,-0.2580401612574344,-0.025601283664849924
2734,SIDM00146,Crizotinib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-0.4987228,-0.04333176,0.342513513977371,0.006146780038912109
95141,SIDM00866,Alisertib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-2.3500075,-0.13811935,-1.2259501069472054,-0.049252532283046074
8085,SIDM00893,NU7441,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.46368858,-0.041698758,-1.406610805035945,-0.06493449305180159
53603,SIDM00774,AZD6482,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,48.0,0.41093078,0.026142446,-0.05359295533772291,0.05319153244656566
51,SIDM00893,SCH772984,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.9429716,-0.11781434,-0.06560115078419974,-0.010159070813541537
62502,SIDM00097,OSI-027,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.8420522,0.22219576,0.05456659991670161,-0.02157099853891405
36224,SIDM00774,Taselisib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.6286491,0.024160286,0.19247998140608993,0.011029463777493101
5166,SIDM00146,Temozolomide,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,1.1670367,0.03454508,0.24600749369169436,0.015967566758918358
57263,SIDM00332,AZD7762,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7889577,-0.14543039,0.21068990197443233,0.018169062126876676
73026,SIDM00774,Lapatinib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.6605996,-0.070888616,0.6787856253103851,0.006433176923381708
74886,SIDM00878,Olaparib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.8200092,0.02984936,0.2016696674638754,0.005478273206684219
20873,SIDM00628,ZM447439,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.44792786,-0.039722327,0.3549502964408828,0.0030686475545658558
28770,SIDM00878,Luminespib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-1.6872191,-0.1771032,-1.0425918370760772,-0.0717244015843261
101815,SIDM00628,Trametinib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.72435147,-0.06522532,-0.5710086728702882,0.02270502879943921
54303,SIDM01233,Olaparib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,2.8720968,0.024374504,0.11111395132116883,0.03471377929638091
99562,SIDM00146,Luminespib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.4280936,0.033377986,-0.39842641843490956,-0.05251556504594421
100832,SIDM00893,Afatinib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.63546205,0.054550517,-0.06793107000754513,0.009527971607596252
67094,SIDM00359,Linsitinib,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7192267,-0.111601174,-1.9696513653625507,-0.050928604177968816
57469,SIDM00954,Axitinib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-0.88138187,-0.06915673,-1.1014990341065325,-0.15657607500147921
51031,SIDM00529,Alisertib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.2183199,-0.028021123,-2.5269847035048847,-0.09351591415002476
50969,SIDM00628,NU7441,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,1.9303681,0.1718044,0.9055328760637918,-0.01651937530289911
90516,SIDM00971,Afatinib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.3325564,0.013517643,-0.6272454139265732,0.0027650919756497514
10010,SIDM00866,AZD6482,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,1.3928975,0.08511548,0.9074963112177928,0.07659488331929858
71856,SIDM00776,Linsitinib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.5572779,-0.08527919,0.7980053939316855,0.06784740623018183
100668,SIDM00146,Cisplatin,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.91948754,0.03899884,2.6179004199072153,0.09788854768854396
74453,SIDM00097,Dabrafenib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.6020975,-0.07975189,0.14944960822782488,0.011089714937255859
25685,SIDM00778,Navitoclax,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,2.2989254,0.06961839,1.9164541035123823,0.06014571494257698
18659,SIDM01233,Vinorelbine,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-0.35498515,-0.020106416,-1.2238918784136583,0.04004226283013693
49328,SIDM00954,AZD6482,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,1.0945734,0.0743694,0.5966037754774343,0.08453412115554419
36737,SIDM00782,SB505124,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.0452001,-0.07900041,-0.2971051060067545,-0.02871374096680102
85363,SIDM00628,Docetaxel,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.5164382,-0.04680652,-0.5069993472251775,-0.02759437804452887
32617,SIDM00893,Navitoclax,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.9005757,-0.090298526,0.9877357756241233,0.07673558474133033
94554,SIDM00954,AZD6482,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,0.88340765,0.04476065,0.8269171781102997,0.08511237189160208
60095,SIDM00971,5-Fluorouracil,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.5489016,0.055252068,0.1819233891216045,0.022013821092435017
61252,SIDM00971,PD173074,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.4932327,-0.03375551,-0.7245145513796858,0.031881785444810344
70741,SIDM00332,Linsitinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.2122328,0.07066347,2.6329071422800467,0.10552528798548934
104541,SIDM00893,Bortezomib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.3946397,-0.034202002,-0.6002006681902262,-0.009582795269238688
103559,SIDM00875,Uprosertib,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2978125,-0.11339575,-0.5936912847305503,0.03614037333805621
52591,SIDM00778,Trametinib,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,69.0,-1.1462535,-0.03515572,-0.6607071331795958,-0.008018739796490811
68745,SIDM00146,Vorinostat,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.2774425,0.10720767,0.22998899418817917,0.05993526708116445
48034,SIDM01233,Linsitinib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,72.0,-1.1438316,-0.06057253,-2.230341737932978,-0.06997782923694149
93510,SIDM00954,Paclitaxel,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-2.0595758,-0.1197225,-3.990037325688851,-0.2754814487611784
36138,SIDM00359,Trametinib,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.3122936,0.007712194,0.0004606982969341865,-0.03914769428398402
28534,SIDM00971,Ribociclib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.104297,-0.08077489,-1.0546971414198636,-0.006092871762739748
65562,SIDM00332,Dabrafenib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,4.272154,0.28255564,-0.5746329174383443,-0.0017360329106171626
22453,SIDM00097,Pictilisib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.2064579,-0.20513892,-0.9002928983190199,-0.10025482486232794
65027,SIDM00878,Navitoclax,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,0.67628115,0.013018044,0.911035474736815,0.057891634869392035
58893,SIDM00878,Uprosertib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-1.0481228,-0.051346112,-1.3731866978828366,-0.10028397727084781
44993,SIDM00866,AZD7762,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-0.55484223,-0.038765408,0.0386466857763434,0.08642048528787577
67531,SIDM00628,Camptothecin,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-2.5676725,-0.09846379,-1.2874145664515797,-0.06803119386216129
100662,SIDM00893,Uprosertib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.4096984,-0.096086085,-1.4255828646696256,-0.13067248611983745
65134,SIDM00893,Sorafenib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.060084414,0.0055453544,-1.7820108108546757,-0.10325616405421129
100479,SIDM00776,Taselisib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,65.0,-1.4511099,-0.11653773,-0.8003252170287564,-0.05714279069748921
62598,SIDM00628,Alisertib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-1.3094387,-0.025764382,-3.9109957756412475,-0.10423467538438375
18456,SIDM00893,PD173074,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.5825725,-0.039081115,0.6401473193219678,0.008252551186938498
99846,SIDM00893,Afatinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,7.8966317,0.4329871,2.3651500282066364,0.14990040986245723
51658,SIDM00893,MK-1775,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.5959967,-0.15005943,-0.8690247921207362,-0.04423905756809283
79795,SIDM00097,Alpelisib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5836797,-0.187295,-1.5134202287599032,-0.11864218711950893
20892,SIDM00660,Olaparib,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,32.0,1.1656008,0.03714164,1.8424016600052613,0.05158281033982434
86204,SIDM00411,Lapatinib,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,2.5442677,0.09204771,3.1016405959171904,0.12560304548635617
75251,SIDM00332,Cisplatin,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,3.334597,0.13128209,2.0280031624051893,0.043222639290087184
5953,SIDM00878,5-Fluorouracil,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-1.6453639,-0.10095303,-0.47612108007031523,0.009150166460791464
64268,SIDM00529,Alpelisib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-1.5998081,-0.07451792,-0.36204058255278326,0.012967746008552189
45583,SIDM00778,Linsitinib,LGK974,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,1.1584535,0.07261572,0.12653792034281802,0.02638574899044949
78269,SIDM00097,Tozasertib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.7185609,0.02979434,0.8229016872504958,0.07032033031700956
92168,SIDM00529,PF-4708671,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,2.163757,0.1574184,-0.5246451203739073,0.03499922319905491
9536,SIDM00875,OSI-027,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.2314022,0.024386607,0.3004380401402873,0.05734527358461871
34038,SIDM00411,Cisplatin,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,2.9900181,0.07664488,2.3546206550472943,0.08516493659715774
53530,SIDM00954,Alisertib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-2.161624,-0.12642565,0.5942998726102396,0.08107486797788986
85614,SIDM00971,AZD6482,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7082859,-0.035142336,0.6116901961360968,0.026970758551076765
25652,SIDM00875,Linsitinib,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.01631,0.17091924,1.0217971708698683,0.06091386303987348
27635,SIDM00529,Wee1 Inhibitor,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Black,44.0,-0.4606961,-0.04537947,-0.7136017193972866,-0.017939814414568482
37385,SIDM00301,LGK974,OSI-027,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.4186988,-0.07988961,-1.842779279486495,-0.03388560717922325
88952,SIDM00878,AZD8055,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.43346626,-0.037649795,0.9427599165486996,0.043050674456988756
41317,SIDM00971,Vorinostat,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.8416067,-0.077666014,1.6100212471697146,0.08140389109457714
49699,SIDM00954,PF-4708671,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-0.66109574,-0.027919436,0.8850542751237487,0.0738836902318354
106511,SIDM00971,Temozolomide,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.8428757,-0.0378978,-1.045038879065389,0.012033852964508636
44493,SIDM00411,Crizotinib,Trametinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.5337893,0.03131149,1.8919443530050002,0.10327939429034619
52308,SIDM00411,MK-1775,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,43.0,2.0681403,0.13274398,-1.0725915214547066,-0.010708894628114573
38751,SIDM00893,Axitinib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,4.38756,0.33694088,2.432224981423413,0.26021986584989076
17915,SIDM00893,AZD6482,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.1058831,0.07548938,-0.051189378962106305,0.019461853581951145
13244,SIDM00146,GSK269962A,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.2727456,-0.0841983,-0.14677231096498713,0.02431072742086209
61645,SIDM00660,AZD7762,Taselisib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,32.0,-0.3832977,-0.03681553,0.07435835230845807,0.01208393052341651
33720,SIDM00875,Afatinib,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4229264,-0.101230524,0.2318649364008895,-0.023450756302348476
61395,SIDM00673,Sorafenib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.7185726,-0.04465246,-0.9818311618469346,-0.05769927760214977
104523,SIDM00866,Palbociclib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-0.13981497,-0.0035597235,1.9411164859820853,0.09725270378321324
27289,SIDM00660,Dabrafenib,Nutlin-3a (-),Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-0.41115335,-0.04529166,0.4447056832005269,0.009650342178228933
57838,SIDM00193,Palbociclib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.5088212,-0.064816505,0.2223590056558015,0.04442596864639076
76979,SIDM00875,Gemcitabine,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.27333945,-0.00046173434,-1.4049738251045465,-0.05220617457728045
68706,SIDM00893,ZM447439,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.66852236,-0.049762975,0.6114990746451567,0.11727332521573919
78250,SIDM00893,Temozolomide,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.5876731,0.01686818,0.3688625195599989,0.03611949250886561
59464,SIDM00878,Tozasertib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,70.0,0.52604926,0.046447054,-1.6022296450249327,-0.05836326413620296
103231,SIDM00332,PD173074,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7071617,-0.17896803,-2.036867296205704,-0.08802820817808589
70173,SIDM00893,Gemcitabine,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.06845127,-0.0063894503,-0.9201897579845866,-0.01862140432937379
60166,SIDM00782,Taselisib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.953973,-0.16550288,-0.8586986125769521,-0.062350402924441994
94836,SIDM00301,Ruxolitinib,Dasatinib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,50.0,2.0096116,0.093054116,1.5910763631668159,0.060884625553619884
23766,SIDM00779,MK-2206,Trametinib,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,33.0,2.1700814,0.14149721,0.3394811653921368,-0.0015057586086915868
82075,SIDM00673,Afatinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.8924242,0.071702026,-0.3318975510629328,0.02904306885104792
77176,SIDM00774,Camptothecin,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.836425,-0.11680587,-1.4203784847940675,-0.07322930535451093
54469,SIDM00954,Axitinib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-0.6966398,-0.047518194,-0.1662661745684763,-0.005252932790434804
77536,SIDM00875,Cisplatin,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.6358545,0.14581753,2.1243869229584607,0.023266863267268414
25753,SIDM00411,Lapatinib,Trametinib,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,43.0,3.3880892,0.14870542,3.0428403560635244,0.11574070445458637
73174,SIDM00359,MK-2206,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.7277682,0.11521893,1.1715269691278722,0.05456199103218912
64102,SIDM00097,Docetaxel,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0708401,-0.1339459,-1.0108588664114335,-0.07159600667553477
5820,SIDM00673,5-Fluorouracil,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,1.5647961,0.090907685,0.17540973903168958,0.028501534931966572
28339,SIDM00878,Palbociclib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-1.3074279,-0.07872089,0.2556052472286018,0.0011197786103477746
102963,SIDM00529,Temozolomide,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.046325,0.0064473096,1.0557532301018466,0.045162068838262924
105969,SIDM00779,Taselisib,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.6712414,-0.14102185,0.09902963190046431,-0.043783847634742364
82056,SIDM00774,Luminespib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,48.0,-0.14498705,-0.012891668,-0.6533727358634278,0.018317873776763784
91329,SIDM00971,Pictilisib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.7076496,0.03543734,0.1512723063464523,0.02569369042129853
53993,SIDM00628,5-Fluorouracil,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.5153965,-0.027723636,-0.02147594279389972,0.05435714147219023
7095,SIDM00866,Nutlin-3a (-),Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,2.244271,0.09639239,0.35505233967965716,0.009722124656046827
93032,SIDM00531,Ruxolitinib,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.3309757,0.05544239,1.4798969924156578,0.030884998254121405
15856,SIDM00193,Navitoclax,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.74457306,-0.049977243,0.5048160141245764,0.027575334589941995
9853,SIDM01233,Navitoclax,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,0.44823438,0.025599819,1.068183011259965,0.02607681735687674
81262,SIDM00301,OSI-027,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,-0.7740467,-0.10848471,-1.2663095024600688,-0.04174094947731567
94646,SIDM00673,Taselisib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-3.8359737,-0.21510553,-1.6162715332217374,-0.17106609662899952
103050,SIDM00146,Trametinib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.0202539,-0.07307275,-0.9973858601085477,-0.07738321399097758
19940,SIDM00130,Crizotinib,Navitoclax,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.5507083,0.23247197,3.411240968975747,0.21165755452042317
90053,SIDM00673,Crizotinib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.7142166,-0.06342354,-0.6170174076804594,-0.0021386801293199168
13480,SIDM00782,SCH772984,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,1.43775,0.11970864,0.5802265590270925,0.016304016615106002
70941,SIDM00971,Entinostat,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.52542645,-0.015280647,1.4798307439687648,0.06123436974996831
30254,SIDM00529,Gemcitabine,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-4.0835156,-0.19226885,-2.363841938712411,-0.0467417583413693
42641,SIDM00954,Vorinostat,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,-0.98420066,-0.07806264,-0.3934739730359689,-0.055796649021096614
62353,SIDM00878,Nutlin-3a (-),AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,0.7721688,0.011141028,0.3799633535598949,0.028804088305801886
91733,SIDM00878,Axitinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.8860953,-0.229112,-1.3455536979737894,-0.1205885064455537
65458,SIDM00971,Nilotinib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.0389489,0.05236246,0.13607736705230597,-0.016533502410297822
100573,SIDM00146,ZM447439,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,1.398252,0.12518403,-0.04626113238724155,0.024699817918655248
39913,SIDM00778,Trametinib,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,0.9256586,0.028460704,2.966244684156932,0.027443799548397683
75246,SIDM00866,Luminespib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-2.1190267,-0.1335612,-1.6202797707875978,-0.05476945351323717
76330,SIDM00529,Nilotinib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,2.4249208,0.10114346,1.7239248494329882,0.11012802957602727
87024,SIDM00130,5-Fluorouracil,Irinotecan,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.2983239,-0.08445098,-2.262390906289339,-0.10633714657722776
55308,SIDM00411,Gemcitabine,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,43.0,-2.782084,-0.14040561,-2.0865468708813326,-0.07543558616384188
56924,SIDM00146,Bortezomib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.30093452,-0.019123157,-0.17412523023478513,-0.02509766263227229
23639,SIDM00531,Sorafenib,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.67753756,0.09103352,-0.6453731441513436,-0.027253145026729403
24662,SIDM00954,Pictilisib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.0,-1.0445977,-0.051349893,0.9015431431302123,0.08042494683609493
47123,SIDM00529,GSK269962A,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.0233425,-0.07833817,-0.9559574180163848,0.003213034644555893
3185,SIDM00778,Linsitinib,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,69.0,-0.7272074,-0.039793383,-1.0604740751745816,-0.0374116036225168
31726,SIDM00193,AZD8055,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.2171212,-0.07876681,-0.4045418069150841,0.014091120018763238
105526,SIDM00097,Wee1 Inhibitor,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.982307,-0.1158208,-1.6037168005420397,-0.11827566456556911
90389,SIDM00146,RO-3306,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.44040433,0.036289137,0.6913273729527277,0.04953593433352914
86666,SIDM00411,SCH772984,Sorafenib,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.1738908,-0.041507855,-0.5222477721243342,0.005043054954322657
46356,SIDM00332,Palbociclib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.1140115,-0.09474414,-1.5683838737290428,-0.1280600415436648
89731,SIDM00774,Venetoclax,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-0.5720941,-0.012200599,1.9110691724565683,0.0373639056546399
27660,SIDM00628,OSI-027,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,1.1807281,0.09787084,0.7526505096969138,0.058949252590526004
30872,SIDM00776,Navitoclax,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.6127815,0.034767777,1.3363774619822337,0.07332055466431601
41355,SIDM00529,Doramapimod,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,0.65582067,0.025228614,0.9679208193133065,0.04434208493432451
89767,SIDM00954,Venetoclax,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.9527055,-0.070693254,-0.4522783129071076,-0.014669809649492625
6883,SIDM00097,PF-4708671,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2908373,0.06025377,0.2738904789527017,0.0032012675706370084
83872,SIDM00774,Gemcitabine,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,2.8736508,0.16406406,2.163336780527383,0.049558652621199586
60972,SIDM00097,Navitoclax,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.881163,-0.04470552,1.7170722973788268,0.10804408925033004
92246,SIDM00893,Wee1 Inhibitor,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.61052394,0.053262983,-0.10997020488010818,-0.0035125450587919246
37011,SIDM00866,AZD7762,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,52.0,-0.2637921,-0.017701253,-1.907099476965092,-0.050158953992426765
44675,SIDM00301,5-Fluorouracil,MK-2206,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,50.0,-1.8361645,-0.21076876,-0.6231117148394717,-0.02388761675922158
84930,SIDM00778,AZD7762,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,69.0,-0.47053474,-0.016337462,-0.6316003182397899,-0.038357759993832306
88033,SIDM00660,5-Fluorouracil,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,1.366609,0.12565935,-0.7583848869946649,0.021461362763797086
83071,SIDM00146,Cisplatin,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,2.2453072,0.11107002,4.282519111771403,0.2850582157013755
70765,SIDM00332,Lapatinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7498021,0.13759726,1.5036944812135664,0.1315739139050537
107011,SIDM00878,Linsitinib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,1.0691485,0.07328669,0.9002260771378876,0.04611044077999723
70877,SIDM00332,Vorinostat,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.2507718,0.14513032,0.2791397621684043,0.06610161149333178
74141,SIDM00778,SB505124,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-0.91381735,-0.03880034,-0.5442557210510335,-0.031141870039176425
69958,SIDM00359,Oxaliplatin,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.782173,-0.11549777,-1.3092151174715578,-0.05791446416289744
43956,SIDM00878,Gemcitabine,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,70.0,1.7865199,0.17237166,0.10085646321766208,0.02085939019270155
96765,SIDM00529,PD173074,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-2.5224764,-0.1018868,0.5881521166532844,0.036227631759970944
8414,SIDM00866,Uprosertib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-2.2836673,-0.09508397,-1.1411157019865839,-0.026965126492222553
74390,SIDM00774,Afatinib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.79222447,0.054952774,-0.09574958354080469,0.0710628256138156
63164,SIDM00531,Ruxolitinib,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.0482569,0.20512319,0.22891874342595853,-0.014116227563209375
27848,SIDM00411,Gemcitabine,Taselisib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,-0.9516059,-0.044446893,-0.44213195687925294,-0.010798189655596088
78221,SIDM00774,Trametinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,3.993983,0.16766246,3.4740063658528886,0.07377199217885294
21233,SIDM00971,Luminespib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.3228645,-0.10634043,0.33829177652551967,0.01492643294618261
10802,SIDM00130,LGK974,Crizotinib,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.1394982,-0.1085864,-2.289824043501873,-0.0536655714594344
45222,SIDM00359,Palbociclib,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.533413,-0.028996173,-2.6179192007012855,-0.05428094366809461
61078,SIDM00628,MK-2206,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-1.9826046,-0.123076834,-0.6297529076488618,0.03787960680560492
48243,SIDM00866,Camptothecin,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.4258585,0.032031544,2.4778998096728584,0.06525577378681421
87710,SIDM00779,Afatinib,Nutlin-3a (-),Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-0.69259703,-0.06311351,1.1432912727782074,0.06772774293807507
24713,SIDM00875,Lapatinib,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1637872,0.020163035,0.7856791748004207,0.011870185384712543
80963,SIDM00971,ZM447439,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.301802,0.13569784,-1.6124399820938804,-0.05839953512655647
44964,SIDM00628,Nilotinib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-1.0242033,-0.096122,-0.5169544413997593,-0.05550276034234241
77977,SIDM00411,Crizotinib,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.8754492,0.05614645,0.2849108818662571,0.010409905130489793
24823,SIDM00954,Sorafenib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,0.46679637,0.03483306,0.13938720511975802,0.012145214267161315
2596,SIDM00776,Dabrafenib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,4.218741,0.105035275,-0.2959664253714473,0.008640950454147483
54032,SIDM00628,SCH772984,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,1.3648555,0.11380668,-0.020258629102004794,0.017981314995545675
1891,SIDM00779,Vinorelbine,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,33.0,-2.384496,-0.17521882,-0.6842654711088272,0.007440744785476681
44897,SIDM00866,Afatinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-1.8887208,-0.14054056,0.6383566630214075,0.09373663558668696
100547,SIDM00776,Dabrafenib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.211177,-0.06842761,-1.328213794052286,-0.025675319963124478
80143,SIDM00130,AZD7762,MK-2206,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.3559481,-0.028851148,-0.6599797983361737,0.00013724465766559778
3823,SIDM00782,Oxaliplatin,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-2.6799312,-0.1037369,-1.2033860413630626,-0.03481785705570412
60140,SIDM00332,PF-4708671,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,3.7745583,0.1804936,1.7884563333433308,0.07275889903391702
29308,SIDM00954,Ribociclib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,6.433597,0.090386435,1.3765363100483456,0.02904100304736884
59965,SIDM00301,Gemcitabine,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.80317867,0.059247777,0.48422382494706473,-0.006134089305904322
15668,SIDM00875,Luminespib,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.49056804,-0.04404227,-1.6540061964400865,-0.06303482606330751
90471,SIDM00774,BI-2536,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.7485316,-0.049628947,0.35941767941482916,0.04203898576957889
76262,SIDM00332,Doramapimod,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.69921786,-0.052734684,-0.7258140902105861,-0.03649032984806056
82747,SIDM00893,Paclitaxel,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-3.9392905,-0.33866125,-3.067524203995875,-0.24707049512643303
43573,SIDM00875,AZD6482,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.7983577,-0.105522744,-0.6940345782319014,-0.04635433449344123
33834,SIDM00954,MK-2206,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.983904,-0.14320114,0.2419820420381698,-0.01771496426319203
84640,SIDM00971,KU-55933,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.9112198,-0.025533818,1.0595293514922781,0.02583278485133517
45282,SIDM00531,Gemcitabine,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.064089246,-0.005563331,-1.9546819923242502,-0.13489652332073687
50353,SIDM00332,AZD6482,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9865272,-0.064818926,0.9788504493256917,0.04999977887505892
25643,SIDM00359,Olaparib,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.9490008,0.100196466,1.0802371986913553,0.017950254267706387
24700,SIDM00146,Docetaxel,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.7382537,-0.071123496,-0.13688441821925995,0.08074421062720079
94949,SIDM00776,Palbociclib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,-1.9154015,-0.0524822,-0.5059266244530644,-0.02604130597962541
74489,SIDM00866,Palbociclib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,0.7933167,0.025132934,0.5020919480236862,0.041027834361509675
92012,SIDM00332,JQ1,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,3.3082092,0.18435924,-0.17860529417348414,-0.016154432710962396
76195,SIDM00776,Dabrafenib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-1.0602336,-0.034817018,0.4711244574806077,-0.007386339466372457
86720,SIDM00878,Vorinostat,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.78644955,-0.09602478,-0.33937308240273484,-0.04222946560302875
32186,SIDM00660,Crizotinib,Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.5690355,0.05006308,-1.1439364617481662,-0.09376077759334459
104472,SIDM00774,Taselisib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,6.573666,0.050868474,-0.6015047010933754,0.028814591601238972
85187,SIDM00954,Lapatinib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.3608435,0.019400746,0.03018574091162395,-0.037639329880845354
52821,SIDM00529,Afatinib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Black,44.0,1.414559,0.11636535,-0.13254490506173136,0.009476360331073174
95778,SIDM00834,Vinorelbine,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,White,66.0,-2.5298803,-0.106529616,-1.6101655518044955,-0.0332093361429333
91467,SIDM00660,AZD4547,Crizotinib,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,32.0,1.7222313,0.1479776,0.6038037132189986,0.07923400558184432
98813,SIDM00866,NU7441,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-0.15924892,-0.011895964,0.1846101160438712,0.06817931793549127
102816,SIDM00866,Lapatinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-0.811351,-0.069565885,-0.9285334398892567,-0.037535460151224186
45288,SIDM00673,Ribociclib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-2.1538954,-0.064452685,0.05994373788557469,0.023600477810598573
59450,SIDM00130,Paclitaxel,Erlotinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.3730142,-0.08898176,-0.7487651836271244,-0.024964256020276493
70126,SIDM00411,5-Fluorouracil,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.7348991,0.028486267,-0.2059552433314274,0.00238033281989326
31447,SIDM00776,Taselisib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,1.9267246,0.09620738,2.088782399190351,0.09803268697469127
103006,SIDM00971,Nilotinib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.47759312,0.03274945,0.7816412233189625,0.06070326681184835
60456,SIDM00971,MK-2206,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.0383524,0.067712754,0.18286706831867813,0.058972277505464896
59405,SIDM00779,Oxaliplatin,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,-2.6936343,-0.052537974,-1.6235105644797205,-0.06963221274324229
13075,SIDM00529,JQ1,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,1.921553,0.16274557,1.5265517027144258,0.09449681569534037
17871,SIDM00097,AZD8055,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.73647994,-0.05441006,-0.12698071278370518,-0.04224151026915601
100250,SIDM00971,KU-55933,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.9810257,-0.027412808,0.8625360391375776,0.0030011841369636367
34653,SIDM00875,BI-2536,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.865686,-0.18455909,-0.8394865897859347,-0.02775449742459145
65216,SIDM00866,Docetaxel,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,0.5251083,0.045630977,-0.9019815706705764,-0.05225842384736509
28945,SIDM00778,Olaparib,Navitoclax,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,-3.1559656,-0.08340538,0.875700888505164,0.04135995756835675
105305,SIDM00954,MK-1775,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.0,-1.1289254,-0.08706412,-0.8031134487756434,-0.06894988569497537
56237,SIDM00778,Dabrafenib,Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,1.8047864,0.044282608,0.9014638032969498,0.03666767556188036
51402,SIDM00130,LGK974,Oxaliplatin,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.23316,-0.085272,-2.3479921064726414,-0.049278527267946556
51485,SIDM00776,Nutlin-3a (-),Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.2008593,-0.030646058,0.21165818492739744,0.03140429167734246
52612,SIDM00332,Bortezomib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.9454958,-0.14247864,-0.5224272978789927,-0.039331370567047386
69611,SIDM00332,Linsitinib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.97823673,-0.030586453,2.572660612701823,0.08033905434752635
57722,SIDM00971,Camptothecin,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.904342,0.085630514,1.9364937507190156,0.0816279633315318
90203,SIDM00660,Camptothecin,SCH772984,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,32.0,0.5852709,0.047371265,0.2585326101698748,0.023873012196899523
11285,SIDM00893,ZM447439,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.83509344,-0.061376166,-0.9856395515825795,-0.08058258949542897
24392,SIDM00673,Nilotinib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.6636206,-0.026541974,-0.6656777162594405,0.01483008171290677
93743,SIDM00779,Crizotinib,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-0.6094007,-0.047041953,-0.17701653669861694,-0.025593567307522287
10220,SIDM00866,ZM447439,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,1.1342138,0.04508933,0.5465112779124746,0.038440155125754424
29116,SIDM00660,LGK974,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,1.0800685,0.032454483,0.21674973823865554,0.05185343584264041
30892,SIDM00779,AZD8055,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,1.5134681,0.13211517,-0.5895330593606025,-0.023917079715129443
98350,SIDM00673,OSI-027,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0153865,-0.100953065,-0.39631176215103686,0.007933623968566096
81691,SIDM00776,LGK974,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-1.1795594,-0.04375197,-1.5128240593174234,0.011894339586136508
50495,SIDM00673,Sorafenib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.9902188,-0.048223708,-1.5642071190754905,-0.04933385274556636
55378,SIDM00097,Lapatinib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.43955368,0.029364241,-0.24989202532021496,-0.017450632026905905
33429,SIDM00776,SCH772984,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,-1.3548057,-0.111653976,-1.7327386305624488,-0.09945660705096686
17227,SIDM00779,AZD7762,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,0.74331856,0.042393483,-1.1998637346156384,-0.06263658621170398
65633,SIDM00776,MK-1775,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-0.5344266,-0.030850189,-0.6717993436401982,-0.05349110090349111
64636,SIDM00332,Nilotinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8175321,-0.06407477,-0.014695849132169618,-0.011784012131787832
45012,SIDM00774,Vorinostat,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.15799089,-0.01148012,-0.08688971876873484,-0.036628303423913475
19203,SIDM00778,SB505124,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-1.8753614,-0.05316299,-1.7845422988682722,-0.0917705649304371
36990,SIDM00193,Afatinib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,53.0,0.50775224,0.044747457,1.194794100196564,0.07418096771060315
59735,SIDM00782,Afatinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,3.3397954,0.13457811,1.2253188098935068,0.08308377362461541
88167,SIDM00628,Nilotinib,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,0.7227072,0.06962454,0.11668987277326091,0.018984336065348325
11657,SIDM00893,MK-2206,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.547095,0.1331956,0.7835815339278129,0.12752134415483804
1959,SIDM00301,Ruxolitinib,SCH772984,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.7676595,0.06675228,1.2041668547538764,0.03952952062336809
94241,SIDM00097,SCH772984,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.4806824,-0.02555156,-1.219720939700862,-0.09217829912188086
81659,SIDM00097,JQ1,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6191906,-0.08174611,-1.4077932660081116,-0.07812714059798861
66056,SIDM00878,Temozolomide,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-0.5873256,-0.015174118,0.0673389028975287,0.008710335679085862
100555,SIDM00673,Linsitinib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,0.5247148,0.010801463,2.538991476202645,0.0071584217532726655
93752,SIDM00130,Sorafenib,Oxaliplatin,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.0025039,-0.13473183,-1.5936662571754046,-0.061134903269233036
38234,SIDM00866,Olaparib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,52.0,-1.1060083,-0.024637043,-0.2789930647250698,-0.0012423553551168484
89887,SIDM00834,Nutlin-3a (-),AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,4.23589,0.20975137,0.5883627056510443,0.05315047609293874
85995,SIDM00971,Vorinostat,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.602711,-0.029547708,0.6200037292324656,0.06488853048576226
77486,SIDM00332,Navitoclax,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.1324904,0.0889013,1.568608220166349,0.07412145670977353
95115,SIDM00774,Entinostat,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,2.2064617,0.10448519,3.6851212413761525,0.1156424107719873
14159,SIDM00971,Wee1 Inhibitor,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.7812855,-0.020950224,0.9983655345464418,0.02011113648201931
38852,SIDM00971,Dabrafenib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.8548326,0.06784846,1.4055030524216994,0.06208191159632036
63684,SIDM00097,AZD8055,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4677482,-0.09894882,0.43724576728558096,-0.007828429451739066
57863,SIDM00146,Camptothecin,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,2.4333284,0.19782208,-0.7125876751652312,-0.02183145544092101
97735,SIDM00893,Doramapimod,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.7631955,-0.026249044,0.10751476859489267,0.00040272919438408787
74530,SIDM00097,Crizotinib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1343162,-0.10925364,-1.4532051595157356,-0.06995895369302596
84714,SIDM00875,PF-4708671,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.2697387,0.12057127,2.049741792374571,0.05659373535813275
94551,SIDM00301,Dactolisib,Gemcitabine,Pancreas,0.1,Pancreatic Carcinoma,Male,East Asian,50.0,-2.8984764,-0.098714724,-1.72047598458755,-0.07413426281021158
18538,SIDM00875,BI-2536,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1279204,-0.043660235,0.8265414383125267,0.014683797784432902
45610,SIDM00130,Dasatinib,Palbociclib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.8528674,0.06857418,0.3784614847278441,0.06441677372431678
58565,SIDM00097,GSK269962A,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.5090782,-0.019110804,1.1236735970244982,0.04128298258723815
44957,SIDM00531,Olaparib,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.9199185,0.100579664,0.0362371738421695,0.0022367185089615816
49733,SIDM00097,Paclitaxel,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.3904953,-0.23177853,-3.3229689582185573,-0.2737522969455712
102047,SIDM00875,Axitinib,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.6672425,0.054248653,0.095048831257855,-0.02242099367687511
33953,SIDM00782,Navitoclax,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,Unknown,72.0,-1.4100703,-0.13119718,0.5376710650551215,0.06698591290300548
55758,SIDM00097,Ribociclib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.4308681,-0.0639256,-1.3598461286472483,-0.04276515842749977
42101,SIDM00878,Sorafenib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.9202874,0.16565277,-0.7190310452260508,-0.006077138432264769
92466,SIDM00875,JQ1,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.822636,-0.09893611,0.7936333491932647,0.026307364461029388
25830,SIDM00146,NU7441,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,1.4258418,0.103929594,0.5860576786981364,-0.0018977143662364658
62234,SIDM00954,Paclitaxel,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,-0.6544744,-0.05323651,-0.7878689418551375,-0.06694738101439769
106334,SIDM00359,Vinorelbine,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0357869,-0.053485624,0.04992712518159993,0.07299295608738186
20304,SIDM00673,MK-2206,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,2.4034712,0.097883455,0.8007281075096413,-0.003926227477056293
46956,SIDM00531,Dactolisib,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.1279228,0.19173431,-1.7980030225284402,-0.08005801121901894
18582,SIDM00971,Pictilisib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1965256,-0.05296239,-0.7685490254054206,-0.04928230516301878
91028,SIDM00146,Ribociclib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.6013954,-0.038378343,-0.820851951399766,0.021923719057191777
24593,SIDM00628,Doramapimod,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,3.2791157,0.15271609,2.5875200305363837,0.0986223131737812
70350,SIDM00097,Doramapimod,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.843926,0.05790474,2.0034704493180664,0.056418500552942334
83683,SIDM00359,BMS-754807,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.42324814,-0.037603054,-0.9815716999663535,-0.02105099221312293
38949,SIDM00332,Dabrafenib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4577514,-0.08154835,-0.7343527656102545,0.0037879633340570794
95722,SIDM00971,Bortezomib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.4529982,0.079171404,0.5566255769653575,0.06728570085582615
49888,SIDM00628,Bortezomib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,1.1014813,0.03735278,0.9246503519674317,-0.002370000923498419
80967,SIDM00529,Venetoclax,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.7572387,0.008938604,0.7897612069450375,0.022337236937473214
37487,SIDM00875,PF-4708671,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6022069,0.02902149,-0.483714332540843,0.024871699108066577
40845,SIDM00146,ZM447439,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.8223244,0.1669364,-0.21114778316412822,0.016176964944932686
46769,SIDM00971,Navitoclax,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.3277682,-0.008630661,0.07608604176300907,0.0677130690650832
52621,SIDM00954,GSK269962A,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,0.50897336,0.043506213,-0.6188162450388658,-0.04051002713136321
91436,SIDM00893,Entinostat,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.7041801,0.038606137,2.032166035922753,0.01548454960898767
47716,SIDM00954,Docetaxel,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-0.91428083,-0.045622647,0.877609321981112,0.043145308587862675
60889,SIDM00332,Luminespib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1905018,-0.09543147,0.40719788397845297,-0.01840326752046023
26785,SIDM00971,AZD8055,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.50038266,0.030410524,-0.5155885450661566,-0.036857400463602696
67101,SIDM00097,SCH772984,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.1754124,-0.0901677,-0.45592621973586167,0.01560893157551202
6203,SIDM00097,Temozolomide,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.7706302,0.013791699,1.0938828547451172,0.024436771242058567
71810,SIDM00673,Paclitaxel,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-4.8070397,-0.25740427,-2.507348244637743,-0.09571166675007939
7047,SIDM00782,Crizotinib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.20616075,-0.018892681,1.331897230600332,0.07640809234474452
89781,SIDM00875,BI-2536,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,6.479431,0.08567329,2.311409665076151,0.07018594015953793
97756,SIDM00673,KU-55933,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,-2.757369,-0.13752392,-1.5049198347410133,-0.03719233062914142
55898,SIDM00193,LGK974,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.9668252,-0.08905022,-0.5019798166265766,0.03476796055062535
103052,SIDM00097,Luminespib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1155372,-0.05960429,-0.532708943184935,-0.033554833701394254
15016,SIDM00971,GSK269962A,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.34062827,-0.020152863,-0.8169443531554265,-0.024169773396077752
47211,SIDM00866,Docetaxel,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-4.567874,-0.23801988,-3.5963017575387344,-0.23414348812904712
94430,SIDM00130,OSI-027,Oxaliplatin,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.4190097,-0.19794427,-1.7797817675955498,-0.1090931952588292
58929,SIDM00774,Palbociclib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,48.0,0.8666726,0.03620418,0.5963019466585885,0.03728090668880872
99096,SIDM00971,Venetoclax,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.9701261,0.017396767,0.14644645257734049,0.01923640277165954
36899,SIDM00866,AZD8055,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.2167422,-0.035313167,0.6692955810410399,0.03658648625734073
74423,SIDM00531,AZD7762,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.75188017,-0.04308167,-0.34435479204357167,-0.005727060916319539
99066,SIDM00954,Crizotinib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.59792256,0.04177379,0.7122022463099177,0.094832125833418
43682,SIDM00628,Cisplatin,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.1229557,0.011549436,-0.21911507935039265,0.01564511134027514
1105,SIDM00834,Palbociclib,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,2.8098507,0.19223526,-0.8276547262302018,-0.041804862132404634
51186,SIDM00411,Ruxolitinib,LGK974,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.9843998,0.018733302,0.9077129292932555,0.021961564265621878
99913,SIDM00878,Venetoclax,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.8088901,0.082334764,0.6056807990658406,0.061349589243185475
21747,SIDM00866,Alpelisib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-3.664057,-0.19983888,-1.1196548437157847,-0.054090827900442694
91938,SIDM00782,Dabrafenib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.54040277,-0.014137847,0.9875300161867737,0.03019897001950236
45676,SIDM00782,Oxaliplatin,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,0.22212976,0.014970524,0.40893904429315314,0.05282533921949444
99094,SIDM00529,Gemcitabine,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Black,44.0,3.1568062,0.039390344,-0.39091241842881114,0.025626596408651493
63963,SIDM00628,Docetaxel,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,0.4398293,0.036242012,-0.6568167139600818,-0.04821269544365109
54985,SIDM00893,ZM447439,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.3734453,-0.16386685,-1.6737237072431232,-0.10160542330405098
86072,SIDM00878,Bortezomib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.20364352,0.0027723846,-0.3270778896967135,0.03309024352377278
12171,SIDM01233,Oxaliplatin,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,72.0,-2.8278997,-0.1680268,-2.0650220159263943,-0.1327320774092005
34109,SIDM00875,Alpelisib,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6211582,0.059607547,-0.2815258290249681,0.04102191895509479
25668,SIDM00628,NU7441,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-0.20547059,-0.01956994,0.0753211263690211,0.004517629333309411
23275,SIDM00628,Alpelisib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.6636384,0.04105745,0.07766130543991262,0.0659662920179932
9642,SIDM00971,Wee1 Inhibitor,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.4401207,0.053390082,1.5942590993152608,0.05065297741066579
64037,SIDM00971,KU-55933,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.4830539,-0.02181777,0.65083524087069,0.03255373906097107
63132,SIDM00971,Venetoclax,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,9.753442,0.27487913,2.677316989462708,0.07489072390588744
50476,SIDM00146,Lapatinib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,0.9862893,0.08609816,1.4491301813998323,0.10658817146528808
95899,SIDM00660,Navitoclax,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.79665935,0.08289622,1.4578206703983065,0.06368827265913629
26623,SIDM00774,SCH772984,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.2997477,0.03516668,1.042995088213293,0.08285117580572006
90110,SIDM00660,Taselisib,SCH772984,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,32.0,1.2495632,0.12302291,1.6865608252960826,0.08513902013990785
10784,SIDM00130,AZD7762,Irinotecan,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.044975,-0.04986045,0.851874983093997,0.08061540261981341
67506,SIDM00628,Uprosertib,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.22465268,0.012966623,-0.3624007929758065,-0.023485050601400066
72398,SIDM00834,MK-1775,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,1.0683306,0.075409286,1.230734226323526,0.048803352033892994
50364,SIDM00411,Dactolisib,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.979079,0.05083285,0.4897094146306064,0.02540888432970175
20455,SIDM00146,Venetoclax,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.18941003,-0.0044895303,2.862967528181663,0.1153066274623415
45119,SIDM00778,Afatinib,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,3.0469642,0.123032585,0.5859335291048694,0.026346024614420604
31410,SIDM00878,PD173074,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.3245784,-0.121491246,-0.33308597853141,0.01859315559186739
25173,SIDM00332,Trametinib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3347064,-0.13002725,-1.1930853416671066,-0.09158506450462019
34167,SIDM00531,OSI-027,Crizotinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.6301694,-0.028161902,3.32429535176552,0.13493373732670505
182,SIDM00893,Alisertib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.6678921,-0.048411738,-0.6924090385832381,-0.09194706001700263
96431,SIDM00954,NU7441,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.0,0.27909032,0.01939945,0.25869085762500704,0.052310624504757125
89273,SIDM00097,AZD8055,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6839616,-0.123897955,-1.6908894644990915,-0.1302987316418617
75541,SIDM00779,SCH772984,Trametinib,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,33.0,2.6198304,0.11054181,-4.027738069166146,-0.17070570401508336
76015,SIDM00529,RO-3306,Olaparib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.41561458,0.015490466,0.4394303416334033,0.058287544726678076
55627,SIDM00359,5-Fluorouracil,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.2065017,-0.109119646,-2.148244601894532,-0.07395724768233222
9423,SIDM00411,AZD7762,MK-1775,Pancreas,0.2,Pancreatic Carcinoma,Male,East Asian,43.0,3.2030473,0.16912624,2.3925319701756558,0.08541096690519702
75413,SIDM00529,Taselisib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.0045594,0.07252886,-0.8576540434502381,0.01810533333765619
18506,SIDM00971,Temozolomide,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.3455002,-0.047524065,-0.8221110386619196,0.000598172774155644
22409,SIDM00893,Nutlin-3a (-),Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.85776865,0.023652108,2.0713353326721355,0.020515573704093463
51090,SIDM00193,Dabrafenib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.88949037,-0.018237825,0.6752664362114765,0.049935219333309626
64278,SIDM00954,Gemcitabine,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.9506172,-0.07542745,-0.5395172733241147,-0.0005985352719610395
76512,SIDM00529,Entinostat,Luminespib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-2.1360416,-0.10648068,-0.4687094864229761,0.009948527750848193
79524,SIDM00146,Paclitaxel,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-1.5354364,-0.1253448,0.020691269122431546,0.006611200253893315
77985,SIDM00097,SCH772984,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1096293,-0.05725987,-0.22348291137763138,-0.045587470597449296
58425,SIDM00878,AZD8055,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-0.8168084,-0.063426666,0.4694281293337689,0.0190078196164592
51620,SIDM00130,Ruxolitinib,Navitoclax,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.4110343,0.084665194,2.511826478988806,0.086784054187291
48660,SIDM00673,Entinostat,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.66021115,0.053790238,-0.49933393062972836,0.012511631345337438
22683,SIDM00782,AZD8055,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.344857,-0.027180163,-0.4371312215472994,-0.03839874176048888
30871,SIDM00954,NU7441,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-1.2694677,-0.08897662,-1.34512747813635,-0.04799552205203517
97671,SIDM00893,Paclitaxel,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.304771,0.085114606,-0.43259486386434154,-0.010607264658297267
42598,SIDM00875,Nutlin-3a (-),Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4262651,0.059212044,0.36385396674676107,0.03761970403827046
93128,SIDM00774,Gemcitabine,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,0.9468359,0.06699249,2.2300571684774217,0.09657559128061102
66892,SIDM00866,Docetaxel,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,52.0,0.79802424,0.06614037,0.18098123378685027,0.013679269345474365
61400,SIDM00954,Axitinib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-0.6412589,-0.049244497,-0.4407885789078643,-0.024355117842258387
8099,SIDM00878,OSI-027,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,1.0371941,0.10963736,1.1647846023296453,0.1234866233209966
82581,SIDM00411,Navitoclax,Trametinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.492512,0.14415114,0.9211066820244782,0.05684956956570605
25771,SIDM00778,5-Fluorouracil,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-3.4420097,-0.1036649,-1.4325890119187839,-0.03954970169713861
79891,SIDM00866,Uprosertib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-1.9051468,-0.086406715,-0.7781632271041781,0.050739340134184345
41030,SIDM00332,Crizotinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7028486,0.15822281,0.8052119119082488,0.07648941861540588
37514,SIDM00954,Ribociclib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,1.6449529,0.060960684,0.2942222033925318,0.10549392667805392
87685,SIDM00130,MK-2206,Crizotinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.518912,0.049116306,-0.7884200669783007,-0.018349699336996393
107177,SIDM00878,JQ1,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.3439417,-0.11474653,-0.0810908864636599,0.036789391931030785
47157,SIDM00146,AZD6482,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,2.4411733,0.18966198,0.4405852181317704,0.1266180906415181
19498,SIDM00875,Taselisib,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.7818184,-0.10738003,-1.1437527408524877,-0.08973820588495368
2156,SIDM00878,Olaparib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,0.87494147,0.015368871,1.8550954275172893,0.059204484495913666
18037,SIDM00146,Camptothecin,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.4813347,0.13578634,-0.4221260532968934,-0.052742418233235944
97478,SIDM00875,Gemcitabine,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.5894077,-0.0084700845,-0.9059824621688812,-0.022706635158882583
56792,SIDM00628,MK-2206,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.9020373,-0.073442444,-0.9254177421139178,-0.03762121497970975
428,SIDM00779,Dabrafenib,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-0.4034176,-0.006477067,-1.3685692274327566,-0.02566252232671559
23579,SIDM00097,Docetaxel,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.946598,-0.098901756,-0.3890007897048489,-0.03345362004212609
32978,SIDM00893,Cisplatin,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.0432557,0.02813767,1.2982680869691468,0.014016743727691764
38995,SIDM00782,Nutlin-3a (-),Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,3.724654,0.12393727,1.946703406702553,0.062248004444743044
60670,SIDM00130,Crizotinib,Taselisib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.04338392,-0.0037755514,-1.2013954752426856,0.0019350504024748063
41311,SIDM00866,Bortezomib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,0.32539794,0.026100675,-0.7034996397073996,-0.03926664983253302
74389,SIDM00875,OSI-027,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.76776665,0.06645418,-1.0903628191775878,-0.07991624353996125
41089,SIDM00146,Axitinib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.1869812,-0.07938615,-1.086997758845289,-0.02430811681026065
26515,SIDM01233,AZD8055,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,72.0,-0.65269345,-0.05053523,-1.4310478354203158,-0.14755013498806055
2470,SIDM00673,Entinostat,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.2041577,-0.09683703,-1.0257892466284797,-0.01908752798395216
8032,SIDM00971,Nilotinib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.40431824,-0.029050441,-0.07303412424202002,0.04700488443191181
32345,SIDM00301,Erlotinib,Ruxolitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.389924,0.07526792,1.3824360952575443,0.029977638496919562
52723,SIDM00146,Trametinib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,3.7106228,0.18087313,0.4798303038050543,0.05246746522040445
27875,SIDM00954,Alisertib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,1.1392106,0.08827332,-0.3236927296229981,-0.0903110395485624
20744,SIDM00529,KU-55933,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-0.88582623,-0.014878865,-0.5499315015358577,-0.03339658800779606
24163,SIDM00878,Cisplatin,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,2.3552783,0.11145722,1.1586739893037274,0.0709629055304178
41595,SIDM00893,JQ1,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.9808474,0.05310322,1.619624591118102,0.08693472361049512
56954,SIDM00332,Palbociclib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.0754828,-0.11797649,-1.3613638459342496,-0.1176177057389446
20845,SIDM00866,Temozolomide,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,-1.2735379,-0.020456443,0.8801140189227622,0.019547117120500303
44244,SIDM00332,Temozolomide,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.98869985,-0.017912038,0.935105373796111,-0.0163808376954905
16032,SIDM00673,GSK269962A,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.6843076,-0.12483665,0.6776023003804134,0.05025190380642258
2667,SIDM00146,Nilotinib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.7231032,-0.06759958,1.1697381358803671,0.039910895076854504
21930,SIDM00529,Gemcitabine,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,-4.756855,-0.21257807,-1.5868234175028242,-0.08121603893414947
79786,SIDM00097,RO-3306,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.64872515,0.03586821,-0.23126630908292706,-0.05269697816194407
57264,SIDM00673,Dabrafenib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,2.4264147,0.06630441,2.5610396579025045,0.09569130293952613
5819,SIDM00954,Navitoclax,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,1.8180368,0.045117628,0.4064922048003106,0.018152665824761854
46652,SIDM00529,OSI-027,MK-2206,Breast,0.25,Breast Carcinoma,Female,Black,44.0,0.91620016,0.08733514,0.7080532420298512,0.17155094247474761
44607,SIDM00673,Ribociclib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-2.0259323,-0.045875117,0.4474128642130008,0.05403771256789075
22973,SIDM00097,KU-55933,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.9398284,-0.056741394,-0.3143101482361758,0.002691290548479182
71565,SIDM00878,Crizotinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.22568414,-0.02258701,0.6666424024177022,-0.011780993357751854
70834,SIDM00971,Crizotinib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.4484465,-0.07317727,-1.4350551002859033,-0.014339450364948488
87966,SIDM00971,MK-1775,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.5695113,0.024072098,-0.7476678268017924,0.006505981082892705
38004,SIDM00878,Uprosertib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.109017916,0.005285231,-0.18946122453884753,-0.002499761330168358
9004,SIDM00301,Taselisib,Lapatinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.526712,-0.1604602,0.2180912107557877,0.03488140350908536
53418,SIDM00301,Navitoclax,OSI-027,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.8991147,-0.09939385,1.1097164668097883,0.05958630384991115
105770,SIDM00893,GSK269962A,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.8020114,0.062191874,0.02550124566045148,0.0588724977100031
29796,SIDM00193,Trametinib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.23030315,-0.015030624,-0.35950490566501925,0.012518333933816439
103994,SIDM00834,MK-1775,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,0.7523288,0.052564185,-0.13982823122729404,-0.012248347020644578
35018,SIDM00097,Uprosertib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.82663053,-0.05261377,-0.23618702310816636,0.0016217189767106417
5206,SIDM00332,Taselisib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,0.53371763,0.0455322,-1.4342714525603295,-0.0870911100373431
67429,SIDM00778,Vinorelbine,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-2.554051,-0.07526876,-1.4514443086697537,-0.05567921104821142
11594,SIDM00866,MK-2206,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,52.0,-1.3620347,-0.08618705,0.3653445852712055,-0.014898714322520717
33241,SIDM00531,Cisplatin,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.9555641,-0.07083929,-1.6201705742318242,-0.08485867258275784
49403,SIDM00146,Cisplatin,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,2.81395,0.110783115,2.101729943756995,0.0919224952583472
64960,SIDM00782,Palbociclib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.5092862,0.039303582,2.1581406846064746,0.07518254110608832
33003,SIDM00834,AZD4547,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,0.5791038,0.013949315,1.5680937521640652,0.06111935863197069
72871,SIDM00779,SCH772984,Taselisib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,2.299972,0.12230701,1.0624041981902417,-0.013207571246054916
58281,SIDM00834,Palbociclib,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,White,66.0,-1.9666531,-0.10993285,-2.366682624864571,-0.13180540686221334
80824,SIDM00130,Lapatinib,MK-1775,Pancreas,0.2,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.7664933,0.16730294,1.040875696411123,0.09465737469829359
46223,SIDM00097,Cisplatin,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2285591,0.026721219,0.5317881655614022,0.01627813677151922
64400,SIDM00529,Tozasertib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-0.95903414,-0.033324134,-0.5166659673947542,0.014549296422295976
5023,SIDM00866,Taselisib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.2313769,-0.08267459,-1.615048640983671,-0.02499747008286268
42024,SIDM00954,Wee1 Inhibitor,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-1.6198549,-0.082895994,-0.19524272090910452,-0.01207382476737235
42834,SIDM00774,Sorafenib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,48.0,1.2133867,0.08782435,-0.06624259158489676,0.013882827407096676
34729,SIDM00529,Afatinib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-0.8661587,-0.04988157,0.9559619407866988,0.04519887096679283
94010,SIDM00893,SCH772984,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.1736672,-0.12449263,-1.39595181345954,-0.06327998091975574
5577,SIDM00332,Luminespib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.3771996,-0.17076787,0.059549030172338764,-0.078754257690508
68004,SIDM00529,PD173074,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.58171976,-0.03248071,-2.1840677001495896,-0.08872206656423663
100699,SIDM00673,GSK269962A,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-2.4922943,-0.11950855,0.16982679531998662,-0.006600327839460229
69583,SIDM00875,GSK269962A,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8162145,0.016436314,1.2582247158076678,0.0006016941226508555
16449,SIDM00866,Dabrafenib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-0.50528175,-0.015190457,0.18705291727531223,0.05322638149468937
101244,SIDM00834,Vinorelbine,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-0.3998149,-0.028670691,1.7409589269623797,0.15439304391954556
66833,SIDM00893,MK-2206,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.7890391,-0.08171202,-1.4672794572878896,-0.09180266425952083
5212,SIDM00778,AZD7762,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,2.234379,0.043884683,0.9386378449086149,-0.02236587034981157
84285,SIDM00359,SB505124,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.272948,-0.07389552,-0.7543624190684887,-0.024952580221379264
55722,SIDM00193,MK-2206,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.2037104,-0.083049305,-0.6330795595596059,0.04087317060630115
42338,SIDM00834,Crizotinib,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-0.58766335,-0.03849849,-1.412740516939361,-0.044058673827321905
38900,SIDM00774,Crizotinib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,0.95199627,0.12475815,-0.21576989265993896,0.005100058583047796
5210,SIDM00866,Wee1 Inhibitor,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,0.5571902,0.04326561,0.3846424671503159,0.041258690835014586
20232,SIDM00628,Alisertib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.94074315,0.022012375,0.44224012918747674,0.09762384833942817
26817,SIDM00893,AZD6482,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.1353787,0.0876674,-0.7670196434233125,-0.03395883381181408
44580,SIDM00146,Taselisib,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.2420922,0.021567333,-0.6982437868516004,-0.015916340742894566
91985,SIDM00866,ZM447439,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-0.51005656,-0.030357283,-1.440453004105327,-0.11254001984171222
69527,SIDM00332,NU7441,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.42017367,0.02660411,1.2504092578815982,0.0804086874586614
82825,SIDM00529,Luminespib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.78666526,0.081311084,0.023832472364494105,0.024944854452732736
6624,SIDM00782,Nutlin-3a (-),Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,Unknown,72.0,5.054288,0.2712372,4.049309761331101,0.24400320985957413
24029,SIDM00673,JQ1,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-2.895233,-0.112739384,1.2372050903987915,0.09226932150282714
94305,SIDM00954,AZD6482,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-0.7615926,-0.044650074,0.03314117259899259,0.026634796123886938
13047,SIDM00866,MK-1775,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.7511907,-0.13988236,-0.3201794573472576,-0.0033003172533808793
59178,SIDM00893,5-Fluorouracil,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.7034538,0.039846245,-0.5502102508535989,0.03120324072951984
62776,SIDM00954,Cisplatin,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,0.76419884,0.017135492,0.36169465633026776,0.07420958638906895
28050,SIDM00875,PD173074,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5034307,-0.028428625,-0.8542725730967685,-0.03392608373676922
91524,SIDM00893,OSI-027,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.5977992,0.1630395,-0.8913478492212296,-0.028119133250641234
5654,SIDM00411,Ruxolitinib,Palbociclib,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.9734209,0.04601334,3.062458501948774,0.055036920299867766
39659,SIDM00628,Trametinib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-1.0992141,-0.08488855,0.4765815061014974,0.04583737035640317
5069,SIDM00146,Bortezomib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,2.103831,0.065061085,1.1392569008773967,0.029603252629208165
80436,SIDM00673,JQ1,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,1.1006627,0.078711905,-0.27914708510540426,0.03998616891505343
158,SIDM00146,JQ1,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-1.8461832,-0.16148178,-0.6029891808959738,-0.03773593630381863
20921,SIDM00332,Alpelisib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.21658298,0.0156200435,1.0128941866793773,0.09352036964890627
32762,SIDM00146,Linsitinib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,1.4454886,0.045700267,1.228481795170289,0.0433570494239054
102048,SIDM00097,BI-2536,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6073209,-0.11180812,-1.4250886889928789,-0.10889498097257304
28822,SIDM00628,MK-1775,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,0.652887,0.06363931,-0.13197578964077059,0.015668667430366302
54917,SIDM00193,Afatinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,1.2568903,0.09543599,0.5073414970233716,0.08510616083533616
1536,SIDM00782,Oxaliplatin,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.6215912,-0.08126775,-1.3507230021891539,-0.037883902863661535
105942,SIDM00893,Ribociclib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.9323643,-0.07124123,-1.383870574130456,-0.02542824902425982
87734,SIDM00893,Gemcitabine,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.81116825,0.07528452,4.172308818582734,0.28283789581243984
88312,SIDM00660,Camptothecin,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,-0.73800284,-0.050226428,0.3688609688719634,0.048464369704101444
97591,SIDM00332,Nutlin-3a (-),Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.8390299,0.036133226,0.08565059752166729,-0.003763186197252002
16289,SIDM00774,Pictilisib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.519865,-0.022338059,-1.0909064398670207,-0.08332303827669105
17154,SIDM00529,Trametinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.0111439,-0.055157874,0.27571121073654503,0.04342964996748655
10557,SIDM00878,Gemcitabine,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.0002546,-0.07608486,-0.1932637813431113,-0.03587253597225607
54543,SIDM00866,Linsitinib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-2.241064,-0.11375319,-0.8969632210145773,-0.018976748488678034
76514,SIDM00359,Dabrafenib,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.0335038,0.11974582,-1.2515693334790066,-0.03345536601301988
36635,SIDM00971,JQ1,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.439543,-0.06105583,-0.3507019865255661,-0.018541782494480852
42022,SIDM00301,Oxaliplatin,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-3.1981132,-0.34360325,-1.4843755756776689,-0.10030109384430463
53751,SIDM00529,Uprosertib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.3815066,-0.06650007,-0.4046875919571021,0.05698721020936406
18197,SIDM01233,Navitoclax,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,72.0,0.48869044,0.027743509,1.3612832490798026,0.015045031050250526
12532,SIDM01233,BMS-754807,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,72.0,-1.4280627,-0.094921514,-2.28339883651466,-0.16012029947927836
99474,SIDM00875,KU-55933,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.07377,-0.07731031,-0.6666552492807148,-0.01631577923981094
92970,SIDM00359,AZD8055,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.765717,-0.11288135,-0.8461905093967605,-0.055362737067838313
88785,SIDM00097,Cisplatin,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.94316584,0.018843869,0.5560478148271045,0.05379706436089479
69474,SIDM00971,Docetaxel,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.8462707,-0.060727295,-1.906592139876261,-0.027283315659839505
2641,SIDM00866,Gemcitabine,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,-1.3161187,-0.0770221,-0.6279691517541188,0.035382301786702916
23115,SIDM00971,Entinostat,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.7923532,0.05946271,1.9657411551208825,0.1250221503153626
9263,SIDM00774,Trametinib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,1.6023536,0.07058848,1.2830163287194762,0.03474748886978409
92148,SIDM00878,Ribociclib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-2.8507154,-0.115477785,-1.7994153830537172,-0.05512177435931323
62652,SIDM00411,OSI-027,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.7328337,-0.042192206,-0.693601051594992,-0.04962419951145631
43241,SIDM00875,Palbociclib,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.71042347,0.023648327,1.4208606186665937,0.06402874459756154
60519,SIDM00628,RO-3306,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,Black,51.0,-1.0269408,-0.09641634,0.2077125265484189,-0.028146298313761264
79652,SIDM00774,GSK269962A,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.61991674,-0.023057096,0.6199775778433612,0.07520346910076195
4440,SIDM00529,Luminespib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.38874978,0.02962865,-1.1871571251043316,-0.0523360108367025
2173,SIDM00628,AZD6482,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,3.6417334,0.16994753,0.5096653997984161,0.059175016641153565
50814,SIDM00146,Wee1 Inhibitor,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.7298161,-0.058502734,-0.4694326000981701,-0.05483517508856219
54931,SIDM00866,NU7441,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-0.41818947,-0.029860275,-0.5155548920397176,0.016599107609686164
89922,SIDM00875,Camptothecin,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.34927455,-0.039901484,-0.4200264654051271,-0.0005372795186414034
88384,SIDM00529,RO-3306,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.22781259,0.0069551165,0.9440324506865805,0.08306720671938045
18040,SIDM00628,AZD6482,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,1.1867652,0.10788486,0.5437552012621102,0.060528364208450786
6332,SIDM00866,Docetaxel,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-5.1780686,-0.28888375,-3.5785491865755232,-0.21869209602316006
96803,SIDM00628,KU-55933,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-1.1969889,-0.06415088,-1.5395971754550484,-0.034361204851622466
99340,SIDM00875,Nilotinib,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.70938724,-0.049642343,0.13687135708028275,0.05737996724068872
26607,SIDM00779,Taselisib,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,33.0,-2.206325,-0.1780596,-1.1806977440480655,-0.02820428855315097
72777,SIDM00411,Sorafenib,Gemcitabine,Pancreas,0.1,Pancreatic Carcinoma,Male,East Asian,43.0,-2.752583,-0.109764874,-1.5776979254169194,-0.06072974256183372
66644,SIDM00878,Taselisib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,70.0,2.6796186,0.1709407,-0.34363298612708065,0.030097605068748166
86417,SIDM00411,AZD7762,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.9427239,-0.047736038,0.8665991042838134,0.04281355632511669
30212,SIDM00531,OSI-027,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.8153977,-0.034425408,0.2079946191102376,-0.011781695060596151
21276,SIDM00774,Nilotinib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.15295357,-0.010644723,0.6876328287137616,0.06323038795593722
79451,SIDM00673,AZD6482,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,1.5121075,0.095578656,-0.1991239789130831,-0.00037658676092228605
44961,SIDM00971,MK-1775,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.89384484,0.03796183,-0.829072273509652,-0.015636287805024237
18827,SIDM00628,Dabrafenib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,1.1835221,0.083037354,-0.5654980816677336,0.023294763699732247
42536,SIDM00875,Vorinostat,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0149043,0.10565142,1.2767203534871836,0.08140844103629484
1756,SIDM00411,Irinotecan,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.5845265,0.08338092,-0.08492860950688338,0.03997790559852892
5771,SIDM00954,MK-2206,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-0.9232275,-0.05428252,-0.806419104673141,-0.07771109155693118
65022,SIDM00971,Tozasertib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.917584,0.07767277,1.4935364447864652,0.027663314987562675
55686,SIDM00332,Tozasertib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.5056882,-0.07273369,-1.7638247754130594,-0.10600462219502836
10500,SIDM00332,BI-2536,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,6.0780544,0.25529382,2.4058140159408103,0.09825512951048229
63959,SIDM00332,Pictilisib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.96322507,-0.0947896,-1.2065282715934538,-0.11105601597572565
108389,SIDM00359,Olaparib,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.48508874,0.007646536,1.4469782173836605,0.040048235723516346
68695,SIDM00673,BI-2536,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,1.2482777,0.08779294,-2.0151935645672725,-0.10402961349010259
73548,SIDM00778,BMS-754807,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-0.6281025,-0.037556484,-0.6394895527531195,-0.01394399247647852
17359,SIDM00776,Trametinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.5079413,-0.046023805,-0.8706539381376986,-0.07346407143909704
29427,SIDM00954,AZD7762,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-2.2705796,-0.10812207,-0.7088532428787553,-0.04543135215182254
53119,SIDM00779,Camptothecin,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,2.657515,0.050353277,0.8696192503109283,0.0339081529673853
25472,SIDM00411,Taselisib,OSI-027,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.0797236,-0.051321734,0.5726177043043884,0.06530402605622039
87008,SIDM00628,OSI-027,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,1.0823117,0.10396025,0.7388024688026255,0.04043471666371868
7396,SIDM00097,SCH772984,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6012461,-0.06985146,2.0094969510246297,0.12859539914529805
60034,SIDM00875,Gemcitabine,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0016544,-0.0023376546,-1.2703034075901705,-0.002102853827214735
55802,SIDM00411,Taselisib,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,0.8863662,0.04875871,2.876293409369113,0.11818364052168001
819,SIDM00774,Palbociclib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,2.034774,0.12421993,1.273427127361217,0.055117455654988774
97242,SIDM00531,Linsitinib,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,4.290201,0.38849425,2.5038940479361638,0.12817797382245913
98558,SIDM00878,Vorinostat,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-0.5050283,-0.055456135,0.913286736424651,0.058719793116866495
38269,SIDM00866,Doramapimod,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.4892434,0.036498334,1.5602965180714503,0.02658927651417467
23175,SIDM00673,PD173074,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.1021543,-0.0917933,-1.823619903140015,-0.03558875971519252
85983,SIDM00628,Axitinib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.20949079,-0.016929045,-0.7416712839696612,-0.036715834743953374
108100,SIDM00782,Trametinib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-1.2072425,-0.099979945,-0.8108044649910391,-0.0419005225182027
85097,SIDM00878,Alpelisib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.0309713,0.087925084,0.06721519002421183,0.08456022242991369
94433,SIDM00778,MK-1775,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-2.6688602,-0.123237416,-2.3712833309949204,-0.11222418952210245
8511,SIDM00097,NU7441,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.6688874,-0.034784783,0.08483992532289306,0.012026901481568547
13432,SIDM01233,Taselisib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.2709217,0.09228814,-1.692778260930554,-0.07458024774916651
101153,SIDM00628,Nutlin-3a (-),MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,0.472301,0.023710443,0.5115731611720766,0.036986955924177715
54005,SIDM00628,Camptothecin,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,Black,51.0,-0.8175737,-0.0750688,-1.2269796082930247,-0.06505160679666934
83808,SIDM00893,MK-1775,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.9075694,-0.031531196,-0.743857587774818,-0.05889728287558268
61087,SIDM00531,LGK974,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-2.7538247,-0.15593056,-2.469862077941118,-0.03419063990399491
20171,SIDM00878,Bortezomib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.35586673,0.02281626,-0.017467076066637312,0.016058286827053268
75969,SIDM00529,BI-2536,Trametinib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,0.9591789,0.075382374,-0.3500342130997036,-0.052138832519170626
50145,SIDM00529,MK-2206,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.48878828,-0.017926749,2.2003060249944753,0.13950595966623175
81225,SIDM00893,Vorinostat,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.9178044,-0.09978125,-0.8106170293563251,-0.0474442197374841
35517,SIDM00774,Sorafenib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.0471988,-0.08201099,1.3178094053755043,0.06190121270623569
63065,SIDM00834,5-Fluorouracil,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,1.7194817,0.08959186,-0.20681916339687134,0.004459962239267514
26893,SIDM00866,Nutlin-3a (-),Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.110592,-0.032493927,-0.15570681817634352,0.02075519192288432
14726,SIDM00301,Sorafenib,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,50.0,-1.7170978,-0.07947657,-0.23426552678843116,-0.036145453054569496
14910,SIDM00774,Axitinib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,48.0,1.0638212,0.12098094,-0.7162697370147877,-0.0005661174853048947
105612,SIDM00776,Camptothecin,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-2.909757,-0.16441843,-1.7316354081707455,-0.09908670209045699
97320,SIDM00673,MK-1775,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.2197927,-0.086681835,-1.3796321888931296,-0.071404784123659
104761,SIDM00097,Linsitinib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7865202,-0.069900215,1.0965875513278243,0.04115538471094038
75343,SIDM00673,Nilotinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.4033514,-0.06992259,-0.7515634743150141,-0.05126206099439796
3629,SIDM00875,Ribociclib,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6431423,-0.04717448,-0.23983987404315332,0.02015777698917509
32370,SIDM00301,AZD7762,Paclitaxel,Pancreas,0.0025,Pancreatic Carcinoma,Male,East Asian,50.0,2.0851588,0.18285504,0.7787197176416913,0.04780727504856753
25182,SIDM00359,AZD8055,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.4386994,-0.10439812,-0.9367275109946176,-0.04485319101781886
98879,SIDM00776,Trametinib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-1.0828456,-0.07504027,-3.719985776311628,-0.14135482950909875
105439,SIDM00628,Ribociclib,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.37935662,-0.010040867,-0.5703905648260316,-0.015929126322984672
100133,SIDM00146,Camptothecin,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-0.008569609,-0.0008561353,0.14939543979756123,-0.001248436447676977
101178,SIDM00146,Crizotinib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,0.5497138,0.052337166,0.2965279039051665,0.10593167243406457
85057,SIDM01233,Camptothecin,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,4.2587266,0.09809223,2.244427529669345,0.06982087365493743
55377,SIDM00866,Afatinib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.917261,-0.078573786,-0.8279685770493477,0.006615694599508404
75211,SIDM00878,Cisplatin,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.9438389,0.022638945,2.2751595676294865,0.06386194040278155
65723,SIDM00359,Taselisib,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.683421,-0.11878254,-3.5868409581628002,-0.1390360822606236
100078,SIDM00834,MK-2206,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,3.330667,0.1555149,1.4714914570667226,0.11809422385549007
45413,SIDM00782,BMS-754807,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-2.6413043,-0.2227871,0.4159183803243359,-0.03533257695894248
97823,SIDM00834,SB505124,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,0.810451,0.064184316,-0.43805950792041126,-0.009508362218199872
49006,SIDM00130,Irinotecan,Lapatinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.47312403,0.041279994,0.36258436110268905,-0.002142942224091108
65978,SIDM00774,RO-3306,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.7792966,-0.042368792,-0.6675876964346923,-0.020902320972811566
91349,SIDM00878,Palbociclib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.9888841,-0.06594239,-0.2368772083231185,-0.010109536636880318
41768,SIDM00779,AZD4547,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-3.071001,-0.020877615,-1.3482073660051743,-0.027647781430988838
70881,SIDM00146,Nutlin-3a (-),Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.65805155,-0.0194551,1.056670954418865,0.055660933874283405
53596,SIDM00660,Linsitinib,Nutlin-3a (-),Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-0.79039544,-0.048747323,1.6103119430984727,0.07004828779583068
6599,SIDM00332,Camptothecin,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7721519,0.019682165,1.2702172505152547,0.039779787511695225
80419,SIDM00529,Tozasertib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,1.4128038,0.07598112,0.07010266430198415,0.06664700841875575
17722,SIDM00834,Nutlin-3a (-),MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,0.367288,0.009356174,1.4643536827215387,0.055717814616207166
50703,SIDM00782,Nutlin-3a (-),AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,3.962572,0.15895401,1.7309745869025142,0.039582168182978106
18168,SIDM00875,AZD7762,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.19435123,0.011809811,-0.2651900624094177,-0.0016593228864515963
91333,SIDM00673,MK-2206,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.4363575,0.026758378,-0.7123813913601991,-0.11004367906888989
34378,SIDM00529,Alisertib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-2.0602827,-0.16609398,-1.596026413928782,-0.09223551895577492
7725,SIDM00359,AZD8055,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6289711,-0.09406539,-2.557624781092091,-0.11662326539092734
15615,SIDM00774,Palbociclib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,2.2229824,0.14465123,0.34546325812771633,0.014150325556886683
43394,SIDM00893,Sorafenib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.65106046,0.05742753,-0.033607476152705894,0.015566810709208638
10311,SIDM00660,Camptothecin,Oxaliplatin,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,2.2334342,0.20645465,-0.012980790107539684,0.023883063350701932
47195,SIDM00778,Afatinib,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-0.55444443,-0.03517197,-0.09524482998825733,-0.018121793484687843
106510,SIDM00866,BI-2536,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-2.5716412,-0.139278,-1.1275058010152352,-0.0295593443588096
80527,SIDM00411,Palbociclib,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.4469495,0.10528608,1.5520418910217857,0.0798990730221299
76615,SIDM00193,Navitoclax,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.5027827,-0.035013635,-0.082094398358695,0.026113946095205152
69650,SIDM00954,BI-2536,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-1.9048613,-0.044947393,-0.9014401520549644,-0.022953324335367772
64743,SIDM00332,Luminespib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.65227574,-0.06294286,-1.0108161572983894,-0.027915622934689025
42653,SIDM00774,Tozasertib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,-0.9210016,-0.023684531,0.6601224923742974,0.003636161972860875
37038,SIDM00875,Paclitaxel,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7147823,-0.04442341,-1.416192193972187,-0.03657142570678956
56819,SIDM00673,Doramapimod,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,2.3887331,0.0469097,4.69883024503277,0.07639534613718577
23837,SIDM00332,NU7441,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,4.7124863,0.3217532,2.123417029436064,0.12937280244474847
94895,SIDM00301,Trametinib,Lapatinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.5953549,-0.19467768,0.4001833695084015,0.04081268292563887
69405,SIDM00971,RO-3306,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.56392527,0.033123575,-0.9699433445434625,-0.007936040003352855
30279,SIDM00097,Luminespib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3766327,-0.07516543,-0.8782210394448793,-0.04860974898486312
103910,SIDM00301,Crizotinib,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,-0.9064145,-0.12449977,-2.0850213882758286,-0.11562968674014636
37573,SIDM00130,Palbociclib,Olaparib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.4404911,-0.09047166,-1.8893359179152893,-0.07190473100265429
75152,SIDM00779,MK-2206,Crizotinib,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,33.0,-0.6719774,-0.046646953,-0.8846474979780682,-0.059054747053380534
39542,SIDM00332,RO-3306,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4173169,-0.05928577,0.49391530009841217,0.0010792797251110982
22778,SIDM00097,Ribociclib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3551441,-0.04318177,-0.6205866124364855,-0.012916267459488732
27210,SIDM00971,5-Fluorouracil,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.3277303,-0.034786534,-0.31386620120302416,0.004671590826560891
49689,SIDM00866,PD173074,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.7851417,0.082393825,1.4856491998106998,0.11674515453108386
30219,SIDM00332,AZD7762,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.801023,0.14130604,0.7210371359369578,0.03674013626141809
105469,SIDM00878,JQ1,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.6113931,0.13647911,1.2427092098596288,0.09684421805119654
7717,SIDM00878,Axitinib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.44635275,-0.052955955,-1.554478352383854,-0.1422954287127583
73180,SIDM00971,Dabrafenib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.67113906,0.015718084,0.731684130777582,0.0664589080534211
1623,SIDM00971,Vorinostat,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.627115,-0.10733784,-1.1404994399123687,-0.06194376375293557
58308,SIDM00097,Vorinostat,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.46995986,0.0333422,-0.6789267106888269,0.010768766057948867
97749,SIDM00954,RO-3306,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.0,-1.3534102,-0.10389011,-0.4049448679564307,0.004633661006438332
101101,SIDM00971,5-Fluorouracil,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.2704266,-0.031718384,0.10972159715959422,0.03373530983580531
29962,SIDM00673,Palbociclib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,0.91081244,0.02502571,-0.653633520788195,-0.01849705168569528
71897,SIDM00776,BMS-754807,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,2.8468678,0.20575184,0.25077627228954563,0.037438312829519094
34832,SIDM00878,Camptothecin,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.2833067,0.027526708,3.0771989410157286,0.05401256446618796
87337,SIDM00774,Cisplatin,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.436598,0.054286867,0.45472169376049854,0.061740700912222654
5730,SIDM00893,Gemcitabine,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,5.6790137,0.50383705,0.94423354731068,0.08873753112832275
40509,SIDM00411,LGK974,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.9735256,-0.048844706,-2.611951719985905,-0.0631242626130973
37,SIDM00146,Luminespib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.5819395,-0.11725864,-0.7202819865661811,-0.04507650047604817
30360,SIDM00301,MK-2206,Linsitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,0.7311022,0.09725029,1.2752780873773895,0.11326524533364941
45597,SIDM00774,PF-4708671,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-2.0096505,-0.08616405,-0.4351360629778406,-0.028109636789149985
73306,SIDM00971,Navitoclax,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.41073778,-0.0096236495,-1.2932091901079712,-0.018286044569623558
58950,SIDM00971,Linsitinib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.3112457,0.11913414,-0.4841234367974729,0.00916483544782311
65966,SIDM00673,Navitoclax,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.9258559,0.07731025,-0.03258715494761534,-0.04629870783786513
15534,SIDM00971,Dabrafenib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.9374624,0.018020043,1.3009756752439694,0.07878570057218319
15412,SIDM00673,GSK269962A,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,49.0,-1.2308376,-0.08982088,0.10393439186116862,-0.026918756637882138
83328,SIDM00660,Nutlin-3a (-),AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,2.863866,0.10454508,2.896057164104558,0.10750017676615581
36034,SIDM00878,JQ1,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,70.0,1.0294919,0.09273736,0.2449160845866589,0.024734705402055596
69766,SIDM00782,BMS-754807,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,1.1748062,0.07206363,-0.3376775651008133,-0.022969899999553123
36681,SIDM00097,Axitinib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.43478975,0.026920019,-0.07712317090069762,-0.062028517721784644
87127,SIDM00097,KU-55933,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.4065917,-0.09145269,-0.2925010235485519,0.009172869153908591
74080,SIDM00529,Lapatinib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.7661208,-0.074385256,-1.39448348610303,-0.06082665379901658
11818,SIDM00146,Bortezomib,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-0.4108533,-0.029117303,-0.2511956940865182,-0.040466670802370056
7800,SIDM00097,Ribociclib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0312943,-0.0684226,-1.386169497467658,-0.03353739646981067
5365,SIDM00866,Linsitinib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,1.0446848,0.059796065,0.46284955596034005,-0.03585836324256725
65947,SIDM00660,MK-1775,AZD7762,Large Intestine,0.0625,Cecum Adenocarcinoma,Male,White,32.0,2.4824626,0.082023084,1.647192287456418,0.07400046587235311
14378,SIDM00628,Trametinib,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,1.4723854,0.14048952,-0.791625731155393,-0.054708259454494174
82150,SIDM00097,AZD6482,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0326078,-0.13183618,-0.6185681880811057,-0.0667230570866824
4811,SIDM00875,Bortezomib,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.06062069,-0.006285513,-0.4635677500183756,-0.011236481066033015
80390,SIDM00628,MK-2206,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.33055642,-0.022759056,-0.18428913723014156,0.02901712495339398
96136,SIDM00954,Paclitaxel,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-1.2176261,-0.09488823,-0.18099798249270665,-0.06675729565754185
5060,SIDM00628,Afatinib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.7334265,0.051493205,0.3356498707034627,0.04432591863057077
33178,SIDM00332,Taselisib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,5.009,0.23747784,-0.17750654217581538,-0.038956595528189364
84657,SIDM00673,Dabrafenib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.4147935,0.071138136,1.8545426369449438,0.03488827595237521
54542,SIDM00778,BMS-754807,Crizotinib,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,69.0,-0.93706053,-0.063888684,-1.5171016352623257,-0.11081194163160137
107703,SIDM00529,AZD8055,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-1.5612375,-0.11831983,-2.4696353066927847,-0.10448637681844457
50587,SIDM01233,5-Fluorouracil,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,72.0,0.5824129,0.03467956,-1.1763410820092803,-0.018665583113538775
2110,SIDM00332,Lapatinib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.0518074,-0.16580704,-0.6203039469738069,-0.004112070047849552
11625,SIDM00097,MK-1775,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.3687825,0.025880374,0.13435880756074572,-0.014653372371560981
38608,SIDM00130,Dasatinib,Crizotinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.4476022,0.12280785,2.2568708778034616,0.17946852502986554
7626,SIDM00779,Trametinib,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.9186956,-0.08771959,-1.3868578676002623,-0.09300172335173969
24921,SIDM00301,Crizotinib,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.4738668,0.14196007,1.1992561338067806,0.0995461156358408
47361,SIDM00893,Tozasertib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2109659,-0.05257617,0.6487916301754695,0.058557674528053195
9752,SIDM00878,KU-55933,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.8139594,0.019346295,0.12119116727514324,0.02918564908454426
7101,SIDM00779,LGK974,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,1.4256598,0.043325886,-0.09501616383367087,0.006598894139205616
13750,SIDM00146,JQ1,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,0.7181172,0.0556303,1.543781503180291,0.07149009151490143
54182,SIDM00359,Olaparib,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.32960224,0.005572295,1.397001165066653,0.08445061980719325
19172,SIDM00332,GSK269962A,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,5.073893,0.19168092,2.0574877517749104,0.03836104543914242
81358,SIDM00866,GSK269962A,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,0.26296827,0.010631394,0.9357034830260654,0.09663380363164842
54916,SIDM00878,Bortezomib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,0.29664263,0.019121762,-0.6009212148277256,-0.07436443377585394
66982,SIDM00834,SB505124,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,White,66.0,-0.9907336,-0.07615899,-1.985952550928609,-0.10601135145876556
82671,SIDM00779,Oxaliplatin,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,33.0,-3.338417,-0.1288215,-1.980913223233027,-0.04092875252905508
6012,SIDM00954,Entinostat,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-0.30088088,-0.02208635,0.062036047590413854,0.01821470307182287
20895,SIDM00971,Camptothecin,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.9394703,0.18243237,3.2686439409079995,0.11393106001330663
103825,SIDM00954,Axitinib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-2.083336,-0.14819019,-0.46084464027031413,-0.041818661844498985
26342,SIDM00971,Entinostat,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.2944143,0.08621511,-0.0923614108935088,0.02738982104119387
61108,SIDM00146,Tozasertib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.60674495,0.048157416,0.5814219473915605,0.03435967279112915
72141,SIDM00146,PF-4708671,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.8472044,0.07611834,2.8625573757244025,0.12878768433387877
8523,SIDM00359,SB505124,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.31977054,0.026122814,-0.7585845238371413,-0.028664028054756003
30250,SIDM00359,Navitoclax,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.12814322,-0.008147637,0.1805601718841848,0.026028723575290177
91321,SIDM00776,AZD7762,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.5901416,0.043636862,-0.2168640945335025,0.02034252784940946
78444,SIDM00146,Tozasertib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,6.617977,0.50562125,4.377271719067815,0.21748440623096013
107968,SIDM00097,AZD8055,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0540106,-0.1408829,-0.4115151805255454,-0.10801995047617503
94196,SIDM00332,Olaparib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,3.1189291,0.17637746,1.2501473702016108,0.03865486515907007
66339,SIDM00531,Palbociclib,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.1916664,-0.041830555,-0.7869050390871765,0.002665144079147963
20443,SIDM00893,Alpelisib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.0074243024,0.00062882906,-0.44817713941918663,0.011205607652006103
48936,SIDM00130,MK-1775,Dasatinib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.36924964,0.027334888,0.4604909842368904,0.055706035004147295
67638,SIDM00193,Olaparib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.7318695,-0.050617047,-0.48126708931443746,0.01051409673208598
94230,SIDM00893,Palbociclib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.147777,0.13716955,-0.31354524206957923,0.0018026956514223134
2831,SIDM00782,SB505124,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,Unknown,72.0,-0.4162181,-0.036589958,-0.4641730792853769,-0.004772541982078624
101291,SIDM00146,Afatinib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.207716,-0.1085615,-0.29227873973757795,-0.02922060244493235
93279,SIDM00628,Entinostat,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,2.9018104,0.21978053,0.49417426009924453,0.03715534742601371
42183,SIDM00893,Afatinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.4633129,0.18857902,1.7837415653746225,0.10085750108127868
78038,SIDM00673,AZD6482,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.0149621,0.065905154,0.5322419789783265,0.03352557551982245
14328,SIDM00130,SCH772984,Irinotecan,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.7831405,0.09428724,-1.6369975590980517,-0.042502751519259
26075,SIDM00332,RO-3306,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7155949,0.06750705,1.0332342335586966,0.05800455755034758
37816,SIDM00954,Cisplatin,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.0,-0.50459796,-0.017608458,-0.35262650256520583,0.013834434265623766
28266,SIDM00146,MK-1775,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,-0.27874777,-0.021254698,-0.6110674848400096,-0.025497690254453545
92913,SIDM00878,Navitoclax,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.2178576,0.018848214,0.801796122086672,-0.004107074100738441
42910,SIDM00834,LGK974,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-1.5850229,-0.08524397,-0.8861196839412787,-0.029987968483118434
29246,SIDM00673,Alpelisib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.0947547,0.16011828,-0.30860961898494943,-0.02022188001247764
71079,SIDM00878,ZM447439,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-1.3469504,-0.046363134,-0.5620867016200446,-0.0028043485463875696
65148,SIDM00097,Axitinib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.154637,-0.15081362,-1.5273737527464897,-0.1114828731647107
7497,SIDM00776,Taselisib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-3.2123535,-0.14725113,-0.820120083744672,-0.07246169755211977
64760,SIDM00893,Luminespib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.8739264,-0.13398518,-1.6410406637984158,-0.07977790275597887
74704,SIDM00774,Crizotinib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,0.6181875,0.09337464,-1.1403963541344726,-0.04461623481751777
44951,SIDM00875,5-Fluorouracil,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5734019,0.050114956,-1.1907009558049193,-0.04609802872030202
73567,SIDM00660,Olaparib,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,1.4938873,0.036044348,2.1991828372432094,0.08241090725506986
36239,SIDM00971,Ribociclib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.7009575,0.11327607,-0.963401601076442,0.0267375467223666
3066,SIDM00954,Palbociclib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-1.1591266,-0.045317296,-2.502226758469375,-0.08807637483858088
54557,SIDM00971,AZD6482,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.7136754,0.036482852,2.3840506721060124,0.10344979487254018
63627,SIDM00411,Cisplatin,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,3.036025,0.07451994,2.498805404240467,0.09157118028382845
56879,SIDM00097,Paclitaxel,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.55923975,0.04172542,-0.6879493084129228,-0.06092508712411058
72818,SIDM00875,ZM447439,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.9364464,-0.10749379,-0.6915944194059199,-0.02460047362060855
93869,SIDM00779,Camptothecin,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,33.0,1.4050417,0.0754051,0.06957945334847064,0.010429120025570377
34557,SIDM00774,Paclitaxel,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.0791147,-0.077464364,-2.5343872976430775,-0.057876738908046704
31949,SIDM00628,Linsitinib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.8346312,0.10715929,1.3287293057979135,0.11496179067273528
105289,SIDM00673,Docetaxel,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-5.3373914,-0.43157908,-3.2894588802790445,-0.25761185192497676
106239,SIDM00776,MK-1775,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,0.33689296,0.021118352,-1.622605584935987,-0.07755831153615335
104793,SIDM00097,Afatinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.62008756,0.045677766,-0.15168389171117747,-0.039842145290082245
25309,SIDM00332,AZD7762,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.4735641,-0.10905247,-1.285541693754626,-0.12170821491853223
79760,SIDM00193,SB505124,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.3339911,0.031832665,-0.08677139651747409,-0.017812871718648274
27646,SIDM00776,Olaparib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-1.3589915,-0.0522655,1.2955301485866577,0.052169455223053766
141,SIDM00673,AZD7762,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6872192,-0.053679664,-0.8627506310063222,-0.021153831804376518
23468,SIDM00531,AZD7762,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.3350167,0.11230403,1.2363979783781478,0.04974267172427391
4245,SIDM00878,Afatinib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-0.8238893,-0.08000116,-1.0636145497334457,-0.07644619709565903
27006,SIDM00193,SB505124,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,53.0,-0.7178686,-0.06137192,-0.3272208849396209,-0.028384701705594415
81938,SIDM00332,Cisplatin,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4709765,0.03155727,2.370985352731853,0.06631208753268863
1879,SIDM00778,Palbociclib,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-1.226519,-0.030752974,-0.34983233811597986,-0.012024664015595975
27690,SIDM00673,Temozolomide,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.23938791,-0.0050442233,1.1636365734737817,0.004218031464784002
79650,SIDM00673,GSK269962A,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-2.7747433,-0.11990187,0.7202744738558269,0.011760421603467778
59069,SIDM00776,Crizotinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,2.0045338,0.11694918,3.2145823871712302,0.14438398241921027
63261,SIDM00774,Sorafenib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-2.16053,-0.10495891,-0.7489822980935112,-0.025172172057136406
5720,SIDM00954,Linsitinib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-4.3024726,-0.2933238,-1.3895462094927218,-0.058103605489306945
90960,SIDM00782,Dabrafenib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,Unknown,72.0,-1.0783578,-0.032487493,0.7365580125057801,0.03696429296451468
21639,SIDM00332,Cisplatin,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,4.2638216,0.1934423,1.6021201388612238,0.07049627507337203
72740,SIDM00776,Nutlin-3a (-),Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,-1.7654303,-0.043778133,0.08432669082084134,0.02448734887075583
36167,SIDM00301,Cisplatin,5-Fluorouracil,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.4284472,-0.2045345,-1.5365512929714225,-0.09331367452812031
94863,SIDM00097,Olaparib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.9180799,0.09629863,0.7484383067240468,0.0008258919469961014
65632,SIDM01233,Dabrafenib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,72.0,-1.5779902,-0.04253087,0.6777485449971987,0.008330371763423109
34553,SIDM00776,Olaparib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,-1.1888726,-0.038383093,-0.46105681183888725,-0.03024840592534949
58601,SIDM00776,AZD4547,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.2236884,-0.032138757,0.9921485918468662,0.07663110127715722
35397,SIDM00146,Entinostat,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.63945657,-0.04461135,0.4445294745205816,0.06555165226476721
98449,SIDM00866,Vorinostat,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,-0.35111293,-0.022919962,0.4541975119116242,0.08182496115124827
13771,SIDM00774,5-Fluorouracil,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.5388753,0.06383675,0.30273602448329423,-0.00010435088267008645
74227,SIDM01233,5-Fluorouracil,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,1.2396781,0.08712221,-1.0373523934615148,-0.06612850709822028
50815,SIDM00146,Tozasertib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-1.1455506,-0.07593888,-1.7157433972852743,0.003482025326988096
12435,SIDM00893,MK-1775,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.29479915,-0.029893052,-0.6776921783063967,-0.08646455065290826
5444,SIDM00130,Dactolisib,Palbociclib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.134485,-0.11301049,0.21678447512687013,-0.009482690136515814
60040,SIDM00097,Nutlin-3a (-),Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.4908226,-0.07645832,-0.5718152654154556,-0.006675314766500312
1672,SIDM00531,Navitoclax,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.59466857,0.06924796,0.6137484715679955,0.041560818174390106
41584,SIDM00893,Lapatinib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.1596344,0.10447886,-0.45415207527246665,-0.08024758793081803
63877,SIDM00097,5-Fluorouracil,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.8915653,-0.1201944,-2.3114227351788963,-0.13473468033361094
45742,SIDM00673,5-Fluorouracil,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.622795,0.016157452,1.378883114370463,0.07947693605307275
50166,SIDM00359,Dabrafenib,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.9265393,0.11707179,-0.2979489353991537,0.02792052305553856
98415,SIDM00866,Taselisib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-0.3831813,-0.034226574,-0.21209396122460278,0.007507543252893677
23973,SIDM00782,SB505124,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.6053956,0.13777179,1.3616805860140493,0.06969803523220987
15843,SIDM00893,Sorafenib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.48483706,-0.042904723,-1.3095311504723404,-0.037925579317519234
27462,SIDM00301,Linsitinib,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,-1.8091477,-0.06281733,0.6306221030637317,0.05049966828372629
22710,SIDM00893,Alpelisib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.0479048,0.0653218,-0.6121058732105248,0.008011193598175129
12846,SIDM00660,BMS-754807,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,32.0,4.8020873,0.169432,1.2979832313646489,0.03904176108339991
77990,SIDM00782,Camptothecin,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,Unknown,72.0,-0.5011685,-0.04468408,-0.41986211165044063,-0.05801226530757603
28681,SIDM01233,SB505124,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,-0.56614363,-0.027773993,-2.323506695798998,-0.08709645237867886
27066,SIDM00954,Wee1 Inhibitor,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-1.1244851,-0.08413635,-0.39460390850847615,-0.026308196446029972
68018,SIDM00774,Ribociclib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-3.225998,-0.09940205,-2.5777614093707086,-0.06725298390004521
13734,SIDM00332,Alpelisib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9530036,0.07378128,0.259361421414395,0.04469639289273259
79573,SIDM00875,Doramapimod,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.469201,0.085495435,1.5463419916348842,0.05990111024333012
96553,SIDM00774,JQ1,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,48.0,-0.0678975,-0.0040098303,0.1642223080105314,0.017919074096244707
66245,SIDM00628,PD173074,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,1.7368464,0.06814783,1.3330007398995651,0.11745729212812632
70218,SIDM00866,KU-55933,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-2.0692673,-0.080485806,-1.2752889375409688,-0.05129492135764487
101412,SIDM00660,Oxaliplatin,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,32.0,-1.675789,-0.12309292,-1.0893265130100054,-0.08231710063032321
15336,SIDM00531,Paclitaxel,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-2.3402424,-0.16311081,-3.5950671726021444,-0.19415534976382054
977,SIDM00971,JQ1,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.1745939,0.06612394,-0.4091241742109018,-0.025882291749648678
2275,SIDM00782,Camptothecin,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,-2.0504375,-0.13878489,-1.137702400862011,-0.013762701021980444
75041,SIDM00782,Navitoclax,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,2.8981795,0.14664875,2.0494930175469364,0.07744041189628244
21279,SIDM00971,ZM447439,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.9153386,0.07840274,0.10699055693185276,0.07853893604085802
10481,SIDM00146,NU7441,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.56908125,-0.053273875,0.6734327237808544,0.02274225195201248
66162,SIDM00778,Oxaliplatin,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-1.3570439,-0.033150204,-1.17201228785484,-0.041099019659619214
38886,SIDM00628,Pictilisib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,1.1321082,0.08346445,-0.7139736163290799,0.024968086833381736
74194,SIDM00834,Crizotinib,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,White,66.0,-1.304187,-0.09257954,-0.21006376005241717,0.0048600360789683395
52338,SIDM00146,Entinostat,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.66195434,0.053812437,0.3881779634134924,0.04339005468382595
26725,SIDM00301,Irinotecan,Sorafenib,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,50.0,-1.2016575,-0.12937482,-1.0948159490952334,-0.05472021373001822
33026,SIDM00673,Docetaxel,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.2664508,-0.10783118,-0.32888918513713167,-0.054976810922796146
106880,SIDM00628,Doramapimod,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,Black,51.0,1.5397199,0.06269334,1.1972533569342545,0.04154448552556146
89311,SIDM00778,Oxaliplatin,5-Fluorouracil,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-2.1263373,-0.063402556,-1.5419095514775023,-0.04909268262294448
51041,SIDM00774,Entinostat,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-1.2874696,-0.0744354,-0.10648432889253479,-0.023885124773476454
34281,SIDM00954,Dabrafenib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.0,-0.55294263,-0.018959086,0.16640355364373208,-0.017338281718044773
21915,SIDM00146,PD173074,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-2.989283,-0.15815948,-1.3375397320641425,-0.036345339093838094
73580,SIDM00866,Nilotinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,52.0,-0.4493944,-0.0287028,-1.1715185080202106,-0.038938318338466775
90255,SIDM00531,Palbociclib,MK-2206,Pancreas,1.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.6210681,0.11904674,0.5918557165324899,0.0054019473663257985
22043,SIDM00097,Lapatinib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.9437369,-0.058757454,0.22143525714500625,-0.021027302831831112
37588,SIDM00332,Tozasertib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.73942155,-0.051101677,-0.05904566484494617,-0.016243249426583468
72672,SIDM00893,Alisertib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,5.6840835,0.3697513,4.196787914157474,0.26395911765601227
99985,SIDM00774,Docetaxel,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,0.74380636,0.05506218,-0.09767903129319838,-0.011035499672021106
87835,SIDM00146,Venetoclax,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.74392724,0.013642306,1.5924364091790126,0.07760469655263581
80025,SIDM00878,Bortezomib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.024799328,-0.0017682547,-1.3702902964251673,-0.02173839894293101
52992,SIDM00130,AZD7762,Dasatinib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.18538928,-0.017976118,0.15955303950261945,0.04818512621696751
68620,SIDM00971,5-Fluorouracil,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.722585,0.055358358,0.5550301180951737,0.05380611386125239
84035,SIDM00660,Navitoclax,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,4.527861,0.14896424,2.0243635954090538,0.06107953350452484
75669,SIDM00359,Taselisib,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.5045353,-0.04500178,-0.7249640727888845,-0.05781504429405772
95608,SIDM00529,Doramapimod,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.71700794,0.026170777,1.3030725768361908,0.07463107285811793
79338,SIDM00774,Venetoclax,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-0.6965887,-0.015106746,1.1416013985946063,0.010349749123208322
6448,SIDM00628,Pictilisib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,1.3431333,0.13743013,-0.846563539759546,-0.038284044275341024
17680,SIDM00673,AZD8055,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,1.0147628,0.049703527,0.5820438612244173,0.0475527435593658
91618,SIDM00893,Alisertib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.6321507,0.14424405,1.5503766684896516,0.09380700543154608
61293,SIDM00954,Alpelisib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-0.6790641,-0.053917263,1.4655810646862515,0.08650917052807243
67009,SIDM00411,Olaparib,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.2039194,0.022768334,2.0398658877671734,0.0369085779319506
20159,SIDM00971,AZD6482,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.2805946,0.040972542,0.7617813236927499,0.03786870819804076
831,SIDM01233,AZD4547,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,2.2341895,0.07387247,0.4166400684623003,-0.03797029461545882
53400,SIDM00628,Cisplatin,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,-0.97672504,-0.06630315,-1.212333866662165,-0.0014592627651928245
71464,SIDM00411,Dactolisib,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-3.4864275,-0.11743624,-0.9115003473973795,-0.02989494223682184
70501,SIDM00097,Luminespib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.749872,-0.099414065,-0.7048948097000935,-0.03238554737670412
3494,SIDM00097,AZD7762,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.5681262,-0.12478825,-1.5049370170658194,-0.06214117505014886
65175,SIDM00628,Crizotinib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-0.6848908,-0.06406986,-0.8675663560769896,-0.056936968377258125
57482,SIDM00774,NU7441,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,-1.052408,-0.05602708,0.3899656126747348,0.06845948218876902
76192,SIDM00866,Bortezomib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,2.1467872,0.09196331,0.566555181510535,0.053142949350987886
64553,SIDM00779,Crizotinib,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,0.4067924,0.02198671,0.40066042381045974,-0.010889579130393774
26715,SIDM00893,Trametinib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.0534627,0.19302477,0.08575250840243062,-0.01045800264739456
24154,SIDM00778,Linsitinib,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,1.8985355,0.10137707,-0.1993291360664651,-0.010928446771768973
101685,SIDM00673,Gemcitabine,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,1.0119246,0.089589275,-1.2036438760080241,-0.06260377385074253
27350,SIDM00878,NU7441,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,70.0,1.2995139,0.113236345,0.5375133282108021,0.014805788708999484
73303,SIDM00146,Alisertib,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.51392466,-0.039582763,-0.3009162552166122,-0.08663742823132757
37987,SIDM00146,RO-3306,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.8959674,0.17741795,0.5255311351278331,-0.02824232392869269
57783,SIDM00778,BMS-754807,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,69.0,-2.9844263,-0.15351345,-1.2131990791131586,-0.10001864128536402
51456,SIDM00146,Pictilisib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.9099941,-0.12874888,0.8068549238870484,0.08151135785362124
39072,SIDM00301,Dasatinib,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.7064332,0.19374527,2.326184062755395,0.20081814572090084
56732,SIDM00875,Dabrafenib,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.1245077,0.04664416,-0.2853506872442163,-0.02731613485112035
59325,SIDM00411,Linsitinib,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,43.0,1.4765762,0.08313042,0.3705198030866074,0.08084579288626208
73684,SIDM00954,Tozasertib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-3.4330032,-0.14258091,-0.89726831642879,-0.008151764294012038
95402,SIDM00875,MK-1775,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.4927854,0.021421999,-0.12336006151464715,0.018698928419562322
52859,SIDM00866,AZD6482,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,0.6112812,0.036802948,0.6211903632904361,0.03669878521980259
50216,SIDM00782,5-Fluorouracil,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,-0.5070624,-0.018337602,1.9382889001201369,0.06050862495767969
46706,SIDM00359,AZD7762,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.71859384,0.054764286,1.6887393753256257,0.05323794358234149
16854,SIDM00673,Doramapimod,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.5797619,0.02573469,4.2214763597332885,0.06377675958664437
58136,SIDM00779,Crizotinib,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-0.6986783,-0.055530973,-0.42242931361077113,-0.014081103464200488
59105,SIDM00628,ZM447439,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,0.26270667,0.020959206,-0.011651476532148217,-0.015588676504284138
72712,SIDM00097,Ribociclib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5046587,-0.07130186,-1.2801477936057475,-0.0059575879191125876
57928,SIDM00529,Lapatinib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.1506264,-0.06614971,-0.2279038938450528,0.013581719865072566
24663,SIDM00878,KU-55933,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-1.3995143,-0.03525611,-1.1259482252517525,0.01923400427569904
101263,SIDM00332,Wee1 Inhibitor,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2519892,0.08540852,1.064911857587769,0.06538691215448632
108342,SIDM00782,MK-1775,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,2.2969933,0.08520284,1.624350829441395,0.0552518770156968
6087,SIDM00531,Dactolisib,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.1034801,0.10882549,-1.1518120983050384,-0.04268211303508239
68842,SIDM00893,Pictilisib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.95709455,0.0830871,0.3800809120290597,0.046538109374318765
101835,SIDM00673,AZD6482,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0862986,-0.08943411,-1.4989917284517449,-0.0536767376999266
41159,SIDM00411,Ruxolitinib,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.3779628,0.023037825,2.157589086522612,0.06441553929483579
74711,SIDM00193,Crizotinib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,53.0,-0.5723406,-0.02596816,0.6676666467030761,0.10828659013071906
97610,SIDM00779,Afatinib,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-0.35848823,-0.031337216,0.304004443405557,-0.0658395142489161
18759,SIDM00774,Ribociclib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-0.66670007,-0.026491314,-0.8252640363093785,0.027247405814400105
106436,SIDM00193,SCH772984,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.32778144,0.027217489,-0.17751714517988978,0.047768707764871444
31571,SIDM00628,Dabrafenib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-1.6418611,-0.12051852,-0.8797414238363556,-0.018643866413437512
51703,SIDM00628,Ribociclib,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,Black,51.0,-0.40657794,-0.009697301,-0.027083317492479643,0.06800245202743317
40815,SIDM00834,AZD7762,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,White,66.0,1.694385,0.11990744,-0.14018839647987286,0.05074150101949038
24425,SIDM00411,Trametinib,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,43.0,-1.7228347,-0.046934355,-0.7463203939967978,0.0003273675363154135
833,SIDM00146,Taselisib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,1.5092506,0.12634565,0.6880768223890237,0.0010247115353976004
44502,SIDM00875,Ribociclib,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6878674,0.027665641,0.5651580174353819,0.008924636947911267
21901,SIDM00875,Olaparib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1007822,0.109993264,-0.1329045599881753,0.04685407103668003
8497,SIDM00628,KU-55933,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.11200459,-0.0070626433,-0.3221284344145775,-0.01728493023251173
5679,SIDM00097,ZM447439,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1651005,0.048455022,0.48541898484438495,0.10478711610659705
21190,SIDM00778,MK-1775,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,69.0,-4.400901,-0.23396403,-3.2157784149081237,-0.2588928696488654
73173,SIDM00529,PD173074,Axitinib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.6320215,-0.07777433,-1.7408029246928272,-0.031183438340912473
31297,SIDM00866,Camptothecin,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.3955514,0.028642293,2.4991889085797316,0.09337869964847119
80670,SIDM00893,Olaparib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.1299976,-0.043078814,-0.10507679137343584,0.032378102290148994
68424,SIDM00893,Ribociclib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.901035,-0.09431575,-0.7255794113324472,0.03747542528077
28136,SIDM00130,Cisplatin,SCH772984,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.81958574,-0.043299403,-0.6557994778295526,0.0172267505834755
43237,SIDM00130,Irinotecan,SCH772984,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.7204189,0.054566868,-0.8641034931168905,-0.0009668434233285128
48698,SIDM00954,ZM447439,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-1.2455506,-0.07457396,-0.14878629146782812,0.00912549526243462
48988,SIDM00866,Wee1 Inhibitor,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-0.8480023,-0.07635161,-0.9685531573341266,-0.03074317525756126
3866,SIDM01233,Olaparib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,72.0,0.59532064,0.010451554,0.7669055272474293,0.05353995656574571
23454,SIDM00097,MK-1775,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3628334,-0.09483109,-0.3585454242464798,-0.03752065549589653
6151,SIDM00193,Olaparib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.0087131,-0.0401561,-0.925387934468799,-0.009949653998485002
43782,SIDM00776,BMS-754807,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.5637491,-0.04805704,-0.9414928937092445,-0.04386999439384049
34585,SIDM00893,Doramapimod,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.6069989,-0.019833775,-0.7339269075149611,-0.017762475935470333
52667,SIDM00774,Vorinostat,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.6913317,0.023087721,0.8863318773904113,0.055541710972588636
83303,SIDM00097,Gemcitabine,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8393066,0.03918191,-0.809768227125649,0.0073466708908845255
12059,SIDM00779,SCH772984,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,33.0,0.5706455,0.0497087,-1.5174350235042937,-0.11597636171984375
65794,SIDM00893,Navitoclax,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.4652536,0.12672465,0.9945348044282313,-0.010006913255162975
9358,SIDM00893,PF-4708671,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.3243154,-0.045570273,-0.2553493972121213,-0.025952953269295923
47197,SIDM00776,Oxaliplatin,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.61507595,-0.030428609,-0.8318591276830116,-0.01577996315978026
67814,SIDM00411,Linsitinib,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.8020582,0.16201879,3.042360432426798,0.1262935451998853
47087,SIDM00529,BI-2536,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-0.63112366,-0.0564782,-1.4475996227331875,-0.07892352273582437
40762,SIDM00774,Taselisib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.5960717,0.018675428,0.33285619019109586,0.0028823908025361954
70451,SIDM00774,Cisplatin,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,1.124152,0.037245736,1.2971080798413117,0.07842380966215443
67339,SIDM00954,Palbociclib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-1.0148543,-0.03448981,1.596079121044397,0.07815140226102067
24925,SIDM00673,KU-55933,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.646207,-0.11964589,-1.276308160318388,-0.012456459288098154
71597,SIDM00834,SB505124,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,1.424002,0.11816611,-0.46766723048768405,-0.06432315908875325
36441,SIDM00875,Dabrafenib,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6953601,0.10779004,-0.5459782324613854,-0.009838887169387486
79015,SIDM00866,Pictilisib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-4.3619037,-0.11064983,-1.2940843858339661,-0.038352823602905546
75713,SIDM00878,BI-2536,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,70.0,-1.3129414,-0.12218392,-0.16313915745925478,-0.018763949878666357
30211,SIDM00660,Nutlin-3a (-),MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,1.6216301,0.03913771,3.099826666196276,0.06627684684325391
88762,SIDM00779,BMS-754807,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-3.2794833,-0.04190013,-4.190513864653856,-0.11294572836435506
34088,SIDM00529,Camptothecin,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,2.1614583,0.1355481,0.030220737916728035,0.04468029898918045
68374,SIDM00359,Crizotinib,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.820849,0.054247677,-1.7458878066004906,-0.06822051129529148
65811,SIDM00778,Oxaliplatin,Nutlin-3a (-),Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-1.2681748,-0.04795647,-1.0730354008688727,-0.038800441149998435
36069,SIDM00332,Temozolomide,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0475963,-0.023409788,1.0471014154734066,0.026945818215353152
37147,SIDM00878,Docetaxel,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-2.5931215,-0.22421834,-1.4141019488448872,-0.12649243459637957
96088,SIDM00531,OSI-027,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,4.1247005,0.42487913,2.250465823424356,0.18166663151979118
64251,SIDM00776,SB505124,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.2094433,-0.09375095,-0.9772175738624086,-0.024233235903397723
27814,SIDM00779,Crizotinib,Dabrafenib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-0.7796202,-0.0593851,-0.8870151386113969,-0.05201610497154199
107264,SIDM00673,Alisertib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.3942046,0.085441016,0.9313981170713858,0.06974079313837589
11303,SIDM00628,Luminespib,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-2.821209,-0.18637997,-0.8863348730568724,-0.012050483276457233
93359,SIDM00529,Camptothecin,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,0.91876006,0.047109157,0.4516156862033918,0.0400472170174334
25063,SIDM00628,OSI-027,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,1.3765957,0.094849,-0.5365948792145705,-0.011020288533158396
33816,SIDM00878,BI-2536,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.1344026,-0.10794771,-2.1744963879055765,-0.14887149139868192
81362,SIDM00097,Camptothecin,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.6251264,-0.098357745,-1.3316803639103756,-0.03703756016835566
85858,SIDM00779,Afatinib,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,2.3933773,0.12093046,1.3561428701891032,0.10925176753217028
89979,SIDM00531,Ruxolitinib,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.52204037,-0.014927955,1.65454771998106,0.047363812488679075
26472,SIDM00673,Docetaxel,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.5193321,-0.050064374,-0.45062599014428883,-0.0232470502571078
69477,SIDM00875,Dabrafenib,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.139119,0.22405173,-0.5984444063691412,0.02011370897729928
6361,SIDM00332,Tozasertib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.4232023,-0.15580755,-2.030826913635176,-0.16101046978870406
12534,SIDM00866,GSK269962A,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.3001753,-0.037020493,1.5010783025138053,0.04315879649455514
71298,SIDM00193,MK-1775,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.5243294,-0.21113874,-0.9738479771973356,-0.053412271535991096
37526,SIDM00866,Alisertib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-4.100804,-0.2186415,-2.403476855267688,-0.1376954451338062
84974,SIDM00778,AZD8055,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-0.8621431,-0.04283418,-0.5751105232575906,-0.03657668882632821
21063,SIDM00776,Olaparib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.52853024,-0.010051425,0.3990969947225216,0.018371120273673408
47781,SIDM00875,Axitinib,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6325496,-0.027927153,-1.324835225971659,-0.02859614601594033
88266,SIDM00971,Pictilisib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.56385946,0.02749918,0.9304769399160635,0.054941572072388284
36442,SIDM00954,RO-3306,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-1.4699919,-0.102117896,0.29318136606200307,0.033384435709417196
39050,SIDM00529,NU7441,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.74981695,0.063626625,0.7023600596121415,0.08646547275582303
100005,SIDM00778,Navitoclax,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,0.11077127,0.00559828,0.8469810344154803,0.08065827579838676
97928,SIDM00531,Sorafenib,Dactolisib,Pancreas,0.0125,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.61979914,0.08079987,-0.8062569927612397,-0.009276498105825473
94355,SIDM00097,Venetoclax,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.9283616,-0.025619088,-0.37427293501578873,-0.003488159089915228
85262,SIDM00776,MK-2206,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.1279068,-0.087289475,-0.09014016762187564,0.026008943202638985
104203,SIDM00971,Camptothecin,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.7998095,0.048206776,1.7145378755358962,0.045980626566006155
42341,SIDM00778,AZD7762,LGK974,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,1.8264928,0.09415097,-0.5444177010462721,-0.05800335526858895
35772,SIDM00628,Crizotinib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,Black,51.0,-0.2688585,-0.02564603,-0.33687864963909325,-0.009853462640390987
102889,SIDM00778,MK-1775,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,-2.3112934,-0.06456692,-1.1660754153136779,-0.05779153521346399
107401,SIDM00628,MK-1775,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.26043546,0.02542226,-0.7331404294288945,-0.047918580430528344
53127,SIDM00954,Tozasertib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,2.1185226,0.16093682,0.7121416734335263,0.09482918983542372
105261,SIDM00954,Crizotinib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-2.2051334,-0.16611826,-0.811156123521599,-0.1042852789433737
101964,SIDM00878,Axitinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.3922069,0.12583314,0.7452149863644636,0.057554372558147694
86632,SIDM00834,AZD7762,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,2.333547,0.17178097,2.498023628117643,0.14440785424340657
24305,SIDM00628,Lapatinib,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,0.3035817,0.025247145,0.8317522546911833,0.06430306292387457
55569,SIDM00776,BMS-754807,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-1.1970702,-0.08442277,-1.5384589783479885,-0.06823534568827101
80666,SIDM00774,Axitinib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,2.2304134,0.27662495,1.1837781735440598,0.08487792493108914
51306,SIDM00628,Lapatinib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.6546286,-0.058915008,-1.5149286054171898,-0.09915136981003064
24855,SIDM00193,Linsitinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,53.0,2.8332286,0.11881,2.9768549781567883,0.146285099961548
24859,SIDM00834,BMS-754807,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,White,66.0,-1.928522,-0.12398623,-1.964030031100306,-0.10820295356212967
86994,SIDM00971,Afatinib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.8417991,-0.087105766,-0.8349137405956991,-0.026738779451039908
35654,SIDM00774,Cisplatin,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.1008998,0.03685385,1.3427301218594756,0.10243698920276528
8124,SIDM00628,Nilotinib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,-0.16467309,-0.015432038,-1.1067455852160448,-0.06762575407196506
16257,SIDM00954,Bortezomib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,-0.4013287,-0.024928173,-0.47946507853373155,-0.05224463879191275
71319,SIDM00776,Oxaliplatin,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-2.6166131,-0.12832643,1.6637493950103306,0.08845591307892559
57994,SIDM00628,Axitinib,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,Black,51.0,-0.30388802,-0.025042271,-0.059353599713471525,-0.056872441689855696
14723,SIDM00531,OSI-027,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.3081264,0.29550827,1.8875818801326194,0.12319366263244001
26423,SIDM00779,Vinorelbine,Navitoclax,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,4.039415,0.31233314,2.298371177528884,0.1814206507232942
29610,SIDM00628,Vorinostat,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.18313523,0.018427102,0.7597326918170616,0.0679687418220212
88059,SIDM00893,5-Fluorouracil,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.31402388,-0.01538468,-0.17109597283632477,0.016756304900019656
100299,SIDM00774,Uprosertib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-4.5985584,-0.19249253,-0.026635127950405405,-0.04351201262209078
39401,SIDM00332,Gemcitabine,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6147716,-0.10031351,1.0095110686956965,0.02088135528173413
38100,SIDM00529,Navitoclax,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Black,44.0,-0.29451317,-0.025742322,0.1754270909214758,0.006821386183046926
35786,SIDM00954,Entinostat,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-0.9969593,-0.05528561,0.34778347910053414,0.01561145344893366
3208,SIDM00531,Crizotinib,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.9707881,-0.114213586,-0.9795725420988387,-0.016484738427927404
34724,SIDM00529,Camptothecin,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Black,44.0,6.3009257,0.5233437,4.270849936068667,0.2895164970420354
74521,SIDM00878,Luminespib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,2.8686962,0.30996487,-0.9446184023968884,-0.09144323489679686
49644,SIDM00878,MK-2206,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-0.70705855,-0.030557096,-0.6931750244115298,-0.01454712359102362
80957,SIDM00146,Linsitinib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,5.7059946,0.28500086,3.757261376822295,0.2855412029877206
12502,SIDM00866,SCH772984,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-1.4185504,-0.10441216,-0.8166687089126667,-0.0443152862694691
44956,SIDM00660,AZD8055,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,2.0364692,0.14526764,1.247442798438436,0.0691651264615236
87857,SIDM00660,AZD8055,AZD4547,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-0.59460366,-0.053772766,-1.2202494450706813,-0.06561285737993239
44686,SIDM00774,Entinostat,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.87307966,0.057725865,0.05772837256990925,0.05360676444678853
16027,SIDM00097,Alisertib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.076536,-0.14300436,-2.3268065614795104,-0.11230164144098345
83838,SIDM00971,Alisertib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,5.8053575,0.18496116,1.4279358181599413,0.10218582255890302
93031,SIDM01233,BMS-754807,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,0.742074,0.04821891,0.2097191623985861,0.04306030986797935
26188,SIDM00893,Trametinib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.8878595,-0.08157383,-1.3635618513316008,-0.036790983170153266
49987,SIDM00146,Cisplatin,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,0.7383569,0.029999562,1.3157672877815758,0.07448096389330561
26836,SIDM00673,PF-4708671,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.7389565,-0.09799984,0.14199230903366633,0.015365806935742628
90327,SIDM00146,Temozolomide,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,0.741172,0.017440217,1.378497184227623,0.06440943261333035
13524,SIDM00778,Taselisib,AZD4547,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-0.5583478,-0.034319412,-0.7958260785087293,-0.03116511308316674
79144,SIDM00628,Entinostat,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.4264756,0.08587909,1.181894891515317,0.12222812733709355
77382,SIDM00778,Nutlin-3a (-),SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,69.0,-0.2940159,-0.006451675,1.4822485694551233,-0.005126173639558942
76124,SIDM00673,Palbociclib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.51576334,-0.022138458,-1.1077972472780713,-0.0241582261757452
104043,SIDM00893,Axitinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.843745,-0.07512808,-1.1000087931481282,0.015023017214580854
90470,SIDM00866,AZD8055,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-1.0625973,-0.031513374,1.29086791546663,0.030606730586953554
103047,SIDM00778,Crizotinib,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,1.2783979,0.06967704,-0.6046413607035649,-0.014472708436813688
96644,SIDM00673,Palbociclib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,0.9353969,0.05481706,-0.2614286944114458,0.011733703846786105
68456,SIDM00193,LGK974,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.909964,-0.027853461,1.1490598012951372,0.07181261277261856
87656,SIDM00893,Alisertib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.3016697,0.100462176,0.2611657370905691,-0.06355667660951118
26312,SIDM00529,Navitoclax,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Black,44.0,0.16254595,0.01564058,-0.39337908333895094,-0.047418533664554424
53776,SIDM00529,Pictilisib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.4876521,-0.08966092,0.6533470051385091,0.07098223141230936
54947,SIDM00954,Palbociclib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.4309543,-0.048108146,-0.5347340927079245,0.01649359684659786
23213,SIDM00875,AZD8055,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1607125,-0.110594176,-0.521832394029621,-0.03720898961611548
6989,SIDM00628,Doramapimod,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,0.5794937,0.019581549,0.47038983512460963,0.05352445427770004
49411,SIDM00878,Trametinib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.999498,-0.16133365,-1.8174995616558263,-0.12823651596477972
102967,SIDM00954,Gemcitabine,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-0.27445313,-0.01406245,0.17546586970504083,0.02794637829347926
1664,SIDM00875,Uprosertib,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.47908,-0.10463775,-0.4949131722432211,0.020853407524273802
87988,SIDM00332,Lapatinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1463301,-0.10576317,-0.3104792924758623,-0.006794505911186848
75301,SIDM00893,ZM447439,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.2444177,0.0983954,0.822054064882311,0.052606054716701454
103502,SIDM00411,Dactolisib,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,43.0,-1.3472883,-0.066948965,-0.3914802830646251,0.00926591906886882
61171,SIDM00097,Entinostat,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.1968234,0.13921528,-0.3122052552595547,-0.04071400966728217
51411,SIDM00531,SCH772984,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.5164107,-0.100431696,-1.8973281205477834,-0.023244991326065525
20249,SIDM00778,Olaparib,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-1.4679455,-0.04348955,-1.238632530398141,-0.032114798526875786
104725,SIDM00097,AZD7762,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2312317,-0.048864096,-0.003988092326566652,0.014567129660457086
64896,SIDM00954,GSK269962A,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,1.6447601,0.10941518,0.49020872140102484,0.037357286049073075
62420,SIDM00954,Uprosertib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-1.9130075,-0.16334762,-0.6902000860236769,-0.023969517144006566
64301,SIDM00146,Sorafenib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.67808056,0.03124924,-1.0111698121660677,-0.09617189521983545
81979,SIDM00866,Vorinostat,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.19899087,-0.016680101,0.2571482853496076,0.09365165912501582
40339,SIDM00411,MK-2206,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.5713558,-0.084305525,-0.5956644776974815,0.03421550205605181
56320,SIDM00146,Pictilisib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,1.0780112,0.08625302,-0.165399405397777,0.0312827738410129
97186,SIDM00774,Doramapimod,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,48.0,-2.1251147,-0.074621126,1.427876589053264,0.04215962380645665
25250,SIDM00878,PF-4708671,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,2.625523,0.14760754,0.390106903444364,0.027435259774017312
38645,SIDM00660,MK-1775,MK-2206,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.4392569,0.019164342,-0.34021022068370504,-0.008346947290366013
1121,SIDM00778,Camptothecin,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,1.9144304,0.10870786,3.6122944034886726,0.1978944533691455
38333,SIDM00660,BMS-754807,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,32.0,-2.2396991,-0.19421858,-2.0255234092984264,-0.09614671082377368
30569,SIDM00776,Olaparib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-0.8572272,-0.019010603,0.4518373033198428,0.03309839220880892
22331,SIDM00411,AZD7762,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.8156607,0.115247756,0.3198662536216606,-0.0005584687042713758
49772,SIDM00776,Oxaliplatin,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.5046685,-0.06777918,-1.7643919638041603,-0.02646218050253254
22806,SIDM00193,Linsitinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.81538844,0.0325853,1.7326696785242592,0.1150389792280519
102796,SIDM00774,RO-3306,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,48.0,2.2694387,0.14784494,0.9266969011430666,0.013314909191741203
6059,SIDM00875,Lapatinib,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.75352955,-0.072044834,0.0950354299618549,0.023470921560478555
52771,SIDM00774,Sorafenib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.2907405,-0.07802968,-0.3569935556392073,0.01433519961002402
62099,SIDM00529,Palbociclib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.7079623,-0.019494852,-1.4501925150830275,-0.023287523972547488
9922,SIDM00875,Nutlin-3a (-),Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9161038,0.023389675,0.8624542053722801,0.041703452357835735
69094,SIDM00779,Dabrafenib,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-2.4398263,-0.04056538,0.9487111522107059,0.0852277341894795
68095,SIDM00628,Alisertib,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,Black,51.0,-0.60336,-0.02194559,0.422521294696202,0.03151868154344413
56481,SIDM00954,AZD8055,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,-2.9581428,-0.19592535,-1.1043781239542523,-0.0538744202592096
12712,SIDM01233,Navitoclax,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,72.0,2.1330962,0.058650743,1.3247941781298902,0.018456071790403313
82379,SIDM00529,Axitinib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.1806624,0.033952005,-1.9081856305269533,-0.06329297820068419
63267,SIDM00193,Navitoclax,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,0.26424372,0.016136419,0.7091385658321535,0.037359525680857535
37927,SIDM00778,AZD4547,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-2.0457664,-0.07182663,0.0580899272808911,-0.019269325750659927
20001,SIDM00971,AZD7762,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.88655853,0.02399444,-0.4338567794053965,0.010938516613120028
29875,SIDM00779,Linsitinib,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.6023251,-0.06505335,-0.9474738632020414,-0.13680388261118323
31936,SIDM00971,Crizotinib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7866849,-0.05310489,0.5678904866556672,0.05244090622406293
92245,SIDM00193,Palbociclib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-2.397289,-0.062455576,-0.8227001850631191,0.015599017354862342
73221,SIDM00673,Vorinostat,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.5464973,-0.051828828,-1.1565886403773797,-0.07626500013086202
60897,SIDM00778,Oxaliplatin,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,69.0,-2.0262177,-0.042932037,-0.9589768012862071,-0.03256051289209845
99188,SIDM00878,Alisertib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.499989,-0.13156548,-1.3367312883800062,-0.07593717548814734
10937,SIDM00954,Axitinib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.2862481,-0.10195553,-0.12764801758975547,-0.0992678563232588
92102,SIDM00130,OSI-027,Olaparib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.8015294,-0.07584653,-0.5912784332602642,-0.05794916689954016
63806,SIDM00878,JQ1,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.9755757,-0.09320406,-1.2350997799800434,-0.08814940711454679
14155,SIDM00878,Nutlin-3a (-),Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.7758409,-0.03441573,0.8505848230560978,0.05969987086852054
17682,SIDM00774,Crizotinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,0.8180813,0.120992765,0.2529248296987352,-0.0017098190419740102
50616,SIDM00359,Taselisib,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.65472096,0.058585368,0.26372663991937784,4.897844356540925e-05
17534,SIDM00971,Doramapimod,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.5180303,0.059777714,0.4904301968331134,0.03775244951640352
54477,SIDM00359,BMS-754807,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0957279,-0.07097177,-0.518492930188333,0.0005999285795243956
32675,SIDM00893,Camptothecin,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.62282753,-0.056344055,-2.1683580327527583,-0.08335877147360896
36309,SIDM00776,MK-2206,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,1.8791158,0.13562062,0.9717646465382267,0.0822166161287094
24430,SIDM00097,Alisertib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9919554,-0.09720689,-0.462634936574355,-0.06740622440210285
58772,SIDM00866,Cisplatin,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.3455071,0.032745715,1.516320048932078,0.0435660740009008
74094,SIDM00193,Vinorelbine,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,East Asian,53.0,0.28800043,0.028818516,0.031972232349846336,-0.02108453926206763
44284,SIDM00774,Gemcitabine,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,4.6761866,0.15671144,1.513532734357666,0.10285032783332643
69340,SIDM00097,AZD6482,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.54122484,-0.03799658,0.32020846232790406,-0.00966107370185077
40068,SIDM00673,Dabrafenib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,2.1680744,0.062381573,1.286721509511708,0.0686506463790641
93317,SIDM00097,GSK269962A,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0155525,0.050212335,0.5818745923164662,0.04574902586349604
59355,SIDM00301,MK-1775,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.44819978,-0.047999132,0.5785549705083215,0.02483853956697052
63604,SIDM00893,GSK269962A,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.3127405,-0.024445271,-0.9937026405533288,-0.02515554060474178
61414,SIDM00893,Wee1 Inhibitor,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.67421603,-0.053550217,-0.41892995765320706,-0.016551194008067406
73729,SIDM00673,AZD6482,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,1.1226107,0.06151289,-0.19437521754048823,-0.053642976540407374
82160,SIDM00878,Tozasertib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.43788886,0.021693777,-0.2915213384103914,-0.007711725925607372
21733,SIDM00193,SCH772984,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.659701,0.05700093,0.3817722900685557,0.056397421973297675
22403,SIDM00332,AZD8055,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2873127,0.09181951,0.30633108640627127,0.01827981690709669
24771,SIDM00834,LGK974,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,0.4773275,0.03556457,-1.0918494274586037,-0.051453222991632755
88282,SIDM00359,Olaparib,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.6408895,0.014400874,0.8760107200903232,0.01948713394782546
27856,SIDM00531,Sorafenib,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.6070504,0.07842323,-0.9715561225357152,-0.0730443950436762
65272,SIDM00146,Taselisib,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,2.2723646,0.15779328,3.5856773277666534,0.2110181690114737
103771,SIDM00673,NU7441,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.8366136,-0.061339255,-0.14102188169451277,-0.01783839313688712
28471,SIDM00866,Trametinib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,52.0,-0.78338516,-0.06635739,-0.7592343168783929,-0.033287738996055236
39321,SIDM00531,Taselisib,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.0375177,0.08671055,0.6531922735080967,0.06628048684218349
101704,SIDM00529,Trametinib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,1.2499523,0.09509226,1.847119177479878,0.1187621674620457
59055,SIDM00776,Linsitinib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.2769613,-0.06549333,0.10310907228609228,0.04093978387972088
27130,SIDM00954,Tozasertib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,6.9089355,0.19565962,4.5680354390201305,0.23250717903429471
83282,SIDM00359,MK-2206,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.3523272,0.07889811,-0.059012400300014534,0.04996585759134637
93936,SIDM00779,MK-2206,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,33.0,-2.724607,-0.18657704,-1.50016213654452,-0.1259210870736321
65129,SIDM00954,PF-4708671,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,-1.5931163,-0.07986463,-1.215691923510621,-0.05920034806323016
59089,SIDM00097,Nilotinib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.38453633,-0.02605889,-0.5934502118325964,-0.06862376584783209
3438,SIDM00779,Dabrafenib,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.8873445,-0.11510785,0.06538784314832302,0.02865860439858985
59438,SIDM00301,Ruxolitinib,Palbociclib,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.8484187,0.13416766,2.449287674040218,0.04944297556796197
48982,SIDM00954,Temozolomide,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,0.6040126,0.00726276,1.9860204215858033,0.06419727852800293
205,SIDM00875,Uprosertib,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3355027,0.14200293,0.8595080035931236,0.10077519885021553
107328,SIDM00332,Gemcitabine,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.5376058,0.1214203,-0.44419525525675246,-0.027577832222597024
96343,SIDM00779,BMS-754807,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,33.0,-0.7337872,-0.014520787,-0.6934247815786594,-0.03818080011703474
19143,SIDM00834,Nutlin-3a (-),Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,White,66.0,1.0793917,0.039358053,3.578655671046449,0.15383794572429138
55696,SIDM00097,Doramapimod,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1275169,0.03256007,1.2128057018746832,0.05452241802923202
5535,SIDM00130,Trametinib,AZD7762,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.1717232,-0.095786646,-0.6485964227370759,-0.03624404351090143
60209,SIDM00875,Luminespib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.29161283,-0.032454565,-0.7588299426944628,-0.05824927464378009
36685,SIDM00875,Dabrafenib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.2293865,0.008469276,0.6779465167754066,0.05488345078213653
84254,SIDM00954,RO-3306,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-1.9894117,-0.12218001,-0.4067743163806116,-0.020354975234043907
103908,SIDM00130,Erlotinib,Sorafenib,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.96796244,-0.06297891,-0.4548128549515746,-0.018064414832666142
83018,SIDM00875,RO-3306,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.37243447,0.03718422,0.060828041798335335,-0.013362370083824952
4106,SIDM00774,Paclitaxel,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.2232529,-0.04860351,1.5085562220365292,0.10496428628409277
47110,SIDM00531,Navitoclax,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.0871136,0.18800189,1.022400218752566,0.06998220959010722
3199,SIDM00893,MK-2206,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.77689314,-0.07704592,-1.4181276327370664,-0.1334203433357183
50873,SIDM00782,Taselisib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,Unknown,72.0,-1.0103408,-0.07389067,-0.015388945295175017,-0.009961112359203642
99546,SIDM00782,Camptothecin,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,-3.9714997,-0.2947613,-1.0526526427477287,-0.04826325479926236
9939,SIDM00774,Vorinostat,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,0.7287676,0.03367253,-0.3628265079697153,-0.05093431364121915
41290,SIDM00529,Cisplatin,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.1498506,0.025294775,1.3031010300275274,0.039278862620563924
50772,SIDM00097,Uprosertib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.42400444,-0.026712317,0.8292255511828945,0.048246992616283034
63367,SIDM00776,LGK974,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.69729835,-0.03039857,-1.2656528663479774,-0.007966204826947793
84666,SIDM00332,Sorafenib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7933506,0.10539744,-0.5544851680311852,-0.05429946687784804
26547,SIDM00893,Doramapimod,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.811207,0.031624027,0.3423974879463804,0.053065525143690805
99735,SIDM00971,Entinostat,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.2657099,0.043907844,-0.8187406955323979,-0.021166466566888795
97693,SIDM00332,Docetaxel,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.934014,-0.25637415,-1.5478820175110282,-0.15163730996220662
45535,SIDM00866,KU-55933,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-2.5479996,-0.07225831,-0.04211917803492352,0.008472192477949225
43463,SIDM00774,Olaparib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-1.0268006,-0.038730185,1.2629485013509243,0.03724258429048482
49057,SIDM00778,SB505124,Dabrafenib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-1.3651695,-0.09021164,-2.1698067506311602,-0.06341033025279706
53749,SIDM00776,BMS-754807,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,1.5886846,0.07183741,1.0823925684578601,0.028712015988329103
99934,SIDM00673,Paclitaxel,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-3.505924,-0.16445637,-0.41350695532120274,-0.01149409218830421
5294,SIDM00673,Temozolomide,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.25524846,-0.0057083555,1.0008647454070505,0.04284783275449589
47271,SIDM00628,Navitoclax,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.46784118,-0.046986185,-1.7264878830159054,-0.11180884552260105
9350,SIDM00529,Gemcitabine,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-6.463827,-0.2803404,-3.5307037430026127,-0.09740735512350139
106649,SIDM00878,Bortezomib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.24899182,-0.017533148,-0.36393640381493764,-0.010272199792363093
85362,SIDM00893,AZD8055,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.67140925,-0.059822157,-1.8266161993502954,-0.15110304895032037
67674,SIDM00875,NU7441,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7830768,-0.059763767,0.7853133158596844,0.046101399933096435
36884,SIDM00782,Crizotinib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,3.0462892,0.22138861,0.5921477309334591,0.068005465243705
11253,SIDM00332,Alisertib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.640585,0.031339098,-0.4829291282500746,-0.03182771748224976
101584,SIDM00866,Luminespib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.7911847,-0.06827939,-0.6515019983339835,-0.021572974789928864
44749,SIDM00529,RO-3306,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Black,44.0,2.2381506,0.123516396,1.431152752089224,0.05479372167948315
88095,SIDM00782,AZD8055,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,0.82315964,0.07137516,0.610008864537226,0.05757257621673209
22944,SIDM00193,Vinorelbine,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,East Asian,53.0,-0.2909771,-0.020719541,-0.31920384673534646,-0.01896023548869582
12008,SIDM00673,5-Fluorouracil,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.019779172,0.0006607299,-0.08358603903542611,0.0349545042379151
80437,SIDM00774,Gemcitabine,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.7251769,0.053788185,0.8378921025411686,0.05299593170619909
70794,SIDM00893,Sorafenib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.8234831,-0.11140687,-1.6444743990515207,-0.09118968706748776
71834,SIDM00531,LGK974,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.7799189,0.21767712,-1.7115535292068165,0.00018826546567956627
74445,SIDM00359,Taselisib,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.389936,-0.15246516,-1.81978914987542,-0.02998744248022282
84955,SIDM00774,GSK269962A,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.3874097,-0.08145531,0.11704876059842612,0.026017714680855453
77632,SIDM00097,PF-4708671,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.52394724,0.023273755,-0.06109372383821628,0.03479728400579559
21373,SIDM00954,Dabrafenib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,1.1743805,0.036814623,1.3476083332905178,0.07850244197639206
105571,SIDM00834,SCH772984,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,White,66.0,-0.7850933,-0.031446375,-3.673503548727479,-0.12294514260282279
22255,SIDM00954,MK-2206,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,1.4043347,0.09278626,0.444524907894368,0.0966564073695674
80871,SIDM00529,Cisplatin,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,2.0291328,0.03455164,2.627548358263315,0.09540179102471708
29483,SIDM00774,KU-55933,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.6133873,-0.07495587,-0.22870533745793675,0.0069635695583029605
83415,SIDM00971,Docetaxel,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.6964073,-0.07202024,-1.0514367686219175,-0.006280935344066996
84546,SIDM00776,Linsitinib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-1.52118,-0.06814942,1.9184604058558663,0.08622312887431821
25378,SIDM00866,Alisertib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-2.338286,-0.16028659,-0.661140760026876,-0.03053721220468979
28647,SIDM00971,Bortezomib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.1789809,-0.0068122214,-0.24251463424669958,0.02085902875853854
58159,SIDM00359,Crizotinib,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.30116275,-0.024286881,-2.8916249066772792,-0.12566764717013917
85198,SIDM00875,KU-55933,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4945076,-0.04841801,0.3874702401083472,0.022829025486100454
2461,SIDM00893,Docetaxel,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.5986491,-0.048461877,-1.7456814200283426,-0.06899311035001537
4606,SIDM00628,AZD8055,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,0.7484711,0.060529105,-0.12541534183460812,-0.013606551281967192
91238,SIDM00628,Luminespib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,0.45587853,0.04347253,-0.6240487413620472,-0.06042155021225677
33478,SIDM00971,BI-2536,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.712532,0.15766451,3.106627769848707,0.18794049553480593
77759,SIDM00097,Pictilisib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.5577865,-0.24194479,-1.32694472968125,-0.08641927350553445
65528,SIDM00193,SB505124,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,1.6740464,0.07955824,1.4425897247553792,0.08407217034436969
23897,SIDM00778,Linsitinib,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,1.2313479,0.033974648,0.7427001427531746,0.11871771762310737
9123,SIDM00875,Temozolomide,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2009536,0.030430967,0.762050729587088,0.012257454382615503
21842,SIDM00782,Vinorelbine,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.6310544,0.14180258,-0.5908358886962202,0.08409805649572998
25372,SIDM00774,MK-2206,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.5028325,-0.028608348,-1.2462058190858922,-0.0798529568515023
14756,SIDM00875,MK-2206,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.4444141,0.1115642,1.562096674060956,0.02416604753719932
80529,SIDM00332,SCH772984,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9409863,0.061594103,2.710244339605297,0.19393135899504763
82736,SIDM00673,MK-1775,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.4711918,0.046169244,-1.2781824639748198,-0.0543748162136824
89968,SIDM00954,JQ1,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-1.0881914,-0.08157695,1.5340557219028188,0.0704235455265415
90175,SIDM00875,Paclitaxel,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.46269557,0.03080195,-0.45094308462338284,0.03119868074217344
58055,SIDM00875,Gemcitabine,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1434551,-0.002912103,-1.6595998352213566,-0.08825320727513247
25238,SIDM00411,5-Fluorouracil,Gemcitabine,Pancreas,0.1,Pancreatic Carcinoma,Male,East Asian,43.0,-2.387846,-0.053700108,-2.0040480824959435,-0.029172655944178474
92763,SIDM01233,Camptothecin,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,72.0,1.7633442,0.07713359,2.3721385265814283,0.08082520927096712
75658,SIDM00971,Olaparib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7557042,-0.046756197,-1.0145150555874058,-0.0076157258812616264
31018,SIDM01233,AZD7762,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,0.6232489,0.016636057,1.5006127251012786,0.07174614168812671
58542,SIDM00332,MK-2206,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5810894,-0.1682683,-0.8800700718057961,-0.09884430039986511
48296,SIDM00878,PD173074,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,70.0,0.43157038,0.04618447,1.237928987492727,0.12486030304625803
29426,SIDM00660,MK-2206,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,32.0,4.4707513,0.37696514,1.378983693763847,0.11394278250009597
14533,SIDM00778,MK-1775,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,69.0,-4.2166705,-0.1847718,-1.7224208665725134,-0.060139940629771786
87114,SIDM00893,Nilotinib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.33870855,-0.028026078,-0.4770113761356091,-0.039877939815699266
85402,SIDM00332,Afatinib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.75383896,0.057559792,-0.020244928957791123,0.060662250084688306
18945,SIDM00779,BMS-754807,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,0.9182265,0.01358179,0.10306611639547132,-0.021139807170221705
64588,SIDM00774,Camptothecin,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-2.228828,-0.0760541,-0.8627946847696446,-0.03340433080432204
30156,SIDM00673,Wee1 Inhibitor,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-0.8745448,-0.05151667,-0.6623701710932707,-0.021368059033258585
19296,SIDM00774,PF-4708671,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-1.1409183,-0.054401018,0.5990958146066353,0.022424438769976657
77947,SIDM00893,Olaparib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.325118,-0.050510027,-0.41009860044203594,0.00573918500185093
52526,SIDM01233,Palbociclib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,3.942543,0.14015594,2.5987168058761787,0.09914284530739988
93995,SIDM00954,Doramapimod,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-1.0196542,-0.05042541,-0.6422307685433504,0.017741643336369368
17344,SIDM00866,Vorinostat,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.51173586,0.04375029,-0.3267216206345487,-0.010974677489441751
1691,SIDM00411,Paclitaxel,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.053545,-0.051279955,-0.5519840649402552,0.03635956665685305
58917,SIDM00866,BI-2536,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.254329,-0.07260574,0.5719888499251601,0.01876818403247246
15461,SIDM00774,Gemcitabine,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.6354312,0.15302616,0.5760630559068985,0.058990612792488135
3598,SIDM00193,SCH772984,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,53.0,-2.5492804,-0.15467362,-0.3281338616217733,-0.028834657813230045
61501,SIDM00130,LGK974,Palbociclib,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.54619867,0.03414502,-0.903222840392944,-0.046176031278560424
35116,SIDM00097,Venetoclax,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.077081,-0.058385454,-0.9539241702791788,-0.03882995568137115
100356,SIDM00776,Dabrafenib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-0.6804725,-0.014216922,0.5893560195811873,0.019076123993736416
47025,SIDM00411,5-Fluorouracil,Navitoclax,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.911706,-0.095969684,-0.19069662757960854,0.05664076143344117
73251,SIDM00359,Afatinib,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.84235775,-0.0658587,-1.7665766928652473,-0.043493465580727586
107759,SIDM00782,BMS-754807,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-1.2793175,-0.11708958,0.3241071760993214,-0.014947701750733117
61219,SIDM00130,LGK974,Olaparib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.2576076,-0.07272597,-1.4894915451498867,-0.06909926182658907
107211,SIDM00971,Doramapimod,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7428726,-0.04628642,-0.5163010128413518,-0.005783685829074291
56901,SIDM01233,AZD4547,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,2.8041956,0.030077511,0.2612889346415886,0.00629410468676369
57645,SIDM00875,PD173074,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.021659,-0.079933085,-1.788692774631545,-0.10407948458481338
56369,SIDM01233,AZD7762,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,1.7105,0.052973438,1.4137362681848185,0.11249731354759207
25981,SIDM00146,Nutlin-3a (-),Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,2.1855478,0.06123224,1.8352008867650844,0.08891145020154291
63647,SIDM00146,Nilotinib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,1.106156,0.09383119,1.4677549051793028,0.0705167186744142
64652,SIDM00954,Taselisib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-0.19991516,-0.016362555,-0.20853413213717104,0.0026187053114127873
9124,SIDM00774,MK-2206,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,1.0589255,0.03288515,-0.4072563288035451,-0.003118773364278478
59294,SIDM00878,AZD8055,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,0.4643842,0.042513303,0.15856171104462483,-0.03370531054092633
20456,SIDM00673,Taselisib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.1022248,0.09465034,2.2401709523786937,0.09487685281019306
29059,SIDM00673,Gemcitabine,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.4594148,0.03417571,-1.2215475068620927,-0.013794517178428858
78835,SIDM00531,Trametinib,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.7166457,0.17500897,-0.8390330893016158,-0.00976683729479523
68569,SIDM00778,BMS-754807,Oxaliplatin,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-1.772983,-0.11535062,-2.3101035811466946,-0.15392214260897769
58091,SIDM00529,Lapatinib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Black,44.0,3.9813309,0.25244364,1.3923721998322807,0.08610755312639186
12894,SIDM00146,SCH772984,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.2963883,0.10496897,0.6969878768812143,0.034101091314491724
18616,SIDM00782,Linsitinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.943981,0.11087027,1.1084356683218672,0.09493578255992315
3695,SIDM00866,Crizotinib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.3976867,0.1165698,0.36759628535085825,0.0820261884397198
38929,SIDM00529,Sorafenib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.593464,-0.14429885,-1.46178549847257,-0.04181096166635579
64946,SIDM00193,Olaparib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,53.0,-1.1729119,-0.0541866,-0.5394053567550015,-0.002660652890296898
6485,SIDM00628,Temozolomide,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,1.5736057,0.041741587,-0.48080897390483224,0.01319440456189081
83208,SIDM00628,Dabrafenib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-2.0812738,-0.14491406,-0.7090629660035045,0.007290925361459737
36157,SIDM00782,SB505124,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.39352512,0.026763173,0.2132432787321918,0.00728112633302784
102510,SIDM00673,Afatinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0604256,-0.0750989,-0.5830567440813699,-0.05408589703175135
5786,SIDM00146,AZD8055,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.2510832,0.022894641,-0.2386038093660481,-0.05672227119809607
99475,SIDM00866,MK-1775,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-0.4625334,-0.035894234,-0.2579273314336323,-0.019662327537170753
58468,SIDM00673,Afatinib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,2.6775825,0.18276699,1.0178873364244536,0.05476544655441067
8508,SIDM00878,Crizotinib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,70.0,1.5210694,0.13719393,-1.2013459931501032,-0.06701594896927238
62125,SIDM00875,PF-4708671,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8408818,0.088343844,2.3529799675677943,0.04209782739205313
86392,SIDM00332,Tozasertib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5609728,-0.12527259,-1.2859247827898899,-0.1730413866926754
24772,SIDM00359,MK-2206,Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.088428,0.076342784,-0.8097221840846092,0.010456890756761214
84419,SIDM00130,MK-2206,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,4.351816,0.27229813,2.6002010457022715,0.21802745958743294
78657,SIDM00628,Sorafenib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.6323039,-0.056985717,-1.0547645268092134,-0.07535392895327313
9646,SIDM00628,Axitinib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-0.1201908,-0.009709787,-0.5442842365431794,-0.021867680736308685
46675,SIDM00146,PD173074,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,1.4415604,0.07582356,0.010287561361024397,0.042719053806913675
67868,SIDM00097,GSK269962A,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2389438,-0.040769346,0.4822528876404856,0.03318197836257977
33716,SIDM00954,Docetaxel,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-0.43632382,-0.02967791,-0.07533930870821606,-0.004905885869073391
58162,SIDM00529,AZD7762,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,0.064101614,0.0027510787,0.28786364150798965,-0.0385182951697781
101693,SIDM00531,Navitoclax,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.727344,0.29262194,4.187878172409656,0.20888693713828016
24494,SIDM00332,Crizotinib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6769472,-0.1521998,-1.5763634552258565,-0.14986273761883126
33666,SIDM00778,Nutlin-3a (-),Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,0.2546122,0.005794355,2.0547751420470988,0.046408219242563026
105860,SIDM00774,Camptothecin,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.32516,-0.06326316,0.21374385023576895,0.023337361590506533
60542,SIDM00097,Pictilisib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.660457,-0.040579256,-0.8591795811595399,-0.06023464333749092
40201,SIDM00301,MK-2206,Sorafenib,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,50.0,-1.0893404,-0.09749797,0.36262934982615663,0.03193302626189187
96544,SIDM00628,PD173074,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,3.2697878,0.17815466,1.3297696625593878,0.08411420237706368
47579,SIDM00146,JQ1,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,0.5683275,0.037960414,-0.5031666234695197,-0.024056033746563416
12371,SIDM01233,Camptothecin,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,1.019965,0.04064636,2.130993929603084,0.04420719752964905
101908,SIDM00097,AZD7762,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5322679,-0.06295899,-1.1443611300857623,-0.10044681575359793
64641,SIDM00130,Ruxolitinib,Oxaliplatin,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.9333632,0.12861112,1.2733591793607035,0.045885126294821145
40124,SIDM00097,JQ1,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.230941,-0.065666705,-0.982276873660992,-0.08650838340142288
58456,SIDM00673,Uprosertib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.4054292,0.023946442,0.4511497350686793,0.04453934898793546
99553,SIDM00893,Cisplatin,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.0049525,0.031009523,0.7617686115897165,0.04261968395520084
78559,SIDM00834,Oxaliplatin,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,White,66.0,-1.4566942,-0.11764832,-1.0596601819985987,-0.04688146676072277
104062,SIDM00866,SCH772984,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.2175062,-0.082354985,-0.012906712988292704,0.037352395182931236
22623,SIDM00529,ZM447439,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,0.9824839,0.083499186,0.15326671827332616,0.0325842407623973
63018,SIDM00332,Vorinostat,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.613152,0.07510701,-0.3828772847091447,-0.020501550392038152
28486,SIDM00673,Pictilisib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,1.6825111,0.12811427,0.022413527703633897,0.015353970988153375
98400,SIDM00531,Dactolisib,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.0450786,0.09201364,-0.3130128314049872,0.006480572607241921
31787,SIDM00893,Vorinostat,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.52370924,0.03681105,-0.6667003359139344,-0.02103403476978819
74213,SIDM00529,Cisplatin,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.0843078,0.023120862,0.7438743486300357,0.03883654316115062
12398,SIDM00130,Cisplatin,Gemcitabine,Pancreas,0.1,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.88422596,0.031092789,0.7152211579706304,0.03697853019864592
24420,SIDM00529,SCH772984,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-0.9213304,-0.037730888,-0.5773377787460928,-0.006412186788705877
88415,SIDM00146,Axitinib,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-2.0274992,-0.1452409,-0.06774387266196495,0.01720382636635891
63050,SIDM00893,PF-4708671,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.4340951,-0.11032758,-2.2544423724026847,-0.16116071543209354
79311,SIDM00875,Uprosertib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.9763393,-0.08315714,-0.08855926558101344,0.042264695105179335
1461,SIDM00878,Sorafenib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.3186646,0.103675164,1.2582851967956414,0.07955985108016107
74987,SIDM00628,NU7441,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.7031727,0.071427524,0.2789175666247005,0.04038780584139283
5863,SIDM00954,Vorinostat,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-0.57378715,-0.041266106,0.06897155874874764,0.05132354731222664
90867,SIDM00359,Nutlin-3a (-),AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,3.1026149,0.098589346,1.4533628378365726,0.03857078864535574
13050,SIDM00878,Alpelisib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.2893579,-0.026905205,0.04831406025409638,-0.029067946770693735
90022,SIDM00878,Nilotinib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.6392502,0.13875864,0.8657939890462091,0.059224396376286445
4625,SIDM00776,SCH772984,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-2.9324768,-0.21776283,-1.296360087999008,-0.051906571303429704
80927,SIDM00332,Temozolomide,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.4996333,0.052592076,0.8035898306802143,0.029492781865248653
12267,SIDM00529,BI-2536,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-3.28103,-0.32776073,-2.6880692697299775,-0.10424309725641563
10868,SIDM00673,ZM447439,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,0.6361927,0.044829704,-0.5585734804350599,-0.008333525068366604
11348,SIDM00774,Trametinib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,1.8977997,0.0738093,0.9667876506368374,0.09237388697342468
96734,SIDM00673,RO-3306,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,0.37506893,0.028357528,0.04396684935872687,-0.017776060752918623
64222,SIDM00875,Olaparib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.093503,-0.13339463,-1.3658847523385151,-0.09810113870491662
37916,SIDM00411,Olaparib,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,-1.3316419,-0.030487157,0.056374913223133934,0.022461862130873884
26426,SIDM00193,Palbociclib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,-1.7418969,-0.042186975,1.6492866374622925,0.0877383997504728
67082,SIDM00866,Lapatinib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-1.3789079,-0.118308306,-0.05641831950607245,0.035888674266699186
35438,SIDM00359,Olaparib,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.18058515,0.004172754,0.8471699729654787,0.010133078897427579
50085,SIDM00193,Linsitinib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.635245,0.024746887,1.775770352704415,0.13111611432947862
71971,SIDM00146,Camptothecin,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.1414435,-0.08591675,-1.3388537285452176,-0.051419263702400984
15472,SIDM00628,Vorinostat,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-0.6793207,-0.067307465,-1.2854038779223582,-0.0660601832279246
97127,SIDM00673,Nilotinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,2.0545037,0.13874601,1.1241679481221438,0.08216060566311027
104037,SIDM00878,Venetoclax,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,3.7355149,0.18178102,1.283417373961622,0.08616514393169523
73881,SIDM00782,SB505124,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.1726055,0.06652015,-0.7353233544780299,-0.022412528950313603
27200,SIDM00954,Tozasertib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.956163,0.07261227,0.5395744892348256,0.11276507318115044
47556,SIDM00673,Linsitinib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.62370193,0.012123369,1.3090610513758019,0.06008808691242239
16091,SIDM00878,Ribociclib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.3478364,-0.061999943,-1.0608756414572198,-0.04098707692614566
64093,SIDM00875,Dabrafenib,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.2186238,-0.00950965,-0.20633900581879625,0.02965524917198447
32668,SIDM00866,Palbociclib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.5166126,0.007016789,1.0636089417660481,0.025880020238407783
65597,SIDM00531,LGK974,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.29364783,0.03221002,-2.411801832278551,-0.040007365755796664
41097,SIDM00971,Cisplatin,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.77621,0.099749185,1.7026809804343292,0.05725473165597757
66779,SIDM00774,Pictilisib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,0.3146703,0.011551687,-0.03320281359103012,-0.0037269396865824904
70049,SIDM00097,AZD8055,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.97932625,0.07110093,1.05072642673002,0.06767395945954154
86498,SIDM00097,Venetoclax,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5633595,-0.039008055,0.40061663023806493,0.0075670132952782515
34821,SIDM00529,Taselisib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-1.1941669,-0.064457074,-0.540838614846851,0.004626062602015517
22399,SIDM00778,Navitoclax,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,1.3382368,0.061453708,1.790440972168759,0.1030145771321118
32367,SIDM00954,Navitoclax,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,2.2287247,0.03123966,1.1604605822486713,0.05427484770922201
79239,SIDM00130,Olaparib,Dactolisib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.8502506,0.03842006,-0.38953831495527036,0.01880481372812498
105001,SIDM00878,Crizotinib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.8252908,0.07590052,0.984573630915024,0.0027675668357216125
5747,SIDM00875,SCH772984,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.96445644,-0.027878065,-0.46442286224649776,-0.031295302789262035
34053,SIDM00875,RO-3306,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.847588,-0.048403975,-2.544123533867891,-0.11946679031128837
30129,SIDM00529,Uprosertib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-1.0032948,-0.051499136,1.0215694753837283,0.12730444881939165
101760,SIDM00529,AZD7762,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-2.961042,-0.24885814,-0.4808052002530938,-0.03979864231218011
53403,SIDM00193,AZD8055,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,53.0,-0.8894194,-0.06834448,-0.7492125709278648,-0.02483876068647186
62854,SIDM00673,AZD6482,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,1.2060508,0.07146965,1.3615423437537177,0.08668578644331641
44524,SIDM00778,AZD4547,5-Fluorouracil,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,1.3937666,0.079840265,-1.2588128303159327,-0.05184598330697868
99210,SIDM00893,NU7441,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.5777372,0.05211579,-0.8916172837711596,-0.06705506431599155
73479,SIDM00954,Wee1 Inhibitor,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-0.9112822,-0.05937122,0.06179186236281503,0.02317068186180098
3917,SIDM00878,Docetaxel,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.3465945,-0.11853391,-3.2209634109631,-0.21562118746912892
63307,SIDM00875,AZD8055,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.22019836,-0.02285038,1.7271838924260579,0.09157128921377641
26638,SIDM00673,Wee1 Inhibitor,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.740894,0.1263387,-0.674210531415694,-0.08641737283572463
70805,SIDM00628,Lapatinib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,0.24619694,0.021329436,-0.014526681812819657,-0.019284010428518294
86490,SIDM00834,5-Fluorouracil,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-1.9367466,-0.0829062,-0.9053207473282435,-0.058709879426393406
104493,SIDM00774,Gemcitabine,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,0.3796264,0.025544152,0.35317904153771457,0.021971121010277157
70626,SIDM00971,Sorafenib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.6050143,-0.08756956,0.028438544828228784,0.023853947945334037
55705,SIDM00782,Crizotinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,Unknown,72.0,-2.440033,-0.14789443,-1.3800440004125267,-0.0644892880387006
21132,SIDM00529,Afatinib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,2.389955,0.097490065,0.7411412134398809,0.06429905696120561
89381,SIDM00971,Alisertib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.4357871,0.037807405,0.6420134990248216,0.015185480068183075
18615,SIDM00660,AZD4547,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,32.0,-0.70710313,-0.041597065,-0.8779517370093928,-0.029739683626225564
930,SIDM00866,ZM447439,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.19261767,-0.0127401585,-0.026016975039705764,-0.03428532524849506
14489,SIDM00146,Temozolomide,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.32837304,-0.008188303,0.6063759549913436,0.029367756404304595
25742,SIDM00875,Uprosertib,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1845282,0.13023467,-0.4919781750190699,0.05797088627787499
17210,SIDM00782,SB505124,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.4799825,0.041224655,0.8538085015511501,0.0491135284910987
35494,SIDM00954,RO-3306,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.032111,-0.07735556,0.5066620666753691,0.025353043496200184
26748,SIDM00529,GSK269962A,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,-1.0905001,-0.079242475,-0.07998211595952874,0.028524132390844704
44828,SIDM00529,Venetoclax,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Black,44.0,-1.242784,-0.032467432,-0.4509334031153591,0.009690901987387061
75384,SIDM00774,Navitoclax,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.1604479,-0.0056617656,-0.08570769743465899,-0.019300200823647314
21537,SIDM00954,Nilotinib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,1.455688,0.08623249,0.23578492708511165,-0.011303407439026336
16613,SIDM00332,AZD7762,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9254841,-0.08963468,-1.7913456767610956,-0.09611005323161669
95737,SIDM00130,Erlotinib,Gemcitabine,Pancreas,0.01,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.215101,-0.11183691,-0.4953653240194119,-0.04267269830664823
9640,SIDM00673,Lapatinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.8751438,0.09763936,0.9377382988868006,0.013175482973082315
66808,SIDM00097,Lapatinib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.532374,-0.13683613,-2.042379547337209,-0.07443853606473814
56500,SIDM00866,Temozolomide,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-1.2621924,-0.022207579,1.1360046406222541,-0.005657286712106408
29110,SIDM00332,OSI-027,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5512799,-0.12533543,0.5362092886592563,0.007687084943690184
100164,SIDM00782,Olaparib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.8075537,-0.019055167,0.9746242467133145,0.023305732217965943
38903,SIDM00954,Nutlin-3a (-),Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,2.88723,0.11112714,1.0643994937213288,0.0746379054642012
68269,SIDM00878,Entinostat,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,3.1883137,0.043522574,3.682932899144622,0.19852714384033782
60760,SIDM00332,Tozasertib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.373808,-0.21011211,-2.7261475531505406,-0.20228749031478663
38017,SIDM00866,KU-55933,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.9159994,-0.03952246,0.3789829586954791,0.043555795148468496
72496,SIDM00774,Luminespib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.34422588,0.029903622,-0.79790008733206,-0.036082277241394616
83323,SIDM00531,Crizotinib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.8952055,0.10645028,2.0211664619198273,0.09641635921044046
16242,SIDM00097,Entinostat,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8170793,0.049140114,-0.7222038074708738,-0.07767609236026762
72452,SIDM00878,SCH772984,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-0.8525117,-0.07112539,-0.3526895773067128,-0.012777926580056156
64476,SIDM00529,Paclitaxel,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Black,44.0,-0.52044153,-0.0518227,-0.7728274609880431,-0.024524662756961284
6960,SIDM00774,Palbociclib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,1.5883876,0.084432326,0.22212419699382796,0.01243592139947933
47708,SIDM00673,Uprosertib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.1453968,-0.080398,-1.6737739510174332,-0.11024752542413675
86605,SIDM00779,SB505124,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-0.65099835,-0.064906575,-1.5422661737166463,-0.09733017126767148
25829,SIDM00673,JQ1,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.54871494,-0.038050696,-0.7940480369694582,0.017553776955437965
13036,SIDM00866,Lapatinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-0.95118797,-0.075468175,-1.0978775604250401,-0.06244741364781658
82528,SIDM00866,JQ1,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,2.1540377,0.18543768,-2.652278410283335,-0.08209868561414786
762,SIDM00776,Nutlin-3a (-),LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,2.212604,0.10643629,-0.2147485690754416,0.012039794555077529
81953,SIDM00332,Nilotinib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2780668,-0.09513568,-0.979913681301092,-0.08687911338620558
47037,SIDM00866,PF-4708671,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-0.9470404,-0.043965284,-0.7498573304877975,0.007737715124049692
97316,SIDM00146,Palbociclib,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,1.4943035,0.117712535,-0.7243418018846907,0.02340342857188596
39668,SIDM00866,Dabrafenib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.7744424,0.012107849,-0.009295926406194492,0.012685245927743238
42828,SIDM00660,Camptothecin,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,5.690844,0.51663244,1.962709287789337,0.15716934283403267
76040,SIDM00866,Lapatinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-0.6043285,-0.047202665,-0.2671284220957258,-0.0032383622749610156
3571,SIDM00097,MK-2206,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.32723305,-0.024131559,-0.7642150114881997,-0.06769319465855186
66061,SIDM00875,Trametinib,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3871677,-0.041467696,-0.18631814217740916,0.013469629855271689
4585,SIDM00673,NU7441,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.7449523,-0.0558375,0.2668306789433067,0.06482927164968907
50908,SIDM00875,KU-55933,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6351703,-0.019207483,0.053374912832382826,0.02537303858920273
46156,SIDM00774,Uprosertib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.81434333,-0.045350198,-0.16689024840738964,-0.011621994686466344
76094,SIDM00774,Ribociclib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.8641934,-0.06442455,-0.7573576165751039,-0.0022911148776888816
107032,SIDM00834,Camptothecin,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,-0.27549127,-0.022241782,-0.2794507911370806,0.04595495668889821
106439,SIDM00866,RO-3306,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-3.2693205,-0.16720964,-0.9844648457482333,-0.058791478008862315
67130,SIDM00146,Olaparib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.6932739,-0.033162862,-0.2967846546587713,0.003160896172900923
91494,SIDM00954,Venetoclax,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,2.042351,0.08593882,0.04157802693217898,0.003971607269761184
26259,SIDM00893,Sorafenib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.30153108,-0.026139287,0.06634754654215923,0.00884284663342504
14949,SIDM00332,Crizotinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.8894472,0.07926746,0.2680488224109709,0.048789073778889094
7473,SIDM01233,Linsitinib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,2.2801836,0.18072088,1.332890541149064,0.11634209973534497
78925,SIDM00893,Lapatinib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.5576981,0.12817115,0.8816136901212509,0.054963227784775026
72462,SIDM00673,PF-4708671,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-1.6385456,-0.08888996,-1.4204988733280959,-0.10113678218533557
58394,SIDM00359,AZD7762,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-4.9098644,-0.3282221,-2.493636087089565,-0.1375654262016336
5097,SIDM00673,MK-2206,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.5804446,-0.07347465,-0.6499074456790581,-0.12228849529784322
14891,SIDM01233,AZD7762,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,4.6147227,0.1928386,5.859051839070384,0.20315547690088623
42819,SIDM00878,Palbociclib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,70.0,-1.2662528,-0.05566413,-0.765063300392152,-0.053551969015078124
61193,SIDM00866,Gemcitabine,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-3.430339,-0.20830466,-2.989147329844961,-0.1099876627629341
32476,SIDM00411,Navitoclax,MK-2206,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,43.0,-0.806846,-0.040866084,1.3913601517763228,0.09185348273853554
47056,SIDM00673,Palbociclib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-0.39784455,-0.016067674,-0.9117654542967271,-0.020630757570888527
49165,SIDM00774,JQ1,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.28253418,-0.014574793,-0.40981975522379976,0.04887843676231448
45726,SIDM00878,Alpelisib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-1.2126948,-0.077801995,-1.1568832853997653,-0.024129211062250966
90222,SIDM00628,AZD7762,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,-0.031613026,-0.0026353498,-0.1339390724029174,0.039404716826279086
11705,SIDM00875,Vorinostat,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.58147454,0.028420426,-0.48096881483122067,-0.011931256224367871
25010,SIDM00778,SCH772984,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-0.23101914,-0.009751294,0.5707417166073481,-0.03647676519322797
35092,SIDM00529,Crizotinib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-0.52559185,-0.033092007,-0.5831092638598662,0.01300858138033331
63107,SIDM00954,Trametinib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.6001647,-0.026834628,-0.39622444335662854,-0.01611369569915807
95481,SIDM00954,Uprosertib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-1.5306373,-0.09546731,-1.0865870264939257,-0.05955054232105079
63725,SIDM00971,BI-2536,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1895219,-0.061602645,-0.15374016894358425,-0.00779383659926798
32044,SIDM00660,Palbociclib,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,32.0,1.6126683,0.07968011,1.8159797514920324,0.05283919127824788
78941,SIDM00193,AZD4547,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-2.0230317,-0.082468465,-0.5295193682211896,-0.01351633183944755
30354,SIDM00146,Crizotinib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.09531821,0.008141918,1.0572707204057066,0.08690433186765259
60815,SIDM00097,JQ1,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.7466898,-0.12369149,-1.34155110992259,-0.08270698315530788
43525,SIDM00893,Crizotinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,5.1347904,0.24794078,3.991414725619425,0.1721179291579635
4795,SIDM00673,Afatinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.9911801,0.15451048,0.872134424718304,0.07742044774719668
103193,SIDM00628,NU7441,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.45539227,-0.045086753,0.14912674801288678,-0.0642655027457933
82465,SIDM00628,Palbociclib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,0.48642662,0.013719685,-0.48012471143345364,-0.007464887162669937
58211,SIDM00130,Navitoclax,Ruxolitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.60818785,-0.06650138,-0.8653051206918184,-0.008345112420251164
38733,SIDM00776,Palbociclib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,2.593825,0.10249097,1.8386894084969194,0.061464023708527
9632,SIDM00875,Crizotinib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.0474048,0.19257073,2.923638820559617,0.16924744664654173
20714,SIDM00954,PF-4708671,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-3.0701811,-0.13231239,-0.06786380342490111,-0.05024567294401506
27924,SIDM00660,Taselisib,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,2.4496548,0.17843133,-1.0856644258285262,-0.03396173471036122
11126,SIDM00628,Lapatinib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-1.3165135,-0.11762072,-0.4355527600233723,0.014633350065912005
12625,SIDM00954,Axitinib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,2.2667751,0.17583455,-1.5574217191133835,-0.11619505886115504
63396,SIDM00529,AZD8055,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,1.0137447,0.09350003,-0.15626913708403872,0.004046593298721802
16282,SIDM00628,Navitoclax,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.38848582,-0.038902987,0.2748676765691633,-0.004311585205622935
7665,SIDM00531,AZD7762,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.197202,0.22068748,2.132906009809953,0.11651647605802676
51939,SIDM00628,Linsitinib,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.7073211,-0.05044746,-1.073453748062188,-0.03903055902911576
61392,SIDM00146,Alpelisib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,2.373351,0.15046638,0.5930891265780455,0.0776866615069261
772,SIDM00301,Oxaliplatin,LGK974,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.237267,-0.24303673,-1.4574006577106757,-0.09452434848871702
58761,SIDM00673,Pictilisib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,1.2084742,0.105971836,0.09329807432406667,0.0046189482562320645
93561,SIDM00301,Navitoclax,Trametinib,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,-2.935557,-0.17547911,0.5052933871720418,0.04283698934349417
55295,SIDM00866,Crizotinib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,0.30575842,0.021809084,-0.6698002016588415,-0.03996049120763306
82628,SIDM00146,Afatinib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,0.18844624,0.015796157,-0.16659061278883977,0.004760097007994115
57186,SIDM00146,Docetaxel,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-1.4373732,-0.13851438,-0.6715726465689689,0.003353672605731963
100144,SIDM00411,Sorafenib,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.2371119,0.064944945,0.38948928436018787,0.014077535973243405
65962,SIDM00660,BMS-754807,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,2.6516604,0.22396949,1.4318740767823865,0.05294403478641126
68947,SIDM01233,AZD4547,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,0.89014965,0.029001802,0.034221575883592974,0.025239664781565706
36663,SIDM00774,PF-4708671,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,0.50340706,0.026617998,0.14091241259406478,-0.006490328608910207
104965,SIDM00130,Irinotecan,5-Fluorouracil,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.3577936,-0.16354536,-2.3036788546279507,-0.09401268268850298
71124,SIDM00673,Entinostat,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.5529439,-0.04106572,-0.8564994857307923,-0.04706811303008834
62903,SIDM00774,Linsitinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-0.898446,-0.056065142,-0.6265571922303035,0.01579610402577266
26830,SIDM00834,Dabrafenib,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,0.7175303,0.02826227,0.4793368770208296,0.05986764901264886
79228,SIDM00893,Camptothecin,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.3816641,0.032230582,-1.7628122744896717,-0.11726165088312093
87064,SIDM00834,BMS-754807,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,2.3887339,0.13653016,1.2558513003034242,0.06767492225203134
65428,SIDM00954,Docetaxel,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-7.6305823,-0.4659599,-3.1954972959456494,-0.2715770626502301
42283,SIDM00673,Camptothecin,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.6563627,0.06825157,0.3976776511078556,0.011216907329977653
37996,SIDM00332,Nutlin-3a (-),Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,2.575798,0.13592878,2.526052910654188,0.07467007521582365
16942,SIDM00878,Wee1 Inhibitor,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.8165775,-0.011304778,0.8640936673630363,0.07076447004290753
89373,SIDM00301,Crizotinib,Trametinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.3698704,0.12599622,0.9557440076647741,0.04616065311706718
32716,SIDM00954,JQ1,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,3.2787337,0.22088405,0.683292174544023,0.06828047966316396
96207,SIDM00628,Ribociclib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,1.4540459,0.049915496,0.34864646005237176,0.041457853243061
64360,SIDM00834,MK-1775,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-0.8695343,-0.069160834,-1.0801518881269567,-0.04111004653844664
103357,SIDM00893,Venetoclax,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.5597754,-0.08019638,-1.623990732527155,-0.03620840738957977
100101,SIDM00893,AZD8055,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.1377745,-0.012198729,-0.8345290868664575,-0.022690363004427557
42617,SIDM00628,OSI-027,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,Black,51.0,-0.7523285,-0.07343733,-1.1203370057251916,-0.07040647504665101
27365,SIDM00411,Palbociclib,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,3.1290245,0.14103338,1.4283562435395734,0.11428616437843238
19929,SIDM00774,AZD6482,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-2.0863745,-0.099571414,0.5094761883614357,0.014056876823780413
54430,SIDM00875,Bortezomib,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9069803,0.070499085,-0.2570402576373182,-0.020116302814726636
99708,SIDM01233,Navitoclax,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,0.52375704,0.03944861,0.003429997172076087,0.02141637487974814
79711,SIDM00776,Palbociclib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.8563743,-0.042077567,1.140750938175035,0.05060638385250196
11690,SIDM00529,Olaparib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Black,44.0,-2.9974055,-0.09489081,-1.943083914300968,-0.05110549042731293
84863,SIDM00531,Sorafenib,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.904333,0.115514666,-0.13925263802719307,-0.021075326847029282
23314,SIDM00411,Crizotinib,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-1.8531749,-0.10747264,-0.15854886643122412,-0.08017380654792586
15960,SIDM00130,Trametinib,Paclitaxel,Pancreas,0.025,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.2683125,0.15240799,0.7667138236972478,0.06811878424027336
28967,SIDM00660,5-Fluorouracil,AZD7762,Large Intestine,0.0625,Cecum Adenocarcinoma,Male,White,32.0,1.8366498,0.18942183,0.9003761553749059,0.11755217641894829
27201,SIDM00130,Cisplatin,Taselisib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.72018754,-0.032792564,-0.04252557200442739,0.02707280894942963
41251,SIDM00878,NU7441,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,0.36104095,0.035114963,0.17510508619360254,0.020938935210869314
84184,SIDM00893,Camptothecin,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.080533,-0.09626562,-1.9638434733937697,-0.08842976794041882
21098,SIDM00673,BI-2536,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.45328024,-0.02551089,-0.24098198363999054,-0.009015269690710497
107779,SIDM00954,5-Fluorouracil,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,1.0076046,0.05461092,0.029516033858891396,0.029192487833841325
46374,SIDM00878,Temozolomide,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.38120353,-0.009864077,-0.0315037236699584,0.03374386441600303
106878,SIDM00660,Crizotinib,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,-1.3392495,-0.10342843,-0.9373165530737816,-0.06305163243330499
89293,SIDM00673,AZD6482,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.1244657,-0.07041248,0.551592326855041,0.05622537944192109
76833,SIDM00778,MK-1775,LGK974,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-1.6418105,-0.09448466,-1.0496914804293664,-0.07508206339271808
38620,SIDM00778,Nutlin-3a (-),Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,0.17968982,0.004045225,0.8512123787534547,-0.0327594911828456
16313,SIDM00332,Pictilisib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9570678,-0.09518669,-0.6106469905652266,-0.02301306150474125
17407,SIDM00776,Taselisib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-0.7707445,-0.06638567,-2.0064959403650575,-0.09476980087275072
69144,SIDM00878,Docetaxel,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,0.45797166,0.04584035,-0.01457193680187641,0.04141854227004829
82400,SIDM00893,Palbociclib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.9148102,0.047087118,-0.8918876483697964,0.01260338898514367
89779,SIDM00097,Axitinib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.218008,-0.10685782,-1.068009903126952,-0.08267695869543978
40917,SIDM00776,Crizotinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.1947346,0.0963257,0.9604977478447365,0.01367066971346006
41882,SIDM00774,Uprosertib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,-0.33061832,-0.025175367,-0.47074394740402803,-0.035606019293438124
86581,SIDM00628,Dabrafenib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-2.9315252,-0.16020663,-1.745495126258888,-0.10173922791145608
93952,SIDM00660,Crizotinib,Nutlin-3a (-),Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,0.28950402,0.029931724,0.5244780270555103,0.02266076716677814
92450,SIDM00878,Tozasertib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,2.9226065,0.23408967,0.5528355067369713,0.030947279258976768
12586,SIDM00954,Taselisib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.72941136,0.054243553,-0.26314178966934154,-0.012003041969177465
45111,SIDM00411,Irinotecan,Ruxolitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.5921227,-0.02863539,-1.8703649475625865,-0.05691193331946222
57023,SIDM00878,Afatinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.42333663,0.015947508,-0.2829873718777853,0.0231923332021417
5056,SIDM00660,Afatinib,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,32.0,-1.9895226,-0.15456161,-0.3041812881684955,-0.03867416887655598
47156,SIDM00893,Nilotinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.6844647,-0.18770249,-1.7973644644394036,-0.1870564442276502
85133,SIDM00660,Nutlin-3a (-),Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,32.0,2.0187674,0.060605954,3.8747206141581336,0.08264391130772934
80034,SIDM00332,JQ1,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.8836046,0.08782972,0.6890380621526,0.04585503616169415
19861,SIDM00193,Nutlin-3a (-),Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.55860966,0.010667397,1.3475919009467843,0.0699917458420325
47761,SIDM00146,BI-2536,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.1782148,0.03531718,-0.5420214480615128,-0.03430626119334292
62629,SIDM00301,Navitoclax,Gemcitabine,Pancreas,0.1,Pancreatic Carcinoma,Male,East Asian,50.0,6.7393746,0.21061698,1.861068656100776,0.06913363718300558
103681,SIDM00628,KU-55933,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-2.2509804,-0.09857361,-1.5268114441568759,-0.05215767164077271
44045,SIDM00875,MK-2206,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.509911,0.20684388,2.9830821131395653,0.13084782648035254
38106,SIDM00146,JQ1,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-1.4473388,-0.100828394,-0.5097029759109027,-0.030702172187602808
55588,SIDM00146,Entinostat,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,0.9288815,0.064019494,0.5257537769399465,0.07250492635109644
20884,SIDM00893,Axitinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.9280331,-0.037868895,-0.22124376327161493,0.05601043415767266
27310,SIDM00774,Dabrafenib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,48.0,2.0713384,0.077772826,1.6443143587920885,0.010245955772548413
24250,SIDM00954,Uprosertib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-2.167095,-0.16774035,-0.8254514101968826,-0.0697476714399409
96793,SIDM00628,Camptothecin,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-0.90673965,-0.068631075,-0.5426284861541792,-0.01686499542290867
82726,SIDM00529,Sorafenib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.67720205,0.069083184,0.11144143759342848,0.04634022515553413
96487,SIDM00529,GSK269962A,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,2.472363,0.24104725,1.821330702812687,0.13770496418331687
33257,SIDM00779,Navitoclax,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.5859829,-0.0650413,-0.6226961455627771,-0.05558432041332074
58905,SIDM00782,Dabrafenib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,2.9967687,0.17638856,0.4631889856669466,0.013361991088740408
15355,SIDM00332,Navitoclax,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.43818104,-0.042019363,1.0021322101880532,0.06797008459274581
103782,SIDM00529,5-Fluorouracil,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.4673811,-0.1306385,-2.0282881142191274,-0.10316615808895928
84540,SIDM00893,Tozasertib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.4797662,-0.059795406,-0.719955401331881,-0.0084573119428238
40130,SIDM00301,Cisplatin,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,50.0,1.2796202,0.14179748,-0.029365789445464623,0.000523527923519923
38766,SIDM00875,Docetaxel,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0111582,-0.06761061,-0.7365672694400892,-0.05197526393802354
46750,SIDM00893,NU7441,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.9853898,0.13729088,-0.7691552568436807,-0.020446588282953076
12633,SIDM00411,Erlotinib,Trametinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,3.0298023,0.15630229,1.6582150636214525,0.11997593538047237
13465,SIDM00893,KU-55933,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.9160235,-0.06020169,-0.12456399171905569,-0.006198269613877178
85783,SIDM00097,PD173074,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5510094,-0.105449624,-1.5010810568916377,-0.0939400969756364
13730,SIDM00529,AZD6482,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Black,44.0,1.1146992,0.04148858,1.304322187140154,0.06508513551920332
48918,SIDM00776,Oxaliplatin,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,65.0,-1.7150152,-0.09386743,-1.7672301355734172,-0.04203779152941029
64579,SIDM00954,Paclitaxel,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-0.5927032,-0.047322076,-0.26828371479729773,-0.023406346540343657
34102,SIDM00301,Sorafenib,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.2395372,-0.14692819,0.1798093641702809,0.016264749409721627
82192,SIDM00193,Dabrafenib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,53.0,-0.8964066,-0.020037344,0.47359043272033957,0.03137226933293098
26697,SIDM00529,Nilotinib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,0.9049582,0.03776374,1.2465402596279407,0.1456298173533984
106275,SIDM00779,Taselisib,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-0.8598069,-0.016782409,-1.3821570430115682,-0.03209479851881526
11910,SIDM00673,SCH772984,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,5.1472,0.21016984,0.14473722751478701,-0.018655763686180618
19486,SIDM00193,LGK974,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,53.0,-0.649579,-0.03589121,-0.39851216552961843,0.009163380439892415
73972,SIDM00097,BI-2536,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.3988204,0.10129916,-0.8071449489907304,-0.04636399091075321
21807,SIDM00779,Taselisib,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,33.0,1.8838398,0.089468196,-0.2586834873688404,-0.03611788657322452
101439,SIDM00332,Uprosertib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.68082047,-0.047923766,-0.6386629399053547,-0.09939316421385216
83444,SIDM00529,GSK269962A,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-3.5849195,-0.20210439,-2.1112592385824027,-0.09103143848743968
101398,SIDM00878,Trametinib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.50194603,-0.030903514,0.08278345030489552,0.023271895823671316
78764,SIDM00531,Crizotinib,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.8761119,0.10154681,-0.7662942865998952,-0.037204633812826474
9626,SIDM00332,BI-2536,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,4.2876177,0.21507719,0.18326852600207397,-0.021111545062074827
41673,SIDM00411,Cisplatin,Oxaliplatin,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,3.5060747,0.11747464,2.079445825144151,0.10099901586232593
84541,SIDM00878,Tozasertib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-2.2834904,-0.17171505,-0.7653881970987776,-0.003447722708572044
74735,SIDM00628,Sorafenib,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-1.1194452,-0.07574285,-0.7506012374184542,-0.013721867082230466
48951,SIDM00954,Crizotinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,0.5136648,0.032118496,0.37197206069523264,0.02787315876118903
91157,SIDM00628,Gemcitabine,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,Black,51.0,-1.6500734,-0.066856265,-0.4791918398941169,0.04262528814604629
84465,SIDM00673,Crizotinib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.16178672,0.014943139,0.5554961907162638,0.06728926472518869
15320,SIDM00875,RO-3306,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.96881926,-0.103052676,-0.8517987639321717,-0.0709250232508352
17487,SIDM00878,SCH772984,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.95990825,-0.077343225,-0.7365656434853115,-0.06797916725366629
12162,SIDM00893,Crizotinib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.3680776,0.06379542,0.8435460673633313,0.042894636656030036
41787,SIDM00875,5-Fluorouracil,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2260394,-0.10520908,-1.6171023639280735,-0.1293844750790591
54487,SIDM00332,Alpelisib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.4501956,0.16975081,0.4290576387720713,0.11169399919352488
89182,SIDM00875,PF-4708671,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.139155,0.018714571,2.1309610421053233,-0.03172216876964658
43810,SIDM00779,Navitoclax,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,33.0,0.028337918,0.000838562,-1.0257913871353042,-0.05276840344882998
104180,SIDM00971,Venetoclax,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.3136675,0.01874661,0.9048986473769486,0.04025959118091695
69461,SIDM00971,BI-2536,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.6317306,0.03553685,-0.13587758908535874,-0.0022013890753863983
43307,SIDM00954,OSI-027,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-0.5061608,-0.023961311,-0.05267707658307385,0.006121934207196858
97599,SIDM00332,BI-2536,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-4.7201242,-0.36514774,-1.653246495909136,-0.1378847076293835
6036,SIDM00097,Alisertib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4188021,-0.059933774,1.0983177845100807,0.055190248426869204
29034,SIDM00971,GSK269962A,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.31264398,-0.019119348,-0.8542951232324384,-0.025392443212529398
85068,SIDM00971,Linsitinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.055288,-0.03899459,0.831125858322853,0.06544652045993912
93945,SIDM00097,MK-1775,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4557636,-0.1041733,-1.1370118259230249,-0.06616097495715553
83613,SIDM00359,Camptothecin,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.3981134,-0.10930622,-0.3029327778622904,-0.028455465211524505
6054,SIDM00878,Afatinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-1.5745063,-0.14110868,0.06966693718251712,-0.0047559904459291156
56906,SIDM00130,Gemcitabine,Irinotecan,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-3.4115932,-0.14718734,-2.502207400974397,-0.10155103182662631
39036,SIDM00146,Dabrafenib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.4423578,0.16368322,0.9915436280699361,0.12748745754179425
39655,SIDM00673,Crizotinib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.8845525,-0.12552853,-0.7622599481373099,-0.027200612204265895
3103,SIDM00875,Temozolomide,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.51036793,0.013189923,0.15823358790869052,0.01143234685111104
51920,SIDM00778,MK-2206,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,2.8759096,0.15101743,0.6568730914009401,0.06736535452050663
43053,SIDM00301,Sorafenib,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,3.006784,0.26667285,1.272253384217005,0.08674505153849124
97084,SIDM00878,AZD6482,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,2.290243,0.1658668,-0.5784775608897673,-0.0429677086482584
71187,SIDM00866,OSI-027,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-0.2514062,-0.016300214,-0.2929693653069204,0.013753669998203983
104445,SIDM00531,Sorafenib,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.2258415,0.2937764,-0.5126101132472328,0.01511729557782155
56936,SIDM00778,Crizotinib,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,69.0,-1.4231232,-0.07677387,-1.0506023661148718,-0.05462296857441617
7859,SIDM00866,Pictilisib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.20824088,-0.018253345,-0.38452804249619404,-0.04477158622258704
76780,SIDM00359,MK-2206,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.75783604,-0.042605903,-0.29774255703142805,0.03071334089230207
84507,SIDM00673,Tozasertib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.90087706,-0.06255274,-1.5303906926951731,-0.10621217373101416
7261,SIDM00893,Tozasertib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.9956849,-0.08045282,-2.499793124844993,-0.07416940715034523
47909,SIDM00878,Uprosertib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-0.48645502,-0.024955224,1.054211618400872,0.04923904888602426
87275,SIDM00411,LGK974,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.193785,0.046674762,0.44023289184827163,0.0034382792591464402
92576,SIDM00834,Dabrafenib,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,-1.746968,-0.040823147,0.5384652230064604,0.016200927536091383
1595,SIDM00146,Paclitaxel,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,0.29390362,0.02678779,-1.0617860432122648,-0.05763262539303319
27316,SIDM00893,Olaparib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.306913,-0.05058332,0.28978849597301326,0.023430900670155817
10392,SIDM00359,SB505124,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.4607842,-0.10099888,-0.5188210273277182,-0.024422749105677617
45750,SIDM00097,ZM447439,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0510724,-0.05171436,0.7511222098629905,0.09539939529676691
28751,SIDM00660,SCH772984,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,32.0,-4.128505,-0.15590638,-3.4217030886663276,-0.1029325901451777
92004,SIDM00834,Vinorelbine,AZD4547,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-1.7274419,-0.13077866,-1.1702777563811018,-0.027017761313241538
51237,SIDM00130,MK-1775,LGK974,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.9440519,-0.0874989,-0.9643486001669114,-0.08934058857416206
49022,SIDM00146,Entinostat,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.57851833,0.046702582,-0.40382624604574613,0.031018852606990676
85271,SIDM00866,PD173074,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,3.5185978,0.16547582,0.14569382454418797,0.012838729863813429
51157,SIDM00875,MK-1775,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8030741,0.03735253,-0.22504410163356048,-0.06892638089107143
68589,SIDM00529,Venetoclax,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.1986609,-0.031007014,0.26186742638226834,0.004357035821663679
98802,SIDM00097,Bortezomib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0147971,-0.057330072,-0.038848047118453195,0.004508902851308211
14888,SIDM00529,Taselisib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Black,44.0,2.4103298,0.18513294,-0.6159619803381358,0.06307987917335359
28761,SIDM00875,NU7441,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8984847,0.083755195,1.6114211903512274,0.1572910714196393
44218,SIDM00097,Docetaxel,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.719371,-0.16249833,-2.0968987731517976,-0.124697614623461
26811,SIDM00834,BMS-754807,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,White,66.0,-1.9652195,-0.09954195,-3.0805132031671105,-0.09320382701358634
46258,SIDM00673,Ribociclib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.3242662,-0.07356731,-0.837526251410994,0.007562864992136761
14287,SIDM00301,SCH772984,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.8828733,0.35518482,2.79012634511232,0.13066705251256955
44064,SIDM00774,Sorafenib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.1485823,0.08252262,2.996629794616661,0.12030558327403384
40777,SIDM00778,AZD4547,Crizotinib,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,69.0,3.3437824,0.22071551,0.896319280592291,0.002063699525370315
13172,SIDM00971,SCH772984,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.8276043,0.07982811,0.7779767244498549,0.04920981470956131
16400,SIDM00628,MK-1775,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-0.3832416,-0.03764354,-2.1899961244842197,-0.15305731764173935
42543,SIDM00359,MK-1775,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.1166466,-0.09378041,-0.9265509483962308,-0.014435363765953798
48341,SIDM00628,ZM447439,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.36999986,-0.023833629,-2.6404528201517152,-0.12673747175249184
46206,SIDM00866,Linsitinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,52.0,-0.9812659,-0.060416985,-0.06465343124052254,-0.011950444746547184
106559,SIDM00774,Navitoclax,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,-0.21497168,-0.007098326,-0.3246869849891467,-0.008305303222446407
84875,SIDM00301,Erlotinib,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,3.387467,0.100997955,2.231445029977105,0.10117266262383835
65052,SIDM00146,Afatinib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,2.5472753,0.16105938,1.4420589978479945,0.10112157895127367
842,SIDM00878,KU-55933,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.44510373,0.016973661,-0.3519114776957285,0.043433181081461776
28350,SIDM00875,Gemcitabine,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.70983976,-0.0015774263,-0.969613826817892,-0.06400087963896653
27437,SIDM00628,KU-55933,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,Black,51.0,0.71282697,0.049826983,-0.7203286846170001,0.010629041138428256
95188,SIDM00779,Navitoclax,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,1.3712918,0.024084818,0.23083708389845747,0.0070576806695648074
80271,SIDM00531,Linsitinib,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.3514379,-0.051611703,-0.23133727437802526,0.029693513972413974
29613,SIDM00673,Alpelisib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.153296,0.08395324,-0.9791109081559564,-0.012806778832993894
30019,SIDM00866,MK-2206,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-2.0025687,-0.098786466,0.7241657966731234,0.10925744698753143
89362,SIDM00782,Afatinib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,1.4401146,0.12074926,1.3526322375105562,0.05698531084516881
55432,SIDM00673,Alpelisib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.1676984,0.08131133,-0.40807977132507245,-0.01826560583087114
56414,SIDM00774,Camptothecin,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,0.13100985,0.0053043393,0.7316582797794678,0.00947156356096686
7217,SIDM01233,SB505124,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,0.7397654,0.025542311,-1.1861764599146871,-0.044554210841258
10394,SIDM00954,Vorinostat,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-0.86163753,-0.059650067,-0.2412563023606328,-0.056936961867226674
96491,SIDM00971,NU7441,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.95720375,0.041211974,1.5789869016217233,0.06635650561144343
7128,SIDM00778,Afatinib,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,2.1022637,0.0951417,1.6606205111081673,0.02825527188077904
2686,SIDM00971,PD173074,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.3259835,-0.03031821,-2.1387935271381053,-0.007296239320013753
46572,SIDM00529,Temozolomide,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-0.36215174,-0.0077494057,-0.09000514192152952,0.026471856722082958
87644,SIDM00893,5-Fluorouracil,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.155373,-0.05212861,-0.6428611598595095,0.005571480114074522
73661,SIDM00146,Venetoclax,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.9100339,0.025250226,1.133003421827913,0.03615974546225166
40741,SIDM00146,AZD8055,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,0.39192748,0.035915017,-0.9486044134968156,-0.061259391158082196
27486,SIDM00301,5-Fluorouracil,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.7035363,-0.19265637,-0.8019310760620157,-0.08407750101770416
46147,SIDM00893,Trametinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.66976374,-0.06775205,-1.0588012297455207,0.010878534749668625
5665,SIDM00146,Docetaxel,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.7898872,-0.1426828,-2.202247696812002,-0.2188337091333209
14651,SIDM00531,Olaparib,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.9879269,-0.03977547,0.28888646541963736,0.026929090156457565
33929,SIDM00628,PF-4708671,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-1.5243306,-0.12317896,-0.5063682312164478,0.018720315650685746
43837,SIDM00301,AZD7762,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,50.0,5.8310585,0.6164008,3.1696192246829367,0.24359038532569258
95136,SIDM00866,AZD6482,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-0.6755702,-0.035936907,-0.672393004866942,-0.043173883594806894
25841,SIDM00875,BI-2536,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-3.5447588,-0.17144218,-2.1446255316749503,-0.0633065444959067
65117,SIDM00628,Docetaxel,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,Black,51.0,-0.34946185,-0.03170936,-0.9303189778676126,-0.06680850047788979
65737,SIDM00834,Afatinib,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-0.96871006,-0.037183814,1.2641537023247265,0.03067553180224357
50048,SIDM00529,Vorinostat,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Black,44.0,0.39865682,0.039762247,0.6263770881489515,0.11006456517020784
19097,SIDM00193,Afatinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,2.731586,0.23483007,1.366333466339053,0.1381581394195507
92689,SIDM00146,JQ1,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.9590168,-0.08191166,0.07990952381167904,-0.008534186660437065
84485,SIDM00301,MK-1775,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,50.0,-0.64733434,-0.05259523,-0.1463422113754218,-0.009835164514014637
35193,SIDM00774,Vorinostat,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.5028667,0.027038647,-0.051163019050160734,-0.0470617093876557
1650,SIDM00774,Nilotinib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,48.0,-2.0695748,-0.13170001,-0.49689599431859793,-0.027925994619475127
68877,SIDM00774,Paclitaxel,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,-1.6751707,-0.061319914,-0.23800567708820244,0.0524311882908675
85840,SIDM00146,Sorafenib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-0.5829159,-0.055856932,-0.025803987118887,-0.017653119562228342
102289,SIDM00954,Sorafenib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,1.4741746,0.1173533,-0.7542702829306782,-0.037000093266695115
21869,SIDM00359,Navitoclax,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.74892664,-0.055580225,-0.11536126194238712,0.022760932482310498
80993,SIDM00673,Tozasertib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-3.473752,-0.19929257,-2.4077546843873923,-0.1594186704041533
75546,SIDM00529,Trametinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.5142182,-0.085021816,0.749499380574353,0.026103485187322174
30771,SIDM00411,Linsitinib,Dasatinib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,43.0,1.967404,0.11033357,3.602803625145972,0.1691961166304082
20702,SIDM00628,Afatinib,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-1.7460886,-0.14825815,-0.7569756362586803,-0.09963539654140395
42066,SIDM00971,Linsitinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.5394974,0.017317709,-0.7395273817100881,0.0021886034328247894
35892,SIDM00834,Nutlin-3a (-),SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,1.4596151,0.04955101,1.2529903525345887,0.06320737167161024
35914,SIDM00971,Gemcitabine,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.4285333,-0.08135995,-0.7624232048759487,0.016324147482254664
58661,SIDM00774,Camptothecin,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.4781617,-0.015939338,1.5069766405586913,0.06794601361960886
55810,SIDM01233,Nutlin-3a (-),Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,1.682998,0.07413989,-0.06516100357682501,0.023911580349139955
48049,SIDM00130,Olaparib,SCH772984,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.0846055,-0.052727416,-0.7863783216603846,-0.04312256028501427
25179,SIDM00776,Vinorelbine,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.3553977,-0.023038557,0.11303126778937142,0.0038459527604350753
19758,SIDM00779,Afatinib,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,1.0467523,0.0781943,1.4280160514215228,0.07618930570122168
89593,SIDM00866,Tozasertib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,-1.316968,-0.07443208,-1.8268326607579957,-0.06867375719155142
66943,SIDM00130,Paclitaxel,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-3.5604084,-0.18296021,-2.8012228861452524,-0.1279333324700974
22959,SIDM00778,LGK974,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,69.0,2.6530435,0.09147935,0.7301749212414896,0.02629055569597432
31025,SIDM00875,KU-55933,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7624718,0.014086444,-0.47173359683650773,-0.013910277802174222
73645,SIDM00531,Dactolisib,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.1137325,0.090588495,0.3358313611429001,0.05086609242423715
51364,SIDM00097,MK-2206,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.725891,-0.2584182,-0.7649938431984411,-0.065742951629329
59808,SIDM00097,AZD7762,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.1820343,-0.11284689,-1.285177185698701,-0.06511975200117767
13751,SIDM01233,BMS-754807,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-2.5950105,-0.16237353,-0.8395307915624018,-0.07587791720741877
35645,SIDM00628,SCH772984,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-0.6412818,-0.04408699,-1.0798836695593808,-0.06134055830728336
98544,SIDM00301,MK-2206,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.0106676,-0.09982891,0.6815335285835006,0.047726094588071935
73272,SIDM00531,Irinotecan,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.1866726,-0.14528818,1.5581946948795156,0.09728962818364315
39130,SIDM00673,ZM447439,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.8591271,-0.037322357,-0.8134783884295437,-0.06241010722656955
80800,SIDM00893,Wee1 Inhibitor,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.4910309,0.13587563,0.9168542658932292,0.02414757314833916
20506,SIDM00193,AZD7762,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,5.830673,0.44174707,3.6687289998847263,0.2187343722868861
17969,SIDM00531,Oxaliplatin,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.0215364,0.10977603,2.5513336446535817,0.09323890428092053
43997,SIDM01233,Taselisib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,1.9350042,0.15161538,-0.2719525199960897,-0.022423191769271714
71656,SIDM00834,BMS-754807,AZD4547,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-0.38675103,-0.0335215,-1.6761387819121787,-0.07480248977579446
45765,SIDM00193,LGK974,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,East Asian,53.0,-1.443183,-0.07421039,-2.0748250651428575,-0.06662439629428635
80191,SIDM00673,SCH772984,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.3091521,-0.17191432,-1.1151986026965957,-0.10935333866127266
39049,SIDM00146,PF-4708671,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,2.385154,0.062333707,0.9209737281408608,0.04879599966045139
55566,SIDM00878,Afatinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.0075496,-0.0975543,-0.41800869524174283,-0.026449863026977983
20716,SIDM00779,Oxaliplatin,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-4.3447185,-0.21754853,-1.8040380522668356,-0.0821166416084946
70827,SIDM00411,MK-2206,Ruxolitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-3.5059364,-0.18076663,-0.531790265855756,0.009810927385635876
65446,SIDM00971,Paclitaxel,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.2938728,-0.105871834,-1.7981333723058126,-0.06886811591758722
40137,SIDM00193,Palbociclib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,53.0,-2.2264297,-0.051854607,0.5598831170356254,0.043141601292396276
18682,SIDM00878,Vorinostat,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-0.5525211,-0.070060834,0.048715732325994576,-0.011904009964753296
1717,SIDM00971,Crizotinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.4932138,-0.03760202,0.46980190390864557,0.045129911416572834
26891,SIDM00193,Afatinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,4.434266,0.2752571,2.1971758454729104,0.16072493684725406
73616,SIDM00097,5-Fluorouracil,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.09718832,-0.004667448,-0.1893775139887247,-0.028461511683120323
44229,SIDM00866,Vorinostat,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,52.0,-0.44786718,-0.038673937,-0.2637993363971236,-0.053089907438907104
38376,SIDM00529,MK-2206,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.0988606,-0.03828786,2.116073277715297,0.17871305591790473
65596,SIDM00146,Linsitinib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.4831765,0.04526526,1.4455910808567738,0.12706813660245
1800,SIDM00875,Alpelisib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6627357,0.06005691,1.0528410444454073,0.03206846366553097
63003,SIDM00776,5-Fluorouracil,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.932013,-0.06452032,-0.35905777239390996,0.012923534186280913
31480,SIDM00529,Docetaxel,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.1055169,-0.08895907,-0.0036291644490757226,0.049942738584801714
6950,SIDM00531,Dasatinib,Ruxolitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.70551956,-0.074231535,0.48723986333144664,0.0566626172693385
38181,SIDM01233,SCH772984,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,72.0,-3.849049,-0.17071858,-2.4980833476724755,-0.08242892848960619
97032,SIDM01233,Dabrafenib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,1.920316,0.08427967,-0.4718575945223629,-0.004106322677318715
33115,SIDM00779,Vinorelbine,Oxaliplatin,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-0.8839319,-0.083665244,-2.1693005452274,-0.10282598043418607
24626,SIDM00097,MK-1775,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1113062,0.07711927,1.2533928705981223,0.11861875303849977
46272,SIDM00130,Cisplatin,Olaparib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,3.0311925,0.26110992,-0.45014548467374027,-0.007126451842010731
25580,SIDM00332,Olaparib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.8225708,-0.040505458,0.2588992955641852,0.006369499544607233
60620,SIDM00971,MK-1775,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.0821095,-0.06919353,-1.2043558832266297,-0.02399740009972147
93381,SIDM00971,Dabrafenib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.072142,0.06934317,1.4691087548348527,0.08058361657580822
100639,SIDM00776,Crizotinib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-0.6735471,-0.05149831,-0.4618982540290731,-0.026415538331626666
34570,SIDM01233,MK-1775,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,1.3821367,0.10871909,1.101913947498096,0.061606751084652016
16389,SIDM00097,Uprosertib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.50238,-0.13107817,-0.6940551164933989,-0.04891374145102872
36501,SIDM00971,Linsitinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.42013595,-0.013772438,0.504695694052522,0.05467976592446559
38986,SIDM00660,Trametinib,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,4.3023157,0.12732683,0.6929684332630711,-0.020065545491494124
38121,SIDM00529,SCH772984,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-2.083096,-0.07174573,-1.725501387056131,-0.010128349368034263
95985,SIDM00673,Lapatinib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6466653,-0.055270646,0.560876812009304,-0.024532815574930172
75980,SIDM00628,Gemcitabine,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-3.0344238,-0.121886134,-0.9912431118907247,-0.039626338041616554
23363,SIDM00878,PD173074,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.37340766,-0.044154517,-0.6902392978718843,-0.05685448184080348
61105,SIDM00146,Doramapimod,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,3.521654,0.22122566,0.5968967331684293,0.0706556170446511
2870,SIDM00878,Navitoclax,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,70.0,0.39338386,0.007037782,1.1565419217734179,0.05691211234263738
101494,SIDM00893,AZD8055,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.4834826,-0.04194152,-0.7875997698873459,-0.06488016620054035
57673,SIDM00332,AZD8055,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.45690984,-0.036132578,-0.3625066301776967,-0.021463587680813013
89020,SIDM00628,Doramapimod,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,0.29767418,0.009511286,0.9184821581610937,0.022926719726553475
52596,SIDM00529,Trametinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-1.5148667,-0.08423958,-0.7890847617227278,-0.016960153326690746
77031,SIDM00531,Palbociclib,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.150994,-0.03937657,1.1138352950943489,0.010424684148805433
9980,SIDM00130,Oxaliplatin,MK-1775,Pancreas,0.2,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.4912114,0.10591377,-1.5870134379969434,-0.021412349137446718
100180,SIDM00146,Venetoclax,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,0.8165096,0.020588083,1.6150207235872633,0.0746189104726534
73421,SIDM00971,Taselisib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.0662284,-0.17037068,-1.9571878784798584,-0.11179722676805949
33651,SIDM00332,Wee1 Inhibitor,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4590198,-0.10129645,-0.5460191152973876,-0.0627837719964833
9399,SIDM00529,SCH772984,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,-0.27031955,-0.010492495,1.1959291733598911,0.11785008344109835
96041,SIDM00673,Camptothecin,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,0.38364163,0.010159352,1.9995713027534587,0.0847460509198645
17017,SIDM00097,AZD7762,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.127831,-0.054157205,0.24808621252768645,0.04458661031054969
105917,SIDM00971,Trametinib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1288916,-0.015848389,0.16856726860836546,0.0035112689722863687
26266,SIDM00628,Lapatinib,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,Black,51.0,-1.134799,-0.09908488,0.05334426624248954,0.04348454233006844
19684,SIDM00628,Paclitaxel,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-4.7188754,-0.20720382,-2.461208179777444,-0.1210723476677134
16600,SIDM00531,Crizotinib,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.32502222,0.03562595,-0.722206534500372,-0.043958494138952066
100577,SIDM00866,Paclitaxel,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-0.23533942,-0.01856159,-0.8855277745070809,-0.0397645711213253
64025,SIDM00193,AZD4547,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.97033525,0.043376878,1.3314770824280238,0.0800662003410443
6586,SIDM00529,Pictilisib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-2.575847,-0.14555734,-1.1042285791635906,-0.012879864958376475
62618,SIDM00782,Dabrafenib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,-1.094124,-0.029381584,0.5118474565803902,0.009962165679490768
54304,SIDM00660,SCH772984,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,3.0179663,0.1268753,0.615702981855501,0.046913697224681944
85336,SIDM00971,RO-3306,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.6978557,-0.08363503,0.3350076570926641,-0.009531734679275032
77924,SIDM00628,Palbociclib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,0.72690225,0.013528327,1.0702591902570828,0.041331825954510605
90100,SIDM00130,LGK974,MK-2206,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.8323427,0.1344191,-0.14804181514255343,0.00013774264880257845
84927,SIDM00834,Trametinib,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,1.9797295,0.045378603,-1.0827322939506852,-0.05720785756797686
71205,SIDM00878,Nutlin-3a (-),Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.7751082,0.11964842,-0.13500453843624852,-0.03244287228510171
26632,SIDM00893,Ribociclib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.5097258,-0.080857344,-1.136739733485848,-0.04400865754728194
71620,SIDM00193,Taselisib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.2962584,-0.13557807,-0.7798735297599418,-0.02872141748804981
89046,SIDM00146,Luminespib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.80450815,-0.06574492,-0.5124498595133785,-0.03194964201709066
28517,SIDM00332,Gemcitabine,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,2.8241067,0.2614821,3.3372791843248835,0.2383322226896389
101765,SIDM00628,Nilotinib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.5410551,-0.05480208,0.5449959553031197,-0.023290300673104617
105851,SIDM00673,NU7441,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6622762,-0.0474718,-0.9364015603237259,-0.07229487272663146
35428,SIDM00673,Temozolomide,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,0.15823546,0.0024322113,1.435454200177131,-0.011999417115465934
89764,SIDM00774,Crizotinib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.6436989,0.096913375,0.7357105268173451,-0.001956316307173788
38132,SIDM00776,SB505124,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,0.45529386,0.028000573,-0.827935503595948,-0.03760722994523796
65066,SIDM00673,SCH772984,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-4.2720437,-0.2967205,-2.183471992354609,-0.09418957124924984
77862,SIDM00782,LGK974,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-2.0612156,-0.10473069,-0.635685429326111,-0.03983600728825686
38676,SIDM00097,PF-4708671,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.539796,0.19197814,0.7805523998107133,0.021025151556067868
17388,SIDM00893,BI-2536,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.0034144,-0.08285002,-1.6027539694968373,-0.07697470939732587
51915,SIDM00628,Sorafenib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-0.44531676,-0.021457147,-0.4726617233139625,0.024767070276753022
1686,SIDM00779,Olaparib,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,0.89724493,0.015606989,1.09879269410218,0.021326548661358642
20977,SIDM00971,Tozasertib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.215298,0.038420733,1.6893078871303278,0.040221644125247105
63988,SIDM00875,OSI-027,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.80461925,-0.06368971,0.021890795150222846,0.003668424574882868
4114,SIDM00875,Crizotinib,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.19301695,-0.022503871,0.6958363321612125,0.05642087749141719
11606,SIDM00660,Vinorelbine,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-1.2090818,-0.12650546,-0.35485004988683677,-0.08060884089117648
42603,SIDM00893,Trametinib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.6648321,-0.06837965,-1.499597977817987,-0.061793227713246
104675,SIDM01233,Afatinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-0.51250315,-0.037251316,-0.6154793687312836,-0.018900912654889395
4986,SIDM00971,AZD7762,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.0784585,0.05377799,0.06727990022555001,0.034216027866066805
85970,SIDM00779,Crizotinib,AZD7762,Large Intestine,0.0625,Cecum Adenocarcinoma,Male,White,33.0,-0.45687252,-0.03272026,-0.9170628096456399,-0.0829550509985651
26872,SIDM00146,Entinostat,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,3.102001,0.18183498,-0.5030148321104386,-0.007480053322439087
61774,SIDM00301,5-Fluorouracil,Sorafenib,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,50.0,-0.8858276,-0.1183028,-0.8750140381270286,-0.05625891335015754
22197,SIDM00673,Axitinib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,1.5020753,0.14641888,2.27174328314638,0.1925220402509157
78598,SIDM00673,Nilotinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.363458,-0.09707358,0.3558011319534146,0.07200763193643615
11022,SIDM00146,Taselisib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-3.1896293,-0.19559096,-0.8603091992266836,0.003929846432175407
89065,SIDM00411,AZD7762,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.3109825,-0.030794168,-0.31844629126500906,0.0015146333987818116
44477,SIDM00628,PD173074,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,3.5942557,0.15559511,0.3831990867779749,0.09014819825200886
7425,SIDM00628,5-Fluorouracil,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.5720369,0.048360396,0.6108264131027578,0.06287446125084606
100169,SIDM00660,Dabrafenib,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,3.044129,0.24991357,-0.31256330163549,0.03571875056273535
99904,SIDM01233,LGK974,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,72.0,0.8665675,0.04200399,-1.799026393253152,-0.05615007127597517
103120,SIDM00779,MK-1775,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,-2.3948789,-0.06655228,-2.48816340893846,-0.058583394060802214
53037,SIDM00778,AZD7762,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,0.44962156,0.015758865,-0.6978014917798487,-0.003689356464121719
63347,SIDM00778,AZD4547,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-1.5419092,-0.042695913,-0.6046360019214986,-0.03078234527442477
55756,SIDM00531,AZD7762,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.28466251,-0.017157227,1.053149134605557,0.04848418829028825
24320,SIDM00834,Navitoclax,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,3.548536,0.2311976,2.565383884356529,0.14209877024854864
14322,SIDM00954,AZD8055,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,0.38011762,0.027313173,0.3387879103352961,0.027199550300648648
2634,SIDM00529,Gemcitabine,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-2.5850272,-0.09986058,-1.0573107428039494,-0.011100701503546929
34329,SIDM00531,Oxaliplatin,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.5637631,0.20599763,1.3229253902399905,0.05606935958672733
56592,SIDM00782,SCH772984,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.5514301,0.1492911,2.910272299465962,0.17772081626250844
98519,SIDM00146,Gemcitabine,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,6.3434443,0.19760036,0.7308164006629837,0.024824633745107415
60936,SIDM00628,MK-2206,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,1.0065007,0.087552056,-0.969570954036322,-0.029968612935401005
12438,SIDM00954,5-Fluorouracil,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.0,-1.2498411,-0.055121113,-0.47026324025606586,0.029925752664951004
11900,SIDM00628,Doramapimod,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,1.732299,0.057418782,1.6359269101904779,0.08171754271524238
68127,SIDM00130,Dasatinib,Paclitaxel,Pancreas,0.025,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.7930244,0.113098845,0.2608342064306794,0.036949381329872646
6604,SIDM00411,5-Fluorouracil,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,43.0,-2.2746081,-0.06836891,-1.0471614384340182,0.009516791032945332
74529,SIDM01233,Dabrafenib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,72.0,1.7388445,0.06889873,0.6202175650283489,0.022927473891681243
58747,SIDM00301,Gemcitabine,Ruxolitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-0.6931502,-0.06652023,-0.25172011296223645,-0.09966307497834749
28779,SIDM00529,BI-2536,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.5134692,-0.1208067,-1.4082621653908354,-0.0545249106612169
100628,SIDM00097,AZD7762,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.185777,-0.0394673,-0.6078561208083262,-0.050958700246816896
2497,SIDM00866,AZD8055,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-1.345057,-0.04122161,0.0541196512915143,0.009015591073066128
39683,SIDM00673,Sorafenib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.2576393,0.080818735,0.8605974128826447,0.030949138902616947
26593,SIDM00971,GSK269962A,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.38383296,-0.0208477,0.9142031855277855,0.009019994209619216
54028,SIDM00878,Gemcitabine,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.1346006,0.044775873,2.6689776430522665,0.12027828511091158
35483,SIDM00193,AZD8055,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,East Asian,53.0,-0.71059716,-0.05682819,0.022547686224151677,-0.014619835846268917
15977,SIDM00866,Nutlin-3a (-),MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,0.9671334,0.037065115,0.20813333637844175,0.009294166054023289
107745,SIDM00971,Axitinib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.35361913,-0.015207682,-1.8306548601384218,-0.056904630505872876
71217,SIDM00774,Crizotinib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.12637883,0.01853002,-1.0428779392477028,-0.04975656376209791
69159,SIDM00776,AZD8055,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,-0.8441982,-0.071147315,-0.410746431717784,-0.033397659435819134
37279,SIDM00971,Olaparib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.15154073,0.0040301657,-0.65176162673289,-0.0022787505663336483
93455,SIDM00097,PF-4708671,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.166212,-0.06291906,-1.24093220124431,-0.019002189667225184
44406,SIDM00529,AZD7762,MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.5918305,-0.04082222,-0.9579204327665689,-0.03898008861597592
50620,SIDM00301,Paclitaxel,AZD7762,Pancreas,0.0625,Pancreatic Carcinoma,Male,East Asian,50.0,1.1684794,0.034888923,-0.729799287440416,-0.08670669331266145
59806,SIDM00332,Ribociclib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.740877,0.1948067,-1.6965058713860546,-0.08590855405321716
17474,SIDM00628,Afatinib,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.34510294,-0.02553098,0.34291257719134555,0.0383082457415152
42644,SIDM00774,JQ1,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-0.26403555,-0.012633037,-0.5374175052250361,-0.006475801890001632
104969,SIDM00774,Venetoclax,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,-0.34553355,-0.0072958386,0.6937907026023895,0.03919221651980335
101611,SIDM00359,SB505124,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.75984645,-0.036779176,-0.10369219073900568,-0.009562703592285133
113,SIDM00875,Luminespib,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.39765707,-0.04338731,-0.9586923790577682,-0.0693119693727991
88509,SIDM00628,Luminespib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-0.85408115,-0.08230763,-0.4512366889370835,-0.013866426306002468
825,SIDM00774,Nutlin-3a (-),Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.7946498,0.18591973,0.6033507382656808,0.024019659927415393
103696,SIDM00097,Dabrafenib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.3912232,-0.12298773,-1.9508846016190602,-0.1323148872255072
54973,SIDM00971,MK-1775,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.0396199,-0.03496787,-0.022164967406376152,-0.011396844678449484
30931,SIDM00628,RO-3306,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,Black,51.0,0.2153502,0.019202486,-0.782863699024773,-0.026084236486275475
93656,SIDM00673,Venetoclax,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-0.654114,-0.017514851,0.36948892197449823,0.030761674807482438
94770,SIDM00954,Pictilisib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-2.4251785,-0.15804793,0.12062715423409283,-0.015852684342177462
10202,SIDM00529,Temozolomide,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.7798838,0.018810153,-0.20572201843179633,0.035146172478573975
71695,SIDM00954,Gemcitabine,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,1.3699597,0.103680395,-0.16287876018345576,0.00970604384657701
63404,SIDM00660,Palbociclib,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,1.8398542,0.0977208,1.3677880395166353,0.03975360523902093
53506,SIDM00146,JQ1,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,3.4543912,0.18101865,2.6049064167201568,0.06813830629925612
45481,SIDM00146,PF-4708671,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,1.6953495,0.060801122,-0.2001422878351428,0.03939117909941888
21047,SIDM00359,AZD4547,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.588206,0.21666417,-0.9120424229962724,0.006472969885950776
31353,SIDM00332,Nutlin-3a (-),Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2818491,0.059233803,0.8129306643948487,0.011266694892233125
98258,SIDM00097,Crizotinib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.69324607,-0.040131476,-1.0481013839689575,-0.08127950703784183
21142,SIDM01233,AZD8055,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.3153262,0.09724324,2.129521442984317,0.12634895156066847
26450,SIDM00531,Dactolisib,Palbociclib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.0128677,0.09179455,0.14329164083930468,0.04932510882505269
106475,SIDM00774,Sorafenib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.2409456,-0.12943,1.0609029272525727,0.057787598606439096
9911,SIDM00130,MK-2206,Olaparib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.5759497,0.13911209,-0.24466102998975012,-0.04870318237914155
9611,SIDM00628,Tozasertib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-2.988975,-0.2542096,-2.288211940704414,-0.13435345067905022
94578,SIDM00778,SB505124,Vinorelbine,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,69.0,0.8492291,0.040435594,-0.6474011072628538,-0.004877070062357731
13087,SIDM00628,Trametinib,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-1.8763857,-0.116679214,-1.0239431595893709,-0.010313348253011166
98508,SIDM00954,Sorafenib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,0.6604923,0.04810371,0.5084719756753114,0.04885064195434824
40900,SIDM00193,Navitoclax,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,0.6815333,0.037713137,0.3420775601437991,0.06380985150932895
22318,SIDM00774,AZD8055,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,1.445484,0.10553858,2.213820180599981,0.09357539826100525
57569,SIDM00954,Ribociclib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,1.6440569,0.07094999,0.5991920229110612,0.10778347069596354
104408,SIDM00531,MK-2206,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,5.60545,0.5295639,4.23254962345766,0.16747399691525267
96057,SIDM00332,Alisertib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,0.23954979,0.011297952,-1.1145719307766704,-0.042221538168962174
75231,SIDM00779,Nutlin-3a (-),AZD7762,Large Intestine,0.0625,Cecum Adenocarcinoma,Male,White,33.0,-1.7435024,-0.05968384,0.5698614889050085,0.048550079877232824
81229,SIDM00893,Venetoclax,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.5336204,-0.07822928,-2.424711784953236,-0.029240653664086475
53043,SIDM00875,Camptothecin,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2685269,-0.14519125,-0.5136558079750615,-0.06580195229704784
65879,SIDM00778,BMS-754807,Nutlin-3a (-),Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-0.290284,-0.018735513,0.75731970039207,-0.01260009899248862
39455,SIDM00878,PF-4708671,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-0.8856015,-0.043397307,-1.4787520041727975,-0.052101273802484666
91665,SIDM00673,Ribociclib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.7381396,-0.05901345,-1.2080508398896919,-0.02321491725412355
54576,SIDM00954,Venetoclax,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,3.8074682,0.12990919,-0.8777483309223146,0.0037309169960881307
81211,SIDM00893,Entinostat,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.13642,0.052634742,1.4969693149925887,0.05071078512993859
24474,SIDM00130,AZD7762,Dactolisib,Pancreas,0.0125,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.2854083,0.12697257,-0.42112247717130613,-0.0031984603579791994
50821,SIDM00130,Dasatinib,Olaparib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.7127973,0.1462659,0.8983173852562364,0.047919671463112365
5471,SIDM00774,MK-1775,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,0.5665341,0.058027048,-0.6833374385006408,0.0005111339598189257
22761,SIDM00878,Palbociclib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-1.7354198,-0.09189957,-1.0728691186762027,-0.057300471155586986
90309,SIDM00332,Doramapimod,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6939199,0.05137313,0.03645303412087548,-0.06858911809340933
29164,SIDM00878,Linsitinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,4.00275,0.29160443,1.3668360470698815,0.05172605685621239
16922,SIDM00779,Palbociclib,SCH772984,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,33.0,-2.023592,-0.1669002,-0.9926769278037807,-0.041926368644194974
477,SIDM00779,SCH772984,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,2.8838584,0.09095026,1.5638794615903766,0.050433549893863124
50431,SIDM00301,Crizotinib,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.53175974,0.06377468,1.212210011987422,0.059374464290664196
107393,SIDM00954,ZM447439,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-1.5128887,-0.093420446,-0.8733695291254013,-0.04148080682644841
45909,SIDM00193,Palbociclib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.3715365,-0.061469182,-0.43328971154516727,0.025944117858000326
86370,SIDM00774,Olaparib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.3531524,-0.05472183,0.2362568632362855,0.01918669120632481
66899,SIDM01233,Camptothecin,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.1806262,0.04574069,2.013144990273016,0.024768110351652578
3581,SIDM00529,Afatinib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Black,44.0,0.5270406,0.03419117,0.17497484941961264,-0.023811583331132688
29788,SIDM00866,Nilotinib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.4205539,0.08896119,0.08156301448231693,0.05500778859580642
74068,SIDM00971,MK-2206,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-5.226428,-0.20947556,-0.39710098181195924,-0.03280095931163242
102552,SIDM00776,5-Fluorouracil,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,1.8105819,0.039086156,0.6543018649707261,0.026120223470499956
5985,SIDM00146,Navitoclax,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.036158323,-0.002804277,1.0807364338454413,0.014490231217733554
93680,SIDM00878,Docetaxel,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,70.0,-2.0630145,-0.15007122,-0.6118956576969942,0.011787766295625402
94368,SIDM00893,KU-55933,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.1213255,-0.061881434,-0.7013612629262852,-0.052072677234673716
71764,SIDM00531,Dactolisib,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.5556309,0.15835564,1.3122071932914394,0.08737340101754389
80890,SIDM00866,Doramapimod,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.9369566,0.047075614,2.2359786604466385,0.058983617557616004
29079,SIDM00878,Uprosertib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.7415426,-0.04535025,-0.6870945419120815,-0.014897469239868793
26939,SIDM00779,SB505124,Dabrafenib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-0.25780782,-0.024742283,-0.9199281101657278,-0.07635562806029825
71274,SIDM00673,Cisplatin,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,4.3259764,0.24765028,1.75763681071956,0.07136111331330412
74050,SIDM00673,Axitinib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,0.46004188,0.049276643,-0.7587509532085108,-0.02817393253114578
73335,SIDM00971,GSK269962A,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7220837,-0.10834401,-1.3656011422868486,-0.1306570585456042
59933,SIDM00411,5-Fluorouracil,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,-3.4809842,-0.10728806,-2.6936365254695716,-0.05467431034623684
61448,SIDM00628,AZD7762,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,Black,51.0,0.75019634,0.07618364,-0.8956295424244854,0.008146686230375578
6699,SIDM01233,5-Fluorouracil,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,72.0,1.5084418,0.106457025,-1.7755397581390002,-0.06536804345295287
97957,SIDM00531,Lapatinib,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.284917,0.34913263,-0.24843076975201517,0.05942064710235549
19563,SIDM00301,Ruxolitinib,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.0921175,0.01529511,2.471466706542393,0.056478549026869475
71618,SIDM00628,KU-55933,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,2.5849056,0.18335848,-0.8765396464669909,-0.005480196988196819
106556,SIDM00332,KU-55933,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9052264,-0.036993753,-1.4626514151393277,-0.06100169872768379
9226,SIDM00875,MK-1775,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.208943,0.010924893,0.23649824562584526,-0.04319207074239106
43856,SIDM00774,Alisertib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,0.6216407,0.045771714,-0.7997703672866696,-0.04183066378609541
102354,SIDM00673,Gemcitabine,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,3.2109487,0.28591236,3.78720451527513,0.18609143174203788
16834,SIDM00893,BI-2536,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.286537,0.18260528,1.648860827809224,0.1273826166720357
103593,SIDM00779,SCH772984,Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-1.1981171,-0.08630051,-1.1683609544760631,-0.05096420408175261
36900,SIDM00359,BMS-754807,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2468898,-0.10416642,-2.6053448057957884,-0.10960590591759325
44430,SIDM00146,Gemcitabine,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,2.7169168,0.12228465,3.9998348932268546,0.13099486012686304
23674,SIDM00875,Crizotinib,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6341188,0.06704714,-0.03695492191337432,0.009708030710593273
32249,SIDM00778,Palbociclib,Trametinib,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,69.0,3.2595248,0.12408243,0.06758658177501788,0.007991637236704886
105489,SIDM00332,AZD8055,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.959246,0.11257299,1.026000094474721,0.07134942304570294
72794,SIDM00146,JQ1,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.64697933,-0.05513606,0.424016747713833,-0.015142550853686649
73859,SIDM00971,Gemcitabine,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7218307,-0.05820869,-0.38528540405258743,0.00973194125597074
13856,SIDM00301,LGK974,Taselisib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,4.083174,0.51961946,-1.2015122918705672,-0.02505474670305485
58887,SIDM00628,Bortezomib,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,Black,51.0,-0.10951156,-0.0065237237,-0.5417645754413652,-0.019026123521696213
26175,SIDM00332,SCH772984,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2414494,-0.07084489,1.3559109007724617,-0.01229298055588608
101647,SIDM00146,AZD8055,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-0.31552348,-0.019532537,-1.3438468922527866,-0.07486302768769873
65753,SIDM00878,AZD8055,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-1.0832382,-0.09907981,0.4008787028181061,-0.009379213036286596
1735,SIDM01233,LGK974,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,0.94273,0.054915078,-0.6356782302713538,-0.046337291615192226
80723,SIDM00301,MK-2206,Crizotinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.4945846,-0.14250582,0.3105559416976959,0.06308227652637553
46435,SIDM00097,Olaparib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6419692,-0.032928802,-0.02455245976179398,0.017504336964829403
106004,SIDM00146,Tozasertib,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.429917,-0.08790389,0.7188257314497455,0.04116809524023405
74364,SIDM00878,Paclitaxel,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-4.374639,-0.29867268,-2.627736009746295,-0.2502474798527297
41483,SIDM01233,SCH772984,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,3.7338214,0.23667447,1.9222432986689812,0.16518743281179257
13143,SIDM00774,Paclitaxel,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.5038835,0.070091926,0.33559077546748695,0.06619985018267917
83409,SIDM00971,Lapatinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.44079563,-0.023720793,-0.15930235013702745,0.001082035508023965
24436,SIDM00193,Crizotinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,53.0,-0.5573081,-0.02008246,0.017780673894966195,0.034281485953049716
98616,SIDM00878,GSK269962A,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.9695743,-0.07484525,0.8953578361778785,0.05731794744767073
49949,SIDM00529,Vorinostat,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.61395675,-0.06190165,-1.2641520578202041,-0.07249535228709574
54194,SIDM00971,Entinostat,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.7108831,0.11104786,0.7277712851105297,0.059022179777250376
60007,SIDM00875,Taselisib,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.4932157,0.04292894,2.3694227193034725,0.10276705489890273
62254,SIDM00778,Taselisib,Trametinib,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,69.0,1.3469609,0.039232638,1.4378684065092762,0.07989426412367999
65921,SIDM00774,GSK269962A,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,48.0,0.7865865,0.04801518,-0.6205154318981473,-0.011675813805729528
60713,SIDM00971,Crizotinib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.8424282,0.08664154,-0.47542862940862207,0.037557645627867446
74266,SIDM00893,Taselisib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.95050734,-0.04086422,-1.3045510110930858,-0.06917139871159217
28415,SIDM00954,Ribociclib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,0.11700096,0.0038592312,-0.1663286519935773,0.025782589477575613
37220,SIDM00673,Navitoclax,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,1.965864,0.10891817,1.7574467752620124,0.056242843715947205
45017,SIDM00774,Paclitaxel,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,0.4000765,0.018393712,-2.758568880164518,-0.031192860818493637
49058,SIDM00954,Tozasertib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-2.1634054,-0.130991,-0.9358111160547469,-0.06340664314965101
26224,SIDM00776,Camptothecin,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,0.6667257,0.047132477,-0.1751276316286361,-0.001501007326984864
7732,SIDM00673,Trametinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,0.9664938,0.09458006,-0.7271163732796257,-0.06580763023867582
22753,SIDM00531,Cisplatin,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.5128071,0.12188513,0.45212555848449854,0.056721846900491514
74418,SIDM00332,Pictilisib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.404723,0.19915642,0.3014540820338713,-0.03841842046032206
60393,SIDM00301,MK-2206,Trametinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.893444,0.28172925,2.3352863117228493,0.11406355774975763
16038,SIDM00893,Vorinostat,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.3439826,-0.07639983,-1.164764844179915,-0.00848173367522514
49462,SIDM00660,Dabrafenib,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,0.24598205,0.025136044,-0.7508297259597332,-0.014433556427978689
5520,SIDM00193,AZD8055,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,53.0,1.6860589,0.15100434,0.32617976992891445,0.05560719476382051
55499,SIDM00774,Afatinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,0.25842696,0.018875575,-0.7800164928876637,-0.03322952525493886
6846,SIDM00866,Dabrafenib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,52.0,1.846756,0.07428088,1.171288856315913,0.04921320903466939
105528,SIDM00673,Venetoclax,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.3396512,0.0455822,1.0547737803385326,0.03553642617126757
13894,SIDM00097,Axitinib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.9985604,-0.1647432,-0.4291404590702119,-0.06484888082585126
56980,SIDM00529,Cisplatin,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,1.1497247,0.025036316,1.1259468850169858,0.011449740145660572
29536,SIDM01233,AZD7762,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,0.97639984,0.026970547,1.3423161887534303,0.12666863745659165
14870,SIDM00130,Ruxolitinib,Irinotecan,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.7219673,0.02668999,1.9140118746211066,0.05077276579278544
80176,SIDM00893,Axitinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.1309891,-0.04718617,-0.24790991608277782,-0.016158073637960534
2117,SIDM00866,NU7441,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.5223606,-0.10698691,-1.0394522472719216,-0.028946213943302705
40481,SIDM00834,Olaparib,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,0.6668202,0.015821667,2.074058768786586,0.06274561437231853
24697,SIDM00893,MK-1775,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.43790683,-0.040923327,-1.0292600031981531,-0.06176942371360505
29236,SIDM00954,Vorinostat,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.0,-1.1745558,-0.09026767,0.20559061930575798,-0.03580929244377704
85592,SIDM00971,Sorafenib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.49195698,-0.034169048,0.2062205898565055,0.0014801994436468582
87801,SIDM00875,Crizotinib,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.144238,-0.03212812,-1.2797076392847546,-0.08898880526688739
86274,SIDM00529,Afatinib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-2.306522,-0.11119551,-0.8483499157309521,-0.009949451036430568
94209,SIDM00628,Alpelisib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,2.25019,0.14905441,1.0219916971559826,0.11606367783313679
62445,SIDM00193,5-Fluorouracil,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.627081,-0.12501523,-1.2129709717676262,-0.09547149720539648
103123,SIDM00332,Sorafenib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8682185,-0.056305967,-0.9955706796728887,-0.0907004552317834
89053,SIDM00954,Lapatinib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,1.7092811,0.12072558,0.28548057745263655,0.027311494437251067
76573,SIDM00878,RO-3306,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.5400662,-0.037532464,-0.578256981676961,-0.05061337861446611
85597,SIDM00875,Doramapimod,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.550829,0.045603845,1.0408991759274775,0.046540890006725705
11527,SIDM00146,Lapatinib,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.7201455,0.065872826,1.77851852069013,0.12800520047114625
65329,SIDM00332,Ribociclib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.6806068,-0.109653495,-0.8397719012615318,0.01088074827467935
28619,SIDM00097,5-Fluorouracil,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.8116233,-0.12404557,0.6918707155536786,0.06382345771030586
37812,SIDM00130,SCH772984,Ruxolitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.2652708,0.12999065,-0.925438765965301,-0.02416535747839759
11845,SIDM00146,RO-3306,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.26400104,0.021757688,-0.3763038744163796,-0.00025860039068304445
68461,SIDM00878,RO-3306,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.1277031,-0.05562485,-0.8111339307106861,-0.03421128925598284
25598,SIDM00097,Cisplatin,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.5302054,0.034435816,0.8981104849666249,0.051910112546396076
66257,SIDM00776,BMS-754807,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,2.2641335,0.16575491,1.3040490514110663,0.08458184284787841
99923,SIDM00893,PD173074,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.0158277,0.03954194,1.3311303345168233,0.13722511279376953
29252,SIDM00866,Gemcitabine,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-2.7727556,-0.17250943,-1.8558944861898976,-0.08821489402899647
5596,SIDM00878,Uprosertib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,0.65711504,0.027734995,0.5984025774464058,0.06919115037165427
71579,SIDM00097,Alpelisib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.7946431,-0.05753152,0.2921999312585855,0.0190633827074041
85608,SIDM00332,Paclitaxel,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7481905,0.11811203,-0.33135471455049337,-0.052334777068539
42321,SIDM00954,Trametinib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-1.3097875,-0.053234108,-1.5347689945770697,-0.03800978391887702
42156,SIDM00866,AZD6482,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,52.0,1.2281455,0.084670074,-0.33504145546148556,0.0032932156033423587
97564,SIDM00332,AZD8055,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7266881,0.06724997,0.5114277569643674,-0.010028779157083768
43701,SIDM00875,Cisplatin,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.348005,0.019977825,0.09591918891930634,0.013680339360236342
45271,SIDM00332,AZD6482,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.3474371,0.17585935,-0.3856006384214405,-0.03369832464673341
23129,SIDM00866,Uprosertib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,52.0,-1.6863168,-0.08430992,-0.6776483659937242,-0.01394629568720686
11897,SIDM00875,Sorafenib,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3932226,-0.038213003,-0.7676257771605429,-0.037237640221916155
78782,SIDM00097,Linsitinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.789357,-0.092569165,1.4212656406646818,0.04193578056501563
90994,SIDM00875,Navitoclax,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6545105,0.071565665,0.8210159585330744,0.039113149647616974
29620,SIDM00954,Lapatinib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.9363036,0.03671814,0.5183188466421118,0.02981836220821487
84109,SIDM00411,Crizotinib,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,43.0,-1.7221013,-0.07551358,1.095280187974302,0.07710510140549667
65798,SIDM00893,Temozolomide,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.7575694,-0.016292294,0.3358769158985722,-0.01016920461698049
28207,SIDM00628,5-Fluorouracil,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,0.1251036,0.0062376466,-0.6631902291187851,0.0007901038459794914
60370,SIDM00954,Afatinib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,-0.53413033,-0.04328238,-0.9127462503374502,-0.026473027715097384
61945,SIDM00893,AZD8055,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.3405702,0.072741054,1.287737066392173,0.048701663233868986
71051,SIDM00359,Trametinib,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.79902077,-0.032201193,-2.2512109960798092,-0.1117109530388789
88687,SIDM00529,Palbociclib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Black,44.0,-2.5863972,-0.09899367,-0.5244694558342423,0.013250816556095165
16121,SIDM00660,Crizotinib,Camptothecin,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,32.0,-0.19638534,-0.020458264,-1.5033819113052338,-0.10688548651027908
53059,SIDM00971,Lapatinib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.3919863,-0.07519761,1.3915431289193299,0.0560686250893363
20293,SIDM00779,Dabrafenib,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-2.8031154,-0.06318284,0.22689473084456624,0.04383268522441327
96100,SIDM00866,PF-4708671,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-0.7700258,-0.037954476,-0.47530620248964445,-0.014526091183680935
97423,SIDM00529,Docetaxel,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-2.5163646,-0.17990558,-2.8978220221245103,-0.16007291882189711
87887,SIDM00893,Venetoclax,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.3532381,-0.047874417,0.561177686956604,0.07154471140050522
38726,SIDM00779,5-Fluorouracil,MK-2206,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-1.7090349,-0.04701558,0.804408009276308,0.06548188767611476
21678,SIDM00146,Alisertib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.9380512,-0.08360831,-1.526250246138661,-0.08031565023679424
43295,SIDM00893,AZD8055,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.0743607,-0.09393889,0.8179755704348297,0.023642560924472145
48969,SIDM00673,RO-3306,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.5563599,-0.084388934,-0.7291128081717985,-0.046577472130913705
82413,SIDM00301,Navitoclax,Erlotinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,1.6928931,0.23229627,-1.0623830409235286,-0.035569604079040286
2155,SIDM00954,Vorinostat,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.6286293,-0.027390156,-0.01860400155330959,0.02616189530402066
45704,SIDM00146,OSI-027,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-1.4112022,-0.13114713,-0.8539386668087299,-0.08178553564772136
44089,SIDM00834,Taselisib,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-0.58278805,-0.041424032,-0.9153291213576079,0.02252752482755325
8978,SIDM00301,MK-1775,Palbociclib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.2094061,-0.25303718,-2.480008040831535,-0.21904546277427756
100073,SIDM00673,Entinostat,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.8476069,-0.1565978,-1.3667766994677548,-0.05784294568401069
25813,SIDM00529,Trametinib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,3.3836782,0.107169166,-0.7536921664510975,-0.044095461904652765
105124,SIDM00893,Navitoclax,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.2399645,0.2749038,1.1685093359363068,0.019149591919979083
101165,SIDM00529,Palbociclib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-2.8316624,-0.1026197,-1.7068679402896836,-0.03643247063699843
2229,SIDM00130,Olaparib,Erlotinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.6409904,-0.032281574,-0.24246327859609565,-0.004855372092240513
6049,SIDM00866,Tozasertib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-1.5106518,-0.08319383,-0.8621637343429387,0.046960695842808826
78247,SIDM00875,Camptothecin,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.77136743,-0.07004289,-0.9365297789414232,-0.008210743409623626
107964,SIDM00971,Wee1 Inhibitor,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.83242315,-0.021190515,0.3906913290309987,-0.0034202998789323097
49902,SIDM00782,SB505124,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.47336304,-0.042101264,0.28154264705259924,-0.0180480550333017
19448,SIDM00146,Venetoclax,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.8308985,0.105603114,0.706014993135439,0.0743999133944427
86767,SIDM00359,Palbociclib,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.5526639,-0.04462178,-1.2974699833397183,-0.004694350691038156
77769,SIDM00774,Cisplatin,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,1.133344,0.038242146,1.5965015083276657,0.07616734932891484
598,SIDM00097,Bortezomib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.67125046,-0.03607729,-0.162944201685826,0.014948894234169561
80611,SIDM00878,MK-2206,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.4095407,-0.023174038,1.5187420700790648,0.06063985335057521
31035,SIDM00774,PD173074,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,0.8678034,0.0611812,0.5345975781814915,0.07407049191184881
67917,SIDM00971,Tozasertib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.2950466,0.05376521,1.124498257698134,0.04875253410123457
6322,SIDM00193,MK-2206,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,2.9110115,0.27529058,1.588493007453025,0.12583412974396138
65024,SIDM00146,Pictilisib,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-0.87810624,-0.07039496,-0.27652564819763903,-0.023891927699288017
59492,SIDM00673,PF-4708671,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.4891171,-0.056314096,-0.862076822657787,-0.025411380221116487
105362,SIDM00893,Pictilisib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.7494364,-0.07581078,-1.2578746281880897,-0.07769805594042382
64453,SIDM00332,Axitinib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6439247,-0.14267126,-2.5209955715460928,-0.17040694378377283
80555,SIDM00774,Trametinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,4.4309783,0.10926341,2.8903405069860146,0.059743937638310644
103322,SIDM00782,SB505124,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,Unknown,72.0,-1.4929508,-0.10024445,-0.3773701885412593,0.006422093255304303
64696,SIDM00774,Lapatinib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,0.89784825,0.083619654,-0.420022307698866,-0.09006505337919977
84861,SIDM00130,5-Fluorouracil,MK-2206,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.95798945,-0.082682244,-0.7989376429230737,-0.03241604901707882
64245,SIDM00529,Tozasertib,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,2.3135915,0.1418954,0.2591690146191429,0.04067384821280414
2492,SIDM00893,Cisplatin,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.5199816,0.092967294,2.79224605935596,0.12493989091217537
106811,SIDM00774,Taselisib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,-0.21967481,-0.01075521,-1.1512011249338152,-0.008395866026871616
14401,SIDM00774,Sorafenib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.6346796,-0.04150586,0.49748182343513525,0.12594108539155344
70856,SIDM00332,NU7441,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.74953264,-0.04716406,0.7121431894216753,0.028906431801781738
4710,SIDM00875,Trametinib,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.30604362,0.033168755,0.8001084354164952,0.08997864479049907
25408,SIDM00971,GSK269962A,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.4024833,-0.085075006,-0.3820263722177637,-0.048473631541120075
29355,SIDM01233,LGK974,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-2.5790129,-0.12036461,-1.8772087250561076,-0.12162091703981363
87197,SIDM00628,Olaparib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-1.7118056,-0.055039812,-1.4875074435633624,-0.007986442429320909
69246,SIDM00866,Taselisib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-0.61116886,-0.050973117,-0.914539337904759,-0.01217298784530308
43297,SIDM00971,ZM447439,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.4524379,-0.1286126,-0.30404602280154647,-0.014838336420997909
84843,SIDM00660,MK-1775,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-1.4711347,-0.072142236,-2.4533158351290134,-0.09142948433422005
11682,SIDM00774,Nutlin-3a (-),Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,0.31917167,0.010072766,0.8761641345833708,0.027472841034121825
87443,SIDM00954,Bortezomib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-0.4297947,-0.024388574,-0.42442800455676266,-0.024858957957599744
104773,SIDM00778,Trametinib,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,0.19482248,0.004784792,-0.27214831251203214,-0.03398562464291612
67436,SIDM00628,Nilotinib,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,Black,51.0,-0.07048139,-0.0065375105,-0.6326978337565307,-0.0247533439978347
101339,SIDM00146,RO-3306,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.27448598,0.02404722,-0.9133095174012814,-0.034919046251799125
10725,SIDM00954,Temozolomide,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-0.20398013,-0.0034625859,1.3537252998691967,0.03348756415187701
7294,SIDM00878,Gemcitabine,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,-1.539025,-0.10113014,-0.6261909552641614,-0.028531231803481622
83917,SIDM00954,Docetaxel,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.80126226,-0.057946984,-0.158229587542132,-0.0029443006413464234
95227,SIDM00866,Dabrafenib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,52.0,-0.35983273,-0.011194419,-0.06011932036841714,0.011930620002455376
33949,SIDM00359,SCH772984,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.6680495,0.0969244,0.4111922893411094,0.02107992277561386
44727,SIDM00673,Dabrafenib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.5554113,0.033527642,2.4975303419365833,0.0785558155242016
4773,SIDM00954,KU-55933,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.0,-3.4433148,-0.11260906,-1.0861628458937056,-0.056959126846623055
10307,SIDM00834,AZD7762,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,5.22618,0.39158654,2.6606855566807197,0.23753884200167807
64546,SIDM00097,Camptothecin,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9895263,-0.08113165,-1.1327822782878496,-0.029623318288078203
76781,SIDM00834,Trametinib,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-1.2515625,-0.04564835,-0.07398473375632293,0.04270955305392848
47741,SIDM00878,PF-4708671,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-1.9894356,-0.08615178,-0.14730027324640715,-0.017184199380331003
51794,SIDM00954,KU-55933,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-2.5614338,-0.07995077,-0.522636174986397,0.03343886569586002
54531,SIDM00097,Afatinib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4942906,-0.09887861,-0.31315707072143545,-0.03993332248549657
51153,SIDM00774,Tozasertib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.4598838,0.01454534,1.1686815651874078,0.09186748866593829
40861,SIDM01233,MK-1775,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,72.0,-4.0439706,-0.30695453,-2.956133803014241,-0.18146358984425046
35931,SIDM00097,Ribociclib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8603079,-0.052015737,0.17625202071549415,0.023989448592717424
35771,SIDM00893,OSI-027,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.0857837,0.19145647,0.2701208503317209,0.020645371268600846
12639,SIDM00834,SB505124,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,1.1034689,0.08766051,-0.26987079742025866,0.02559469770048146
79334,SIDM00146,Nutlin-3a (-),Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.59026456,-0.016713666,1.320023488432941,0.0964235193566192
44399,SIDM00193,Olaparib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,-2.3048222,-0.055752546,-0.15367499604305526,0.017421195171958705
82636,SIDM00332,Uprosertib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.807551,0.12392946,1.6340908267714005,0.058385443625879226
70918,SIDM00875,Vorinostat,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1209177,0.10902627,0.39581486203455424,0.05269210683145703
3911,SIDM00954,Afatinib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,2.0583427,0.12312482,0.49793601147737204,0.009465653817221103
77143,SIDM00774,BI-2536,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.5009527,-0.095123366,-0.2197264738250902,0.011952520244043047
26944,SIDM00673,Paclitaxel,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-5.1564465,-0.31400073,-4.261425176386488,-0.29493888288641734
87267,SIDM00146,Venetoclax,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.29125854,0.0068429722,1.3794950353705728,0.10965065592443028
563,SIDM00893,NU7441,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.33482042,-0.02804896,-1.3074406897047826,-0.047970935768961276
38447,SIDM00971,Camptothecin,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.4459255,0.06891897,2.0982339221359183,0.0750527665608679
42025,SIDM00954,Wee1 Inhibitor,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.5960413,-0.049307335,-0.7774640680679026,-0.06723937953843641
49046,SIDM00971,ZM447439,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.9397422,-0.07800291,0.3179365095336276,0.06985914074766823
30388,SIDM00332,KU-55933,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.503642,-0.06651782,0.1617494648902031,0.03508697667466197
10843,SIDM00875,Gemcitabine,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0098975,-0.0025263545,0.06371118990678387,0.0612973339174504
38684,SIDM00776,AZD8055,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-0.7062765,-0.04632836,0.1693149764365045,0.014219767234335866
19440,SIDM00332,Sorafenib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9100966,-0.07028203,-0.8379793622215693,-0.03496265487012089
8058,SIDM00866,Entinostat,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-1.9947404,-0.10982967,-0.9708976808422777,-0.030232642043008705
21668,SIDM00660,Navitoclax,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,2.4773269,0.18619017,0.680964184944867,0.046607752925263424
85646,SIDM00866,Bortezomib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-2.8518963,-0.09355482,-1.8197465092864527,-0.06020032689690826
84154,SIDM00878,PD173074,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.0657752,-0.11502498,-0.6863128691618,-0.047366670370473596
6985,SIDM00673,KU-55933,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-1.8747779,-0.090527564,-0.8400331407676567,-0.02679162607483435
14199,SIDM00971,OSI-027,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.4758127,0.118487425,1.7275365484981113,0.11679058560565912
44882,SIDM00301,Navitoclax,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.26875,0.30593866,1.7452757248773856,0.08954915031162575
82881,SIDM00097,Nutlin-3a (-),AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.305583,-0.075450435,-0.9983133009269964,-0.06340360753461291
20084,SIDM00193,AZD4547,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,53.0,-2.1594565,-0.06941631,-0.8788867742299983,0.007754426150933607
35128,SIDM00875,Paclitaxel,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.8118193,0.12573783,2.521089651706177,0.1338250807100191
97208,SIDM00146,Doramapimod,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.4986393,0.08300029,0.13419325809909766,0.01625295303931511
75527,SIDM00332,Palbociclib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3464434,0.11635133,-1.174091811125202,-0.0699200879647988
65571,SIDM01233,Vinorelbine,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,1.9128187,0.10539047,0.43391806081094847,0.03811509774663636
38043,SIDM00875,Docetaxel,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5411528,-0.118296236,-0.9886733613318403,-0.06948818577600732
95802,SIDM00971,Palbociclib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.4158158,-0.03948438,-0.30924239981116086,0.001384396934809742
9380,SIDM00878,Trametinib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,2.250879,0.24295096,1.042655469101921,0.03925106648586237
77514,SIDM00954,GSK269962A,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,-0.68256867,-0.058115575,-0.16490637910574477,-0.013507093009330891
19193,SIDM00146,SCH772984,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.9210877,0.2077048,-0.41353805908774127,0.007401396921549363
104084,SIDM00774,KU-55933,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-1.4158728,-0.036435597,-1.1566262936591818,-0.05475649182179797
84411,SIDM00774,Palbociclib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,1.3150359,0.06784699,0.9928900491356157,0.07168340632719189
4595,SIDM00529,Entinostat,Trametinib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-2.553622,-0.11711106,-0.43984021660560685,0.005535960642532151
27180,SIDM00778,5-Fluorouracil,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,69.0,-2.1416528,-0.07627551,-1.541349155192904,-0.06516151837879887
20093,SIDM01233,MK-2206,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,-1.7030381,-0.07904374,0.6176873896703834,0.026917616369827146
15053,SIDM00097,SCH772984,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.7067368,-0.11920299,-1.0641924890930505,-0.06244803371753055
39039,SIDM00146,Uprosertib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-1.8932841,-0.10223323,1.0113202964872658,0.13248453409086677
79528,SIDM00531,Dasatinib,Lapatinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.41012546,-0.04064949,1.4976888565071402,0.07584505470378021
9785,SIDM00673,Linsitinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.7177393,0.0154681625,2.237489517965092,0.0642703743331496
65948,SIDM00776,MK-2206,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,0.9647031,0.06617049,1.1757075055908581,0.08755721534440415
85805,SIDM00954,Entinostat,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,1.3054322,0.09796943,0.16996556406190677,0.10894464822327449
14925,SIDM00097,Doramapimod,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.191012,0.028055344,1.2241693071309685,0.045834678023334165
29592,SIDM00893,Crizotinib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.7694068,0.033391755,0.002779424567946704,0.04358209576626201
24433,SIDM00774,Alisertib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,1.0618644,0.07865155,-1.1251431176584046,0.019354022541291756
95108,SIDM00866,Sorafenib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,52.0,1.8040881,0.11118376,0.15421369007278732,0.037392567567411474
39764,SIDM00893,Linsitinib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.1702123,0.070942834,1.2706002179007683,0.07574431332200054
74146,SIDM00774,5-Fluorouracil,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.6379684,0.076742545,0.06857406229604618,0.0715844171734769
74698,SIDM00673,Luminespib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.5275517,-0.052974164,-1.1125505034393965,-0.10982277694600313
31991,SIDM00954,Linsitinib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,1.2149934,0.08280951,-0.1394399043040797,0.011553486547825372
21670,SIDM00866,JQ1,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-4.470643,-0.23422377,-2.303131368864845,-0.05091278462699923
87670,SIDM00673,Luminespib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.22598536,-0.023250086,-0.08119083693448675,-0.007676636510380373
68874,SIDM00866,Tozasertib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.2547842,-0.051273815,-0.8213659159367034,-0.018022971361846166
40558,SIDM00411,Dactolisib,Trametinib,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,43.0,2.407948,0.13555227,0.2728228222972357,0.046072669676813685
65720,SIDM00097,Docetaxel,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.5452123,-0.23423858,-2.8334574659279155,-0.17782249659191623
97122,SIDM00875,AZD8055,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1327152,0.12820755,0.3750187401686087,0.0012171316960656086
23098,SIDM00778,Nutlin-3a (-),MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,2.146449,0.0381932,1.7331344549988539,0.03931331855097296
108152,SIDM00878,Luminespib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-0.9626561,-0.104850866,-1.5061041702637712,-0.10334348649154707
63944,SIDM00628,Nilotinib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.21542734,-0.02164853,-0.5592788045660217,-0.07404777861879151
27260,SIDM00146,Docetaxel,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.51111144,-0.0435564,-0.9166765198037348,-0.04762348212859098
65005,SIDM00866,Trametinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-1.9119982,-0.1347232,-2.1294097288416385,-0.05709905856661
14683,SIDM00097,Tozasertib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5725093,-0.076527156,0.13824763070423035,-0.015430645321678347
88757,SIDM00628,AZD6482,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-1.0874804,-0.1035101,-0.9094628842967799,-0.0498377662191737
8709,SIDM00097,Camptothecin,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4398837,-0.048419278,0.5638793640353421,0.019183393250868746
71922,SIDM00628,Trametinib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,1.1753759,0.047884595,-0.9320709665610126,-0.015210865598244713
1070,SIDM00866,NU7441,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-1.0233059,-0.07591746,-0.7728895599235976,-0.046627437632771516
97493,SIDM00411,Olaparib,Crizotinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.8168533,-0.018452333,0.3752295415073038,0.01875840411454347
79151,SIDM00301,Paclitaxel,Linsitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,0.565107,0.019589718,-0.6270747759079219,-0.03751637417685479
27500,SIDM00146,MK-1775,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.0756998,0.07800752,-0.11758203416834047,-0.001437051899315795
48073,SIDM00782,LGK974,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.5375722,-0.042791616,-0.9215089090197246,-0.05583853208686826
5196,SIDM00834,SB505124,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-0.7317746,-0.052214477,-0.5041182312663722,-0.02520464918786513
19206,SIDM00971,Alisertib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.7348958,0.018190611,0.7420351025687647,0.06214823137514101
64420,SIDM00875,Crizotinib,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6239597,0.07111721,0.8228928399995649,0.03241445221897376
21789,SIDM00301,OSI-027,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.107111,-0.13982265,-0.3294397700187107,-0.04866236519592627
14460,SIDM00778,MK-1775,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,69.0,-2.0839834,-0.12538901,-1.8127642654200993,-0.1312945383255542
7259,SIDM00130,AZD7762,5-Fluorouracil,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.854186,0.27073547,2.207019009591675,0.11852500390581129
4249,SIDM00673,Gemcitabine,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.949435,-0.06501848,-1.6900648919275727,-0.05319051503570149
54705,SIDM00146,Alpelisib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.5315202,-0.026809553,0.8169906374314396,0.06084146491112924
62188,SIDM00834,Nutlin-3a (-),MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,1.9868675,0.057122637,2.2185487620901774,0.09930530530978389
60803,SIDM00130,SCH772984,Olaparib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.107687,0.10320149,-0.17499384145987493,-0.008935368613290565
92574,SIDM00146,Paclitaxel,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,-1.321112,-0.1186147,0.4065007107321611,0.02717374900737034
77284,SIDM00332,RO-3306,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.1667762,0.12882754,1.925392429740784,0.07315690122010256
333,SIDM00893,NU7441,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.415541,0.18373427,0.41347891233895856,0.03589386652561353
35920,SIDM00866,Trametinib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-1.0007663,-0.08447937,-0.7388778645939633,-0.01959842979203921
11108,SIDM00301,Oxaliplatin,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-3.2561448,-0.30803293,-1.7161338076094277,-0.1030543339607227
87449,SIDM00531,Lapatinib,Navitoclax,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.613493,0.26185703,3.455516385637138,0.20831030589343466
14565,SIDM00866,Olaparib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,52.0,-1.8530145,-0.036610033,-0.2243089395429748,0.00455477357320256
15911,SIDM00628,Navitoclax,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,2.8078036,0.09904408,1.3204253170555713,0.08442278890219974
108146,SIDM00332,Alisertib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5398281,0.025227807,0.10304192903808868,0.003019405197356897
100209,SIDM00893,Taselisib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.7941917,-0.09145684,-1.4987442597416618,-0.07899684157458388
22473,SIDM00628,Palbociclib,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,Black,51.0,0.5709055,0.022502514,-0.3829269115351218,0.016496799180323693
83837,SIDM00954,NU7441,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.0,-0.7095831,-0.034409482,1.7124094888253076,0.09677016974633007
85525,SIDM00628,Taselisib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-0.6328226,-0.059078068,-0.7632582409587096,-0.006248013815689504
49884,SIDM00774,Linsitinib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,-0.5109384,-0.027237073,0.9198719440762343,0.04078006817177838
19953,SIDM00146,PD173074,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-2.3671663,-0.10550143,-0.9383364221633506,-0.002488280723126447
46180,SIDM00411,Erlotinib,OSI-027,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.8051836,0.07367974,0.9071464744996703,0.11897217001884508
89171,SIDM00866,KU-55933,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-1.2906516,-0.047681686,0.32747245731547103,0.010283303239724087
103212,SIDM00660,Dabrafenib,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-1.7806106,-0.17542106,0.25833409143078045,-0.01972371304696466
73117,SIDM00097,Trametinib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7450895,-0.043852195,-0.7997877002262793,-0.028428466275325217
7361,SIDM00866,Lapatinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.4947787,-0.015470069,-0.05153580153782807,-0.00912376595481548
39853,SIDM00130,Cisplatin,Sorafenib,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.9091705,-0.095681034,-1.2645988242847965,-0.04304718232013931
98219,SIDM00529,5-Fluorouracil,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-3.890468,-0.2784432,-2.5546523862203863,-0.15687074853145774
73005,SIDM00779,Palbociclib,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,-2.6288292,-0.063989274,-1.628631362333687,-0.016099282654537132
83890,SIDM00673,JQ1,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,4.792562,0.34252733,-0.142598563432566,0.04376124912317778
13764,SIDM00875,Gemcitabine,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6922559,-0.004018117,-0.7787653709083681,-0.02009239507086898
94215,SIDM00875,AZD6482,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2209982,-0.065569386,-1.05432642813961,-0.036200273840777196
107849,SIDM00782,LGK974,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,Unknown,72.0,-2.0906558,-0.11438987,-1.6115446965869193,-0.08151037086426784
48496,SIDM00971,Linsitinib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.8582683,0.08850829,-0.8789953758949713,0.005201551617392169
99236,SIDM00971,Olaparib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.88308275,0.032141343,-0.6022049840054627,0.012221547508779261
43656,SIDM00774,AZD8055,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,-1.4920567,-0.10128131,-0.8819939259012728,-0.0818140902020679
21212,SIDM00146,Ribociclib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.9633307,-0.04185547,-0.3450854474264783,0.038429723698234844
20406,SIDM00332,Luminespib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4913771,-0.13998918,-0.7647229373608974,-0.05325911234789043
51476,SIDM00778,Linsitinib,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-0.64331514,-0.035308283,-0.028992094411876317,0.03812734614828406
37422,SIDM00954,Olaparib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,3.2231529,0.16107228,-0.4738591283486847,0.06030687850954315
5174,SIDM00774,AZD7762,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,-0.25850946,-0.027179457,-0.07147393979960877,0.029294726656196847
67862,SIDM00782,BMS-754807,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,Unknown,72.0,-0.6391833,-0.05863266,-1.9367974751637103,-0.08635407380276244
99570,SIDM00660,Afatinib,Vinorelbine,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,32.0,0.8031938,0.08205498,1.5537389984832637,0.05200776879431494
24047,SIDM00875,Nutlin-3a (-),Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7204645,-0.021632472,-0.1530717067959066,0.0035327638042888286
39298,SIDM00776,Navitoclax,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.18554808,-0.012089998,0.3538073583793637,0.006705524569674894
34060,SIDM00834,MK-1775,Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,White,66.0,-0.20933186,-0.016020602,-0.4509225750804111,-0.0009845542615429012
62208,SIDM00673,Bortezomib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.250042,0.009792914,-1.0738843325573417,-0.04506440325283946
22743,SIDM00866,ZM447439,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,3.1144004,0.21908805,2.1232397838002974,0.09914127337006125
32751,SIDM00332,Dabrafenib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.0881631,-0.13955136,-1.6322484057358886,-0.12375880639087213
64065,SIDM00782,Dabrafenib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,Unknown,72.0,1.8295405,0.09186728,1.201652887199119,0.04977347984699657
24851,SIDM00776,Palbociclib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.8985893,-0.05838438,0.12470146524648543,0.018597207344749782
44434,SIDM00878,Luminespib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.5893634,0.05152318,-0.5047651733266292,-0.05118269012993389
81654,SIDM00411,MK-1775,Irinotecan,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,-4.075494,-0.15184289,0.006876620001074591,0.05598078039512467
34242,SIDM00529,Alisertib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-1.0164385,-0.09463963,-0.7345121804002293,-0.030671081473119772
25969,SIDM00878,Docetaxel,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.4465928,-0.111878455,-0.6758141965233735,-0.03490285153308911
47746,SIDM00529,PD173074,Taselisib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-2.8697774,-0.105229646,0.14029690814103565,0.07890890479816633
61919,SIDM00628,JQ1,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,Black,51.0,-1.5836782,-0.09191805,-0.8962204421510171,-0.03151523550489067
2241,SIDM00359,Dabrafenib,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.3203259,-0.09138537,-0.4628110214158941,-0.013538978583995581
435,SIDM00301,Linsitinib,Erlotinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.2293835,-0.035506934,1.4045234539464242,0.09715932701883437
11777,SIDM00875,Palbociclib,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.8011117,0.19894205,2.9807281246850263,0.1354425798317072
74963,SIDM00193,SB505124,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-0.8684052,-0.06825241,-0.42380946283051196,-0.0011360734042470152
12182,SIDM00411,SCH772984,Cisplatin,Pancreas,0.8,Pancreatic Carcinoma,Male,East Asian,43.0,-2.5677729,-0.115435734,-1.3086741858810265,-0.0209967311287322
36846,SIDM00332,Vorinostat,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,1.465146,0.12489596,0.3261134440476899,0.04687815709241056
31314,SIDM00660,Crizotinib,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,2.1333513,0.1854984,1.4287978455134525,0.07143976821416823
107770,SIDM00332,Olaparib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2958795,-0.033708263,0.30254341929301354,0.01883296738980731
12297,SIDM00893,ZM447439,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.7245927,-0.12111597,-1.1773426054547471,-0.0859928756852656
83578,SIDM00529,Ribociclib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,-0.6879907,-0.01747777,0.9281489250803181,0.05448861267056342
48682,SIDM00146,Bortezomib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-0.17575863,-0.011972412,-0.36562839589188767,-0.026261744588292946
76089,SIDM00782,5-Fluorouracil,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,0.7319986,0.03436533,0.5322183866421358,0.014664304819255111
55867,SIDM00866,KU-55933,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-2.0877016,-0.05737601,-1.2155501113883294,-0.019723432142830406
20671,SIDM00529,MK-1775,PD173074,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.6018263,0.059529204,-0.04008677234848504,-0.010420157826568577
2551,SIDM00146,Olaparib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.7615961,-0.036477406,0.2892879337050312,0.030570548679791087
26247,SIDM00971,Vorinostat,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.051267903,-0.0027081985,-0.45088214712606706,0.03320880523870598
100301,SIDM00332,Navitoclax,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5699698,-0.05528401,0.601070802343844,0.012150031255309958
10974,SIDM00954,MK-1775,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,1.7629685,0.11922151,2.196825662744067,0.1004930250000268
79826,SIDM00875,Ribociclib,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0304295,-0.014982191,0.13508832543840868,0.03622367524453139
63376,SIDM00776,Camptothecin,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.95810026,0.03873329,1.258231279522135,0.11564890679945553
53544,SIDM00778,SCH772984,Nutlin-3a (-),Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-0.3352259,-0.018739305,-0.10385186891098283,0.021391740950062944
91022,SIDM00146,Nilotinib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,0.9334549,0.087897524,1.0852991261888938,0.08447782327550014
99593,SIDM00411,Paclitaxel,SCH772984,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.528486,0.12367893,0.6557779468225332,0.06446711275834392
70750,SIDM00359,Camptothecin,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.69595426,-0.055657063,-1.0333023781929063,-0.03300548112296158
40206,SIDM00971,Alisertib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.3513106,0.03426756,1.157442003213335,0.08098107415210144
80846,SIDM00531,Dasatinib,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.9807914,-0.08994429,-0.7964841058550969,-0.0016923661068119543
90776,SIDM00866,Taselisib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.22433765,-0.017247643,0.43194838178413986,0.005899635128110535
10026,SIDM00893,PF-4708671,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.4500672,-0.03324601,-1.396728306178856,-0.07934035912113252
77925,SIDM00097,BI-2536,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.29983103,-0.02069966,-0.7561901916711433,-0.04252258259688914
13497,SIDM00878,Tozasertib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,70.0,2.0795357,0.19094506,-0.6985477980798808,0.006095660345738426
77620,SIDM00193,Nutlin-3a (-),Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,5.5607214,0.18341985,2.6416631831639332,0.0925800475332126
4534,SIDM00779,Trametinib,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,1.3158674,0.016198155,0.3937855529597393,-0.030875453389925745
62434,SIDM00411,AZD7762,Dasatinib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,43.0,2.153866,0.09143118,1.8812118208124549,0.06440832331253132
35907,SIDM00779,MK-2206,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-0.652503,-0.056654107,-0.6460805131926928,-0.03845914628757815
103592,SIDM00628,SCH772984,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,Black,51.0,1.0403917,0.08581819,-1.0384113571105023,-0.036250092054351896
82338,SIDM00673,MK-1775,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,0.3393453,0.03237903,-0.5210490645170495,-0.038660138591654326
51861,SIDM00628,KU-55933,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-1.1830047,-0.044389043,-0.03441353977484731,0.019876807898542417
93472,SIDM00875,Trametinib,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.842025,0.09312917,-0.13285517004928218,0.038390567294330075
70544,SIDM00954,Lapatinib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.331412,-0.10493105,-1.452754412804103,-0.09078114674771307
63854,SIDM00531,AZD7762,Navitoclax,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.0780978,0.20430058,0.9311505060512888,0.08373482735915684
17496,SIDM00193,AZD8055,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,53.0,1.2954897,0.11879612,-0.2825131552250205,0.009658783629354425
47571,SIDM00529,Lapatinib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-2.1716206,-0.11161951,-0.08458349528860153,0.03991425729390915
70536,SIDM00673,Entinostat,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.7996086,-0.06661114,-0.942082666686101,-0.03718103089129788
94512,SIDM00193,Nutlin-3a (-),Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,53.0,0.7828562,0.015947863,1.4638982911549583,0.058011338998861864
71141,SIDM00774,Entinostat,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.2631717,-0.06384378,0.5065404019516406,0.03512662827697457
33457,SIDM00130,Linsitinib,Crizotinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.24443145,0.015226186,-0.4072405920854839,0.016664731586838146
58106,SIDM00776,SB505124,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.6155232,-0.067694,-2.3415638059171258,-0.07402874001118025
10765,SIDM00893,NU7441,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.75698614,0.0639936,-0.22596689836123957,0.07825674843979846
30779,SIDM00529,Docetaxel,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-3.2469947,-0.17318194,-1.9840115799015892,-0.03535319899968885
17165,SIDM00529,Taselisib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-2.4918644,-0.12202367,-1.805225068826896,-0.06572461304857642
1678,SIDM00971,Dabrafenib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.53342986,0.012086869,0.5028163075784459,0.025114826221525142
59720,SIDM01233,AZD7762,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,1.0369264,0.022960693,2.455503972122552,0.09351966185959114
60422,SIDM00673,RO-3306,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.8060227,0.055497836,-0.24192941547411703,-0.0026775554308652427
27546,SIDM00673,RO-3306,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.44870615,-0.029211074,-0.7964122400940794,-0.020675091514707703
22012,SIDM00359,Nutlin-3a (-),5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.5023791,0.039841942,1.5652434988029384,0.037233757855752884
28776,SIDM00531,Erlotinib,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.2164106,0.23885426,0.3790293368214187,0.061942292921048844
79558,SIDM00628,Temozolomide,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.7245715,0.11986068,0.5865310465381924,0.009301492941288205
102020,SIDM00774,Nutlin-3a (-),OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,3.83131,0.26321483,1.1861012648003149,0.028193291172778384
14057,SIDM00411,Palbociclib,Dactolisib,Pancreas,0.0125,Pancreatic Carcinoma,Male,East Asian,43.0,-2.5969882,-0.08619813,0.4217654648523389,0.035387347085126204
32299,SIDM00971,Linsitinib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.2425874,0.057178643,0.1767847723074644,0.0422667498857909
26160,SIDM00782,Camptothecin,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,-2.2431445,-0.14406386,-1.4390169555300638,-0.05431784997934961
1957,SIDM00875,Docetaxel,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6894433,-0.05438714,-0.3600961695234071,0.00207958750616243
67157,SIDM00782,Olaparib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,2.9461277,0.12426238,1.5841780643172458,0.02190073185779549
74064,SIDM00954,GSK269962A,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.0150735,-0.086050816,-1.2868978262302402,-0.09205216487627838
28507,SIDM00776,AZD8055,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.4616531,-0.10062292,1.1948824910502942,0.09346032163380598
90315,SIDM00866,Crizotinib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-3.4179065,-0.23215115,-1.055354001520755,-0.062470048280063105
4242,SIDM00774,PD173074,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,3.0717854,0.15432712,1.8434554837891142,0.09682674432427116
48602,SIDM00893,AZD8055,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.7792708,-0.14208457,-0.515658438726512,-0.045358831315542164
213,SIDM00529,Camptothecin,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,-1.3795398,-0.04901111,0.587620729712987,0.02529162768627478
85019,SIDM00778,Trametinib,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-0.18653168,-0.006466584,-1.184873750137406,-0.0588391587158984
80181,SIDM00193,AZD7762,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-0.7808439,-0.031522326,0.8556589501897612,0.08910474737448451
2090,SIDM00673,NU7441,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.9819446,0.07723059,-0.4601544390261987,0.005053815489601045
42788,SIDM00878,Dabrafenib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.4101925,0.056876954,0.8948278179129668,0.03833366719265109
35986,SIDM00875,Linsitinib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0909669,0.081856,0.33849903828180816,0.034986528409447416
20118,SIDM00782,Palbociclib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,Unknown,72.0,-0.5458633,-0.011431445,1.3517281051306032,0.0004960022334192489
28076,SIDM00673,Wee1 Inhibitor,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.8493285,-0.09784482,0.8024208776517853,0.029991866860442196
9126,SIDM00628,Palbociclib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,1.3585593,0.05478594,0.014203299243203113,0.015481054468226943
71549,SIDM00359,Trametinib,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2894875,-0.03886561,-1.452633588750726,-0.06788818745254346
45341,SIDM00529,Bortezomib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.44076318,0.03075859,0.4803455160989639,0.03425507727460491
18323,SIDM00673,Tozasertib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.0161288,0.042599592,0.3607640480134053,-0.019896596420626127
10239,SIDM00660,MK-1775,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,32.0,0.76004475,0.028943038,-0.27707280405210405,-0.021017649686254435
105412,SIDM00529,GSK269962A,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Black,44.0,0.6436082,0.057777338,-0.7443003596433289,-0.002296570620040982
84772,SIDM00893,AZD7762,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2804763,-0.0509367,-0.917513902805937,-0.004261290596814801
103569,SIDM00673,Sorafenib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,2.625586,0.15668313,-0.2950158251735187,-0.0037189721086665433
104409,SIDM00673,Lapatinib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,0.84969944,0.082210034,0.9875956747611948,0.03720643037826886
37848,SIDM00782,Afatinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.7623269,0.07002917,0.9370703816702515,0.018428637085729994
79268,SIDM00531,Dactolisib,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.59270114,0.053164963,0.23625121084856956,0.016276569536919007
21818,SIDM00893,Trametinib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.81020635,-0.08124767,-0.21225655904547552,-0.014890235639254963
64845,SIDM00531,Ruxolitinib,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.4970785,0.06842774,2.540356532694327,0.0790176212175338
47273,SIDM00893,Docetaxel,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.4948713,0.046312112,-0.6801084530885746,0.01790385109263614
98547,SIDM00628,KU-55933,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-1.1331918,-0.058646556,-0.5048416643557412,-0.042321911611081425
84361,SIDM00782,Palbociclib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,Unknown,72.0,0.61623114,0.014402018,2.4743223387446034,0.057660129833558296
98513,SIDM00130,MK-1775,OSI-027,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.0755026,-0.067782,-0.03930970218167467,0.0034423495145813996
96353,SIDM00628,Cisplatin,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.6678372,0.0649707,-0.8503060619784468,-0.06104205629553751
26827,SIDM00866,Venetoclax,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-0.6515111,-0.012214803,0.5840692301948821,0.05041144343166287
90918,SIDM00673,Temozolomide,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,0.25929758,0.00355888,0.47221007741568405,0.02757293934654299
99061,SIDM00301,Cisplatin,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-2.3461792,-0.19665009,-1.6723588779547547,-0.09784895543010952
92975,SIDM00971,AZD7762,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.429632,0.06902639,0.12558467694651126,0.038854616635475195
65611,SIDM00893,Wee1 Inhibitor,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.656553,0.054174315,-0.8489621809226986,-0.09265105252937753
34603,SIDM00359,Crizotinib,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.5674777,0.030627716,-0.7346380547848828,-0.008238253023640788
43447,SIDM00529,Afatinib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Black,44.0,1.0412859,0.07959975,0.15815538378974733,0.04049104873397783
29336,SIDM00097,Camptothecin,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3470745,-0.08223061,-1.7370490652378336,-0.04247387494097947
94103,SIDM00332,BI-2536,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7807443,-0.06270124,-1.5107065016424581,-0.06667198761847698
40528,SIDM00971,KU-55933,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1242099,-0.014694974,1.6123889703705254,0.06288015505302558
67974,SIDM00628,Uprosertib,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,Black,51.0,-1.3669922,-0.08128452,0.2883548004952588,0.042688785393614224
55922,SIDM00628,Axitinib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.34234792,-0.029136527,-0.8514595767425758,-0.048060151097270756
61759,SIDM00774,Entinostat,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,48.0,-2.5340645,-0.12945706,-0.20635952646582845,-0.01539477503659601
11414,SIDM00878,Axitinib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,70.0,-1.2459351,-0.100939035,-0.6076539187716055,-0.017914809024756253
43653,SIDM00673,Doramapimod,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,1.5255998,0.03705197,3.532319176821231,0.09950532398449201
35952,SIDM00878,SCH772984,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-2.7323995,-0.07266391,-0.523032713619664,-0.006601045073408408
13077,SIDM00097,Sorafenib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.642771,0.08919337,0.8977085590005273,0.011635908204828564
4518,SIDM00954,SCH772984,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-3.4524512,-0.1949585,-0.2137817541377104,-0.02531338908216593
80837,SIDM00146,Ribociclib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-2.355781,-0.08478268,-0.008153686362671976,0.062215082604580835
35048,SIDM00971,Cisplatin,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.6170343,0.02299819,2.3392855810275885,0.04239780210715951
21527,SIDM00628,Alisertib,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-4.1433234,-0.18648036,-2.597449732840159,-0.058937070502682334
49624,SIDM00332,AZD8055,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,0.8732507,0.059478763,-0.036828381230426525,-0.028353431974540207
53476,SIDM00774,KU-55933,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,2.147116,0.10546373,-0.48692552466282546,0.02302463661652812
19798,SIDM00954,NU7441,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-0.5322928,-0.04063921,0.08179927860714764,0.020761639206698088
102691,SIDM00628,Luminespib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.839033,-0.051876064,-1.3319608124125732,-0.06065389189568308
528,SIDM00673,Afatinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,3.733427,0.20513894,1.864376645774112,0.11652473133439496
102655,SIDM00878,Nilotinib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-1.1729035,-0.09536354,-1.5623440851675423,-0.08214866877463388
54144,SIDM00146,Olaparib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.8700876,-0.037475027,0.10118276931456988,0.05085033584293288
64375,SIDM00971,Dabrafenib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.3572404,0.055380363,1.3819329453076592,0.050705637773316596
6083,SIDM00359,Linsitinib,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.0420034,0.121165775,-0.5384017605945719,0.03240492038507123
70713,SIDM00779,LGK974,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,33.0,1.629039,0.08679857,-0.5971733420772454,0.01889840820963329
57218,SIDM00130,Oxaliplatin,Linsitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.76677185,0.048548706,-0.6577321745970047,-0.02867090354687603
98766,SIDM00954,Paclitaxel,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.5781235,0.040986963,-0.5044597166451545,-0.014946804861537126
102982,SIDM00776,SB505124,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-0.34441197,-0.024604728,-0.9396124579072817,-0.01288548660453002
4626,SIDM00866,Cisplatin,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,0.8171813,0.02028847,1.5836127899923975,0.047700466418787224
18878,SIDM00130,Lapatinib,Dasatinib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.124214,0.10142322,1.3962145377525736,0.1400292043952984
57593,SIDM00097,Luminespib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9392742,-0.12217621,-0.0713320329752799,-0.043175782846629124
54732,SIDM00411,Palbociclib,5-Fluorouracil,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.3572145,-0.09155485,-1.22360867625532,-0.03166859325340979
63841,SIDM00097,Ribociclib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.7683513,-0.071219705,-0.7117877381082435,-0.00226259218421069
87231,SIDM00774,Camptothecin,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,-1.0751843,-0.056721576,0.26158822450171143,-0.0022664556712662185
8172,SIDM00411,Navitoclax,Palbociclib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.6448247,-0.12603995,-0.733109251115999,-0.05986834999994543
9212,SIDM00660,Oxaliplatin,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,-1.5636139,-0.14780445,-0.44860946394618617,-0.05091118209108157
66636,SIDM00954,Palbociclib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,0.4261389,0.01704533,0.7384687343305061,0.07490380772628533
26504,SIDM00954,MK-1775,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-0.7809986,-0.06715616,-0.4463688282949147,-0.03363791440514301
27821,SIDM00834,Camptothecin,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,White,66.0,-1.4678485,-0.052536774,-1.7160527968014356,-0.0986532048106186
83682,SIDM00971,Nutlin-3a (-),PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7804189,-0.04877328,-1.6533403025774367,-0.030940950973474258
5618,SIDM00776,Oxaliplatin,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.0396136,-0.06172587,-1.048174445634805,-0.025601676451634064
62564,SIDM00782,Trametinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,Unknown,72.0,-4.182702,-0.28781793,-1.4154435183258727,-0.09032005801203963
46400,SIDM00971,Crizotinib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.2508023,0.049208842,1.2881059571745235,0.12063156864280869
102600,SIDM00893,Tozasertib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.3629577,-0.057635322,-0.9575991849860989,-0.016081015167486175
15228,SIDM00954,Luminespib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,0.977929,0.061641205,0.2553299547345771,-0.022319823745782078
72829,SIDM00954,Sorafenib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.3811198,-0.02836312,-0.6799369873296284,-0.02865502116205634
33299,SIDM00782,Olaparib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-1.0862505,-0.026992472,0.4730963952159293,0.012261354198074939
39194,SIDM00782,Nutlin-3a (-),MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,3.215388,0.10820296,2.1648384708056985,0.054216879331887284
27265,SIDM00893,5-Fluorouracil,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.0100043,0.13116713,-0.8831456513670576,-0.020549719388606717
71490,SIDM00778,Navitoclax,MK-2206,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-1.4392035,-0.075771034,1.5353760699961192,0.0630754591401332
11279,SIDM00866,NU7441,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.1143323,-0.05962766,-0.7989121666085143,-0.024027688496171287
31259,SIDM00673,KU-55933,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.9596387,-0.079451084,-1.7244695182355356,-0.07004765930432379
69090,SIDM00097,Ribociclib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.4059439,-0.053633496,-0.1846208089824106,-0.007037103496293833
1609,SIDM00130,Dactolisib,SCH772984,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.08143903,-0.0066296794,0.2935774182324781,0.011609543157099276
43723,SIDM00776,SB505124,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-0.024059597,-0.001440948,-1.1489155992368432,-0.05462801591680944
33409,SIDM00954,Taselisib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-2.5298867,-0.19820482,-1.2237291118828106,-0.025567591590787222
57022,SIDM00628,Afatinib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,3.2183368,0.12765162,-1.2095424635334562,-0.07495984120962693
79520,SIDM00628,BI-2536,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-5.4541945,-0.19426464,-3.6855157608913105,-0.07687903953420128
69,SIDM00834,LGK974,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,-1.2136483,-0.06391285,-2.0835852358959635,-0.0798443184562645
72309,SIDM00893,AZD8055,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.77987576,0.05691631,0.08742842184324139,0.006841649183307765
84445,SIDM00660,MK-2206,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,32.0,0.71717376,0.041979395,0.7557526560372517,0.07601373479090501
95618,SIDM00332,Pictilisib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5425984,0.13875419,-0.09126954702275623,-0.03119081341589695
46828,SIDM00130,Gemcitabine,AZD7762,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.0262423,0.055690624,2.0259045294752767,0.12725404480156716
98495,SIDM00866,Afatinib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,52.0,-0.3768478,-0.032816447,-0.17985117326798875,0.023682407825001646
23315,SIDM00146,PF-4708671,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.9945838,0.026768653,1.1568539009729415,0.07317342465836722
61966,SIDM00779,Taselisib,Afatinib,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,-1.5571096,-0.12892938,-0.5974267048849226,-0.09394879858458395
47972,SIDM00097,Afatinib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.94405556,-0.05091329,0.7765985024465488,0.023095060218989407
36502,SIDM00097,Paclitaxel,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-5.761544,-0.29452804,-3.840073497910097,-0.29818025209875737
97072,SIDM00301,Ruxolitinib,Irinotecan,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.476121,0.024448667,0.9250513504994203,0.06581813075043806
60223,SIDM00778,Linsitinib,Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,0.6881813,0.03465153,-0.19555115876347193,-0.0012591074793433079
93850,SIDM00660,Trametinib,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,32.0,3.9220636,0.14926925,-0.2916361324822969,-0.007991621438469765
42565,SIDM00778,Vinorelbine,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,3.412088,0.11655869,4.184055049449625,0.21420332078386842
19008,SIDM00193,Palbociclib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-1.606625,-0.045871586,0.3471547726242828,0.06049380282522399
94391,SIDM00411,Palbociclib,MK-1775,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.7348192,-0.06173488,-1.9726968470764454,-0.047526946474241806
97811,SIDM00359,LGK974,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.8850614,0.09522,-1.64534722323205,-0.03222163749986177
952,SIDM00628,Bortezomib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.19259723,-0.011515768,-0.09640555762985946,0.005027783185743938
84238,SIDM00332,PF-4708671,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.5149906,0.10083211,1.0679241739668437,0.1478374657452577
78350,SIDM00878,AZD6482,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,70.0,1.2843175,0.09908948,0.0722140702829407,0.020950874674759628
94052,SIDM00778,SB505124,MK-2206,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,0.94024503,0.05183146,0.15588537202799405,-0.01314527217242139
59897,SIDM00529,Trametinib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Black,44.0,-2.6676676,-0.12762623,-1.3575938726591747,-0.09087159350266572
70634,SIDM00875,ZM447439,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.828557,0.08498229,-2.0028736545037784,-0.0940249674163371
26757,SIDM00875,Nilotinib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8279701,0.08668066,1.3726107594307955,0.11161821829236193
19541,SIDM01233,LGK974,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,72.0,-1.2619765,-0.08161741,-1.0737401445217254,-0.07558164809547407
99219,SIDM00954,Uprosertib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.25211284,-0.018116536,0.7581176322817073,0.049250506282994426
43979,SIDM00774,Camptothecin,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.086766,-0.044852227,0.4801026042739717,0.07806731845480631
63353,SIDM00954,Palbociclib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.7811102,-0.021960845,-0.09496939832109617,-0.007648983841757429
12454,SIDM00778,Camptothecin,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,0.7748908,0.040733967,3.1634511970434143,0.147290884627859
75765,SIDM00893,Temozolomide,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.76263994,-0.016618483,-0.5901952792980015,-0.005249953092448169
102767,SIDM00332,Dabrafenib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.8514451,-0.061359305,0.3422375395202776,0.02318718364447517
22781,SIDM00954,Alpelisib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,-1.6895828,-0.11612679,-0.4932284817603988,-0.0371026816342017
42604,SIDM00673,Nilotinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.5069687,-0.06381686,0.1754753440254469,-0.006045794157789334
91356,SIDM00971,KU-55933,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.9158483,-0.023884404,-0.012276280282951304,-0.02196823888247244
41154,SIDM00332,KU-55933,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.934671,-0.09506644,-2.5617394767941786,-0.08366319537449882
100224,SIDM00878,Temozolomide,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,2.2700617,0.046785887,3.031675246467575,0.05489841353984143
84554,SIDM00954,Nilotinib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-2.2419837,-0.067811534,-0.13802766995058371,-0.04698208072166244
20541,SIDM00878,Pictilisib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.33857787,-0.0334677,0.5694488110958862,0.05361871088022587
57604,SIDM00301,Oxaliplatin,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-3.2940364,-0.29803836,-1.3760140299031134,-0.07811587157922721
26448,SIDM00954,Navitoclax,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.1669055,-0.047742862,0.1930936958315057,0.000852600683410319
85051,SIDM00782,Taselisib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.50480276,0.043351654,0.05243395493953374,-0.0012747403905862572
1144,SIDM00866,Docetaxel,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-1.1729946,-0.09428823,0.2101693425135755,0.017570297130415243
34884,SIDM00628,Lapatinib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.14024459,0.010696931,0.4413759753145451,-0.03015476955182845
29928,SIDM00359,AZD8055,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.2910302,0.13834752,-0.21366069806784202,0.0015233834555574944
16311,SIDM00774,AZD6482,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.6834221,0.045477953,0.46658147650113063,0.04084885427897638
64566,SIDM00893,Nilotinib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.4605129,-0.106543094,1.0394808034027108,0.06558936560003745
64339,SIDM00893,Vorinostat,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.7246437,0.30606666,1.304721274362151,0.09453317584097451
56394,SIDM00411,Crizotinib,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.8157368,-0.07624346,0.992884357316452,0.086232685755916
59219,SIDM00628,Olaparib,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.7588307,0.15809365,-0.8043280830988823,-0.0143290642168678
33446,SIDM00971,Alisertib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.2608688,0.029609682,1.0986737522862569,0.07071144726977821
96003,SIDM01233,Linsitinib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.7207524,0.121357806,0.8488211720064477,0.08154461235356328
68029,SIDM00782,SCH772984,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,1.2138344,0.118542366,1.0545535622274191,0.050290643369344135
72589,SIDM00097,AZD7762,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.4226685,-0.08850355,0.11757338700728713,-0.025205431733427725
71949,SIDM00875,JQ1,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.33207065,0.03522382,-0.856900372073779,-0.0859851869053621
46650,SIDM00866,Sorafenib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.1578686,0.052524626,0.005076677333113851,0.03267175266862472
55077,SIDM01233,Oxaliplatin,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-1.3314267,-0.10905602,-0.787860311458401,-0.06231217791553768
96615,SIDM00774,Paclitaxel,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.3786309,-0.03480502,1.477409606353548,0.15509034717185277
16901,SIDM00097,NU7441,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.0391614,0.12343437,1.7652132952936213,0.16910753056324293
31437,SIDM00332,Afatinib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7406353,-0.12816001,-0.769707585677329,-0.03446208697653586
22981,SIDM00782,SCH772984,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,Unknown,72.0,-1.7674228,-0.14374119,-0.8575952960050395,-0.03134888751514579
68414,SIDM00875,Afatinib,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.11135,-0.03820993,-0.7772999343742454,-0.01133266827335323
63603,SIDM00097,KU-55933,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3285227,-0.075398855,-0.22079330156720628,0.010948079696927297
45342,SIDM00411,5-Fluorouracil,Sorafenib,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,43.0,-1.2791508,-0.049153443,-0.3998991552640687,-0.0038887374437643627
62223,SIDM00529,Nilotinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.7122303,0.08024618,2.2455469828624577,0.10235757942270005
103124,SIDM00774,Doramapimod,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.6867058,-0.07090974,-0.14081386315307773,-0.008194375381066049
11805,SIDM00778,Crizotinib,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,-0.50444275,-0.013086328,0.8719955080587475,0.03056950616000798
106573,SIDM00673,Ribociclib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.4072297,-0.053079072,-1.7089752601570862,-0.037455417315572184
102914,SIDM00531,Lapatinib,Ruxolitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.46314675,0.04008637,0.44718809331277415,0.07431664513250352
18088,SIDM00782,AZD8055,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,3.253775,0.23534867,0.7906038444608942,0.07570482164450826
37269,SIDM00778,LGK974,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,4.755425,0.11432039,0.5546254699185768,0.0527058493372476
82969,SIDM00628,Nilotinib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-0.51139265,-0.022233652,0.23671126167668122,0.020657765831251198
52624,SIDM00776,Linsitinib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.8987111,-0.09397836,-0.06711819005738318,0.027624408139567985
85774,SIDM00673,Tozasertib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.46830153,-0.03516196,0.09126267311951049,0.05962236388499928
106233,SIDM00782,AZD4547,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.3133934,-0.009028119,1.5266995730015713,0.07368399511296887
60067,SIDM00971,Lapatinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.6210878,0.14638604,2.22670308165722,0.09973377350154301
28357,SIDM00776,MK-2206,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,-0.6981689,-0.055411022,-0.38257582615492747,0.0003721545576944471
32597,SIDM00954,AZD7762,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-1.3636522,-0.090636574,-0.32695883956033245,0.020919476198532544
55343,SIDM00776,Oxaliplatin,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,65.0,-2.371464,-0.117849976,-0.9779509426449892,-0.03298841951132888
8070,SIDM00893,Vorinostat,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.0158532,0.16229211,-1.066925909129657,-0.054430102227253384
92560,SIDM00875,Ribociclib,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5628376,-0.042976618,0.4071784438208441,0.04274766705072266
79471,SIDM00301,MK-2206,MK-1775,Pancreas,0.2,Pancreatic Carcinoma,Male,East Asian,50.0,-1.0901028,-0.086653195,1.864778528696602,0.09987318661143742
18813,SIDM00193,Navitoclax,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,East Asian,53.0,-0.5248269,-0.032827742,0.2589287285498758,0.026419473647202357
29486,SIDM00971,Olaparib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.2537622,0.20245646,-0.8373503742398378,-0.023428860232345593
84828,SIDM00660,Nutlin-3a (-),5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,1.2765183,0.03253083,2.785280296465447,0.05577906880307082
38876,SIDM00954,Taselisib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-2.4626138,-0.17679346,-1.2416865390283862,-0.09877241363100585
61609,SIDM00782,AZD4547,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.4204268,0.05233876,0.9690751377249887,0.05385771789817918
49828,SIDM00332,OSI-027,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.61762416,-0.06117881,-0.4124615086375854,-0.11251515739918198
55190,SIDM00529,Alisertib,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-0.41614676,-0.04038413,0.11068101214941432,-0.01689839908627298
68736,SIDM00332,Alisertib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.8687963,0.07628956,-0.25308991802414377,-0.043628067079981216
61153,SIDM00875,PF-4708671,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7995874,0.03531267,1.7745672852615135,0.04809181136539516
42923,SIDM00866,OSI-027,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.5462482,0.03533175,0.25500415945239724,0.04334152781587919
21558,SIDM00875,PD173074,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.9682931,0.15228873,1.455689869948748,0.10929861315038324
56437,SIDM00301,Linsitinib,Navitoclax,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.7323276,-0.060791012,0.8655616146035482,0.04515542675349466
41363,SIDM00332,MK-1775,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2992108,-0.13503174,-0.3805499320658961,-0.07571462848079609
51075,SIDM00971,Alisertib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.7023873,0.08432823,0.7128263608374789,0.0370930611138635
56776,SIDM00866,Vorinostat,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,52.0,0.8417994,0.072260626,-0.8460494831767111,-0.047009078306506656
11076,SIDM00893,Trametinib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.1675048,-0.10574077,0.3424981815056118,0.08189075105301509
63947,SIDM00971,GSK269962A,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.57763666,-0.037707675,-0.5671216634410758,-0.04554623374084698
104971,SIDM00893,Linsitinib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.0476022,-0.048322752,-0.29381586431020834,-0.00018693625626236383
12457,SIDM00193,Nutlin-3a (-),SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,53.0,0.117213786,0.0020144,1.1360653853505527,0.06152544221161428
32517,SIDM00875,GSK269962A,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.0301468,0.17379062,1.2585399555186274,0.036440883780898166
58497,SIDM00875,GSK269962A,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1393433,-0.058350112,0.562414437165699,0.042672972805403005
25600,SIDM00146,Ribociclib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.132874,0.13358757,-1.266563211804454,0.03149559089270438
2980,SIDM00411,Trametinib,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,3.5729642,0.12745215,0.2691788332877425,0.11095567144181348
72132,SIDM00097,Sorafenib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.581262,-0.062573805,0.494110920361676,0.03799635040669529
76116,SIDM00954,Crizotinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-0.3661678,-0.028358534,-0.6600095644712098,-0.06272243095117519
51858,SIDM00332,Uprosertib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9813862,-0.07372877,-0.5910911280574529,-0.07071312053805705
34921,SIDM00971,Temozolomide,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.2881739,-0.0142552825,0.6521510410161325,0.055124219961681896
9177,SIDM00130,Dasatinib,Irinotecan,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.4742229,0.059499726,0.6878833373662838,0.03830572502476169
86441,SIDM00673,5-Fluorouracil,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.2201257,0.010504625,-0.6596932142918494,-0.027573719589441673
67253,SIDM00097,Axitinib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9155185,0.055086292,0.06208196039414079,-0.0031302968243837595
29488,SIDM00301,Cisplatin,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,2.4960012,0.32859182,2.246017801803879,0.21095777434354857
106093,SIDM00893,KU-55933,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.7522858,-0.040452026,-0.33798033921840304,-0.01691133928760291
43840,SIDM00782,Oxaliplatin,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,Unknown,72.0,-0.4393584,-0.026830304,-1.447950624293521,-0.01908055538504042
79126,SIDM01233,Trametinib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,72.0,-1.2078081,-0.09416094,-2.5280809927065184,-0.07040628928501384
33664,SIDM00628,PF-4708671,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.8570274,-0.072984114,-0.473100373365893,-0.01525112316399563
35951,SIDM00628,Wee1 Inhibitor,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,1.059477,0.094082505,-0.1705678160045607,-0.002879471626877344
23261,SIDM00411,Ruxolitinib,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.61986125,0.0119731035,3.819420814059685,0.0718378678602991
99628,SIDM00893,Alpelisib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.9555758,-0.06615935,-1.0833028168378172,0.013362677264992679
102988,SIDM00130,Cisplatin,MK-2206,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,3.1749656,0.25664,0.6744237050416364,0.07413580772311124
95994,SIDM00628,Uprosertib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,3.1821032,0.271383,2.274901230832925,0.21765625788918802
49824,SIDM00301,Taselisib,Olaparib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.3116767,-0.15441777,0.13680195055274122,-0.02252431483076457
34328,SIDM00628,Temozolomide,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-0.71956736,-0.022415366,-0.8796470029205039,-0.01571598825752324
56175,SIDM00778,Camptothecin,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,0.63750046,0.027551955,-0.7122134770928334,0.008679556993241713
15168,SIDM00359,Camptothecin,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8503847,-0.12822913,-1.812472342189753,-0.11380674556905786
38936,SIDM00776,Crizotinib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.77776027,-0.07023391,-0.7742217205809974,-0.05005489522719919
65531,SIDM00875,Camptothecin,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.63833606,-0.06850153,-0.5021327402727197,-0.009666348897019584
77666,SIDM00193,AZD4547,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,53.0,-1.8265405,-0.07981252,0.21700336874795423,0.0512949835095011
69014,SIDM00776,Trametinib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,2.512352,0.17097136,0.4498488455486915,0.024649444486849286
90460,SIDM00097,Doramapimod,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.0392714,0.103684574,1.8466419542507555,0.06311782563048236
84115,SIDM00778,Palbociclib,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,1.1965677,0.04604944,0.45264797013759545,0.029217328493486558
2858,SIDM00954,Tozasertib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.65794224,0.051424157,1.354348343453662,0.06091320446289771
101213,SIDM00954,Alpelisib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.0,-3.432572,-0.21480297,-0.5741466105249022,0.022855550346981144
76354,SIDM00529,MK-1775,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,0.22252743,0.022301888,-0.29894388665950056,0.03153491796880515
45149,SIDM00971,MK-2206,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.691884,-0.13690409,-0.3205739318165124,-0.05548342958802461
18078,SIDM00893,Uprosertib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.24996614,-0.018738005,0.15957930564747502,0.04928190316747326
20894,SIDM00193,MK-1775,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,53.0,-3.233843,-0.22233322,-1.1948162502810098,-0.057644971968949764
92995,SIDM00875,Doramapimod,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.8160517,0.124702424,2.179012077137256,0.0830338731298115
73329,SIDM00529,Luminespib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-0.14235768,-0.014207075,-0.9941194580839089,-0.058694167646848074
19536,SIDM00531,Paclitaxel,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.1376667,-0.11199856,-1.8364365754098946,-0.10984691533424153
55653,SIDM00130,Erlotinib,Linsitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.4920883,0.15257145,1.8015360200183679,0.16768350887160546
102064,SIDM00875,Crizotinib,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.42578563,0.042436976,-0.6869545237409255,-0.024158698586671513
70922,SIDM00332,Docetaxel,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,3.9805691,0.3077088,2.343632154373512,0.17165153301704164
2563,SIDM00411,5-Fluorouracil,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,-2.7964828,-0.09400294,-1.9416765410466865,-0.009781355535298214
51965,SIDM00529,Sorafenib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-1.5253271,-0.075166546,-0.7087772806805549,-0.027156879325863387
22875,SIDM00893,Nutlin-3a (-),Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.4218181,0.009970699,2.7067193372682974,0.0655041488588927
10827,SIDM00776,Taselisib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,3.671855,0.1945603,3.1838375304428217,0.10458325985033975
63106,SIDM00097,Temozolomide,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.5619914,-0.010023926,0.49857833856789247,-0.023244308574419302
98663,SIDM00529,Nutlin-3a (-),Taselisib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-1.7952249,-0.051452834,-0.39302842009700933,0.04275764142487884
21820,SIDM00971,Doramapimod,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.965216,0.14480735,2.155001302984125,0.09188060721807663
93000,SIDM00875,Docetaxel,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-3.4977567,-0.05453164,-2.550670466838651,-0.1494406379655437
27352,SIDM00193,Palbociclib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.1518638,-0.040543634,0.5781034363793623,0.030621721188484663
54832,SIDM00332,MK-2206,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,4.432398,0.24236497,-0.5746864323722607,-0.036162103297818673
45832,SIDM00893,Docetaxel,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.0636313,0.28141356,2.198906488237397,0.18313772031642025
9324,SIDM00834,5-Fluorouracil,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-0.4818333,-0.025805036,-2.0239224484563962,-0.057689603865412234
68413,SIDM00954,Alisertib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.5210754,-0.11416608,0.6776318686618522,0.08171893689767834
87426,SIDM00529,Cisplatin,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,2.2622633,0.060332872,1.278391704124509,0.057349433226348535
47187,SIDM00971,Bortezomib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.0236602,0.18330191,0.5797440390337198,0.059337668552738906
35835,SIDM00875,Navitoclax,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.91993433,0.094606206,1.3719367620730838,0.10023900325406969
12326,SIDM00866,Gemcitabine,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,52.0,0.14792597,0.011560916,-0.3577604905945893,-0.01693068348854747
44122,SIDM00774,Docetaxel,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.6356814,-0.03582234,-0.6102185231361316,-0.09586756968147968
46986,SIDM00146,Tozasertib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.5980131,0.045752626,0.2323004266055375,0.0530305609807441
84734,SIDM00359,Linsitinib,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.51510566,-0.03297213,-0.6446936690093787,-0.020842922562278692
38381,SIDM00875,Luminespib,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.9914293,-0.04473258,-1.171180521650453,-0.04497796395237377
106288,SIDM00628,JQ1,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.1698372,0.14776027,1.3989033440003455,0.15169363207528758
108248,SIDM00097,Navitoclax,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5784802,-0.17548288,0.6378313879334241,0.0836612108025104
69145,SIDM00673,AZD8055,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,0.55804914,0.033097763,-0.20957399408038233,0.01742059130156848
92945,SIDM00774,Trametinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,3.5637999,0.1303681,1.6965784139577818,0.04718133084855061
28118,SIDM00673,SCH772984,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.072107,-0.16008411,0.5486494340481751,0.05025202377744727
36904,SIDM00778,MK-2206,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,3.1086178,0.16664192,-1.2110698378800755,-0.0024142131831978034
106395,SIDM00778,MK-2206,Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,0.22830613,0.012619269,0.16125491533067474,0.05138628689108379
18447,SIDM00130,SCH772984,Gemcitabine,Pancreas,0.01,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.524894,-0.108886264,-0.7122512054653428,-0.04246244156682623
42392,SIDM00778,AZD7762,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,69.0,0.8120296,0.031593453,-1.3897163314995105,-0.05793218480277879
69760,SIDM00097,AZD8055,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1341659,-0.082046434,0.205514628062449,-0.00015654847495195977
57009,SIDM00332,NU7441,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.5737104,0.16162734,2.3613987267650827,0.1024465567130732
87069,SIDM00673,Tozasertib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.278879,-0.08470724,-0.646695094745846,0.01960232336590129
77785,SIDM00875,Vorinostat,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2682705,0.124289714,0.9376056923816998,0.1181261883543915
21819,SIDM01233,Linsitinib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,72.0,-1.1028488,-0.06564807,0.4655087437095184,0.021381379490388097
104615,SIDM00332,Entinostat,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,4.8500276,0.18542601,1.7898882957818072,0.0511394982803987
19807,SIDM00893,AZD6482,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.16571894,-0.013219951,0.027739613807741287,0.00459843581541378
72439,SIDM00332,RO-3306,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.6610307,0.10565945,0.0037504021740744063,0.048560990593614926
7720,SIDM00954,KU-55933,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-2.9906964,-0.08241752,-0.08386919827171817,0.06132215191913063
19084,SIDM00893,Taselisib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.8150549,0.037513435,0.5176924996054845,0.03170822443128121
108430,SIDM00778,Camptothecin,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-0.38505772,-0.014610547,-2.193144357944059,-0.08830622558786291
103953,SIDM00893,NU7441,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.5863261,0.049665775,-0.5038716672244323,-0.006037918467985654
27554,SIDM00878,Linsitinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,70.0,1.072218,0.06921429,1.0941144238271232,0.08526408100432371
101707,SIDM00660,AZD4547,Vinorelbine,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,32.0,0.7524812,0.053225145,-0.12755382475047145,0.011684728642389487
55616,SIDM00954,Alisertib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,2.537377,0.17962572,-0.7166192130396479,0.06063651263719272
106946,SIDM00301,Sorafenib,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.0452205,-0.11029248,-0.3410563208782287,0.008231789699375085
7792,SIDM00779,Linsitinib,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,33.0,-0.30126747,-0.025317296,-0.3128571733124714,-0.013446313939874955
21137,SIDM00628,Nilotinib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,1.1105057,0.054267306,-1.4829315747897098,-0.11208722015115109
60517,SIDM00782,MK-2206,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,2.2979352,0.19584498,1.1907848732706598,0.11906580551205985
83792,SIDM00097,MK-1775,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.010015491,-0.0007104143,0.03857965828821001,0.021356828341938364
5358,SIDM01233,AZD8055,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-1.1998223,-0.09404872,-0.045129497760837314,-0.023657317082447952
98052,SIDM00774,Dabrafenib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,0.1661308,0.0035530687,1.3356697996576339,0.04741216294929092
15926,SIDM00359,Taselisib,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.719968,-0.093882486,-1.305576718732034,-0.04509079034949638
86883,SIDM00893,Pictilisib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.1858829,0.096360564,1.014506586354222,0.11935143640042528
23891,SIDM00878,AZD6482,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.9153914,-0.056709554,-0.6031768255033984,-0.057683583525123136
26001,SIDM00774,Nilotinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.8763388,0.053302016,0.27406024373985877,0.10385571673636439
56446,SIDM00097,AZD6482,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1908665,-0.13164012,-0.5875839895610028,-0.0596607541515848
11532,SIDM00628,Ribociclib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.50957626,0.012123388,0.22556519949862933,0.021093273522913587
60804,SIDM00782,SCH772984,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.87050855,0.06715603,-0.24823632290266498,-0.07252034197767272
68667,SIDM00332,AZD7762,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.644953,-0.18986626,-1.0843563982653182,-0.07932824336404784
36184,SIDM00954,PD173074,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-2.9583457,-0.12521264,-1.2047520989217895,-0.08345101268168613
106228,SIDM01233,Nutlin-3a (-),AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-1.0412362,-0.035256986,0.7191767739930144,0.061710699454004106
41131,SIDM00130,Oxaliplatin,Olaparib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.61107755,0.04048404,-2.0046587723959735,-0.046594746225799885
17694,SIDM00971,Lapatinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.7180995,0.032542586,0.3490982305304756,0.016695557104253855
23340,SIDM00834,Nutlin-3a (-),Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,White,66.0,1.061962,0.021486398,2.887787056341812,0.11448669346974479
36112,SIDM00411,SCH772984,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,43.0,1.7860376,0.09381185,1.1776164928206678,0.10303426570195719
41665,SIDM00866,AZD8055,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,3.5109973,0.18401037,0.18694791382222362,0.026630048364280488
70648,SIDM00866,Cisplatin,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,0.88731635,0.020966616,1.259084111523624,0.03570559056247694
94972,SIDM00866,PD173074,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,1.0836607,0.05041159,-1.7210966131125336,-0.05584676007461214
37662,SIDM00875,KU-55933,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.7783208,-0.068267964,-1.043746083827914,-0.01704717928730889
12581,SIDM00893,MK-2206,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.1514224,-0.01600754,-1.9811123966699755,-0.09380994924326606
87500,SIDM00866,Uprosertib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-2.098134,-0.09980996,-1.2895264694734085,-0.028484412842612484
87831,SIDM00097,Wee1 Inhibitor,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6038324,-0.09443508,-0.3833505779952521,-0.06741197351652879
47105,SIDM00776,Nutlin-3a (-),MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.8493404,-0.021410193,0.5943591563435822,0.021345814879054053
79561,SIDM00146,Pictilisib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-2.3813806,-0.14293459,-0.38206544917833707,-0.044953409651759924
77357,SIDM00875,Entinostat,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3463434,0.14193296,0.4340211544772104,0.03183810947341628
52450,SIDM00193,Taselisib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,East Asian,53.0,-0.5012326,-0.050224308,-0.9656050834767254,-0.03112176193421287
99397,SIDM00301,Lapatinib,Palbociclib,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.717565,0.17150752,3.4638856722212457,0.13988285618561316
64067,SIDM00893,KU-55933,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.357903,-0.047743477,0.04284956200801935,-0.010620045973171231
37042,SIDM00778,Crizotinib,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,0.21009967,0.010601536,0.4629248030465248,0.05998191936232816
2131,SIDM00875,Bortezomib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8420757,0.06572878,-0.07070283440070531,0.05202395942457388
18936,SIDM00893,Palbociclib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.4350156,0.035121355,2.53207715189427,0.11452913537340288
32703,SIDM00332,Crizotinib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1019872,-0.09108779,-0.3329338753269603,-0.03021276644550387
95391,SIDM00954,Uprosertib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.1510218,-0.08674359,1.2055631453028959,0.0481832848662803
84517,SIDM00193,Oxaliplatin,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.29824358,-0.009105516,0.29554005577084197,0.026450499550797927
102226,SIDM00529,BI-2536,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-1.315699,-0.06590741,-1.261923816904066,-0.02207654177838787
104880,SIDM00193,Palbociclib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.55817163,-0.015376407,0.7958359904424853,0.0746818554459949
18657,SIDM00628,OSI-027,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-2.3302045,-0.2015073,-0.3395704523493299,-0.019403673825960973
20153,SIDM00097,Taselisib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.3652456,0.12929483,-0.8218874821905823,-0.10476330859162869
105049,SIDM00660,Afatinib,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,3.2931285,0.21788067,0.797569401490719,0.025965828702952245
89684,SIDM00782,AZD4547,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,Unknown,72.0,-0.7572254,-0.020766476,0.8924455613758531,0.044656195912560606
41039,SIDM00778,BMS-754807,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,1.7835535,0.108292036,0.01395870157579733,-0.026550756730771338
73045,SIDM00878,Uprosertib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-1.4009783,-0.020575972,1.2736622998558083,0.029122484210074986
44161,SIDM00529,Paclitaxel,OSI-027,Breast,1.0,Breast Carcinoma,Female,Black,44.0,1.9794347,0.195889,-0.3580312462663863,-0.016762757749178563
64615,SIDM00332,AZD7762,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.9518341,0.18206154,-0.6460065388178394,-0.01738160989000921
61687,SIDM00332,Olaparib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,2.8266475,0.14252707,0.956393122515406,0.05144733797762366
66734,SIDM00359,Nutlin-3a (-),Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0835763,0.02421937,2.5548574140758475,0.04969084278391996
99159,SIDM00628,JQ1,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-1.5530881,-0.089280844,-1.4904559867545812,-0.07132865298985255
51030,SIDM00628,Alpelisib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-0.7278456,-0.03659925,-0.3318250383960751,0.019477547545315287
90509,SIDM00776,AZD7762,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,65.0,0.2791061,0.026037386,-0.5248645166318441,-0.043221714014553464
95905,SIDM00866,Vorinostat,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,1.1192693,0.072692156,-0.4127315024442003,0.023022494781562614
35272,SIDM00411,AZD7762,Dactolisib,Pancreas,0.0125,Pancreatic Carcinoma,Male,East Asian,43.0,1.0734435,0.04284396,0.7212034045214928,0.0633598442184296
105553,SIDM00531,Taselisib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.497621,-0.08423643,-0.34968060218817154,-0.03819661717881918
1124,SIDM00893,MK-1775,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.5786601,0.13790247,-0.7064271214685011,-0.054573115749946506
71015,SIDM00954,JQ1,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,1.8523686,0.14303552,-0.14446360417184542,-0.014530253017906579
55848,SIDM00971,AZD7762,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.47370562,-0.010347477,-0.2105365771923705,0.014032762895495765
35575,SIDM00332,Venetoclax,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1757679,0.023365533,2.632017414338202,0.06289784892197366
45672,SIDM00878,BI-2536,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.678925,0.049478922,0.8405749449115953,0.06848504369221385
65319,SIDM00359,MK-1775,AZD4547,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.5436883,-0.13699614,-1.654250318802478,-0.08697336464506862
66139,SIDM00146,GSK269962A,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.99178004,-0.07076755,0.6466051536563074,0.011553298566937478
71287,SIDM01233,BMS-754807,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-2.8010879,-0.1333929,-0.6386301052207342,-0.05080774736460918
12892,SIDM00130,Lapatinib,Olaparib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.3754853,0.13357602,0.6662260824322266,0.06155209002334976
105658,SIDM00779,Vinorelbine,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,-0.70237625,-0.019501299,0.07247623387257703,0.05747343353428389
87166,SIDM00866,Pictilisib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.86103797,-0.06031286,0.27499207643259266,0.03134593874463385
48829,SIDM00954,Axitinib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,0.6343217,0.05201817,0.3672520416923919,0.037036189044337246
24664,SIDM00332,Linsitinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4047043,-0.040937427,1.3886743670233654,0.04206255310042989
58186,SIDM00660,MK-2206,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,32.0,2.644803,0.19532545,2.8293545968027956,0.15449635710322257
22086,SIDM00774,AZD6482,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.618672,0.123640336,0.7906912841351998,0.08501801582921524
80265,SIDM00954,Palbociclib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.0,-1.356627,-0.0629338,-1.425555781754914,-0.06436845205352221
17484,SIDM00529,PD173074,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.95011836,-0.049139224,-0.6761210614915109,0.02856477399668164
87309,SIDM00971,Taselisib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.3269503,0.15886708,0.9089804614424123,0.0790579149209333
69924,SIDM00660,MK-2206,5-Fluorouracil,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,2.4314513,0.1865085,1.1588102467291341,0.08412935867638903
95888,SIDM00097,Doramapimod,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.42772764,-0.0112616215,1.1687636278830436,0.02011789115465504
66962,SIDM00954,Tozasertib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-2.7171414,-0.107515395,1.391129124580391,0.07191630099336542
82605,SIDM00097,Trametinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.044623,-0.056162454,-1.4276799746748985,-0.08311620926895313
3762,SIDM00782,Nutlin-3a (-),Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,-0.37200204,-0.006980035,1.4232541603599638,0.053524208263573056
94117,SIDM00875,Olaparib,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.9242545,-0.10633673,-0.6610916484359936,-0.05422312889418766
37289,SIDM00782,Palbociclib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.4477013,0.010351274,2.7172578217908194,0.05426474208120566
11418,SIDM00774,ZM447439,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-0.87405485,-0.0498642,3.3772431976430815,0.23618904011084915
89567,SIDM00782,MK-2206,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,2.433698,0.16195591,1.3092773059125047,0.11021068642804686
80200,SIDM00097,Doramapimod,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.82144177,0.023839867,1.4759405209301824,0.048501017565563305
11609,SIDM00301,Linsitinib,OSI-027,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.1773658,0.10809705,2.998777049706357,0.17818545503511515
10638,SIDM00893,Alisertib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.4339147,-0.036549687,-0.9529967122571383,-0.11028558520489054
104962,SIDM00779,SCH772984,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-0.84456235,-0.07365195,-1.4794892567317148,-0.10336704127060656
86684,SIDM00866,5-Fluorouracil,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-1.1842366,-0.037878457,-0.3311613709422625,-0.003512578896186167
75715,SIDM00097,Wee1 Inhibitor,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.948561,-0.118239015,-0.4762858491643135,-0.09313755614150734
19459,SIDM00779,Dabrafenib,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-2.2368803,-0.12468198,-0.0064615704157580355,0.0009358926697649547
61218,SIDM00146,Lapatinib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,2.7347183,0.10512416,3.1242596372622318,0.19573069245499122
33860,SIDM00866,AZD8055,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,1.1488395,0.050502267,0.6247252171308002,0.055684438515812694
105195,SIDM00779,Navitoclax,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,-1.0016372,-0.013904624,-0.22022080489140083,-0.005654575681894548
83914,SIDM00971,KU-55933,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.0192196,-0.029758595,0.318590405517339,0.029900420204316547
25574,SIDM00193,Dabrafenib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,-0.37450287,-0.008107314,1.251705810904465,0.03523727146703827
40974,SIDM00779,SB505124,SCH772984,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,33.0,-1.1239144,-0.10422973,-0.8443929344973565,-0.054102236984173484
6544,SIDM00531,Navitoclax,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Male,East Asian,60.0,6.578716,0.24244,3.0380453388387267,0.17998734347654247
100697,SIDM00875,AZD7762,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6990454,0.077176325,-0.5998863789672556,-0.02513641999814849
87367,SIDM00954,Vorinostat,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.0,-1.0885801,-0.08842459,-0.2760459506522547,-0.011056062465817881
42110,SIDM00774,Palbociclib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.87717855,0.03651513,0.33855375737555815,-0.00575670199027803
43379,SIDM00301,Palbociclib,OSI-027,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.7659925,0.16115864,0.3468095591192231,0.009108721594271058
24306,SIDM00411,Olaparib,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,0.88325876,0.019055776,1.6987003845358342,0.04643935123308436
41477,SIDM00954,Gemcitabine,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,0.81112355,0.06369598,0.39952909478790033,0.030330406033903613
82078,SIDM00529,Cisplatin,MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,1.2239925,0.026527703,0.9248735440828832,0.050677319977413295
38693,SIDM00529,Uprosertib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Black,44.0,0.7298779,0.04528297,0.1744053677634063,0.09247522999790467
10250,SIDM00866,BI-2536,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-2.9094138,-0.20643763,-3.00475669456437,-0.08320948828511456
54062,SIDM01233,AZD8055,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,72.0,0.6611808,0.054496046,-0.6413813235555584,-0.058334089988374936
46590,SIDM00130,LGK974,Taselisib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.0329778,0.12905182,-0.7228314377827864,-0.0148193801290424
12964,SIDM00529,SCH772984,OSI-027,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.8238447,-0.05882298,-0.5197747926616467,0.014036246683988885
66701,SIDM00954,AZD7762,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-1.7236254,-0.07753798,-0.27793991650693256,-0.03542893428626336
2486,SIDM00834,Nutlin-3a (-),Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,3.2486098,0.14248326,1.2753378461924536,0.06345650127272866
38586,SIDM00971,Bortezomib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.58273077,0.02967944,-0.010192284327118488,0.06165908136845506
89202,SIDM00971,OSI-027,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.607372,-0.08394219,-0.1074174834725762,0.013064156321694277
38357,SIDM00954,Entinostat,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,2.8848398,0.049283694,2.161563973325235,0.18760151673700864
43663,SIDM00359,Oxaliplatin,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0973039,0.07976977,-1.3908096307066218,-0.055818665643896745
75193,SIDM00866,Ribociclib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-3.3013508,-0.09483143,-1.7246863137098,-0.09921683735311256
21937,SIDM00878,Sorafenib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.41976824,-0.036827553,0.7487276715055726,0.039191605224503503
72531,SIDM00878,Vorinostat,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,0.5427243,0.056792565,1.0162309478983031,0.07927808342942486
75145,SIDM00954,Crizotinib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.6144581,-0.04868587,0.2002726240721532,0.00903793177067895
70487,SIDM00529,AZD6482,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,2.467798,0.11897067,2.0035768828703038,0.063892881450654
84069,SIDM00529,Vorinostat,MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.6862812,-0.064271614,0.0954421679868113,0.045142076006509296
5828,SIDM00411,Taselisib,SCH772984,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,3.5768428,0.20877479,3.815295321840759,0.1833923103659607
15475,SIDM00130,Linsitinib,Oxaliplatin,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.5732203,-0.090280995,-0.7741126093616649,-0.026339355455435382
40372,SIDM00774,Nilotinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.52387905,-0.03299091,0.20460203885364617,0.0418217210421513
97903,SIDM00146,Docetaxel,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,4.3498755,0.3106289,1.6552535148970173,0.19242418101424752
100111,SIDM00834,Olaparib,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,White,66.0,1.0338699,0.026274836,2.885211168292728,0.08852560020523324
61537,SIDM00301,SCH772984,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.1814693,0.1658573,1.308651732198673,0.0195014236809928
95910,SIDM00774,Bortezomib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.21243156,0.01653969,0.2866065145749885,0.07082511113256214
12966,SIDM00097,PD173074,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.8442433,-0.088911615,-0.37855732518362545,-0.0019879544483099912
89326,SIDM00971,RO-3306,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.5604277,-0.03139999,-0.5669910720857632,-0.03672108313226854
84590,SIDM00893,Temozolomide,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.7027849,-0.016465364,0.11710168435537487,0.014752351089287264
82414,SIDM00529,JQ1,Trametinib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,0.6231238,0.047122177,0.04590948951537249,0.09729521897787219
107826,SIDM00628,PF-4708671,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-2.3823977,-0.17898098,-2.0581760923194707,-0.09647218259109169
107448,SIDM00776,5-Fluorouracil,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.0195456,-0.06661251,-0.6202588961160611,-0.015665388655096264
31075,SIDM00097,PF-4708671,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.969765,-0.032252055,-0.15921129113882027,0.008284838689131678
54563,SIDM00776,Afatinib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.66545,0.05582993,-0.46484648255664246,-0.07715715647485724
8019,SIDM00782,Camptothecin,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,Unknown,72.0,-4.445557,-0.3620202,-3.0751923429224983,-0.20774850027425368
33146,SIDM00776,MK-1775,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.5251204,-0.11954275,-1.3761987398615905,-0.06514928089206111
2403,SIDM00782,Olaparib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,2.3631334,0.080788456,-0.03491449806630213,-0.0136638954461808
63913,SIDM00971,Afatinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.6117209,-0.07174818,0.4159186181068653,-0.02460670140195005
45914,SIDM00778,Linsitinib,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-0.4394509,-0.015513319,-0.5905273073649793,0.04704752942199385
36006,SIDM00332,Gemcitabine,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1574308,-0.08322828,-0.08413573811374529,0.01504288347085446
64482,SIDM00531,AZD7762,Ruxolitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.4243332,-0.079594776,-1.2627904938423675,-0.013757542383762957
56349,SIDM00875,Axitinib,Vorinostat,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0701869,0.080636874,0.9130388173726016,0.019693666638670823
57596,SIDM00660,Linsitinib,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,0.9874481,0.0630097,-0.8480353279378711,-0.03977994836150352
49660,SIDM00673,Temozolomide,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.24135739,-0.0051531666,0.560813427465124,0.0011951346685550263
81771,SIDM00097,Pictilisib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.0416489,-0.1794411,-0.8664732532036821,-0.11804419083438301
100638,SIDM00875,Bortezomib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.95246863,0.084135346,0.8510525234339695,0.07721735956569134
9937,SIDM00146,Nilotinib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-0.7479339,-0.042022534,-0.301562955399725,0.01381627350974465
26039,SIDM00875,Lapatinib,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.2286282,0.07501143,0.15607518545857085,-0.05613152227962215
6885,SIDM00971,Ribociclib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.7419467,-0.07682657,-2.0034267867703046,-0.017930908486666616
25468,SIDM00332,MK-2206,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1373789,-0.11781488,-0.5255418860020068,0.010137995999805307
98396,SIDM00954,Ribociclib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,0.88376945,0.024317365,0.11430584363653076,0.05311696810887834
95177,SIDM00774,Axitinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.3238716,0.1629752,-0.11991581556115546,-0.024570599099448254
75639,SIDM00875,Gemcitabine,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-8.348851,-0.16951227,-6.122295937856075,-0.22925828407991947
60441,SIDM00332,Camptothecin,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,6.0371923,0.095662355,3.985365413604627,0.10757465872375507
5462,SIDM00146,KU-55933,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-1.1030244,-0.047571942,-0.43599700704950406,0.07038315624904877
10219,SIDM00866,5-Fluorouracil,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.0030252,-0.034168232,0.25330692655788895,-0.0002941055225573544
102314,SIDM00628,Afatinib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.22743483,-0.01732529,0.5636969635477721,0.018354341576837713
36420,SIDM00971,Luminespib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.8623619,0.05064767,-0.6207087691009957,-0.03228865529339212
63694,SIDM01233,Navitoclax,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,2.1300957,0.11667308,0.8946474086014858,0.06278005635653977
32338,SIDM00097,JQ1,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.6677363,0.17418322,0.27295907442867057,-0.029247531943793086
53108,SIDM00875,Crizotinib,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.014480743,-0.0014620874,0.07870483200833087,-0.014150480778305842
67970,SIDM00411,OSI-027,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-1.3377054,-0.07379868,-0.8523785274955461,-0.03459274283345247
11820,SIDM00782,MK-1775,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.210948,-0.049031474,-1.2311937990789734,-0.055614139798438926
101864,SIDM00529,Camptothecin,PD173074,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.5513794,-0.021346543,0.24448600171842322,0.02809000415146096
25913,SIDM00660,Taselisib,Trametinib,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,32.0,3.9823375,0.14477159,2.2986460706265825,0.05658086897935294
50827,SIDM00660,AZD7762,Trametinib,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,32.0,-0.542263,-0.04383646,-0.626103520161194,-0.015368525208850025
99806,SIDM00673,Uprosertib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.66576475,-0.03629216,-1.02575116723681,-0.07892619920176146
19513,SIDM00774,Palbociclib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,0.8168945,0.03481795,0.18425290974690545,0.04114343261218736
80889,SIDM00954,Venetoclax,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.0,-0.48481596,-0.03565411,-0.5535563208808225,0.01148019885531529
15803,SIDM00875,Taselisib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5930367,0.14124294,1.3117312313742169,0.05622855692815509
84981,SIDM00529,SCH772984,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,2.2281332,0.14511013,0.4761428546018239,0.034063171118357466
41556,SIDM00529,Ribociclib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,0.43913412,0.014949607,0.9579463914150993,0.05133763704236544
63302,SIDM00954,Pictilisib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,2.5201628,0.062369492,0.48572572982258916,0.10013164809196522
95550,SIDM00529,Vorinostat,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-2.255746,-0.12359521,-0.802005170154508,0.013883581451301464
9619,SIDM00529,Crizotinib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Black,44.0,2.4919612,0.20128404,-0.4676142585650993,0.035551940472096276
17827,SIDM00529,Alpelisib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Black,44.0,-2.093965,-0.09493403,-0.6684990446915535,-0.030520106730131866
59818,SIDM00779,Taselisib,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.9366091,-0.12539625,-0.8671842953149516,-0.00745921769977861
50607,SIDM00774,Wee1 Inhibitor,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.8352357,-0.098241776,1.2876066549722103,0.09691487635356609
87619,SIDM00097,Pictilisib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.3954793,-0.028240547,0.09576635688441007,-0.013817492016627079
1794,SIDM00774,Venetoclax,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.2711554,0.03389014,1.2819559869041581,0.030175833834457235
25436,SIDM00875,AZD6482,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5294716,0.034776952,0.20418619968076313,0.04272124601023241
24872,SIDM00875,Luminespib,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.48480934,-0.045091897,-0.4874430778047042,-0.003549111837754348
100118,SIDM00146,OSI-027,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.5093954,0.041194748,-1.2882295871896756,-0.07050559426061165
8695,SIDM00971,Gemcitabine,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7823805,-0.06033584,0.15030676520093209,0.030239221741506853
47648,SIDM00097,Wee1 Inhibitor,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.5159593,-0.019764641,-0.3283535464723723,-0.022571310546630294
57301,SIDM00531,OSI-027,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.0135661,0.058578104,0.36223242584962906,0.047473646655337036
75576,SIDM00893,Pictilisib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.213665,0.0208214,-0.6906986903677678,-0.0706049439168136
53152,SIDM00878,Tozasertib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.1413122,-0.094655834,-0.7150537290027099,0.01573625388876106
97155,SIDM00778,Crizotinib,AZD7762,Large Intestine,0.0625,Cecum Adenocarcinoma,Male,White,69.0,-0.1797368,-0.012365566,-0.04684326844160749,-0.002057089956910533
88299,SIDM00529,Ribociclib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Black,44.0,0.67750174,0.024283703,0.45569295907467094,0.07282377842641172
21596,SIDM00971,AZD7762,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.6068977,-0.012192701,-0.8641311184964147,0.011333700875468453
57533,SIDM00146,NU7441,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-0.9988886,-0.065013334,0.1345078781183963,-0.024261935493069663
106611,SIDM00673,OSI-027,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.1331034,-0.06523025,1.2399250963072674,0.05907154586674692
43283,SIDM00971,Pictilisib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.2626617,0.12872526,-0.34067923992694893,-0.01098364520629412
10820,SIDM00774,Olaparib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.33193305,0.019799216,-0.5514511643094371,0.0006485502740716158
39057,SIDM00875,OSI-027,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0912768,-0.10188527,-1.1532211699195816,-0.03784500021221456
85231,SIDM00531,Navitoclax,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.1535465,-0.13344948,-0.7863551078077846,-0.07027746785814704
97449,SIDM00332,Doramapimod,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.2540762,0.072906636,0.975170118459496,0.05845716029418271
21295,SIDM00332,AZD7762,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5471485,0.15229833,-0.801527025883741,-0.07451943238201023
107074,SIDM00954,Ribociclib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,2.6286604,0.12566042,0.7404342774060336,0.0421369332974262
77823,SIDM00097,PF-4708671,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.98006725,-0.023656366,0.39104745862279733,0.035293297541887265
34041,SIDM00774,Palbociclib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.3003972,0.06264624,0.7314378734991991,0.044417678631163096
5019,SIDM00529,Navitoclax,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,0.7006153,0.05311109,1.7624696782252356,0.08761115729673587
74599,SIDM01233,SCH772984,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,0.72111,0.06045433,-0.12298297199211743,0.00038563025465933906
22757,SIDM00875,Palbociclib,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.36776683,0.011545025,0.659118741130954,0.06610618205010937
5299,SIDM00097,PF-4708671,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3772904,-0.04650283,0.07680885974363286,0.025754085519714653
94809,SIDM01233,MK-2206,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-2.8149643,-0.1618373,-0.6070527155223643,-0.07612638283420545
55258,SIDM00866,NU7441,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-2.3938165,-0.13656586,-0.43858186205909055,0.04422327769311734
91151,SIDM00359,Taselisib,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.9090304,-0.2264947,-2.976057220996906,-0.14974699763950466
66005,SIDM00332,RO-3306,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3462124,0.07453809,-0.22459972523400132,0.01587957576452907
64903,SIDM00875,AZD7762,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.2138883,0.013917483,0.430878382988693,0.024554659068996426
13899,SIDM00628,Taselisib,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,-0.76579964,-0.065758795,-1.120409325150365,-0.04468908467504267
3789,SIDM00529,Crizotinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-0.3982238,-0.02632822,-0.6757185934005004,0.00566733608946274
40540,SIDM00130,Navitoclax,Crizotinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.3131869,0.13049515,2.87735724104881,0.186743494605468
67659,SIDM00529,Taselisib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-1.0316156,-0.02917612,-1.1965109773252365,-0.022488967263728007
36872,SIDM00301,Gemcitabine,Oxaliplatin,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.8348614,-0.0853046,-1.1227639063526162,-0.06352492727155022
71280,SIDM00971,Palbociclib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.5879896,0.07481789,1.155665455133978,0.06726354985596569
95420,SIDM00778,Palbociclib,Nutlin-3a (-),Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,0.8205768,0.037557576,-1.4535283119297344,-0.06322193172207244
97422,SIDM00779,Nutlin-3a (-),Trametinib,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,33.0,-0.3835294,-0.014970071,1.4569183539161605,0.0714399772947874
39189,SIDM00893,Nilotinib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.0071507,-0.14296664,0.21452106439612278,0.007093697362269005
84456,SIDM00875,Olaparib,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.0737123,0.25776422,0.7670719750156778,0.05602688904090695
34124,SIDM00531,Ruxolitinib,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.2524165,-0.007259241,0.960676070680215,0.014776252699676149
101154,SIDM00332,Alpelisib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5276861,0.050892532,-0.20113143888869112,0.020961562897733054
32677,SIDM00411,Gemcitabine,OSI-027,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.8284831,-0.08650397,-1.0265755603934033,-0.0013522409857444188
69354,SIDM00529,Paclitaxel,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.9684483,-0.033001076,-2.6323633447867683,-0.09624029150120014
19022,SIDM00878,Sorafenib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,0.09312669,0.0085634785,0.7389059935643036,0.05903363301904032
5842,SIDM00878,Vorinostat,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,-1.185169,-0.12176459,-0.48668859768563755,-0.023846750150689187
82967,SIDM00878,AZD6482,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.684306,-0.09270088,0.7967480732687281,0.011076873169092076
51077,SIDM00332,Doramapimod,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.83664,0.04119187,0.629400858650709,0.028607646875437806
47013,SIDM00778,Olaparib,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,69.0,4.344119,0.20090096,-0.5769610189067617,-0.017795960471175782
88992,SIDM00531,Taselisib,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.8800962,-0.08973629,-0.36849519975794437,0.047945794237429167
94922,SIDM00774,BI-2536,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.778559,0.13322222,2.0573775676741795,0.07281533214964706
99043,SIDM00529,Alpelisib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-2.3085392,-0.10026892,0.5805392688097413,0.07340323210095522
50622,SIDM00673,Wee1 Inhibitor,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.6051661,-0.066090696,-0.0667764584226295,0.015420737149750742
28543,SIDM00893,AZD6482,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.9218239,-0.077004544,-0.890425901552987,-0.1142299900020249
16120,SIDM00146,KU-55933,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,1.2950276,0.04907358,-0.14311715597625332,0.037572898781656455
87866,SIDM00332,Ribociclib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.9780414,-0.14837976,-1.73722083379113,-0.11879710259288584
67085,SIDM00529,OSI-027,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,1.2133503,0.108348176,0.5437620568723557,0.10061624385722728
28120,SIDM00878,Lapatinib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.929533,0.11404063,0.03862083791496752,0.049203795354434185
65011,SIDM00411,Oxaliplatin,Trametinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.8374542,-0.027791727,-1.3859911294246894,-0.021311851653615873
88172,SIDM00146,Luminespib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-0.45350444,-0.038064655,-1.2113198870992004,-0.07508484379119335
47492,SIDM00866,OSI-027,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.6147138,0.12627724,0.9637666714054706,0.09800929876608949
86442,SIDM00531,AZD7762,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.9485053,-0.048150208,-0.5005568763615401,0.005950741353555834
71431,SIDM01233,MK-2206,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-2.9540799,-0.17388119,0.14784520413914432,-0.03222231993756945
91749,SIDM01233,Linsitinib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,72.0,-1.6928765,-0.09816391,0.3893506767581584,0.050156967914395265
40260,SIDM00866,PF-4708671,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-1.9981294,-0.07899491,-1.6813063214632131,-0.030909084928395225
26126,SIDM00673,Nilotinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.28691378,-0.014103074,0.22013322005438296,0.053408578625419235
100069,SIDM00893,Crizotinib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.0250127,0.08869346,1.9965232983656194,0.03819188944050895
100899,SIDM00866,Linsitinib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-0.85140747,-0.03663131,0.08469677449834291,0.05634921994343711
65476,SIDM00878,Bortezomib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,0.7961649,0.046509046,-0.3454993165770753,-0.013019047914468966
2743,SIDM00673,JQ1,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,2.7233343,0.1760202,1.1646840238157286,0.07807151332892047
7003,SIDM00878,Doramapimod,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.7081427,0.045403864,0.9323826883268702,0.06143290180741057
96990,SIDM00893,Navitoclax,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.8418634,0.17903486,-0.4210063324406139,-0.02972743805283877
39438,SIDM00673,AZD6482,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.79266894,-0.06320045,-0.5717331192925622,0.011741257004902694
64355,SIDM00774,Wee1 Inhibitor,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-3.8139527,-0.17333652,-0.10260474428583113,-0.016420908532834563
85161,SIDM00529,Doramapimod,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.20433229,0.007119314,0.2693648840781147,0.007209708965421125
87135,SIDM00332,Nutlin-3a (-),AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4648105,0.046318963,1.5110450684423227,0.008186441121358641
30490,SIDM00146,Pictilisib,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-0.6300769,-0.043894168,-0.15916090874344885,0.03288190000481632
59949,SIDM00097,Dabrafenib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.211668,-0.063618936,0.06307827712762604,0.0011065508652786473
10462,SIDM01233,Nutlin-3a (-),5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-1.7707413,-0.054867227,-0.26501797752075934,0.019069135983494374
77506,SIDM00878,Paclitaxel,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,1.7135438,0.14446309,0.3051358502322044,0.04740572378092043
99101,SIDM00954,Camptothecin,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,6.0875187,0.13011539,4.226651467818803,0.18015142545952598
4772,SIDM00359,AZD4547,Navitoclax,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.45914868,-0.03205475,-0.55643484329209,-0.006755555363659841
100059,SIDM00673,ZM447439,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.42791727,-0.035051093,-0.6504958389384536,-0.01199931848662673
34835,SIDM00673,MK-2206,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,2.5738857,0.08668012,-0.2941933209185579,0.00034471704361586876
77298,SIDM00866,Trametinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-2.8571975,-0.08470205,-1.5858026959212383,-0.0660542151830401
20777,SIDM00332,Navitoclax,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3981047,0.037349697,0.9543176324053774,0.07994202828574562
35377,SIDM00332,AZD8055,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5933673,-0.104920976,0.11134343478131577,0.033630991957488345
106478,SIDM00971,Luminespib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.5764754,0.17682587,0.59879664294604,0.0665384770934494
51437,SIDM00971,SCH772984,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.552361,0.13662241,3.639436542509261,0.11868771302233123
37922,SIDM00628,PD173074,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,3.199088,0.12234027,1.4467438170783462,0.12834483630725013
21831,SIDM00332,RO-3306,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.0475388,0.10653192,1.3827391317458275,0.1279794536857682
19947,SIDM00097,Uprosertib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9032714,-0.10256809,0.07972910355969107,-0.007047806148816841
48407,SIDM00778,Dabrafenib,Navitoclax,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,1.9556375,0.05422417,1.2048286369598618,0.027256032508327133
107028,SIDM00971,Alisertib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.4286022,0.034474403,1.1111711481199016,0.08111438611104785
54672,SIDM00301,Dactolisib,Lapatinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-3.7325966,-0.47035518,-0.2427218172238962,-0.023504723940521798
11098,SIDM00193,Dabrafenib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.6259805,-0.010777023,1.3077782102624371,0.0391089295412901
65000,SIDM00660,SB505124,Taselisib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,32.0,-0.21467277,-0.021348964,-0.10716310944778322,-0.006779596634108172
25082,SIDM00301,MK-1775,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,50.0,-1.0536623,-0.021356616,-1.3203435253359106,-0.0068514117885994244
72559,SIDM00971,Nutlin-3a (-),Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.1214807,-0.05211003,-0.11314401106603879,0.002649209544095521
92000,SIDM00332,5-Fluorouracil,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4328836,0.102682106,1.0671829464516447,0.09951758547242315
83502,SIDM00332,Tozasertib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.1157906,0.1376903,0.05435046858163794,0.004840036864495465
88102,SIDM00359,5-Fluorouracil,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.2460861,-0.14373584,-1.0736534760419434,-0.042969689530245166
54614,SIDM00628,AZD8055,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-0.45213148,-0.035300754,-0.05716937928222939,-0.012422729985235885
51175,SIDM00954,Olaparib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.55112946,-0.017154422,-0.5287434200712542,0.02892410057349642
97778,SIDM00301,Olaparib,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.6155741,0.19855684,-0.047940009169109586,0.01430434558245311
89419,SIDM00774,Venetoclax,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,3.2888381,0.0791814,3.012559832805754,0.02852860415090412
71582,SIDM00332,JQ1,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.2968547,0.117631905,0.6662452265751649,0.07098857186630879
107741,SIDM00774,Palbociclib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,2.4393127,0.06541669,2.683067133592821,0.06075026240058135
72341,SIDM01233,SB505124,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-1.2914841,-0.050707676,-0.9049818783166957,-0.11878383723256486
100968,SIDM00673,SCH772984,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-3.6135106,-0.25072503,-0.7929165616891608,0.002735523292681627
23659,SIDM00893,Venetoclax,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.4372079,-0.017858336,-2.0875506707357148,-0.04943183738746288
49438,SIDM00875,Docetaxel,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0409527,-0.082525305,-1.5094288655457084,-0.16045102365017333
43223,SIDM00193,Olaparib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-2.8580704,-0.083124,-1.412625306753077,-0.04858484976277271
23672,SIDM00878,MK-1775,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-0.80563956,-0.08790276,-0.2276435973151129,0.02815066226365791
52087,SIDM00875,Entinostat,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3362571,0.14247602,1.9355993524254347,0.1274582094008259
11828,SIDM00866,Uprosertib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-1.889752,-0.06659948,0.2764755681280507,0.07141188249158388
12660,SIDM00146,Ribociclib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-2.1262822,-0.07719967,-0.6610838886893557,0.0664532124585267
79709,SIDM00774,Navitoclax,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.7449602,-0.030367415,-0.2987151727872299,-0.004754870960725003
29881,SIDM00097,NU7441,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8441719,-0.040150553,0.8152416474166487,0.030374419876012092
47269,SIDM00866,Ribociclib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-3.3983269,-0.11837399,-0.7167247436178211,-0.07085909025120166
48238,SIDM00875,Doramapimod,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,4.579287,0.124263994,2.321182844318244,0.06177146553597909
57579,SIDM00529,AZD8055,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Black,44.0,2.1016376,0.19762377,0.15094913741794908,0.08057436603590021
46920,SIDM00875,Afatinib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4914237,0.0811504,1.1402187852850036,0.009184646667989174
26397,SIDM00097,AZD7762,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.4945745,-0.080647066,-0.7474802159114412,-0.033949107117375
32630,SIDM00097,OSI-027,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9792218,-0.11958888,0.6422161300520627,0.020756430773167946
25811,SIDM00866,Lapatinib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.4511202,-0.034883942,0.2854105442413913,0.06015013715051513
73265,SIDM00954,SCH772984,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-3.1344657,-0.18757427,-1.1287721595589695,-0.09055195263270122
30975,SIDM00778,Dabrafenib,Taselisib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,3.6034558,0.085280955,2.3342430102940677,0.09197266670444833
106838,SIDM01233,AZD7762,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,2.208903,0.06979587,1.6381495260905237,0.0692977504749903
53277,SIDM00130,OSI-027,Taselisib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.8828882,0.17325577,2.413704564875405,0.15041309401614264
14716,SIDM00878,Dabrafenib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.64707375,0.024358967,0.5718999428531185,0.03686735293018678
15901,SIDM00097,Cisplatin,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.9479829,0.038588762,1.6145996467822428,0.042316534193850806
66591,SIDM00411,Erlotinib,AZD7762,Pancreas,0.0625,Pancreatic Carcinoma,Male,East Asian,43.0,1.3807877,0.07413182,1.038437807089323,0.07656777730092379
41625,SIDM00097,Palbociclib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1826556,-0.08737378,-0.8180590588197728,-0.057920323651462775
75841,SIDM00332,GSK269962A,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6557252,-0.066018075,0.3713237587052609,0.0007964630896316218
27213,SIDM00893,Axitinib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.8017783,-0.039243963,0.14066591497346953,0.0168215406286348
56410,SIDM00529,Uprosertib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Black,44.0,-2.471966,-0.09255638,-0.0322561671581545,0.010994349026849128
68156,SIDM00875,Taselisib,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.0953952,0.00293794,-0.24207571468848935,-0.03167472483469793
100115,SIDM00774,Wee1 Inhibitor,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,48.0,-2.2830722,-0.1295159,1.769077627327242,0.09825384438656418
19697,SIDM00774,JQ1,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.3874254,0.022452213,3.0243511969066805,0.1666725931765429
10897,SIDM00893,Nutlin-3a (-),Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.47341028,-0.010115199,2.5303541274960444,0.07934288928461564
98245,SIDM00146,Docetaxel,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.9922589,0.17610432,0.13247683944512312,0.02101315786805156
102023,SIDM00529,Crizotinib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.5867286,-0.037917543,-0.9071579226791946,0.01981637338152182
107621,SIDM00875,AZD8055,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5742242,-0.1375812,-1.4816091457800442,-0.07239364119687415
89281,SIDM00146,RO-3306,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,1.3662359,0.12601522,-1.0462239549854462,-0.0340425817298387
68918,SIDM00359,5-Fluorouracil,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.5625875,-0.14181578,-2.904250406889927,-0.09185008732774677
48448,SIDM00130,Sorafenib,Dactolisib,Pancreas,0.0125,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.14980905,-0.012730522,-1.2140147257890923,-0.03516743514003062
17296,SIDM00146,Ribociclib,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-1.6606865,-0.059837688,-0.20736116464913174,0.023180115178109407
55808,SIDM00130,Cisplatin,Oxaliplatin,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.7540798,0.24687459,0.2243135970166541,0.024806190185667366
85930,SIDM00878,Sorafenib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,70.0,0.39793232,0.037296046,-0.04453871580294565,0.016021538240992436
87641,SIDM00332,Luminespib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,0.95980686,0.0920152,-0.8171229081253263,-0.029229510713427796
64298,SIDM00628,ZM447439,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.6903277,-0.06363611,-1.635993216637308,-0.1216599958719749
106331,SIDM00971,Camptothecin,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.452636,0.03724233,1.3720682693520883,0.05096908579941866
62836,SIDM00866,AZD8055,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,1.6402191,0.055659607,0.8480589854944887,0.040789291403233695
45782,SIDM00971,RO-3306,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.1894312,0.066959254,0.5632328530578555,0.07677404517365344
7931,SIDM00878,Gemcitabine,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,1.4909986,0.14278987,0.26653708047568353,0.049225505036591406
41503,SIDM00130,AZD7762,Oxaliplatin,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.7573316,-0.1522659,-2.1544929020706833,-0.06359157447512812
92291,SIDM00301,Linsitinib,Trametinib,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,1.2535053,0.060446896,1.8171443972238495,0.06823870137931734
2260,SIDM00778,BMS-754807,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,2.468152,0.06481414,0.5602226124278936,0.0210322932761226
74139,SIDM00776,Palbociclib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-0.76444525,-0.016880073,0.8247991618265449,0.011080515640609695
4890,SIDM00834,Trametinib,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-0.5332618,-0.010165809,-1.7658933516719502,-0.08291224238681771
4976,SIDM00779,Palbociclib,LGK974,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-3.1052907,-0.21190014,-1.1914215322217372,-0.09538907870241765
51311,SIDM00130,Crizotinib,Oxaliplatin,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.485332,-0.1223595,-1.438346422347169,-0.07614600981565592
69711,SIDM00529,Taselisib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,1.4080417,0.100753136,1.5459804501534384,0.18959956582826037
72121,SIDM00673,Luminespib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.4075536,-0.041833162,-0.5757363660833485,0.006398354657233941
30066,SIDM00776,Olaparib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,1.3338217,0.06119249,-0.5799962718642087,-0.009685718012866258
40498,SIDM00954,Venetoclax,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.0569036,-0.078509204,-0.7431321795726312,-0.012937582094091718
62216,SIDM00866,Axitinib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.93034655,0.07183406,-0.15262361945460617,-0.03159367467013383
65501,SIDM00779,Nutlin-3a (-),Crizotinib,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,33.0,1.2387601,0.061535496,0.21525671137384272,0.0225504196287511
75266,SIDM00774,JQ1,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.345076,0.07140349,1.1010211525712617,0.1097207707476265
32429,SIDM00774,Alisertib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.1937752,-0.11072144,0.5132555026245988,0.07543578554499954
66670,SIDM00954,Nutlin-3a (-),Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,1.0991105,0.023464013,0.9665775050871954,0.08453231845978018
96670,SIDM00893,Ribociclib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.7781518,-0.08333348,-1.6709881607994523,-0.04132963741877894
53437,SIDM00779,5-Fluorouracil,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.8604115,-0.056334026,0.15806667872440192,0.046234991568682
76427,SIDM00774,AZD8055,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,0.22280402,0.016364427,-0.1955851895183319,-0.004777859563451478
53860,SIDM00776,MK-1775,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.70617455,-0.014940505,-0.7787477194148186,-0.03775884504884504
81070,SIDM01233,Olaparib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,72.0,2.0911732,0.036605824,2.0951144814327303,0.1065071900289233
99815,SIDM00779,Taselisib,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-2.2138429,-0.17606996,-1.5167041792895941,-0.07858187062504876
31943,SIDM00878,Uprosertib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.6926919,-0.03173685,-1.2396842362744578,-0.12987570313082844
38238,SIDM00954,Alisertib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-1.7756058,-0.13744096,-0.1713098966552136,-0.00609445064268238
4135,SIDM00301,AZD7762,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.7829838,0.23844667,1.518537830063399,0.14283854918268693
73822,SIDM00628,Entinostat,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-1.3470945,-0.070144534,-0.13232524023543182,0.0099237993499296
73983,SIDM00954,Olaparib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,2.1468513,0.09240663,0.5112028607839413,0.08817949746621247
14745,SIDM00332,PD173074,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.6251799,0.13860738,0.04265339585150596,0.014878778359909963
23604,SIDM00971,Luminespib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.2846249,-0.06394919,-0.5422954227972138,-0.03429290488501254
86043,SIDM00954,Paclitaxel,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-2.5182035,-0.19407202,-0.9698272865736509,-0.15320206740603276
53444,SIDM00097,Crizotinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2300192,0.066526435,0.11695819162950688,0.056072718527119106
16460,SIDM00893,PF-4708671,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.9772988,0.07977172,-1.7460391909934716,-0.10457900188346993
96135,SIDM00301,Gemcitabine,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,0.8634916,0.051669028,-0.10046944432940293,-0.03704382247826648
32664,SIDM00782,Palbociclib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,5.1876287,0.22712833,3.219483397398122,0.11036429241247779
69279,SIDM00301,LGK974,AZD7762,Pancreas,0.0625,Pancreatic Carcinoma,Male,East Asian,50.0,0.82882905,0.08897967,-1.6292031987620101,-0.053122037592761
46710,SIDM00774,Tozasertib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.49032846,0.010490252,1.7363624077666535,0.05275200289101268
81568,SIDM00359,Linsitinib,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,4.116351,0.33767596,-0.09924176374269691,0.021657321794240424
31762,SIDM00332,Docetaxel,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,1.133316,0.12103911,-0.07494230931945361,-0.04212949495241143
31819,SIDM00875,Linsitinib,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.1131017,0.04921119,1.7220718473280587,0.04733811253495193
43874,SIDM00878,Camptothecin,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,0.74121624,0.018401783,1.1483396414521554,0.05756874232977437
22907,SIDM00875,Olaparib,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9295158,0.08965266,-0.31644031771896264,0.005655203727900696
1234,SIDM00779,5-Fluorouracil,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,33.0,-1.9194973,-0.052055474,-0.9631825493518648,0.033514121865697334
103902,SIDM00971,Ribociclib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.549051,-0.034820173,-1.4024284461296956,-0.015556748770113312
3267,SIDM00097,JQ1,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.8475714,-0.12501864,-1.0211845607827033,-0.04432564565551228
104707,SIDM00301,Irinotecan,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.8431553,-0.14878783,-0.2547059321012491,0.025013177391956073
78328,SIDM00359,AZD4547,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.0147448,-0.08557793,-1.453675393448755,-0.0832732247541895
70469,SIDM00097,Bortezomib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.6643963,0.027718445,-0.27493596244851276,-0.014964080716196869
77921,SIDM00332,Lapatinib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4596289,-0.11758483,-0.8127200874965446,-0.0005883521157939944
97561,SIDM00878,Camptothecin,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,2.3326793,0.085334435,2.295718138812192,0.09476028210505855
92276,SIDM00359,Taselisib,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6279112,-0.11823595,-1.7715578669172214,-0.11833557831394279
105611,SIDM00778,Vinorelbine,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,69.0,-0.77482533,-0.0471058,-1.9096753513423348,-0.10588561987460603
94253,SIDM01233,AZD8055,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,1.7938799,0.06819311,0.9248835255279529,0.022756557620361783
46019,SIDM00893,BI-2536,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.357147,-0.11410536,-0.9628514920631729,-0.031609847859786704
9163,SIDM00774,SCH772984,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.9567423,0.06471624,3.078550855538097,0.10388474703524112
25365,SIDM00774,MK-1775,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,1.5064315,0.16503133,-0.30497872941709353,0.006758478887613026
73916,SIDM01233,Taselisib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,72.0,-0.71674037,-0.061874744,-0.7609218458366747,-0.05463699814314539
37533,SIDM00097,AZD7762,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.929985,-0.10025115,-0.4102707425927494,0.03165232936043503
50274,SIDM00673,Sorafenib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.8260073,0.054785848,-0.0008636259468461242,0.04331278352744749
15773,SIDM00971,Pictilisib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1549464,-0.05039036,-1.0778649098558717,-0.015916619953326352
90939,SIDM00893,Trametinib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.4154824,-0.13355546,-1.1836880314210352,0.017949707892575165
43322,SIDM00130,Sorafenib,SCH772984,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.5138099,0.12590633,-0.5614064459277028,0.002446133897366477
21765,SIDM00878,Olaparib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.48717374,-0.011601076,1.1470262066021357,0.04505185430863898
21392,SIDM00332,Lapatinib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7436047,0.07277607,0.5197589821474597,0.04160394245747923
60309,SIDM00146,Gemcitabine,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.9828537,-0.15617077,-1.3448646926905075,-0.13144660053076218
50933,SIDM00359,Taselisib,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.8901484,-0.078418516,-0.5979761887246917,-0.027112435387841097
1294,SIDM00529,Docetaxel,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-2.9546144,-0.079842724,-0.39749565868135733,-0.015076654442832325
43224,SIDM00875,Bortezomib,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.46523714,0.04424608,-0.862326137518969,-0.021986193368957366
95872,SIDM00146,5-Fluorouracil,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.6598496,-0.043693956,0.08145371405796507,0.02381179825833378
95829,SIDM00146,Sorafenib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,-0.26755428,-0.025291326,-0.49888514853795446,-0.05070284866792318
102794,SIDM00097,Venetoclax,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4064522,-0.039433062,-0.19794374896837694,-0.021464685135992798
21686,SIDM00193,AZD8055,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.7625892,0.06800493,0.4109553999720753,0.08194535067778624
79669,SIDM00146,Sorafenib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,0.8176766,0.073554285,-0.526349166062331,-0.016183457580304324
19682,SIDM00779,MK-1775,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-0.83401054,-0.0245884,-0.6689836054812278,-0.033745109389850876
55996,SIDM00301,Linsitinib,Paclitaxel,Pancreas,0.0025,Pancreatic Carcinoma,Male,East Asian,50.0,2.542624,0.14842677,3.124376444839104,0.053157396727676096
19161,SIDM00130,Navitoclax,Dactolisib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.607076,0.039518017,0.411874872698172,0.02517699307201817
52926,SIDM00146,PF-4708671,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,3.6636825,0.1746554,2.252525303079196,0.10554166771513969
59031,SIDM00660,AZD7762,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,32.0,0.49370515,0.043751884,-0.23508037586844616,-0.030422957787123787
57017,SIDM00628,Nilotinib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,0.7373559,0.07249686,-0.14110022429198887,0.0033661450471014127
55235,SIDM00628,Pictilisib,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-0.7525448,-0.07412563,-1.1461051956009913,-0.08305180903061109
29659,SIDM00301,Dactolisib,Paclitaxel,Pancreas,0.0025,Pancreatic Carcinoma,Male,East Asian,50.0,-1.5283589,-0.14395392,-1.7294704965900418,-0.08534446750513064
13520,SIDM00628,Nutlin-3a (-),5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-2.4607773,-0.108099714,-1.6782273041557367,-0.07190772438733725
53798,SIDM00782,AZD7762,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,0.63566804,0.051426046,1.230728648935329,0.03376393243942101
84784,SIDM00866,Paclitaxel,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-3.5252793,-0.18482074,-3.3145151542244062,-0.15216032408682675
89591,SIDM00193,MK-1775,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.7892916,-0.10257798,-0.05527587470825944,-0.015768150629720666
65878,SIDM00778,Crizotinib,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-0.5416709,-0.021646077,-0.39669783822415633,-0.00961163947393538
68384,SIDM00097,Alisertib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.597077,-0.17236046,-2.336045441402345,-0.13828527462742307
101993,SIDM00971,Tozasertib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.245203,0.038243067,3.550824983899774,0.11246233158303862
48914,SIDM00359,SB505124,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6121696,-0.12115698,-1.3588198452195077,-0.06487926822459508
107092,SIDM00193,Navitoclax,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,53.0,-0.7125627,-0.051632587,0.05520338751384091,0.037978077446935016
61391,SIDM00193,Trametinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,3.4295366,0.19587654,1.8692297839133596,0.07134778285527521
56188,SIDM00893,Palbociclib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.3731674,0.080581106,1.4165834951836862,0.07751366229038344
31827,SIDM00954,Sorafenib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,1.4312769,0.09428998,-0.3873960172048633,-0.007381674864322004
40490,SIDM00866,Crizotinib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-2.1589386,-0.15433109,-1.1471821057603802,-0.03982986977726971
32532,SIDM00529,AZD8055,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.6573235,0.053951498,0.015189498202675046,0.04996675420869786
105461,SIDM00893,Venetoclax,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.4039582,-0.04478941,-0.9483581714431638,0.040007102018594115
23145,SIDM00776,Nutlin-3a (-),SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.4546721,-0.025566926,-0.17311014317768056,0.007055546353663469
76303,SIDM00529,Lapatinib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,-1.1280648,-0.07123801,-0.14716018592587524,0.001457614292379587
52707,SIDM00782,BMS-754807,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-1.6845945,-0.15827788,-1.3446165124673741,-0.11810534104071635
86656,SIDM00878,Sorafenib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.6479192,-0.057474013,0.224451365420805,0.03843688426689241
81862,SIDM00875,Axitinib,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.8060765,0.052206572,0.24774246243701015,-0.02660399347600097
30414,SIDM00875,Gemcitabine,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3856054,-0.00057783717,0.7917351812732066,0.1001334674609023
9024,SIDM00878,Trametinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.4843228,0.051104695,-0.39823693914807357,-0.08819257169751171
73042,SIDM00146,Linsitinib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.74968845,0.020096602,1.5102446811891412,0.04183182059354503
21876,SIDM00878,Alpelisib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,0.5310504,0.04795901,-0.21087808240314368,-0.02199697384519777
6453,SIDM00776,Camptothecin,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,0.6058257,0.051883228,-0.010591110457417431,-0.015497356111653685
5059,SIDM00893,JQ1,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.9638666,-0.07829202,0.32950888825271873,0.13050672724697118
69178,SIDM00866,Cisplatin,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.0596747,0.022886962,1.7790216125546472,0.0599718238034656
16140,SIDM00971,Camptothecin,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.2372575,0.061146494,1.991047043720317,0.06655967361313679
94158,SIDM00971,5-Fluorouracil,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.2023274,-0.0059031453,-0.20467506767625698,0.01910890898551322
84962,SIDM00875,MK-2206,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.42460886,-0.032765303,0.04728640859318371,0.008877889572242588
28440,SIDM00332,AZD7762,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2077951,-0.09888564,-0.446971108042191,-0.06322437961217502
65554,SIDM00893,RO-3306,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-3.3241565,-0.20486781,-1.573404469485093,-0.08875795383888187
99271,SIDM00875,Alpelisib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.37766358,0.035005134,1.2366313464183865,0.1322057920492322
37250,SIDM00146,Venetoclax,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,1.9663064,0.04217463,1.7216974281484692,0.056078729645951716
10056,SIDM00778,Dabrafenib,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-0.63368756,-0.012579378,1.0129143810922014,0.006766078674012866
61582,SIDM00193,Oxaliplatin,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,53.0,-0.4339522,-0.014596051,1.2418683519202893,0.02667552684557395
100418,SIDM00954,Olaparib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,3.0160568,0.13489659,0.8946540378742986,0.09309293930642344
11236,SIDM00782,Nutlin-3a (-),Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,Unknown,72.0,1.2116232,0.034923386,1.3095254161188574,0.07291696927355376
24003,SIDM00776,LGK974,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,65.0,-3.0473726,-0.11159313,-1.8718248578599026,-0.046618287617327205
84731,SIDM00359,Vinorelbine,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,4.404958,0.29857513,0.46701367748969347,0.08408064000876686
1047,SIDM00878,PF-4708671,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.8188931,0.043105,-0.3903977086189263,-0.001396653557707164
71799,SIDM00866,Temozolomide,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.89814055,-0.014733094,0.6234149103084528,-3.196606260806997e-05
18802,SIDM00778,AZD8055,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,-0.75642633,-0.019475328,-0.3407521325430957,0.04023347217939699
69713,SIDM00411,Ruxolitinib,Sorafenib,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.2826463,0.02008377,2.012426618876384,0.00827925452189801
107644,SIDM00834,AZD8055,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,White,66.0,1.6446322,0.14149183,0.41086901906500395,0.02195520507183866
43085,SIDM00130,Lapatinib,Taselisib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.7936707,0.14610122,0.8155597059215065,0.08665529329823106
7541,SIDM00411,Erlotinib,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.7233741,0.092339955,0.30997026001323114,0.07095680061970802
89905,SIDM00097,Paclitaxel,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-5.1728907,-0.257123,-3.7057966683369448,-0.3237669627622153
10826,SIDM00359,MK-1775,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.149702,0.15391076,0.7056883079784754,0.0702281469732509
61515,SIDM00628,MK-1775,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,1.3441749,0.110882156,0.8849683494751523,0.07860396228741372
45926,SIDM00893,KU-55933,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.22797075,0.00998785,1.2473193441470443,0.022060634800512426
24555,SIDM00673,Linsitinib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.8418513,0.0142682195,4.131302080533261,0.12976251919728712
24989,SIDM00673,Ribociclib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.8938956,-0.08674509,-1.6482537284218033,-0.03500563708860644
75323,SIDM00673,Linsitinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.6081329,0.013026596,1.6997317634066549,0.049301982572720254
95175,SIDM00531,MK-2206,Navitoclax,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.2704528,0.017237036,1.8036431052835742,0.08519139084406563
31200,SIDM00673,MK-1775,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0765384,-0.10273676,-0.7933769737605479,-0.05360639248771867
63549,SIDM00875,Venetoclax,Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4882543,-0.011209528,-0.11655986869103321,0.03453002860142233
88083,SIDM00628,Cisplatin,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.889737,-0.07523893,-0.3384689045521348,0.04159702361688182
16110,SIDM00673,Nutlin-3a (-),PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.059396166,0.001346088,1.2114445543619727,0.040126904569579486
74964,SIDM00866,Venetoclax,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.71863335,-0.015781749,-0.06665177234735023,0.02166479788842338
41743,SIDM00673,Afatinib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,1.8281134,0.14332986,-0.24419245863251288,0.06197495000195034
60123,SIDM00097,Nutlin-3a (-),Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.1155024,-0.0991707,-2.0024502986738004,-0.022281808758859777
50088,SIDM00866,Palbociclib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,-0.22813927,-0.0057743336,0.05546235808924331,-0.0009324515575776092
15328,SIDM00332,Bortezomib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.66763204,-0.04422376,-0.7937914948686954,-0.0989671158078713
67054,SIDM00529,Uprosertib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-2.170445,-0.06815141,-0.221167605327648,0.04369527018172544
6956,SIDM00146,Alpelisib,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,1.3501511,0.07804705,0.49985834750307634,0.11348054510518381
87505,SIDM00875,SCH772984,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6329037,-0.11184224,-1.1399101408535355,-0.07523361657205442
75922,SIDM00774,Tozasertib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,2.36633,0.094024226,1.2553814963658012,0.04180245199607643
70247,SIDM00778,BMS-754807,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,3.9687183,0.17580706,0.597692235746231,0.02797491966134567
56223,SIDM00875,Nutlin-3a (-),MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.43924665,-0.013990312,0.7237167887937102,0.018472197033732558
50941,SIDM00866,Camptothecin,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,1.6413068,0.03521632,2.4756026615472435,0.10584493108557237
105786,SIDM00097,Nilotinib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.6386598,-0.039325364,0.6981243612005906,0.02434913099953207
32424,SIDM00878,Crizotinib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,0.9893921,0.06665993,-0.719033813655143,-0.08728985991684295
54605,SIDM00529,Docetaxel,Trametinib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-2.5088625,-0.16203322,-0.9769594305887692,-0.026291006243813128
41927,SIDM00193,Vinorelbine,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,1.5938306,0.15019114,1.2745207881747171,0.13611461829078417
9894,SIDM00097,Afatinib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0705088,-0.07681698,-0.6521391804609489,-0.06271158322328314
54156,SIDM01233,Taselisib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,2.0928516,0.14427137,0.8827649370842726,0.07677073969391833
14265,SIDM00779,AZD8055,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.1272535,-0.10229459,-0.26387070650925387,-0.037883160991935894
35123,SIDM00097,Lapatinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.350612,-0.14122914,-0.47341156347381247,-0.05305735087570617
75180,SIDM00971,Paclitaxel,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.5484126,-0.05546084,-1.1552079300715794,0.017248442892929823
29359,SIDM00332,Axitinib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.9452171,-0.19763033,-0.5570185859522875,-0.0854437775274552
65635,SIDM00878,5-Fluorouracil,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.8227884,-0.118130766,-1.0027186579428673,-0.08930165746046823
84166,SIDM00529,Temozolomide,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-0.4194385,-0.008428536,-0.29616989319761267,0.012942103213881064
108155,SIDM00097,GSK269962A,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8079824,-0.07177922,0.4096313955955631,-0.02334089150203423
7997,SIDM00971,Luminespib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.7567378,0.04048451,0.942928419477002,0.01398549739624154
72890,SIDM00954,Nilotinib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.311989,-0.10319134,1.3328283128622556,0.10203343995904904
99848,SIDM00301,Taselisib,Navitoclax,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.2314612,0.17307748,0.9755273818016122,0.11649326751546868
41588,SIDM00673,Wee1 Inhibitor,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.5679063,-0.033437587,-0.049333730645639076,-0.010968501133262882
6518,SIDM00660,AZD8055,Dabrafenib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,-1.017076,-0.069815174,-0.12895980375189936,-0.0040840973627834145
6656,SIDM00971,OSI-027,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.774566,-0.10792389,-0.029391766391288817,0.013871526037373518
45577,SIDM00774,Olaparib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.405591,-0.057762004,-0.9390118949033834,0.016840797314207394
99866,SIDM00097,GSK269962A,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1445352,-0.03498753,0.9237918382158489,0.04512927331132934
18009,SIDM01233,Camptothecin,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,1.1683824,0.04889719,2.3880173613664195,0.10217234400458756
69596,SIDM00834,5-Fluorouracil,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-1.7753649,-0.091173775,-1.2113977373592395,-0.0254420266666722
12520,SIDM00779,Camptothecin,Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-1.3515432,-0.046606228,-0.6356397877016955,-0.04536502658905655
96539,SIDM00778,Vinorelbine,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,1.4146383,0.042923678,-0.21711817620869217,-0.008348730352286574
20391,SIDM00146,Taselisib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.32548347,-0.026475474,-1.5151456995395853,-0.03539504957842859
36851,SIDM00529,Doramapimod,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Black,44.0,0.71334505,0.027140861,0.780302609584621,0.051129621936600256
59284,SIDM00301,Erlotinib,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,50.0,3.8751528,0.055767592,3.9270085177277254,0.07324856733519751
57957,SIDM00875,Taselisib,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7248466,-0.08507305,-0.5099500147515231,-0.11830593798260337
14627,SIDM00875,Nutlin-3a (-),Vorinostat,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6112613,-0.017642505,0.9956447800319937,0.047278184442830176
67048,SIDM00893,MK-2206,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.81535304,-0.0780141,-0.852442870752935,-0.043507220653021116
15916,SIDM00776,MK-2206,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,1.1670481,0.10218843,-0.9179944020657314,-0.07052673813861077
4490,SIDM00097,Paclitaxel,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.380101,0.23567577,2.9224662222458537,0.19232908364623277
11582,SIDM00359,LGK974,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.770268,-0.020742673,-0.6117108482069917,-0.0009209819416922451
35802,SIDM00529,Ribociclib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Black,44.0,1.8561727,0.07766239,0.3263142039431129,0.043823698732222055
83200,SIDM00878,Crizotinib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.12389993,-0.014844172,-0.3605202147059046,-0.0780828929723205
92848,SIDM00332,Taselisib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.8358417,-0.18451361,-0.9135090908318957,-0.1034669431825673
72636,SIDM00878,Docetaxel,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,70.0,-2.7583308,-0.19649181,-1.8343557259083874,-0.07290042615643111
22225,SIDM00628,Entinostat,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-1.4411234,-0.07823408,0.015647358819047764,0.027195992295176153
18145,SIDM00529,Venetoclax,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,-1.0367645,-0.02493065,0.5092184138042979,0.017867033779663522
43012,SIDM00673,Crizotinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6888392,-0.06371291,-0.5376023535341841,-0.033571395179885014
104902,SIDM00301,Paclitaxel,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.8295677,-0.09998234,-3.4984213471310164,-0.20865075914793343
84804,SIDM00130,Olaparib,Dasatinib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.3158693,-0.10529472,0.07650900876767143,0.022166381402504542
83757,SIDM00774,MK-1775,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,0.42812157,0.047900338,-0.8452971387227315,-0.030519757704829672
81123,SIDM00660,Linsitinib,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,5.1054964,0.4735909,0.8318867333029945,0.08227480946929706
45775,SIDM00146,MK-2206,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,2.1435308,0.07534916,1.8004333749679329,0.1023040563849536
34795,SIDM00866,Alpelisib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-2.0294178,-0.104124755,-0.4766912298547399,-0.012527160217372614
13569,SIDM00411,Dasatinib,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.5429754,0.08912095,2.207729398362207,0.20721533288994215
73023,SIDM00146,JQ1,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.6506268,-0.07844574,-1.1643785734652734,-0.057690509268115586
69891,SIDM00628,Alisertib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.2763603,0.039345536,3.6985511564961766,0.20008284374798505
9063,SIDM00971,SCH772984,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.3934155,0.14894551,1.419285639743049,0.04350948348633033
85265,SIDM00673,Afatinib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.0371614,0.06714217,0.8258242715749015,0.09189099191575834
95499,SIDM00893,Ribociclib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.1059046,0.061010618,-0.667056512115602,-0.04564548636877899
27776,SIDM00971,Sorafenib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.64634293,-0.046381827,-0.8435095627911605,-0.04075647445659366
12041,SIDM00893,Nilotinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.6654707,-0.09181257,-2.339900124978415,-0.17123522962562046
19762,SIDM00332,Sorafenib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.1418645,-0.09618406,-0.7288704285901437,-0.04944758436467429
78468,SIDM00193,Oxaliplatin,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,1.6097858,0.06578304,1.634282138435628,0.030741359396006272
106957,SIDM00529,Taselisib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Black,44.0,1.2277825,0.052135188,0.7301090103371387,0.07366119512595688
16531,SIDM00875,Tozasertib,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1387057,-0.028171265,-0.7799821212408258,-0.06071112820515878
37321,SIDM00660,SCH772984,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,0.9873934,0.03696189,-0.0016668480366809275,0.005227062284509659
16904,SIDM00628,PF-4708671,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-3.1330478,-0.24389546,-1.1896663306526398,-0.009979318034185378
72534,SIDM00774,JQ1,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-3.349314,-0.15110204,-0.818728519727734,-0.07123974887644077
100015,SIDM00893,Pictilisib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.6913103,-0.16231413,-0.7261707862507476,0.00500759695393061
77201,SIDM00971,Olaparib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.0287693,-0.0503698,-1.485515098323111,-0.016133968067722108
7479,SIDM00146,Bortezomib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-0.1445504,-0.0077965297,-1.2009999772305824,-0.030112039998479275
55567,SIDM00893,Alpelisib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.3791282,0.029590908,-0.9202891871668356,-0.02392690185723977
78215,SIDM00146,Linsitinib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,3.3262987,0.06500037,2.3184806703546963,0.11247876302143987
2194,SIDM00146,AZD8055,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.2722142,-0.11890231,0.15824479835339375,0.018159668940467246
66298,SIDM00529,BI-2536,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,1.5333531,0.1113792,-0.0012475576225501903,-0.02595697806889588
103738,SIDM00130,Navitoclax,Taselisib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.8889029,0.13066983,2.0376017945771667,0.13834040058039096
99364,SIDM00834,BMS-754807,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-1.5397147,-0.11602923,-1.2195897777204137,-0.019542510929533925
14320,SIDM00411,SCH772984,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,-3.6213064,-0.1467694,-1.8469008633244406,-0.09436736141548106
76702,SIDM00878,Wee1 Inhibitor,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.37452203,-0.034647882,-0.4451945545954124,-0.041329991185679434
99877,SIDM01233,Palbociclib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-0.1882897,-0.004138299,2.1866155280007655,0.08076844522292512
103182,SIDM00875,GSK269962A,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.29727745,-0.01735217,1.1098453352908415,0.054767774599795566
64036,SIDM00774,Bortezomib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-0.13437745,-0.011308415,0.0019654450669753486,0.013114577252056052
55505,SIDM00359,MK-2206,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.1563436,-0.046797942,0.6893842200902252,0.07201439303670286
62671,SIDM00660,AZD4547,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-0.6937574,-0.041758046,-0.5279352869203418,-0.06299400859723375
42136,SIDM00875,Nutlin-3a (-),Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5479736,0.056342248,1.1539923451848844,0.06693143445463914
71213,SIDM00332,Nilotinib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,0.21913005,0.016862314,0.5495375994479426,0.06463400663631659
23821,SIDM00954,Lapatinib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-0.26404378,-0.021269776,0.0775589975254683,-0.019428066999774497
105938,SIDM00954,OSI-027,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-0.55636936,-0.037730355,0.5203388253360318,-0.04957470077271232
29746,SIDM00529,JQ1,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-0.7575609,-0.047177702,1.4210168427286594,0.1481165348187609
7066,SIDM00971,NU7441,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.853303,0.14365184,2.1379193514637898,0.0713513890196557
107405,SIDM00776,Linsitinib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.88579,-0.047104005,0.9874218225854338,0.04370547490091588
49209,SIDM00097,Crizotinib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0221856,-0.09936142,-1.395835995867025,-0.06646138189700496
95154,SIDM00332,AZD7762,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.660992,0.16816156,0.982423940918219,0.1090935838389674
45269,SIDM00774,AZD7762,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.696414,0.10288333,0.8439261406496514,0.07267949803557956
38918,SIDM00954,Docetaxel,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-0.4222204,-0.030522527,-0.3988491934102176,-0.031634349876631156
93603,SIDM00779,AZD8055,MK-2206,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,0.84363174,0.056094363,0.980957585802255,0.06162613176705567
25994,SIDM00097,Tozasertib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6404986,-0.034448396,0.40180943523881996,0.05858681450277481
3636,SIDM00193,AZD7762,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.2001836,-0.046161965,-0.2720256047911413,-0.010939458803860316
11560,SIDM00954,Wee1 Inhibitor,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-0.90182996,-0.075277224,-0.9736781953075596,-0.06473740956668424
44885,SIDM00130,Dasatinib,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.766769,0.17564777,-0.39011319971765845,-0.0006923727378010835
42863,SIDM00411,SCH772984,Oxaliplatin,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-3.1287043,-0.11748829,-1.2380371454341812,-0.05157528403157033
20798,SIDM00146,PF-4708671,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,4.4725137,0.23567049,1.7743310999575888,0.07769160717582504
68628,SIDM00834,Taselisib,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,White,66.0,2.1493971,0.15766293,-0.9632338878604565,0.003318194660086168
48997,SIDM00774,Nilotinib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,48.0,0.38473943,0.026338289,1.3952988156505215,0.050121990899731225
87216,SIDM00782,Trametinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,Unknown,72.0,0.49540964,0.037762813,0.6308394796641037,0.01016197072583035
28455,SIDM00875,PF-4708671,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.80086064,0.041373666,2.580057688913626,0.052585220425300054
43715,SIDM00779,Oxaliplatin,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-3.1115744,-0.14310978,-1.5235888867174312,-0.0920428236293613
2685,SIDM00146,JQ1,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-1.9673725,-0.17658995,-0.6198917556609421,-0.06827340584563983
94326,SIDM00776,AZD7762,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,0.93590045,0.06201463,-1.0980493581652224,-0.10255586870358135
57540,SIDM00866,BI-2536,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,52.0,-0.70065737,-0.04230797,-0.5348059227261296,-0.07382857371374447
29457,SIDM00529,KU-55933,OSI-027,Breast,1.0,Breast Carcinoma,Female,Black,44.0,2.3791962,0.07145543,0.5207223122141137,-0.01585641522600775
36627,SIDM00628,Luminespib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,-1.6312348,-0.11046295,-0.5973537371576882,-0.09315353531020767
32736,SIDM00146,Navitoclax,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.85710126,0.060627937,0.9064723587076642,0.02800668359394524
78700,SIDM00774,Temozolomide,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,1.346496,0.021104772,1.011031788158399,-0.0056291380578551925
62604,SIDM00332,Entinostat,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,2.3130486,0.066991016,1.5385785205524924,-0.013399842003930712
11333,SIDM00875,ZM447439,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.3224243,0.035990544,-1.0867124413380354,-0.05043736224081821
56514,SIDM00782,MK-2206,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.7010847,0.14635599,0.48822859508937877,0.09841205703918883
106683,SIDM00954,Wee1 Inhibitor,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.639128,-0.053720277,0.13287537871802033,0.005465907699232745
13122,SIDM00954,AZD8055,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.6399794,-0.118035756,0.07638664522031122,-0.023107829852908088
66805,SIDM00529,GSK269962A,Trametinib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,1.136288,0.10363699,-0.3015404180867853,0.04086522743756185
39812,SIDM00529,Paclitaxel,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,2.7053518,0.26392496,2.7722436452516157,0.17449611006648605
41410,SIDM00301,AZD7762,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,5.010787,0.41484064,1.6812332699265966,0.16189656842687725
55372,SIDM00778,Trametinib,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-4.66462,-0.13917673,-2.1546636385673326,-0.05414533993949768
3233,SIDM00628,Vorinostat,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,1.1003965,0.10472506,0.8914787961069224,0.09425987985553647
42527,SIDM00834,AZD7762,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,1.9601264,0.12699641,0.5260444145721788,0.05813922997035194
66704,SIDM00878,Temozolomide,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.3323212,0.03595448,1.015601090839491,0.006096446812519781
37100,SIDM00875,PF-4708671,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7112955,0.009518467,1.5908833030832112,0.017017419283447122
101177,SIDM00146,BI-2536,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.41290066,0.014256519,0.5061094329551551,0.002389144846201552
108079,SIDM00146,Gemcitabine,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,2.6581295,0.065486334,-0.6133464959931454,-0.04267579030078353
71111,SIDM00332,JQ1,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5128096,0.069782756,0.17724101321785948,-0.027183117874612098
104533,SIDM00875,5-Fluorouracil,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.08480124,-0.009041401,-0.405467870007373,0.005042180088420276
5201,SIDM01233,LGK974,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,72.0,-1.310713,-0.082817934,-1.89389339667341,-0.15749812233399269
105369,SIDM00301,SCH772984,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,4.031331,0.42977184,2.0864279600644964,0.09127184896052781
96575,SIDM00954,Docetaxel,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-4.3133817,-0.188781,-3.9379512341209697,-0.28138239286450983
33305,SIDM00971,Cisplatin,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.13473313,-0.002247839,0.758208242573934,-0.007203448105389921
42895,SIDM00146,Olaparib,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.1064883,0.059627425,-0.406645527506199,0.036931794287916875
40934,SIDM00628,Sorafenib,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-0.47789967,-0.043437924,-0.7960422571148787,-0.04635306701768853
35463,SIDM00782,AZD8055,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.27260897,-0.024525752,-0.09720610915408645,-0.012447197604365233
86260,SIDM00875,Alisertib,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2699372,-0.09763331,0.835528506176577,0.07701407421431078
82387,SIDM00782,Olaparib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,Unknown,72.0,-0.7548702,-0.017599137,1.1996730284670816,0.033230935488650276
37769,SIDM00878,Uprosertib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,70.0,0.3931213,0.019442955,-0.669675229224263,0.05153866332689371
43280,SIDM00782,BMS-754807,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,1.0667107,0.07864176,0.08084965416201399,-0.02394739399280268
25726,SIDM00097,Temozolomide,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.84499925,0.01650379,0.662290030803817,0.003445782935864859
82843,SIDM00878,Camptothecin,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.26466286,0.007679161,0.9610348803111043,0.005243312816474343
61389,SIDM00878,GSK269962A,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,1.037301,0.08308345,0.1868855742465408,0.013896944417062103
19483,SIDM01233,Camptothecin,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,0.292153,0.010442409,0.4541936514365892,-0.005938055814010566
49639,SIDM00774,PF-4708671,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.5310508,0.09376227,0.8465315484406745,0.01849515239428151
98792,SIDM00529,SCH772984,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-1.3944435,-0.052847676,-0.2530722117396014,0.004665389621835295
54836,SIDM00359,Vinorelbine,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2856632,-0.062450446,-0.3540786374010083,-0.021281638982454245
17839,SIDM00971,Navitoclax,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,6.0801253,0.22738197,2.369673777585347,0.1504767947851179
98640,SIDM00875,OSI-027,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8022318,0.087643646,-0.735507048311467,-0.047797259604080315
71092,SIDM00774,Trametinib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,2.4292035,0.10094248,2.755694111969177,0.08634625200241645
94931,SIDM00097,AZD6482,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.58415145,0.041090082,0.15417518843185993,0.029161439111705323
32656,SIDM00411,Cisplatin,OSI-027,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.6560051,0.055555042,2.286587133547505,0.09421882132842782
25573,SIDM00774,Lapatinib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.9627327,0.14795907,0.14717870621177787,-0.025351806278960866
16634,SIDM00301,Navitoclax,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.4908286,0.18716127,1.4733519236605335,0.07931724706066551
46162,SIDM00774,AZD7762,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,0.24064304,0.0023090485,0.7300937160238906,0.07385612740342314
105298,SIDM00193,Oxaliplatin,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-0.4514751,-0.015346599,0.6956378964309035,0.029375109249738424
5352,SIDM00660,AZD4547,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,2.3159463,0.18146902,-0.359587990474386,0.015093303775091837
18908,SIDM00673,Ribociclib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-2.8740082,-0.085202135,-0.8262109843177023,0.016006958384234004
49090,SIDM00774,Uprosertib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.596894,0.18975903,2.1447784431785006,0.10371076999649904
96879,SIDM00673,Alpelisib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.45042777,-0.025405757,0.11794212446442183,0.025562048978662124
4287,SIDM00332,ZM447439,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.635624,-0.10030749,-0.3429525125703048,-0.04414938675210049
36988,SIDM00875,BI-2536,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.063834675,-0.0025219992,0.07695779425384826,-0.004597479996299545
21359,SIDM00146,SCH772984,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.0195935,0.14971715,2.9234919639886696,0.14824902371379745
89975,SIDM00332,Trametinib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2367666,-0.11135271,-0.8869444650967657,-0.041738995252941745
104016,SIDM00774,SCH772984,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.94096094,0.025658272,1.870987313987472,0.10422132519050581
67407,SIDM00834,Crizotinib,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,White,66.0,-0.9270054,-0.04654358,-1.514643136487846,-0.06470002948649443
63714,SIDM00834,5-Fluorouracil,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,White,66.0,-0.87629926,-0.050429817,-1.3082498793380521,-0.05097973622879373
14577,SIDM00332,5-Fluorouracil,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2516855,0.072735526,0.878983519633491,0.040188424891091555
35372,SIDM00866,Wee1 Inhibitor,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-4.838249,-0.13863905,-3.310929667849356,-0.10424984231743607
62274,SIDM00301,Trametinib,Crizotinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.7726873,0.20938037,0.9826663487146283,0.05755866543971082
24426,SIDM00954,RO-3306,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.6495869,0.042805012,0.7885979742909005,0.021375825281098708
22446,SIDM00866,Taselisib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,2.7476695,0.16999227,-0.3286747539005286,0.05406416198267314
36907,SIDM00673,Gemcitabine,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.9167215,-0.11503307,-2.6011039589326486,-0.09635085744470653
91784,SIDM00878,Nilotinib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,70.0,0.47994137,0.044944387,-0.164632452673081,-0.02538413073409824
14311,SIDM00866,Vorinostat,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.16401644,-0.011450421,1.1427088138007024,0.05800597005897453
4263,SIDM01233,Camptothecin,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,1.6154678,0.07217181,0.8487026655366251,0.02673254288715789
31912,SIDM00529,Gemcitabine,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-0.41668856,-0.011180743,-1.9616080806300056,-0.005060637121771244
67226,SIDM00954,Ribociclib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,1.2049063,0.0347116,0.8041801058317218,0.09637615273806074
73352,SIDM00146,Alisertib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,1.6785781,0.096049756,-0.8474092417322712,-0.09371394419085241
26467,SIDM00776,Camptothecin,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.75076467,-0.035156555,0.06844113224567781,0.036044619024009475
35619,SIDM00529,AZD8055,Olaparib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-0.1675287,-0.013268141,-0.7895993407550693,-0.03559581601729218
31524,SIDM00628,JQ1,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,2.7466376,0.24114272,-0.7085780026488823,-0.007675237064258924
74680,SIDM00628,Luminespib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,0.82642144,0.07375066,-0.3410351596343311,-0.019923629264884165
31584,SIDM00301,Navitoclax,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-0.73508686,-0.09003588,0.17772662490851762,0.014415082902341699
57698,SIDM00628,Sorafenib,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,0.48523912,0.0414846,-0.31952555359826434,-0.00607155496756604
101807,SIDM00332,GSK269962A,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.473646,0.022334883,0.842898553666004,0.00889227382139247
7670,SIDM00359,Oxaliplatin,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.9616424,0.06177313,-1.706613262579448,-0.06483194543649234
19418,SIDM00146,Cisplatin,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.941338,0.03744128,2.757279289391517,0.12650158538650907
10476,SIDM00146,BI-2536,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.3160439,0.054910097,-1.2082739698554135,-0.03437462130303029
50990,SIDM00878,Gemcitabine,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.215062,0.112014785,-0.44602696568201555,0.022987929237469933
7039,SIDM01233,Crizotinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,72.0,-0.6031953,-0.0390458,-0.7343030665719875,-0.007161674213473743
56337,SIDM00954,Cisplatin,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-0.5743747,-0.019401083,-0.3031358800565883,0.021812536250849165
34004,SIDM00146,MK-1775,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.396666,-0.03458945,-0.5843687022281377,-0.0429266295619883
45496,SIDM00971,Nutlin-3a (-),Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.4647099,-0.032086153,-0.428461669216758,-0.013916870189426628
56594,SIDM00531,Taselisib,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.4381638,0.22015785,1.8905052613291053,0.13019239528513046
103162,SIDM00097,Camptothecin,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.7243916,-0.031535324,-0.5267583772068847,0.01787456279943118
101667,SIDM00628,Venetoclax,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,Black,51.0,-0.88738483,-0.04035861,-1.0398548547413753,-0.0029446499113253426
22705,SIDM00146,Bortezomib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,0.6353833,0.03921039,-0.10241375769682239,-0.01060037503320527
52312,SIDM00875,Alisertib,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3615706,0.033058543,-1.621575869956038,-0.07751627786040562
45123,SIDM00332,Axitinib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5114886,-0.15338665,-0.7167519838178311,-0.05602763891512367
35879,SIDM00628,Crizotinib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,1.2345494,0.09567078,1.7689232257340965,0.13403439841171924
90290,SIDM00529,NU7441,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Black,44.0,0.9329443,0.08151745,0.5432693815972374,0.07091322854246657
92099,SIDM00146,Luminespib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.87538844,-0.074915774,-0.5041018199909001,-0.040676820488051296
107424,SIDM00673,PF-4708671,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-3.267318,-0.1532828,-2.301067404180141,-0.12503672703056604
4910,SIDM00628,Doramapimod,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,3.2037935,0.112637594,1.190789378890921,0.036289232337241795
8224,SIDM00971,Gemcitabine,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.20381968,0.0051629185,-0.06605376722205941,0.03849241033739077
27838,SIDM00971,Navitoclax,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.5311054,-0.012922506,-1.4981072104037831,-0.03648321440106286
56381,SIDM00628,Venetoclax,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.4778751,-0.02378996,-0.6881590086855034,-0.016559681923698045
79087,SIDM00097,AZD8055,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2488511,-0.08624312,-0.6334848328612338,-0.044025096512174726
90783,SIDM00893,Cisplatin,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.507733,0.1760958,3.0091046934471604,0.18038654168615664
36565,SIDM00954,JQ1,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,2.3162458,0.12776232,1.5941655314589025,0.06316541968260306
73855,SIDM00774,Alpelisib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.87139034,-0.03788828,-0.26901143139984623,0.04853282067418627
41277,SIDM00130,Ruxolitinib,Erlotinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.5094281,0.034096114,1.7410819619034685,0.05134802208729927
107429,SIDM00359,BMS-754807,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.3177881,-0.1647151,-1.3399141576214793,-0.09920991908513269
10925,SIDM00779,AZD7762,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.3824213,-0.10627382,-0.9492842191897721,-0.1135051674433529
62205,SIDM00866,Camptothecin,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.6981199,0.03174886,2.6818009593384913,0.050832973114162926
103968,SIDM00782,MK-2206,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.335784,0.11471355,0.5920999591237428,0.08640697927646519
51906,SIDM00529,Paclitaxel,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Black,44.0,-0.46372315,-0.044388883,-1.5743959999932169,-0.05900629488507695
13207,SIDM00531,Sorafenib,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.31709582,-0.04085607,-0.5357477110150708,-0.02121549161442912
35883,SIDM00878,Cisplatin,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,2.627993,0.12510464,2.0975410420619447,0.06508261840373775
86866,SIDM00531,Dactolisib,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.6604908,-0.048105836,-1.2392951270849453,-0.0486724139410197
83296,SIDM00878,Paclitaxel,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-2.3530598,-0.19111381,-1.3229643157620519,-0.13223209538604092
66350,SIDM00971,Olaparib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.9408565,-0.06614693,-2.11545434201028,-0.0674398029066037
22859,SIDM00673,Trametinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,1.1714902,0.05497094,-0.5339427018752319,-0.020991821565487036
68534,SIDM00529,Bortezomib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.18842936,-0.013724487,-1.3348740208334102,-0.03316814618828536
77853,SIDM00531,Erlotinib,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.6101072,0.05475943,-0.17434411462871063,0.012900433650317105
102280,SIDM00673,JQ1,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-1.5416818,-0.09393608,0.6509038118305661,0.051679917003613504
107773,SIDM00332,Tozasertib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.62025696,-0.04815285,0.34429697650030483,0.008141883364645714
82547,SIDM00301,Navitoclax,Cisplatin,Pancreas,0.8,Pancreatic Carcinoma,Male,East Asian,50.0,-1.0554361,-0.14834085,1.0237497211986588,0.072848983846054
3284,SIDM00971,Dabrafenib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.3823073,0.065705754,0.8254600570306267,0.06703527851921676
70592,SIDM00673,Entinostat,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.1588724,-0.11805293,-1.4449993904199945,-0.031982032794612786
45090,SIDM00359,AZD8055,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.7867929,-0.02721922,0.7902259648288829,0.03282138129859632
3747,SIDM00660,MK-2206,Trametinib,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,32.0,4.1694856,0.32344446,3.291664071854685,0.17627782440476342
76334,SIDM00776,Afatinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,-1.2024933,-0.09787124,-0.20399451907088773,-0.052936015608837254
88568,SIDM00878,Bortezomib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-0.22638658,-0.013511869,-0.8861928313860654,-0.028380789719885707
92916,SIDM00673,Docetaxel,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.68197465,0.06311203,0.6545108172999001,0.000951980264619541
107482,SIDM00971,MK-2206,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.0601747,-0.1194709,0.8733420340062982,0.09810990103942446
82821,SIDM00893,JQ1,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.5459254,-0.05377612,0.27144674016640286,0.08236480831985654
94313,SIDM00529,Crizotinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,0.41539314,0.02958594,-1.9963706177998513,-0.06180137475471158
72283,SIDM00971,AZD8055,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.3820188,-0.066036426,-0.4275235744961236,-0.011693687246821072
61832,SIDM00776,SB505124,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,-0.745063,-0.057633135,-0.2753297177830774,-0.046019029697932395
83752,SIDM00097,SCH772984,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.076495,-0.11747881,-0.29779582878246796,-0.05416896912845221
73407,SIDM00193,Palbociclib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,-2.114402,-0.054851223,1.907762178633647,0.07970889125621297
58098,SIDM00954,MK-2206,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,1.314202,0.08645526,0.479854493882268,0.08282209660323711
56281,SIDM00146,Nutlin-3a (-),5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.51239485,-0.015331232,0.8306240595653738,0.013875967746203251
48278,SIDM00954,AZD6482,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-2.073305,-0.102198735,-0.7212350539911699,-0.00135945729788629
25536,SIDM00774,Linsitinib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.23788178,0.013743092,1.4430112751043076,0.11667475806301349
78447,SIDM00628,Luminespib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,Black,51.0,1.1125835,0.10456955,0.1538163112131416,0.009263896315217561
108134,SIDM00779,BMS-754807,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,-0.5291738,-0.005796905,-0.7313498010622442,-0.019880347529948623
34371,SIDM00097,Paclitaxel,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2494295,0.08539585,-0.71090098268036,-0.022813472822807143
27170,SIDM00332,Navitoclax,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1355076,0.09785609,0.5454891938338303,0.059114942604615965
58436,SIDM00146,Wee1 Inhibitor,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-2.0607698,-0.16421214,-1.8227374996380812,-0.15099592768844333
65002,SIDM00359,Palbociclib,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.4033216,0.101721846,-1.749620141561323,-0.0578833011768234
82745,SIDM00529,Linsitinib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Black,44.0,-0.3693106,-0.013887913,1.0519518876762672,0.10805468610898306
61754,SIDM00779,Camptothecin,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,1.3410704,0.080934554,-0.12459668776059273,0.05591984964960978
75398,SIDM00954,Sorafenib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,1.0617151,0.079941414,-0.3152379378566997,0.014183950490954578
73655,SIDM00774,MK-2206,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,48.0,2.144026,0.048589442,-0.8309733645961498,-0.03942082297336148
47002,SIDM00779,Afatinib,AZD7762,Large Intestine,0.0625,Cecum Adenocarcinoma,Male,White,33.0,-3.167435,-0.2387782,0.7969895105739347,0.07553517403638789
5738,SIDM00146,Navitoclax,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.8345101,0.05968195,1.0790799575194587,0.045203776128746334
79615,SIDM00529,Docetaxel,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Black,44.0,-1.1791366,-0.08384378,0.16219639912714423,0.11112804197057943
31197,SIDM00531,Trametinib,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.2060233,-0.07970226,-1.1256256345194378,-0.027752445385128485
78497,SIDM00875,NU7441,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4980586,0.12977096,1.1243410349722016,0.061094410628248344
12749,SIDM00893,Venetoclax,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.073926,-0.06041029,-1.5007043574659529,-0.0074751261325137755
62820,SIDM00878,BI-2536,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,0.3659452,0.032540612,0.4563650499934487,-0.012922124875790465
5742,SIDM00146,AZD7762,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.7300503,0.06603769,-0.09550391353253058,0.0056512725443902175
22955,SIDM00878,SCH772984,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-0.25384212,-0.020344581,1.764097260036206,0.08586931845460002
52842,SIDM00359,BMS-754807,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.900489,-0.22211745,-0.6097545651170588,0.02145978335135315
90747,SIDM01233,BMS-754807,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,4.1866117,0.30071765,0.44903452478061084,0.03359474192101873
73000,SIDM00779,AZD8055,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,33.0,-1.7812809,-0.140684,-0.35876407571698826,-0.04285625462101941
52498,SIDM00866,Nilotinib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,0.9888716,0.0687679,-1.0850565701534132,0.05312774060731087
76977,SIDM00146,AZD6482,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.8047682,0.06530821,1.7002674781939564,0.13328824198577763
81432,SIDM00411,LGK974,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,-3.4805393,-0.1067894,-2.1053617573559587,-0.06173110564707796
39407,SIDM00878,Cisplatin,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,70.0,0.92033607,0.025216814,2.2588318192042514,0.06923228645809223
55858,SIDM00531,Crizotinib,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.5511153,0.30862734,2.8775474981436897,0.20454133963122664
32140,SIDM00097,Sorafenib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.91661763,-0.037713986,0.5895141061808988,0.0008095961473966922
97881,SIDM00875,Nutlin-3a (-),5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7139247,-0.021294568,0.15379736266733665,0.03028812897593742
7942,SIDM00332,RO-3306,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6987559,-0.06502889,-1.537195456876829,-0.045917484066262504
106027,SIDM00893,Cisplatin,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.3105006,0.00863142,0.628539503887457,0.021089332020767494
71394,SIDM00531,Palbociclib,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.34444705,-0.015999319,0.7673970973901646,0.06273202906228274
97955,SIDM00866,JQ1,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-1.5145437,-0.10633961,-0.12312088227808562,0.07126917496386032
96537,SIDM00660,Oxaliplatin,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,0.08267586,0.008809021,0.5134668097863371,0.029909728891984982
83796,SIDM00660,LGK974,Crizotinib,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,32.0,-1.7631034,-0.07486646,-0.3586802212426492,-0.028373939468523828
21625,SIDM00628,Taselisib,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,-0.7813652,-0.07159921,1.2779119117612767,0.17939899492137815
5904,SIDM00529,Axitinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.5939838,-0.048537083,-0.8153120841185401,-0.019886226722476755
64146,SIDM00628,OSI-027,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,1.0244719,0.080254935,-1.2836733032613812,-0.03745182555966126
40667,SIDM00146,Palbociclib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-1.3310348,-0.06310153,-1.556153931129189,-0.023116250715704615
39472,SIDM00779,Palbociclib,Camptothecin,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,33.0,-3.4776137,-0.24632002,-2.116601469358781,-0.16643068874833647
103846,SIDM00529,MK-2206,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-2.0511189,-0.06727222,-0.2340241326226725,0.02428312598701107
32373,SIDM00774,Sorafenib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,0.5867928,0.039909966,0.34358861395084483,0.0600646847607569
57103,SIDM00878,Uprosertib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.3017756,-0.06350602,-1.4872177486113034,-0.08994400042298209
14488,SIDM00893,Gemcitabine,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.6075795,-0.1040488,-1.5070863039842801,-0.08473353957403595
33137,SIDM00834,Olaparib,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-0.5376116,-0.011385863,1.0276441073523175,0.012608826713720971
56817,SIDM00193,Linsitinib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,1.8112271,0.08550572,2.1354135410295534,0.06757805705408332
40576,SIDM00971,Taselisib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.3794075,-0.024965713,-0.42649055456280427,-0.0182998409355849
55475,SIDM00529,Afatinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.5168319,0.114991784,2.2175086939393935,0.06738832526819419
84645,SIDM01233,Linsitinib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,2.9682248,0.20065908,0.8497835655343995,0.05613246584647545
77174,SIDM00097,NU7441,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2011724,-0.09294119,1.0837211196773378,0.05569277759393838
91544,SIDM00097,Cisplatin,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.90629107,0.018475778,0.23620173021834767,0.025352300316791008
8341,SIDM00778,AZD7762,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,1.1134396,0.044723652,-1.57840944820593,-0.0916391505759442
85085,SIDM00146,KU-55933,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,-2.1272337,-0.075524524,-0.5119033685888887,0.015105630948419296
84910,SIDM00834,Oxaliplatin,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-2.924436,-0.18219209,-1.8826145593987766,-0.09800556366779682
105763,SIDM00193,AZD4547,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.6875453,-0.09242434,-0.997759428923242,0.005852066427086287
49270,SIDM00673,Venetoclax,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.4851669,0.052499108,-0.33354101064764685,0.007248793265012532
79285,SIDM00893,KU-55933,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.9561409,-0.06503655,-1.5659371686446881,-0.07799876861331197
94237,SIDM00411,Oxaliplatin,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,43.0,-0.7743702,-0.024629287,-2.352459792597639,-0.054256960183360424
107646,SIDM00875,Venetoclax,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.34975705,-0.0071774945,0.7356318347219861,0.04569662238328891
46010,SIDM00866,AZD7762,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-0.10502228,-0.006071547,-0.709807561568869,-0.03835863031498469
9991,SIDM00878,Venetoclax,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,1.289416,0.05050294,1.180496821655648,0.034416666861282134
8357,SIDM00893,Alisertib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.161232,-0.0938944,-0.09179534403520963,-0.04806133814710852
91566,SIDM00866,Alpelisib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,52.0,-1.6391608,-0.11462102,-0.7200169230606847,-0.03335531334691339
28860,SIDM00146,Gemcitabine,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-4.331742,-0.29571274,-3.8343654880908664,-0.31395557925378875
103972,SIDM00774,Entinostat,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.9210022,-0.055996753,-0.5998886079684141,-0.05315452833864154
19404,SIDM00893,AZD6482,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.35980666,0.030106654,-0.42356943643134154,-0.03727613065525249
25228,SIDM00971,Taselisib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.1783445,-0.13473004,1.3439363681190986,0.04618102909857944
10577,SIDM00954,ZM447439,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-1.6145893,-0.1176826,-0.9225324477103473,-0.1645721119778516
24503,SIDM00893,BI-2536,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.43015304,-0.039280042,-1.0224174415879617,-0.023194637843116393
53438,SIDM00774,Lapatinib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,-0.99387753,-0.10360404,0.8471272151756604,0.01965606076395325
11373,SIDM00875,Axitinib,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.08638088,-0.004462828,0.9283672662440683,0.08684543751196505
1715,SIDM00673,AZD8055,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.7356567,0.08589465,-1.4673177316651367,-0.024949481596751866
38003,SIDM00628,Cisplatin,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,1.8651062,0.17341146,-0.2776263216555709,-0.04150905089821347
41488,SIDM00301,LGK974,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.283686,-0.08299579,-1.6567348576181615,-0.019072842135467893
91514,SIDM00411,Irinotecan,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.942187,-0.10725431,-2.6688952063733136,-0.08147233661447663
85581,SIDM00529,Wee1 Inhibitor,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.61232847,0.057181563,0.17761215353965398,0.0408832934964207
15490,SIDM00776,Dabrafenib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-2.209037,-0.06888961,0.020878094818055106,0.009865865478063156
84732,SIDM00893,Linsitinib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.119144,0.062478065,0.13221101078108316,0.007437388223215425
105342,SIDM00971,Trametinib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1918976,-0.017023917,-0.6266696723631324,-0.04748483594716093
78568,SIDM00411,LGK974,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,43.0,-1.1891313,-0.03423813,-0.49171975574143256,-0.010793423036060932
57665,SIDM00529,Alisertib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.7465664,0.07202411,0.8165238856340886,0.10756841544161579
36009,SIDM00529,JQ1,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Black,44.0,0.8238781,0.063966855,0.49225823690395026,-0.03309530480634756
50802,SIDM00146,Uprosertib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-2.0382614,-0.13165417,0.9360875962484952,0.1772820153725396
82668,SIDM00893,RO-3306,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.2024326,-0.16741914,-2.0503450339488816,-0.08086228866126906
33686,SIDM00782,Nutlin-3a (-),5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.41792163,-0.008397165,1.1525769004217985,0.040808682757507764
104859,SIDM00866,MK-1775,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.509313,-0.04253458,-1.168009492712294,-0.030793178589259194
41633,SIDM00878,MK-2206,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.3017108,-0.15834957,-0.01905532769440199,-0.0630737450214232
62777,SIDM00778,5-Fluorouracil,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,5.926619,0.33523706,2.0950681315574977,0.07592494814089897
30094,SIDM00971,Trametinib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.30330998,-0.0041386755,0.1414733804869238,-0.001696278067405892
45485,SIDM00628,SCH772984,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,1.4316801,0.11513707,1.0011196283699526,0.10467195735374189
32033,SIDM00193,SCH772984,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,53.0,-1.4095919,-0.10449979,0.07969489665862749,0.018557407744177967
9693,SIDM00660,Crizotinib,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,32.0,-1.3032099,-0.100260444,-1.2604361150830696,-0.09401973583630294
28035,SIDM00411,5-Fluorouracil,Lapatinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,1.3504983,0.060021758,0.8288901487292435,0.023367653478211257
100612,SIDM00893,Alpelisib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.2306222,-0.017197683,-0.47258062575017457,0.002757369171250282
53104,SIDM00893,Sorafenib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.51654077,0.046795726,-0.9386270108991571,-0.05301803041859702
64634,SIDM00866,Trametinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.7203839,-0.13065417,-0.9927485727802219,-0.03266654742347785
56885,SIDM00146,Cisplatin,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.9155462,0.03743842,1.8571220713678922,0.10482216041160518
68863,SIDM00774,Axitinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,2.6546683,0.32961863,-0.19998891347988987,-0.010878030019395538
52425,SIDM00971,Luminespib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.7412043,-0.04008498,-0.24300211999967006,-0.004325379921433269
51427,SIDM00332,KU-55933,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.8402238,-0.11041196,-1.3464523188260424,-0.08414001383079145
28161,SIDM00130,Palbociclib,LGK974,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.6370793,0.05773784,-0.7525928085482814,-0.08189846938994783
108264,SIDM00411,Oxaliplatin,5-Fluorouracil,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.0421555,-0.039123297,-2.0731426659362526,-0.04792724156918585
2445,SIDM00097,Olaparib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2896205,0.028105391,0.8609777735619548,-0.00021948822471292635
53795,SIDM00875,Linsitinib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8758558,0.06735647,0.10652951036574732,0.033010417335521375
2449,SIDM00529,BI-2536,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.8878768,-0.07778369,-1.9117155246094968,-0.13850036361003704
19556,SIDM00774,Afatinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,-0.69931245,-0.05262529,0.8745413822042184,0.016959895060446355
34499,SIDM00971,Entinostat,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.1713605,0.07749237,0.22300279620734592,0.02635551536717366
81581,SIDM00529,Linsitinib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,1.112029,0.05955417,1.3693875795491943,0.08362848008916202
17169,SIDM00893,PF-4708671,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.42727408,0.035854947,-0.3059346028978003,0.035855453439093646
106508,SIDM00628,Linsitinib,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,Black,51.0,-0.17557774,-0.012091381,-0.9103016273123772,0.015168545692534955
47749,SIDM00529,Navitoclax,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.7749212,0.046243377,1.8290973222387708,0.026125061402115863
17137,SIDM00971,Olaparib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.6786466,-0.03935796,-2.1235046337148025,-0.04598960699441333
28232,SIDM00875,Olaparib,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0707735,-0.08473588,-0.21035238936271503,-0.02342818007003881
12257,SIDM00893,Dabrafenib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2270057,-0.033638354,-0.49633508993956893,0.013758658541117106
81673,SIDM00301,Navitoclax,MK-2206,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,50.0,-2.4254959,-0.17207105,1.0457844104770515,0.09654502137196226
54281,SIDM00893,GSK269962A,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.75949866,0.06419657,-0.9096510242506398,0.010909477788375933
40907,SIDM00971,Uprosertib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.3693566,0.2944453,-0.5832108333912567,0.031314355831448974
106665,SIDM00628,Nutlin-3a (-),MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-1.4427707,-0.07243074,-0.36311728580951824,0.05799531108719019
10255,SIDM00875,Doramapimod,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.9662046,0.074038364,2.249431751233244,0.10321000478822691
100264,SIDM00529,Dabrafenib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,3.128052,0.092616916,1.3585275734149231,0.08252068267736024
51786,SIDM00893,Afatinib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.29550493,0.022335814,-0.3770440326790162,-0.03795927807301031
21664,SIDM00529,OSI-027,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.4242566,-0.12470453,-0.8651975936264583,0.0676206440765356
93699,SIDM00779,Camptothecin,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,1.0614637,0.02130937,1.3741168809891964,0.03856699323595645
12524,SIDM00529,Camptothecin,Taselisib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,1.0366528,0.05331097,1.2768143136491255,0.07261065086435994
73348,SIDM00834,MK-2206,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,0.9239086,0.04813427,0.600015947934534,0.06360700843922397
67005,SIDM00130,Paclitaxel,Sorafenib,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.2400581,-0.09320909,-1.2424848573951075,-0.04504500734099937
73157,SIDM00878,RO-3306,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.6702493,-0.09632349,-0.8795727145949132,-0.04283277788561093
104595,SIDM00878,Nutlin-3a (-),Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,0.7711367,0.056859467,0.20546270566977595,0.055616239714639
27800,SIDM00193,Taselisib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-0.09846249,-0.009689841,-0.22452917714835258,0.03469048910560088
32938,SIDM00774,Olaparib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-1.402246,-0.05754285,-0.9506485378364607,0.004898577105133746
45262,SIDM00875,Entinostat,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4927254,0.041765545,-0.014025725517433286,-0.043332896051211954
86532,SIDM00954,Paclitaxel,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-4.2070518,-0.24010666,-4.032756846277217,-0.31182624648062757
69858,SIDM00971,Tozasertib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.4182177,0.090082094,1.9989412275619813,0.07690484019209295
59884,SIDM00146,PD173074,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.58695054,0.021641238,-0.9541166881108857,0.04171300243340246
17986,SIDM00893,BI-2536,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.7942708,0.23022985,-0.2288868461622057,-0.0231390227273819
81807,SIDM00893,Venetoclax,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.590468,-0.08254089,-1.8293421546787323,-0.07813682731569907
92504,SIDM00774,5-Fluorouracil,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,0.58416194,0.05415679,-1.1665816432600913,-0.0045441657227343005
1459,SIDM00628,AZD8055,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-1.6459779,-0.105120406,-0.07844231731023006,0.01902091365018172
51769,SIDM00776,Dabrafenib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.9104879,-0.059034087,-0.8495215499396508,-0.01449262554592775
53046,SIDM01233,Trametinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,3.0318644,0.2205899,2.008196165457862,0.16562609524961308
30100,SIDM00971,Gemcitabine,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.942824,-0.093676336,-1.3258732376525149,-0.056840746845220017
23585,SIDM00411,Palbociclib,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,43.0,-2.6622536,-0.09048081,-1.6094628089199619,-0.029873860780085176
96652,SIDM00301,Dasatinib,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,50.0,2.2554963,0.23682235,1.2919344294178365,0.08751687397745747
33443,SIDM00146,AZD8055,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-1.1922246,-0.10492217,-0.20446905937211107,-0.034250422244397574
32178,SIDM00628,Temozolomide,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.8005221,-0.02452033,-1.6064966697562446,-0.014737331417221203
29318,SIDM00878,Entinostat,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-1.0117136,-0.04778511,-0.059238845495697634,0.023767928391502678
83432,SIDM00774,GSK269962A,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.9315886,-0.082265645,1.4084721061827041,0.029032309568648246
27713,SIDM00875,Dabrafenib,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0380874,0.05791918,0.15979645420727068,0.003086610361646096
74757,SIDM00097,AZD6482,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.76854473,-0.05481665,-1.118495661983083,-0.060523917571179066
91952,SIDM00893,AZD7762,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,4.858015,0.40632582,1.2877486220036496,0.040299050813096066
47939,SIDM00954,Tozasertib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-2.9938543,-0.12128685,-1.7513427331898284,-0.08501924964915052
21957,SIDM01233,Palbociclib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,3.5816064,0.13249584,0.9554824073409045,0.01211413054796588
97436,SIDM00097,Luminespib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.4480189,-0.030433716,-1.035029819274898,-0.06136615428246485
42268,SIDM00954,PF-4708671,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.0,-1.8174903,-0.08763963,-1.8927297338683926,-0.09954310759321065
62378,SIDM00628,Axitinib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,-1.1291813,-0.06706527,-0.6415285238441335,-0.054476518228283616
78012,SIDM00774,MK-1775,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.286375,0.035463165,-0.46174972016615096,-0.013093515983302533
71814,SIDM00971,Cisplatin,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.27192768,0.0042637363,1.5470788998780853,0.05779983560385923
7602,SIDM00673,Doramapimod,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.021569,0.022032874,3.406793768775071,0.07598863180604787
103213,SIDM00146,Gemcitabine,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,1.3470834,0.085987486,-0.4225031847581906,-0.03813042320983907
65471,SIDM00774,RO-3306,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.5893856,0.08797173,0.1634111896672462,0.012105914802867091
34108,SIDM00628,Taselisib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-1.375155,-0.122290455,-0.1559427017069772,0.027737233506619927
103597,SIDM00779,Afatinib,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,33.0,-1.0584772,-0.093035765,0.09710989162259856,0.02020914931089795
15725,SIDM00628,Cisplatin,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,0.6932967,0.068349995,-1.2585078869624577,-0.07474564603989124
2750,SIDM00531,Paclitaxel,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-2.0503533,-0.14034921,-1.64218765504898,-0.028202860622245918
58407,SIDM00834,MK-2206,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,3.5637443,0.23080775,1.4971408844690235,0.04802882178685787
82394,SIDM00893,Camptothecin,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.63041,0.13980739,1.3794271956978117,0.11092910799171174
1329,SIDM00971,PF-4708671,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.3805377,-0.13256371,0.30558774413645867,0.026083284420866742
63240,SIDM00673,Trametinib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,1.592979,0.107911356,-1.174186668731814,-0.022007106252396685
93460,SIDM00359,Navitoclax,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.79086006,0.037122227,1.789879732909884,0.08862063263871715
3220,SIDM00332,Camptothecin,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,6.7940087,0.3092402,4.387128145913081,0.20262047621305726
18948,SIDM00878,MK-2206,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,2.3015413,0.16919361,-0.4221735464844607,-0.058161467142887766
9983,SIDM00097,RO-3306,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.055893,0.037958365,0.5066634521096022,0.03213520224945528
69324,SIDM00130,Dasatinib,Dactolisib,Pancreas,0.0125,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,3.4781485,0.29202476,2.6807483500752816,0.143337637987464
108175,SIDM00529,Pictilisib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Black,44.0,-1.235835,-0.0825734,-0.40811921899495646,0.05239128024963235
58033,SIDM00193,Navitoclax,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,53.0,0.41237023,0.026963424,0.5979925824754083,0.02604204019655361
106502,SIDM00097,MK-2206,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8614571,-0.056729894,0.862526565805677,0.0022831029303557065
99384,SIDM00893,GSK269962A,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.3613766,0.030911924,-0.8145166912832885,-0.024702440243702682
45618,SIDM00834,Olaparib,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,1.6801517,0.042204425,2.1894566881621373,0.04045328638577278
79049,SIDM00875,JQ1,Vorinostat,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.88768375,-0.094704665,2.5718402388272392,0.09159995940400693
65659,SIDM00411,Navitoclax,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.9906992,-0.07770518,0.07945938481208095,-0.008901887935589048
64834,SIDM00776,Palbociclib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.5853225,-0.019510055,0.25204526390780413,0.0032411293637779697
41898,SIDM00673,Camptothecin,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.2283832,-0.03502139,0.4404387813569661,0.007588864543623055
21501,SIDM00301,AZD7762,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,50.0,1.8925421,0.111742906,0.9270219081325348,0.0987603864508535
12175,SIDM00866,5-Fluorouracil,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,52.0,4.046824,0.2762387,3.514301281623349,0.16421159217024212
14447,SIDM00146,5-Fluorouracil,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,1.0314695,0.07771228,-0.37633556052281786,-0.002727864215795806
103798,SIDM01233,Linsitinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,72.0,1.435222,0.1052546,1.6064684714294861,0.07483632201248616
67158,SIDM00834,Olaparib,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,0.17273188,0.003454767,1.3467218883641698,0.012269821450413254
50556,SIDM00782,Taselisib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-1.1697425,-0.108764544,-0.5126788034415106,-0.06250959723377575
81663,SIDM00130,LGK974,Paclitaxel,Pancreas,0.025,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.3799349,-0.047912538,-1.9254421659561916,-0.018271910179629338
38916,SIDM00954,Ribociclib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,0.24931373,0.008511663,0.07287538026788018,0.05007311303436625
46039,SIDM00146,Nutlin-3a (-),OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.36405218,0.011956752,1.3779795497342742,0.08437391674718059
26233,SIDM00866,PF-4708671,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.8462099,0.10047431,0.10015862029452942,0.03036390496233198
14604,SIDM00146,Wee1 Inhibitor,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.1583887,0.0750168,-0.5089294752425859,-0.056971896138402325
47043,SIDM00146,Uprosertib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.2780001,-0.08954098,0.864004222730434,0.11015638752690834
47102,SIDM00971,Pictilisib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.096046,-0.104125805,-0.5150986007697935,0.01718622580627076
6279,SIDM00529,Palbociclib,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-2.7356424,-0.101043396,-0.5773840035296791,-0.0072322803782065
49655,SIDM00529,Alisertib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-3.5140991,-0.2915593,-2.541111437210235,-0.1945784476971105
48279,SIDM00774,Wee1 Inhibitor,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.1327788,-0.06275984,0.0660174623660227,0.02862398479549102
87193,SIDM00774,Crizotinib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,0.60785013,0.09026487,0.23365012952903838,-0.034284293728835555
16580,SIDM00893,Camptothecin,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.5383165,0.13097924,-1.12675140064159,-0.064658556229983
63354,SIDM00971,Tozasertib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.2724298,0.027292227,0.5152820979411802,-0.01355459494540676
3904,SIDM00774,Nilotinib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.1840008,0.088835396,1.3923421192558925,0.026155972478469187
3034,SIDM00893,Cisplatin,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.6551081,0.019583492,1.4946143446797968,0.06889671549433066
81134,SIDM00332,PF-4708671,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,2.4915507,0.058821004,0.13585504217381553,0.019616204166863552
84527,SIDM00866,AZD8055,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,0.7635679,0.027600864,1.953894319567043,0.06210681169262839
44014,SIDM01233,5-Fluorouracil,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,72.0,-1.5532166,-0.050302822,-1.3803111270529795,-0.05326811975413647
61296,SIDM00878,BI-2536,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-0.9151499,-0.08055266,-1.977458202820984,-0.10939417631046967
105286,SIDM00359,5-Fluorouracil,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.6220129,-0.04174702,-1.2092222795696166,-0.03475012871849313
56018,SIDM00673,Venetoclax,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,0.9910633,0.019594382,1.674145392251554,0.047900233859667046
33,SIDM00779,Linsitinib,Dabrafenib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-1.3061856,-0.11302847,0.13268941097653753,-0.016657354751217532
22656,SIDM00971,Linsitinib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.2395794,0.09817628,2.691227896444849,0.10480751208767555
81302,SIDM00893,Vorinostat,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.6432654,-0.038713917,-0.7463365167941067,-0.03417130516454725
99142,SIDM00529,AZD6482,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Black,44.0,2.9796045,0.15881588,1.8556073066906684,0.10928378752175903
105032,SIDM00954,ZM447439,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,2.0167742,0.038304675,2.809391695223005,0.13823654162910362
71037,SIDM00782,Oxaliplatin,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,Unknown,72.0,-3.1931498,-0.12611866,-1.1684596753977392,-0.012346543386499074
47683,SIDM00954,AZD6482,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.2671771,-0.0753001,0.512833118663308,0.058159522550099214
75278,SIDM00146,AZD7762,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.60050875,0.052597284,-0.4213937975137876,0.023776185240701263
24400,SIDM00779,SCH772984,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,33.0,-2.2042964,-0.20026505,-2.019916119985022,-0.0926397611919644
106736,SIDM00893,Dabrafenib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.770745,-0.017377956,0.6838551564947809,0.048570432464807065
44933,SIDM00954,AZD8055,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-1.6342996,-0.11503468,-1.0552167702065915,-0.08896634131155993
45630,SIDM00954,SCH772984,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-1.3477771,-0.08555235,0.4026151581027582,0.08767880234585336
20615,SIDM00878,Doramapimod,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.0013536,0.06734037,-0.26238253397761263,0.014140196697495899
22456,SIDM00774,NU7441,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,0.5644402,0.035398435,0.38622728956415686,0.07159837859872928
7317,SIDM00531,Paclitaxel,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.3632064,-0.11932874,-0.7955624552544133,-0.06724306143357986
24402,SIDM00954,MK-2206,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-0.80508816,-0.064390056,-1.704324302680293,-0.10123885631496109
108339,SIDM00531,Taselisib,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.6118035,0.25532532,2.152489329629718,0.15729657210432896
8863,SIDM00673,AZD8055,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,1.1626849,0.07823073,0.9589518649998118,0.07519168277064407
50272,SIDM00834,LGK974,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,1.629305,0.11323204,-0.35399314092757345,0.020761246325382864
42548,SIDM00774,PF-4708671,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-2.0684693,-0.079432525,-1.6694187855074525,-0.09597083411521645
39733,SIDM00529,Bortezomib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-0.46050283,-0.033842932,-1.6708976136955653,-0.07187715597251589
48373,SIDM00359,MK-2206,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.7237623,0.12698019,1.8863407386511322,0.1845412565233212
81227,SIDM00834,Taselisib,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,3.662392,0.2810541,1.7280939729519995,0.12092716801032066
108316,SIDM00875,Entinostat,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4604058,-0.03585709,0.36260224438961813,0.0142780583449627
107619,SIDM00778,MK-2206,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,0.7934667,0.051396687,1.4762787859413373,0.1346820809428294
10043,SIDM00893,Linsitinib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.9936881,-0.051194657,-0.7139467196186263,-0.021509787024727244
79963,SIDM00878,MK-2206,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-0.49812466,-0.044791646,-0.3023089107840783,-0.04984224079111279
75182,SIDM00660,Vinorelbine,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,2.4370964,0.22393285,1.0381368586173711,0.13416594722438835
33295,SIDM00774,Paclitaxel,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.4420492,-0.019714147,-0.909953633284104,-0.01273628858513308
49159,SIDM00893,PD173074,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.5568414,-0.038681764,-0.6317766805282214,-0.003228598619548962
105048,SIDM00673,GSK269962A,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.62145376,0.038100854,-0.5656943377293436,-0.032055050184232894
45091,SIDM00146,Navitoclax,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,-0.37388894,-0.029962152,0.016754526227073803,-0.014974008345422316
60955,SIDM00097,Linsitinib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5327449,-0.06343403,-0.22532130844910375,0.004245393370005546
106200,SIDM00628,ZM447439,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-2.6162956,-0.23946586,-3.0352228566791806,-0.14510405225552783
92950,SIDM00660,Olaparib,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,1.3241721,0.04648632,1.6158887458159488,0.048839251554405154
39196,SIDM00628,Bortezomib,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,Black,51.0,-0.14039643,-0.008403862,-0.7577533193447927,-0.018601310356924677
25350,SIDM00146,GSK269962A,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,1.5867953,0.14335763,-0.1785415849595727,0.00847529405124281
2867,SIDM00971,MK-1775,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.10325,-0.06866558,0.053179569325913674,-0.02243831777380974
46412,SIDM00971,PF-4708671,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.88314486,-0.053529322,-1.994236069965172,-0.11519327637379909
52987,SIDM00660,Nutlin-3a (-),Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,0.46871156,0.011075863,1.9686009868630463,0.0978316188062644
8218,SIDM00971,Navitoclax,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.26278055,0.0067760036,0.4465053127781286,0.038245451209551126
44290,SIDM00673,Trametinib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.44407108,-0.035719715,-0.7089384040757973,-0.004773400117828914
99973,SIDM00332,ZM447439,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0581174,0.071418226,1.102551758289792,0.07176223813514639
96327,SIDM01233,Vinorelbine,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.4243475,0.08472187,-1.3323217094308577,0.018923362871473264
26288,SIDM00359,Camptothecin,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.3899696,-0.15871114,-2.3308148776397744,-0.11914887183705666
99390,SIDM00359,5-Fluorouracil,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8101735,-0.110652596,-1.8112665581071008,-0.03805086836681775
25743,SIDM00774,Temozolomide,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,0.640749,0.016143788,0.2776750949063702,0.0006726803565332207
29789,SIDM00834,AZD7762,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,1.3621484,0.09665335,0.7839908451534211,0.05231737303154233
106869,SIDM00332,Nilotinib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3205185,0.086208954,0.14818832766463275,0.04226195115611309
32100,SIDM00893,5-Fluorouracil,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.008287,0.060563855,0.2552994072277958,0.024519173520227953
19567,SIDM00411,Sorafenib,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,43.0,-1.485731,-0.08712717,-0.8955011868295633,-0.0149185975360505
27145,SIDM00660,Trametinib,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,32.0,3.804634,0.15106072,-0.7076544081929713,-0.03564752935485808
62658,SIDM00130,Taselisib,Paclitaxel,Pancreas,0.0025,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.68964255,0.07161013,0.7070433994162346,0.11369611092729515
8311,SIDM00332,Gemcitabine,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7961453,-0.100084424,-2.469222338601193,-0.08949674529249198
24168,SIDM00954,Lapatinib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,1.8557717,0.10250422,0.7551161435776441,-0.02258620506607814
90830,SIDM00866,NU7441,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,-0.51378196,-0.038555354,0.21951958997122403,0.008567726468235894
19034,SIDM00875,5-Fluorouracil,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.2269278,-0.021911703,-1.9267485547656011,-0.08258521994295409
52870,SIDM00332,KU-55933,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.3841233,-0.037370678,-0.22720042265614715,0.028308306513446155
85301,SIDM00866,MK-1775,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-1.2421715,-0.07844646,-0.7900866090638441,-0.03497228848672502
100257,SIDM00875,Trametinib,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2836596,0.14738636,1.6970811041883238,0.1553037286250253
58954,SIDM00130,Lapatinib,MK-2206,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,3.4409108,0.2954373,1.857047599504722,0.17288380430031433
38762,SIDM00130,Navitoclax,Palbociclib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.8009483,-0.07721895,-0.712208672525455,-0.009745623161510491
55157,SIDM00529,Uprosertib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-0.9501587,-0.0492486,1.3910465455156489,0.08407901468538899
72572,SIDM00673,Vorinostat,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.761966,-0.079080604,-1.2928522484434402,-0.05049829785759762
67951,SIDM00875,Venetoclax,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.7207859,0.1216387,0.4733386229860658,0.06832246859068511
73615,SIDM00332,Gemcitabine,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.9564664,0.1327978,-0.0047554436682252866,-0.010069215254005415
2163,SIDM00411,Oxaliplatin,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.5005283,-0.05846352,-1.7833387526458884,-0.05584850674211058
38964,SIDM00782,Vinorelbine,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.5006464,0.12974608,1.5919980567571863,0.10590204361343744
46953,SIDM00954,Axitinib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-2.680399,-0.17850679,-1.0909945004307238,-0.12442122831238248
54976,SIDM00673,AZD8055,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-0.22355352,-0.017709533,-1.038146425577965,-0.00482131837075471
79322,SIDM00774,Alisertib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-4.304418,-0.20531866,0.095917040373175,0.025126250338292647
8009,SIDM00531,Trametinib,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.7289022,-0.061306886,-1.7153311671429654,-0.07842709285126837
25721,SIDM00359,MK-1775,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.4334676,-0.18622468,-0.7755525639441121,-0.014802033655592222
69775,SIDM00193,SB505124,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,53.0,-0.8932043,-0.07782971,0.25522147420156427,0.00865126161417151
58807,SIDM00531,MK-2206,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.0817027,-0.050527122,-0.07553376835448421,-0.012811341704471568
32942,SIDM00782,MK-1775,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.86353284,-0.044082213,-0.13820604509457385,-0.03759098849468555
36952,SIDM00893,Cisplatin,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.7134054,0.062412135,0.479354434990964,0.036614212725114864
9103,SIDM00875,Gemcitabine,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5106194,-0.0034019817,-0.9947570873423593,-0.05703968676351235
6573,SIDM00660,Trametinib,AZD7762,Large Intestine,0.0625,Cecum Adenocarcinoma,Male,White,32.0,-0.70271784,-0.054561224,-0.3762638996157419,-0.04927539851861295
102555,SIDM00673,OSI-027,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,1.4209877,0.09880942,1.4388624069347642,0.11068249970478751
41177,SIDM00097,GSK269962A,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.119350865,-0.0059108064,0.0829879136185962,-0.03217805314240218
66820,SIDM00130,Oxaliplatin,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.7944793,0.039024286,-1.3300187313059033,-0.03259982434762623
106410,SIDM00146,PF-4708671,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,2.0095572,0.07387817,2.5278020208369525,0.09518029261601012
78548,SIDM00097,Venetoclax,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.39445767,0.014567444,-0.31296221091137066,0.0022162729007306706
102399,SIDM00893,Axitinib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.1883929,-0.052086975,-0.5024044643481631,0.012300374860344108
99569,SIDM00531,Paclitaxel,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-2.7463408,-0.18528344,-2.666413016617758,-0.17645122737268812
95797,SIDM00893,Paclitaxel,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.6139327,-0.05073564,-0.8987614622244566,-0.07190745017362442
11269,SIDM00193,Dabrafenib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.5079555,-0.008496159,2.3670378768888605,0.06308002328368328
76103,SIDM00097,Afatinib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0846926,-0.054725356,0.8610228664481224,-0.00548359448592553
32019,SIDM00146,Bortezomib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.43401167,-0.029268527,-0.8024747026073376,-0.05010832124501206
4807,SIDM00954,Luminespib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-0.61903113,-0.04282805,-0.5809229451977528,0.005877103524156444
32865,SIDM00146,Doramapimod,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.8425269,0.04739604,1.153275611091139,0.0742088329948498
42031,SIDM01233,Nutlin-3a (-),SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,72.0,1.118913,0.027286932,0.279099691096072,0.018084794512602902
4310,SIDM00774,GSK269962A,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,0.7868582,0.04861294,0.3830171681715798,0.021298446686318775
6951,SIDM00146,Sorafenib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.49929827,-0.042945087,-0.09159954816475115,-0.02172866358006522
83210,SIDM00146,JQ1,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.85712916,-0.06742331,-1.0273494421168186,-0.08182037810989144
53449,SIDM00301,Trametinib,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,6.162986,0.55739534,2.2064214154752824,0.13939583206862272
56324,SIDM00332,GSK269962A,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,6.869188,0.33303028,3.537630342802639,0.18173668769136544
42795,SIDM00193,Crizotinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.2136312,0.010873551,-0.30042447951146867,0.07370961346643169
89679,SIDM00097,Luminespib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.6228955,0.03909307,-0.658682872947259,-0.04805715152565724
103200,SIDM00954,Temozolomide,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,0.103014454,0.001392641,1.3872341559538635,0.034028916699941646
42707,SIDM01233,MK-1775,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.0429596,0.075380504,-0.2924885271676849,0.011729239144106427
39230,SIDM00332,Alpelisib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3782374,-0.09396062,-0.4759351454648731,0.0012397716128688258
6605,SIDM01233,Palbociclib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,72.0,-0.17791373,-0.00365632,1.3467839148242962,0.07090525253579977
47855,SIDM00954,Paclitaxel,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-1.070315,-0.07942198,-1.5262726509074591,-0.09540863292041694
43768,SIDM00097,NU7441,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.64824146,0.03751529,0.2821505849387737,0.03621450572267792
39025,SIDM01233,MK-1775,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,72.0,0.9095074,0.062771544,-1.096773076479102,-0.031197893765138488
5587,SIDM00878,Entinostat,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-0.30195257,-0.006730793,-0.22374346587748425,0.009162274079367882
50010,SIDM00893,Crizotinib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.6985033,0.069105856,3.2332025282905974,0.13574530704931814
76601,SIDM00529,OSI-027,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.8481727,0.1741009,0.8455877486533568,0.12930445992668965
74274,SIDM00146,MK-2206,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,1.7680926,0.130684,1.5472108791499122,0.14595777766719695
100791,SIDM00834,Linsitinib,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-1.6503338,-0.11221107,-1.521367095962603,-0.030812761867442934
35849,SIDM00878,KU-55933,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,70.0,2.5773418,0.1270906,0.18744185274862557,0.04220102701891038
89640,SIDM00359,Vinorelbine,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.1672305,-0.04625177,-0.2185088898638233,0.05267134860619018
45764,SIDM00875,Temozolomide,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.667295,0.015079601,0.11364126616137112,0.025825546257833922
92269,SIDM00834,AZD7762,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,White,66.0,-0.9254279,-0.04779422,-0.03944549377939977,0.020474651486062635
63560,SIDM00673,Cisplatin,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.46955216,0.01243072,1.679316490599514,0.08027338058604694
102870,SIDM00866,Axitinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,52.0,-1.238398,-0.0863799,-0.08709231977532694,-0.00697918637311106
6769,SIDM00097,Camptothecin,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.5352946,0.027574886,0.047818870635474325,0.01954955916963982
45746,SIDM00531,MK-1775,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.99593425,0.116816305,0.20624583385596076,-0.014494001039841132
98355,SIDM00971,AZD8055,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.9071067,-0.046053868,1.505968028573516,0.12719022335182076
93327,SIDM00660,Palbociclib,SCH772984,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,32.0,3.4420984,0.24072102,2.161799901093839,0.09101463266767876
38666,SIDM00778,Trametinib,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,-3.5140707,-0.071011506,-1.062353900544246,-0.050249438083193744
84226,SIDM00878,KU-55933,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,0.586965,0.02279504,0.21123038536239772,0.04926180165908625
187,SIDM00097,5-Fluorouracil,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.6525872,-0.018378023,-0.018146613888226224,-0.014186683498361637
14426,SIDM00673,RO-3306,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.609832,0.20017335,2.232125436821066,0.11814215757410002
63887,SIDM00878,ZM447439,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,2.1615453,0.13002487,0.9929904737217745,0.010694446995298552
90738,SIDM00776,SB505124,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-0.25499755,-0.016557666,-0.422536165279805,-0.029473309420501914
97466,SIDM00193,SB505124,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.91521126,-0.0703743,0.2524071432133153,0.01795433782151166
97352,SIDM00971,KU-55933,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.0365925,-0.029100224,0.3056496566164769,-0.019764116030329258
29701,SIDM00628,Ribociclib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.49423426,-0.012729458,0.4617308645287001,0.07453922875318326
25475,SIDM00673,ZM447439,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.54939145,-0.046357658,-1.7888606211716722,-0.09444226476127267
69262,SIDM00866,Luminespib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,-0.22051068,-0.016149757,-1.168734738995845,-0.05453130738258047
72870,SIDM00878,Dabrafenib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.8612851,0.0801548,0.5475069201331741,0.0231995940299248
71643,SIDM00359,Camptothecin,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.640483,-0.18616165,-2.428424468339325,-0.103752653468933
79063,SIDM00782,Crizotinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.7153271,-0.06179105,-0.8612818070576017,-0.02940076568077222
92818,SIDM00628,RO-3306,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,-2.862986,-0.19470704,-0.27217023332723334,-0.0900076991275935
5291,SIDM00628,PD173074,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.9874675,0.089180805,1.2198708856949116,0.08872490343636333
108386,SIDM00893,Docetaxel,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-4.2938333,-0.25760213,-2.4846149490676637,-0.16163275506470853
34657,SIDM00332,BI-2536,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,2.6702724,0.14052387,-0.004584224219917563,0.00659846800048165
59068,SIDM00193,SCH772984,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,53.0,-1.151871,-0.088996165,-1.1623830655142207,-0.03443384069824049
43046,SIDM00332,Crizotinib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7988424,0.16440217,-0.7179903437725212,-0.08154670436798292
57441,SIDM00411,LGK974,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,-4.1587048,-0.11698373,-3.059380692357006,-0.0669249283594812
65958,SIDM00834,SB505124,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,-0.60539913,-0.053700656,-1.8020791332809956,-0.05120214249363538
97104,SIDM00774,Uprosertib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.0597566,-0.051671557,0.8500717828612121,0.09147672023377189
90400,SIDM00097,Crizotinib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.6060982,0.112153746,0.36210585140222695,0.04699832274295036
58765,SIDM00776,LGK974,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,-2.8946748,-0.088974416,-2.131007254568786,-0.045964503145500685
45690,SIDM00774,PD173074,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,2.769871,0.19020042,0.8261790763265153,0.0954557832441181
55620,SIDM00193,LGK974,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,53.0,-0.970643,-0.048567805,-0.8238027848254977,0.016824269894070938
5213,SIDM00878,ZM447439,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.2886332,0.019636864,0.015010322890335572,0.021220774351026837
39465,SIDM00411,Trametinib,MK-1775,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,3.1481824,0.096967354,-0.1662438977792739,0.0073936008271283755
93156,SIDM00774,SCH772984,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.8072698,0.044580422,2.9459067665169516,0.08931171245673385
91183,SIDM00359,Trametinib,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.5568249,-0.0546866,-1.172992385013019,-0.02096838890215266
60283,SIDM00878,Afatinib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.083770424,-0.007761512,-0.5682119149590692,-0.08575034234401928
31759,SIDM00529,Nutlin-3a (-),Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.9080188,-0.058825795,-0.646080657995914,-0.010699268368202926
69699,SIDM00776,Navitoclax,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,0.3545329,0.02260227,0.37519005664523747,-0.0027032442633414147
52291,SIDM00834,Taselisib,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,0.6027418,0.038290422,-0.26708973408292486,0.07492958294872136
77370,SIDM00893,Venetoclax,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.073459,-0.06684173,-0.751477690561483,0.008129387821015042
99931,SIDM00774,Tozasertib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.97385836,-0.024508227,1.67106182629061,0.06911586340717615
59246,SIDM01233,Olaparib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,0.574092,0.010721584,0.7957930577308493,0.008241323498024755
90575,SIDM00332,Gemcitabine,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.8115349,-0.088413,-1.0956046825478445,-0.10158296177904669
91844,SIDM00878,Uprosertib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,0.5924595,0.02846235,-1.4632874015589985,-0.048319441675143224
9191,SIDM00411,Paclitaxel,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,43.0,-1.9942762,-0.078619204,-0.267174643058597,-0.02274847449165414
15263,SIDM00529,JQ1,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-2.0074418,-0.10791451,-1.4365080949819478,-0.07032519875345432
73709,SIDM00097,Entinostat,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2072712,-0.05913275,-0.1473457889177903,0.01349710335521153
83460,SIDM00301,Ruxolitinib,5-Fluorouracil,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.93203723,-0.027791105,0.939371148983707,0.05216747790466243
46004,SIDM00097,Uprosertib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8756896,0.061849616,0.36393499216849795,0.01570022090354696
80132,SIDM00875,AZD7762,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.26462972,-0.018459577,-2.514051003291272,-0.09156823915352096
94372,SIDM00875,Docetaxel,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.49056223,0.037811346,-0.2387771371995765,-0.036123691220638666
51293,SIDM00359,AZD7762,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.4146602,0.07954169,-0.4903655318583334,-0.03986459434039666
28740,SIDM00130,Erlotinib,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.2153121,0.09163893,1.7531399832731507,0.07227810643319833
48871,SIDM00673,AZD6482,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.2943792,-0.1688092,-1.507565382973822,-0.10839536081810966
59324,SIDM00301,Crizotinib,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,50.0,-0.5945625,-0.067555346,-1.3575344147915547,-0.08730715692370665
23200,SIDM00834,BMS-754807,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,White,66.0,3.3148983,0.21919847,-0.8672263324342425,-0.009691185795017682
22952,SIDM00774,Entinostat,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-0.72293156,-0.044446137,3.3480979094255856,0.2089162993015
100926,SIDM00834,Olaparib,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,1.0309324,0.026098425,2.1416810645066566,0.06691024203021129
584,SIDM00954,Palbociclib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-1.7782798,-0.07273941,-1.851195598987769,-0.07937962864542739
97525,SIDM00193,Linsitinib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,East Asian,53.0,2.5729256,0.118966304,3.350117366272717,0.13684334394505673
1192,SIDM00878,Lapatinib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,3.1798973,0.3119603,1.1384416449207535,0.12507659080897784
105878,SIDM00866,Wee1 Inhibitor,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-0.58849615,-0.04147513,-0.4489674607001436,-0.023164626086768794
46501,SIDM00971,Wee1 Inhibitor,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.79829717,-0.023514342,-0.9730750262486894,-0.05513481066563719
73832,SIDM00774,Camptothecin,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,0.5351778,0.030940287,-0.5512954206443903,0.02079495828886678
105053,SIDM00628,Vorinostat,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,0.24812481,0.026026897,-0.4497781751345122,-0.04677640904766755
100830,SIDM00673,NU7441,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.7237706,0.21134116,0.5704488831988663,0.10383117590453109
63935,SIDM00673,Dabrafenib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,2.2424018,0.033393078,2.5324535841198865,0.04990346843630638
82076,SIDM00954,Taselisib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-1.8334211,-0.122119896,-0.9897968233873697,-0.10091342725829543
68561,SIDM00866,KU-55933,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-2.537413,-0.09438706,-1.1881144824703698,-0.020957170844644903
34997,SIDM00097,Alisertib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.522144,-0.12574293,0.01329915194991197,-0.008986799065790878
50449,SIDM00301,Erlotinib,Cisplatin,Pancreas,0.8,Pancreatic Carcinoma,Male,East Asian,50.0,3.1501472,0.22073025,3.0530522286168567,0.1219387547915594
92518,SIDM00778,LGK974,Trametinib,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,69.0,4.8080344,0.09892234,0.9613669100573115,0.039339126845904314
90439,SIDM00097,Entinostat,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4208527,-0.0703784,-1.243589036542469,-0.05540678194836005
89835,SIDM00531,SCH772984,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.3792465,0.38716176,-0.2177985067394331,0.03680443359954378
86272,SIDM00866,Taselisib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.07975011,-0.006747997,-1.232938223893286,-0.035892801643263396
74904,SIDM00628,Trametinib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,1.3613416,0.089100145,-1.4440776680641045,-0.02089436896524004
94965,SIDM00971,Pictilisib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.9698402,-0.06774108,-0.35459825180765325,0.012371621301452968
53698,SIDM00332,ZM447439,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.95010024,-0.05957322,-0.055455429677024284,-0.03627176079882942
96055,SIDM00866,Nilotinib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.021905,0.069792464,-0.2636272748840698,0.01987179250950733
90988,SIDM00875,JQ1,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5520943,-0.058415867,0.0617788450534556,0.009388277031609563
61341,SIDM00779,MK-1775,AZD4547,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-3.662774,-0.06653425,-4.407459888011713,-0.09084469361180543
50399,SIDM00673,Wee1 Inhibitor,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,1.2970339,0.090220965,0.581510114426634,0.015168124460209008
36030,SIDM00097,JQ1,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.009292,-0.13748766,-1.2161279341158178,-0.09876204681949184
61636,SIDM00776,SCH772984,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,-2.230717,-0.17125213,-1.9526480441070728,-0.0944360640547846
66572,SIDM00529,SCH772984,Trametinib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-0.28902766,-0.012523504,-0.6058077064650677,0.01929119615462917
59056,SIDM00146,Alpelisib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.6989514,-0.07191339,-2.0699481859764037,-0.02178966740387485
36697,SIDM00097,Wee1 Inhibitor,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.59080386,-0.032487426,-0.7548831299646163,-0.060958762151689605
102235,SIDM00529,Nutlin-3a (-),Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-0.17846338,-0.0075702164,1.1047047435685278,0.08147280564030021
80741,SIDM00779,Camptothecin,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,-1.5726383,-0.07055214,2.0625943371204394,0.17986434269404383
33685,SIDM00529,Cisplatin,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.5285192,0.03264936,1.2298556691939522,0.032808201632487134
76012,SIDM00332,Vorinostat,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.68088156,-0.068817735,-0.33548517168286074,-0.037758309808023235
78686,SIDM00301,Erlotinib,AZD7762,Pancreas,0.0625,Pancreatic Carcinoma,Male,East Asian,50.0,2.509353,0.18522877,2.2091923582236697,0.11109792101038232
40507,SIDM00193,Palbociclib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.4486544,-0.06029514,0.6742773359440838,0.059480873169954755
17628,SIDM00878,Olaparib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,70.0,0.29051775,0.008064495,1.3486826952959179,0.03464329934737244
86934,SIDM00411,Gemcitabine,Irinotecan,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,-5.2516456,-0.17555234,-2.1885035072991768,-0.10007942844915933
1521,SIDM00878,PD173074,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-1.4299792,-0.14503175,0.2394888851982886,0.07650534287036756
55339,SIDM00146,Axitinib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.6628081,-0.041902333,-1.3098229004347246,-0.003304541243596449
415,SIDM00332,Docetaxel,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-5.078974,-0.29844317,-3.0650288473154594,-0.26292239098295395
85444,SIDM00193,LGK974,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,53.0,-1.3750829,-0.071838655,-0.3040948167167655,0.006912557332975192
73979,SIDM01233,Oxaliplatin,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-0.41087127,-0.030946877,-1.9136096628097512,-0.1420746665888666
31928,SIDM00332,Tozasertib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.6680405,-0.13530788,0.10247242249544693,-0.014146448381251666
34954,SIDM00971,ZM447439,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.713717,-0.07395262,-2.184882816569345,-0.0697449942729132
45708,SIDM00779,SCH772984,Crizotinib,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,33.0,1.8558426,0.1298643,0.06018984247902024,-0.06439832917723495
104672,SIDM00301,Linsitinib,Irinotecan,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,3.288459,0.097381555,3.349171619333375,0.12921012670858043
77133,SIDM00875,GSK269962A,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.41482463,0.02840434,2.294427897348943,0.04417596362988778
11906,SIDM00097,Afatinib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5347062,-0.107197605,1.1033049657140388,0.07505250630335217
8123,SIDM00866,AZD6482,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-2.6282837,-0.12562191,-1.0078531733609326,-0.006880900136783464
21577,SIDM00782,AZD7762,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.513255,0.13641417,-0.16169469224231314,0.042542369491479916
10270,SIDM00628,Vorinostat,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,Black,51.0,-0.19839145,-0.02039795,-0.707787319993209,-0.03608758686373276
7281,SIDM00097,Nilotinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0664487,0.06886263,0.6683221231813712,0.020882974798952524
22533,SIDM00893,Camptothecin,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.1949082,-0.014582835,-0.8478382710074432,-0.026444846763538928
76159,SIDM00673,PF-4708671,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.0331173,-0.08076013,-0.5286146865673356,-0.032154377889209135
73798,SIDM00628,Docetaxel,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,1.7988951,0.12132485,1.9268904324600087,0.16401458670708463
87255,SIDM00673,Trametinib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,3.5485408,0.3469476,1.07740998469412,0.08608366660223252
87894,SIDM00878,Navitoclax,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.1392739,0.019869136,1.2797827887083755,-0.0025636520598971762
22106,SIDM00774,KU-55933,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.2658292,-0.0443716,0.08830007199593816,0.0023069326686520303
66489,SIDM00878,Trametinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.4277924,0.1091973,0.15276542818358915,-0.007515954631349556
33033,SIDM00359,Crizotinib,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.5689997,-0.04894226,0.4264025196803714,0.028709976135183956
79356,SIDM00954,Temozolomide,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.82298166,0.008218449,2.805962353590259,0.061045877646931125
13200,SIDM00776,Navitoclax,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.9328579,0.058968674,0.9362958396106884,-1.577478796383951e-05
97900,SIDM00097,AZD8055,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3666971,-0.06372906,0.8871453573001853,0.03778656542631907
77541,SIDM00673,PD173074,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.106407,-0.049083114,-1.1702515889835212,-0.005311673873529084
57433,SIDM00878,Paclitaxel,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-0.7378923,-0.06686834,-2.3079343399344077,-0.20446671118430262
5523,SIDM00778,Taselisib,Camptothecin,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,69.0,-1.2345519,-0.07766794,-0.5705751362118129,-0.022387528276467027
71802,SIDM00954,Temozolomide,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.0,0.3758093,0.006795178,1.197003360393535,0.03804187833931624
55389,SIDM00097,Sorafenib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.351294,0.1327032,2.7209646397084444,0.12858796795865068
56066,SIDM00097,Entinostat,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1706588,-0.10234389,0.011001903347238912,-0.01307841682636572
46419,SIDM00893,Pictilisib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.300994,-0.10883,-1.1814565788092448,-0.09473926726867672
45891,SIDM00866,MK-1775,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,-0.5107993,-0.03554153,-0.9653430037308351,-0.03744987544112694
42039,SIDM00332,Bortezomib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,0.44409874,0.024983134,-1.059689709971224,-0.034891231489410854
20124,SIDM00673,Paclitaxel,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-3.2349021,-0.22704618,-1.5686607618145263,-0.08655673332976278
97731,SIDM00130,Navitoclax,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.1714861,0.09597679,2.426130762478206,0.09921337601772948
90504,SIDM00193,Vinorelbine,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,East Asian,53.0,-5.1167364,-0.36005464,-4.128607725927776,-0.25839658302799745
59991,SIDM00776,Crizotinib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,65.0,-1.1964391,-0.10646502,-0.96722335406672,-0.06582270663147712
57166,SIDM00146,PF-4708671,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.8539203,0.07377713,2.363777749290412,0.11772889190181286
101174,SIDM00529,SCH772984,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.037963,0.050465535,-0.7506688025928698,-0.03663021660671991
47206,SIDM00834,Vinorelbine,Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,White,66.0,-2.8349762,-0.19968192,-3.467718528831988,-0.22623300768029406
21787,SIDM00130,Palbociclib,Irinotecan,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.4890726,-0.14599821,-2.2952824664365434,-0.09735674880996292
84683,SIDM00660,MK-1775,LGK974,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-0.06499907,-0.00342663,-0.7303777848600312,-0.01790352968926064
23957,SIDM00774,MK-2206,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.5641346,0.021856777,0.22696067440636805,0.08660888591528129
97153,SIDM00778,Oxaliplatin,AZD4547,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-1.2333698,-0.04158965,-1.0143648624382815,-0.029924689051930395
4979,SIDM00875,Vorinostat,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2369651,0.12985232,0.4560724966393384,0.04825730402785803
107297,SIDM00954,AZD6482,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-1.4116275,-0.07904929,-0.9622173861088502,-0.044129582202523526
51151,SIDM00774,KU-55933,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-2.1809125,-0.066841826,0.1397576837564816,0.011282533550891384
13231,SIDM00628,Temozolomide,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,1.6373421,0.056791734,0.657809946741836,0.06741421541251713
10486,SIDM00778,Olaparib,SCH772984,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,69.0,-1.0936611,-0.030465258,-0.3500463225992314,0.008910895974331732
91447,SIDM00529,Palbociclib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-2.1161094,-0.08868902,-1.2858236387683832,-0.054007029768581516
74279,SIDM00875,Lapatinib,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.280632,-0.11715976,-1.3874393149667275,-0.0682302559293017
82468,SIDM00878,Temozolomide,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,70.0,-0.37168825,-0.008043293,1.7152454574217344,0.027805023072234102
56024,SIDM00971,Vorinostat,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.5176806,0.09397022,1.7939409759929004,0.12941176613866223
93835,SIDM00529,Luminespib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Black,44.0,1.0578346,0.10820293,-0.05247728102536218,0.05143295749763582
3699,SIDM00893,OSI-027,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.4003404,0.038592916,-1.230736121327657,-0.00842687017668222
75272,SIDM00411,Lapatinib,Oxaliplatin,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,1.5644264,0.061039817,-0.1460830839484309,0.051067288250605664
97033,SIDM00193,Oxaliplatin,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.20477393,-0.006137428,1.4113250706347895,0.030141680464641274
11186,SIDM00628,Alpelisib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,1.9734417,0.08562569,-0.5762783714419568,0.01669893051840384
90594,SIDM00529,Paclitaxel,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.5598331,0.057176843,0.06992848192225444,0.013532518519803645
55611,SIDM00866,Wee1 Inhibitor,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,-1.0472012,-0.057852115,-0.44484756356359506,0.01758701522432285
101851,SIDM00411,MK-2206,Palbociclib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.2580572,0.07296968,1.0976025812416734,0.10234459432866899
46236,SIDM00866,Nutlin-3a (-),OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,3.0327096,0.15011393,-0.6306620268827398,-0.016104623198913252
8861,SIDM00782,Afatinib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.71102846,-0.065057784,-0.35764005507546115,-0.031511855354945995
98248,SIDM00301,Navitoclax,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,50.0,7.490768,0.2233676,6.059402649565584,0.14810792405157938
21338,SIDM00673,Lapatinib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,2.4277227,0.19573298,0.4092258101261292,0.06796700220626031
87892,SIDM00529,Venetoclax,Taselisib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-0.82518363,-0.022156421,-0.1365763642487435,0.043200416790477265
74054,SIDM00782,Crizotinib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,-0.50495785,-0.043577015,-0.7716357910197229,-0.005408843422364394
55444,SIDM00359,Taselisib,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.896784,-0.059327837,-2.060766072700674,-0.08507140259143321
52254,SIDM00673,Sorafenib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,0.41624078,0.024378086,-0.16502767294318985,0.0026403347519092352
45807,SIDM00673,Linsitinib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,0.61709803,0.012041983,1.7957270335486764,0.03276237454548922
13019,SIDM00411,MK-1775,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,43.0,0.8001223,0.046012018,-0.20040475960789206,0.02147151204076509
99307,SIDM00332,Uprosertib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.6665145,-0.046680108,-0.04337017511677737,-0.042817729293950266
16124,SIDM00660,Taselisib,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.6361001,0.05398879,0.3322413880877325,-0.003391961701340881
79274,SIDM00673,Taselisib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,0.34602535,0.032084923,-1.4859876755029955,-0.05842575316566332
8873,SIDM00359,MK-2206,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.984504,0.12989399,-0.36635867182209453,0.10491571265208498
34930,SIDM00875,Uprosertib,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1885895,-0.10406336,-1.0616853440870746,-0.03929208126144975
41437,SIDM00146,Afatinib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,-0.41744855,-0.036819153,0.8654335151462919,0.031351217983960115
105693,SIDM00097,RO-3306,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.32257554,-0.017880049,-0.904981963228916,-0.05102721296144077
56107,SIDM00193,Olaparib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,53.0,-2.1948268,-0.08455843,-1.2573990169963403,-0.020994104030398166
40425,SIDM00971,SCH772984,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,9.520519,0.40065086,3.466258460018814,0.15297120545814305
13555,SIDM00971,Alpelisib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.60160756,0.04119919,0.029407384374517096,-0.016621770453718782
37259,SIDM00529,Temozolomide,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-0.50231075,-0.010126359,-0.5317378006788424,0.015646428371060207
92453,SIDM00673,Olaparib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.80990887,-0.041712593,-1.5383374655882323,-0.04176182016596034
36762,SIDM00628,Vorinostat,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,0.5621225,0.052988846,0.7035311977418929,0.0857330398846424
61195,SIDM00776,LGK974,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,0.60907775,0.030675689,-0.578867445050114,0.01784459214356358
72342,SIDM00774,Gemcitabine,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,11.708239,0.7484423,4.634367747638771,0.28543751391226846
2258,SIDM00878,Linsitinib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.854078,0.1279069,-0.30542057397415523,0.00090879582794048
91210,SIDM00097,Ribociclib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8900061,-0.062504165,-1.335955232649582,-0.040720589579191405
9151,SIDM00529,Palbociclib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-2.7590837,-0.10528009,-1.4160977511492603,0.020355711425268767
51864,SIDM00097,GSK269962A,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.3460045,0.07065201,0.3519921672186158,-0.0007108833699057026
91098,SIDM00774,AZD8055,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-0.6294566,-0.04334369,-1.6390744945915998,-0.08321642635498767
96576,SIDM00529,Tozasertib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-1.5212765,-0.05183122,-0.9364560194873691,0.0033195129947116565
31084,SIDM00097,BI-2536,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.0999882,0.14016996,1.2745195918198762,0.09282517762571217
7424,SIDM00529,PF-4708671,OSI-027,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-1.9928315,-0.088588774,-1.3870764521802856,-0.02906448010732996
45249,SIDM00893,Crizotinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.2893723,0.02591698,2.647643972575198,0.10334929036754606
104574,SIDM00875,MK-2206,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3110355,0.11747549,-0.5618688433901515,0.016267553175345378
88418,SIDM00146,Luminespib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.1228436,-0.07601124,-0.15159666865654237,-0.05178209965463696
782,SIDM00893,Nilotinib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.32371837,0.027564805,0.34739319470176255,0.06991074987956408
33873,SIDM00673,PF-4708671,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.236143,-0.116451055,-2.1612047120988875,-0.07487992381218267
15203,SIDM00866,Paclitaxel,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-1.117889,-0.09191023,-1.7636969214444367,-0.08701848552911401
37908,SIDM00628,AZD7762,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.6575675,-0.06370045,-1.051551816498699,-0.051019181653069345
36142,SIDM00866,Entinostat,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,52.0,-1.8061258,-0.12967207,-0.6525904661310973,0.0059802439167268105
17174,SIDM00097,AZD6482,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.75245863,-0.054661766,-0.1235564069464181,-0.05426459134768842
104553,SIDM00660,Camptothecin,Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,-0.41021845,-0.027622651,-1.2018063152056517,-0.0061167658809722705
17744,SIDM00193,5-Fluorouracil,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,53.0,0.9603475,0.09444925,-1.6706587736865572,-0.071553852608155
27764,SIDM00531,Oxaliplatin,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.1585276,0.03866873,0.49766821637514697,0.028879741090170545
27751,SIDM00866,MK-1775,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-1.1225188,-0.03343557,0.266045862490579,0.035704801629777155
45992,SIDM00782,Dabrafenib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.1512247,-0.032400403,0.2544441691629088,0.005591532607841511
26918,SIDM00878,Dabrafenib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,70.0,3.016539,0.15429443,1.0271367932951763,0.06003911355054298
17427,SIDM00893,Cisplatin,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.0593429,0.033938956,1.0238906659026994,0.053526483723570925
9673,SIDM00130,Dactolisib,Cisplatin,Pancreas,0.8,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.2719663,-0.028698884,0.18179294820532182,0.0034895429160873865
11482,SIDM00782,Palbociclib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.2624893,0.036383003,1.1323397802515238,0.019294600382002897
101472,SIDM00628,Gemcitabine,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.1975622,0.03653574,-2.1628624975005586,-0.05704257252467804
105932,SIDM00146,MK-2206,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.0529697,0.14667419,1.544073388884617,0.15313534719158295
91515,SIDM00531,Cisplatin,Erlotinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.2446213,0.13227169,-0.808797500236733,-0.03179647115438977
93255,SIDM00774,Alpelisib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.8047758,-0.054519176,0.12251011021600822,0.022358477105033477
106965,SIDM00779,Crizotinib,Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-0.9164053,-0.05742371,-1.190099247959134,-0.07898059965885365
52983,SIDM00529,PD173074,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-3.13055,-0.121129036,-1.492104264111096,0.0021051175325852898
51159,SIDM00875,Entinostat,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.12950374,-0.013281104,-0.09668710456586967,-0.03252227057788528
69983,SIDM00529,Sorafenib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,0.6969687,0.073655985,-1.4457444433975746,-0.010991152062208846
71082,SIDM00301,Sorafenib,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,-0.8796614,-0.11918354,-1.3371580562473755,-0.07013757806421225
103973,SIDM00834,Trametinib,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,0.88149726,0.016343739,-1.028960468883307,-0.03228196388848433
46517,SIDM00971,Nutlin-3a (-),Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.0072618,-0.044463076,-0.35692822909425637,0.015049616550948447
63534,SIDM00673,PD173074,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.0006113,-0.0866744,-0.9327812464177286,-0.020707237158182165
70882,SIDM00954,Navitoclax,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-1.1075712,-0.043512467,-0.7772645621190842,-0.022306351544779095
83316,SIDM00875,Uprosertib,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.336996,-0.1037099,0.15537677982661027,-0.0339566701875213
36041,SIDM00782,AZD4547,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.1973175,0.047260676,0.5275483996270993,0.05921341599566957
64351,SIDM00097,Wee1 Inhibitor,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1348393,0.0758383,1.3444890308824686,0.13303848202929552
780,SIDM00411,Olaparib,Trametinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.8265007,0.09087895,0.5813388136068308,0.04860142440021791
86261,SIDM00146,Gemcitabine,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-1.8178487,-0.10540827,-1.1811825027425613,-0.08297614051940025
104886,SIDM00529,Nutlin-3a (-),Linsitinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.0808938,0.052620035,0.7665453599902362,0.07920791928310239
96281,SIDM01233,SB505124,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,0.7755277,0.032916833,1.3799769168038827,-0.008888858415592298
101223,SIDM00529,Alisertib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,-0.37891838,-0.038860004,-0.4603821847852175,-0.0317279654475535
20859,SIDM00628,BI-2536,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,2.4779341,0.037683226,-3.0362094252008163,-0.04870543336059213
95537,SIDM00529,Alisertib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.4351371,0.04076994,0.9164594601699042,0.051756095967972225
18787,SIDM00529,Dabrafenib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Black,44.0,0.90966725,0.020103775,0.8411564768900297,0.046361326390978244
100245,SIDM00130,Taselisib,5-Fluorouracil,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.612141,0.05960061,-1.9158899880039806,-0.07927481741085765
4888,SIDM00411,5-Fluorouracil,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.0106502,-0.026703693,-1.7866696384409566,-0.027554622129193237
51804,SIDM00954,Doramapimod,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-2.1362467,-0.072059095,0.3394695304696449,0.0968816250417599
45706,SIDM00971,Ribociclib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.9707623,-0.054643147,-1.9857092546461848,-0.03318745544316892
98273,SIDM00673,Linsitinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.2371187,0.015395518,3.630262506504101,0.0683294412354178
6334,SIDM00774,Docetaxel,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-0.23697795,-0.024591684,0.18006934910170808,-0.037982279718147355
73274,SIDM00866,Dabrafenib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.7800739,-0.024124723,-0.7502985655237794,-0.022156090492789212
16669,SIDM00893,Navitoclax,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.4688427,0.13760418,1.4456513019618988,0.03911453975884232
11604,SIDM00971,GSK269962A,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.5796263,0.10272296,-0.1641372966848454,0.006631885748790301
107579,SIDM00531,Sorafenib,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.2629534,0.033810806,-1.2456611974589167,-0.07156949795610269
86623,SIDM00529,Alisertib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Black,44.0,1.197395,0.11736515,0.5922025737560562,0.07894123386811676
56928,SIDM00834,LGK974,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-1.1659186,-0.07541856,-1.13151453684768,-0.06770610381401375
28678,SIDM00130,Palbociclib,Dasatinib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.30518222,0.025795655,0.2516765756285491,0.06573679395417209
48974,SIDM00893,Doramapimod,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.338989,0.049295254,0.8824262874160215,0.08399783147191438
76606,SIDM00971,Taselisib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.3206453,0.07874579,-0.6245929238085632,0.015966056860171485
67408,SIDM00875,Camptothecin,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.54531825,-0.057930253,-0.755945198616394,-0.040583918882407054
28133,SIDM00971,Olaparib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.7838712,-0.0583587,-2.3906249580196133,-0.04639028319010657
59307,SIDM00332,MK-1775,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1751419,0.104343325,-0.18373492617785223,-0.04949191151225023
95800,SIDM00774,MK-2206,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,0.45677888,0.019517627,-0.4085010639016233,-0.03012851235268667
18270,SIDM00782,AZD4547,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.8395147,0.060120128,2.0777718529286666,0.12200610062179659
100235,SIDM00130,Paclitaxel,Dactolisib,Pancreas,0.0125,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.3624707,-0.122836106,-0.0708286633431886,-0.04285252331731728
10178,SIDM00893,PF-4708671,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.5146139,-0.072464064,-2.3954099415355303,-0.07544010347207543
14545,SIDM00782,MK-2206,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.14834258,-0.010795589,-0.1432405215241416,0.02940745819688799
20690,SIDM00359,Nutlin-3a (-),Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.6957009,0.040341124,2.5728376382375107,0.08035934621044886
72051,SIDM00332,PF-4708671,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.549733,0.045268144,1.3569435935447587,0.1001619813421584
75370,SIDM00628,Bortezomib,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-0.27234882,-0.011854188,-1.7541734559974007,-0.05445251627893574
3229,SIDM00875,Docetaxel,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.17044991,-0.013360933,-0.8612884637347717,-0.03332550434508362
51465,SIDM01233,Crizotinib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,1.1076719,0.081636935,0.0019788620675604083,-0.02389387808549561
36197,SIDM00130,Gemcitabine,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.6932073,-0.15195318,-0.6050430369341779,-0.04605114969345972
75505,SIDM00954,AZD8055,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-4.224228,-0.18690747,0.06308605121518876,0.0052077139100033315
29218,SIDM00971,Bortezomib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.3196228,0.069494106,-0.48813371340624184,0.0071351674128935
66319,SIDM00130,LGK974,Dactolisib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.1006005,0.058404908,-1.2224888249781156,-0.0020016350222008114
84169,SIDM00778,SB505124,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,69.0,-0.42919967,-0.017747238,-1.0388491300505343,-0.044539870906471775
5417,SIDM00878,GSK269962A,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.6652376,0.05344037,0.9799180932101467,0.07580599918107035
98761,SIDM00878,Entinostat,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,-0.92643297,-0.040327284,-0.7443936774203472,-0.031668576972600046
93118,SIDM00301,Erlotinib,Palbociclib,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.738571,0.16074573,3.011421105354957,0.11727625290095982
66330,SIDM00673,Nutlin-3a (-),Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.971099,0.09865111,1.9675628785882755,0.007790986074445068
101754,SIDM00332,MK-1775,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.840874,-0.11312967,-0.7892747422454931,-0.04775263831360984
105507,SIDM00301,Palbociclib,Cisplatin,Pancreas,0.8,Pancreatic Carcinoma,Male,East Asian,50.0,-1.7491021,-0.20469946,-1.896299893646807,-0.13667471642172768
68387,SIDM00875,Temozolomide,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8847977,0.018533295,0.3638394362658195,0.038266736637456576
16307,SIDM00782,AZD8055,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-3.397883,-0.21415144,0.48124663184552013,-0.010340166583968283
102544,SIDM00782,5-Fluorouracil,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,Unknown,72.0,-1.2038047,-0.04311963,0.8679277710778484,0.03941640205035886
98815,SIDM00130,Crizotinib,SCH772984,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.52788645,-0.045901455,0.1505440764841674,0.03691541167024914
33801,SIDM00332,Taselisib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2467616,0.11510293,-0.9204931931431194,-0.05316997130242844
50012,SIDM00776,AZD4547,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,1.332458,0.044854145,1.0560825307848498,0.04584893221201642
17266,SIDM00834,Afatinib,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,White,66.0,-1.3531696,-0.080523066,-0.9915221750316564,-0.06139887194630803
56573,SIDM00673,Entinostat,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.7377933,0.10283443,-1.030067835139961,-0.06063861935406726
62018,SIDM00146,PF-4708671,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,2.3505604,0.09616738,2.18759964604986,0.057307644023714605
40648,SIDM00878,Palbociclib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.5837039,0.016054204,-0.5365291563219144,-0.04644527513275662
90962,SIDM00660,AZD7762,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,4.285566,0.25418356,1.7734931375752936,0.10901024577538318
56780,SIDM00875,AZD6482,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.3461342,0.096874855,0.9572347982369324,-0.0018108762882955893
18999,SIDM00097,Luminespib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.4793339,0.107446566,-0.27442839288023674,-0.003939108694568815
79436,SIDM00097,NU7441,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.439259,-0.07041013,-1.5643511068486378,-0.07872087238951699
64885,SIDM00971,5-Fluorouracil,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1024926,-0.029960243,-0.4206796118288378,-0.00229191411696758
8193,SIDM00411,Cisplatin,Irinotecan,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.482845,0.025534157,0.6040802324674517,0.023012109435876043
31156,SIDM00893,NU7441,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.4467784,-0.03872329,-0.9313433313678469,-0.05341702400316738
86890,SIDM00782,SB505124,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.6767098,-0.05120046,-0.07571539293853992,0.01560416912425015
105112,SIDM00097,AZD6482,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8193025,0.05729334,-0.253354026511116,-0.05260462743283335
2483,SIDM00774,Camptothecin,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.927202,0.19742303,2.9642120262835965,0.17893671477205098
11169,SIDM00531,Cisplatin,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.89070684,0.10029444,0.20171787562327256,0.045081066672601464
53694,SIDM00332,Gemcitabine,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.925479,-0.13262415,-0.15752435916438218,-0.021557198787131873
52343,SIDM00776,SB505124,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.38107485,0.022611804,-1.3720723133541148,-0.029506503942576544
13966,SIDM00673,AZD6482,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,1.9368306,0.1057811,-0.38593160542024413,-0.019247877438052004
52324,SIDM00954,Bortezomib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-0.40760636,-0.026027901,-0.7186004442764085,-0.016412841134319737
3472,SIDM00954,Olaparib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.2535101,-0.0034796945,2.5767247248855947,0.08036575528750345
72697,SIDM00332,Docetaxel,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.198224,-0.29612952,-2.605811377256181,-0.26385830879941313
16744,SIDM00878,Pictilisib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.5082582,-0.04179667,0.19062065705054154,-0.03024601034489485
56593,SIDM00954,Luminespib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-1.0835658,-0.0775827,-1.163106736402376,-0.03126259056386579
54257,SIDM00332,BI-2536,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,3.6248016,0.19877134,-0.5909822317869974,-0.038896958255831726
10606,SIDM00971,Doramapimod,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.6215525,-0.021710841,0.1946914553611528,0.03696536597493177
73401,SIDM00130,Ruxolitinib,Gemcitabine,Pancreas,0.1,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.2020996,0.021532487,1.6385643577883517,0.009906019849530366
44915,SIDM00878,Navitoclax,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.4330544,-0.012740974,-0.04804195856711157,0.002318564195219707
103376,SIDM00097,Lapatinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.615945,-0.086722076,-0.531114521992765,-0.053026303765987666
21069,SIDM00529,Lapatinib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,2.4006672,0.07025592,0.605878481902069,0.0809333740051629
99625,SIDM00954,Trametinib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.0,3.3889377,0.196525,1.956655005035348,0.08492907314502016
86034,SIDM00782,Trametinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,3.349051,0.13393879,2.207807327961955,0.09576901364498208
2889,SIDM00097,Linsitinib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.169752,-0.10633032,-0.8659759601245147,0.019160275442288852
98498,SIDM00531,Irinotecan,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.40513155,-0.04695362,-2.1179785553298007,-0.1438255310538659
86908,SIDM00866,Afatinib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,-0.9188197,-0.07820676,1.367300098787785,0.06811749318471039
105438,SIDM00866,Vorinostat,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.866679,-0.13975196,-0.37237569715278435,-0.01360540028638756
86479,SIDM00628,Nutlin-3a (-),Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-1.881492,-0.09084474,-2.1478600913886483,-0.07305331412361019
31852,SIDM00359,Taselisib,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.6803236,-0.17269945,-1.5631388001797006,-0.07630930487141636
51705,SIDM00954,PF-4708671,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,3.0219805,0.051343877,1.8744297037471636,0.07302595834275886
95436,SIDM00875,MK-1775,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.0428033,-0.044232942,-2.1741822885492352,-0.07023415172437034
30986,SIDM00130,MK-1775,Oxaliplatin,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.8789546,-0.17563118,-1.706364290531853,-0.11725301354429397
98328,SIDM01233,Linsitinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-0.30208448,-0.018087234,0.8979784348153022,0.0960409238694279
81756,SIDM00954,Nilotinib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.4846378,-0.026950806,1.21436062337105,0.13706737323818113
96899,SIDM00779,Oxaliplatin,Navitoclax,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,1.5174928,0.121632986,0.5518263360758987,0.03776721424349545
29469,SIDM00130,OSI-027,Dasatinib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.4071162,0.22303809,0.7803065876967379,0.08763004443663407
5378,SIDM00774,Tozasertib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-0.4913715,-0.012857508,0.2290325628380684,0.016253888350569342
72678,SIDM00529,Afatinib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Black,44.0,-1.6273457,-0.08377859,0.09493777200186937,0.006566031455033555
26807,SIDM00529,Uprosertib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.6896172,-0.06768286,-1.3566985528153017,-0.007217666877026064
86230,SIDM00834,MK-1775,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-0.47189096,-0.038055018,-1.052039852786312,-0.044803285122017145
38318,SIDM00954,Wee1 Inhibitor,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-3.5586798,-0.11102627,-1.6915538615607986,-0.11848960678386629
90626,SIDM00301,Dactolisib,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.84562314,-0.09507723,0.05511883865492858,-0.014078638471987539
55591,SIDM00531,Paclitaxel,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.4612222,-0.04679654,0.06633849300174921,0.0012509739161815651
8090,SIDM00531,MK-1775,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.1654215,0.22921388,-0.6020606561282137,-0.03335120180591814
3115,SIDM00529,NU7441,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-2.2920432,-0.1369952,-2.597001141866856,-0.11745890207592853
4268,SIDM00875,Palbociclib,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.2311847,0.1803523,2.195269943047964,0.11194184246009618
18847,SIDM00971,Uprosertib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.9035379,-0.04425454,-1.0285896297878652,-0.005353673862850733
44622,SIDM00529,Paclitaxel,PD173074,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.6145246,0.06338622,0.3618210211325058,0.029787983635273945
52486,SIDM00782,LGK974,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,Unknown,72.0,-1.3078054,-0.091959424,-0.9045931371662416,-0.050000420404428834
25655,SIDM00893,Olaparib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.2325282,-0.07326077,-0.7464585530661825,-0.042978023624974826
45499,SIDM00774,Docetaxel,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,-0.22181349,-0.021131936,0.3463266434139707,-0.0055560069895173436
30738,SIDM00954,PF-4708671,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-2.221806,-0.10433316,-0.33007590939994397,-0.014269630070447528
20146,SIDM00954,OSI-027,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-0.45167762,-0.028057065,0.35504362766093733,0.04014220016865286
57490,SIDM00954,GSK269962A,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,1.1940511,0.074521326,-0.48021086057692375,-0.0014461666294173382
6201,SIDM00878,Palbociclib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,0.42959315,0.03520486,1.3439251094845333,0.04538914625496577
84723,SIDM00097,5-Fluorouracil,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5287216,-0.11947709,-2.4122587345772537,-0.13604979653997482
105579,SIDM00673,Pictilisib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.46104473,-0.046517607,-0.7291099966537421,-0.1250581454610318
20844,SIDM00628,Nutlin-3a (-),OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-2.8408768,-0.12170992,-0.5457868248695231,0.025414991266671735
86864,SIDM00411,Sorafenib,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.1918001,-0.06546271,-0.7724411158922009,-0.053720501833434076
77104,SIDM00359,SCH772984,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7171067,-0.13003042,-1.1163578062997606,-0.026025824103873448
102828,SIDM00673,5-Fluorouracil,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,1.9186362,0.12302503,1.5028886759926319,0.06076246052333054
97210,SIDM00893,Ribociclib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.73647565,0.02901501,-1.0195043450019652,0.018943801137856243
90318,SIDM00866,Entinostat,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.94415164,0.060923357,0.9806656708861827,0.09495847843804442
55366,SIDM00097,Olaparib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.8211747,0.056520708,-0.8877200125791438,-0.013614498050506704
5332,SIDM00954,MK-1775,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.8384557,-0.09575538,-0.20204536220903524,0.0536830758190104
84211,SIDM00878,Wee1 Inhibitor,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.2061215,-0.017369317,-0.1303727235884952,-0.0304078856517474
26809,SIDM00332,Trametinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.42776,-0.12947443,0.9451677814341907,0.022424921321500032
6111,SIDM00971,Camptothecin,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.8915117,0.06596095,2.806274591200842,0.10485962478754426
52256,SIDM00673,AZD7762,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,0.9206417,0.06398535,0.727099862343823,0.05853839984362409
3030,SIDM00954,AZD8055,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-0.730134,-0.055113655,-0.061285172365259065,-0.010396291412910196
77497,SIDM00193,BMS-754807,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.3636062,-0.10498185,-0.9010357152696712,-0.004448167722240348
101118,SIDM00301,LGK974,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,50.0,-1.9232146,-0.042612765,-1.5443286216039844,-0.05493744057100803
18600,SIDM00866,BI-2536,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-4.2174315,-0.1557277,-2.345852098498603,-0.0870909498796105
23715,SIDM00193,Afatinib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,53.0,-1.3363367,-0.09908335,-0.4136437428487797,0.030766399596888705
35976,SIDM00778,SCH772984,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-0.7402799,-0.030857202,-0.19021144276146812,-0.036959824275505385
97070,SIDM00628,Luminespib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-0.3999297,-0.03309605,-0.8304370349331529,-0.027304625682523637
39617,SIDM00774,Doramapimod,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.1246555,0.041636724,1.6997049177518668,0.03617359434120725
42020,SIDM00411,Sorafenib,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.0943651,0.1138799,1.2802801522358054,0.10677749311911597
82173,SIDM00628,Sorafenib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,Black,51.0,0.13711514,0.012930764,-0.6634838446894774,-0.018019246240045653
107758,SIDM00834,SB505124,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-0.54670787,-0.045230605,-1.3497586553537415,-0.05940172773788634
60472,SIDM00866,5-Fluorouracil,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.6148907,-0.022568963,1.089849478152134,0.028550430420532822
97675,SIDM00779,Crizotinib,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,0.65113896,0.017383328,1.1217375307041553,0.07746514079007136
26335,SIDM00097,Cisplatin,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.4303305,0.04205776,1.8463281416727566,0.03924087289751482
33489,SIDM00893,Doramapimod,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.5017018,-0.017691683,-0.4463655355429245,-0.023196240362003788
92422,SIDM00875,Alisertib,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5275919,0.047775313,0.6870286078936079,0.0828159058814808
62011,SIDM00130,Taselisib,Crizotinib,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.6351864,-0.04649114,-0.5791956757570113,-0.013402427300792108
46239,SIDM00529,Gemcitabine,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-4.2353153,-0.18821733,-3.5800840633593007,-0.1106701180443
47858,SIDM01233,MK-1775,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,-0.65986574,-0.027308494,-0.5448558855059,-0.022438667025557035
56986,SIDM00866,Venetoclax,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.7187911,-0.014219777,-0.4990248857093049,0.012493099282927262
77336,SIDM00878,Olaparib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.63314676,0.014522953,1.6941650745781225,0.047555634184802215
2916,SIDM00673,Sorafenib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,0.3079602,0.022009121,-0.38204703395690087,-0.04383490444172347
82493,SIDM00097,Crizotinib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.42617583,-0.026909282,0.01785764718760891,0.01226586018834501
5905,SIDM00878,Nilotinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.7505407,0.13165958,0.9814359617528439,0.056579627311182476
59018,SIDM00531,AZD7762,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.9309216,0.3329598,2.508218298860875,0.20133607065914685
59937,SIDM00778,Taselisib,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,1.1119429,0.030945743,1.6759831004341506,0.08572192422283774
39585,SIDM00875,Doramapimod,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5858705,0.05665742,2.0012472127665015,0.08613556255660079
105310,SIDM00875,NU7441,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.537134,0.019716578,-0.1396519653866555,0.003879937521977378
107564,SIDM00628,Pictilisib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,1.2290726,0.10657834,0.43381344907608427,0.01244968306012416
92646,SIDM00875,Venetoclax,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.40163264,-0.008875167,0.15866571119857792,0.008481179288558252
80960,SIDM00875,Sorafenib,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3714554,0.13700484,0.5496537275423241,0.031297814329229
43993,SIDM00332,Palbociclib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4813873,-0.062996335,-0.6917993557261302,-0.031605504214070726
50233,SIDM00778,Dabrafenib,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,4.163776,0.12891565,0.8817822302111546,0.021420196531366315
46845,SIDM00893,Trametinib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.3181003,-0.13774008,-1.9872171857482501,-0.118052629072588
1553,SIDM00779,SCH772984,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,0.23301981,0.019832548,0.14316371994195431,-0.02183765381379653
10677,SIDM00774,MK-2206,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.3992673,0.016682543,-1.2861420410211526,-0.06867157137690774
107974,SIDM00146,Alpelisib,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,1.4285461,0.08882075,-0.5550184576829678,-0.008752517223737929
81424,SIDM00971,RO-3306,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.8335474,-0.09289575,-0.7368069846806571,-0.06512354543114665
23361,SIDM00776,AZD7762,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.79701596,0.06386291,0.7782507082470257,0.07763005368265323
75960,SIDM00628,Navitoclax,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,3.5813906,0.13305256,2.8213024305503445,0.0693556543607498
97630,SIDM00971,Docetaxel,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.8209708,-0.06988159,-2.213134572907393,-0.035540359105655145
49928,SIDM01233,Afatinib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,72.0,-0.6044828,-0.04560129,1.2931963802793718,0.10711640499565235
80735,SIDM00660,SCH772984,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,2.3870287,0.07721248,0.07802162684869189,0.015476832648094638
58135,SIDM00097,Trametinib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.96697205,0.032349046,-0.459125668051585,-0.017335812956861662
106700,SIDM00359,Linsitinib,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.1896839,0.011012642,-1.3486732581195844,0.005563249745771438
19207,SIDM00954,Linsitinib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-0.62333363,-0.04784248,-0.47934547520635523,0.013792400736631174
69113,SIDM00359,Taselisib,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.2344186,0.15862131,1.8953633139653427,0.07884680515599113
59044,SIDM00332,Trametinib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5782351,-0.12928028,-0.460123055199236,-0.06186290375918295
21895,SIDM00301,Trametinib,Olaparib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.123143,-0.13585463,-0.5724320135146531,-0.040998381095282026
44388,SIDM00866,Paclitaxel,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-1.3763623,-0.11036983,-1.4550549553608014,-0.06044278060552087
97031,SIDM00359,Oxaliplatin,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.8413994,-0.111027196,-1.7045236630633465,-0.060864781307718066
21984,SIDM00193,Linsitinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,2.9086719,0.11564495,2.8843193103403877,0.11711542030340821
51544,SIDM00971,Pictilisib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.8694936,0.10591142,-0.2072408894064802,-0.00986222155377968
8628,SIDM00878,Axitinib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-2.6162539,-0.20590563,-1.425193249581477,-0.12607853407201772
74895,SIDM00778,AZD8055,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,69.0,-0.80189764,-0.043915093,-1.255818388241609,-0.031112447770310213
105779,SIDM00529,PF-4708671,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.1639807,0.0819358,1.2057710188245316,0.07512890776440673
9823,SIDM00301,Sorafenib,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,-0.6291587,-0.08214061,-0.8164257557720349,0.002305920305307734
77782,SIDM00875,Dabrafenib,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.0535753,0.031384405,-0.058147136735519606,0.007221197094344227
32874,SIDM00301,Lapatinib,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,50.0,1.6076092,0.02450001,3.5071812161274223,0.048910343182622766
59304,SIDM00193,Taselisib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.16698451,0.016178375,-1.5725320465177177,-0.018846572699946555
89490,SIDM00097,Doramapimod,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.91087765,0.027558668,1.4823401520861996,0.03715552883374911
41899,SIDM00834,SB505124,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,0.56085867,0.043002404,-1.2009519785581426,-0.043200082336341865
42120,SIDM00774,Paclitaxel,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,1.7999597,0.10078267,-0.8601495400118574,0.08566241654815657
20269,SIDM00660,Taselisib,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,2.4089015,0.14259535,-1.7042691331279636,-0.12137362694016106
22220,SIDM00332,Trametinib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.6887614,0.1748494,1.4713042336663278,0.10274379856296353
13162,SIDM00779,Dabrafenib,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,4.6354594,0.2544973,-0.9360584032160656,-0.004404317222404012
47908,SIDM00782,AZD4547,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,Unknown,72.0,-0.6339516,-0.0183056,1.3016722477326759,0.0654116251391047
62974,SIDM00893,Crizotinib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,4.4130344,0.2657654,4.424737596889333,0.17367672930572667
102233,SIDM00332,Wee1 Inhibitor,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8625934,-0.057834197,-0.44904953800428876,-0.06578047341412109
84932,SIDM00359,Olaparib,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.11344881,0.002175388,1.2862099123632025,0.033637969499603855
103817,SIDM00673,Lapatinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-2.4911804,-0.116375096,0.28695781078080845,0.02558275067956713
18696,SIDM00673,AZD7762,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.4352403,0.09612668,1.5514208909671543,0.10829052248975736
106598,SIDM00774,Alpelisib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.6514342,-0.11191235,-1.555025030586192,-0.05100603416607429
11681,SIDM00332,BI-2536,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.167713,-0.090101644,0.22029371928818045,0.019125430765368157
69476,SIDM00774,KU-55933,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,0.8233145,0.036924474,0.8507546778456989,0.018349099096985042
98964,SIDM00866,Alisertib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.4621756,-0.110824995,0.6891058335599254,0.06340211822975514
88786,SIDM00893,Nutlin-3a (-),Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.0109012,0.012307853,2.421652210328575,-0.006993256745509888
90187,SIDM00878,Sorafenib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-0.85872054,-0.053738635,0.16909629641217352,-0.025644641795354386
41191,SIDM00875,AZD7762,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.39087617,-0.027557455,-1.5849264030586148,-0.08518547215972773
86774,SIDM00866,AZD7762,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-1.7808268,-0.101499915,-0.8605450783819698,-0.057753347470599695
72403,SIDM00097,Alpelisib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2328019,0.08711374,2.2775564038773046,0.14396071710344685
92648,SIDM00673,PD173074,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-1.8583449,-0.08867903,-1.3881125713500817,-0.08289214570492387
4889,SIDM00529,Lapatinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.72115827,-0.045448847,0.9275971726261334,0.08926269432548208
10435,SIDM00531,Crizotinib,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.76140195,-0.057267684,-0.33989261274063093,0.021743718772127763
99044,SIDM00878,Paclitaxel,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,70.0,-1.6390138,-0.13625364,-0.8708600599317452,-0.05818839433823676
50740,SIDM00332,Axitinib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7335501,-0.12914322,-0.7526641745761988,-0.0093806713208666
57695,SIDM00954,PD173074,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,1.8875737,0.13311167,-0.9541704280921912,-0.040240957565069915
11601,SIDM00866,PF-4708671,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.932717,-0.087452784,-1.2936138717131758,0.006420592970742292
3561,SIDM00971,PF-4708671,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.0629277,-0.06333891,-0.8418097166789942,-0.02736351843063817
75755,SIDM00673,Nutlin-3a (-),AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,1.3099875,0.023108866,2.5620515364341565,0.058017329533799226
46540,SIDM00971,OSI-027,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.9076217,-0.086035624,-1.2793060426369953,-0.08147227074592753
39855,SIDM00971,NU7441,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,6.789171,0.19379887,3.6906269874733746,0.14831172396463752
97382,SIDM00954,ZM447439,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-2.0400562,-0.109617874,0.3599390899442613,-0.011258567618112383
18253,SIDM00193,SB505124,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,53.0,-1.8402052,-0.12784387,-0.5542807752999462,-0.024477845766476623
89232,SIDM00673,SCH772984,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-3.6105509,-0.25694564,0.10651447424761384,-0.022303172892590234
5445,SIDM00628,Venetoclax,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.0564277,0.12890892,1.1094793975536212,0.05429909310822748
97518,SIDM00673,Taselisib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,0.40853763,0.036168758,0.20671030764408824,-0.0415576873054892
7482,SIDM00529,Cisplatin,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,2.9086142,0.036246434,2.8661784209903702,0.13397706022123074
89147,SIDM00954,Alisertib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-3.2198713,-0.11024712,-1.7795992091427397,-0.07164813465752651
45923,SIDM00878,Luminespib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,1.8496418,0.19063516,-0.050132975028659134,-0.03313747295292614
52065,SIDM00866,Linsitinib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.9480388,-0.034326643,0.7113411293168127,0.02286062316309644
35026,SIDM00875,PF-4708671,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.2688112,0.008763462,1.5683450247010213,0.06692371912890628
104849,SIDM00628,RO-3306,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,Black,51.0,-0.3664776,-0.03265952,-0.42281607957382566,-0.04883134637316627
27124,SIDM00971,Venetoclax,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.5606767,0.031811196,1.0115746308276603,0.04675606817324876
42109,SIDM00332,Uprosertib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,0.15310809,0.009697734,-0.7724679945802473,-0.059701734503405095
51098,SIDM00971,Venetoclax,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.8611298,0.11238577,1.392017405103816,0.06080816524054311
82725,SIDM00097,Linsitinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.649084,0.15454553,1.2626817926885765,0.11383607745573084
51122,SIDM00954,Sorafenib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,0.50231373,0.036543053,-0.3985140552220394,-0.011849694928752215
38991,SIDM00146,Trametinib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.3113252,-0.051429696,2.7388485581706874,0.05345209881829476
87904,SIDM00529,GSK269962A,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,-0.21071516,-0.017670445,-0.25929412499166027,0.06842481314849094
58406,SIDM00774,RO-3306,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,1.0002683,0.062277067,-0.16212141558439613,0.040621538309313074
46776,SIDM00531,Erlotinib,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.5420462,0.15445448,1.098680386969608,0.08886681348089198
58012,SIDM00529,Palbociclib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-1.6609387,-0.033224396,-1.237652083106902,-0.04158084007666273
57649,SIDM00359,MK-2206,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.63089865,0.040749654,0.6442981155181758,0.0700568554432596
26193,SIDM00971,Wee1 Inhibitor,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.3447803,0.011662866,0.11764092492097691,0.047315700365024145
35890,SIDM01233,AZD8055,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-1.9425774,-0.11732798,0.8880216103484565,0.028483135768941112
90160,SIDM00971,Camptothecin,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.2894117,0.030727938,1.1152303185558874,0.014830620102512328
104647,SIDM00774,BI-2536,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.5708388,-0.06796458,2.952219879562167,0.19428760994613944
14066,SIDM01233,Oxaliplatin,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-2.3718836,-0.14841966,-1.7087933143555682,-0.1273933827629173
44643,SIDM00673,Bortezomib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.37462813,-0.019474737,-0.8145763041440192,-0.07880584029032281
88193,SIDM01233,LGK974,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,-1.3787882,-0.07740588,-1.8454328747285664,-0.054904326061200694
49915,SIDM00660,MK-2206,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,2.689826,0.20517252,2.0876782824170843,0.10077854967964457
26376,SIDM00834,MK-2206,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,White,66.0,2.2703469,0.119595885,0.5843168210056621,0.04748233137736239
35955,SIDM00893,Nilotinib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.5044551,0.1296483,-1.0257392967568784,-0.03801684795188298
57456,SIDM00301,Palbociclib,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,-2.771494,-0.2387533,-1.7232705163122606,-0.0636688793958665
72293,SIDM00332,KU-55933,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5844117,-0.0641664,-0.5489308146363735,-0.001715009696121144
85018,SIDM00866,PD173074,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.0924234,-0.038508862,-2.184797405848864,-0.04166525649428798
86242,SIDM00301,Dasatinib,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,50.0,3.7346902,0.14231929,1.9942011247948426,0.05518764513583416
107831,SIDM00097,ZM447439,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5127664,-0.09190741,-1.4915177759513492,-0.044845597605429305
41042,SIDM00531,Erlotinib,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.0568379,0.0839676,0.753879751137922,0.056933476916261626
53253,SIDM00954,NU7441,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,2.699508,0.029835105,2.159547602855828,0.12933180914694453
77673,SIDM00893,PF-4708671,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.74054074,-0.057354268,-1.3700378444049377,-0.04233526207338253
92250,SIDM00866,GSK269962A,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.70274377,-0.024219168,3.0040347176258306,0.09221068884528341
10467,SIDM00332,Crizotinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1533538,-0.119587585,-0.575927414039404,-0.049972161546261454
67125,SIDM00893,Palbociclib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.30797803,-0.013269194,0.3072705414078777,0.05703499331908358
4143,SIDM00878,Crizotinib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.104349874,-0.012358678,0.19838859515397658,-0.05849997595105534
97897,SIDM00301,Gemcitabine,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,-0.97862893,-0.08988593,-2.0393732081362503,-0.15599768129999803
761,SIDM00146,BI-2536,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.8998974,-0.036173277,-1.3024150809270163,-0.08187105706596591
7372,SIDM00866,Trametinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,3.0705926,0.18848197,-0.5519004993065648,0.0321494164603937
19089,SIDM00954,Crizotinib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,-0.9124228,-0.07396093,-0.27417778911290164,-0.026042413049430762
89283,SIDM00893,Trametinib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2069501,-0.12265246,-1.8355245360264012,-0.17334244856501055
72465,SIDM00779,LGK974,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,2.3687177,0.0665655,1.6334229724026184,0.05187837699832977
58951,SIDM00834,Oxaliplatin,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,White,66.0,-1.1020434,-0.08508964,-3.3986068037351305,-0.15277635844437376
79211,SIDM00893,RO-3306,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.5982219,-0.107893795,-1.616505466489441,-0.06102028403300681
4497,SIDM00332,AZD8055,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.66609645,-0.053072363,-0.5347003484809794,-0.06485377446234838
38675,SIDM00834,Navitoclax,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,0.42411703,0.026381906,-0.5061561102142691,0.0099713581668786
49424,SIDM00893,Afatinib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.086925,0.16411248,0.7794127306156716,0.07267540967761883
39240,SIDM00097,AZD6482,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2572173,0.091183096,2.380254384876949,0.17770789056843458
4774,SIDM00301,Navitoclax,Dactolisib,Pancreas,0.0125,Pancreatic Carcinoma,Male,East Asian,50.0,1.0033269,0.124507815,-0.02107173579513619,0.020631026469903665
58549,SIDM00878,AZD6482,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,0.9992967,0.07604639,-0.7147007738634986,-0.03930164634659476
108281,SIDM00971,Cisplatin,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.22829838,0.003771761,-0.00161593089303521,-0.025410569670802397
79879,SIDM00875,MK-1775,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.092869,-0.033162594,0.915848431871316,0.01471027331718541
102442,SIDM00834,Vinorelbine,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,-2.348407,-0.15124436,0.3051635840802591,0.04019202343410321
11862,SIDM00893,Navitoclax,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,6.431664,0.23582117,2.0779871395517775,0.09872061616353332
80924,SIDM00774,Sorafenib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.57670194,-0.040012296,0.1559587966495755,0.04601037653634145
46082,SIDM00954,Bortezomib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-0.6018485,-0.028697398,-1.654835871365344,-0.057478072530065843
102690,SIDM00531,Paclitaxel,Ruxolitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.7271787,-0.08170968,-1.1599655784934286,-0.05488097397880697
95554,SIDM00782,MK-2206,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.0989726,-0.07005129,-0.15538102242497942,0.05411704890561227
101968,SIDM00332,5-Fluorouracil,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.173021,0.07334202,0.9819541101198442,0.020447675814533328
10562,SIDM00954,GSK269962A,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-0.81039745,-0.06444734,-0.30086059149319605,-0.0006301170922479704
50217,SIDM00971,Alisertib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.543825,0.07213019,3.5509540636874695,0.14581833175239212
3462,SIDM00146,AZD6482,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,1.0396721,0.06565592,0.8035522068813977,0.1321316447593087
54083,SIDM00782,LGK974,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.78032464,-0.056276865,-1.249453662663247,-0.07791238231088257
5761,SIDM00628,Olaparib,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-1.9053707,-0.12488219,-1.7914534800748318,-0.10894111585998095
80240,SIDM00411,Irinotecan,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.7846575,-0.08167083,-3.1866805479782996,-0.049907652067409616
67219,SIDM00301,Cisplatin,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,50.0,2.2408352,0.22002788,0.8623730514203962,0.07096128492051766
85884,SIDM00531,Trametinib,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.735038,0.28068542,0.4997466230007434,0.06225917727093354
94527,SIDM00628,Trametinib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.25536332,0.025925476,-0.7010196385093128,0.028962806277091354
42749,SIDM00146,Nilotinib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.35955465,0.032271758,2.123235319335248,0.12959059565368486
97809,SIDM00531,SCH772984,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.268042,0.3712325,-2.1013927264539816,-0.050544326964979236
37516,SIDM00097,Olaparib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.872936,0.09085638,1.6148626978957625,0.03318610084331307
37743,SIDM00193,SCH772984,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-0.50485075,-0.035985213,-0.4962085995259031,-0.01779020615058568
85687,SIDM00971,Tozasertib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.0420258,0.048502922,2.0135225924182265,0.1112891030067755
57489,SIDM00097,Ribociclib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1872588,-0.04209124,-0.5063179155801202,0.00714465558659789
48662,SIDM00301,Dasatinib,Ruxolitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.8492304,0.223359,0.956073217428937,0.04022028299125055
50544,SIDM00673,Doramapimod,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.785316,0.033865977,3.2977381865082442,0.11290882522634739
21594,SIDM00130,Taselisib,Irinotecan,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.4300131,0.07436283,0.8615632106526265,0.025299432601345727
35097,SIDM00878,Crizotinib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,0.90955573,0.091459535,0.6307059760685643,-0.01829941880499107
19752,SIDM00301,OSI-027,Erlotinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,1.934387,0.19681065,1.3164099715757824,-0.002927785857827429
71041,SIDM00971,PF-4708671,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.6248395,-0.03958693,-1.356121653344884,-0.038917479706284876
59399,SIDM00146,Paclitaxel,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,4.683388,0.20981513,2.8385009386042324,0.18000674859880852
26743,SIDM00778,Camptothecin,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,0.73885083,0.022294538,0.7674264809677073,0.00495961813265538
54214,SIDM00954,Luminespib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-1.821894,-0.14088483,-1.659636239344103,-0.10803491984414752
59510,SIDM00866,PF-4708671,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,0.008476474,0.00038266368,0.13318176324680658,0.0666141304825193
94880,SIDM00531,Taselisib,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.0134163,0.3095916,0.14641981742535365,0.08866725305741202
106243,SIDM00332,Nilotinib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5035774,-0.038553458,-1.2442733171514995,-0.07271407313285623
22760,SIDM01233,Trametinib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-2.4552202,-0.17785451,0.04955044730014408,-0.028605885204494693
23415,SIDM00875,Ribociclib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6230884,0.028566502,-0.3123667959167866,0.028908946814214753
81783,SIDM00628,AZD8055,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.57261664,-0.01850321,-1.1188768840738237,-0.032667467223970306
27909,SIDM00146,PF-4708671,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,3.6294084,0.17707866,1.8977850792099362,0.08767496976316085
42943,SIDM00301,Cisplatin,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,50.0,2.2170615,0.11189657,-0.8700546162456115,-0.04445262831039066
40482,SIDM00411,AZD7762,Ruxolitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.5187802,-0.07507718,-0.5052682522351883,-0.001084943112232329
39423,SIDM00673,Sorafenib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.3491193,-0.076727055,-1.0155918345388868,-0.04610029535721846
84197,SIDM00673,RO-3306,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.9049702,-0.08167241,-1.0668542572257846,-0.045170288388729496
59787,SIDM00332,Bortezomib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.706826,-0.2868692,-0.8807931750348956,-0.06675346449867572
85314,SIDM00411,Navitoclax,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,4.405737,0.24762347,2.314626954367602,0.1212220953981701
90359,SIDM00359,Nutlin-3a (-),Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.2012781,0.03280184,1.5137684296325107,0.06347649147913012
101240,SIDM00193,MK-2206,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,53.0,5.435239,0.45079178,2.5619986064583156,0.15471829637205373
48707,SIDM00193,Taselisib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,2.0753295,0.17086987,1.6569601980328594,0.12514649428884736
8546,SIDM00774,AZD7762,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.9064908,-0.08670726,0.16656501202929205,0.021391511991413106
68204,SIDM00130,Ruxolitinib,Taselisib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.15457074,0.0032658097,1.3142136483121667,0.05043666115643628
106340,SIDM00875,Camptothecin,Vorinostat,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2479776,0.1317737,-0.00428411574927488,-0.0054034150995403655
51959,SIDM00866,Bortezomib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-1.2729023,-0.10565901,-0.8132486203173256,-0.03869459089892777
19869,SIDM00875,Tozasertib,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.72871,-0.06305664,-0.8264853208177302,-0.07907567821260265
98347,SIDM00782,AZD8055,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,Unknown,72.0,-1.0100384,-0.08930233,-0.8606513633530936,-0.06018578716289955
81073,SIDM00660,Trametinib,LGK974,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,1.2110989,0.070707016,-0.8243694384857978,-0.028575591860487342
100285,SIDM00673,Paclitaxel,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,0.6137261,0.049016498,-0.999000659830994,-0.01751194274773791
84182,SIDM00130,Trametinib,Gemcitabine,Pancreas,0.01,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.7956985,-0.07580206,-0.5697192352534332,-0.06716747875052456
30627,SIDM00332,NU7441,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.9571828,0.097882316,0.3293769469611836,0.04096166737524608
34244,SIDM00130,Sorafenib,5-Fluorouracil,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.46866697,-0.035861526,-1.1770429354412713,-0.08461704403966239
102339,SIDM00954,Afatinib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,1.2880907,0.081353016,-0.25777514551618297,0.036556083147643956
3379,SIDM00893,Doramapimod,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.6492527,0.03352338,0.9435767297412583,0.014220284745033179
81722,SIDM00875,Dabrafenib,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5335884,0.027739305,-0.4202797152783021,0.02504858691387669
64460,SIDM00878,Entinostat,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.1637429,0.060604393,0.9164483376582663,0.09528825852065184
72603,SIDM00971,Luminespib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.2474275,-0.05995245,-1.835026281659689,-0.06634711958168284
31340,SIDM00782,5-Fluorouracil,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,-1.0907251,-0.033162978,0.48975619274638693,0.03596154552783705
30597,SIDM00332,Cisplatin,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.2525277,0.03898375,2.0472994087553156,0.07576460604352885
28002,SIDM00971,Luminespib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.4398608,-0.110985845,0.6622922257307279,0.06033676708348293
61895,SIDM00971,RO-3306,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.2586781,0.0589848,0.5517557905197819,0.048917256710481645
87269,SIDM00529,Docetaxel,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Black,44.0,-1.4367267,-0.112190925,-1.3822837923341638,-0.058945924566554966
92452,SIDM00193,SCH772984,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,1.5493932,0.117092766,1.5358073244830133,0.12388750638163237
33168,SIDM00097,Nutlin-3a (-),Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8577,-0.0316569,-0.25136750039067646,0.010456462787658072
83188,SIDM00782,Camptothecin,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-4.9945183,-0.38058782,-2.139604587101862,-0.11907575770052935
89624,SIDM00954,Dabrafenib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,3.721938,0.037577853,1.6651698603860352,0.006987829850572993
634,SIDM00776,5-Fluorouracil,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,3.4145434,0.20271005,2.344069340493149,0.13137640565402878
11771,SIDM00776,Navitoclax,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.26402497,-0.018621232,-0.018253209577231085,-0.0024033589566086534
102851,SIDM00332,MK-2206,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2510006,0.12134059,-0.04885139012113598,0.02528045150669936
104438,SIDM00097,5-Fluorouracil,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.64269227,0.035739552,-0.8007120891597965,-0.08654729217561592
26162,SIDM00774,Sorafenib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.7732815,0.0563923,-0.19880567051785414,0.01679629820329531
40443,SIDM00893,OSI-027,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.473576,0.3008172,0.4883124656170685,0.12074066611876139
79428,SIDM00866,Bortezomib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.23889074,-0.020122541,-0.391021593706235,-0.018589337551527352
68465,SIDM00893,OSI-027,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.33059627,0.030248078,-1.046542640269689,-0.08496225231677645
27504,SIDM00097,Uprosertib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.93958265,-0.06043568,2.0622639887257272,0.1618062712474791
36422,SIDM00893,Nutlin-3a (-),MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.8409843,0.04834242,3.158670350108008,0.13966583486882997
16966,SIDM00628,Alpelisib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,0.4021616,0.021580055,0.6994945341265372,0.08032275487227021
99079,SIDM01233,Crizotinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,0.84072345,0.0609471,1.3036725961628624,0.04076801494865796
103577,SIDM00954,Uprosertib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,2.4506013,0.167508,1.420898152256388,0.13541880545802756
56601,SIDM00531,LGK974,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.1865046,-0.10750547,-1.3074837725915667,-0.07542876742529725
38061,SIDM00531,5-Fluorouracil,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.800064,0.14274736,1.6559566086619533,0.04617132486048482
106985,SIDM00660,Afatinib,MK-2206,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.9531074,0.100018725,1.4177430130809272,0.03565931869179948
487,SIDM00332,KU-55933,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.3137865,-0.098505735,-2.660631087605702,-0.08544082762071904
13604,SIDM00779,Olaparib,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,33.0,0.9202202,0.017826982,1.9680325814474322,0.02707071483230816
83802,SIDM00875,Venetoclax,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.054344963,0.0011077884,1.1894252251070128,0.037639105953755664
62426,SIDM00097,Tozasertib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6038737,-0.046060987,-0.1067479826085274,0.00780317180924964
23199,SIDM00146,NU7441,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.3718317,-0.10724998,-0.28141820432850867,-0.029359873959522054
43574,SIDM00893,MK-1775,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.090201,0.13844757,1.2395821067666293,0.10275620037723622
72859,SIDM00774,Cisplatin,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.1423916,0.037544653,0.1304144783016405,0.044180686391253325
83507,SIDM00954,Afatinib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.63203466,-0.045036,1.0211796947435996,0.03619491576827245
34505,SIDM00673,PF-4708671,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.5564279,-0.03517327,-0.91674722004485,-0.028421783503976204
81693,SIDM00146,Afatinib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.6802631,0.061789177,0.8928324487623694,0.006812125741949744
86680,SIDM00971,Docetaxel,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.5293177,-0.04813624,0.8518761896076055,0.11853895190482637
105044,SIDM00146,Dabrafenib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,1.532773,0.09790448,1.2805908562199706,0.10671446232105695
26174,SIDM00359,AZD8055,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0502083,-0.06279619,-0.39506623211396985,-0.04207800294931611
40794,SIDM00359,SCH772984,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.4360925,0.03039131,-1.3957280399969447,-0.03502377035132007
84460,SIDM00529,OSI-027,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-1.0588502,-0.08979184,-0.08052780212806396,-0.00995323346464774
104591,SIDM00776,MK-1775,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.8816412,-0.06681724,-0.9229516028294692,-0.07411448363601082
31501,SIDM00411,Lapatinib,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,4.678712,0.23846401,3.830664149234661,0.18376107024661453
81484,SIDM00359,Camptothecin,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.1400142,0.10206209,1.9363675528180295,0.09477592027975729
86936,SIDM00866,Wee1 Inhibitor,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-0.5460439,-0.0400821,-0.18505406968524163,-0.039485192364820385
25622,SIDM00878,Tozasertib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-4.524556,-0.27482778,-2.6327284938827606,-0.11315595409334055
97377,SIDM00954,MK-2206,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.0,-1.0391425,-0.08168218,-0.04699142430650345,0.013860009833458278
36065,SIDM00529,Doramapimod,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Black,44.0,1.0740665,0.044579174,0.8611714906144522,0.05981720077403419
84293,SIDM00193,Vinorelbine,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,1.6077503,0.13742827,0.3769606017323083,0.006424199853213047
103350,SIDM00146,Olaparib,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,1.3811995,0.09110692,1.2496942409828036,0.13382565607455404
78865,SIDM00878,Doramapimod,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,70.0,1.8497877,0.11216464,0.8274474810112049,0.11633475342498244
26311,SIDM00097,Sorafenib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1807008,0.059472084,1.0495697778765751,0.03260841632478666
91953,SIDM00875,KU-55933,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.583881,0.08605677,1.0652635653082485,0.03912310329629526
3023,SIDM00782,AZD7762,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,Unknown,72.0,0.1864711,0.017210022,-0.008847718081148703,-0.0018212523853354849
59033,SIDM00130,Crizotinib,Sorafenib,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.141786,-0.11915299,-0.7623661643231525,-0.04343464783655288
58704,SIDM00779,SB505124,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,-0.5328842,-0.03071838,-1.1144129522122974,-0.07346276737805366
36058,SIDM00130,Ruxolitinib,Olaparib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.4520104,0.046699557,1.7874434195793782,0.034200036085067415
104209,SIDM00774,Ribociclib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.8082302,-0.08640526,-2.24185452514045,-0.07029563283255029
32800,SIDM00954,Dabrafenib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,2.0677652,0.04630349,0.19257912106229091,0.004639484149546136
47673,SIDM00673,Lapatinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.3085902,0.16987336,0.9551320657295851,0.04545184169158163
35218,SIDM00146,AZD6482,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-1.9517429,-0.1051472,0.45565259265619934,0.06661313458368878
100297,SIDM00332,ZM447439,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7583882,0.052964397,2.094373358493486,0.13124987261122792
26780,SIDM00146,Dabrafenib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-0.6391543,-0.023946704,-0.6132859221263292,0.03956501224904144
60076,SIDM00875,Camptothecin,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.591718,-0.04811673,0.125169564778769,0.004808254441031239
61934,SIDM00971,Venetoclax,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,6.6550155,0.1916006,1.81132317422563,0.05177869596938381
5767,SIDM00193,Navitoclax,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.8187074,0.0494568,0.4371336747447266,-0.027512838065679748
85400,SIDM00776,Linsitinib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-1.7492816,-0.087257385,-0.8603210874280413,-0.024409521485100633
33470,SIDM00673,Alpelisib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.67705566,0.0445018,-0.4443110275764262,0.012683489840818503
37836,SIDM00660,Navitoclax,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,3.4169843,0.2436803,2.1613977613819193,0.07702476614850468
37561,SIDM00782,AZD4547,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.4168147,0.0498413,0.4374665321855487,0.05722493601811371
47444,SIDM00097,Palbociclib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3908463,-0.086143985,-0.7723075608149503,-0.07142418615453021
5159,SIDM00893,Dabrafenib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.3016896,0.08545844,0.8761480115350831,0.027267716000156293
52092,SIDM00782,Linsitinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.8455207,0.03258252,0.8698542832178595,0.04261771320484657
23577,SIDM00834,MK-1775,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,2.326033,0.14126588,1.2534113928074404,0.06472744393569618
39257,SIDM00774,Cisplatin,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.1082823,0.036979597,0.9255185772545025,0.061678358721831
76433,SIDM01233,AZD8055,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-3.4620678,-0.22542222,-0.9812157322846509,-0.12957161225875058
97361,SIDM00778,Camptothecin,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,0.7306793,0.03490172,1.6220590730057824,0.07776475731854758
80943,SIDM00875,Pictilisib,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.17877856,-0.018302348,-0.8635538240361911,-0.05519514017645737
33791,SIDM00875,Nilotinib,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.2745976,0.24177723,-0.3977801046295571,0.02576887012211205
49161,SIDM00954,PD173074,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-2.5443678,-0.13767952,-0.6155597621608265,-0.04173817291384921
81252,SIDM00628,Luminespib,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-2.0602188,-0.1507746,-2.040969101388194,-0.06865311423427681
25662,SIDM00866,GSK269962A,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-1.7299342,-0.049504757,0.6742760323235749,0.04896676616601164
70670,SIDM00971,NU7441,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.2646537,0.06090899,0.7976378902615584,0.032662714539256274
21352,SIDM00954,Cisplatin,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,0.28998575,0.007606595,1.2282988094960983,0.11715762415813293
76711,SIDM00878,Cisplatin,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,1.5004696,0.050414786,1.2675358038891777,0.08488918543957695
72689,SIDM00411,Erlotinib,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.7917764,0.13849904,2.519312266939479,0.1764757852751654
104254,SIDM00332,Afatinib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.51634073,0.0371618,0.4238493300241732,0.07108885876009258
402,SIDM00893,OSI-027,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.4625022,-0.07455538,-1.3758944603325187,-0.022473109731159492
100330,SIDM00893,SCH772984,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.7111622,-0.10475502,-0.40604402178073135,-0.0002443358268940096
15357,SIDM00411,Navitoclax,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,3.3918257,0.13938665,2.522139113100012,0.17838645909473874
38590,SIDM00146,OSI-027,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.2360673,0.097971156,0.07577071356710799,-0.005555635442950139
14504,SIDM00954,Crizotinib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-0.060870137,-0.004360894,-1.0206625401002716,-0.07492804452291887
101560,SIDM00097,KU-55933,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2451177,-0.046565037,-0.6444706379756757,0.008535979790576492
93581,SIDM00673,NU7441,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.20363216,-0.01244065,-0.2337842917696919,-0.017987556678217272
36733,SIDM00531,SCH772984,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.8241399,0.07682157,-1.936528924811334,-0.029613964366237592
84819,SIDM00774,Doramapimod,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.8850043,0.11543601,1.3458863957044283,0.1067551144101615
9696,SIDM00893,AZD6482,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.09053982,-0.0066782366,0.12352585899597686,0.034659362958935624
76448,SIDM00411,Taselisib,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-3.0102825,-0.13561554,-0.16001144054128275,-0.024518716863212452
108053,SIDM00875,ZM447439,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.4272995,0.04153337,0.10207928218229495,0.05483083695762419
35080,SIDM00628,Uprosertib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,-0.5389366,-0.029805908,-0.17379261866965315,0.027226371684356727
99824,SIDM00954,Venetoclax,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,2.0008695,0.10599835,-0.7356250341639582,0.004760534060859025
29322,SIDM00875,Sorafenib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.42807114,0.038486287,0.5324323421833763,0.023750890033178238
14490,SIDM00776,Navitoclax,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,1.1467615,0.04380693,1.1993022179244874,0.010516715445318459
49990,SIDM00834,Afatinib,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,White,66.0,0.902201,0.05374303,-0.15539948173765739,-0.01160323871680378
100077,SIDM00893,NU7441,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.6171752,0.12661919,-0.9068539531133123,-0.08862614624961512
104529,SIDM00954,Nutlin-3a (-),Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-0.23011222,-0.0060603498,0.6791823305792333,0.06410451777258146
14698,SIDM00774,Wee1 Inhibitor,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,48.0,-1.8186464,-0.10604026,-1.1753284702164715,-0.04741831077340091
35322,SIDM00097,Paclitaxel,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0574226,-0.07081187,-1.0064480390932768,-0.05443332489766471
72135,SIDM01233,Crizotinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.6198381,0.109198466,2.707327090383615,0.1742460493962392
37075,SIDM00332,Olaparib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4719592,-0.02244756,0.9611634279005793,0.02620264708925845
4707,SIDM00893,Doramapimod,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.657607,-0.021828147,-0.7563470550267842,-0.03424289756887306
70905,SIDM01233,Palbociclib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,3.1518857,0.11390643,1.4701347019080393,0.047144014351445454
51161,SIDM00875,KU-55933,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.3497413,-0.05669677,-0.6813115200889186,0.025967504153994025
51446,SIDM00332,MK-2206,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,3.3584611,0.22762503,1.030468459431578,0.08711205429825425
61300,SIDM00097,Linsitinib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.2178764,0.11077617,1.0454054753668571,0.006509400866491805
31370,SIDM00875,Dabrafenib,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.4982493,0.0874389,0.22862769220825752,-0.05162897329669723
47662,SIDM00875,Uprosertib,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.40178555,0.04354124,-0.3370693786470567,-0.01218912937940121
45687,SIDM00893,MK-1775,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.651102,0.06597131,-1.0724075785147231,-0.05832177248863623
51005,SIDM00097,Temozolomide,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.4423496,-0.0074113943,1.0988655121693964,0.013658080038167989
32295,SIDM00875,Doramapimod,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,7.306861,0.15674664,4.079630131981815,0.05372609121301604
4605,SIDM00673,AZD6482,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6718518,-0.047430556,-0.7806320379589535,-0.0851444661947632
374,SIDM00954,Nutlin-3a (-),Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,1.8818623,0.049416363,0.8788908139872041,0.07051744848240081
50516,SIDM00146,Paclitaxel,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.7685546,0.06711518,0.7448179444501256,0.016173603852920448
40435,SIDM00971,Venetoclax,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.58003175,0.01026698,0.48429508747510097,-0.001114274604730731
27570,SIDM00954,MK-1775,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.0,0.74377894,0.05315627,-0.12927394288227667,0.0345263284476067
41921,SIDM00529,Docetaxel,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Black,44.0,2.0897205,0.20226523,2.0359579971882833,0.15555013568909193
16075,SIDM00146,GSK269962A,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-2.8140702,-0.14403367,0.2846417788064633,0.05237351172127054
37254,SIDM00529,KU-55933,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Black,44.0,-0.8608743,-0.01411615,0.26551654732622093,-0.02340670330142526
13154,SIDM00097,Venetoclax,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0275562,-0.054512706,-0.6134555276932478,-0.017574030762913268
29810,SIDM00878,Uprosertib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-3.4654565,-0.087440304,-1.9927640652545997,-0.07076910104457684
76246,SIDM00097,Taselisib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1184083,0.06689445,0.07594053404913949,0.02912238926231001
70303,SIDM00893,MK-2206,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.1952603,-0.20857596,-1.7315806560866458,-0.1420849047416716
31971,SIDM00774,Navitoclax,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,3.20035,0.037213996,1.173873023881046,0.03712296760298543
26797,SIDM00971,ZM447439,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.5747162,-0.06117931,-0.45828480079760436,-0.009927814734275743
12569,SIDM00893,Wee1 Inhibitor,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.0027671,0.09095492,-1.0807973458025921,-0.011811909178646775
100068,SIDM00774,RO-3306,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,-0.90429085,-0.048913095,-0.5801974129850326,-0.03225400132163506
37058,SIDM00529,Temozolomide,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.6641131,0.016978301,-0.3606707801270231,0.005820020661013844
93009,SIDM00660,Crizotinib,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,0.8925951,0.06867221,-0.556820652105002,-0.04041914484087902
19875,SIDM00954,Olaparib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.0,-2.299605,-0.053508177,-1.083007395659112,-0.005031796917147835
64521,SIDM00301,Linsitinib,Crizotinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.7604883,0.13584375,0.9625854068077514,0.04299439829828052
58072,SIDM00774,Dabrafenib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,2.6562195,0.09372324,0.7471315704859901,0.0247873116025354
49920,SIDM00774,Venetoclax,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,2.3107452,0.048983164,2.2951779315894365,0.09686896040354447
34516,SIDM00529,Crizotinib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.2319176,-0.05711261,-1.24828818545122,-0.014280440680382294
75893,SIDM00628,Axitinib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,0.6278319,0.042261526,0.37617952044735437,0.05917486933413883
24355,SIDM00774,Linsitinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,3.4868941,0.092235744,2.9207416533594,0.07996013207059835
68385,SIDM00411,Dactolisib,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.3280249,-0.042863317,1.197351835441063,0.06224525537534821
100074,SIDM00774,ZM447439,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,2.4436212,0.14226557,2.046724277441562,0.09668604989439188
35205,SIDM00866,Afatinib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,52.0,-1.7724885,-0.15020464,-0.6919327944050552,-0.02457386583308138
22878,SIDM00834,Linsitinib,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-0.1265521,-0.010621643,-1.6876558768595165,-0.024403359467116418
39865,SIDM00875,Pictilisib,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6087509,0.16266523,0.44572431005500845,0.05001427530522047
13020,SIDM00875,Pictilisib,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6195559,0.06886478,-0.6432726549511926,-0.024984139390836987
19290,SIDM00097,Nutlin-3a (-),5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.885106,-0.09180762,-1.2525888536665122,-0.033695626224563874
76935,SIDM00779,Navitoclax,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.9361565,-0.08288851,0.5864749928836308,0.0004594733902411868
56456,SIDM00866,Venetoclax,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,52.0,-0.8043404,-0.017624188,-0.30678512397446184,0.015802376064502258
107892,SIDM00866,Vorinostat,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-0.89387226,-0.07036276,-1.183160185227218,-0.06504750228719372
28382,SIDM00875,Cisplatin,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.1765232,0.040297866,3.5846146661608507,0.10600246989592495
36144,SIDM00529,MK-2206,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Black,44.0,-1.9510038,-0.06013645,-0.621998988783964,0.013927564956027825
100606,SIDM00097,ZM447439,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2343396,0.067041576,-0.10254391282789316,0.031801454827375994
10887,SIDM00971,Paclitaxel,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.6449986,-0.088951394,-0.5943003227996323,-0.001537620779102337
26955,SIDM00673,Pictilisib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.5823584,-0.05825679,-0.8316708361126979,-0.0748634907542182
75743,SIDM00893,Luminespib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.001104,0.17434101,-0.7722685563997872,-0.023857216464814326
12220,SIDM00971,Camptothecin,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.3492577,0.032989882,1.4980547096913486,0.04666574494881597
48744,SIDM00673,RO-3306,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.76134753,-0.05398243,-0.6335084876761715,-0.02478946346206202
6347,SIDM00778,Palbociclib,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,69.0,-1.7235307,-0.05063919,-1.076233640211599,-0.03263490296255149
2233,SIDM00301,Paclitaxel,Sorafenib,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.559181,-0.076510206,-0.9673304148918498,-0.0474482540948537
14250,SIDM00893,Axitinib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.9554052,0.121015534,0.9963429889994581,0.029078994039787413
91633,SIDM00660,SB505124,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,1.5800682,0.14959705,0.9006544607399272,0.06864115259713123
37483,SIDM00971,Linsitinib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.6737847,0.06366368,0.12147778470992374,0.02917560725440807
58142,SIDM00411,Irinotecan,OSI-027,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.910142,-0.05637446,-1.410481145866914,-0.0046759621650377305
81670,SIDM00776,AZD4547,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.69977057,-0.020954428,0.25881910812500847,0.04204843417483953
51037,SIDM00411,Taselisib,Ruxolitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-1.7897196,-0.1154751,-0.6776553663685472,-0.04414832381718335
87317,SIDM00779,5-Fluorouracil,Camptothecin,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,33.0,-2.329117,-0.08371212,-0.8890132446262198,0.017075976683293383
41524,SIDM00411,Erlotinib,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,2.307611,0.098977536,2.3015475018813385,0.12281381308956507
82156,SIDM00146,Wee1 Inhibitor,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,1.1821855,0.083714604,-0.3728644334404308,-0.048225371503490294
62952,SIDM00097,JQ1,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.0970263,-0.11874561,0.11255438071748014,0.02803469990260873
76579,SIDM00774,Paclitaxel,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,1.3850852,0.073778704,0.14154853027002495,0.017866191781813333
102818,SIDM00878,Entinostat,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.2325771,-0.05160982,0.3038185009397005,0.0590167028291616
106418,SIDM00875,PD173074,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2311367,-0.024280487,-1.2636018074154955,-0.08917933359690126
96713,SIDM00776,5-Fluorouracil,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.2613908,0.007515261,1.2176932665747078,0.03656222669955432
1120,SIDM00778,MK-2206,AZD7762,Large Intestine,0.0625,Cecum Adenocarcinoma,Male,White,69.0,0.9485015,0.06272982,-0.8331103974986991,-0.024036744378284382
96598,SIDM00971,AZD7762,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.6810634,0.041038387,1.0263571146244543,0.017902214891845722
33480,SIDM00971,Axitinib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7565162,-0.06688786,-1.3976489322657615,-0.04452482219500986
103170,SIDM00875,SCH772984,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7838799,0.19024524,2.292286623535978,0.1429925412796515
52757,SIDM00971,Taselisib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-4.6528287,-0.2522967,-1.3607455319176505,-0.09944650650900108
31829,SIDM00531,Taselisib,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,5.1464767,0.52729386,2.7741246865248534,0.19148332434063736
1926,SIDM00954,Temozolomide,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,1.0681348,0.002231872,2.6035494950621465,0.011600780811122416
15547,SIDM00332,AZD8055,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9331585,0.06489264,-0.2009271836348249,-0.04591374316355597
48952,SIDM00774,Axitinib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,1.2466683,0.15207972,0.5620990708065001,0.052553075688992236
34989,SIDM00628,BI-2536,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-3.1651888,-0.1675449,-1.1488130128299598,-0.026484171891784376
91540,SIDM00778,Crizotinib,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,69.0,-0.10317923,-0.006918072,-0.12559843406255694,-0.08495348278803351
14789,SIDM00866,Taselisib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.448023,-0.12137151,-1.2451085548016403,-0.0439378542203318
91088,SIDM00130,OSI-027,SCH772984,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.521896,0.13624144,1.908912620985633,0.0877870302485708
76927,SIDM00673,Entinostat,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.3676599,-0.059331004,-0.8030648373250387,-0.03372974636133898
52984,SIDM00779,MK-1775,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-0.70263094,-0.041847285,-0.8496118701525975,-0.021645464425446747
9842,SIDM00301,Gemcitabine,LGK974,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.4194362,-0.26290488,-1.2864554012541438,-0.09436347852846519
55311,SIDM00774,Alisertib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,-1.3530686,-0.08826394,0.2209095874461316,0.004877181857600487
3053,SIDM00130,Crizotinib,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.5562258,-0.10170739,-0.6687486380188179,-0.06010846889626033
430,SIDM00893,PF-4708671,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.37177637,0.030461457,-0.6755992598597954,-0.028079982423633798
24988,SIDM00834,Vinorelbine,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,1.1144398,0.09440948,1.4557191826237148,0.14057019371436597
71803,SIDM00878,Alisertib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,70.0,0.74311036,0.07016792,-0.25165240861535226,-0.05784505443660827
24024,SIDM00529,Trametinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-0.1831645,-0.012178755,-0.48692592699328785,-0.024939130460510953
30295,SIDM00776,Afatinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-2.2144916,-0.17530945,-0.29138168767710537,-0.06257798755880221
89927,SIDM00774,Vorinostat,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.7291757,0.040609002,-0.08569261243251176,-0.01954606967614659
62512,SIDM00834,AZD4547,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,4.4665513,0.16974916,3.3030711340256222,0.047798741755662864
11127,SIDM00866,Axitinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-1.5489278,-0.09812225,-1.7734339731073998,-0.06623320040598053
11636,SIDM00130,Sorafenib,Crizotinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.5327348,0.052560832,-0.4506612260577993,0.011960115241918983
33329,SIDM00628,Venetoclax,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-2.4812384,-0.083668284,-0.4896543952886157,-0.010297841441602269
95624,SIDM00097,Alpelisib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.9554987,-0.068528935,-0.49246426210920463,-0.044345159885716204
828,SIDM00971,MK-1775,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.4889965,-0.05115633,-0.6685720990014672,-0.015351007802783426
22940,SIDM00875,Palbociclib,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4135237,0.05418016,1.5567062559969873,0.1287393654467284
11865,SIDM00146,Vorinostat,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.3608207,0.11732651,-0.3087835890333679,-0.011762401241912754
100886,SIDM00893,Taselisib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.2706751,-0.010211195,-1.0217506080675214,-0.03410351282463345
98351,SIDM00875,Luminespib,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.46569267,-0.04225015,0.6249515948227249,0.0024747198229339126
99630,SIDM00878,JQ1,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.9556833,0.085684046,-0.32100526242255717,-0.01596636904487818
79840,SIDM00628,AZD7762,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,0.9723244,0.09462457,-0.523493061202203,0.009640596395874874
89369,SIDM00332,Venetoclax,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.667728,0.019630404,1.3725393056364215,0.04069843075706334
61223,SIDM00146,OSI-027,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.77342767,0.070870124,-0.47465439138719306,-0.020522606500921997
83805,SIDM00146,Navitoclax,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,2.4935918,0.10554404,2.075247372639312,0.07427386750708809
67503,SIDM00097,Palbociclib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2009866,0.054483764,0.528368548150746,-0.004891609386731433
59939,SIDM00146,ZM447439,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,2.1596453,0.12222508,-0.5665780377554575,-0.003599220319063341
4629,SIDM00193,5-Fluorouracil,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-0.22381742,-0.018625105,-0.9466584735789042,-0.06175647018632697
38785,SIDM00779,Navitoclax,AZD4547,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-1.2222667,-0.011581572,0.5961470589268778,0.0005849868696361359
46450,SIDM00779,Oxaliplatin,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-1.5728673,-0.11978582,-0.9399690132287972,-0.10412133552074948
85751,SIDM00866,Tozasertib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-3.7010746,-0.16821538,-1.4457264696273169,-0.028826255310686895
74817,SIDM00359,Taselisib,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.1945691,0.10857245,0.25638037671585,-0.011702571555075156
33308,SIDM00673,Gemcitabine,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.4846138,-0.09466104,-1.3869320484081042,-0.07043740700245878
28861,SIDM00893,Nutlin-3a (-),Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.2476017,0.033689126,2.4737818177333675,0.07415880642217017
7762,SIDM00193,Taselisib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.5320995,0.050977618,0.2359405708893111,0.056319975243910206
6702,SIDM00875,5-Fluorouracil,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.96669173,0.091766715,2.1412104698524845,0.10374213440145076
25018,SIDM00893,Ribociclib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.863886,-0.02769547,-0.3787605895610846,0.006606355441906359
71651,SIDM00866,Afatinib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,0.95052886,0.06729644,0.3897171344721851,0.06836506304581784
107219,SIDM00774,Olaparib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,1.8561037,0.1242483,1.6579150568904386,0.060432283975680234
39338,SIDM00628,Nutlin-3a (-),Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-1.6019782,-0.038956925,-0.5834604096413846,0.015497485397433853
46871,SIDM00878,Nilotinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.2513881,-0.100282036,-0.4857830997224928,-0.0712494204992188
80633,SIDM00779,Vinorelbine,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-2.3691337,-0.2066092,-2.0933245550413124,-0.11520887067869383
63691,SIDM00878,GSK269962A,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.7431637,0.13836637,-0.7847320891944611,-0.04094242217120038
9147,SIDM00146,Docetaxel,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.4115016,0.037406694,0.03166865952184897,0.03860013615032347
61496,SIDM00782,Crizotinib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,Unknown,72.0,0.7665849,0.072342336,-0.13140738294235066,-0.025432810328490388
78379,SIDM00673,Entinostat,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.4456537,-0.082770325,-2.0688672373095818,-0.07625052817573574
84840,SIDM00531,AZD7762,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.581037,0.046964735,0.33460130844070474,0.019147229190314936
33422,SIDM00893,MK-1775,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.49672306,-0.05246487,-0.8225933866194381,-0.07252480683958801
40303,SIDM00866,Vorinostat,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,1.8327271,0.1505696,-1.3664824889494291,-0.0829084570655304
79283,SIDM00359,SCH772984,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.5513189,0.093926765,2.0909402076865145,0.08884462281446696
95336,SIDM00529,NU7441,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Black,44.0,-1.442154,-0.09657997,0.1027226450622265,0.027866727840171985
78704,SIDM00878,Axitinib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.1126804,0.119541146,0.454599132890298,0.020220860032483013
51496,SIDM00774,Nutlin-3a (-),Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,1.0575882,0.03458688,1.6766790890867709,0.07025651114401762
66991,SIDM00893,Docetaxel,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.0262514,0.051194455,-1.2100266168112546,0.011973206573825727
55516,SIDM00866,Docetaxel,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-2.4481194,-0.16694775,-1.2730584506556648,-0.05010647277665803
32348,SIDM00359,MK-2206,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.9802785,0.1131152,2.2918338387648474,0.14174863168197824
54533,SIDM00628,AZD7762,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,1.80601,0.15880232,-0.6799694799620336,-0.02502337009136027
12954,SIDM00774,Doramapimod,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,-0.93760103,-0.03277891,2.2584735648661116,0.06730929313732528
76209,SIDM00778,MK-1775,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-4.6125693,-0.1998023,-2.37118897828572,-0.11231105905439662
35148,SIDM00332,Paclitaxel,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.4849763,-0.27012122,-3.1139928164987345,-0.3041866620837383
98941,SIDM00529,Venetoclax,Trametinib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-1.3606951,-0.035098914,-0.6774624581399383,0.005179170198367945
103143,SIDM00779,Oxaliplatin,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-2.3217862,-0.046600264,-1.4369519085460616,-0.060024996341067116
78887,SIDM00878,NU7441,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,0.59136647,0.04026391,0.3664890488968796,0.03886432577491974
68794,SIDM00778,Taselisib,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,69.0,-2.130834,-0.11362533,-2.6058247493740505,-0.12167186790344361
74525,SIDM00332,Afatinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7263002,0.08163008,1.7759987512246462,0.11507698324183759
15289,SIDM00971,Dabrafenib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.8376892,0.08260601,1.3180419721994936,0.04815440568494253
103102,SIDM00866,Sorafenib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,52.0,0.87842965,0.050386526,0.20526042666800012,0.007115097252361109
57059,SIDM00834,AZD4547,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,0.49820402,0.009799864,1.9335571030751362,0.04572128830754429
29519,SIDM00954,MK-2206,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,1.7220716,0.044070058,1.6461847317554934,0.06506120210900919
2365,SIDM00301,Palbociclib,MK-1775,Pancreas,0.2,Pancreatic Carcinoma,Male,East Asian,50.0,-1.7952815,-0.17195594,-2.3891724105344108,-0.08452612482065769
674,SIDM00332,Nilotinib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7436774,0.126464,0.5513978560926888,0.0785818482920379
58709,SIDM00875,Uprosertib,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.15973623,-0.016523657,-1.107272969173865,-0.016547838740814964
47233,SIDM00778,Nutlin-3a (-),AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,69.0,1.7093691,0.028220952,2.4291917973446564,0.03719033758668492
56781,SIDM00776,AZD7762,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-0.953007,-0.07852179,-0.8879634832770587,-0.060766226112630016
24689,SIDM00776,Olaparib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,1.3463993,0.0726491,0.4319673769127741,0.028172491830024952
51278,SIDM00301,AZD7762,Trametinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.0641487,0.15498117,0.7927478910425723,0.061197068983085835
62589,SIDM01233,Trametinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,72.0,-2.8637848,-0.18599242,-0.8452176578139738,-0.08874813664126494
18395,SIDM00971,BI-2536,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.85743254,-0.04597567,-2.447849706153089,-0.08284396303005222
46520,SIDM00954,Sorafenib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,1.5377703,0.10093085,0.4517105091270318,0.007580407981835986
37874,SIDM00332,OSI-027,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5131613,0.15687193,-0.1154762454854863,-0.034652221613307936
93375,SIDM00866,SCH772984,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,3.566248,0.20076689,0.5272085144786,0.06674509041997397
80862,SIDM00130,Erlotinib,Lapatinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.4644917,-0.042302135,-0.9714706031079023,-0.013349924312207323
68108,SIDM00301,AZD7762,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.1490254,-0.096958734,-0.3083408749381829,-0.010561058851426565
55927,SIDM01233,Afatinib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,0.3996571,0.032440133,-0.5393645544401571,-0.04609457635025395
70228,SIDM00332,OSI-027,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.98083156,0.09486595,-0.3647326094488977,0.011213592658961062
94643,SIDM00971,JQ1,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.5536363,-0.09439548,1.1343239798915958,0.11919049029651221
72300,SIDM00878,Afatinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.2605442,-0.11539456,-0.10486732126405342,-0.03799557596134479
36709,SIDM00146,Sorafenib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.99708086,-0.09677231,-0.03516184284123497,-0.021111192975184954
59252,SIDM00673,Alpelisib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.69318455,0.037922658,-0.888361533585931,-0.06427705706882386
25204,SIDM00866,Temozolomide,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.2061296,-0.018595895,0.5355913041293822,0.002714125199462297
74166,SIDM00628,Taselisib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.8538284,-0.059000596,1.925526370886986,0.15992272934692317
36999,SIDM00866,Sorafenib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,-0.79978776,-0.029504944,0.15513425704393294,0.0190211428977133
97459,SIDM00660,Camptothecin,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.80406487,0.06682655,0.7455978395644178,0.0570113237409943
98445,SIDM00866,Alpelisib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.683323,-0.04459984,1.098818687936145,0.062424641317405875
23671,SIDM00878,Axitinib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-0.73497045,-0.0875832,-1.0516195986520154,-0.05653096245748715
56676,SIDM00893,Nilotinib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.33179334,-0.028348342,-0.9297939281099945,-0.07250494199322648
55948,SIDM00097,MK-2206,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7437066,-0.111590944,-0.21333315711134315,-0.05678195657668017
74339,SIDM00893,MK-1775,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.63976175,-0.063698,-0.22598224704175784,-0.013187335401556088
63172,SIDM00875,Crizotinib,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4432806,-0.14033224,-1.5203382013487383,-0.09955989163812198
42033,SIDM00193,Oxaliplatin,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,53.0,-0.93309957,-0.03143798,-0.19038369589203505,-0.003815562469420559
11280,SIDM00878,Luminespib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.36784557,-0.045536894,-0.21503017941813998,-0.10035323708297474
66700,SIDM00097,JQ1,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6200044,-0.07171583,1.336206733427963,0.07103671538678091
25712,SIDM00875,AZD6482,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.22771105,-0.017719101,-0.5836566011713951,-0.009658823535936898
26108,SIDM00893,ZM447439,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.0813959,-0.12630795,-0.0831655650004636,0.022257138619517027
45628,SIDM00954,PD173074,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.0,0.7354482,0.028478116,0.04007933475380716,0.016697847813285666
94507,SIDM00332,Paclitaxel,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7702492,0.11340569,-0.19601041735988883,0.029631295413695555
93370,SIDM00529,ZM447439,MK-2206,Breast,0.25,Breast Carcinoma,Female,Black,44.0,0.29434615,0.023792809,0.357553016280078,0.12650981850077817
85917,SIDM01233,Camptothecin,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,0.74795765,0.029190082,1.368191192723161,-0.03902408327768039
74780,SIDM00779,AZD8055,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-1.3206602,-0.12403209,-1.2779360743686512,-0.12747904418845254
43720,SIDM00866,Alpelisib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-2.5666606,-0.10805684,-0.10457458486245849,-0.0012849590322460275
67215,SIDM00774,Nilotinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,0.55779815,0.040953983,-0.19756305305190308,0.016467683786678063
83841,SIDM00628,Palbociclib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.5977417,0.022820262,-0.019493106584134515,0.025665129352792526
87225,SIDM00778,Dabrafenib,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,6.576352,0.28119105,0.5742872008040046,0.01513875216071869
84387,SIDM01233,Dabrafenib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,72.0,-1.9007574,-0.050439846,-0.09430514199990102,0.0032559971029717974
95561,SIDM00776,5-Fluorouracil,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,1.1363413,0.03356518,0.6392818702841869,0.05157055540748948
20182,SIDM00774,Palbociclib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,0.91049826,0.03980172,0.7037766937379207,0.018004537365431297
10310,SIDM00529,Ribociclib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.802394,0.06262476,0.08606520760626055,-0.019665130658527284
41212,SIDM00878,AZD8055,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-2.7866552,-0.04390428,2.8273204288856504,0.10548028410203879
72824,SIDM00359,Dabrafenib,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.7434962,0.089399524,-2.0222774902993486,-0.04588688446312591
76362,SIDM00193,AZD7762,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,53.0,-0.7104434,-0.022597505,0.8513531617803981,0.10575441164667959
51896,SIDM00774,PD173074,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,2.0316923,0.18061191,1.539707623510747,0.03975496401912947
74416,SIDM00673,Nilotinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.8029048,-0.08714513,-0.5362763456201949,-0.01172876349861512
42862,SIDM00628,PD173074,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,0.9426209,0.03178788,0.7830278400787205,0.06688435651248217
63808,SIDM00673,Entinostat,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.43424493,-0.033903554,-1.2994840963041883,-0.038560532921891856
26220,SIDM00529,PF-4708671,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-0.8312202,-0.04558268,-1.0431617409621863,-0.03633096947477556
3845,SIDM00878,AZD8055,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.1372236,-0.109601565,-1.4011276308062726,-0.06612425188093903
102515,SIDM00866,PF-4708671,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,1.1561917,0.060521096,0.23583382437996647,0.051061495884731654
74709,SIDM00893,AZD7762,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.77630186,-0.029091096,-0.7205691356157814,0.02551651139253839
28033,SIDM00673,Axitinib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.31053865,-0.03141451,-1.0064809325880177,-0.0299932196247779
25709,SIDM00878,Doramapimod,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,1.3719349,0.08178469,0.8636746953095379,0.08506147057198109
23620,SIDM00529,PF-4708671,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-0.92640007,-0.048798226,-0.4734114637807955,0.025733393784106804
61077,SIDM00954,Navitoclax,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.0,-0.6698632,-0.024200834,-0.9127534582652518,-0.03678306351487768
53906,SIDM00774,Nutlin-3a (-),Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,0.2810775,0.00907216,1.398401351374061,0.03863665045090161
79685,SIDM00875,Afatinib,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6564642,-0.11983651,1.5786704441674115,0.0312750726459461
42147,SIDM00893,Uprosertib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.4776078,-0.047504093,-0.47694624742929154,0.03523052015189123
44479,SIDM00776,Dabrafenib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,-2.067213,-0.05968937,-0.9497026831172961,-0.01842466999588484
82152,SIDM00954,Wee1 Inhibitor,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-2.5022552,-0.17019796,-1.6092599142952635,-0.07242961805137765
56858,SIDM00971,Bortezomib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.58930176,0.029442267,-0.4756585351277325,0.017506191114658055
14492,SIDM00971,Docetaxel,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.7869086,-0.08235251,-3.8673126876014106,-0.07338520127862508
8824,SIDM00866,Palbociclib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.42190155,-0.01073369,0.5099187799429244,0.02671398626829787
20266,SIDM00146,RO-3306,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.0348572,0.08807954,0.4259019680882869,0.03174945076058289
56952,SIDM00660,Crizotinib,MK-2206,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,1.2415215,0.11164246,1.299160798599359,0.04170884437641182
9132,SIDM00146,OSI-027,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-0.4227409,-0.032802835,-0.5397899385425673,-0.05577140506807215
65092,SIDM00875,Palbociclib,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.28227207,0.0084145935,0.7169188942740552,0.06298056929355494
76835,SIDM00971,Uprosertib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.2334448,0.06081645,-1.322873234036196,0.008559205198176989
8878,SIDM00660,AZD8055,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,32.0,-1.7208306,-0.07309475,-0.01371240449207054,-0.01495229682839231
44036,SIDM00878,SCH772984,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.4926805,0.123017535,1.7909955887879896,0.08509591159214466
48248,SIDM00673,Crizotinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-2.2688015,-0.088919334,-0.4189934092451964,-0.036146046604073834
67329,SIDM00531,Irinotecan,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.9687903,-0.1421122,-2.6847083960032183,-0.10320583133555297
106148,SIDM00893,Ribociclib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.0760752,-0.04435592,-0.7574052807407061,-0.02125031975885644
63983,SIDM00776,AZD7762,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,65.0,-0.9299552,-0.08270375,-0.4266891243166207,-0.018325983999297864
45658,SIDM00971,Temozolomide,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.3442488,-0.05255114,-1.442371133599207,0.014865151977566427
25169,SIDM00954,MK-2206,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,-1.7268176,-0.14614563,0.045018882728114724,-0.07019929644438884
70340,SIDM00875,SCH772984,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8146258,0.095139466,-0.5260059076045306,-0.002077185632510704
78623,SIDM00866,Navitoclax,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,0.14807606,0.011643089,-0.44856507705525356,-0.01933038023369995
40640,SIDM00954,Dabrafenib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,1.8952255,0.08421418,-0.3127053984748917,0.028722851465801932
69656,SIDM00673,GSK269962A,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.3212272,-0.08914713,-0.6524197429793004,-0.09256818546809235
43092,SIDM00531,Taselisib,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.3874667,0.02771273,2.7262017525610984,0.14333977865719444
83270,SIDM00971,5-Fluorouracil,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.8611543,0.11362721,-0.21112180004135891,0.053371806924613005
18624,SIDM00359,Crizotinib,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.002934533,-0.000263277,-1.106130386357032,-0.04917764427135378
51797,SIDM00146,Entinostat,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.2785927,0.10613519,0.8293276006288628,0.15386693094858853
24172,SIDM00778,Olaparib,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-1.3598776,-0.020618927,-0.14381521281791612,0.02298372423076483
7240,SIDM00529,Alpelisib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.0262393,-0.04347835,0.08665627180835185,0.06617032517834422
55586,SIDM00893,Lapatinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.188254,0.18650155,-0.6416804359133979,-0.04860698813661212
91351,SIDM00778,SB505124,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,-1.6129426,-0.04145216,-0.7452777350301832,-0.06878617324914486
68993,SIDM00878,Alpelisib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,1.2690439,0.105785035,0.43649362911298983,0.0735526358832351
72613,SIDM00673,OSI-027,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.2504764,-0.11990273,-0.5989667440143035,-0.05316743609752039
38102,SIDM00782,Afatinib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,2.7993116,0.20401716,1.3762312305007565,0.08694234115756265
28343,SIDM00878,Alisertib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-0.3830865,-0.03211542,0.8195597937375075,0.05948898681677143
41219,SIDM00146,5-Fluorouracil,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-1.8602039,-0.11088661,1.0166918815039883,0.18223073031725742
54646,SIDM00531,AZD7762,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.224935,0.253607,0.67514149422178,0.10012932497972869
78517,SIDM00971,Crizotinib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.1447527,-0.048990503,-0.07448420428438,0.026950701973619606
107595,SIDM00893,5-Fluorouracil,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.904234,0.17142552,0.06058193960015714,0.06768353452180915
93434,SIDM00834,Oxaliplatin,SCH772984,Large Intestine,0.05,Rectal Adenocarcinoma,Female,White,66.0,-0.6840308,-0.058785982,-1.869984394654609,-0.06938320036341522
87499,SIDM00529,Navitoclax,OSI-027,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.931472,-0.08243107,-0.18949561132495427,0.003814165593187832
79004,SIDM00866,AZD8055,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.94498193,0.040928897,-0.3753305945898002,0.011772177957001704
76594,SIDM00660,Nutlin-3a (-),Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,1.0780662,0.02709679,2.341030803055842,0.08722025614058246
36741,SIDM00130,MK-2206,Navitoclax,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.5453364,0.13407563,1.9315220811236036,0.1475058055941964
89668,SIDM00146,Venetoclax,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.62059456,0.016525995,1.207531011072797,0.09510666372986282
906,SIDM00359,Navitoclax,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.38598615,0.018828651,0.745050037731093,0.05655302583669903
3211,SIDM00875,MK-2206,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7872151,0.0634501,-0.2716586526310999,0.039336682186174476
36576,SIDM00954,NU7441,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,-1.0036671,-0.067119785,-0.5197112142033646,0.019801040569894447
95570,SIDM01233,MK-1775,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,72.0,-0.9725003,-0.08481288,-1.9667165403886178,-0.11084654430550685
76135,SIDM00893,Alisertib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.38569212,0.033809077,-0.430940658130834,-0.034091463210588695
45984,SIDM00097,JQ1,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5210502,-0.107499085,0.11225972993284904,0.026301867235000855
68924,SIDM00146,AZD7762,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-2.062463,-0.11872695,-0.6382606247372256,-0.011576372879598807
21057,SIDM00774,AZD7762,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.1911813,0.17232184,0.19948400038206984,0.04955584874972149
17896,SIDM00778,LGK974,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,1.8353318,0.032224424,0.6129471245566845,0.03205592043140014
107604,SIDM00866,MK-2206,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-2.1250877,-0.119960696,-1.4480920487503897,-0.053977194592763955
100166,SIDM00359,Trametinib,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.314585,-0.05234564,-1.7673685566200132,-0.056857306230161136
45924,SIDM00954,Alpelisib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,0.49248108,0.039514832,-0.290890688321114,-0.0765009138780722
31529,SIDM00531,SCH772984,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.68602145,-0.055760216,-0.11480131138055685,0.021782150163202868
55652,SIDM00778,Camptothecin,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,1.0658157,0.058851395,-0.026412070548786703,-0.04496815639034016
88460,SIDM00673,Dabrafenib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,2.0857303,0.056792974,1.90316725554545,0.05374398357661619
23632,SIDM00971,MK-1775,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.8901801,-0.063294806,-0.25813250246884156,0.06548787308044135
39429,SIDM00411,AZD7762,Paclitaxel,Pancreas,0.0025,Pancreatic Carcinoma,Male,East Asian,43.0,1.4760239,0.06095469,1.2014004551605926,0.033134687789978565
75975,SIDM00782,BMS-754807,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.21827781,0.015074649,0.07586316961552222,-0.0028920037322368126
78392,SIDM00193,AZD4547,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,-2.5246375,-0.09315086,-1.1615053046578683,-0.02571069786196255
78009,SIDM01233,Navitoclax,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-0.3202642,-0.025624158,-1.345661556373164,-0.06257801356500842
27418,SIDM00971,Paclitaxel,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.7849605,-0.06275537,-0.19793401156704551,0.03606281365734074
3788,SIDM00774,JQ1,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.3612764,-0.10444319,-1.4420737090249578,-0.07834654329672901
31808,SIDM00878,AZD6482,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,2.4175432,0.18901849,0.4025176159926009,0.04584725287751704
107498,SIDM00778,AZD4547,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,69.0,-1.7325298,-0.07419914,-1.1462686694331092,-0.058549479117672346
57585,SIDM00332,NU7441,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.4082298,0.17096293,0.9751845528059785,0.028513668744504905
100475,SIDM00411,Trametinib,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,6.256464,0.3212113,0.9279021890025229,0.07787684227314116
55443,SIDM00866,GSK269962A,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.3755828,-0.047822822,-1.2382655256371136,-0.02099687810941908
54870,SIDM00971,Nutlin-3a (-),Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.5769739,-0.029796544,0.9749850055821649,0.04651439463933513
21077,SIDM00875,Luminespib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.74974585,0.07131409,-0.710133485007105,-0.054236043140471486
67028,SIDM00893,Paclitaxel,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.2774869,0.021491416,-0.8115164362725319,-0.04658967694831039
100725,SIDM00673,Afatinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.3234943,-0.09523127,-0.9975296804339409,-0.04708806648023587
31838,SIDM00628,ZM447439,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,-0.70853245,-0.051622268,-1.3336296849828342,-0.0745440796056848
10389,SIDM00146,NU7441,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.35062134,-0.03246965,0.8322813032936811,0.012532652008396598
56182,SIDM00875,ZM447439,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2153505,0.029741505,0.12212502928806147,-0.06732319364419946
92151,SIDM00893,NU7441,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.97908956,0.07185302,-0.7685622604384515,-0.027983484755170703
103266,SIDM00834,LGK974,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,0.9224307,0.073490754,-1.7089582252366982,-0.04733641264916527
42848,SIDM00673,Olaparib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.60270315,-0.03248133,-1.3088073639152158,-0.035706647061200754
66510,SIDM00866,Camptothecin,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.5722682,0.030772105,1.976752203013749,0.06841865694318168
81996,SIDM00359,Crizotinib,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.1312315,-0.082254305,-2.6062302566592144,-0.07460475285821033
13723,SIDM00971,GSK269962A,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.4948833,0.091337144,1.6464605670469779,0.09992431119088173
11492,SIDM00193,SB505124,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,East Asian,53.0,0.8037812,0.07806911,-0.14505843978104777,-0.03491289829675985
85554,SIDM00875,GSK269962A,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5289273,0.030566154,1.2393025666017874,0.02440238752935622
72493,SIDM00097,Taselisib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-5.0823417,-0.30142495,0.05990979878079297,-0.013479094816177402
25125,SIDM00673,Cisplatin,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.20287,0.06959341,2.3555946174255933,0.045245958662733995
69870,SIDM01233,AZD4547,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,2.2629602,0.086198024,1.0459926930967165,0.03125090839497935
45363,SIDM00875,Luminespib,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.8392105,-0.12815104,-0.6996816313762048,-0.06948552376319003
104599,SIDM00866,Paclitaxel,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,-1.6756632,-0.09939903,-1.7986975405286012,-0.07971534819655045
24568,SIDM00776,5-Fluorouracil,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.833937,-0.0574376,-0.49429561654471543,0.0181781306549076
24796,SIDM00779,Linsitinib,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,33.0,-1.9597973,-0.12919866,-0.7253896909500356,-0.1525661798760264
59874,SIDM00673,Pictilisib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,1.1786344,0.08061427,-0.8305933216845425,-0.0058148397599124746
85886,SIDM00866,Tozasertib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,52.0,-2.0193372,-0.10460851,-1.1906768768994007,-0.01645515386680408
94337,SIDM00660,Olaparib,Dabrafenib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,1.9183831,0.05553975,2.374289807759031,0.07614575207864606
23348,SIDM00774,Trametinib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,0.6931958,0.023327643,0.3245017986047732,-0.010341096899349008
32026,SIDM00660,LGK974,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,1.4051607,0.031758104,1.4242018069317315,0.03158176074708782
97075,SIDM00875,Olaparib,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8053755,0.07573498,-0.10487674041347271,-0.03447050806678974
78546,SIDM00097,Sorafenib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.8815356,0.104264066,0.8386961925459213,0.023451385140943713
48258,SIDM00893,Luminespib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.433822,-0.11400811,-1.8517676529840776,-0.036695643325021864
99821,SIDM00146,Dabrafenib,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.9377465,0.054112036,-0.4728657124403831,-0.025593048460161714
72187,SIDM00774,AZD7762,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.45947155,0.05454805,0.023163743990393348,0.007667894582799503
46204,SIDM00146,Gemcitabine,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,7.1593256,0.22026843,3.086143018200536,0.12240953685877533
86433,SIDM00954,SCH772984,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-2.6275096,-0.16409545,-1.349556117521403,-0.10642188032121269
96021,SIDM00954,Alisertib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-2.5457926,-0.19652985,-0.05296468339074217,0.04711749813974611
72530,SIDM00673,Alpelisib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-0.6748503,-0.040081445,-0.962418673620494,-0.07051353769068752
3417,SIDM01233,SB505124,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,72.0,-0.72554857,-0.023160025,-1.1385064117101957,-0.06179531628211064
96706,SIDM00332,Linsitinib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3431348,0.02913805,2.368213568857382,0.055659751994460625
52436,SIDM00878,Olaparib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,1.3072163,0.049479306,0.9510283874973987,0.02219867852325473
77730,SIDM00531,Trametinib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,6.888845,0.6790227,2.9078711213373976,0.17584964296672478
77894,SIDM00776,AZD4547,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,1.7079787,0.06601282,0.13987585118082324,0.040274575309093806
45200,SIDM00778,Dabrafenib,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,0.6650388,0.007026584,1.1323231278442822,0.018133220298215468
83094,SIDM00529,Luminespib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.1372325,0.1134231,0.16698670710360805,0.03285618704832101
61655,SIDM00673,Luminespib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0391613,-0.09900941,-1.1876246647177051,-0.051094641465188016
31805,SIDM00866,Entinostat,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-1.0711042,-0.08288935,-0.7703007703212531,-0.01783228141808805
103475,SIDM00411,Taselisib,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,43.0,-1.7663116,-0.10576349,-1.3741848933454066,-0.06443157453040599
55718,SIDM00411,Oxaliplatin,Sorafenib,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,43.0,3.3482296,0.17060462,-0.11173783409833413,0.010717921200733886
60605,SIDM00332,Wee1 Inhibitor,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.6997253,0.117552735,-0.948425263069347,-0.023591189251250144
99536,SIDM00097,Vorinostat,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.33738565,-0.018951735,-0.6418427716751144,0.002500995469952131
41766,SIDM00774,Temozolomide,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.5916591,0.03244957,1.3840042299842341,0.025076103145513628
66993,SIDM00531,Taselisib,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.8199914,-0.09881462,-0.8167309911772842,-0.013417310691542552
35470,SIDM00628,Alisertib,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-1.662746,-0.07014472,-0.5645724237760682,0.022254968866752985
75281,SIDM00146,AZD8055,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,1.3689283,0.10657545,-0.33053530539388526,-0.035259065830602634
52173,SIDM00774,PD173074,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,-1.3356454,-0.0700726,-1.8609137270943903,-0.019904236063175745
3359,SIDM00673,Cisplatin,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.13498615,-0.0044204625,0.41702464436900705,0.05199237100706253
57705,SIDM00130,Lapatinib,Navitoclax,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,3.6797466,0.32048103,3.4535329360540645,0.1972974989172976
40468,SIDM00893,Bortezomib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.6499734,-0.050294045,-0.6596080545970026,-0.022700606459075196
71086,SIDM00130,Lapatinib,OSI-027,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.72567016,0.06514637,-0.1958246229244333,0.037505826133342336
41427,SIDM00878,KU-55933,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,2.173479,0.10441005,-0.23977593688784152,0.0449863540737904
25139,SIDM00834,Camptothecin,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,0.7324901,0.06374249,-0.7669052332086008,0.040338889368518885
75432,SIDM00628,Pictilisib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,1.1669854,0.11055565,-0.8241464496312723,-0.06823746726337253
70422,SIDM00332,Wee1 Inhibitor,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.36085382,-0.027681906,-0.7153854181933367,-0.057035716313196025
63271,SIDM00971,Nutlin-3a (-),Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.1315858,-0.056243394,-1.375990153548803,-0.030022913779910315
45208,SIDM00782,SB505124,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,Unknown,72.0,-0.9242643,-0.07347814,-0.13787195507029945,0.004608977911529183
38050,SIDM00782,AZD8055,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,Unknown,72.0,-1.5057418,-0.12004473,0.15362499657806242,-0.012187277096791911
16243,SIDM00971,Dabrafenib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.030341,0.08737679,0.48536479751661477,0.015693409228576698
69631,SIDM00529,Sorafenib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.76448685,0.07723578,0.8308845702273223,0.11628178241195018
81237,SIDM00673,Nutlin-3a (-),OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.36416665,0.0070672254,1.6217957993780572,0.024346959563850683
107706,SIDM00878,JQ1,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,70.0,2.0720565,0.17902641,0.8612435125284899,0.06601630230887094
106546,SIDM00875,Gemcitabine,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.513656,-0.007773892,-3.8944582017007257,-0.0992169797627537
106351,SIDM00866,SCH772984,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,52.0,-0.7251543,-0.05586203,-0.6356293541508158,-0.04886550560248853
91621,SIDM00130,Trametinib,LGK974,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.26631287,-0.024621638,-1.0710354319813817,-0.08457642031557132
105704,SIDM00529,Taselisib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Black,44.0,-2.0878904,-0.08810744,-1.7970288316170184,-0.0634217281206996
47454,SIDM00954,Bortezomib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-0.6994399,-0.026124723,-0.6511302019782809,-0.055313009645113785
100422,SIDM00673,NU7441,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,1.5105183,0.11703749,-0.6301333098180717,-0.011983103694170863
82463,SIDM00097,Wee1 Inhibitor,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.596897,0.10105661,-0.31085954669900073,-0.022011455434709826
2896,SIDM00332,Pictilisib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.2149026,-0.08309371,-0.8162332490564703,-0.06299645330640401
104964,SIDM00866,Sorafenib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,0.45263588,0.022486042,0.08883883285378764,0.008959354271038415
51973,SIDM00878,Doramapimod,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,70.0,0.80550617,0.051234297,0.2660307119010028,0.07465427460924579
28001,SIDM00097,Linsitinib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.6057992,-0.083151944,-0.016773616855507958,0.024222129186119216
37835,SIDM00866,AZD6482,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,52.0,1.0180513,0.06964018,0.2173738902214322,0.021671148632764755
10236,SIDM00673,Bortezomib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.34949458,-0.018145869,-0.3533960626199766,0.004710377187051096
15823,SIDM00866,Paclitaxel,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,52.0,0.8742214,0.07214324,-0.3661343468562935,-0.0338792855938045
49864,SIDM00193,Taselisib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,53.0,-0.9276812,-0.08387578,-0.9357297740924855,-0.02775973830836863
62684,SIDM00774,Vorinostat,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.950559,0.04268783,1.00823623493045,0.02343884918252704
49937,SIDM00359,5-Fluorouracil,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6416321,-0.084194146,-0.4207948143153085,0.012917828539187947
26079,SIDM00193,Trametinib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,53.0,-2.400035,-0.12212089,0.03820112421447823,0.0009553653118234051
46403,SIDM00954,AZD8055,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-1.9164121,-0.14820188,-1.478091326213511,-0.09345629255310392
25501,SIDM00529,Gemcitabine,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.0236132,-0.029149825,-0.939694600437304,0.007139357891880455
51738,SIDM01233,AZD7762,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,2.3809197,0.083571285,1.5506700146467687,0.01747915620102083
85462,SIDM00301,Taselisib,Ruxolitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.0686901,-0.117423296,-0.34532349735658524,-0.06089340561771208
35220,SIDM00875,Luminespib,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-3.2904081,-0.11893392,-1.666301550893639,-0.11474055863786778
17072,SIDM00146,Trametinib,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,2.987238,0.17391838,2.1076650863659974,0.03652396381545057
13330,SIDM00834,Dabrafenib,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,-1.0172955,-0.031147288,0.11077105165292238,0.011991655485369226
107050,SIDM00878,Gemcitabine,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.7811393,-0.12549923,-2.3627750684356648,-0.053923100326946805
83678,SIDM00130,Dactolisib,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.2885144,-0.14393368,-0.6865568320230699,-0.030137221614582897
32442,SIDM00097,MK-1775,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.040535,0.1210069,-0.5985728847753603,-0.04964755133195287
42371,SIDM00660,Afatinib,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,1.0484164,0.072759174,0.971610077712218,0.05865903748316389
18743,SIDM00971,GSK269962A,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.24101952,-0.014715243,0.48269161694686713,0.037099314948255836
44182,SIDM00893,Sorafenib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.11995245,-0.010006205,-0.711432178678242,-0.010101474520509387
71905,SIDM00097,Nutlin-3a (-),MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1402643,-0.044216644,0.24357509948625533,0.01925738844919222
13035,SIDM00878,Wee1 Inhibitor,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,0.44207346,0.035555728,-0.24418421972303106,-0.008016384904006033
64446,SIDM00866,KU-55933,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-2.8691473,-0.084439434,-1.8248966782647442,-0.09272773002787496
42844,SIDM00875,Ribociclib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4752533,-0.043476213,-0.856063003766115,0.015968277610720283
46047,SIDM00531,MK-2206,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Male,East Asian,60.0,5.0653725,0.43474075,1.596512316542256,0.08928099800891164
36882,SIDM00673,Bortezomib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.45545214,-0.025780588,-0.7258857555496682,-0.03293330351685358
90312,SIDM01233,5-Fluorouracil,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,72.0,0.8607159,0.05994241,-1.1059756985165543,-0.004622948561744513
106755,SIDM00359,Dabrafenib,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.39954352,-0.019132549,-1.780489622352626,-0.045575701985567575
13152,SIDM00893,OSI-027,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.8994528,-0.06966888,-1.8448559950301915,-0.09320206058623959
38054,SIDM00774,Alisertib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.4748993,0.10457417,0.7211208363388558,0.08572705686202292
47441,SIDM00774,Linsitinib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,0.41177717,0.036447804,-0.7380825785710486,0.020754362838690785
103807,SIDM00866,Wee1 Inhibitor,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-0.9431108,-0.07798318,-0.49405480987678235,-0.02784534456729185
91402,SIDM00778,AZD7762,Navitoclax,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,1.4366934,0.07369215,1.047161922981832,0.053538729796560255
42885,SIDM00893,Crizotinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.0999577,0.1159421,2.6353916039321272,0.09606202393295446
70308,SIDM00834,Taselisib,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,1.1345035,0.085937865,0.18736784299720322,0.012199508460614255
80856,SIDM00193,Camptothecin,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.70357853,-0.024062606,0.551077716947819,0.02949037826751029
77618,SIDM00971,JQ1,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.2926605,0.20843208,-2.13494440936625,-0.06703269985597521
8050,SIDM00529,AZD6482,Luminespib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,0.11078755,0.0033363337,0.15016712548419522,0.0018427502894422536
6306,SIDM00971,Docetaxel,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.1541703,-0.08835944,-2.251108210292898,-0.0688873025463466
6076,SIDM00628,MK-2206,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-2.214615,-0.048838314,0.15549542146936174,0.04980006576847348
63482,SIDM00660,Palbociclib,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,32.0,5.6099744,0.45883745,1.8386082812583338,0.047055705184948296
80136,SIDM00531,Crizotinib,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.1985197,-0.092796415,-1.410909745563939,-0.09359714698616144
4600,SIDM00954,Olaparib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-1.9654242,-0.050041627,-0.9913850326477494,-0.002445584903061659
8977,SIDM00301,Sorafenib,Trametinib,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,-0.7519709,-0.08503731,-0.4634294049584247,-0.014904018594839235
73006,SIDM00146,MK-2206,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.469218,0.095637485,0.1515174998610587,0.0006938548751579262
31799,SIDM00332,Sorafenib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5192859,0.03716255,-0.14617791863069426,-0.004300471115660876
67419,SIDM00774,PF-4708671,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-0.79277265,-0.037749697,1.8542755580059214,0.06843164947175702
60821,SIDM00673,Cisplatin,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,2.7667835,0.156667,1.5805340045539187,0.07967268656445778
2253,SIDM00875,5-Fluorouracil,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.130611,-0.17532721,-1.5678708206414724,-0.1056366138487773
73699,SIDM00878,Alpelisib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,2.9320953,0.03886311,1.980411860965689,0.11125725255139471
95092,SIDM00875,Venetoclax,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.47692347,-0.010694769,0.7529980170024652,0.036788458040512596
80275,SIDM00971,Afatinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.46561167,0.018548293,-1.4626803327884128,-0.03268959715255766
52242,SIDM00954,Nutlin-3a (-),Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,1.8568113,0.06690626,0.027252924197228023,0.007095809732532624
38156,SIDM00875,Cisplatin,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7319331,-0.035433684,-0.8394970133487506,0.006391052171451507
4716,SIDM00673,NU7441,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.9273432,-0.07292427,-0.9408574011910614,-0.06152748888926584
47838,SIDM00332,Luminespib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.4452248,0.24210064,0.34339646668471835,0.010321518346257132
47850,SIDM00893,5-Fluorouracil,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.5207642,-0.025486367,-1.0208605061896627,-0.014791925966218715
25859,SIDM00130,Navitoclax,MK-2206,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.8045624,-0.07041684,0.7786221555121634,0.11922683726061425
36672,SIDM00875,Trametinib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.96512645,-0.106326714,-1.205027271858119,-0.030388739983361213
19886,SIDM00130,OSI-027,MK-2206,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.472526,0.23596245,2.2641242818658247,0.17017275523862474
74547,SIDM00411,Gemcitabine,LGK974,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-4.9074035,-0.19746386,-1.6726239730325825,-0.09589042188828002
13632,SIDM00628,MK-2206,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-2.1547346,-0.14485875,-0.6887359445594466,-0.012859186006794712
3326,SIDM00529,MK-2206,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.2395053,-0.042818937,1.5636876146940555,0.05210622320722943
55031,SIDM00130,Cisplatin,Lapatinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.501105,-0.07323445,0.16243513364442935,0.017054291527012475
7192,SIDM00193,Olaparib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.3596777,-0.061240572,-0.6319080371657498,-0.019923670690764672
72546,SIDM00878,Sorafenib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.9444687,0.03556385,2.8046646787828715,0.1295763332615345
26440,SIDM00866,Nutlin-3a (-),Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.5284514,0.04667004,1.3980915756763705,0.042412103557409785
34500,SIDM00954,GSK269962A,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.0,1.2683946,0.091383465,-0.07266000670705017,-0.0008076885306505757
28780,SIDM00146,Tozasertib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.33966434,-0.022122215,-1.2267203808799587,-0.046900603044774614
4767,SIDM00193,Linsitinib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,2.3459015,0.12102459,0.9154663469204528,0.016683017013980738
105171,SIDM00893,Sorafenib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.0761654,0.15808871,1.0091188059770626,0.13302431086781777
95017,SIDM00146,SCH772984,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-4.8956714,-0.28153753,-4.333072450814416,-0.14116796657194078
107197,SIDM00529,Alisertib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-0.14993683,-0.014410904,-0.8607618939280522,-0.060697485302767876
491,SIDM00193,Palbociclib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,East Asian,53.0,-0.86881745,-0.028538225,-0.2123360474928843,0.0009651407531039011
89967,SIDM00673,OSI-027,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,0.8833119,0.08513158,0.08196112470403942,0.048006047917768926
70593,SIDM00971,Gemcitabine,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.1285791,-0.06302985,-0.18476108405258357,0.021423918961415288
11097,SIDM00146,Entinostat,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,-0.2310116,-0.016556025,-0.9480920621772806,-0.008950014094714713
17094,SIDM00301,Olaparib,Oxaliplatin,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,2.2278345,0.19846715,1.0034758536723476,0.04446035332631192
79435,SIDM00411,MK-1775,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.6654477,0.17417656,2.5410554540651806,0.12701057609364463
81579,SIDM00193,Oxaliplatin,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,1.1389992,0.04462305,1.0078227087482947,0.05799965021436056
36661,SIDM00954,Docetaxel,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-1.9590515,-0.085104614,-0.7833791727277184,-0.028418995991634315
35346,SIDM00332,AZD6482,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5423253,0.054664414,-0.3691317656279912,-0.04261453902628964
75912,SIDM00097,BI-2536,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.2329972,-0.015817776,0.4708841908412655,0.006215286827191956
2501,SIDM00529,Palbociclib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-2.7410662,-0.09595057,-0.7727359183096869,-0.04840094611364464
40588,SIDM00971,AZD6482,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.9324243,-0.044197332,1.0124199507910427,0.07063534611025221
42347,SIDM00146,ZM447439,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.7087708,-0.11286062,-1.276814279341253,-0.07205980354902207
30553,SIDM00878,KU-55933,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,70.0,-0.42805594,-0.014342081,0.6866207625213105,0.04828933689139407
3008,SIDM00878,Tozasertib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,70.0,-3.7602615,-0.19130896,0.4452570124302068,-0.007409545371830854
44550,SIDM01233,Olaparib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,0.15165704,0.00241977,1.982695756429666,0.04024805357518803
55355,SIDM00954,Docetaxel,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-3.3002796,-0.030807724,1.9921432242335235,0.11574657852844565
104946,SIDM00332,Axitinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8372354,-0.07908206,0.570036414915811,0.04355875752803421
21334,SIDM00878,ZM447439,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.40761653,-0.038302146,-1.5082546986585346,-0.12005066514307017
64575,SIDM00097,Taselisib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.76950663,-0.0468269,1.4027487541934676,0.06917998014259205
37944,SIDM00866,ZM447439,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.989765,-0.111056484,-1.3124336819136067,-0.06922233070237517
6664,SIDM00301,Crizotinib,Ruxolitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,0.6067608,0.05119358,0.5835638161612366,0.03137067774303758
52266,SIDM00971,AZD8055,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.2963757,-0.01888286,-0.08949713655608416,0.013189066280366682
51618,SIDM00782,Nutlin-3a (-),AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,Unknown,72.0,1.3472602,0.033927515,2.367974272341777,0.06509983778257304
49730,SIDM00359,Taselisib,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.39455,-0.103532605,-0.8247781303355023,-0.03465806998559241
16012,SIDM00875,AZD7762,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1128668,-0.029333986,0.1570456987748642,0.06998978313450718
6378,SIDM00893,KU-55933,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.5258406,-0.05094961,-0.8180770201686082,-0.006682163093414489
92050,SIDM00834,BMS-754807,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,0.63835174,0.05004011,2.0286869529418294,0.09906827254801755
53151,SIDM00146,Palbociclib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-1.8002504,-0.106077574,-1.9798648079055305,-0.04352211101695407
76499,SIDM00359,AZD7762,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.5820186,-0.16673031,-1.354057149654234,-0.07598288096987606
107627,SIDM00411,Lapatinib,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,5.318134,0.20922315,2.281467080127809,0.17601767227854867
85916,SIDM00130,Paclitaxel,Olaparib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.3589628,-0.13412358,-1.6630841964951348,-0.12716766921104428
93059,SIDM01233,Palbociclib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,72.0,3.891942,0.12805842,1.560879969701529,0.05678813813841152
105719,SIDM00529,Uprosertib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Black,44.0,-2.6455517,-0.10877388,-0.1301117491652872,0.02419615864049196
78863,SIDM00660,MK-1775,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,32.0,-1.1276037,-0.02392597,-1.2136742300328343,-0.03538727852977912
60973,SIDM00359,Navitoclax,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.09073158,-0.006672188,1.3904616574107367,0.034006770481765064
101030,SIDM00875,Lapatinib,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.48125786,0.010838615,0.6880447093302845,0.004988285919498351
2873,SIDM00971,Entinostat,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,5.293593,0.21323189,0.27284553290009866,0.02978814620961998
5681,SIDM00834,Linsitinib,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,0.025319887,0.002223006,-0.022374644448187726,0.04195860073510404
103781,SIDM00954,Alisertib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-4.4152856,-0.25937915,-2.0811308546776157,-0.08113099090400074
77609,SIDM00866,Entinostat,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.50869226,-0.036386687,-0.31821329501897466,0.03254078146317778
91044,SIDM00411,Paclitaxel,Ruxolitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-2.3395457,-0.07348023,-1.133695178497494,0.027841239461189535
27528,SIDM00875,Palbociclib,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.2146964,0.020076133,1.1619664973517327,0.02394180860098658
105879,SIDM00628,GSK269962A,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,0.758993,0.07655677,-0.4854611716074667,-0.02325023706937635
45469,SIDM00774,Afatinib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.5533494,-0.038306467,-0.8643311128149038,-0.07303137748796165
46252,SIDM00673,BI-2536,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.341543,-0.11054146,-0.836723718726413,-0.11680786034736408
18136,SIDM00878,ZM447439,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.627622,0.046028137,0.31287434587107604,-0.002135943495974681
85217,SIDM00893,Olaparib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.7241709,-0.04095921,-0.10034115656032688,-0.009535730074680795
59980,SIDM00954,Bortezomib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-0.2770849,-0.017228313,-0.7653802084184568,-0.01959565774980171
4902,SIDM00834,Trametinib,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,1.8739626,0.041888356,-0.17444287573501926,-0.025678940748936303
77869,SIDM00411,5-Fluorouracil,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.2596965,-0.038865652,-0.1645843041432233,0.028667742807221782
53834,SIDM00531,OSI-027,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.2398703,0.08151658,0.554460942345425,0.021401194284738495
83317,SIDM00332,Palbociclib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.006149,-0.05554358,-0.46348904612511116,-0.03448396624279848
39956,SIDM00529,Luminespib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-0.8855636,-0.08648472,-0.7482537698806233,0.025352639911644197
67847,SIDM00146,Trametinib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.867396,-0.07371234,-0.9268452527563862,-0.054428486100221676
64694,SIDM00097,Alisertib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2060435,-0.0683677,-0.6113322239021934,-0.02462017016457745
21156,SIDM00971,OSI-027,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.6978035,-0.099455334,1.7084351094358534,0.10750453235574949
66801,SIDM01233,Crizotinib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,72.0,-0.39313397,-0.025783777,1.0045984750732844,0.1162703461663016
49310,SIDM00893,Taselisib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.51006806,-0.021387164,-0.7424478725286877,-0.01694913977269896
14773,SIDM00673,PF-4708671,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.5747146,-0.03153676,-1.617138700020446,-0.1043578643685037
27429,SIDM00971,Vorinostat,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.7166483,-0.11046039,-0.4858566931478387,-0.013356479349444247
81696,SIDM00782,Linsitinib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.4417042,0.08051283,0.9227247791750933,0.03890214916642596
13387,SIDM00146,BI-2536,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.5036024,-0.067285456,-3.024006958956324,-0.1061585465498073
87223,SIDM00411,Paclitaxel,MK-2206,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,43.0,0.77940583,0.029003365,0.741829502716878,0.08110506848969949
71063,SIDM00411,Gemcitabine,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-3.4664922,-0.13600777,-0.13953455674267076,-0.029012161718905034
18856,SIDM00866,Ribociclib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-3.3617346,-0.09390917,-2.408622823628158,-0.06364764172766839
99965,SIDM00332,JQ1,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.453618,0.054474235,3.5308963134617564,0.16827876130489386
98808,SIDM00529,Taselisib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.1819502,-0.063917294,0.3690947849880172,0.07636828463029562
37864,SIDM00359,Palbociclib,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.1063266,-0.09591955,-3.060648645540551,-0.09773440426596847
13713,SIDM00146,Pictilisib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.1174313,0.090079196,-0.6161758777732907,0.01671569319888896
78975,SIDM00146,Paclitaxel,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-2.0702062,-0.16886406,-0.2812440266992863,-0.06709941462730837
48059,SIDM00866,Bortezomib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-0.20930603,-0.017930936,0.21276939375117854,0.030100521366384726
51630,SIDM00359,5-Fluorouracil,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.918408,-0.13569751,-0.9342540193697721,-0.023969408441710704
50898,SIDM00774,5-Fluorouracil,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,48.0,-1.3206501,-0.0992012,-1.2097839296775357,-0.025256825140202423
90250,SIDM00878,PD173074,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.2357363,-0.018849423,0.7741201730981243,0.08178285940689427
4635,SIDM00866,ZM447439,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,52.0,0.7736019,0.057336133,0.2550140974481058,-0.0015847072872774497
81957,SIDM00332,AZD7762,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.3198092,-0.17519487,-0.42504435835504284,-0.04794708095490672
105987,SIDM00875,SCH772984,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5164695,-0.055638943,-0.6037731658579066,-0.015128647262450546
43666,SIDM00878,Bortezomib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.28879642,0.014485426,-0.2397539817769848,-0.029892447837766067
93218,SIDM00834,Palbociclib,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-1.3695626,-0.066311106,-2.829489645095127,-0.09583129386951307
63315,SIDM00774,AZD6482,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-4.304885,-0.19484773,-0.9820476808622589,-0.023071328339233765
61107,SIDM00660,Olaparib,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,2.128368,0.07751554,1.0768233342604248,0.05521482566810874
104848,SIDM00866,Axitinib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-2.6080081,-0.14650255,-1.9851363898367194,-0.08024733495108836
101921,SIDM00782,AZD4547,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,Unknown,72.0,-0.8706145,-0.025068041,0.2459711730141222,0.02783998314555761
79258,SIDM00875,Lapatinib,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.8560821,-0.092140876,-0.5627966603302462,-0.06008149862925179
54372,SIDM00673,Bortezomib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.21186908,-0.010707739,0.6015490193473656,0.0005343701255214707
905,SIDM00301,Navitoclax,Oxaliplatin,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.5014689,-0.19196577,0.975042174055116,0.011474381400487833
29505,SIDM00146,PD173074,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,0.29498398,0.022523083,0.27197115644583836,0.12766683227406259
93657,SIDM00146,Ribociclib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.3773077,0.07725224,-0.48382316233021766,0.0657815650259999
85391,SIDM00774,SCH772984,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,1.8681635,0.054536674,2.862477185161665,0.09667186419512593
104144,SIDM00097,NU7441,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8927732,-0.07110396,0.3806294323577794,0.03134995810580257
39167,SIDM00875,Pictilisib,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.58473957,-0.065810494,-0.6117626727113575,-0.05257100150276855
66289,SIDM00893,Ribociclib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.2260756,-0.07470812,-0.44661103549600556,0.034556586738938494
101605,SIDM00954,Ribociclib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.11928429,0.0042738123,-0.6190299314235772,0.02470142256068823
35429,SIDM00660,LGK974,SCH772984,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,32.0,0.674961,0.04073698,0.6657325284006563,0.041713824160839734
9775,SIDM00779,AZD8055,Navitoclax,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,2.0097682,0.15332596,1.4054154160656223,0.07774361277830143
37685,SIDM00332,Paclitaxel,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-5.2520013,-0.33104602,-3.6714371577915665,-0.2907256396233852
53246,SIDM00529,MK-1775,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.8325293,0.07883516,-1.9321669225673694,-0.08610105721899745
104797,SIDM00971,Cisplatin,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.05480647,0.00084367837,1.6571550842830847,0.02308761254840106
5048,SIDM00878,Entinostat,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,2.3635125,0.15701915,-0.286766218071185,0.042241829421328696
66407,SIDM00097,Docetaxel,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.5760574,-0.0367717,-1.3378148722957457,-0.07775703265566923
11933,SIDM00954,Olaparib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,1.2374873,0.04883816,-0.9728718880506736,0.02113558282275508
62630,SIDM00954,Luminespib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.8991427,-0.10258226,-1.4412339784634363,-0.08464541150171316
18391,SIDM00866,Luminespib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-0.38247684,-0.032748714,-0.28867013005252706,-0.050680622760706534
15832,SIDM00301,Trametinib,MK-1775,Pancreas,0.2,Pancreatic Carcinoma,Male,East Asian,50.0,-1.5966762,-0.1695927,0.047097807309883416,0.021176879353857713
72974,SIDM00878,Paclitaxel,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-4.3175645,-0.21912521,-3.435260003091468,-0.27642755025563287
108001,SIDM00529,Uprosertib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,-2.0685482,-0.0904291,0.7494269775149623,0.09985722476241857
40277,SIDM00673,Alpelisib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.4411584,0.0902938,0.7362347311102667,0.053596013403461894
94297,SIDM00660,MK-2206,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,2.3751178,0.16913183,0.7972706445526967,0.06726248551000309
73710,SIDM00529,Cisplatin,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,1.3493068,0.02540079,1.105492844486999,0.05494985447773463
33316,SIDM00193,Camptothecin,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,53.0,-0.86684996,-0.029106554,1.017400271635827,0.0758788006663027
95709,SIDM00130,Dasatinib,Oxaliplatin,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.97922385,0.086093724,-0.4756442631740768,-0.009117080364445406
15253,SIDM00971,Venetoclax,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.0293437,0.016663564,0.9563098281197605,0.028364932246256913
55354,SIDM00878,Camptothecin,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,3.5239844,0.034625165,4.601673135132668,0.19675809600049787
72741,SIDM00130,Gemcitabine,Sorafenib,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.8692813,-0.108489856,-2.892348738461,-0.11292259222355322
98787,SIDM00778,SCH772984,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,69.0,-1.252865,-0.07018812,-1.689860226339014,-0.08716244725750458
104342,SIDM00628,Crizotinib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,0.45207578,0.03443022,0.4288765237516071,-0.010480883982486462
75795,SIDM00359,Taselisib,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7809329,-0.14360136,-0.9805415732380695,-0.04214135453462498
101773,SIDM00130,Oxaliplatin,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.9214889,-0.033770513,-0.9794348974955496,-0.01326832267715188
54884,SIDM00778,Trametinib,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,-1.3020365,-0.047654122,-1.8984803865622821,-0.08026439225737003
68709,SIDM01233,LGK974,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,72.0,-0.5421243,-0.036845323,-1.1930280492384566,-0.07968419412712158
102744,SIDM00673,Crizotinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.8945634,0.18214633,1.9211476293865113,0.14551747114416322
98440,SIDM00673,NU7441,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.516006,-0.100208655,-1.1521744926810997,-0.08862009496945267
33271,SIDM00332,Alpelisib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.41317326,-0.030229991,-0.26973035086696934,-0.005215609469525693
84344,SIDM00875,ZM447439,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.30469018,0.035425052,-0.7326401371917995,-0.08752836077058372
30128,SIDM00146,Navitoclax,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.254668,0.082458034,3.2120187544640966,0.1144235043843031
66378,SIDM00875,Cisplatin,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.88532084,-0.042013563,-0.8606941144538683,-0.0001156359577763469
88425,SIDM00971,Sorafenib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.24875028,-0.017593531,-0.4041980495640076,-0.04559404931286391
75735,SIDM00971,OSI-027,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.6604206,-0.037846163,-0.22105629911155406,0.003756212452170373
28838,SIDM00878,AZD7762,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.38416722,-0.021702869,-1.2046111578559204,-0.07221626003270677
35725,SIDM00332,Sorafenib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.4417856,0.1335265,-0.3156239254247058,-0.019544805191645132
50592,SIDM00531,LGK974,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.60797125,0.063654594,-3.0754812860924203,-0.10743028802659672
36912,SIDM00332,Temozolomide,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2204801,-0.025101203,-0.009884986878045069,0.00755990598163296
5563,SIDM00954,Wee1 Inhibitor,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.0,-0.5482987,-0.04549905,-0.9787724589522245,-0.10261510218192657
100214,SIDM00130,AZD7762,Erlotinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.4681807,0.033831425,-1.4072408270972416,-0.02887570834092891
1254,SIDM00774,Entinostat,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,0.9670442,0.0643743,0.06894701089076243,-0.002732115337417888
39396,SIDM00866,Lapatinib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-1.1133114,-0.09494212,-1.4918474583679429,-0.0777454706196583
5615,SIDM00875,Paclitaxel,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.44798675,-0.02992398,-0.4028066798927431,-0.02872842615651441
9867,SIDM00774,ZM447439,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.033726,-0.094259866,-0.4595106743721573,0.02188964787191867
71279,SIDM00776,Crizotinib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.8523683,-0.07645293,-1.5066246535102537,-0.08354588697687541
65746,SIDM00529,BI-2536,MK-2206,Breast,0.25,Breast Carcinoma,Female,Black,44.0,0.8578331,0.06662919,0.3025094723588456,0.003488806645934751
3360,SIDM00875,Bortezomib,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.10976122,0.009279766,-0.3160675127841149,-0.014232047842367208
99763,SIDM00660,Linsitinib,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,0.9411228,0.077547215,0.20697424444947704,0.0229525077597103
52695,SIDM00774,MK-1775,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,0.5738996,0.073086545,-0.49898463080598965,-0.00871843559180052
4028,SIDM00782,AZD7762,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.90499514,-0.0829347,-1.0414933646130191,-0.07058663765331041
35082,SIDM00782,Olaparib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,Unknown,72.0,-1.1288106,-0.028759897,1.5403215610263434,0.03192149602127867
13528,SIDM00875,AZD7762,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.06614905,-0.0036123258,-0.6884151482261726,0.016544493594747054
92612,SIDM00878,Alpelisib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.5306895,-0.13853651,-1.2671821480139565,-0.09412278486124391
51100,SIDM00779,BMS-754807,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,33.0,-1.4145249,-0.029061161,-2.375607888282113,-0.14765597325281912
56630,SIDM00359,Nutlin-3a (-),MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.4993093,0.064988516,1.9837661293657887,0.08502511640704209
70021,SIDM01233,Olaparib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,3.9060445,0.14285347,-0.4068500229921174,-0.018036106420198053
96929,SIDM00971,Crizotinib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.9816406,-0.058366816,-0.4083077166808315,0.02265498476605049
86460,SIDM00673,Crizotinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.49685994,-0.045203753,-0.3784324911294531,-0.023759700264001725
58013,SIDM00130,Cisplatin,OSI-027,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.0505211,0.034421246,0.4014051992122869,0.055175523671890596
59480,SIDM00097,Entinostat,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2349975,-0.09407154,-0.28499603013807534,-0.026783560641851837
102482,SIDM00628,Dabrafenib,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.4143769,-0.032557797,-0.5008677670064746,-0.0489236004126303
24349,SIDM00146,BI-2536,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.37166438,0.012308024,0.424083053285191,0.012899050042520078
81439,SIDM00673,JQ1,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,1.9432456,0.13263334,0.08588144172658056,0.004357079533967639
38521,SIDM00866,Linsitinib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,1.0550579,0.075910784,0.10731639784585327,0.009899257102324142
27985,SIDM00954,Lapatinib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.287706,-0.014960273,0.771057305847192,0.047277109527999975
82137,SIDM00893,Linsitinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.5914283,-0.065479904,-0.3895331809616638,0.011446233500146159
13571,SIDM00878,Sorafenib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.25377977,-0.02344014,-0.5003588881578542,-0.04788524410722945
23181,SIDM00778,Linsitinib,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-1.1735553,-0.03186926,-0.4659812158695124,-0.013558478793954743
8990,SIDM00779,Trametinib,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-1.5355316,-0.028026795,-0.321128523737271,-0.05427142038990478
11663,SIDM00782,AZD7762,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,-1.4301445,-0.086440854,-1.2566845591769558,-0.04993774943918913
103069,SIDM00875,PD173074,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.91933423,0.0608867,0.016506109603772023,0.03437248426630932
58461,SIDM01233,Dabrafenib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,72.0,0.7984598,0.03287889,1.315619191230752,0.002903215178227927
66525,SIDM00834,Afatinib,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-0.29824057,-0.010467827,-0.9229678100895248,-0.0009374975276622645
40294,SIDM00411,Cisplatin,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,43.0,2.8208435,0.064866446,2.8245799718291447,0.10744293451773473
40714,SIDM00875,BI-2536,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4973196,-0.021162445,-1.217310713366375,-0.029682124486529748
76898,SIDM00628,Ribociclib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,1.9641925,0.03889062,1.2997213906512617,0.07588231314850225
62308,SIDM00628,MK-1775,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,0.8810426,0.071268156,1.8070997630365184,0.12124457668453952
90027,SIDM00875,MK-2206,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8977411,0.15863484,1.4381154210335458,0.06496050732372825
41261,SIDM00878,Doramapimod,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.277701,0.083033904,0.6667357441234765,0.08408996444257792
86447,SIDM00834,Nutlin-3a (-),AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,1.5580634,0.059738953,0.6045874086458376,0.03092938841999937
5545,SIDM00878,ZM447439,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.6745222,-0.060513616,-1.4379861804958567,-0.14073882813434846
973,SIDM00146,Paclitaxel,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.9837908,-0.09639559,-2.4924093121920223,-0.12835142741831884
97622,SIDM00529,OSI-027,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-2.3370702,-0.18615733,-1.9579344529198004,-0.12339441650196327
62086,SIDM00971,Vorinostat,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.602599,0.031125074,-0.6602777366145743,-0.0016032278463909777
42487,SIDM00878,Pictilisib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.856309,-0.103014305,-0.6514777386107259,-0.04509700987796248
33460,SIDM00529,Sorafenib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.2723627,-0.040734738,-1.0049590290397024,-0.05164018491860602
46015,SIDM00778,AZD4547,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,69.0,-2.2899973,-0.11305564,-1.107570695018651,-0.09514195836179302
33857,SIDM00673,Crizotinib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.0064025,-0.09049575,0.6900068674417633,0.07275132273582936
50856,SIDM00866,Nutlin-3a (-),5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.14185365,0.0046780594,-0.7120016326987388,-0.019028085819505925
13615,SIDM00130,Crizotinib,Ruxolitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.8429259,0.0902907,0.6946654331087525,0.05250498202217081
101120,SIDM00893,Paclitaxel,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.8233771,0.028766032,-0.570572024617596,-0.03807695903836529
73442,SIDM00146,Temozolomide,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,2.1865122,0.03382413,0.6773744743345961,0.04478138723770041
101280,SIDM00531,Gemcitabine,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.4813343,0.10127011,2.9527270448280114,0.1303478777712696
60867,SIDM00130,Palbociclib,Trametinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.65384597,-0.034699757,-1.1031046048444233,-0.022791153901025037
96145,SIDM00782,Crizotinib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,1.620491,0.13313532,0.8727669363086166,0.07602385426480522
52699,SIDM00411,Lapatinib,MK-1775,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.3704312,0.074317,1.9880442560296907,0.09610077802528487
47890,SIDM00866,JQ1,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.0970888,-0.0636078,-0.3070197069851641,0.06579652942686316
30617,SIDM00628,Taselisib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-1.5011495,-0.11456103,-0.6228011184447452,-0.025880724312192207
75446,SIDM00130,Paclitaxel,AZD7762,Pancreas,0.0625,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.9385616,-0.09586434,-0.1113901978535871,-0.033172053622588515
86088,SIDM00893,Trametinib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.2906394,0.18590808,0.33221484771417736,0.06112358582071516
86165,SIDM00531,Paclitaxel,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.49310157,-0.047283422,0.2146082597702158,0.014256690359732392
104175,SIDM00774,Entinostat,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.5902958,-0.08519984,0.3045604479291791,0.01784302376124028
41486,SIDM00776,Dabrafenib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,2.5978878,0.113944516,0.3907607960704304,0.02133544536136961
38,SIDM00774,NU7441,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.3474772,0.08826491,0.6192867409531582,0.05592278431389599
24830,SIDM00782,Afatinib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.7745693,-0.07571527,-0.6566584099792665,-0.04557876900576444
30874,SIDM00776,LGK974,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-2.3039248,-0.050854523,-1.5625059671679082,0.005720594912448217
100397,SIDM00878,Taselisib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.89210707,-0.091798335,-0.7126615585836364,-0.07867236420451747
33589,SIDM00531,Ruxolitinib,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.088684,0.10836876,1.938336551632147,0.0232622651337239
91025,SIDM00971,Paclitaxel,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.4922357,-0.098959155,-2.889537439495622,-0.07655368795238118
1252,SIDM00130,Ruxolitinib,OSI-027,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.3132515,0.028775923,1.1853897426827644,0.04479225098329805
63529,SIDM00779,MK-2206,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,1.1530725,0.08790724,-1.117706370874676,-0.033155827083934185
101881,SIDM00893,Luminespib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2350663,-0.095902935,-1.09895231331219,-0.056109283669535825
8086,SIDM00301,Crizotinib,Oxaliplatin,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-3.5242865,-0.22528836,-1.0114600341850293,-0.08959872173240538
74324,SIDM00834,5-Fluorouracil,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,White,66.0,0.37624368,0.024216468,0.46861159596642066,-0.003701812079827395
36784,SIDM00193,Dabrafenib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,53.0,-0.3189665,-0.006061268,1.7409406603632693,0.047625037013330214
42630,SIDM00359,Vinorelbine,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.9575901,-0.09626814,-3.4624513119086155,-0.08597886020636528
86575,SIDM00878,Sorafenib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,0.51342595,0.04249949,0.17943881903329642,0.049143956871579665
36878,SIDM00878,AZD6482,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,0.12918468,0.0035858068,-0.14352162619271874,0.01940639546341759
20177,SIDM00954,Cisplatin,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.95019853,0.03219892,0.7451462660933496,0.09679165382668238
15684,SIDM00971,Bortezomib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.6688942,-0.067580804,-0.9317865735770582,-0.03811404274924465
54661,SIDM00673,JQ1,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.9863235,0.12783805,-0.6134538013608092,-0.029043400395906634
69752,SIDM00774,Doramapimod,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,0.7652542,0.03939571,2.984261981482238,0.13219990156105826
86814,SIDM00097,AZD6482,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6416755,-0.08465167,-0.8538795127882841,-0.054082362319383126
81067,SIDM00193,Nutlin-3a (-),AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,53.0,1.7454083,0.04294798,0.5011449366119036,0.0029381916918815817
53560,SIDM00146,AZD6482,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,1.6859759,0.10795626,1.9730362826235441,0.21878479342469492
105845,SIDM00301,Dactolisib,MK-1775,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.0714946,-0.10829222,-0.9605834547067851,-0.02610077825822079
27982,SIDM01233,BMS-754807,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,-1.0323435,-0.051685274,-0.05371514881271276,0.07979159479764497
89320,SIDM00776,Dabrafenib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.1609926,-0.018580617,0.6017918299328661,0.05997267827264423
17520,SIDM00774,Linsitinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,10.505949,0.47596756,1.608399731708273,0.12159916621902118
40012,SIDM00529,SCH772984,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.7861916,-0.06395842,-0.14328167692484947,0.03871911456617098
50551,SIDM00332,Bortezomib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.4937252,0.02202279,1.3450789311392277,0.00254874744157837
8943,SIDM00782,5-Fluorouracil,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.412568,-0.04629955,-0.33061761841634874,0.021466573193667435
18988,SIDM00971,GSK269962A,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.75042254,0.050705962,0.06908309044799213,0.00040301663000236984
17189,SIDM00359,Camptothecin,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-4.498309,-0.26413962,-3.4158416746298204,-0.1867830978727949
32559,SIDM00878,Pictilisib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-3.1139238,-0.23968272,-1.3851172284306916,-0.14866932005094693
32111,SIDM00954,JQ1,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-1.6213632,-0.13408948,-0.7426399990031529,-0.012597883089106487
25035,SIDM00193,Palbociclib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,53.0,-2.3291166,-0.059013315,0.2922741872092676,0.05133166693150887
66028,SIDM00531,Taselisib,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.8400619,0.07382241,0.4823464341767678,0.06661215092311094
107895,SIDM00301,Navitoclax,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.901922,0.09805455,0.9501791112942698,0.09627883455286661
80640,SIDM00411,MK-1775,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,43.0,1.2076629,0.078546755,0.38769883159518753,0.06900421160613378
61639,SIDM00660,SB505124,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,2.2191777,0.20755865,0.44350893161432053,-0.023148946170952173
37361,SIDM00130,Irinotecan,OSI-027,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.5870336,-0.09628874,-0.7684684728674703,-0.0616920894667544
12948,SIDM00660,LGK974,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,0.36535978,0.014812552,0.05735240585359636,0.004841280604566347
59857,SIDM00332,Sorafenib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5442382,0.03960321,0.5161648979839553,0.076559936872661
51276,SIDM00878,ZM447439,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.029074,0.08428934,-0.955670214438882,-0.11441921033380271
99647,SIDM00893,Luminespib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.65711236,-0.051369894,-1.2041295514895782,-0.07192357442693315
83429,SIDM00782,MK-2206,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,Unknown,72.0,3.1151862,0.2818041,2.177636687138452,0.1719495767346992
45869,SIDM00332,PD173074,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5965533,-0.062844984,-0.3446520862678056,0.027014158030019813
478,SIDM00531,Gemcitabine,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.38932127,0.03042537,-0.6247869364121288,-0.016186477977754608
65250,SIDM00971,Gemcitabine,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.58936435,-0.023681844,0.20047633094171183,0.02547680865777078
5800,SIDM00971,RO-3306,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.2938776,-0.06805587,-0.903792431422483,0.003850105437048605
62931,SIDM00971,Crizotinib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.75811,-0.026863039,0.15222776430342824,0.029407099960420145
96954,SIDM00332,Nutlin-3a (-),Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,2.90556,0.123820715,1.2907564780345535,-0.0021824873231180843
77902,SIDM00146,Ribociclib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.1723399,-0.044270378,0.1799876532484948,0.05474802733169666
47572,SIDM00359,Afatinib,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.604258,0.11752552,-0.28084218314621817,0.01668179403260822
3557,SIDM00866,Ribociclib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-2.768144,-0.039308716,0.007361117996130876,0.017936037186796816
25379,SIDM00971,5-Fluorouracil,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1011481,-0.02793154,-1.337301712358173,-0.005328633859118622
2507,SIDM01233,MK-1775,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,-1.6291965,-0.10291589,0.119572802481389,-0.016216894274147894
18019,SIDM00971,SCH772984,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,5.916768,0.21749805,1.0049873059965513,0.02548675177195608
81162,SIDM00146,Nutlin-3a (-),MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.42224059,-0.012752655,1.5765214866484467,0.062143455964858756
100836,SIDM00529,Uprosertib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-0.6699324,-0.034203377,0.34543978649403906,0.11036921705454736
22296,SIDM00954,Alpelisib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-1.5385549,-0.080544524,0.2004383279056554,0.02202281484416287
52040,SIDM00875,Dabrafenib,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5928081,0.07985429,0.387805235833067,0.0017406201721045745
2261,SIDM00875,Afatinib,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.20246144,0.014387831,0.509325044670029,0.00023711049748534481
26560,SIDM00301,Olaparib,5-Fluorouracil,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.0219027,-0.0837812,-1.0643659892583097,-0.0478455694458291
95313,SIDM00782,Dabrafenib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.4707898,-0.03870085,0.5672382973113159,0.02897077845846793
13867,SIDM00097,Docetaxel,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.7090394,-0.17042042,-2.358924442406619,-0.14413832348221772
67858,SIDM00779,Oxaliplatin,LGK974,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-3.2538853,-0.19161618,-1.6716889645312831,-0.0793794395565893
81645,SIDM00954,GSK269962A,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-2.7006507,-0.14360552,-1.7973987553589015,-0.0902973827320726
17140,SIDM00875,Linsitinib,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0109793,0.07980266,0.7371653697505629,0.04759066772737196
848,SIDM00971,Doramapimod,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.12952726,-0.0046654544,0.04366844241166785,0.04301965846908802
52998,SIDM00529,NU7441,MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.5713426,-0.043110766,0.21354956387872442,0.06784139310146389
61922,SIDM00146,PF-4708671,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,1.8008319,0.04513062,2.245511881896554,0.08945704857192441
17908,SIDM00628,Doramapimod,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,0.6393501,0.020425146,1.981761207495705,0.07655563259622514
2323,SIDM00875,Pictilisib,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.14900818,-0.016271703,-0.8364984152359843,-0.0722399409502725
24147,SIDM00878,Dabrafenib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.7151787,0.052233372,1.5462936853622797,0.043459125242220294
105967,SIDM00971,AZD8055,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.0302546,-0.116614014,-1.887170169594057,-0.11098373244376186
94856,SIDM00774,Luminespib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-0.26405573,-0.025351344,-0.6178920912589564,-0.07296066094079358
55041,SIDM00332,Vorinostat,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1177882,0.088574536,0.011238705556985546,-0.054860717233799844
1468,SIDM00774,Docetaxel,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,48.0,-0.70256585,-0.08063253,-0.14592010506293918,0.02484710848140689
23539,SIDM00359,Camptothecin,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.5071875,-0.09544311,-1.6005039175006097,-0.05521759270358046
13818,SIDM00893,Dabrafenib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.2528436,0.05017722,0.33906411897751526,0.040529405064926374
616,SIDM00146,Pictilisib,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,0.94457257,0.07998923,0.5216327939415142,0.14651966332848643
46290,SIDM00875,OSI-027,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.46107396,-0.04624073,-0.6187993701626361,-0.004343525560026257
25869,SIDM00893,Temozolomide,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.6171534,-0.011493155,0.19539693019187176,0.025749992708425026
42233,SIDM00776,SCH772984,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,-1.7398853,-0.15278459,-0.9768478916317951,-0.071619296738295
77036,SIDM00529,PF-4708671,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.6936688,-0.06452784,-0.10194864245086402,0.04730117164678277
30649,SIDM00954,PD173074,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,0.35185537,0.021279229,0.9202959127374074,0.08574487032193583
90560,SIDM00878,PF-4708671,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,2.4016988,0.13887948,1.028690311155934,0.033867665520233126
45299,SIDM00332,SCH772984,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0942992,-0.05145777,0.5888605236454598,-0.022396120385174138
51885,SIDM00673,Temozolomide,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.8213618,0.012843899,1.5222881573318918,-0.010026011864997552
96399,SIDM00954,ZM447439,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-0.9238161,-0.06744488,0.09777171322860034,-0.051980725702960286
25604,SIDM00875,Wee1 Inhibitor,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7296773,0.04170514,-0.518910197789209,-0.03753612880680638
28433,SIDM00774,AZD7762,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,0.9338504,0.11103945,0.14734048351726092,0.056595433435916165
73315,SIDM00332,Crizotinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.4716632,0.20444372,1.245593002008334,0.11431718371143502
36798,SIDM00866,Doramapimod,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,5.8160696,0.108412415,3.890049858113878,0.08465718774289835
40055,SIDM00673,Navitoclax,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.34373337,-0.02859706,-0.5810266045625292,0.024380331556323156
43306,SIDM00097,Temozolomide,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.5496714,-0.009768231,0.9819844027294868,0.024290740869583133
32700,SIDM00673,Vorinostat,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.420906,0.13427943,0.2555056632548758,0.047418473966070206
71197,SIDM00529,Venetoclax,OSI-027,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-1.3143177,-0.03261265,-0.3283498820104311,0.01135885488453984
7582,SIDM00146,KU-55933,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-1.8866942,-0.054747846,0.016679881656250208,0.07112706853220171
5064,SIDM00628,Wee1 Inhibitor,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.94203407,-0.08182936,-0.04545561560817462,0.026112403244059553
52840,SIDM00529,AZD6482,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,3.2669032,0.17693146,2.4729202303498448,0.08330277105867682
106174,SIDM00878,OSI-027,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.2508126,-0.10981401,0.3349147127135256,0.09634580250562638
22445,SIDM00673,Lapatinib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.24426633,-0.021621548,-1.5097078987109254,-0.10952666235752892
89034,SIDM00954,PD173074,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-2.8132827,-0.13147877,-1.8917643787880454,-0.05291721385782513
38745,SIDM00097,Dabrafenib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.2561545,-0.11620847,-1.2091709235033006,-0.10416700737514492
98839,SIDM00130,Dasatinib,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.7977626,0.18588953,0.41158152715407753,0.06023943704503805
8326,SIDM00411,Crizotinib,AZD7762,Pancreas,0.0625,Pancreatic Carcinoma,Male,East Asian,43.0,0.8297979,0.05328911,0.5606714065295126,0.01931849871321558
78708,SIDM00097,OSI-027,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9586177,0.04388659,1.5032278100759158,0.072798725103152
24322,SIDM00529,JQ1,Taselisib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,1.9722685,0.17299743,-0.001398213046044648,0.02026519659014273
93082,SIDM00875,Olaparib,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.9066322,-0.033214916,-1.0650469090761783,-0.0592453526119432
97495,SIDM00529,Wee1 Inhibitor,OSI-027,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-0.825557,-0.07715448,-0.5716041868103756,-0.04630661542158732
80376,SIDM00301,Dasatinib,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,-2.010319,-0.13179362,-1.0956750362495065,0.02300074904488391
56995,SIDM00130,Palbociclib,Ruxolitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.5231462,-0.15480329,-1.0845520546125422,-0.08419477297175179
69869,SIDM00359,Dabrafenib,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.52243,-0.069644555,-0.7476116540159181,-0.03868366083909592
96524,SIDM00893,Venetoclax,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.3115108,-0.06967187,-0.8993528451314962,0.002151200753296245
37609,SIDM00529,AZD8055,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,2.3700097,0.22985552,0.8890183220450616,0.09936064344130131
53839,SIDM00628,Cisplatin,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.49171603,-0.045699883,-1.805279168169949,-0.11884333031789066
33762,SIDM00146,Taselisib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.6015607,-0.11130653,0.39144606021893696,0.09419400884993859
33063,SIDM00893,Tozasertib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.3012707,0.07793254,-0.30867006578009176,0.029544571640107577
74965,SIDM00866,Olaparib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,1.362689,0.025621671,0.8826340574700224,0.027802601740636545
12314,SIDM00893,Afatinib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.9185934,0.20983489,1.3766756538296328,0.050390310156073585
55851,SIDM00779,Olaparib,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,2.0345972,0.04554607,0.5197663255342396,0.026941647413441648
14030,SIDM00866,Venetoclax,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-0.45035747,-0.009787029,0.08376331595475284,0.04386797367884809
37444,SIDM00628,Dabrafenib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.71749616,-0.05808705,-0.10244960179372932,0.08365013345538948
107781,SIDM00875,NU7441,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.22423957,0.018374983,0.20829545184567488,0.020978314869946203
102290,SIDM00782,MK-1775,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,-1.0066876,-0.055571932,-1.358300467460791,-0.07454691546119098
28062,SIDM00878,Axitinib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-0.5785279,-0.05760188,-0.5896279002738394,-0.0225085446399217
42287,SIDM00130,Olaparib,Cisplatin,Pancreas,0.8,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.8302494,-0.051074132,-0.8665216843302966,-0.046904330107154904
20641,SIDM00332,Cisplatin,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.8977205,0.058416452,0.8709681731769671,0.06592625502930424
73523,SIDM00411,Lapatinib,5-Fluorouracil,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.5305942,-0.04707525,-0.7208432819104981,0.011822667162296031
97623,SIDM00778,Dabrafenib,Nutlin-3a (-),Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,0.85343415,0.021155288,0.26930775030020315,0.0017268203796488872
31672,SIDM00531,Trametinib,Palbociclib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.0926244,0.12549873,-1.1080142373959285,0.01454091990372065
90723,SIDM00866,AZD7762,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.20950526,-0.013462509,-1.2189194610970964,-0.0712849571266438
85914,SIDM00332,GSK269962A,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.0318758,0.056896266,1.3679838748420297,0.028408886701741205
36989,SIDM00875,NU7441,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.2462168,0.23708116,0.892954556667441,0.09648568257539769
89664,SIDM00660,Dabrafenib,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,3.3851597,0.2825915,0.010648693211537118,0.08105552369346744
98289,SIDM00834,Trametinib,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-1.9248599,-0.04472883,-2.1381775256762676,-0.027755581733380833
70986,SIDM00130,Olaparib,Ruxolitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.6625691,-0.042083196,-0.34788339008961416,-0.0515755960168523
55622,SIDM00529,Pictilisib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Black,44.0,0.96741503,0.050401263,-0.6357486010222442,0.026848103229320828
47828,SIDM00628,Luminespib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.7497946,-0.072425835,-0.12461689847146916,-0.027231019263757438
45515,SIDM00097,Afatinib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.18440875,-0.013634356,-0.01685170517729363,-0.02823684859219814
43534,SIDM00776,5-Fluorouracil,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-1.4015108,-0.030973533,0.5506779097105899,0.010729687170535924
35154,SIDM00097,Trametinib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.9777302,0.05942209,1.8109652843258914,0.056007149206515144
60607,SIDM00878,Alpelisib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.5704622,-0.051689725,0.20913314836963443,0.023670822299543287
32864,SIDM00411,Cisplatin,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,3.586593,0.10267612,1.9983513463763733,0.08614695289399284
42096,SIDM00971,Linsitinib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.23387858,0.010348893,0.40855046860095334,0.05426527393347104
81035,SIDM00971,Palbociclib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.50104237,0.018128635,-0.4134260032745578,0.013327003830878896
6911,SIDM00776,Vinorelbine,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,5.6080103,0.35000384,4.187580349483731,0.23298397621935432
105118,SIDM00531,Navitoclax,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.038071,0.28348604,2.1932669104352382,0.13908898098490408
7612,SIDM00146,Tozasertib,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-1.1640048,-0.076492555,0.06718082189220698,0.05050977942723936
32209,SIDM00193,AZD8055,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,East Asian,53.0,-2.2610526,-0.149287,-0.6536142842450654,0.00555978681866613
87482,SIDM00673,Afatinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.56287974,0.04276629,-0.5820026130006634,-0.044827823853596925
52382,SIDM00673,Camptothecin,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-0.747216,-0.022102691,1.156928445284088,0.06647932384920327
50224,SIDM00332,Venetoclax,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9778583,-0.027736302,-0.7355125789259527,0.010284223594624714
24323,SIDM00411,Olaparib,Oxaliplatin,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,3.2754333,0.11534226,1.3082132275909804,0.010232797556525215
49146,SIDM01233,Vinorelbine,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,4.098265,0.27443478,2.205446731668393,0.13179243522761644
100749,SIDM00774,Taselisib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,0.5424823,0.021025699,1.1934006571929947,0.06923703121769743
8137,SIDM00628,Tozasertib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-1.758924,-0.08770579,-1.164831568541466,-0.049348499441648416
88913,SIDM00332,BI-2536,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-5.566628,-0.34829158,-0.408382329681432,-0.057095546034577754
94810,SIDM00954,Entinostat,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,-1.1057776,-0.08699825,-0.673089390633154,-0.04556732153825234
104589,SIDM00893,Axitinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.5900073,0.047180783,-0.11689629470397653,-0.005762955235601971
75515,SIDM00875,Nutlin-3a (-),Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.1612012,0.044964384,1.8661222500823291,0.04538286786797854
31798,SIDM00130,5-Fluorouracil,Crizotinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.103021,-0.18487254,-2.054563363532425,-0.10166932506226807
45566,SIDM00130,Sorafenib,LGK974,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.8032544,-0.06415643,0.22771885971213013,0.01884916451881738
15131,SIDM00097,Tozasertib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2796144,-0.06513789,0.10544962989157658,-0.014397638124688592
49222,SIDM00893,Paclitaxel,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.7993396,0.059848994,-0.06689487720734229,-0.034205159926474826
58734,SIDM00774,Bortezomib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,-0.30894974,-0.021768667,-0.8796116943189227,-0.06253766286417485
56873,SIDM00954,ZM447439,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-3.8740053,-0.22391753,-1.8111799943887992,-0.15373875742604196
95768,SIDM00971,Wee1 Inhibitor,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.7708343,-0.022461418,-0.7696878365484695,0.014672917345834112
20302,SIDM00893,Axitinib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.27208093,0.015607983,0.6397855257240191,0.07525379667084198
14065,SIDM00774,Ribociclib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,0.62210214,0.02726333,-0.9628456896583331,-0.03146467765649491
47647,SIDM00776,Oxaliplatin,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.3390138,-0.08730583,-1.1689674758477404,-0.028693715917451287
85511,SIDM00130,Navitoclax,5-Fluorouracil,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.70939887,0.062183715,0.7997334614555491,0.07716345909160931
85806,SIDM00774,BI-2536,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,48.0,1.6061611,0.118422225,2.4827311947370916,0.17411070289545116
40892,SIDM00971,AZD7762,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.06397576,0.0015292803,-0.45200527653966066,0.000408177999637397
77289,SIDM00776,AZD4547,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,3.206762,0.1621461,1.242898588693499,0.03658877552636071
25081,SIDM00146,Crizotinib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.735625,-0.056922156,-0.22429436312791426,-0.00016596542601772719
17379,SIDM01233,Afatinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,-2.3681614,-0.11241787,-0.4543014077915164,0.022934861406601524
37820,SIDM00301,Navitoclax,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,3.1060998,0.23072337,3.335844453439195,0.1807504980046358
28597,SIDM00531,5-Fluorouracil,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.9508087,0.02801566,2.80356749017651,0.058787172531902694
87666,SIDM00774,5-Fluorouracil,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.89364034,0.11081934,-0.7910325718633937,-0.04185888701848725
78400,SIDM00954,Palbociclib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-2.007808,-0.081226714,-0.8130012626320897,-0.021865534517200087
27921,SIDM00411,Irinotecan,Trametinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.6856308,0.14810152,-0.20780195208596222,0.06098462443837725
98144,SIDM00097,RO-3306,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.06366,0.05887361,0.5480572128510295,0.029722375193253037
84868,SIDM00954,Dabrafenib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.83319944,-0.029001996,-0.9545100744056104,-0.003592032634160813
78706,SIDM00529,Navitoclax,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-0.10797441,-0.009876076,1.2218096500959517,0.08159778175036873
75953,SIDM00893,AZD7762,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.3585625,0.07877649,-0.3777950202531357,-0.00014486002056089507
17605,SIDM00878,Ribociclib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.8203957,-0.042282894,-0.4988036266095645,-0.019632395934030697
103005,SIDM00193,Taselisib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,53.0,-0.5539808,-0.055972766,-2.2433423454636876,-0.09673267548029942
418,SIDM00332,Uprosertib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7107378,-0.09560183,-2.7315316249854527,-0.13383881205787057
21913,SIDM00673,AZD7762,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.7925263,0.056342598,-0.4037023671985394,-0.000442503964729357
36573,SIDM00146,Lapatinib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.32623407,0.029301984,0.5304092696868186,0.047957695377838214
74257,SIDM00529,AZD6482,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Black,44.0,1.5181714,0.06499431,0.5828972818158136,0.043469234314944205
101597,SIDM00875,Docetaxel,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5959375,0.09821075,1.8738473081240432,0.16284042657851538
40213,SIDM00301,Dasatinib,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.7641189,0.07714984,1.0795167845097504,0.0946768261199156
25594,SIDM00529,Alpelisib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-1.3137412,-0.06245525,-0.5890560475390711,0.009984245706597108
70588,SIDM00893,Bortezomib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.18105012,-0.018114403,-1.102364423101218,-0.029966197432782872
88590,SIDM00146,Gemcitabine,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.8718547,-0.0598745,-1.516429737592495,-0.13521381579723188
88341,SIDM00834,Navitoclax,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,1.4653419,0.11611364,1.0205273312586134,0.06358834245494173
32912,SIDM00954,Tozasertib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-3.3793912,-0.17670242,-1.5736612001557773,-0.09740005170718807
25874,SIDM00660,AZD8055,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-0.3109118,-0.022717124,-0.022837804049904837,-0.0177785479093668
76883,SIDM00529,SCH772984,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.3206006,-0.049132142,0.07881843289020016,0.031894463726991056
9005,SIDM00146,OSI-027,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.0148892,0.0868388,1.0435423029274058,0.08094045754907715
34052,SIDM00893,Gemcitabine,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.3379622,-0.10725789,-1.1195736697276606,-0.024246820690773222
35417,SIDM00301,Sorafenib,MK-1775,Pancreas,0.2,Pancreatic Carcinoma,Male,East Asian,50.0,-0.98964685,-0.123028815,-1.2801814055380758,-0.05915387273887866
4416,SIDM00776,LGK974,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.5932627,-0.029616585,-1.3329830509622613,-0.007370062608650943
40112,SIDM00866,Olaparib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-1.741463,-0.03295627,-0.20783429323176736,0.031553903780685365
48762,SIDM00097,PD173074,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2788361,-0.051566336,-0.5255692200351206,-0.041298794895052324
74137,SIDM00332,Trametinib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1600568,-0.11217634,-0.8484515940227774,-0.036228503474753676
107487,SIDM00954,Bortezomib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,0.45615807,0.023987897,-0.9207400631709001,-0.03329754704911535
21481,SIDM00954,Afatinib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-1.2142816,-0.09418706,-0.9332478582540943,-0.012778064777804196
73849,SIDM01233,Vinorelbine,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-1.416823,-0.06266649,-0.19330921386935715,0.0930392396687641
37162,SIDM00531,Dasatinib,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.31618303,0.03627339,1.1082745272967474,0.0885728770962036
815,SIDM00878,MK-2206,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.7538812,0.07360119,-0.3748725330574382,-0.031793299284075975
96969,SIDM00660,Afatinib,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,0.7697526,0.07725404,-0.345347058348314,-0.027774606604655583
47771,SIDM00130,Dactolisib,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.2920392,-0.11881585,-0.4771489179177166,-0.03358453231351663
107876,SIDM00628,Navitoclax,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.35338253,-0.034206074,0.64408820336501,0.04266934320006059
81471,SIDM00778,5-Fluorouracil,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,69.0,-3.1630828,-0.06781575,-1.3996278612382282,-0.03333794771506044
107728,SIDM00097,Wee1 Inhibitor,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0994282,-0.050079003,0.19105407803982566,0.0017638865214619744
47155,SIDM00878,Camptothecin,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,70.0,2.4886167,0.08764284,2.8461127381349343,0.07278581621293781
78363,SIDM00097,Wee1 Inhibitor,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.3160539,0.09282098,0.08025010936194266,0.009836947610500428
72022,SIDM00301,Cisplatin,MK-2206,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,50.0,1.214756,0.15160453,0.4068610181277255,0.09231826661209251
57208,SIDM00971,KU-55933,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.9736176,-0.028031705,0.9721749359758098,0.07187984868635156
32714,SIDM00834,BMS-754807,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,White,66.0,0.24241301,0.020973464,-1.7951059055023941,-0.07543503159570016
25066,SIDM00776,Camptothecin,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,65.0,-2.3319275,-0.15061611,-1.5663592239877913,-0.07436281886558986
63660,SIDM00954,PD173074,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,-3.2333548,-0.13828605,-1.2400450669922405,-0.028903268384885158
36856,SIDM00878,Doramapimod,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,-1.7678078,-0.08372179,-0.4661093761325102,0.03997250490246702
74192,SIDM00893,Cisplatin,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.75979483,0.022891758,1.461547868214194,0.024906031192486907
68586,SIDM00531,AZD7762,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.7499239,0.051851455,0.8863324523568342,0.06053501680905491
67680,SIDM00411,OSI-027,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.4524689,0.07277052,1.715253387806832,0.12004495463854606
55757,SIDM00866,Uprosertib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-1.9501436,-0.09696094,-0.9864481467067142,-0.03534774728846664
75906,SIDM00776,Dabrafenib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,2.47854,0.13306156,-0.8730110995517062,-0.03570727599330455
53917,SIDM00774,AZD8055,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.4126561,-0.09353612,-0.4729140678057335,-0.023401598617149806
100974,SIDM00332,Bortezomib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.4089839,-0.024891209,-0.42387534109408465,-0.05452591639736092
811,SIDM00146,Lapatinib,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,0.787432,0.07010524,1.053131196980643,0.09391293069350691
10448,SIDM01233,Crizotinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-1.8145486,-0.088851,0.23925330570191478,0.011935536604054966
64448,SIDM00130,Irinotecan,Ruxolitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.7618672,-0.079801306,-1.145169623014776,-0.05581018912926687
15173,SIDM00097,Navitoclax,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.5716272,0.040523198,-0.07877256603756391,0.06866274710258614
19679,SIDM00779,MK-1775,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,-2.2849164,-0.052009966,-2.9472215614739077,-0.06414500835502036
59563,SIDM00893,KU-55933,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.5810274,0.05687202,1.319972220853821,0.006801655901397706
70587,SIDM00529,Linsitinib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.35940543,0.017087128,-0.1891343109908691,0.00743968144631761
82479,SIDM00954,Ribociclib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,1.2258308,0.034520455,0.5073596917968679,0.08698526767026664
77834,SIDM00301,SCH772984,Crizotinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.4076349,0.13964267,0.039679449189226355,0.01513202833054244
31539,SIDM00875,Luminespib,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.83974785,-0.087926224,-0.823046993997374,-0.0667005845862459
104095,SIDM00097,Taselisib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-5.5457273,-0.26143408,-2.7037305871766932,-0.1434682896353206
55989,SIDM00130,OSI-027,Palbociclib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.7481173,-0.07007137,0.3813868626741363,0.04355739943425275
43827,SIDM00875,5-Fluorouracil,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.098515,-0.10821324,-1.1806547842796837,-0.03974820272869782
87740,SIDM00875,RO-3306,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4157037,-0.045735564,-0.9677475456243562,-0.07299004875136708
56355,SIDM00954,Nilotinib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-2.6960902,-0.20116861,-1.3272097868800503,-0.1165367532028987
43702,SIDM00971,Nutlin-3a (-),Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.5792842,-0.017184597,-1.089292366043455,-0.0023632664658710567
78995,SIDM00774,Docetaxel,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,1.547281,0.056763995,1.8825102673049843,0.07640855391774852
23448,SIDM00097,Gemcitabine,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,6.1237555,0.32346106,1.9180541385890568,0.18128397423121947
7816,SIDM00097,ZM447439,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1236615,0.057851773,-0.009927076140222809,0.04591119854307723
85940,SIDM00660,AZD8055,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,-0.021578696,-0.00197865,0.019712719008825114,-0.03311356611229604
57388,SIDM00146,Wee1 Inhibitor,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-3.4101868,-0.13379967,-3.5746092406442447,-0.15825602079224535
27042,SIDM00529,Dabrafenib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.0280033,0.022028463,1.029949732970489,0.06851656975166104
100070,SIDM00776,AZD4547,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.2426248,-0.030324647,0.37616167916047927,0.05374739882669676
72979,SIDM00774,NU7441,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,3.6758873,0.25618693,3.053336825352722,0.17099634400158503
71265,SIDM00971,Temozolomide,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.9823405,-0.045064375,-0.781909579681144,-0.011243084751717803
77695,SIDM00971,5-Fluorouracil,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.76670176,0.022035938,1.0126316637988415,0.07632799613926508
42128,SIDM00411,AZD7762,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.73570794,-0.020425696,0.9121122423069662,0.07309313362893484
57260,SIDM00834,BMS-754807,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,0.6654747,0.056858145,-0.9894409727312814,0.01717137909308114
106433,SIDM00954,MK-2206,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-1.2421199,-0.07563248,-0.37025562538356127,0.030296945349093357
85540,SIDM00529,Navitoclax,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-0.29294538,-0.028323574,0.26943746640549743,0.01795014400585597
21630,SIDM00866,Wee1 Inhibitor,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-2.2169108,-0.15827584,-1.488509110028051,-0.012272819108954976
59734,SIDM00878,Olaparib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,5.1719747,0.42348474,0.6129722810612724,0.026695978863964888
76789,SIDM00673,Cisplatin,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.2349137,0.05512198,0.5909742284644148,0.06763263402279171
106994,SIDM00954,Temozolomide,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,0.5188519,0.009729902,2.2538708548805557,0.04354604434280923
15722,SIDM01233,MK-1775,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,0.75625706,0.06043136,-0.11811641418259017,0.013984106438742015
82548,SIDM00774,MK-1775,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.7513326,0.08676194,-0.06196736618568454,0.07873780246518364
4532,SIDM00673,OSI-027,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,0.20302917,0.019762995,1.082423105260978,0.03839550878782248
100727,SIDM00130,OSI-027,Sorafenib,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.5973394,0.061327755,-0.0631676469966021,0.002960662185388667
20569,SIDM00097,Venetoclax,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5925411,-0.046041105,-1.1233976588891799,-0.035458459924407215
64995,SIDM00875,Docetaxel,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.34456775,-0.02393192,-0.49846044898210135,-0.042402615858543075
86112,SIDM00779,LGK974,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,3.2731495,0.06606184,0.0847163445137379,0.022965969767876935
10968,SIDM00411,Taselisib,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.0275128,-0.04795025,0.36149000552690497,0.06346462900340244
9159,SIDM00097,MK-1775,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5597569,-0.06025792,-0.492677530734718,-0.06631451665473358
32045,SIDM00774,Vorinostat,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-0.11733845,-0.008171302,0.3802972107285332,-0.04596536539427608
93166,SIDM00866,ZM447439,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,1.0465381,0.0751891,0.9121686777267703,0.06916498505383284
31123,SIDM00673,Trametinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,3.445384,0.18982655,-1.1944441340729233,-0.046663965377209335
15165,SIDM00146,Docetaxel,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.7839871,-0.071650945,-1.595464795836857,-0.1377144033859771
34479,SIDM00673,Crizotinib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-2.1714048,-0.1652861,-0.8862100726089797,-0.037277874834324806
70381,SIDM00130,AZD7762,Palbociclib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.6621058,-0.20858982,-2.2056493286629264,-0.14750843686568657
20158,SIDM00954,Sorafenib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,1.549595,0.11875309,0.0662678481034322,-0.009059061599056466
87822,SIDM00779,Navitoclax,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,0.29510888,0.009699266,-0.2823787639547971,-0.04310945672957183
70201,SIDM00332,SCH772984,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.1621544,-0.10115498,-1.0816700558832817,-0.07941975511371421
99156,SIDM00673,Camptothecin,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-1.1748239,-0.030378776,0.4216449519288008,0.03864043031021817
71957,SIDM00774,Luminespib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,2.9856942,0.03214447,-0.5884155492926536,-0.050357328946179565
87694,SIDM00628,OSI-027,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-1.1622251,-0.10484317,-0.5452558308591523,-0.025782936704848762
46690,SIDM00097,AZD7762,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.0994303,0.109176256,0.529322999972545,0.05247163041364258
96072,SIDM00782,Oxaliplatin,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-2.3550878,-0.08600038,-1.2974343014469691,-0.011824460293633977
41858,SIDM00893,Tozasertib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.9439341,-0.0823501,-2.259866588958831,-0.032980646372395166
97699,SIDM00673,Docetaxel,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.44551343,-0.044188008,-1.0655599764877524,-0.07820020983101172
82337,SIDM00866,Temozolomide,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.1586142,-0.017382003,1.321178042998621,0.025365463615917364
23296,SIDM00529,JQ1,PD173074,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.1371487,-0.06396161,-0.20138956382007975,0.047003554405135775
49180,SIDM00628,Wee1 Inhibitor,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,1.0853493,0.09268371,1.1172464575063545,0.11037870625610384
73824,SIDM00097,KU-55933,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2552924,-0.05652663,0.4385630671411612,0.047161189732418445
70683,SIDM00673,Ribociclib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.301113,-0.07628042,-1.1676829552646582,-0.00312188071444653
29356,SIDM00529,AZD7762,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.19431835,-0.012803018,0.42581949331711316,0.03268091090864637
62214,SIDM00774,Dabrafenib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.55712837,-0.013496012,0.6582682253326971,-0.02184801038033839
86244,SIDM00130,Dasatinib,Gemcitabine,Pancreas,0.1,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.52888894,0.019068757,1.7467159367094955,0.09867136108193786
22775,SIDM00673,KU-55933,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-4.475246,-0.1675437,-2.3132142667765607,-0.1090672296465243
18990,SIDM00628,Docetaxel,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-4.036525,-0.12101655,-3.833325661576463,-0.3083440042534313
83784,SIDM00529,Uprosertib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.8250646,-0.04345279,0.746915256285587,0.14508531321187598
17832,SIDM00359,LGK974,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,3.7053254,0.1362377,-0.5532178513413777,0.032861534668841376
76328,SIDM00971,Paclitaxel,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.6349773,-0.076016724,-3.236427285491257,-0.06955352004358921
98242,SIDM00130,SCH772984,Taselisib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.7070322,0.22663912,2.521657473912487,0.15287912846046395
59761,SIDM00866,Olaparib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-1.7162051,-0.035784665,-0.44601792070850177,-0.007449293161515178
104305,SIDM00834,Olaparib,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,White,66.0,-0.6368131,-0.013424415,0.9602212430457523,0.0821175048255859
64387,SIDM00866,Crizotinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-1.8727787,-0.051543176,-0.24156011298376498,0.00950002972618478
6826,SIDM00332,Linsitinib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3808777,-0.039084073,1.3903078396692736,0.027907074098463
84389,SIDM00529,Doramapimod,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,1.4823332,0.060187124,1.302271644664209,0.07700106430878698
4458,SIDM00097,Doramapimod,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.9227216,0.10769415,2.220347418372542,0.07931247061367003
66822,SIDM00774,PD173074,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,2.519315,0.30682603,-0.21516409718880936,0.06956506700178783
75675,SIDM00782,5-Fluorouracil,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.4279457,-0.048591778,-0.045057186994612586,0.019242298914808127
48282,SIDM00878,Pictilisib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.65048397,-0.066106535,0.6252804281200641,0.04043947736295203
29067,SIDM00779,Taselisib,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,3.6700027,0.10342961,1.058251227667159,0.05379934507089015
71838,SIDM00971,Vorinostat,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.3388011,-0.082515225,-0.9506886746881298,-0.008198245357676461
33145,SIDM00301,Dasatinib,Sorafenib,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,50.0,0.60995305,0.06398304,-0.5900154679730533,0.023744606864684645
45940,SIDM00660,LGK974,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,0.85691094,0.05238238,0.6582292337091676,0.0544907223592873
27383,SIDM00146,SCH772984,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.40633824,-0.036123395,1.8708578563247575,0.07208745495480001
18468,SIDM00878,Entinostat,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.9739749,-0.039357148,0.2673606454291812,0.013619534182716551
5211,SIDM00893,Alpelisib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.026187,-0.08939865,-1.11359531613108,-0.08431880380108757
38258,SIDM00660,Dabrafenib,Oxaliplatin,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.58926374,0.056506097,-1.7628294840072567,-0.08196491787094218
59023,SIDM00866,Paclitaxel,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-0.12587476,-0.011107396,0.20139772002951908,-0.010365809068405469
26057,SIDM00411,Palbociclib,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.5505939,-0.061274737,0.007977570871868773,0.04899976497313713
105811,SIDM00866,Ribociclib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-2.8460884,-0.099038966,-0.14434411098464556,0.010417771519005659
4020,SIDM00834,Linsitinib,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,0.6963269,0.059130035,0.31828842991827266,0.044232683573482215
50122,SIDM00146,Venetoclax,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,2.2550554,0.074657336,1.4146363643505744,0.07103822678881762
67161,SIDM00531,Gemcitabine,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.018971,0.07208257,-1.3020302367215497,-0.04207097004713772
25805,SIDM00971,Ribociclib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.2894273,-0.0629133,-1.9108130482032937,-0.03446963143381156
92685,SIDM00193,SB505124,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.62146455,-0.054636355,0.8173640903745196,0.01918515139340337
54125,SIDM00660,SCH772984,Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.65821874,0.029288176,-0.017991032554394545,0.011381738307438943
56706,SIDM00529,Alpelisib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,0.42026988,0.027341768,0.6047472517915251,0.0799281006438786
108414,SIDM00628,JQ1,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,4.8142715,0.40866712,2.039173128493082,0.13541826658848724
44788,SIDM00866,Doramapimod,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,1.7361456,0.04545265,1.942711977905452,0.06485802647072711
106782,SIDM00529,Navitoclax,Luminespib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-0.118520334,-0.011444967,-0.1986830121674898,-0.04692972367642455
81972,SIDM00097,Linsitinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.723337,-0.08300497,-0.48173382151488153,-0.03008876641770635
59296,SIDM00875,KU-55933,Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5471987,-0.06400408,0.31437222461765213,0.07222559212593793
55692,SIDM00628,GSK269962A,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,1.6864777,0.15608703,0.2631030801614412,0.0153823675897152
5079,SIDM00779,Vinorelbine,SCH772984,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,33.0,0.6641075,0.06324757,-0.10447001020545289,0.02037680544569866
36605,SIDM00628,NU7441,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,Black,51.0,-0.4074034,-0.04016702,-0.45631410014126145,-0.006730008285908999
98799,SIDM00866,Temozolomide,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.2836721,-0.02086473,1.090504857050325,0.006601897861991244
88157,SIDM00954,GSK269962A,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.0,-0.45684367,-0.037603408,-0.48879999577537503,-0.018132317196941108
41385,SIDM00866,MK-1775,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,0.2661689,0.020233033,-0.5154822565457998,-0.06496374455078847
15387,SIDM00660,Navitoclax,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,3.375182,0.24546577,-0.3822822287907346,0.007854396817128613
97506,SIDM00411,OSI-027,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.2862766,-0.11885635,-0.33954956377992845,-0.03273367464330759
41808,SIDM00628,Docetaxel,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,-1.8431146,-0.13359813,-1.3796031019750177,-0.10073017985694929
105839,SIDM00834,Olaparib,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-0.63063467,-0.013423303,1.0275011691572626,0.04011904844431079
58231,SIDM00954,Palbociclib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-2.1056473,-0.08909299,-1.0885534435248096,-0.07998785316950639
35549,SIDM00673,KU-55933,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,49.0,-3.6636736,-0.16138645,-2.4160211513163197,-0.09177136573016748
106568,SIDM00673,Axitinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.2816792,-0.08933897,-0.7066539308918295,-0.039845855587101534
39377,SIDM00628,Wee1 Inhibitor,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-1.3603729,-0.10613374,-0.3266412484161221,-0.04806506261054331
54320,SIDM00774,Uprosertib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.64538306,-0.047263324,1.1605183185036034,0.07727780287399298
15188,SIDM00332,Dabrafenib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.2900107,-0.12955165,-1.1919182748078438,-0.10034288716813528
35467,SIDM00146,GSK269962A,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.8478084,-0.059111807,0.7854586364319928,0.03763531469902947
34215,SIDM00332,NU7441,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.95874804,-0.05143031,1.5748944540272394,0.1151775234780608
40757,SIDM00529,Crizotinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,1.6003078,0.1025067,0.2953120814640791,0.09519264068997706
53466,SIDM00531,Navitoclax,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.8426718,0.11150593,1.4158367051866554,0.0833162031692216
91484,SIDM00875,Cisplatin,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4676046,-0.022557093,0.151398394671309,0.023056361516459036
29559,SIDM00893,Cisplatin,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.39437145,0.010267069,1.3299187484422568,0.03875834970503357
53269,SIDM00628,Afatinib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.93603534,-0.079166405,-0.8745731062963287,-0.0650263904490265
33723,SIDM00866,Alpelisib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,0.35070285,0.029502846,0.6576004535684196,0.04902491436766719
7552,SIDM00875,Nilotinib,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.85793054,0.07086956,0.27812400529255615,0.005465119161868925
59463,SIDM00774,Navitoclax,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.3726981,0.029918661,0.014907942733785474,-0.040807477420435855
83830,SIDM00866,5-Fluorouracil,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-1.5395675,-0.060163118,-0.9888540689967927,-0.011813872089579425
51399,SIDM00146,Docetaxel,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-1.8405515,-0.12292654,-0.3434222360711416,-0.0019237931322324542
81935,SIDM00866,Linsitinib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-0.83878475,-0.04241927,1.070804558694795,0.05553767741758723
63363,SIDM00146,OSI-027,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.37019226,-0.036181215,-0.620897924566356,-0.07877752843250645
66001,SIDM00971,Ribociclib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.774637,-0.077780925,-1.8242796525145806,-0.039992873947736395
31699,SIDM00146,BI-2536,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-2.4431925,-0.107954435,-1.4558428612368124,-0.045687446698943396
7911,SIDM00097,OSI-027,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2656343,-0.13891158,-1.010888564671871,-0.13371454052742343
52355,SIDM00673,Doramapimod,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.0431124,0.023257002,1.8078977047505662,0.05103622040596568
67065,SIDM00146,Doramapimod,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,3.30639,0.24769558,-0.2301401857387107,0.007473143515562224
39490,SIDM00097,AZD7762,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.2942057,-0.10894578,-1.1485881947185317,-0.09098977188908522
19897,SIDM00954,Doramapimod,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-1.235703,-0.050609622,0.5331793751940875,0.09539058305444502
4863,SIDM00332,BI-2536,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.8073351,-0.09159394,-1.7029987598945282,-0.09088999450953923
50895,SIDM00782,LGK974,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,1.4145033,0.11950435,-1.6199415341357124,-0.04477712140213704
44193,SIDM00782,Palbociclib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,0.5601046,0.012000117,2.4696291018267966,0.058096052344146096
10317,SIDM00130,Dasatinib,OSI-027,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,3.9325466,0.28801122,0.7686380169184687,0.07699510518098196
49484,SIDM00529,GSK269962A,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Black,44.0,-0.7889437,-0.064275146,-0.6637486598865281,-0.015900122931712033
18181,SIDM00875,Pictilisib,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.2927593,0.034510393,-0.029941615990443083,-0.0058173240795411935
66223,SIDM00875,Paclitaxel,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.1835089,-0.11708864,-0.5103248897086909,-0.05164760366656138
82433,SIDM00878,Nilotinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.1807308,0.10899441,-0.22087893825172192,0.006326402649050051
87428,SIDM00660,MK-1775,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,-0.54172564,-0.021599473,-1.7411948807758757,-0.06445637936042681
79453,SIDM00531,Trametinib,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,5.7197995,0.56751645,1.7283486142745603,0.13009606907469198
42434,SIDM00130,Linsitinib,SCH772984,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.985765,0.22059934,2.598210466618873,0.10467577594146925
7239,SIDM00875,Venetoclax,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9279888,0.0075825527,2.1070049780187543,0.06722996834719655
103622,SIDM00878,MK-1775,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.6949291,0.07847802,0.013197971413942952,0.01499557786985611
7651,SIDM00779,SB505124,LGK974,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-1.4723585,-0.14372471,-0.9867497788850849,-0.06997774703031695
27493,SIDM00954,Uprosertib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-2.4923463,-0.18008275,-1.3319015156450584,-0.13071579809959555
36977,SIDM00893,ZM447439,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.73346376,0.05867201,-0.6371692221132746,-0.007458275996072879
3790,SIDM00660,BMS-754807,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,-0.23156449,-0.02498275,0.3383961018761695,-0.015550531852473355
16630,SIDM00834,Trametinib,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,White,66.0,-1.0300604,-0.034425955,1.1247456337302828,0.04586117154737938
92842,SIDM00531,Cisplatin,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.7121233,0.07292726,-0.10201325810510165,0.029474947687513825
25505,SIDM00411,Olaparib,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.2560389,0.033455838,1.4472455630013554,0.01608921430413965
82672,SIDM00146,Venetoclax,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,1.2307814,0.029465238,1.2995376638687464,0.07431353996461862
108193,SIDM00893,AZD6482,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.7047084,0.05900853,-0.07740022800678488,0.0371313388073427
101596,SIDM00779,AZD7762,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,33.0,1.1053047,0.08112279,2.168959950873625,0.06016768145662675
8936,SIDM00866,Alpelisib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-0.71580595,-0.056050755,-0.2661812181206558,-0.04316113150591008
104013,SIDM00660,Camptothecin,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,4.1576114,0.39315858,2.270074866260165,0.14770812914141637
458,SIDM00893,BI-2536,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.5609915,-0.044990074,-1.9959999892389821,-0.14293940376099443
1573,SIDM00332,Docetaxel,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5123552,0.14939399,-0.6201063821871419,-0.0011758985143200625
36981,SIDM00782,LGK974,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,0.50592774,0.044049393,-0.7231423803751407,-0.03895193178241789
70897,SIDM00834,Navitoclax,AZD4547,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-2.312889,-0.12578022,-0.45649559013411084,-0.03547015670098848
21885,SIDM00660,MK-2206,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,2.408623,0.16035895,0.7936441388644873,0.07285374342751973
57359,SIDM00673,Luminespib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-1.2055473,-0.10843112,-0.2157290406815188,-0.037991182655256986
17398,SIDM00778,Vinorelbine,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,0.40267405,0.02468482,-0.7140436542424252,-0.04505973563158617
8698,SIDM00411,OSI-027,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,-0.9096922,-0.036776837,0.5651274801845814,0.0487347685781342
25951,SIDM00776,Olaparib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,65.0,-2.0331807,-0.073222876,-1.2130737976680577,-0.04973459030387595
60706,SIDM00332,Temozolomide,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,1.8242767,0.054305967,0.9677092624478797,0.03633963104936504
51083,SIDM00660,AZD4547,Dabrafenib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,-1.2383265,-0.04614541,0.37088718350219285,0.03584437795710494
24799,SIDM00628,AZD8055,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.11134459,-0.009894206,-0.8419573561212574,-0.06492653273629335
82230,SIDM00774,Gemcitabine,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,2.8398116,0.23747782,1.7250952512569846,0.07100136843395734
46185,SIDM00531,Taselisib,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.6154979,0.050176825,1.1412820268533086,0.13282460038407873
44210,SIDM00774,RO-3306,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.50667036,-0.02843239,-0.7971341491981082,0.0034502393044822167
26808,SIDM00411,Navitoclax,Linsitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,1.7328353,0.094991885,1.4129262330700574,0.13519772120080364
59422,SIDM00971,Luminespib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.161481,-0.06488102,-1.7223047379936158,-0.06899604621550333
39450,SIDM00673,PF-4708671,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.9209964,-0.110818535,-1.1609027866016275,-0.06115302858530096
40942,SIDM00529,Taselisib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-2.072577,-0.10404171,0.14830960294776324,0.045293235417419406
67335,SIDM00673,Entinostat,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.1737107,0.09264572,0.5698661326863655,0.07045796023660218
16039,SIDM00971,SCH772984,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.0618885,0.023673039,1.4737440419205228,0.05110542945984335
87311,SIDM00673,OSI-027,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,1.308588,0.106161155,-1.0447392477577913,-0.0897239340401547
31737,SIDM00529,Dabrafenib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,2.2849164,0.06518107,0.7646428302720695,0.08085441894620411
22116,SIDM00628,Venetoclax,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-2.4497888,-0.08684342,-0.870178177720003,-0.0010722528720704912
22645,SIDM00411,5-Fluorouracil,MK-1775,Pancreas,0.2,Pancreatic Carcinoma,Male,East Asian,43.0,-1.1090162,-0.03506038,-0.40599043458114686,0.010778377564641353
24371,SIDM00779,LGK974,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,1.0280172,0.033857428,0.21414215480357332,0.026953958074018066
54588,SIDM00893,AZD6482,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.35097966,0.029777719,-0.08806456323201939,0.05349276287228548
63527,SIDM00332,Ribociclib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.0721517,-0.08782431,-1.2973296539139163,-0.017653374662473405
69386,SIDM00673,KU-55933,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.2250637,0.08825983,-2.3785252659417724,-0.1269455950310911
27514,SIDM00779,Nutlin-3a (-),AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,0.72333306,0.009829086,1.4825907709062829,0.11577468937125684
52993,SIDM00971,Gemcitabine,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.8976927,-0.091917366,-1.4855031758156128,-0.05293101067123021
63970,SIDM00774,NU7441,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.8177897,0.049975418,-0.10254254503570712,0.04404431926827927
27120,SIDM00971,BI-2536,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.059834,0.119645685,-0.9649776332414646,-0.03055767827799697
75028,SIDM00146,Venetoclax,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,1.36353,0.03672843,0.5745074205488401,0.07544844849770035
97645,SIDM00878,RO-3306,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-1.0445099,-0.06936099,-0.8319661354111837,0.0023848507476012955
86390,SIDM00893,Wee1 Inhibitor,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.5027265,0.04419906,-1.0830032584635472,-0.0819332507590971
22877,SIDM00866,Temozolomide,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,52.0,-1.1408908,-0.020420875,2.3156089156165707,0.01366710999698512
107210,SIDM00774,Nutlin-3a (-),MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.5473292,0.03041927,2.009489380609664,0.02702470359261286
103752,SIDM00875,AZD6482,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1006931,0.08804414,0.42339902605493446,0.01647223529475064
66107,SIDM00875,Venetoclax,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.46045625,-0.010168187,0.09104588177644016,0.006094441714443724
81604,SIDM00875,JQ1,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8164541,0.069766,1.2069985148369533,0.008132458076031976
13891,SIDM00673,Bortezomib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6431961,-0.0267361,-0.7974095733745251,-0.034631240721648145
75725,SIDM00779,MK-2206,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-0.5649809,-0.047635116,-1.557630059192797,-0.08525053258501832
43271,SIDM00774,PD173074,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.85169965,-0.04973155,-0.1349710794857881,-0.017863433753121112
8446,SIDM00774,Entinostat,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.0921054,-0.11127027,-0.09720264900206765,0.007074147915598829
14693,SIDM00332,Bortezomib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.3426067,-0.020557988,1.075640540513592,0.02051090671005613
8027,SIDM00130,Sorafenib,Gemcitabine,Pancreas,0.01,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.82461584,-0.033559795,-1.6735959813289787,-0.07664407869719894
93553,SIDM00097,Navitoclax,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.31969988,-0.02157811,2.872489314832156,0.1341257517389983
28726,SIDM00834,Taselisib,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-2.2350392,-0.14011309,-0.3007483596602298,0.05170010794047032
91950,SIDM00673,Cisplatin,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.4592221,0.02695296,3.818622716544796,0.11989978300520689
29041,SIDM00529,GSK269962A,PD173074,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-2.0590665,-0.13859902,-0.3318847850050569,0.030519298947727546
103316,SIDM00097,Palbociclib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.414504,-0.08126733,-0.6983132701135795,-0.04709835918385159
4883,SIDM00778,Navitoclax,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-0.6689495,-0.028026566,0.21241765806542992,0.014760342162504585
67996,SIDM00628,Lapatinib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,0.5004098,0.039442495,-0.36220751654714417,-0.02215139851118152
19013,SIDM00628,Luminespib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-2.5452623,-0.14178474,-1.6840298156898619,-0.07895208199199684
73553,SIDM00866,5-Fluorouracil,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,-1.3186978,-0.0442593,-0.6644658746067453,-0.03511642281394657
87032,SIDM00529,Wee1 Inhibitor,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Black,44.0,0.34042105,0.030635137,-0.10501146577998263,0.045154441908151675
10177,SIDM00531,Palbociclib,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.3439182,-0.05110811,-0.737462998138146,-0.03204739890288783
50638,SIDM00875,AZD6482,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4178382,0.13369487,0.35132129481088165,0.006639580123519426
60188,SIDM00628,MK-2206,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,3.295171,0.226516,2.4255781745040346,0.18297797425516876
74346,SIDM00782,Olaparib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.1113372,-0.027988195,0.9011581932225179,0.007826980224550851
45793,SIDM00097,Linsitinib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.7087634,0.22425742,0.6403658145302957,0.030544399800525986
100645,SIDM00878,Entinostat,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-1.1983994,-0.046852965,0.6602783093637857,0.05894538365072957
26816,SIDM00628,Nutlin-3a (-),PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-2.8119004,-0.11924433,-1.7100484932760396,-0.05334281723335451
43631,SIDM00097,KU-55933,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7157338,-0.056776997,-0.07355923461169879,-0.014332280933494384
47129,SIDM00774,Entinostat,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,3.0939362,0.15293334,3.9218493035468516,0.13683764353966227
20072,SIDM00834,Olaparib,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,1.7811289,0.052029356,1.8381513207913152,0.055645951754949706
23235,SIDM00673,AZD7762,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,0.92237586,0.06194278,-0.4885219879406374,-0.04121783419862436
51609,SIDM00778,Trametinib,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,69.0,-2.5983584,-0.09161217,-1.0921479948743265,-0.07908774362489872
38891,SIDM00866,BI-2536,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.4450039,0.061610844,-0.43633645089469936,-0.05805577594077787
73456,SIDM00893,Alpelisib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.7181226,-0.15298301,-1.5746702652909064,-0.15529534628779476
29333,SIDM00774,Alisertib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,48.0,-0.37077567,-0.025518732,-0.6588786737193291,-0.05800013364097083
93702,SIDM00774,Wee1 Inhibitor,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.1626326,-0.05113985,-0.3465227222311898,0.009178356107709843
29290,SIDM00779,Vinorelbine,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,2.9144506,0.14489226,1.1856678199143535,0.07338111163819723
104762,SIDM00778,LGK974,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,4.47424,0.18378083,-0.14455338094651873,0.017641988506478596
49282,SIDM00866,Navitoclax,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-2.1501546,-0.064588614,1.521774853309948,-0.023189615563304896
44336,SIDM00529,SCH772984,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.2982331,0.01447917,1.8026525421830568,0.15467270922384924
102181,SIDM00954,PD173074,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-3.5133836,-0.17195871,-0.7471394098453213,-0.07047567054106824
70903,SIDM00146,5-Fluorouracil,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.3124999,-0.08350363,-0.6007163816247287,-0.027625753579366176
29377,SIDM00628,SCH772984,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,Black,51.0,-1.7459877,-0.09770617,-0.5398311780869536,0.005445937690811578
59101,SIDM01233,Taselisib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,1.1572372,0.08892614,0.005520053603976181,0.0226568112425209
89082,SIDM00411,Oxaliplatin,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,-1.9849677,-0.05040671,-0.054608327718560584,-0.016628604877207052
68912,SIDM00875,ZM447439,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.72216904,0.0656338,-0.11197948823856439,0.014970195188921943
56135,SIDM00673,JQ1,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.60968715,-0.041009467,-0.14472906858298265,-0.0015194072112452073
57570,SIDM00332,Taselisib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.6862135,0.14141418,0.38888366944136865,-0.0010018299630353174
52747,SIDM00529,BI-2536,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-3.27553,-0.10910235,-2.4230066591559827,-0.08060968641768974
41450,SIDM00531,Oxaliplatin,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.18829902,0.0062743444,-0.14122219333898664,0.02038976054618328
88601,SIDM00866,Nilotinib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,1.3123835,0.09386261,-0.3309989418676723,-0.01897530347261084
95374,SIDM00529,Docetaxel,Olaparib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.6858569,-0.12921345,-1.9298326882668955,-0.10775039655628743
12738,SIDM00130,Oxaliplatin,Crizotinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.47752228,0.032306753,-1.032247450643335,-0.02352917202020497
62207,SIDM00776,Trametinib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,2.696446,0.18219456,2.4838790399961876,0.09482514543073603
76359,SIDM00332,Alpelisib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2966359,0.09321394,-0.6214093911268063,0.02467633037487736
100148,SIDM00529,Afatinib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,1.9843796,0.14416166,0.8294255743685608,0.12086150040881122
12473,SIDM00332,MK-1775,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4335438,-0.11787023,-1.132452615820888,-0.07825883844397222
23039,SIDM00359,Navitoclax,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.22842728,-0.016232548,0.2486947129489932,0.025086905026864573
50076,SIDM00774,RO-3306,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.47785026,-0.026928566,-0.5613331465469688,-0.029670184358454053
63300,SIDM00359,SCH772984,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.480455,0.039969917,-1.309023730442014,-0.04491891182613808
65850,SIDM00146,ZM447439,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,0.1809711,0.013025737,-0.7435666438983178,0.013804773278253685
17704,SIDM00529,PD173074,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Black,44.0,-2.8297594,-0.09243009,-0.8057581092745199,-0.001616981447524703
105509,SIDM00130,Taselisib,Palbociclib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.56465155,0.061752733,-0.266500334786967,0.020967409912644747
13977,SIDM00954,AZD7762,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,2.9878688,0.1619056,3.0145253874446967,0.17333253014679612
41632,SIDM00332,AZD6482,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.4330439,-0.032546364,-0.8236192492039784,-0.08073053515777316
106328,SIDM00774,Lapatinib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.4072031,0.116905145,-0.04067665359902414,-0.05034900033614417
71796,SIDM00971,BI-2536,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.5708807,0.1653278,1.303686263369191,0.17862990871092663
97240,SIDM00878,NU7441,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.62246925,-0.041388273,0.7257654932708861,0.031829429825696906
93941,SIDM00660,Linsitinib,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,2.2302992,0.14513685,1.5748387448349004,0.11523052159477122
80944,SIDM00097,Trametinib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7773336,-0.046715934,-0.718683957804418,-0.019274652422467533
54371,SIDM00529,Gemcitabine,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-2.8259678,-0.11876294,-6.25966260074936,-0.2750170691778052
82377,SIDM00834,Taselisib,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Female,White,66.0,-2.7795641,-0.16909896,-1.7633639203910036,-0.043115428708332904
102272,SIDM00782,Nutlin-3a (-),SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,1.7272674,0.053078957,2.0527886902092582,0.08813070665013176
40061,SIDM00332,AZD8055,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.786061,-0.05796303,0.11517469733829384,-0.04543950685958332
7692,SIDM00779,Crizotinib,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,-2.247669,-0.0627336,-0.4448527771367477,-0.004184128599936512
61179,SIDM00193,Palbociclib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.4875598,-0.06503848,-0.14267433944198188,0.038619448500267176
6791,SIDM00332,BI-2536,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-5.084432,-0.38248542,-1.1535737272387336,-0.03897318554176477
86818,SIDM00531,Linsitinib,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.1208386,0.2510638,1.4790726311715456,0.07951351460799969
97512,SIDM00529,Navitoclax,Trametinib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,0.7195652,0.06117423,-0.11593217689175253,-0.005403811970354026
53483,SIDM00834,LGK974,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,-0.9377042,-0.06525626,-1.727481169972257,0.0030569509629677274
38538,SIDM00971,Afatinib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.9477078,-0.03969126,0.1880912993178587,0.004457026973958868
2965,SIDM00146,Luminespib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.39759853,-0.030178156,-1.0447365115888785,-0.06872627537779873
9107,SIDM00778,Crizotinib,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,1.1566057,0.07425829,-1.2104723712442451,-0.041496576072835634
93158,SIDM00954,OSI-027,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-1.5734103,-0.09805528,-0.9248884468966352,-0.0625309959220895
69971,SIDM01233,Crizotinib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-0.8938297,-0.055015143,-0.46489238238778297,-0.01875503033740837
74634,SIDM00332,Afatinib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5865517,-0.11261449,-0.19776581305011326,-0.01642468530784555
3859,SIDM00146,JQ1,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,1.1271582,0.060201697,1.7668191513493274,0.1213433380425049
26974,SIDM00878,Gemcitabine,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-0.5609546,-0.043441772,0.42212112529398765,0.006732524238980019
80296,SIDM00411,Dasatinib,Sorafenib,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,43.0,-1.6376889,-0.09690599,-0.7810003252745674,-0.022437834678203625
63057,SIDM00866,Pictilisib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.1152416,0.062472567,0.8948081376679882,0.06617698975921245
96965,SIDM00778,Dabrafenib,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,2.7073817,0.025001474,1.968495813996893,0.031816449024020185
19246,SIDM00673,KU-55933,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.1649147,-0.04842389,-0.03453090826647247,0.013715596977154024
43311,SIDM00971,Palbociclib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.27830014,0.0080569405,1.017524029697255,0.08386962374597953
43617,SIDM00954,Crizotinib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-1.1384982,-0.09213392,0.5429685486781148,-0.0017794179184483917
67002,SIDM00866,Navitoclax,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-0.4996121,-0.04414191,0.43973812707106136,0.011223591498600617
75294,SIDM00673,GSK269962A,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.97227,-0.071673505,-0.3268009901225612,-0.046342523190889724
4131,SIDM00146,Alpelisib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-1.7432917,-0.0720077,-0.41941825596558674,0.04254349163708131
72881,SIDM00834,BMS-754807,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-3.3324642,-0.18967728,-2.502387935735086,-0.0346994936346312
48888,SIDM00776,SCH772984,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.4951291,-0.13221398,2.567474044436587,0.15010992845343235
69835,SIDM00097,Alisertib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.6220815,0.106080145,1.1057727090993819,0.04360287201678086
82225,SIDM00954,Pictilisib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.9241401,-0.07428309,-0.2179139856076784,-0.054430000426919624
4476,SIDM00193,Afatinib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,53.0,0.85144335,0.07535644,0.9906672985685844,0.10160650988032521
95048,SIDM00782,SB505124,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.9865845,0.17519093,-0.7092324000454638,-0.008316608865993568
75086,SIDM00301,Taselisib,Trametinib,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,4.181291,0.38667718,1.9642278051249662,0.09677379461762992
5252,SIDM00866,Uprosertib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,1.1920109,0.066049874,1.5033597569036175,0.12174912513470983
34062,SIDM00878,5-Fluorouracil,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-0.94415367,-0.06405785,-1.0077597111011585,-0.05129366332245633
89912,SIDM00774,Bortezomib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.075919144,-0.0065118396,-0.13725727675414562,-0.030410163014311677
45949,SIDM00332,Cisplatin,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,4.5384836,0.11356243,2.3434037183235747,0.06652722976267579
13640,SIDM00660,MK-2206,Oxaliplatin,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,1.7323085,0.12193465,0.7974495876666159,0.0849200898649795
106138,SIDM00359,Palbociclib,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6609182,-0.07496375,-2.026597792682356,-0.0494734921211732
7443,SIDM00673,Vorinostat,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.16748528,-0.017634613,-1.2256631936437543,-0.0175774966671164
39536,SIDM00875,Taselisib,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9503598,0.09462853,-1.0072471775753928,-0.06890637074027937
86522,SIDM00359,Crizotinib,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0562325,0.07671151,-0.13380978356428305,-0.0014858731050154828
16438,SIDM00529,Temozolomide,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.3979751,0.009689575,0.6706277359037273,0.092496285204949
84603,SIDM00779,Crizotinib,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,33.0,-0.5881414,-0.044431344,-0.7420784466280477,-0.062334489416366
45337,SIDM00782,Olaparib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,Unknown,72.0,2.29811,0.097484596,0.6305113996401108,0.040772936815168075
37867,SIDM00628,Pictilisib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,0.19138996,0.016783316,-0.8351123601265078,-0.03958412389243068
106603,SIDM01233,Vinorelbine,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-0.7402765,-0.04589771,0.012296152482314535,0.09706577748936493
32531,SIDM00531,LGK974,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.0417739,-0.09285565,-2.4471329414164606,-0.08201467300201613
2138,SIDM00971,Trametinib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.9266095,0.037233543,0.6807874674112654,0.04948326814754339
95211,SIDM00875,Uprosertib,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.631465,0.27413487,0.5869689513233345,0.05110331703980761
98881,SIDM00776,AZD4547,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-1.2468274,-0.03065654,0.5725727450091473,0.03561700123799912
67016,SIDM00660,BMS-754807,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,3.4611351,0.23939699,0.3410505124657842,0.006519412153704503
51137,SIDM00529,Wee1 Inhibitor,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-0.4896677,-0.048705354,-0.427753274664304,-0.032891986375059405
39540,SIDM00673,Taselisib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,0.5164833,0.04689594,-1.413894268545966,-0.06407678387280967
23997,SIDM00097,Crizotinib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.27753717,0.011553296,-0.6585962045253714,-0.0019935974812904213
51071,SIDM00301,LGK974,Crizotinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.9544954,-0.14026889,-1.8733257400491035,-0.08217036066416096
108056,SIDM00875,Crizotinib,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.3913896,-0.100928016,-0.577958069467713,-0.06479522204853193
93615,SIDM00097,JQ1,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.45002413,-0.02508067,-0.30225881262577703,-0.004329748679225187
101306,SIDM00146,RO-3306,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,0.11720649,0.008896694,0.212425125836775,0.009535185816607004
5440,SIDM00097,RO-3306,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7561892,-0.08090291,0.741282212325763,0.046672758617674275
77715,SIDM00779,AZD8055,AZD7762,Large Intestine,0.0625,Cecum Adenocarcinoma,Male,White,33.0,-0.4011264,-0.035171073,-0.37297499144609075,-0.012557269708029605
93310,SIDM00782,MK-1775,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,Unknown,72.0,-0.7482935,-0.046843473,-1.37978395817178,-0.07050465245813195
88270,SIDM00628,Entinostat,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.11336851,-0.0074344673,0.9737952735354576,0.1639106778524163
90908,SIDM00971,Bortezomib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.1008983,0.058059614,-0.8620158584292623,-0.018550836199106732
71040,SIDM00660,MK-1775,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,-0.26750422,-0.012150375,-0.5214090346240469,-0.010321594375031566
3105,SIDM00332,Cisplatin,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.213905,0.058153726,2.7138363668664547,0.11059457336045864
19239,SIDM00878,Crizotinib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,70.0,0.91137546,0.092587546,-0.5028713670164926,-0.027978487790356454
12912,SIDM00301,Paclitaxel,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,50.0,-1.4191145,-0.08245961,-0.8763580951474916,-0.08672337992987622
86520,SIDM00332,PD173074,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.8849308,-0.28937694,-1.9176063420306686,-0.11289823066456214
67994,SIDM00660,Afatinib,Nutlin-3a (-),Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-1.0432526,-0.11594722,1.1739610738296027,-0.017899824186172496
6547,SIDM00097,Navitoclax,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.731874,0.041148506,2.2206307045956275,0.15268432084682595
102198,SIDM00971,Doramapimod,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.72968453,-0.01922761,1.534105452864856,0.06673097568081612
90135,SIDM00193,LGK974,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,East Asian,53.0,-1.6237644,-0.08111344,-0.45164191245796764,-0.014537897273340766
5764,SIDM00529,Navitoclax,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.5561031,0.049667407,-0.008402562962927306,-0.012418818289491027
52435,SIDM00893,SCH772984,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-3.1275365,-0.13227746,-1.7831712494809677,-0.06004281542557966
102571,SIDM00660,Navitoclax,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,32.0,4.371721,0.26412544,2.105590023385015,0.11890337267933059
65483,SIDM00097,Pictilisib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0286391,0.053461973,0.9455073379411763,0.02659355995253786
75374,SIDM00130,Paclitaxel,Trametinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.1779253,0.08777326,-1.046530066489114,-0.024578036157659775
10079,SIDM00097,Venetoclax,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.41357678,0.012633073,1.145204333996252,0.04241129039279024
15087,SIDM00673,Linsitinib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.7326151,0.015567697,3.21731697316322,0.09074454586783967
66183,SIDM00866,Doramapimod,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,2.2876546,0.061237033,3.0207385559775783,0.06880764327276584
78125,SIDM00875,Sorafenib,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.3000443,0.04535249,-0.15734363019309308,-0.028472211053321532
29208,SIDM00893,AZD8055,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.4338514,-0.10996141,-0.4430204865848717,-0.08070378194356595
25212,SIDM00673,ZM447439,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,49.0,-0.95390135,-0.07787169,-0.14886684546011128,-0.02619285656072467
72255,SIDM00097,Navitoclax,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.4107948,-0.02368702,1.1525565736409593,0.0998418272139657
73397,SIDM00971,ZM447439,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.59569544,-0.025570586,0.24597962293163836,-0.002090740283989184
38609,SIDM00146,Bortezomib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.46521112,0.027620101,-0.08319186326415007,5.140850542149705e-05
75165,SIDM00529,NU7441,Trametinib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,0.6325931,0.053289652,0.43476747438201685,0.008446887072785052
74411,SIDM00097,BI-2536,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.36642757,0.02417846,-1.0293720482728452,-0.01986576804591729
13843,SIDM00673,AZD7762,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.59811485,-0.05037539,-0.9788785520663034,-0.015982952090346097
62361,SIDM00893,Gemcitabine,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.995211,-0.078519806,-0.8258762062890088,0.007531730819531509
14530,SIDM00146,Crizotinib,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-0.8293855,-0.063779294,-0.2629817521088932,-0.01577709792803451
17428,SIDM00776,Camptothecin,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,65.0,-1.6848378,-0.07419493,-0.40587225150868017,0.004659154104717514
82762,SIDM00529,RO-3306,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-0.5098834,-0.017200155,-0.4076936946996447,0.011903085567927053
57720,SIDM00301,Gemcitabine,AZD7762,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,2.2823973,0.1365939,4.391639093136354,0.15374646252097504
70604,SIDM00893,Taselisib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.1709392,0.08339543,1.8776508949009247,0.045890164474664846
76140,SIDM00779,SCH772984,AZD4547,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-1.726583,-0.039209332,-1.6471883903591773,-0.03231841110601807
19322,SIDM00529,Luminespib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.9474771,0.096185334,-0.6304522138303561,0.0218197851447602
6988,SIDM00834,Vinorelbine,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,White,66.0,0.8784154,0.03851503,0.7480753203179773,0.05186435024213737
78773,SIDM00673,Luminespib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.7633013,0.07588062,-1.1592204295626538,-0.040374005923939145
73660,SIDM00779,MK-2206,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.4235027,-0.12929335,-0.08836994336235784,-0.05964909710966905
42409,SIDM00673,SCH772984,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-3.0528827,-0.1865848,-0.5723787612850288,-0.04327958319484026
14103,SIDM00301,Palbociclib,Oxaliplatin,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-2.9756708,-0.22478788,-1.4511712246191475,-0.12264994183303192
73293,SIDM00875,Vorinostat,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.1461715,0.016139098,-0.738600041933474,-0.008337737155808055
9444,SIDM00875,Uprosertib,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.7077749,0.22843924,2.5064070293891234,0.1256774124451267
62612,SIDM00411,5-Fluorouracil,Olaparib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-3.0487916,-0.097999975,-1.4162208527097275,-0.02041735253952351
41699,SIDM00782,SB505124,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.89147145,-0.07053801,-0.2571857728250853,0.023420825260264688
35837,SIDM00875,Linsitinib,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4146887,0.11386705,-0.3130432581460225,0.015600269351133332
106758,SIDM00774,Ribociclib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-3.0114353,-0.08335192,-1.7125811565579352,-0.04065023404767375
31864,SIDM01233,Oxaliplatin,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-0.5436846,-0.043491405,-1.4717638671967768,-0.12341707710796603
95842,SIDM00954,GSK269962A,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-1.1775364,-0.09563416,-1.2224448713746208,-0.024926937756365234
103600,SIDM00673,Temozolomide,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.2892084,-0.006460049,0.9229141305847633,0.02397705569201481
98465,SIDM00971,Wee1 Inhibitor,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.6968467,-0.021040568,-0.1427391020469276,-0.01487465696826074
51962,SIDM00954,Luminespib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-0.45385697,-0.032494128,-1.4041135782029421,-0.04134445097153605
105829,SIDM00628,Venetoclax,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-1.8256263,-0.07345803,-0.24946278358600824,0.018412422507301223
29084,SIDM00779,Vinorelbine,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,1.7661948,0.16734698,0.23612730765473355,0.09852107632225429
84193,SIDM01233,LGK974,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-1.5411154,-0.091294006,-1.2781988013027508,-0.060760421235722464
95272,SIDM00531,Sorafenib,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.52547544,-0.057961527,-0.1201575133815957,0.02478974964524009
81009,SIDM00893,OSI-027,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.7962248,0.076051705,-1.159823624195869,-0.0833063459206362
1704,SIDM00673,RO-3306,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.84043914,0.06344739,-0.571712654405777,-0.049638978900753555
8402,SIDM01233,AZD8055,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-1.3784388,-0.10437099,-0.5738500242219173,-0.061850223266604956
29224,SIDM00673,Alpelisib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.0547982,-0.06458228,-1.832287692501741,-0.02534117604279481
17665,SIDM00878,Temozolomide,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.38866743,-0.009204258,0.4956163884765752,0.002556938975419181
15021,SIDM00878,Alisertib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.194196,0.111491784,0.5663941278246942,-0.004668547372780394
101859,SIDM00778,Vinorelbine,SB505124,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,69.0,-0.71658164,-0.048446864,0.22511734507857012,-0.0002803122110105568
25851,SIDM01233,5-Fluorouracil,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-1.0203688,-0.060608298,-0.9040801723780728,-0.03519714553019731
32280,SIDM00866,5-Fluorouracil,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.3293757,-0.044677068,-0.12199168752387984,-0.005955849970785177
47072,SIDM00531,Paclitaxel,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.960641,-0.19132118,-2.0137376599646353,-0.1317544450314669
12597,SIDM00628,Ribociclib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-0.55041474,-0.013432435,0.7760859626789643,0.034520194410772045
48087,SIDM00878,Luminespib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.6816354,-0.07118855,-0.04737604208156331,-0.0193727645187049
13900,SIDM00954,SCH772984,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,1.2055725,0.064706706,0.20198628097580879,0.0017571877487486454
861,SIDM01233,AZD4547,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,1.6115172,0.06258811,-0.2265704438921612,0.02476055744821359
90354,SIDM00146,Alisertib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.74488753,0.06599807,-0.12282424979986009,-0.09235197483898454
29807,SIDM00529,Doramapimod,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Black,44.0,0.5302745,0.018835502,2.2884128578754046,0.11010189475477916
81269,SIDM00332,ZM447439,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.0380895,-0.09856411,-1.076573805376569,-0.06935658358974822
56247,SIDM00411,Gemcitabine,Oxaliplatin,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.3630583,-0.1231319,-1.4164091625600945,-0.10386904310302791
100353,SIDM00776,SB505124,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.66856915,0.024199814,-0.4364273389371398,0.013542479904021784
52136,SIDM00097,Entinostat,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0472544,-0.052164588,-0.893905370664769,-0.03781249179650359
14388,SIDM00893,Wee1 Inhibitor,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.3463302,-0.109425955,-1.8518590738545866,-0.10184055273355459
50664,SIDM00878,Axitinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-0.25495857,-0.022728948,0.2589172106460188,0.042281520025188916
22789,SIDM00097,Lapatinib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.4093735,-0.17924902,0.1793619780910414,-0.05906237725770997
29459,SIDM00778,SCH772984,Taselisib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,0.37928033,0.015167259,2.066665690983834,0.04437513969223413
5379,SIDM00779,Vinorelbine,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,1.9008218,0.13579382,-0.5313994383195743,0.02978947616118884
15381,SIDM00875,Nilotinib,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2700344,0.14142494,0.9861619135237573,0.12039091897765798
60555,SIDM00628,KU-55933,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,1.521615,0.11327596,-1.1496888165185677,-0.042860098935603705
39803,SIDM00332,PD173074,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.2303386,-0.21910538,-0.94250189005061,-0.02689783224388319
67856,SIDM00875,Uprosertib,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.9708659,-0.088000424,-0.9461147785145863,-0.028545833172449894
97773,SIDM00774,Bortezomib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.38503844,-0.028766451,-0.49453380453185264,-0.0364964371780431
20751,SIDM00878,GSK269962A,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,70.0,1.063012,0.10125699,-0.21767879415406785,-0.022439723448646594
48845,SIDM00875,Afatinib,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.1659417,-0.16904286,-0.05274276143844838,-0.036284156533350695
58435,SIDM00878,Bortezomib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,70.0,0.24753219,0.014302786,0.05122952763058953,0.033623362191592385
85155,SIDM00531,Erlotinib,Navitoclax,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.899011,0.3153035,2.8831599826995666,0.1578145043711072
9694,SIDM00660,AZD7762,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,-1.2552749,-0.12318515,-0.40469372509418894,-0.038368184319010144
29969,SIDM00097,Camptothecin,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8767664,0.045190632,0.43851647047298314,0.05147026486012686
64742,SIDM00673,Paclitaxel,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-4.3623247,-0.26436883,-2.162294702373058,-0.15350288510390622
77163,SIDM00332,MK-2206,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,0.8315808,0.06771608,0.01552208602131867,0.017631485435733504
42553,SIDM00673,MK-2206,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.6261371,0.08122,1.3725844841289228,0.07113821959814215
50594,SIDM00193,Vinorelbine,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-1.6085194,-0.15156734,-1.2772847537719962,-0.06381127697585696
68650,SIDM00875,Ribociclib,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5011272,-0.044214603,0.3810912135506312,0.01144007478308401
71503,SIDM00332,Linsitinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.070029,0.0893716,3.59347763808861,0.11952098190732798
93917,SIDM00097,Dabrafenib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.95766,-0.061563578,0.3110295372187104,-0.0007126520472197287
65382,SIDM00130,Crizotinib,Palbociclib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.0061585,0.10323532,-0.5862345169971189,-0.032006237842145804
86674,SIDM00097,Vorinostat,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.7272432,-0.042365476,0.6718112389056704,0.049873512000492434
7313,SIDM00673,Taselisib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.5448616,-0.05311875,-0.5972344502449642,0.0013021588104692456
56301,SIDM00954,Cisplatin,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,1.7438401,0.063373305,0.5727198800402169,0.047712451876752
87343,SIDM00875,Linsitinib,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.1566792,0.1889608,0.23914330790481417,0.05702495654563191
72543,SIDM00779,Crizotinib,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-0.84579724,-0.036791887,-0.9903991863892398,-0.04659464847725811
71220,SIDM00628,ZM447439,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,0.25302774,0.021129712,-0.4691830411660825,-0.0565188659261619
2748,SIDM00954,Doramapimod,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-1.7597936,-0.09349938,1.5150357566336243,0.16115753067857833
4896,SIDM00628,Entinostat,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,1.638916,0.12724556,1.3972694898017861,0.14280177900187546
42773,SIDM00774,Olaparib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-1.353152,-0.05392194,0.007722755542836834,0.025815642578347897
559,SIDM00782,Dabrafenib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.60703725,-0.019938543,0.9529700018656934,0.03747384032381946
79235,SIDM00628,ZM447439,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.4764048,0.09379698,0.583005622900927,0.055315013629765916
105789,SIDM00628,Tozasertib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-0.4670772,-0.045023922,-0.5216231414226907,-0.05652798337029031
9604,SIDM00774,Afatinib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,0.79399025,0.044061236,1.2486463525688865,0.06480195435867889
44898,SIDM00301,Ruxolitinib,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.2285064,0.032483656,1.5849029602656246,0.041259627069000354
55625,SIDM00971,Nutlin-3a (-),MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.1237218,-0.048974525,-1.1290209324624758,-0.010001723341413797
71578,SIDM00529,Taselisib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.6047374,-0.08571528,-1.0367640157393407,0.03370654054447082
61061,SIDM00359,Afatinib,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6163006,-0.12849873,-1.6345298234870624,-0.07216663321882072
85876,SIDM00954,Tozasertib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-4.0920095,-0.213511,-1.8897218270689906,-0.07773949643801024
51007,SIDM00774,Alpelisib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.7850004,-0.10114593,2.60104980167724,0.08767704748932664
6659,SIDM00875,Docetaxel,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-5.010687,-0.513077,-3.7790094193815187,-0.31661827054543706
41156,SIDM00893,MK-2206,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2187549,-0.11144155,-0.8146147383573056,-0.03787010441815262
74305,SIDM00954,Pictilisib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-1.4962773,-0.07079355,-0.992319522874184,-0.06838806881594497
30997,SIDM00411,Olaparib,Gemcitabine,Pancreas,0.1,Pancreatic Carcinoma,Male,East Asian,43.0,2.9171472,0.06705237,0.7632161852529487,0.027713879057987875
61124,SIDM00971,Paclitaxel,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.9562275,-0.089738995,-1.225113179752428,-0.027868446597089567
96302,SIDM00359,AZD7762,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.4533336,-0.20977114,-1.9743378457460294,-0.05227799658662073
69799,SIDM00878,Vorinostat,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-0.56530166,-0.01753043,0.31872231487166003,0.03789500905810638
495,SIDM00097,Alpelisib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.93396294,-0.064624205,1.0757130711405847,0.07931508315937554
71439,SIDM00971,Doramapimod,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.4499139,0.05184837,0.7815835357812139,0.04454640223387399
35681,SIDM00866,OSI-027,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.3205599,-0.074786,-0.15411057763677782,-0.01647708697927886
1986,SIDM00875,OSI-027,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2107031,0.13628088,0.9630475752467079,0.10389342887076389
106519,SIDM00097,KU-55933,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.685896,-0.09727852,-0.6669860091151267,-0.0037449202721246944
28942,SIDM00628,Nutlin-3a (-),Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-1.5903318,-0.063308634,-0.3230686384436769,0.03874740442531244
49570,SIDM00866,Lapatinib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,0.23742805,0.018053396,1.697655311927497,0.1303261337747438
44734,SIDM00146,AZD6482,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,2.743552,0.20918813,1.5755265641314775,0.13615031413086193
72789,SIDM00778,MK-1775,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,69.0,-4.901393,-0.19979587,-1.8692930570275688,-0.0924696331135754
64324,SIDM00866,ZM447439,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,52.0,0.9849123,0.077898145,-0.5292575239745777,-0.04445502013431481
36821,SIDM00776,Vinorelbine,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,1.8967562,0.14897864,0.6471537657515964,0.029990776305333314
13932,SIDM00660,Dabrafenib,Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,1.8806682,0.15605298,-0.7175429845518375,-0.048129883233678165
94420,SIDM00193,AZD8055,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.9608608,-0.05084503,1.761258532034612,0.15271368645613043
30608,SIDM00779,BMS-754807,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,33.0,0.97764933,0.009814543,-2.93386890499932,-0.0997154365448485
79233,SIDM00893,Cisplatin,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.53142214,0.015088698,0.3434286476065515,0.022010255478985594
102426,SIDM00893,SCH772984,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.94106555,0.05949044,0.15554183948601077,0.030062852689936734
56688,SIDM00301,OSI-027,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,50.0,2.6134086,0.20785992,-1.324080729911946,-0.06321384552788456
38262,SIDM00673,Docetaxel,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.7742192,-0.10713972,0.4956282317007021,-0.011055301592418718
21090,SIDM00411,MK-2206,Oxaliplatin,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-3.4598374,-0.15262307,-1.0110558129426144,-0.054223352328193454
27176,SIDM00971,Trametinib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.2166007,-0.017729182,-0.31017264994532573,-0.0014902750021105332
24132,SIDM00332,Lapatinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.171166,-0.14720838,0.9451366916580722,0.1304506266520082
8516,SIDM00875,AZD8055,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0493991,-0.09038103,-0.18353999532800813,-0.015720872297984995
99350,SIDM00146,AZD8055,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-0.71980315,-0.06497671,-0.6099324128011306,-0.10023512323823797
11639,SIDM00529,Linsitinib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.3644725,-0.042724967,-0.45669951708710194,0.024229464314927094
30584,SIDM00954,Nilotinib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-1.35064,-0.10330555,0.13959599258018154,0.040888347221862506
53517,SIDM00411,Linsitinib,Crizotinib,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.6230633,-0.08438194,-0.3208174567013219,0.0817311294907485
91670,SIDM00893,Gemcitabine,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.5763353,0.13684021,-1.0068898991499668,-0.002605586418113557
11399,SIDM00878,Wee1 Inhibitor,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.5344363,-0.04857986,-0.9898356165758011,-0.05771941697512955
55710,SIDM00628,JQ1,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,3.1934454,0.28747076,1.1271184854106724,0.07127041628275332
96229,SIDM00332,Dabrafenib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.0761511,-0.06183769,-0.2456228589387832,0.006317462863240597
17919,SIDM00301,Sorafenib,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.7614715,-0.26819152,-1.517991221947472,-0.05676577504528341
41254,SIDM00301,5-Fluorouracil,Taselisib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.0545447,-0.1289584,-0.5650939015478641,-0.037383774112472935
104432,SIDM00673,Bortezomib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.5723569,-0.016859628,-1.7052572911684187,-0.04302800795387444
56341,SIDM00628,MK-1775,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-1.3372841,-0.049677897,-1.5090889407712305,-0.0818609350243581
42624,SIDM00774,AZD8055,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-2.1879365,-0.13272977,-0.20718428462473953,0.019791752617315556
19180,SIDM00628,Bortezomib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-0.268483,-0.01344582,-0.2781947506924344,-0.027937517453396336
8191,SIDM00660,Afatinib,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,2.749147,0.22925687,1.150150560787669,0.03120362168366386
104418,SIDM00866,Paclitaxel,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-3.289842,-0.2181117,-4.220549989423072,-0.3070708310427736
91692,SIDM00875,Linsitinib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.88298386,0.06251617,1.8255102116821484,0.09657335846977631
101252,SIDM00529,SCH772984,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Black,44.0,-2.003066,-0.069920525,-0.23362505283704002,-0.015559939828243448
55265,SIDM00146,Doramapimod,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,1.1326526,0.059379343,1.1299587703835596,0.05523707091562166
83343,SIDM00834,Oxaliplatin,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,0.47749844,0.041017298,-1.6829285957081226,-0.08302690557033628
61646,SIDM00130,MK-2206,Dasatinib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.6789329,0.16008314,0.7202188370052964,0.12378047745004088
27936,SIDM00673,Paclitaxel,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-3.0778863,-0.21858044,-3.0478493670286615,-0.21639364138488357
7892,SIDM00866,Gemcitabine,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-1.2374924,-0.08855337,0.021089313366672385,0.036095412575554535
47917,SIDM01233,Camptothecin,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,1.8766434,0.086683445,4.694070323438165,0.26668940729115626
45495,SIDM00411,Crizotinib,Taselisib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,-1.5062044,-0.07156859,-0.2287756188643763,0.029792985941059724
86240,SIDM00774,Palbociclib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,3.5347433,0.13683696,2.117505806059514,0.09840793388777938
91115,SIDM00776,Nutlin-3a (-),Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.4526159,-0.046848156,-0.16476816564858487,0.020865645795268485
88619,SIDM00628,Lapatinib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.9312051,0.067593135,0.482195236557007,0.03129053324807292
23524,SIDM00971,NU7441,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.3357522,0.12057522,1.1633151987856112,0.06088941919211842
48344,SIDM00866,KU-55933,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.0797881,-0.042514414,-0.9863381392976063,0.010647034404644257
95911,SIDM00146,AZD7762,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,4.0776706,0.3110192,1.2356528574093877,0.21129507321315558
58228,SIDM00893,AZD7762,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.20457034,-0.009384107,0.025973153938068077,0.027563120209340854
10237,SIDM00531,AZD7762,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.1471673,0.035922617,3.3035574219353925,0.15211629756289136
33744,SIDM00776,MK-2206,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,1.571237,0.14128637,-0.2862813405617267,-0.010306767032119392
40142,SIDM00193,5-Fluorouracil,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.276819,0.026115362,-0.8109600933262012,-0.06896978157947228
16772,SIDM00146,Docetaxel,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-2.8424659,-0.19810821,-2.879931338026856,-0.24271207310621962
27807,SIDM00893,KU-55933,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.4521594,-0.073061995,-1.0945082712103409,-0.0773611992123119
74573,SIDM00954,Venetoclax,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,2.452309,0.098036945,0.10413112147155101,0.007559706675963074
45185,SIDM00893,Entinostat,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.2809521,0.028175833,0.4423648782075825,0.009750380893972234
42040,SIDM00411,Oxaliplatin,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.1278114,0.08411326,-0.9693058161879606,-0.046339415340098326
99619,SIDM00660,5-Fluorouracil,Trametinib,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,32.0,-0.3814842,-0.028956683,-1.0465412861342132,-0.047143663936158965
43740,SIDM00130,Dactolisib,LGK974,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.21169871,-0.021866096,-1.7198964243180959,-0.10419059572287716
31424,SIDM00878,Lapatinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.1525235,0.13454519,0.4963270256872966,0.06851353993317826
45137,SIDM00146,Bortezomib,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.09404093,-0.004779972,-0.7659394105287531,-0.0527668462716623
83135,SIDM00130,Ruxolitinib,LGK974,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.29286274,0.006792092,0.9209466536068546,0.009685500008758842
54158,SIDM00954,Gemcitabine,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-0.5908885,-0.042024493,0.15867090438545148,-0.03393722806332071
23034,SIDM00776,Navitoclax,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.0160886,-0.07635002,-0.08358566152317569,-0.030136637019805054
68512,SIDM00673,Alpelisib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,1.0067047,0.07194124,0.6928647826206967,0.0712840823676331
10390,SIDM00529,BI-2536,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-1.5670214,-0.1460609,-0.8383473864616092,-0.05409252663048423
45120,SIDM00332,Alpelisib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5333474,-0.03859896,0.19296603253760783,0.07236680632181965
98070,SIDM01233,Trametinib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-1.8874912,-0.12864283,-0.9679452474469902,-0.0627191427098031
13141,SIDM00774,Tozasertib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.6675751,-0.01794006,-0.4293034904347557,0.012976439930506904
97685,SIDM00954,Afatinib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-1.205527,-0.08997461,1.2544163714729304,0.08239181079331898
59467,SIDM00301,Dactolisib,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.71190727,-0.10087256,0.7130507354680481,0.01494489494018099
19625,SIDM00774,Docetaxel,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,0.441146,0.039902326,0.09683069179093474,-0.03780669366222227
65764,SIDM00628,MK-2206,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.002594,0.19377267,0.7851508121296873,0.1242617487533443
21521,SIDM00146,Wee1 Inhibitor,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,0.80754834,0.043350298,-0.7298891688488544,-0.01654831720179263
34135,SIDM00359,MK-2206,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.94240576,0.06572235,-0.18364248427386592,0.026746681227781306
64215,SIDM00834,Linsitinib,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-0.036532633,-0.002676715,-0.7709424108387378,-0.012386326920694668
25252,SIDM00776,Linsitinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.6427185,-0.03724816,-0.043634780515135085,0.04972883749087533
6689,SIDM00778,SCH772984,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-1.1998847,-0.039279398,-1.3369957273023396,-0.0831518079143133
67877,SIDM00779,Crizotinib,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-0.46545807,-0.034273345,0.0073160792151114205,-0.01524125283850428
91146,SIDM00301,Dactolisib,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.8066725,-0.09973181,0.7702608349702574,0.036249942232302095
10795,SIDM00875,Vorinostat,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8526783,0.01397244,-0.25096023726670835,0.006481480296258085
9368,SIDM00628,Camptothecin,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,-0.26766425,-0.02520656,-0.39954805650070063,-0.010559852119040633
78165,SIDM00332,Entinostat,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,4.505679,0.08863754,2.785435047440379,0.07019139399191564
35889,SIDM00776,Camptothecin,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.9715524,-0.11696375,-0.7050634309624576,-0.061390033521386
82526,SIDM00301,Lapatinib,AZD7762,Pancreas,0.0625,Pancreatic Carcinoma,Male,East Asian,50.0,2.0157356,0.1539888,2.2898529650644965,0.07535131915945757
88643,SIDM00529,Afatinib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.78371614,0.0564661,-0.6750119751043421,-0.02159465319067945
94068,SIDM00834,Palbociclib,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-2.9315982,-0.124981575,-2.7165481292481446,-0.09012707349045235
14268,SIDM00660,SB505124,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,1.5909635,0.14721324,-0.4869153510985643,-0.009490481638460377
98804,SIDM00893,Bortezomib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.5941899,-0.05789692,-1.3529159936481614,-0.08430838791940697
93253,SIDM00875,AZD6482,Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.64292777,-0.04604592,2.0534093025577955,0.12610858887407633
106096,SIDM00301,Olaparib,Gemcitabine,Pancreas,0.1,Pancreatic Carcinoma,Male,East Asian,50.0,2.561987,0.09707069,0.31998019577153997,-0.006671624823287609
88903,SIDM00097,Temozolomide,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.30833367,0.0054079695,0.6644382544751052,0.014389354221500453
102715,SIDM00774,Olaparib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,-0.817718,-0.036777146,0.04347417893461592,0.025856596532798357
40603,SIDM00866,JQ1,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-1.6377159,-0.09796052,-0.024550913391808527,0.09635937831585936
44914,SIDM00146,Paclitaxel,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-2.7995934,-0.23420587,-3.792445973170221,-0.30839640413145997
54727,SIDM00878,ZM447439,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-0.38134673,-0.026111795,0.3785223843997029,-0.03696880702711213
25325,SIDM00359,BMS-754807,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.3324608,0.11760735,-0.9107113858820797,-0.030020305435043214
61398,SIDM00954,Gemcitabine,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.0001122,-0.067692764,0.4948481879640846,0.0300297173110961
70613,SIDM00146,Nilotinib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.6092312,0.05644934,1.4854184007624203,0.03222423576496117
57591,SIDM00531,SCH772984,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.0949292,0.10611714,1.7510797537376563,0.12354369194878394
106601,SIDM00628,OSI-027,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.0056297,0.06637025,0.5888320035162435,0.0612115232188376
29522,SIDM00146,Temozolomide,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,2.9849093,0.060678504,1.9277785852232971,0.03338673989026677
101135,SIDM01233,Navitoclax,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,1.8496866,0.064798854,0.6509052167149779,0.0429166175349677
36222,SIDM00146,Paclitaxel,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-4.666021,-0.26757276,-1.008763252187929,-0.043205328825779335
83598,SIDM00971,Taselisib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.3118709,-0.08388655,-0.41088891335422073,-0.011148232894936194
12796,SIDM00332,Wee1 Inhibitor,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.42222553,-0.02260366,-0.9427061764988676,0.002668821845590292
70878,SIDM00673,Linsitinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.61790955,0.012052037,1.8849382360780584,0.038370345226143604
88594,SIDM00332,Camptothecin,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.92936957,0.021752955,0.6440245401166124,0.06037561373020909
12999,SIDM00660,MK-1775,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,-1.2466817,-0.04554723,-0.8187914749046735,-0.03630545622306116
98058,SIDM00834,AZD4547,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,4.4453464,0.19889861,1.5925664254119853,0.06295840434474179
14033,SIDM00954,Sorafenib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,0.6242991,0.044073176,0.2128072820789942,-0.016380253534955695
1563,SIDM00971,AZD7762,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.1949418,-0.0043828515,0.6227653399907281,0.15442857037820304
26907,SIDM00834,AZD8055,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-0.866263,-0.067095004,-1.0259985285525246,-0.04212460524078717
106901,SIDM00878,Bortezomib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.038911924,-0.0025476965,-0.2444199020323093,-0.0028586195672629304
4160,SIDM00776,BMS-754807,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,1.947123,0.12176792,3.4654097810270215,0.1493142970961605
43942,SIDM00875,PF-4708671,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.814607,-0.026935637,1.1817705386345088,0.0007156834541764623
68329,SIDM00778,Trametinib,Taselisib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,0.8054455,0.018666033,1.330242788819575,0.08108491671469864
48007,SIDM00146,Nutlin-3a (-),MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,3.618899,0.0915584,2.3400991325567153,0.09249694241096744
80048,SIDM00628,SCH772984,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.3747922,0.028515311,-0.9889026722344905,0.004517016037747714
16906,SIDM00332,Taselisib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,5.3799887,0.19611189,2.0958726732069963,0.10731683653977668
78051,SIDM00875,Axitinib,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8637633,0.066593915,-0.7301010777593632,-0.05656350366514749
88934,SIDM00146,AZD7762,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,2.9738233,0.1884797,-0.16202887809857486,0.04730596690443766
93965,SIDM00875,Entinostat,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8788979,0.13781703,-0.1923865160227572,-0.02913713710375491
70330,SIDM01233,Trametinib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-1.5080894,-0.1070641,-0.7347589071391566,-0.12878713657786708
13981,SIDM00529,Paclitaxel,Olaparib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.7700967,-0.15038705,-1.385096051811418,-0.10092647061505151
48055,SIDM00529,Axitinib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Black,44.0,-0.50169384,-0.041049242,-1.6029866233419285,-0.0281930543371644
25778,SIDM00866,Ribociclib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,52.0,-2.2270997,-0.09580213,-0.7067156749055996,-0.05693629622410495
71284,SIDM00893,BI-2536,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,3.633853,0.2889028,1.3468262441851633,0.15554244711450016
10822,SIDM00878,Sorafenib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.0199082,0.07673522,-0.0807406263106453,-0.025418633760991946
11175,SIDM00332,Venetoclax,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5288031,0.060628444,-0.1025465468942222,0.00956809413270929
69641,SIDM00332,Paclitaxel,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-4.791264,-0.16088492,-4.288285891586377,-0.3506923400184221
11892,SIDM00673,Lapatinib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.5500474,0.053886436,0.3065143159206682,0.06758812664793985
81618,SIDM00673,Axitinib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.9242674,-0.13258246,-1.1727891588507142,-0.05668390617580643
60064,SIDM00776,MK-1775,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,2.2302408,0.101074845,1.3975856103195679,0.08234299901221341
69430,SIDM00359,AZD7762,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.81968474,-0.065388694,-0.32693034824575407,0.00019107344355977235
51355,SIDM00893,Bortezomib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.4620682,0.0462934,-0.8654773409683292,-0.027478654348877047
53984,SIDM00332,Palbociclib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9032831,-0.04337968,0.11324000541185254,-0.026464697040063108
16248,SIDM00673,Camptothecin,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.2522025,-0.034427058,1.3534953616123089,0.04865481677822663
85973,SIDM00774,MK-2206,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,0.82190794,0.031486034,-1.0791810349716024,-0.05504375643726032
74828,SIDM00097,Ribociclib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.601034,-0.071231805,-1.2610168233398216,-0.04290264963339005
94986,SIDM00359,Nutlin-3a (-),Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.2007732,0.06426959,1.092759950372292,0.030127945030153314
39662,SIDM00971,Axitinib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.31925762,0.014616064,-1.9136728592820513,-0.028422592865775906
81419,SIDM00866,PF-4708671,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.64464486,-0.031578038,-0.7196442571692206,-0.01942481166733344
48899,SIDM00782,Vinorelbine,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,0.8235007,0.059086554,0.04010968453721794,0.0755852375750945
88108,SIDM00332,Lapatinib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5937688,-0.06416777,1.383319840561544,0.07046832107669235
85176,SIDM00628,PF-4708671,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-0.5819615,-0.056547727,-0.658213865546617,-0.008092705619909603
35910,SIDM00146,MK-1775,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,-0.6502152,-0.053430654,-0.6813077744385053,-0.05545950498672564
55473,SIDM00301,Lapatinib,OSI-027,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.6242872,-0.01816006,2.650841462144526,0.08175283272539696
21414,SIDM00875,Alpelisib,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3064075,0.1382769,-0.565282617892481,0.03399881738288993
1681,SIDM00097,Entinostat,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.7261582,0.03394989,1.7596494569911725,0.08884730165220953
61626,SIDM00411,Crizotinib,MK-1775,Pancreas,0.2,Pancreatic Carcinoma,Male,East Asian,43.0,1.653463,0.10552751,-0.10858434037854875,-0.020416209398243696
97705,SIDM00146,Doramapimod,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.4783837,0.09378584,1.0065892055105772,0.06434896915685664
49371,SIDM00778,AZD7762,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,1.6680202,0.04980735,0.5876110936652952,0.07380434346342644
50615,SIDM00097,MK-2206,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.9456944,-0.16576697,-0.9943910349510566,-0.09344991753229999
66442,SIDM00097,Pictilisib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.057982,-0.20696846,-0.47200104841122836,-0.03877481210199152
2391,SIDM00332,5-Fluorouracil,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0286607,0.057818573,0.5397422887191483,0.024574350308607048
20440,SIDM00130,Oxaliplatin,Palbociclib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.9086764,0.14070222,-1.048556826634025,-0.021990646153071485
42786,SIDM00875,AZD8055,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.09512197,-0.010390628,-0.28093975309467906,-0.042839475306609885
60376,SIDM00097,Entinostat,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.32026553,-0.017285276,-0.16526365085448863,-0.0315590268362123
96475,SIDM00971,Navitoclax,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.5910217,0.015508311,1.1818424647978696,0.10829145376923985
69036,SIDM00971,Cisplatin,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.0398483,0.043400463,1.0764738731055405,0.026673866760089548
53971,SIDM00971,Navitoclax,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,10.275168,0.3524421,4.510016285847911,0.1935671520538974
19512,SIDM00878,Nilotinib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.1414388,0.021411993,1.8505036627073914,0.07192461632376847
14045,SIDM00954,Nilotinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,-2.0113683,-0.14032543,-0.3628884562045177,-0.06707728765133641
102393,SIDM00875,Camptothecin,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.3040342,-0.25649416,-3.2624910237099805,-0.17290860368355848
93601,SIDM00776,Palbociclib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-2.103648,-0.06043042,1.0887659672687227,-0.005895887196329531
26349,SIDM00529,AZD8055,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.8593936,0.0778359,0.2754089699643645,0.015713040834001345
84703,SIDM00875,Afatinib,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5075348,-0.04151608,-1.1387886906301004,-0.08854516188588812
64459,SIDM00878,KU-55933,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,70.0,1.6556783,0.033552196,-0.3536539961379436,-0.01030399558989739
40040,SIDM00130,Trametinib,Dasatinib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,4.6014595,0.3388508,1.8609487252915504,0.14731581418531253
11376,SIDM00776,AZD7762,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,3.7320855,0.30689356,0.6449878856917957,0.05642922292989658
41940,SIDM00774,Lapatinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.3402287,0.05863662,1.5999654071890768,-0.021826075842135036
92112,SIDM00875,Olaparib,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.084971,-0.067705646,-2.0531752535279795,-0.08909186344478477
51167,SIDM00971,PD173074,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.0078756,-0.024416624,-1.3365379678684908,0.01119976660903288
96870,SIDM00628,Trametinib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-1.2101203,-0.07901608,-0.559846224711707,-0.040667430531434255
82550,SIDM00097,Olaparib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.697009,-0.016161289,-0.009457992309601426,0.005555315328495615
50380,SIDM00673,NU7441,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,0.7717311,0.0601498,0.14084421286409818,0.021076060344084876
74755,SIDM00834,Camptothecin,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,0.9078301,0.06120056,-1.7926488074375673,-0.07705128749030386
37286,SIDM00529,MK-1775,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.17865607,-0.018053414,-2.2149695066989383,-0.14678285630898344
101729,SIDM00779,Vinorelbine,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,0.84696436,0.05393748,-1.0155211039605683,0.0030817712779853445
104453,SIDM00866,RO-3306,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-3.6220777,-0.14419496,-1.2227096488694482,-0.060764276322926636
53919,SIDM00776,Oxaliplatin,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-2.5486572,-0.09320638,-1.4187339114241302,-0.06411150514789547
104851,SIDM00146,Linsitinib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,3.9600706,0.17762564,2.5900196000631306,0.1389546913869269
93196,SIDM00146,Entinostat,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-0.6817215,-0.040510796,0.8688285789559899,0.07006355773530298
26176,SIDM00893,AZD8055,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.24013649,0.021875964,-0.28888250877609983,-0.0607727916562333
57491,SIDM00779,Vinorelbine,Crizotinib,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,33.0,1.3955426,0.1340357,-1.561809919003774,-0.03207382268154303
86559,SIDM00332,Nutlin-3a (-),Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.2671793,0.102576,0.3647054034106519,-0.02996901916100792
46670,SIDM00359,Linsitinib,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.7511482,0.13016278,1.3705836775795603,0.06646979362140802
44699,SIDM00301,MK-2206,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,4.9261203,0.56861997,2.7830516582204314,0.21943530188086124
53051,SIDM00301,MK-1775,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,1.4980853,0.14249097,0.34474924254552114,0.057298123240099634
12404,SIDM00779,MK-2206,Navitoclax,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,4.115849,0.1990633,0.5309353935617341,0.02036142742926352
36634,SIDM00778,AZD8055,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,0.20373154,0.008013898,-1.099867398335962,-0.04287473289373601
693,SIDM00778,Oxaliplatin,SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-3.5129714,-0.09032887,-1.5280630655545528,-0.04983424140731234
83468,SIDM00954,Bortezomib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.18095227,0.0065933163,-0.8491030781136909,-0.04105065217749546
70085,SIDM00866,AZD8055,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-0.87038684,-0.02638055,0.5315063404346935,0.03223313970571286
54115,SIDM00954,Taselisib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-1.9361843,-0.14565195,-1.1072102487652808,-0.06885219091520549
33680,SIDM00359,Vinorelbine,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,4.172999,0.26136494,4.403328293597442,0.2211845793309165
108215,SIDM00834,LGK974,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-2.7587557,-0.14836642,-2.744914959367052,-0.10808083378916634
57171,SIDM00954,AZD8055,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,1.1343414,0.014418199,2.3360909617513146,0.16622204140934144
105481,SIDM00866,Tozasertib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-2.369898,-0.103117645,-0.5970366822169524,-0.006307819945675792
45918,SIDM00774,Tozasertib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,1.2683312,0.03801356,-0.1266676636147185,0.004820475403238577
83149,SIDM00130,Irinotecan,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.2234602,-0.124666125,-1.6639614896314345,-0.06604125670320286
78087,SIDM00332,Nilotinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6835615,0.036735974,0.9549004449504351,0.05809507850751772
29890,SIDM00878,Luminespib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,70.0,0.4727161,0.060450237,-0.6035977984042078,-0.09305732049102215
103560,SIDM00774,Palbociclib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,1.3284271,0.06709144,1.4291377510726782,0.07717876384113473
32064,SIDM00673,AZD6482,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,-0.73016495,-0.059653148,-0.4137155409299268,-0.009887722306455468
101656,SIDM01233,Camptothecin,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,72.0,0.71853006,0.027836485,1.1418549222489374,0.04222864106635366
86560,SIDM00531,Lapatinib,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,3.1003025,0.14418189,1.7082140166312831,0.07869991075550943
65228,SIDM00146,Navitoclax,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-1.0761772,-0.0913858,0.29189431533553695,-0.008524766484306934
94919,SIDM00878,Nutlin-3a (-),Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.3437831,-0.06909944,-1.036822369699982,-0.00969144927228519
2158,SIDM00673,Olaparib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.1326725,-0.09002572,-1.1330462542035356,0.0009046346334077768
19471,SIDM00673,Alisertib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-2.6046314,-0.12109757,-1.9565486339090914,-0.08279857273703324
11665,SIDM00774,AZD6482,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,-1.6455449,-0.091473915,0.7653586908809393,0.04348593010881662
33206,SIDM00529,NU7441,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-1.8382237,-0.118236035,-0.20594281125361713,0.036880153905991565
35919,SIDM00301,SCH772984,OSI-027,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.467873,0.14486341,0.6046388331714156,0.04239508155950812
95275,SIDM00954,AZD6482,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.0,-2.3433325,-0.12456414,-0.3281328982174128,-0.0011366317676416355
46087,SIDM00529,Camptothecin,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.2512373,0.06796402,1.304607032743995,0.13211351820794898
10570,SIDM00971,Vorinostat,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.6684085,0.08922218,-0.08002398960480571,0.017307032316338004
40720,SIDM00954,Crizotinib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-0.4205633,-0.027626714,-0.5454938876044447,-0.033613113941805016
44505,SIDM00893,AZD6482,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.8176516,-0.07314487,-1.802682501679678,-0.13435793796015325
71090,SIDM00834,Camptothecin,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,-0.86506957,-0.051963333,-1.7437671706042126,-0.0744791186999758
104457,SIDM00878,Alisertib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,70.0,0.9448211,0.07931013,0.3379234142303055,0.08852078223031833
49111,SIDM00097,KU-55933,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.2769747,-0.088540256,-0.8173783109800692,-0.020662382245058206
38543,SIDM00954,NU7441,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.9465774,-0.06887932,0.5061509885477535,0.010901690112086183
39210,SIDM00778,Camptothecin,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,69.0,-0.50130427,-0.014879142,-0.5167280162587594,-0.02771465431452934
38585,SIDM00301,Crizotinib,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,50.0,0.8961577,0.07221467,0.6406757622606872,0.04407722204735481
52362,SIDM00971,Cisplatin,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.20107998,0.0027899262,1.3400712566432504,0.009002339509257381
20343,SIDM00878,Nilotinib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.8202832,-0.07193295,-0.640916798592416,-0.07247761875529188
85929,SIDM00301,Erlotinib,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,3.0789897,0.17675051,2.589779705229072,0.09929888135483625
9521,SIDM00866,MK-2206,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-1.5449625,-0.09737165,-0.025146244768683823,0.01569752957876307
100456,SIDM00778,Navitoclax,AZD4547,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-1.001475,-0.06443568,0.8302162033896686,0.07541873732242123
48481,SIDM00097,Gemcitabine,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1486658,0.038416732,0.6247471300332447,0.044856383005624424
62913,SIDM00301,MK-2206,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.8129916,0.09183364,2.0038050306334885,0.05845336021262698
29014,SIDM00660,Navitoclax,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,3.5708306,0.27743995,0.8651628547321556,0.055180522225070874
90795,SIDM00866,GSK269962A,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-0.39549586,-0.017300367,-0.08277433982485718,0.04641790537119524
81239,SIDM00097,Entinostat,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.7116292,-0.110429175,0.2246616974019665,-0.0005598523690840228
18870,SIDM00893,PF-4708671,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.89292085,0.06698998,0.09718190847698652,0.04125819943401
12382,SIDM00193,Oxaliplatin,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.48945087,-0.016363882,0.6916597561424267,0.00034078461460560177
97528,SIDM00774,Uprosertib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,-4.0265884,-0.16728684,-0.5128603051878421,-0.018144050384866037
43327,SIDM00301,5-Fluorouracil,Trametinib,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,4.090482,0.40039986,-0.9714104320066075,-0.0483177133990987
24002,SIDM01233,Vinorelbine,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,3.7722878,0.29444432,1.564428704211285,0.09077997595514362
65732,SIDM00130,Irinotecan,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.2786683,-0.09271793,-0.6506763609759199,-0.021371102171086793
5199,SIDM00779,5-Fluorouracil,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.0918099,-0.051612407,-0.604810478702678,-0.015109754657549037
47808,SIDM00893,Crizotinib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.134134,0.042701628,1.2093170485916138,0.06575285791734749
86187,SIDM00875,Navitoclax,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3655155,-0.040442612,0.5300738913114569,0.0880918159944024
5024,SIDM00954,Luminespib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-1.4006182,-0.07367892,-1.8024384764187495,-0.04929708134993415
85893,SIDM00779,Nutlin-3a (-),SB505124,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,0.9437102,0.038244776,-0.0808099918584184,-0.014213798979232709
71422,SIDM00531,Taselisib,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.6376952,0.1280888,-0.5776588249038648,-0.0033071451434652354
41929,SIDM00529,JQ1,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Black,44.0,2.4959538,0.21588872,-0.2917794774524841,0.025650037170884304
35303,SIDM00097,AZD7762,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.1915658,-0.09931562,-0.7317798973089865,-0.06704567186493321
48053,SIDM00866,MK-1775,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-0.8155771,-0.05965058,-1.3985981271198662,-0.0629587307349361
56155,SIDM00193,Camptothecin,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,3.8294053,0.248774,2.3171094611412455,0.08177716577850955
78438,SIDM00774,Axitinib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,1.5316168,0.18876286,0.10129211520103266,0.05941112222533421
54994,SIDM00332,PD173074,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,7.3297668,0.2902479,0.5339152704863616,0.03704134113814959
59166,SIDM00878,Doramapimod,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-1.3631135,-0.059745885,0.8819726216476911,0.05330740468587352
82569,SIDM00411,SCH772984,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,43.0,-1.1439005,-0.052768406,-1.331297070336705,-0.04319397279735809
61747,SIDM00954,5-Fluorouracil,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-1.7782629,-0.06941801,-1.2828614006047696,-0.02857116171153416
87424,SIDM00834,SCH772984,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,1.862064,0.14646086,1.0440700825108564,0.09633562245711162
71145,SIDM00875,Wee1 Inhibitor,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.07617872,-0.0048287935,-0.5105375146919972,-0.04699537356798221
49917,SIDM00878,Nutlin-3a (-),Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.2923183,0.100010455,1.0593483863481643,0.059674570737914726
68967,SIDM00130,SCH772984,Linsitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.4646678,0.22778098,2.1014876123471193,0.16227477504969354
78174,SIDM00875,GSK269962A,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.514046,-0.062491957,-0.0576224327947813,-0.016190831219833928
8258,SIDM00673,5-Fluorouracil,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.44872555,-0.017427642,-0.27016039605112785,0.02567808027443473
95870,SIDM00529,Camptothecin,MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.0702245,-0.038187105,0.943389214853518,0.07445147106007151
39041,SIDM00774,Docetaxel,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.37176326,0.03533414,-1.0004453319075504,-0.10905082453887882
18644,SIDM00954,BI-2536,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,-1.7039545,-0.0450525,-1.158551226423533,-0.02454577182773674
42892,SIDM00301,Dasatinib,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.3684974,0.19148089,1.1798527214449661,0.1052434047165024
19397,SIDM00359,AZD4547,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,3.3540206,0.23268622,-2.3465782705098626,-0.08900123774798609
2262,SIDM00875,Nutlin-3a (-),Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.1756995,0.10215294,0.49114814841664683,0.05390513492379314
76190,SIDM00673,AZD6482,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.9627596,0.14629042,0.661329883189509,0.10637776882282562
37024,SIDM00971,ZM447439,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.8550678,0.044109967,2.3057358751924393,0.14154124328501372
63615,SIDM00954,Luminespib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-0.7156286,-0.04536672,-0.7493187829511387,-0.018053816715630312
24188,SIDM00097,Uprosertib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.2820153,-0.21781974,-1.3923675728963818,-0.14487619882451802
21924,SIDM00673,AZD8055,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.1006126,-0.17723309,-0.6726716251632673,-0.011935752929689313
53365,SIDM00660,Taselisib,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,32.0,-0.40093732,-0.0410286,-0.7445157250341617,-0.016297258607278046
82646,SIDM00628,SCH772984,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,1.0525471,0.07751252,-1.427594245834566,-0.0670021674423438
7909,SIDM00893,Dabrafenib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.1397558,0.042066924,0.832646161672818,0.038568169274953094
39707,SIDM00774,Tozasertib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.77951664,0.023253566,1.9742827768417985,0.0953502335862629
63142,SIDM00628,Trametinib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.57641566,-0.053352885,0.15672535561338252,0.0375623693544025
17020,SIDM00301,MK-2206,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.3495424,-0.15422995,-0.48026090547244044,-0.013117735777655303
20634,SIDM00878,Pictilisib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.1643558,-0.13055298,-0.5606473570893017,-0.09594662174376642
51281,SIDM00673,Vorinostat,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.3607052,-0.035987813,-0.9301596630593861,-0.01356525791300492
14107,SIDM00529,MK-1775,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.23145348,-0.021442577,-0.1510256807696889,0.02036300028865147
95397,SIDM00866,Ribociclib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-2.6658838,-0.035634812,-1.3772805346314974,-0.015515113112714116
9920,SIDM00866,Ribociclib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-2.4974258,-0.07703739,0.39386141826648147,0.02300284218538145
97327,SIDM00779,Navitoclax,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,1.241545,0.016859317,0.23082277744015695,-0.03974013727501875
43591,SIDM00359,Taselisib,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.5042545,0.11943656,-0.3594673525813048,-0.0544559382269152
75022,SIDM00628,SCH772984,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.029361146,-0.0020382148,-0.4724367576905493,-0.0004924095449872983
77915,SIDM00866,Navitoclax,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,52.0,-0.3907924,-0.03504004,-0.08218764737771822,-0.0013116736710995125
16889,SIDM00866,SCH772984,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,52.0,-1.037467,-0.074278906,-1.2990790105778742,-0.0061166742061985165
35103,SIDM00332,Docetaxel,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-4.76944,-0.26534003,-1.1260220698836072,-0.06745879441362233
89170,SIDM00301,Dactolisib,Palbociclib,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,50.0,-0.85399747,-0.101123445,-0.3039378531940935,-0.018021516133332215
33909,SIDM00782,SB505124,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,Unknown,72.0,1.4252472,0.1189344,-1.7181847081032728,-0.07142738996769697
65394,SIDM00332,Pictilisib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,3.1235971,0.21004264,1.5709040592369854,0.08515522901067782
2705,SIDM00359,SB505124,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.3513002,-0.09034876,-1.8345503318891703,-0.06968258450533138
81132,SIDM00834,Vinorelbine,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,-1.6610054,-0.09376081,-0.6090868601190064,0.020428415053623087
88085,SIDM00971,Docetaxel,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.1425042,-0.0880604,-3.4468596747368014,-0.013382037565735897
62544,SIDM00146,Temozolomide,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.21692225,-0.0056693135,1.2720470706633105,0.06711995008119508
30288,SIDM00774,Axitinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.3198787,-0.09577164,0.2985179125537886,0.014309451898714482
103071,SIDM00878,Paclitaxel,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.6978572,-0.05870259,0.4685221617032307,-0.03878598705050552
37924,SIDM00782,Navitoclax,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.46421048,0.033198416,-0.02335554080493607,-0.027139874104386445
59759,SIDM00531,Oxaliplatin,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.5633372,0.019072844,0.6603652113596943,0.02477961229100029
76005,SIDM00673,KU-55933,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-3.0706012,-0.14637804,-1.6854018591846183,-0.0666166571683755
107463,SIDM00097,BI-2536,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.6607308,0.16662809,0.11327588968198277,0.05501146350980648
96297,SIDM00529,Navitoclax,Taselisib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-0.6729123,-0.061927196,-0.6183193907688577,0.05375514658653313
85411,SIDM00774,Trametinib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,0.70343524,0.02305655,-0.6069155407957268,0.015357354414482235
97187,SIDM00130,Cisplatin,Erlotinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.724074,0.09236988,0.8691269901228194,0.05115797238554748
33890,SIDM00893,Alpelisib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.3262498,0.14016935,1.485399068319664,0.0868178706096812
12190,SIDM00301,AZD7762,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,-2.0444248,-0.099701256,0.7881897253926392,0.08264232829311795
69385,SIDM00971,Temozolomide,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.4646776,-0.028553942,-0.6994735577024795,0.005372684198107921
24576,SIDM00130,Olaparib,Gemcitabine,Pancreas,0.1,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.8408299,-0.022998672,-0.23788303530272786,-0.019143324229213665
15158,SIDM00893,Ribociclib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.8016148,-0.09417509,-2.1851867167588295,-0.07573782483138972
41269,SIDM00878,Nutlin-3a (-),Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,0.85718936,0.034085326,0.1491763067326765,0.025630812435726576
48545,SIDM00673,Wee1 Inhibitor,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.32924554,-0.019619869,-0.12943309449505835,0.03773179616319419
80850,SIDM00878,Alpelisib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.4075447,0.12059448,0.9968316129867981,0.04643910210640481
77327,SIDM00866,Nilotinib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,1.0459884,0.074697904,-0.14132923619972618,0.07773419021726267
67968,SIDM00529,Alpelisib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-2.1699195,-0.095584884,1.1742670786416471,0.04213831529776305
97060,SIDM00954,Doramapimod,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.3834068,-0.052100573,0.9877325518773491,0.15157865315355498
54360,SIDM00332,Trametinib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.568585,-0.058887478,-0.07476516583643293,0.002311549371997814
83676,SIDM00875,Paclitaxel,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.53099525,0.03348516,-0.1568368694923528,-0.028047662251476077
100852,SIDM00893,SCH772984,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.3066975,0.10113368,-0.8171509873542993,0.022321004067814888
72180,SIDM00774,Vorinostat,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.4059257,-0.029928174,0.0736327356611816,-0.04974500850164071
86538,SIDM00359,AZD4547,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.9579515,-0.05491063,-0.6943714467097712,-0.026032047993893012
79045,SIDM00529,Olaparib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,-2.0694115,-0.08140774,-0.4134443769257072,0.005920711033366569
10306,SIDM00130,MK-1775,Linsitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.3801581,0.036714785,0.1308729284490273,0.011609863985118563
85223,SIDM00097,MK-2206,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.66542435,-0.048232894,-1.0295393902139953,-0.12320829111085392
45379,SIDM00301,OSI-027,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.2787931,-0.15507713,0.11843521096888592,0.03262958895287932
59954,SIDM00193,AZD8055,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,0.77278024,0.0685971,-0.14902978919776938,0.013891596369138944
49228,SIDM00893,RO-3306,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2120807,-0.09547993,-0.6825705636247104,-0.006876079297005532
106674,SIDM00834,Vinorelbine,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-1.3490175,-0.05113072,-1.3007402270280148,0.035313322994155044
82947,SIDM00097,Palbociclib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1010076,0.041733637,0.9767820062056011,0.11219054514801421
54893,SIDM00660,Trametinib,5-Fluorouracil,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,1.290636,0.07737876,-1.1671046349976275,-0.057454526845005724
280,SIDM00332,AZD7762,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.8474163,-0.08611517,-1.1344324058142556,-0.0825542681122742
97647,SIDM00130,AZD7762,Sorafenib,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.83251476,0.08937819,-0.038873308263403406,0.006185995935769022
55602,SIDM00866,Camptothecin,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,2.3950713,0.051812373,2.2233986217267097,0.06942377276222098
98100,SIDM00097,RO-3306,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.4066296,0.15148167,0.3314357860354524,0.03808362230571303
100391,SIDM00193,Camptothecin,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,2.899681,0.15863252,3.9075047414012447,0.15589581054254656
18532,SIDM00332,Pictilisib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.80742526,-0.080008626,-0.4298443827428481,-0.07793349381368096
10717,SIDM00146,Cisplatin,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.92021656,0.022131113,2.455914993387798,0.090744277977779
105259,SIDM00774,Dabrafenib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,0.27374655,0.008938991,1.3515081858459346,0.024437868539012402
75687,SIDM00779,AZD8055,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,-1.2148949,-0.031324808,-0.12498924476027473,0.010458572427382271
60408,SIDM00893,KU-55933,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.4539526,-0.0499573,-0.7718296062907753,-0.04532970826469603
56019,SIDM00673,AZD7762,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.49314052,-0.04117439,-1.1129494277941263,-0.08806841582556338
16931,SIDM00834,MK-1775,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,-1.4154141,-0.08861599,-1.5234185104384848,-0.05365214325145159
28379,SIDM00531,Cisplatin,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.9824597,-0.151208,-2.1541764223544213,-0.08354445740882462
6936,SIDM00529,Axitinib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Black,44.0,-2.3554866,-0.16778727,-1.1082372001690362,-0.038532175325095286
61825,SIDM00954,Crizotinib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-1.2407234,-0.10069646,-0.7782112623216043,-0.10937752534551153
103119,SIDM00971,Temozolomide,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.381017,-0.050799012,-1.3570829288640378,-0.005848240923722384
10187,SIDM01233,LGK974,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,72.0,1.6232282,0.12895581,-2.0532171948519577,-0.12103659307413549
14844,SIDM00193,Afatinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.7279366,0.06326974,-0.2978658696799207,0.030648192900430752
75468,SIDM00878,GSK269962A,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-0.7130404,-0.06284761,-1.2855738582950735,-0.09723680454130655
12902,SIDM00146,MK-2206,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.0569607,0.072414026,0.5140017150848049,0.0783338401105382
55003,SIDM00866,NU7441,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-0.98631024,-0.0754651,-0.355791322414949,-0.013355951809908518
84743,SIDM00778,Taselisib,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,69.0,-3.205173,-0.16881639,-2.5620001808025625,-0.15701477811185313
70433,SIDM00332,Navitoclax,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3144785,0.10856909,1.2958682621600204,0.04977621866020732
38115,SIDM00301,Irinotecan,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.9494223,0.11528186,-0.04702921807759056,-0.030570383145159353
31108,SIDM00673,Luminespib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.88133526,-0.09309531,-0.7940153527083673,-0.02749856157580292
71065,SIDM00193,MK-2206,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,3.9179883,0.3603525,2.6287289306032102,0.18098163130586
23140,SIDM00866,Afatinib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,52.0,-0.59135854,-0.051507648,-0.11013464724809399,0.008660375999787409
82119,SIDM00301,Ruxolitinib,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,50.0,1.1376735,0.050839204,1.1997080732470844,0.02214004889167336
13821,SIDM00332,AZD6482,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.0959492,-0.13412881,0.4654465146517651,0.001417980063986458
44826,SIDM00954,Camptothecin,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.6717831,-0.0222221,1.751793698037485,0.1347273219173676
46375,SIDM00834,AZD7762,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,White,66.0,2.5365071,0.18962845,0.8721252932130406,0.06214649253906472
24665,SIDM00531,Crizotinib,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.12473213,-0.012671331,0.14492571026924495,0.028840562015730892
39023,SIDM00875,AZD6482,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.17111452,-0.013189939,0.7804204188813133,0.04291226920977809
12410,SIDM00866,Cisplatin,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,1.9728398,0.04644723,1.6997500443078322,0.03960690494460214
35162,SIDM01233,Palbociclib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,2.7880702,0.08567778,2.0451156449915313,0.07975243982988582
9184,SIDM00774,Tozasertib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,-1.0816113,-0.028380081,1.2541114454925195,0.060294282187961935
102817,SIDM00660,AZD7762,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.5560183,0.051291093,-0.00452446255831264,0.03063931984823496
80223,SIDM00411,Ruxolitinib,OSI-027,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.5921078,0.029979788,1.7143552027539766,0.03737114474380522
60049,SIDM00673,NU7441,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-2.0911822,-0.0906359,-0.6640122756584547,-0.02824684488275658
73327,SIDM00146,Crizotinib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.68957144,0.066640414,2.1422189581052464,0.22592590976470983
102029,SIDM00359,SB505124,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.3566959,-0.08307372,0.40012596608752826,0.02730017288281
34141,SIDM00332,Docetaxel,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6085843,-0.13777106,-1.2771527401365654,-0.06466149791092402
108245,SIDM00673,Nutlin-3a (-),Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,1.9291208,0.05704553,1.9919771694208501,0.07202828317331225
5215,SIDM00146,MK-2206,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.5046143,0.030511346,1.9497873929040324,0.1417676158179726
36866,SIDM00529,Nutlin-3a (-),MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.7266409,-0.052477427,-0.45081806615352615,0.02391864438009152
23783,SIDM00779,5-Fluorouracil,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,33.0,-2.0417674,-0.06238153,-1.7602878027585607,0.015436795728420471
17187,SIDM00146,Palbociclib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.3494124,-0.038646646,-2.048370113857004,-0.05638371484712967
72547,SIDM00878,Crizotinib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.7922012,-0.0955872,-0.8201000184047141,-0.08750541778105474
45053,SIDM00628,Taselisib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,Black,51.0,-1.2532692,-0.11489074,-0.6049590409165305,0.04013112469150079
18153,SIDM00971,Vorinostat,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.798093,-0.07508508,-0.04328245397974675,0.0471898409262338
50818,SIDM00893,JQ1,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.44644955,0.024650605,1.5467029845796827,0.14244496533142634
101830,SIDM00097,Alisertib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4028643,-0.05379616,0.5786193290498998,0.10641514890408066
59498,SIDM00411,LGK974,Trametinib,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,43.0,-1.8845485,-0.058869954,-1.2781377636921005,-0.016327733693051755
63925,SIDM00673,Docetaxel,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.30803964,-0.029826544,-0.195776345043982,0.05697760690640476
80947,SIDM00301,MK-1775,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.43119824,0.049977005,0.05280684506932546,0.006078342690793682
29364,SIDM00878,Navitoclax,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.50165504,-0.014849594,0.43642631978703855,0.00880510258649134
64520,SIDM00097,Trametinib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.7633893,-0.022786155,0.4448611642047324,0.011034918504518241
80780,SIDM01233,Afatinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,0.91391,0.066858254,0.8414217965236537,0.10815832116636617
104687,SIDM00146,Doramapimod,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,0.9196933,0.054062933,0.5098775904085676,0.018730263211020014
3156,SIDM00301,Trametinib,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.1611063,0.16107297,-0.01908940067301651,-0.02428865733756707
32282,SIDM00782,Olaparib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,-0.73933834,-0.016967049,0.9426018251496066,0.014397089712100759
21632,SIDM00875,Luminespib,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5308591,0.0549485,-0.4480822538471086,-0.018138557974834664
58463,SIDM00359,AZD4547,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2913514,-0.06991926,0.20016801312894297,-0.014989892070228305
94652,SIDM00875,RO-3306,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0094929,-0.104736805,-0.38218761128121276,-0.016559093521598425
76179,SIDM00097,PF-4708671,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6450537,-0.0539936,0.17830421402742389,0.029829491466318424
13561,SIDM00531,Dactolisib,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.458926,-0.039685678,-0.6282221256946391,0.007068150217131332
42000,SIDM00097,Linsitinib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1488353,-0.045222204,1.2234433014220754,0.07006563405738045
85104,SIDM00628,AZD7762,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,3.0379102,0.24791089,1.2713727713478349,0.09586619902236108
70542,SIDM00097,Nutlin-3a (-),Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.53813,-0.06699293,-1.5220449958275415,-0.06371934182580005
71974,SIDM00673,Navitoclax,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,2.4777112,0.19822867,1.3597851812269541,0.1439146017036052
72356,SIDM00130,Taselisib,Dasatinib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.365811,-0.21794876,0.6876217916441859,0.12498993964079207
82503,SIDM00774,AZD6482,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,48.0,1.5539577,0.098027796,2.922938774538488,0.13019681888604942
66420,SIDM00628,Pictilisib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,1.0541939,0.10823826,-0.7978597250123142,-0.015364189629198543
103258,SIDM00776,5-Fluorouracil,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.6480088,-0.041630093,-0.30830311497006035,0.002601810455355888
96509,SIDM00628,Tozasertib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-1.0362219,-0.10604038,-0.5577031081344087,-0.05297545158829825
80095,SIDM00673,Tozasertib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.3353727,-0.09615515,-0.6211380957506428,-0.06063442215661921
54398,SIDM00130,AZD7762,MK-1775,Pancreas,0.2,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.702497,0.2768768,0.43204106703742273,0.10518543228623943
209,SIDM00971,Entinostat,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.8623084,0.0691423,-0.794514259375642,0.026451777980012598
33290,SIDM00628,Tozasertib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-1.5725749,-0.100879565,-0.11544679721738864,-0.0030052118028581465
105793,SIDM00778,Taselisib,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-2.9306626,-0.14239702,-2.0633462720231184,-0.07016168747286916
14172,SIDM00660,SB505124,Afatinib,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,0.47802764,0.050629005,0.3298132127247401,0.012927391268047627
44815,SIDM00866,JQ1,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-0.41575846,-0.030994225,0.5313980952674262,0.024226314807380578
5683,SIDM00097,Palbociclib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7643886,-0.067129076,-0.4612388808807684,-0.013499160423340506
86862,SIDM00529,Paclitaxel,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.92181337,0.08947503,-0.04381085645160228,0.04567454637229969
30707,SIDM00301,Trametinib,Sorafenib,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.711974,-0.09877835,-0.046747585330619804,-0.008652582689282559
44322,SIDM00531,Palbociclib,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,4.4397616,0.38499102,1.4100734441706906,0.06164770540606161
18531,SIDM00875,Alpelisib,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8183068,0.17440419,1.0925525944420853,0.05637395572079455
49047,SIDM00893,Pictilisib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.30756873,-0.02854727,-0.9950021894859077,-0.10290685933719351
86751,SIDM00971,Linsitinib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.3208276,-0.048922066,-1.5777155039693527,-0.06430102799106574
94893,SIDM00779,Afatinib,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,33.0,-1.912355,-0.15562649,-0.2297862872888327,-0.05559219849330997
34095,SIDM01233,Oxaliplatin,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,-1.7903372,-0.10579421,-2.3801928917955184,-0.10708180043451343
92700,SIDM00301,LGK974,Linsitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.110086,0.20511758,0.8064490461513084,0.025780375355619257
31292,SIDM00875,Linsitinib,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.256239,0.17579529,2.5126033257591494,0.10053482736413304
77822,SIDM00359,MK-1775,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2317812,-0.07122569,-1.2056320039229829,-0.036735834663114586
70696,SIDM00097,Sorafenib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.737099,0.19924608,0.9477904707028476,0.04522285116576266
71849,SIDM00130,Crizotinib,Erlotinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.98239225,0.0880228,2.444548964865982,0.11384245629444945
100652,SIDM00866,PF-4708671,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-0.54653,-0.026873685,-0.5985990936330164,0.0027160390959804644
59209,SIDM00146,GSK269962A,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.6057276,-0.042655062,0.29817191992243375,0.07154025108252539
79002,SIDM00893,Paclitaxel,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-7.1715636,-0.550384,-4.627117102413838,-0.354348352077633
62606,SIDM00660,AZD4547,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,2.1684134,0.11627598,0.7641856847815492,0.07472492839849697
86298,SIDM00673,Pictilisib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6303662,-0.05848046,-1.3776945141973174,-0.11471090279368011
40451,SIDM00673,MK-1775,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.1908207,-0.11054696,-1.3111762085358385,-0.061368341077548766
54743,SIDM00875,Paclitaxel,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4247183,-0.031939123,-1.0520848855368623,-0.03141114507981301
51085,SIDM00893,Olaparib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.6449461,-0.048007287,-0.3897858668999441,-0.0038355317241232944
107998,SIDM00971,Afatinib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.8862174,-0.09864787,-3.898521129980139,-0.06653401396853521
72429,SIDM00146,Uprosertib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-2.2521775,-0.14028507,1.5736623015081295,0.19401397112755958
70159,SIDM00628,Taselisib,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,Black,51.0,-2.103814,-0.1647281,-0.07500236365898028,0.04692543856115299
73833,SIDM00628,Sorafenib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-0.47433162,-0.042873736,-1.1150223980782181,-0.029858801437947016
29938,SIDM00673,Tozasertib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-4.276409,-0.205765,-1.149113024532596,-0.031941760197487866
17259,SIDM00673,Doramapimod,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.9274159,0.019641185,1.811169103220121,0.052175439892512526
63304,SIDM00776,AZD4547,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-1.4365021,-0.03813186,-0.8524930846248862,0.027084872561211545
2010,SIDM00146,GSK269962A,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.0086665,0.07061264,1.0385854769154494,0.06721034448368454
108150,SIDM00875,Alisertib,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.49386224,0.037114255,0.4513004078753507,0.021806097350779194
39014,SIDM00531,Olaparib,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.3355445,-0.013491201,0.19949052184497684,0.021523078011827467
44825,SIDM00097,Temozolomide,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.52807736,-0.009332577,0.773056398979422,0.008154345444789513
7472,SIDM00529,Temozolomide,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,0.4783675,0.0041991672,0.501233142456134,0.021900226950487964
49430,SIDM00628,MK-2206,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,Black,51.0,0.5366965,0.048595738,0.048173691890790224,0.0447675872704991
11576,SIDM00146,Sorafenib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.7745347,-0.06975301,1.06978616228823,0.08144842602957289
86262,SIDM00332,Taselisib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.7559526,-0.07324034,-1.5619075403810647,-0.03002314706227454
25007,SIDM00628,Wee1 Inhibitor,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-0.46448246,-0.04429154,-0.27273664675354153,-0.043297658018406744
51142,SIDM00193,Taselisib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.2943395,-0.11309346,-0.026099226666875183,0.007698559660553886
61234,SIDM00146,Navitoclax,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.2194239,0.07195799,2.42039676936497,0.06766661063624321
97738,SIDM00529,Olaparib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-2.3666391,-0.08605715,-1.3752352693346956,-0.026167202463788057
51285,SIDM00628,Alisertib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-4.769121,-0.17624642,-2.283074188795777,-0.08199818603917068
34,SIDM00866,Nilotinib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,1.5184788,0.10581274,0.8056014482873641,0.07410080845054522
10122,SIDM00660,Oxaliplatin,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,32.0,-0.6121692,-0.053211402,-0.9673464962111655,-0.05358700004022191
26442,SIDM00971,Lapatinib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.0480678,-0.058289513,-1.4606064771492393,-0.051875066356205604
61735,SIDM00971,NU7441,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.561147,0.19739167,1.375116327075198,0.09528797662339612
37911,SIDM00971,GSK269962A,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.018191071,-0.0010910814,-0.2910031571358033,-0.01972035954069183
3010,SIDM00893,Bortezomib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.23976547,0.024388287,-0.41510051656702945,-0.0122314562939864
34401,SIDM00971,PD173074,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7319349,-0.039379798,-1.986674444259595,-0.026626233412902815
74134,SIDM00971,Camptothecin,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.311273,0.031635787,1.0696665712907383,0.045461452735451505
4844,SIDM00774,Axitinib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,2.4176483,0.2850521,0.3029365835519398,0.005989859081680202
57534,SIDM00782,MK-2206,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,4.327587,0.27440238,2.693894526621962,0.18136617532759566
68990,SIDM00332,Camptothecin,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.0952635,0.035719916,3.1747733694004987,0.10535308812918136
36548,SIDM00878,Sorafenib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.5337186,0.019119415,-0.4039992418589549,-0.007471590950447079
15950,SIDM00954,Linsitinib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-0.3723084,-0.027760005,1.3973379704514126,0.1030447520502402
52554,SIDM00628,NU7441,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.7908595,0.12327168,0.6905343027285985,0.0902350891526445
33980,SIDM00878,Camptothecin,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.6939797,0.01832096,2.4079394580874225,0.04067108060562807
27677,SIDM00774,Uprosertib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.74745685,-0.054300204,1.008774710498972,0.02712043418974627
20165,SIDM00146,Afatinib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.9154273,-0.07792722,1.499943008461824,0.08866642191060475
17468,SIDM00673,Paclitaxel,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,1.7450217,0.10130709,0.4221275985507172,0.06577846492009183
25693,SIDM00193,Vinorelbine,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.7626491,-0.062562265,0.05732159585788414,0.009449886125357333
20328,SIDM00097,Taselisib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8449004,-0.048784018,0.7182684728050868,-0.017286533617392064
21884,SIDM00878,Tozasertib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-0.9955366,-0.0734662,-0.14669868021737723,0.0404283897807446
505,SIDM00193,Camptothecin,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.44960976,-0.013076511,2.1614995377776896,0.07307378748013849
57442,SIDM00628,OSI-027,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-2.0627162,-0.11076334,0.365437252897642,0.06942958014643134
26791,SIDM00893,Dabrafenib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.36312827,-0.007022839,0.16769983429190127,0.029372671991026483
39078,SIDM00782,LGK974,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-2.0864754,-0.14262144,-1.4651862335651318,-0.08685063220666991
31061,SIDM00878,Sorafenib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,1.5757258,0.114967935,0.34383895298297,0.005000191094591358
24938,SIDM00866,Linsitinib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-1.8883922,-0.10441732,-0.945714454688082,0.004473866599439839
70107,SIDM00628,JQ1,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,-1.1725671,-0.06674239,0.3041870353928363,0.016913521960792932
83053,SIDM00673,AZD8055,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.6508873,-0.048259452,-1.1346148418500985,-0.016403995635882147
84561,SIDM00130,Olaparib,Linsitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.2591314,0.09488729,0.8154191325749567,-0.013738035910920193
64168,SIDM00954,Luminespib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-1.2796926,-0.0905451,-1.009729845024319,-0.03189548238692242
48028,SIDM00097,Palbociclib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.4722958,-0.084997475,-1.310443343126294,-0.06953190012202394
27631,SIDM00875,Ribociclib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.58558226,-0.018640526,0.19614993921908105,0.029206884364590523
47815,SIDM00660,Palbociclib,Dabrafenib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,4.975451,0.3096294,1.8612344231936941,0.07227582336705926
82121,SIDM00146,SCH772984,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-3.6720078,-0.28998417,-1.236659917561855,-0.07370787904465476
53599,SIDM00673,Olaparib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.259288,-0.05023827,-0.6502446145894459,-0.0007161716180697223
2791,SIDM00529,Linsitinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-1.5740747,-0.056293387,-0.26614642988365983,0.054398800311812115
17425,SIDM00875,RO-3306,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.10634,-0.08906802,-0.21322727367404717,0.026571523516926345
24811,SIDM00130,Dasatinib,LGK974,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.30870253,-0.021334864,-1.1531455942324402,-0.03922439520568967
1658,SIDM00673,AZD6482,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-0.6258796,-0.05133181,0.4032750728595778,0.02489415007207975
17748,SIDM01233,Camptothecin,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,1.8610622,0.06217972,2.35029094218139,0.060661425667023865
16202,SIDM00411,Trametinib,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.8300414,-0.051274028,-2.134107241174394,-0.020604377427110118
37022,SIDM00878,Lapatinib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.48758605,-0.056676228,-0.004139237537748842,0.017435426718994146
86434,SIDM00531,Navitoclax,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.35524553,0.044920433,0.192210925956914,-0.014972308663887084
35215,SIDM00878,Pictilisib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.0320191,-0.099940054,-0.6978814000610288,-0.035173654315216824
56005,SIDM00146,NU7441,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.8788176,-0.08740295,0.6810655773458733,0.01832300049691945
41799,SIDM00411,Oxaliplatin,Olaparib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.860293,-0.061092548,-1.9515354932752798,-0.06437281821479204
13578,SIDM00878,Taselisib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,1.4473946,0.113061145,-1.2619096369033598,-0.0952046436278045
53687,SIDM00673,Bortezomib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.27063477,-0.014932103,-0.44861389482442077,0.003533395198182225
78346,SIDM00673,Dabrafenib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,1.5076591,0.03285853,1.445328588578291,0.0520321197998368
24687,SIDM00332,PF-4708671,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,3.0469642,0.052288447,2.02701823686974,0.03935125998760245
8837,SIDM00097,OSI-027,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3294133,-0.064487875,0.8378605926162883,0.05172645965088706
65982,SIDM00778,Camptothecin,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-1.5180345,-0.0452549,-2.5014129543528414,-0.09304296166189514
42404,SIDM00529,Nutlin-3a (-),AZD7762,Breast,0.0625,Breast Carcinoma,Female,Black,44.0,-1.7282217,-0.047677133,0.9993983886297233,0.027556119947021892
44731,SIDM00875,Sorafenib,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.35630885,-0.03401012,-0.41090771319368863,-0.042790670717156726
30470,SIDM00878,Dabrafenib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,70.0,1.0915278,0.043228783,0.2588675530000894,0.0329795101811548
34148,SIDM00531,Sorafenib,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.9913251,-0.1698827,-1.4761825347413022,-0.04770737561085123
12971,SIDM00893,Luminespib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.0443165,-0.13962504,-1.4964716458597922,-0.06969490553321152
89041,SIDM00660,MK-1775,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,32.0,-0.75259185,-0.03406265,-0.8574753601351671,-0.038560401642738745
37191,SIDM00673,Nilotinib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.2548861,0.014961443,-0.23131227677666147,0.053368555982381764
13374,SIDM00782,SCH772984,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.8552414,0.08088249,0.371748155455348,0.04639773298199094
83486,SIDM00332,MK-1775,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4447587,-0.14151618,-2.09514765613974,-0.1790812137805141
94162,SIDM00776,Taselisib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-3.7328246,-0.16621593,0.413092053987242,0.020430356451626785
63327,SIDM00130,Navitoclax,Olaparib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.38830402,0.040727604,0.38135969792017127,0.06036670950795168
12225,SIDM00332,Navitoclax,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.9787209,-0.19281654,-0.913394108267268,-0.07016071888139672
77808,SIDM00878,JQ1,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,-1.0742117,-0.09799324,-1.3963409394589033,-0.08057058206042383
64811,SIDM00834,Oxaliplatin,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,White,66.0,0.56075835,0.04893033,-1.9470607991097302,-0.1060021497958589
46216,SIDM00774,MK-2206,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.5224699,0.020832974,0.3034030217083082,-0.002721429137070467
105905,SIDM00834,Olaparib,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-0.5894648,-0.012385088,1.6900136150453506,0.06394091943156385
73945,SIDM00332,Doramapimod,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,1.226465,0.048258852,1.336427480222722,0.05981917462856913
103896,SIDM00673,Pictilisib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.5727847,-0.03165154,-1.3027315927232432,-0.09922931262465678
46542,SIDM00778,Afatinib,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,69.0,-1.3937745,-0.081334196,-0.1911430436488514,-0.09631431291211384
25757,SIDM00774,Paclitaxel,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,1.667921,0.09126818,4.375362106675307,0.22015900589612727
94204,SIDM00878,Doramapimod,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,0.44917685,0.025934871,-0.08611453972350673,0.018016055881859484
38843,SIDM00893,Temozolomide,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.99366635,0.030800521,0.1357951377411196,0.017531187536597558
34525,SIDM00529,Axitinib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-0.6501976,-0.05450069,-1.8291802751461455,-0.08339357217001275
69597,SIDM00779,AZD4547,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-6.466539,-0.060328785,-6.497106704557615,-0.1334941486266238
30671,SIDM00193,Nutlin-3a (-),AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,East Asian,53.0,1.2201861,0.025849368,2.142092041013203,0.0810882209036294
78465,SIDM00146,Temozolomide,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,1.3772669,0.04482812,0.9222857300687113,0.051244556896047226
56978,SIDM00529,AZD8055,AZD7762,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-1.7836399,-0.059279475,-0.2102456480189558,-0.0171821610367541
67384,SIDM00628,Pictilisib,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.8390346,0.1877308,-0.46872749152299503,0.04007715462015095
26729,SIDM00529,KU-55933,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.79564196,-0.01276035,1.9076501990256043,-0.006993789686969839
31579,SIDM00332,Cisplatin,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.3789053,0.06705842,2.2066880198657213,0.05266863792818712
58112,SIDM00878,BI-2536,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,0.14660184,0.012063307,0.28200303046635994,0.01761817654103076
68844,SIDM00774,Taselisib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.656034,0.026613789,-0.9859172223253305,-0.10369459231919076
11237,SIDM00866,Temozolomide,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,52.0,-1.2904339,-0.022327464,1.2758311913986546,0.014815496544511794
98963,SIDM00146,Luminespib,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-1.1554943,-0.07654598,-1.8403176462011377,-0.07310779221518611
16694,SIDM00332,Luminespib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3523765,-0.13253717,-1.0580049679575065,-0.08892688584893556
25459,SIDM00097,AZD8055,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.5912216,0.09828679,2.1226537308104243,0.11235778131302114
1358,SIDM00875,Venetoclax,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.45492622,-0.010028301,-0.1919326699587695,0.03584743202299632
46570,SIDM00878,Wee1 Inhibitor,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.38157892,-0.033911537,-0.30052314746421277,-0.02208426560348539
86445,SIDM00146,Dabrafenib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.8677615,0.12323941,0.7060279359850274,0.017543433126229892
60186,SIDM00893,Temozolomide,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.85081184,-0.018690772,-0.45951370516721596,0.003913871695365381
96784,SIDM00971,MK-1775,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.6145186,0.12881786,0.7327475112655885,0.06429273196292805
75099,SIDM00971,MK-2206,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.7194698,-0.15893224,-1.449217367849362,-0.0617829925604903
45851,SIDM00971,Doramapimod,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.81568426,-0.02695701,0.5647745311587107,0.019006630628355902
107138,SIDM00673,5-Fluorouracil,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,0.9069899,0.026606783,4.201329459647509,0.17886182641749251
38690,SIDM00531,Ruxolitinib,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.09281949,0.0030473361,1.611692219187747,0.032844238078327564
16419,SIDM00778,AZD4547,SCH772984,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,69.0,0.04450738,0.002328056,0.16209502902439324,0.005711723501716114
43198,SIDM00097,Temozolomide,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.614161,0.069412775,1.060027693381809,0.0318187376606141
78627,SIDM00359,Olaparib,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.2366574,0.030526025,0.814624891061998,0.004669919576314952
106584,SIDM00301,MK-2206,SCH772984,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.1868331,0.25067407,3.258254077862924,0.1288488076008835
34787,SIDM00954,AZD6482,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-2.3207,-0.11392934,-0.07555405436416936,-0.052528699327370684
82059,SIDM00954,Dabrafenib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,0.5506645,0.020394236,0.1150733554973005,0.05839045248400054
77644,SIDM00971,KU-55933,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.9054589,-0.023444481,0.6688891390334253,0.020287741620547858
87115,SIDM00130,Erlotinib,Palbociclib,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.8579964,-0.06871553,1.0257960663235506,0.06432498535258914
102409,SIDM00971,OSI-027,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.3231814,-0.117335044,-0.009711639492920318,0.030998251610120646
33740,SIDM00097,Gemcitabine,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8206401,-0.026914917,-1.5424145762455905,-0.029650459484308844
52460,SIDM00774,JQ1,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,-1.0540422,-0.036793333,2.6144189071684782,0.07659640740403859
42870,SIDM00875,Temozolomide,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9788257,0.024605019,0.45235510033493564,0.04439986671124419
93652,SIDM00893,JQ1,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.1199756,-0.08157794,-2.437036721762009,-0.0654796742862127
55384,SIDM00782,Vinorelbine,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,Unknown,72.0,1.5600796,0.15104985,-1.165171990213765,0.019112586625036083
70428,SIDM00628,Olaparib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,0.23505062,0.020235116,-0.6473820554805662,0.016711585828875584
69102,SIDM00332,Tozasertib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4990747,-0.09407165,-0.42030177099656546,-0.016546511752412826
9149,SIDM00774,Lapatinib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.57903737,-0.073706836,-1.0702789036641787,-0.07351758523125007
101332,SIDM00529,RO-3306,OSI-027,Breast,1.0,Breast Carcinoma,Female,Black,44.0,2.3763254,0.12425459,0.7214220719750636,0.03407180406884001
98134,SIDM00866,Trametinib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-1.5759618,-0.11910252,-1.683912450092503,-0.10313768669890493
77054,SIDM00529,Afatinib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Black,44.0,2.697216,0.13166742,0.7616347972960283,0.1136399972262989
43128,SIDM00301,OSI-027,Trametinib,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,2.3961706,0.1706471,0.41237386558865735,-0.0318936626456166
57908,SIDM00146,Luminespib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.2995231,-0.08247973,-1.8556793958358317,-0.10184816023473163
66419,SIDM00628,Crizotinib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,-0.20399827,-0.019117627,-0.4233249553140254,-0.019193948099058774
91809,SIDM00097,Cisplatin,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.6200968,0.03825586,2.1480896557089273,0.045723642098915454
20683,SIDM00878,Linsitinib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,1.9422038,0.14711283,0.4611799940997237,-0.004591756683203975
65273,SIDM00893,Linsitinib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.863807,-0.07689154,-1.3490441421859,-0.03893914632639606
48898,SIDM00673,NU7441,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.72809136,-0.052440546,-0.17202871945058798,-0.05206186962759641
23952,SIDM00782,Navitoclax,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.21314861,-0.01993051,-0.12083021694924434,0.004292705950027972
64415,SIDM00146,Gemcitabine,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.7157753,-0.053223357,-1.4619218657386581,-0.1408393232372109
26601,SIDM00097,Entinostat,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.6583395,0.038227756,0.4943692187856845,0.02945134661459522
94178,SIDM00411,Palbociclib,LGK974,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.6929308,0.077135466,-0.10768901362253165,0.023214840110498857
99125,SIDM00628,Alpelisib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.7402445,-0.032901794,0.3833195386470667,0.09389204973472584
67288,SIDM00301,Cisplatin,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.7138283,0.0885846,0.305077765079155,0.0012265127922567913
55876,SIDM00146,Temozolomide,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.909157,0.028405989,1.3081759978234733,0.03902786924519974
27266,SIDM00875,Axitinib,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.948602,0.05897906,0.07075334469054445,-0.018879178120340102
31987,SIDM00529,Camptothecin,Trametinib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,2.324345,0.14415893,1.438596890240202,0.0627669343285433
102596,SIDM00097,SCH772984,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3960242,-0.0685405,1.4079648702058734,0.05697073031375672
54779,SIDM00146,Palbociclib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.0218068,-0.06746049,-1.067001762833039,0.0118957016559939
46927,SIDM00673,Alpelisib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.261861,-0.07424534,-1.3397323962713241,-0.08440104982035883
58465,SIDM00893,Pictilisib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.8631124,-0.080194615,-0.534113926113036,0.025648382958248395
29065,SIDM00673,RO-3306,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,0.8933788,0.04304755,-0.27254112141479125,0.011873431888622676
85140,SIDM00660,SB505124,SCH772984,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,32.0,0.36489576,0.03941794,0.491206060749916,-0.005135791837922807
7642,SIDM00776,Nutlin-3a (-),AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.9959745,-0.05185671,0.7612953875985294,0.056012584995015234
92695,SIDM00531,Dasatinib,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.8605419,-0.12888779,1.2662466734122126,0.10874436264004446
26200,SIDM00628,MK-2206,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,1.1830232,0.100369655,0.09656555590038411,0.05952387278528234
40709,SIDM00332,PF-4708671,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.6117492,0.09557217,0.9819191463140309,0.10511025345562237
21607,SIDM00529,SCH772984,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-1.8202773,-0.06308443,0.3418228904286128,0.05249032625864431
41693,SIDM00778,Crizotinib,Camptothecin,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,69.0,-1.6069113,-0.10386575,-1.349294625322858,-0.08055737563277776
108465,SIDM00332,Axitinib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.8521228,-0.12582646,-1.750864728757792,-0.11489423405893869
92193,SIDM00660,AZD8055,Olaparib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,-0.5785333,-0.05501816,-0.12102539107570563,-0.024412031097223112
72656,SIDM00875,Pictilisib,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.6946754,-0.09114416,-1.9222974279081682,-0.045280147479245726
48246,SIDM01233,Vinorelbine,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,3.403343,0.26352388,0.17952251618371648,0.05948759558901682
86838,SIDM00875,AZD8055,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.46917424,0.051537678,2.6994220458535056,0.17850211034253594
62593,SIDM00866,Axitinib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,52.0,0.38529766,0.027305523,0.07720882629991395,0.030922936690403784
26915,SIDM00774,Entinostat,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,48.0,-2.420041,-0.13082902,0.29734774110368817,-0.02842158217398161
101989,SIDM00875,GSK269962A,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.63428944,0.04415664,0.4945484628929874,0.007872748295585074
81189,SIDM00146,Alisertib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.81342894,0.06613113,1.6972830471114604,0.07139507994272452
50305,SIDM00778,AZD8055,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-1.1378876,-0.058271732,-0.2027103939013041,-0.038438809238191804
20172,SIDM00130,Sorafenib,Dasatinib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.0639503,0.09215169,-0.47853094522973605,0.02507542764299798
40643,SIDM00628,Navitoclax,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,4.401142,0.1189681,2.5318446649012394,0.05802197120248604
49205,SIDM00146,Dabrafenib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,0.9799975,0.042738795,0.22257294448166656,0.047827799062545494
105574,SIDM00332,Docetaxel,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.6356058,0.2598587,-0.5408589425251932,0.020801907226162063
63490,SIDM00834,LGK974,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,-1.7823223,-0.100482434,-0.302007168019585,-0.03722137407371842
73051,SIDM00866,NU7441,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,52.0,-1.9448088,-0.13116215,-0.7662393258671807,-0.014664717176636574
30715,SIDM00776,Linsitinib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-2.112978,-0.10717286,-0.33982680310664964,0.001627034521318446
88145,SIDM00359,AZD4547,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.333624,0.17518328,-1.840807483150187,-0.05285393130774893
17561,SIDM00529,Palbociclib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.7081355,-0.06739656,-0.7943279539832916,0.014424454197203717
17289,SIDM00411,Crizotinib,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.7943273,0.13569233,2.2106817884857084,0.12547965488651025
39575,SIDM01233,Trametinib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,-2.084685,-0.15556449,-1.4204586271255233,-0.07469526107076435
41107,SIDM00875,Venetoclax,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.47192985,0.013159815,-0.5403843413206499,0.0062831751794339575
54045,SIDM00778,Linsitinib,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,0.55864024,0.03432513,0.15203026293280636,0.011462358505942787
12207,SIDM00193,AZD7762,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,1.148765,0.06335901,1.2829559283912586,0.12445938008041252
87972,SIDM00628,AZD7762,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.4411581,-0.041557934,-0.5361242669832792,-0.014403099927759243
33731,SIDM00878,PF-4708671,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,-1.9013838,-0.08120483,0.19344040003057927,0.011464606262487045
18399,SIDM00359,MK-1775,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.14932543,-0.012981429,-0.5080702274216299,-0.03795087400153023
25590,SIDM00673,Palbociclib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.34646523,0.016418543,0.4318222441969013,0.04014699979776208
4880,SIDM00531,5-Fluorouracil,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.5496084,0.008863629,1.7566090770035918,0.06146252233741047
3114,SIDM00411,Trametinib,Irinotecan,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,4.274371,0.15376857,-1.2396200559646453,0.033627529464199765
3392,SIDM00411,Lapatinib,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,3.9959676,0.1835735,3.856490279055782,0.2292371201685166
17312,SIDM00332,Uprosertib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4987676,0.08988765,0.5858780362112928,0.030269891996305105
19058,SIDM00130,Dactolisib,Sorafenib,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.6467321,-0.06774064,-1.3754633529859701,-0.12679217748438207
93759,SIDM00146,KU-55933,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-1.4804286,-0.059208658,0.1568741199386868,0.0635032070779532
72605,SIDM00193,BMS-754807,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,53.0,-1.9168459,-0.09740779,2.037474744718708,0.09939808764905406
2744,SIDM00893,Linsitinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.8089887,0.024631256,1.0901539867105003,0.1273649405417734
93607,SIDM00097,Vorinostat,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.5147614,0.05950335,1.3435372258203204,0.08026100850992025
104068,SIDM00301,Cisplatin,Olaparib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.3175524,-0.1361111,0.15474046805107122,0.04206828031158352
21939,SIDM00359,LGK974,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.5791586,-0.01909087,-1.5903483240269995,-0.0410796913063132
47411,SIDM00875,OSI-027,Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3612335,0.15063082,0.8594262549417503,0.07795597225951541
68196,SIDM00834,BMS-754807,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,1.1562126,0.081648156,-0.6626755420570156,0.01336340835988985
5580,SIDM00774,Uprosertib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,-0.09317649,-0.0070416396,-0.932726175960024,-0.041220228507525415
40723,SIDM00146,Axitinib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,1.4597402,0.09042931,-0.38638971084514256,0.07202489933435587
73302,SIDM00146,ZM447439,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.8540033,0.07149102,1.6355593727874869,0.08580354200907045
79450,SIDM00776,Linsitinib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,-2.127494,-0.110520825,0.40523053124103775,0.04201040650237283
99599,SIDM00193,Vinorelbine,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,53.0,0.49259663,0.04624635,-0.16637604875200238,0.014974948635213602
46016,SIDM00130,Dactolisib,Olaparib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.23379032,-0.023917345,-1.389266739693942,-0.028107058282807677
50666,SIDM00529,SCH772984,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.98381203,-0.015087958,-0.06054555166097253,0.017410108992370683
28797,SIDM00866,Uprosertib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.4148736,-0.02260632,0.7849227001234836,0.1380597494694166
2594,SIDM00866,Nutlin-3a (-),Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,0.6315708,0.022462351,-1.0231684738925202,-0.012745451615543581
88957,SIDM00673,Axitinib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,49.0,0.89871156,0.093360595,0.10629947605949835,0.012530282161431192
35385,SIDM00301,Crizotinib,SCH772984,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.725357,0.07067274,0.631552308981158,0.0424138555732088
86405,SIDM00875,Navitoclax,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.09274877,-0.008211561,2.0939060342337488,0.06113691908941323
100706,SIDM00971,Docetaxel,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.3558586,-0.06880767,-2.980112330002765,-0.011636121108201706
4706,SIDM00866,Gemcitabine,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.9256946,-0.13720895,-1.757508908983617,-0.07180941523745779
39275,SIDM00628,Venetoclax,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,0.5412602,0.028698862,-0.7247619813030611,0.015933390133467482
86432,SIDM00332,AZD6482,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,0.73804617,0.055341136,-0.6979252787575995,-0.0479180244563222
28437,SIDM00301,Palbociclib,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,50.0,-2.438039,-0.08003952,-1.9446921229108105,-0.08050325258489877
11154,SIDM00660,SB505124,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,32.0,0.7491398,0.06420013,-0.3880105130396793,-0.029358571618957947
93408,SIDM00774,Taselisib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,0.5389183,0.021706281,-1.266868983049246,-0.01456024991516624
37612,SIDM00673,Alpelisib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,0.82852954,0.049755994,0.19344457329827766,0.08789594376217619
50346,SIDM00834,Camptothecin,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,White,66.0,-0.48128837,-0.04159827,-0.9019633914800869,-0.054609380873777064
45104,SIDM00954,AZD7762,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.0,-1.8040229,-0.13971707,-0.8820392851878119,-0.05186830684826117
8611,SIDM00660,Linsitinib,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,2.7811396,0.26462266,0.6760798081945026,0.04310963141836869
24849,SIDM00146,SCH772984,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.7883617,0.13858493,0.4476806049547988,-0.01659851319021395
83163,SIDM00779,AZD7762,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,33.0,1.6238222,0.085887015,-0.7144208786425004,-0.06758041896819333
11660,SIDM00875,Uprosertib,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4472599,-0.042889453,-0.16628966421938507,0.011037055758261714
79673,SIDM00529,Sorafenib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,1.8247304,0.17347354,-0.44373938105922556,0.010757560199661542
47213,SIDM00878,Alpelisib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.8724016,0.078847006,0.5474098843401343,0.033519687505990596
15488,SIDM00531,Erlotinib,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.2713974,0.24190289,1.2513507765770135,0.07088149494436885
65008,SIDM00866,Palbociclib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,0.8507104,0.027871143,-0.11018405291956652,-0.02149990842767925
103563,SIDM00359,Camptothecin,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0127672,0.07534373,-1.5701162797247503,-0.03449947810872459
57924,SIDM00776,Nutlin-3a (-),MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,-1.9292276,-0.054792933,0.7380305481762575,0.047913061356794635
20567,SIDM00628,Entinostat,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,Black,51.0,-1.4971182,-0.07683651,-0.08857951865126916,0.012125376902188371
27874,SIDM00778,Crizotinib,Navitoclax,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,-0.58883923,-0.038992614,3.0655112478928426,0.16893376272213095
45871,SIDM00878,Vorinostat,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,-0.7000083,-0.07993608,0.11631898120715704,-0.0006021024721934574
98389,SIDM00779,MK-2206,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,33.0,-2.804991,-0.19366464,-0.5952473153391835,-0.10140370699896298
2046,SIDM00146,NU7441,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-0.79014444,-0.07242625,0.8102694440499977,0.02433817233873975
29238,SIDM00875,MK-2206,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.7685199,0.2305101,3.581081476793403,0.21199737022648177
81793,SIDM00628,Nutlin-3a (-),Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,0.71505886,0.05049179,-0.6160923461381178,-0.009474895829960066
13342,SIDM00878,Sorafenib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,1.3263019,0.115056604,0.24352173199154126,0.06439192178457923
39463,SIDM00529,Pictilisib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.5139711,-0.036324855,-1.4085870640262843,-0.053482324533538544
91810,SIDM00866,Cisplatin,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.3981196,0.029155226,1.6502706170916046,0.02358794337540559
58079,SIDM00359,Taselisib,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.8147211,0.10129457,0.8165033306065197,0.058970081571929865
18462,SIDM00776,Oxaliplatin,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.4634376,-0.07901477,-1.337529227340621,-0.04019092547401777
97299,SIDM00531,LGK974,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-2.3285625,-0.14308526,-1.6196037929580838,-0.03790612696536771
4679,SIDM00529,Doramapimod,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,0.08486743,0.0027819786,0.30788130285968945,0.027129337946054866
85986,SIDM00779,AZD7762,Crizotinib,Large Intestine,0.625,Cecum Adenocarcinoma,Male,White,33.0,1.8286487,0.12898165,-1.5587683560843533,-0.07066892560834538
67914,SIDM00628,Paclitaxel,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.88255614,-0.06171308,-1.5003419311044517,-0.11048137369549962
41622,SIDM00130,Paclitaxel,LGK974,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.6141758,-0.060395226,-1.0340550516398408,-0.09452126738287338
15584,SIDM00774,Navitoclax,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.49855164,0.014094925,0.42034728048623904,-0.001168452012663804
60505,SIDM00866,Axitinib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,52.0,-0.20385547,-0.014936038,-0.8639716850470752,-0.03842126954741342
30215,SIDM00531,MK-2206,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.6733913,0.04582485,2.3457185952309145,0.14163885189428915
55797,SIDM00878,Temozolomide,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,1.3539943,0.054722697,0.35178541766294597,0.026152943510544233
39106,SIDM00776,Oxaliplatin,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.4645,-0.1253374,-0.9900491734132009,-0.03801722616974685
20857,SIDM00776,BMS-754807,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,0.73360366,0.06786299,-0.6944161349590725,-0.011176936532454477
61397,SIDM00875,GSK269962A,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,4.11407,0.3667395,2.0384174206082166,0.09879970026471785
44121,SIDM00301,Paclitaxel,OSI-027,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.6511993,-0.043384355,-0.5884318491528481,-0.02937501410500821
102723,SIDM00774,Dabrafenib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,1.3652859,0.039420065,1.4993529801667498,0.02445236007041004
91426,SIDM00130,Erlotinib,LGK974,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.0680425,-0.08855787,-1.2339139857354158,-0.07806648708664932
84622,SIDM00673,Palbociclib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,0.38670242,0.01818716,0.890972113385696,0.043048629994626
107125,SIDM00332,AZD8055,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.9821243,-0.1500219,-1.7688048540595653,-0.16320680971138288
72320,SIDM00834,BMS-754807,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,2.465556,0.17144069,1.2227868391552181,0.014729640144991568
10671,SIDM00866,MK-2206,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,1.212589,0.08696588,-0.29247331192353593,0.027854019360648456
8072,SIDM00673,AZD7762,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.12536386,-0.0074668527,-0.9255469527566086,-0.05067742301129334
6695,SIDM00782,AZD4547,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,Unknown,72.0,1.2573743,0.04987262,1.8719335520280391,0.10755247508022829
18336,SIDM00878,Olaparib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.23970644,-0.0048594116,0.760985542695071,0.07122104168876446
70070,SIDM00146,NU7441,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,-1.4541113,-0.13026614,0.5615332437345262,0.010685963979049693
3874,SIDM00954,Taselisib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-2.4919345,-0.18818337,-1.0260669026416076,-0.05574168651025432
6129,SIDM00971,Temozolomide,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.3788898,-0.049984347,-0.8174904218005097,-0.014774122150100488
89620,SIDM00673,Vorinostat,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.81493527,0.08697948,-0.4853506456994296,0.03310068890954208
14146,SIDM00628,Camptothecin,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.76944673,-0.07789817,-1.4332235526074513,-0.11316448823521087
86924,SIDM00660,MK-1775,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,32.0,-1.5758477,-0.06018904,-2.4361401794718938,-0.060412907204848224
12798,SIDM00866,Dabrafenib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.0320184,0.037967946,0.09146303118948527,0.03467338529905373
56966,SIDM00628,KU-55933,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-1.5089086,-0.04168934,-2.0897367491281664,-0.08401016874480419
6619,SIDM00954,Pictilisib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,1.6861959,0.111892775,-0.37241693538757636,0.008319477485720862
57743,SIDM00660,Vinorelbine,MK-2206,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,2.6406279,0.15803818,1.3303466574206917,0.08635751707075638
53144,SIDM00893,NU7441,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.1979086,-0.015872119,-0.5278627502240801,-0.04119756400328407
33256,SIDM00097,Navitoclax,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.6608781,-0.048661824,0.11321667877408816,0.005498288695538817
82186,SIDM00531,5-Fluorouracil,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.6246922,0.020714775,2.0723679437451263,0.014106131301048555
69034,SIDM00954,GSK269962A,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,2.2905688,0.03437932,2.324355567152484,0.13171714509705645
86363,SIDM00673,Uprosertib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.5771369,-0.09597433,-1.209260306441308,-0.10334895994384269
28863,SIDM00776,Navitoclax,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.6696437,0.03622263,0.08885051896487442,-0.019789545971901894
81247,SIDM00866,Afatinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.643056,-0.14281486,-0.7259072885798439,-0.005001318801693114
11775,SIDM00097,Afatinib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5630655,-0.10572335,-0.08210026557507469,-0.012649454294950936
45911,SIDM00673,OSI-027,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-0.02554007,-0.0026493422,-0.7996253749441142,-0.06387686800561398
64019,SIDM00130,Palbociclib,Linsitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.4949064,-0.09898168,-0.7061524184370859,-0.0008946851298218717
37902,SIDM00529,Olaparib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.8150454,-0.073234595,-0.7288618138842594,-0.030691459984312178
34819,SIDM00193,Crizotinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,-1.1159942,-0.036707092,0.8025644687291293,0.08817752827979129
11004,SIDM00893,Taselisib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.24805613,-0.015131874,-0.2186020645207001,-0.05731059834886349
78029,SIDM00893,Lapatinib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.99620104,-0.104894124,-1.9759817018400407,-0.09224329962962444
107280,SIDM00097,Tozasertib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1852381,-0.06699274,-0.8009770948564284,-0.009280396960036838
41079,SIDM00193,Crizotinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.4356409,-0.046606664,0.7731174970788559,0.05631453216685849
65901,SIDM00411,Linsitinib,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,3.2261696,0.15381786,1.3353437651955027,0.10798008927136536
27715,SIDM00332,MK-2206,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4203991,-0.14201032,-1.0952203215564802,-0.08549014703624154
23339,SIDM00660,BMS-754807,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,0.25548348,0.02676492,0.739519876308195,0.002395143523037225
30708,SIDM00531,Sorafenib,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.5997416,-0.061581027,0.16441656262667562,-0.018329909608058366
45424,SIDM00531,Crizotinib,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.323346,0.24826355,0.6067030926013806,0.0806680077573792
65455,SIDM00411,5-Fluorouracil,Dactolisib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,43.0,-1.4128537,-0.039565112,-0.611946647201841,0.011095595792647678
22957,SIDM00673,ZM447439,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.601322,-0.048248447,-0.22112034860884805,-0.019546419112840073
7114,SIDM00529,Uprosertib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.5175492,-0.073948175,-0.676710144121671,0.036523933098664335
24813,SIDM00893,Camptothecin,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.312433,-0.09573636,-1.5774790067013524,-0.1369040376607005
67561,SIDM00774,RO-3306,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-2.1379385,-0.08129513,-0.7944357135998461,-0.03928360437003214
31376,SIDM00193,Camptothecin,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,53.0,0.48359713,0.020084873,1.9933711694970289,0.05070741708722741
63073,SIDM00971,5-Fluorouracil,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.0325968,0.028466478,1.2662313983642355,0.065011007566883
8620,SIDM00673,Axitinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.1237383,-0.16478823,-0.47156972005552783,-0.0013472005529766838
81515,SIDM00778,AZD4547,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,69.0,-0.8477496,-0.028755078,-0.41178105990331226,-0.004398942965065018
77599,SIDM00776,Afatinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.2045753,-0.09520995,0.03020067014666314,0.021135051845826945
100796,SIDM00146,BI-2536,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.6173208,-0.070372656,1.084261498543652,0.018476700682678173
57229,SIDM00411,Taselisib,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.8024553,0.053542856,2.3306833184160043,0.15737570517498298
87825,SIDM00954,SCH772984,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.8670986,0.049654093,-0.6527369579305824,-0.04371409235741786
1676,SIDM00097,Bortezomib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2179427,-0.0481203,-1.0561861374065749,-0.0531502368021736
18705,SIDM00628,ZM447439,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,1.0255746,0.083435774,-0.2374549360631589,-0.033838327344225094
48464,SIDM00531,Irinotecan,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.42729312,-0.050051525,-1.3224148143444376,-0.06892271504998991
36050,SIDM00893,Uprosertib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.36951914,-0.024242204,0.4179652956037921,0.02521266600859722
4119,SIDM00531,Navitoclax,Erlotinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.238025,0.14081508,0.13551192821577837,0.005379149493585326
43894,SIDM00097,Cisplatin,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2334673,0.025306363,0.0938429738934748,0.013064058975628007
1910,SIDM00774,Vorinostat,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,0.42190015,0.021615494,0.2867786910646694,-0.024727266815425048
456,SIDM00954,JQ1,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,-2.3002074,-0.19082661,0.8253130286465913,0.04946550000999197
40217,SIDM00130,Oxaliplatin,LGK974,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.1847177,-0.049836375,-1.9296775560695862,-0.071486053864658
67772,SIDM00332,Navitoclax,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,1.9137886,0.14173833,0.9481445751696223,0.044528202583154715
104811,SIDM00531,5-Fluorouracil,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.30730453,-0.008459197,1.342184269809328,0.024172609898260554
69368,SIDM00130,Sorafenib,Navitoclax,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.252114,-0.10576123,1.872937039379354,0.09051470344287754
51722,SIDM00779,AZD4547,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-3.640492,-0.010539483,-1.9953593512416155,-0.07942986079705323
92242,SIDM00332,Temozolomide,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3550746,-0.030728137,0.7340458567110085,0.004503697954789354
2843,SIDM00893,SCH772984,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.0081041,-0.06551357,-1.6638926296642935,-0.08812824893532044
58877,SIDM01233,Palbociclib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,72.0,0.71554995,0.014059118,2.2810022172720874,0.0977178637826479
39244,SIDM00628,Venetoclax,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-1.6313467,-0.06677445,-1.0759317407011302,0.02956306390858864
93725,SIDM00146,Ribociclib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,-0.9237034,-0.03967564,-0.5616014962264743,0.05658655837490106
12423,SIDM00673,Doramapimod,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,1.2346535,0.0236064,2.7119112066986975,0.08292316285412561
96208,SIDM00779,MK-2206,Nutlin-3a (-),Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-0.39045158,-0.036106735,-0.7277746829413776,-0.021672377585492963
71841,SIDM00411,Dactolisib,Sorafenib,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,-3.1758213,-0.08867681,-1.856434724763841,-0.1156100483826314
27901,SIDM00782,Dabrafenib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,2.1273255,0.07015252,1.7835296354696661,0.05358590913520012
32496,SIDM00660,AZD4547,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,1.816614,0.13971269,0.4148865886352438,0.05669852217535498
41570,SIDM00782,LGK974,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,Unknown,72.0,-0.62966573,-0.049023323,-0.9053427611317747,-0.06868625266081435
42408,SIDM00875,JQ1,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1224071,0.097831026,-1.210974539581835,-0.11178650501905461
67177,SIDM00097,Afatinib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.22264887,-0.013597988,1.6569189912646576,0.058410268958368906
62490,SIDM00875,SCH772984,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.60253155,-0.0673112,0.35149154810168776,0.05470725550003229
74174,SIDM00778,SCH772984,Camptothecin,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,69.0,-1.3475574,-0.076283894,-1.4942572885025245,-0.11278945171950246
90283,SIDM00130,5-Fluorouracil,SCH772984,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.18273151,0.014628885,-0.8671170952540198,-0.04057816520839497
24514,SIDM00359,BMS-754807,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.9482335,0.14215554,0.90906462440453,0.03930056790980076
63754,SIDM00628,SCH772984,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-0.42657298,-0.030279396,-1.0425874096473597,-0.034793270538673406
80885,SIDM00529,PD173074,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-2.5468156,-0.069876134,-1.384367994698123,-0.03390996471843018
59432,SIDM00875,AZD7762,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6226379,0.07137606,0.9226125721996313,0.08765748969507833
6495,SIDM00878,JQ1,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,0.60109866,0.051408928,-0.4562384171810529,0.10025213802477939
64288,SIDM00866,RO-3306,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-3.1668057,-0.16645841,-0.46444011867369034,-0.012600898360314111
35767,SIDM00893,5-Fluorouracil,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.7522809,-0.03261722,0.22868684612388687,0.06522067908436326
53390,SIDM00774,Vorinostat,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.06698653,-0.0047336016,-0.12077601706277648,-0.023268163623907857
4964,SIDM00411,Cisplatin,Sorafenib,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.6495769,0.028358236,2.1330558185728337,0.04165256435475157
78013,SIDM00359,BMS-754807,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.0843456,0.16724464,-0.4188013943448642,-0.04438775558551962
104898,SIDM00779,LGK974,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,1.5892822,0.05112671,0.9695791457776297,0.06761172197944505
57521,SIDM00878,Trametinib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,-0.6359676,-0.05487869,2.865023995606162,0.10442584045172186
85814,SIDM00893,AZD6482,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.4732297,-0.037721667,-0.27656337637813694,-0.014846575107947568
12317,SIDM00875,BI-2536,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6022199,-0.081463195,-3.4528387465661083,-0.1348195687864695
93760,SIDM00971,AZD8055,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.9728012,-0.060007896,-0.5437394699419736,-0.04974655851772887
57798,SIDM00660,Crizotinib,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,0.56934357,0.040982716,0.34353603852229603,-0.0012980117189784449
12508,SIDM00834,AZD8055,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,0.2422451,0.020553727,-0.7271884278971659,-0.02827120705397631
93356,SIDM00971,Uprosertib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.5889602,0.16697744,-0.504451678605078,-0.0008404107325644235
100918,SIDM00301,Irinotecan,Erlotinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.3739549,0.19167213,0.4685719370507805,0.04934432012670431
29541,SIDM00146,Lapatinib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.93662906,0.09025304,0.48042630078755316,0.07278855422126937
48518,SIDM00332,Afatinib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5086328,0.10282174,0.582733021101765,0.05327312011892318
90459,SIDM00531,Erlotinib,Palbociclib,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.2514446,0.13291824,1.1650530920483628,0.08657248665306187
13173,SIDM00774,Luminespib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.20874326,-0.01762128,0.20128545157214522,-0.036268664606763666
90690,SIDM00130,Ruxolitinib,Dactolisib,Pancreas,0.05,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,2.2961268,0.065396585,1.2647988350714232,0.04408220223296408
72981,SIDM00893,Olaparib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.3184652,0.0601435,-0.03683669577322392,0.06455490155838314
56094,SIDM00359,Olaparib,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.1144345,0.06028275,0.9561618469241465,0.03728942328271079
103082,SIDM00875,Sorafenib,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.34568608,0.03343806,-1.1106346854565352,-0.058983451668489825
44557,SIDM00359,5-Fluorouracil,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.32938734,0.021474108,-2.472697448895575,-0.05419621676943567
95024,SIDM00774,Tozasertib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.54285175,-0.014284227,4.478681165383203,0.239901803051778
94760,SIDM00097,Alisertib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6784838,-0.08152427,-0.12943860804632612,-0.011147833251288007
16735,SIDM00875,AZD7762,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.11863159,-0.008065349,-0.7852245018858636,-0.032145587898352375
86093,SIDM00359,Olaparib,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.7634184,0.04729651,0.56461508337393,-0.008444362933600976
82445,SIDM00529,ZM447439,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.3902075,0.031489957,-0.41952203133817345,-0.013657668668973952
38039,SIDM00529,PF-4708671,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.2118492,-0.061012667,-0.5439607304823783,-0.007669405751029772
43097,SIDM00834,Camptothecin,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,0.2771555,0.024391199,-0.8297544715997904,-0.0010799064132968013
83277,SIDM00628,Trametinib,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,0.33182532,0.02880252,-0.2140273756818431,-0.015476216054471142
70505,SIDM00673,Ribociclib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.94944596,-0.033324596,-0.30939984971932105,0.03515980300687815
53389,SIDM00878,Trametinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,3.7063675,0.3650308,0.8296443758651307,0.04095070761883625
71498,SIDM00866,Gemcitabine,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.2437167,-0.08072987,-1.0392296677549404,-0.0333645543454961
59559,SIDM00531,OSI-027,MK-2206,Pancreas,1.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.6081693,0.1201992,2.2851297177143133,0.11680414903327659
15949,SIDM00332,Tozasertib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.9568508,-0.11956347,-0.5835117435396057,-0.08592657020558087
94695,SIDM00779,Oxaliplatin,Camptothecin,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,33.0,-3.1225436,-0.18205377,-1.4203121465691275,-0.10128676719247234
6046,SIDM00774,Wee1 Inhibitor,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.9721282,-0.062191617,-1.0561863966388558,-0.08477138438936771
18703,SIDM00893,AZD7762,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.44805077,0.010292443,0.78612621851902,0.04342410501015424
20923,SIDM00778,Taselisib,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-3.5881896,-0.1387001,-1.6236816445971203,-0.07007610330153322
14484,SIDM00660,AZD4547,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,32.0,0.5545945,0.02846392,-0.6348352912419234,-0.015760721365541217
57646,SIDM00954,Trametinib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,3.6951668,0.18219635,1.547972244157734,0.10979126855972457
98132,SIDM00628,Taselisib,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.5691833,0.05393113,-0.7278743451793039,0.04523426332278183
12205,SIDM00875,Entinostat,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.88654166,-0.03985237,-0.16541225223697256,-0.05605996501563947
64955,SIDM00130,Palbociclib,SCH772984,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.1664408,-0.07023613,-0.1912353241190969,-0.0020969945807275377
64854,SIDM00628,Camptothecin,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,1.0601338,0.09941762,-0.4079456828125493,-0.016967468594996607
68346,SIDM00954,Vorinostat,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.049133956,-0.0022341327,0.34988515683875576,0.023320113645447383
16182,SIDM00359,Camptothecin,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.6827137,-0.05045894,-0.9203554543441926,-0.033302944415540846
75340,SIDM00878,Axitinib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,2.2222524,0.03464502,2.171642080867323,0.17884983809357327
2968,SIDM00774,Alisertib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-3.6295824,-0.18287888,-0.8560428766958649,-0.049966609309649586
63318,SIDM00875,Dabrafenib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5677249,0.02778825,0.5919874362089599,0.03830419718649829
6766,SIDM00146,Linsitinib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.8680642,0.018153027,2.5143359979388,0.1092558546504082
14167,SIDM00673,KU-55933,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.6772006,-0.14483432,-2.4452449723401766,-0.13191437875159773
85050,SIDM00782,AZD4547,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,Unknown,72.0,-0.22355202,-0.006227071,1.4512529794496474,0.06822547431098124
97416,SIDM00971,Dabrafenib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.1687878,0.027597161,1.0019452853935609,0.07484048833789671
89853,SIDM00529,AZD8055,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Black,44.0,0.3351862,0.030234471,-0.6108172171176028,-0.0582182111533747
34216,SIDM00628,Gemcitabine,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,3.4752753,0.042646326,0.018877304720691032,0.0015343766545412288
74145,SIDM00774,Doramapimod,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,-2.6434546,-0.09677592,0.05605893153503234,0.01790898392931205
80833,SIDM00875,BI-2536,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-3.1471949,-0.19925866,-1.5933397762863208,-0.09258363598072102
5696,SIDM00146,MK-2206,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-0.35037744,-0.01917606,-0.04531426016478078,0.004843345201742976
4948,SIDM00529,Luminespib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Black,44.0,0.82204556,0.08637059,-1.277712003317137,-0.04497426739003596
70134,SIDM00628,Camptothecin,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.40724838,0.040358245,-0.5358701730132056,-0.013309140514531845
38968,SIDM00130,Palbociclib,Crizotinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.4643921,0.13597344,-1.06943955855602,-0.008462652688501271
94345,SIDM00628,Afatinib,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.83394814,-0.07069286,-1.259464564149592,-0.10536750558215345
102213,SIDM00332,Tozasertib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.7143812,-0.21427748,-1.657393106205817,-0.15680335680093815
77920,SIDM00893,Navitoclax,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.8561609,0.088675156,0.9514108446243712,0.0482126666501262
24998,SIDM00628,Ribociclib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,2.5836859,0.09945699,0.5014715719688987,0.11423755397051408
7879,SIDM00673,Uprosertib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.5848762,-0.043773066,-0.547520458646271,0.011622879673758786
18708,SIDM00778,Oxaliplatin,LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-0.9133456,-0.03086787,-1.4216340428692853,-0.03209066543476152
73243,SIDM00954,Doramapimod,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,2.4686527,0.030688725,2.9918972134226998,0.14407539707845404
21388,SIDM00834,AZD4547,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,0.4650652,0.010762249,0.867222976802875,0.025241901382455006
30393,SIDM00130,SCH772984,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,4.819153,0.32091853,2.197444918705777,0.12438474070612195
34815,SIDM00893,Paclitaxel,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.551783,0.14383098,2.6103347347405155,0.11724781789327948
101061,SIDM00628,Luminespib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.07900355,-0.0064594904,-0.41868412474111244,-0.011973550746474694
97566,SIDM00774,KU-55933,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.3409752,0.063248605,0.030543376356342467,0.0030255620410586334
44237,SIDM00529,Nutlin-3a (-),MK-1775,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-0.8177875,-0.016150486,0.9456353032652436,0.05762393135535143
26625,SIDM00782,BMS-754807,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,Unknown,72.0,-0.5379057,-0.045978386,1.1358769128380148,0.030053873052600728
101311,SIDM00673,GSK269962A,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.0950987,-0.14884569,-0.7738482670565839,-0.037295206633540606
95571,SIDM00673,Bortezomib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.20682357,0.010386048,-0.7921652396922607,-0.02344467747016968
47750,SIDM00782,Taselisib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.64072233,-0.05103636,0.06612835862606137,-0.04992815312667613
42566,SIDM00529,Nutlin-3a (-),Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,-0.72276753,-0.02725089,0.2421342438958625,0.06630802949343313
59956,SIDM00875,PF-4708671,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.46005362,0.021757957,1.903189036673213,0.07842309537806237
64327,SIDM00954,Afatinib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.5108573,-0.12261292,-0.7473671628392531,-0.05826262351410887
106348,SIDM00332,Luminespib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.1675353,-0.08808856,-2.636341863683919,-0.11961603443291718
78015,SIDM00866,Navitoclax,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,-0.77761966,-0.05793493,1.0795523049014688,0.0620541101811333
29929,SIDM00097,Cisplatin,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.4070508,0.033721395,1.959277725160412,0.08226649723548883
7668,SIDM00782,Taselisib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,-0.7839979,-0.06792603,0.5743934910933284,0.007698305167666356
42433,SIDM00893,Lapatinib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.6377995,-0.16287856,-0.273238176496039,-0.046236814844438964
59700,SIDM00529,Palbociclib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-2.9418144,-0.113984264,-2.5424432484914448,-0.09000494904899098
48822,SIDM00774,Nutlin-3a (-),Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,5.2492433,0.18622859,3.3574811650555536,0.07378868983861303
8271,SIDM00332,Vorinostat,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.88189507,0.041875627,1.7151645577637076,0.09384251683968778
26511,SIDM00774,AZD8055,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,-1.8468484,-0.11533751,-0.465359217140418,-0.012968243867601932
10576,SIDM00875,Uprosertib,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4128466,-0.08613999,-1.098416310740363,-0.04299424898865625
65917,SIDM00866,Luminespib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.8779398,-0.02720005,-2.5876785265757785,-0.11582416918953148
408,SIDM00875,Docetaxel,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6482099,-0.053261228,-1.755740982173786,-0.18203790749215035
70267,SIDM00834,Afatinib,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-1.6570818,-0.12121438,-1.320052243577525,-0.07363968603418351
58221,SIDM00628,Doramapimod,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.4630831,0.046246056,2.3426915328617564,0.09769701621768627
97198,SIDM00779,Dabrafenib,Navitoclax,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-2.2248368,-0.039787814,0.2615974453602574,0.01981802226286954
90387,SIDM00971,AZD6482,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.8181186,-0.050009828,0.24178338660867627,0.022159414636780485
43889,SIDM00866,Sorafenib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,0.83817357,0.033049785,0.7344673888495649,0.017585739064246132
63690,SIDM00774,Luminespib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.83164644,-0.089298196,-0.8589785407334132,-0.08361437447174913
41551,SIDM00529,KU-55933,Trametinib,Breast,0.1,Breast Carcinoma,Female,Black,44.0,-0.52646744,-0.008785047,0.7098908871890823,0.013392163587111929
64014,SIDM00779,Vinorelbine,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,33.0,-1.2062055,-0.090199545,-2.0095168138923287,-0.11671159775850885
104105,SIDM00893,KU-55933,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.70579374,-0.02709671,0.14065658891562205,-0.020411259690387675
74165,SIDM00954,Camptothecin,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,0.14510198,0.005209775,1.5859312530001979,0.09721454650597167
29567,SIDM00866,AZD8055,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-1.7195041,-0.05520325,-0.8956180069465414,-0.05541415715004455
101951,SIDM00774,Nilotinib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,-0.748581,-0.05325405,-0.3753890721915884,-0.008147736306447015
3915,SIDM00866,Sorafenib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-0.6427394,-0.025497613,0.13819194398368415,0.04055620051812211
73723,SIDM00359,SB505124,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8963684,-0.14714895,-1.027513270739366,-0.03125566091482165
83868,SIDM00628,Navitoclax,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,0.5496571,0.039089706,0.792437808395614,0.0038228568166470034
105882,SIDM00774,OSI-027,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,48.0,0.3158342,0.04359967,-1.0043431115830699,-0.06858279006600958
13566,SIDM00778,LGK974,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,69.0,2.722685,0.073347434,1.899136614036355,0.05774248015858796
34958,SIDM00875,MK-2206,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.9712063,0.17899935,-0.044418408760043736,-0.01750566243561745
934,SIDM00628,Cisplatin,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,0.29890522,0.02625199,-0.8859119045200436,-0.01738646181661427
87553,SIDM00971,Gemcitabine,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.6414487,-0.08930733,-1.1992514868076267,-0.06826296236863003
100223,SIDM00359,Nutlin-3a (-),Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.3500276,0.029948637,1.7024296146885145,0.03877843312963893
50112,SIDM00774,PF-4708671,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,0.42822835,0.024895646,-1.089346782233125,-0.11043123186165466
1844,SIDM00193,Vinorelbine,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.80672306,-0.07395967,1.0967200543249929,0.0679733821534493
5753,SIDM00531,Crizotinib,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.4603437,0.1669314,-0.3003555527259735,0.04712614413099693
97000,SIDM00834,Linsitinib,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-0.3273986,-0.027622396,1.3153027050489214,0.10228334908819094
7068,SIDM00628,Lapatinib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,1.1354387,0.08738481,0.2745429110512547,0.014504309012237303
71440,SIDM00301,Palbociclib,Dactolisib,Pancreas,0.0125,Pancreatic Carcinoma,Male,East Asian,50.0,1.4334416,0.16562365,0.2834575947072969,-0.007343723693479894
75045,SIDM00866,Docetaxel,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,-3.2457988,-0.12610795,-2.0845635828866396,-0.12415265369581623
28235,SIDM00130,Taselisib,Erlotinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.8535774,-0.06004415,-0.5826059491348768,0.026119118825911166
24653,SIDM00774,RO-3306,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,48.0,0.80006164,0.050898146,-0.3701321342559386,-0.05757999338060408
42320,SIDM00193,MK-2206,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.91158503,-0.06757561,1.2025599332263814,0.14317229478932406
88947,SIDM00778,Nutlin-3a (-),LGK974,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,2.6899939,0.07669604,0.682326925792232,-0.010117824004666267
79546,SIDM00875,BI-2536,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-4.9915543,-0.1272802,-3.4852334186605884,-0.07223207491553026
14596,SIDM00971,Sorafenib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.5472313,-0.034987006,0.6010733048999938,0.002945140855818738
62487,SIDM00146,Palbociclib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.7578043,0.038288534,-1.3218272184549626,0.008998692704247446
1907,SIDM00954,AZD8055,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-2.3159294,-0.064948715,-0.3308631466788715,0.01968338248202374
104839,SIDM00779,5-Fluorouracil,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,33.0,-1.8145627,-0.04761846,-0.9606949825920138,0.021560602701989107
20120,SIDM00778,AZD7762,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,69.0,0.96103966,0.03618219,-1.8868814860095207,-0.055810575496382485
95555,SIDM00954,Cisplatin,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,1.2966801,0.034534667,1.4757621238669618,0.10197659180495576
73750,SIDM00146,Vorinostat,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.1260054,0.07588487,0.012438535529613243,0.01772347705439558
103026,SIDM00778,BMS-754807,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,0.9082636,0.026827259,1.2318993108461247,0.02834968846179149
4612,SIDM00529,Afatinib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.7630172,-0.07408985,-0.945580310450702,-0.03121564105016106
19666,SIDM00628,Camptothecin,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-1.0922229,-0.10620208,-2.3993197661314976,-0.1729308293082283
102300,SIDM00776,Trametinib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.47627452,-0.04358304,-0.039179125295127286,-0.006175557291562912
85326,SIDM00779,SB505124,AZD7762,Large Intestine,0.0625,Cecum Adenocarcinoma,Male,White,33.0,0.59564525,0.053549502,-0.4253645443709241,-0.04447604403739846
11062,SIDM01233,Oxaliplatin,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,0.2967984,0.021758156,-1.5011781352584552,-0.07791863824944205
44217,SIDM00529,Nutlin-3a (-),OSI-027,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-1.8761679,-0.0566871,-0.733925183209634,0.012645730347004601
73967,SIDM00878,OSI-027,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,70.0,2.2194135,0.26529548,-0.5530039489616447,-0.013129146501340184
93689,SIDM00146,AZD6482,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.3115919,0.10635942,1.1855467616140443,0.13397231049374225
107173,SIDM00097,Temozolomide,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.3373013,-0.00613795,0.8538353217276125,0.02394359512582493
63531,SIDM00359,Linsitinib,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0263852,-0.0580978,-0.048236987147538504,0.0059960539656609465
73872,SIDM00954,KU-55933,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-2.6290717,-0.088417314,0.008328359683932939,0.03277237410496263
33505,SIDM00130,Olaparib,Trametinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,3.0245163,0.18896511,-0.5790220443795169,-0.037569242154304856
45000,SIDM00774,Olaparib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.3384297,0.04465313,0.7723016076919871,0.07594714281594528
100243,SIDM00673,Olaparib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-2.2364228,-0.09045803,-0.9000572859669175,-0.019233759831175715
10694,SIDM00301,Sorafenib,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.2898744,0.15615839,0.5408968084350225,0.08914109527727777
55163,SIDM00529,JQ1,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.997863,-0.04363439,0.4389061836852194,0.0647769044517923
60151,SIDM00782,SCH772984,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,3.399871,0.2293618,0.25949758937193723,0.07225071834761028
85345,SIDM00776,SB505124,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-1.2205806,-0.09050697,-0.8971825088891552,-0.030415668503895956
9887,SIDM00875,Tozasertib,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8237036,0.102831684,1.5416411453716086,0.07380710450473625
94632,SIDM00893,Afatinib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.1615804,0.10347301,-1.0746666259673374,-0.09834291502591437
7867,SIDM00878,KU-55933,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,1.6654314,0.07129219,1.761837130684996,0.05100239386233571
49216,SIDM00130,Paclitaxel,Dasatinib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.3047069,-0.12517011,-0.7469657984744967,0.0519998699016973
17397,SIDM00971,Nilotinib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.17201,0.0766421,-0.2530692120579808,-0.01889917757091988
58357,SIDM00628,Docetaxel,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.13386145,-0.011993952,-0.6466884777375174,-0.049582941552816194
94027,SIDM00130,MK-2206,Linsitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.5055349,0.1407866,0.6396402121716566,0.12130296080933202
64196,SIDM00529,Ribociclib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.2480761,-0.031706307,-0.016438981023595915,0.02134652622962759
52781,SIDM00893,Bortezomib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.43057448,-0.03095099,-1.2555351710732197,-0.060671965034571416
69222,SIDM00834,5-Fluorouracil,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Female,White,66.0,-1.5051342,-0.080422655,-1.7389444734662525,-0.07569811406813043
93537,SIDM00301,Cisplatin,Ruxolitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.852989,0.10453101,-0.09639648530099373,-0.02340944322952839
21167,SIDM00193,SCH772984,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,2.0843525,0.13005829,0.6951029050788574,0.06835404203560631
55008,SIDM00776,AZD4547,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,65.0,-1.4083825,-0.037627436,-0.6861026278068334,0.017032936332001123
30080,SIDM00301,Taselisib,AZD7762,Pancreas,0.0625,Pancreatic Carcinoma,Male,East Asian,50.0,-1.3986554,-0.14251776,-0.7027536973258441,-0.05104427279871453
17602,SIDM00660,BMS-754807,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,3.2735026,0.21642345,0.23131427092917028,-0.01519101354270412
91541,SIDM00893,Palbociclib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.57194316,-0.02447519,-0.6363970285713341,0.008741397124592697
74761,SIDM00971,ZM447439,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.1748476,-0.07130535,1.0733363947327486,0.07637005839369479
67487,SIDM00774,KU-55933,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.5943802,-0.015380889,0.18168663466751483,0.06028471828628003
7893,SIDM00529,Venetoclax,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.343239,-0.034025103,-0.3852359098320472,0.03468292238631222
65738,SIDM00411,Olaparib,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.209882,0.062468763,2.475012993872305,0.06503142248165214
53111,SIDM00628,JQ1,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,1.0915911,0.07552532,0.3036117586182568,0.02188453233928429
37934,SIDM00130,Cisplatin,Irinotecan,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.3617461,0.110595524,-0.725523150169575,-0.05262344188717651
3822,SIDM00776,Trametinib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,1.6159179,0.13114624,-0.7318772969550825,-0.09142904962326673
88322,SIDM00529,Luminespib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,0.33003414,0.03357946,-2.0103017824856626,-0.058712636808052804
66754,SIDM00954,AZD6482,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.8926792,-0.054343168,0.397156634974366,0.00542720018577735
91255,SIDM00971,Tozasertib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.939612,0.08292215,1.7096649986172183,0.06386213761684593
50984,SIDM00971,Trametinib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.2018313,-0.01730607,-0.3013673726712151,-0.004160958754772086
50761,SIDM00954,Afatinib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,0.87860346,0.045982137,-0.04940526692468178,0.0345829533589813
32183,SIDM00774,NU7441,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,0.45188618,0.02735604,0.3970163194801053,0.09291292978911776
68180,SIDM00332,Doramapimod,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.0052757957,-0.00041835807,-0.7256953752779951,-0.019169315318456424
46613,SIDM00954,Venetoclax,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-0.2295254,-0.016583178,-0.9757729553593742,-0.004616503148080028
94612,SIDM00146,RO-3306,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,0.9780934,0.073147886,0.13154879096364047,0.0027925357500983954
22693,SIDM00332,AZD8055,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4272966,-0.1088283,-0.1584099828725188,-0.01646757530335364
90973,SIDM01233,MK-2206,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-2.3511465,-0.1466565,0.051741212394407904,0.0033316718905779964
47529,SIDM00146,Taselisib,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,-0.141981,-0.0114416685,0.5195286958193716,0.03125355698483234
98997,SIDM00628,Camptothecin,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,2.66006,0.24889371,2.1339369729258792,0.16366198893721823
91476,SIDM00332,Dabrafenib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,0.99849355,0.04259377,0.020696518438529907,-0.013705385283354053
51135,SIDM00531,Ruxolitinib,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.48329124,0.009244882,1.5039912727829152,0.04435601736798509
33637,SIDM00097,NU7441,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.93375003,-0.035553504,1.2340315065860548,0.08788957240304923
11923,SIDM00529,Venetoclax,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.3290389,-0.033823494,0.799181552013147,0.097816387402972
58837,SIDM00954,Entinostat,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,0.81944877,0.07003407,-0.39075492037496706,-0.03168835316082004
67358,SIDM00529,Gemcitabine,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-0.6302657,-0.016936267,-1.378000620239079,-0.022696788715158643
476,SIDM00774,Ribociclib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.91637456,0.034000874,-1.3949084975647734,-0.023480185429297997
69212,SIDM00875,Taselisib,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5918382,-0.17064795,0.35203796577764734,0.004313603685859233
94251,SIDM00660,AZD8055,MK-2206,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.78358316,0.061811153,0.9387072394434023,0.059822072533049796
67307,SIDM00774,Dabrafenib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,1.7355278,0.06756969,0.0545108373576323,0.015430881952531979
52896,SIDM00875,KU-55933,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1184101,-0.043266125,0.8151790924915635,0.05052230369103248
5740,SIDM00782,AZD7762,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,0.5126725,0.04118952,-0.7117878270194973,-0.03971873693311751
29121,SIDM00628,Alisertib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-1.49562,-0.056639988,-1.9918403034228833,-0.01987733739078193
27695,SIDM00971,PD173074,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1440641,-0.027039,-1.7874618528687216,-0.0008161059152798181
74003,SIDM00628,Alisertib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,-1.2518284,-0.040425193,-1.3668350736863124,-0.017996692390976964
78220,SIDM00875,PD173074,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0104371,-0.05181783,-1.0136455498026593,-0.03828383611132618
37456,SIDM00875,Alisertib,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7677321,0.17798992,-0.5893248040678283,0.026968167056074823
22319,SIDM00778,Olaparib,Camptothecin,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,69.0,-3.2026627,-0.08613948,-1.5405538160278538,-0.0475582798639061
37615,SIDM00301,SCH772984,MK-1775,Pancreas,0.2,Pancreatic Carcinoma,Male,East Asian,50.0,0.69846076,0.09364706,0.19012573876353117,0.03756365369543696
6486,SIDM00146,Wee1 Inhibitor,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.6170319,0.045104485,0.021548873794344246,-0.025733383490573768
21468,SIDM00529,AZD6482,Olaparib,Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.12444302,0.003730877,1.610489527265025,0.10284152303112756
4728,SIDM00954,RO-3306,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-2.1042385,-0.17070505,-0.8798831830890262,-0.06741701312733145
104034,SIDM00779,MK-1775,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,0.81702673,0.028756319,-1.2780422936694593,0.010944519871622331
69358,SIDM00776,Taselisib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,0.8845327,0.07026838,-1.358539485795265,-0.04044107723407787
91302,SIDM00971,Axitinib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.4799012,0.0756704,0.7877441222791646,0.12365785401310303
84325,SIDM00628,Lapatinib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.27230442,-0.0209117,-0.11479402862294062,0.03271054872896091
2455,SIDM01233,AZD8055,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,-1.2086476,-0.07986993,1.434141989012882,0.11355694793066715
88215,SIDM00954,Linsitinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-2.8264568,-0.21457054,-1.0061684326732327,-0.06822712458567139
92008,SIDM00778,AZD4547,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,69.0,-1.139734,-0.0420852,-1.7932591417250003,-0.03335289749035981
70570,SIDM00875,Alpelisib,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.5209405,0.12684374,0.3516878939651935,0.05307802727955933
104661,SIDM00878,BI-2536,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.5603572,-0.049627125,-0.07983725100327455,-0.08624091926901926
2196,SIDM00866,Bortezomib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,52.0,-1.2455919,-0.09814023,-0.6931328147584664,-0.02563247807539663
66418,SIDM00893,Dabrafenib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.85792786,-0.019577244,0.7421600001366304,0.06457941099639997
43791,SIDM00834,SCH772984,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-0.41757476,-0.03671532,-0.873565240528624,-0.028532813604752894
83673,SIDM00146,Afatinib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.5414533,-0.052033488,0.38152777075507405,0.025822853947555485
76521,SIDM00301,Cisplatin,Trametinib,Pancreas,0.25,Pancreatic Carcinoma,Male,East Asian,50.0,-2.1320105,-0.14571027,-0.152709267821915,-0.028750514059136208
24613,SIDM00878,OSI-027,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.9921454,0.11889702,-0.2546163151848557,-0.05726307049664755
7882,SIDM00875,Bortezomib,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.46608067,-0.034400135,-0.9674244776311957,-0.022301066463741016
2540,SIDM00878,Gemcitabine,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,1.1261086,0.1214468,1.0005658810291036,0.08254412205386899
53678,SIDM00875,Pictilisib,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.20761706,0.022767179,-0.4436451682021819,-0.058928233432174085
48299,SIDM00628,AZD8055,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.31715217,0.025302857,-0.03185186708706285,0.001662544475597653
93377,SIDM00673,Navitoclax,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.035187304,-0.0029764685,-0.6135516056473492,-0.05291893736068243
95121,SIDM00332,Olaparib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.8723202,0.09757502,0.8436254072762551,0.03922018076504451
31055,SIDM00778,SB505124,AZD7762,Large Intestine,0.0625,Cecum Adenocarcinoma,Male,White,69.0,-0.2691353,-0.017852293,-0.5010722362259623,-0.023994500569382488
54219,SIDM00673,Cisplatin,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,1.2476782,0.056376535,1.6977912800319284,0.09613695765796944
78457,SIDM00866,Olaparib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,2.119769,0.055868782,1.2551452125868279,0.0358887247046215
85498,SIDM00971,Gemcitabine,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.8463743,0.094647534,3.080826200512183,0.13913970466856093
35178,SIDM00893,Camptothecin,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2477356,-0.09854073,-1.8581967771726666,-0.10452477618980403
12293,SIDM00529,NU7441,Olaparib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.4111586,-0.10147519,-0.12105547080849535,0.011964190468605734
49822,SIDM00971,Doramapimod,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.41598734,-0.0131019885,1.2616750844253082,0.06985401034256503
77520,SIDM00954,AZD6482,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.9302552,-0.10386829,-1.0336437764610515,-0.06452596832610062
36326,SIDM00779,AZD8055,Olaparib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-0.2857534,-0.027014045,-0.15513643543394862,-0.06284965730650098
12884,SIDM00971,RO-3306,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.44813848,0.02693775,-0.8591035392737216,-0.04067334992692977
92224,SIDM00866,MK-1775,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.4668213,0.036225647,-0.30360816180047184,-0.03884722800266506
66860,SIDM00778,Taselisib,Dabrafenib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,1.8470354,0.084894,-1.0845549540311832,-0.06969425500895657
87958,SIDM00660,Olaparib,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,32.0,4.490796,0.1188444,2.1394464806619635,0.051684713607642506
54253,SIDM00893,Navitoclax,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.0994797,-0.107940994,-1.931302143653819,-0.14035612142889303
8924,SIDM00875,Dabrafenib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5064325,0.025021363,0.1408421569793055,0.01932342251615792
19249,SIDM00779,Trametinib,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.0272208,-0.04115258,-1.455678524031179,-0.06494229063729193
61468,SIDM00878,Palbociclib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.9245774,-0.11087238,-1.3230665229638705,-0.08210047770455167
30454,SIDM00332,OSI-027,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0854629,0.11557388,-0.18358248962204882,-0.017027611713432617
18155,SIDM00954,Navitoclax,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-0.5624715,-0.019187467,-1.0405111417664028,-0.02361379022790428
78786,SIDM00778,Afatinib,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,0.7749874,0.03537858,0.23180636463988302,0.016606421176646437
60205,SIDM00193,Olaparib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.7247634,-0.08606258,-1.5796448263517946,-0.03776552946642716
36227,SIDM00866,Navitoclax,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,0.96202844,0.07790307,0.544625381748445,0.02846601231724021
104556,SIDM00971,PF-4708671,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.62380964,-0.037104763,-1.7183829590885609,-0.06363644737612255
37582,SIDM00782,5-Fluorouracil,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,Unknown,72.0,2.4144356,0.13299459,0.14892092203036963,0.017482320493903983
43749,SIDM00834,Taselisib,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,White,66.0,4.1510735,0.2654868,3.739373641904429,0.09624636826427384
100402,SIDM00893,ZM447439,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.12285241,-0.009788711,-1.2636637883703021,-0.07459766102977831
68952,SIDM00875,Bortezomib,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.59827447,0.056208786,-0.008520730763768367,0.026961263349883535
51978,SIDM00146,AZD7762,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.5949667,0.052390754,0.5804550068884092,0.0473957707723415
89267,SIDM00531,LGK974,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-2.3693602,-0.06296755,-2.5552238508934817,-0.0648584582403191
45214,SIDM00531,OSI-027,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.1603327,0.16546537,-1.2643737894332971,-0.057835707453088844
107027,SIDM00782,MK-1775,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.5896467,-0.031296033,-2.475670195856153,-0.12445815025281241
34454,SIDM00359,SCH772984,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.3007852,0.02211477,-0.4804516510408876,-0.005966396999954775
2944,SIDM00146,AZD8055,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.206356,0.09347267,-0.06426025101617071,0.020377667136878698
1979,SIDM00301,Oxaliplatin,OSI-027,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-1.7521054,-0.15384154,-0.49303467946871776,-0.03073752606684989
15638,SIDM00782,Olaparib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,Unknown,72.0,-0.8894756,-0.019806353,1.2423339912850508,0.03816933224959726
69135,SIDM01233,Vinorelbine,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,3.5760841,0.07542268,1.4863954503989532,0.06112731444494944
103737,SIDM00673,Camptothecin,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.0174258,-0.030067557,0.9206635490555396,0.09162353791549387
98960,SIDM00779,SCH772984,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,-1.364068,-0.0295066,-0.5984608168931043,-0.06598215806398526
48011,SIDM00130,Gemcitabine,Erlotinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-3.134742,-0.1885574,-0.8613287682820875,-0.06359682067836901
82585,SIDM00954,Vorinostat,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-0.854706,-0.06523205,-0.22930993451348888,-0.062265681888111275
14941,SIDM00954,Alisertib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,1.8877286,0.11520743,0.43941061162209116,0.07542215821549586
37233,SIDM00774,Temozolomide,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,3.995366,0.13096094,2.5371512409078267,0.03549361281783226
77766,SIDM00529,Dabrafenib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Black,44.0,1.309025,0.029775152,1.3938229752126183,0.025608451705302515
85254,SIDM00531,Oxaliplatin,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.5304756,0.015377355,0.4932644740711944,0.05079297865805998
84668,SIDM00875,Wee1 Inhibitor,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.45024642,-0.02674142,-0.5307552328453025,-0.03785773503675885
9712,SIDM00097,MK-2206,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.780191,-0.22920062,-0.9320469523756607,-0.1566739959477398
68653,SIDM00332,RO-3306,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1848109,-0.06244189,-0.5216883763485692,-0.012973668956975463
96166,SIDM00866,Paclitaxel,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.35201555,0.027767546,-0.7499930446902675,-0.024909865984795276
21776,SIDM00130,AZD7762,Ruxolitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.5158935,-0.14936158,-1.3801366792610528,-0.05709936547213612
33405,SIDM00778,LGK974,MK-2206,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,1.7671492,0.05039168,1.3619893943195316,0.07069087104121789
39519,SIDM00628,Pictilisib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,-1.2927581,-0.11715014,-1.2750930445949495,-0.0832630464075141
99306,SIDM00628,NU7441,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.11653863,0.012017874,0.20540134636600343,0.06858455009521222
2081,SIDM00878,Tozasertib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-1.6039263,-0.045295976,-0.6053925517100519,0.05125533266097173
27090,SIDM00954,GSK269962A,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-0.7575663,-0.06321341,-0.9564488684519111,-0.06205060796168266
95349,SIDM00782,LGK974,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,-0.9199873,-0.050969306,-1.6311389989346483,-0.016744210329030527
83747,SIDM00301,OSI-027,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-1.0702392,-0.14460611,-0.4005830032925973,-0.027908803094540857
17115,SIDM00954,BI-2536,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-0.53895295,-0.0103279175,0.3717316717292813,0.03167162373856716
19295,SIDM00146,Vorinostat,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.5244512,0.04971701,0.7844865273963741,0.04267759842396892
80564,SIDM00146,Taselisib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.78813636,0.062027954,-0.5088428308810711,0.051470306561526784
86156,SIDM00779,Camptothecin,Navitoclax,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,4.4879403,0.32034114,2.5863673395345317,0.16229540666069195
97253,SIDM00332,Doramapimod,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.3949344,-0.026434027,0.5157355243893166,0.02813552040320326
27256,SIDM00411,Taselisib,Oxaliplatin,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-5.061304,-0.24542865,-1.789629509113505,-0.06397501728445781
86313,SIDM00673,Bortezomib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.22677237,0.011444507,-0.9235497392300973,-0.03241924743009789
66522,SIDM00776,5-Fluorouracil,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-1.5419371,-0.051626828,-0.24803937695020906,-0.01754997055416817
52144,SIDM00359,BMS-754807,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.4431067,0.115826376,-0.9336561470054975,0.03204536332826232
92308,SIDM00673,5-Fluorouracil,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.0512556,0.045088336,0.8245797754268784,0.025701510764592907
107286,SIDM00774,Camptothecin,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,-1.6540012,-0.07601397,0.3929704917665206,0.03976824267658464
31235,SIDM00359,SB505124,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.32517213,-0.027917791,-0.8812999391625276,-0.042696437595454204
2887,SIDM00878,Vorinostat,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,0.97934514,0.082775354,0.14074153616083754,0.03010158333065051
103894,SIDM00359,BMS-754807,SCH772984,Large Intestine,0.05,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.6076689,0.14013311,1.2510963743934571,0.08055135924329679
2296,SIDM00332,Paclitaxel,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9739554,-0.07446692,-0.4118428971206947,-0.0917904205524861
100483,SIDM00875,Linsitinib,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7496903,0.11800938,1.6446175679379251,0.07775504402507863
53986,SIDM00774,Taselisib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-0.7025773,-0.04276407,-0.7524254344445347,-0.06516187633621376
95924,SIDM00359,BMS-754807,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.6130946,0.052115217,-0.0854556020865474,0.00174173750459617
81566,SIDM00878,Doramapimod,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,1.138492,0.022824064,1.3113369336326628,0.07987529680147956
76577,SIDM00774,OSI-027,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,0.60915786,0.07764285,-0.2062345018813382,0.007378590496539134
46006,SIDM00660,AZD8055,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-0.28503597,-0.021392534,-0.6700875708527912,-0.06701574976749139
45433,SIDM01233,AZD4547,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,3.7890804,0.17506254,1.921020902620855,0.0799416915420904
25507,SIDM00411,Irinotecan,Linsitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,1.6036185,0.07535656,0.5295862918382678,0.06717098791841723
49019,SIDM00332,Uprosertib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0382677,-0.07080063,-1.7806940993741514,-0.10933110166790627
105436,SIDM00774,Taselisib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,48.0,4.85285,0.033697173,-1.351901957358768,-0.10013052724118329
103290,SIDM00673,BI-2536,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.46922234,-0.033223405,0.375513252366131,0.036385278093389414
75537,SIDM00332,MK-2206,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9067498,-0.09585223,-1.555404970458291,-0.1313688901623671
21308,SIDM00193,Crizotinib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,53.0,-0.6293189,-0.028050048,-0.009082663687618254,0.028974409453583056
1887,SIDM00782,Afatinib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,1.3933157,0.11828949,0.6721308146772424,0.04756113238715026
95705,SIDM00193,Navitoclax,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,53.0,-0.6329968,-0.046649538,-0.5534267355410134,-0.030445325519301833
63557,SIDM00531,Oxaliplatin,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.5106032,0.014922111,1.1787418378631935,0.04467004781137304
14427,SIDM00971,Linsitinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.4587499,-0.050321274,-0.6564037133555365,0.02581721410274809
95291,SIDM00332,Luminespib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.8187925,-0.14675851,-0.4862795088048603,-0.09280136090125116
87815,SIDM00878,Ribociclib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-1.5630022,-0.022858156,-0.9148535403489988,-0.002659638240661433
50668,SIDM00529,Dabrafenib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,4.545247,0.18271233,1.7807153762324999,0.0707081547953297
57644,SIDM00834,Dabrafenib,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,1.5886258,0.06486404,0.34615842789255896,0.037214171476792526
65452,SIDM00893,Ribociclib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-2.5624492,-0.08750014,-1.5236761361988271,-0.025500578933958833
106638,SIDM00893,Entinostat,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,5.903115,0.09964341,3.7747596775144974,0.12723427894146172
53841,SIDM00875,OSI-027,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.90601444,0.08037888,1.2418695677601597,0.08685625161260688
63204,SIDM00529,Wee1 Inhibitor,PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-0.43131706,-0.0417367,0.30717710773411905,0.007095481081326814
83589,SIDM00097,Trametinib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6931486,-0.043732908,-0.7948748526327243,-0.004306850324280121
5041,SIDM00097,RO-3306,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3021375,-0.06350448,-0.29641158273018997,-0.012639403925164832
97251,SIDM00779,Afatinib,Taselisib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,0.15186095,0.010424725,0.7179293406425474,0.046348287477973135
105689,SIDM00146,KU-55933,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.78332853,0.03876465,-1.3205418394091852,-0.022916405062880684
81658,SIDM00531,5-Fluorouracil,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.0865976,0.04168321,1.9169314340141785,0.07890685526274516
33714,SIDM00529,Doramapimod,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,0.92641,0.034900095,1.6634447607356646,0.053621071166975315
93295,SIDM00971,PF-4708671,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.7439937,-0.03957234,-0.2978177234319637,0.01065697921587903
23307,SIDM00971,Palbociclib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.831194,-0.050545312,-1.2180183689528907,-0.004463194581568942
11026,SIDM00782,SCH772984,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-1.6845415,-0.09973273,-0.18469946863382977,-0.013059973008350902
47968,SIDM00097,Luminespib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0925742,-0.075934805,-1.6318835040781456,-0.10595237830267963
86189,SIDM00628,Venetoclax,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-2.6518536,-0.09834527,-1.003597861860176,0.01457812225803214
31899,SIDM00878,Lapatinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,70.0,2.4935322,0.26896688,1.041681793297831,0.14406371448352237
21086,SIDM00673,PD173074,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6611949,-0.038081538,-1.1663953101238105,-0.05799069443598345
24501,SIDM00779,5-Fluorouracil,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-1.5496905,-0.040209226,1.6012072479402908,0.07754230935959809
36840,SIDM00875,Palbociclib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7601279,0.057058375,2.288325020980113,0.1384501144039695
20248,SIDM00866,Axitinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.0456635,0.0685574,-1.279231683357366,-0.005137190283045793
102700,SIDM00411,Linsitinib,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-0.7370471,-0.03917755,-0.29734060447111954,0.038042353917870385
37065,SIDM00628,Pictilisib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,1.4574623,0.115599155,-0.4977231775548145,-0.00521603579889255
97214,SIDM00875,Cisplatin,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.78160274,0.040298518,0.5939525007873894,0.05481460625268444
2829,SIDM00893,AZD8055,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.55450016,-0.04980182,-0.6036645316834158,-0.07340258507142249
103184,SIDM00774,AZD7762,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.68458414,-0.07459295,0.31558197721214776,0.026545104780120368
20681,SIDM00834,Taselisib,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-1.4193974,-0.084897496,-0.38339802583456056,0.03251695521451224
62247,SIDM00531,Linsitinib,Dactolisib,Pancreas,0.0125,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.4043872,0.09520502,2.1053660454296645,0.15981871523554225
71138,SIDM00332,MK-1775,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.8688543,-0.079385564,-1.7092888266844695,-0.040807581264954505
34356,SIDM00893,ZM447439,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.002518548,-0.00020520361,0.19648017904925513,0.0041517477723246815
81565,SIDM00529,BI-2536,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-2.9912806,-0.30495685,-2.5830459188079624,-0.17392623089336998
58518,SIDM00097,Alisertib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2698122,-0.07330595,-0.7885034226754414,-0.034486398461646785
31171,SIDM00774,Entinostat,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,-1.4090127,-0.062187325,-0.08183244067558985,0.027731289710204277
34707,SIDM00954,Nutlin-3a (-),MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,2.3898823,0.068938434,1.9813756074813729,0.10249591750666696
68526,SIDM00411,SCH772984,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,43.0,4.3756127,0.23491824,3.4823864953201786,0.17793653761504669
89694,SIDM00660,AZD8055,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,-0.427423,-0.021713657,-0.48654603838718213,-0.01803181962579645
22857,SIDM00878,Axitinib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.4495285,-0.05634136,-0.6411455662050591,-0.0402429692545365
74014,SIDM00866,GSK269962A,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-1.9163048,-0.068827905,0.052086384300008615,0.01946653234494044
33395,SIDM00529,Doramapimod,Luminespib,Breast,0.01,Breast Carcinoma,Female,Black,44.0,0.19924535,0.006641668,0.637288848215595,-0.026700921200356675
29933,SIDM00529,Trametinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-2.7430074,-0.12797971,0.07863915970336352,0.01629589040707548
74849,SIDM00776,MK-1775,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-2.0950668,-0.13961321,-2.0975350121531124,-0.09092423575841367
48356,SIDM00673,Trametinib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.7881249,-0.1347678,-0.8721631838393965,-0.026556152077543825
67079,SIDM00878,BI-2536,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.1948249,0.08868593,-0.013083746358351373,0.004602565238038263
69628,SIDM00782,5-Fluorouracil,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.9010208,0.09387966,1.7656121461138037,0.05192562379724437
93164,SIDM00971,Doramapimod,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.3546844,0.08311365,0.6238713086566512,0.02176056478435781
80485,SIDM00193,AZD4547,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.4706457,-0.09729984,-1.1093213079388793,-0.04926096016928186
35808,SIDM00411,MK-1775,5-Fluorouracil,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,1.166947,0.07457772,-0.7342473162217913,-0.016605800247820744
39420,SIDM00628,ZM447439,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.19525324,-0.016614396,-0.3410674703147911,-0.031073123197331572
70351,SIDM00097,Afatinib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2379521,0.08961156,0.7203598338174927,0.008147468394686205
38775,SIDM01233,Navitoclax,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.5337867,0.1028044,1.125265581453956,0.07171144436240554
70204,SIDM00774,Lapatinib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.4890999,-0.054259174,0.6921617472826828,0.03767895217810639
102337,SIDM00778,Dabrafenib,Oxaliplatin,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-0.8666578,-0.017540736,-0.7237534639536194,-0.015873496751391825
79294,SIDM00778,5-Fluorouracil,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-3.5158317,-0.07331176,-1.322292791680901,-0.0327349591633938
72666,SIDM00779,Oxaliplatin,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,33.0,-4.0804157,-0.16815935,-1.0822311083231346,-0.045485983568706846
21081,SIDM00866,Crizotinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,52.0,-0.8879989,-0.076018915,-0.3819189525473505,-0.026443529259302604
87833,SIDM00529,Entinostat,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-2.5838618,-0.12450149,-2.4085028120751657,-0.09068831132202827
47729,SIDM00146,PD173074,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-3.7405767,-0.19671845,-1.9879496411543436,-0.10038720385755959
8307,SIDM00834,AZD8055,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-2.9472263,-0.16044179,-3.1070085567254897,-0.11304191587374986
46987,SIDM00893,Alpelisib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.0533073,0.1272181,0.2867064149918162,-0.01619810704241718
92195,SIDM00193,Oxaliplatin,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,53.0,0.26209944,0.00977247,1.2816538331085798,0.05759729414727425
96880,SIDM00954,Afatinib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-1.4895929,-0.09817884,-0.7464290251726856,0.04018001267621514
9524,SIDM00779,SB505124,Navitoclax,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,33.0,0.99919367,0.081039935,0.16869820815132427,0.037615230977906144
77517,SIDM00971,5-Fluorouracil,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.42158675,-0.011623438,-0.7018479345686384,0.013841420430033382
32568,SIDM00878,Venetoclax,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,70.0,2.001402,0.07360387,1.3438277569254014,0.05881450749433228
74797,SIDM00301,LGK974,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,50.0,-2.2019937,-0.14779799,-2.338408246857141,-0.01665352138133372
65478,SIDM00866,Dabrafenib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,1.8806716,0.08115277,0.41035396228217147,0.05151980893189559
32179,SIDM00529,KU-55933,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,1.2899297,0.03183726,0.5710394316108478,0.0249006880171443
107506,SIDM00878,Pictilisib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.013372,-0.1191243,-0.017789862211374297,-0.043080575142098086
29618,SIDM00628,Ribociclib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,0.6395222,0.019494617,0.0579129347515396,0.0169094157550138
100882,SIDM00954,Nutlin-3a (-),Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,0.08749739,0.0020434193,0.3400704439818772,0.06895468785524217
68218,SIDM00332,Venetoclax,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2475736,0.04146535,1.4563659095650991,0.03750808548464672
4958,SIDM00130,AZD7762,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.541901,0.124751076,0.29747893349480126,0.030555150944942877
59071,SIDM00193,Linsitinib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,53.0,1.2316648,0.054140694,2.3659917161645363,0.1160277669336056
99349,SIDM00971,GSK269962A,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.8239398,0.023629386,0.5974371156469177,0.05749326792654282
12614,SIDM00673,JQ1,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.5371097,0.039396234,-2.0737965293299956,-0.1107336057221803
967,SIDM00660,Crizotinib,LGK974,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-0.0063311,-0.000641943,-0.06725996048582975,-0.04125869169956337
12759,SIDM00301,Erlotinib,Dasatinib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,50.0,2.5569117,0.16428041,1.8568773675705312,0.08883761647965843
70532,SIDM00146,Wee1 Inhibitor,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.34635296,-0.029378619,0.3835528652084922,-0.008082296797884884
84330,SIDM00774,Alisertib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.857378,-0.15862027,-0.7761318773401368,-0.03642491388477094
90940,SIDM00774,Alisertib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,-0.81662506,-0.054641172,0.4442859502017236,0.01975141339166392
5364,SIDM00628,Alisertib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-0.3373103,-0.011834782,0.4192606112111402,0.06724887234825003
85661,SIDM00878,Tozasertib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-2.1424973,-0.122198254,-1.697665264092958,-0.06536889256045157
98584,SIDM00893,Dabrafenib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.55762637,-0.016835714,0.19654640860242106,0.027966364495685046
45964,SIDM00130,Crizotinib,Gemcitabine,Pancreas,0.01,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-3.1219945,-0.12353686,-1.0075303126390547,-0.06013659373161852
24001,SIDM00893,Luminespib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.4011909,-0.10378275,-1.414354376390028,-0.07812831980031333
9720,SIDM00778,Navitoclax,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,1.702413,0.086678416,0.6513387199592605,0.08366466912939083
82195,SIDM01233,Nutlin-3a (-),SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,72.0,2.27411,0.11283003,0.9528727549744709,0.04390777238375359
60997,SIDM00774,Nilotinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,0.920871,0.07026291,-0.6779876218638373,-0.017133615513231587
69787,SIDM00954,AZD8055,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-2.2297637,-0.16091225,-1.3449476806420309,-0.043951941166160795
76057,SIDM00779,Camptothecin,AZD7762,Large Intestine,0.0625,Cecum Adenocarcinoma,Male,White,33.0,3.2348201,0.24976373,3.3271733070245824,0.35330348499776726
97618,SIDM00875,Venetoclax,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5502695,0.013155101,2.7032369520612987,0.04564253554951457
75474,SIDM00875,MK-1775,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.26741835,-0.017114658,-2.3133454135884963,-0.10875376996141049
53891,SIDM00774,RO-3306,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,1.3021963,0.08696472,-0.18098149461343224,-0.03193892853337381
84898,SIDM00097,Afatinib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8807762,0.061655145,0.605344766452769,0.0227382509451486
107769,SIDM00834,Oxaliplatin,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,White,66.0,-1.5826393,-0.1217424,-2.215944917046335,-0.11676617189366201
45624,SIDM00878,Lapatinib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,70.0,2.667621,0.3160457,0.21592947613832186,0.08667032060735567
7826,SIDM00529,Cisplatin,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.2856711,0.024961216,3.206659407936348,0.07605710299839681
56345,SIDM00411,Ruxolitinib,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,3.9472723,0.102329366,2.062854726797224,0.058877934055936235
18276,SIDM00097,Axitinib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0001936,-0.04711614,0.17916525990925875,0.004996632439739522
105061,SIDM00779,Afatinib,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-0.8425042,-0.019062782,1.2074031103383056,0.04402495268498627
74057,SIDM00332,ZM447439,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.0622518,-0.09457358,-0.5772164479585433,-0.03950004177517385
80287,SIDM00359,MK-2206,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,4.4557786,0.28173012,2.1871414466380568,0.08298181537919938
97317,SIDM00411,Gemcitabine,Dasatinib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,43.0,-0.8094236,-0.04648678,0.13864297314441063,-0.0067704903969574345
73650,SIDM00301,Linsitinib,Sorafenib,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,4.3790417,0.27610353,4.251461579338081,0.1634818424686621
75997,SIDM00146,Vorinostat,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.86822253,0.07801604,-0.22732586424066595,-0.007914406970676436
45785,SIDM00782,5-Fluorouracil,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,Unknown,72.0,-1.6746193,-0.05118499,0.6267060286554633,0.025581018666148054
89665,SIDM00893,OSI-027,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.50529855,0.047187272,-1.2002366209196988,-0.03462808014741272
23518,SIDM00097,AZD6482,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0154201,-0.06902628,0.8238745114984518,0.024721761614393278
35712,SIDM00332,Bortezomib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1462657,0.040196687,0.351292249380211,-0.03917742085118224
14750,SIDM00097,Taselisib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.3509026,0.12976891,0.6654473724329832,0.07976020922963692
90583,SIDM00971,Trametinib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.2435578,-0.018512622,-0.38526906900296526,-0.051651005825341316
21059,SIDM00628,RO-3306,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.22304235,-0.014334325,-0.37685470204344956,-0.0180683448400937
74822,SIDM00097,Lapatinib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,4.1116776,0.2819818,-0.2738606806654515,-0.023592817657077703
51680,SIDM00529,Axitinib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.8426744,-0.06711618,0.42930527996666557,0.0814190340676473
103056,SIDM00146,Afatinib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-1.136952,-0.11040032,0.05621095554033899,-0.013022905464520144
94210,SIDM00531,OSI-027,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.0622631,0.06273617,1.7770443694076632,0.048507310269876744
44630,SIDM00779,MK-1775,Oxaliplatin,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,33.0,-0.8132984,-0.04983996,-1.8005930358280215,-0.05169590763277367
81465,SIDM00893,Nutlin-3a (-),Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.51734954,-0.010304769,1.264645403774537,0.011734623415348764
75829,SIDM00628,Axitinib,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,-0.36087683,-0.02565943,-0.849999767498954,-0.0627503654137963
6189,SIDM00866,Camptothecin,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,1.9144075,0.03563017,3.783121312544413,0.10091544751263039
61475,SIDM00097,Cisplatin,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.4194075,0.02950155,0.5406815817544861,0.007624139276471114
101812,SIDM00875,Ribociclib,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.660313,0.02838608,0.3510857206224336,0.05197598907113779
38424,SIDM00531,Gemcitabine,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.41608372,-0.036133077,-0.035569797742842406,-0.017102853744005147
20019,SIDM00778,Oxaliplatin,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,69.0,-3.684317,-0.101364516,-1.76094859853134,-0.04884360091516188
68541,SIDM00660,Nutlin-3a (-),LGK974,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,0.8056327,0.019728074,2.9644879930262893,0.07174488117202203
49436,SIDM00878,SCH772984,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.7981682,-0.06757338,-0.5357457192029303,-0.013174707194993857
44642,SIDM00971,Pictilisib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.2596352,-0.105079055,-1.1230608350838862,-0.019060695243309656
31958,SIDM00146,Sorafenib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,0.3251261,0.021051103,-0.22614352113166658,-0.014280580005946748
20745,SIDM00893,Navitoclax,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.3388095,-0.03557222,-0.7310541892724658,-0.03414569328048002
57911,SIDM00971,Luminespib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.5472455,-0.03250989,-0.5118617572820141,-0.04109950846279895
81948,SIDM01233,Camptothecin,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,0.6260151,0.022000937,4.633897305454783,0.18233427227823296
56266,SIDM00146,Doramapimod,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,2.2983768,0.16115567,0.6447684133589183,0.03712207014019934
4022,SIDM00411,Taselisib,MK-1775,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,-1.0430387,-0.048765685,-0.4623064277225312,0.01879758131006598
89360,SIDM00193,AZD8055,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-1.1176361,-0.07999281,-0.5773312108740002,-0.0076921034439371904
97779,SIDM00779,Crizotinib,BMS-754807,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,-1.9789104,-0.046028823,-2.1084171713734996,-0.06759766940742619
59251,SIDM00776,AZD4547,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,1.7357656,0.043906275,1.9378928977844343,0.0519000079620662
9314,SIDM00893,AZD6482,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.63421947,-0.055017937,-1.1194870786742255,-0.005932390933672566
44455,SIDM00529,Nilotinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,1.5907521,0.071395226,0.31170143563521246,0.12906482150478313
60837,SIDM00875,BI-2536,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.649053,-0.07956372,-1.0678556440172193,-0.0522340232823034
7808,SIDM00776,BMS-754807,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.35714686,0.032600664,-1.0886773037371744,-0.04255115456821662
96419,SIDM00673,Nilotinib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-3.3980942,-0.12131583,-1.3441311799734539,-0.0801768644849915
23258,SIDM00359,Linsitinib,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.5871626,0.05032105,0.5773371706549454,0.08545707736673737
18989,SIDM00893,Dabrafenib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.68422323,-0.019581286,0.7361232345914226,0.03858945701707141
96571,SIDM00146,Nilotinib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.2503117,0.10058489,0.26567988058019315,-0.017145980679479672
22565,SIDM00866,Gemcitabine,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,-3.0920858,-0.15467125,-1.2404684858542243,-0.061394417165891675
9934,SIDM00893,Camptothecin,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.9642646,0.078717045,-1.0649929089202732,-0.010219309875729892
60975,SIDM00628,KU-55933,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,Black,51.0,1.078755,0.080422685,-1.2567274310083583,-0.06526132356038103
77118,SIDM00332,Ribociclib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.725974,-0.054980807,-0.7786539056480817,-0.0451533776347494
101104,SIDM00774,Trametinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,0.8681283,0.029278072,0.46183123370166074,0.011019213287924075
62828,SIDM00875,AZD7762,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3450437,-0.024386264,-0.6870793437711572,0.056727184647189746
91603,SIDM00954,Linsitinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.0,-1.5941284,-0.1138462,-0.19976495537434458,0.005832189481601632
50654,SIDM00774,Luminespib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,48.0,0.36281458,0.03086445,-1.2782017653382198,-0.07174225339690748
28279,SIDM00778,AZD7762,AZD4547,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,2.3741174,0.07267849,-0.26669430914546866,-0.00010421125598373354
21566,SIDM00893,Trametinib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2529886,-0.124916874,-0.36157897111026766,0.012588137523183156
85591,SIDM00893,Pictilisib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.0529828,-0.10615193,-0.8174971818393049,0.002179537237503031
37235,SIDM00673,Nutlin-3a (-),Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,1.5847236,0.038760636,3.735837136079741,0.07696080506638676
35814,SIDM00866,Axitinib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,52.0,-1.4717795,-0.07622939,-0.6235145752718131,-0.03823342188926685
94787,SIDM00332,Doramapimod,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.044927355,-0.003563608,0.563653287268688,0.065483977843748
53495,SIDM00673,Venetoclax,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.3334929,-0.035116814,-1.0288499872362138,0.01497872713251781
84269,SIDM00628,Gemcitabine,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,0.5099793,0.013581428,-0.6342632603861248,0.02471245119761694
45210,SIDM00971,Crizotinib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.29919,-0.041089457,-0.5770686779472397,0.0026062267144012674
57267,SIDM00776,Palbociclib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,2.3844144,0.08902268,2.562813449096512,0.10223096591647683
35383,SIDM00866,Crizotinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,2.5795197,0.18593751,1.6079960631709835,0.10417915587884513
44811,SIDM00673,Navitoclax,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.0130997,-0.13246648,0.005076285122668374,0.022312618874243427
37199,SIDM00778,Camptothecin,Afatinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-0.56190634,-0.02098533,0.35844107304877654,-0.034316209775261605
67658,SIDM00673,Paclitaxel,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.8882697,-0.0730319,-0.9283836014947303,-0.08209175728821762
103098,SIDM00628,Trametinib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,Black,51.0,-0.37629604,-0.035550423,2.1850234781199718,0.07746470929839423
65606,SIDM00866,Taselisib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,2.708533,0.11733855,0.78125227513348,0.09952780794868066
74087,SIDM00878,Camptothecin,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,70.0,0.2744339,0.008163358,1.477803856227852,0.06881546677332818
27722,SIDM00146,RO-3306,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.3092763,-0.025558852,-0.91444716035679,-0.009685230831450323
2964,SIDM00673,Docetaxel,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-3.0168211,-0.2400152,-1.408538546844963,-0.10505308195452803
63650,SIDM00875,Dabrafenib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3900217,0.0792233,0.546729956438696,0.02221947557861203
18352,SIDM00673,Temozolomide,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.17114305,-0.0036487423,1.4925564623408172,0.00823481307208013
84305,SIDM00893,Docetaxel,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-3.8012545,-0.23645405,-4.398499731978394,-0.2738191398427501
9069,SIDM00774,Crizotinib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,1.9545726,0.2803956,0.4818838767021482,0.01461227691332038
12045,SIDM00878,Gemcitabine,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.71549135,-0.043550182,-0.8436407616178815,-0.04029396529844834
44346,SIDM00097,RO-3306,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0476,-0.092513904,-1.2456500492542721,-0.08408567509489864
83338,SIDM00776,Oxaliplatin,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,-0.7598522,-0.046447556,-0.8359585962222554,-0.01975523481871179
77537,SIDM00097,Tozasertib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.6823435,-0.07968283,-0.8911482143373737,-0.028143568375956128
66912,SIDM00875,SCH772984,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.17808628,-0.020505542,-0.8631778826275757,0.0003256558433809539
93325,SIDM00954,Wee1 Inhibitor,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-0.81579477,-0.06436212,-1.5144952119020412,-0.10407514685678527
10605,SIDM00146,Docetaxel,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.6374773,0.0620804,-0.06274097611769605,0.026179129744530173
58898,SIDM00529,MK-2206,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-1.9967475,-0.0633392,-0.8138417532777322,0.010620809343675612
20746,SIDM00954,AZD8055,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-0.5674372,-0.038432043,0.02604978174510842,-0.0007023071718457735
59673,SIDM00628,Doramapimod,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.7071161,0.025573447,0.6290548740834272,0.00749065731371772
77595,SIDM00332,Trametinib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.495926,0.12881151,-0.7836111098999063,-0.004446651680527901
87784,SIDM00875,Entinostat,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0840908,0.10265396,0.6886014701276805,0.04693588213182764
26037,SIDM00971,NU7441,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,3.749819,0.16399403,1.414208642053746,0.08620889639656698
85082,SIDM00097,Doramapimod,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2321556,0.0399858,1.4603652357585684,0.05342781448992546
6285,SIDM00411,Dactolisib,Erlotinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,1.1962961,0.07020346,0.8766055925875357,0.04645204110549065
31130,SIDM00774,Olaparib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,2.5836687,0.26451284,0.13746907207643091,0.10607705574478961
89213,SIDM00673,Vorinostat,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.26151532,0.024978146,-0.43486161207737006,-0.011000806296483987
98491,SIDM00146,Navitoclax,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.8098346,0.106790505,0.41389133594980837,0.0015652261350851866
105502,SIDM00531,AZD7762,Crizotinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.471116,0.13776107,0.3933623926182972,0.04427458994388722
50609,SIDM00097,Gemcitabine,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.84523016,-0.02885183,0.17926088106031413,0.01301553897484509
5918,SIDM00893,JQ1,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.6024636,0.07924356,0.18113590551997388,0.028350294200414083
47715,SIDM00332,PF-4708671,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.0986142,0.0707325,2.146923421138912,0.13970744938207608
32520,SIDM00866,AZD7762,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-2.9524295,-0.075250484,-0.22300784263908513,0.04345062295143263
34978,SIDM00774,RO-3306,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,-2.1388407,-0.102887,-0.48565921445169447,-0.03538636572976667
87558,SIDM00628,Afatinib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,Black,51.0,1.6463547,0.098345675,1.6569635619515612,0.10764616572940132
66595,SIDM00866,Linsitinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,-2.991339,-0.14670722,-0.33790488592475987,-0.04350607817939657
87926,SIDM00878,Cisplatin,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,5.0320997,0.1529846,3.739923713794833,0.14362548729436317
99793,SIDM00193,SB505124,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,53.0,-1.7811242,-0.1026039,0.03047728549922613,-0.008243198035180302
62161,SIDM00529,Wee1 Inhibitor,Axitinib,Breast,1.0,Breast Carcinoma,Female,Black,44.0,0.8095088,0.07359547,-0.2427230618967522,-0.03729238792164653
85466,SIDM00866,AZD6482,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.6135814,-0.035527308,0.3628781608747145,0.062262058059269876
57794,SIDM00774,AZD8055,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,2.523903,0.1873606,-0.5155093850448179,-0.027438973697029904
64972,SIDM00146,MK-1775,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.9919193,0.1281849,1.3455976885376257,0.09858203744580075
98184,SIDM00130,Erlotinib,OSI-027,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.6549251,0.05996643,1.0095873067062082,0.0392656947393337
59605,SIDM00893,MK-1775,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.63672787,0.05064327,-0.22241672238667112,-0.03138679240537144
64167,SIDM00893,Uprosertib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.6076728,0.079690605,1.7574404327096103,0.13061056362657614
3768,SIDM00834,Dabrafenib,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,1.3429908,0.053135954,0.44682297322185655,0.054564998640778066
37532,SIDM00660,Nutlin-3a (-),AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,32.0,3.5738506,0.13105513,3.125242871659054,0.08583559432151558
10651,SIDM00146,Docetaxel,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-1.279219,-0.12050381,-0.9728796588224357,-0.06178502117237143
54151,SIDM00893,Doramapimod,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.5822606,0.019988097,0.5830869375727238,0.03551696075609724
60969,SIDM00878,Alpelisib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.9768029,-0.09256518,-0.32628354738267,-0.006737433048791351
25695,SIDM00130,Lapatinib,AZD7762,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.9625468,0.17417736,0.754923839808272,0.07396723845311544
58574,SIDM00332,BI-2536,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.1720278,-0.16634165,-0.3196206970821499,0.04288471962808196
8003,SIDM00673,Camptothecin,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.8299983,0.09953166,2.7157795198669255,0.10357333436469136
32333,SIDM00779,MK-1775,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,33.0,-0.2721129,-0.010601056,-1.8397664794304947,-0.03773175638500036
17303,SIDM00776,Camptothecin,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,0.21333681,0.007753943,-0.49348300850026433,-0.008672775367661012
61181,SIDM00130,Linsitinib,Trametinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-2.310939,-0.07698017,1.0461767327063591,0.04079909838659318
39097,SIDM00359,SB505124,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8585562,-0.14860061,-1.3955304735315515,-0.07518831183508258
40440,SIDM00893,Axitinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.8159057,-0.03560587,-0.667602941970622,0.018202337835177846
43139,SIDM00628,Navitoclax,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,0.95857745,0.027843576,2.045718979671383,0.1096729637163008
88201,SIDM00971,Axitinib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.7740468,-0.0659546,-1.7823730804933615,-0.03616958822091547
22983,SIDM00146,SCH772984,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.36319512,-0.03480616,0.2975010023520852,-0.013933696117780546
41482,SIDM00779,5-Fluorouracil,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,33.0,-1.9839119,-0.059116833,-0.6054793006553736,0.027319188531483535
68779,SIDM00778,5-Fluorouracil,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,-1.7682792,-0.019725299,-0.9314667634351654,-0.04052183943198562
100123,SIDM00866,SCH772984,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.3355402,-0.098884575,-0.8086562817292705,-0.015988275288735133
27895,SIDM00146,ZM447439,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.0408292,-0.06324986,-0.55862788663748,-0.016588926068020874
74539,SIDM00673,GSK269962A,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.3724424,0.09802562,-1.683628612786118,-0.12766900512262797
1289,SIDM00332,Afatinib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1710286,0.055269312,-0.5519245953237314,0.0014604186866747702
53788,SIDM00673,AZD6482,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.2620835,0.12975128,-1.0283581096955068,-0.04457263889667829
49390,SIDM00628,AZD8055,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,-0.08777813,-0.0074137943,-0.5670414909118432,-0.03530349783651811
7954,SIDM00866,Luminespib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,-3.7628062,-0.17180774,-1.1924045507555578,-0.09167903125985725
59582,SIDM00359,Linsitinib,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.440218,-0.1203443,-1.1279879105812036,0.02082415024588112
59253,SIDM00146,Pictilisib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-2.0772028,-0.15041415,-0.7138019634670026,-0.009951779933670545
30685,SIDM00893,Vorinostat,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.6254644,0.12171449,0.16437321160996626,0.035233917327144364
27349,SIDM00878,Bortezomib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-0.4839732,-0.012351929,-1.6419382306935109,-0.008168532132197974
95620,SIDM00531,5-Fluorouracil,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.7579964,0.076810285,1.763517291933077,0.06604581328933605
48072,SIDM00146,AZD8055,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,0.23651987,0.020914335,-0.1269212445455792,-0.06925074596085848
4721,SIDM00782,LGK974,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-1.8363254,-0.10972895,-0.9071677147369939,-0.05745157215178808
76170,SIDM00193,Navitoclax,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.167426,-0.13917875,1.0546163760390626,0.04110224936456773
59840,SIDM00130,Oxaliplatin,Paclitaxel,Pancreas,0.025,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.833274,0.035512175,-0.6956715349769143,-0.004311814314152111
80281,SIDM00875,MK-2206,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2283219,-0.09012596,0.005075003881697734,-0.01695748563991533
56475,SIDM00673,Navitoclax,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.60636127,-0.048936695,-1.5184227512314168,-0.11413011342624983
26321,SIDM00193,SB505124,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.2902588,-0.092549376,-0.5003934980220293,-0.05235742422176261
53053,SIDM00875,Afatinib,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.59431034,-0.048855834,0.7439944122907558,-0.02266756067926489
24169,SIDM00359,Oxaliplatin,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0098292,0.07477374,-0.859484122704835,-0.017416391925512996
88347,SIDM00875,Axitinib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1961217,0.0899724,0.48753085838183274,-0.018788696713254577
6198,SIDM00866,PD173074,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,52.0,-1.8375484,-0.0635363,-0.86993417078726,-0.03038168594120563
94569,SIDM00893,Crizotinib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.51077235,0.019054128,1.106998975904958,0.025683678138460102
34024,SIDM00878,Navitoclax,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.26080057,0.004201775,0.8791340166269616,-0.020508051254097846
98620,SIDM00628,Pictilisib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,0.2079592,0.020563073,-0.8904432316660542,-0.07787641378757713
92198,SIDM00531,Irinotecan,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.529081,0.055542134,-0.3355881025327986,-0.0028999651562491967
79526,SIDM00628,Bortezomib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,Black,51.0,0.19749749,0.011552798,-0.13910422685028137,-0.03943827914078596
66347,SIDM00628,Dabrafenib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,Black,51.0,0.43672237,0.031292487,-1.501875320808178,-0.027647393937928668
59439,SIDM00411,5-Fluorouracil,Dasatinib,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,-2.5312061,-0.06382192,0.2637018561729149,0.031977685918594415
14944,SIDM00954,Venetoclax,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-1.0270321,-0.07579506,0.060803423623100726,-0.005441232442480223
102106,SIDM00875,Afatinib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.8973053,0.13055786,1.982697500980907,0.06120633004087352
19011,SIDM00779,Trametinib,Palbociclib,Large Intestine,4.0,Cecum Adenocarcinoma,Male,White,33.0,-1.3138677,-0.044510525,-1.0185968803429564,-0.0539408993001559
734,SIDM00971,Entinostat,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.444311,-0.038880605,0.13704530299211,0.05392603978106523
12632,SIDM00628,Afatinib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,2.277587,0.1458601,0.7411305500869534,-0.013693341829596497
96156,SIDM00097,PD173074,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.620915,-0.06765049,0.06715650671453387,0.04691829509255501
80409,SIDM00954,Lapatinib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.0,0.2813711,0.019115513,-0.10689969759445711,-0.05489074316369248
14546,SIDM00971,Docetaxel,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.534557,-0.089288205,-2.120845491334376,-0.06532342480405502
53658,SIDM01233,Crizotinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,72.0,-1.1186713,-0.06974824,-1.1453959733672028,-0.07700214678485082
83709,SIDM00875,Docetaxel,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.07197827,-0.0052306964,0.09475048963434235,0.04227580294712939
87157,SIDM00146,ZM447439,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.5113211,0.12661594,1.4142160792399492,0.11073497245047585
74616,SIDM01233,Navitoclax,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-1.0066125,-0.08066044,0.30734203793012776,-0.037342814243385467
93247,SIDM00146,Dabrafenib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.7582643,0.1767627,-0.2805496703449317,0.0877489985251123
34234,SIDM00893,Alisertib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-3.278138,-0.23934704,-1.4325862694699145,-0.175007561429438
36444,SIDM00875,Ribociclib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6661002,-0.02065849,0.3396283628100402,0.01587501104825389
72665,SIDM00301,Oxaliplatin,Paclitaxel,Pancreas,0.0025,Pancreatic Carcinoma,Male,East Asian,50.0,1.2170136,0.12694968,-0.8640949476832297,-0.008933390559347255
76274,SIDM00776,Trametinib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.37248537,-0.032383062,1.334793224194403,0.05356412410000454
29741,SIDM00971,Navitoclax,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.0812999,0.029948821,2.378746323994674,0.10769826029098313
80069,SIDM00411,Linsitinib,Lapatinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,4.3175607,0.23865162,2.8272469886888323,0.17632628579820858
82562,SIDM00660,SB505124,AZD7762,Large Intestine,0.0625,Cecum Adenocarcinoma,Male,White,32.0,1.7046133,0.18356848,0.12392541827058336,0.010576703620510481
67803,SIDM00097,Wee1 Inhibitor,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.66251886,0.044046175,0.23672283248563272,-0.012178719535413373
36,SIDM00359,SB505124,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.6564782,-0.022822522,-2.4083385650428433,-0.046080219413532957
24155,SIDM00774,Entinostat,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.7710806,-0.09771158,0.39845622613876,0.036585725977401284
26082,SIDM00954,Dabrafenib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,3.259583,0.1707243,0.6388446994802237,0.09115633521001328
73522,SIDM00531,Paclitaxel,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-1.08491,-0.11452886,-0.8694430676003194,-0.0265781485014204
52007,SIDM00660,MK-2206,BMS-754807,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,32.0,7.2732,0.6253441,1.8560971938029225,0.09668475207412924
80469,SIDM00893,Axitinib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.40357718,-0.02078694,-0.736369266890282,-0.034638708893552465
15470,SIDM00146,Palbociclib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.1911047,-0.07613657,-2.407653327460348,-0.07946027695188879
13261,SIDM01233,AZD8055,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,72.0,0.9334295,0.062071837,-0.005450341804594614,0.01756232481323394
81918,SIDM00866,Entinostat,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,52.0,-0.44008613,-0.034894142,-0.9173438843049181,-0.0044696431283606855
21143,SIDM00971,Pictilisib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.9881322,0.10827233,-0.13532468004227832,-0.005925341436140651
16916,SIDM00097,Axitinib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3254789,-0.071848914,-1.260446003843733,-0.10328463028462433
46351,SIDM00954,KU-55933,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-2.8073158,-0.09645159,-1.2965830690808893,0.016423116817295285
43332,SIDM00529,Ribociclib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Black,44.0,-1.2263725,-0.031993497,-0.23611285489389908,0.048672002980501734
90118,SIDM00411,Dactolisib,Gemcitabine,Pancreas,0.01,Pancreatic Carcinoma,Male,East Asian,43.0,1.5025258,0.083047174,-1.2812741176927491,-0.03646466290557083
30806,SIDM00971,AZD8055,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1990347,-0.07159349,-0.5527454159082079,0.0007372862730662205
23834,SIDM00778,Taselisib,MK-1775,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-1.0960608,-0.040035933,-0.7789594827395444,0.005162798674012
95859,SIDM00878,MK-2206,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,0.7177671,0.06851527,-1.0780658668863854,-0.08506067932081686
90658,SIDM00628,Tozasertib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-1.6130766,-0.15979029,-1.0067809927939375,-0.07712862830274918
101763,SIDM00782,Linsitinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.73667085,0.03496421,1.1801249811997616,0.06745809745852266
71667,SIDM00628,Sorafenib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.3319432,-0.02702815,-0.20301341232285852,0.007344745918604333
8160,SIDM00866,Taselisib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-2.2685902,-0.17795594,-1.596034852508599,-0.060057089116357674
99578,SIDM00971,Uprosertib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.031168,-0.13653935,-1.819021551951527,-0.09488563546532047
25849,SIDM00146,AZD8055,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-0.87550306,-0.074615985,0.7922160625445231,0.038395771255480056
13464,SIDM00778,Camptothecin,Crizotinib,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-2.2850635,-0.07549747,-1.0271643040751297,-0.02546558794280691
75712,SIDM00875,ZM447439,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.48315287,0.05672961,-0.19717719408507567,0.026486434258074936
31135,SIDM00660,Trametinib,MK-1775,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,32.0,2.489992,0.123015605,-1.0184870195595124,-0.017479252843979127
69120,SIDM00782,Palbociclib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,1.2507274,0.026585855,2.066463456313683,0.03606047186343786
103768,SIDM00954,AZD8055,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-3.3140283,-0.24272893,-0.9070577938068352,-0.08502543610014163
19831,SIDM00529,Paclitaxel,MK-2206,Breast,0.25,Breast Carcinoma,Female,Black,44.0,1.0499271,0.10585783,0.3417686069980763,0.04780202141135027
37567,SIDM00875,Ribociclib,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5081375,-0.045783896,-0.853099257987602,0.006141046249882822
8476,SIDM00878,Crizotinib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-0.4235062,-0.049755502,-0.7434774464901038,-0.07998654073353782
48985,SIDM00146,Doramapimod,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,2.4090579,0.12157042,2.045206905538994,0.11158901835418686
31029,SIDM00834,AZD4547,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,0.52905977,0.011562783,1.8986133200755366,-0.007842709539394309
7265,SIDM00778,LGK974,Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,2.736975,0.09034376,0.398934785557275,0.02038689962442643
83435,SIDM00146,KU-55933,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,2.372501,0.14574867,-0.7353140247222917,0.030963163274730976
47134,SIDM00146,Paclitaxel,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-2.4622653,-0.21111472,-1.3415481048643285,-0.07361441964451358
80079,SIDM00332,Doramapimod,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0823517,0.072364554,1.3733242757895203,0.05321644835100556
92226,SIDM00878,Olaparib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,3.1492286,0.18654352,1.1385959739214824,0.042141727232579536
56570,SIDM00411,Sorafenib,MK-2206,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,43.0,-1.4882044,-0.07081741,0.2028450141404406,0.03248471956254417
4989,SIDM00774,5-Fluorouracil,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.9685288,-0.08779902,-1.0000246123439598,-0.019712172945310278
10420,SIDM00529,GSK269962A,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-1.4282837,-0.10649211,-0.4896115614502648,-0.018479890386437568
47190,SIDM00529,Dabrafenib,PD173074,Breast,2.5,Breast Carcinoma,Female,Black,44.0,1.0729582,0.021716166,1.3660296390598599,0.05496536730699691
100754,SIDM00332,NU7441,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.151261,0.10760115,1.2215544576540116,0.07497230124566914
71522,SIDM00146,Olaparib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,1.3115513,0.0829074,0.14924914199693842,0.04251218671722928
51418,SIDM00893,Wee1 Inhibitor,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.9992503,-0.07102879,-1.539897876946525,-0.059201751685436926
72421,SIDM00130,MK-2206,Cisplatin,Pancreas,0.8,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.12070145,-0.0112320855,-0.6235985766921966,-0.026228847698710412
32798,SIDM00332,AZD8055,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,2.1079247,0.14329806,0.7678909904910187,0.01128095500065729
43549,SIDM00776,Dabrafenib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.6097795,-0.015867032,1.3781566332860236,0.0446829000353013
104069,SIDM00628,BI-2536,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-1.8767629,-0.08842473,-0.5739619419190841,-0.01716402893129792
90497,SIDM00875,Ribociclib,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5062383,-0.04505524,-0.17224803220900456,0.053841755672334714
6934,SIDM00893,Ribociclib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.8067292,-0.06701317,-1.3554039478346191,-0.04529600523627733
57948,SIDM00628,Paclitaxel,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-3.193552,-0.16633447,-5.2109540858293855,-0.3297702105433223
51832,SIDM00628,Cisplatin,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,Black,51.0,-0.0051221624,-0.0005092006,-0.9682221528856619,-0.020250403070377326
12606,SIDM00673,Alpelisib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.917884,-0.030586997,-0.4604676147122072,0.02148745790981617
19955,SIDM00971,Uprosertib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.1725554,0.070781685,-0.344043244590585,-0.020071299876976884
85671,SIDM00673,Vorinostat,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.48163226,-0.051082157,-1.6248425506715898,-0.08778155069561168
63657,SIDM00146,Palbociclib,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.21561068,0.015319871,-0.13958967847357212,0.017903302279003358
27686,SIDM00097,Tozasertib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2951969,0.055332568,0.9748689899697125,0.04917301675993157
65741,SIDM00954,Temozolomide,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,0.7349818,0.014748514,1.887465251627781,0.03489672110822844
44871,SIDM00776,Navitoclax,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.21512659,-0.01354136,-0.22000882680825157,-0.027472351594689838
25062,SIDM00866,Olaparib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.6354975,-0.027574142,0.11006178802029766,-0.005594828434130174
92177,SIDM00875,Navitoclax,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.97115815,0.019663747,1.6602066204438635,0.0383298926189135
88907,SIDM00673,Nutlin-3a (-),Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.6269815,0.012200839,2.0590731479428497,0.07124723980431975
39955,SIDM00673,Tozasertib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-4.083651,-0.16063115,-1.324382629641874,-0.10590799779692887
97266,SIDM00893,Pictilisib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.80647016,-0.08086299,-0.8573479417432127,-0.09333284650200414
92179,SIDM00834,MK-2206,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,White,66.0,3.313358,0.20198292,0.9586659538983008,0.10357387218445137
11459,SIDM00866,AZD8055,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,3.1378691,0.07364176,2.0499373589454506,0.06998683288424949
2344,SIDM00893,Paclitaxel,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.9547212,-0.166455,-2.0975841895013216,-0.1751760775180755
74607,SIDM00130,Navitoclax,Gemcitabine,Pancreas,0.01,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,4.1732802,0.13948789,3.115119066021232,0.1486818861075862
41058,SIDM00774,Navitoclax,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,48.0,3.5203903,0.039184105,1.368955657881965,0.08152687455922077
33944,SIDM00875,OSI-027,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.91450536,0.09388961,-0.6960191336982501,-0.0036169241523518773
31968,SIDM00628,Camptothecin,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-0.679785,-0.06299429,-1.5646744783792452,-0.0676020445959493
8629,SIDM00660,Nutlin-3a (-),Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,32.0,1.5271548,0.033127982,3.166064932123604,0.12034044982412216
97105,SIDM01233,Vinorelbine,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,72.0,-2.1603675,-0.12604707,-3.435457132167912,-0.21907831922743495
86990,SIDM00875,Crizotinib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8038362,0.15955618,2.4135111910071694,0.13651593200554463
61060,SIDM00628,PF-4708671,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-0.9474602,-0.08984927,-0.4854718061477865,-0.03273561250957854
48202,SIDM00529,Nutlin-3a (-),PD173074,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-1.575407,-0.049794078,-0.3900067275838801,0.030930824976243984
94434,SIDM00097,Luminespib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.9212217,-0.15629898,-1.5419552020738883,-0.1041793682589508
5011,SIDM00776,Taselisib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.061753396,-0.005616871,-0.8738338452517108,-0.025388629820751275
107901,SIDM00778,Olaparib,Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,1.0992684,0.024109144,-0.007733794426214836,-0.024617273292577367
104717,SIDM00893,NU7441,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.0715562,0.09445084,-0.21036896666770738,0.028923791744464324
8626,SIDM00628,Camptothecin,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,Black,51.0,0.26704052,0.027128901,-0.8796535634186607,-0.03149164689759432
84401,SIDM00971,Paclitaxel,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.6683068,-0.08079482,-0.6501692091834262,-0.04670823757350899
8948,SIDM00529,NU7441,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,0.76224643,0.05358899,-0.25614235645848493,0.034176026782408366
42719,SIDM00774,5-Fluorouracil,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.358493,-0.10390873,-0.44669247374847254,-0.03964266679837847
75220,SIDM00774,Docetaxel,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-3.7348714,-0.45944744,-4.05194718029774,-0.27056653474113307
64124,SIDM00628,Crizotinib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,-1.0399004,-0.09655911,-0.3779569570423133,-0.03677020428307651
75000,SIDM00782,Oxaliplatin,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,Unknown,72.0,1.7554626,0.10527174,-0.6435785510012697,-0.017437211328614036
49023,SIDM00673,PD173074,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,-2.8593423,-0.11615936,-0.1003513742350338,0.02669682815040599
28016,SIDM00893,AZD8055,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.95741326,-0.086143926,-1.2147831003717657,-0.15645202623748386
80106,SIDM00971,Palbociclib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.3025126,-0.009553595,-0.5144622774496966,0.05071976152459925
99002,SIDM00628,Alisertib,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,0.49030977,0.013615654,-0.5683312825701278,-0.046955600859877954
13358,SIDM00875,Bortezomib,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8279831,0.021429738,-2.672201152897463,-0.08006347668904241
34314,SIDM00875,Afatinib,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0140395,-0.03456104,0.9575248665978767,0.013395679881636731
11704,SIDM00774,Docetaxel,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,48.0,-0.5611584,-0.06401229,-0.1336119610842058,-0.027857695161661467
80212,SIDM00893,RO-3306,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.5323664,-0.04393482,-1.3035240558839247,-0.03635622085804184
33088,SIDM00866,Taselisib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.2489498,0.09766187,0.5431253932968364,0.019400179516589563
56525,SIDM00774,SCH772984,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,2.3511887,0.0742518,1.1257405945484376,0.09422179970470433
68099,SIDM00893,Olaparib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.2576138,-0.047517933,-1.080533785653844,-0.046534375535394946
103926,SIDM00878,Camptothecin,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,70.0,0.35851312,0.010068346,1.07243499778667,0.05954366647352865
93806,SIDM00875,JQ1,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.07751331,-0.006337657,0.5147838793241716,0.027174208666674957
62602,SIDM00673,5-Fluorouracil,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-0.36098656,-0.016098196,-0.05661298723672738,0.029398968083661974
16617,SIDM00834,Navitoclax,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,5.1397777,0.24309388,2.9291707341044355,0.12379488971924912
58856,SIDM00673,Crizotinib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.9562935,-0.16170278,-1.1457727469377486,-0.0800556992485371
103543,SIDM00782,Navitoclax,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.7606875,-0.05906367,-0.2986286912427311,0.06247589200010981
108014,SIDM00971,MK-2206,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.980996,-0.14762866,-0.15132602947361795,0.006199596325513735
86357,SIDM00673,Luminespib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.8305716,-0.08722796,-1.4539413043579146,-0.06135887082574866
22917,SIDM00866,OSI-027,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,52.0,-1.4214265,-0.09204596,-0.716479561677404,-0.06503174360084882
94188,SIDM00628,Entinostat,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.951237,-0.028250333,-0.6781316784873663,0.007732928769886124
46947,SIDM00778,Linsitinib,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,69.0,1.7774616,0.094101995,-1.9158106875072167,-0.04183854180152705
3280,SIDM00782,MK-1775,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,-0.7218434,-0.03500031,-1.7740039197258157,-0.05912534044197892
35319,SIDM00411,Olaparib,LGK974,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,-1.1237837,-0.023110993,0.7073687236610655,0.0039375704551545924
53965,SIDM00628,KU-55933,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,1.6208647,0.057547353,-0.9346539513149955,-0.03185058527999559
60952,SIDM00778,SCH772984,Trametinib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,-5.377171,-0.13121426,-4.223293502246528,-0.19082503346437715
15084,SIDM00875,Doramapimod,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,5.025094,0.0735224,3.415590009244514,0.04476825094374254
32254,SIDM00782,Afatinib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,Unknown,72.0,2.8599794,0.17188816,1.7364559692478536,0.09225501831294611
5348,SIDM00660,MK-2206,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,5.8260236,0.5225081,1.9565362604930303,0.17395567350946253
6462,SIDM00834,Camptothecin,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,1.3184046,0.11837494,-1.1165725180164667,-0.01322860239983007
46372,SIDM01233,SB505124,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,72.0,1.1390609,0.038933795,-1.7748711408444837,-0.12833611708453782
37295,SIDM00774,Camptothecin,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,0.63825375,0.037189245,2.603597146739031,0.2349194732146799
53035,SIDM00628,Camptothecin,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.68147343,-0.0688343,-1.9471508692762185,-0.14669349808138454
82571,SIDM00097,Bortezomib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.7678887,-0.046425592,-0.4034370749575039,-0.014659973465211288
28376,SIDM00834,Nutlin-3a (-),Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,1.0468589,0.02300078,3.1841423205423207,0.08130337930671569
16816,SIDM00097,Tozasertib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.6777692,-0.079588346,-0.9750913899532926,-0.02238283797686219
62265,SIDM00776,Navitoclax,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.6637984,0.026810994,0.8954212213292074,0.03959845974552457
94270,SIDM00954,Trametinib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,2.8561275,0.16326037,0.14881291835886876,-0.007029816690094124
84040,SIDM00954,Nutlin-3a (-),AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.0,-0.13297577,-0.0035472717,1.0189115675583067,0.06062499028790155
6503,SIDM00146,Crizotinib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.6941079,0.067379825,0.9620794790990839,0.07003427963378907
36037,SIDM00875,Taselisib,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.35336953,0.041629173,-1.148721518206031,-0.06121476564570143
87626,SIDM00971,Palbociclib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.3893285,-0.011740968,0.5634667646213973,0.0620030087497676
101036,SIDM00875,KU-55933,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.714145,-0.06079179,-0.34067438274647904,0.01680722109537985
37620,SIDM00893,PD173074,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.4859701,-0.035121687,0.4207861129113986,0.09331887979863038
100172,SIDM00359,Vinorelbine,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.1128993,-0.05454232,-0.43862168523046824,0.04545015390459426
15965,SIDM00531,MK-1775,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.8235773,0.23057008,0.43866688028714146,0.056208456308374614
11500,SIDM00097,Uprosertib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.1031547,0.13051516,0.7697451582648362,0.09358371462063061
54112,SIDM00673,MK-1775,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,49.0,-0.7910656,-0.07186457,-0.8948199927474774,-0.045990001536381955
85315,SIDM00193,LGK974,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.0659337,-0.075520426,0.1743098028010045,0.03334757256788306
60846,SIDM00660,Taselisib,5-Fluorouracil,Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,32.0,-0.5093286,-0.045666438,-0.6425224897765888,-0.03404878552868935
17753,SIDM00866,Nutlin-3a (-),Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,52.0,2.8647003,0.13588725,0.17475306104066274,-0.00021902665970085212
107700,SIDM01233,LGK974,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,-1.3035009,-0.0185141,-0.7242875668832331,-0.042918081676431956
9839,SIDM00778,Vinorelbine,Trametinib,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,69.0,1.5353197,0.04956907,0.2826475656630719,-0.004660843379819363
105454,SIDM00411,5-Fluorouracil,OSI-027,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.8615575,0.030967595,-0.4965559147123584,0.03766709852414039
38906,SIDM00411,Navitoclax,Dasatinib,Pancreas,0.05,Pancreatic Carcinoma,Male,East Asian,43.0,2.1523025,0.13546398,1.4772071747932733,0.1033844129638259
38279,SIDM00673,Alisertib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,1.8667641,0.13318285,3.6558366226589154,0.24768065432044037
62412,SIDM00628,RO-3306,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,Black,51.0,-2.3465974,-0.11179065,-1.266149230705449,-0.11279803091835064
7328,SIDM00878,MK-1775,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,0.4781468,0.05078093,-0.24302859335073537,-0.0020645748995198297
79536,SIDM00774,Axitinib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,0.8927735,0.10902525,-0.7482956965854749,0.0035024003479173986
24345,SIDM00893,Docetaxel,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.41900143,0.04137565,-2.405383801029669,-0.1318658328663527
42154,SIDM00971,JQ1,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-3.3021212,-0.12882385,-2.335779080180347,-0.07838192457044903
74464,SIDM00774,SCH772984,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,3.0985286,0.10534366,1.0472563818366911,0.0716363654961856
73076,SIDM00782,Vinorelbine,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,-0.27250582,-0.025051033,-1.9855482156772686,-0.042706524387344624
10622,SIDM00529,5-Fluorouracil,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Black,44.0,-2.0865214,-0.17404646,-2.0316492176476704,-0.12806807014872407
38527,SIDM00971,Venetoclax,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.34448442,0.0061603286,0.9823028858278893,0.10125657042081108
42356,SIDM00834,Olaparib,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,White,66.0,1.5732713,0.043572105,2.5534504543778027,0.05403475247662504
103900,SIDM00301,Crizotinib,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.179989,0.12954733,-0.33401408747490957,-0.03034467119108367
80245,SIDM00866,OSI-027,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,2.387585,0.06953597,-0.8384291558866895,-0.03442927583839983
53448,SIDM00097,Dabrafenib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5513508,-0.0583474,0.03180955431172109,-0.020436256660007594
5548,SIDM00875,BI-2536,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.6937673,-0.16986929,-2.307944936879387,-0.11574016697011538
79178,SIDM00875,Crizotinib,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.15142825,0.016885167,0.6042342378815176,0.06523208810701252
89987,SIDM00193,SB505124,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,53.0,-1.6836065,-0.09202391,0.9392803758742312,0.03265638059454634
27411,SIDM00097,Palbociclib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6573625,-0.061852876,-0.06025810367747605,0.014834118324157982
69689,SIDM00774,ZM447439,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,0.7915781,0.04971871,0.519926504855449,0.04551416387713996
75831,SIDM00875,Olaparib,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0293304,-0.062021665,-0.13203152681270036,-0.016373058548624364
92406,SIDM00866,OSI-027,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,1.5758257,0.101104766,0.15520224639616975,0.0037538191651658335
61411,SIDM00673,Wee1 Inhibitor,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-2.51256,-0.08660169,2.493238482837921,0.11081544548658857
81738,SIDM00673,Alisertib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.0949745,0.12224807,1.5334929658826584,0.09115850212115269
45239,SIDM00529,GSK269962A,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Black,44.0,-2.0481298,-0.13019069,-0.677525382040521,-0.008439530056854324
66171,SIDM00774,Afatinib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-1.150919,-0.084290415,-0.6623649251342866,-0.07746846247484603
52937,SIDM00878,ZM447439,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,70.0,-0.8611038,-0.078589015,-0.5319980711804561,-0.047616077584531735
28656,SIDM00971,RO-3306,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.5748509,0.08215797,0.944813598870831,0.08087364659861603
80134,SIDM00893,Venetoclax,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.4108989,-0.016859556,-0.6466751798633127,0.0265958915000673
50043,SIDM00411,MK-1775,Oxaliplatin,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-5.1545825,-0.20166384,-2.7816038483873653,-0.12857560558673806
78754,SIDM00875,Camptothecin,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7889623,-0.07272351,-0.45912336915202356,-0.016926133504002135
93832,SIDM00954,Dabrafenib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,1.1889182,0.050758384,-0.23921414458897744,0.03324509148759731
30736,SIDM00529,Bortezomib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,0.68925023,0.04023117,-1.3381396771950254,-0.030637362064590654
38335,SIDM00193,Camptothecin,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,East Asian,53.0,0.72137606,0.026535274,2.157146734950657,0.07133059454381115
12241,SIDM00193,Olaparib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-0.63966924,-0.030088423,-0.16663657948082025,0.009673035418994336
33151,SIDM00774,Sorafenib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.1175654,-0.12878779,-0.7133229223500654,0.022007690048095354
86333,SIDM00628,GSK269962A,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,-0.6442346,-0.066363424,-0.8492637472431069,-0.03666236271522059
92036,SIDM00875,Paclitaxel,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.2683003,-0.051054023,-0.8064847709132056,-0.025787314177278697
102839,SIDM00673,Camptothecin,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.29728222,-0.006659627,2.39761494909532,0.02201558608370445
35896,SIDM00301,Cisplatin,OSI-027,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.906542,0.19389582,-0.014054611838429026,0.04100691110209256
53081,SIDM00628,Linsitinib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-0.38842386,-0.02704606,-0.8550330307692302,-0.029102346968668875
6653,SIDM00130,Dactolisib,MK-2206,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.49985567,0.044389635,0.8469685388740886,0.0893402660802266
46425,SIDM00130,Olaparib,Paclitaxel,Pancreas,0.025,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.9351029,-0.044290043,-0.683380512821507,-0.04878768633854925
42067,SIDM00776,Vinorelbine,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,65.0,1.2244604,0.062460545,0.13348475966762818,0.06014598421373308
101342,SIDM00673,Ribociclib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,49.0,-2.3777087,-0.0704525,0.40261293350692695,0.04493607841596324
58491,SIDM00774,Nilotinib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,48.0,0.8900828,0.063356556,-0.9308321414612899,-0.038655568361021735
84715,SIDM00875,RO-3306,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.9885572,-0.083099894,0.2907219305083628,-0.01191926381734003
36320,SIDM00146,ZM447439,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.1935593,0.09417053,0.40819564612940124,0.025524260787505734
61859,SIDM00866,Docetaxel,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,52.0,1.6957831,0.1474621,-0.5604604686146608,-0.01447772614825548
83313,SIDM00778,Palbociclib,Taselisib,Large Intestine,0.1,Cecum Adenocarcinoma,Male,White,69.0,0.7249067,0.025924228,1.4981996873676047,0.08377903481935683
20472,SIDM00146,Temozolomide,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.21225896,-0.0051001464,0.800395733134391,0.050720022075132244
41275,SIDM00971,Lapatinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.5114577,-0.11181355,-0.4234746625760887,-0.05158978464944068
12722,SIDM00866,Trametinib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,-1.9849784,-0.13288343,0.522092169325619,0.04681439992599011
59940,SIDM00866,Cisplatin,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,2.1826465,0.05055859,2.483729379717666,0.06752101288874607
93580,SIDM00774,Sorafenib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.72299355,-0.046283957,-0.22413571370591895,0.00817112748545124
1314,SIDM00332,Alpelisib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,3.2471418,0.23533638,0.7997823311689518,0.10453360517613511
58023,SIDM00146,Wee1 Inhibitor,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.48725638,0.03791564,-0.42955820301080305,-0.050760288204245364
56314,SIDM00778,MK-2206,Linsitinib,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,1.7057414,0.08330386,-0.016578304014748114,0.05656907538930848
58440,SIDM00332,MK-2206,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-4.283299,-0.16630565,-2.5208217295427526,-0.152425771010583
10514,SIDM00779,Nutlin-3a (-),SCH772984,Large Intestine,0.05,Cecum Adenocarcinoma,Male,White,33.0,-1.7975537,-0.0629621,1.5636940914553366,0.06480880146387547
94500,SIDM00778,Nutlin-3a (-),Taselisib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,1.3002242,0.018778106,1.1848204622021488,0.006876415689473057
106708,SIDM00146,Lapatinib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.64370185,0.043603137,1.1157053030571347,0.0334311643538346
4217,SIDM00332,Alisertib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.742618,-0.14190866,-2.166129787342372,-0.11677434817827334
10736,SIDM00097,Entinostat,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2421353,-0.08800391,-0.11160324227134642,-0.0203874644444481
45167,SIDM00193,Palbociclib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,53.0,0.38395423,0.015524525,0.18735746837407105,0.04404345836076458
98736,SIDM00332,Trametinib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4256816,0.1344488,0.29862684887706564,0.04501419373905267
52794,SIDM00529,MK-2206,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-1.9635876,-0.06201613,0.5065901565817243,0.033858569757583515
2844,SIDM00660,Vinorelbine,AZD7762,Large Intestine,0.0625,Cecum Adenocarcinoma,Male,White,32.0,1.8178985,0.19075404,0.4515387184179702,0.06427608737929112
73142,SIDM00146,GSK269962A,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.717701,0.05449462,-0.7864503387263,0.03532518353117977
39243,SIDM00834,SB505124,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,White,66.0,1.1955462,0.097561345,-1.3765019542836077,-0.03733064166616131
33105,SIDM00146,Palbociclib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-2.7186093,-0.14350826,-0.6898386298172023,-0.00865350167822077
105393,SIDM00332,PF-4708671,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,3.1241484,0.13883863,1.8286058723168617,0.06993437563929032
105760,SIDM00097,Crizotinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0411327,-0.10231885,-0.8087485086928728,-0.016831082008144663
21099,SIDM00878,AZD7762,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,-1.0480478,-0.057217006,-1.289488927154754,-0.03006825975852935
60044,SIDM01233,Navitoclax,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,72.0,1.1197346,0.07888325,1.223431425489768,0.059867837638368455
67702,SIDM00774,5-Fluorouracil,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,-1.4812995,-0.12025917,-1.3302196017361092,-0.07491693230069393
89224,SIDM00954,JQ1,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-0.8499902,-0.057408188,1.4868096452715354,0.07664032545989068
73027,SIDM00146,AZD8055,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.6136761,-0.059284307,-0.8498027888891039,0.017101034320364493
21060,SIDM00097,Trametinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.73067707,-0.020386204,0.5103004551470485,0.029330842335939692
16792,SIDM00628,NU7441,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-0.049148176,-0.004769612,-0.28349469049154663,-0.0029530025165145912
98435,SIDM00411,Taselisib,Sorafenib,Pancreas,1.25,Pancreatic Carcinoma,Male,East Asian,43.0,1.6696017,0.11256571,1.2463820374139092,0.02600283149387397
50677,SIDM00954,Lapatinib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,0.49133873,0.031692415,0.6063411312608936,0.0457769542942632
65389,SIDM00971,Luminespib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.0580627,-0.059239194,-0.02277618148910904,-0.00922228746375865
91419,SIDM00673,JQ1,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,6.4187226,0.4711494,1.9609769608428138,0.1611742740656426
66280,SIDM00359,SB505124,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.66469735,-0.05473974,-1.3436275784269247,-0.07470866947573333
47298,SIDM00411,LGK974,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,43.0,0.61630577,0.02107699,-0.7476250567311086,-0.018258956290323283
10414,SIDM00866,Temozolomide,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,52.0,-1.3401926,-0.023039872,0.907633525726353,-0.013792515439649329
75007,SIDM00971,MK-1775,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.8398762,-0.030415315,-0.37280882144817185,-0.01112943684302707
16262,SIDM00866,Nutlin-3a (-),PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,0.3663021,0.010853049,-0.2522539167581245,0.017271361256538557
88633,SIDM00673,Uprosertib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.0284044,0.06399539,-0.4484437224308149,0.08745697028617974
86643,SIDM00301,Crizotinib,Navitoclax,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.3951637,0.15503845,1.4839622569708752,0.12815438196633686
100247,SIDM00529,MK-1775,OSI-027,Breast,1.0,Breast Carcinoma,Female,Black,44.0,0.50474703,0.045309618,-0.259519087440541,-0.03653180552656911
88178,SIDM00097,Afatinib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8726402,0.058009084,1.4203014224567418,0.05883457633609308
1064,SIDM00878,Temozolomide,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-0.35607967,-0.009264639,0.8116225674837205,0.023479839394617265
107911,SIDM00673,BI-2536,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.07575,0.07957727,-0.7565934995945571,-0.06305126463240272
36288,SIDM00774,RO-3306,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,2.2662675,0.12201795,0.8622272060565883,0.02543108027588118
56347,SIDM00660,MK-1775,Linsitinib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.5920227,0.023375472,-0.23804989002891452,0.010272278600994854
31481,SIDM00878,GSK269962A,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,1.9281918,0.18041341,0.41167059715511994,0.021007229804844707
57620,SIDM00531,Gemcitabine,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.826564,0.102566764,-0.2329996530141656,0.007802332891088469
90034,SIDM00774,Lapatinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,0.7434915,0.07188962,0.3399900166914099,-0.0052755206322217685
40719,SIDM00774,JQ1,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,2.2005742,0.14845668,-0.002610113991351742,0.026614963624839807
23017,SIDM00954,Linsitinib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,1.8946218,0.032775305,2.1055130509354414,0.10925367257940016
48905,SIDM00332,Bortezomib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.58252096,-0.036699012,0.5403113871009982,-0.037761621828646036
29320,SIDM00893,MK-2206,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.7369747,0.15714769,0.3478519449406155,-0.059629881323393884
90508,SIDM00954,Dabrafenib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-0.43563542,-0.0160508,-0.9664248670131367,-0.013121157082588172
34380,SIDM00130,Dasatinib,Ruxolitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.4301043,0.12680352,0.1699541561504245,0.02365358420548406
7307,SIDM00875,Nilotinib,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.3376656,-0.14710027,-1.3998268642780023,-0.09356724834496898
46358,SIDM00954,Trametinib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,3.942485,0.25236797,-0.2623233574640197,-0.02921628695999495
79892,SIDM00779,Oxaliplatin,Nutlin-3a (-),Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,33.0,-2.1142256,-0.14913785,-0.1536259478632087,-0.005284856992670211
16160,SIDM00332,NU7441,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.4362976,-0.025837589,0.36360461461023175,0.01285361951117798
83000,SIDM00971,Afatinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.6434587,0.0572977,0.40215375491224736,0.011283867443142819
52150,SIDM00778,Crizotinib,SCH772984,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,69.0,-0.62967914,-0.018388592,0.14894495263268873,0.038462473494380464
64863,SIDM00954,Vorinostat,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.0,-0.5809557,-0.045237597,-0.058844184072572164,-0.0331058265283772
91569,SIDM00954,Palbociclib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-0.70641327,-0.0314664,-0.014517257895487664,0.03656227845525072
55216,SIDM01233,5-Fluorouracil,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,-0.9648319,-0.04668532,-0.7505049977532995,-0.020151584206429464
78357,SIDM00834,Camptothecin,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,White,66.0,-1.0649067,-0.026258627,-1.261766753441178,-0.03464256220881871
71449,SIDM00774,Pictilisib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,48.0,0.9197686,0.028311556,0.18727895178482354,0.022264200156246812
31455,SIDM00834,AZD8055,Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,White,66.0,-0.792854,-0.06327077,-0.7104059401967866,-0.03344149733830092
4778,SIDM00875,Olaparib,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2455782,-0.08233865,-0.7012530856498136,-0.1047447186275857
10977,SIDM00774,Olaparib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.58269453,-0.028038291,-0.4412499792694462,0.023919666156548777
21039,SIDM00878,Venetoclax,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,70.0,-1.1168702,-0.033705764,0.017871656880701362,0.039888642341504806
69797,SIDM00628,Navitoclax,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,Black,51.0,0.35182315,0.03061845,-0.32336299590219286,-0.006615414011107897
43064,SIDM00673,ZM447439,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.96628433,-0.07797235,-2.2616259862329855,-0.13302442766328723
106291,SIDM00971,NU7441,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.63480973,0.028597485,-0.7804468475660014,-0.057101960826272315
97805,SIDM00834,BMS-754807,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-1.0851417,-0.08598287,-2.8647114208019935,-0.12946630913789342
16921,SIDM00778,5-Fluorouracil,Palbociclib,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-3.712464,-0.10599805,-1.3654602438941128,-0.05715382547397989
63551,SIDM00332,MK-1775,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.87155557,-0.083307534,-0.8079790679270963,-0.08563338154491507
107033,SIDM00778,LGK974,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,69.0,1.2038071,0.0359495,-0.9707652713061887,-0.03889146369384404
89382,SIDM00834,Dabrafenib,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,-1.847719,-0.04434813,0.08617070380076336,0.013777956065559436
10150,SIDM00529,Uprosertib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Black,44.0,0.47983754,0.029566435,-0.3974097629835559,0.05046164158333988
94335,SIDM00893,Lapatinib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.8445063,-0.08206509,-0.4764680650359131,-0.010223412044369131
82513,SIDM00893,OSI-027,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.7233521,0.06643629,0.16426296300244964,0.06859312526058392
88875,SIDM00954,KU-55933,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-2.0558999,-0.06944928,-0.3609289119342818,0.013018209370092713
97234,SIDM00971,Alpelisib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,4.9854374,0.32630402,1.0642558366676826,0.12144963014366934
24262,SIDM00866,Luminespib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,0.5072642,0.039916426,-1.5085979009982602,-0.06253016496792961
49104,SIDM00866,Vorinostat,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,1.6334891,0.083968855,-1.2115280631964627,-0.01912910617168375
71673,SIDM00875,AZD7762,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.23055781,0.011988579,-0.6408401231150079,0.00396499961102742
13596,SIDM00954,Sorafenib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,1.0006999,0.033516172,-0.39790570313385115,0.030795222792863407
5356,SIDM00875,GSK269962A,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3085649,0.10612282,0.2143717465349259,-0.023519043069073646
11579,SIDM00893,SCH772984,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.7117889,-0.099704735,-0.5901624574614279,0.027185587655710546
74845,SIDM00878,Vorinostat,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.9818767,-0.096795805,-0.029948862933832053,-0.008805163212348057
40980,SIDM00782,Navitoclax,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,0.98124915,0.08394437,1.520706903971627,0.045180506919459996
93087,SIDM00193,Nutlin-3a (-),LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-0.16568471,-0.002787974,1.62331332906054,0.06911762326913014
16542,SIDM01233,AZD8055,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,72.0,-1.5524715,-0.117689505,-1.1982161657730699,-0.08688831114066267
31476,SIDM00146,Venetoclax,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.28183982,0.0069231736,1.0045741984588015,0.06754161673142407
57400,SIDM00529,Crizotinib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,-0.22723223,-0.015090888,0.8595372927367463,0.08760753002755298
93023,SIDM00954,Temozolomide,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,0.15974,0.0022328214,0.8689235206141631,0.04978942942084838
13923,SIDM00529,Vorinostat,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-1.7703316,-0.05155094,-0.43989454469463546,-0.012807939966365653
17622,SIDM00673,AZD6482,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.6308465,-0.1103642,-1.0870969239375332,-0.07669583164452869
50189,SIDM00971,Tozasertib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,1.8743684,0.04087613,1.8866441292263785,0.015100021768979708
20725,SIDM00954,KU-55933,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.0,-0.9802153,-0.030280365,-0.07063885248778788,0.052920451323573016
76948,SIDM00529,Tozasertib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Black,44.0,0.29707867,0.010981228,-0.43993449864213835,-0.006564167234800718
15081,SIDM01233,Olaparib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,72.0,0.37048852,0.009196231,0.2475447443635596,0.03612258355634543
46877,SIDM00193,Nutlin-3a (-),Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,53.0,5.09283,0.19584534,4.4217172514079275,0.1725375215546968
14017,SIDM00893,Paclitaxel,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.778361,0.05768727,-0.2154012304031091,0.0037976890953290076
8648,SIDM00875,Dabrafenib,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4089522,0.08059352,1.0043866990315122,0.0741634486251261
58243,SIDM00628,Wee1 Inhibitor,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,Black,51.0,-0.8247323,-0.06747599,0.09491948435506697,-0.04530668044486752
107443,SIDM00875,NU7441,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.84958833,0.07753396,0.5327893151669642,0.06147653936077559
69271,SIDM00866,MK-2206,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-1.0889791,-0.031252302,0.9926738662355172,0.055401660217544745
55940,SIDM00774,Palbociclib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,2.8425798,0.075195216,1.6346541439532243,0.011622629652150482
18521,SIDM00359,AZD8055,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.7549296,-0.058878586,-0.15107409808974165,0.031533080415397576
41108,SIDM00332,SCH772984,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.098315,-0.13153689,-0.4161859066899355,-0.034100174096246015
42860,SIDM00411,Linsitinib,Irinotecan,Pancreas,0.5,Pancreatic Carcinoma,Male,East Asian,43.0,-4.596286,-0.19233608,-1.0561289395717741,0.08664344982542048
69389,SIDM00875,Ribociclib,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5994947,0.078159854,0.03428266227240788,0.020142523380161672
98873,SIDM00529,Taselisib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Black,44.0,-0.7322693,-0.03198289,-1.5418057153631206,-0.015832720029200435
881,SIDM00628,Alisertib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-4.9152417,-0.27918297,-1.1337613840859952,-0.059966379164462374
48672,SIDM00954,Palbociclib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,-1.8369392,-0.0712503,0.234828042826457,-0.03901266936708441
49885,SIDM00893,GSK269962A,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.029149065,-0.002275846,-0.3473650532922319,-0.018601068653190604
21001,SIDM00875,GSK269962A,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.3157468,0.30948934,3.765477938644352,0.16218007687530908
31094,SIDM00193,LGK974,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.4474406,-0.11157818,-1.7843614757878272,-0.052388909456447426
15825,SIDM00660,5-Fluorouracil,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,-2.3345249,-0.09387811,-2.1741304156220282,-0.10271720758307595
108223,SIDM00673,Alisertib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.2352272,0.08610451,-0.3442286254411267,-0.014978689743804527
86429,SIDM00779,5-Fluorouracil,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,33.0,-2.1218784,-0.06497085,-0.6927806014117338,0.04075923299491448
9391,SIDM00776,BMS-754807,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,0.7920428,0.071941555,-0.30608600465672553,-0.0008457756042831221
1768,SIDM00774,MK-1775,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,48.0,1.6413525,0.17058548,2.2291773948471847,0.1667135105319578
39649,SIDM00531,Dasatinib,Dactolisib,Pancreas,0.0125,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.108239,0.13528799,0.5593172185538103,0.08009875916899876
12603,SIDM00971,AZD6482,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.6292567,-0.04343268,-0.760682915742812,0.014344466580805479
92838,SIDM00893,Cisplatin,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.4776132,0.048087645,1.5241731517281922,0.05921317913989752
37251,SIDM00971,Vorinostat,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.1245303,-0.052262396,-1.5585740761054314,-0.03893631055860492
88408,SIDM00673,BI-2536,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,-0.11315247,-0.0084966,0.5011725568977963,0.038477169641866045
17678,SIDM00971,Linsitinib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.74884295,0.029774316,-0.2000864552594564,0.03664841309659202
68685,SIDM00193,MK-2206,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,0.49302202,0.03956688,0.33536176253386857,0.0427044778494483
105247,SIDM00893,Olaparib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.5535856,0.022450354,0.766532829017518,0.05310026539881262
3879,SIDM00411,Oxaliplatin,OSI-027,Pancreas,4.0,Pancreatic Carcinoma,Male,East Asian,43.0,2.0552154,0.06923793,-0.7025963463853215,-0.012663196629255241
24956,SIDM00893,Taselisib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.4605783,0.062986724,0.7102772348107717,0.019955783354987457
45880,SIDM00971,Lapatinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.9759803,-0.046939418,-0.796173229734177,-0.005179746727061768
33539,SIDM01233,Olaparib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,72.0,1.535166,0.040876623,1.8610394865211206,0.05776922659729439
80190,SIDM00954,Doramapimod,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,-1.1594998,-0.059196353,1.2111704960019185,0.16820251503778247
11692,SIDM00193,Oxaliplatin,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,0.21451807,0.005060861,1.124624586948147,0.004166279953096154
47319,SIDM00529,Bortezomib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Black,44.0,0.44400072,0.03121561,-1.0772250664543626,0.01240375186942292
88314,SIDM00971,BI-2536,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.9247046,-0.05046541,0.48314987259010705,0.03174869680506199
95689,SIDM00774,AZD6482,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,-1.9768854,-0.10379078,0.09749498331174755,0.022454163216977224
42333,SIDM00673,PD173074,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-2.6185951,-0.10951409,-2.349420393050237,-0.10240173496305523
11334,SIDM00778,Vinorelbine,Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,69.0,-3.6894906,-0.21304373,-3.9425635537700088,-0.25856362061640165
45758,SIDM00097,Bortezomib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3909501,-0.08910894,-0.687746011638486,-0.04269780633394283
39954,SIDM00529,Bortezomib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Black,44.0,-0.08305196,-0.005352109,-1.9373892079067354,-0.02422119918717643
59391,SIDM00774,Alisertib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-3.3811967,-0.11794827,2.306911739931539,0.12798925842964184
99565,SIDM00531,5-Fluorouracil,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Male,East Asian,60.0,0.49276084,0.008376798,1.3920677925256253,0.030975256395170025
10228,SIDM00971,Dabrafenib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.3680906,0.05506391,1.2167585218655643,0.05906726551249375
90230,SIDM00332,Dabrafenib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.912594,-0.10137369,-1.5231845534500925,-0.07329483708202746
88953,SIDM00778,5-Fluorouracil,Nutlin-3a (-),Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-0.68664354,-0.030387828,-1.025986300559874,-0.08286499061978696
59960,SIDM00411,Erlotinib,Ruxolitinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,43.0,1.3836608,0.07234441,0.13313911876018247,0.020512921690334102
46984,SIDM00875,Palbociclib,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.2508113,0.032608762,1.259873135681926,0.021114545920835694
53158,SIDM00866,PF-4708671,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,52.0,1.4945422,0.083500944,0.4456553027155871,0.04690563684547579
59574,SIDM00779,Trametinib,Nutlin-3a (-),Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,33.0,-1.5536866,-0.06875645,-1.0774095622308937,-0.032869198731442714
88372,SIDM00146,Camptothecin,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,2.9149508,0.23433504,3.0148365810601088,0.2013546731044355
101207,SIDM00893,Afatinib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,0.99736804,0.088691995,-0.40664306153504104,-0.03555001145681076
33090,SIDM00834,Taselisib,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,White,66.0,1.1607593,0.08322166,-0.5409393834175124,-0.011034450115992836
89990,SIDM00971,Afatinib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,0.9853739,0.03472081,0.7715938086255576,0.017136283477728727
61568,SIDM00878,AZD7762,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,70.0,-1.9247388,-0.10053155,-0.5904462011005167,-0.06931379621904904
30488,SIDM00782,Trametinib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,Unknown,72.0,-1.3099651,-0.118790455,0.24597333961667292,0.0016962295337651565
84837,SIDM00411,Oxaliplatin,Ruxolitinib,Pancreas,10.0,Pancreatic Carcinoma,Male,East Asian,43.0,-2.2724311,-0.070440955,-2.5606993932560247,-0.04539383374553386
97069,SIDM00774,Dabrafenib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.516904,-0.01416186,0.26919568977464214,0.024144549797558427
39759,SIDM00332,Doramapimod,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5359358,0.037959713,1.0910460434100786,0.01765474714209986
76686,SIDM00660,Olaparib,AZD8055,Large Intestine,0.5,Cecum Adenocarcinoma,Male,White,32.0,1.9613782,0.04061215,2.219318328931362,0.058280532927335066
12645,SIDM00875,PF-4708671,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.3055671,-0.04571309,0.8738482386325901,0.049263751978462465
2343,SIDM00193,SCH772984,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,53.0,-0.3520188,-0.026808193,0.011519112905966833,0.010239597421294416
98887,SIDM00531,Lapatinib,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,1.1998141,0.1157176,1.2356015487932575,0.10695823188819215
81455,SIDM00774,Navitoclax,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-0.5650659,-0.021034295,-1.3341136136987486,-0.10429178511292497
11317,SIDM00146,RO-3306,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,1.2180998,0.09311357,2.998870608578239,0.1263601541952165
73276,SIDM00866,Dabrafenib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,52.0,-0.5049388,-0.014306719,-0.6736771647865896,-0.026321996720456185
65114,SIDM00782,Trametinib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,Unknown,72.0,-1.0891566,-0.088125214,-1.1096859656962126,-0.07339590867916851
12921,SIDM00628,Tozasertib,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,1.5639904,0.13198392,0.274502490850056,-0.031382248144129724
47115,SIDM00954,Camptothecin,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.0,0.62563026,0.02514248,0.5870265239918325,0.043135778484388425
77638,SIDM00097,AZD6482,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7645519,-0.10668609,-0.8983671144678118,-0.05879923670624402
59131,SIDM00778,Olaparib,5-Fluorouracil,Large Intestine,10.0,Cecum Adenocarcinoma,Male,White,69.0,-1.3144171,-0.037328877,-0.6512370812570095,-0.032344514746315486
14483,SIDM00130,Crizotinib,5-Fluorouracil,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-1.0317901,-0.09556148,-1.780786279796757,-0.08636578642627707
38710,SIDM00332,MK-1775,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.84686524,0.07421555,-1.2256133329154535,-0.049445300348566784
46846,SIDM00332,Palbociclib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,0.88683045,0.080165714,0.002527665282857999,0.029403337339381237
91296,SIDM00878,Entinostat,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,2.480023,0.15932754,2.0429772866692946,0.13196561061155834
84774,SIDM00193,MK-1775,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,53.0,-1.5324596,-0.14195134,-0.6329184077808864,-0.07770385830530799
101405,SIDM00774,Linsitinib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.78781855,0.07239562,0.1347616286654688,0.02615475959542586
23765,SIDM00628,Doramapimod,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,Black,51.0,1.8914064,0.07498422,2.6859019134190434,0.077191986528901
65797,SIDM00893,GSK269962A,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.0801135,0.043385472,-0.4628320086854202,0.00026119815126045173
2954,SIDM00146,KU-55933,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.2979896,-0.03852335,-1.472071839770428,0.02710897726670219
20535,SIDM00628,Wee1 Inhibitor,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,Black,51.0,-0.2345151,-0.021919377,-0.5763080636835527,-0.06711553495665072
15150,SIDM00878,Doramapimod,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,70.0,1.355701,0.087054834,0.15799388479308504,0.08754474396875431
60200,SIDM00130,Palbociclib,Dactolisib,Pancreas,0.0125,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.0324408,0.08677828,0.09129426175169104,0.024965864938226945
69546,SIDM00954,Uprosertib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.0,-0.78754604,-0.0594172,-1.0676889154643077,-0.12625719577537814
30809,SIDM00097,AZD6482,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9094795,-0.11172007,0.787801741935463,0.006208517518217314
78303,SIDM00782,Vinorelbine,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,Unknown,72.0,0.5375923,0.042545564,1.0145025653964503,0.11967603345115825
28427,SIDM00893,Dabrafenib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.6704066,-0.019842813,0.5919928036710155,0.030162010881440007
63329,SIDM00875,Docetaxel,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.7001711,-0.12632637,-1.7194049569103766,-0.14707862002572494
93366,SIDM00193,Vinorelbine,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,East Asian,53.0,-2.6061344,-0.21404628,-2.192471180825988,-0.19663825232119508
21603,SIDM00954,SCH772984,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,1.6746982,0.114361525,-0.027123810473170158,-0.0172198416569345
98800,SIDM00866,Pictilisib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,52.0,0.63570285,0.045201343,-0.6803519084038755,-0.0455034607708198
28658,SIDM00893,Vorinostat,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.1191351,0.07843912,0.9442703168706497,0.11254711772351142
96701,SIDM00193,SB505124,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,East Asian,53.0,-1.6056341,-0.12649731,-1.0192812465720174,-0.09198034263712251
47474,SIDM00529,PF-4708671,MK-1775,Breast,2.5,Breast Carcinoma,Female,Black,44.0,-0.6111064,-0.01244614,-1.323404975673269,-0.010513732736032901
33427,SIDM00130,Sorafenib,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,1.794169,0.13558942,1.7020412770788973,0.05584606289959144
58269,SIDM00359,Linsitinib,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.7082048,0.03660043,0.8141509419140072,0.0873380658225923
89330,SIDM00971,SCH772984,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,2.4538367,0.053138196,2.3375932458082236,0.09270486219852177
69043,SIDM00529,Alpelisib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Black,44.0,-2.7328856,-0.11548269,-2.0264102353555957,-0.06938226984359695
33100,SIDM00146,SCH772984,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.0383043,-0.093205065,0.9301256429497077,0.019156866102163224
100733,SIDM00628,RO-3306,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,Black,51.0,-0.14612365,-0.0121587,-0.2439767645619926,0.005960267817293371
11498,SIDM00673,OSI-027,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.6821263,-0.069575235,-0.39721527820109487,-0.08592722422517454
76181,SIDM00673,ZM447439,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.373033,-0.11393042,-0.37353399104192747,-0.08160887627509604
24059,SIDM00866,PD173074,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,52.0,2.4425278,0.13261622,-1.8286726219512985,-0.03344781913276507
1642,SIDM00774,Wee1 Inhibitor,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,48.0,-2.4150121,-0.12616049,-0.9723701411568558,-0.09557120232802253
41736,SIDM00097,Uprosertib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0100825,0.0677705,0.05355927584881106,0.06928347474312208
41573,SIDM00193,Taselisib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,-1.1683432,-0.10168078,-1.135010314205988,-0.07322376269696536
5896,SIDM00875,PD173074,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2741246,-0.053190146,-0.07417289528675883,0.007107666877918906
84341,SIDM00875,Uprosertib,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,4.4577875,0.15183665,1.191612673460346,0.022222897799059615
452,SIDM00778,Palbociclib,AZD8055,Large Intestine,0.125,Cecum Adenocarcinoma,Male,White,69.0,-0.85327303,-0.021744452,-0.030591138926583033,0.01826535313047517
88213,SIDM00332,AZD7762,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.1796243,0.21393529,-1.1148877037992404,-0.03509096934807683
11505,SIDM00529,Taselisib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Black,44.0,-1.9150553,-0.09250119,-1.9038838456790141,-0.0006595484256250708
10126,SIDM00971,Gemcitabine,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.2557322,-0.04659785,-0.5936044409277146,-0.028239000022953015
89879,SIDM00673,5-Fluorouracil,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.4267005,0.011735084,1.7569611360278423,0.031285939202688864
943,SIDM00782,Trametinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,3.045235,0.12723316,0.29418671704815436,0.03270902185946826
42125,SIDM00301,Dasatinib,Navitoclax,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.2785621,0.15507507,0.26141443724250507,0.11747049319843848
99903,SIDM00146,SCH772984,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,1.3369639,0.119522825,1.0025797177303704,0.03332340801969147
86953,SIDM00878,Bortezomib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,70.0,0.3984185,0.021455888,-0.5260245362983194,-0.028104900984575788
7832,SIDM00875,Sorafenib,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6551273,0.065888636,0.3385187339158529,-0.0033961924606485784
80163,SIDM00531,Palbociclib,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Male,East Asian,60.0,-0.44545215,-0.019518817,1.0710952946351702,0.042549876673092756
71492,SIDM00875,Dabrafenib,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1349101,0.06591656,-0.01766040985458531,0.028056595047197375
21252,SIDM00332,Afatinib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.256637,-0.07093538,0.3808810892084086,0.04107109096480798
90562,SIDM00866,SCH772984,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,0.8728047,0.06833184,1.0221613350482892,0.10708114000872555
96110,SIDM00954,AZD7762,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.0,1.3718839,0.039793853,0.8727810943815741,0.08228963371430269
49997,SIDM00332,Palbociclib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.132895,0.15408568,0.3634803748490348,-0.005269387131881074
68253,SIDM00782,Crizotinib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,Unknown,72.0,1.5551445,0.13639161,0.9349025727505825,0.10288106956989641
102906,SIDM00878,Olaparib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,70.0,-0.21833852,-0.0054792487,0.7060157382068446,0.04201158366353484
52189,SIDM00673,Crizotinib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,0.9711904,0.09188423,3.102957472252355,0.1674008149833109
10545,SIDM00954,Temozolomide,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,0.40898436,0.005452603,0.9319039280855922,0.0014514229785411727
70383,SIDM00097,GSK269962A,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7748188,-0.06805228,-0.5589662483896324,-0.027576210541250163
44001,SIDM00301,LGK974,MK-2206,Pancreas,5.0,Pancreatic Carcinoma,Male,East Asian,50.0,1.0186722,0.11343091,-0.5597008203785017,0.03093261098511422
67056,SIDM00628,Paclitaxel,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,-1.3409901,-0.11142059,-0.7927884427332448,-0.08998528784040462
49507,SIDM00893,SCH772984,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,1.5298867,0.11336302,-0.18456909876454752,0.0008775791471022046
92405,SIDM00875,KU-55933,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.75032794,-0.009150859,-1.653665899820103,-0.07303059371816306
84225,SIDM00971,Gemcitabine,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.6745262,-0.048280224,0.29875206935545273,0.02664668381827428
72904,SIDM00673,Vorinostat,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-2.9750447,-0.13056448,0.006176133916483426,-0.04045557377827221
74262,SIDM00866,Venetoclax,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,52.0,-0.28205675,-0.0070548053,0.05824320781933367,0.044901550632061145
84851,SIDM00332,Doramapimod,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.62326616,-0.046071887,0.7745158824494673,0.054505122073686
13100,SIDM00954,AZD6482,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,3.5458245,0.04922752,2.853099341330392,0.12416904754816689
57748,SIDM00878,Paclitaxel,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,70.0,1.5433971,0.1304486,0.923814595545123,0.0685464329208622
36137,SIDM00529,Afatinib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Black,44.0,1.1997627,0.09208545,0.9860082954922305,0.04262909694122102
68617,SIDM00301,MK-1775,Erlotinib,Pancreas,2.5,Pancreatic Carcinoma,Male,East Asian,50.0,-0.97231996,-0.11710957,-0.6265985973086479,-0.06119781297766123
91878,SIDM00774,Sorafenib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,48.0,-1.9991213,-0.12397839,-0.16921991876610276,-0.023511029684806263
76623,SIDM00359,Trametinib,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.9524177,-0.08238033,-3.064218357458352,-0.07710227452045756
37102,SIDM00130,SCH772984,Palbociclib,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.93085617,0.08241869,-0.31237650665112937,0.02400103687320946
32310,SIDM00774,AZD8055,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,48.0,1.4538401,0.10858336,3.147987949369897,0.1293045718298638
97596,SIDM00301,Olaparib,Paclitaxel,Pancreas,0.025,Pancreatic Carcinoma,Male,East Asian,50.0,2.1496427,0.06278994,0.3415829429760308,-0.023359204605536168
96890,SIDM00778,Trametinib,Nutlin-3a (-),Large Intestine,2.5,Cecum Adenocarcinoma,Male,White,69.0,-0.7093194,-0.02606007,-0.46584289701596926,0.00039843752552450783
27166,SIDM00332,GSK269962A,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.86514235,-0.04272711,0.12638601306323496,-0.01129162345630861
12574,SIDM00774,Crizotinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,48.0,0.720202,0.10961664,0.4695643279695478,0.031788341227656794
40453,SIDM01233,SCH772984,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,72.0,2.034177,0.1548857,-0.027690178124015728,0.02236785595576177
96064,SIDM00130,Sorafenib,Paclitaxel,Pancreas,0.025,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,-0.66273165,-0.037052575,-0.678281725934117,0.03982230060690062
37728,SIDM00411,Linsitinib,Cisplatin,Pancreas,8.0,Pancreatic Carcinoma,Male,East Asian,43.0,-3.8341823,-0.16526352,-1.7000502110451117,0.022861739879833216
55911,SIDM00332,MK-1775,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3505884,0.07653635,0.7598369983171619,0.018206016268036848
12851,SIDM00146,Temozolomide,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.33053985,-0.008352597,0.7571920476171725,0.017735142328640915
27318,SIDM00130,5-Fluorouracil,Cisplatin,Pancreas,0.8,Pancreatic Ductal Adenocarcinoma,Male,White,26.0,0.5681655,0.059395988,-1.9832781339188823,-0.10285483620805463
82117,SIDM00628,Palbociclib,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,Black,51.0,1.5660809,0.073284306,1.17215371054707,0.07292483375729976
8266,SIDM00628,Uprosertib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,1.1939886,0.10032329,-0.4543597741813507,0.01457920224501648
17143,SIDM00875,PF-4708671,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.92807174,-0.03335964,1.3968551653368941,0.0221467029345303
62092,SIDM00359,Oxaliplatin,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.15956685,-0.010650256,-1.5371159344563439,-0.054698618133942604
84564,SIDM00779,Taselisib,AZD7762,Large Intestine,0.25,Cecum Adenocarcinoma,Male,White,33.0,1.5662807,0.06347795,-1.724216982326091,-0.09750722518052535
70223,SIDM00332,Venetoclax,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.46157223,0.015187438,1.3086018721040815,0.10572977039480626
91392,SIDM00776,5-Fluorouracil,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.9848901,-0.059347995,-0.25754807828888,0.0018228459675032637
22851,SIDM00878,AZD7762,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,70.0,-0.8996338,-0.05650358,-3.383816935218283,-0.2313281478883145
83142,SIDM00146,Alisertib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.8933653,-0.15689127,-1.9118031066176993,-0.14491378891618473
25026,SIDM00971,Axitinib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-1.864661,-0.06384653,-0.9593920728372892,-0.0407781907752056
80999,SIDM00301,Cisplatin,Crizotinib,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,-3.0394647,-0.1854838,-0.9725531384645622,-0.027860540184912068
1096,SIDM00332,Wee1 Inhibitor,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.809453,-0.11434569,-0.8599198762989946,-0.034468338908435744
95806,SIDM00893,Linsitinib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-1.1210154,-0.05234333,-0.055980963232974974,0.012971469727197716
80473,SIDM00193,SB505124,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,53.0,-0.21527119,-0.019359572,0.315569538136565,0.004902260306556912
63630,SIDM01233,Palbociclib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,White,72.0,1.5446482,0.04301815,1.172977521170686,0.06510948235486663
26248,SIDM00779,Dabrafenib,Vinorelbine,Large Intestine,0.01,Cecum Adenocarcinoma,Male,White,33.0,-1.3637941,-0.06972952,-0.8837251638213779,0.01516681141581043
1953,SIDM00529,Dabrafenib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Black,44.0,1.2212349,0.026511751,1.6636626678450903,0.07463631883510867
58858,SIDM00193,Crizotinib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,53.0,2.6029203,0.17933074,0.033154836735116905,0.07284087034796445
94413,SIDM00866,Gemcitabine,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,52.0,1.7911977,0.084292196,-0.16274386676389285,-0.027598293545919857
54453,SIDM00866,SCH772984,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,52.0,2.8098063,0.21368895,-0.6669903122773995,0.02877420499242732
85557,SIDM00146,BI-2536,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,3.6149452,0.052950736,-1.752380201702886,-0.00958505894742358
80172,SIDM00529,Nilotinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Black,44.0,-0.77241236,-0.023944227,-0.13490525062131414,0.054182203935547374
55065,SIDM00875,PD173074,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2838564,-0.05648264,-1.2651854911199043,-0.022598628774481978
93888,SIDM00834,AZD8055,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Female,White,66.0,-0.30755752,-0.024018755,-1.1170438980276594,0.042142061819975284
88464,SIDM00628,AZD6482,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,Black,51.0,-1.4198143,-0.117404744,-0.31391721089622654,-0.03833207463685166
49070,SIDM00660,AZD7762,MK-2206,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,32.0,0.29317743,0.028062541,-0.18003068362704955,0.011951712257476224
79384,SIDM00660,Olaparib,Oxaliplatin,Large Intestine,5.0,Cecum Adenocarcinoma,Male,White,32.0,1.1405926,0.025841424,2.421030541235301,0.05913951011240998
21075,SIDM00673,NU7441,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.39680576,-0.029780697,-0.7682357318233916,-0.051855443585263006
85957,SIDM00332,MK-2206,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5784643,-0.06223217,0.4253659823657699,0.05942822185746716
22637,SIDM00893,OSI-027,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,2.4843469,0.21160394,-0.5556457708985107,-0.02518169821489939
92800,SIDM00971,Docetaxel,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-2.906383,-0.05878229,-0.42942323261129667,0.04384858005261643
83490,SIDM00531,Erlotinib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Male,East Asian,60.0,2.8827808,0.3393755,3.026228472644449,0.15757855442218344
79078,SIDM00954,Tozasertib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.0,-0.71293586,-0.03607995,0.3022989623545701,0.058487782618176824
66322,SIDM00097,PF-4708671,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.9823136,-0.09139057,-0.4710796386665231,-0.03709692380689295
50542,SIDM00778,LGK974,Oxaliplatin,Large Intestine,1.0,Cecum Adenocarcinoma,Male,White,69.0,-0.63560915,-0.015870696,-0.62610778712705,0.009227686887420315
70389,SIDM00774,Temozolomide,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,48.0,0.21110262,0.0054378603,0.28219576139989777,0.03982602527778455
21725,SIDM00954,SCH772984,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.0,-2.8091023,-0.1691027,-1.762707901277615,-0.08115736141962104
42942,SIDM00893,Palbociclib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.7304668,-0.030098151,-1.5495559260310632,-0.03275020721786335
4850,SIDM00954,JQ1,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.0,1.4164891,0.10206897,0.43850046249184743,0.05629022473490343
12688,SIDM00673,AZD8055,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,1.9616506,0.11008079,-0.9437446538044458,-0.01461013868857072
84936,SIDM00359,Crizotinib,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.7059662,-0.048238557,-1.6907684130049603,-0.07958115373938177
90599,SIDM00893,Camptothecin,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.8771879,-0.07371011,-0.8152740273949282,-0.0367709360296572
74589,SIDM00359,Oxaliplatin,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.0953708,-0.0966933,-1.195731945963891,-0.03764728647729227
107411,SIDM00660,AZD4547,Camptothecin,Large Intestine,0.0025,Cecum Adenocarcinoma,Male,White,32.0,-0.9601189,-0.059002034,-1.734826429077427,-0.07048622266175368
105303,SIDM00301,Trametinib,OSI-027,Pancreas,1.0,Pancreatic Carcinoma,Male,East Asian,50.0,2.5334141,0.2533525,1.3856582706878378,0.04737977968024359
75380,SIDM00954,Afatinib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.0,-0.88303626,-0.055265088,0.5322415833447183,0.023502643455012545
78172,SIDM00878,AZD6482,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,70.0,0.9184245,0.06099804,0.4799609084440421,0.06242070485244187
103865,SIDM00776,Afatinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.9248093,-0.08329284,0.7414687782720061,-0.0010473280225492963
9953,SIDM00301,Gemcitabine,Taselisib,Pancreas,2.0,Pancreatic Carcinoma,Male,East Asian,50.0,0.7648699,0.05296259,-0.272033357169636,-0.03581066264417237
79516,SIDM00673,PD173074,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,49.0,-2.8035855,-0.10994223,-1.5301639060807355,-0.070934681571081
86975,SIDM00971,AZD7762,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,47.0,-0.2752828,-0.006179792,-1.5101505473336845,-0.03486959843926864
34768,SIDM00866,OSI-027,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,52.0,-0.8237416,-0.055786405,-0.9467363874693309,-0.03606504353520976
46196,SIDM00834,LGK974,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Female,White,66.0,-1.5900561,-0.103887856,-1.1856165618830787,-0.056730615760418865
86544,SIDM00954,GSK269962A,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.0,-2.0117521,-0.14644022,0.0068270974747650995,0.05997588704325882
13976,SIDM00779,Nutlin-3a (-),Camptothecin,Large Intestine,0.025,Cecum Adenocarcinoma,Male,White,33.0,-1.5692031,-0.049815223,-0.9626569791900158,-0.018885401137463256
78472,SIDM00893,Temozolomide,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.86738575,-0.019455474,-0.6066197188377739,0.013179873906369169
19021,SIDM00774,NU7441,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,48.0,-0.20349711,-0.012067057,0.3981372249958189,0.044923352066411466
912,SIDM00893,Palbociclib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,74.0,-0.47999567,-0.018461948,1.0117022407350205,0.0737323409727774
33204,SIDM00529,Entinostat,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Black,44.0,-2.873669,-0.13291201,-0.04828589838708064,0.004732086021288858
88001,SIDM00834,Dabrafenib,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,White,66.0,1.7120391,0.036327966,1.3716803147820475,0.050026030276509745
63593,SIDM00673,Crizotinib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-1.1634542,-0.09042143,-0.847391721517825,-0.05213973956393919
